PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rowley, JJL; Tran, DTA; Frankham, GJ; Dekker, AH; Le, DTT; Truong, QN; Vinh, QD; Hoang, HD				Rowley, Jodi J. L.; Tran, Dao T. A.; Frankham, Greta J.; Dekker, Anthony H.; Le, Duong T. T.; Truong Q. Nguyen; Vinh Q. Dau; Hoang, Huy D.			Undiagnosed Cryptic Diversity in Small, Microendemic Frogs (Leptolalax) from the Central Highlands of Vietnam	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; NEOTROPICAL FROGS; NICHE MODELS; SAMPLE-SIZE; BODY-SIZE; ANURA; EVOLUTION; AMPHIBIA; PATTERNS; COMPLEX	A major obstacle in prioritizing species or habitats for conservation is the degree of unrecognized diversity hidden within complexes of morphologically similar, "cryptic" species. Given that amphibians are one of the most threatened groups of organisms on the planet, our inability to diagnose their true diversity is likely to have significant conservation consequences. This is particularly true in areas undergoing rapid deforestation, such as Southeast Asia. The Southeast Asian genus Leptolalax is a group of small-bodied, morphologically conserved frogs that inhabit the forest-floor. We examined a particularly small-bodied and morphologically conserved subset, the Leptolalax applebyi group, using a combination of molecular, morphometric, and acoustic data to identify previously unknown diversity within. In order to predict the geographic distribution of the group, estimate the effects of habitat loss and assess the degree of habitat protection, we used our locality data to perform ecological niche modelling using MaxEnt. Molecular (mtDNA and nuDNA), acoustic and subtle morphometric differences revealed a significant underestimation of diversity in the L. applebyi group; at least two-thirds of the diversity may be unrecognised. Patterns of diversification and microendemism in the group appear driven by limited dispersal, likely due to their small body size, with several lineages restricted to watershed basins. The L. applebyi group is predicted to have historically occurred over a large area of the Central Highlands of Vietnam, a considerable portion of which has already been deforested. Less than a quarter of the remaining forest predicted to be suitable for the group falls within current protected areas. The predicted distribution of the L. applebyi group extends into unsurveyed watershed basins, each potentially containing unsampled diversity, some of which may have already been lost due to deforestation. Current estimates of amphibian diversity based on morphology alone are misleading, and accurate alpha taxonomy is essential to accurately prioritize conservation efforts.	[Rowley, Jodi J. L.; Frankham, Greta J.] Australian Museum, Australian Museum Res Inst, Sydney, NSW 2000, Australia; [Tran, Dao T. A.; Le, Duong T. T.; Hoang, Huy D.] Univ Sci Ho Chi Minh City, Fac Biol, Ho Chi Minh City, Vietnam; [Dekker, Anthony H.] Federat Univ Ballarat, Mt Helen, Vic, Australia; [Truong Q. Nguyen; Vinh Q. Dau] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam	Australian Museum; Federation University Australia; Vietnam Academy of Science & Technology (VAST)	Rowley, JJL (corresponding author), Australian Museum, Australian Museum Res Inst, 6-8 Coll St, Sydney, NSW 2000, Australia.	jodi.rowley@austmus.gov.au	Rowley, Jodi J. L./F-2466-2012; Nguyen, Truong/F-3730-2012	Nguyen, Truong/0000-0002-6601-0880; Quang Vinh, Dau/0000-0002-8976-1644; Le, Duong/0000-0002-3832-7944; Rowley, Jodi/0000-0002-2011-9143	ADM Capital Foundation, Conservation International; National Geographic Conservation Trust; John D. and Catherine T. MacArthur Foundation; Alexander Koenig Society (Alexander Koenig Gesellschaft - AKG); Alexander Koenig Foundations (Alexander Koenig Stiftung - AKS); IDEA WILD, Nagao Natural Environment Foundation (NEF); Vietnamese Ministry of Education and Training (322 Project); German Academic Exchange Service (DAAD); Project of the National Program Tay Nguyen III [TN3/T07]; Alexander von Humboldt Stiftung/Foundation [VIE 114344]	ADM Capital Foundation, Conservation International; National Geographic Conservation Trust(National Geographic Society); John D. and Catherine T. MacArthur Foundation; Alexander Koenig Society (Alexander Koenig Gesellschaft - AKG); Alexander Koenig Foundations (Alexander Koenig Stiftung - AKS); IDEA WILD, Nagao Natural Environment Foundation (NEF); Vietnamese Ministry of Education and Training (322 Project); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Project of the National Program Tay Nguyen III; Alexander von Humboldt Stiftung/Foundation(Alexander von Humboldt Foundation)	Funding for aspects of this study was provided by ADM Capital Foundation, Conservation International, the National Geographic Conservation Trust, a grant from The John D. and Catherine T. MacArthur Foundation to the North Carolina Museum of Natural Sciences to JR; The Alexander Koenig Society (Alexander Koenig Gesellschaft - AKG), The Alexander Koenig Foundations (Alexander Koenig Stiftung - AKS), IDEA WILD, Nagao Natural Environment Foundation (NEF), the Vietnamese Ministry of Education and Training (322 Project), and the German Academic Exchange Service (DAAD) to DT; Project TN3/T07 of the National Program Tay Nguyen III Project TN3/T07 of the National Program Tay Nguyen III and the Alexander von Humboldt Stiftung/Foundation (VIE 114344) to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; [Anonymous], 2010, MAPPING SPECIES DIST; Ben-David A, 2008, ENG APPL ARTIF INTEL, V21, P874, DOI 10.1016/j.engappai.2007.09.009; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Brook BW, 2006, BIOTROPICA, V38, P302, DOI 10.1111/j.1744-7429.2006.00141.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brown RM, 2008, ZOOTAXA, P47, DOI 10.11646/zootaxa.1888.1.3; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Che J, 2009, MOL PHYLOGENET EVOL, V50, P59, DOI 10.1016/j.ympev.2008.10.007; Chek AA, 2001, MOL PHYLOGENET EVOL, V18, P370, DOI 10.1006/mpev.2000.0889; CHERRY LM, 1978, SCIENCE, V200, P209, DOI 10.1126/science.635583; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Coloma Luis A., 2010, Zootaxa, V2574, P1; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Duellman W.E., 1970, Monograph Mus nat Hist Univ Kans, V1, P1; Edwards SV, 2000, EVOLUTION, V54, P1839; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Freilich X, 2014, MOL PHYLOGENET EVOL, V71, P157, DOI 10.1016/j.ympev.2013.11.015; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gower DJ, 2005, RAFFLES B ZOOL, P153; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASS CA, 1995, BIOTROPICA, V27, P238, DOI 10.2307/2389000; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Heyer W.R., 1984, Amphibia-Reptilia, V5, P97; Heyer W. Ronald, 1996, Amphibia-Reptilia, V17, P7, DOI 10.1163/156853896X00252; Highton R, 1989, ILLINOIS BIOL MONOGR, V57; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILLIS DM, 1983, SYST ZOOL, V32, P132, DOI 10.2307/2413277; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McLeod DS, 2010, MOL PHYLOGENET EVOL, V56, P991, DOI 10.1016/j.ympev.2010.04.004; Mendelson JR, 2010, ZOOTAXA, P61, DOI 10.11646/zootaxa.2396.1.5; Meyfroidt P, 2008, LAND USE POLICY, V25, P182, DOI 10.1016/j.landusepol.2007.06.001; Meyfroidt P, 2013, GLOBAL ENVIRON CHANG, V23, P1187, DOI 10.1016/j.gloenvcha.2013.04.005; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; Urbina-Cardona JN, 2010, CONSERV BIOL, V24, P1031, DOI 10.1111/j.1523-1739.2009.01432.x; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; Pilliod DS, 2002, CAN J ZOOL, V80, P1849, DOI 10.1139/Z02-175; Pimm SL, 2005, SCI AM, V293, P66, DOI 10.1038/scientificamerican0905-66; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Rambaut A., 2007, TRACER V1 4; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Richards CM, 1996, MOL PHYLOGENET EVOL, V5, P522, DOI 10.1006/mpev.1996.0047; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowley J, 2010, BIOL LETTERS, V6, P336, DOI 10.1098/rsbl.2009.0793; Rowley Jodi J.L., 2014, Amphibian Biology, V11, P264; Rowley JJL, 2010, ZOOTAXA, P57, DOI 10.11646/zootaxa.2567.1.3; Rowley JJL, 2011, ZOOTAXA, P15, DOI 10.11646/zootaxa.2796.1.2; Rowley JJL, 2009, ZOOTAXA, P51, DOI 10.11646/zootaxa.2198.1.5; Ryan MJ, 2003, SPR HDB AUD, V16, P225; Santos JC, 2011, P NATL ACAD SCI USA, V108, P6175, DOI 10.1073/pnas.1010952108; Shimada T, 2011, ZOOL J LINN SOC-LOND, V161, P157, DOI 10.1111/j.1096-3642.2010.00641.x; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; SPIGHT TM, 1968, PHYSIOL ZOOL, V41, P195, DOI 10.1086/physzool.41.2.30155450; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stibig HJ, 2007, J BIOGEOGR, V34, P625, DOI 10.1111/j.1365-2699.2006.01637.x; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sung Y, 2014, ASIAN HERPETOL RES, V5, P80, DOI 10.3724/SP.J.1245.2014.00080; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tateishi R., 2014, J GEOGR GEOL, V6, P99, DOI [10.5539/jgg.v6n3p99, DOI 10.5539/JGG.V6N3P99]; Tedesco PA, 2014, CONSERV BIOL, V28, P1360, DOI 10.1111/cobi.12285; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217; Wynn A, 2001, TROP ZOOL, V14, P255, DOI 10.1080/03946975.2001.10531157; Zheng YC, 2008, MOL PHYLOGENET EVOL, V46, P695, DOI 10.1016/j.ympev.2007.09.019	95	43	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128382	10.1371/journal.pone.0128382	http://dx.doi.org/10.1371/journal.pone.0128382			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020250	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300106
J	Spychala, J; Spychala, P; Gomez, S; Weinreb, GE				Spychala, Jozef; Spychala, Pawel; Gomez, Shawn; Weinreb, Gabriel E.			Visinets: A Web-Based Pathway Modeling and Dynamic Visualization Tool	PLOS ONE			English	Article							NETWORKS	In this report we describe a novel graphically oriented method for pathway modeling and a software package that allows for both modeling and visualization of biological networks in a user-friendly format. The Visinets mathematical approach is based on causal mapping (CMAP) that has been fully integrated with graphical interface. Such integration allows for fully graphical and interactive process of modeling, from building the network to simulation of the finished model. To test the performance of Visinets software we have applied it to: a) create executable EGFR-MAPK pathway model using an intuitive graphical way of modeling based on biological data, and b) translate existing ordinary differential equation (ODE) based insulin signaling model into CMAP formalism and compare the results. Our testing fully confirmed the potential of the CMAP method for broad application for pathway modeling and visualization and, additionally, showed significant advantage in computational efficiency. Furthermore, we showed that Visinets web-based graphical platform, along with standardized method of pathway analysis, may offer a novel and attractive alternative for dynamic simulation in real time for broader use in biomedical research. Since Visinets uses graphical elements with mathematical formulas hidden from the users, we believe that this tool may be particularly suited for those who are new to pathway modeling and without the in-depth modeling skills often required when using other software packages.	[Spychala, Jozef; Spychala, Pawel; Weinreb, Gabriel E.] Visinets Inc, Chapel Hill, NC 27515 USA; [Gomez, Shawn] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC USA; [Gomez, Shawn] NC State Univ, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Spychala, J (corresponding author), Visinets Inc, Chapel Hill, NC 27515 USA.	jsp@visinets.com; gw@visinets.com		Gomez, Shawn/0000-0002-8251-4552	Visinets, Inc.	Visinets, Inc.	Visinets, Inc., provided support in the form of salaries for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Di Cara A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-462; Ferrari E, 2011, J BIOL CHEM, V286, P4173, DOI 10.1074/jbc.M110.157420; Helikar T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-96; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; MacLeod M, 2015, STUD HIST PHI PART C, V49, P1, DOI 10.1016/j.shpsc.2014.10.004; Nijhout HF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00245; Saraiya P, 2005, IEEE T VIS COMPUT GR, V11, P443, DOI 10.1109/TVCG.2005.53; SMITH A, 2012, BMC BIOINFORMATICS, V13, P8, DOI DOI 10.1186/1471-2105-13-8; Tautz L, 2013, METHODS MOL BIOL, V1053, P179, DOI 10.1007/978-1-62703-562-0_13; Weinreb GE, 2006, CELL MOTIL CYTOSKEL, V63, P523, DOI 10.1002/cm.20143; Weinreb GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005378; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	14	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0123773	10.1371/journal.pone.0123773	http://dx.doi.org/10.1371/journal.pone.0123773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020230	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300004
J	Ananth, CV; Keyes, KM; Hamilton, A; Gissler, M; Wu, C; Liu, S; Luque-Fernandez, MA; Skjaerven, R; Williams, MA; Tikkanen, M; Cnattingius, S				Ananth, Cande V.; Keyes, Katherine M.; Hamilton, Ava; Gissler, Mika; Wu, Chunsen; Liu, Shiliang; Luque-Fernandez, Miguel Angel; Skjaerven, Rolv; Williams, Michelle A.; Tikkanen, Minna; Cnattingius, Sven			An International Contrast of Rates of Placental Abruption: An Age-Period-Cohort Analysis	PLOS ONE			English	Article							PERINATAL-MORTALITY; CIGARETTE-SMOKING; UNITED-STATES; RISK-FACTORS; HYPERTENSIVE DISORDERS; TEMPORAL VARIATION; MATERNAL SMOKING; CANCER RATES; FOLIC-ACID; PREGNANCY	Background Although rare, placental abruption is implicated in disproportionately high rates of perinatal morbidity and mortality. Understanding geographic and temporal variations may provide in-sights into possible amenable factors of abruption. We examined abruption frequencies by maternal age, delivery year, and maternal birth cohorts over three decades across seven countries. Methods Women that delivered in the US (n = 863,879; 1979-10), Canada (4 provinces, n = 5,407,463; 1982-11), Sweden (n = 3,266,742; 1978-10), Denmark (n = 1,773,895; 197808), Norway (n = 1,780,271, 1978-09), Finland (n = 1,411,867; 1987-10), and Spain (n = 6,151,508; 1999-12) were analyzed. Abruption diagnosis was based on ICD coding. Rates were modeled using Poisson regression within the framework of an age-period-cohort analysis, and multi-level models to examine the contribution of smoking in four countries. Results Abruption rates varied across the seven countries (3-10 per 1000), Maternal age showed a consistent J-shaped pattern with increased rates at the extremes of the age distribution. In comparison to births in 2000, births after 2000 in European countries had lower abruption rates; in the US there was an increase in rate up to 2000 and a plateau thereafter. No birth cohort effects were evident. Changes in smoking prevalence partially explained the period effect in the US (P = 0.01) and Sweden (P < 0.01). Conclusions There is a strong maternal age effect on abruption. While the abruption rate has plateaued since 2000 in the US, all other countries show declining rates. These findings suggest considerable variation in abruption frequencies across countries; differences in the distribution of risk factors, especially smoking, may help guide policy to reduce abruption rates.	[Ananth, Cande V.] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10027 USA; [Ananth, Cande V.; Keyes, Katherine M.; Hamilton, Ava] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Sweden; [Gissler, Mika] NHV Nord Sch Publ Hlth, Gothenburg, Sweden; [Wu, Chunsen] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Liu, Shiliang] Publ Hlth Agcy Canada, Ctr Chron Dis Prevent, Hlth Surveillance & Epidemiol Div, Ottawa, ON, Canada; [Luque-Fernandez, Miguel Angel; Williams, Michelle A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Skjaerven, Rolv] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Skjaerven, Rolv] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Tikkanen, Minna] Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki, Finland; [Cnattingius, Sven] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden	Columbia University; Columbia University; Aarhus University; Public Health Agency of Canada; Harvard University; Harvard T.H. Chan School of Public Health; University of Bergen; Norwegian Institute of Public Health (NIPH); University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet	Ananth, CV (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10027 USA.	cande.ananth@columbia.edu	FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021	FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Gissler, Mika/0000-0001-8254-7525	National Institutes of Health [K01-AA021511]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA021511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This is an unfunded project. Dr. Keyes is partially supported by a grant (K01-AA021511) from the National Institutes of Health. None of the authors received specific funding for this work.	Ananth CV, 2008, HUM GENET, V124, P137, DOI 10.1007/s00439-008-0531-7; Ananth CV, 2007, AM J EPIDEMIOL, V166, P289, DOI 10.1093/aje/kwm073; Ananth CV, 2006, OBSTET GYNECOL, V107, P785, DOI 10.1097/01.AOG.0000207560.41604.19; Ananth CV, 2010, J MATERN-FETAL NEO M, V23, P887, DOI 10.3109/14767050903334885; Ananth CV, 1996, OBSTET GYNECOL, V88, P511, DOI 10.1016/0029-7844(96)00236-0; Ananth CV, 1997, BRIT J OBSTET GYNAEC, V104, P572, DOI 10.1111/j.1471-0528.1997.tb11535.x; Ananth CV, 2005, AM J OBSTET GYNECOL, V192, P191, DOI 10.1016/j.ajog.2004.05.087; Ananth CV, 1999, OBSTET GYNECOL, V93, P622, DOI 10.1016/S0029-7844(98)00408-6; Ananth CV, 1996, OBSTET GYNECOL, V88, P309, DOI 10.1016/0029-7844(96)00088-9; Ananth CV, 1996, AM J EPIDEMIOL, V144, P881, DOI 10.1093/oxfordjournals.aje.a009022; Ananth CV, 2001, AM J EPIDEMIOL, V153, P332, DOI 10.1093/aje/153.4.332; Ananth CV, 2001, AM J EPIDEMIOL, V153, P771, DOI 10.1093/aje/153.8.771; Andersen TF, 1999, DAN MED BULL, V46, P263; Broers Teresa, 2004, Chronic Dis Can, V25, P16; Canada PHAO, 2008, CAN PER HLTH REP 200; Carstensen B, 2012, EPI PACKAGE STAT ANA; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Cnattingius S, 1997, AM J EPIDEMIOL, V145, P319; DeFrances Carol J, 2007, Vital Health Stat 13, P1; Degenhardt L, 2007, DRUG ALCOHOL DEPEN, V90, P210, DOI 10.1016/j.drugalcdep.2007.03.007; Ekblad M, 2014, EUR J PUBLIC HEALTH, V24, P544, DOI 10.1093/eurpub/ckt128; Elsasser DA, 2010, EUR J OBSTET GYN R B, V148, P125, DOI 10.1016/j.ejogrb.2009.10.005; Gissler M, 2002, MED INFORM INTERNET, V27, P33, DOI 10.1080/14639230110119234; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Health Canada, 2003, CAN PER HLTH REP 200; HIBBARD BM, 1975, S AFR MED J, V49, P1223; Jiang XH, 2012, LUNG CANCER, V78, P16, DOI 10.1016/j.lungcan.2012.06.002; Kallen B., 2003, SWEDISH MED BIRTH RE; KAREGARD M, 1986, OBSTET GYNECOL, V67, P523; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kozak Lola Jean, 2004, Vital Health Stat 13, P1; Kramer MS, 1997, OBSTET GYNECOL, V89, P221, DOI 10.1016/S0029-7844(96)00478-4; NAEYE RL, 1980, OBSTET GYNECOL, V55, P701; Nilsen RM, 2008, AM J EPIDEMIOL, V167, P867, DOI 10.1093/aje/kwm373; OMALLEY PM, 1988, AM J PUBLIC HEALTH, V78, P1315, DOI 10.2105/AJPH.78.10.1315; Oyelese Y, 2006, OBSTET GYNECOL, V108, P1005, DOI 10.1097/01.AOG.0000239439.04364.9a; Pariente G, 2014, PAEDIATR PERINAT EP, V28, P32, DOI 10.1111/ppe.12089; Rasmussen S, 1996, ACTA OBSTET GYN SCAN, V75, P229, DOI 10.3109/00016349609047092; Rasmussen S, 1997, BRIT J OBSTET GYNAEC, V104, P1292, DOI 10.1111/j.1471-0528.1997.tb10977.x; Rasmussen S, 1996, ACTA OBSTET GYN SCAN, V75, P222, DOI 10.3109/00016349609047091; Rasmussen S, 2000, ACTA OBSTET GYN SCAN, V79, P496, DOI 10.1034/j.1600-0412.2000.079006496.x; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; RAYMOND EG, 1993, ACTA OBSTET GYN SCAN, V72, P633, DOI 10.3109/00016349309021156; SAFTLAS AF, 1991, OBSTET GYNECOL, V78, P1081; Sanchez SE, 2006, AM J OBSTET GYNECOL, V194, P225, DOI 10.1016/j.ajog.2005.05.013; SKJAERVEN R, 1988, AM J EPIDEMIOL, V128, P1352, DOI 10.1093/oxfordjournals.aje.a115088; Tikkanen M, 2013, ACTA OBSTET GYN SCAN, V92, P298, DOI 10.1111/aogs.12030; Tikkanen M, 2012, ACTA OBSTET GYN SCAN, V91, P1046, DOI 10.1111/j.1600-0412.2012.01457.x; WILCOX AJ, 1982, EARLY HUM DEV, V7, P165, DOI 10.1016/0378-3782(82)90135-9; WILLIAMS MA, 1991, AM J EPIDEMIOL, V134, P965, DOI 10.1093/oxfordjournals.aje.a116181; Yang Y, 2013, AGE PERIOD COHORT AN; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	55	51	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125246	10.1371/journal.pone.0125246	http://dx.doi.org/10.1371/journal.pone.0125246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018653	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000355185600015
J	Bergman, P; Sperneder, S; Hoijer, J; Bergqvist, J; Bjorkhem-Bergman, L				Bergman, Peter; Sperneder, Susanne; Hoijer, Jonas; Bergqvist, Jenny; Bjorkhem-Bergman, Linda			Low Vitamin D Levels Are Associated with Higher Opioid Dose in Palliative Cancer Patients - Results from an Observational Study in Sweden	PLOS ONE			English	Article							QUALITY-OF-LIFE; 25-HYDROXYVITAMIN D LEVELS; D DEFICIENCY; D SUPPLEMENTATION; RANDOMIZED-TRIAL; SURVIVAL; MORTALITY; DIAGNOSIS; PAIN; D-3	Background Vitamin D deficiency is common among palliative cancer patients and has been connected to an increased risk for pain, depressions and infections. Therefore we wanted to test the hypothesis that low 25-hydroxyvitamin D (25OHD) levels are associated with higher opioid dose, higher infectious burden and impaired quality of life in palliative cancer patients. The secondary aim was to investigate the association between 25OHD-levels and survival time. Method In this prospective, observational study in palliative cancer-patients (n = 100) we performed univariate and multiple linear regression analysis to assess the association of 25OHD levels with opioid dose, infectious burden (antibiotic consumption), quality of life (Edmonton Symptom Assessment Scale, ESAS) and survival time, controlling for potential confounding factors. Results The median 25OHD level was 40 nmol/L (range 8-154 nmol/L). There was a significant association between 25OHD levels and opioid dose, beta coefficient -0.67; p=0.02; i.e. a low 25OHD level was associated with a higher opioid dose. This association remained significant after adjustment for stage of the cancer disease in a multivariate analysis, beta coefficient -0.66; p = 0.04. There was no association between 25OHD levels and antibiotic use or quality of life. Univariate cox regression analysis showed a weak correlation between survival time and 25OHD levels (p<0.05). However, decreased albumin levels and increased CRP levels were superior markers to predict survival time; p<0.001 for both analyses. Conclusion Low 25OHD-levels are associated with increased opioid consumption in palliative cancer patients. Future interventional studies are needed to investigate if pain can be reduced by vitamin D supplementation in these patients. In addition, this study confirms previous findings that low albumin and increased CRP levels are useful markers for survival time in palliative cancer patients.	[Bergman, Peter; Bjorkhem-Bergman, Linda] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Bergman, Peter; Bjorkhem-Bergman, Linda] Karolinska Univ Hosp, Stockholm, Sweden; [Sperneder, Susanne; Bergqvist, Jenny; Bjorkhem-Bergman, Linda] ASIH Stockholm Sodra, Palliat Home Care & Hospice Ward, Alvsjo, Sweden; [Hoijer, Jonas] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden; [Bergqvist, Jenny] Karolinska Inst & Stockholms Sjukhem, Dept Oncol Pathol, Unit Palliat Care, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Bjorkhem-Bergman, L (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	linda.bjorkhem-bergman@ki.se		Bergman, Peter/0000-0003-3306-3713; Bergqvist, Jenny/0000-0002-9875-7946	(ALF) between Karolinska Institutet; (ALF) between Stockholm County Council; Cancerfonden; Magnus Bergwall Stiftelse; Karolinska Institutet; Swedish Research Council [2013-2709]	(ALF) between Karolinska Institutet; (ALF) between Stockholm County Council; Cancerfonden(Swedish Cancer Society); Magnus Bergwall Stiftelse; Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Financial support was provided through the regional agreement on training and clinical research (ALF) between Karolinska Institutet and Stockholm County Council, Cancerfonden, Magnus Bergwall Stiftelse, Karolinska Institutet and the Swedish Research Council (2013-2709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergman P, 2015, VITAMIN D SUPP UNPUB; Bergman P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001663; Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Carlberg C, 2009, ANTICANCER RES, V29, P3485; Chabas JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065034; Der T, 2014, MIL MED, V179, P81, DOI 10.7205/MILMED-D-12-00540; Dev R, 2011, ONCOLOGIST, V16, P1637, DOI 10.1634/theoncologist.2011-0151; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Hauser K, 2014, SUPPORT CARE CANCER, V22, P1931, DOI 10.1007/s00520-014-2154-y; Hoffmann MR, 2015, J ACAD NUTR DIET; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2008, AM J CLIN NUTR, V88, p507S, DOI 10.1093/ajcn/88.2.507S; Jesus CAS, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0355-6; Kaasa S, 1995, EUR J CANCER, V31A, P2260, DOI 10.1016/0959-8049(95)00296-0; Kuru P, 2015, RHEUMATOL INT, V35, P315, DOI 10.1007/s00296-014-3099-7; Li G, 2013, J CLIN ENDOCR METAB; Maser RE, 2015, ENDOCR PRACT, V21, P174, DOI 10.4158/EP14332.OR; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Mohr SB, 2014, J STEROID BIOCH MOL; Muller DC, 2014, AM J EPIDEMIOL, V180, P810, DOI 10.1093/aje/kwu204; Naesgaard PA, 2013, CARDIOL RES PRACT, V2013, DOI [10.1155/1013/398034, 10.1155/2013/398034]; Raczkiewicz A, 2015, JCR-J CLIN RHEUMATOL, V21, P126, DOI 10.1097/RHU.0000000000000233; Rohrmann S, 2013, NUTR METAB CARDIOVAS, V23, P960, DOI 10.1016/j.numecd.2013.05.005; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sakalli H, 2012, RHEUMATOL INT, V32, P2279, DOI 10.1007/s00296-011-1943-6; Salehin D, 2012, ANTICANCER RES, V32, P265; Schottker B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3656; Shi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086467; Spedding S, 2013, NUTRIENTS, V5, P5127, DOI 10.3390/nu5125127; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Virtanen JK, 2011, EUR J NUTR, V50, P305, DOI 10.1007/s00394-010-0138-3; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Watanabe SM, 2012, PSYCHO-ONCOLOGY, V21, P977, DOI 10.1002/pon.1996; Wepner F, 2014, PAIN, V155, P261, DOI 10.1016/j.pain.2013.10.002; Wesa KM, 2015, NUTR CANCER, V67, P424, DOI 10.1080/01635581.2015.998838; Whitehurst JL, 2014, PALLIATIVE MED, V28, P87, DOI 10.1177/0269216313511142; Wynn Richard L, 2013, Gen Dent, V61, P10; Zgaga L, 2014, J CLIN ONCOL, V32, P2430, DOI 10.1200/JCO.2013.54.5947	39	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128223	10.1371/journal.pone.0128223	http://dx.doi.org/10.1371/journal.pone.0128223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018761	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600114
J	Gomez-Roig, MD; Mazarico, E; Valladares, E; Guirado, L; Fernandez-Arias, M; Vela, A				Dolores Gomez-Roig, M.; Mazarico, Edurne; Valladares, Esther; Guirado, Laura; Fernandez-Arias, Mireia; Vela, Antonio			Aortic Intima-Media Thickness and Aortic Diameter in Small for Gestational Age and Growth Restricted Fetuses	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; WALL THICKNESS; CHILDREN; ATHEROSCLEROSIS; NEWBORNS; MARKER; ADULTS; ARTERY	Objective The objective of this study is to measure aortic intima-media thickness (aIMT) and aortic diameter (AD) in appropriate for gestational age (AGA) fetuses, small for gestational age (SGA) fetuses, and intrauterine growth restricted (IUGR) fetuses. Methods Case-control study performed between June 2011 and June 2012. Forty-nine AGA fetuses, 40 SGA fetuses, and 35 IUGR fetuses underwent concomitant measurement of aIMT and AD at a mean gestational age of 34.4 weeks. Results Median aIMT was higher in fetuses with IUGR (0.504mm [95% CI: 0.477-0.530mm]), than in SGA fetuses (0.466mm[95% CI: 0.447-0.485 mm]), and AGA fetuses (0.471mm[95% CI: 0.454-0.488 mm]) (p = 0.023). Mean AD was significantly lower in fetuses with IUGR (4.451 mm[95% CI: 4.258-4.655 mm]), than in AGA fetuses (4.74 mm[95% CI: 4.63-4.843mm]) (p = 0.028). Conclusions Growth restricted fetuses have a thicker aortic wall than AGA and SGA fetuses, which possibly represents preclinical atherosclerosis and a predisposition to later cardiovascular disease.	[Dolores Gomez-Roig, M.; Mazarico, Edurne; Valladares, Esther; Guirado, Laura; Fernandez-Arias, Mireia; Vela, Antonio] Sant Joan de Deu Univ Hosp, Dept Obstet & Gynecol, Barcelona, Spain; [Dolores Gomez-Roig, M.; Mazarico, Edurne; Vela, Antonio] SAMID Network Spanish Collaborat & Child Hlth Res, Madrid, Spain		Gomez-Roig, MD (corresponding author), Sant Joan de Deu Univ Hosp, Dept Obstet & Gynecol, Barcelona, Spain.	lgomezroig@hsjdbcn.org	Roig, Maria Dolores Gómez/F-4345-2016	Roig, Maria Dolores Gómez/0000-0003-2329-1851	Sant Joan de Deu University Hospital [AFR00028]	Sant Joan de Deu University Hospital	The authors are thankful for an internship grant awarded by the Sant Joan de Deu University Hospital (AFR00028), and for the methodological and statistical support provided by the Sant Joan de Deu Research Foundation, and Spanish Collaborative Maternal and Child Heatlh Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Cosmi E, 2009, OBSTET GYNECOL, V114, P1109, DOI 10.1097/AOG.0b013e3181bb23d3; GORDON T, 1971, J AMER MED ASSOC, V215, P1617, DOI 10.1001/jama.215.10.1617; Jarvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522; Mc Tigue K, 2007, JAMA-J AM MED ASSOC, V298, P2028; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P836, DOI 10.1161/01.ATV.20.3.836; Molina M, 2000, REV MED CHILE, V128, P741; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Raitakari OT, 1999, ANN MED, V31, P33, DOI 10.1080/07853890.1999.11904397; Sehgal A, 2013, J PEDIAT; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; Stergiotou I, 2014, ULTRASOUND OBST GYN, V43, P625, DOI 10.1002/uog.13245; Zanardo V, 2013, HYPERTENS RES, V36, P440, DOI 10.1038/hr.2012.219; Zanardo V, 2011, KIDNEY INT, V80, P119, DOI 10.1038/ki.2011.99	14	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126842	10.1371/journal.pone.0126842	http://dx.doi.org/10.1371/journal.pone.0126842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017141	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600062
J	Edson, D; Field, H; McMichael, L; Jordan, D; Kung, N; Mayer, D; Smith, C				Edson, Daniel; Field, Hume; McMichael, Lee; Jordan, David; Kung, Nina; Mayer, David; Smith, Craig			Flying-Fox Roost Disturbance and Hendra Virus Spillover Risk	PLOS ONE			English	Article							STRESS; GLUCOCORTICOIDS; INFECTION; REPRODUCTION; CHIROPTERA; RESPONSES; HORSES	Bats of the genus Pteropus (flying-foxes) are the natural host of Hendra virus (HeV) which periodically causes fatal disease in horses and humans in Australia. The increased urban presence of flying-foxes often provokes negative community sentiments because of reduced social amenity and concerns of HeV exposure risk, and has resulted in calls for the dispersal of urban flying-fox roosts. However, it has been hypothesised that disturbance of urban roosts may result in a stress-mediated increase in HeV infection in flying-foxes, and an increased spillover risk. We sought to examine the impact of roost modification and dispersal on HeV infection dynamics and cortisol concentration dynamics in flying-foxes. The data were analysed in generalised linear mixed models using restricted maximum likelihood (REML). The difference in mean HeV prevalence in samples collected before (4.9%), during (4.7%) and after (3.4%) roost disturbance was small and non-significant (P = 0.440). Similarly, the difference in mean urine specific gravity-corrected urinary cortisol concentrations was small and non-significant (before = 22.71 ng/mL, during = 27.17, after = 18.39) (P = 0.550). We did find an underlying association between cortisol concentration and season, and cortisol concentration and region, suggesting that other (plausibly biological or environmental) variables play a role in cortisol concentration dynamics. The effect of roost disturbance on cortisol concentration approached statistical significance for region, suggesting that the relationship is not fixed, and plausibly reflecting the nature and timing of disturbance. We also found a small positive statistical association between HeV excretion status and urinary cortisol concentration. Finally, we found that the level of flying-fox distress associated with roost disturbance reflected the nature and timing of the activity, highlighting the need for a 'best practice' approach to dispersal or roost modification activities. The findings usefully inform public discussion and policy development in relation to Hendra virus and flying-fox management.	[Edson, Daniel; Field, Hume; McMichael, Lee; Kung, Nina; Smith, Craig] Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Biosecur Queensland, Brisbane, Qld, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA; [McMichael, Lee] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Jordan, David] Dept Primary Ind, Wollongbar, NSW, Australia; [Mayer, David] Dept Agr & Fisheries, Brisbane, Qld, Australia	Queensland Department of Agriculture & Fisheries; EcoHealth Alliance; University of Queensland	Field, H (corresponding author), Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Biosecur Queensland, Brisbane, Qld, Australia.	hume.field@ecohealthalliance.org	Jordan, David/P-7281-2019; Kung, Nina Y/H-1260-2012; Mayer, David G/F-8616-2011; McMichael, Lee UQ/C-7948-2018	Mayer, David G/0000-0001-9564-9176; McMichael, Lee UQ/0000-0002-7675-4859	Queensland, New South Wales government through the National Hendra virus Research Program [NHeVRP 04]; Queensland, Australian government through the National Hendra virus Research Program [NHeVRP 04]; Queensland Centre for Emerging Infectious Diseases; New South Wales Department of Primary Industries; Queensland Department of Agriculture, Fisheries, and Forestry	Queensland, New South Wales government through the National Hendra virus Research Program; Queensland, Australian government through the National Hendra virus Research Program; Queensland Centre for Emerging Infectious Diseases; New South Wales Department of Primary Industries; Queensland Department of Agriculture, Fisheries, and Forestry	The project was primarily funded by the Queensland, New South Wales and Australian governments through the National Hendra virus Research Program (Grant# NHeVRP 04) [DE, LMc]. Additional support was provided by the Queensland Centre for Emerging Infectious Diseases [HF, NK, CS], the New South Wales Department of Primary Industries [DJ], and the Queensland Department of Agriculture, Fisheries, and Forestry [DM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anon, 2014, WHAT IS HENDRA VIRUS; [Anonymous], 2014, FLYING FOX CAMP MAN; [Anonymous], 2014, FLYING FOX RELOCATIO; [Anonymous], 2009, YARRA BEND PARK FLYI; [Anonymous], 2014, AUTH FLYING FOX ROOS; [Anonymous], 2004, MANUAL DIAGNOSTIC TE, P1101; [Anonymous], 2013, HENDRA VIRUS CONFIRM; [Anonymous], 2001, PTER POL; [Anonymous], 2012, TOPIC HENDRA VIRUS I; Bennett C, 2008, ZOO BIOL, V27, P381, DOI 10.1002/zoo.20208; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Churchill S, 2008, AUSTR BATS, V2nd; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; GenStat, 2013, GENSTAT WIND REL 15; Hall L, 2009, WILD AUSTR GUIDE BAT; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Hanna JN, 2006, MED J AUSTRALIA, V185, P562, DOI 10.5694/j.1326-5377.2006.tb00692.x; MacDonald A, 2013, QUEENSLAND LOCAL AUT; McCullagh P, 1989, GEN LINEAR MODELS; McMichael LA, 2014, ECOHEALTH, V11, P400, DOI 10.1007/s10393-014-0954-7; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Parry-Jones KA, 2001, AUSTRAL ECOL, V26, P47, DOI 10.1046/j.1442-9993.2001.01072.x; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Reeder DM, 2004, J EXP ZOOL PART A, V301A, P682, DOI 10.1002/jez.a.58; Roberts BJ, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P277; Roberts BJ, 2005, THESIS GRIFFITH U NA; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Selvey L., 1996, Communicable Diseases Intelligence, V20, P477; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Shilton LA, 2008, AUSTRAL ECOL, V33, P549, DOI 10.1111/j.1442-9993.2008.01910.x; Smith CS, 2014, PLOS ONE, V9, P1; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Srivastava RK, 2008, J EXP ZOOL PART A, V309A, P94, DOI 10.1002/jez.440; Tait J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109810; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Underwood AJ, 2003, J EXP MAR BIOL ECOL, V296, P49, DOI 10.1016/S0022-0981(03)00304-6; WIDMAIER EP, 1994, J EXP ZOOL, V269, P442, DOI 10.1002/jez.1402690507; WIDMAIER EP, 1993, J EXP ZOOL, V265, P533, DOI 10.1002/jez.1402650509	45	25	26	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125881	10.1371/journal.pone.0125881	http://dx.doi.org/10.1371/journal.pone.0125881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016629	Green Submitted, gold, Green Published			2022-12-27	WOS:000355185600038
J	van Alfen, N; van Eijk, JJJ; Ennik, T; Flynn, SO; Nobacht, IEG; Groothuis, JT; Pillen, S; van de Laar, FA				van Alfen, Nens; van Eijk, Jeroen J. J.; Ennik, Tessa; Flynn, Sean O.; Nobacht, Inge E. G.; Groothuis, Jan T.; Pillen, Sigrid; van de Laar, Floris A.			Incidence of Neuralgic Amyotrophy (Parsonage Turner Syndrome) in a Primary Care Setting - A Prospective Cohort Study	PLOS ONE			English	Article							IMPAIRMENT; THERAPY	Objective Neuralgic amyotrophy is considered a rare peripheral nervous system disorder but in practice seems grossly under recognized, which negatively affects care for these patients. In this study we prospectively counted the one-year incidence rate of classic neuralgic amyotrophy in a primary care setting. Methods In a prospective cohort study during the year 2012 we registered all new cases of neck, shoulder or arm complaints from two large primary care centers serving a population of 14,118. Prior to study, general practitioners received a short training on how to diagnose classic neuralgic amyotrophy. Neuralgic amyotrophy was defined according to published criteria irrespective of family history. Only patients with a classic phenotype were counted as definite cases. After inclusion, patients with suspected neuralgic amyotrophy who had not yet seen a neurologist were offered neurologic evaluation for diagnostic confirmation. Results Of the 492 patients identified with new onset neck, shoulder or arm complaints, 34 were suspected of having neuralgic amyotrophy. After neurologic evaluation the diagnosis was confirmed in 14 patients. This amounts to a one-year incidence rate for classic neuralgic amyotrophy of 1 per 1000. Conclusions Our findings suggest that neuralgic amyotrophy is 30-50 times more common than previously thought. Unawareness of the disorder and its clinical presentation seems the most likely explanation for this difference. An incidence rate of 1 per 1000 and the long-term sequelae many patients suffer warrant more vigilance in diagnosing the disorder, to pave the way for timely treatment and prevent complications.	[van Alfen, Nens] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [van Eijk, Jeroen J. J.] Jeroen Bosch Hosp, Dept Neurol, Den Bosch, Netherlands; [Ennik, Tessa] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Flynn, Sean O.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Nobacht, Inge E. G.] Primary Hlth Ctr Oosterhout, Nijmegen, Netherlands; [Groothuis, Jan T.] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands; [Pillen, Sigrid] Canisius Wilhelmina Hosp, Dept Neurol, Nijmegen, Netherlands; [van de Laar, Floris A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [van de Laar, Floris A.] Acad Hlth Ctr Therm, Lent, Netherlands	Radboud University Nijmegen; Jeroen Bosch Ziekenhuis; Erasmus University Rotterdam; Erasmus MC; Royal College of Surgeons - Ireland; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	van Alfen, N (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Neurol, NL-6525 ED Nijmegen, Netherlands.	nens.vanalfen@radboudumc.nl	Pillen, Sigrid/D-6962-2019; van de Laar, Floris/CAI-2875-2022; van de Laar, F.A./L-4467-2015; van Alfen, Nens/L-4172-2015; van Eijk, Jeroen JJ/C-4468-2018; Groothuis, Jan T/D-3439-2009	Pillen, Sigrid/0000-0001-8679-9535; van de Laar, Floris/0000-0001-7373-8864; Groothuis, Jan T/0000-0003-3436-2475; Flynn, Sean/0000-0002-0106-0887	Dutch Rare Diseases Fund (Stichting Zeldzame Ziekten Fonds); ZABAWAS Foundation	Dutch Rare Diseases Fund (Stichting Zeldzame Ziekten Fonds); ZABAWAS Foundation	This study was sponsored by an unsolicited and unconditional gift from the Dutch Rare Diseases Fund (Stichting Zeldzame Ziekten Fonds; www.zzf.nl) and the ZABAWAS Foundation (www.zabawas.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, ORPH ONL RAR DIS ORP; BEGHI E, 1985, ANN NEUROL, V18, P320, DOI 10.1002/ana.410180308; Cup EH, 2013, ARCH PHYS MED REHAB, V94, P67, DOI 10.1016/j.apmr.2012.07.014; IJspeert J, 2013, NEUROREHABILITATION, V33, P657, DOI 10.3233/NRE-130993; Johnson NE, 2011, MUSCLE NERVE, V44, P304, DOI [10.1002/mus22100, 10.1002/mus.22100]; Kuhlenbaumer G, 2000, NEUROMUSCULAR DISORD, V10, P515, DOI 10.1016/S0960-8966(00)00109-7; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; Moriguchi K, 2011, J NEUROIMMUNOL, V238, P107, DOI 10.1016/j.jneuroim.2011.08.005; Naito K, 2012, INTERNAL MED, V51, P1493, DOI 10.2169/internalmedicine.51.7049; Nakajima M, 2006, EUR NEUROL, V55, P227, DOI 10.1159/000093875; van Alfen N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006976.pub2; van Alfen N., 2006, PRACT NEUROL, V6, P298, DOI DOI 10.1136/JNNP.2006.101261; van Alfen N, 2012, SOURCEGENEREVIEWS, P1993; van Alfen N, 2007, J NEUROL, V254, P695, DOI 10.1007/s00415-006-0246-4; van Alfen N, 2011, NAT REV NEUROL, V7, P315, DOI 10.1038/nrneurol.2011.62; van Alfen N, 2009, AM J PHYS MED REHAB, V88, P941, DOI 10.1097/PHM.0b013e3181a5b980; van Alfen N, 2009, ARCH PHYS MED REHAB, V90, P435, DOI 10.1016/j.apmr.2008.08.216; van Eijk JJJ, 2009, J NEUROL NEUROSUR PS, V80, P1120, DOI 10.1136/jnnp.2008.163386; van Eijk JJJ, 2014, NEUROLOGY, V82, P498, DOI 10.1212/WNL.0000000000000112; Van Weel Chris, 2008, Eur J Gen Pract, V14 Suppl 1, P5, DOI 10.1080/13814780802436028; WHO, INT CLASS PRIM CAR	21	68	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128361	10.1371/journal.pone.0128361	http://dx.doi.org/10.1371/journal.pone.0128361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016482	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600117
J	Dong, X; Zhu, CY; Qian, YM; Zhang, FQ; Jiao, T				Dong, Xian; Zhu, Chenyuan; Qian, Yumei; Zhang, Fuqiang; Jiao, Ting			The Influence of Obturators on the Respiration of Patients with Maxillary Defects: A Clinical Study	PLOS ONE			English	Article							FUNCTIONAL RESIDUAL CAPACITY	The study evaluated the effects of obturators on respiratory function by analyzing the changes in nasal anatomic structures and physiologic function in maxillectomy patients with and without obturators. Twenty-six patients who underwent maxillectomy were chosen and rehabilitated with obturators by a single maxillofacial prosthodontist. The geometric shape of the nasal cavity, the nasal airway resistance, and the ratio of residual volume to total lung capacity (RV/TLC) were evaluated using acoustic rhinometry, rhinomanometry, and a pulmonary function test apparatus, respectively. All patients were tested twice, with and without their obturators. The results were statistically analyzed with a paired t-test. The nasal cavities (0-7 cm to the anterior nostril) of the patients with obturators had a significantly smaller volume ([-8.92, -0.60], P = 0.027), smaller effective nasal cross-sectional area MCA2 ([-3.80, -1,81], P< 0.0001), increased airflow in the nasal cavity ([17.76, 147.39], P = 0.015), reduced nasal airway resistance ([-0.11, -0.02], P = 0.009), and reduced RV/TLC ([-5.32, -1.30], P = 0.004) compared with the patients without obturators. According to the results of this study, obturators can improve respiratory function by effectively decreasing the volume of enlarged nasal cavities as well as the nasal air resistance and volume of anatomical dead space after maxillectomy.	[Dong, Xian; Zhu, Chenyuan; Qian, Yumei; Zhang, Fuqiang; Jiao, Ting] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dept Prosthodont,Sch Med, Shanghai 200030, Peoples R China; [Dong, Xian] Shanghai Inst Hlth Sci, Dept Prosthodont, Shanghai, Peoples R China; [Qian, Yumei] Branch Hosp, Shanghai Stomatol Dis Ctr, Dept Prosthodont, Shanghai, Peoples R China	Shanghai Jiao Tong University	Jiao, T (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Peoples Hosp 9, Dept Prosthodont,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 200030, Peoples R China.	jiao_ting@126.com			Innovation Key Project of Shanghai Education Committee Issues [11ZZ102]; National Natural Science Foundation of China [81100774]; Shanghai Leading Academic Discipline Project [T0202, S30206]	Innovation Key Project of Shanghai Education Committee Issues; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This research is supported by Innovation Key Project of Shanghai Education Committee Issues (Project Number: 11ZZ102), the National Natural Science Foundation of China (Project Number: 81100774) and Shanghai Leading Academic Discipline Project: (Project Number: T0202, S30206).	Beumer J, 2011, MAXILLOFACIAL REHABILITATION: PROSTHODONTIC AND SURGICAL MANAGEMENT OF CANCER-RELATED, ACQUIRED AND CONGENITAL DEFECTS OF THE HEAD AND NECK, THIRD EDITION, P155; Brewer L, 2011, J CLIN MONIT COMPUT, V25, P397, DOI 10.1007/s10877-011-9318-9; Bu G, 2002, RHINOLOGY, P131; Chhabra N, 2009, OTOLARYNG CLIN N AM, V42, P311, DOI 10.1016/j.otc.2009.02.001; Clement PAR, 2005, RHINOLOGY, V43, P169; Diederi G, 2014, CURR OPIN CRIT CARE, V20, P347, DOI [10.1097/MCC.0000000000000099, DOI 10.1097/MCC.0000000000000099]; Fan Z, 1996, PRACTICE OTORHINOLAR, p[234, 243]; FREEDMAN HM, 1979, LARYNGOSCOPE, V89, P421; Gai D, 2013, J SHANGHAI JIAOTONG, P602; Heinze H, 2010, RESP CARE, V55, P589; Huang X, 1995, OTORHINOLARYNGOLOGY; Jiang SW, 1994, MODERN OTORHINOLARYN, P253; Kornblith AB, 1996, HEAD NECK-J SCI SPEC, V18, P323, DOI 10.1002/(SICI)1097-0347(199607/08)18:4<323::AID-HED3>3.3.CO;2-1; Mu K, 1992, PRINCIPLES CLIN APPL, P52; Newth CJL, 1997, EUR RESPIR J, V10, P2174, DOI 10.1183/09031936.97.10092174; Ozlugedik S, 2008, LARYNGOSCOPE, V118, P330, DOI 10.1097/MLG.0b013e318159aa26; Papp J, 2008, ARCH OTOLARYNGOL, V134, P931, DOI 10.1001/archotol.134.9.931; Patroniti N, 2004, INTENS CARE MED, V30, P282, DOI 10.1007/s00134-003-2109-0; Qian Y, 2012, J MED BIOMECHANICS, V27, P219; Qian YM, 2013, INT J PROSTHODONT, V26, P268, DOI 10.11607/ijp2970; [钱玉梅 Qian Yumei], 2012, [医用生物力学, Journal of Medical Biomechanics], V27, P192; Shifu D, 2002, BIOSTATISTICS, P1; Wang Hong, 2002, Zhonghua Er Bi Yan Hou Ke Za Zhi, V37, P177; Zhao K, 2011, PERCEIVING NASAL PAT; Zhao Y, 2004, MAXILLOFACIAL PROSTH, P2; Zheng C, 1994, CHINESE J OTORHINOLA, V30, P343	26	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127597	10.1371/journal.pone.0127597	http://dx.doi.org/10.1371/journal.pone.0127597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011127	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900116
J	Fatnassi, H; Pizzol, J; Senoussi, R; Biondi, A; Desneux, N; Poncet, C; Boulard, T				Fatnassi, Hicham; Pizzol, Jeannine; Senoussi, Rachid; Biondi, Antonio; Desneux, Nicolas; Poncet, Christine; Boulard, Thierry			Within-Crop Air Temperature and Humidity Outcomes on Spatio-Temporal Distribution of the Key Rose Pest Frankliniella occidentalis	PLOS ONE			English	Article							WESTERN FLOWER THRIPS; THYSANOPTERA THRIPIDAE; BENEFICIAL ARTHROPODS; PERGANDE THYSANOPTERA; NATURAL ENEMIES; GREENHOUSE; SIMULATION; PESTICIDES; MANAGEMENT; DISPERSAL	Frankliniella occidentalis (Pergande) is a key pest of various crops worldwide. In this study, we analyse the dependence of the infestation of this pest on spatially distributed micro climatic factors in a rose greenhouse. Despite the importance of this subject, the few existing studies have been realized in laboratory rather than in greenhouse conditions. However, recent progress on greenhouse microclimate characterisation has highlighted the strong indoor climate heterogeneity that may influence the within-crop pest distribution. In this study, both microclimate (air temperature and humidity) and thrips distribution were simultaneously mapped in a rose greenhouse. The measurements were sensed in a horizontal plane situated at mid-height of the rose crop inside the greenhouse. Simultaneously, thrips population dynamics were assessed after an artificial and homogeneous infestation of the rose crop. The spatio-temporal distribution of climate and thrips within the greenhouse were compared, and links between thrips infestation and climatic conditions were investigated. A statistical model was used to define the favourable climate conditions for thrips adults and larvae. Our results showed that (i) the air temperature and air humidity were very heterogeneously distributed within the crop, (ii) pest populations aggregated in the most favourable climatic areas and (iii) the highest population density of thrips adults and larvae were recorded at 27 degrees C and 22 degrees C for temperature and 63% and 86% for humidity, respectively. These findings confirm, in real rose cropping conditions, previous laboratory studies on the F. occidentalis climatic optimum and provide a solid scientific support for climatic-based control methods against this pest.	[Fatnassi, Hicham; Pizzol, Jeannine; Biondi, Antonio; Desneux, Nicolas; Poncet, Christine; Boulard, Thierry] INRA, UMR1355, ISA, F-06903 Sophia Antipolis, France; [Senoussi, Rachid] INRA, UR 0546, Biostat & Proc Spatiaux, F-84914 Montfavet, France; [Biondi, Antonio] Univ Catania, Di3A, I-95123 Catania, Italy	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; INRAE; University of Catania	Fatnassi, H (corresponding author), INRA, UMR1355, ISA, 400 Route Chappes, F-06903 Sophia Antipolis, France.	hicham.fatnassi@sophia.inra.fr	BIONDI, Antonio/I-6381-2012; Desneux, Nicolas/J-6262-2013; Boulard, Thierry/B-5381-2011	BIONDI, Antonio/0000-0002-1982-7716; fatnassi, Hicham/0000-0002-4676-6461				Aguilar-Fenollosa E, 2013, J PEST SCI, V86, P469, DOI 10.1007/s10340-013-0494-x; Bartzanas T, 2002, COMPUT ELECTRON AGR, V34, P207, DOI 10.1016/S0168-1699(01)00188-0; Bergh JC, 1997, J ECON ENTOMOL, V90, P679, DOI 10.1093/jee/90.2.679; Berndt O, 2004, BIOL CONTROL, V30, P17, DOI 10.1016/j.biocontrol.2003.09.009; Bielza P, 2007, J ECON ENTOMOL, V100, P916, DOI 10.1603/0022-0493(2007)100[916:GOSRIF]2.0.CO;2; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Bournier A., 1987, PHYTOMA, V388, P14; BRODSGAARD HF, 1994, J APPL ENTOMOL, V117, P498, DOI 10.1111/j.1439-0418.1994.tb00767.x; Cox DR, 1974, THEORETICAL STAT; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Egger B, 2014, J PEST SCI, V87, P53, DOI 10.1007/s10340-013-0532-8; Fatnassi H, 2006, BIOSYST ENG, V93, P301, DOI 10.1016/j.biosystemseng.2005.11.014; Fatnassi H, 2003, AGR FOREST METEOROL, V118, P97, DOI 10.1016/S0168-1923(03)00071-6; Immaraju J.A., 1992, J ECON ENTOMOL, V89, P9; KAREIVA PM, 1983, OECOLOGIA, V57, P322, DOI 10.1007/BF00377175; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Kogan M, ANN REV ENTOMOL, V43, P243; Kumm S, 2010, J APPL ENTOMOL, V134, P491, DOI 10.1111/j.1439-0418.2009.01473.x; Lewis T, 1997, THRIPS CROP PESTS; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; McDonald JR, 1998, EUR J ENTOMOL, V95, P301; Mehle N, 2012, J PEST SCI, V85, P179, DOI 10.1007/s10340-012-0423-4; Molina-Aiz FD, 2010, COMPUT ELECTRON AGR, V72, P69, DOI 10.1016/j.compag.2010.03.002; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Mound L.A., 1997, THRIPS CROP PESTS; Mound LA, 2005, ANNU REV ENTOMOL, V50, P247, DOI 10.1146/annurev.ento.49.061802.123318; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; Navarro-Campos C, 2013, J PEST SCI, V86, P459, DOI 10.1007/s10340-013-0489-7; Nyasani JO, 2013, J PEST SCI, V86, P515, DOI 10.1007/s10340-013-0491-0; Pizzol J, 2006, IOBC WPRS B, V29, P31; Pizzol J, 2010, J PEST SCI, V83, P191, DOI 10.1007/s10340-010-0286-5; Rahman T, 2012, CROP PROT, V42, P281, DOI 10.1016/j.cropro.2012.07.020; Reitz SR, 2009, FLA ENTOMOL, V92, P7, DOI 10.1653/024.092.0102; Rhainds M, 2004, CAN ENTOMOL, V136, P241; Robb, 1991, UNDERSTANDING THYSAN, P343; ROBB KL, 1989, THESIS U CALIF RIVER; SHIPP JL, 1993, ENVIRON ENTOMOL, V22, P726, DOI 10.1093/ee/22.4.726; Stavrinides MC, 2010, ENVIRON ENTOMOL, V39, P1232, DOI 10.1603/EN09288; Steiner MY, 2011, AUST J ENTOMOL, V50, P179, DOI 10.1111/j.1440-6055.2010.00798.x; Steiner MY, 1998, AUST J ENTOMOL, V37, P101, DOI 10.1111/j.1440-6055.1998.tb01554.x; van Lenteren JC, 2000, CROP PROT, V19, P375, DOI 10.1016/S0261-2194(00)00038-7; VANRIJN PCJ, 1995, B ENTOMOL RES, V85, P285, DOI 10.1017/S0007485300034386; WEISENBURGER DD, 1993, HUM PATHOL, V24, P571, DOI 10.1016/0046-8177(93)90234-8; Zappala L, 2012, EUR J ENTOMOL, V109, P561, DOI 10.14411/eje.2012.070	44	15	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126655	10.1371/journal.pone.0126655	http://dx.doi.org/10.1371/journal.pone.0126655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011275	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900038
J	Gill, SV				Gill, Simone V.			Walking to the Beat of Their Own Drum: How Children and Adults Meet Timing Constraints	PLOS ONE			English	Article							DUAL-TASK CONSTRAINTS; ADAPTATION; OVERWEIGHT; INFANTS	Walking requires adapting to meet task constraints. Between 5- and 7-years old, children's walking approximates adult walking without constraints. To examine how children and adults adapt to meet timing constraints, 57 5- to 7-year olds and 20 adults walked to slow and fast audio metronome paces. Both children and adults modified their walking. However, at the slow pace, children had more trouble matching the metronome compared to adults. The youngest children's walking patterns deviated most from the slow metronome pace, and practice improved their performance. Five-year olds were the only group that did not display carryover effects to the metronome paces. Findings are discussed in relation to what contributes to the development of adaptation in children.	[Gill, Simone V.] Boston Univ, Dept Occupat Therapy, Boston, MA 02215 USA; [Gill, Simone V.] Boston Univ, Dept Med, Program Rehabil Sci PhD, Boston, MA 02215 USA	Boston University; Boston University	Gill, SV (corresponding author), Boston Univ, Dept Occupat Therapy, Boston, MA 02215 USA.	simvgill@bu.edu						Adolph KE, 2003, CHILD DEV, V74, P475, DOI 10.1111/1467-8624.7402011; Adolph KE, 2008, PSYCHOL ACTION; Berger SE, 2007, PROG BRAIN RES, V164, P237, DOI 10.1016/S0079-6123(07)64013-8; BRENIERE Y, 1989, J MOTOR BEHAV, V21, P20; BRIL B, 1989, HUM MOVEMENT SCI, V8, P99, DOI 10.1016/0167-9457(89)90012-2; Bril B, 1991, DEV TIMING CONTROL T; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; Cohen J., 1988, STAT POWER ANAL BEHA, P20, DOI DOI 10.4324/9780203771587; Cole WG, 2014, INFANT BEHAV DEV, V37, P305, DOI 10.1016/j.infbeh.2014.04.006; Forhan M, 2013, BEST PRACT RES CL EN, V27, P129, DOI 10.1016/j.beem.2013.01.003; Getchell N, 2007, MOTOR CONTROL, V11, P1; Getchell N, 2006, DEV PSYCHOBIOL, V48, P675, DOI 10.1002/dev.20186; Gill SV, 2014, RES DEV DISABIL, V35, P46, DOI 10.1016/j.ridd.2013.10.024; Gill SV, 2012, AM J PHYS MED REHAB, V91, P625, DOI 10.1097/PHM.0b013e31824fa81e; Gill SV, 2009, DEVELOPMENTAL SCI, V12, P888, DOI 10.1111/j.1467-7687.2009.00828.x; HAY JC, 1966, J EXP PSYCHOL, V71, P150, DOI 10.1037/h0022611; HAY JC, 1963, SCIENCE, V141, P167, DOI 10.1126/science.141.3576.167; Hung YC, 2013, GAIT POSTURE, V38, P450, DOI 10.1016/j.gaitpost.2013.01.009; Hung YC, 2013, AM J PHYS MED REHAB, V92, P461, DOI 10.1097/PHM.0b013e31828cd59d; INMAN VT, 1966, CAN MED ASSOC J, V94, P1047; OUNPUU S, 1991, J PEDIATR ORTHOPED, V11, P341; Sutherland D., 1988, DEV MATURE WALKING; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336, DOI 10.2106/00004623-198062030-00004; Sebastian M, 2016, J ATTEN DISORD, V20, P87, DOI 10.1177/1087054713510738; WINTER DA, 1983, J MOTOR BEHAV, V15, P302	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127894	10.1371/journal.pone.0127894	http://dx.doi.org/10.1371/journal.pone.0127894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011538	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900160
J	Gong, L; Zhang, HX; Gan, XY; Zhang, L; Chen, YC; Nie, FJ; Shi, L; Li, M; Guo, ZQ; Zhang, GH; Song, YX				Gong, Lei; Zhang, Hongxia; Gan, Xiaoyan; Zhang, Li; Chen, Yuchao; Nie, Fengjie; Shi, Lei; Li, Miao; Guo, Zhiqian; Zhang, Guohui; Song, Yuxia			Transcriptome Profiling of the Potato (Solanum tuberosum L.) Plant under Drought Stress and Water-Stimulus Conditions	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; ABSCISIC-ACID; RESPONSIVE GENES; TOLERANCE; IDENTIFICATION; ARABIDOPSIS; RECOVERY; PATHWAYS; LIPOXYGENASE	Drought stress can seriously affect tuberization, yield and quality of potato plant. However, the precise molecular mechanisms governing potato stolon's response to drought stress and water supply are not very well understood. In this work, a potato (Solanum tuberosum L.) variant, Ningshu 4, was subjected to severe drought stress treatment (DT) and re-watering treatment (RWT) at tuber bulking stage. Strand-specific cDNA libraries of stolon materials were constructed for paired-end transcriptome sequencing analyses and differentially expressed gene (DEG) examination. In comparison to untreated-control (CT) plants, 3189 and 1797 DEGs were identified in DT and RWT plants and 4154 solely expressed DEGs were screened out from these two comparison groups. Interestingly, 263 genes showed opposite expression patterns in DT and RWT plants. Among them, genes homologous to Protein Phosphatase 2C (PP2C), Aspartic protease in guard cell 1 (ASPG1), auxin-responsive protein, Arabidopsis pseudo response regualtor 2 (APRR2), GA stimulated transcripts in Arabidopsis 6 (GASA6), Calmodulin-like protein 19 (CML19), abscisic acid 8'-hydroxylases and calcium-transporting ATPase, et al. were related with drought-stress and water stimulus response. Sixteen DEGs involved in starch synthesis, accumulation and tuber formation exhibited significantly different expression upon re-watering. In addition, 1630, 1527 and 1596 transcription factor encoding genes were detected in CT, DT and RWT. DEGs of ERF, bHLH, MYB, NAC, WRKY, C2H2, bZIP and HD-ZIP families accounted for 50% in three comparison groups, respectively. Furthermore, characteristics of 565 gene ontology (GO) and 108 Kyoto Encyclopedia of Genes and Genomes pathways (KEGG) were analyzed with the 4154 DEGs. All these results suggest that the drought-and water-stimulus response could be implemented by the regulated expression of metabolic pathway DEGs, and these genes were involved in the endogenous hormone biosynthesis and signal transduction pathways. Our data provide more direct information for future study on the interaction between key genes involved in various metabolic pathways under drought stress in potato.	[Gong, Lei; Gan, Xiaoyan; Zhang, Li; Chen, Yuchao; Nie, Fengjie; Shi, Lei; Li, Miao; Song, Yuxia] Ningxia Acad Agr & Forestry Sci, Agr Biotechnol Ctr, Ningxia Key Lab Agrobiotechnol, Yinchuan, Ningxia Hui Nat, Peoples R China; [Zhang, Hongxia] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Guo, Zhiqian; Zhang, Guohui] Ningxia Acad Agr & Forestry Sci, Natl Potato Improvement Ctr, Guyuan Subctr, Guyuan, Ningxia Hui Nat, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, YX (corresponding author), Ningxia Acad Agr & Forestry Sci, Agr Biotechnol Ctr, Ningxia Key Lab Agrobiotechnol, Yinchuan, Ningxia Hui Nat, Peoples R China.	songyx666@163.com			China Agriculture Research System [CARS-10-ES30]; Mega Crop Breeding Project of Ningxia District-Engineering of New Potato Cultivars, Natural Science Foundation of Ningxia [NZ13098]; Scientific and Technological Innovation Priority Research Program of Ningxia Academy of Agriculture and Forestry Science [NKYG-13-05, NKYG-14-05, NKYG-15-06]	China Agriculture Research System; Mega Crop Breeding Project of Ningxia District-Engineering of New Potato Cultivars, Natural Science Foundation of Ningxia; Scientific and Technological Innovation Priority Research Program of Ningxia Academy of Agriculture and Forestry Science	This work has been jointly supported by the following grants: The China Agriculture Research System (CARS-10-ES30), The Mega Crop Breeding Project of Ningxia District-Engineering of New Potato Cultivars, Natural Science Foundation of Ningxia (NZ13098) and The Scientific and Technological Innovation Priority Research Program of Ningxia Academy of Agriculture and Forestry Science (NKYG-13-05, NKYG-14-05 and NKYG-15-06).	Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Alexandersson E, 2010, PLANT J, V61, P650, DOI 10.1111/j.1365-313X.2009.04087.x; Anithakumari AM, 2012, MOL BREEDING, V30, P1413, DOI 10.1007/s11032-012-9728-5; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Evers D, 2010, J EXP BOT, V61, P2327, DOI 10.1093/jxb/erq060; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hussain SS, 2011, BIOTECHNOL PROGR, V27, P297, DOI 10.1002/btpr.514; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kloosterman B, 2005, PLANT BIOTECHNOL J, V3, P505, DOI 10.1111/j.1467-7652.2005.00141.x; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Kolomiets MV, 2001, PLANT CELL, V13, P613, DOI 10.1105/tpc.13.3.613; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Liu GT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-174; Liu ZN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-594; Livaja M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-628; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XD, 2013, PLANT PHYSIOL, V162, P440, DOI 10.1104/pp.113.214874; Marshall A, 2012, PLANT CELL, V24, P2262, DOI 10.1105/tpc.112.096677; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; Mizuno H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-121; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nam KH, 2008, J PLANT PHYSIOL, V165, P233, DOI 10.1016/j.jplph.2007.04.003; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; O'Brien M, 2002, PLANTA, V215, P485, DOI 10.1007/s00425-002-0770-0; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Sarkar D, 2008, PLANT CELL REP, V27, P1, DOI 10.1007/s00299-007-0457-x; Seiler C, 2014, PLANT PHYSIOL, V164, P1677, DOI 10.1104/pp.113.229062; Shin D, 2011, PLANT PHYSIOL, V155, P421, DOI 10.1104/pp.110.163634; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vasquez-Robinet C, 2008, J EXP BOT, V59, P2109, DOI 10.1093/jxb/ern073; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang N, 2014, MOL BIOL REP, V41, P505, DOI 10.1007/s11033-013-2886-7	43	70	77	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128041	10.1371/journal.pone.0128041	http://dx.doi.org/10.1371/journal.pone.0128041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010543	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900188
J	LeBlanc, A; Wang, AT; Wyatt, K; Branda, ME; Shah, ND; Van Houten, H; Pencille, L; Wermers, R; Montori, VM				LeBlanc, Annie; Wang, Amy T.; Wyatt, Kirk; Branda, Megan E.; Shah, Nilay D.; Van Houten, Holly; Pencille, Laurie; Wermers, Robert; Montori, Victor M.			Encounter Decision Aid vs. Clinical Decision Support or Usual Care to Support Patient-Centered Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial II	PLOS ONE			English	Article							ADHERENCE; SCALE	Purpose Osteoporosis Choice, an encounter decision aid, can engage patients and clinicians in shared decision making about osteoporosis treatment. Its effectiveness compared to the routine provision to clinicians of the patient's estimated risk of fracture using the FRAX calculator is unknown. Methods Patient-level, randomized, three-arm trial enrolling women over 50 with osteopenia or osteoporosis eligible for treatment with bisphosphonates, where the use of Osteoporosis Choice was compared to FRAX only and to usual care to determine impact on patient knowledge, decisional conflict, involvement in the decision-making process, decision to start and adherence to bisphosphonates. Results We enrolled 79 women in the three arms. Because FRAX estimation alone and usual care produced similar results, we grouped them for analysis. Compared to these, use of Osteoporosis Choice increased patient knowledge (median score 6 vs. 4, p = .01), improved understanding of fracture risk and risk reduction with bisphosphonates (p = .01 and p<.0001, respectively), had no effect on decision conflict, and increased patient engagement in the decision making process (OPTION scores 57% vs. 43%, p = .001). Encounters with the decision aid were 0.8 minutes longer (range: 33 minutes shorter to 3.0 minutes longer). There were twice as many patients receiving and filling prescriptions in the decision aid arm (83% vs. 40%, p = .07); medication adherence at 6 months was no different across arms. Conclusion Supporting both patients and clinicians during the clinical encounter with the Osteoporosis Choice decision aid efficiently improves treatment decision making when compared to usual care with or without clinical decision support with FRAX results.	[LeBlanc, Annie; Shah, Nilay D.] Mayo Clin, Dept Hlth Sci Res, Div Hlth Care Policy & Res, Rochester, MN USA; [LeBlanc, Annie; Wyatt, Kirk; Branda, Megan E.; Shah, Nilay D.; Pencille, Laurie; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA; [LeBlanc, Annie] Mayo Clin, Robert D & Patricia E Kern Mayo Clin Ctr Sci Hlth, Rochester, MN USA; [Wang, Amy T.] Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst Harbor, Div Gen Internal Med, Torrance, CA 90509 USA; [Wyatt, Kirk] Mayo Clin, Dept Med, Div Pediat, Rochester, MN USA; [Branda, Megan E.; Van Houten, Holly] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Wermers, Robert; Montori, Victor M.] Mayo Clin, Dept Med, Div Endocrinol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Mayo Clinic; Mayo Clinic; Mayo Clinic	Montori, VM (corresponding author), Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA.	Montori.victor@mayo.edu	LeBlanc, Annie/AAZ-1381-2020	Montori, Victor/0000-0003-0595-2898	Informed Medical Decisions Foundation	Informed Medical Decisions Foundation	This study was supported by a grant from the Foundation for Informed Medical Decision Making (Now the Informed Medical Decisions Foundation, http://www.informedmedicaldecisions.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; Crandall CJ, 2012, TREATMENT PREVENT FR; Cranney A, 2002, PATIENT EDUC COUNS, V47, P245, DOI 10.1016/S0738-3991(01)00218-X; Elwyn G, 2003, QUAL SAF HEALTH CARE, V12, P93, DOI 10.1136/qhc.12.2.93; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Kanis JA, 2007, ASSESSMENT OSTEOPORO; Karve S, 2008, MED CARE, V46, P1125, DOI 10.1097/MLR.0b013e31817924d2; McCloskey E, 2012, CURR OPIN RHEUMATOL, V24, P554, DOI 10.1097/BOR.0b013e328356d2f5; Montori VM, 2011, AM J MED, V124, P549, DOI 10.1016/j.amjmed.2011.01.013; Montori VM, 2001, CAN MED ASSOC J, V165, P1339; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Pencille LJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-113; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Scoville EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018468; Seeman E, 2007, OSTEOPOROSIS INT, V18, P711, DOI 10.1007/s00198-006-0294-8; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Wyatt KD, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-26	19	120	125	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128063	10.1371/journal.pone.0128063	http://dx.doi.org/10.1371/journal.pone.0128063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010755	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900190
J	Liu, H; Sun, M; Du, DL; Pan, HT; Cheng, TR; Wang, J; Zhang, QX				Liu, Hua; Sun, Ming; Du, Dongliang; Pan, Huitang; Cheng, Tangren; Wang, Jia; Zhang, Qixiang			Whole-Transcriptome Analysis of Differentially Expressed Genes in the Vegetative Buds, Floral Buds and Buds of Chrysanthemum morifolium	PLOS ONE			English	Article							MOLECULAR-CLONING; ARABIDOPSIS; SUPERFAMILY; PROFILES; PROTEIN	Background Chrysanthemum morifolium is an important floral crop that is cultivated worldwide. However, due to a lack of genomic resources, very little information is available concerning the molecular mechanisms of flower development in chrysanthemum. Results The transcriptomes of chrysanthemum vegetative buds, floral buds and buds were sequenced using Illumina paired-end sequencing technology. A total of 15.4 Gb of reads were assembled into 91,367 unigenes with an average length of 739 bp. A total of 43,137 unigenes showed similarity to known proteins in the Swissprot or NCBI non-redundant protein databases. Additionally, 25,424, 24,321 and 13,704 unigenes were assigned to 56 gene ontology (GO) categories, 25 EuKaryotic Orthologous Groups (KOG) categories, and 285 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, respectively. A total of 1,876 differentially expressed genes (DEGs) (1,516 up-regulated, 360 down-regulated) were identified between vegetative buds and floral buds, and 3,300 DEGs (1,277 up-regulated, 1,706 down-regulated) were identified between floral buds and buds. Many genes encoding important transcription factors (e.g., AP2, MYB, MYC, WRKY, NAC and CRT) as well as proteins involved in carbohydrate metabolism, protein kinase activity, plant hormone signal transduction, and the defense responses, among others, were considerably up-regulated in floral buds. Genes involved in the photoperiod pathway and flower organ determination were also identified. These genes represent important candidate genes for molecular cloning and functional analysis to study flowering regulation in chrysanthemum. Conclusion This comparative transcriptome analysis revealed significant differences in gene expression and signaling pathway components between the vegetative buds, floral buds and buds of Chrysanthemum morifolium. A wide range of genes was implicated in regulating the phase transition from vegetative to reproductive growth. These results should aid researchers in the study of flower-time regulation, breeding and molecular biology in chrysanthemum.	[Liu, Hua; Sun, Ming; Du, Dongliang; Pan, Huitang; Cheng, Tangren; Wang, Jia; Zhang, Qixiang] Beijing Forestry Univ, Beijing Lab Urban & Rural Ecol Environm, Beijing Key Lab Ornamental Germplasm Innovat & Mo, Natl Engn Res Ctr Floriculture,Coll Landscape Arc, Beijing 100083, Peoples R China	Beijing Forestry University	Zhang, QX (corresponding author), Beijing Forestry Univ, Beijing Lab Urban & Rural Ecol Environm, Beijing Key Lab Ornamental Germplasm Innovat & Mo, Natl Engn Res Ctr Floriculture,Coll Landscape Arc, Beijing 100083, Peoples R China.	zqxbjfu@126.com	du, dongliang/N-4308-2015; Cheng, Tangren/HDM-6455-2022		12th Five Years Key Programs for Science and Technology Development of China [2012BAD01B07, 2013BAD01B07]; Special Fund for Beijing Common Construction Project	12th Five Years Key Programs for Science and Technology Development of China(Chinese Academy of Sciences); Special Fund for Beijing Common Construction Project	This research was supported by the 12th Five Years Key Programs for Science and Technology Development of China (2012BAD01B07,2013BAD01B07), Special Fund for Beijing Common Construction Project.	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; [Anonymous], 2002, DEV GENETICS PLANT E; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BODSON M, 1977, PLANTA, V135, P19, DOI 10.1007/BF00387970; Broholm SK, 2010, J EXP BOT, V61, P75, DOI 10.1093/jxb/erp279; Chen SM, 2009, PLANT MOL BIOL REP, V27, P503, DOI 10.1007/s11105-009-0103-6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Hu JX, 2010, J AM STAT ASSOC, V105, P1215, DOI 10.1198/jasa.2010.tm09329; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Jaworski K, 2003, PHYTOCHEMISTRY, V62, P1047, DOI 10.1016/S0031-9422(02)00677-5; Lee J, 2008, PLANT J, V55, P832, DOI 10.1111/j.1365-313X.2008.03552.x; Lenartowski R, 2014, PLANTA, V239, P437, DOI 10.1007/s00425-013-1971-4; Litt A, 2010, SEMIN CELL DEV BIOL, V21, P129, DOI 10.1016/j.semcdb.2009.11.019; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057338; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Shchennikova AV, 2004, PLANT PHYSIOL, V134, P1632, DOI 10.1104/pp.103.036665; Urao T, 1996, PLANT MOL BIOL, V32, P571, DOI 10.1007/BF00019112; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang Y, 2014, PLANT CELL TISS ORG, V116, P297, DOI 10.1007/s11240-013-0404-1; Wilmowicz E, 2011, BIOL PLANTARUM, V55, P757, DOI 10.1007/s10535-011-0182-8; Wu XL, 2003, DEVELOPMENT, V130, P3735, DOI 10.1242/dev.00577; Xie XL, 2014, MOL BIOL REP, V41, P4261, DOI 10.1007/s11033-014-3297-0; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662	30	41	43	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128009	10.1371/journal.pone.0128009	http://dx.doi.org/10.1371/journal.pone.0128009			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009891	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900182
J	Ohkubo, T; Tamiya, M; Abe, K; Ishiguro, M				Ohkubo, Takayuki; Tamiya, Minoru; Abe, Keiko; Ishiguro, Masaji			Structural Basis of pH Dependence of Neoculin, a Sweet Taste-Modifying Protein	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; PURIFICATION; CURCULIN; RECEPTOR; FRUIT	Among proteins utilized as sweeteners, neoculin and miraculin are taste-modifying proteins that exhibit pH-dependent sweetness. Several experiments on neoculin have shown that His11 of neoculin is responsible for pH dependence. We investigated the molecular mechanism of the pH dependence of neoculin by molecular dynamics (MD) calculations. The MD calculations for the dimeric structures of neoculin and His11 mutants showed no significant structural changes for each monomer at neutral and acidic pH levels. The dimeric structure of neoculin dissociated to form isolated monomers under acidic conditions but was maintained at neutral pH. The dimeric structure of the His11Ala mutant, which is sweet at both neutral and acidic pH, showed dissociation at both pH 3 and 7. The His11 residue is located at the interface of the dimer in close proximity to the Asp91 residue of the other monomer. The MD calculations for His11Phe and His11Tyr mutants demonstrated the stability of the dimeric structures at neutral pH and the dissociation of the dimers to isolated monomers. The dissociation of the dimer caused a flexible backbone at the surface that was different from the dimeric interface at the point where the other monomer interacts to form an oligomeric structure. Further MD calculations on the tetrameric structure of neoculin suggested that the flexible backbone contributed to further dissociation of other monomers under acidic conditions. These results suggest that His11 plays a role in the formation of oligomeric structures at pH 7 and that the isolated monomer of neoculin at acidic pH is responsible for sweetness.	[Ohkubo, Takayuki; Tamiya, Minoru; Ishiguro, Masaji] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Akiha Ku, Niigata, Japan; [Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	Niigata University; University of Tokyo	Ishiguro, M (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Akiha Ku, Niigata, Japan.	ishiguro@nupals.ac.jp			Grants-in-Aid for Scientific Research [26242007] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		[Anonymous], 2010, AMBER 11 USERS MANUA; IGETA H, 1991, BIOCHIM BIOPHYS ACTA, V1079, P303, DOI 10.1016/0167-4838(91)90073-9; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; KURIHARA K, 1968, SCIENCE, V161, P1241, DOI 10.1126/science.161.3847.1241; Kurimoto E, 2007, J BIOL CHEM, V282, P33252, DOI 10.1074/jbc.C700174200; LIU XZ, 1993, EUR J BIOCHEM, V211, P281, DOI 10.1111/j.1432-1033.1993.tb19896.x; MING D, 1994, FEBS LETT, V355, P106, DOI 10.1016/0014-5793(94)01184-2; MORRIS JA, 1972, BIOCHIM BIOPHYS ACTA, V261, P114, DOI 10.1016/0304-4165(72)90320-0; Nakajima KI, 2008, FASEB J, V22, P2323, DOI 10.1096/fj.07-100289; Nakajima K, 2011, BIOSCI BIOTECH BIOCH, V75, P1600, DOI 10.1271/bbb.110081; Nakajima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019448; Shimizu-Ibuka A, 2006, J MOL BIOL, V359, P148, DOI 10.1016/j.jmb.2006.03.030; Shirasuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1403, DOI 10.1271/bbb.68.1403; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; YAMASHITA H, 1990, J BIOL CHEM, V265, P15770	16	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126921	10.1371/journal.pone.0126921	http://dx.doi.org/10.1371/journal.pone.0126921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010443	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900047
J	Orhan, E; Dalkara, D; Neuille, M; Lechauve, C; Michiels, C; Picaud, S; Leveillard, T; Sahel, JA; Naash, MI; Lavail, MM; Zeitz, C; Audo, I				Orhan, Elise; Dalkara, Deniz; Neuille, Marion; Lechauve, Christophe; Michiels, Christelle; Picaud, Serge; Leveillard, Thierry; Sahel, Jose-Alain; Naash, Muna I.; Lavail, Matthew M.; Zeitz, Christina; Audo, Isabelle			Genotypic and Phenotypic Characterization of P23H Line 1 Rat Model	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; INDUCED RETINAL DEGENERATION; RESTORES VISUAL RESPONSES; RHODOPSIN GENE; TRANSGENIC RAT; PHOTORECEPTOR DEGENERATION; RIBOZYME RESCUE; MUTATIONS; OPSIN; MICE	Rod-cone dystrophy, also known as retinitis pigmentosa (RP), is the most common inherited degenerative photoreceptor disease, for which no therapy is currently available. The P23H rat is one of the most commonly used autosomal dominant RP models. It has been created by incorporation of a mutated mouse rhodopsin (Rho) transgene in the wild-type (WT) Sprague Dawley rat. Detailed genetic characterization of this transgenic animal has however never been fully reported. Here we filled this knowledge gap on P23H Line 1 rat (P23H-1) and provide additional phenotypic information applying non-invasive and state-of-the-art in vivo techniques that are relevant for preclinical therapeutic evaluations. Transgene sequence was analyzed by Sanger sequencing. Using quantitative PCR, transgene copy number was calculated and its expression measured in retinal tissue. Full field electroretinography (ERG) and spectral domain optical coherence tomography (SD-OCT) were performed at 1-, 2-, 3-and 6-months of age. Sanger sequencing revealed that P23H-1 rat carries the mutated mouse genomic Rho sequence from the promoter to the 3' UTR. Transgene copy numbers were estimated at 9 and 18 copies in the hemizygous and homozygous rats respectively. In 1-month-old hemizygous P23H-1 rats, transgene expression represented 43% of all Rho expressed alleles. ERG showed a progressive rod-cone dysfunction peaking at 6 months-of-age. SD-OCT confirmed a progressive thinning of the photoreceptor cell layer leading to the disappearance of the outer retina by 6 months with additional morphological changes in the inner retinal cell layers in hemizygous P23H-1 rats. These results provide precise genotypic information of the P23H-1 rat with additional phenotypic characterization that will serve basis for therapeutic interventions, especially for those aiming at gene editing.	[Orhan, Elise; Dalkara, Deniz; Neuille, Marion; Lechauve, Christophe; Michiels, Christelle; Picaud, Serge; Leveillard, Thierry; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle] INSERM, U968, Paris, France; [Orhan, Elise; Dalkara, Deniz; Neuille, Marion; Lechauve, Christophe; Michiels, Christelle; Picaud, Serge; Leveillard, Thierry; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle] CNRS, UMR 7210, Paris, France; [Orhan, Elise; Dalkara, Deniz; Neuille, Marion; Lechauve, Christophe; Michiels, Christelle; Picaud, Serge; Leveillard, Thierry; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle] Sorbonne Univ, Univ Paris 06, UMR S 968, Inst Vis, Paris, France; [Sahel, Jose-Alain; Audo, Isabelle] Ctr Hosp Natl Ophtalmol Quinze Vingts, DHU ViewMaintain, INSERM DHOS CIC 1423, Paris, France; [Sahel, Jose-Alain; Audo, Isabelle] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] Acad Sci, Inst France, Paris, France; [Naash, Muna I.] Univ Oklahoma Hlth Sci, Dept Cell Biol, Oklahoma City, OK USA; [Lavail, Matthew M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Lavail, Matthew M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Fondation Adolphe de Rothschild; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Audo, I (corresponding author), INSERM, U968, Paris, France.	isabelle.audo@inserm.fr	Léveillard, Thierry/AAR-1804-2020; Dalkara, Deniz/D-5057-2017; Picaud, Serge/H-4012-2014; Zeitz, Christina/F-2757-2017; Sahel, Jose-Alain/F-3172-2017; Lechauve, Christophe/AAH-8873-2019	Léveillard, Thierry/0000-0001-5692-8770; Dalkara, Deniz/0000-0003-4112-9321; Picaud, Serge/0000-0002-0548-5145; Zeitz, Christina/0000-0002-3510-1712; Sahel, Jose-Alain/0000-0002-4831-1153; Orhan, Elise/0000-0002-8306-5250; Audo, Isabelle/0000-0003-0698-5309	Fondation Valentin Hauy; Retina France; e-rare RHORCOD; Fondation de l'Oeil - Fondation de France; Foundation Voir et Entendre; Foundation Fighting Blindness (FFB) [CD-CL-0808-0466-CHNO]; FFB center grant [CD-CL-0808-0466-CHNO]; Ville de Paris; Region Ile de France; Labex Lifesenses [ANR-10-LABX-65]; ANR within the Investissements d'Avenir programme [ANR-11-IDEX-0004-0]; Regional Council of Ile de France [I09 - 1727/R]; National Institute of Health [EY10609, EY001919, EY006842]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R56EY010609, R37EY001919, R55EY010609, R01EY010609, R01EY001919, U01EY006842, R01EY006842] Funding Source: NIH RePORTER	Fondation Valentin Hauy; Retina France; e-rare RHORCOD; Fondation de l'Oeil - Fondation de France; Foundation Voir et Entendre; Foundation Fighting Blindness (FFB); FFB center grant; Ville de Paris; Region Ile de France(Region Ile-de-France); Labex Lifesenses; ANR within the Investissements d'Avenir programme(French National Research Agency (ANR)); Regional Council of Ile de France(Region Ile-de-France); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Fondation Valentin Hauy (IA, EO), Retina France (IA, EO), e-rare RHORCOD (IA), Fondation de l'Oeil - Fondation de France (IA), Foundation Voir et Entendre (CZ), Foundation Fighting Blindness (FFB) (CD-CL-0808-0466-CHNO) (IA), and the FFB center grant (CD-CL-0808-0466-CHNO), Ville de Paris and Region Ile de France, Labex Lifesenses (reference ANR-10-LABX-65) supported by French state funds managed by the ANR within the Investissements d'Avenir programme (ANR-11-IDEX-0004-0), the Regional Council of Ile de France (I09 - 1727/R) (EO), the National Institute of Health grants EY10609 (MIN), EY001919 (MML) and EY006842 (MML) and the Foundation Fighting Blindness (MIN and MML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila M, 2014, HUM MOL GENET, V23, P2164, DOI 10.1093/hmg/ddt613; Aleman TS, 2008, INVEST OPHTH VIS SCI, V49, P1580, DOI 10.1167/iovs.07-1110; Aleman TS, 2001, INVEST OPHTH VIS SCI, V42, P1873; ALUBAIDI MR, 1990, J BIOL CHEM, V265, P20563; Audo I, 2010, INVEST OPHTH VIS SCI, V51, P3687, DOI 10.1167/iovs.09-4766; Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Berson EL, 1976, T SECTION OPHTHALM 1, V81, pOP659; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Cuenca N, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00151; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Fernandez-Sanchez L, 2012, HUM GENE THER, V23, P1290, DOI 10.1089/hum.2012.067; Fernandez-Sanchez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043074; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Garcia-Ayuso D, 2010, EXP EYE RES, V91, P800, DOI 10.1016/j.exer.2010.10.003; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gorbatyuk M, 2007, EXP EYE RES, V84, P44, DOI 10.1016/j.exer.2006.08.014; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; Ishikawa F, 2006, INVEST OPHTH VIS SCI, V47, P5204, DOI 10.1167/iovs.05-1149; Jayaram H, 2014, STEM CELL TRANSL MED, V3, P323, DOI 10.5966/sctm.2013-0112; Jelcick AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021858; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kolomiets B, 2010, NEUROBIOL DIS, V38, P47, DOI 10.1016/j.nbd.2009.12.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; LAVAIL MM, 1987, CURR EYE RES, V6, P825, DOI 10.3109/02713688709034850; Lax P, 2014, EXP EYE RES, V120, P175, DOI 10.1016/j.exer.2014.01.019; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Mace E, 2015, MOL THER, V23, P7, DOI 10.1038/mt.2014.154; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Mohand-Said S, 2000, ARCH OPHTHALMOL-CHIC, V118, P807, DOI 10.1001/archopht.118.6.807; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Moriguchi K, 2003, EXP EYE RES, V77, P167, DOI 10.1016/S0014-4835(03)00114-3; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Parfitt DA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.214; Saliba RS, 2002, J CELL SCI, V115, P2907; Steinberg R. H., 1996, Investigative Ophthalmology and Visual Science, V37, pS698; Stenkamp RE, 2005, ARCH PHARM, V338, P209, DOI 10.1002/ardp.200400995; STONE EM, 1991, OPHTHALMOLOGY, V98, P1806; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; Yang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013469; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	58	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127319	10.1371/journal.pone.0127319	http://dx.doi.org/10.1371/journal.pone.0127319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009893	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900082
J	Smith, AL; Carter, SM; Dunlop, SM; Freeman, B; Chapman, S				Smith, Andrea L.; Carter, Stacy M.; Dunlop, Sally M.; Freeman, Becky; Chapman, Simon			The Views and Experiences of Smokers Who Quit Smoking Unassisted. A Systematic Review of the Qualitative Evidence	PLOS ONE			English	Review							OPTIMAL SEARCH STRATEGIES; NATURAL RECOVERY; SELF-CHANGE; CESSATION; MAINTENANCE; VALIDATION; BEHAVIOR; PREDICT; MODEL; SCALE	Background Unassisted cessation - quitting without pharmacological or professional support - is an enduring phenomenon. Unassisted cessation persists even in nations advanced in tobacco control where cessation assistance such as nicotine replacement therapy, the stop-smoking medications bupropion and varenicline, and behavioural assistance are readily available. We review the qualitative literature on the views and experiences of smokers who quit unassisted. Method We systematically searched for peer-reviewed qualitative studies reporting on smokers who quit unassisted. We identified 11 studies and used a technique based on Thomas and Harden's method of thematic synthesis to discern key themes relating to unassisted cessation, and to then group related themes into overarching concepts. Findings The three concepts identified as important to smokers who quit unassisted were: motivation, willpower and commitment. Motivation, although widely reported, had only one clear meaning, that is 'the reason for quitting'. Willpower was perceived to be a method of quitting, a strategy to counteract cravings or urges, or a personal quality or trait fundamental to quitting success. Commitment was equated to seriousness or resoluteness, was perceived as key to successful quitting, and was often used to distinguish earlier failed quit attempts from the final successful quit attempt. Commitment had different dimensions. It appeared that commitment could be tentative or provisional, and also cumulative, that is, commitment could be built upon as the quit attempt progressed. Conclusion A better understanding of what motivation, willpower and commitment mean from the smoker's perspective may provide new insights and direction for smoking cessation research and practice.	[Smith, Andrea L.; Carter, Stacy M.] Univ Sydney, Sch Publ Hlth, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Dunlop, Sally M.; Chapman, Simon] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Dunlop, Sally M.] Canc Inst NSW, Canc Screening & Prevent, Sydney, NSW, Australia; [Freeman, Becky] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Smith, AL (corresponding author), Univ Sydney, Sch Publ Hlth, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia.	andrea.smith@sydney.edu.au	Chapman, Simon/D-4114-2009; Carter, Stacy/A-6544-2011	Carter, Stacy/0000-0003-2617-8694; Smith, Andrea Lynne Leslie/0000-0002-9194-4888	National Health and Medical Research Council (NHMRC), Australia [1024459]; NHMRC Career Development Fellowship [1032963]	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the National Health and Medical Research Council (NHMRC), Australia, grant number 1024459. SMC is supported by NHMRC Career Development Fellowship 1032963. www.nhmrc.gov.au.	Abdullah ASM, 2006, SUBST USE MISUSE, V41, P1735, DOI 10.1080/10826080601006433; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2004, HDB SELF REGULATION; Atkins S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-21; BAER PE, 1977, J BEHAV THER EXP PSY, V8, P71, DOI 10.1016/0005-7916(77)90108-2; Balmford J, 2011, NICOTINE TOB RES, V13, P94, DOI 10.1093/ntr/ntq215; Bandura A., 1986, SOCIAL FDN THOUGHT A; Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Becker MH, 1974, HLTH BELIEF MODEL PE; Borland R, 2010, NICOTINE TOB RES, V12, pS4, DOI 10.1093/ntr/ntq050; Bottorff JL, 2009, SOCIOL HEALTH ILL, V31, P185, DOI 10.1111/j.1467-9566.2008.01126.x; Burt RS, 2005, BROKERAGE CLOSURE IN; Cahill K, 2014, JAMA-J AM MED ASSOC, V311, P193, DOI 10.1001/jama.2013.283787; CAREY MP, 1989, COGNITIVE THER RES, V13, P323, DOI 10.1007/BF01173477; Chapman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000216; COHEN S, 1989, AM PSYCHOL, V44, P1355, DOI 10.1037/0003-066X.44.11.1355; Deci E.L., 2010, INTRINSIC MOTIVATION, P1, DOI DOI 10.1002/9780470479216.CORPSY0467; DICLEMENTE CC, 1982, ADDICT BEHAV, V7, P133, DOI 10.1016/0306-4603(82)90038-7; Dixon-Woods Mary, 2007, J Health Serv Res Policy, V12, P42, DOI 10.1258/135581907779497486; Eakin JM, 2003, J EVAL CLIN PRACT, V9, P187, DOI 10.1046/j.1365-2753.2003.00392.x; Edwards SA, 2014, ADDICT BEHAV, V39, P512, DOI 10.1016/j.addbeh.2013.10.036; Etter JF, 2000, ADDICTION, V95, P901, DOI 10.1046/j.1360-0443.2000.9569017.x; Hung WT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-592; Kahler CW, 2007, ADDICT BEHAV, V32, P2420, DOI 10.1016/j.addbeh.2007.04.002; Kluge A, 2009, QUALITATIVE INQUIRY; Lipworth WL, 2011, QUAL HEALTH RES, V21, P714, DOI 10.1177/1049732311399781; Mariezcurrena R, 1996, COGNITIVE BEHAV THER, V25, P57; McDermott E, 2004, EXPERIENCES BEING TE; McDermott E, 2006, SOC SCI MED, V63, P1546, DOI 10.1016/j.socscimed.2006.03.025; McKibbon KA, 2006, EVAL HEALTH PROF, V29, P440, DOI 10.1177/0163278706293400; Medbo A, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-42; Miller PM, 2010, ADDICTION, V105, P1521, DOI 10.1111/j.1360-0443.2010.03034.x; Murray RL, 2010, ADDICTION, V105, P1299, DOI 10.1111/j.1360-0443.2010.02980.x; Murray RL, 2009, THESIS U NOTTINGHAM; Nezami E, 2003, SUBST USE MISUSE, V38, P25, DOI 10.1081/JA-120016564; Nichter M, 2007, HEALTH EDUC BEHAV, V34, P748, DOI 10.1177/1090198106290397; Noyes J., 2008, COCHRANE HDB SYSTEMA; Ockene JK, 2000, HEALTH PSYCHOL, V19, P17, DOI 10.1037/0278-6133.19.Suppl1.17; Ogden J, 2008, HEALTH-LONDON, V12, P419, DOI 10.1177/1363459308094417; Orford J, 2006, ADDICTION, V101, P60, DOI 10.1111/j.1360-0443.2005.01291.x; Prochaska J, 1994, PROGR BEHAV MODIFICA, P184; Prochaska J O, 1984, Prog Clin Biol Res, V156, P131; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Saini M., 2012, SYSTEMATIC SYNTHESIS; Sandelowski M., 2007, HDB SYNTHESIZING QUA; Segan CJ, 2002, PSYCHOL HEALTH, V17, P417, DOI 10.1080/0887044022000004911; Shaw Rachel L, 2004, BMC Med Res Methodol, V4, P5, DOI 10.1186/1471-2288-4-5; Slutske WS, 2010, ADDICTION, V105, P1520, DOI 10.1111/j.1360-0443.2010.03035.x; Smit ES, 2011, ADDICTION, V106, P844, DOI 10.1111/j.1360-0443.2010.03317.x; Smith AL, 2013, WHAT DO WE KNOW UNAS; Sobell LC, 2010, PROMOTING SELF CHANG, P1; Solheim K, 1989, J HOLISTIC NURSING, V7, P26; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub3; Stead LF, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009670.pub4, 10.1002/14651858.CD002850.pub3]; Stewart C, 1999, J DRUG ISSUES, V29, P167, DOI 10.1177/002204269902900111; Stewart JC, 1998, THESIS FLORIDA STATE; Sutton A, 2004, INTEGRATIVE APPROACH; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Thompson EM, 1995, THESIS GEORGIA STATE; West R, 2006, BRIT MED J, V332, P458, DOI 10.1136/bmj.38723.573866.AE; Wilczynski NL, 2007, QUAL HEALTH RES, V17, P705, DOI 10.1177/1049732306294515; Winstanley M., 2012, TOBACCO AUSTR FACTS; Wong SSL, 2004, STUD HEALTH TECHNOL, V107, P311	63	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127144	10.1371/journal.pone.0127144	http://dx.doi.org/10.1371/journal.pone.0127144			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010369	Green Published, gold			2022-12-27	WOS:000355183900066
J	Wagage, S; Pritchard, GH; Dawson, L; Buza, EL; Sonnenberg, GF; Hunter, CA				Wagage, Sagie; Pritchard, Gretchen Harms; Dawson, Lucas; Buza, Elizabeth L.; Sonnenberg, Gregory F.; Hunter, Christopher A.			The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection	PLOS ONE			English	Article							TOXOPLASMA-GONDII; COMMENSAL BACTERIA; IMMUNE-RESPONSE; ORAL INFECTION; GAMMA; PROMOTE; GUT; DIFFERENTIATION; ACTIVATION; MICROBIOTA	Intestinal infection with the intracellular parasite Toxoplasma gondii results in the translocation of commensal bacteria to peripheral organs and the development of a T cell response specific to the microbiota. In naive mice, the recently described ROR gamma t(+) group 3 innate lymphoid cell (ILC) population plays a critical role in promoting intestinal barrier function and limiting responses to gut-resident commensal bacteria. Given this role for group 3 ILCs, studies were performed to evaluate whether these cells might influence the immune response to mucosal infection with T. gondii. Phenotypic characterization of ROR gamma t(+) ILCs in T. gondii infected mice revealed that this population decreased following challenge but the population that remained expressed costimulatory molecules and IL-22. One factor that influences the maintenance of ROR gamma t(+) ILCs is the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, and Ahr(-/-) mice have a marked defect in the lamina propria group 3 ILC population. When Ahr(-/-) mice were challenged with T. gondii, they lost more weight than wild type controls. This disease course in Ahr(-/-) animals was associated with increased T cell responses to Toxoplasma antigen and crude commensal antigen preparations. Together, these data suggest that group 3 ILCs have a role in limiting T cell activation during intestinal infection.	[Wagage, Sagie; Pritchard, Gretchen Harms; Dawson, Lucas; Buza, Elizabeth L.; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.] Univ Penn, Div Gastroenterol, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.] Univ Penn, Div Gastroenterol, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu			 [NIHR01AI-110201]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, R01AI110201] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported ny the NIHR01AI-110201 (http://www.niaid.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt MC, 2013, CURR OPIN MICROBIOL, V16, P4, DOI 10.1016/j.mib.2012.12.002; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Bannenberg GL, 2004, J EXP MED, V199, P515, DOI 10.1084/jem.20031325; Benson A, 2012, J IMMUNOL, V188, P800, DOI 10.4049/jimmunol.1100769; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gregg B, 2013, INFECT IMMUN, V81, P1635, DOI 10.1128/IAI.01126-12; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Sanchez Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/505694; Schreiner M, 2009, MEM I OSWALDO CRUZ, V104, P221, DOI 10.1590/S0074-02762009000200015; Silva NM, 2002, INFECT IMMUN, V70, P859, DOI 10.1128/IAI.70.2.859-868.2002; Silver JS, 2011, J IMMUNOL, V187, P350, DOI 10.4049/jimmunol.1004144; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Villeret B, 2013, AM J CLIN EXP IMMUNO, V2, P107; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wagage S, 2015, CURRENT IMM IN PRESS; Wagage S, 2014, J IMMUNOL, V192, P1661, DOI 10.4049/jimmunol.1300497; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016	47	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128335	10.1371/journal.pone.0128335	http://dx.doi.org/10.1371/journal.pone.0128335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010337	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900226
J	Xue, Z; Zhao, JD; Niu, LY; An, G; Guo, YS; Ni, LY				Xue, Zhen; Zhao, Jindong; Niu, Liyuan; An, Gang; Guo, Yashan; Ni, Linying			Up-Regulation of MiR-300 Promotes Proliferation and Invasion of Osteosarcoma by Targeting BRD7	PLOS ONE			English	Article							GLIOMA STEM-CELLS; TUMOR-SUPPRESSOR; MOLECULAR CHARACTERIZATION; MESENCHYMAL TRANSITION; SELF-RENEWAL; EXPRESSION; CARCINOMA; GLIOBLASTOMA; METASTASIS; CANCER	Increasing reports suggest that deregulated microRNAs (miRNAs) might provide novel therapeutic targets for cancers. However, the expression and function of miR-300 in osteosarcoma is still unknown. In our study, we found that the expression of miR-300 was up-regulated in osteosarcoma tissues and cells compared with paired adjacent non-tumor bone tissues and osteoblastic cells using RT-qPCR. The enforced expression of miR-300 could promote cell proliferation, invasion and epithelial-mesenchymal transition (EMT). Moreover, we identified that bromodomain-containing protein 7 (BRD7), a new tumor suppressor gene, was a direct target of miR-300. Ectopic expression of BRD7 could significantly inhibit miR-300-promoted proliferation, invasion and EMT. Therefore, our results identify an important role for miR-300 in osteosarcoma through regulating BRD7 expression.	[Xue, Zhen; An, Gang; Guo, Yashan] Harbin Med Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Harbin 150086, Heilongjiang, Peoples R China; [Zhao, Jindong] Fifth Hosp Harbin City, Harbin 150040, Heilongjiang, Peoples R China; [Niu, Liyuan] Harbin Inst Technol, Affiliated Hosp, Dept Phys Diag, Harbin 150001, Heilongjiang, Peoples R China; [Ni, Linying] Harbin Med Univ, Tumor Hosp, Dept Orthopaed Surg, Harbin 150086, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Institute of Technology; Harbin Medical University	Xue, Z (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Orthopaed Surg, Harbin 150086, Heilongjiang, Peoples R China.	tlyu1d@126.com						Babae N, 2014, ONCOTARGET, V5, P6687, DOI 10.18632/oncotarget.2235; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Chiu YH, 2014, MOL CELL, V54, P193, DOI 10.1016/j.molcel.2014.02.016; Chong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114585; Cuppen E, 1999, FEBS LETT, V459, P291, DOI 10.1016/S0014-5793(99)01191-6; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Fu LL, 2013, CELL PROLIFERAT, V46, P67, DOI 10.1111/cpr.12005; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Harte MT, 2010, CANCER RES, V70, P2538, DOI 10.1158/0008-5472.CAN-09-2089; Hasei J, 2013, MOL CANCER THER, V12, P314, DOI 10.1158/1535-7163.MCT-12-0869; Hirata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051056; Hu H, 2012, ONCOL LETT, V4, P1037, DOI 10.3892/ol.2012.866; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Lee HK, 2013, ONCOTARGET, V4, P346, DOI 10.18632/oncotarget.868; Lee JE, 2011, CELL PROLIFERAT, V44, P59, DOI 10.1111/j.1365-2184.2010.00717.x; Li HR, 2012, ONCOTARGET, V3, P1653; Li J, 2014, CELL PROLIFERAT, V47, P152, DOI 10.1111/cpr.12093; Li M, 2013, CELL PROLIFERAT, V46, P223, DOI 10.1111/cpr.12013; Li Z, 2015, CELL PROLIFERAT, V48, P1, DOI 10.1111/cpr.12160; Li Z, 2015, GASTRIC CANCER, V18, P43, DOI 10.1007/s10120-014-0340-8; Liu G, 2014, TUMOUR BIOLOGY THE J; Liu HY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-253; Luo JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040127; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Novello C, 2013, INT J ONCOL, V42, P667, DOI 10.3892/ijo.2012.1717; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Park SW, 2014, CELL METAB, V20, P73, DOI 10.1016/j.cmet.2014.04.006; Park YA, 2014, CLIN CANCER RES, V20, P565, DOI 10.1158/1078-0432.CCR-13-1271; Schirmer U, 2014, ONCOTARGET, V5, P462, DOI 10.18632/oncotarget.1552; Staal A, 2000, J CELL PHYSIOL, V185, P269, DOI 10.1002/1097-4652(200011)185:2<269::AID-JCP12>3.0.CO;2-L; Tang J, 2014, CELL PROLIFERAT, V47, P427, DOI 10.1111/cpr.12129; Thayanithy V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043720; Tsai HC, 2014, ONCOTARGET, V5, P3800, DOI 10.18632/oncotarget.1998; Wang Z, 2014, ONCOTARGET; Wu WJ, 2013, EUR J CLIN INVEST, V43, P131, DOI 10.1111/eci.12024; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048917; Yu JS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-121; Yu X, 2014, INT J MOL MED, V34, P923, DOI 10.3892/ijmm.2014.1853; Yu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083080; Zhang C, 2014, ONCOTARGET, V5, P9106, DOI 10.18632/oncotarget.2379; Zhang DM, 2014, J MOL NEUROSCI, V53, P637, DOI 10.1007/s12031-014-0230-x; Zhou J, 2004, J CELL PHYSIOL, V200, P89, DOI 10.1002/jcp.20013; Zhou M, 2006, MOL CELL BIOCHEM, V292, P205, DOI 10.1007/s11010-006-9233-4	43	51	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127682	10.1371/journal.pone.0127682	http://dx.doi.org/10.1371/journal.pone.0127682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010572	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900129
J	Zhang, ZJ; Chen, JM; Su, YY; Liu, HM; Chen, Y; Luo, PG; Du, XG; Wang, D; Zhang, HY				Zhang, Zijin; Chen, Jieming; Su, Yongying; Liu, Hanmei; Chen, Yanger; Luo, Peigao; Du, Xiaogang; Wang, Dan; Zhang, Huaiyu			TaLHY, a 1R-MYB Transcription Factor, Plays an Important Role in Disease Resistance against Stripe Rust Fungus and Ear Heading in Wheat	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; CIRCADIAN-RHYTHMS; ARABIDOPSIS; MYB; GENES; PROTEIN; CLOCK; IDENTIFICATION; EXPRESSION; ENCODES	LHY (late elongated hypocotyl) is an important gene that regulates and controls biological rhythms in plants. Additionally, LHY is highly expressed in the SSH (suppression subtractive hybridization) cDNA library-induced stripe rust pathogen (CYR32) in our previous research. To identify the function of the LHY gene in disease resistance against stripe rust, we used RACE-PCR technology to clone TaLHY in the wheat variety Chuannong19. The cDNA of TaLHY is 3085 bp long with an open reading frame of 1947 bp. TaLHY is speculated to encode a 70.3 kDa protein of 648 amino acids, which has one typical plant MYB-DNA binding domain; additionally, phylogenetic tree shows that TaLHY has the highest homology with LHY of Brachypodium distachyon(BdLHY-like). Quantitative fluorescence PCR indicates that TaLHY has higher expression in the leaf, ear and stem of wheat but lower expression in the root. Infestation of CYR32 can result in up-regulated expression of TaLHY, peaking at 72 h. Using VIGS (virus-induced gene silencing) technology to disease-resistant wheat in the fourth leaf stage, plants with silenced TaLHY cannot complete their heading stage. Through the compatible interaction with the stripe rust physiological race CYR32, Chuannong 19 loses its immune capability toward the stripe rust pathogen, indicating that TaLHY may regulate and participate in the heading of wheat, as well as the defense responses against stripe rust infection.	[Zhang, Zijin; Chen, Jieming; Su, Yongying; Liu, Hanmei; Chen, Yanger; Du, Xiaogang; Zhang, Huaiyu] Sichuan Agr Univ, Biophys & Immune Engn Lab, Yaan, Sichuan, Peoples R China; [Luo, Peigao] Sichuan Agr Univ, State Key Lab Plant Breeding & Genet, Chengdu, Sichuan, Peoples R China; [Wang, Dan] Puyang Acad Agr Sci, Dept Wheat Breeding, Puyang, Henan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zhang, HY (corresponding author), Sichuan Agr Univ, Biophys & Immune Engn Lab, Yaan, Sichuan, Peoples R China.	zhyu@sicau.edu.cn		Su, Yongying/0000-0003-4459-1837	National Natural Scinece Funcdation of China [31171557]	National Natural Scinece Funcdation of China	HYZ received support from National Natural Scinece Funcdation of China (No.31171557). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Boddu J, 2006, PLANT MOL BIOL, V60, P185, DOI 10.1007/s11103-005-3568-1; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Jiang CH, 2004, GENE, V326, P13, DOI 10.1016/j.gene.2003.09.049; Kim JY, 2003, EMBO J, V22, P935, DOI 10.1093/emboj/cdg075; Lee MM, 2002, PLANT CELL, V14, P611, DOI 10.1105/tpc.010434; Lipsick JS, 1996, ONCOGENE, V13, P223; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo PG, 2008, GENOME, V51, P922, DOI 10.1139/G08-079; Luo PG, 2005, PHYTOPATHOLOGY, V95, P1266, DOI 10.1094/PHYTO-95-1266; Maeda K, 2005, PLANT MOL BIOL, V59, P739, DOI 10.1007/s11103-005-0910-6; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Payne CT, 2000, GENETICS, V156, P1349; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Raffaele S, 2006, FEBS LETT, V580, P3498, DOI 10.1016/j.febslet.2006.05.027; Ridley A, 2004, MYB TRANSCRIPTION FA, P6; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Uimari A, 1997, PLANT J, V12, P1273, DOI 10.1046/j.1365-313x.1997.12061273.x; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Yang XY, 2007, PLANT CELL REP, V26, P219, DOI 10.1007/s00299-006-0229-z; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3	32	16	22	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127723	10.1371/journal.pone.0127723	http://dx.doi.org/10.1371/journal.pone.0127723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010918	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900135
J	Qiu, F; Yang, JC; Ma, XY; Xu, JJ; Yang, QL; Zhou, X; Xiao, YS; Hu, HS; Xia, LH				Qiu, Feng; Yang, Jin-Cheng; Ma, Xiang-Yang; Xu, Jun-Jie; Yang, Qing-Lei; Zhou, Xin; Xiao, Yao-Sheng; Hu, Hai-Sheng; Xia, Li-Hui			Relationship between Spinal Cord Volume and Spinal Cord Injury due to Spinal Shortening	PLOS ONE			English	Article							VERTEBRAL COLUMN RESECTION; SINGLE POSTERIOR APPROACH; IDIOPATHIC SCOLIOSIS; EVOKED-POTENTIALS; SURGERY; DEFORMITY; OSTEOTOMY; KYPHOSCOLIOSIS; RECORDINGS; ANESTHESIA	Vertebral column resection is associated with a risk of spinal cord injury. In the present study, using a goat model, we aimed to investigate the relationship between changes in spinal cord volume and spinal cord injury due to spinal shortening, and to quantify the spinal cord volume per 1-mm height in order to clarify a safe limit for shortening. Vertebral column resection was performed at T10 in 10 goats. The spinal cord was shortened until the somatosensory-evoked potential was decreased by 50% from the baseline amplitude or delayed by 10% relative to the baseline peak latency. A wake-up test was performed, and the goats were observed for two days postoperatively. Magnetic resonance imaging was used to measure the spinal cord volume, T10 height, disc height, osteotomy segment height, and spinal segment height pre- and postoperatively. Two of the 10 goats were excluded, and hence, only data from eight goats were analyzed. The somatosensory-evoked potential of these eight goats demonstrated meaningful changes. With regard to neurologic function, five and three goats were classified as Tarlov grades 5 and 4 at two days postoperatively. The mean shortening distance was 23.6 +/- 1.51 mm, which correlated with the d-value (post-pre) of the spinal cord volume per 1-mm height of the osteotomy segment (r = 0.95, p < 0.001) and with the height of the T10 body (r = 0.79, p = 0.02). The mean d-value (post-pre) of the spinal cord volume per 1-mm height of the osteotomy segment was 142.87 +/- 0.59 mm(3) (range, 142.19-143.67 mm(3)). The limit for shortening was approximately 106% of the vertebral height. The mean volumes of the osteotomy and spinal segments did not significantly change after surgery (t = 0.310, p = 0.765 and t = 1.241, p = 0.255, respectively). Thus, our results indicate that the safe limit for shortening can be calculated using the change in spinal cord volume per 1-mm height.	[Qiu, Feng; Yang, Jin-Cheng; Ma, Xiang-Yang; Xu, Jun-Jie; Yang, Qing-Lei; Zhou, Xin; Xiao, Yao-Sheng; Hu, Hai-Sheng; Xia, Li-Hui] Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Orthoped, Guangzhou 510010, Guangdong, Peoples R China	Southern Theater Command General Hospital	Ma, XY (corresponding author), Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Orthoped, 111 Liuhua Ave,POB 510010, Guangzhou 510010, Guangdong, Peoples R China.	spinemaxy2014@126.com			National Natural Science Foundation of China [NO:81171768]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Foundation funds were received in support of this work from the National Natural Science Foundation of China (NO:81171768).	Alemdaroglu KB, 2007, EUR SPINE J, V16, P1451, DOI 10.1007/s00586-007-0325-y; BOHLMAN HH, 1979, JOHNS HOPKINS MED J, V145, P115; Braun JT, 2006, SPINE, V31, P1314, DOI 10.1097/01.brs.0000218662.78165.b1; Bridwell KH, 2006, SPINE, V31, pS171, DOI 10.1097/01.brs.0000231963.72810.38; Chandanwale A S, 2008, J Orthop Surg (Hong Kong), V16, P277; Dabney KW, 2004, SPINE, V29, P2357, DOI 10.1097/01.brs.0000143108.65385.74; DAWSON EG, 1991, SPINE, V16, pS361; Gunnarsson T, 2004, SPINE, V29, P677, DOI 10.1097/01.BRS.0000115144.30607.E9; Hamzaoglu A, 2011, SPINE, V36, pE340, DOI 10.1097/BRS.0b013e3182015712; Hermanns H, 2007, BRIT J ANAESTH, V98, P362, DOI 10.1093/bja/ael365; Hilibrand AS, 2004, J BONE JOINT SURG AM, V86A, P1248, DOI 10.2106/00004623-200406000-00018; Kawahara N, 2005, SPINE, V30, P613, DOI 10.1097/01.brs.0000155407.87439.a2; Lenke LG, 2010, CLIN ORTHOP RELAT R, V468, P687, DOI 10.1007/s11999-009-1037-x; Lenke LG, 2009, SPINE, V34, P2213, DOI 10.1097/BRS.0b013e3181b53cba; Liljenqvist UR, 2000, SPINE, V25, P1247, DOI 10.1097/00007632-200005150-00008; LIN HC, 1993, CORNELL VET, V83, P117; Metzler P, 2014, J ORAL MAXILLOFAC SU; Modi HN, 2011, J BONE JOINT SURG AM, V93A, P1781, DOI [10.2106/JBJS.J.01794, 10.2106/JBJS.I.01794]; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052910; Qiu Y, 2008, SPINE, V33, P519, DOI 10.1097/BRS.0b013e3181657d93; Schwartz DM, 2007, J BONE JOINT SURG AM, V89A, P2440, DOI 10.2106/Jl3JS.F01476; Shimode M, 2002, SPINE, V27, P2260, DOI 10.1097/00007632-200210150-00015; Strahm C, 2003, SPINAL CORD, V41, P483, DOI 10.1038/sj.sc.3101493; Suk SI, 2005, SPINE, V30, pE703, DOI 10.1097/01.brs.0000188190.90034.be; Suk SI, 2005, SPINE, V30, P1682, DOI 10.1097/01.brs.0000170590.21071.c1; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Wang Y, 2008, EUR SPINE J, V17, P361, DOI 10.1007/s00586-007-0566-9; WEINSTEIN JN, 1992, CLIN ORTHOP RELAT R, P34; Weinstein SL, 2000, J BONE JOINT SURG AM, V82A, P1517, DOI 10.2106/00004623-200010000-00041; Yang JH, 2014, CLIN ORTHOP SURG, V6, P290, DOI 10.4055/cios.2014.6.3.290; Yang JC, 2011, INT ORTHOP, V35, P1827, DOI 10.1007/s00264-010-1155-9; Zhang HQ, 2013, ARCH ORTHOP TRAUM SU, V133, P1211, DOI 10.1007/s00402-013-1794-6	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127624	10.1371/journal.pone.0127624	http://dx.doi.org/10.1371/journal.pone.0127624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001196	gold, Green Published, Green Submitted			2022-12-27	WOS:000354931700069
J	Kouzoukas, DE; Meyer-Siegler, KL; Ma, F; Westlund, KN; Hunt, DE; Vera, PL				Kouzoukas, Dimitrios E.; Meyer-Siegler, Katherine L.; Ma, Fei; Westlund, Karin N.; Hunt, David E.; Vera, Pedro L.			Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain	PLOS ONE			English	Article							CYCLOPHOSPHAMIDE-INDUCED CYSTITIS; URINARY-TRACT-INFECTION; RAT BLADDER; UP-REGULATION; INTERSTITIAL CYSTITIS; ACTIVATED RECEPTORS; THERAPEUTIC TARGET; FACTOR MIF; INFLAMMATION; EXPRESSION	Introduction Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, is constitutively expressed in urothelial cells that also express protease-activated receptors (PAR). Urothelial PAR1 receptors were shown to mediate bladder inflammation. We showed that PAR1 and PAR4 activator, thrombin, also mediates urothelial MIF release. We hypothesized that stimulation of urothelial PAR1 or PAR4 receptors elicits release of urothelial MIF that acts on MIF receptors in the urothelium to mediate bladder inflammation and pain. Thus, we examined the effect of activation of specific bladder PAR receptors on MIF release, bladder pain, micturition and histological changes. Methods MIF release was measured in vitro after exposing immortalized human urothelial cells (UROtsa) to PAR1 or PAR4 activating peptides (AP). Female C57BL/6 mice received intravesical PAR1- or PAR4-AP for one hour to determine: 1) bladder MIF release in vivo within one hour; 2) abdominal hypersensitivity (allodynia) to von Frey filament stimulation 24 hours after treatment; 3) micturition parameters 24 hours after treatment; 4) histological changes in the bladder as a result of treatment; 5) changes in expression of bladder MIF and MIF receptors using real-time RT-PCR; 6) changes in urothelial MIF and MIF receptor, CXCR4, protein levels using quantitative immunofluorescence; 7) effect of MIF or CXCR4 antagonism. Results PAR1- or PAR4-AP triggered MIF release from both human urothelial cells in vitro and mouse urothelium in vivo. Twenty-four hours after intravesical PAR1- or PAR4-AP, we observed abdominal hypersensitivity in mice without changes in micturition or bladder histology. PAR4-AP was more effective and also increased expression of bladder MIF and urothelium MIF receptor, CXCR4. Bladder CXCR4 localized to the urothelium. Antagonizing MIF with ISO-1 eliminated PAR4- and reduced PAR1-induced hypersensitivity, while antagonizing CXCR4 with AMD3100 only partially prevented PAR4-induced hypersensitivity. Conclusions Bladder PAR activation elicits urothelial MIF release and urothelial MIF receptor signaling at least partly through CXCR4 to result in abdominal hypersensitivity without overt bladder inflammation. PAR-induced bladder pain may represent an interesting pre-clinical model of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) where pain occurs without apparent bladder injury or pathology. MIF is potentially a novel therapeutic target for bladder pain in IC/PBS patients.	[Kouzoukas, Dimitrios E.; Ma, Fei; Westlund, Karin N.; Hunt, David E.; Vera, Pedro L.] Lexington Vet Affairs Med Ctr, Res & Dev, Lexington, KY 40502 USA; [Meyer-Siegler, Katherine L.] St Petersburg Coll, Dept Nat Sci, St Petersburg, FL USA; [Ma, Fei; Westlund, Karin N.; Vera, Pedro L.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Vera, Pedro L.] Univ Kentucky, Dept Surg, Lexington, KY USA; [Kouzoukas, Dimitrios E.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Kentucky; University of Kentucky; University of Kentucky	Kouzoukas, DE (corresponding author), Lexington Vet Affairs Med Ctr, Res & Dev, Lexington, KY 40502 USA.	dimitrios.kouzoukas@va.gov	Kouzoukas, Dimitrios/AAH-4616-2020; Kouzoukas, Dimitrios E/D-4964-2013; Kouzoukas, Dimitrios/N-6575-2019; Vera, Pedro/AAE-1514-2021; Westlund, Karin/R-6960-2019	Kouzoukas, Dimitrios E/0000-0002-1922-670X; Kouzoukas, Dimitrios/0000-0002-1922-670X; Westlund High, Karin/0000-0002-7388-4834	National Institutes of Health [DK0093496]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from the National Institutes of Health (DK0093496; P.L.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JK, 2012, EXP NEUROL, V236, P351, DOI 10.1016/j.expneurol.2012.04.018; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; Bjorling DE, 2011, NEUROUROL URODYNAM, V30, P673, DOI 10.1002/nau.21078; BOUCHER W, 1995, BRIT J UROL, V76, P94, DOI 10.1111/j.1464-410X.1995.tb07840.x; D'Andrea MR, 2003, AM J PATHOL, V162, P907, DOI 10.1016/S0002-9440(10)63886-2; Dattilio A, 2005, J UROLOGY, V173, P635, DOI 10.1097/01.ju.0000143191.55468.1d; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Guerios SD, 2006, NEUROSCI LETT, V392, P193, DOI 10.1016/j.neulet.2005.09.026; Hoi Alberta Y., 2007, Inflammation & Allergy Drug Targets, V6, P183, DOI 10.2174/187152807781696455; Izgi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072067; Kuromitsu S, 2008, SCAND J UROL NEPHROL, V42, P455, DOI 10.1080/00365590802025881; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; McDougall JJ, 2009, ARTHRITIS RHEUM-US, V60, P728, DOI 10.1002/art.24300; Meyer-Siegler KL, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/535348; Meyer-Siegler KL, 2006, J UROLOGY, V175, P1523, DOI 10.1016/S0022-5347(05)00650-6; Meyer-Siegler KL, 2005, J UROLOGY, V173, P615, DOI 10.1097/01.ju.0000143188.02802.f3; Meyer-Siegler KL, 2004, J UROLOGY, V171, P1698, DOI 10.1097/01.ju.0000115883.49365.1a; Moffatt JD, 2007, N-S ARCH PHARMACOL, V375, P1, DOI 10.1007/s00210-007-0139-9; Oz HS, 2012, WORLD J GASTROENTERO, V18, P4257, DOI 10.3748/wjg.v18.i32.4257; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Rudick CN, 2010, J INFECT DIS, V201, P1240, DOI 10.1086/651275; Russell FA, 2011, PAIN, V152, P354, DOI 10.1016/j.pain.2010.10.038; Saban Ricardo, 2007, BMC Physiology, V7, P4, DOI 10.1186/1472-6793-7-4; Saban Ricardo, 2007, BMC Physiology, V7, P3, DOI 10.1186/1472-6793-7-3; Sugino Y, 2008, NEUROUROL URODYNAM, V27, P548, DOI 10.1002/nau.20552; Vera PL, 2008, J UROLOGY, V180, P373, DOI 10.1016/j.juro.2008.02.040; Vera PL, 2008, EXP BIOL MED, V233, P620, DOI 10.3181/0709-RM-240; Vera PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015904; Vera PL, 2010, NEUROUROL URODYNAM, V29, P1451, DOI 10.1002/nau.20878; Vera PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005835; Vera PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003898; Vera PL, 2005, J UROLOGY, V174, P338, DOI 10.1097/01.ju.0000161606.15696.79; Vera PL, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-17; Wang FZ, 2011, ANESTHESIOLOGY, V114, P643, DOI 10.1097/ALN.0b013e31820a4bf3; Wang ZJ, 2013, J NEUROSCI RES, V91, P1551, DOI 10.1002/jnr.23280; Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067	37	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127628	10.1371/journal.pone.0127628	http://dx.doi.org/10.1371/journal.pone.0127628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020638	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300048
J	Mansur, A; Liese, B; Steinau, M; Ghadimi, M; Bergmann, I; Tzvetkov, M; Popov, AF; Beissbarth, T; Bauer, M; Hinz, J				Mansur, Ashham; Liese, Benjamin; Steinau, Maximilian; Ghadimi, Michael; Bergmann, Ingo; Tzvetkov, Mladen; Popov, Aron Frederik; Beissbarth, Tim; Bauer, Martin; Hinz, Jose			The CD14 rs2569190 TT Genotype Is Associated with an Improved 30-Day Survival in Patients with Sepsis: A Prospective Observational Cohort Study	PLOS ONE			English	Article							CD14-260C-GREATER-THAN-T POLYMORPHISM; MORTALITY; SUSCEPTIBILITY; RECOGNITION; EXPRESSION; RISK; LPS	According to previous investigations, CD14 is suggested to play a pivotal role in initiating and perpetuating the pro-inflammatory response during sepsis. A functional polymorphism within the CD14 gene, rs2569190, has been shown to impact the pro-inflammatory response upon stimulation with lipopolysaccharide, a central mediator of inflammation in sepsis. In this study, we hypothesized that the strong pro-inflammatory response induced by the TT genotype of CD14 rs2569190 may have a beneficial effect on survival (30-day) in patients with sepsis. A total of 417 adult patients with sepsis (and of western European descent) were enrolled into this observational study. Blood samples were collected for rs2569190 genotyping. Patients were followed over the course of their stay in the ICU, and the 30-day mortality risk was recorded as the primary outcome parameter. Sepsis-related organ failure assessment (SOFA) scores were quantified at sepsis onset and throughout the observational period to monitor organ failure as a secondary variable. Moreover, organ support-free days were evaluated as a secondary outcome parameter. TT-homozygous patients were compared to C-allele carriers. Kaplan-Meier survival analysis revealed a higher 30-day mortality risk among C-allele carriers compared with T homozygotes (p = 0.0261). To exclude the effect of potential confounders (age, gender, BMI and type of infection) and covariates that varied at baseline with a p-value < 0.2 (e.g., comorbidities), we performed multivariate Cox regression analysis to examine the survival time. The CD14 rs2569190 C allele remained a significant covariate for the 30-day mortality risk in the multivariate analysis (hazard ratio, 2.11; 95% CI, 1.08-4.12; p = 0.0282). The 30-day mortality rate among C allele carriers was 23%, whereas the T homozygotes had a mortality rate of 13%. Additionally, an analysis of organ-specific SOFA scores revealed a significantly higher SOFA-Central nervous system score among patients carrying the C allele compared with T-homozygous patients (1.9 +/- 1.1 and 1.6 +/- 1.0, respectively; p = 0.0311). In conclusion, CD14 rs2569190 may act as a prognostic variable for the short-term outcome (30-day survival) in patients with sepsis.	[Mansur, Ashham; Liese, Benjamin; Steinau, Maximilian; Bergmann, Ingo; Bauer, Martin; Hinz, Jose] Univ Gottingen, Univ Med Ctr, Dept Anesthesiol, D-37073 Gottingen, Germany; [Ghadimi, Michael] Univ Gottingen, Univ Med Ctr, Dept Gen & Visceral Surg, D-37073 Gottingen, Germany; [Tzvetkov, Mladen] Univ Gottingen, Univ Med Ctr, Inst Clin Pharmacol, D-37073 Gottingen, Germany; [Popov, Aron Frederik] Royal Brompton & Harefield Hosp, Dept Cardiothorac Transplantat & Mech Support, Harefield, Middx, England; [Beissbarth, Tim] Univ Gottingen, Univ Med Ctr, Dept Med Stat, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital; University of Gottingen	Mansur, A (corresponding author), Univ Gottingen, Univ Med Ctr, Dept Anesthesiol, D-37073 Gottingen, Germany.	ashham.mansur@med.uni-goettingen.de	Popov, Aron-Frederik/AAA-9933-2020	Popov, Aron-Frederik/0000-0003-4226-3004; Tzvetkov, Mladen/0000-0003-1670-5534; Mansur, Ashham/0000-0002-0322-2480	German Research Foundation (DFG); Open Access Publication Funds of Gottingen University	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of Gottingen University	This study was supported by the German Research Foundation (DFG) and the Open Access Publication Funds of Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CRIT CARE MED; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Barber RC, 2006, CLIN MED RES, V4, P250, DOI 10.3121/cmr.4.4.250; Barber RC, 2007, SHOCK, V27, P232, DOI 10.1097/01.shk.0000239770.10528.9a; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; D'Avila LC, 2006, IMMUNOL CELL BIOL, V84, P342, DOI 10.1111/j.1440-1711.2006.01432.x; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Fallavena PRV, 2013, SCAND J IMMUNOL, V77, P62, DOI 10.1111/sji.12002; Fallavena PRV, 2009, IMMUNOL INVEST, V38, P797, DOI 10.3109/08820130903258818; Fan LW, 2005, J NEUROSCI RES, V82, P71, DOI 10.1002/jnr.20623; Gibot S, 2002, CRIT CARE MED, V30, P969, DOI 10.1097/00003246-200205000-00003; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gu W, 2008, CRIT CARE MED, V36, P2274, DOI 10.1097/CCM.0b013e318180b1ed; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hsieh PF, 2002, NEUROREPORT, V13, P277, DOI 10.1097/00001756-200203040-00006; Kristjansdottir H, 2010, ARTHRITIS RHEUM-US, V62, P1702, DOI 10.1002/art.27417; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lin J, 2007, SHOCK, V28, P148, DOI 10.1097/shk.0b013e3180341d35; Mansur A, 2015, BMJ OPEN, V5, DOI [10.1136/bmjope, 10.1136/bmjopen-2014-006616]; Mansur A, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-177; Mansur A, 2014, J INVEST MED, V62, P638, DOI 10.2310/JIM.0000000000000059; Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Siddiqui Shahla, 2007, J Indian Med Assoc, V105, P221; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; Tzvetkov MV, 2010, PHARMACOGENOMICS, V11, P449, DOI [10.2217/pgs.10.14, 10.2217/PGS.10.14]; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Zhang AQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071237	35	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127761	10.1371/journal.pone.0127761	http://dx.doi.org/10.1371/journal.pone.0127761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020644	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300054
J	Farrag, M; Laufenberg, LJ; Steiner, JL; Weller, GE; Lang, CH; Ruiz-Velasco, V				Farrag, Mohamed; Laufenberg, Lacee J.; Steiner, Jennifer L.; Weller, Gregory E.; Lang, Charles H.; Ruiz-Velasco, Victor			Modulation of Voltage-Gated Ca2+ Channels by G Protein-Coupled Receptors in Celiac-Mesenteric Ganglion Neurons of Septic Rats	PLOS ONE			English	Article							NOCICEPTIN/ORPHANIN FQ; MOLECULAR-MECHANISMS; SYMPATHETIC NEURONS; SEVERE SEPSIS; CANINE MODEL; INFLAMMATION; OPIOIDS; SYSTEM; NERVE; SHOCK	Septic shock, the most severe complication associated with sepsis, is manifested by tissue hypoperfusion due, in part, to cardiovascular and autonomic dysfunction. In many cases, the splanchnic circulation becomes vasoplegic. The celiac-superior mesenteric ganglion (CSMG) sympathetic neurons provide the main autonomic input to these vessels. We used the cecal ligation puncture (CLP) model, which closely mimics the hemodynamic and metabolic disturbances observed in septic patients, to examine the properties and modulation of Ca2+ channels by G protein-coupled receptors in acutely dissociated rat CSMG neurons. Voltage-clamp studies 48 hr post-sepsis revealed that the Ca2+ current density in CMSG neurons from septic rats was significantly lower than those isolated from sham control rats. This reduction coincided with a significant increase in membrane surface area and a negligible increase in Ca2+ current amplitude. Possible explanations for these findings include either cell swelling or neurite outgrowth enhancement of CSMG neurons from septic rats. Additionally, a significant rightward shift of the concentration-response relationship for the norepinephrine (NE)-mediated Ca2+ current inhibition was observed in CSMG neurons from septic rats. Testing for the presence of opioid receptor subtypes in CSMG neurons, showed that mu opioid receptors were present in similar to 70% of CSMG, while NOP opioid receptors were found in all CSMG neurons tested. The pharmacological profile for both opioid receptor subtypes was not significantly affected by sepsis. Further, the Ca2+ current modulation by propionate, an agonist for the free fatty acid receptors GPR41 and GPR43, was not altered by sepsis. Overall, our findings suggest that CSMG function is affected by sepsis via changes in cell size and a2-adrenergic receptor-mediated Ca2+ channel modulation.	[Farrag, Mohamed; Weller, Gregory E.; Ruiz-Velasco, Victor] Penn State Coll Med, Dept Anesthesiol, Hershey, PA 17033 USA; [Laufenberg, Lacee J.] Penn State Coll Med, Dept Surg, Hershey, PA USA; [Steiner, Jennifer L.; Lang, Charles H.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ruiz-Velasco, V (corresponding author), Penn State Coll Med, Dept Anesthesiol, Hershey, PA 17033 USA.	vruizvelasco@psu.edu			National Institutes of Health [DA-025574, GM-38032, F32-AA023422]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038032, R29GM038032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA023422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support for this study was provided by the National Institutes of Health grants DA-025574 (VRV), GM-38032 (CHL) and F32-AA023422 (JLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Bellahcene M, 2013, BRIT J NUTR, V109, P1755, DOI 10.1017/S0007114512003923; BENEDICT CR, 1992, CIRC SHOCK, V38, P165; Bindels LB, 2013, TRENDS PHARMACOL SCI, V34, P226, DOI 10.1016/j.tips.2013.02.002; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; CARRIER GO, 1992, PFLUG ARCH EUR J PHY, V421, P7, DOI 10.1007/BF00374726; CARRIER GO, 1995, BRAIN RES, V701, P1, DOI 10.1016/0006-8993(95)00756-6; Carvalho D, 2008, INTENS CARE MED, V34, P2284, DOI 10.1007/s00134-008-1313-3; Das S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/409694; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; FADEN AI, 1980, J PHARMACOL EXP THER, V212, P441; Fan HK, 2011, BBA-MOL CELL RES, V1813, P466, DOI 10.1016/j.bbamcr.2011.01.012; Goddard CM, 1996, AM J PHYSIOL-HEART C, V270, pH1446, DOI 10.1152/ajpheart.1996.270.4.H1446; Hausberg M, 2008, J HYPERTENS, V26, P2276, DOI 10.1097/HJH.0b013e328318efd4; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; ILLNER HP, 1981, ARCH SURG-CHICAGO, V116, P1302; Kannan Y, 1996, J IMMUNOL, V157, P313; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Laufenberg LJ, 2013, J SURG RES, V184, P973, DOI 10.1016/j.jss.2013.03.076; Lukewich MK, 2015, NEUROSCIENCE, V284, P668, DOI 10.1016/j.neuroscience.2014.10.039; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Molina PE, 2006, J INTERN MED, V259, P138, DOI 10.1111/j.1365-2796.2005.01569.x; Molina PE, 2002, CLIN EXP PHARMACOL P, V29, P248, DOI 10.1046/j.1440-1681.2002.03638.x; Motagally MA, 2009, J PHYSIOL-LONDON, V587, P2623, DOI 10.1113/jphysiol.2009.172312; Motagally MA, 2009, AM J PHYSIOL-GASTR L, V296, pG1077, DOI 10.1152/ajpgi.00006.2009; Ozdem SS, 2005, VASC PHARMACOL, V43, P56, DOI 10.1016/j.vph.2005.04.001; Pugsley MK, 2002, PHARMACOL THERAPEUT, V93, P51, DOI 10.1016/S0163-7258(02)00165-1; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; RUOKONEN E, 1993, CRIT CARE MED, V21, P1296; Sayk F, 2008, AM J PHYSIOL-REG I, V295, pR891, DOI 10.1152/ajpregu.90444.2008; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Serrano-Gomez A, 2011, BRIT J ANAESTH, V106, P6, DOI 10.1093/bja/aeq337; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smeding L, 2012, SHOCK, V37, P449, DOI 10.1097/SHK.0b013e31824c3238; SOLOMON MA, 1994, AM J PHYSIOL, V266, pH757, DOI 10.1152/ajpheart.1994.266.2.H757; Solomon SB, 2003, SHOCK, V19, P215, DOI 10.1097/00024382-200303000-00004; Straub RH, 2005, J INFECT DIS, V192, P560, DOI 10.1086/432134; Swaminath G, 2008, ARCH PHARM, V341, P755, DOI 10.1002/ardp.200800096; Thomas R, 2014, J ANESTH, V28, P759, DOI 10.1007/s00540-014-1818-6; Thompson JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076682; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Vallet B, 2003, CRIT CARE, V7, P130, DOI 10.1186/cc1864; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Williams JP, 2008, BRIT J ANAESTH, V100, P810, DOI 10.1093/bja/aen093; Won YJ, 2013, J NEUROSCI, V33, P19314, DOI 10.1523/JNEUROSCI.3102-13.2013; Wu LL, 1999, SHOCK, V11, P39, DOI 10.1097/00024382-199901000-00006	51	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125566	10.1371/journal.pone.0125566	http://dx.doi.org/10.1371/journal.pone.0125566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017846	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600027
J	Slama, H; Deliens, G; Schmitz, R; Peigneux, P; Leproult, R				Slama, Hichem; Deliens, Gaetane; Schmitz, Remy; Peigneux, Philippe; Leproult, Rachel			Afternoon Nap and Bright Light Exposure Improve Cognitive Flexibility Post Lunch	PLOS ONE			English	Article							SLEEP-DEPRIVATION; BRAIN RESPONSES; BLUE-LIGHT; PERFORMANCE; TASK; ALERTNESS; MOOD; RECONFIGURATION; SENSITIVITY; VIGILANCE	Beneficial effects of napping or bright light exposure on cognitive performance have been reported in participants exposed to sleep loss. Nonetheless, few studies investigated the effect of these potential countermeasures against the temporary drop in performance observed in mid-afternoon, and even less so on cognitive flexibility, a crucial component of executive functions. This study investigated the impact of either an afternoon nap or bright light exposure on post-prandial alterations in task switching performance in well-rested participants. Twenty-five healthy adults participated in two randomized experimental conditions, either wake versus nap (n = 15), or bright light versus placebo (n = 10). Participants were tested on a switching task three times (morning, post-lunch and late afternoon sessions). The interventions occurred prior to the post-lunch session. In the nap/wake condition, participants either stayed awake watching a 30-minute documentary or had the opportunity to take a nap for 30 minutes. In the bright light/placebo condition, participants watched a documentary under either bright blue light or dim orange light (placebo) for 30 minutes. The switch cost estimates cognitive flexibility and measures task-switching efficiency. Increased switch cost scores indicate higher difficulties to switch between tasks. In both control conditions (wake or placebo), accuracy switch-cost score increased post lunch. Both interventions (nap or bright light) elicited a decrease in accuracy switch-cost score post lunch, which was associated with diminished fatigue and decreased variability in vigilance. Additionally, there was a trend for a post-lunch benefit of bright light with a decreased latency switch-cost score. In the nap group, improvements in accuracy switch-cost score were associated with more NREM sleep stage N1. Thus, exposure to bright light during the post-lunch dip, a countermeasure easily applicable in daily life, results in similar beneficial effects as a short nap on performance in the cognitive flexibility domain with possible additional benefits on latency switch-cost scores.	[Slama, Hichem; Deliens, Gaetane; Schmitz, Remy; Peigneux, Philippe; Leproult, Rachel] Univ Libre Bruxelles, CRCN, Neuropsychol & Funct Neuroimaging Res Grp, UR2NF, Brussels, Belgium; [Slama, Hichem; Deliens, Gaetane; Schmitz, Remy; Peigneux, Philippe; Leproult, Rachel] Univ Libre Bruxelles, UNI, ULB Neurosci Inst, Brussels, Belgium; [Slama, Hichem] Univ Libre Bruxelles, CRCN, Res Unit Cognit Neurosci, UNESCOG, Brussels, Belgium; [Deliens, Gaetane] Univ Libre Bruxelles, CRCN, Consciousness Cognit & Computat Grp, CO3, Brussels, Belgium; [Schmitz, Remy] Univ Geneva, Dept Neurosci & Clin Neurol, LABNIC Lab Neurol & Imaging Cognit, Geneva, Switzerland	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Geneva	Leproult, R (corresponding author), Univ Libre Bruxelles, CRCN, Neuropsychol & Funct Neuroimaging Res Grp, UR2NF, Brussels, Belgium.	Rachel.Leproult@ulb.ac.be	Slama, Hichem/HGA-3213-2022; Schmitz, Remy/A-6592-2012	Slama, Hichem/0000-0003-3856-4488; Schmitz, Remy/0000-0002-6303-1846; Peigneux, Philippe/0000-0003-4745-1434	"Greentic" grant from the "Departement du developpement technologique", Region Wallonne (Belgium) [DGO6]; Brussels Institute for Research and Innovation (Belgium)	"Greentic" grant from the "Departement du developpement technologique", Region Wallonne (Belgium); Brussels Institute for Research and Innovation (Belgium)(Innoviris)	GD is a postdoctoral researcher supported by a "Greentic" grant from the "Departement du developpement technologique" (DGO6), Region Wallonne (Belgium). RS is a Postdoctoral Researcher at the Belgian Fonds National de la Recherche Scientifique (FNRS). RL is currently a recipient of a grant "Brains Back to Brussels" from the Brussels Institute for Research and Innovation (Belgium). Other than providing the luminotherapy device (Luminette), Lucimed was not involved in any part of the current study (finances, study design, data collection, data analysis, preparation of the manuscript).	BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blake M. J. F., 1967, PSYCHON SCI, V9, DOI [10.3758/BF03327842, DOI 10.3758/BF03327842]; Brainard GC, 2005, J BIOL RHYTHM, V20, P314, DOI 10.1177/0748730405278951; Brainard GC, 2001, J NEUROSCI, V21, P6405; Bratzke D, 2009, J SLEEP RES, V18, P167, DOI 10.1111/j.1365-2869.2008.00729.x; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Campbell S.S., 1992, WHY WE NAP EVOLUTION, P71; Campbell SS, 1995, J BIOL RHYTHM, V10, P129, DOI 10.1177/074873049501000205; CARSKADON MA, 1992, SLEEP, V15, P396, DOI 10.1093/sleep/15.5.396; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Couyoumdjian A, 2010, J SLEEP RES, V19, P64, DOI 10.1111/j.1365-2869.2009.00774.x; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Fernandez-Mendoza J, 2010, SLEEP, V33, P459, DOI 10.1093/sleep/33.4.459; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; Gottselig JM, 2004, NEUROSCIENCE, V127, P557, DOI 10.1016/j.neuroscience.2004.05.053; Hayashi M, 1999, INT J PSYCHOPHYSIOL, V32, P173, DOI 10.1016/S0167-8760(99)00009-4; Hayashi M, 1999, CLIN NEUROPHYSIOL, V110, P272, DOI 10.1016/S1388-2457(98)00003-0; Heuer H, 2004, ACTA PSYCHOL, V117, P29, DOI 10.1016/j.actpsy.2004.04.005; Horne J., 2001, TRANSP RES F, V4, P63, DOI [10.1016/s1369-8478(01)00014-6, DOI 10.1016/S1369-8478(01)00014-6]; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Iber C., 2007, AASM MANUAL SCORING; Ikeda H, 2008, SLEEP BIOL RHYTHMS, V6, P120, DOI 10.1111/j.1479-8425.2008.00341.x; Jersild A.T., 1927, ARCH PSYCHOL, V14, P81; Kaida K, 2006, SLEEP, V29, P462, DOI 10.1093/sleep/29.4.462; Kaida K, 2013, SLEEP BIOL RHYTHMS, V11, P125, DOI 10.1111/sbr.12013; Kalanthroff E, 2014, PSYCHOL RES-PSYCH FO, V78, P276, DOI 10.1007/s00426-013-0495-7; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P8, DOI 10.1017/S1355617713001185; Lehrl S, 2007, J NEURAL TRANSM, V114, P457, DOI 10.1007/s00702-006-0621-4; Leproult R, 1997, J BIOL RHYTHM, V12, P245, DOI 10.1177/074873049701200306; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lockley SW, 2006, SLEEP, V29, P161; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; Mednick SC, 2009, VISION RES, V49, P2557, DOI 10.1016/j.visres.2009.04.011; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Milner CE, 2006, BIOL PSYCHOL, V73, P141, DOI 10.1016/j.biopsycho.2006.01.015; Milner CE, 2009, J SLEEP RES, V18, P272, DOI 10.1111/j.1365-2869.2008.00718.x; Monk Timothy H, 2005, Clin Sports Med, V24, pe15, DOI 10.1016/j.csm.2004.12.002; Owens DS, 2000, BRIT J PSYCHOL, V91, P41, DOI 10.1348/000712600161664; Pack AI, 1995, ACCIDENT ANAL PREV, V27, P769, DOI 10.1016/0001-4575(95)00034-8; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; Phipps-Nelson J, 2003, SLEEP, V26, P695, DOI 10.1093/sleep/26.6.695; Plessow F, 2011, J SLEEP RES, V20, P279, DOI 10.1111/j.1365-2869.2010.00878.x; Rahman SA, 2014, SLEEP, V37, P271, DOI 10.5665/sleep.3396; Ramirez C, 2012, SLEEP BIOL RHYTHMS, V10, P136, DOI 10.1111/j.1479-8425.2012.00540.x; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Ruger M, 2005, J SLEEP RES, V14, P221, DOI 10.1111/j.1365-2869.2005.00452.x; Serkh K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003523; SISSA Language CaDL, 2006, PSYSCOPE X; STAHL ML, 1983, SLEEP, V6, P29, DOI 10.1093/sleep/6.1.29; Stephenson KM, 2012, SLEEP MED REV, V16, P445, DOI 10.1016/j.smrv.2011.09.002; Takahashi M, 2004, ERGONOMICS, V47, P1003, DOI 10.1080/00140130410001686320; Takahashi M, 1998, EUR J APPL PHYSIOL O, V78, P93, DOI 10.1007/s004210050392; Takahashi M, 2000, SLEEP, V23, P813; Tempesta D, 2013, MED EDUC, V47, P1013, DOI 10.1111/medu.12256; Tietzel AJ, 2002, J SLEEP RES, V11, P213, DOI 10.1046/j.1365-2869.2002.00299.x; Vandewalle G, 2007, CEREB CORTEX, V17, P2788, DOI 10.1093/cercor/bhm007; Vandewalle G, 2006, J SLEEP RES, V15, P54; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Vandierendonck A, 2010, PSYCHOL BULL, V136, P601, DOI 10.1037/a0019791; Wever RA, 1985, HOURS WORK TEMPORAL, P15; Wright KP, 1997, J SLEEP RES, V6, P26, DOI 10.1046/j.1365-2869.1997.00022.x; Young SN, 2002, CAN MED ASSOC J, V166, P205; Zhang G.J., 2009, HEALTH-LONDON, V1, P284, DOI [10.4236/health.2009.14046, DOI 10.4236/HEALTH.2009.14046]	69	20	22	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125359	10.1371/journal.pone.0125359	http://dx.doi.org/10.1371/journal.pone.0125359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26016658	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600018
J	Thom, MD; Daniels, JC; Kobziar, LN; Colburn, JR				Thom, Matthew D.; Daniels, Jaret C.; Kobziar, Leda N.; Colburn, Jonathan R.			Can Butterflies Evade Fire? Pupa Location and Heat Tolerance in Fire Prone Habitats of Florida	PLOS ONE			English	Article							PRESCRIBED FIRE; TALLGRASS PRAIRIE; MANAGEMENT; ABUNDANCE; CONSERVATION; HERPETOFAUNA; TEPHRITIDAE; ARTHROPODS; STRATEGIES; DIVERSITY	Butterflies such as the atala hairstreak, Eumaeus atala Poey, and the frosted elfin, Callophrys irus Godart, are restricted to frequently disturbed habitats where their larval host plants occur. Pupae of these butterflies are noted to reside at the base of host plants or in the leaf litter and soil, which may allow them to escape direct mortality by fire, a prominent disturbance in many areas they inhabit. The capacity of these species to cope with fire is a critical consideration for land management and conservation strategies in the locations where they are found. Survival of E. atala pupae in relation to temperature and duration of heat pulse was tested using controlled water bath experiments and a series of prescribed fire field experiments. Survival of E. atala pupae was correlated to peak temperature and heat exposure in both laboratory and field trials. In addition, E. atala survival following field trials was correlated to depth of burial; complete mortality was observed for pupae at the soil surface. Fifty percent of E. atala survived the heat generated by prescribed fire when experimentally placed at depths >= 1.75cm, suggesting that pupation of butterflies in the soil at depth can protect from fatal temperatures caused by fire. For a species such as E. atala that pupates above ground, a population reduction from a burn event is a significant loss, and so decreasing the impact of prescribed fire on populations is critical.	[Thom, Matthew D.] USDA ARS, N Cent Soil Conservat Res Lab, Morris, MN 56267 USA; [Daniels, Jaret C.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Daniels, Jaret C.; Colburn, Jonathan R.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Kobziar, Leda N.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Thom, MD (corresponding author), USDA ARS, N Cent Soil Conservat Res Lab, Morris, MN 56267 USA.	matt.thom@ars.usda.gov	Jaret, Daniels/AAY-2404-2020	Kobziar, Leda/0000-0002-5882-8498	UF Alumni Assistantship	UF Alumni Assistantship	This paper was part of MDT's Ph.D. dissertation conducted at the University of Florida (UF) Entomology and Nematology Department, funded in part by a UF Alumni Assistantship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnan X, 2013, ECOGRAPHY, V36, P1182, DOI 10.1111/j.1600-0587.2013.00155.x; Battisti A, 2000, BIOCONTROL, V45, P311, DOI 10.1023/A:1009992321465; Benson TJ, 2007, J WILDLIFE MANAGE, V71, P1949, DOI 10.2193/2006-412; Borth RJ, 1997, KARNER BLUE MANAGEME, pB; Busse MD, 2010, SOIL SCI SOC AM J, V74, P947, DOI 10.2136/sssaj2009.0322; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; CHRISTIAN KA, 1992, PHYSIOL ZOOL, V65, P885, DOI 10.1086/physzool.65.5.30158548; Clayton Dale L., 2004, Journal of the Lepidopterists' Society, V58, P227; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cook JH, 1906, CAN ENTOMOL, V38, P141; Dimou I, 2003, J APPL ENTOMOL, V127, P12, DOI 10.1046/j.1439-0418.2003.00686.x; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ford WM, 1999, FOREST ECOL MANAG, V114, P233, DOI 10.1016/S0378-1127(98)00354-5; Freeman JE, 2011, ECOL APPL, V21, P61, DOI 10.1890/09-0948.1; FYE RE, 1978, J ECON ENTOMOL, V71, P570, DOI 10.1093/jee/71.4.570; FYE RE, 1973, J ECON ENTOMOL, V66, P657, DOI 10.1093/jee/66.3.657; Garrison E.G., 2003, NAT SCI ARC; Gongalsky KB, 2013, SOIL BIOL BIOCHEM, V57, P182, DOI 10.1016/j.soilbio.2012.07.005; Grigore MT, 1996, NAT AREA J, V16, P41; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harper MG, 2000, NAT AREA J, V20, P325; Hester T. R., 1997, FIELD METHODS ARCHAE; Heuberger KA, 2003, RESTOR ECOL, V11, P72, DOI 10.1046/j.1526-100X.2003.09982.x; Hughes Patrick R., 1993, American Entomologist, V39, P109; Keeley Jon E., 1998, P219; Kim TN, 2012, OECOLOGIA, V168, P997, DOI 10.1007/s00442-011-2130-x; Kirk K, 1996, KARNER BLUE COMMUNIT, pB; McCullough DG, 1998, ANNU REV ENTOMOL, V43, P107, DOI 10.1146/annurev.ento.43.1.107; Menges ES, 1998, ECOL APPL, V8, P935, DOI 10.1890/1051-0761(1998)008[0935:IEOFAM]2.0.CO;2; Meyer R, 2006, LUPINUS PERENNIS; Montoya P, 2008, FLA ENTOMOL, V91, P643; Myers R.L., 1990, P150; Neary D.G., 2005, WILDLAND FIRE ECOSYS; Panzer R, 2000, BIOL CONSERV, V96, P363, DOI 10.1016/S0006-3207(00)00065-3; Panzer R, 2002, CONSERV BIOL, V16, P1296, DOI 10.1046/j.1523-1739.2002.01077.x; Panzer R, 2003, NAT AREA J, V23, P14; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pavlovic NB, 2009, RESTOR ECOL, V17, P807, DOI 10.1111/j.1526-100X.2008.00417.x; PLATT WJ, 1988, AM NAT, V131, P491, DOI 10.1086/284803; Possley J, 2009, RESTOR ECOL, V17, P668, DOI 10.1111/j.1526-100X.2008.00395.x; Prodon R., 1987, P121; Ricouart F, 2013, J INSECT CONSERV, V17, P95, DOI 10.1007/s10841-012-9489-9; Rowe J.S., 1983, ROLE FIRE NO CIRCUMP, P18; Russell KR, 1999, WILDLIFE SOC B, V27, P374; Schultz CB, 1998, RESTOR ECOL, V6, P244, DOI 10.1046/j.1526-100X.1998.00637.x; SCHWEITZER D. F., 2011, RARE DECLINING POORL; Schwilk DW, 2001, OIKOS, V94, P326, DOI 10.1034/j.1600-0706.2001.940213.x; Snyder J.R., 1990, P230; Stout IJ, 1993, BIODIVERSITY SE US L; Swengel AB, 1998, BIOL CONSERV, V83, P77, DOI 10.1016/S0006-3207(96)00129-2; Swengel AB, 1996, BIOL CONSERV, V76, P73, DOI 10.1016/0006-3207(95)00085-2; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1757, DOI 10.1023/A:1012051510584; Swengel AB, 2007, J INSECT CONSERV, V11, P263, DOI 10.1007/s10841-006-9042-9; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Vogel JA, 2010, J INSECT CONSERV, V14, P663, DOI 10.1007/s10841-010-9295-1; Waltz AEM, 2004, RESTOR ECOL, V12, P85, DOI 10.1111/j.1061-2971.2004.00262.x; Whelan R.J.., 1995, ECOLOGY FIRE; Wikars LO, 2001, FOREST ECOL MANAG, V141, P189, DOI 10.1016/S0378-1127(00)00328-5; Zheng XL, 2011, B INSECTOL, V64, P209	60	86	87	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126755	10.1371/journal.pone.0126755	http://dx.doi.org/10.1371/journal.pone.0126755			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016779	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600059
J	Akkad, DA; Olischewsky, A; Reiner, F; Hellwig, K; Esser, S; Epplen, JT; Curk, T; Gold, R; Haghikia, A				Akkad, Denis A.; Olischewsky, Alexandra; Reiner, Franziska; Hellwig, Kerstin; Esser, Sarika; Epplen, Joerg T.; Curk, Tomaz; Gold, Ralf; Haghikia, Aiden			Combinations of Susceptibility Genes Are Associated with Higher Risk for Multiple Sclerosis and Imply Disease Course Specificity	PLOS ONE			English	Article							GENETICS; LOCI	Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system that predominantly affects young adults. The genetic contributions to this multifactorial disease were underscored by a genome wide association study (GWAS) conducted by the International Multiple Sclerosis Genetic Consortium in a multinational cohort prompting the discovery of 57 non-MHC MS-associated common genetic variants. Hitherto, few of these newly reported variants have been replicated in larger independent patient cohorts. We genotyped a cohort of 1033 MS patients and 644 healthy controls with a consistent genetic background for the 57 non-MHC variants reported to be associated with MS by the first large GWAS as well as the HLA DRB1*1501 tagging SNP rs3135388. We robustly replicated three of the 57 non-MHC reported MS-associated single nucleotide polymorphisms (SNPs). In addition, our study revealed several genotype-genotype combinations with an evidently higher degree of disease association than the genotypes of the single SNPs. We further correlated well-defined clinical phenotypes, i.e. ataxia, visual impairment due to optic neuritis and paresis with single SNPs and genotype combinations, and identified several associations. The results may open new avenues for clinical implications of the MS associated genetic variants reported from large GWAS.	[Akkad, Denis A.; Esser, Sarika; Epplen, Joerg T.] Ruhr Univ Bochum, Dept Human Genet, Bochum, Germany; [Olischewsky, Alexandra; Reiner, Franziska; Hellwig, Kerstin; Gold, Ralf; Haghikia, Aiden] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; [Curk, Tomaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia	Ruhr University Bochum; Ruhr University Bochum; University of Ljubljana	Akkad, DA (corresponding author), Ruhr Univ Bochum, Dept Human Genet, Univ Str 150, Bochum, Germany.	amer.akkad@ruhr-uni-bochum.de; aiden.haghikia@ruhr-uni-bochum.de	Curk, Tomaž/D-9836-2015	Curk, Tomaž/0000-0003-4888-7256; Epplen, Joerg T./0000-0002-6087-3327	German Research Council (DFG); Medical Faculty of The Ruhr-University Bochum (FoRUM)	German Research Council (DFG)(German Research Foundation (DFG)); Medical Faculty of The Ruhr-University Bochum (FoRUM)	Aiden Haghikia has received funding from the German Research Council (DFG) Denis A Akkad has received funding from the Medical Faculty of The Ruhr-University Bochum (FoRUM).	Akkad DA, 2015, NEUROGENETICS; Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Couturier N, 2011, BRAIN, V134, P693, DOI 10.1093/brain/awr010; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Faresjo T, 2010, INT J ENV RES PUB HE, V7, P325, DOI 10.3390/ijerph7010325; Gauderman WJ, 2006, QUANTO 1 1 A COMPUTE; Gourraud PA, 2011, ANN NEUROL, V69, P65, DOI 10.1002/ana.22323; Gravitz L, 2012, NATURE, V484, pS2, DOI 10.1038/nature11103; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Haghikia A, 2013, TRENDS MOL MED, V19, P309, DOI 10.1016/j.molmed.2013.03.004; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Hughes T, 2012, ARTHRITIS RHEUM-US, V64, P485, DOI 10.1002/art.33354; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Oksenberg JR, 2010, NAT REV NEUROL, V6, P429, DOI 10.1038/nrneurol.2010.91; Pritchard JK, 2000, GENETICS, V155, P945; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawcer S, 2010, ANN NEUROL, V67, P3, DOI 10.1002/ana.21911; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411	20	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127632	10.1371/journal.pone.0127632	http://dx.doi.org/10.1371/journal.pone.0127632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011527	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900119
J	Ghate, NB; Chaudhuri, D; Das, A; Panja, S; Mandal, N				Ghate, Nikhil Baban; Chaudhuri, Dipankar; Das, Abhishek; Panja, Sourav; Mandal, Nripendranath			An Antioxidant Extract of the Insectivorous Plant Drosera burmannii Vahl. Alleviates Iron-Induced Oxidative Stress and Hepatic Injury in Mice	PLOS ONE			English	Article							THALASSEMIA MAJOR; LONG-TERM; LIVER; OVERLOAD; ACID; HEMOCHROMATOSIS; SUPEROXIDE; MECHANISMS; RESERPINE	Free iron typically leads to the formation of excess free radicals, and additional iron deposition in the liver contributes to the oxidative pathologic processes of liver disease. Many pharmacological properties of the insectivorous plant Drosera burmannii Vahl. have been reported in previous studies; however, there is no evidence of its antioxidant or hepatoprotective potential against iron overload. The antioxidant activity of 70% methanolic extract of D. burmannii (DBME) was evaluated. DBME showed excellent DPPH, hydroxyl, hypochlorous, superoxide, singlet oxygen, nitric oxide, peroxynitrite radical and hydrogen peroxide scavenging activity. A substantial iron chelation (IC50 = 40.90 +/- 0.31 mu g/ml) and supercoiled DNA protection ([P](50) = 50.41 +/- 0.55 mu g) were observed. DBME also displayed excellent in vivo hepatoprotective activity in iron-overloaded Swiss albino mice compared to the standard desirox treatment. Administration of DBME significantly normalized serum enzyme levels and restored liver antioxidant enzymes levels. DBME lowered the raised levels of liver damage parameters, also reflected from the morphological analysis of the liver sections. DBME also reduced liver iron content by 115.90% which is also seen by Perls' staining. A phytochemical analysis of DBME confirms the presence of various phytoconstituents, including phenols, flavonoids, carbohydrates, tannins, alkaloids and ascorbic acid. Alkaloids, phenols and flavonoids were abundantly found in DBME. An HPLC analysis of DBME revealed the presence of purpurin, catechin, tannic acid, reserpine, methyl gallate and rutin. Purpurin, tannic acid, methyl gallate and rutin displayed excellent iron chelation but exhibited cytotoxicity toward normal (WI-38) cells; while DBME found to be non-toxic to the normal cells. These findings suggest that the constituents present in DBME contributed to its iron chelation activity. Additional studies are needed to determine if DBME can be used as a treatment for iron overload diseases.	[Ghate, Nikhil Baban; Chaudhuri, Dipankar; Das, Abhishek; Panja, Sourav; Mandal, Nripendranath] Bose Inst, Div Mol Med, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute	Mandal, N (corresponding author), Bose Inst, Div Mol Med, P 1-12,Scheme VIIM, Kolkata, W Bengal, India.	mandaln@rediffmail.com	PANJA, SOURAV/AAA-7163-2022; Mandal, Nripendranath/ABC-3918-2020; Panja, Sourav/AFO-5798-2022; Chudhuri, Dipankar/AAU-6215-2021; Ghate, Nikhil/T-4153-2017	Mandal, Nripendranath/0000-0002-8733-3566; Panja, Sourav/0000-0001-8540-5266; Ghate, Nikhil/0000-0002-4447-3737; Chaudhuri, Dipankar/0000-0001-7991-0469	Department of Biotechnology (DBT), Govt. of India	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India)	Dr. Abhishek Das is grateful to the Department of Biotechnology (DBT), Govt. of India for the support of Research Associateship.	ALREFAIE FN, 1992, BLOOD, V80, P593; [Anonymous], 1998, WEALTH INDIA, V3; Arezzini B, 2003, INT J BIOCHEM CELL B, V35, P486, DOI 10.1016/S1357-2725(02)00298-4; Arthur MJP, 1996, J GASTROEN HEPATOL, V11, P1124, DOI 10.1111/j.1440-1746.1996.tb01840.x; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; BARRY M, 1971, LANCET, V1, P100; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Begum S, 2012, NAT PROD RES, V26, P2084, DOI 10.1080/14786419.2011.625502; Bibhabasu Hazra, 2012, American Journal of Pharmacology and Toxicology, V7, P109; BONAVENTURA J, 1972, ARCH BIOCHEM BIOPHYS, V150, P606, DOI 10.1016/0003-9861(72)90080-X; BONKOWSKY HL, 1981, BIOCHEM J, V196, P57, DOI 10.1042/bj1960057; Buege J A, 1978, Methods Enzymol, V52, P302; Christophe W, 2006, ETHNOPHARMACOLOGY ME, P37; Das A., 2012, ASIAN J PHARM CLIN R, V5, P74; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gardi C, 2002, BIOCHEM PHARMACOL, V64, P1139, DOI 10.1016/S0006-2952(02)01257-1; Ghate NB, 2014, CYTOTECHNOLOGY, V66, P209, DOI 10.1007/s10616-013-9553-7; Ghate NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082293; GOLDIN A, 1957, SCIENCE, V125, P156, DOI 10.1126/science.125.3239.156-a; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Harborne J.B., 1995, PHYTOCHEMICAL DICT H; Haro-Vicente JF, 2006, FOOD CHEM, V98, P639, DOI 10.1016/j.foodchem.2005.06.040; Hazra B, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-63; Hema B., 2009, INT J APPL RES NAT P, V2, P1; Hermes-Lima M, 1998, FREE RADICAL BIO MED, V25, P875, DOI 10.1016/S0891-5849(98)00117-8; Hynes MJ, 2002, J INORG BIOCHEM, V90, P18, DOI 10.1016/S0162-0134(02)00383-5; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kochevar IE, 2000, METHOD ENZYMOL, V319, P20; Kokate C, 2017, PHARMACOGNOSY, V53rd, pA22; Kumar M., 2012, ASIAN PAC J TROP DIS, V2S, pS692, DOI [DOI 10.1016/S2222-1808(12)60245-X, 10.1016/S2222-1808(12)60245-X]; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; Madhavan V, 2009, PHARM BIOL, V47, P128, DOI 10.1080/13880200802437149; MAXWELL SRJ, 1995, DRUGS, V49, P345, DOI 10.2165/00003495-199549030-00003; Nabavi S M, 2008, PHARMACOLOGYONLINE, V2, P560, DOI DOI 10.1007/BF01091994; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; OBRIEN RT, 1974, ANN NY ACAD SCI, V232, P221, DOI 10.1111/j.1749-6632.1974.tb20588.x; OLYNYK J, 1995, J HEPATOL, V22, P671, DOI 10.1016/0168-8278(95)80222-3; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Raju A., 2012, Journal of Pharmacy Research, V5, P1418; Ramm GA, 2005, SEMIN LIVER DIS, V25, P433, DOI 10.1055/s-2005-923315; Reddy ACP, 1996, TOXICOLOGY, V107, P39, DOI 10.1016/0300-483X(95)03199-P; Richardson, 1999, Expert Opin Investig Drugs, V8, P2141, DOI 10.1517/13543784.8.12.2141; Sarkar R, 2013, INDIAN J EXP BIOL, V51, P165; Sarkar R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/896341; Sayre Lawrence M, 2005, Ann Ist Super Sanita, V41, P143; de Jesus NZT, 2012, INT J MOL SCI, V13, P3203, DOI 10.3390/ijms13033203; VINKENBORG J, 1969, Pharmaceutisch Weekblad, V104, P45; Visioli F, 1998, BIOCHEM BIOPH RES CO, V247, P60, DOI 10.1006/bbrc.1998.8735; Wagner H., 1984, PLANT DRUG ANAL; Wang Q, 1998, Zhong Yao Cai, V21, P401; Ward FM, 1999, CLIN PHARMACOL THER, V5thed, P195; Wolf P L, 1999, Indian J Clin Biochem, V14, P59, DOI 10.1007/BF02869152; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7	56	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128221	10.1371/journal.pone.0128221	http://dx.doi.org/10.1371/journal.pone.0128221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010614	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900209
J	Gross, JA; Bureau, A; Croteau, J; Galfalvy, H; Oquendo, MA; Haghighi, F; Merette, C; Giegling, I; Hodgkinson, C; Goldman, D; Rujescu, D; Mann, JJ; Turecki, G				Gross, Jeffrey A.; Bureau, Alexandre; Croteau, Jordie; Galfalvy, Hanga; Oquendo, Maria A.; Haghighi, Fatemeh; Merette, Chantal; Giegling, Ina; Hodgkinson, Colin; Goldman, David; Rujescu, Dan; Mann, J. John; Turecki, Gustavo			A Genome-Wide Copy Number Variant Study of Suicidal Behavior	PLOS ONE			English	Article							BIPOLAR DISORDER; LRRK2; POPULATION; PHOSPHORYLATION; MUTATIONS; LINKAGE; RISK; CNVS	Suicide and suicide attempts are complex behaviors that result from the interaction of different factors, including genetic variants that increase the predisposition to suicidal behaviors. Copy number variations (CNVs) are deletions or duplications of a segment of DNA usually larger than one kilobase. These structural genetic changes, although quite rare, have been associated with genetic liability to mental disorders, such as autism, schizophrenia, and bipolar disorder. No genome-wide level studies have been published investigating the potential role of CNVs in suicidal behaviors. Based on single-nucleotide polymorphism array data, we followed the Penn-CNV standards to detect CNVs in 1,608 subjects, comprising 475 suicide and suicide attempt cases and 1,133 controls. Although the initial algorithms determined the presence of CNVs on chromosomes 6 and 12 in seven and eight cases, respectively, compared with none of the controls, visual inspection of the raw data did not support this finding. Furthermore we were unable to validate these findings by CNV-specific real-time polymerase chain reaction. Additionally, rare CNV burden analysis did not find an association between the frequency or length of rare CNVs and suicidal behavior in our sample population. Although our findings suggest CNVs do not play an important role in the etiology of suicidal behaviors, they are not inconsistent with the strong evidence from the literature suggesting that other genetic variants account for a portion of the total phenotypic variability in suicidal behavior.	[Gross, Jeffrey A.; Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Bureau, Alexandre; Croteau, Jordie; Merette, Chantal] Univ Laval, Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Galfalvy, Hanga; Haghighi, Fatemeh] Columbia Univ, Dept Psychiat, Div Biostat, New York, NY USA; [Oquendo, Maria A.; Mann, J. John] Columbia Univ, Dept Psychiat, Mol Imaging & Neuropathol Div, New York, NY USA; [Hodgkinson, Colin; Goldman, David] NIAAA, Neurogenet Lab, NIH, Rockville, MD 20852 USA; [Giegling, Ina; Rujescu, Dan] Univ Halle Wittenberg, Psychiat Clin, D-06108 Halle, Saxony Anhalt, Germany	McGill University; Laval University; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Martin Luther University Halle Wittenberg	Turecki, G (corresponding author), Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada.	gustavo.turecki@mcgill.ca	Oquendo, Maria/AAC-6237-2019; Turecki, Gustavo/K-5100-2015; Giegling, Ina/ABA-3677-2021; Majid, Salma/AAT-2616-2020; Rujescu, Dan/GRS-3875-2022; Goldman, David/F-9772-2010; Galfalvy, Hanga/AAI-5492-2020	Majid, Salma/0000-0002-1724-5405; Goldman, David/0000-0002-1724-5405; Galfalvy, Hanga/0000-0001-7156-6106; Hodgkinson, Colin/0000-0002-5365-8119; Bureau, Alexandre/0000-0001-8220-9999; Turecki, Gustavo/0000-0003-4075-2736	NIH [R01MH082188]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support was provided by NIH grant R01MH082188 to GT, JJM, and DR (http://projectreporter.nih.gov/project_info_description.cfm?aid=7527841&icde=21862620&ddparam=&ddvalue=&ddsub=&cr=5&csb=default&cs=ASC).	[Anonymous], 2012, WORLD HLTH STAT; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Brent DA, 1996, ARCH GEN PSYCHIAT, V53, P1145; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Ernst C, 2009, PROG NEUROBIOL, V89, P315, DOI 10.1016/j.pneurobio.2009.09.001; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Glessner JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015463; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Kelly TM, 1996, ACTA PSYCHIAT SCAND, V94, P337, DOI 10.1111/j.1600-0447.1996.tb09869.x; Li HL, 2013, CNS NEUROSCI THER, V19, P207, DOI 10.1111/cns.12062; Ling H, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.011; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Manzoni C, 2013, BIOCHEM BIOPH RES CO, V441, P862, DOI 10.1016/j.bbrc.2013.10.159; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; McGirr A, 2009, AM J PSYCHIAT, V166, P1124, DOI 10.1176/appi.ajp.2009.08111744; McQuillin A, 2011, EUR J HUM GENET, V19, P588, DOI 10.1038/ejhg.2010.221; Muda K, 2014, P NATL ACAD SCI USA, V111, pE34, DOI 10.1073/pnas.1312701111; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oquendo MA, 2014, MOL PSYCHIATR, V19, P902, DOI 10.1038/mp.2013.128; Perlis RH, 2012, AM J PSYCHIAT, V169, P1213, DOI 10.1176/appi.ajp.2012.12050592; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samarakoon PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-661; Statham DJ, 1998, PSYCHOL MED, V28, P839, DOI 10.1017/S0033291798006916; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Turecki G, 2001, BIPOLAR DISORD, V3, P335, DOI 10.1034/j.1399-5618.2001.30608.x; Turecki G, 2012, TRENDS NEUROSCI, V35, P14, DOI 10.1016/j.tins.2011.11.008; van Heeringen K, 2014, LANCET PSYCHIAT, V1, P63, DOI 10.1016/S2215-0366(14)70220-2; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weaver S, 2010, METHODS, V50, P271, DOI 10.1016/j.ymeth.2010.01.003; Zackrisson AL, 2010, CLIN PHARMACOL THER, V88, P354, DOI 10.1038/clpt.2009.216	38	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128369	10.1371/journal.pone.0128369	http://dx.doi.org/10.1371/journal.pone.0128369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010658	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900230
J	Lichtenstein, JHR; Hsu, YH; Gavin, IM; Donaghey, TC; Molina, RM; Thompson, KJ; Chi, CL; Gillis, BS; Brain, JD				Lichtenstein, Jamie H. Rosenblum; Hsu, Yi-Hsiang; Gavin, Igor M.; Donaghey, Thomas C.; Molina, Ramon M.; Thompson, Khristy J.; Chi, Chih-Lin; Gillis, Bruce S.; Brain, Joseph D.			Environmental Mold and Mycotoxin Exposures Elicit Specific Cytokine and Chemokine Responses	PLOS ONE			English	Article							ACUTE PULMONARY HEMORRHAGE; BLOOD MONONUCLEAR-CELLS; STACHYBOTRYS-CHARTARUM; FUNGAL SPORES; RESPIRATORY HEALTH; ATOPIC-DERMATITIS; ALLERGIC-ASTHMA; SATRATOXIN-G; TIME-COURSE; CANCER	Background Molds can cause respiratory symptoms and asthma. We sought to use isolated peripheral blood mononuclear cells (PBMCs) to understand changes in cytokine and chemokine levels in response to mold and mycotoxin exposures and to link these levels with respiratory symptoms in humans. We did this by utilizing an ex vivo assay approach to differentiate mold-exposed patients and unexposed controls. While circulating plasma chemokine and cytokine levels from these two groups might be similar, we hypothesized that by challenging their isolated white blood cells with mold or mold extracts, we would see a differential chemokine and cytokine release. Methods and Findings Peripheral blood mononuclear cells (PBMCs) were isolated from blood from 33 patients with a history of mold exposures and from 17 controls. Cultured PBMCs were incubated with the most prominent Stachybotrys chartarum mycotoxin, satratoxin G, or with aqueous mold extract, ionomycin, or media, each with or without PMA. Additional PBMCs were exposed to spores of Aspergillus niger, Cladosporium herbarum and Penicillium chrysogenum. After 18 hours, cytokines and chemokines released into the culture medium were measured by multiplex assay. Clinical histories, physical examinations and pulmonary function tests were also conducted. After ex vivo PBMC exposures to molds or mycotoxins, the chemokine and cytokine profiles from patients with a history of mold exposure were significantly different from those of unexposed controls. In contrast, biomarker profiles from cells exposed to media alone showed no difference between the patients and controls. Conclusions These findings demonstrate that chronic mold exposures induced changes in inflammatory and immune system responses to specific mold and mycotoxin challenges. These responses can differentiate mold-exposed patients from unexposed controls. This strategy may be a powerful approach to document immune system responsiveness to molds and other inflammation-inducing environmental agents.	[Lichtenstein, Jamie H. Rosenblum; Hsu, Yi-Hsiang; Donaghey, Thomas C.; Molina, Ramon M.; Thompson, Khristy J.; Brain, Joseph D.] Harvard Univ, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, TH Chan Sch Publ Hlth, Boston, MA 02163 USA; [Lichtenstein, Jamie H. Rosenblum] Emerson Coll, Inst Liberal Arts, Boston, MA 02116 USA; [Hsu, Yi-Hsiang] Hebrew Senior Life Inst Aging Res, Boston, MA USA; [Hsu, Yi-Hsiang] Harvard Univ, Sch Med, Boston, MA USA; [Hsu, Yi-Hsiang] Broad Inst & Harvard, Cambridge, MA USA; [Gavin, Igor M.] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Chi, Chih-Lin] Univ Minnesota, Sch Nursing, Inst Hlth Informat, Minneapolis, MN 55455 USA; [Gillis, Bruce S.] Univ Illinois, Coll Med, Dept Med, Chicago, IL USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Hebrew SeniorLife; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lichtenstein, JHR (corresponding author), Harvard Univ, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, TH Chan Sch Publ Hlth, Boston, MA 02163 USA.	jrosenbl@hsph.harvard.edu			National Institutes of Health; National Institute of Environmental Health Sciences [ES000002]; Harvard University; Bruce S. Gillis, MD, MPH, Inc.; National Institutes of Health (US) [HL007118]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Harvard University; Bruce S. Gillis, MD, MPH, Inc.; National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health and National Institute of Environmental Health Sciences www.nih.gov ES000002 (JHRL, YH, TCD, RMM, KJT, JDB), Harvard University www.harvard.edu Cecil K. and Philip Drinker Professorship (JDB) and Bruce S. Gillis, MD, MPH, Inc. bgillis@epicgtx.com (JDB). National Institutes of Health (US) grant #HL007118 to JHRL. BSG was actively involved in study design, patient and control recruitment, sample collection, and writing and editing the manuscript. Bruce S. Gillis, MD, MPH, Inc. provided some of the funding for the study and BSG has a financial interest in Bruce S. Gillis, MD, MPH, Inc.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Al-Ahmad M, 2010, ALLERGY, V65, P245, DOI 10.1111/j.1398-9995.2009.02157.x; Alkhalaf A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013421; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bae HK, 2009, TOXICOL APPL PHARM, V237, P137, DOI 10.1016/j.taap.2009.03.006; Barbeau DN, 2010, ANNU REV PUBL HEALTH, V31, P165, DOI 10.1146/annurev.publhealth.012809.103643; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Baxi SN, 2013, PEDIAT ALLERG IMM-UK, V24, P697, DOI 10.1111/pai.12127; Behm FG, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-25; Betancourt DA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-283; Bisset LR, 2005, CURR OPIN PULM MED, V11, P35, DOI 10.1097/01.mcp.0000144502.50149.e0; Blatter Joshua, 2014, Ann Am Thorac Soc, V11, P925, DOI 10.1513/AnnalsATS.201402-077OC; Boardman M, 2006, INT JOINT C NEUR NET; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P33; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P180; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chung YJ, 2003, TOXICOL MECH METHOD, V13, P247, DOI 10.1080/713857196; Clark N, 2004, DAMP INDOOR SPACES H; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Crook Brian, 2010, Fungal Biology Reviews, V24, P106, DOI 10.1016/j.fbr.2010.05.001; Dales RE, 1997, INT J EPIDEMIOL, V26, P120, DOI 10.1093/ije/26.1.120; de Mello LM, 2009, IMMUNOL LETT, V124, P88, DOI 10.1016/j.imlet.2009.04.011; Dearborn DG, 2002, PEDIATRICS, V110, P627, DOI 10.1542/peds.110.3.627; Dearborn DG, 1999, ENVIRON HEALTH PERSP, V107, P495, DOI 10.1289/ehp.99107s3495; Engman LH, 2007, SCAND J PUBLIC HEALT, V35, P125, DOI 10.1080/14034940600975658; Etzel RA, 1998, ARCH PEDIAT ADOL MED, V152, P757; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; Fitzpatrick DR, 2003, CLIN IMMUNOL, V109, P37, DOI 10.1016/S1521-6616(03)00205-5; Flamant-Hulin M, 2013, PEDIAT ALLERG IMM-UK, V24, P345, DOI 10.1111/pai.12082; Flemming J, 2004, TOXICOL SCI, V78, P267, DOI 10.1093/toxsci/kfh064; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Garrett MH, 1998, CLIN EXP ALLERGY, V28, P459, DOI 10.1046/j.1365-2222.1998.00255.x; Gavin IM, 2007, ENVIRON MOL MUTAGEN, V48, P650, DOI 10.1002/em.20331; Gillis B, 2007, GENOMICS, V90, P324, DOI 10.1016/j.ygeno.2007.05.003; Grazziutti ML, 1997, J INFECT DIS, V176, P1579, DOI 10.1086/514157; Grimsley LF, 2012, ENVIRON HEALTH PERSP, V120, P1600, DOI 10.1289/ehp.1104840; Hastie T, 2004, J MACH LEARN RES, V5, P1391; Havaux X, 2005, CLIN EXP IMMUNOL, V139, P179, DOI 10.1111/j.1365-2249.2004.02679.x; Hope AP, 2007, ALLERGY ASTHMA PROC, V28, P262, DOI 10.2500/aap.2007.28.3004; Hudson B, 2005, J TOXICOL ENV HEAL A, V68, P1321, DOI 10.1080/15287390590953572; Huttunen K, 2003, ENVIRON HEALTH PERSP, V111, P85, DOI 10.1289/ehp.5478; Hyvarinen A, 2003, ARCH ENVIRON HEALTH, V58, P275; Immonen J, 2002, PEDIATR ALLERGY IMMU, V13, P125, DOI 10.1034/j.1399-3038.2002.01003.x; Inoue Y, 2005, J IMMUNOL, V175, P5439, DOI 10.4049/jimmunol.175.8.5439; Islam Z, 2008, TOXICOL SCI, V105, P142, DOI 10.1093/toxsci/kfn110; Jarvis BB, 1998, APPL ENVIRON MICROB, V64, P3620; Jin GX, 2008, J PROTEOME RES, V7, P4013, DOI 10.1021/pr8002886; Johanning E, 1996, INT ARCH OCC ENV HEA, V68, P207; Kanda N, 2002, CLIN EXP ALLERGY, V32, P1243, DOI 10.1046/j.1365-2745.2002.01459.x; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; KIM MS, 1990, APPL OPTICS, V29, P1203, DOI 10.1364/AO.29.001203; Kimura M, 1999, CLIN EXP IMMUNOL, V118, P192; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Lappalainen MHJ, 2012, INT ARCH ALLERGY IMM, V159, P194, DOI 10.1159/000335596; LEAVITT RD, 1977, J BIOL CHEM, V252, P2961; Leino M, 2003, CLIN EXP ALLERGY, V33, P1603, DOI 10.1046/j.1365-2222.2003.01808.x; Lichtenstein JHR, 2006, AM J RESP CELL MOL, V35, P415, DOI 10.1165/rcmb.2005-0483OC; Lichtenstein JHR, 2010, TOXICOL SCI, V116, P113, DOI 10.1093/toxsci/kfq104; Liu JJ, 2005, BIOINFORMATICS, V21, P2691, DOI 10.1093/bioinformatics/bti419; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Murtoniemi T, 2001, INHAL TOXICOL, V13, P233; O'Driscoll B Ronan, 2005, BMC Pulm Med, V5, P4, DOI 10.1186/1471-2466-5-4; Ozdemir Cevdet, 2009, Ther Adv Respir Dis, V3, P253, DOI 10.1177/1753465809349522; Peng SH, 2003, FEBS LETT, V555, P358, DOI 10.1016/S0014-5793(03)01275-4; Pestka JJ, 2008, TOXICOL SCI, V104, P4, DOI 10.1093/toxsci/kfm284; Purokivi MK, 2001, EUR RESPIR J, V18, P951, DOI 10.1183/09031936.01.00201201; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quansah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047526; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rao CY, 2000, MYCOPATHOLOGIA, V149, P27, DOI 10.1023/A:1007239017018; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shahan TA, 1998, AM J RESP CELL MOL, V18, P435, DOI 10.1165/ajrcmb.18.3.2856; Shalit I, 2006, J ANTIMICROB CHEMOTH, V57, P230, DOI 10.1093/jac/dki441; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Stark H, 2006, INHAL TOXICOL, V18, P1033, DOI 10.1080/08958370600904579; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Swirski FK, 2002, J IMMUNOL, V169, P3499, DOI 10.4049/jimmunol.169.7.3499; Tischer CG, 2013, INT J HYG ENVIR HEAL, V216, P109, DOI 10.1016/j.ijheh.2012.05.002; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Viana ME, 2002, TOXICOL SCI, V70, P98, DOI 10.1093/toxsci/70.1.98; Weinmayr G, 2013, CLIN EXP ALLERGY, V43, P762, DOI 10.1111/cea.12107; Xiong MM, 2001, GENOME RES, V11, P1878, DOI 10.1101/gr.190001; YACHNIN S, 1972, IMMUNOLOGY, V22, P871; Yike I, 2005, TOXICOL SCI, V84, P408, DOI 10.1093/toxsci/kfi080; Yike I, 2006, ENVIRON HEALTH PERSP, V114, P1221, DOI 10.1289/ehp.9064; Zhang F, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S4; Zock JP, 2002, J ALLERGY CLIN IMMUN, V110, P285, DOI 10.1067/mai.2002.126383	93	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126926	10.1371/journal.pone.0126926	http://dx.doi.org/10.1371/journal.pone.0126926			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010737	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900050
J	Scobie, HM; Ray, A; Routray, S; Bose, A; Bahl, S; Sosler, S; Wannemuehler, K; Kumar, R; Haldar, P; Anand, A				Scobie, Heather M.; Ray, Arindam; Routray, Satyabrata; Bose, Anindya; Bahl, Sunil; Sosler, Stephen; Wannemuehler, Kathleen; Kumar, Rakesh; Haldar, Pradeep; Anand, Abhijeet			Cluster Survey Evaluation of a Measles Vaccination Campaign in Jharkhand, India, 2012	PLOS ONE			English	Article							ROUTINE IMMUNIZATION; POLIO ERADICATION; COVERAGE; ELIMINATION	Introduction India was the last country in the world to implement a two-dose strategy for measles-containing vaccine (MCV) in 2010. As part of measles second-dose introduction, phased measles vaccination campaigns were conducted during 2010-2013, targeting 131 million children 9 months to < 10 years of age. We performed a post-campaign coverage survey to estimate measles vaccination coverage in Jharkhand state. Methods A multi-stage cluster survey was conducted 2 months after the phase 2 measles campaign occurred in 19 of 24 districts of Jharkhand during November 2011-March 2012. Vaccination status of children 9 months to < 10 years of age was documented based on vaccination card or mother's recall. Coverage estimates and 95% confidence intervals (95% CI) for 1,018 children were calculated using survey methods. Results In the Jharkhand phase 2 campaign, MCV coverage among children aged 9 months to < 10 years was 61.0% (95% CI: 54.4-67.7%). Significant differences in coverage were observed between rural (65.0%; 95% CI: 56.8-73.2%) and urban areas (45.6%; 95% CI: 37.3-53.9%). Campaign awareness among mothers was low (51.5%), and the most commonly reported reason for non-vaccination was being unaware of the campaign (69.4%). At the end of the campaign, 53.7% (95% CI: 46.5-60.9%) of children 12 months to < 10 years of age received >= 2 MCV doses, while a large proportion of children remained under-vaccinated (34.0%, 95% CI: 28.0-40.0%) or unvaccinated (12.3%, 95% CI: 9.3-16.2%). Conclusions Implementation of the national measles campaign was a significant achievement towards measles elimination in India. In Jharkhand, campaign performance was below the target coverage of >= 90% set by the Government of India, and challenges in disseminating campaign messages were identified. Efforts towards increasing two-dose MCV coverage are needed to achieve the recently adopted measles elimination goal in India and the South-East Asia region.	[Scobie, Heather M.; Wannemuehler, Kathleen; Anand, Abhijeet] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA 30332 USA; [Scobie, Heather M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Ray, Arindam; Routray, Satyabrata; Bose, Anindya; Bahl, Sunil; Sosler, Stephen] WHO, Country Off, Natl Polio Surveillance Project, New Delhi, India; [Kumar, Rakesh; Haldar, Pradeep] Govt India, Minist Hlth & Family Welf, New Delhi, India	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Scobie, HM (corresponding author), Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA 30332 USA.	hscobie@cdc.gov	Ray, Arindam/AAN-1525-2020	Ray, Arindam/0000-0002-5955-0352; Wannemuehler, Kathleen/0000-0001-9535-6277; Bose, Anindya Sekhar/0000-0002-7657-8648	National Polio Surveillance Project; World Health Organization Country Office; U.S. Centers for Disease Control and Prevention (CDC)	National Polio Surveillance Project; World Health Organization Country Office(World Health Organization); U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by the National Polio Surveillance Project, World Health Organization Country Office and U.S. Centers for Disease Control and Prevention (CDC). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. CDC or other organizations.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P349; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1321; Bagonza J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-202; Bahl S, 2014, MMWR-MORBID MORTAL W, V63, pCOVER1; BALRAJ V, 1986, B WORLD HEALTH ORGAN, V64, P861; Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819; Closser S, 2014, J INFECT DIS, V210, pS504, DOI 10.1093/infdis/jit232; Fields R, 2013, VACCINE, V31, pB115, DOI 10.1016/j.vaccine.2012.11.094; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Government of India, 2011, VILLAGE TOWN WISE PR; Government of India Ministry of Health and Family Welfare, 2015, MEASL SUPPL IMM ACT; Government of India Ministry of Health and Family Welfare, 2010, MEASL CATCH IMM CAMP; Gupta SK, 2011, INDIAN PEDIATR, V48, P379, DOI 10.1007/s13312-011-0066-1; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Kish L, 1965, SURVEY SAMPLING; Miles M, 2013, VACCINE, V31, P1560, DOI 10.1016/j.vaccine.2012.10.089; Obregon R, 2009, B WORLD HEALTH ORGAN, V87, P624, DOI 10.2471/BLT.08.060863; Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P103; Sosler Stephen, 2011, Morbidity and Mortality Weekly Report, V60, P1315; United Nations Population Division, 2011, STAT ANN NUMB BIRTHS; Vashishtha VM, 2013, INDIAN PEDIATR, V50, P561, DOI 10.1007/s13312-013-0165-2; *WHO, 2004, IMM COV CLUST SURV R; World Health Organization (WHO) and United Nations Children's Fund (UNICEF), 2012, WHO UNICEF EST NAT I; Zuber PLF, 2003, J INFECT DIS, V187, pS86, DOI 10.1086/368052	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127105	10.1371/journal.pone.0127105	http://dx.doi.org/10.1371/journal.pone.0127105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010084	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900063
J	Sun, WQ; Li, DP; Zhang, W; Bao, ZZ; Wang, YH				Sun, Wenqiang; Li, Dongping; Zhang, Wei; Bao, Zhenzhou; Wang, Yanhui			Family Material Hardship and Chinese Adolescents' Problem Behaviors: A Moderated Mediation Analysis	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; CHILD-DEVELOPMENT; SOCIOECONOMIC-STATUS; PROMOTIVE FACTORS; PHYSICAL HEALTH; ECONOMIC-STRESS; INCOME; RESILIENCE; POVERTY; RISK	In the current study, we examined a moderated mediation model using the risk and resilience framework. Specifically, the impact of family material hardship on adolescent problem behaviors was examined in a Chinese sample; we used the family stress model framework to investigate parental depression and negative parenting as potential mediators of the relation between family material hardship and adolescents' problem behaviors. In addition, based on resilience theory, we investigated adolescents' resilience as a potential protective factor in the development of their internalizing and externalizing problems. Participants included 1,419 Chinese adolescents (mean age = 15.38 years, SD = 1.79) and their primary caregivers. After controlling for covariates (age, gender, location of family residence, and primary caregiver), we found that parental depression and negative parenting mediated the association between family material hardship and adolescents' problem behaviors. Furthermore, the adolescent resilience moderated the relationship between negative parenting and internalizing problems in a protective-stabilizing pattern; in addition, a protective-reactive pattern also emerged when adolescent resilience was examined as a moderator of the relationship between negative parenting and externalizing problems. These findings contribute to a comprehensive understanding of the mechanisms of risk and resilience in youth development. Moreover, the findings have important implications for the prevention of adolescent problem behaviors.	[Sun, Wenqiang; Zhang, Wei; Bao, Zhenzhou] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Sun, Wenqiang; Zhang, Wei; Bao, Zhenzhou] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Li, Dongping] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Wang, Yanhui] Jiaying Univ, Sch Educ Sci, Meizhou, Peoples R China	South China Normal University; South China Normal University; Central China Normal University; Jiaying University	Zhang, W (corresponding author), S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China.	zhangwei@scnu.edu.cn						Achenbach TM, 1991, MANUAL YOUTH SELF RE, DOI [10.1016/j.eatbeh.2008.10.011, DOI 10.1016/J.EATBEH.2008.10.011]; Arnett JJ, 2008, AM PSYCHOL, V63, P602, DOI 10.1037/0003-066X.63.7.602; Ashiabi GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000940; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beverly SG, 2001, SOC WORK RES, V25, P143, DOI 10.1093/swr/25.3.143; Bickel G., 2000, J COOK GUIDE MEASURI; Boushey H., 2001, HARDSHIPS AM REAL ST; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brandt H, 2014, STRUCT EQU MODELING, V21, P181, DOI 10.1080/10705511.2014.882660; Bronfenbrenner U., 2007, HDB CHILD DEV, V6th ed., P793, DOI DOI 10.1002/9780470147658.CHPSY0114; Chien NC, 2013, CHILD DEV, V84, P209, DOI 10.1111/j.1467-8624.2012.01846.x; Compas B. E., 2013, CHILD ADOLESCENT PSY, P143; Compas BE., 2009, HDB ADOLESCENT PSYCH, P561, DOI DOI 10.1002/9780470479193.ADLPSY001017; Compas BE, 2010, J CONSULT CLIN PSYCH, V78, P623, DOI 10.1037/a0020459; Conger RD, 2007, ANNU REV PSYCHOL, V58, P175, DOI 10.1146/annurev.psych.58.110405.085551; Conger RD, 2010, J MARRIAGE FAM, V72, P685, DOI 10.1111/j.1741-3737.2010.00725.x; Conger RD, 2002, DEV PSYCHOL, V38, P179, DOI 10.1037/0012-1649.38.2.179; CONGER RD, 1992, CHILD DEV, V63, P526, DOI 10.1111/j.1467-8624.1992.tb01644.x; CONGER RD, 1993, DEV PSYCHOL, V29, P206, DOI 10.1037/0012-1649.29.2.206; CONGER RD, 1994, CHILD DEV, V65, P541, DOI 10.1111/j.1467-8624.1994.tb00768.x; deGroot A, 1996, J ABNORM CHILD PSYCH, V24, P651, DOI 10.1007/BF01670105; Diler RS, 2009, J CHILD ADOL PSYCHOP, V19, P23, DOI 10.1089/cap.2008.067; Edwards JR, 2007, PSYCHOL METHODS, V12, P1, DOI 10.1037/1082-989X.12.1.1; England MJ, 2009, DEPRESSION PARENTS P; Evans GW, 2013, CHILD DEV PERSPECT, V7, P43, DOI 10.1111/cdep.12013; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Fergus S, 2005, ANNU REV PUBL HEALTH, V26, P399, DOI 10.1146/annurev.publhealth.26.021304.144357; GARMEZY N, 1984, CHILD DEV, V55, P97, DOI 10.1111/j.1467-8624.1984.tb00276.x; Gerard JM, 2004, CHILD DEV, V75, P1832, DOI 10.1111/j.1467-8624.2004.00820.x; Gershoff ET, 2007, CHILD DEV, V78, P70, DOI 10.1111/j.1467-8624.2007.00986.x; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Grant KE, 2006, CLIN PSYCHOL REV, V26, P257, DOI 10.1016/j.cpr.2005.06.011; Grant KE, 2003, PSYCHOL BULL, V129, P447, DOI 10.1037/0033-2909.129.3.447; Gundersen C, 2009, J HEALTH ECON, V28, P971, DOI 10.1016/j.jhealeco.2009.06.012; Heflin C, 2009, SOC PROBL, V56, P746, DOI 10.1525/sp.2009.56.4.746; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; [胡月琴 HU YueQin], 2008, [心理学报, Acta Psychologica Sinica], V40, P902; Kelava A, 2011, STRUCT EQU MODELING, V18, P465, DOI 10.1080/10705511.2011.582408; Klein A, 2000, PSYCHOMETRIKA, V65, P457, DOI 10.1007/BF02296338; Klein AG, 2007, MULTIVAR BEHAV RES, V42, P647, DOI 10.1080/00273170701710205; Klein R.B., 2005, PRINCIPLES PRACTICE; Lahey BB, 2000, J ABNORM PSYCHOL, V109, P488, DOI 10.1037/0021-843X.109.3.488; Leech NL, 2011, IBM SPSS INTERMEDIAT, P223; Li ST, 2007, AM J COMMUN PSYCHOL, V39, P21, DOI 10.1007/s10464-007-9088-1; Lim J, 2011, J FAM PSYCHOL, V25, P137, DOI 10.1037/a0022452; Luthar S. S., 2015, DEV PSYCHOPATHOL, V3, P739, DOI [DOI 10.1002/9780470939406.CH20, 10.1002/9780470939406.CH20]; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Masten AS, 2012, ANNU REV PSYCHOL, V63, P227, DOI 10.1146/annurev-psych-120710-100356; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; MAYER SE, 1989, J HUM RESOUR, V24, P88, DOI 10.2307/145934; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; McLoyd VC, 2011, NEBR SYM MOTIV, V57, P33, DOI 10.1007/978.1.4419.7092.3_3; Mistry RS, 2002, CHILD DEV, V73, P935, DOI 10.1111/1467-8624.00448; Muhtadie L, 2013, DEV PSYCHOPATHOL, V25, P653, DOI 10.1017/S0954579413000084; Munoz RF, 2012, AM PSYCHOL, V67, P285, DOI 10.1037/a0027666; Muthen LK, 1998, MPLUS USERS GUIDE, DOI [10.1037/met0000028, DOI 10.1037/MET0000028]; Nelson G, 2011, POVERTY PUBLIC POLIC, V3, DOI 10.2202/1944-2858.1077; Ostaszewski K, 2006, AM J COMMUN PSYCHOL, V38, P237, DOI 10.1007/s10464-006-9076-x; Ouellette T, 2004, MEASURES MAT HARDSHI; Perren S, 2013, J CHILD PSYCHOL PSYC, V54, P46, DOI 10.1111/j.1469-7610.2012.02618.x; Population Census Office under the State Council & Department of Population and Employment Statistics of National Bureau of Statistics, 2012, TAB 2010 POP CENS PE, DOI [10.3109/09286586.2014.884603, DOI 10.3109/09286586.2014.884603]; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitz E, 2005, J YOUTH ADOLESCENCE, V34, P577, DOI 10.1007/s10964-005-8947-z; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Robinson CC, 2001, HDB FAMILY MEASUREME, P319; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schoon I, 2006, RISK AND RESILIENCE: ADAPTATIONS IN CHANGING TIMES, P1, DOI 10.2277/ 0521833744; Sesma JA, 2013, HDB RESILIENCE CHILD, P427; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Siefert K, 2001, WOMEN HEALTH, V32, P159, DOI 10.1300/J013v32n01_08; UNDP in China, 2014, ER EXTR HUNG POV WE; Wang X.Q., 2012, PSYCHOL DEV ED, V1, P91; Yoo JP, 2009, AM J PUBLIC HEALTH, V99, P829, DOI 10.2105/AJPH.2007.119776; Yoshikawa H, 2012, AM PSYCHOL, V67, P272, DOI 10.1037/a0028015; Zhou Q, 2008, CHILD DEV, V79, P493, DOI 10.1111/j.1467-8624.2008.01139.x; Zilanawala A, 2012, CHILD YOUTH SERV REV, V34, P814, DOI 10.1016/j.childyouth.2012.01.008; Zimmerman MA, 2013, CHILD DEV PERSPECT, V7, P215, DOI 10.1111/cdep.12042	78	15	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128024	10.1371/journal.pone.0128024	http://dx.doi.org/10.1371/journal.pone.0128024			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010256	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900185
J	Vuchkova, J; Comper, WD				Vuchkova, Julijana; Comper, Wayne D.			Inhibition of the Metabolic Degradation of Filtered Albumin Is a Major Determinant of Albuminuria	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINS; PROXIMAL TUBULE CELLS; FRACTIONAL CLEARANCE; RENAL DEGRADATION; RAT; BARRIER; MECHANISMS; CATABOLISM; FILTRATION; FRAGMENTS	Inhibition of the degradation of filtered albumin has been proposed as a widespread, benign form of albuminuria. There have however been recent reports that radiolabeled albumin fragments in urine are not exclusively generated by the kidney and that in albuminuric states albumin fragment excretion is not inhibited. In order to resolve this controversy we have examined the fate of various radiolabeled low molecular weight protein degradation products (LMWDPs) introduced into the circulation in rats. The influence of puromycin aminonucleoside nephrosis on the processing and excretion of LMWDPs is also examined. The status and destinies of radiolabeled LMWDPs in the circulation are complex. A major finding is that LMWDPs are rapidly eliminated from the circulation (>97% in 2 h) but only small quantities (<4%) are excreted in urine. Small (<4%) but significant amounts of LMWDPs may have prolonged elimination (> 24 h) due to binding to high molecular weight components in the circulation. If LMWDPs of albumin seen in the urine are produced by extra renal degradation it would require the degradation to far exceed the known catabolic rate of albumin. Alternatively, if an estimate of the role of extra renal degradation is made from the limit of detection of LMWDPs in plasma, then extra renal degradation would only contribute <1% of the total excretion of LMWDPs of albumin. We confirm that the degradation process for albumin is specifically associated with filtered albumin and this is inhibited in albuminuric states. This inhibition is also the primary determinant of the massive change in intact albuminuria in nephrotic states.	[Vuchkova, Julijana] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Comper, Wayne D.] SalAqua Diagnost Inc, New York, NY 10019 USA	Monash University	Comper, WD (corresponding author), SalAqua Diagnost Inc, Suite 258,888c 8th Ave, New York, NY 10019 USA.	wcomper@salaqua.com			AusAm Biotechnologies (New York); SalAqua Diagnostics Inc. (New York); SalAqua Diagnostics Inc. (Melbourne Australia)	AusAm Biotechnologies (New York); SalAqua Diagnostics Inc. (New York); SalAqua Diagnostics Inc. (Melbourne Australia)	This work was supported by AusAm Biotechnologies (New York). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by SalAqua Diagnostics Inc. (New York and Melbourne Australia), who provided support in the form of a salary for author WDC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Axelsson J, 2011, AM J PHYSIOL-RENAL, V301, pF708, DOI 10.1152/ajprenal.00183.2011; BOHRER MP, 1977, J CLIN INVEST, V60, P152, DOI 10.1172/JCI108751; Burne MJ, 1998, CLIN SCI, V95, P67, DOI 10.1042/CS19980016; Burne MJ, 1999, KIDNEY INT, V55, P261, DOI 10.1046/j.1523-1755.1999.00234.x; Candiano G, 2006, J AM SOC NEPHROL, V17, P3139, DOI 10.1681/ASN.2006050486; Carson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099771; CHRISTENSEN EI, 1976, KIDNEY INT, V10, P301, DOI 10.1038/ki.1976.113; Clavant SP, 2003, J LAB CLIN MED, V142, P372, DOI 10.1016/S0022-2143(03)00150-1; Comper WD, 2014, CONNECT TISSUE RES, V55, P2, DOI 10.3109/03008207.2013.867334; Comper WD, 2009, CURR OPIN NEPHROL HY, V18, P336, DOI 10.1097/MNH.0b013e32832cb96a; Comper WD, 2008, AM J PHYSIOL-RENAL, V295, pF1589, DOI 10.1152/ajprenal.00142.2008; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Dobrinskikh E, 2014, AM J PHYSIOL-RENAL, V306, pF941, DOI 10.1152/ajprenal.00532.2013; ENG LA, 1985, J IMMUNOL METHODS, V81, P239, DOI 10.1016/0022-1759(85)90209-1; Eppel GA, 2000, AM J KIDNEY DIS, V35, P418, DOI 10.1016/S0272-6386(00)70194-6; Ferrell N, 2012, BIOTECHNOL BIOENG, V109, P797, DOI 10.1002/bit.24339; FREEMAN T, 1959, CLIN CHIM ACTA, V4, P788, DOI 10.1016/0009-8981(59)90029-4; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Greive KA, 2001, AM J PATHOL, V159, P1159, DOI 10.1016/S0002-9440(10)61792-0; Gudehithlu KP, 2004, KIDNEY INT, V65, P2113, DOI 10.1111/j.1523-1755.2004.00633.x; HAAS M, 1993, KIDNEY INT, V43, P949, DOI 10.1038/ki.1993.133; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Hilliard LM, 2006, J LAB CLIN MED, V147, P36, DOI 10.1016/j.lab.2005.08.008; HYSING J, 1986, BIOCHIM BIOPHYS ACTA, V887, P42, DOI 10.1016/0167-4889(86)90120-5; HYSING J, 1990, ACTA PHYSIOL SCAND, V140, P419, DOI 10.1111/j.1748-1716.1990.tb09017.x; JOHNSON V, 1977, AM J PHYSIOL, V233, pF185, DOI 10.1152/ajprenal.1977.233.3.F185; KAYSEN GA, 1982, AM J PHYSIOL, V243, pF372, DOI 10.1152/ajprenal.1982.243.4.F372; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Koltun M, 2005, AM J PHYSIOL-HEART C, V288, pH1604, DOI 10.1152/ajpheart.00808.2004; Koltun M, 2004, MICROCIRCULATION, V11, P351, DOI 10.1080/10739680490437513; KSHIRSAGAR B, 1984, CLIN CHIM ACTA, V143, P265, DOI 10.1016/0009-8981(84)90076-7; Hellin JL, 2009, AM J KIDNEY DIS, V54, P871, DOI 10.1053/j.ajkd.2009.07.011; MAACK T, 1971, AM J PHYSIOL, V221, P1609, DOI 10.1152/ajplegacy.1971.221.6.1609; MAACK T, 1975, AM J MED, V58, P57, DOI 10.1016/0002-9343(75)90533-1; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; Maack T., 1992, KIDNEY PHYSL PATHOPH, P3005; MEGO JL, 1984, BIOCHEM J, V218, P775, DOI 10.1042/bj2180775; Nosaka K, 1997, FREE RADICAL BIO MED, V22, P597, DOI 10.1016/S0891-5849(96)00349-8; Oqvist BW, 1999, NEPHROL DIAL TRANSPL, V14, P1898, DOI 10.1093/ndt/14.8.1898; Osicka TM, 1997, CLIN SCI, V93, P65, DOI 10.1042/cs0930065; Osicka TM, 1996, NEPHROLOGY, V2, P199, DOI 10.1111/j.1440-1797.1996.tb00088.x; Osicka TM, 1997, CLIN SCI, V93, P557, DOI 10.1042/cs0930557; Osicka TM, 1999, AM J PHYSIOL-RENAL, V277, pF139, DOI 10.1152/ajprenal.1999.277.1.F139; Osicka TM, 2000, DIABETES, V49, P1579, DOI 10.2337/diabetes.49.9.1579; Rowland M, 1985, CLIN PHARMACOKINETIC; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Russo LM, 2013, FEBS LETT, V587, P3738, DOI 10.1016/j.febslet.2013.09.045; Scandling J D, 1992, Adv Nephrol Necker Hosp, V21, P159; Slattery C, 2008, KIDNEY INT, V74, P1480, DOI 10.1038/ki.2008.463; Strong KJ, 2005, J LAB CLIN MED, V145, P239, DOI 10.1016/j.lab.2004.11.021; TACK BF, 1980, J BIOL CHEM, V255, P8842; Verhoelst CHJ, 2004, J ENDOCRINOL, V181, P85, DOI 10.1677/joe.0.1810085; Vuchkova J, 2014, AM J PHYSIOL-RENAL, V307, pF525, DOI 10.1152/ajprenal.00228.2014; Weyer K, 2012, J AM SOC NEPHROL, V23, P591, DOI 10.1681/ASN.2011101034; YAGAME M, 1995, INTERNAL MED, V34, P463, DOI 10.2169/internalmedicine.34.463; YEDGAR S, 1983, AM J PHYSIOL, V244, pE101, DOI 10.1152/ajpendo.1983.244.1.E101	56	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127853	10.1371/journal.pone.0127853	http://dx.doi.org/10.1371/journal.pone.0127853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010895	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900153
J	Williams, RJ; Tse, T; DiPiazza, K; Zarin, DA				Williams, Rebecca J.; Tse, Tony; DiPiazza, Katelyn; Zarin, Deborah A.			Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; PUBLICATION; REGISTRATION; PREVALENCE; BENEFIT; UPDATE; IMPACT; BIAS	Background Clinical trials that end prematurely (or "terminate") raise financial, ethical, and scientific concerns. The extent to which the results of such trials are disseminated and the reasons for termination have not been well characterized. Methods and Findings A cross-sectional, descriptive study of terminated clinical trials posted on the ClinicalTrials.gov results database as of February 2013 was conducted. The main outcomes were to characterize the availability of primary outcome data on ClinicalTrials.gov and in the published literature and to identify the reasons for trial termination. Approximately 12% of trials with results posted on the ClinicalTrials. gov results database (905/7,646) were terminated. Most trials were terminated for reasons other than accumulated data from the trial (68%; 619/905), with an insufficient rate of accrual being the lead reason for termination among these trials (57%; 350/619). Of the remaining trials, 21% (193/905) were terminated based on data from the trial (findings of efficacy or toxicity) and 10% (93/905) did not specify a reason. Overall, data for a primary outcome measure were available on ClinicalTrials. gov and in the published literature for 72% (648/905) and 22% (198/905) of trials, respectively. Primary outcome data were reported on the ClinicalTrials. gov results database and in the published literature more frequently (91% and 46%, respectively) when the decision to terminate was based on data from the trial. Conclusions Trials terminate for a variety of reasons, not all of which reflect failures in the process or an inability to achieve the intended goals. Primary outcome data were reported most often when termination was based on data from the trial. Further research is needed to identify best practices for disseminating the experience and data resulting from terminated trials in order to help ensure maximal societal benefit from the investments of trial participants and others involved with the study.	[Williams, Rebecca J.; Tse, Tony; Zarin, Deborah A.] NIH, Natl Lib Med, DHHS, Bethesda, MD 20892 USA; [DiPiazza, Katelyn] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Williams, RJ (corresponding author), NIH, Natl Lib Med, DHHS, Bldg 10, Bethesda, MD 20892 USA.	williamsre@mail.nih.gov		Tse, Tony/0000-0002-9906-6864	Intramural Research Program of the National Institutes of Health (NIH), National Library of Medicine (NLM); NATIONAL LIBRARY OF MEDICINE [ZIALM008926] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (NIH), National Library of Medicine (NLM); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Library of Medicine (NLM). The views expressed in this article are those of the authors and do not necessarily reflect the positions of the NIH. NLM had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation of the manuscript and decision to submit the manuscript for publication. NLM reviewed and approved the manuscript prior to publication.	[Anonymous], FREQ ASK QUEST DO SU; [Anonymous], BAS RES DAT EL DEF; [Anonymous], PROT DAT EL DEF; [Anonymous], 2003, CLIN TRIAL REG NUMB; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Becker JE, 2014, JAMA-J AM MED ASSOC, V311, P1063, DOI 10.1001/jama.2013.285634; Bernardez-Pereira S, 2014, AM HEART J, V168, P213, DOI 10.1016/j.ahj.2014.04.013; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Carlisle B, 2015, CLIN TRIALS, V12, P77, DOI 10.1177/1740774514558307; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chapman SJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6870; Denicoff AM, 2013, J ONCOL PRACT, V9, P267, DOI 10.1200/JOP.2013.001119; Department of Health and Human Services (US), 2014, FED REGISTER, V79, P69566; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Hartung DM, 2014, ANN INTERN MED, V160, P477, DOI 10.7326/M13-0480; Ide NC, 2007, J AM MED INFORM ASSN, V14, P253, DOI 10.1197/jamia.M2233; Ioannidis JPA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7089; Kasenda B, 2014, JAMA-J AM MED ASSOC, V311, P1045, DOI 10.1001/jama.2014.1361; Kitterman DR, 2011, ACAD MED, V86, P1360, DOI 10.1097/ACM.0b013e3182306440; Korn EL, 2011, AM J BIOETHICS, V11, P2, DOI 10.1080/15265161.2010.546471; Korn EL, 2010, J CLIN ONCOL, V28, P5197, DOI 10.1200/JCO.2010.31.5382; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Malmqvist E, 2011, KENNEDY INST ETHIC J, V21, P51, DOI 10.1353/ken.2011.0002; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; National Institute of Allergy and Infectious Diseases (NIAID), 2000, RES REG RIT TREATM E; Psaty BM, 2003, JAMA-J AM MED ASSOC, V289, P2128, DOI 10.1001/jama.289.16.2128; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Schroen AT, 2012, CLIN CANCER RES, V18, P256, DOI 10.1158/1078-0432.CCR-11-1633; SCHWARTZ PJ, 1994, CIRCULATION, V89, P2892; Stensland KD, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju229; Tice Debra G, 2013, J Clin Med Res, V5, P185, DOI 10.4021/jocmr1320w; Tse T, 2009, CHEST, V136, P304, DOI 10.1378/chest.09-1219; Tse T, 2009, CHEST, V136, P295, DOI 10.1378/chest.08-3022; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	40	101	101	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127242	10.1371/journal.pone.0127242	http://dx.doi.org/10.1371/journal.pone.0127242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011295	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900075
J	Wu, B; Shi, Y; Gong, X; Yu, L; Chen, QJ; Wang, J; Sun, ZG				Wu, Bi; Shi, Yan; Gong, Xia; Yu, Lin; Chen, Qiuju; Wang, Jian; Sun, Zhaogui			Evaluation of Follicular Synchronization Caused by Estrogen Administration and Its Reproductive Outcome	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; GRANULOSA-CELLS; IN-VITRO; PREGNANCY; OOCYTE; WOMEN; MICE; RAT; RECEPTORS; ESTRADIOL	To evaluate multiple follicular development synchronization after estrogen stimulation in prepubertal mice, follicular responsiveness to gonadotropin superovulation, the prospective reproductive potential and ovarian polycystic ovary syndrome (PCOS)-like symptoms at adulthood, prepubertal mice were intraperitoneally injected with estrogen to establish an animal model with solvent as control. When synchronized tertiary follicles in ovaries, in vitro oocyte maturation and fertilization rates, blastocyst formation rate, developmental potential into offspring by embryo transfer, adult fertility and PCOS-like symptoms, and involved molecular mechanisms were focused, it was found that estrogen stimulation (10 mu g/gBW) leads to follicular development synchronization at the early tertiary stage in prepubertal mice; reproduction from oocytes to offspring could be realized by means of the artificial reproductive technology though the model mice lost their natural fertility when they were reared to adulthood; and typical symptoms of PCOS, except changes in inflammatory pathways, were not remained up to adulthood. So in conclusion, estrogen can lead to synchronization in follicular development in prepubertal mice, but does not affect reproductive outcome of oocytes, and no typical symptoms of PCOS remained at adulthood despite changes related to inflammation.	[Wu, Bi] Fudan Univ, Inst Reprod & Dev, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Shi, Yan; Yu, Lin; Wang, Jian; Sun, Zhaogui] Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices Natl Populat &, Shanghai, Peoples R China; [Gong, Xia] Shanghai Business Sch, Dept Food Sci, Shanghai, Peoples R China; [Chen, Qiuju] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Assisted Reprod, Shanghai 200030, Peoples R China	Fudan University; Shanghai Business School; Shanghai Jiao Tong University	Sun, ZG (corresponding author), Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices Natl Populat &, Shanghai, Peoples R China.	sunzgbio@126.com			National Natural Science Foundation of China [81170569, 81370682]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors were funded by the National Natural Science Foundation of China (81170569, 81370682, both to ZGS); http://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 1998, TRENDS ENDOCRIN MET, V9, P62, DOI 10.1016/S1043-2760(98)00019-8; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; BAIRD DT, 1975, J REPROD FERTIL, V45, P611, DOI 10.1530/jrf.0.0450611; Boomsma CM, 2008, SEMIN REPROD MED, V26, P72, DOI 10.1055/s-2007-992927; CARSON RS, 1981, ENDOCRINOLOGY, V109, P1433, DOI 10.1210/endo-109-5-1433; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; Chapman JC, 2001, AM J REPROD IMMUNOL, V46, P288, DOI 10.1034/j.1600-0897.2001.d01-15.x; Chapman JC, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-47; FELICIO LS, 1984, BIOL REPROD, V31, P446, DOI 10.1095/biolreprod31.3.446; Findlay JD, 2001, REPROD FERT DEVELOP, V13, P543, DOI 10.1071/RD01071; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; GOLDZIEHER JW, 1963, FERTIL STERIL, V14, P631; Gu Yan-Qiong, 2009, Shengli Xuebao, V61, P175; Kollmann M, 2014, HUM REPROD UPDATE, V20, P463, DOI 10.1093/humupd/dmu005; Kuang YP, 2014, FERTIL STERIL, V101, P105, DOI 10.1016/j.fertnstert.2013.09.007; Li H, 2013, ENDOCRINE, V43, P184, DOI 10.1007/s12020-012-9739-3; Liu KC, 2011, ENDOCRINOLOGY, V152, P4418, DOI 10.1210/en.2011-1065; MAHESH VB, 1964, RECENT PROG HORM RES, V20, P341; Miyoshi T, 2013, BIOCHEM BIOPH RES CO, V434, P401, DOI 10.1016/j.bbrc.2013.04.002; Nikolajsen CL, 2012, BIOCHEMISTRY-US, V51, P4735, DOI 10.1021/bi3004022; Pasquali R, 2011, CLIN ENDOCRINOL, V74, P424, DOI 10.1111/j.1365-2265.2010.03956.x; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Singh KB, 2005, FERTIL STERIL, V84, P1228, DOI 10.1016/j.fertnstert.2005.06.013; Viana JHM, 2010, THERIOGENOLOGY, V73, P966, DOI 10.1016/j.theriogenology.2009.11.025; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; WILSON EA, 1979, AM J OBSTET GYNECOL, V134, P56, DOI 10.1016/0002-9378(79)90796-8; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Yao YW, 2011, HISTOCHEM CELL BIOL, V136, P205, DOI 10.1007/s00418-011-0825-z; Zarate-Trevino Arturo, 2014, Ginecol Obstet Mex, V82, P246; Zhang MJ, 2011, ENDOCRINOLOGY, V152, P4377, DOI 10.1210/en.2011-1118	30	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127595	10.1371/journal.pone.0127595	http://dx.doi.org/10.1371/journal.pone.0127595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010950	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900114
J	Chen, LW; Chien, CY; Yang, KJ; Kuo, SF; Chen, CH; Chien, RN				Chen, Li-Wei; Chien, Chih-Yi; Yang, Kai-Jie; Kuo, Sheng-Fong; Chen, Chih-Hung; Chien, Rong-Nan			Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based Study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; MODEL ASSESSMENT; CUTOFF VALUES; ASSOCIATION; PREVALENCE; LEPTIN; INFLAMMATION; METAANALYSIS	This study aimed to analyze the influence of H. pylori infection on insulin resistance and metabolic syndrome (MS) by multivariate analysis of a community-based cohort study. From January 2013 to February 2014,811 subjects were enrolled in a community-based cohort study from the northeastern region of Taiwan. All subjects received a demographic survey and blood tests, including an H. pylori antibody test, liver biochemistry tests, lipid profiles, sugar/insulin levels for Homeostatic model assessment (HOMA-IR index), and measurements of adipokines and inflammatory cytokines. A total of 264 men and 547 women were included in this study. The mean age was 59.2 +/- 12.7 years. Subjects seropositive for H. pylori antibodies exhibited higher rates of hypertension, an increased incidence of a HOMA-IR index >2.5 and a higher level of tumor necrosis factor-a than those without H. pylori antibodies. We found a significant difference in the presence of H. pylori antibodies between subjects with MS and those without MS (76.7% vs. 53.7%, p = 0.007) among subjects <50 y/o. A HOMA-IR index >2.5, H. pylori antibody presence and leptin were predictors for MS in subjects <50 y/o. The estimated odds ratio of MS for a subject with H. pylori antibodies was 3.717 (95% CI = 1.086-12.719) times that of a subject without H. pylori antibodies. In addition, no difference in H. pylori antibody status was detected for MS prediction in subjects that were. 50 y/o (p = 0.861). In conclusion, subjects with H. pylori antibodies had a higher incidence of a HOMA-IR >2.5 than those without H pylori antibodies. For subjects aged <50 y/o, the H. pylori antibody was a predictor for MS.	[Chen, Li-Wei; Chien, Rong-Nan] Chang Gung Mem Hosp & Univ, Dept Gastroenterol & Hepatol, Keelung, Taiwan; [Chen, Li-Wei; Chien, Chih-Yi; Yang, Kai-Jie; Kuo, Sheng-Fong; Chen, Chih-Hung; Chien, Rong-Nan] Chang Gung Mem Hosp & Univ, Community Med Res Ctr, Keelung, Taiwan; [Kuo, Sheng-Fong; Chen, Chih-Hung] Chang Gung Mem Hosp & Univ, Metab & Endocrinol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chien, RN (corresponding author), Chang Gung Mem Hosp & Univ, Dept Gastroenterol & Hepatol, Keelung, Taiwan.	ronald@cgmh.org.tw		Chen, Chih-Hung/0000-0003-3718-2373	Chang-Gung Memorial Hospital [CMRPG2B0122, CMRPG2B0172]	Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from Chang-Gung Memorial Hospital (No CMRPG2B0122 and CMRPG2B0172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaker WI, 2011, SAUDI J GASTROENTERO, V17, P165, DOI 10.4103/1319-3767.80377; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Aslan M, 2006, WORLD J GASTROENTERO, V12, P6865, DOI 10.3748/wjg.v12.i42.6865; Aydemir S, 2005, DIGEST DIS SCI, V50, P2090, DOI 10.1007/s10620-005-3012-z; Azuma T, 2001, GUT, V49, P324, DOI 10.1136/gut.49.3.324; Breidert M, 1999, SCAND J GASTROENTERO, V34, P954, DOI 10.1080/003655299750025039; Cammarota G, 2000, DIGEST LIVER DIS, V32, P65, DOI 10.1016/S1590-8658(00)80047-X; Candelli M, 2003, PEDIATRICS, V111, P800, DOI 10.1542/peds.111.4.800; Chimienti G, 2003, CLIN BIOCHEM, V36, P359, DOI 10.1016/S0009-9120(03)00063-8; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Crabtree JE, 1996, ALIMENT PHARM THER, V10, P29, DOI 10.1046/j.1365-2036.1996.22164003.x; Danesh J, 1998, BRIT MED J, V316, P1130, DOI 10.1136/bmj.316.7138.1130; ERNST PB, 1994, SCAND J GASTROENTERO, V29, P22, DOI 10.3109/00365529409091405; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Gillum RF, 2004, J NATL MED ASSOC, V96, P1470; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gunji T, 2008, AM J GASTROENTEROL, V103, P3005, DOI 10.1111/j.1572-0241.2008.02151.x; Gunji T, 2009, HELICOBACTER, V14, P144, DOI 10.1111/j.1523-5378.2009.00705.x; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kanbay M, 2005, DIGEST DIS SCI, V50, P1228, DOI 10.1007/s10620-005-2764-9; Kinjo K, 2002, CIRC J, V66, P805, DOI 10.1253/circj.66.805; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Liston R, 1996, LANCET, V347, P269, DOI 10.1016/S0140-6736(96)90450-X; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MOSS SF, 1994, GUT, V35, P1567, DOI 10.1136/gut.35.11.1567; Naja F, 2012, HELICOBACTER, V17, P444, DOI 10.1111/j.1523-5378.2012.00970.x; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Saad MAN, 2014, ARQ BRAS CARDIOL, V102, P263, DOI 10.5935/abc.20140013; Polyzos SA, 2011, HELICOBACTER, V16, P79, DOI 10.1111/j.1523-5378.2011.00822.x; Roper J, 2008, J CLIN ENDOCR METAB, V93, P2350, DOI 10.1210/jc.2007-2057; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Sung KC, 2005, INT J CARDIOL, V102, P411, DOI 10.1016/j.ijcard.2004.05.040; Thalmaier U, 2002, INFECT IMMUN, V70, P3149, DOI 10.1128/IAI.70.6.3149-3155.2002; Tresaco B, 2005, J PHYSIOL BIOCHEM, V61, P381, DOI 10.1007/BF03167055; Tseng Hsu-Min, 2003, Health Qual Life Outcomes, V1, P72, DOI 10.1186/1477-7525-1-72; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Woodward M, 2000, J CLIN EPIDEMIOL, V53, P175, DOI 10.1016/S0895-4356(99)00171-7	42	31	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128671	10.1371/journal.pone.0128671	http://dx.doi.org/10.1371/journal.pone.0128671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020514	gold, Green Submitted, Green Published			2022-12-27	WOS:000355187300119
J	Jackman, SD; Bohlmann, J; Birol, I				Jackman, Shaun D.; Bohlmann, Joerg; Birol, Inanc			UniqTag: Content-Derived Unique and Stable Identifiers for Gene Annotation	PLOS ONE			English	Article								When working on an ongoing genome sequencing and assembly project, it is rather inconvenient when gene identifiers change from one build of the assembly to the next. The gene labelling system described here, UniqTag, addresses this common challenge. UniqTag assigns a unique identifier to each gene that is a representative k-mer, a string of length k, selected from the sequence of that gene. Unlike serial numbers, these identifiers are stable between different assemblies and annotations of the same data without requiring that previous annotations be lifted over by sequence alignment. We assign UniqTag identifiers to ten builds of the Ensembl human genome spanning eight years to demonstrate this stability. The implementation of UniqTag in Ruby and an R package are available at https://github.com/sjackman/uniqtag sjackman/uniqtag. The R package is also available from CRAN: install. packages ("uniqtag"). Supplementary material and code to reproduce it is available at https://github.com/sjackman/uniqtag-paper.	[Jackman, Shaun D.; Birol, Inanc] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Jackman, Shaun D.] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V5Z 1M9, Canada; [Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Birol, Inanc] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Jackman, SD (corresponding author), British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada.	sjackman@bcgsc.ca; ibirol@bcgsc.ca	Birol, Inanc/G-5440-2011; Jackman, Shaun/G-9622-2013	Birol, Inanc/0000-0003-0950-7839; Jackman, Shaun/0000-0002-9275-5966	Natural Sciences and Engineering Research Council of Canada; Genome British Columbia; Genome Quebec; Genome Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome British Columbia; Genome Quebec; Genome Canada(Genome Canada)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/), Genome British Columbia (http://www.genomebc.ca/), Genome Quebec (http://www.genomequebec.com/) and Genome Canada (http://www.genomecanada.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broder AZ, 1997, COMPRESSION COMPLEXI, P21; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dang QH, 2012, NIST FIPS, V180, P1; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748	5	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128026	10.1371/journal.pone.0128026	http://dx.doi.org/10.1371/journal.pone.0128026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020645	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300072
J	Li, XB; Zuo, R; Teng, YG; Wang, JS; Wang, B				Li, Xianbo; Zuo, Rui; Teng, Yanguo; Wang, Jinsheng; Wang, Bin			Development of Relative Risk Model for Regional Groundwater Risk Assessment: A Case Study in the Lower Liaohe River Plain, China	PLOS ONE			English	Article							MODIFIED DRASTIC MODEL; ECOLOGICAL RISK; VULNERABILITY ASSESSMENT; CONTAMINATED SITES; GIS; AQUIFER; POLLUTION; CATCHMENT; BASIN	Increasing pressure on water supply worldwide, especially in arid areas, has resulted in groundwater overexploitation and contamination, and subsequent deterioration of the groundwater quality and threats to public health. Environmental risk assessment of regional groundwater is an important tool for groundwater protection. This study presents a new approach for assessing the environmental risk assessment of regional groundwater. It was carried out with a relative risk model (RRM) coupled with a series of indices, such as a groundwater vulnerability index, which includes receptor analysis, risk source analysis, risk exposure and hazard analysis, risk characterization, and management of groundwater. The risk map is a product of the probability of environmental contamination and impact. The reliability of the RRM was verified using Monte Carlo analysis. This approach was applied to the lower Liaohe River Plain (LLRP), northeastern China, which covers 23604 km(2). A spatial analysis tool within GIS which was used to interpolate and manipulate the data to develop environmental risk maps of regional groundwater, divided the level of risk from high to low into five ranks (V, IV, III, II, I). The results indicate that areas of relative risk rank (RRR) V cover 2324 km(2), covering 9.8% of the area; RRR IV covers 3986 km(2), accounting for 16.9% of the area. It is a new and appropriate method for regional groundwater resource management and land use planning, and is a rapid and effective tool for improving strategic decision making to protect groundwater and reduce environmental risk.	[Li, Xianbo; Zuo, Rui; Teng, Yanguo; Wang, Jinsheng; Wang, Bin] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Li, Xianbo; Zuo, Rui; Teng, Yanguo; Wang, Jinsheng; Wang, Bin] Minist Educ, Engn Res Ctr Groundwater Pollut Control & Remedia, Beijing 100875, Peoples R China	Beijing Normal University	Zuo, R (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	zr@bnu.edu.cn			Specific Research on Public Service of Environmental Protection in China [201009009]; National Natural Science Foundation in China [41402211]; Ministry of environmental protection, China [201009009]	Specific Research on Public Service of Environmental Protection in China; National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Ministry of environmental protection, China	This work was supported by the Specific Research on Public Service of Environmental Protection in China (No. 201009009) and the National Natural Science Foundation in China (No. 41402211). The Specific Research on Public Service of Environmental Protection in China (No. 201009009) is from the Ministry of environmental protection, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JJ, 2012, ENVIRON MONIT ASSESS, V184, P6637, DOI 10.1007/s10661-011-2448-1; Almasri MN, 2008, J ENVIRON MANAGE, V88, P577, DOI 10.1016/j.jenvman.2007.01.022; Almasri MN, 2007, J HYDROL, V343, P211, DOI 10.1016/j.jhydrol.2007.06.016; Babiker IS, 2005, SCI TOTAL ENVIRON, V345, P127, DOI 10.1016/j.scitotenv.2004.11.005; Chen QY, 2012, SCI TOTAL ENVIRON, V420, P79, DOI 10.1016/j.scitotenv.2011.09.044; Chinese Standardization, 1993, 1484893 GBT AQSIQ PE; De Lange HJ, 2010, SCI TOTAL ENVIRON, V408, P3871, DOI 10.1016/j.scitotenv.2009.11.009; Dixon B, 2005, APPL GEOGR, V25, P327, DOI 10.1016/j.apgeog.2005.07.002; Gao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033503; Geological Survey of China, 2008, RES REPORT; Hamza MH, 2007, J ENVIRON MANAGE, V84, P12, DOI 10.1016/j.jenvman.2006.04.004; Howard J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011249; Huan H, 2012, SCI TOTAL ENVIRON, V440, P14, DOI 10.1016/j.scitotenv.2012.08.037; Hynds PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093301; Kattaa B, 2010, J ENVIRON MANAGE, V91, P1103, DOI 10.1016/j.jenvman.2009.12.008; Landis WG, 1997, HUM ECOL RISK ASSESS, V3, P287, DOI 10.1080/10807039709383685; Li DQ, 2014, ENVIRON INT, V65, P16, DOI 10.1016/j.envint.2013.12.004; Li Y, 2012, ENVIRON POLLUT, V165, P77, DOI 10.1016/j.envpol.2011.12.042; Liu JL, 2011, ECOTOXICOLOGY, V20, P1131, DOI 10.1007/s10646-011-0618-0; Miller TK, 2010, BIOL CONSERV, V143, P2070, DOI 10.1016/j.biocon.2010.05.015; Moraes R, 2010, HUMAN ECOLOGICAL RIS, V8, P1779; Pizzol L, 2011, ENVIRON INT, V37, P1307, DOI 10.1016/j.envint.2011.05.010; Rahman A, 2008, APPL GEOGR, V28, P32, DOI 10.1016/j.apgeog.2007.07.008; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; Schafer RB, 2011, SCI TOTAL ENVIRON, V409, P2055, DOI 10.1016/j.scitotenv.2011.01.053; Walker R, 2001, HUM ECOL RISK ASSESS, V7, P417, DOI 10.1080/20018091094439; Wang JJ, 2012, SCI TOTAL ENVIRON, V432, P216, DOI 10.1016/j.scitotenv.2012.06.005; Wen QC, 2011, PROCEDIA ENVIRON SCI, V8, P26, DOI 10.1016/j.proenv.2011.10.007; Xu LY, 2009, J ENVIRON MANAGE, V90, P3290, DOI 10.1016/j.jenvman.2009.05.011; Yu C, 2010, SCI TOTAL ENVIRON, V408, P6108, DOI 10.1016/j.scitotenv.2010.09.002; Yu WT, 2011, ATMOS RES, V101, P460, DOI 10.1016/j.atmosres.2011.04.011; Zabeo A, 2011, ENVIRON INT, V37, P1295, DOI 10.1016/j.envint.2011.05.005; Zhao YY, 2012, PROCEDIA ENVIRON SCI, V13, P1739, DOI 10.1016/j.proenv.2012.01.167; Zhou Ting, 2009, Shengtaixue Zazhi, V28, P762	34	10	11	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128249	10.1371/journal.pone.0128249	http://dx.doi.org/10.1371/journal.pone.0128249			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020518	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300095
J	Babic Bozovic, I; Stankovic, A; Zivkovic, M; Vranekovic, J; Kapovic, M; Brajenovic-Milic, B				Babic Bozovic, Ivana; Stankovic, Aleksandra; Zivkovic, Maja; Vranekovic, Jadranka; Kapovic, Miljenko; Brajenovic-Milic, Bojana			Altered LINE-1 Methylation in Mothers of Children with Down Syndrome	PLOS ONE			English	Article							GENOMIC DNA METHYLATION; CHROMOSOMAL INSTABILITY; METHYLENETETRAHYDROFOLATE REDUCTASE; EPIGENETIC REGULATION; FOLATE METABOLISM; COMMON MUTATION; RISK-FACTORS; HYPOMETHYLATION; ORIGIN; METHYLTRANSFERASES	Down syndrome (DS, also known as trisomy 21) most often results from chromosomal nondisjunction during oogenesis. Numerous studies sustain a causal link between global DNA hypomethylation and genetic instability. It has been suggested that DNA hypomethylation might affect the structure and dynamics of chromatin regions that are critical for chromosome stability and segregation, thus favouring chromosomal nondisjunction during meiosis. Maternal global DNA hypomethylation has not yet been analyzed as a potential risk factor for chromosome 21 nondisjunction. This study aimed to asses the risk for DS in association with maternal global DNA methylation and the impact of endogenous and exogenous factors that reportedly influence DNA methylation status. Global DNA methylation was analyzed in peripheral blood lymphocytes by quantifying LINE-1 methylation using the MethyLight method. Levels of global DNA methylation were significantly lower among mothers of children with maternally derived trisomy 21 than among control mothers (P = 0.000). The combination of MTHFR C677T genotype and diet significantly influenced global DNA methylation (R-2 = 4.5%, P = 0.046). The lowest values of global DNA methylation were observed in mothers with MTHFR 677 CT+TT genotype and low dietary folate. Although our findings revealed an association between maternal global DNA hypomethylation and trisomy 21 of maternal origin, further progress and final conclusions regarding the role of global DNA methylation and the occurrence of trisomy 21 are facing major challenges.	[Babic Bozovic, Ivana; Vranekovic, Jadranka; Kapovic, Miljenko; Brajenovic-Milic, Bojana] Univ Rijeka, Sch Med, Dept Biol & Med Genet, Rijeka, Croatia; [Stankovic, Aleksandra; Zivkovic, Maja] Univ Belgrade, Lab Radiobiol & Mol Genet, Vinca Inst Nucl Sci, Belgrade, Serbia	University of Rijeka; University of Belgrade	Brajenovic-Milic, B (corresponding author), Univ Rijeka, Sch Med, Dept Biol & Med Genet, Rijeka, Croatia.	bojanabm@medri.uniri.hr	Babic Bozovic, Ivana/T-1112-2018; Stankovic, Aleksandra D/T-1064-2018; Zivkovic, Maja/T-1038-2018; Brajenovic-Milic, Bojana/C-4275-2014; VRANEKOVIĆ, JADRANKA/I-4219-2014; Kapović, Miljenko/S-8310-2018	Babic Bozovic, Ivana/0000-0002-6071-4430; Stankovic, Aleksandra D/0000-0002-1050-5913; Zivkovic, Maja/0000-0002-0447-6626; Brajenovic-Milic, Bojana/0000-0002-9440-9346; VRANEKOVIĆ, JADRANKA/0000-0001-6365-5686; Kapović, Miljenko/0000-0002-8466-1011	University of Rijeka, Rijeka, Croatia [13.06.1.2.38]	University of Rijeka, Rijeka, Croatia	This study was supported by a grant (No. 13.06.1.2.38) from the University of Rijeka, Rijeka, Croatia.	Allen EG, 2009, HUM GENET, V125, P41, DOI 10.1007/s00439-008-0603-8; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Attig L, 2010, P NUTR SOC, V69, P221, DOI 10.1017/S002966511000008X; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Baric IC, 2009, INT J FOOD SCI NUTR, V60, P10, DOI 10.1080/09637480802249074; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chowdhury S, 2011, BIRTH DEFECTS RES A, V91, P69, DOI 10.1002/bdra.20761; Coppede F, 2006, AM J MED GENET A, V140A, P1083, DOI 10.1002/ajmg.a.31217; Coppede F, 2013, OA GENETICS, V1, P1; Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; EUROCAT, 2014, EUR NETW POP BAS REG; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freeman SB, 2007, PUBLIC HEALTH REP, V122, P62, DOI 10.1177/003335490712200109; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Herrera LA, 2008, CURR GENOMICS, V9, P43, DOI 10.2174/138920208783884883; James SJ, 1999, AM J CLIN NUTR, V70, P495; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; Lehmann E. L., 2006, NONPARAMETRICS STAT; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Morris JK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3794; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Oliver TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000033; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Piyathilake CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054544; Pogribny IP, 2009, CELL MOL LIFE SCI, V66, P2249, DOI 10.1007/s00018-009-0015-5; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Richardson BC, 2002, J NUTR, V132, p2401S, DOI 10.1093/jn/132.8.2401S; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Sigurdsson MI, 2009, GENOME RES, V19, P581, DOI 10.1101/gr.086181.108; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Subirana JA, 2010, NUCLEIC ACIDS RES, V38, P1172, DOI 10.1093/nar/gkp1094; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; VOGT P, 1990, HUM GENET, V84, P301; Vranekovic J, 2012, GENET TEST MOL BIOMA, V16, P70, DOI 10.1089/gtmb.2011.0066; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wilson IM, 2006, CELL CYCLE, V5, P155, DOI 10.4161/cc.5.2.2367; Woo HD, 2007, PLOS ONE, V7; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zeschnigk M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh122; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhu ZZ, 2012, INT J EPIDEMIOL, V41, P126, DOI 10.1093/ije/dyq154	65	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127423	10.1371/journal.pone.0127423	http://dx.doi.org/10.1371/journal.pone.0127423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017139	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600082
J	Butts, A; Martin, JA; DiDone, L; Bradley, EK; Mutz, M; Krysan, DJ				Butts, Arielle; Martin, Jennifer A.; DiDone, Louis; Bradley, Erin K.; Mutz, Mitchell; Krysan, Damian J.			Structure-Activity Relationships for the Antifungal Activity of Selective Estrogen Receptor Antagonists Related to Tamoxifen	PLOS ONE			English	Article							CRYPTOCOCCAL MENINGITIS; CALMODULIN; BINDING; DRUGS	Cryptococcosis is one of the most important invasive fungal infections and is a significant contributor to the mortality associated with HIV/AIDS. As part of our program to repurpose molecules related to the selective estrogen receptor modulator (SERM) tamoxifen as anti-cryptococcal agents, we have explored the structure-activity relationships of a set of structurally diverse SERMs and tamoxifen derivatives. Our data provide the first insights into the structural requirements for the antifungal activity of this scaffold. Three key molecular characteristics affecting anti-cryptococcal activity emerged from our studies: 1) the presence of an alkylamino group tethered to one of the aromatic rings of the triphenylethylene core; 2) an appropriately sized aliphatic substituent at the 2 position of the ethylene moiety; and 3) electronegative substituents on the aromatic rings modestly improved activity. Using a cell-based assay of calmodulin antagonism, we found that the anti-cryptococcal activity of the scaffold correlates with calmodulin inhibition. Finally, we developed a homology model of C. neoformans calmodulin and used it to rationalize the structural basis for the activity of these molecules. Taken together, these data and models provide a basis for the further optimization of this promising anti-cryptococcal scaffold.	[Butts, Arielle] Univ Rochester, Dept Chem, Rochester, NY 14642 USA; [Martin, Jennifer A.; DiDone, Louis; Krysan, Damian J.] Univ Rochester, Dept Pediat, Rochester, NY 14642 USA; [Krysan, Damian J.] Univ Rochester, Dept Microbiol Immunol, Rochester, NY 14642 USA; [Bradley, Erin K.] LigDCipher, San Diego, CA 92121 USA; [Mutz, Mitchell] Amplyx Pharmaceut, San Diego, CA 92121 USA	University of Rochester; University of Rochester; University of Rochester	Krysan, DJ (corresponding author), Univ Rochester, Dept Pediat, 601 Elmwood Ave, Rochester, NY 14642 USA.	damian_krysan@urmc.rochester.edu		Krysan, Damian/0000-0001-6330-3365	National Institute of Allergy and Infectious Diseases [1R01AI091422]; LigDCipherd; Amplyx Pharmaceutical; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091422] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); LigDCipherd; Amplyx Pharmaceutical(Johnson & Johnson); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grant 1R01AI091422 from the National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov. LigDCipherd and Amplyx Pharmaceutical provided support in the form of salaries for authors Erin K. Bradleyd and Mitchell Mutz but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bisson WH, 2012, CURR TOP MED CHEM, V12, P1867; Butts A, 2014, MBIO, V5, DOI 10.1128/mBio.00765-13; Butts A, 2013, EUKARYOT CELL, V12, P278, DOI 10.1128/EC.00314-12; Butts A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002870; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; COOK WJ, 1994, BIOCHEMISTRY-US, V33, P15259, DOI 10.1021/bi00255a006; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; Dolan K, 2009, ANTIMICROB AGENTS CH, V53, P3337, DOI 10.1128/AAC.01564-08; Hardcastle IR, 1996, J MED CHEM, V39, P999, DOI 10.1021/jm9505472; HERRMANN JL, 1994, J ANTIMICROB CHEMOTH, V34, P1051, DOI 10.1093/jac/34.6.1051; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Krysan DJ, 2015, FUNGAL GENET BIOL, V78, P93, DOI 10.1016/j.fgb.2014.12.001; Lev S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051403; LIEN EA, 1991, BRIT J CANCER, V63, P641, DOI 10.1038/bjc.1991.147; LOPES MCF, 1990, CANCER RES, V50, P2753; Morello KC, 2003, CLIN PHARMACOKINET, V42, P361, DOI 10.2165/00003088-200342040-00004; National Committee for Clinical Laboratory Standards, 2002, M27A2 NAT COMM CLIN; Odom AR, 2014, MBIO, V5, DOI 10.1128/mBio.01126-14; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Sloan DJ, 2009, CURR OPIN INFECT DIS, V22, P455, DOI 10.1097/QCO.0b013e32832fa214; Spitzer M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.31; Springer DJ, 2012, CURR FUNGAL INFECT R, V6, P245, DOI 10.1007/s12281-012-0111-0; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; WISEMAN H, 1989, BIOCHEM SOC T, V17, P1038, DOI 10.1042/bst0171038	27	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125927	10.1371/journal.pone.0125927	http://dx.doi.org/10.1371/journal.pone.0125927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016941	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600041
J	Fan, HQ; He, W; Xu, KF; Wang, ZX; Xu, XY; Chen, H				Fan, Hong-Qi; He, Wei; Xu, Kuan-Feng; Wang, Zhi-Xiao; Xu, Xin-Yu; Chen, Heng			FTO Inhibits Insulin Secretion and Promotes NF-kappa B Activation through Positively Regulating ROS Production in Pancreatic beta cells	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE-EPSILON; NEGATIVE REGULATOR; ADULT OBESITY; GENE; KINASE; EXPRESSION; CHILDHOOD; VARIANTS	FTO (Fat mass and obesity-associated) is associated with increased risk of obesity and type 2 diabetes incurrence. Pancreas islet beta cells dysfunction and insulin resistance are major causes of type 2 diabetes. However, whether FTO plays an important functional role in pancreatic beta cells as well as the related molecular mechanism is still unclear. In the present study, the tissue expression profile of FTO was firstly determined using quantitative PCR and western blot. FTO is widely expressed in various tissues and presented with relative high expression in pancreas tissue, especially in endocrine pancreas. FTO overexpression in MIN6 cells achieved by lentivirus delivery significantly inhibits insulin secretion in the presence of glucose stimulus as well as KCl. FTO silence has no effect on insulin secretion of MIN6 cells. However, FTO overexpression doesn't affect the transcription of insulin gene. Furthermore, reactive oxygen species (ROS) production and NF-kappa B activation are significantly promoted by FTO overexpression. Inhibition of intracellular ROS production by N-acetyl-L-cysteine (NAC) can alleviate NF-kappa B activation and restore the insulin secretion mediated by FTO overexpression. A whole transcript-microarray is employed to analyze the differential gene expression mediated by FTO overexpression. The genes which are modulated by FTO are involved in many important biological pathways such as G-protein coupled receptor signaling and NF-kappa B signaling. Therefore, our study indicates that FTO may contribute to pancreas islet beta cells dysfunction and the inhibition of FTO activity is a potential target for the treatment of diabetes.	[Fan, Hong-Qi; He, Wei; Xu, Kuan-Feng; Wang, Zhi-Xiao; Xu, Xin-Yu; Chen, Heng] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Fan, HQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	hqfan_2004@163.com			National Natural Science Foundation of China [81100578]; Specialized Research Fund for the Doctoral Program of Higher Education [20113234120011]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by grants from the National Natural Science Foundation of China (81100578), the Specialized Research Fund for the Doctoral Program of Higher Education (20113234120011), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. All the grants support the study design, data collection and decision to publish.	Aga-Mizrachi S, 2008, ENDOCRINOLOGY, V149, P605, DOI 10.1210/en.2007-0908; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; de Luis DA, J DIABETES COMPLICAT, V27, P346, DOI [10.1016/j.jdiacomp.2013.02.003, DOI 10.1016/J.JDIAC0MP.2013.02.003]; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, PLOS ONE, V5, DOI [10.1371/journal.pone.0014005, DOI 10.1371/J0URNAL.P0NE.0014005]; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Guigas B, 2014, DIABETIC MED, V31, P1001, DOI 10.1111/dme.12464; Holmkvist J, 2007, DIABETOLOGIA, V50, P2467, DOI 10.1007/s00125-007-0846-2; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Maurya CK, MOL CELL ENDOCRINOL, V395, P51, DOI [10.1016/j.mce.2014.08.003, DOI 10.1016/J.MCE.2014.08.003]; Merkestein M, PLOS ONE, V9, DOI [10.1371/journal.pone.0097162, DOI 10.1371/J0URNAL.P0NE.0097162]; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakagawa Y, 2005, ZOOL SCI, V22, P169, DOI 10.2108/zsj.22.169; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Russell MA, 2011, CLIN SCI, V120, P403, DOI 10.1042/CS20100416; Salem HH, 2014, DIABETES, V63, P960, DOI 10.2337/db13-1037; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tan S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-12; Trombetta M, PLOS ONE, V7, DOI [10.1371/journal.pone.0032755, DOI 10.1371/J0URNAL.P0NE.0032755]; van Weenen JED, 2011, EXP DIABETES RES, DOI 10.1155/2011/928523; Wang X, 2007, BIOCHEM BIOPH RES CO, V352, P463, DOI 10.1016/j.bbrc.2006.11.032; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Zdrojowy-Welna A, 2014, ENDOKRYNOL POL, V65, P224, DOI 10.5603/EP.2014.0031; Zhang YD, 2004, CANCER RES, V64, P1902, DOI 10.1158/0008-5472.CAN-03-3361	32	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127705	10.1371/journal.pone.0127705	http://dx.doi.org/10.1371/journal.pone.0127705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018652	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600094
J	Han, JW; Liu, SY; Guo, W; Bao, ZY; Wang, XL; Li, L; Liu, YJ; Zhuang, DM; Li, HP; Jia, L; Gui, T; Sui, HS; Li, TY; Li, JY				Han, Jingwan; Liu, Siyang; Guo, Wei; Bao, Zuoyi; Wang, Xiaolin; Li, Lin; Liu, Yongjian; Zhuang, Daomin; Li, Hanping; Jia, Lei; Gui, Tao; Sui, Hongshuai; Li, Tianyi; Li, Jingyun			Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GUANGXI PROVINCE; GENOME SEQUENCE; WESTERN YUNNAN; RECOMBINANT; IDENTIFICATION; RESISTANCE; INFECTION; EPIDEMIC; CRF01-AE	Background The complex epidemic and significant diversity of HIV-1 strains in China pose serious challenges for surveillance and diagnostic assays, vaccine development and clinical management. There is a lack of HIV-1 isolates in current canonical HIV-1 subtype panels that can represent HIV-1 diversity in China; an HIV-1 subtype panel for China is urgently needed. Methods Blood samples were collected from HIV-1 infected patients participating in the drug-resistance surveillance program in China. The samples were isolated, cultured and stored as neat culture supernatant. The HIV-1 isolates were fully characterized. The panel was used to compare 2 viral load assays and 2 p24 assays as the examples of how this panel could be used. Results An HIV-1 subtype panel for China composed of 30 HIV-1 primary strains of four subtypes (B [including Thai-B], CRF01_AE, CRF07_BC and G) was established. The samples were isolated and cultured to a high-titer (10(6)-10(9) copies/ml)/high-volume (40ml). The HIV-1 isolates were fully characterized by the final viral load, p24 concentration, gag-pol and envC2V3 sequencing, co-receptor prediction, determination of the four amino acids at the tip of the env V3-loop, glycosylation sites in the V3 loop and the drug-resistance mutations. The comparison of two p24 assays and two viral load assays on the isolates illustrated how this panel may be used for the evaluation of diagnostic assay performance. The Pearson value between p24 assays were 0.938. The viral load results showed excellent concordance and agreement for samples of Thai-B, but lower correlations for samples of CRF01_AE. Conclusion The current panel of 30 HIV-1 isolates served as a basis for the development of a comprehensive panel of fully characterized viral isolates, which could reflect the current dynamic and complex HIV-1 epidemic in China. This panel will be available to support HIV-1 research, assay evaluation, vaccine and drug development.	[Han, Jingwan; Liu, Siyang; Guo, Wei; Bao, Zuoyi; Wang, Xiaolin; Li, Lin; Liu, Yongjian; Zhuang, Daomin; Li, Hanping; Jia, Lei; Gui, Tao; Sui, Hongshuai; Li, Tianyi; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing 0007, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept AIDS Res, Beijing 0007, Peoples R China.	lijy@nic.bmi.ac.cn	Liu, Yong/GWQ-6163-2022		National Science and Technology Special Projects on Major Infectious Diseases [2012ZX10001-002]	National Science and Technology Special Projects on Major Infectious Diseases	This study was supported by the National Science and Technology Special Projects on Major Infectious Diseases (Grant No. 2012ZX10001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Chen J, 1999, AIDS RES HUM RETROV, V15, P81, DOI 10.1089/088922299311754; Church D, 2011, J CLIN MICROBIOL, V49, P118, DOI 10.1128/JCM.00685-10; Feng Y, 2014, AIDS RES HUM RETROV, V30, P598, DOI [10.1089/aid.2013.0233, 10.1089/AID.2013.0233]; Feng Y, 2013, AIDS, V27, P1793, DOI 10.1097/QAD.0b013e328360db2d; Foglieni B, 2011, TRANSFUSION, V51, P719, DOI 10.1111/j.1537-2995.2010.02942.x; Gao L, 2008, J BIOL CHEM, V283, P9196, DOI 10.1074/jbc.M710148200; Guan Y, 1997, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V11, P8; Han X, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00050-12, DOI 10.1128/GEN0MEA.00050-12]; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Henquell C, 2008, J CLIN MICROBIOL, V46, P2453, DOI 10.1128/JCM.02217-07; Hsi J, 2014, AIDS RES HUM RETROV, V30, P389, DOI [10.1089/aid.2013.0234, 10.1089/AID.2013.0234]; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kline NE, 2002, PEDIATR INFECT DIS J, V21, P885, DOI 10.1097/00006454-200209000-00023; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li X, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00326-13, DOI 10.1128/GEN0MEA.00326-13]; Li Y W, 1997, Zhonghua Liu Xing Bing Xue Za Zhi, V18, P217; Liu W, DISTRIBUTION HIV 1 S; Liu Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/j.virol.2008.01.029; Manak M, 2012, AIDS RES HUM RETROV, V28, P594, DOI [10.1089/aid.2011.0271, 10.1089/AID.2011.0271]; Ntemgwa M, 2008, AIDS RES HUM RETROV, V24, P995, DOI 10.1089/aid.2008.0064; Nubling CM, 2009, TRANSFUSION, V49, P1850, DOI 10.1111/j.1537-2995.2009.02212.x; Obaro SK, 2005, PEDIATR INFECT DIS J, V24, P183, DOI 10.1097/01.inf.0000151040.57772.40; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qin G, 1998, Zhonghua Liu Xing Bing Xue Za Zhi, V19, P39; Sanchez AM, 2014, J IMMUNOL METHODS, V409, P117, DOI 10.1016/j.jim.2014.01.004; Sezgin E, 2010, JAIDS-J ACQ IMM DEF, V54, P343, DOI 10.1097/QAI.0b013e3181deaf4d; Snoeck J, 2006, ANTIMICROB AGENTS CH, V50, P694, DOI 10.1128/AAC.50.2.694-701.2006; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; UNAIDS, 2014, 2014 GAP REP UNAIDS; Wang FX, 2007, CHINESE MED J-PEKING, V120, P2006, DOI 10.1097/00029330-200711020-00013; Wei HM, 2014, AIDS RES HUM RETROV, V30, P384, DOI [10.1089/aid.2013.0228, 10.1089/AID.2013.0228]; Wei HM, 2014, AIDS RES HUM RETROV, V30, P380, DOI [10.1089/aid.2013.0235, 10.1089/AID.2013.0235]; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Xing Hui, 2004, Zhonghua Yufang Yixue Zazhi, V38, P300; Xu JQ, 2006, CHINESE MED J-PEKING, V119, P1941, DOI 10.1097/00029330-200612010-00002; Xu SH, 2012, J CLIN VIROL, V53, P33, DOI 10.1016/j.jcv.2011.10.001; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m	43	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127696	10.1371/journal.pone.0127696	http://dx.doi.org/10.1371/journal.pone.0127696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018591	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600093
J	Lee, EJ; Merriwether, DA; Kasparov, AK; Nikolskiy, PA; Sotnikova, MV; Pavlova, EY; Pitulko, VV				Lee, Esther J.; Merriwether, D. Andrew; Kasparov, Alexei K.; Nikolskiy, Pavel A.; Sotnikova, Marina V.; Pavlova, Elena Yu; Pitulko, Vladimir V.			Ancient DNA Analysis of the Oldest Canid Species from the Siberian Arctic and Genetic Contribution to the Domestic Dog	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; WOLF; ORIGIN; HAPLOTYPE; MULTIPLE; WOLVES; LUPUS; PHYLOGEOGRAPHY; SEQUENCE; HUMANS	Modern Arctic Siberia provides a wealth of resources for archaeological, geological, and paleontological research to investigate the population dynamics of faunal communities from the Pleistocene, particularly as the faunal material coming from permafrost has proven suitable for genetic studies. In order to examine the history of the Canid species in the Siberian Arctic, we carried out genetic analysis of fourteen canid remains from various sites, including the well-documented Upper Paleolithic Yana RHS and Early Holocene Zhokhov Island sites. Estimated age of samples range from as recent as 1,700 years before present (YBP) to at least 360,000 YBP for the remains of the extinct wolf, Canis cf. variabilis. In order to examine the genetic affinities of ancient Siberian canids species to the domestic dog and modern wolves, we obtained mitochondrial DNA control region sequences and compared them to published ancient and modern canid sequences. The older canid specimens illustrate affinities with pre-domestic dog/wolf lineages while others appear in the major phylogenetic clades of domestic dogs. Our results suggest a European origin of domestic dog may not be conclusive and illustrates an emerging complexity of genetic contribution of regional wolf breeds to the modern Canis gene pool.	[Lee, Esther J.; Merriwether, D. Andrew] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Lee, Esther J.] Texas Tech Univ, Dept Sociol Anthropol & Social Work, Lubbock, TX 79409 USA; [Kasparov, Alexei K.; Pitulko, Vladimir V.] Russian Acad Sci, Inst Hist Mat Culture, St Petersburg 196140, Russia; [Nikolskiy, Pavel A.; Sotnikova, Marina V.] Russian Acad Sci, Inst Geol, Moscow V71, Russia; [Pavlova, Elena Yu] Arctic & Antarct Res Inst, St Petersburg, Russia	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Texas Tech University System; Texas Tech University; Russian Academy of Sciences; Institute for the History of Material Culture, Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Geological Institute, Russian Academy of Sciences; Russian Academy of Sciences	Lee, EJ (corresponding author), Texas Tech Univ, Dept Sociol Anthropol & Social Work, Lubbock, TX 79409 USA.	esther.lee@ttu.edu	Pavlova, Elena/AAA-3291-2019; Pitulko, Vladimir/E-2200-2015; Nikolskiy, Pavel A/C-5041-2012; Pitulko, Vladimir/N-4009-2019	Pitulko, Vladimir/0000-0001-5672-2756; Kasparov, Aleksei/0000-0001-7761-9301; Pavlova, Elena/0000-0002-3010-6290	Rock Foundation	Rock Foundation	This experimental procedures and excavations for Zhokhov, Yana RHS, and New Siberian Islands were supported by the Rock Foundation. The Ford Motor Company aided in the research of the Aachim Lighthouse site. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2003, MOL ECOL, V12, P541, DOI 10.1046/j.1365-294X.2003.01708.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; Barnett R, 2009, MOL ECOL, V18, P1668, DOI 10.1111/j.1365-294X.2009.04134.x; Campos PF, 2010, P NATL ACAD SCI USA, V107, P5675, DOI 10.1073/pnas.0907189107; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Clutton-Brock J, 1995, DOMESTIC DOG ITS EVO, V14, P7; Crockford S.J., 2006, RHYTHMS LIFE THYROID; CRoCKFoRD s. J., 2000, DOGS TIME ARCHAEOLOG, V889; Crockford SJ, 2012, J ARCHAEOL SCI, V39, P2797, DOI 10.1016/j.jas.2012.04.033; DAVIS SJM, 1978, NATURE, V276, P608, DOI 10.1038/276608a0; Dikov Nikolai N., 1996, P244; Ding ZL, 2012, HEREDITY, V108, P507, DOI 10.1038/hdy.2011.114; Drake AG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08299; Druzhkova AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057754; Germonpre M, 2013, J ARCHAEOL SCI, V40, P786, DOI 10.1016/j.jas.2012.06.016; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Giterman R.E., 1982, PALEOECOLOGY BERINGI, P43, DOI [10.1016/b978-0-12-355860-2.50011-9, DOI 10.1016/B978-0-12-355860-2.50011-9]; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; Ishiguro N, 2010, ZOOL SCI, V27, P320, DOI 10.2108/zsj.27.320; Ishiguro N, 2009, ZOOL SCI, V26, P765, DOI 10.2108/zsj.26.765; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kaplina T. N., 1978, B QUAT RES COMM, V48, P49; Klutsch CFC, 2011, ANIM GENET, V42, P100, DOI 10.1111/j.1365-2052.2010.02069.x; Kurten B., 1980, PLEISTOCENE MAMMALS; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Lee EJ, 2009, J ARCHAEOL SCI, V36, P2805, DOI 10.1016/j.jas.2009.09.008; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Losey RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063740; Losey RJ, 2011, J ANTHROPOL ARCHAEOL, V30, P174, DOI 10.1016/j.jaa.2011.01.001; Macdonald D.W., 2004, CANIDS FOXES WOLVES; Miyao T., 1980, Journal of the Mammalogical Society of Japan, V8, P181; Musil R., 1984, BAR International Series, P23; Napierala H, 2012, INT J OSTEOARCHAEOL, V22, P127, DOI 10.1002/oa.1182; Nikolskiy PA, 2010, THESIS RUSSIAN ACAD; Nobis G, 1986, BONNER JB, V186; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Pei W.C., 1941, PAL SIN C, V11, P1; Pionnier-Capitan M, 2011, J ARCHAEOL SCI, V38, P2123, DOI 10.1016/j.jas.2011.02.028; Pitul'ko VV, 2007, DOKL EARTH SCI, V417, P1256, DOI 10.1134/S1028334X07080284; Pitulko V.V.., 2010, GEOARCHEOLOGY RADIOC; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Pitulko VV, 1996, ARCTIC ANTHROPOL, V33, P1; Pitulko VV, 2010, ADAPTATIONS PEOPLES, P38; Pitulko VV, 2001, DIKOV READINGS, P64; Pitulko VV, 2003, HUNTER GATHERERS N P, P141; Pitulko VV, 2003, P ARCT SYST SCI PROG, P189; Pitulko VV, 2006, NEOLIT PALEOMETALL S, P50; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Sher A. V., 1979, 14 PAC SCI C TOUR GU, P1; Skoglund P, 2011, MOL BIOL EVOL, V28, P1505, DOI 10.1093/molbev/msq342; Sotnikova M, 2010, QUATERN INT, V212, P86, DOI 10.1016/j.quaint.2009.06.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tedford Richard H., 2009, Bulletin of the American Museum of Natural History, V325, P1, DOI 10.1206/574.1; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Tsuda K, 1997, GENES GENET SYST, V72, P229, DOI 10.1266/ggs.72.229; Vasil'chuk YK, 2001, RADIOCARBON, V43, P541; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Wayne RK, 1998, CONSERV BIOL, V12, P726, DOI 10.1046/j.1523-1739.1998.97468.x; Weckworth BV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019582; Weckworth BV, 2010, J MAMMAL, V91, P363, DOI 10.1644/09-MAMM-A-036.1; Yashina S, 2012, P NATL ACAD SCI USA, V109, P4008, DOI 10.1073/pnas.1118386109; Zanina OG, 2011, QUATERNARY SCI REV, V30, P2107, DOI 10.1016/j.quascirev.2011.01.021	71	17	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125759	10.1371/journal.pone.0125759	http://dx.doi.org/10.1371/journal.pone.0125759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018528	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600031
J	Abouna, S; Gonzalez-Rizzo, S; Grimonprez, A; Gros, O				Abouna, Sylvie; Gonzalez-Rizzo, Silvina; Grimonprez, Adrien; Gros, Olivier			First Description of Sulphur-Oxidizing Bacterial Symbiosis in a Cnidarian (Medusozoa) Living in Sulphidic Shallow-Water Environments	PLOS ONE			English	Article							CALIFORNICUM HYMAN ANTHOMEDUSA; DEEP-SEA; CLADONEMA-CALIFORNICUM; RAMAN MICROSPECTROMETRY; CHARACTER EVOLUTION; ECTOSYMBIONTS; DIVERSITY; NITROGEN; HYDROZOA; CARBON	Background Since the discovery of thioautotrophic bacterial symbiosis in the giant tubeworm Riftia pachyptila, there has been great impetus to investigate such partnerships in other invertebrates. In this study, we present the occurrence of a sulphur-oxidizing symbiosis in a metazoan belonging to the phylum Cnidaria in which this event has never been described previously. Methodology/Principal Findings Scanning Electron Microscope (SEM), Transmission Electron Microscope (TEM) observations and Energy-dispersive X-ray spectroscopy (EDXs) analysis, were employed to unveil the presence of prokaryotes population bearing elemental sulphur granules, growing on the body surface of the metazoan. Phylogenetic assessments were also undertaken to identify this invertebrate and microorganisms in thiotrophic symbiosis. Our results showed the occurrence of a thiotrophic symbiosis in a cnidarian identified as Cladonema sp. Conclusions/Significance This is the first report describing the occurrence of a sulphur-oxidizing symbiosis in a cnidarian. Furthermore, of the two adult morphologies, the polyp and medusa, this mutualistic association was found restricted to the polyp form of Cladonema sp.	[Abouna, Sylvie; Gonzalez-Rizzo, Silvina; Grimonprez, Adrien; Gros, Olivier] Univ Antilles Guyane, UFR Sci Exactes & Nat, UMR Evolut Paris Seine 7138, Inst Biol Paris Seine,Equipe Biol Mangrove,Dept B, BP 592, F-97159 Pointe A Pitre, Guadeloupe, France; [Gros, Olivier] Univ Antilles Guyane, UFR Sci Exactes & Nat, C3MAG, F-97159 Pointe A Pitre, Guadeloupe, France	UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Universite des Antilles; Universite de Montpellier; Universite des Antilles	Gros, O (corresponding author), Univ Antilles Guyane, UFR Sci Exactes & Nat, UMR Evolut Paris Seine 7138, Inst Biol Paris Seine,Equipe Biol Mangrove,Dept B, BP 592, F-97159 Pointe A Pitre, Guadeloupe, France.	olivier.gros@univ-ag.fr		GONZALEZ-RIZZO, Silvina/0000-0002-0097-138X				Aerne B, 1996, SCI MAR, V60, P7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bates AE, 2011, BIOL BULL-US, V220, P118, DOI 10.1086/BBLv220n2p118; Bauermeister J, 2013, INT J SPELEOL, V42, P141, DOI 10.5038/1827-806X.42.2.6; BauerNebelsick M, 1996, EUR J PROTISTOL, V32, P18, DOI 10.1016/S0932-4739(96)80036-8; BERG CJ, 1984, AQUACULTURE, V39, P165, DOI 10.1016/0044-8486(84)90264-3; BOERO F, 1995, SCI MAR, V59, P65; Bosch TCG, 2012, BIOL BULL-US, V223, P78, DOI 10.1086/BBLv223n1p78; Bouillon J, 2000, PHYLOGENY CLASSIFICA; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Carlos C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01624; Cartwright P, 2010, INTEGR COMP BIOL, V50, P456, DOI 10.1093/icb/icq089; Cavanaugh CM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P475, DOI 10.1007/0-387-30741-9_18; Chaston J, 2010, FEMS MICROBIOL REV, V34, P41, DOI 10.1111/j.1574-6976.2009.00193.x; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Costello J, 1998, J EXP MAR BIOL ECOL, V225, P13, DOI 10.1016/S0022-0981(97)00204-9; COSTELLO J, 1991, MAR BIOL, V108, P119, DOI 10.1007/BF01313479; COSTELLO J, 1988, J EXP MAR BIOL ECOL, V123, P177, DOI 10.1016/0022-0981(88)90168-2; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Dattagupta S, 2009, ISME J, V3, P935, DOI 10.1038/ismej.2009.34; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Deming JW, 1997, MICROSC RES TECHNIQ, V37, P162, DOI 10.1002/(SICI)1097-0029(19970415)37:2<162::AID-JEMT4>3.0.CO;2-Q; Di Camillo CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039926; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715, DOI 10.4319/lo.1979.24.4.0715; Edgcom VP, 2011, ISME J, V5, P231, DOI 10.1038/ismej.2010.121; Fautin DG, 2009, TOXICON, V54, P1054, DOI 10.1016/j.toxicon.2009.02.024; FELBECK H, 1981, NATURE, V293, P291, DOI 10.1038/293291a0; FENCHEL TM, 1970, MAR BIOL, V7, P255, DOI 10.1007/BF00367496; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Frenkiel L, 1996, MAR BIOL, V125, P511; Galliot B, 2002, INT J DEV BIOL, V46, P39; Ganot P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002187; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Girnth AC, 2011, ENVIRON MICROBIOL, V13, P495, DOI 10.1111/j.1462-2920.2010.02353.x; Goodson MS, 2001, HYDROBIOLOGIA, V461, P79, DOI 10.1023/A:1012766609448; Gravier-Bonnet N, 2002, INVERTEBR REPROD DEV, V41, P101, DOI 10.1080/07924259.2002.9652740; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; Hentschel U, 1999, MAR ECOL PROG SER, V183, P149, DOI 10.3354/meps183149; Himmel D, 2009, BIOL CELL, V101, P43, DOI 10.1042/BC20080051; Jean MRN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117832; Kawaida H, 2013, MOL PHYLOGENET EVOL, V66, P906, DOI 10.1016/j.ympev.2012.11.018; Kimbell JR, 2003, INTEGR COMP BIOL, V43, P254, DOI 10.1093/icb/43.2.254; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Laurent MCZ, 2013, MAR ENVIRON RES, V87-88, P85, DOI 10.1016/j.marenvres.2013.03.007; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Marques AC, 2002, TOXICON, V40, P213, DOI 10.1016/S0041-0101(01)00196-9; Maurin LC, 2010, MAR ENVIRON RES, V69, P382, DOI 10.1016/j.marenvres.2010.02.001; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Meyer E, 2012, BIOL BULL-US, V223, P44, DOI 10.1086/BBLv223n1p44; Miranda LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010182; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Muller F, 2010, ENVIRON MICROBIOL, V12, P2371, DOI 10.1111/j.1462-2920.2010.02309.x; Novo M, 2007, PLANT PATHOL, V56, P998, DOI 10.1111/j.1365-3059.2007.01683.x; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; REES JT, 1982, PAC SCI, V36, P439; REES JT, 1979, J NAT HIST, V13, P295, DOI 10.1080/00222937900770231; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Rinke C, 2006, APPL ENVIRON MICROB, V72, P2014, DOI 10.1128/AEM.72.3.2014-2021.2006; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Ruehland C, 2010, ENVIRON MICROBIOL, V12, P2312, DOI 10.1111/j.1462-2920.2010.02256.x; Schauer R, 2011, ENVIRON MICROBIOL, V13, P2633, DOI 10.1111/j.1462-2920.2011.02530.x; Schuett C, 2012, HELGOLAND MARINE RES, V64, P205; Stachowicz JJ, 2000, OECOLOGIA, V124, P280, DOI 10.1007/s004420000372; Stewart FJ, 2005, TRENDS MICROBIOL, V13, P439, DOI 10.1016/j.tim.2005.07.007; Suescun-Bolivar LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047182; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Tokuda G, 2008, MAR ECOL-EVOL PERSP, V29, P106, DOI 10.1111/j.1439-0485.2007.00211.x; Turk T, 2009, TOXICON, V54, P1031, DOI 10.1016/j.toxicon.2009.06.031; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Verde EA, 1998, MAR ECOL PROG SER, V168, P147, DOI 10.3354/meps168147; Vopel K, 2005, LIMNOL OCEANOGR, V50, P128, DOI 10.4319/lo.2005.50.1.0128; WILKERSON FP, 1980, MICROB ECOL, V6, P85, DOI 10.1007/BF02020377; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Yamamoto M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00192; Young C, 2002, IRELANDS MARINE ATLA	84	9	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127625	10.1371/journal.pone.0127625	http://dx.doi.org/10.1371/journal.pone.0127625			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011278	Green Published, gold			2022-12-27	WOS:000355183900117
J	Arpino, JAJ; Baldwin, AJ; McGarrity, AR; Tippmann, EM; Jones, DD				Arpino, James A. J.; Baldwin, Amy J.; McGarrity, Adam R.; Tippmann, Eric M.; Jones, D. Dafydd			In-Frame Amber Stop Codon Replacement Mutagenesis for the Directed Evolution of Proteins Containing Non-Canonical Amino Acids: Identification of Residues Open to Bio-Orthogonal Modification	PLOS ONE			English	Article							EXPANDED GENETIC-CODE; FREE CLICK CHEMISTRY; CYTOCHROME B(562); ESCHERICHIA-COLI; BIOORTHOGONAL REACTIONS; APOCYTOCHROME B(562); MOLECULAR DIVERSITY; UNRELATED PROTEINS; ELECTRON-TRANSPORT; DOMAIN INSERTION	Expanded genetic code approaches are a powerful means to add new and useful chemistry to proteins at defined residues positions. One such use is the introduction of non-biological reactive chemical handles for site-specific biocompatible orthogonal conjugation of proteins. Due to our currently limited information on the impact of non-canonical amino acids (nAAs) on the protein structure-function relationship, rational protein engineering is a "hit and miss" approach to selecting suitable sites. Furthermore, dogma suggests surface exposed native residues should be the primary focus for introducing new conjugation chemistry. Here we describe a directed evolution approach to introduce and select for in-frame codon replacement to facilitate engineering proteins with nAAs. To demonstrate the approach, the commonly reprogrammed amber stop codon (TAG) was randomly introduced in-frame in two different proteins: the bionanotechnologically important cyt b(562) and therapeutic protein KGF. The target protein is linked at the gene level to sfGFP via a TEV protease site. In absence of a nAA, an in-frame TAG will terminate translation resulting in a non-fluorescent cell phenotype. In the presence of a nAA, TAG will encode for nAA incorporation so instilling a green fluorescence phenotype on E. coli. The presence of endogenously expressed TEV proteases separates in vivo target protein from its fusion to sfGFP if expressed as a soluble fusion product. Using this approach, we incorporated an azide reactive handle and identified residue positions amenable to conjugation with a fluorescence dye via strain-promoted azide-alkyne cycloaddition (SPAAC). Interestingly, best positions for efficient conjugation via SPAAC were residues whose native side chain were buried through analysis of their determined 3D structures and thus may not have been chosen through rational protein engineering. Molecular modeling suggests these buried native residues could become partially exposed on substitution to the azide containing nAA.	[Arpino, James A. J.; Baldwin, Amy J.; McGarrity, Adam R.; Jones, D. Dafydd] Cardiff Univ, Sch Biosci, Cardiff CF10 3AT, Wales; [Tippmann, Eric M.] Indiana Purdue Univ Ft Wayne, Dept Chem, Ft Wayne, IN 46815 USA	Cardiff University; Purdue University System; Indiana University Purdue University Fort Wayne	Jones, DD (corresponding author), Cardiff Univ, Sch Biosci, Main Bldg,Pk Pl, Cardiff CF10 3AT, Wales.	jonesdd@cf.ac.uk	Jones, Dafydd/A-4330-2010	Baldwin, Amy/0000-0002-2162-3771	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H003746/1, BB/E007384]; Engineering and Physical Sciences Research Council (EPSRC) [EP/J015318/1]; Medical Research Council Developmental Pathway Funding Scheme (MRC DPFS) [G0900868]; Biotechnology and Biological Sciences Research Council [983743, BB/H003746/1, BB/E007384/1, BB/M000249/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J015318/1] Funding Source: researchfish; BBSRC [BB/H003746/1, BB/M000249/1, BB/E007384/1] Funding Source: UKRI; EPSRC [EP/J015318/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council Developmental Pathway Funding Scheme (MRC DPFS)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC): BB/H003746/1 & BB/E007384, Engineering and Physical Sciences Research Council (EPSRC): EP/J015318/1, and Medical Research Council Developmental Pathway Funding Scheme (MRC DPFS): G0900868. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Antonczak AK, 2009, J BIOL CHEM, V284, P28795, DOI 10.1074/jbc.M109.027409; Arnesano F, 1999, BIOCHEMISTRY-US, V38, P8657, DOI 10.1021/bi982785f; Arnold FH, 2001, NATURE, V409, P253, DOI 10.1038/35051731; Arpino JAJ, 2014, STRUCTURE, V22, P889, DOI 10.1016/j.str.2014.03.014; Arpino JAJ, 2012, J AM CHEM SOC, V134, P13632, DOI 10.1021/ja301987h; Axup JY, 2012, P NATL ACAD SCI USA, V109, P16101, DOI 10.1073/pnas.1211023109; Baldwin AJ, 2009, MOL BIOSYST, V5, P764, DOI 10.1039/b904031e; Baldwin AJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn358; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Best MD, 2009, BIOCHEMISTRY-US, V48, P6571, DOI 10.1021/bi9007726; Bianco A, 2012, NAT CHEM BIOL, V8, P748, DOI [10.1038/nchembio.1043, 10.1038/NCHEMBIO.1043]; Blijlevens N, 2007, ANN ONCOL, V18, P817, DOI 10.1093/annonc/mdl332; Blomberg R, 2013, NATURE, V503, P418, DOI 10.1038/nature12623; Brodin JD, 2012, NAT CHEM, V4, P375, DOI [10.1038/NCHEM.1290, 10.1038/nchem.1290]; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; D'Amelio N, 2002, BIOCHEMISTRY-US, V41, P5505, DOI 10.1021/bi011863n; Daggett KA, 2009, ACS CHEM BIOL, V4, P109, DOI 10.1021/cb800271f; Dalby PA, 2003, CURR OPIN STRUC BIOL, V13, P500, DOI 10.1016/S0959-440X(03)00101-5; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Della Pia EA, 2012, SMALL, V8, P2341, DOI 10.1002/smll.201102416; Della Pia EA, 2012, CHEM COMMUN, V48, P10624, DOI 10.1039/c2cc34302a; Della Pia EA, 2012, ACS NANO, V6, P355, DOI 10.1021/nn2036818; Della Pia EA, 2011, NANO LETT, V11, P176, DOI 10.1021/nl103334q; Edwards WR, 2010, BIOCHEMISTRY-US, V49, P6541, DOI 10.1021/bi100793y; Edwards WR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn363; Feng SJ, 1997, CANCER RES, V57, P5369; FENG YQ, 1994, NAT STRUCT BIOL, V1, P30, DOI 10.1038/nsb0194-30; Forman CJ, 2012, ACS NANO, V6, P1332, DOI 10.1021/nn204140a; Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Haapa S, 1999, NUCLEIC ACIDS RES, V27, P2777, DOI 10.1093/nar/27.13.2777; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218; Jewett JC, 2010, J AM CHEM SOC, V132, P3688, DOI 10.1021/ja100014q; Jones DD, 2014, METHODS MOL BIOL, V1179, P159, DOI 10.1007/978-1-4939-1053-3_11; Jones DD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni077; Jones DD, 2005, ANGEW CHEM INT EDIT, V44, P6337, DOI 10.1002/anie.200463035; Jones DD, 2004, CHEMBIOCHEM, V5, P964, DOI 10.1002/cbic.200300569; Kim CH, 2013, CURR OPIN CHEM BIOL, V17, P412, DOI 10.1016/j.cbpa.2013.04.017; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lang K, 2014, ACS CHEM BIOL, V9, P16, DOI 10.1021/cb4009292; LEDERER F, 1981, J MOL BIOL, V148, P427, DOI 10.1016/0022-2836(81)90185-6; Li FH, 2013, ANGEW CHEM INT EDIT, V52, P9700, DOI 10.1002/anie.201303477; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Liu CC, 2008, P NATL ACAD SCI USA, V105, P17688, DOI 10.1073/pnas.0809543105; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Miyake-Stoner SJ, 2010, BIOCHEMISTRY-US, V49, P1667, DOI 10.1021/bi901947r; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Oohora K, 2014, CURR OPIN CHEM BIOL, V19, P154, DOI 10.1016/j.cbpa.2014.02.014; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reddington S, 2013, BIOCHEM SOC T, V41, P1177, DOI 10.1042/BST20130094; Reddington SC, 2015, CHEM SCI, V6, P1159, DOI 10.1039/c4sc02827a; Reddington SC, 2013, ANGEW CHEM INT EDIT, V52, P5974, DOI 10.1002/anie.201301490; Reddington SC, 2012, CHEM COMMUN, V48, P8419, DOI 10.1039/c2cc31887c; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Yuen CM, 2007, NAT METHODS, V4, P995, DOI 10.1038/nmeth1207-995; Zhang WH, 2013, CURR OPIN STRUC BIOL, V23, P581, DOI 10.1016/j.sbi.2013.06.009	68	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127504	10.1371/journal.pone.0127504	http://dx.doi.org/10.1371/journal.pone.0127504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011713	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000355183900101
J	Beko, G; Allen, JG; Weschler, CJ; Vallarino, J; Spengler, JD				Beko, Gabriel; Allen, Joseph G.; Weschler, Charles J.; Vallarino, Jose; Spengler, John D.			Impact of Cabin Ozone Concentrations on Passenger Reported Symptoms in Commercial Aircraft	PLOS ONE			English	Article							STRATOSPHERE-TROPOSPHERE EXCHANGE; US OFFICE BUILDINGS; AIR-QUALITY; INDOOR AIR; INITIATED CHEMISTRY; RELATIVE-HUMIDITY; INTERCONTINENTAL FLIGHTS; RESPIRATORY SYMPTOMS; AIRLINE CREWS; OUTDOOR OZONE	Due to elevated ozone concentrations at high altitudes, the adverse effect of ozone on air quality, human perception and health may be more pronounced in aircraft cabins. The association between ozone and passenger-reported symptoms has not been investigated under real conditions since smoking was banned on aircraft and ozone converters became more common. Indoor environmental parameters were measured at cruising altitude on 83 US domestic and international flights. Passengers completed a questionnaire about symptoms and satisfaction with the indoor air quality. Average ozone concentrations were relatively low (median: 9.5 ppb). On thirteen flights (16%) ozone levels exceeded 60 ppb, while the highest peak level reached 256 ppb for a single flight. The most commonly reported symptoms were dry mouth or lips (26%), dry eyes (22.1%) and nasal stuffiness (18.9%). 46% of passengers reported at least one symptom related to the eyes or mouth. A third of the passengers reported at least one upper respiratory symptom. Using multivariate logistic (individual symptoms) and linear (aggregated continuous symptom variables) regression, ozone was consistently associated with symptoms related to the eyes and certain upper respiratory endpoints. A concentration-response relationship was observed for nasal stuffiness and eye and upper respiratory symptom indicators. Average ozone levels, as opposed to peak concentrations, exhibited slightly weaker associations. Medium and long duration flights were significantly associated with more symptoms compared to short flights. The relationship between ultrafine particles and ozone on flights without meal service was indicative of ozone-initiated chemistry.	[Beko, Gabriel; Weschler, Charles J.] Tech Univ Denmark, Dept Civil Engn, Int Ctr Indoor Environm & Energy, DK-2800 Lyngby, Denmark; [Allen, Joseph G.; Vallarino, Jose; Spengler, John D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Weschler, Charles J.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA	Technical University of Denmark; Harvard University; Harvard T.H. Chan School of Public Health; Rutgers State University New Brunswick	Beko, G (corresponding author), Tech Univ Denmark, Dept Civil Engn, Int Ctr Indoor Environm & Energy, DK-2800 Lyngby, Denmark.	gab@byg.dtu.dk	Weschler, Charles J/A-9788-2009; Beko, Gabriel/C-8684-2009	Weschler, Charles J/0000-0002-9097-5850; Beko, Gabriel/0000-0001-6107-8336	American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) [1262-RP]; Federal Aviation Administration (FAA) [04-C-ACE, 07-C-RITE]; Danish Otto Monsteds Fond [14-70-0008]	American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE); Federal Aviation Administration (FAA); Danish Otto Monsteds Fond	This project was funded by the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE; Project 1262-RP) and the Federal Aviation Administration (FAA; Cooperative Agreements 04-C-ACE and 07-C-RITE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Danish Otto Monsteds Fond partially supported the research stay of GB at Harvard School of Public Health during which the analyses were performed and the manuscript was drafted (Grant #14-70-0008).	Allen JG, 2013, J EXPO SCI ENV EPID, V23, P337, DOI 10.1038/jes.2012.62; Allen JG, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-17; Anderson SE, 2012, TOXICOL SCI, V127, P371, DOI 10.1093/toxsci/kfs102; Apte MG, 2008, INDOOR AIR, V18, P156, DOI 10.1111/j.1600-0668.2008.00521.x; Apte MG, 2000, INDOOR AIR, V10, P246, DOI 10.1034/j.1600-0668.2000.010004246.x; Beatty AL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-81; Beko G, 2013, ENVIRON SCI TECHNOL, V47, P10240, DOI 10.1021/es402429h; Bell ML, 2005, EPIDEMIOLOGY, V16, P436, DOI 10.1097/01.ede.0000165817.40152.85; BENNETT G, 1962, AEROSPACE MED, V33, P969; Bhangar S, 2008, ENVIRON SCI TECHNOL, V42, P3938, DOI 10.1021/es702967k; Bhangar S, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014006; BISCHOF W, 1973, Water Air and Soil Pollution, V2, P3, DOI 10.1007/BF00572385; Chen C, 2012, ENVIRON HEALTH PERSP, V120, P235, DOI 10.1289/ehp.1103970; Coleman BK, 2008, ATMOS ENVIRON, V42, P642, DOI 10.1016/j.atmosenv.2007.10.001; DAUBS J, 1980, AM J OPTOM PHYS OPT, V57, P95; de Ree H, 2000, AM SOC TEST MATER, V1393, P243, DOI 10.1520/STP14497S; Ebbert JO, 2007, ENVIRON HEALTH-GLOB, V6, P1, DOI 10.1186/1476-069X-6-28; Fadeyi MO, 2013, ENVIRON SCI TECHNOL, V47, P3933, DOI 10.1021/es3050828; Foucher PY, 2011, ATMOS CHEM PHYS, V11, P2455, DOI 10.5194/acp-11-2455-2011; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; Giaconia C, 2013, BUILD ENVIRON, V67, P69, DOI 10.1016/j.buildenv.2013.05.006; Grun G, 2012, BUILD ENVIRON, V47, P23, DOI 10.1016/j.buildenv.2011.05.004; Haghighat F, 1999, INDOOR BUILT ENVIRON, V8, P58, DOI 10.1159/000024610; HAUGLI L, 1994, AVIAT SPACE ENVIR MD, V65, P27; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hubbell BJ, 2005, ENVIRON HEALTH PERSP, V113, P73, DOI 10.1289/ehp.7186; Knudsen HN, 2003, INDOOR AIR, V13, P223, DOI 10.1034/j.1600-0668.2003.00182.x; Law KS, 2000, J GEOPHYS RES-ATMOS, V105, P1503, DOI 10.1029/1999JD900474; Lee SC, 1999, INDOOR AIR, V9, P180, DOI 10.1111/j.1600-0668.1999.t01-1-00004.x; Lee SC, 2000, AM SOC TEST MATER, V1393, P259, DOI 10.1520/STP14498S; Lindgren T, 2005, INDOOR AIR, V15, P65, DOI 10.1111/j.1600-0668.2005.00353.x; Lindgren T, 2002, INDOOR AIR, V12, P263, DOI 10.1034/j.1600-0668.2002.01121.x; Lindgren T, 2002, INT ARCH OCC ENV HEA, V75, P475, DOI 10.1007/s00420-002-0330-8; McDonnell WF, 1999, ENVIRON RES, V80, P110, DOI 10.1006/enrs.1998.3894; McNeely E, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-13; Mendell MJ, 2006, J OCCUP ENVIRON HYG, V3, P225, DOI 10.1080/15459620600628589; Morawska L, 2013, INDOOR AIR, V23, P462, DOI 10.1111/ina.12044; Nagda NL, 2003, AVIAT SPACE ENVIR MD, V74, P101; Nagda NL, 2001, INDOOR AIR, V11, P200, DOI 10.1034/j.1600-0668.2001.011003200.x; NAGDA NL, 1992, ATMOS ENVIRON A-GEN, V26, P2203, DOI 10.1016/0960-1686(92)90409-E; NASTROM GD, 1980, J AIRCRAFT, V17, P246, DOI 10.2514/3.44654; Nojgaard JK, 2005, TOXICOL LETT, V156, P241, DOI 10.1016/j.toxlet.2004.11.013; Norback D, 2006, SCAND J WORK ENV HEA, V32, P138, DOI 10.5271/sjweh.989; Persily A.K., 1997, ASHRAE T, V103, P193; Poppendieck D, 2007, ATMOS ENVIRON, V41, P3166, DOI 10.1016/j.atmosenv.2006.06.060; Pui DYH, 2008, ENVIRON HEALTH PERSP, V116, P863, DOI 10.1289/ehp.11169; Quality, 2002, STAND GUID US IND CA; Rai AC, 2013, ATMOS ENVIRON, V77, P885, DOI 10.1016/j.atmosenv.2013.05.062; Rankin WL, 2000, AM SOC TEST MATER, V1393, P269, DOI 10.1520/STP14499S; Reed D, 1980, Am J Ind Med, V1, P43, DOI 10.1002/ajim.4700010107; Samoli E, 2009, J EPIDEMIOL COMMUN H, V63, P960, DOI 10.1136/jech.2008.084012; Spengler JD, 2004, INDOOR AIR, V14, P67, DOI 10.1111/j.1600-0668.2004.00275.x; Spix C, 1998, ARCH ENVIRON HEALTH, V53, P54, DOI 10.1080/00039899809605689; Stohl A, 2003, B AM METEOROL SOC, V84, P1565, DOI 10.1175/BAMS-84-11-1565; Strom-Tejsen P, 2007, INDOOR AIR, V17, P92, DOI 10.1111/j.1600-0668.2006.00458.x; Strom-Tejsen P, 2008, J EXPO SCI ENV EPID, V18, P272, DOI 10.1038/sj.jes.7500586; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; Sunyer J, 1997, THORAX, V52, P760, DOI 10.1136/thx.52.9.760; Tamas G, 2006, INDOOR AIR, V16, P168, DOI 10.1111/j.1600-0668.2005.00413.x; TASHKIN DP, 1983, INT ARCH OCC ENV HEA, V52, P117, DOI 10.1007/BF00405416; US EPA (US ENVIRONMENT PROTECTION AGENCY), 2008, FED REG, V73; VANHEUSDEN S, 1978, AVIAT SPACE ENVIR MD, V49, P1056; Veres PR, 2013, ATMOS ENVIRON, V77, P1052, DOI 10.1016/j.atmosenv.2013.05.076; Wahlstedt K, 2010, AM J IND MED, V53, P716, DOI 10.1002/ajim.20822; Wang CY, 2014, ATMOS ENVIRON, V84, P222, DOI 10.1016/j.atmosenv.2013.11.009; Weisel C, 2013, ENVIRON SCI TECHNOL, V47, P4711, DOI 10.1021/es3046795; Weschler CJ, 2016, INDOOR AIR, V26, P6, DOI 10.1111/ina.12185; Weschler CJ, 2007, ENVIRON SCI TECHNOL, V41, P6177, DOI 10.1021/es0708520; Weschler CJ, 2006, ENVIRON HEALTH PERSP, V114, P1489, DOI 10.1289/ehp.9256; Weschler CJ, 1999, ATMOS ENVIRON, V33, P2301, DOI 10.1016/S1352-2310(99)00083-7; Weschler CJ, 2004, INDOOR AIR, V14, P184, DOI 10.1111/j.1600-0668.2004.00287.x; Weschler CJ, 2000, INDOOR AIR, V10, P269, DOI 10.1034/j.1600-0668.2000.010004269.x; WESCHLER CJ, 2003, INDOOR ENV AIRBORNE, P171; WHO, 2008, HLTH RISK OZ LONG RA; Wisthaler A, 2005, ENVIRON SCI TECHNOL, V39, P4823, DOI 10.1021/es047992j; Wisthaler A, 2010, P NATL ACAD SCI USA, V107, P6568, DOI 10.1073/pnas.0904498106; Wolkoff P, 2008, TOXICOL LETT, V181, P171, DOI 10.1016/j.toxlet.2008.07.018; Wolkoff P, 2013, TOXICOL LETT, V216, P54, DOI 10.1016/j.toxlet.2012.11.008; YOUNG WA, 1962, AEROSPACE MED, V33, P311	80	26	26	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128454	10.1371/journal.pone.0128454	http://dx.doi.org/10.1371/journal.pone.0128454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011001	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900235
J	Artese, HPC; Foz, AM; Rabelo, MD; Gomes, GH; Orlandi, M; Suvan, J; D'Aiuto, F; Romito, GA				Carillo Artese, Hilana Paula; Foz, Adriana Moura; Rabelo, Mariana de Sousa; Gomes, Giovane Hisse; Orlandi, Marco; Suvan, Jean; D'Aiuto, Francesco; Romito, Giuseppe Alexandre			Periodontal Therapy and Systemic Inflammation in Type 2 Diabetes Mellitus: A Meta-Analysis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; GLYCEMIC CONTROL; COMPLICATIONS TRIAL/EPIDEMIOLOGY; INSULIN-RESISTANCE; METABOLIC-CONTROL; DISEASES; INTERVENTION; CYTOKINES; ADIPONECTIN	Aim The aim of this systematic review was to assess the effect of periodontal therapy (PT) on serum levels of inflammatory markers in people with type 2 diabetes mellitus (T2DM). Methods of Study Selection A literature search was carried out using MEDLINE via Pubmed, EMBASE, LILACS and Cochrane Central Register of Controlled Trials (CENTRAL) databases. Randomized-controlled trials (RCTs) and controlled clinical trials (CCTs) evaluating the effect of PT on systemic inflammatory markers were deemed eligible. Case series (CS), reports and pilot trials were excluded. Study quality was assessed using the Cochrane Collaboration's risk assessment tool. Meta-analysis was carried out using random effect methods. Results The search strategy identified 3,164 potential studies of which 61 were assessed for eligibility and 9 (6 RCTs and 3 CCTs) were included in this systematic review. Three RCTs were classified by the authors as being at low risk of bias and three were "unclear" and classified as uncertain risk of bias. All CCTs were considered to be at a high risk of bias. The meta-analysis showed a statistically significant mean difference (MD) for TNF-alpha (-1.33 pg/ml, 95% CI: -2.10; -0.56, p<0.001) and CRP (-1.28 mg/l, 95% CI: -2.07; -0.48, p<0.001) favoring periodontal intervention versus control. Conclusion The results of this meta-analysis support the hypothesis that PT reduces serum levels of TNF-alpha and CRP in T2DM individuals. The decrease of inflammatory burden has important implications for metabolic control and can, in part, explain the mechanisms linking periodontitis and increased risk for complications in people with T2DM.	[Carillo Artese, Hilana Paula; Foz, Adriana Moura; Rabelo, Mariana de Sousa; Gomes, Giovane Hisse; Romito, Giuseppe Alexandre] Univ Sao Paulo, Sch Dent, Dept Stomatol, Div Periodont, Sao Paulo, SP, Brazil; [Orlandi, Marco; Suvan, Jean; D'Aiuto, Francesco] UCL Eastman Dent Inst, Unit Periodontol, London, England	Universidade de Sao Paulo; University of London; University College London	Romito, GA (corresponding author), Univ Sao Paulo, Sch Dent, Dept Stomatol, Div Periodont, Sao Paulo, SP, Brazil.	garomito@usp.br	Romito, Giuseppe Alexandre/C-3592-2012; Rabelo, Mariana/AAP-7698-2020; Rabelo, Mariana/AAT-9257-2020; Carillo Artese, Hilana Paula/C-8773-2013	Romito, Giuseppe Alexandre/0000-0001-5669-912X; Rabelo, Mariana/0000-0003-1385-8471; Carillo Artese, Hilana Paula/0000-0001-8421-9592	Clinical Senior Lectureship Award; UK Clinical Research Collaboration; Department of Health's National Institute of Health Research (NIHR) Biomedical Research Centers funding scheme	Clinical Senior Lectureship Award; UK Clinical Research Collaboration; Department of Health's National Institute of Health Research (NIHR) Biomedical Research Centers funding scheme	No external funding was received and all authors were self-funded or supported by their institution. FD holds a Clinical Senior Lectureship Award supported by the UK Clinical Research Collaboration. FD and JS work at UCL, which received a proportion of funding from the Department of Health's National Institute of Health Research (NIHR) Biomedical Research Centers funding scheme.	Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; ATKINSON MA, 1990, SCI AM, V263, P62, DOI 10.1038/scientificamerican0790-62; Bergman M, 2013, ENDOCRINE, V43, P504, DOI 10.1007/s12020-012-9830-9; Cefalu WT, 2014, DIABETES CARE, V37, P5, DOI 10.2337/dc13-2369; Chen L, 2012, J PERIODONTOL, V83, P435, DOI 10.1902/jop.2011.110327; Choi YH, 2011, DIABETES CARE, V34, P381, DOI 10.2337/dc10-1354; Christgau M, 1998, J CLIN PERIODONTOL, V25, P112, DOI 10.1111/j.1600-051X.1998.tb02417.x; Correa FOB, 2010, J CLIN PERIODONTOL, V37, P53, DOI 10.1111/j.1600-051X.2009.01498.x; D'Aiuto F, 2013, J CLIN PERIODONTOL, V40, pS85, DOI [10.1902/jop.2013.134007, 10.1111/jcpe.12061]; Dag A, 2009, AUST DENT J, V54, P17, DOI 10.1111/j.1834-7819.2008.01083.x; Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026; Ebersole JL, 2000, PERIODONTOL 2000, V23, P19, DOI 10.1034/j.1600-0757.2000.2230103.x; Engebretson SP, 2013, JAMA-J AM MED ASSOC, V310, P2523, DOI 10.1001/jama.2013.282431; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Gorska R, 2003, J CLIN PERIODONTOL, V30, P1046, DOI 10.1046/j.0303-6979.2003.00425.x; Grossi S G, 1998, Ann Periodontol, V3, P51, DOI 10.1902/annals.1998.3.1.51; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Iwamoto Y, 2001, J PERIODONTOL, V72, P774, DOI 10.1902/jop.2001.72.6.774; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Janket SJ, 2005, J DENT RES, V84, P1154, DOI 10.1177/154405910508401212; Kardesler L, 2010, J PERIODONTOL, V81, P24, DOI 10.1902/jop.2009.090267; Katagiri S, 2009, DIABETES RES CLIN PR, V83, P308, DOI 10.1016/j.diabres.2008.10.016; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; Koromantzos PA, 2012, J PERIODONTOL, V83, P3, DOI 10.1902/jop.2011.110148; Lalla E, 2007, J PERIODONTAL RES, V42, P274, DOI 10.1111/j.1600-0765.2006.00945.x; Lin SJ, 2012, CLIN ORAL INVEST, V16, P599, DOI 10.1007/s00784-011-0535-x; Ling AY, 2012, J PERIODONTOL, V83, P621, DOI 10.1902/jop.2011.110133; Llambes F, 2012, MED ORAL PATOL ORAL, V17, pE562, DOI 10.4317/medoral.17793; Makiura N, 2008, ORAL MICROBIOL IMMUN, V23, P348, DOI 10.1111/j.1399-302X.2007.00426.x; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Morgan CL, 2000, DIABETES CARE, V23, P1103, DOI 10.2337/diacare.23.8.1103; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; O'Connell PAA, 2008, J PERIODONTOL, V79, P774, DOI [10.1902/jop.2008.070250, 10.1902/jop.2008.070250 ]; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pradeep AR, 2013, J INVESTIG CLIN DENT, V4, DOI 10.1111/jicd.12008; SEPPALA B, 1993, J CLIN PERIODONTOL, V20, P161, DOI 10.1111/j.1600-051X.1993.tb00338.x; Serrano Carlos, 2012, J Int Acad Periodontol, V14, P26; Simpson T. C., 2010, COCHRANE DATABASE SY, V12; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; Sun WL, 2011, INTERNAL MED, V50, P1569, DOI 10.2169/internalmedicine.50.5166; Sun WL, 2010, ARCH ORAL BIOL, V55, P970, DOI 10.1016/j.archoralbio.2010.08.001; Talbert Jennifer, 2006, J Dent Hyg, V80, P7; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; Teeuw WJ, 2014, J CLIN PERIODONTOL, V41, P70, DOI 10.1111/jcpe.12171; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Tuter G, 2010, J PERIODONTOL, V81, P1132, DOI 10.1902/jop.2010.090694; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; World Health Organization, 2006, DEF DIAGN DIAB MELL; Zinman B, 2014, DIABETES CARE, V37, P8, DOI 10.2337/dc13-2111	51	69	76	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128344	10.1371/journal.pone.0128344	http://dx.doi.org/10.1371/journal.pone.0128344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010492	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900228
J	Chang, SH; Wang, XY				Chang, Shuhua; Wang, Xinyu			Modelling and Computation in the Valuation of Carbon Derivatives with Stochastic Convenience Yields	PLOS ONE			English	Article							FINITE-VOLUME METHOD; POWER PENALTY METHOD; FUTURES; OPTIONS; PRICES; ASSETS	The anthropogenic greenhouse gas (GHG) emission has risen dramatically during the last few decades, which mainstream researchers believe to be the main cause of climate change, especially the global warming. The mechanism of market-based carbon emission trading is regarded as a policy instrument to deal with global climate change. Although several empirical researches about the carbon allowance and its derivatives price have been made, theoretical results seem to be sparse. In this paper, we theoretically develop a mathematical model to price the CO2 emission allowance derivatives with stochastic convenience yields by the principle of absence of arbitrage opportunities. In the case of American options, we formulate the pricing problem to a linear parabolic variational inequality (VI) in two spatial dimensions and develop a power penalty method to solve it. Then, a fitted finite volume method is designed to solve the nonlinear partial differential equation (PDE) resulting from the power penalty method and governing the futures, European and American option valuation. Moreover, some numerical results are performed to illustrate the efficiency and usefulness of this method. We find that the stochastic convenience yield does effect the valuation of carbon emission derivatives. In addition, some sensitivity analyses are also made to examine the effects of some parameters on the valuation results.	[Chang, Shuhua; Wang, Xinyu] Tianjin Univ Finance & Econ, Res Ctr Math & Econ, Tianjin 300222, Peoples R China; [Chang, Shuhua] Chinese Acad Sci, Inst Policy & Management, Beijing 100190, Peoples R China	Tianjin University of Finance & Economics; Chinese Academy of Sciences; CAS Institutes of Science & Development	Chang, SH (corresponding author), Tianjin Univ Finance & Econ, Res Ctr Math & Econ, Tianjin 300222, Peoples R China.	shuhua55@126.com; xywang1990@gmail.com	Zhang, Shuhua/U-2908-2019; Wang, Xinyu/U-2910-2019	Wang, Xinyu/0000-0003-0490-1626; Zhang, Shuhua/0000-0003-1572-0804	National Basic Research Program [2012CB955804]; Major Research Plan of the National Natural Science Foundation of China [91430108]; National Natural Science Foundation of China [11171251]; Tianjin University of Finance and Economics [ZD1302]	National Basic Research Program(National Basic Research Program of China); Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin University of Finance and Economics	This project was supported in part by the National Basic Research Program (2012CB955804), the Major Research Plan of the National Natural Science Foundation of China (91430108), the National Natural Science Foundation of China (11171251), and the Major Program of Tianjin University of Finance and Economics (ZD1302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz E, 2008, THESIS; Benz E, 2009, ENERG ECON, V31, P4, DOI 10.1016/j.eneco.2008.07.003; BLACK F, 1976, J FINANC ECON, V3, P167, DOI 10.1016/0304-405X(76)90024-6; Brennan M.J., 1979, J BANKING FINANCE, V3, P133, DOI [DOI 10.1016/0378-4266(79)90011-6, 10.1016/0378-4266(79)90011-6]; Byun SJ, 2013, ENERG ECON, V40, P207, DOI 10.1016/j.eneco.2013.06.017; Chang K, 2013, SPANISH REV FINANCIA, V11, P39, DOI [10.1016/j.srfe.2013.01.001, DOI 10.1016/J.SRFE.2013.01.001]; Chevallier J, 2010, ECON MODEL, V27, P717, DOI 10.1016/j.econmod.2010.01.012; Cortazar G, 2003, ENERG ECON, V25, P215, DOI 10.1016/S0140-9883(02)00096-8; Cramton P, 2002, ENERG POLICY, V30, P333, DOI 10.1016/S0301-4215(01)00100-8; Crocker T., 1966, EC AIR POLLUT, V61, P81; Daskalakis G, 2009, J BANK FINANC, V33, P1230, DOI 10.1016/j.jbankfin.2009.01.001; Edwards TH, 2001, ENERG ECON, V23, P371, DOI 10.1016/S0140-9883(00)00077-3; HAHN RW, 1984, Q J ECON, V99, P753, DOI 10.2307/1883124; Hilliard JE, 1998, J FINANC QUANT ANAL, V33, P61, DOI 10.2307/2331378; Huang CS, 2010, IMA J NUMER ANAL, V30, P1101, DOI 10.1093/imanum/drp016; Huang CC, 2010, OPER RES LETT, V38, P72, DOI 10.1016/j.orl.2009.09.009; Huang CS, 2006, COMPUTING, V77, P297, DOI 10.1007/s00607-005-0164-4; Hull J. C., 2011, OPTIONS FUTURES OTHE; Jin Q, 2012, CHAOS SOLITON FRACT, V45, P395, DOI 10.1016/j.chaos.2012.01.004; Klaassen G, 2005, ECOL ECON, V53, P47, DOI 10.1016/j.ecolecon.2004.12.017; Leveque R. J., 2004, FINITE VOLUME METHOD; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Liu JG, 2011, J COMPUT APPL MATH, V235, P5422, DOI 10.1016/j.cam.2011.05.051; Medina V, 2014, ENERG ECON, V42, P378, DOI 10.1016/j.eneco.2014.01.008; Mnif W, 2011, COMPUT RISK MANAG, P95, DOI 10.1007/978-3-642-19339-2_11; MONTGOMERY WD, 1972, J ECON THEORY, V5, P395, DOI 10.1016/0022-0531(72)90049-X; Rubin JD, 1996, J ENVIRON ECON MANAG, V31, P269, DOI 10.1006/jeem.1996.0044; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P41; Schwartz ES, 1997, J FINANC, V52, P923, DOI 10.2307/2329512; Szolnoki A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00576; Tillmann M, 2008, THESIS I NUMERISCHE; Wagner W, 2007, CO2 EMISSIONSZERTIFI; Wang S, 2006, J OPTIMIZ THEORY APP, V129, P227, DOI 10.1007/s10957-006-9062-3; Wang S, 2004, IMA J NUMER ANAL, V24, P699, DOI 10.1093/imanum/24.4.699; Wang S, 2008, OPER RES LETT, V36, P211, DOI 10.1016/j.orl.2007.06.006; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Wang Z, 2011, J THEOR BIOL, V277, P19, DOI 10.1016/j.jtbi.2011.02.016; [王志勇 Wang Zhiyong], 2013, [南水北调与水利科技, South-to-North Water Diversion and Water Science & Technology], V11, P1; Zhang K, 2009, NUMER MATH-THEORY ME, V2, P202	41	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125679	10.1371/journal.pone.0125679	http://dx.doi.org/10.1371/journal.pone.0125679			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010900	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900013
J	Feng, Y; Desjardins, CA; Cooper, O; Kontor, A; Nocco, SE; Naya, FJ				Feng, Yi; Desjardins, Cody A.; Cooper, Olivia; Kontor, Akuah; Nocco, Sarah E.; Naya, Francisco J.			EGR1 Functions as a Potent Repressor of MEF2 Transcriptional Activity	PLOS ONE			English	Article							EXPRESSION; CARDIOMYOCYTES; REGULATOR; COSTAMERES; FAMILY; TARGET; SITES; CELLS	The myocyte enhancer factor 2 (MEF2) transcription factor requires interactions with co-factors for precise regulation of its target genes. Our lab previously reported that the mammalian MEF2A isoform regulates the cardiomyocyte costamere, a critical muscle-specific focal adhesion complex involved in contractility, through its transcriptional control of genes encoding proteins localized to this cytoskeletal structure. To further dissect the transcriptional mechanisms of costamere gene regulation and identify potential co-regulators of MEF2A, a bioinformatics analysis of transcription factor binding sites was performed using the proximal promoter regions of selected costamere genes. One of these predicted sites belongs to the early growth response (EGR) transcription factor family. The EGR1 isoform has been shown to be involved in a number of pathways in cardiovascular homeostasis and disease, making it an intriguing candidate MEF2 coregulator to further characterize. Here, we demonstrate that EGR1 interacts with MEF2A and is a potent and specific repressor of MEF2 transcriptional activity. Furthermore, we show that costamere gene expression in cardiomyocytes is dependent on EGR1 transcriptional activity. This study identifies a mechanism by which MEF2 activity can be modulated to ensure that costamere gene expression is maintained at levels commensurate with cardiomyocyte contractile activity.	[Feng, Yi; Desjardins, Cody A.; Cooper, Olivia; Kontor, Akuah; Nocco, Sarah E.; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, Program Cell & Mol Biol, 5 Cummington St, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health [HL73304]; American Heart Association; Undergraduate Research Opportunities Program at Boston University; Beckman Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Undergraduate Research Opportunities Program at Boston University; Beckman Scholars Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant (HL73304) from the National Institutes of Health to FJN. Additional support was provided by the American Heart Association to YF, the Undergraduate Research Opportunities Program at Boston University to YF, OC, and AK, and the Beckman Scholars Program to SEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Chabane N, 2009, J CELL BIOCHEM, V106, P453, DOI 10.1002/jcb.22027; Chapman NR, 2000, J BIOL CHEM, V275, P4719, DOI 10.1074/jbc.275.7.4719; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; DANOWSKI BA, 1992, J CELL BIOL, V118, P1411, DOI 10.1083/jcb.118.6.1411; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Giraldo A, 2012, BIOCHEM J, V444, P343, DOI 10.1042/BJ20120125; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grote K, 2004, J BIOL CHEM, V279, P55675, DOI 10.1074/jbc.M406532200; Hsu SC, 2013, CARDIOVASC RES, V100, P222, DOI 10.1093/cvr/cvt190; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Kasneci A, 2009, CARDIOVASC RES, V81, P695, DOI 10.1093/cvr/cvn357; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Lin L, 2005, MOL CELL BIOL, V25, P10285; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Naya FJ, 1999, DEVELOPMENT, V126, P2045; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Pacini L, 2013, CAN J PHYSIOL PHARM, V91, P1135, DOI 10.1139/cjpp-2012-0419; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Reynolds JG, 2007, BBA-MOL CELL RES, V1773, P891, DOI 10.1016/j.bbamcr.2007.04.004; Saadane N, 2000, AM J PHYSIOL-HEART C, V278, pH796, DOI 10.1152/ajpheart.2000.278.3.H796; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; van Oort RJ, 2006, CIRCULATION; Wang CL, 2005, CARDIOVASC RES, V65, P187, DOI 10.1016/j.cardiores.2004.09.026; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030	31	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127641	10.1371/journal.pone.0127641	http://dx.doi.org/10.1371/journal.pone.0127641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011708	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900121
J	Gaisl, T; Schlatzer, C; Schwarz, EI; Possner, M; Stehli, J; Sievi, NA; Clarenbach, CF; Dey, D; Slomka, PJ; Kaufmann, PA; Kohler, M				Gaisl, Thomas; Schlatzer, Christian; Schwarz, Esther I.; Possner, Mathias; Stehli, Julia; Sievi, Noriane A.; Clarenbach, Christian F.; Dey, Damini; Slomka, Piotr J.; Kaufmann, Philipp A.; Kohler, Malcolm			Coronary Artery Calcification, Epicardial Fat Burden, and Cardiovascular Events in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							RISK-FACTORS; PERICARDIAL FAT; BETA-BLOCKERS; MORTALITY; COPD; ATHEROSCLEROSIS; PREDICTOR; CALCIUM; HEART; QUANTIFICATION	Rationale Patients with chronic obstructive pulmonary disease (COPD) suffer from significantly more cardiovascular comorbidity and mortality than would be anticipated from conventional risk factors. The aim of this study was to determine whether COPD patients have a higher coronary artery calcium score (CACS) and epicardial fat burden, compared to control subjects, and their association with cardiovascular events. Methods From a registry of 1906 patients 81 patients with clinically diagnosed COPD were one-to-one matched to 81 non-COPD control subjects with a smoking history, according to their age, sex, and the number of classic cardiovascular risk factors (arterial hypertension, diabetes mellitus, dyslipidemia, family history of premature coronary artery disease). CACS, epicardial fat, and subsequent major adverse cardiovascular events (MACE) during follow-up were compared between groups. Results Patients with COPD (Global Initiative for Chronic Obstructive Lung Disease-classification I: 5%, II: 23%, III: 16% and IV: 56%) showed no difference in CACS (median difference 68 Agatston Units [95% confidence interval -176.5 to 192.5], p=0.899) or epicardial fat volume (mean difference -0.5 cm(3) [95% confidence interval -20.9 to 21.9], p=0.961) compared with controls. After a median follow-up of 42.6 months a higher incidence of MACE was observed in COPD patients (RR=2.80, p=0.016) compared with controls. Cox proportional hazard regression identified cardiac ischemias and CACS as independent predictors for MACE. Conclusion COPD patients experienced a higher MACE incidence compared to controls despite no baseline differences in coronary calcification and epicardial fat burden. Other mechanisms such as undersupply of medication seem to account for an excess cardiovascular comorbidity in COPD patients.	[Gaisl, Thomas; Schlatzer, Christian; Schwarz, Esther I.; Sievi, Noriane A.; Clarenbach, Christian F.; Kohler, Malcolm] Univ Zurich Hosp, Dept Pulmonol, CH-8091 Zurich, Switzerland; [Possner, Mathias; Stehli, Julia; Kaufmann, Philipp A.] Univ Zurich Hosp, Dept Nucl Med, CH-8091 Zurich, Switzerland; [Dey, Damini; Slomka, Piotr J.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Dey, Damini; Slomka, Piotr J.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Kohler, Malcolm] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich, Ctr Interdisciplinary Sleep Res, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Kohler, M (corresponding author), Univ Zurich Hosp, Dept Pulmonol, CH-8091 Zurich, Switzerland.	Malcolm.Kohler@usz.ch	Possner, Mathias/X-9812-2019; Stehli, Julia/GRR-8802-2022; Schwarz, Esther/AAA-2325-2021; Gaisl, Thomas/I-7762-2019	Possner, Mathias/0000-0002-1683-5868; Gaisl, Thomas/0000-0002-9017-6143; Kaufmann, Philipp/0000-0002-9451-5210; Dey, Damini/0000-0003-2236-6970; Schwarz, Esther Irene/0000-0001-8840-981X	NIH; Siemens Medical Systems	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siemens Medical Systems(Siemens AG)	PS and DD report grants from NIH, grants from Siemens Medical Systems, outside the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Chae EJ, 2013, J COMPUT ASSIST TOMO, V37, P743, DOI 10.1097/RCT.0b013e318299f9e7; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Cheng VY, 2010, JACC-CARDIOVASC IMAG, V3, P352, DOI 10.1016/j.jcmg.2009.12.013; Clarenbach CF, 2013, EUR RESPIR J, V42, P1194, DOI 10.1183/09031936.00144612; Clarenbach CF, 2012, EXPERT REV RESP MED, V6, P37, DOI [10.1586/ers.11.82, 10.1586/ERS.11.82]; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; de Lucas-Ramos P, 2008, ARCH BRONCONEUMOL, V44, P233, DOI 10.1016/S1579-2129(08)60037-3; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dey D, 2008, INVEST RADIOL, V43, P145, DOI 10.1097/RLI.0b013e31815a054a; Dey D, 2010, ATHEROSCLEROSIS, V209, P136, DOI 10.1016/j.atherosclerosis.2009.08.032; Enriquez JR, 2011, CHEST, V140, P604, DOI 10.1378/chest.10-2644; Hesse B, 2005, EUR J NUCL MED MOL I, V32, P855, DOI 10.1007/s00259-005-1779-y; Iskander S, 1998, J AM COLL CARDIOL, V32, P57, DOI 10.1016/S0735-1097(98)00177-6; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; O'Hare PE, 2014, J COMPUT ASSIST TOMO, V38, P753, DOI 10.1097/RCT.0000000000000119; Patel ARC, 2011, EXPERT REV RESP MED, V5, P647, DOI [10.1586/ERS.11.62, 10.1586/ers.11.62]; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rasmussen T, 2013, EUR HEART J-CARD IMG, V14, P1159, DOI 10.1093/ehjci/jet057; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Selvaraj CL, 2005, AM J CARDIOL, V96, P756, DOI 10.1016/j.amjcard.2005.05.016; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; TOCKMAN MS, 1995, AM J RESP CRIT CARE, V151, P390, DOI 10.1164/ajrccm.151.2.7842197; Topsakal R, 2009, HEART VESSELS, V24, P164, DOI 10.1007/s00380-008-1103-4; van der Woude HJ, 2005, CHEST, V127, P818, DOI 10.1378/chest.127.3.818; van Gestel AJR, 2012, DISCOV MED, V14, P359; van Gestel YRBM, 2008, AM J RESP CRIT CARE, V178, P695, DOI 10.1164/rccm.200803-384OC; Watz H, 2009, EUR RESPIR J, V33, P262, DOI 10.1183/09031936.00024608; Williams MC, 2014, THORAX, V69, P718, DOI 10.1136/thoraxjnl-2012-203151; Yasue H, 2008, J CARDIOL, V51, P2, DOI 10.1016/j.jjcc.2008.01.001; Yates T, 2014, LANCET, V383, P1059, DOI 10.1016/S0140-6736(13)62061-9; Zagaceta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065593	37	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126613	10.1371/journal.pone.0126613	http://dx.doi.org/10.1371/journal.pone.0126613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011039	gold, Green Published, Green Accepted			2022-12-27	WOS:000355183900036
J	Alvarez, FJ; Revuelta, M; Santaolalla, F; Alvarez, A; Lafuente, H; Arteaga, O; Alonso-Alconada, D; Sanchez-del-Rey, A; Hilario, E; Martinez-Ibarguen, A				Jose Alvarez, Francisco; Revuelta, Miren; Santaolalla, Francisco; Alvarez, Antonia; Lafuente, Hector; Arteaga, Olatz; Alonso-Alconada, Daniel; Sanchez-del-Rey, Ana; Hilario, Enrique; Martinez-Ibargueen, Agustin			Effect of Neonatal Asphyxia on the Impairment of the Auditory Pathway by Recording Auditory Brainstem Responses in Newborn Piglets: A New Experimentation Model to Study the Perinatal Hypoxic-Ischemic Damage on the Auditory System	PLOS ONE			English	Article							INDUCED NEURONAL LOSS; CELL-DEATH; EVOKED-POTENTIALS; PRETERM LAMBS; INJURY; TERM; INFANTS; CANNABIDIOL; CAT	Introduction Hypoxia-ischemia (HI) is a major perinatal problem that results in severe damage to the brain impairing the normal development of the auditory system. The purpose of the present study is to study the effect of perinatal asphyxia on the auditory pathway by recording auditory brain responses in a novel animal experimentation model in newborn piglets. Method Hypoxia-ischemia was induced to 1.3 day-old piglets by clamping 30 minutes both carotid arteries by vascular occluders and lowering the fraction of inspired oxygen. We compared the Auditory Brain Responses (ABRs) of newborn piglets exposed to acute hypoxia/ischemia (n = 6) and a control group with no such exposure (n = 10). ABRs were recorded for both ears before the start of the experiment (baseline), after 30 minutes of HI injury, and every 30 minutes during 6 h after the HI injury. Results Auditory brain responses were altered during the hypoxic-ischemic insult but recovered 30-60 minutes later. Hypoxia/ischemia seemed to induce auditory functional damage by increasing I-V latencies and decreasing wave I, III and V amplitudes, although differences were not significant. Conclusion The described experimental model of hypoxia-ischemia in newborn piglets may be useful for studying the effect of perinatal asphyxia on the impairment of the auditory pathway.	[Jose Alvarez, Francisco; Lafuente, Hector] Cruces Univ Hosp, Res Unit Expt Perinatal Physiopathol, Baracaldo 48080, Bizkaia, Spain; [Revuelta, Miren; Alvarez, Antonia; Arteaga, Olatz; Alonso-Alconada, Daniel; Hilario, Enrique] Univ Basque Country, Fac Med & Dent, Dept Cell Biol & Histol, Leioa 48940, Bizkaia, Spain; [Santaolalla, Francisco; Sanchez-del-Rey, Ana; Martinez-Ibargueen, Agustin] Univ Basque Country, Fac Med, Basurto Univ Hosp, Dept Otorhinolaryngol, Leioa 48940, Bizkaia, Spain	Hospital Universitario Cruces; University of Basque Country; Basurto Hospital; University of Basque Country	Santaolalla, F (corresponding author), Univ Basque Country, Fac Med, Basurto Univ Hosp, Dept Otorhinolaryngol, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain.	francisco.santaolalla@ehu.es; enrique.hilario@ehu.es	Martinez, Agustin/T-6004-2019; Alvarez, Francisco/GZL-1953-2022; Alvarez, Francisco J./K-8951-2017; José, Antonio/H-3024-2015; Revuelta, Miren/AAH-2410-2019	Martinez, Agustin/0000-0002-6468-5606; Alvarez, Francisco J./0000-0002-8690-0506; José, Antonio/0000-0003-2851-0400; Revuelta, Miren/0000-0001-8126-2050; arteaga, olatz/0000-0002-4328-4408; Alonso-Alconada, Daniel/0000-0002-9874-2947; Hilario, Enrique/0000-0002-8876-8131; santaolalla, francisco/0000-0003-1813-4069; ALVAREZ DIAZ, ANTONIA ANGELES/0000-0002-1730-7565; Ana, Sanchez-del-Rey/0000-0002-8930-1832	ISCIII-General SubDirectorate for Research Assessment and Promotion [PS120852, PI061085, PS091900]; European Regional Development Funds; Basque Country Government [IT773/13]; Fundacion Jesus de Gangoiti Barrera	ISCIII-General SubDirectorate for Research Assessment and Promotion; European Regional Development Funds(European Commission); Basque Country Government(Basque Government); Fundacion Jesus de Gangoiti Barrera	This research has been supported by grants PS120852, PI061085, PS091900 from ISCIII-General SubDirectorate for Research Assessment and Promotion and the European Regional Development Funds and by grants from the Basque Country Government (IT773/13) and Fundacion Jesus de Gangoiti Barrera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alconada D, 2011, NEUROSCI BULL, V27, P275, DOI 10.1007/s12264-011-1008-6; Alonso-Alconada D, 2010, BRAIN RES, V1362, P150, DOI 10.1016/j.brainres.2010.09.050; Alvarez FJ, 2008, PEDIATR RES, V64, P653, DOI 10.1203/PDR.0b013e318186e5dd; Alvarez-Diaz A, 2007, NEONATOLOGY, V92, P227, DOI 10.1159/000103741; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Cao F, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-115; du Plessis AJ, 2002, CURR OPIN NEUROL, V15, P151, DOI 10.1097/00019052-200204000-00005; Echteler SM, 2005, DEV BRAIN RES, V157, P192, DOI 10.1016/j.devbrainres.2005.04.004; Foster KA, 2001, BRAIN RES, V919, P122, DOI 10.1016/S0006-8993(01)03011-6; Goni-de-Cerio F, 2007, BRAIN RES, V1151, P161, DOI 10.1016/j.brainres.2007.03.013; Hilario E, 2005, ACTA PAEDIATR, V94, P903, DOI 10.1080/08035250510031151; Inder T E, 2000, Semin Neonatol, V5, P3, DOI 10.1053/siny.1999.0112; Jiang ZD, 2000, PEDIATR RES, V48, P639, DOI 10.1203/00006450-200011000-00015; Jiang ZD, 2003, PEDIATR RES, V54, P680, DOI 10.1203/01.PDR.0000084084.62571.12; JIANG ZD, 2008, NEW TRENDS BRAIN HYP, P203; Jiang ZD, 2006, ACTA PAEDIATR, V95, P1400, DOI 10.1080/08035250600615143; Jiang ZD, 2009, J NEUROL SCI, V287, P172, DOI 10.1016/j.jns.2009.07.029; Kishan AU, 2011, OPEN J NEUROSCI, V1, P1; Lafuente H, 2011, PEDIATR RES, V70, P272, DOI 10.1203/PDR.0b013e3182276b11; Lefebvre PP, 2002, AUDIOL NEURO-OTOL, V7, P165, DOI 10.1159/000058304; Martinez Ibarguen A, 1993, ACTA OTORRINOLARINGO, V44, P36; Meyer C, 1999, PEDIATRICS, V104, P900, DOI 10.1542/peds.104.4.900; Newton V, 2001, Semin Neonatol, V6, P543, DOI 10.1053/siny.2001.0076; Peeters-Scholte C, 2003, PEDIATR RES, V54, P516, DOI 10.1203/01.PDR.0000081297.53793.C6; Perlman JM, 2004, SEMIN PERINATOL, V28, P415, DOI 10.1053/j.semperi.2004.10.003; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Schubert S, 2005, BRAIN RES, V1058, P129, DOI 10.1016/j.brainres.2005.07.061; Smit AL, 2013, PEDIATR RES, V74, P34, DOI 10.1038/pr.2013.64; Soehle M, 2003, NEUROL RES, V25, P411, DOI 10.1179/016164103101201580; Todd KJ, 2006, J PHYSIOLOGY-PARIS, V99, P75, DOI 10.1016/j.jphysparis.2005.12.002; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; ZAAROOR M, 1991, ELECTROEN CLIN NEURO, V80, P436, DOI 10.1016/0168-5597(91)90092-C; ZAAROOR M, 1991, ELECTROEN CLIN NEURO, V80, P422, DOI 10.1016/0168-5597(91)90091-B	33	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126885	10.1371/journal.pone.0126885	http://dx.doi.org/10.1371/journal.pone.0126885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010092	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900043
J	Karsanina, MV; Gerke, KM; Skvortsova, EB; Mallants, D				Karsanina, Marina V.; Gerke, Kirill M.; Skvortsova, Elena B.; Mallants, Dirk			Universal Spatial Correlation Functions for Describing and Reconstructing Soil Microstructure	PLOS ONE			English	Article							UNSATURATED HYDRAULIC CONDUCTIVITY; STOCHASTIC RECONSTRUCTION; SOLUTE TRANSPORT; POROUS-MEDIA; PORE-SPACE; PERMEABILITY; POROSITY; SIMULATION; SANDSTONE; MODELS	Structural features of porous materials such as soil define the majority of its physical properties, including water infiltration and redistribution, multi-phase flow (e.g. simultaneous water/air flow, or gas exchange between biologically active soil root zone and atmosphere) and solute transport. To characterize soil microstructure, conventional soil science uses such metrics as pore size and pore-size distributions and thin section-derived morphological indicators. However, these descriptors provide only limited amount of information about the complex arrangement of soil structure and have limited capability to reconstruct structural features or predict physical properties. We introduce three different spatial correlation functions as a comprehensive tool to characterize soil microstructure: 1) two-point probability functions, 2) linear functions, and 3) two-point cluster functions. This novel approach was tested on thin-sections (2.21x2.21 cm(2)) representing eight soils with different pore space configurations. The two-point probability and linear correlation functions were subsequently used as a part of simulated annealing optimization procedures to reconstruct soil structure. Comparison of original and reconstructed images was based on morphological characteristics, cluster correlation functions, total number of pores and pore-size distribution. Results showed excellent agreement for soils with isolated pores, but relatively poor correspondence for soils exhibiting dual-porosity features (i.e. superposition of pores and microcracks). Insufficient information content in the correlation function sets used for reconstruction may have contributed to the observed discrepancies. Improved reconstructions may be obtained by adding cluster and other correlation functions into reconstruction sets. Correlation functions and the associated stochastic reconstruction algorithms introduced here are universally applicable in soil science, such as for soil classification, pore-scale modelling of soil properties, soil degradation monitoring, and description of spatial dynamics of soil microbial activity.	[Karsanina, Marina V.] Russian Acad Sci, Inst Geospheres Dynam, Moscow, Russia; [Karsanina, Marina V.] AIR Technol, Moscow, Russia; [Gerke, Kirill M.; Mallants, Dirk] CSIRO Land & Water, Adelaide, SA, Australia; [Skvortsova, Elena B.] Russian Acad Sci, Dokuchaev Soil Sci Inst, Moscow, Russia	Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Dokuchaev Soil Science Institute; Russian Academy of Sciences	Gerke, KM (corresponding author), CSIRO Land & Water, Adelaide, SA, Australia.	kirill.gerke@csiro.au	Mallants, Dirk/A-5727-2012; Gerke, Kirill M./F-5836-2013; Skvortsova, Elena/X-3301-2019	Mallants, Dirk/0000-0001-7282-1981; Gerke, Kirill M./0000-0002-8379-2132; 	Russian Scientific Foundation [14-17-00658]; Russian Foundation for Basic Reserach [12-05-01130-a, 13-04-00409-a, 12-04-32264_MOpi_a, 13-05-01176-a]; Russian Science Foundation [14-17-00658, 14-16-00065] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Reserach; Russian Science Foundation(Russian Science Foundation (RSF))	1) Russian Scientific Foundation (http://www.rscf.ru/), grant number 14-17-00658 (developing optimized computation of diagonal correlation functions), MVK, KMG. 2) Russian Foundation for Basic Reserach (www.rfbr.ru), grants 12-05-01130-a, 13-04-00409-a, 12-04-32264_MO pi_a and 13-05-01176-a (soil tin-sections, expendables), MVK, EBS. AIR Technology provided support in the form of salaries for author Marina V. Karsanina, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bakke S, 1997, SPE J, V2, P136, DOI 10.2118/35479-PA; Baranau V, 2013, SOFT MATTER, V9, P3361, DOI 10.1039/c3sm27374a; BERRYMAN JG, 1988, J PHYS D APPL PHYS, V21, P87, DOI 10.1088/0022-3727/21/1/013; Biswal B, 1998, PHYSICA A, V255, P221, DOI 10.1016/S0378-4371(98)00111-3; Biswal B, 1999, PHYSICA A, V273, P452, DOI 10.1016/S0378-4371(99)00248-4; Biswal B, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061303; Blair JM, 2007, SOIL SCI SOC AM J, V71, P1807, DOI 10.2136/sssaj2006.0113; Blunt MJ, 2013, ADV WATER RESOUR, V51, P197, DOI 10.1016/j.advwatres.2012.03.003; Bogner C, 2012, GEODERMA, V175, P37, DOI 10.1016/j.geoderma.2012.01.019; BRISTOW KL, 1994, SOIL SCI SOC AM J, V58, P1288, DOI 10.2136/sssaj1994.03615995005800050002x; BRYANT SL, 1993, AICHE J, V39, P387, DOI 10.1002/aic.690390303; Bullock P., 1985, HDB SOIL THIN SECTIO; Capek P, 2011, TRANSPORT POROUS MED, V88, P87, DOI 10.1007/s11242-011-9726-9; Capek P, 2014, COMP MATER SCI, V89, P142, DOI 10.1016/j.commatsci.2014.03.003; Chen DD, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.013305; Chou HY, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011653; Chu KW, 1999, J COMPUT PHYS, V148, P646, DOI 10.1006/jcph.1998.6134; Coker DA, 1996, J GEOPHYS RES-SOL EA, V101, P17497, DOI 10.1029/96JB00811; CRAWFORD JW, 1995, EUR J SOIL SCI, V46, P369, DOI 10.1111/j.1365-2389.1995.tb01333.x; Crosbie RS, 2012, HYDROL EARTH SYST SC, V16, P3341, DOI 10.5194/hess-16-3341-2012; Cule D, 1999, J APPL PHYS, V86, P3428, DOI 10.1063/1.371225; Derossi A, 2013, FOOD BIOPHYS, V8, P311, DOI 10.1007/s11483-013-9307-2; DURNER W, 1994, WATER RESOUR RES, V30, P211, DOI 10.1029/93WR02676; Egorov VV, 1977, KLASSIFIKATSIYA DIAG; Falconer RE, 2012, SOIL SCI, V177, P111, DOI 10.1097/SS.0b013e318241133a; Gerke KM, 2012, EURASIAN SOIL SCI+, V45, P861, DOI 10.1134/S1064229312090049; Gerke KM, 2012, EURASIAN SOIL SCI+, V45, P700, DOI 10.1134/S1064229312070034; Gerke KM, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/66002; Gerke KM, 2013, DETERMINING PHYS PRO, DOI [10.2118/167058-MS, DOI 10.2118/167058-MS]; Ghanbarian-Alavijeh B, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066316; Gommes CJ, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051140; Grunat DA, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2013.03.0059; Guo EY, 2014, MATER CHARACT, V89, P33, DOI 10.1016/j.matchar.2013.12.011; Hilfer R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.65.061510; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Hunt AG, 2013, GEODERMA, V207, P268, DOI 10.1016/j.geoderma.2013.05.023; JERAULD GR, 1990, TRANSPORT POROUS MED, V5, P103, DOI 10.1007/BF00144600; Jiao Y, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031110; Jiao Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031135; Jiao Y, 2009, P NATL ACAD SCI USA, V106, P17634, DOI 10.1073/pnas.0905919106; Jiao Y, 2014, J APPL PHYS, V115, DOI 10.1063/1.4867611; Jiao Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011106; Jury W. A., 2004, SOIL PHYS; Kandelous MM, 2012, AGR WATER MANAGE, V109, P81, DOI 10.1016/j.agwat.2012.02.009; Khirevich S, 2011, J CHROMATOGR A, V1218, P6489, DOI 10.1016/j.chroma.2011.07.066; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kohne JM, 2011, VADOSE ZONE J, V10, P1082, DOI 10.2136/vzj2010.0158; Lafond JA, 2012, EUR J SOIL SCI, V63, P861, DOI 10.1111/j.1365-2389.2012.01496.x; Laudone GM, 2013, EUR J SOIL SCI, V64, P345, DOI 10.1111/ejss.12055; LEE SB, 1988, J CHEM PHYS, V89, P6427, DOI 10.1063/1.455411; Li Q, 2011, INT J HEAT MASS TRAN, V54, P2890, DOI 10.1016/j.ijheatmasstransfer.2011.03.010; Lindquist WB, 1996, J GEOPHYS RES-SOL EA, V101, P8297, DOI 10.1029/95JB03039; Mallants D, 1996, HYDROL PROCESS, V10, P55, DOI 10.1002/(SICI)1099-1085(199601)10:1&lt;55::AID-HYP299&gt;3.0.CO;2-N; Mallants D, 1996, SOIL SCI SOC AM J, V60, P747, DOI 10.2136/sssaj1996.03615995006000030010x; Manwart C, 1999, PHYS REV E, V59, P5596, DOI 10.1103/PhysRevE.59.5596; Manwart C, 2000, PHYS REV E, V62, P893, DOI 10.1103/PhysRevE.62.893; Mariethoz G, 2010, WATER RESOUR RES, V46, DOI [10.1029/2010WR009274, 10.1029/2008WR007621]; Mortazavi B, 2012, COMP MATER SCI, V59, P108, DOI 10.1016/j.commatsci.2012.03.002; Mostaghimi P, 2013, MATH GEOSCI, V45, P103, DOI 10.1007/s11004-012-9431-4; Nikooee E, 2013, TRANSPORT POROUS MED, V96, P369, DOI 10.1007/s11242-012-0093-y; Okabe H, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005680; Or D, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0163; Oren PE, 2002, TRANSPORT POROUS MED, V46, P311, DOI 10.1023/A:1015031122338; Piasecki R, 2011, P ROY SOC A-MATH PHY, V467, P806, DOI 10.1098/rspa.2010.0296; Raoof A, 2012, WATER RESOUR RES, V48, DOI 10.1029/2010WR010180; Raoof A, 2010, VADOSE ZONE J, V9, P624, DOI 10.2136/vzj2010.0026; Rintoul MD, 1996, PHYS REV E, V54, P2663, DOI 10.1103/PhysRevE.54.2663; ROBERTS AP, 1995, PHYS REV E, V51, P4141, DOI 10.1103/PhysRevE.51.4141; Rozenbaum O, 2012, CR GEOSCI, V344, P516, DOI 10.1016/j.crte.2012.09.004; Rozman MG, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.135501; Rozman MG, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066701; Russ J.C., 2000, PRACTICAL STEREOLOGY, V2nd ed.; Sahimi M, 2003, HETEROGENEOUS MAT LI; Saucier A, 2002, PHYSICA A, V311, P231, DOI 10.1016/S0378-4371(02)00814-2; Schaap MG, 2000, SOIL SCI SOC AM J, V64, P843, DOI 10.2136/sssaj2000.643843x; Schluter S, 2011, J PLANT NUTR SOIL SC, V174, P395, DOI 10.1002/jpln.201000103; Sevostianova E, 2010, INT J ENG SCI, V48, P1693, DOI 10.1016/j.ijengsci.2010.06.017; Sheidaei A, 2013, COMPOS SCI TECHNOL, V80, P47, DOI 10.1016/j.compscitech.2013.03.001; Shulakova V, 2013, GEOPHYS PROSPECT, V61, P287, DOI 10.1111/j.1365-2478.2012.01082.x; Skvortsova EB, 2009, EURASIAN SOIL SCI+, V42, P1254, DOI 10.1134/S1064229309110088; Skvortsova EB, 2004, EURASIAN SOIL SCI+, V37, P980; Sumanasooriya MS, 2010, ACI MATER J, V107, P413; Tahmasebi P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.078002; Tahmasebi P, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066709; Takada M, 2003, MON NOT R ASTRON SOC, V340, P580, DOI 10.1046/j.1365-8711.2003.06321.x; Tang T, 2009, J MICROSC-OXFORD, V234, P262, DOI 10.1111/j.1365-2818.2009.03173.x; Thovert JF, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056116; Thullner M, 2008, BIOTECHNOL BIOENG, V99, P1337, DOI 10.1002/bit.21708; Torkzaban S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006541; Torquato S, 2010, REV MOD PHYS, V82, P2633, DOI 10.1103/RevModPhys.82.2633; Torquato S., 2002, APPL MECH REV, V55, pB62, DOI [10.1115/1.1483342, DOI 10.1115/1.1483342]; Uzarowicz L, 2013, GEODERMA, V197, P137, DOI 10.1016/j.geoderma.2013.01.006; Valvatne PH, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002627; Vogel HJ, 2010, COMPUT GEOSCI-UK, V36, P1236, DOI 10.1016/j.cageo.2010.03.007; WOOD WW, 1990, SCIENCE, V247, P1569, DOI 10.1126/science.247.4950.1569; Wu KJ, 2004, SOIL SCI SOC AM J, V68, P346, DOI 10.2136/sssaj2004.0346; Yeong CLY, 1998, PHYS REV E, V57, P495, DOI 10.1103/PhysRevE.57.495; Yeong CLY, 1998, PHYS REV E, V58, P224, DOI 10.1103/PhysRevE.58.224; Zachary CE, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056102; Zhang QL, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0090; Zhang XX, 2005, J HYDROL, V306, P59, DOI 10.1016/j.jhydrol.2004.08.039; Zhao F, 2005, ENVIRON SCI TECHNOL, V39, P239, DOI 10.1021/es035228b	102	65	70	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126515	10.1371/journal.pone.0126515	http://dx.doi.org/10.1371/journal.pone.0126515			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010779	Green Published, gold			2022-12-27	WOS:000355183900031
J	Nagata, T; Yasukawa, H; Kyogoku, S; Oba, T; Takahashi, J; Nohara, S; Minami, T; Mawatari, K; Sugi, Y; Shimozono, K; Pradervand, S; Hoshijima, M; Aoki, H; Fukumoto, Y; Imaizumi, T				Nagata, Takanobu; Yasukawa, Hideo; Kyogoku, Sachiko; Oba, Toyoharu; Takahashi, Jinya; Nohara, Shoichiro; Minami, Tomoko; Mawatari, Kazutoshi; Sugi, Yusuke; Shimozono, Koutatsu; Pradervand, Sylvain; Hoshijima, Masahiko; Aoki, Hiroki; Fukumoto, Yoshihiro; Imaizumi, Tsutomu			Cardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules	PLOS ONE			English	Article							JAK-STAT PATHWAY; CONFERS RESISTANCE; INDUCIBLE GENE; KINASE; TRANSCRIPTION-3; TRANSDUCER; HEART; AKT; OVEREXPRESSION; HYPERTROPHY	Myocardial ischemia reperfusion injury (IRI) adversely affects cardiac performance and the prognosis of patients with acute myocardial infarction. Although myocardial signal transducer and activator of transcription (STAT) 3 is potently cardioprotective during IRI, the inhibitory mechanism responsible for its activation is largely unknown. The present study aimed to investigate the role of the myocardial suppressor of cytokine signaling (SOCS)-3, an intrinsic negative feedback regulator of the Janus kinase (JAK)-STAT signaling pathway, in the development of myocardial IRI. Myocardial IRI was induced in mice by ligating the left anterior descending coronary artery for 1 h, followed by different reperfusion times. One hour after reperfusion, the rapid expression of JAK-STAT-activating cytokines was observed. We precisely evaluated the phosphorylation of cardioprotective signaling molecules and the expression of SOCS3 during IRI and then induced myocardial IRI in wild-type and cardiac-specific SOCS3 knockout mice (SOCS3-CKO). The activation of STAT3, AKT, and ERK1/2 rapidly peaked and promptly decreased during IRI. This decrease correlated with the induction of SOCS3 expression up to 24 h after IRI in wild-type mice. The infarct size 24 h after reperfusion was significantly reduced in SOCS3-CKO compared with wild-type mice. In SOCS3-CKO mice, STAT3, AKT, and ERK1/2 phosphorylation was sustained, myocardial apoptosis was prevented, and the expression of anti-apoptotic Bcl-2 family member myeloid cell leukemia-1 (Mcl-1) was augmented. Cardiac-specific SOCS3 deletion led to the sustained activation of cardioprotective signaling molecules including and prevented myocardial apoptosis and injury during IRI. Our findings suggest that SOCS3 may represent a key factor that exacerbates the development of myocardial IRI.	[Nagata, Takanobu; Yasukawa, Hideo; Kyogoku, Sachiko; Oba, Toyoharu; Takahashi, Jinya; Nohara, Shoichiro; Minami, Tomoko; Mawatari, Kazutoshi; Sugi, Yusuke; Shimozono, Koutatsu; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan; [Yasukawa, Hideo; Aoki, Hiroki; Fukumoto, Yoshihiro] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 830, Japan; [Pradervand, Sylvain] Univ Lausanne, LGTF, Lausanne, Switzerland; [Hoshijima, Masahiko] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Imaizumi, Tsutomu] Fukuoka Sanno Hosp, Fukuoka, Japan; [Imaizumi, Tsutomu] Int Univ Hlth & Welf, Fukuoka, Japan	Kurume University; Kurume University; University of Lausanne; University of California System; University of California San Diego; International University of Health & Welfare	Yasukawa, H (corresponding author), Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka 830, Japan.	yahideo@med.kurume-u.ac.jp			Science Frontier Research Promotion Centers; Ministry of Education, Science, Sports, and Culture, Japan [24791957, 25861739, 18590793]; Kimura Memorial Heart Foundation; Japanese Ministry of Health, Labour and Welfare	Science Frontier Research Promotion Centers; Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kimura Memorial Heart Foundation; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant from the Science Frontier Research Promotion Centers (mext.go.jp/english/, to TI), by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture, Japan (mext.go.jp/english/, grant #24791957 to TN, #25861739 to TO, #18590793 to HY), by a Research Grant for Cardiovascular Diseases from Kimura Memorial Heart Foundation (kimura-kinen.com, to HY), and by a Japanese Ministry of Health, Labour and Welfare Research Grant (mhlw.go.jp/english/index.html, to TI).	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Barry SP, 2007, TRENDS MOL MED, V13, P82, DOI 10.1016/j.molmed.2006.12.002; Boengler K, 2008, CIRC RES, V102, P131, DOI 10.1161/CIRCRESAHA.107.164699; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bolli R, 2003, TRENDS CARDIOVAS MED, V13, P72, DOI 10.1016/S1050-1738(02)00230-X; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Burns RJ, 2002, J AM COLL CARDIOL, V39, P30, DOI 10.1016/S0735-1097(01)01711-9; Dabkowski ER, 2008, FREE RADICAL BIO MED, V45, P855, DOI 10.1016/j.freeradbiomed.2008.06.021; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Gibbons RJ, 2004, J AM COLL CARDIOL, V44, P1533, DOI 10.1016/j.jacc.2004.06.071; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hamanaka I, 2001, CIRC RES, V88, P727, DOI 10.1161/hh0701.088512; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; Knight Richard A, 2012, JAKSTAT, V1, P111, DOI 10.4161/jkst.20078; Lecour S, 2005, CIRCULATION, V112, P3911, DOI 10.1161/CIRCULATIONAHA.105.581058; Liao ZH, 2002, CARDIOVASC RES, V53, P902, DOI 10.1016/S0008-6363(01)00531-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsui T, 2001, CIRCULATION, V104, P330; McCormick J, 2006, FASEB J, V20, P2115, DOI 10.1096/fj.06-6188fje; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Oba T, 2012, J AM COLL CARDIOL, V59, P838, DOI 10.1016/j.jacc.2011.10.887; Oshima Y, 2005, CARDIOVASC RES, V65, P428, DOI 10.1016/j.cardiores.2004.10.021; Roubille F, 2013, CARDIOVASC DRUG THER, V27, P315, DOI 10.1007/s10557-013-6461-1; Ruan HM, 2009, J MOL CELL CARDIOL, V46, P193, DOI 10.1016/j.yjmcc.2008.10.021; Sakamoto H, 1998, BLOOD, V92, P1668, DOI 10.1182/blood.V92.5.1668.417k09_1668_1676; Scarabelli TM, 2002, CIRC RES, V90, P745, DOI 10.1161/01.RES.0000015224.07870.9A; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Suleman N, 2008, CARDIOVASC RES, V79, P127, DOI 10.1093/cvr/cvn067; Suzuki K, 2001, CIRCULATION, V104, pI308; Takano H, 2007, TRENDS PHARMACOL SCI, V28, P512, DOI 10.1016/j.tips.2007.09.002; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Wang X, 2013, GENE DEV, V27, P1351, DOI 10.1101/gad.215855.113; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; Xuan YT, 2007, CIRCULATION, V116, P535, DOI 10.1161/CIRCULATIONAHA.107.689471; Yajima T, 2006, CIRCULATION, V114, P2364, DOI 10.1161/CIRCULATIONAHA.106.642454; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Yasukawa H, 2003, J CLIN INVEST, V111, P469, DOI 10.1172/JCI200316491; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yasukawa H, 2001, J CLIN INVEST, V108, P1459, DOI 10.1172/JCI13939; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhao ZQ, 2002, CARDIOVASC RES, V55, P438, DOI 10.1016/S0008-6363(02)00442-X	55	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127942	10.1371/journal.pone.0127942	http://dx.doi.org/10.1371/journal.pone.0127942			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010537	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900168
J	Siengdee, P; Trakooljul, N; Murani, E; Schwerin, M; Wimmers, K; Ponsuksili, S				Siengdee, Puntita; Trakooljul, Nares; Murani, Eduard; Schwerin, Manfred; Wimmers, Klaus; Ponsuksili, Siriluck			MicroRNAs Regulate Cellular ATP Levels by Targeting Mitochondrial Energy Metabolism Genes during C2C12 Myoblast Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE; EXPRESSION; BIOGENESIS; MECHANISMS; PREDICTION; MIR-206	In our previous study, we identified an miRNA regulatory network involved in energy metabolism in porcine muscle. To better understand the involvement of miRNAs in cellular ATP production and energy metabolism, here we used C2C12 myoblasts, in which ATP levels increase during differentiation, to identify miRNAs modulating these processes. ATP level, miRNA and mRNA microarray expression profiles during C2C12 differentiation into myotubes were assessed. The results suggest 14 miRNAs (miR-423-3p, miR-17, miR-130b, miR-301a/b, miR-345, miR-15a, miR-16a, miR-128, miR-615, miR-1968, miR-1a/b, and miR-194) as cellular ATP regulators targeting genes involved in mitochondrial energy metabolism (Cox4i2, Cox6a2, Ndufb7, Ndufs4, Ndufs5, and Ndufv1) during C2C12 differentiation. Among these, miR-423-3p showed a high inverse correlation with increasing ATP levels. Besides having implications in promoting cell growth and cell cycle progression, its function in cellular ATP regulation is yet unknown. Therefore, miR-423-3p was selected and validated for the function together with its potential target, Cox6a2. Overexpression of miR-423-3p in C2C12 myogenic differentiation lead to decreased cellular ATP level and decreased expression of Cox6a2 compared to the negative control. These results suggest miR-423-3p as a novel regulator of ATP/energy metabolism by targeting Cox6a2.	[Siengdee, Puntita; Schwerin, Manfred; Ponsuksili, Siriluck] Res Inst Biol Farm Anim FBN, Res Unit Funct Genom, Dummerstorf, Germany; [Trakooljul, Nares; Murani, Eduard; Wimmers, Klaus] Res Inst Biol Farm Anim FBN, Res Unit Mol Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Ponsuksili, S (corresponding author), Res Inst Biol Farm Anim FBN, Res Unit Funct Genom, Dummerstorf, Germany.	s.wimmers@fbn-dummerstorf.de	Siengdee, Puntita/AAF-4813-2019; Wimmers, Klaus/AAF-9434-2020	Siengdee, Puntita/0000-0003-0665-0912; Wimmers, Klaus/0000-0002-9523-6790; Trakooljul, Nares/0000-0002-3214-2498	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG PO753/7-1, WI 1754/10-14]; FBN (Research Institute for the Biology of Farm Animals)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); FBN (Research Institute for the Biology of Farm Animals)	This research was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG PO753/7-1 and WI 1754/10-14) and the FBN (Research Institute for the Biology of Farm Animals). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Demongeot J, 2013, 27 INT C ADV INF NET; Dong SW, 2012, BIOCHEM BIOPH RES CO, V418, P587, DOI 10.1016/j.bbrc.2012.01.075; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gan ZJ, 2013, J CLIN INVEST, V123, P2564, DOI 10.1172/JCI67652; Goljanek-Whysall K, 2012, J CELL SCI, V125, P3590, DOI 10.1242/jcs.101758; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guan GF, 2014, INT J CLIN EXP PATHO, V7, P5683; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Koene S, 2011, J INHERIT METAB DIS, V34, P293, DOI 10.1007/s10545-009-9005-x; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04734; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Ponsuksili S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-533; Quintens R, 2013, PLOS ONE, V8; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ryten M, 2002, J CELL BIOL, V158, P345, DOI 10.1083/jcb.200202025; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu H, 2012, CELL SIGNAL, V24, P2179, DOI 10.1016/j.cellsig.2012.07.001; Yamamoto H, 2012, AM J PHYSIOL-ENDOC M, V303, pE1419, DOI 10.1152/ajpendo.00097.2012; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	38	32	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127850	10.1371/journal.pone.0127850	http://dx.doi.org/10.1371/journal.pone.0127850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010876	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900152
J	Wu, XM; Yang, HG; Zheng, BA; Cao, HF; Hu, ZM; Wu, WD				Wu, Xiao-Min; Yang, Hong-Guo; Zheng, Bo-An; Cao, Hong-Feng; Hu, Zhi-Ming; Wu, Wei-Ding			Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations	PLOS ONE			English	Article							CARCINOMA; BREAST; SUSCEPTIBILITY; IDENTIFICATION; POLYMORPHISM; ACTIVATION; MIR-509-3P; APOPTOSIS; MIGRATION; VARIANTS	CD44 as one of the most putative stem cell markers plays a key role in many cellular processes, including cancer cell growth and migration. Functional single nucleotide polymorphisms (SNPs) of CD44 may modulate its gene functions and thus cancer risk. In the current study, we investigated if polymorphisms in the 3'-untranslated region (UTR) of CD44 are associated with increased susceptibility to colorectal cancer (CRC) by conducting a case-control study of 946 CRC patients and 989 cancer-free controls. Three polymorphisms (rs13347C/T, rs10836347C/T, rs11821102G/A) in the 3'-UTR of CD44 were genotyped. We found that the variant genotypes (CT and TT) of rs13347 (adjusted odds ratio (OR) = 1.79, 95% confidence interval (CI) = 1.50-2.17) increased an individual's susceptibility to CRC, compared with rs13347CC homozygous genotypes. We also found that CRC patients with the CT/TT genotype had a 1.6-fold increased risk for developing advanced (stage III + IV) CRC. Furthermore, functional assays showed that the C to T base change at rs13347C/T disrupts the binding site for the microRNA hsa-mir-509-3p, thereby increasing CD44 transcriptional activity and expression level. These findings suggest that the rs13347C/T in microRNA binding site may be potential biomarkers for genetic susceptibility to CRC.	[Wu, Xiao-Min] Zhejiang Prov Peoples Hosp, Dept Anesthesiol, Hangzhou, Zhejiang, Peoples R China; [Hu, Zhi-Ming; Wu, Wei-Ding] Zhejiang Prov Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Zhejiang, Peoples R China; [Yang, Hong-Guo] Zhejiang Prov Peoples Hosp, Haining Branch, Dept Gen Surg, Jiaxing, Zhejiang, Peoples R China; [Zheng, Bo-An; Cao, Hong-Feng] Zhejiang Prov Peoples Hosp, Dept Colorectal Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Wu, WD (corresponding author), Zhejiang Prov Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Zhejiang, Peoples R China.	weidingwu@126.com			Zhejiang Provincial Natural Science Foundation [2013C33106]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This study was supported by the Zhejiang Provincial Natural Science Foundation (No. 2013C33106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M T, 2014, Indian J Cancer, V51, P247, DOI 10.4103/0019-509X.146752; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Chou YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093692; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Du HN, 2014, SCI REP-UK, V4, DOI 10.1038/srep06700; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Kozovska Z, 2014, BIOMED PHARMACOTHER, V68, P911, DOI 10.1016/j.biopha.2014.10.019; Lassmann Silke, 2008, Gastroenterology, V134, P1262, DOI 10.1053/j.gastro.2008.02.050; Li N, 2014, CARCINOGENESIS, V35, P2687, DOI 10.1093/carcin/bgu201; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Marhaba R, 2004, J MOL HISTOL, V35, P211; McKallip RJ, 2005, INFECT IMMUN, V73, P50, DOI 10.1128/IAI.73.1.50-61.2005; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Rafi A, 1997, BLOOD, V89, P2901, DOI 10.1182/blood.V89.8.2901; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SETH A, 1991, P NATL ACAD SCI USA, V88, P7877, DOI 10.1073/pnas.88.17.7877; Shang Z, 2014, ONCOTARGET; Sharma KL, 2014, TUMOR BIOL, V35, P2583, DOI 10.1007/s13277-013-1340-8; Song M, 2014, INTERNATIONAL JOURNA; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; Tu L, 2014, MOLECULAR GENETICS A; Tulsyan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071073; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Wang Y, 2014, CANCER LETT, V352, P169, DOI 10.1016/j.canlet.2014.05.007; Wilson BJ, 2011, CURR COLORECT CANC R, V7, P128, DOI 10.1007/s11888-011-0093-2; Winder T, 2011, INT J CANCER, V129, P1096, DOI 10.1002/ijc.25787; Xiao M, 2013, MUTAGENESIS, V28, P577, DOI 10.1093/mutage/get035; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307	35	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127557	10.1371/journal.pone.0127557	http://dx.doi.org/10.1371/journal.pone.0127557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010608	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900109
J	Yue, CH; Huang, CY; Tsai, JH; Hsu, CW; Hsieh, YH; Lin, H; Liu, JY				Yue, Chia-Herng; Huang, Chih-Yang; Tsai, Jen-Hsiang; Hsu, Chih-Wei; Hsieh, Yi-Hsien; Lin, Ho; Liu, Jer-Yuh			MZF-1/Elk-1 Complex Binds to Protein Kinase C alpha Promoter and Is Involved in Hepatocellular Carcinoma	PLOS ONE			English	Article							ZINC-FINGER GENE; PKC-ALPHA; ELK-1; MZF-1; EXPRESSION; TRANSCRIPTION; ACTIVATION; APOPTOSIS; PATHWAY; DOMAIN	In this study, the molecular mechanism of protein kinase C alpha (PKC alpha) gene regulation in hepatocellular carcinoma (HCC) involving Ets-like protein-1 (Elk-1) and myeloid zinc finger-1 (MZF-1) was investigated. The luciferase reporter assay results revealed that the presence of both MZF-1 and Elk-1 significantly contributed to the upregulation of PKC alpha gene transcription activity, and the transcriptional activity decreased when the transfection included a DNA-binding-deficient (Delta DBD) gene vector of either MZF-1 or Elk-1 DNA-binding deficiency (MZF-1 Delta DBD or Elk-1 Delta DBD), thereby indicating that the enhanced expression of PKC alpha was caused by the binding of MZF-1 and/or Elk-1 with the PKC alpha promoter. We investigated MZF-1 and Elk-1 to determine whether they bind to each other. The results of immunoprecipitation (IP), Co-IP, chromatin IP (ChIP), and Re-ChIP analyses indicated that Elk-1 can directly bind to the N-terminal region of MZF-1 and MZF-1 can directly bind to the C-terminal region of Elk-1 to form a complex before attaching to the PKC alpha promoter. Furthermore, when MZF-1 Delta DBD or Elk-1 Delta DBD was added to the cells, PKC alpha expression decreased, and cell proliferation, migration, invasion, and tumorigenicity also decreased. These findings suggest that PKC alpha expression in HCC could be stimulated by the formation of MZF-1/Elk-1 complex, which directly binds to the PKC alpha promoter.	[Yue, Chia-Herng; Lin, Ho] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yue, Chia-Herng; Hsu, Chih-Wei] Tungs Taichung MetroHarbor Hosp, Dept Surg, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Sch Chinese Med, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Tsai, Jen-Hsiang] Fooyin Univ, Coll Med & Hlth, Basic Med Sci Educ Ctr, Kaohsiung, Taiwan; [Hsu, Chih-Wei] Natl Chiayi Univ, Dept Appl Chem, Chiayi, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ Hosp, Clin Lab, Taichung 40201, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ, Coll Med, Inst Biochem & Biotechnol, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan	National Chung Hsing University; Tungs' Taichung MetroHarbor Hospital; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Fooyin University; National Chiayi University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hsieh, YH (corresponding author), Chung Shan Med Univ Hosp, Clin Lab, Taichung 40201, Taiwan.	hyhsien@csmu.edu.tw; hlin@dragon.nchu.edu.tw; jyl@mail.cmu.edu.tw	Yuang, Chih-Yang/O-5111-2015	Lin, Ho/0000-0001-7849-9137	Ministry of Science and Technology, Republic of China [NSC 99-2632-B-039-001-MY3, NSC 102-2320-B-039-049, NSC102-2911-I-002-303]; Taiwan Department of Health Clinical Trial and Research Center of Excellence, Taiwan, Republic of China [DOH102-TD-B-111-004]	Ministry of Science and Technology, Republic of China; Taiwan Department of Health Clinical Trial and Research Center of Excellence, Taiwan, Republic of China	This work was supported by grants from the Ministry of Science and Technology, Republic of China (NSC 99-2632-B-039-001-MY3, NSC 102-2320-B-039-049 and NSC102-2911-I-002-303) and by the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004), Taiwan, Republic of China.	Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; BAVISOTTO L, 1991, J EXP MED, V174, P1097, DOI 10.1084/jem.174.5.1097; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Clark JH, 2002, BIOCHEMISTRY-US, V41, P11847, DOI 10.1021/bi025600k; De Petro G, 1998, CANCER RES, V58, P2234; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Ghosh S, 1996, J BIOL CHEM, V271, P9911, DOI 10.1074/jbc.271.17.9911; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; HROMAS R, 1991, J BIOL CHEM, V266, P14183; HROMAS R, 1995, CANCER RES, V55, P3610; Hsieh YH, 2006, BIOCHEM BIOPH RES CO, V339, P217, DOI 10.1016/j.bbrc.2005.11.015; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Hsieh YH, 2007, CHINESE J PHYSIOL, V50, P9; Hsu YH, 2014, CANCER RES, V74, P4822, DOI 10.1158/0008-5472.CAN-14-0584; Kannan-Thulasiraman P, 2002, J BIOL CHEM, V277, P41230, DOI 10.1074/jbc.M200379200; Khurana A, 2002, FEBS LETT, V527, P119, DOI 10.1016/S0014-5793(02)03192-7; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Martiny-Baron G, 2007, PHARMACOL RES, V55, P477, DOI 10.1016/j.phrs.2007.04.001; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robertson KA, 1998, LEUKEMIA, V12, P690, DOI 10.1038/sj.leu.2401005; Shao NS, 1998, ONCOGENE, V17, P527, DOI 10.1038/sj.onc.1201931; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; Wiren KM, 2004, J MOL ENDOCRINOL, V32, P209, DOI 10.1677/jme.0.0320209; Wu TT, 2007, CLIN CHIM ACTA, V382, P54, DOI 10.1016/j.cca.2007.03.018; Ying TH, 2008, CELL BIOL INT, V32, P210, DOI 10.1016/j.cellbi.2007.08.027	27	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127420	10.1371/journal.pone.0127420	http://dx.doi.org/10.1371/journal.pone.0127420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010542	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900088
J	Schwingshackl, A; Roan, E; Teng, B; Waters, CM				Schwingshackl, Andreas; Roan, Esra; Teng, Bin; Waters, Christopher M.			TREK-1 Regulates Cytokine Secretion from Cultured Human Alveolar Epithelial Cells Independently of Cytoskeletal Rearrangements	PLOS ONE			English	Article							POTASSIUM CHANNEL TREK-1; TNF-ALPHA; DNA-DAMAGE; MECHANISMS; EXPRESSION; HYPEROXIA; VESICLES; PROTEIN; A549; DEGRADATION	Background TREK-1 deficient alveolar epithelial cells (AECs) secrete less IL-6, more MCP-1, and contain less F-actin. Whether these alterations in cytokine secretion and F-actin content are related remains unknown. We now hypothesized that cytokine secretion from TREK-1-deficient AECs was regulated by cytoskeletal rearrangements. Methods We determined F-actin and a-tubulin contents of control, TREK-1-deficient and TREK-1-overexpressing human A549 cells by confocal microscopy and western blotting, and measured IL-6 and MCP-1 levels using real-time PCR and ELISA. Results Cytochalasin D decreased the F-actin content of control cells. Jasplakinolide increased the F-actin content of TREK-1 deficient cells, similar to the effect of TREK-1 overexpression in control cells. Treatment of control and TREK-1 deficient cells with TNF-alpha, a strong stimulus for IL-6 and MCP-1 secretion, had no effect on F-actin structures. The combination of TNF-alpha+cytochalasin D or TNF-alpha+jasplakinolide had no additional effect on the F-actin content or architecture when compared to cytochalasin D or jasplakinolide alone. Although TREK-1 deficient AECs contained less F-actin at baseline, quantified biochemically, they contained more a-tubulin. Exposure to nocodazole disrupted a-tubulin filaments in control and TREK1 deficient cells, but left the overall amount of a-tubulin unchanged. Although TNF-alpha had no effect on the F-actin or a-tubulin contents, it increased IL-6 and MCP-1 production and secretion from control and TREK-1 deficient cells. IL-6 and MCP-1 secretions from control and TREK-1 deficient cells after TNF-alpha+jasplakinolide or TNF-alpha+nocodazole treatment was similar to the effect of TNF-alpha alone. Interestingly, cytochalasin D decreased TNF-alpha-induced IL-6 but not MCP-1 secretion from control but not TREK-1 deficient cells. Conclusion Although cytochalasin D, jasplakinolide and nocodazole altered the F-actin and a-tubulin structures of control and TREK-1 deficient AEC, the changes in cytokine secretion from TREK-1 deficient cells cannot be explained by cytoskeletal rearrangements in these cells.	[Schwingshackl, Andreas] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA; [Schwingshackl, Andreas; Teng, Bin; Waters, Christopher M.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN USA; [Roan, Esra] Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA; [Waters, Christopher M.] Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center	Schwingshackl, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA.	aschwingshackl@gmail.com	Waters, Christopher/V-2759-2019		American Lung Association (ALA) [: RG-260120-N]; NIH [NIH HL118118-01A1];  [K01 HL120912-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL120912, K08HL118118, R01HL123540] Funding Source: NIH RePORTER	American Lung Association (ALA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the American Lung Association (ALA): RG-260120-N (AS) and the NIH: NIH HL118118-01A1 (AS). The study was also supported by a K01 HL120912-02 grant (ER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belperio JA, 2006, SEMIN RESP CRIT CARE, V27, P350, DOI 10.1055/s-2006-948289; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; BENGTSSON T, 1991, J LEUKOCYTE BIOL, V49, P236, DOI 10.1002/jlb.49.3.236; Bittner S, 2013, NAT MED, V19, P1161, DOI 10.1038/nm.3303; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chang B, 2004, MICROB PATHOGENESIS, V37, P295, DOI 10.1016/j.micpath.2004.10.002; Chanteloup NK, 2011, VET MICROBIOL, V147, P435, DOI 10.1016/j.vetmic.2010.07.013; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Chemin K, 2012, J IMMUNOL, V189, P2159, DOI 10.4049/jimmunol.1200156; Cordell PA, 2010, BLOOD, V115, P2674, DOI 10.1182/blood-2009-08-231316; Corsini E, 2013, ARCH TOXICOL, V87, P2187, DOI 10.1007/s00204-013-1071-z; Desai LP, 2008, AM J PHYSIOL-LUNG C, V295, pL958, DOI 10.1152/ajplung.90218.2008; Desai LP, 2007, AM J PHYSIOL-LUNG C, V293, pL769, DOI 10.1152/ajplung.00127.2007; DiPaolo BC, 2010, AM J PHYSIOL-CELL PH, V299, pC345, DOI 10.1152/ajpcell.00379.2009; Garcia-Perez BE, 2008, MICROB PATHOGENESIS, V45, P1, DOI 10.1016/j.micpath.2008.01.009; Fedorko ME, 2004, MED HYPOTHESES, V62, P911, DOI 10.1016/j.mehy.2004.01.007; Goel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023070; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; Guadiz G, 1997, AM J RESP CELL MOL, V17, P60, DOI 10.1165/ajrcmb.17.1.2730; Guo FY, 2012, TOXICOL APPL PHARM, V260, P183, DOI 10.1016/j.taap.2012.02.010; Han CF, 2009, J IMMUNOL, V182, P2986, DOI 10.4049/jimmunol.0802002; Hayot C, 2006, TOXICOL APPL PHARM, V211, P30, DOI 10.1016/j.taap.2005.06.006; Huang FY, 2013, ONCOL REP, V30, P478, DOI 10.3892/or.2013.2423; Islam MN, 2014, AM J PHYSIOL-LUNG C, V306, pL50, DOI 10.1152/ajplung.00252.2013; Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC; Jacquemet G, 2013, J CELL BIOL, V202, P917, DOI 10.1083/jcb.201302041; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Kimura K, 2013, INVEST OPHTH VIS SCI, V54, P2752, DOI 10.1167/iovs.12-11294; Kohwiwattanagun J, 2007, MICROBIOL IMMUNOL, V51, P253, DOI 10.1111/j.1348-0421.2007.tb03897.x; Lacherade JC, 2001, AM J PHYSIOL-LUNG C, V281, pL134, DOI 10.1152/ajplung.2001.281.1.L134; Lagrue K, 2013, IMMUNOL REV, V256, P203, DOI 10.1111/imr.12107; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Liu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012870; McAdams RM, 2006, AM J PHYSIOL-LUNG C, V291, pL166, DOI 10.1152/ajplung.00160.2005; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; Muroya M, 2012, BIOSCI TRENDS, V6, P70, DOI 10.5582/bst.2012.v6.2.70; Ni JX, 2013, FREE RADICAL BIO MED, V61, P26, DOI 10.1016/j.freeradbiomed.2013.03.012; Rahat MA, 2006, J LEUKOCYTE BIOL, V79, P706, DOI 10.1189/jlb.0605302; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Roan E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089429; Sasaki S, 2014, BBA-BIOMEMBRANES, V1838, P514, DOI 10.1016/j.bbamem.2013.06.004; Schwingshackl A, 2014, CRIT CARE MED, V42, pE692, DOI 10.1097/CCM.0000000000000603; Schwingshackl A, 2013, AM J TRANSL RES, V5, P530; Schwingshackl A, 2013, AM J PHYSIOL-LUNG C, V304, pL276, DOI 10.1152/ajplung.00299.2012; Schwingshackl A, 2012, AM J PHYSIOL-LUNG C, V302, pL93, DOI 10.1152/ajplung.00078.2011; Smith AJ, 2003, TRAFFIC, V4, P302, DOI 10.1034/j.1600-0854.2003.00084.x; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Suzuki M, 2003, J ALLERGY CLIN IMMUN, V112, P126, DOI 10.1067/mai.2003.1515; Szczygiel AM, 2012, PFLUG ARCH EUR J PHY, V463, P487, DOI 10.1007/s00424-011-1051-1; Tsakini N, 2008, MOL CELL NEUROSCI, V37, P110, DOI 10.1016/j.mcn.2007.09.001; Tu LN, 2007, INFECT IMMUN, V75, P2996, DOI 10.1128/IAI.01716-06; Uronen-Hansson H, 2004, IMMUNOLOGY, V111, P173, DOI 10.1111/j.0019-2805.2003.01803.x; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; WISPE JR, 1990, J CLIN INVEST, V86, P1954, DOI 10.1172/JCI114929; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Xie JS, 2009, EXP EYE RES, V88, P467, DOI 10.1016/j.exer.2008.10.023; Zoncu R, 2011, SCIENCE, V332, P923, DOI 10.1126/science.1207552	61	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126781	10.1371/journal.pone.0126781	http://dx.doi.org/10.1371/journal.pone.0126781			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001192	gold, Green Published, Green Submitted			2022-12-27	WOS:000354931700027
J	Eze, JI; Correia-Gomes, C; Borobia-Belsue, J; Tucker, AW; Sparrow, D; Strachan, DW; Gunn, GJ				Eze, J. I.; Correia-Gomes, C.; Borobia-Belsue, J.; Tucker, A. W.; Sparrow, D.; Strachan, D. W.; Gunn, G. J.			Comparison of Respiratory Disease Prevalence among Voluntary Monitoring Systems for Pig Health and Welfare in the UK	PLOS ONE			English	Article							ENZOOTIC PNEUMONIA; SLAUGHTER; HERDS; INFECTIONS; PLEURITIS; LESIONS	Surveillance of animal diseases provides information essential for the protection of animal health and ultimately public health. The voluntary pig health schemes, implemented in the United Kingdom, are integrated systems which capture information on different macroscopic disease conditions detected in slaughtered pigs. Many of these conditions have been associated with a reduction in performance traits and consequent increases in production costs. The schemes are the Wholesome Pigs Scotland in Scotland, the BPEX Pig Health Scheme in England and Wales and the Pig Regen Ltd. health and welfare checks done in Northern Ireland. This report set out to compare the prevalence of four respiratory conditions (enzootic pneumonia-like lesions, pleurisy, pleuropneumonia lesions and abscesses in the lung) assessed by these three Pig Health Schemes. The seasonal variations and year trends associated with the conditions in each scheme are presented. The paper also highlights the differences in prevalence for each condition across these schemes and areas where further research is needed. A general increase in the prevalence of enzootic pneumonia like lesions was observed in Scotland, England and Wales since 2009, while a general decrease was observed in Northern Ireland over the years of the scheme. Pleurisy prevalence has increased since 2010 in all three schemes, whilst pleuropneumonia has been decreasing. Prevalence of abscesses in the lung has decreased in England, Wales and Northern Ireland but has increased in Scotland. This analysis highlights the value of surveillance schemes based on abattoir pathology monitoring of four respiratory lesions. The outputs at scheme level have significant value as indicators of endemic and emerging disease, and for producers and herd veterinarians in planning and evaluating herd health control programs when comparing individual farm results with national averages.	[Eze, J. I.; Correia-Gomes, C.; Gunn, G. J.] Scottish Rural Coll, Edinburgh, Midlothian, Scotland; [Borobia-Belsue, J.; Sparrow, D.] MossVet, Craigavon, County Armagh, North Ireland; [Tucker, A. W.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Strachan, D. W.] Boehringer Ingelheim Vetmed, Bracknell, Berks, England	University of Cambridge; Boehringer Ingelheim	Eze, JI (corresponding author), Scottish Rural Coll, Kings Bldg,West Mains Rd, Edinburgh, Midlothian, Scotland.	jude.eze@sruc.ac.uk		Eze, Jude/0000-0001-5308-7080; Gomes, Carla/0000-0002-2909-4608	Scottish Government (RERAD funded programme. Food, Land and People (Programme 2)	Scottish Government (RERAD funded programme. Food, Land and People (Programme 2)	This work was underpinned by Theme 6 work funded by the Scottish Government (RERAD funded programme. Food, Land and People (Programme 2)). MossVet and Boehringer Ingelheim Vetmedica provided support in the form of salaries for authors Borobia-Belsue J, Sparrow D and Strachan, W.D. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BPEX, 2014, EXPL BPHS LES TIM TR; Brockmeier S. L, 2002, POLYMICROBIAL DIS; Cleveland-Nielsen A, 2002, PREV VET MED, V55, P121, DOI 10.1016/S0167-5877(02)00089-2; FALK K, 1991, ACTA VET SCAND, V32, P67; Hansen MS, 2010, J COMP PATHOL, V143, P120, DOI 10.1016/j.jcpa.2010.01.012; Harley S, 2012, IRISH VET J, V65, DOI 10.1186/2046-0481-65-11; Hoinville LJ, 2013, PREV VET MED, V112, P1, DOI 10.1016/j.prevetmed.2013.06.006; Jager HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029655; Jubb K.V.F., 1993, PATHOLOGY DOMESTIC A; Maes DG, 2001, VET REC, V148, P41, DOI 10.1136/vr.148.2.41; Martinez J, 2009, VET J, V179, P240, DOI 10.1016/j.tvjl.2007.10.006; Meyns T, 2011, VET J, V187, P388, DOI 10.1016/j.tvjl.2009.12.027; Nathues H, 2013, ACTA VET SCANDINAVIC, V55; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Pijoan C., 2006, DIS SWINE, P719; Pol JMA, 1997, VET MICROBIOL, V55, P259, DOI 10.1016/S0378-1135(96)01323-5; Sanchez-Vazquez MJ, 2011, VET REC, V169, P413, DOI 10.1136/vr.d4814; Sanchez-Vazquez M. J., 2010, Pig Journal, V63, P25; Sanchez-Vazquez MJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-151; Siugzdaite J, 2005, MED WETER, V61, P42; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Wahba G., 1990, SPLINE MODELS OBSERV; Williamson SM, 2012, VET REC, V171, P271, DOI 10.1136/vr.100673; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodbine KA, 2007, VET REC, V160, P751, DOI 10.1136/vr.160.22.751	25	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128137	10.1371/journal.pone.0128137	http://dx.doi.org/10.1371/journal.pone.0128137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020635	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300084
J	Hlushchuk, Y; Simoes-Franklin, C; Nangini, C; Hari, R				Hlushchuk, Yevhen; Simoes-Franklin, Cristina; Nangini, Cathy; Hari, Riitta			Stimulus-Rate Sensitivity Discerns Area 3b of the Human Primary Somatosensory Cortex	PLOS ONE			English	Article							MEDIAN NERVE-STIMULATION; CEREBRAL-BLOOD-FLOW; POSTCENTRAL GYRUS; FINGER STIMULATION; REPETITION RATE; FMRI SIGNALS; MONKEY; ORGANIZATION; RESPONSES; CONVERGENCE	Previous studies have shown that the hemodynamic response of the primary somatosensory cortex (SI) to electrical median nerve stimulation doubles in strength when the stimulus rate (SR) increases from 1 to 5 Hz. Here we investigated whether such sensitivity to SR is homogenous within the functionally different subareas of the SI cortex, and whether SR sensitivity would help discern area 3b among the other SI subareas. We acquired 3-tesla functional magnetic resonance imaging (fMRI) data from nine healthy adults who received pneumotactile stimuli in 25-s blocks to three right-hand fingers, either at 1, 4, or 10 Hz. The main contrast (all stimulations pooled vs. baseline), applied to the whole brain, first limited the search to the whole SI cortex. The conjunction of SR-sensitive contrasts [4 Hz - 1Hz] > 0 and [10 Hz - 1Hz] > 0 ([4Hz - 1Hz] + [10Hz - 1Hz] > 0), applied to the SI cluster, then revealed an anterior-ventral subcluster that reacted more strongly to both 10-Hz and 4-Hz stimuli than to the 1-Hz stimuli. No other SR-sensitive clusters were found at the group-level in the whole-brain analysis. The site of the SR-sensitive SI subcluster corresponds to the canonical position of area 3b; such differentiation was also possible at the individual level in 5 out of 9 subjects. Thus the SR sensitivity of the BOLD response appears to discern area 3b among other subareas of the human SI cortex.	[Hlushchuk, Yevhen; Simoes-Franklin, Cristina; Nangini, Cathy; Hari, Riitta] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Brain Res Unit, Espoo 00076, Finland; [Hlushchuk, Yevhen; Nangini, Cathy; Hari, Riitta] Aalto Univ, Sch Sci, Aalto NeuroImaging, Adv Magnet Imaging Ctr, Espoo 00076, Finland	Aalto University; Aalto University	Hlushchuk, Y (corresponding author), Univ Helsinki, HUS Med Imaging Ctr, Radiol, Helsinki, Finland.	yevhen@neuro.hut.fi	Simoes-Franklin, Cristina/A-8407-2011; Hari, Riitta K/J-1880-2012	Simoes-Franklin, Cristina/0000-0002-4099-2708; Hari, Riitta K/0000-0002-3142-2703; Hlushchuk, Yevhen/0000-0001-6869-6305	Academy of Finland [218072]; Ministry of Education Finland via Finnish Graduate School of Neuroscience; Aalto University; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Ministry of Education Finland via Finnish Graduate School of Neuroscience; Aalto University; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by the Academy of Finland (National Centers of Excellence Programme 2006-2011 and grant #218072), the Ministry of Education Finland via the Finnish Graduate School of Neuroscience, the aivoAALTO Project Grant from the Aalto University, and by the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthurs OJ, 2000, NEUROSCIENCE, V101, P803, DOI 10.1016/S0306-4522(00)00511-X; Besle J, 2014, HUM BRAIN MAPP, V35, P2027, DOI 10.1002/hbm.22310; Blankenburg F, 2003, CEREB CORTEX, V13, P987, DOI 10.1093/cercor/13.9.987; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Chiappa K.H., 1983, EVOKED POTENTIALS CL; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Ferretti A, 2007, HUM BRAIN MAPP, V28, P645, DOI 10.1002/hbm.20292; FORSS N, 1995, BRAIN RES, V685, P68, DOI 10.1016/0006-8993(95)00424-O; Francis ST, 2000, NEUROIMAGE, V11, P188, DOI 10.1006/nimg.2000.0541; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Geyer S, 2000, NEUROIMAGE, V11, P684, DOI 10.1006/nimg.2000.0548; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Hlushchuk Y, 2006, J NEUROSCI, V26, P5819, DOI 10.1523/JNEUROSCI.5536-05.2006; HUTTUNEN J, 1991, J NEUROL SCI, V105, P37, DOI 10.1016/0022-510X(91)90115-N; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P539, DOI 10.1113/jphysiol.1978.sp012518; IBANEZ V, 1995, BRAIN, V118, P1339, DOI 10.1093/brain/118.5.1339; Iramina K, 2001, IEEE T MAGN, V37, P2918, DOI 10.1109/20.951347; IWAMURA Y, 1993, EXP BRAIN RES, V92, P360; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; Kaas JH, 1981, CORTICAL SENSORY ORG, V1, P29; Kampe KKW, 2000, HUM BRAIN MAPP, V9, P106, DOI 10.1002/(SICI)1097-0193(200002)9:2<106::AID-HBM5>3.0.CO;2-Y; Krause T, 2001, BRAIN RES, V899, P36, DOI 10.1016/S0006-8993(01)02147-3; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Manganotti P, 2009, MAGN RESON IMAGING, V27, P1175, DOI 10.1016/j.mri.2009.05.009; Martuzzi R, 2014, HUM BRAIN MAPP, V35, P213, DOI 10.1002/hbm.22172; Mauguiere F, 1997, EVOKED POTENTIAL, V104, P290, DOI 10.1016/S0013-4694(97)00018-7; Mertens M, 2000, CLIN NEUROPHYSIOL, V111, P1478, DOI 10.1016/S1388-2457(00)00349-7; MERZENICH MM, 1978, J COMP NEUROL, V181, P41, DOI 10.1002/cne.901810104; Moore CI, 2000, J NEUROPHYSIOL, V84, P558, DOI 10.1152/jn.2000.84.1.558; Nangini C, 2009, HUM BRAIN MAPP, V30, P1824, DOI 10.1002/hbm.20787; Nelson AJ, 2008, CEREB CORTEX, V18, P2341, DOI 10.1093/cercor/bhm257; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; POWELL TPS, 1959, B JOHNS HOPKINS HOSP, V105, P133; Ruben J, 2006, CEREB CORTEX, V16, P819, DOI 10.1093/cercor/bhj025; Sanchez-Panchuelo RM, 2012, J NEUROSCI, V32, P15815, DOI 10.1523/JNEUROSCI.2501-12.2012; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; TIIHONEN J, 1989, ELECTROEN CLIN NEURO, V74, P290, DOI 10.1016/0168-5597(89)90059-2; Wikstrom H, 1996, EVOKED POTENTIAL, V100, P479; Young JA, 2004, J CHEM EDUC, V81, P24, DOI 10.1021/ed081p24	41	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128462	10.1371/journal.pone.0128462	http://dx.doi.org/10.1371/journal.pone.0128462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020639	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000355187300114
J	Babineau, K; Taylor, K; Clancy, L				Babineau, Kate; Taylor, Keishia; Clancy, Luke			Electronic Cigarette Use among Irish Youth: A Cross Sectional Study of Prevalence and Associated Factors	PLOS ONE			English	Article							YOUNG-ADULTS; TOBACCO; SMOKING; OBESITY	Purpose To examine prevalence of, and factors associated with, e-cigarette use among young people aged 16-17 in Ireland. Methods In 2014, a representative sample of 821 young people aged 16-17 recruited from secondary schools completed a pen and paper survey on e-cigarette use, tobacco use, and sociodemographic items. Findings A total of 23.8% of respondents had used e-cigarettes at least once. Dual trial of tobacco and e-cigarettes was common with 69.5% of regular smokers and 30.4% of 'ever' smokers having tried e-cigarettes and 10.6% of current smokers using e-cigarettes regularly. 4.2% of never smokers have tried e-cigarettes. Overall, current e-cigarette use (once a month or more) was low (3.2%). Binary logistic regression conducted through generalized estimating equations (GEE) determined that controlling for other variables, current tobacco use and 'ever' tobacco use predicted ever e-cigarette use. Gender and school-level socioeconomic status were also independent predictors of ever e-cigarette use. Gender stood as the only predictor of on-going e-cigarette use, with males being more likely to regularly use e-cigarettes at least once a month. Conclusions E-cigarette use among 16-17 year olds in Ireland is of note, with nearly a quarter of students having tried them. Concurrent or experimental use of e-cigarettes and tobacco is more common than sole use, while a small number have tried e-cigarettes without having tried tobacco.	[Babineau, Kate; Taylor, Keishia; Clancy, Luke] TobaccoFree Res Inst Ireland, DIT Focas, Dublin, Ireland		Babineau, K (corresponding author), TobaccoFree Res Inst Ireland, DIT Focas, Dublin, Ireland.	kbabineau@tri.ie	Clancy, Luke/O-6597-2019; clancy, luke/ABA-1826-2020	Clancy, Luke/0000-0003-2407-2263; 	Irish Department of Health's National Lottery Grant Scheme	Irish Department of Health's National Lottery Grant Scheme	The TobaccoFree Research Institute received grant funding from the Irish Department of Health's National Lottery Grant Scheme which contributed to the salaries of the employees who worked on this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action on Smoking and Health, 2014, ASH FACT SHEET US EL, P1; [Anonymous], 2013, CDCS GLOB TOB SURV S; Central Statistics Office, 2013, POP MIGR EST; Chapman SLC, 2014, J PSYCHIATR RES, V54, P43, DOI 10.1016/j.jpsychires.2014.03.005; Cho JH, 2011, J ADOLESCENT HEALTH, V49, P542, DOI 10.1016/j.jadohealth.2011.08.001; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Czoli CD, 2014, CAN J PUBLIC HEALTH, V105, pE97, DOI 10.17269/cjph.105.4119; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Department of Education and Skills, 2005, DEIS DEL EQ OPP SCH; Fairchild AL, 2014, NEW ENGL J MED, V370, P293, DOI 10.1056/NEJMp1313940; German Cancer Research Center, 2013, EL CIG OV, P1; Goniewicz ML, 2012, PEDIATRICS, V130, pE879, DOI 10.1542/peds.2011-3448; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Hajek P, 2014, ADDICTION IN PRESS; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Legacy for Health, 2014, E CIG POL FDA SHOULD; Melikian AA, 2009, BIOMARKERS, V14, P85, DOI 10.1080/13547500902965401; Offermann FJ, 2014, ASHRAE J, V56, P38; Ramo DE, 2015, ADDICT BEHAV, V41, P142, DOI 10.1016/j.addbeh.2014.10.019; Schober W, 2014, INT J HYG ENVIR HEAL, V217, P628, DOI 10.1016/j.ijheh.2013.11.003; Vardavas Constantine I, 2015, Tob Control, V24, P442, DOI 10.1136/tobaccocontrol-2013-051394; Wagener TL, 2012, ADDICTION, V107, P1554, DOI 10.1111/j.1360-0443.2012.04012.x; Wills TA, 2015, PEDIATRICS, V135, pE43, DOI 10.1542/peds.2014-0760; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zorn CJ, 2011, AM J POLIT SCI, P470	26	57	57	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126419	10.1371/journal.pone.0126419	http://dx.doi.org/10.1371/journal.pone.0126419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018542	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600052
J	Li, YF; Yao, YT; Qian, X; Shi, L; Zhou, JX; Ma, QL; Yao, YF				Li, Yingfu; Yao, Yueting; Qian, Xu; Shi, Li; Zhou, Jingxian; Ma, Qianli; Yao, Yufeng			The Association of Adiponectin Gene Promoter Variations with Non-Small Cell Lung Cancer in a Han Chinese Population	PLOS ONE			English	Article							BREAST-CANCER; ENDOMETRIAL CANCER; COLORECTAL-CANCER; CIRCULATING ADIPONECTIN; INSULIN-RESISTANCE; RISK; ADIPOQ; POLYMORPHISMS; VARIANTS; SHESIS	Recently, in vitro studies have demonstrated that adiponectin has antiangiogenic and tumor growth-limiting properties. Additionally, serum adiponectin levels have been associated with the risk of several cancers; specifically, serum adiponectin was significantly lower in lung cancer patients with advanced-stage disease. In this study, we examined the association of adiponectin gene promoter variations associated with adiponectin gene expression and plasma levels in non-small cell lung cancer (NSCLC) in a Han Chinese population. A total of 319 patients with NSCLC and 489 healthy individuals were recruited to evaluate the association of four adiponectin gene promoter single-nucleotide polymorphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G) with NSCLS risk. Additionally, we constructed haplotypes of these four SNPs and evaluated the association of these haplotypes with NSCLS risk. Our results showed that among these four SNPs, only SNP-12140G>A was associated with NSCLC risk(P < 0.05). The haplotype analysis showed that no haplotype was associated with NSCLC after performing a Bonferroni correction (P>0.05). Additionally, an association analysis of the four SNPs stratified into pathologic stages I+II and III+IV showed that these SNPs did not exhibit significant differences between pathologic stages I+II and III+IV. Moreover, we did not observe any differences in allele and genotype frequency for these SNPs between adenocarcinoma and squamous cell carcinoma. Our results indicated that the G allele of SNP-12140may be a risk factor for NSCLC (OR = 1.516; 95% CI: 1.098-2.094) in this Han Chinese population.	[Li, Yingfu] Kunming Med Univ, Affiliated Hosp 1, Dept Geriatr, Kunming 650032, Peoples R China; [Yao, Yueting; Shi, Li; Zhou, Jingxian; Yao, Yufeng] Chinese Acad Med Sci, Inst Med Biol, Kunming 650118, Peoples R China; [Yao, Yueting; Shi, Li; Zhou, Jingxian; Yao, Yufeng] Peking Union Med Coll, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming 650118, Peoples R China; [Qian, Xu] Yanan Hosp Kunming, Dept Cardiothorac Surg, Kunming 650051, Peoples R China; [Ma, Qianli] Kunming Med Univ, Affiliated Hosp 3, Dept Thorac Surg, Kunming 650118, Peoples R China	Kunming Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Peking Union Medical College; Kunming Medical University	Ma, QL (corresponding author), Kunming Med Univ, Affiliated Hosp 3, Dept Thorac Surg, Kunming 650118, Peoples R China.	maqianli78@126.com; leoyyf@gmail.com			Association Foundation Program of the Yunnan Provincial Science and Technology Department and Kunming Medical University [2012FB064]; Foundation Program of the Yunnan Province [2014NS139]	Association Foundation Program of the Yunnan Provincial Science and Technology Department and Kunming Medical University; Foundation Program of the Yunnan Province	This work was supported by grants from the Association Foundation Program of the Yunnan Provincial Science and Technology Department and Kunming Medical University (No. 2012FB064) and Foundation Program of the Yunnan Province (No. 2014NS139).	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Carvajal-Carmona LG, 2009, HUM MOL GENET, V18, P1889, DOI 10.1093/hmg/ddp109; Cui EH, 2011, BIOCHEM CELL BIOL, V89, P308, DOI [10.1139/o11-005, 10.1139/O11-005]; Cust AE, 2007, J CLIN ENDOCR METAB, V92, P255, DOI 10.1210/jc.2006-1371; Dal Maso L, 2004, J CLIN ENDOCR METAB, V89, P1160, DOI 10.1210/jc.2003-031716; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Johnson JL, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/940405; Kaklamani VG, 2008, JAMA-J AM MED ASSOC, V300, P1523, DOI 10.1001/jama.300.13.1523; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Laumen H, 2009, DIABETES, V58, P984, DOI 10.2337/db07-1646; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Li Y, 2014, J KUNMING MED U, V35, P52; Li YP, 2012, DIABETES-METAB RES, V28, P551, DOI 10.1002/dmrr.2309; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Nigro E, 2013, INT J BIOCHEM CELL B, V45, P1145, DOI 10.1016/j.biocel.2013.03.003; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pei Y, 2015, TUMOR BIOL, V36, P585, DOI 10.1007/s13277-014-2654-x; Petridou E, 2003, J CLIN ENDOCR METAB, V88, P993, DOI 10.1210/jc.2002-021209; Petridou ET, 2007, ONCOLOGY-BASEL, V73, P261, DOI 10.1159/000127424; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Soliman PT, 2006, CANCER-AM CANCER SOC, V106, P2376, DOI 10.1002/cncr.21866; Spyridopoulos TN, 2007, INT J CANCER, V120, P1573, DOI 10.1002/ijc.22526; Tworoger SS, 2007, J CLIN ENDOCR METAB, V92, P1510, DOI 10.1210/jc.2006-1975; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Xu YQ, 2013, MOL BIOL REP, V40, P1135, DOI 10.1007/s11033-012-2154-2; Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150; Yang Y, 2013, CYTOKINE, V61, P565, DOI 10.1016/j.cyto.2012.10.030	34	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127751	10.1371/journal.pone.0127751	http://dx.doi.org/10.1371/journal.pone.0127751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018909	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600096
J	Nemescu, D; Berescu, A; Onofriescu, M; Navolan, DB; Rotariu, C				Nemescu, Dragos; Berescu, Anca; Onofriescu, Mircea; Navolan, Dan Bogdan; Rotariu, Cristian			Safety Indices during Fetal Echocardiography at the Time of First-Trimester Scan Are Machine Dependent	PLOS ONE			English	Article							NUCHAL TRANSLUCENCY; TRICUSPID REGURGITATION; MECHANICAL INDEXES; ACOUSTIC OUTPUT; 13+6-WEEK SCAN; DOPPLER; FETUSES; ULTRASOUND; DEFECTS	The aim of our study was to evaluate the thermal index (TI) and mechanical index (MI), during the assessment of the fetal heart at the time of first-trimester scan, with different ultrasound machines. This was part of an observational study conducted in patients undergoing routine first-trimester screening. Cases were examined with Voluson E8 or 730Pro scanners using 2-8 MHz transabdominal probes. TI and MI were retrieved from the saved displays while in gray mode, color flow mapping and pulsed-wave (PW) Doppler examinations of the fetal heart and also from the ductus venosus (DV) assessment. We evaluated 552 fetal cardiac examinations, 303 (55%) performed with Voluson E8 and 249 (45%) with Voluson 730Pro ultrasound machines. The gray-scale exam of the heart and the PW Doppler DV assessment had TI values significantly lower for the Voluson E8 group (median, 0.04 vs. 0.2 and 0.1 vs. 0.2, respectively). The MI values from gray-scale and color flow mapping of the heart were significantly lower (median, 0.6 vs, 1.2 and 0.7 vs. 1) and for PW Doppler exam of the tricuspid flow were significantly higher (median 0.4 vs. 0.2) in the Voluson E8 group. The TI values from Doppler examinations of the heart, either color flow or PW imaging and MI values from DV assessment were not significantly different between the two groups. A different (newer) generation of ultrasound equipment provides lower or at least the same safety indices for most of the first-trimester heart examinations.	[Nemescu, Dragos; Onofriescu, Mircea] Univ Med & Pharm Gr T Popa, Dept Obstet & Gynecol, Iasi, Romania; [Nemescu, Dragos; Berescu, Anca; Onofriescu, Mircea] Cuza Voda Obstet & Gynecol Hosp, Iasi, Romania; [Navolan, Dan Bogdan] Univ Med & Farm Timisoara, Dept Obstet & Gynecol, Timisoara, Romania; [Rotariu, Cristian] Univ Med & Pharm Gr T Popa, Dept Biomed Sci, Iasi, Romania	Grigore T Popa University of Medicine & Pharmacy; Victor Babes University of Medicine & Pharmacy, Timisoara; Grigore T Popa University of Medicine & Pharmacy	Nemescu, D (corresponding author), Univ Med & Pharm Gr T Popa, Dept Obstet & Gynecol, Iasi, Romania.	dragos.nemescu@umfiasi.ro	Nemescu, Dragos/AAC-7813-2019; Onofriescu, Mircea/Y-5702-2018	Nemescu, Dragos/0000-0003-2345-1077; 				Abuhamad A, 2010, PRACTICAL GUIDE FETA, P128; Faiola S, 2005, ULTRASOUND OBST GYN, V26, P22, DOI 10.1002/uog.1922; Healthcare GE, 2010, VOL E8 E8 EXP BAS US, P2; Kagan KO, 2009, ULTRASOUND OBST GYN, V33, P18, DOI 10.1002/uog.6264; Lombardi CM, 2007, ULTRASOUND OBST GYN, V29, P249, DOI 10.1002/uog.3948; Maiz N, 2008, ULTRASOUND OBST GYN, V31, P256, DOI 10.1002/uog.5262; Nemescu D, 2015, ULTRASOUND MED BIOL, V41, P35, DOI 10.1016/j.ultrasmedbio.2014.08.010; Persico N, 2011, ULTRASOUND OBST GYN, V37, P296, DOI 10.1002/uog.8934; Piscaglia F, 2012, ULTRASCHALL MED, V33, P33, DOI 10.1055/s-0031-1281676; Salvesen KA, 2011, ULTRASOUND OBST GYN, V37, P625, DOI 10.1002/uog.9025; Sande RK, 2013, ACTA OBSTET GYN SCAN, V92, P790, DOI 10.1111/aogs.12114; Shaw A., 2012, SAFE USE ULTRASOUND, V3rd ed., P18; Sheiner E, 2007, J CLIN ULTRASOUND, V35, P245, DOI 10.1002/jcu.20321; Sheiner E, 2009, FETAL DIAGN THER, V25, P8, DOI 10.1159/000184541; Sotiriadis A, 2013, ULTRASOUND OBST GYN, V42, P383, DOI 10.1002/uog.12488; Volpe P, 2012, J ULTRAS MED, V31, P563, DOI 10.7863/jum.2012.31.4.563; Votino C, 2012, ULTRASOUND OBST GYN, V39, P145, DOI 10.1002/uog.9015; WFUMB/ISUOG, 2013, Ultrasound Med Biol, V39, P373, DOI 10.1016/j.ultrasmedbio.2012.11.025	18	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127570	10.1371/journal.pone.0127570	http://dx.doi.org/10.1371/journal.pone.0127570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018336	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600090
J	Osterblom, H; Jouffray, JB; Folke, C; Crona, B; Troell, M; Merrie, A; Rockstrom, J				Osterblom, Henrik; Jouffray, Jean-Baptiste; Folke, Carl; Crona, Beatrice; Troell, Max; Merrie, Andrew; Rockstrom, Johan			Transnational Corporations as 'Keystone Actors' in Marine Ecosystems	PLOS ONE			English	Article							FORAGE FISH; AQUACULTURE; ANTHROPOCENE; EMERGENCE; IMPACTS; RESILIENCE; SYSTEMS; COMMONS; FOOD	Keystone species have a disproportionate influence on the structure and function of ecosystems. Here we analyze whether a keystone-like pattern can be observed in the relationship between transnational corporations and marine ecosystems globally. We show how thirteen corporations control 11-16% of the global marine catch (9-13 million tons) and 19-40% of the largest and most valuable stocks, including species that play important roles in their respective ecosystem. They dominate all segments of seafood production, operate through an extensive global network of subsidiaries and are profoundly involved in fisheries and aquaculture decision-making. Based on our findings, we define these companies as keystone actors of the Anthropocene. The phenomenon of keystone actors represents an increasingly important feature of the human-dominated world. Sustainable leadership by keystone actors could result in cascading effects throughout the entire seafood industry and enable a critical transition towards improved management of marine living resources and ecosystems.	[Osterblom, Henrik; Jouffray, Jean-Baptiste; Folke, Carl; Crona, Beatrice; Merrie, Andrew; Rockstrom, Johan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Jouffray, Jean-Baptiste; Folke, Carl; Crona, Beatrice; Troell, Max] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere Acad Programme, S-10405 Stockholm, Sweden; [Folke, Carl; Troell, Max] Royal Swedish Acad Sci, Beijer Inst Ecol Econ, S-10405 Stockholm, Sweden	Stockholm University; Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics	Osterblom, H (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden.	henrik.osterblom@su.se	Jouffray, Jean-Baptiste/AAN-1329-2020; Crona, Beatrice/HHZ-3183-2022; Troell, Max/I-1724-2019; Folke, Carl/Z-1545-2019	Jouffray, Jean-Baptiste/0000-0002-4105-6372; Crona, Beatrice/0000-0003-1617-4067; Troell, Max/0000-0002-7509-8140; Osterblom, Henrik/0000-0002-1913-5197; Folke, Carl/0000-0002-4050-3281; Rockstrom, Johan/0000-0001-8988-2983	Swedish Government; Nippon Foundation; Family Erling Persson Foundation; Kjell and Marta Beijer Foundation; Ivar Bendixsons fond	Swedish Government; Nippon Foundation(Nippon Foundation); Family Erling Persson Foundation; Kjell and Marta Beijer Foundation; Ivar Bendixsons fond	Baltic Ecosystem Adaptive Management (BEAM) is a strategic research initiative funded by the Swedish Government: http://www.regeringen.se/ (HO), the Nippon Foundation: http://www.nippon-foundation.or.jp/en/(HO, CF, AM), the Family Erling Persson Foundation: http://familjenerlingperssonsstiftelse.se/en/ (CF, BC, JBJ), the Kjell and Marta Beijer Foundation: http://www.beijerstiftelsen.se/(CF, MT, BC), Mistra (CF, JR, HO), Ivar Bendixsons fond (HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2009, FRONT ECOL ENVIRON, V7, P150, DOI 10.1890/070148; Ainley DG, 2010, POLAR REC, V46, P233, DOI 10.1017/S003224740999009X; Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; Alder J, 2008, ANNU REV ENV RESOUR, V33, P153, DOI 10.1146/annurev.environ.33.020807.143204; [Anonymous], 2014, BLOOMBERG BUSINESSWE; [Anonymous], 2012, LONG TERM SUSTAINABI; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berger M, 2013, SUSTAINABLE SEAFOOD; Berry M.A., 1998, ACAD MANAGE PERSPECT, V12, P38, DOI [10.5465/ame.1998.650515, DOI 10.5465/AME.1998.650515]; Biermann F, 2012, SCIENCE, V335, P1306, DOI 10.1126/science.1217255; Chakravarty S, 2009, P NATL ACAD SCI USA, V106, P11884, DOI 10.1073/pnas.0905232106; Cox SP, 2002, CAN J FISH AQUAT SCI, V59, P1736, DOI 10.1139/F02-138; Crona BI, 2016, FISH FISH, V17, P1175, DOI 10.1111/faf.12109; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dicken P., 2011, GLOBAL SHIFT MAPPING, V6th; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; FAO, 2014, FAO YB FISH STAT AQ; FAO, 2011, STAT WORLD FISH AQ O; FAO, 2013, FAO YB FISH STAT AQ; FAO, 2014, FISH AQ AT GLOB CAPT; FishSource, 2014, FISHSOURCE STAT ENV; FOLKE C, 1989, AMBIO, V18, P234; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; GAA, 2014, GLOB AQ ALL FEED WOR; Galaz V, 2011, PUBLIC ADMIN, V89, P361, DOI 10.1111/j.1467-9299.2010.01883.x; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Hamilton A, 2011, MARKET IND DYNAMICS; Heede R, 2014, CLIMATIC CHANGE, V122, P229, DOI 10.1007/s10584-013-0986-y; Howard Philip H., 2009, Sustainability, V1, P1266, DOI 10.3390/su1041266; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; ICIJ, 2012, LOOT SEAS; IntraFish, 2013, INTRAFISH 150 REP; Jacquet J, 2013, SUSTAINABILITY-BASEL, V5, P1036, DOI 10.3390/su5031036; Kerstens D, 2013, INVESTING SEAFOOD 20; Merrick Richard L., 1997, Journal of Northwest Atlantic Fishery Science, V22, P343; Meyfroidt P, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074012; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; OECD, 2010, GLOB FISH AQ OPP CHA; Osterblom H, 2008, OIKOS, V117, P967, DOI 10.1111/j.2008.0030-1299.16501.x; Osterblom H, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0278; Osterblom H, 2013, ECOL SOC, V18, DOI 10.5751/ES-05373-180204; Osterblom H, 2012, CONSERV BIOL, V26, P638, DOI 10.1111/j.1523-1739.2012.01850.x; Osterblom H, 2011, GLOBAL ENVIRON CHANG, V21, P972, DOI 10.1016/j.gloenvcha.2011.04.013; OSTROM E, 1993, J ECON PERSPECT, V7, P93, DOI 10.1257/jep.7.4.93; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; PAULY D., 1987, PERUVIAN ANCHOVETA I; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Rabobank, 2011, SPOTL SEAF INV GUID; Rocha J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0273; Roman M., 2013, BYCATCH NONTUNA CATC; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Smith ADM, 2011, SCIENCE, V333, P1147, DOI 10.1126/science.1209395; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327; Sumaila UR, 2000, ECOL ECON, V32, P457, DOI 10.1016/S0921-8009(99)00120-2; Sutton M, 2008, SEAFOOD ECOLABELLING; Tacon AGJ, 2009, REV FISH SCI, V17, P305, DOI 10.1080/10641260802677074; Tallberg J, 2013, ISA ANN CONV SAN FRA; Torrissen O, 2011, REV FISH SCI, V19, P257, DOI 10.1080/10641262.2011.597890; Troell M, 2014, P NATL ACAD SCI USA, V111, P13257, DOI 10.1073/pnas.1404067111; Undercurrentnews, 2013, UNDERCURRENTNEWS; Valls A, 2015, ECOL MONOGR, V85, P29, DOI 10.1890/14-0306.1; van der Lingen D, 2006, LAR MAR ECOSYST, V14, P147; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Young OR, 2006, GLOBAL ENVIRON CHANG, V16, P304, DOI 10.1016/j.gloenvcha.2006.03.004	69	133	134	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127533	10.1371/journal.pone.0127533	http://dx.doi.org/10.1371/journal.pone.0127533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017777	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600087
J	Petrone, P; Niola, M; Di Lorenzo, P; Paternoster, M; Graziano, V; Quaremba, G; Buccelli, C				Petrone, Pierpaolo; Niola, Massimo; Di Lorenzo, Pierpaolo; Paternoster, Mariano; Graziano, Vincenzo; Quaremba, Giuseppe; Buccelli, Claudio			Early Medical Skull Surgery for Treatment of Post-Traumatic Osteomyelitis 5,000 Years Ago	PLOS ONE			English	Article							MIDDLE BRONZE-AGE; CRANIAL SURGERY; CALLUS FORMATION; BONE; TREPANATION; FRACTURES; RECOMMENDATIONS; TREPHINATION; DIAGNOSIS; INJURY	Here we describe the findings of a unique example of the early techniques adopted in neurosurgery around 5000 years ago, consisting in a double well healed skull trephination associated with a post-cranial traumatic event occurring intra vitam to a young male from the Early Chalcolithic cemetery of Pontecagnano (South Italy, ca. 4,900 - 4,500 cal BP). Morphological, X-ray and 3D-CT scan skull-cap evaluation revealed that the main orifice was produced by scraping, obtained by clockwise rotary motion of a right-handed surgeon facing the patient, while the partial trephination was carried out by using a stone point as a drilling tool. In both cases, bone regrowth is indicative of the individual's prolonged postoperative survival and his near-complete recovery. The right femur shows a poorly healed mid-shaft fracture presumably induced by a high energy injury, and a resulting chronic osteomyelitis, affecting both femurs by hematogenous spread of the infection. Our observations on the visual and radiological features of skull and femur lesions, along with evidence on the timing of experimental bone regrowth vs. healing of lower limb fractures associated to long-term bone infections now suggest that this young man underwent a double skull trephination in order to alleviate his extremely painful condition induced by chronic osteomyelitis, which is thought to have been the cause of death.	[Petrone, Pierpaolo] Univ Naples Federico II, Dept Adv Biomed Sci, Lab Human Osteobiol & Forens Anthropol, I-80131 Naples, Italy; [Niola, Massimo; Di Lorenzo, Pierpaolo; Paternoster, Mariano; Graziano, Vincenzo; Buccelli, Claudio] Univ Naples Federico II, Azienda Osped Univ, Dept Adv Biomed Sci, I-80131 Naples, Italy; [Quaremba, Giuseppe] Univ Naples Federico II, Dept Ind Engn, Div Mech & Energet, I-80135 Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Petrone, P (corresponding author), Univ Naples Federico II, Dept Adv Biomed Sci, Lab Human Osteobiol & Forens Anthropol, I-80131 Naples, Italy.	pipetron@unina.it	Paternoster, Mariano/Y-4332-2018	Paternoster, Mariano/0000-0002-3063-9839; Quaremba, Giuseppe/0000-0002-4956-0303; DI LORENZO, Pierpaolo/0000-0002-8688-6257; Petrone, Pier Paolo/0000-0002-8897-8171; GRAZIANO, Vincenzo/0000-0002-9248-7439; BUCCELLI, Claudio/0000-0002-1070-7048; NIOLA, Massimo/0000-0002-5350-8460				Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca; Alt KW, 1997, NATURE, V387, P360, DOI 10.1038/387360a0; Andrushko VA, 2008, AM J PHYS ANTHROPOL, V137, P4, DOI 10.1002/ajpa.20836; [Anonymous], 1980, J HUM EVOL, V9, P517; Appelboom T, 1999, LANCET, V354, P2153, DOI 10.1016/S0140-6736(99)07113-5; Arensburg B., 1988, B MEM SOC ANTHRO PAR, V5, P139; Asensi V, 2003, AM J MED GENET A, V119A, P132, DOI 10.1002/ajmg.a.20137; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Bailo Modesti G, 1998, AION ARCHSTANT QUAD; Bereczki Z, 2015, INT J OSTEOARCHAEOL, V25, P322, DOI 10.1002/oa.2304; Bereczki ZS., 2005, ACTA MED LITU, V12, P65; Beredjiklian PK, 1999, U PENNSYLVANIA ORTHO, V12, P52; Breasted J.H., 1930, E SMITH SURG PAPYRUS; Broca P., 1876, B MEM SOC ANTHRO PAR, V11, P236; Broca P., 1867, B SOC ANTHROPOL PAR, V32, P866; Brothwell Donald R., 1967, DIS ANTIQUITY, P673; Buikstra Jane E., 1994, RES SERIES, V44; CAMPILLO D, 1984, ACTA NEUROCHIR, V70, P275, DOI 10.1007/BF01406656; Capasso L, 2002, LANCET, V359, P2206, DOI 10.1016/S0140-6736(02)09084-0; Capasso L, 1998, LANCET, V352, P1984; Chege N, 1996, INT J OSTEOARCHAEOL, V6, P249, DOI 10.1002/(SICI)1099-1212(199606)6:3<249::AID-OA269>3.3.CO;2-A; Cierny G, 1999, CLIN ORTHOP RELAT R, P97, DOI 10.1097/00003086-199903000-00012; Cierny III G, 2010, AM ACAD ORTHOP SURG, V7, P71; CIERNY III G, 1985, CONT ORTHOP, V10, P17, DOI DOI 10.1097/01.BLO.0000088564.81746.62; Crubezy E, 2001, CR ACAD SCI II A, V332, P417, DOI 10.1016/S1251-8050(01)01546-4; Crubezy E., 1996, ANTHROPOLOGIE BRNO, V34, P329; Cucina A, 2005, S ASIAN ARCHAEOLOGY, V1, P79; DASTUGUE J, 1973, ANTHROPOLOGIE, V77, P63; Dastugue J, 1962, NECROPOLE EPIPALEOLI, P133; Dimopoulos VG, 2008, J HIST NEUROSCI, V17, P131, DOI 10.1080/09647040701296770; Dobanovacki D., 2012, ARCH ONCOL, V20, P28; DUDAY H, 1990, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V2, P29, DOI 10.3406/bmsap.1990.1740; El Ouarzazi A, 2005, Proceedings of the 13th World Congress of Neurological Surgery, Vols 1 and 2, P517; ERIKSEN EF, 1986, ENDOCR REV, V7, P379, DOI 10.1210/edrv-7-4-379; Ferembach D, 1962, NECROPOLE EPIPALEOLI, P3, DOI [10.1126/scitranslmed.aaa4642, DOI 10.1126/SCITRANSLMED.AAA4642]; FEREMBACH D., 1970, SUMER, V26, P21; Formicola V, 2012, J ANTHROPOL SCI, V90, P1; Fornaciari G, 1993, ORIGINI CHIRURGIA IT, P67; Galloway A, 1999, BROKEN BONES ANTHR A, P160; Germana Franco, 1992, TRAPANAZIONI CRANIOT; GOIKHMAN V. A., 1966, VOPROSY ANTROPOLOGII, V23, P111; Heidecker Karl-Maria, 2006, Wurzbg Medizinhist Mitt, V25, P113; HERSHKOVITZ I, 1991, AM J FOREN MED PATH, V12, P194, DOI 10.1097/00000433-199109000-00004; Hershkovitz I, 1987, JISRPREHISTSOC, V20, P128; Jackes M, 1997, ANTIQUITY, V71, P639, DOI 10.1017/S0003598X00085379; Jordanov J, 1990, HOMO, V41, P266; Kaufman MH, 1997, J ARCHAEOL SCI, V24, P193, DOI 10.1006/jasc.1995.0104; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; Lillie MC, 1998, NATURE, V391, P854, DOI 10.1038/36023; Lisowski F. P, 1967, DIS ANTIQUITY, P651; Littleton J, 2006, ARAB ARCHAEOL EPIGR, V17, P139, DOI 10.1111/j.1600-0471.2006.00267.x; Lopez B, 2011, ANTHROPOL SCI, V119, P247, DOI 10.1537/ase.100913; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lyman R.L., 2001, VERTEBRATE TAPHONOMY; Mastrolorenzo G, 2006, P NATL ACAD SCI USA, V103, P4366, DOI 10.1073/pnas.0508697103; Mastrolorenzo G, 2001, NATURE, V410, P769, DOI 10.1038/35071167; Mastrolorenzo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011127; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Mesching R, 1981, TREPANATIONS AFRIQUE, P17; Miles A., 1963, J DENT RES, V42, P255, DOI [10.1177/00220345630420012701, DOI 10.1177/00220345630420012701]; MOGLE P, 1995, INT J OSTEOARCHAEOL, V5, P77, DOI 10.1002/oa.1390050108; Mogliazza S, 2009, J ANTHROPOL SCI, V87, P187; Muller MENS., 1990, COMPREHENSIVE CLASSI, V1st ed; Nerlich A, 2003, TREPANATION: HISTORY, DISCOVERY, THEORY, P43; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Ozan F, 2010, ACTA ORTHOP TRAUMATO, V44, P313, DOI 10.3944/AOTT.2010.2277; Passariello I, 2010, GEOCHRONOMETRIA, V35, P25, DOI 10.2478/v10003-010-0008-2; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Petrone P, 2000, S ASIAN ARCHAEOLOGY, V1, P285; Petrone PP, 1998, AION ARCHSTANT QUAD, P201; Pineda Carlos, 2009, Semin Plast Surg, V23, P80, DOI 10.1055/s-0029-1214160; Podborsky V, 1993, PRAV KE JINY MORAVY; PODOLSKY S, 1962, Med Ann Dist Columbia, V31, P268; RIFKINSONMANN S, 1988, NEUROSURGERY, V23, P411, DOI 10.1227/00006123-198810000-00001; ROCHE J, 1959, CR HEBD ACAD SCI, V249, P729; ROESGEN M, 1989, ARCH ORTHOP TRAUM SU, V108, P1, DOI 10.1007/BF00934149; Rosing FW, 2007, HOMO, V58, P75, DOI 10.1016/j.jchb.2005.07.002; Salminen S., 2005, FEMORAL SHAFT FRACTU; Santos AL, 2015, INT J OSTEOARCHAEOL, V25, P110, DOI 10.1002/oa.2276; Schenker ML, 2012, J BONE JOINT SURG AM, V94A, P1057, DOI 10.2106/JBJS.K.00582; Skvarilova B, 2007, Acta Chir Plast, V49, P103; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Steinbock R., 1976, PALEOPATHOLOGICAL DI; Tabata Y, 1999, J NEUROSURG, V91, P851, DOI 10.3171/jns.1999.91.5.0851; Verano JW, 2003, TREPANATION: HISTORY, DISCOVERY, THEORY, P223; Wakely J, 1993, HISTOLOGY ANCIENT HU, P205; Weber J, 2006, INT J OSTEOARCHAEOL, V16, P536, DOI 10.1002/oa.844; White TD, 2005, HUMAN BONE MANUAL, P31; Yang TY, 2012, J BONE JOINT SURG BR, V94B, P227, DOI 10.1302/0301-620X.94B2.28193; Zias J., 1992, INT J OSTEOARCHAEOL, V2, P183, DOI [10.1002/oa.1390020210, DOI 10.1002/OA.1390020210]; Zias J, 1982, BASOR, V246, P55	91	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124790	10.1371/journal.pone.0124790	http://dx.doi.org/10.1371/journal.pone.0124790			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018014	gold, Green Submitted, Green Published			2022-12-27	WOS:000355185600008
J	Anota, A; Mouillet, G; Trouilloud, I; Dupont-Gossart, AC; Artru, P; Lecomte, T; Zaanan, A; Gauthier, M; Fein, F; Dubreuil, O; Paget-Bailly, S; Taieb, J; Bonnetain, F				Anota, Amelie; Mouillet, Guillaume; Trouilloud, Isabelle; Dupont-Gossart, Anne-Claire; Artru, Pascal; Lecomte, Thierry; Zaanan, Aziz; Gauthier, Melanie; Fein, Francine; Dubreuil, Olivier; Paget-Bailly, Sophie; Taieb, Julien; Bonnetain, Franck			Sequential FOLFIRI.3+Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; PATTERN-MIXTURE-MODELS; CLINICAL BENEFIT; CANCER; GEMCITABINE; GUIDELINES; FOLFIRINOX; OUTCOMES	Background A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using FOLFIRI.3 and gemcitabine alternately ( Arm 2) compared to gemcitabine alone (Arm 1) in patients with metastatic non pre-treated pancreatic adenocarcinoma. The primary endpoint was the progression-free survival (PFS) rate at 6 months. It concludes that the sequential treatment strategy appears to be feasible and effective with a PFS rate of 43.5% in Arm 2 at 6 months (26.1% in Arm 1). This paper reports the results of the longitudinal analysis of the health-related quality of life (HRQoL) as a secondary endpoint of this study. Methods HRQoL was evaluated using the EORTC QLQ-C30 at baseline and every two months until the end of the study or death. HRQoL deterioration-free survival (QFS) was defined as the time from randomization to a first significant deterioration as compared to the baseline score with no further significant improvement, or death. A propensity score was estimated comparing characteristics of partial and complete responders. Analyses were repeated with inverse probability weighting method using the propensity score. Multivariate Cox regression analyses were performed to identify independent factors influencing QFS. Results 98 patients were included between 2007 and 2011. Adjusting on the propensity score, patients of Arm 2 presented a longer QFS of Global Health Status (Hazard Ratio: 0.52 [0.310.85]), emotional functioning (0.35 [0.21-0.59]) and pain (0.50 [0.31 - 0.81]) than those of Arm 1. Conclusion Patients of Arm 2 presented a better HRQoL with a longer QFS than those of Arm 1. Moreover, the propensity score method allows to take into account the missing data depending on patients' characteristics.	[Anota, Amelie; Bonnetain, Franck] Natl Qual Life Oncol Platform, Besancon, France; [Anota, Amelie; Mouillet, Guillaume; Paget-Bailly, Sophie; Bonnetain, Franck] Univ Hosp Besancon, Methodol & Qual Life Oncol Unit EA 3181, Besancon, France; [Trouilloud, Isabelle; Zaanan, Aziz; Dubreuil, Olivier; Taieb, Julien] Univ Paris 05, Georges Pompidou European Hosp, Dept Gastroenterol & Digest Oncol, Paris, France; [Dupont-Gossart, Anne-Claire; Fein, Francine] Univ Hosp Besancon, Dept Gastroenterol, Besancon, France; [Artru, Pascal] Hosp Jean Mermoz, Hepatogastroenterol & Digest Oncol Dept, Lyon, France; [Lecomte, Thierry] Trousseau Hosp, Univ Hosp Tours, Dept Gastroenterol & Digest Oncol, Chambray Les Tours, France; [Gauthier, Melanie] Ctr Georges Francois Leclerc, Biostat & Qual Life Unit, Dijon, France	Universite de Franche-Comte; CHU Besancon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon; CHU Tours; UNICANCER; Centre Georges-Francois Leclerc	Anota, A (corresponding author), Natl Qual Life Oncol Platform, Besancon, France.	aanota@chu-besancon.fr		Zaanan, Aziz/0000-0001-8372-5653; LECOMTE, Thierry/0000-0001-5093-0212	Pfizer; AGEO; AROLD (Association pour la Recherche en Oncologie Digestive); French Public Health Research Institute	Pfizer(Pfizer); AGEO; AROLD (Association pour la Recherche en Oncologie Digestive); French Public Health Research Institute	Financial support for this research was provided by Pfizer, AGEO and AROLD (Association pour la Recherche en Oncologie Digestive). This study was also supported by a grant from the French Public Health Research Institute (http://www.iresp.net) under the 2012 call for projects as part of the 2009-2013 Cancer Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; [Anonymous], 2006, NCI COMMON TERMINOLO; Anota A, 2015, QUAL LIFE RES, V24, P5, DOI 10.1007/s11136-013-0583-6; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Bernhard J, 2008, J CLIN ONCOL, V26, P3695, DOI 10.1200/JCO.2007.15.6240; Bonnetain F, 2012, EUR J CANCER, V48, P1781, DOI 10.1016/j.ejca.2012.03.016; Bonnetain F, 2010, EUR J CANCER, V46, P2753, DOI 10.1016/j.ejca.2010.07.023; Burris HA, 2013, CANCER-AM CANCER SOC, V119, P1908, DOI 10.1002/cncr.28010; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cortes J, 2013, ANN ONCOL, V24, P2630, DOI 10.1093/annonc/mdt274; Curran D, 1998, STAT MED, V17, P739, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<739::AID-SIM818>3.0.CO;2-M; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Fairclough DL, 2010, DESIGN AND ANALYSIS OF QUALITY OF LIFE STUDIES IN CLINICAL TRIALS, SECOND EDITION, P1, DOI 10.1201/9781420061185; Fairclough DL, 1998, STAT MED, V17, P667, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<667::AID-SIM813>3.3.CO;2-Y; Fairclough DL, 1998, STAT MED, V17, P781, DOI 10.1002/(SICI)1097-0258(19980315/15)17:5/7<781::AID-SIM821>3.3.CO;2-F; Fayers P, 2001, EORTC QLQ C30 SCORIN; Fiteni F, 2014, J VISC SURG, V151, P17, DOI 10.1016/j.jviscsurg.2013.10.001; FLEMING TR, 1982, BIOMETRICS, V38, P143, DOI 10.2307/2530297; Gourgou-Bourgade S, 2013, J CLIN ONCOL, V31, P23, DOI 10.1200/JCO.2012.44.4869; Liao KJ, 2012, STAT MED, V31, P3444, DOI 10.1002/sim.5359; Little R. J. A., 1987, STAT ANAL MISSING DA; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Little RJA, 1996, BIOMETRICS, V52, P98, DOI 10.2307/2533148; Moinpour CM, 2010, J CLIN ONCOL, V28, P3611, DOI 10.1200/JCO.2009.25.8285; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pauler DK, 2003, STAT MED, V22, P795, DOI 10.1002/sim.1397; Ross L, 2004, J CLIN EPIDEMIOL, V57, P1131, DOI 10.1016/j.jclinepi.2004.03.010; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; Sherman DW, 2005, APPL NURS RES, V18, P167, DOI 10.1016/j.apnr.2005.04.003; Team RDC, 2010, R LANG ENV STAT COMP; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Trojano M, 2009, Int MS J, V16, P90; Trouilloud I, 2014, EUR J CANCER, V50, P3116, DOI 10.1016/j.ejca.2014.09.015; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Yang JCH, 2013, J CLIN ONCOL, V31, P3342, DOI 10.1200/JCO.2012.46.1764	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125350	10.1371/journal.pone.0125350	http://dx.doi.org/10.1371/journal.pone.0125350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010884	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900012
J	Cao, SY; Hepowit, N; Maupin-Furlow, JA				Cao, Shiyun; Hepowit, Nathaniel; Maupin-Furlow, Julie A.			Ubiquitin-Like Protein SAMP1 and JAMM/MPN plus Metalloprotease HvJAMM1 Constitute a System for Reversible Regulation of Metabolic Enzyme Activity in Archaea	PLOS ONE			English	Article							MOLYBDOPTERIN SYNTHASE; MOLYBDENUM COFACTOR; BIOSYNTHESIS; PATHWAY	Ubiquitin/ubiquitin-like (Ub/Ubl) proteins are involved in diverse cellular processes by their covalent linkage to protein substrates. Here, we provide evidence for a post-translational modification system that regulates enzyme activity which is composed of an archaeal Ubl protein (SAMP1) and a JAMM/MPN+ metalloprotease (HvJAMM1). Molybdopterin (MPT) synthase activity was found to be inhibited by covalent linkage of SAMP1 to the large subunit (MoaE) of MPT synthase. HvJAMM1 was shown to cleave the covalently linked inactive form of SAMP1-MoaE to the free functional individual SAMP1 and MoaE subunits of MPT synthase, suggesting reactivation of MPT synthase by this metalloprotease. Overall, this study provides new insight into the broad idea that Ub/Ubl modification is a post-translational process that can directly and reversibly regulate the activity of metabolic enzymes. In particular, we show that Ub/Ubl linkages on the active site residues of an enzyme (MPT synthase) can inhibit its catalytic activity and that the enzyme can be reactivated through cleavage by a JAMM/MPN+ metalloprotease.	[Cao, Shiyun; Hepowit, Nathaniel; Maupin-Furlow, Julie A.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Maupin-Furlow, Julie A.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Maupin-Furlow, JA (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	jmaupin@ufl.edu	Maupin-Furlow, Julie/AAW-4035-2020; Hepowit, Nathaniel/GVU-1096-2022; Hepowit, Nathaniel L/J-2282-2016	Maupin-Furlow, Julie/0000-0001-6105-0923; Hepowit, Nathaniel L/0000-0002-7614-2756	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences, Physical Biosciences Program [DE-FG02-05ER15650]; National Institutes of Health [R01 GM57498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057498] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences, Physical Biosciences Program(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge funding awarded to JAM through the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences, Physical Biosciences Program (Grant DE-FG02-05ER15650) for work on ubiquitin-fold protein function in biosynthetic pathways and the National Institutes of Health (Grant R01 GM57498) for work on JAMM/MPN+ metalloproteases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bitan-Banin G, 2003, J BACTERIOL, V185, P772, DOI 10.1128/JB.185.3.772-778.2003; Chavarria NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099104; Hepowit NL, 2012, MOL MICROBIOL, V86, P971, DOI 10.1111/mmi.12038; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Humbard MA, 2010, NATURE, V463, P54, DOI 10.1038/nature08659; Iobbi-Nivol C, 2013, BBA-BIOENERGETICS, V1827, P1086, DOI 10.1016/j.bbabio.2012.11.007; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Maupin-Furlow JA, 2013, TRENDS MICROBIOL, V21, P31, DOI 10.1016/j.tim.2012.09.006; Miranda HV, 2014, MOL CELL PROTEOMICS, V13, P220, DOI 10.1074/mcp.M113.029652; Miranda HV, 2011, P NATL ACAD SCI USA, V108, P4417, DOI 10.1073/pnas.1018151108; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Sapir A, 2014, P NATL ACAD SCI USA, V111, pE3880, DOI 10.1073/pnas.1414748111; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Williams MJ, 2011, J BACTERIOL, V193, P98, DOI 10.1128/JB.00774-10; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200	19	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128399	10.1371/journal.pone.0128399	http://dx.doi.org/10.1371/journal.pone.0128399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010867	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900232
J	Chang, YC; Yao, G; Hu, SC; Wang, JD				Chang, Yu-Chen; Yao, Grace; Hu, Susan C.; Wang, Jung-Der			Depression Affects the Scores of All Facets of the WHOQOL-BREF and May Mediate the Effects of Physical Disability among Community-Dwelling Older Adults	PLOS ONE			English	Article							QUALITY-OF-LIFE; MINI-MENTAL-STATE; BARTHEL INDEX; STROKE REHABILITATION; ALZHEIMERS-DISEASE; PEOPLE; PREVALENCE; TAIWAN; ADAPTATION; VALIDATION	Background Geriatric depression is associated with the overall quality of life (QOL). However, how depressive symptoms affect the different domains and facets of QOL in older adults, and whether depressive symptoms mediate the relationship between physical disability and QOL in older adults are unclear. Methods A total of 490 ambulatory community-dwelling older adults aged 65 years or above were interviewed using the brief version of the World Health Organisation Quality of Life instrument (WHOQOL-BREF), the Modified Barthel Index (MBI), the 15-item Geriatric Depression Scale (GDS-15), and the Mini-Mental State Examination (MMSE). Sequential models for multiple linear regressions were analysed to determine if the MBI, GDS-15 and MMSE scores predict the WHOQOL-BREF scores. The potential mediation effects of depression (as determined by the GDS-15) on the relationship between MBI and WHOQOL-BREF were also analysed. Results The GDS-15 score was predictive of the scores of the four domains and all 26 facets of the WHOQOL-BREF. The significant predictive effects of the MBI score on 15 of the 26 facets of the WHOQOL-BREF were reduced to three after the adjustment for the GDS-15 score. Depression (as assessed by the GDS-15) is a mediator of the relationship between MBI and the physical, psychological and environmental domains of the WHOQOL-BREF. Conclusions Depression (assessed by the GDS-15) may affect the scores of every domain and all facets of the WHOQOL-BREF in the elderly. Furthermore, it may mediate the relationship between the MBI and on QOL scores. We recommend taking depressive symptoms into consideration when measuring community-dwelling older adults' QOL and providing active ageing programs.	[Chang, Yu-Chen] Chia Yi Christian Hosp, Dept Community Hlth, Chiayi, Taiwan; [Chang, Yu-Chen] Chia Yi Christian Hosp, Div Geriatr, Chiayi, Taiwan; [Yao, Grace] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Hu, Susan C.; Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Dept Internal Med, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Dept Occupt & Environm Med, Tainan 70101, Taiwan	National Taiwan University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Wang, JD (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan.	jdwang121@gmail.com	Hu, Susan C./AFU-5419-2022	Hu, Susan C./0000-0003-2437-5918	National Science Council [NSC 101-3114-Y-006-001]; Chia-Yi Christian Hospital [R102-6]	National Science Council(Ministry of Science and Technology, Taiwan); Chia-Yi Christian Hospital	JDW received the fund from National Science Council (NSC 101-3114-Y-006-001), and YCC received the fund from Chia-Yi Christian Hospital (R102-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslantas D, 2009, ARCH GERONTOL GERIAT, V48, P127, DOI 10.1016/j.archger.2007.11.005; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Berlim MT, 2007, PSYCHIAT RES, V153, P253, DOI 10.1016/j.psychres.2006.07.006; Black SA, 1999, J CLIN EPIDEMIOL, V52, P1095, DOI 10.1016/S0895-4356(99)00100-6; Bowling A, 2007, AGE AGEING, V36, P310, DOI 10.1093/ageing/afm023; Chan ACM, 1996, J AGING HEALTH, V8, P238, DOI 10.1177/089826439600800205; Chan SWC, 2009, INT PSYCHOGERIATR, V21, P1171, DOI 10.1017/S1041610209990950; Chong MY, 2001, BRIT J PSYCHIAT, V178, P29, DOI 10.1192/bjp.178.1.29; Chou KL, 2005, INT J GERIATR PSYCH, V20, P41, DOI 10.1002/gps.1246; Fang CT, 2002, QUAL LIFE RES, V11, P753, DOI 10.1023/A:1020870402019; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111498; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P145; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hwang HF, 2003, AGE AGEING, V32, P593, DOI 10.1093/ageing/afg102; IsHak WW, 2011, HARVARD REV PSYCHIAT, V19, P229, DOI 10.3109/10673229.2011.614099; Jang Y, 2004, ARCH PHYS MED REHAB, V85, P1890, DOI 10.1016/j.apmr.2004.02.032; Kucukdeveci AA, 2000, SCAND J REHABIL MED, V32, P87; Lu IC, 2011, QUAL LIFE RES, V20, P1469, DOI 10.1007/s11136-011-9889-4; MAHONEY F I, 1965, Md State Med J, V14, P61; Marc LG, 2008, AM J GERIAT PSYCHIAT, V16, P914, DOI 10.1097/JGP.0b013e318186bd67; Netuveli G, 2006, J EPIDEMIOL COMMUN H, V60, P357, DOI 10.1136/jech.2005.040071; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rodda J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5219; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Sheikh JI, 1986, GERIATRIC DEPRESSION; Spering CC, 2012, J GERONTOL A-BIOL, V67, P890, DOI 10.1093/gerona/gls006; Strine TW, 2009, J NERV MENT DIS, V197, P61, DOI 10.1097/NMD.0b013e3181924ad8; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Ward A, 2002, INT PSYCHOGERIATR, V14, P249, DOI 10.1017/S1041610202008451; Webb E, 2011, J EPIDEMIOL COMMUN H, V65, P542, DOI 10.1136/jech.2009.101758; World Health Organization (WHO), 2014, IMPROVING HLTH WORKP; Yao G, 2007, J FORMOS MED ASSOC, V106, P592, DOI 10.1016/S0929-6646(07)60012-6	36	34	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128356	10.1371/journal.pone.0128356	http://dx.doi.org/10.1371/journal.pone.0128356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010571	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900229
J	de Langavant, LC; Sudraud, S; Verny, C; Krystkowiak, P; Simonin, C; Damier, P; Demonet, JF; Supiot, F; Rialland, A; Schmitz, D; Maison, P; Youssov, K; Bachoud-Levi, AC				de Langavant, Laurent Cleret; Sudraud, Sophie; Verny, Christophe; Krystkowiak, Pierre; Simonin, Clemence; Damier, Philippe; Demonet, Jean-Francois; Supiot, Frederic; Rialland, Amandine; Schmitz, David; Maison, Patrick; Youssov, Katia; Bachoud-Levi, Anne-Catherine			Longitudinal Study of Informed Consent in Innovative Therapy Research: Experience and Provisional Recommendations from a Multicenter Trial of Intracerebral Grafting	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; CLINICAL-TRIALS; PARKINSONS-DISEASE; TRANSPLANTATION; PARTICIPANTS; MISCONCEPTION; INDIVIDUALS; INFORMATION	Background There is an urgent need to assess and improve the consent process in clinical trials of innovative therapies for neurodegenerative disorders. Methods We performed a longitudinal study of the consent of Huntington's disease patients during the Multicenter Fetal Cell Intracerebral Grafting Trial in Huntington's Disease (MIG-HD) in France and Belgium. Patients and their proxies completed a consent questionnaire at inclusion, before signing the consent form and after one year of follow-up, before randomization and transplantation. The questionnaire explored understanding of the protocol, satisfaction with the information delivered, reasons for participating in the trial and expectations regarding the transplant. Forty-six Huntington's disease patients and 27 proxies completed the questionnaire at inclusion, and 27 Huntington's disease patients and 16 proxies one year later. Results The comprehension score was high and similar for Huntington's disease patients and proxies at inclusion (72.6% vs 77.8%; P > 0.1) but only decreased in HD patients after one year. The information satisfaction score was high (73.5% vs 66.5%; P > 0.1) and correlated with understanding in both patients and proxies. The motivation and expectation profiles were similar in patients and proxies and remained unchanged after one year. Conclusions Cognitively impaired patients with Huntington's disease were capable of consenting to participation in this trial. This consent procedure has presumably strengthened their understanding and should be proposed before signing the consent form in future gene or cell therapy trials for neurodegenerative disorders. Because of the potential cognitive decline, proxies should be designated as provisional surrogate decision-makers, even in competent patients.	[de Langavant, Laurent Cleret; Sudraud, Sophie; Youssov, Katia; Bachoud-Levi, Anne-Catherine] Hop Henri Mondor, AP HP, Ctr Reference Maladie Huntington, Neurol Cognit, F-94010 Creteil, France; [de Langavant, Laurent Cleret; Sudraud, Sophie; Youssov, Katia; Bachoud-Levi, Anne-Catherine] Univ Paris Est, Fac Med, Creteil, France; [de Langavant, Laurent Cleret; Sudraud, Sophie; Youssov, Katia; Bachoud-Levi, Anne-Catherine] Hop Henri Mondor, INSERM, U955, Equipe 01,Neuropsychol Intervent, F-94010 Creteil, France; [de Langavant, Laurent Cleret; Youssov, Katia; Bachoud-Levi, Anne-Catherine] PSL Res Univ, Ecole Normale Super, Dept Etudes Cognit, Paris, France; [Verny, Christophe] CHU Angers, Ctr Reference Malad Neurogenet, Serv Neurol, Angers, France; [Verny, Christophe] CHU Angers, INSERM U1083, UMR CNRS 6214, Angers, France; [Krystkowiak, Pierre] CHU Amiens, Serv Neurol, Amiens, France; [Krystkowiak, Pierre] Univ Picardie Jules Verne, Lab Neurosci Fonct & Pathol, EA 4559, Amiens, France; [Simonin, Clemence] Univ Lille Nord France, Lille, France; [Simonin, Clemence] INSERM, UMR837, IRCL, F-59045 Lille, France; [Simonin, Clemence] CHRU Lille, Dept Neurol & Mouvements Anormaux, F-59037 Lille, France; [Damier, Philippe] CHU Nantes, Serv Neurol, F-44035 Nantes 01, France; [Damier, Philippe] Univ Nantes, UFR Med, Nantes, France; [Demonet, Jean-Francois] Lausanne Univ Hosp CHUV, Clin Neurosci Dept, Leenaards Memory Ctr, Lausanne, Switzerland; [Demonet, Jean-Francois] Univ Toulouse, INSERM, U825, Toulouse, France; [Supiot, Frederic] Clin Univ Bruxelles, Hop Erasme, Brussels, Belgium; [Rialland, Amandine; Schmitz, David; Maison, Patrick] Hop Henri Mondor, AP HP, Unite Rech Clin, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes; Nantes Universite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Bachoud-Levi, AC (corresponding author), Hop Henri Mondor, AP HP, Ctr Reference Maladie Huntington, Neurol Cognit, F-94010 Creteil, France.	bachoud@gmail.com	Damier, Philippe/T-7829-2019; Bachoud-Lévi, Anne-Catherine/GYU-8680-2022	Bachoud-Lévi, Anne-Catherine/0000-0003-3000-2210; Demonet, Jean-Francois/0000-0003-0100-6175; Cleret de Langavant, Laurent/0000-0001-6551-4641; Simonin, Clemence/0000-0002-2282-4372	Programme Hospitalier de Recherche Clinique (Ministere de la Sante de France) [AOM00139, AOM 04021]; Assistance Publique - Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); Association Francaise de lutte contre les Myopathies in Belgium; AP-HP/CEA interface contract; NeuroStemCell Consortium (European Community) [222943]; NeurATRIS project (European Advanced Translational Research Infrastructure in Neurosciences); Agence Nationale pour la Recherche [ANR-10-LABX-0087 IEC, ANR-10-IDEX-0001-02 PSL*]	Programme Hospitalier de Recherche Clinique (Ministere de la Sante de France); Assistance Publique - Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement); Association Francaise de lutte contre les Myopathies in Belgium; AP-HP/CEA interface contract; NeuroStemCell Consortium (European Community); NeurATRIS project (European Advanced Translational Research Infrastructure in Neurosciences); Agence Nationale pour la Recherche(French National Research Agency (ANR))	The MIG-HD trial is funded by two grants (AOM00139 and AOM 04021) from Programme Hospitalier de Recherche Clinique (Ministere de la Sante de France), and is sponsored by Assistance Publique - Hopitaux de Paris (Departement de la Recherche Clinique et du Developpement) and by Association Francaise de lutte contre les Myopathies in Belgium. LCL was supported by an AP-HP/CEA interface contract. SS was supported by the NeuroStemCell Consortium (European Community's Seventh Framework Program grant agreement no. 222943). Additional support was provided through the NeurATRIS project (European Advanced Translational Research Infrastructure in Neurosciences) and from Agence Nationale pour la Recherche ANR-10-LABX-0087 IEC and ANR-10-IDEX-0001-02 PSL* grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1976, GERIATRIC PSYCHIAT; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; Bertoli AM, 2007, CONTEMP CLIN TRIALS, V28, P730, DOI 10.1016/j.cct.2007.04.005; Bosk CL, 2002, MED CARE, V40, P64, DOI 10.1097/01.MLR.0000023957.23565.E9; Buckles VD, 2003, NEUROLOGY, V61, P1662, DOI 10.1212/01.WNL.0000098933.34804.FC; Daley GQ, CELL STEM CELL, V10, P740; Ford ME, 2008, J MED ETHICS, V34, P41, DOI 10.1136/jme.2006.018192; Fortun P, 2008, QJM-INT J MED, V101, P625, DOI 10.1093/qjmed/hcn067; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freeman TB, 2011, EXP NEUROL, V227, P1, DOI 10.1016/j.expneurol.2010.08.031; Helgesson G, 2005, J MED ETHICS, V31, P670, DOI 10.1136/jme.2004.009274; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Hoth KF, 2007, J CLIN EXP NEUROPSYC, V29, P365, DOI 10.1080/13803390600718958; Hougham Gavin W, 2003, IRB, VSuppl 25, pS26, DOI 10.2307/3564119; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Karlawish J, 2013, NEUROLOGY, V81, P801, DOI 10.1212/WNL.0b013e3182a05ba5; Karlawish JHT, 2005, NEUROLOGY, V64, P1514, DOI 10.1212/01.WNL.0000160000.01742.9D; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kim SYH, 2012, MOVEMENT DISORD, V27, P506, DOI 10.1002/mds.24940; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Kodish E, 2004, JAMA-J AM MED ASSOC, V291, P470, DOI 10.1001/jama.291.4.470; Krystkowiak P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000166; Kwon BK, 2012, J NEUROTRAUM, V29, P2727, DOI 10.1089/neu.2012.2550; Lidz CW, 2004, SOC SCI MED, V58, P1689, DOI 10.1016/S0277-9536(03)00338-1; Moodley K, 2005, J MED ETHICS, V31, P727, DOI 10.1136/jme.2004.009910; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Ravina B, 2010, PARKINSONISM RELAT D, V16, P60, DOI 10.1016/j.parkreldis.2009.05.007; Schaeffer MH, 1996, AM J MED, V100, P261, DOI 10.1016/S0002-9343(97)89483-1; SHOULSON I, 1981, NEUROLOGY, V31, P1333, DOI 10.1212/WNL.31.10.1333; Sugarman J, 2007, PROG CARDIOVASC DIS, V50, P1, DOI 10.1016/j.pcad.2007.02.003	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128209	10.1371/journal.pone.0128209	http://dx.doi.org/10.1371/journal.pone.0128209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010368	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900206
J	Kreinin, A; Lisson, S; Nesher, E; Schneider, J; Bergman, J; Farhat, K; Farah, J; Lejbkowicz, F; Yadid, G; Raskin, L; Koman, I; Pinhasov, A				Kreinin, Anatoly; Lisson, Serah; Nesher, Elimelech; Schneider, Jenny; Bergman, Josef; Farhat, Kamal; Farah, Joseph; Lejbkowicz, Flavio; Yadid, Gal; Raskin, Leon; Koman, Igor; Pinhasov, Albert			Blood BDNF Level Is Gender Specific in Severe Depression	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; VAL66MET POLYMORPHISM; MAJOR DEPRESSION; MET ALLELE; SERUM; DISORDER; GENE; ASSOCIATION; FLUOXETINE; NEUROPLASTICITY	Though the role of brain derived neurotrophic factor (BDNF) as a marker for major depressive disorder (MDD) and antidepressant efficacy has been widely studied, the role of BDNF in distinct groups of patients remains unclear. We evaluated the diagnostic value of BDNF as a marker of disease severity measured by HAM-D scores and antidepressants efficacy among MDD patients. Fifty-one patients who met DSM-IV criteria for MDD and were prescribed antidepressants and 38 controls participated in this study. BDNF in serum was measured at baseline, 1st, 2nd and 8th treatment weeks. Depression severity was evaluated using the Hamilton Rating Scale for Depression (HAM-D). BDNF polymorphism rs6265 (val66met) was genotyped. We found a positive correlation between blood BDNF levels and severity of depression only among untreated women with severe MDD (HAM-D>24). Serum BDNF levels were lower in untreated MDD patients compared to control group. Anti-depressants increased serum BDNF levels and reduced between-group differences after two weeks of treatment. No correlations were observed between BDNF polymorphism, depression severity, duration of illness, age and BDNF serum levels. Further supporting the role of BDNF in the pathology and treatment of MDD, we suggest that it should not be used as a universal biomarker for diagnosis of MDD in the general population. However, it has diagnostic value for the assessment of disease progression and treatment efficacy in individual patients.	[Kreinin, Anatoly; Bergman, Josef] Technion Israel Inst Technol, Maale HaCarmel Mental Hlth Ctr, Rappaport Fac Med, Haifa, Israel; [Kreinin, Anatoly; Bergman, Josef] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Lisson, Serah; Nesher, Elimelech; Schneider, Jenny; Koman, Igor; Pinhasov, Albert] Ariel Univ, Dept Mol Biol, Ariel, Israel; [Lisson, Serah; Yadid, Gal] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Farhat, Kamal; Farah, Joseph] Bar Ilan Univ, Fac Med, Nazareth Hosp, EMMS, Nazareth, Israel; [Lejbkowicz, Flavio] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel; [Lejbkowicz, Flavio] Natl Canc Control Ctr, Clalit Hlth Serv, Haifa, Israel; [Raskin, Leon] Vanderbilt Univ, Div Epidemiol, Dept Med, Nashville, TN USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Ariel University; Bar Ilan University; Bar Ilan University; Clalit Health Services; Carmel Medical Center; Clalit Health Services; Vanderbilt University	Pinhasov, A (corresponding author), Ariel Univ, Dept Mol Biol, Ariel, Israel.	albertpi@ariel.ac.il	Pinhasov, Albert/X-5304-2019; Raskin, Leon/P-5765-2015; Schneider, Jenny/I-9497-2019; Kreinin, Anatoly/AAN-8803-2021	Pinhasov, Albert/0000-0001-8116-4565; Raskin, Leon/0000-0003-1195-7214; Schneider, Jenny/0000-0001-7315-7269; Nesher, Elimelech/0000-0002-8326-5535				American Psychiatric Association, 2000, DIAGNOSTIC CRITERIA, Vxii; Aydemir C, 2006, PROG NEURO-PSYCHOPH, V30, P1256, DOI 10.1016/j.pnpbp.2006.03.025; Aydemir O, 2005, PROG NEURO-PSYCHOPH, V29, P261, DOI 10.1016/j.pnpbp.2004.11.009; Basterzi AD, 2009, PROG NEURO-PSYCHOPH, V33, P281, DOI 10.1016/j.pnpbp.2008.11.016; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Benton CS, 2012, PSYCHOPHARMACOLOGY, V221, P297, DOI 10.1007/s00213-011-2574-z; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Bus BAA, 2012, NEUROPSYCHOBIOLOGY, V65, P183, DOI 10.1159/000336997; Cardoso TD, 2014, NEUROCHEM RES, V39, P1571, DOI 10.1007/s11064-014-1349-4; Cattaneo A, 2010, INT J NEUROPSYCHOPH, V13, P103, DOI 10.1017/S1461145709990812; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Conti AC, 2002, J NEUROSCI, V22, P3262, DOI 10.1523/JNEUROSCI.22-08-03262.2002; Culpepper Larry, 2011, J Clin Psychiatry, V72, pe19, DOI 10.4088/JCP.10126tx1c; Cusin C, 2010, CURR CLIN PSYCHIAT, P7, DOI 10.1007/978-1-59745-387-5_2; Czira ME, 2012, AGE, V34, P1529, DOI 10.1007/s11357-011-9313-6; Dell'Osso L, 2010, NEUROPSYCHOBIOLOGY, V62, P207, DOI 10.1159/000319946; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Gonul AS, 2005, EUR ARCH PSY CLIN N, V255, P381, DOI 10.1007/s00406-005-0578-6; Gorski JA, 2003, J NEUROSCI, V23, P6856; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Jevtovic S, 2011, PSYCHIAT DANUB, V23, P363; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Karlovic D, 2013, J PSYCHIATR RES, V47, P162, DOI 10.1016/j.jpsychires.2012.09.017; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Ladea M, 2013, PSYCHIAT DANUB, V25, P128; Lang UE, 2009, MOL PSYCHIATR, V14, P120, DOI 10.1038/mp.2008.80; Lee HY, 2008, NEUROPSYCHOBIOLOGY, V57, P194, DOI 10.1159/000149817; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lim JY, 2008, J NEUROSCI RES, V86, P2168, DOI 10.1002/jnr.21669; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Maier W, 1999, J AFFECT DISORDERS, V53, P241, DOI 10.1016/S0165-0327(98)00131-1; Moner R, 2007, WORLD J BIOL PSYCHIA, V8, P141, DOI 10.1080/15622970701263303; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; Oswald P, 2005, EUR NEUROPSYCHOPHARM, V15, P491, DOI 10.1016/j.euroneuro.2005.01.001; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Park YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091061; Reichenstein M, 2008, J MOL NEUROSCI, V36, P330, DOI 10.1007/s12031-008-9116-0; Ribeiro L, 2007, NEUROREPORT, V18, P1291, DOI 10.1097/WNR.0b013e328273bcb0; Ristevska-Dimitrovska G, 2013, PSYCHIAT DANUB, V25, P123; Saveanu RV, 2012, PSYCHIAT CLIN N AM, V35, P51, DOI 10.1016/j.psc.2011.12.001; Schumacher J, 2005, BIOL PSYCHIAT, V58, P307, DOI 10.1016/j.biopsych.2005.04.006; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Studd J, 2004, CLIMACTERIC, V7, P338, DOI 10.1080/13697130400012262; Subbarao A, 2008, J ABNORM CHILD PSYCH, V36, P433, DOI 10.1007/s10802-007-9189-1; Surtees PG, 2007, J PSYCHIATR RES, V41, P404, DOI 10.1016/j.jpsychires.2006.01.004; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Taylor WD, 2007, AM J GERIAT PSYCHIAT, V15, P850, DOI 10.1097/JGP.0b013e318050c9d5; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Wolkowitz OM, 2011, PROG NEURO-PSYCHOPH, V35, P1623, DOI 10.1016/j.pnpbp.2011.06.013; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Zou YF, 2010, NEUROPSYCHOBIOLOGY, V61, P71, DOI 10.1159/000265132	64	53	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127643	10.1371/journal.pone.0127643	http://dx.doi.org/10.1371/journal.pone.0127643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010085	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900123
J	Kunnimalaiyaan, S; Sokolowski, KM; Balamurugan, M; Gamblin, TC; Kunnimalaiyaan, M				Kunnimalaiyaan, Selvi; Sokolowski, Kevin M.; Balamurugan, Mariappan; Gamblin, T. Clark; Kunnimalaiyaan, Muthusamy			Xanthohumol Inhibits Notch Signaling and Induces Apoptosis in Hepatocellular Carcinoma	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITORS; HUMULUS-LUPULUS L.; COLON-CANCER CELLS; PRENYLATED CHALCONE; EXPRESSION; PATHWAY; HOPS; SAFETY; PROLIFERATION; ACTIVATION	Despite improvement in therapeutic strategies, median survival in advanced hepatocellular carcinoma (HCC) remains less than one year. Therefore, molecularly targeted compounds with less toxic profiles are needed. Xanthohumol (XN), a prenylated chalcone has been shown to have anti-proliferative effects in various cancers types in vitro. XN treatment in healthy mice and humans yielded favorable pharmacokinetics and bioavailability. Therefore, we determined to study the effects of XN and understand the mechanism of its action in HCC. The effects of XN on a panel of HCC cell lines were assessed for cell viability, colony forming ability, and cellular proliferation. Cell lysates were analyzed for pro-apoptotic (c-PARP and cleaved caspase-3) and anti-apoptotic markers (survivin, cyclin D1, and Mcl-1). XN concentrations of 5 mu M and above significantly reduced the cell viability, colony forming ability and also confluency of all four HCC cell lines studied. Furthermore, growth suppression due to apoptosis was evidenced by increased expression of pro-apoptotic and reduced expression of anti-apoptotic proteins. Importantly, XN treatment inhibited the Notch signaling pathway as evidenced by the decrease in the expression of Notch1 and HES-1 proteins. Ectopic expression of Notch1 in HCC cells reverses the anti-proliferative effect of XN as evidenced by reduced growth suppression compared to control. Taken together these results suggested that XN mediated growth suppression is appeared to be mediated by the inhibition of the Notch signaling pathway. Therefore, our findings warrants further studies on XN as a potential agent for the treatment for HCC.	[Kunnimalaiyaan, Muthusamy] Med Coll Wisconsin, Div Surg Oncol, Dept Surg, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Kunnimalaiyaan, M (corresponding author), Med Coll Wisconsin, Div Surg Oncol, Dept Surg, Milwaukee, WI 53226 USA.	mkunnima@mcw.edu		Kunnimalaiyaan, Muthusamy/0000-0003-3712-7497	Research Affairs Committee Award-MCW; American Cancer Society [86-004-26]; MCW Cancer Center grant; Medical College of Wisconsin Dean's Program Development; Froedtert Hospital Foundation	Research Affairs Committee Award-MCW; American Cancer Society(American Cancer Society); MCW Cancer Center grant; Medical College of Wisconsin Dean's Program Development; Froedtert Hospital Foundation	This study was supported in part by the grants from Research Affairs Committee Award-MCW, Institutional Research Grant # 86-004-26 from the American Cancer Society and MCW Cancer Center grant, The Medical College of Wisconsin Dean's Program Development, and Froedtert Hospital Foundation (M.K and T.C.G)	Ahn S, 2013, HEPATOB PANCREAT DIS, V12, P286, DOI 10.1016/S1499-3872(13)60046-6; Carter YM, 2014, CANCER BIOL THER, V15, P510, DOI 10.4161/cbt.28015; Chen YQ, 2011, CANCER BIOL THER, V11, P14, DOI 10.4161/cbt.11.1.13730; Cook MR, 2010, AM J SURG, V199, P315, DOI 10.1016/j.amjsurg.2009.08.034; Deeb D, 2010, ANTICANCER RES, V30, P3333; Delmulle L, 2008, PHYTOTHER RES, V22, P197, DOI 10.1002/ptr.2286; Dorn C, 2010, INT J ONCOL, V36, P435, DOI 10.3892/ijo_00000517; Drenzek JG, 2011, GYNECOL ONCOL, V122, P396, DOI 10.1016/j.ygyno.2011.04.027; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Gao J, 2008, DIGEST LIVER DIS, V40, P114, DOI 10.1016/j.dld.2007.08.001; Gerhauser C, 2002, MOL CANCER THER, V1, P959; Hanske L, 2005, MOL NUTR FOOD RES, V49, P868, DOI 10.1002/mnfr.200500048; Hussong R, 2005, MOL NUTR FOOD RES, V49, P861, DOI 10.1002/mnfr.200500089; Kang Y, 2013, BBA-GEN SUBJECTS, V1830, P2638, DOI 10.1016/j.bbagen.2012.12.005; Kim SY, 2013, CHEM-BIOL INTERACT, V203, P565, DOI 10.1016/j.cbi.2013.03.012; Legette L, 2014, MOL NUTR FOOD RES, V58, P248, DOI 10.1002/mnfr.201300333; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Lust S, 2005, MOL NUTR FOOD RES, V49, P844, DOI 10.1002/mnfr.200500045; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Monteiro R, 2008, J CELL BIOCHEM, V104, P1699, DOI 10.1002/jcb.21738; Naganuma S, 2012, AM J CANCER RES, V2, P459; Pan L, 2005, MOL NUTR FOOD RES, V49, P837, DOI 10.1002/mnfr.200500065; Shih IM, 2007, CANCER RES, V67, P1879, DOI 10.1158/0008-5472.CAN-06-3958; Sun Q, 2014, INT J ONCOL, V45, P1638, DOI 10.3892/ijo.2014.2537; Sun Q, 2014, ONCOL REP, V31, P933, DOI 10.3892/or.2013.2917; Vanhoecke B, 2005, INT J CANCER, V117, P889, DOI 10.1002/ijc.21249; Vanhoecke BW, 2005, IN VIVO, V19, P103; Vene R, 2012, MOL MED, V18, P1292, DOI 10.2119/molmed.2012.00174; Wang XQ, 2012, INT J CANCER, V131, pE163, DOI 10.1002/ijc.27336; Worns MA, 2014, INTERNIST, V55, P23, DOI 10.1007/s00108-013-3318-4; Worns MA, 2013, DIGEST LIVER DIS, V45, P408, DOI 10.1016/j.dld.2012.10.010; Worns MA, 2010, EXPERT OPIN INV DRUG, V19, P615, DOI 10.1517/13543781003767418; Worns MA, 2009, J CLIN GASTROENTEROL, V43, P489, DOI 10.1097/MCG.0b013e31818ddfc6; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yabuuchi S, 2013, CANCER LETT, V335, P41, DOI 10.1016/j.canlet.2013.01.054; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang MB, 2013, INT IMMUNOPHARMACOL, V16, P466, DOI 10.1016/j.intimp.2013.04.029; Zajc I, 2012, PHYTOTHER RES, V26, P1709, DOI 10.1002/ptr.4636; Zhou L, 2013, DIGEST DIS SCI, V58, P1016, DOI 10.1007/s10620-012-2434-7; Zhou L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057382, 10.1371/journal.pone.0073724]	41	44	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127464	10.1371/journal.pone.0127464	http://dx.doi.org/10.1371/journal.pone.0127464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011160	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900096
J	Kuznik, A; Muhumuza, C; Komakech, H; Marques, EMR; Lamorde, M				Kuznik, Andreas; Muhumuza, Christine; Komakech, Henry; Marques, Elsa M. R.; Lamorde, Mohammed			Antenatal Syphilis Screening Using Point-Of-Care Testing in Low- and Middle-Income Countries in Asia and Latin America: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HIV; PREGNANCY	Background Untreated syphilis in pregnancy is associated with adverse clinical outcomes to the infant. In low- and middle-income countries in Asia and Latin America, 20%-30% of women are not tested for syphilis during pregnancy. We evaluated the cost-effectiveness of increasing the coverage for antenatal syphilis screening in 11 Asian and 20 Latin American countries, using a point-of-care immunochromatographic strip (ICS) test. Methods The decision analytical cost-effectiveness models reported incremental costs per disability-adjusted life years (DALYs) averted from the perspectives of the national health care payer. Clinical outcomes were stillbirths, neonatal deaths, and congenital syphilis. DALYs were computed using WHO disability weights. Costs included the ICS test, three injections of benzathine penicillin, and nurse wages. Country-specific inputs included the antenatal prevalence of syphilis and the proportion of women in the antenatal care setting that are screened for syphilis infection as reported in the 2014 WHO baseline report on global sexually transmitted infection surveillance. Country-specific data on the annual number of live births, proportion of women with at least one antenatal care visit, and per capita gross national income were also included in the model. Results The incremental cost/DALY averted of syphilis screening is US$53 (range: US$10-US$332; Prob<1*per capita GDP=99.71%) in Asia and US$ 60 (range: US$5-US$225; Prob<1*per capita GDP=99.77%) in Latin America. Universal screening may reduce the annual number of stillbirths by 20,344 and 4,270, neonatal deaths by 8,201 and 1,721, cases of congenital syphilis by 10,952 and 2,298, and avert 925,039 and 197,454 DALYs in the aggregate Asian and Latin American panel, respectively. Conclusion Antenatal syphilis screening is highly cost-effective in all the 11 Asian and 20 Latin American countries assessed. Our findings support the decision to expand syphilis screening in countries with currently low screening rates or continue national syphilis screening programs in countries with high rates.	[Kuznik, Andreas; Lamorde, Mohammed] Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Kuznik, Andreas] Celgene Corp, Summit, NJ USA; [Muhumuza, Christine; Komakech, Henry] Makerere Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Marques, Elsa M. R.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	Bristol-Myers Squibb; Celgene Corporation; University of Bristol	Lamorde, M (corresponding author), Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	mlamorde@idi.co.ug		Marques, Elsa/0000-0003-1360-5677; Lamorde, Mohammed/0000-0003-2218-6822; Komakech, Henry/0000-0001-7137-5940; Kuznik, Andreas/0000-0002-8634-8360	European and Developing Countries Clinical Trials Partnership [TA_11_40200_047]; Celgene Corporation	European and Developing Countries Clinical Trials Partnership; Celgene Corporation(Bristol-Myers SquibbCelgene Corporation)	ML is supported through a grant awarded by the European and Developing Countries Clinical Trials Partnership (TA_11_40200_047). Celgene Corporation provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P142, DOI 10.3402/gha.v6i0.18619; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Futures Group, 2002, MAT NEON PROGR EFF I; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Indian Council of Medical Research, 2010, ICMR NURS STAFF CADR; International Labour Organization, LABORSTA LAB STAT DA; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Kuznik A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001545; Montoya PJ, 2006, B WORLD HEALTH ORGAN, V84, P97, DOI 10.2471/BLT.04.018663; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; National Bureau of Economics Research, OCC WAG AR WORLD OWW; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Owusu-Edusei K, 2014, SEX TRANSM DIS, V41, P103, DOI 10.1097/OLQ.0000000000000085; Pai NP, 2012, INT J STD AIDS, V23, P319, DOI 10.1258/ijsa.2011.011139; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; Strasser S, 2012, JAIDS-J ACQ IMM DEF, V61, pE40, DOI 10.1097/QAI.0b013e318267bc94; Tang W. M., 2012, INT J NURS SCI, V2, P29, DOI [DOI 10.5923/J.NURSING.20120204.01, 10.5923/j.nursing.20120204.01]; The Asia Pacific Prevention of Parent to Child Transmission Task Force, VIETN COUNTR FACT SH; Dinh TH, 2013, SEX TRANSM DIS, V40, P846, DOI 10.1097/OLQ.0000000000000042; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; United Nations Children's Fund, 2012, STAT MONT; World Bank, 2010, 58018LA WORLD BANK; World Health Organization, 2019, CHOOSING INT AR COST; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2014, GLOB GUID CRIT PROC; World Health Organization, 2014, BAS REP GLOB SEX TRA	30	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127379	10.1371/journal.pone.0127379	http://dx.doi.org/10.1371/journal.pone.0127379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010366	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900086
J	Lei, XG; Li, H; Huang, BH; Rizak, J; Li, L; Xu, LQ; Liu, L; Wu, J; Lu, LB; Wang, ZB; Hu, YZ; Le, WD; Deng, XL; Li, JL; Yao, YG; Xu, L; Hu, XT; Zhang, BR				Lei, Xiaoguang; Li, Hao; Huang, Baihui; Rizak, Joshua; Li, Ling; Xu, Liqi; Liu, Li; Wu, Jing; Lu, Longbao; Wang, Zhengbo; Hu, Yingzhou; Le, Weidong; Deng, Xingli; Li, Jiali; Yao, Yonggang; Xu, Lin; Hu, Xintian; Zhang, Baorong			1-Methyl-4-Phenylpyridinium Stereotactic Infusion Completely and Specifically Ablated the Nigrostriatal Dopaminergic Pathway in Rhesus Macaque	PLOS ONE			English	Article							MPTP-TREATED MONKEYS; PARKINSONS-DISEASE; ANIMAL-MODELS; ESSENTIAL TREMOR; BRAIN; MECHANISMS; NEURONS; 6-HYDROXYDOPAMINE; PATHOPHYSIOLOGY; COMMUNICATION	Introduction Complete and specific ablation of a single dopaminergic (DA) pathway is a critical step to distinguish the roles of DA pathways in vivo. However, this kind of technique has not been reported in non-human primates. This study aimed to establish a lesioning method with a complete and specific ablation. Method A carefully designed infusion route based on a MRI stereotactic technique was developed to deliver the highly selective dopaminergic toxin 1-methyl-4-phenylpyridinium (MPP+) unilaterally into multiple sites of compact part of substantia nigra (SNc) and striatum in monkeys. The nigrostriatal DA pathway was selected because lesioning of this pathway may induce symptoms that are suitable for evaluation. The pathological, behavioral, neuropharmacological, and clinical laboratorial data were collected to evaluate the lesioning effects. Result Pathological examination revealed a complete ablation of tyrosine hydroxylase positive (TH+) neurons in the SNc, while preserving intact TH+ neurons in the ventral tegmental area (VTA) nearby. TH+ projections in the striatum were also unilaterally lost. The monkeys displayed stable (>28 weeks) rotations and symptoms which were expected with loss of DA neurons in the SNc, with rest tremor being an exception. No item implied the presence of a severe side effect caused by the operation or the intracerebral MPP+ infusion. The results suggested that rest tremor may not directly rely on the nigrostriatal pathway. Conclusion Taken together, in addition to providing a specific nigrostriatal DA lesioned model, this method, combined with brain stimulation or other techniques, can be applied as a powerful tool for the complete lesion of any desired DA pathway in order to study its specific functions in the brain.	[Lei, Xiaoguang; Zhang, Baorong] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou 310027, Zhejiang, Peoples R China; [Li, Hao; Huang, Baihui; Rizak, Joshua; Wu, Jing; Wang, Zhengbo; Hu, Yingzhou; Li, Jiali; Yao, Yonggang; Xu, Lin; Hu, Xintian] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Li, Hao; Huang, Baihui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Ling; Xu, Liqi; Liu, Li] Kunming Gen Hosp PLA, Dept Med Imaging, Kunming, Yunnan, Peoples R China; [Lu, Longbao] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Le, Weidong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Deng, Xingli] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg, Kunming, Yunnan, Peoples R China; [Yao, Yonggang; Xu, Lin; Hu, Xintian] Chinese Acad Sci, Ctr Excellence Brain Sci, Shanghai, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kunming General Hospital; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Kunming Medical University; Chinese Academy of Sciences	Zhang, BR (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou 310027, Zhejiang, Peoples R China.	xthu@mail.kiz.ac.cn; brzhang@zju.edu.cn	Xu, Lin/T-5531-2017; Li, Hao/GPS-9834-2022; Yao, Yong-Gang/AAH-2303-2021; li, Jiali/HGF-2395-2022	Xu, Lin/0000-0002-2710-3507; Yao, Yong-Gang/0000-0002-2955-0693; li, Jiali/0000-0001-6202-7741; wang, zhengbo/0000-0002-4717-5137; Lei, Xiaoguang/0000-0002-1106-6465; Li, Jiali/0000-0002-0039-3671	CAS [XDB02020000]; National Program on Key Basic Research Project (973 Programs) [2015CB755605, 2012CB825503, 2012CBA01304]; Chinese Academy of Sciences [KZCC-EW-103-2]; National Natural Science Foundation of China [91332120, 31271167, 81271495, 81471312, 81271248]; Yunnan Provincial Project to Attract One-hundred Exceptional Talents from Overseas; CAS; Zhejiang Province Department of Science and Technology [2011C14026]	CAS(Chinese Academy of Sciences); National Program on Key Basic Research Project (973 Programs)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Project to Attract One-hundred Exceptional Talents from Overseas; CAS(Chinese Academy of Sciences); Zhejiang Province Department of Science and Technology	This work was supported by grants from the Strategic Priority Research Program of CAS (XDB02020000), National Program on Key Basic Research Project (973 Programs 2015CB755605, 2012CB825503, 2012CBA01304), Key Program of the Chinese Academy of Sciences (KZCC-EW-103-2), Training Program of the Major Research Plan of the National Natural Science Foundation of China (91332120), National Natural Science Foundation of China (31271167, 81271495, 81471312, 81271248), The Yunnan Provincial Project to Attract One-hundred Exceptional Talents from Overseas, Selected Frontier Scientific Significant Breakthrough Project of CAS, International Cooperation Projection (2011C14026) of Zhejiang Province Department of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 2007, EXP NEUROL, V207, P4, DOI 10.1016/j.expneurol.2007.05.010; [Anonymous], 2011, GUIDE CARE USE LAB A; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Bergman H, 2002, MOVEMENT DISORD, V17, pS28, DOI 10.1002/mds.10140; Bezard E, 2011, MOVEMENT DISORD, V26, P993, DOI 10.1002/mds.23696; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Boulet S, 2008, J NEUROSCI, V28, P9575, DOI 10.1523/JNEUROSCI.3465-08.2008; Bucher SF, 1997, ANN NEUROL, V41, P32, DOI 10.1002/ana.410410108; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Collier TJ, 2003, EXP NEUROL, V183, P258, DOI 10.1016/S0014-4886(03)00246-2; DAMATO RJ, 1986, SCIENCE, V231, P987, DOI 10.1126/science.3080808; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Fox SH, 2012, MOVEMENT DISORD, V27, P1373, DOI 10.1002/mds.25133; Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Helmich RC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0378-8; Imbert C, 2000, J NEUROSCI METH, V96, P71, DOI 10.1016/S0165-0270(99)00184-3; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KOPIN IJ, 1988, ANNU REV NEUROSCI, V11, P81, DOI 10.1146/annurev.neuro.11.1.81; KRAEMER GW, 1981, PSYCHOPHARMACOLOGY, V73, P1, DOI 10.1007/BF00431091; Lieu CA, 2012, BRAIN RES BULL, V87, P1, DOI 10.1016/j.brainresbull.2011.09.013; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Mounayar S, 2007, BRAIN, V130, P2898, DOI 10.1093/brain/awm208; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Neumane S, 2012, NEUROBIOL DIS, V48, P27, DOI 10.1016/j.nbd.2012.06.002; OpackaJuffry J, 1996, J NEURAL TRANSM, V103, P1429, DOI 10.1007/BF01271256; Pain S, 2013, EXP TOXICOL PATHOL, V65, P689, DOI 10.1016/j.etp.2012.09.001; Paxinos G., 1999, RHESUS MONKEY BRAIN, DOI DOI 10.1016/J.CEJA.2021.100223; Porras G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009308; Potts LF, 2013, EXP NEUROL; SABEL BA, 1982, PHYSIOL BEHAV, V28, P1017, DOI 10.1016/0031-9384(82)90169-X; Saper CB, 1999, BRAIN, V122, P1401, DOI 10.1093/brain/122.8.1401; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; SMITH RD, 1993, NEUROSCIENCE, V52, P7, DOI 10.1016/0306-4522(93)90176-G; Storch A, 2004, J NEURAL TRANSM, V111, P1267, DOI 10.1007/s00702-004-0203-2; Tande D, 2006, BRAIN, V129, P1194, DOI 10.1093/brain/awl041; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Watanabe Y, 2005, MED SCI MONITOR, V11, pRA17; Wu J, 2010, J NEUROSCI METH, V193, P203, DOI 10.1016/j.jneumeth.2010.07.039; Yan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088404; Yazdani U, 2006, EXP NEUROL, V200, P172, DOI 10.1016/j.expneurol.2006.02.002	47	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127953	10.1371/journal.pone.0127953	http://dx.doi.org/10.1371/journal.pone.0127953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010745	Green Published, gold			2022-12-27	WOS:000355183900170
J	Lerner, MD; Potthoff, LM; Hunter, SJ				Lerner, Matthew D.; Potthoff, Lauren M.; Hunter, Scott J.			Optimizing Cross-Sectional Prediction of Social Functioning in Youth Referred for Neuropsychological Testing	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; POSITIVE ILLUSORY BIAS; TRAUMATIC BRAIN-INJURY; PRAGMATIC DEFICITS; EXECUTIVE FUNCTION; CHILDREN; AUTISM; SKILLS; BEHAVIOR; ADOLESCENTS	The current study aimed to establish a fine-grained, efficient characterization of the concurrent neuropsychological contributions to social functioning in neuropsychologically-referred youth. A secondary aim was to demonstrate a useful statistic approach for such investigations (Partial Least Squares Regression; PLSR), which is underutilized in this field. Forty-five participants (70 - 164 months; M-age = 110.89; 34 male) were recruited from a large neuropsychological assessment clinic. Participants completed subtests from the NEPSY-II focusing on neuropsychological constructs that have been linked to social functioning (affect decoding, social memory, motor skills, visuomotor skills, response inhibition, attention and set-shifting, and verbal comprehension). Mothers completed the BASC-2, from which Atypicality and Social Skills scales were analyzed. PLSR revealed that difficulty with social memory, sensorimotor integration, and the ability to attend to and accurately discriminate auditory stimuli combine to best predict atypical or "odd" behavior. In terms of social skills, two factors emerged. The first factor indicated that, counterintuitively, greater emotional perception, visuospatial perception, ability to attend to and accurately discriminate auditory stimuli, and understand instructions was related to poorer social skills. The second factor indicated that a pattern of better facial memory, and sensorimotor ability (execution & integration) characterized a distinct profile of greater social ability. PLSR results were compared to traditional OLS and Backwards Stepwise regression approaches to demonstrate utility. Results also suggested that these findings were consistent across age, gender, and diagnostic group, indicating common neuropsychological substrates of social functioning in this sample of referred youth. Overall, this study provides the first characterization of optimized combinations of neuropsychological variables in predicting social functioning in assessment clinic-referred youth, and introduces to this literature a valuable statistical approach for obtaining such characterizations.	[Lerner, Matthew D.] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Potthoff, Lauren M.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Hunter, Scott J.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Northwestern University; Feinberg School of Medicine; University of Chicago	Lerner, MD (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.	matthew.lerner@stonybrook.edu	Hunter, Scott J./AAB-8814-2020; Hunter, Scott/AAC-1179-2020; Hunter, Scott/S-7866-2016	Hunter, Scott/0000-0001-7434-2327; Hunter, Scott/0000-0001-7434-2327; Lerner, Matthew/0000-0002-7373-6663				American Psychiatric Association, 2013, DIAG STAT MAN MENT D; [Anonymous], 2008, MEMORY AUTISM THEORY; BARONCOHEN S, 1988, J AUTISM DEV DISORD, V18, P379, DOI 10.1007/BF02212194; Bart O, 2007, INFANT CHILD DEV, V16, P597, DOI 10.1002/icd.514; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bender HA, 2007, PEDIATR NEUROL, V36, P312, DOI 10.1016/j.pediatrneurol.2007.01.011; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Cartledge G., 1986, TEACHING SOCIAL SKIL; Chin WW, 2003, INFORM SYST RES, V14, P189, DOI 10.1287/isre.14.2.189.16018; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CONTE R, 1995, ALBERTA J EDUC RES, V41, P84; Cummins A, 2005, DEV MED CHILD NEUROL, V47, P437, DOI 10.1017/S001216220500085X; de Boo GM, 2007, CLIN PSYCHOL REV, V27, P78, DOI 10.1016/j.cpr.2006.03.006; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Demopoulos C, 2013, J AUTISM DEV DISORD, V43, P1157, DOI 10.1007/s10803-012-1657-y; DuPaul GJ, 2001, J AM ACAD CHILD PSY, V40, P508, DOI 10.1097/00004583-200105000-00009; Elliott C, 2007, DIFFERENTIAL ABILITY; ELLIOTT SN, 1988, PROF PSYCHOL-RES PR, V19, P68, DOI 10.1037/0735-7028.19.1.68; ERWIN PG, 1994, J PSYCHOL, V128, P299, DOI 10.1080/00223980.1994.9712732; Fujiki M, 2008, INT J LANG COMM DIS, V43, P330, DOI 10.1080/13682820701507377; Gilotty L, 2002, CHILD NEUROPSYCHOL, V8, P241, DOI 10.1076/chin.8.4.241.13504; Ginsburg GS, 1998, J ABNORM CHILD PSYCH, V26, P175, DOI 10.1023/A:1022668101048; GRESHAM FM, 1987, J SPEC EDUC, V21, P167, DOI 10.1177/002246698702100115; Gresham FM, 1997, ED TREATMENT CHILDRE; Gresham FM, 1988, SOCIAL SKILLS; GUEVREMONT DC, 1994, J EMOT BEHAV DISORD, V2, P164, DOI 10.1177/106342669400200304; Haenlein M., 2004, UNDERSTANDING STAT, V3, P283, DOI [10.1207/s15328031us0304_4, DOI 10.1207/S15328031US0304_4]; Harrison JR, 2011, J ATTEN DISORD, V15, P147, DOI 10.1177/1087054709356170; Hass MR, 2012, REM SPEC EDUC, V33, P173, DOI 10.1177/0741932510383160; Holloway J, 2014, SOCIAL SKILLS DEFICI, P1133, DOI [10.1007/978-1-4614-4788-7_62, DOI 10.1007/978-1-4614-4788-7_62]; Howes C., 1988, PEER INTERACTION YOU; HUGHES JN, 1988, J SCHOOL PSYCHOL, V26, P167, DOI 10.1016/0022-4405(88)90018-0; HUMPHREYS AP, 1987, CHILD DEV, V58, P201, DOI 10.2307/1130302; Hunter SJ, 2012, EXECUTIVE FUNCTION AND DYSFUNCTION: IDENTIFICATION, ASSESSMENT AND TREATMENT, P1, DOI 10.1017/CBO9780511977954; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kavale KA, 1996, J LEARN DISABIL, V29, P226, DOI 10.1177/002221949602900301; Kenworthy L, 2009, CHILD NEUROPSYCHOL, V15, P425, DOI 10.1080/09297040802646983; Korkman M, 2007, NEPSY 2 EDITION NEPS; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; LADD GW, 1983, PSYCHOL REV, V90, P127, DOI 10.1037/0033-295X.90.2.127; LADD GW, 1979, CHILD DEV, V50, P402, DOI 10.1111/j.1467-8624.1979.tb04121.x; LaFontana KM, 1999, J GENET PSYCHOL, V160, P225, DOI 10.1080/00221329909595394; Lerner Matthew D, 2012, Dialogues Clin Neurosci, V14, P307; Lerner MD, 2012, J AUTISM DEV DISORD, V42, P2680, DOI 10.1007/s10803-012-1525-9; Lerner MD, 2012, ENCY PRIMARY PREVENT, V3; Lerner MD., 2013, KNOWLEDGE PERFORMANC; Linkenauger SA, 2012, AUTISM RES, V5, P352, DOI 10.1002/aur.1248; Liong B, 2008, J COMMUNITY PSYCHOL, V36, P499, DOI 10.1002/jcop.20246; Lipton M., 2009, J DEV PROCESSES, V4, P99; Losh M, 2003, J AUTISM DEV DISORD, V33, P239, DOI 10.1023/A:1024446215446; Maag J, 2005, EXCEPTIONALITY, V13, P155, DOI [10.1207/s15327035ex1303_2, DOI 10.1207/S15327035EX1303_2]; Maag J. W., 2016, CENGAGE LEARNING; Maccoby E, 1998, 2 GENDERS GROWING AP; Mahan S, 2011, RES AUTISM SPECT DIS, V5, P119, DOI 10.1016/j.rasd.2010.02.007; Manning S, 2001, J ATTEN DISORD, V5, P41, DOI DOI 10.1177/108705470100500104; Marcoulides GA, 2009, MANAGEMENT INFORM SY, V33, P10; Matson JL, 2009, SOCIAL BEHAVIOR AND SKILLS IN CHILDREN, P1, DOI 10.1007/978-1-4419-0234-4; McClean B, 2012, J INTELLECT DEV DIS, V37, P221, DOI 10.3109/13668250.2012.704981; McIntosh HJ, 1988, THESIS U S FLORIDA; McKnight ME, 2012, FOCUS AUTISM DEV DIS, V27, P247, DOI 10.1177/1088357612454917; McMahon CM, 2013, ADOLESC HEALTH MED T, V4, P23, DOI 10.2147/AHMT.S25402; Merrell K.W., 2014, SOCIAL SKILLS CHILDR; Mikami AY, 2013, J CONSULT CLIN PSYCH, V81, P100, DOI 10.1037/a0029654; Mikami AY, 2010, CHILD DEV PERSPECT, V4, P123, DOI 10.1111/j.1750-8606.2010.00130.x; Mikami AY, 2010, CLIN CHILD FAM PSYCH, V13, P181, DOI 10.1007/s10567-010-0067-y; Mikami AY, 2010, J CLIN CHILD ADOLESC, V39, P373, DOI 10.1080/15374411003691735; MUNDY P, 1986, J CHILD PSYCHOL PSYC, V27, P657, DOI 10.1111/j.1469-7610.1986.tb00190.x; Owens JS, 2007, CLIN CHILD FAM PSYCH, V10, P335, DOI 10.1007/s10567-007-0027-3; Patterson ML, 1999, EVOLUTION PARALLEL P; Reinvall O, 2012, J ATTENTIONAL DISORD, V5, P41; Reinvall O, 2013, J AUTISM DEV DISORD, V43, P1367, DOI 10.1007/s10803-012-1692-8; Reynolds C.R., 2004, BEHAV ASSESSMENT CHI; Romanczyk R. G., 2005, J EARLY INTENSIVE BE, V2, P177; RUBIN KH, 1983, MERRILL PALMER QUART, V29, P337; Saalasti S, 2008, J AUTISM DEV DISORD, V38, P1574, DOI 10.1007/s10803-008-0540-3; Schmitt AJ, 2004, ARCH CLIN NEUROPSYCH, V19, P1077, DOI 10.1016/j.acn.2004.02.002; Spence Susan H, 2003, Child Adolesc Ment Health, V8, P84, DOI 10.1111/1475-3588.00051; Staikova E, 2013, J CHILD PSYCHOL PSYC, V54, P1275, DOI 10.1111/jcpp.12082; Tseng WL, 2013, J CHILD PSYCHOL PSYC, V54, P996, DOI 10.1111/jcpp.12072; Volker MA, 2010, J AUTISM DEV DISORD, V40, P188, DOI 10.1007/s10803-009-0849-6; Vrij A, 2002, LAW HUMAN BEHAV, V26, P261, DOI 10.1023/A:1015313120905; WALKER HM, 1994, TOP LANG DISORD, V14, P70, DOI 10.1097/00011363-199405000-00007; Walker HM, 1986, CHILDRENS SOCIAL BEH; Wechsler D, 2003, WISC 4 ADM SCORING M; Wechsler D, 2008, WAIS 4 WECHSLER ADUL, DOI [10.1080/14622200801979019, DOI 10.1080/14622200801979019]; Wilson A, 2013, INFANT CHILD DEV, V22, P151, DOI 10.1002/icd.1773; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Zhu J., 1999, WECHSLER ABBREVIATED	88	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128303	10.1371/journal.pone.0128303	http://dx.doi.org/10.1371/journal.pone.0128303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011533	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900219
J	Li, X; Xiao, J; Frohlich, H; Tu, XM; Li, LL; Xu, Y; Cao, HT; Qu, J; Rappold, GA; Chen, JG				Li, Xue; Xiao, Jian; Froehlich, Henning; Tu, Xiaomeng; Li, Lianlian; Xu, Yue; Cao, Huateng; Qu, Jia; Rappold, Gudrun A.; Chen, Jie-Guang			Foxp1 Regulates Cortical Radial Migration and Neuronal Morphogenesis in Developing Cerebral Cortex	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; DEVELOPING HUMAN BRAIN; DE-NOVO MUTATIONS; INTELLECTUAL DISABILITY; DEVELOPING NEOCORTEX; MENTAL-RETARDATION; PYRAMIDAL NEURONS; PROTEIN; EXPRESSION; DISORDERS	FOXP1 is a member of FOXP subfamily transcription factors. Mutations in FOXP1 gene have been found in various development-related cognitive disorders. However, little is known about the etiology of these symptoms, and specifically the function of FOXP1 in neuronal development. Here, we report that suppression of Foxp1 expression in mouse cerebral cortex led to a neuronal migration defect, which was rescued by overexpression of Foxp1. Mice with Foxp1 knockdown exhibited ectopic neurons in deep layers of the cortex postnatally. The neuronal differentiation of Foxp1-downregulated cells was normal. However, morphological analysis showed that the neurons with Foxp1 deficiency had an inhibited axonal growth in vitro and a weakened transition from multipolar to bipolar in vivo. Moreover, we found that the expression of Foxp1 modulated the dendritic maturation of neurons at a late postnatal date. Our results demonstrate critical roles of Foxp1 in the radial migration and morphogenesis of cortical neurons during development. This study may shed light on the complex relationship between neuronal development and the related cognitive disorders.	[Li, Xue; Xiao, Jian; Tu, Xiaomeng; Li, Lianlian; Xu, Yue; Cao, Huateng; Qu, Jia; Chen, Jie-Guang] Wenzhou Med Univ, Natl Minist Hlth, Key Lab Visual Sci, Wenzhou 325027, Peoples R China; [Li, Xue; Xiao, Jian; Tu, Xiaomeng; Li, Lianlian; Xu, Yue; Cao, Huateng; Qu, Jia; Chen, Jie-Guang] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou 325027, Peoples R China; [Froehlich, Henning; Rappold, Gudrun A.] Heidelberg Univ, Dept Human Mol Genet, D-69120 Heidelberg, Germany	Wenzhou Medical University; Wenzhou Medical University; Ruprecht Karls University Heidelberg	Chen, JG (corresponding author), Wenzhou Med Univ, Natl Minist Hlth, Key Lab Visual Sci, Wenzhou 325027, Peoples R China.	jiesbooks@gmail.com			Natural Science Foundation of Zhejiang Province of China [Z2110700, LQ14C090005]; National Natural Science Foundation of China [31070951]; Scientific Research Fund of Wenzhou Science and Technology Bureau [Y20140363]	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Wenzhou Science and Technology Bureau	This work was supported by the Natural Science Foundation of Zhejiang Province of China (Grants Z2110700 to J.-G Chen and LQ14C090005 to Xue Li) (http://www.zjnsf.gov.cn/1/xm/lx.aspx), the National Natural Science Foundation of China (Grant 31070951 J.-G Chen) (http://www.nsfc.gov.cn/), and by the Scientific Research Fund of Wenzhou Science and Technology Bureau (Grant Y20140363 to Xue Li) (http://www.wzkj.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JB, 2009, J NEUROSCI, V29, P313, DOI 10.1523/JNEUROSCI.4093-08.2009; Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Bacon C, 2014, MOL PSYCHIAT; Bacon C, 2012, HUM GENET, V131, P1687, DOI 10.1007/s00439-012-1193-z; Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Carr CW, 2010, EUR J HUM GENET, V18, P1216, DOI 10.1038/ejhg.2010.96; Cascio CJ, 2010, J NEURODEV DISORD, V2, P62, DOI 10.1007/s11689-010-9046-3; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Grundmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070873; Guerrini R, 2005, J CHILD NEUROL, V20, P287, DOI 10.1177/08830738050200040401; Guerrini R, 2014, LANCET NEUROL, V13, P710, DOI 10.1016/S1474-4422(14)70040-7; GUIJARRO P, 2013, J PEDIATR ONCOL NURS, V30, P871, DOI DOI 10.1002/dneu.22107; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Hatanaka Y, 2013, CEREB CORTEX, V23, P105, DOI 10.1093/cercor/bhr383; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Konstantoulas CJ, 2010, J NEUROCHEM, V113, P836, DOI 10.1111/j.1471-4159.2010.06650.x; LaBerge D, 2006, CONSCIOUS COGN, V15, P235, DOI 10.1016/j.concog.2005.09.007; Le Fevre AK, 2013, AM J MED GENET A, V161, P3166, DOI 10.1002/ajmg.a.36174; Lett RLM, 2009, CEREB CORTEX, V19, P1408, DOI 10.1093/cercor/bhn179; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Morikawa Y, 2009, DEV NEUROSCI-BASEL, V31, P511, DOI 10.1159/000243715; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nishimura YV, 2010, J BIOL CHEM, V285, P5878, DOI 10.1074/jbc.M109.033761; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Palmesino E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000446; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Sin C, 2014, J MOL NEUROSCIENCE M; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Straub C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105584; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Washington SD, 2014, HUM BRAIN MAPP, V35, P1284, DOI 10.1002/hbm.22252; Watanabe K, 2011, DEVELOPMENT, V138, P4979, DOI 10.1242/dev.068155; Zhang C, 2013, NEURON, V78, P986, DOI 10.1016/j.neuron.2013.04.021; Zheng W, 2012, CEREB CORTEX, V22, P2587, DOI 10.1093/cercor/bhr330	61	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127671	10.1371/journal.pone.0127671	http://dx.doi.org/10.1371/journal.pone.0127671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010426	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900127
J	Lourida, I; Thompson-Coon, J; Dickens, CM; Soni, M; Kuzma, E; Kos, K; Llewellyn, DJ				Lourida, Ilianna; Thompson-Coon, Jo; Dickens, Chris M.; Soni, Maya; Kuzma, Elzbieta; Kos, Katarina; Llewellyn, David J.			Parathyroid Hormone, Cognitive Function and Dementia: A Systematic Review	PLOS ONE			English	Review							PRIMARY HYPERPARATHYROID PATIENTS; QUALITY-OF-LIFE; VITAMIN-D; SECONDARY HYPERPARATHYROIDISM; INTRACRANIAL CALCIFICATION; ALZHEIMERS-DISEASE; SENILE DEMENTIA; SERUM-CALCIUM; METAANALYSIS; DYSFUNCTION	Background Metabolic factors are increasingly recognized to play an important role in the pathogenesis of Alzheimer's disease and dementia. Abnormal parathyroid hormone (PTH) levels play a role in neuronal calcium dysregulation, hypoperfusion and disrupted neuronal signaling. Some studies support a significant link between PTH levels and dementia whereas others do not. Methods We conducted a systematic review through January 2014 to evaluate the association between PTH and parathyroid conditions, cognitive function and dementia. Eleven electronic databases and citation indexes were searched including Medline, Embase and the Cochrane Library. Hand searches of selected journals, reference lists of primary studies and reviews were also conducted along with websites of key organizations. Two reviewers independently screened titles and abstracts of identified studies. Data extraction and study quality were performed by one and checked by a second reviewer using predefined criteria. A narrative synthesis was performed due to the heterogeneity of included studies. Results The twenty-seven studies identified were of low and moderate quality, and challenging to synthesize due to inadequate reporting. Findings from six observational studies were mixed but suggest a link between higher serum PTH levels and increased odds of poor cognition or dementia. Two case-control studies of hypoparathyroidism provide limited evidence for a link with poorer cognitive function. Thirteen pre-post surgery studies for primary hyperparathyroidism show mixed evidence for improvements in memory though limited agreement in other cognitive domains. There was some degree of cognitive impairment and improvement postoperatively in observational studies of secondary hyperparathyroidism but no evident pattern of associations with specific cognitive domains. Conclusions Mixed evidence offers weak support for a link between PTH, cognition and dementia due to the paucity of high quality research in this area.	[Lourida, Ilianna; Thompson-Coon, Jo; Llewellyn, David J.] Univ Exeter, Sch Med, NIHR, Collaborat Leadership Appl Hlth Res & Care South, Exeter, Devon, England; [Lourida, Ilianna; Thompson-Coon, Jo; Dickens, Chris M.; Soni, Maya; Kuzma, Elzbieta; Kos, Katarina; Llewellyn, David J.] Univ Exeter, Sch Med, Exeter, Devon, England	University of Exeter; University of Exeter	Llewellyn, DJ (corresponding author), Univ Exeter, Sch Med, NIHR, Collaborat Leadership Appl Hlth Res & Care South, Exeter, Devon, England.	David.Llewellyn@exeter.ac.uk	Llewellyn, David/AAZ-2859-2021; LOURIDA, ILIANNA/W-2730-2019; Kos, Katarina/G-6772-2014; Coon, Jo Thompson/C-7923-2017	LOURIDA, ILIANNA/0000-0003-4439-2192; Coon, Jo Thompson/0000-0002-5161-0234; Dickens, Chris/0000-0001-6326-7544; Llewellyn, David/0000-0002-2441-4246; Kos, Katarina/0000-0003-3761-2249	National Institute for Health Research (NIHR) South West Peninsula Collaboration for Leadership in Applied Health Research and Care (PenCLAHRC); Alzheimer's Association [NIRG-11-200737]; Rosetrees Trust; Mary Kinross Charitable Trust; James Tudor Foundation; Halpin Trust; Norman Family Charitable Trust; Rosetrees Trust [M385] Funding Source: researchfish	National Institute for Health Research (NIHR) South West Peninsula Collaboration for Leadership in Applied Health Research and Care (PenCLAHRC); Alzheimer's Association(Alzheimer's Association); Rosetrees Trust(Rosetrees Trust); Mary Kinross Charitable Trust; James Tudor Foundation; Halpin Trust; Norman Family Charitable Trust; Rosetrees Trust(Rosetrees Trust)	This research has been supported by the National Institute for Health Research (NIHR) South West Peninsula Collaboration for Leadership in Applied Health Research and Care (PenCLAHRC). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. DJL is funded by the Alzheimer's Association [NIRG-11-200737], the Rosetrees Trust, the Mary Kinross Charitable Trust, the James Tudor Foundation, the Halpin Trust, and the Norman Family Charitable Trust.	Aggarwal S, 2013, EUR J ENDOCRINOL, V168, P895, DOI 10.1530/EJE-12-0946; Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Babinska D, 2012, LANGENBECK ARCH SURG, V397, P825, DOI 10.1007/s00423-011-0885-5; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; Benge JF, 2009, J INT NEUROPSYCH SOC, V15, P1002, DOI 10.1017/S1355617709990695; Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bjorkman MP, 2010, AGING CLIN EXP RES, V22, P164, DOI 10.3275/6626; Bonelli RM, 2008, NEUROLOGIST, V14, P100, DOI 10.1097/NRL.0b013e31815b0de2; Brines ML, 1999, NEUROSCI LETT, V274, P13, DOI 10.1016/S0304-3940(99)00664-3; Buell JS, 2008, MOL ASPECTS MED, V29, P415, DOI 10.1016/j.mam.2008.05.001; Caron NR, 2009, WORLD J SURG, V33, P2244, DOI 10.1007/s00268-009-9987-4; Casella C, 2008, ANN ITAL CHIR, V79, P157; Cermik TF, 2007, NEURORADIOLOGY, V49, P379, DOI 10.1007/s00234-006-0198-5; Chiang CY, 2005, CLIN ENDOCRINOL, V62, P99, DOI 10.1111/j.1365-2265.2004.02180.x; Chou FF, 2008, SURGERY, V143, P526, DOI 10.1016/j.surg.2007.11.019; COGAN MG, 1978, AM J MED, V65, P963, DOI 10.1016/0002-9343(78)90748-9; Coker LH, 2005, ANN SURG, V242, P642, DOI 10.1097/01.sla.0000186337.83407.ec; Dotzenrath CME, 2006, WORLD J SURG, V30, P680, DOI 10.1007/s00268-005-0444-8; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; DRIESSEN M, 1995, NEPHRON, V70, P334, DOI 10.1159/000188614; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Gilli P, 1983, CLIN NEPHROL, V19; Goyal A, 2001, Indian J Med Sci, V55, P677; Johansson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081989; Jorde R, 2006, J NEUROL, V253, P464, DOI 10.1007/s00415-005-0027-5; Kalaitzidis RG, 2013, INT UROL NEPHROL, V45, P1637, DOI 10.1007/s11255-013-0450-y; Khudaverdyan DN, 1996, B EXP BIOL MED+, V122, P1069, DOI 10.1007/BF02447647; KIPEN E, 1995, J AM GERIATR SOC, V43, P1088, DOI 10.1111/j.1532-5415.1995.tb07005.x; Kowdley KV, 1999, AM J MED SCI, V317, P273, DOI 10.1097/00000441-199905000-00001; Leinau L, 2009, CLIN J AM SOC NEPHRO, V4, P572, DOI 10.2215/CJN.03370708; Mittendorf Elizabeth A, 2007, Endocr Pract, V13, P338; Murray TM, 2005, ENDOCR REV, V26, P78, DOI 10.1210/er.2003-0024; NUMANN PJ, 1984, SURGERY, V96, P1119; OGIHARA T, 1990, GERONTOLOGY, V36, P25; Papageorgiou SG, 2008, CLIN NEUROL NEUROSUR, V110, P1038, DOI 10.1016/j.clineuro.2008.06.004; Perrier ND, 2009, SURGERY, V146, P1116, DOI 10.1016/j.surg.2009.09.034; Prager G, 2002, SURGERY, V132, P930, DOI 10.1067/msy.2002.128606; Roman SA, 2005, SURGERY, V138, P1121, DOI 10.1016/j.surg.2005.08.033; Roman SA, 2011, ANN SURG, V253, P131, DOI 10.1097/SLA.0b013e3181f66720; Schram MT, 2007, J AM GERIATR SOC, V55, P1786, DOI 10.1111/j.1532-5415.2007.01418.x; SHORE D, 1980, J GERONTOL, V35, P656, DOI 10.1093/geronj/35.5.656; Toescu EC, 2010, CELL CALCIUM, V47, P158, DOI 10.1016/j.ceca.2009.11.013; University of York Centre for Reviews and Dissemination, 2009, SYST REV CRDS GUID U; USDIN TB, 1995, J BIOL CHEM, V270, P15455, DOI 10.1074/jbc.270.26.15455; van Ballegooijen AJ, 2013, AM HEART J, V165, P655, DOI 10.1016/j.ahj.2013.02.014; Walker MD, 2009, J CLIN ENDOCR METAB, V94, P3849, DOI 10.1210/jc.2009-1086; Walker MD, 2009, J CLIN ENDOCR METAB, V94, P1951, DOI 10.1210/jc.2008-2574; Yu N, 2010, CLIN ENDOCRINOL, V73, P30, DOI 10.1111/j.1365-2265.2009.03766.x	48	55	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127574	10.1371/journal.pone.0127574	http://dx.doi.org/10.1371/journal.pone.0127574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010883	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900112
J	Ly, KH; Topooco, N; Cederlund, H; Wallin, A; Bergstrom, J; Molander, O; Carlbring, P; Andersson, G				Ly, Kien Hoa; Topooco, Naira; Cederlund, Hanna; Wallin, Anna; Bergstrom, Jan; Molander, Olof; Carlbring, Per; Andersson, Gerhard			Smartphone-Supported versus Full Behavioural Activation for Depression: A Randomised Controlled Trial	PLOS ONE			English	Article							THERAPY; ADULTS; CBT	Background There is need for more cost and time effective treatments for depression. This is the first randomised controlled trial in which a blended treatment - including four face-to-face sessions and a smartphone application - was compared against a full behavioural treatment. Hence, the aim of the current paper was to examine whether a blended smartphone treatment was non-inferior to a full behavioural activation treatment for depression. Methods This was a randomised controlled non-inferiority trial (NCT01819025) comparing a blended treatment (n=46) against a full ten-session treatment (n=47) for people suffering from major depression. Primary outcome measure was the BDI-II, that was administered at pre- and post-treatment, as well as six months after the treatment. Results Results showed significant improvements in both groups across time on the primary outcome measure (within-group Cohen's d=1.35; CI [-0.82, 3.52] to d=1.47; CI [-0.41, 3.35]; between group d=-0.13 CI [-2.37, 2.09] and d=-0.10 CI [-2.53, 2.33]). At the same time, the blended treatment reduced the therapist time with an average of 47%. Conclusions We could not establish whether the blended treatment was non-inferior to a full BA treatment. Nevertheless, this study points to that the blended treatment approach could possibly treat nearly twice as many patients suffering from depression by using a smartphone application as add-on. More studies are needed before we can suggest that the blended treatment method is a promising cost-effective alternative to regular face-to-face treatment for depression.	[Ly, Kien Hoa; Topooco, Naira; Cederlund, Hanna; Wallin, Anna; Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Bergstrom, Jan; Carlbring, Per] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Molander, Olof] Wemind Psykiatri Stockholm, Stockholm, Sweden; [Andersson, Gerhard] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden	Linkoping University; Stockholm University; Karolinska Institutet	Ly, KH (corresponding author), Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden.	kien.hoa.ly@liu.se	Andersson, Gerhard/J-8529-2012; Carlbring, Per/D-3628-2009; Carlbring, Per/R-1220-2019	Andersson, Gerhard/0000-0003-4753-6745; Carlbring, Per/0000-0002-2172-8813; Carlbring, Per/0000-0002-2172-8813; Molander, Olof/0000-0001-5348-051X	Swedish Research Council [2011-2476]; European Community's Seventh Framework Programme (FP7) [603098]	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission)	This paper was supported by the Swedish Research Council: 2011-2476 (http://www.vr.se/), as well as by the European Community's Seventh Framework Programme (FP7): 603098 (http://www.e-compared.eu/). Wemind Psykiatri Stockholm provided support in the form of salaries for author OM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions' section.	Andersson G, 2014, WORLD PSYCHIATRY, V13, P4, DOI 10.1002/wps.20083; Andrews G, 2004, BRIT J PSYCHIAT, V184, P526, DOI 10.1192/bjp.184.6.526; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Borenstein M., 2009, INTRO METAANALYSIS; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Boschen MJ, 2008, PROF PSYCHOL-RES PR, V39, P546, DOI 10.1037/0735-7028.39.5.546; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Cuijpers P, 2014, J AFFECT DISORDERS, V159, P118, DOI 10.1016/j.jad.2014.02.026; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Ekers D, 2011, BRIT J PSYCHIAT, V198, P66, DOI 10.1192/bjp.bp.110.079111; Frisch M.B., 1992, PSYCHOL ASSESS, V4, P92, DOI [10.1037/1040-3590.4.1.92, DOI 10.1037/1040-3590.4.1.92]; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Harnett P, 2010, CLIN PSYCHOL-UK, V14, P39, DOI 10.1080/13284207.2010.500309; Hayes S, 2004, WHAT IS ACCEPTANCE C, P1; Hopko DR, 2003, BEHAV MODIF, V27, P458, DOI 10.1177/0145445503255489; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kadera S W, 1996, J Psychother Pract Res, V5, P132; Kanter JW, 2010, CLIN PSYCHOL REV, V30, P608, DOI 10.1016/j.cpr.2010.04.001; Kennard BD, 2009, J CONSULT CLIN PSYCH, V77, P1033, DOI 10.1037/a0017411; Ly KH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003440; Martell C.R., 2013, BEHAV ACTIVATION DEP, DOI [10.1080/16506073.2010.514119, DOI 10.1080/16506073.2010.514119]; Mazzucchelli T, 2009, CLIN PSYCHOL-SCI PR, V16, P383, DOI 10.1111/j.1468-2850.2009.01178.x; Meglic M, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1510; Meyer B, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1151; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Montgomery SA., 1994, EUROPEAN NEUROPSYCHO, V4, P283, DOI [DOI 10.1016/0924-977X(94)90093-0, 10.1016/0924-977X(94)90093-0]; Newman MG, 2011, CLIN PSYCHOL REV, V31, P89, DOI 10.1016/j.cpr.2010.09.008; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Rubin D.B., 2002, STAT ANAL MISSING DA; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sundell K, 2012, ATT GORA EFFEKTUTVAR; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; Szegedi A, 2005, BMJ-BRIT MED J, V330, P503, DOI 10.1136/bmj.38356.655266.82; Titov Nickolai, 2011, Cognitive Behaviour Therapy, V40, P126, DOI 10.1080/16506073.2010.550059; Tracey T. J., 1989, PSYCHOL ASSESSMENT, V1, P207, DOI [10.1037/1040-3590.1.3.207, DOI 10.1037/1040-3590.1.3.207]; van der Vaart R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0355-z; Watts S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-49; Weersing VR, 2002, J CONSULT CLIN PSYCH, V70, P299, DOI 10.1037//0022-006X.70.2.299; Yoo B, 2010, PHARM STAT, V9, P87, DOI 10.1002/pst.378	43	74	76	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126559	10.1371/journal.pone.0126559	http://dx.doi.org/10.1371/journal.pone.0126559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010890	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900033
J	Maufroy, A; Chassot, E; Joo, R; Kaplan, DM				Maufroy, Alexandra; Chassot, Emmanuel; Joo, Rocio; Kaplan, David Michael			Large-Scale Examination of Spatio-Temporal Patterns of Drifting Fish Aggregating Devices (dFADs) from Tropical Tuna Fisheries of the Indian and Atlantic Oceans	PLOS ONE			English	Article							CLASSIFICATION; MODELS; BEHAVIOR	Since the 1990s, massive use of drifting Fish Aggregating Devices (dFADs) to aggregate tropical tunas has strongly modified global purse-seine fisheries. For the first time, a large data set of GPS positions from buoys deployed by French purse-seiners to monitor dFADs is analysed to provide information on spatio-temporal patterns of dFAD use in the Atlantic and Indian Oceans during 2007-2011. First, we select among four classification methods the model that best separates "at sea" from "on board" buoy positions. A random forest model had the best performance, both in terms of the rate of false "at sea" predictions and the amount of over-segmentation of "at sea" trajectories (i.e., artificial division of trajectories into multiple, shorter pieces due to misclassification). Performance is improved via post-processing removing unrealistically short "at sea" trajectories. Results derived from the selected model enable us to identify the main areas and seasons of dFAD deployment and the spatial extent of their drift. We find that dFADs drift at sea on average for 39.5 days, with time at sea being shorter and distance travelled longer in the Indian than in the Atlantic Ocean. 9.9% of all trajectories end with a beaching event, suggesting that 1,500-2,000 may be lost onshore each year, potentially impacting sensitive habitat areas, such as the coral reefs of the Maldives, the Chagos Archipelago, and the Seychelles.	[Maufroy, Alexandra; Joo, Rocio; Kaplan, David Michael] CNRS, Inst Rech Dev, UMR MARBEC, IRD Ifremer UM2, Sete, France; [Chassot, Emmanuel] CNRS, Inst Rech Dev, UMR MARBEC, SFA,IRD Ifremer UM2, Victoria, Seychelles; [Joo, Rocio] IMARPE, Lima, Peru; [Kaplan, David Michael] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer; Institut de Recherche pour le Developpement (IRD); Instituto del Mar del Peru; William & Mary; Virginia Institute of Marine Science	Maufroy, A (corresponding author), CNRS, Inst Rech Dev, UMR MARBEC, IRD Ifremer UM2, Ave Jean Monnet, Sete, France.	alexandra.maufroy@gmail.com	Joo, Rocio/H-8238-2019; Kaplan, David/G-5230-2010	Kaplan, David/0000-0001-6087-359X; CHASSOT, Emmanuel/0000-0002-6779-4955; Maufroy, Alexandra/0000-0002-4814-6522	French National Research Agency (ANR) [ANR-08-STRA-03]; France Filiere Peche; IRD; EU [(EC) 1543/2000, 199/2008]	French National Research Agency (ANR)(French National Research Agency (ANR)); France Filiere Peche; IRD; EU(European Commission)	The work of DMK and AM was supported by the AMPED project (www.amped.ird.fr) through a grant from the French National Research Agency (ANR, www.agence-nationale-recherche.fr), Systerra Programme, grant number ANR-08-STRA-03. AM also benefited from a grant of France Filiere Peche (www.francefilierepeche.fr). R. J. was financially supported by an ARTS grant from IRD (www.ird.fr) and managed by Campus France (www.campusfrance.org). The fisheries data analysed in this publication were collected by the Mixed Research Unit 212 'Exploited Marine Ecosystems' of the Institut de Recherche pour le Developpement (IRD) through the EU-funded Data Collection Framework [DCF, Reg (EC) 1543/2000 and 199/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2009, ENTANGLEMENT OLIVE R; Ariz Telleria J, 1999, P INT WORKSH EC FISH, P21; Baske A, 2012, ESTIMATING USE DRIFT; Bertrand S, 2008, PROG OCEANOGR, V79, P379, DOI 10.1016/j.pocean.2008.10.009; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromhead D, 2003, FINAL REPORT FISHERI; Castro JJ, 2001, REV FISH BIOL FISHER, V11, P255, DOI 10.1023/A:1020302414472; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Filmalter JD, 2013, FRONT ECOL ENVIRON, V11, P291, DOI 10.1890/130045; Floch L, 2012, STAT FRENCH PURSE SE, P858; Floch L, 2012, P 14 SESS IOTC WORK, P14; Fonteneau A, 2000, AQUAT LIVING RESOUR, V13, P253, DOI 10.1016/S0990-7440(00)01054-8; Fonteneau A., 2000, PECHE THONIERE DISPO, V28, P15; Fonteneau A, 2013, AQUAT LIVING RESOUR, V26, P37, DOI 10.1051/alr/2013046; Fossette S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3065; Franco J, 2012, COLLECT VOL SCI PAP, V68, P1754; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Graham Nicholas A.J., 2013, P253; GREENBLATT PR, 1979, FISH B-NOAA, V77, P147; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; IOTC, 2012, 1208 IOTC, P3; ISSF, 2012, ISSF GUID NON FADS; ISSF, 2012, 2012 ISSF STOCK ASS; Jaquemet S, 2011, FISH RES, V107, P283, DOI 10.1016/j.fishres.2010.11.011; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Joo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071246; Kaplan DM, 2014, ICES J MAR SCI, V71, P1728, DOI 10.1093/icesjms/fst233; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lee JW, 2005, COMPUT STAT DATA AN, V48, P869, DOI 10.1016/j.csda.2004.03.017; Marsac F, 1999, PECHE THONIERE DISPO; Menard F, 2000, AQUAT LIVING RESOUR, V13, P233, DOI 10.1016/S0990-7440(00)01066-4; Meynard CN, 2013, J BIOGEOGR, V40, P1, DOI 10.1111/jbi.12006; Moron J, 2001, 14 STAND COMM TUN BI; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Picaut J, 1984, CALCOFI REP, V25, P41; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos ML, 2010, IOTC2010WPTT22; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Scott MD, 1992, P INT WORKSH EC FISH; Strobl C, 2009, R J, V1, P14; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; The MathWorks Inc., 2012, MATL STAT TOOLB REL; Venables WN., 2002, MODERN APPL STAT S, V4	48	39	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128023	10.1371/journal.pone.0128023	http://dx.doi.org/10.1371/journal.pone.0128023			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010151	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900184
J	Romanenko, SA; Perelman, PL; Trifonov, VA; Serdyukova, NA; Li, TL; Fu, BY; O'Brien, PCM; Ng, BL; Nie, WH; Liehr, T; Stanyon, R; Graphodatsky, AS; Yang, FT				Romanenko, Svetlana A.; Perelman, Polina L.; Trifonov, Vladimir A.; Serdyukova, Natalia A.; Li, Tangliang; Fu, Beiyuan; O'Brien, Patricia C. M.; Ng, Bee L.; Nie, Wenhui; Liehr, Thomas; Stanyon, Roscoe; Graphodatsky, Alexander S.; Yang, Fengtang			A First Generation Comparative Chromosome Map between Guinea Pig (Cavia porcellus) and Humans	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; GENOME ORGANIZATION; MOLECULAR SYSTEMATICS; PAINTING SHOWS; EVOLUTION; RODENTIA; PHYLOGENY; SCIURIDAE; KARYOTYPES; HOMOLOGY	The domesticated guinea pig, Cavia porcellus (Hystricomorpha, Rodentia), is an important laboratory species and a model for a number of human diseases. Nevertheless, genomic tools for this species are lacking; even its karyotype is poorly characterized. The guinea pig belongs to Hystricomorpha, a widespread and important group of rodents; so far the chromosomes of guinea pigs have not been compared with that of other hystricomorph species or with any other mammals. We generated full sets of chromosome-specific painting probes for the guinea pig by flow sorting and microdissection, and for the first time, mapped the chromosomal homologies between guinea pig and human by reciprocal chromosome painting. Our data demonstrate that the guinea pig karyotype has undergone extensive rearrangements: 78 synteny-conserved human autosomal segments were delimited in the guinea pig genome. The high rate of genome evolution in the guinea pig may explain why the HSA7/16 and HSA16/19 associations presumed ancestral for eutherians and the three syntenic associations (HSA1/10, 3/19, and 9/11) considered ancestral for rodents were not found in C. porcellus. The comparative chromosome map presented here is a starting point for further development of physical and genetic maps of the guinea pig as well as an aid for genome assembly assignment to specific chromosomes. Furthermore, the comparative mapping will allow a transfer of gene map data from other species. The probes developed here provide a genomic toolkit, which will make the guinea pig a key species to unravel the evolutionary biology of the Hystricomorph rodents.	[Romanenko, Svetlana A.; Perelman, Polina L.; Trifonov, Vladimir A.; Serdyukova, Natalia A.; Graphodatsky, Alexander S.] SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Romanenko, Svetlana A.; Perelman, Polina L.; Trifonov, Vladimir A.; Graphodatsky, Alexander S.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Romanenko, Svetlana A.; Perelman, Polina L.; Li, Tangliang; Nie, Wenhui] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Fu, Beiyuan; Ng, Bee L.; Yang, Fengtang] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [O'Brien, Patricia C. M.] Univ Cambridge, Ctr Vet Sci, Dept Vet Med, Cambridge, England; [Liehr, Thomas] Jena Univ Hosp, Inst Human Genet & Anthropol, Jena, Germany; [Stanyon, Roscoe] Univ Florence, Dept Biol, Florence, Italy	Russian Academy of Sciences; Novosibirsk State University; Chinese Academy of Sciences; Kunming Institute of Zoology; Wellcome Trust Sanger Institute; University of Cambridge; Friedrich Schiller University of Jena; University of Florence	Romanenko, SA (corresponding author), SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia.	rosa@mcb.nsc.ru; fy1@sanger.ac.uk	Li, Tangliang/AAN-6866-2020; Liehr, Thomas/H-2852-2019; Yang, Fan/GYU-4249-2022; Perelman, Polina/N-8088-2015; Serdyukova, Natalia/AAU-6393-2021; Trifonov, Vladimir/E-4907-2012; Li, Tangliang/A-6087-2009; Romanenko, Svetlana/N-2500-2015; Perelman, Polina/AAD-9030-2019; Graphodatsky, Alexander/B-4922-2010; Serdyukova, Natalia/N-6476-2015	Li, Tangliang/0000-0003-0671-9166; Liehr, Thomas/0000-0003-1672-3054; Perelman, Polina/0000-0002-0982-5100; Serdyukova, Natalia/0000-0002-0409-1371; Trifonov, Vladimir/0000-0003-0454-8359; Li, Tangliang/0000-0003-0671-9166; Romanenko, Svetlana/0000-0002-0951-5209; Perelman, Polina/0000-0002-0982-5100; Graphodatsky, Alexander/0000-0002-8282-1085; Yang, Fengtang/0000-0002-3573-2354; Stanyon, Roscoe/0000-0002-7229-1092	MCB; SB RAS; Russian Fund for Basic Research; Wellcome Trust [WT098051]; PRIN; DFG [LI 820/32-1]	MCB; SB RAS(Russian Academy of Sciences); Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Wellcome Trust(Wellcome Trust); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); DFG(German Research Foundation (DFG))	This study was funded in part by programs MCB and SB RAS Programs and research grants of the Russian Fund for Basic Research. BF, BLN and FY were supported by Wellcome Trust (grant number WT098051), RS was supported by PRIN grant 2012, MURST, ThL and VAT were supported by DFG (LI 820/32-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; AWA AKIO, 1959, JAPANESE JOUR ZOOL, V12, P257; Badenhorst D, 2011, CHROMOSOME RES, V19, P709, DOI 10.1007/s10577-011-9227-2; Beklemisheva VR, 2011, CHROMOSOME RES, V19, P549, DOI 10.1007/s10577-011-9210-y; BIANCHI NO, 1971, CHROMOSOMA, V34, P254, DOI 10.1007/BF00286151; British cavi council, 2009, BREED STANDARDS FOR; Broad Institute, GUINEA PIG GENOME PR; Broad Institute, 29 MAMMALS PROJECT; CAO Y, 1994, MOL BIOL EVOL, V11, P593; Chowdhary BP, 1998, GENOME RES, V8, P577, DOI 10.1101/gr.8.6.577; Deuve JL, 2008, CHROMOSOME RES, V16, P57, DOI 10.1007/s10577-007-1200-8; Deuve JL, 2006, CHROMOSOME RES, V14, P681, DOI 10.1007/s10577-006-1080-3; Dunnum JL, 2010, J ZOOL SYST EVOL RES, V48, P376, DOI 10.1111/j.1439-0469.2009.00561.x; Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199; FergusonSmith MA, 1997, EUR J HUM GENET, V5, P253, DOI 10.1159/000484775; Fronicke L, 2003, P ROY SOC B-BIOL SCI, V270, P1331, DOI 10.1098/rspb.2003.2383; Gava A, 1998, GENETICS AND MOLECUL, V21; Genome Bioinformatics Group, 2008, GENOME BROWSER; GEORGE W, 1972, J ZOOL, V168, P81, DOI 10.1111/j.1469-7998.1972.tb01339.x; Graphodatsky A, 2012, CYTOGENET GENOME RES, V137, P83, DOI 10.1159/000341502; Graphodatsky AS, 2008, CHROMOSOME RES, V16, P261, DOI 10.1007/s10577-007-1191-5; Graphodatsky AS, 2000, CYTOGENET CELL GENET, V88, P296, DOI 10.1159/000015513; Graphodatsky AS, 1988, CHROMOSOMES OF AGRIC; Graphodatsky S, 2006, ATLAS OF MAMMALIAN C, P324; Honeycutt RL, 2003, MOL PHYLOGENET EVOL, V26, P476, DOI 10.1016/S1055-7903(02)00368-8; HSU TC, 1953, J HERED, V44, P23, DOI 10.1093/oxfordjournals.jhered.a106344; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huchon D, 2001, MOL PHYLOGENET EVOL, V20, P238, DOI 10.1006/mpev.2001.0961; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Kosyakova N, 2013, MOLECULAR CYTOGENETI, V6; Li T, 2006, CYTOGENET GENOME RES, V112, P270, DOI 10.1159/000089881; Li TL, 2004, CHROMOSOME RES, V12, P317, DOI 10.1023/B:CHRO.0000034131.73620.48; LI WH, 1990, P NATL ACAD SCI USA, V87, P6703, DOI 10.1073/pnas.87.17.6703; Lomholt B, 2002, HEREDITAS, V136, P104, DOI 10.1034/j.1601-5223.2002.1360203.x; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; MAIA V, 1984, EXPERIENTIA, V40, P564, DOI 10.1007/BF01982332; Makino S, 1947, J FAC SCI HOKKAIDO 6, V9, P345; MANNA GK, 1964, EXPERIENTIA, V20, P324, DOI 10.1007/BF02171074; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; Mlynarski EE, 2008, CYTOGENET GENOME RES, V121, P288, DOI 10.1159/000138900; MOORE DE, 1982, J NATL CANCER I, V69, P591; NATARAJAN AT, 1974, HEREDITAS, V76, P145; Nie WH, 2009, CHROMOSOME RES, V17, P99, DOI 10.1007/s10577-009-9021-6; Ohi Y, 2014, BRAIN RES, V1581, P12, DOI 10.1016/j.brainres.2014.04.031; OHNO S, 1961, EXP CELL RES, V25, P498, DOI 10.1016/0014-4827(61)90185-9; POPESCU NC, 1976, CANCER RES, V36, P1404; Richard F, 2012, CYTOGENET GENOME RES, V137, P218, DOI 10.1159/000341379; Richard F, 2003, CHROMOSOME RES, V11, P597, DOI 10.1023/A:1024905018685; Romanenko SA, 2012, HEREDITY, V108, P4, DOI 10.1038/hdy.2011.110; Romanenko SA, 2006, MAMM GENOME, V17, P1183, DOI 10.1007/s00335-006-0081-z; Saidullah Bano, 2014, J Smooth Muscle Res, V50, P29; Sannier J, 2011, CYTOGENET GENOME RES, V134, P51, DOI 10.1159/000324691; SCHMID W, 1967, Archiv der Julius Klaus-Stiftung fuer Vererbungsforschung Sozialanthropologie und Rassenhygiene, V42, P1; SEABRIGH.M, 1971, LANCET, V2, P971; Sitnikova NA, 2007, CHROMOSOME RES, V15, P447, DOI 10.1007/s10577-007-1137-y; Spotorno AE, 2004, REV CHIL HIST NAT, V77, P243; Stanyon R, 1999, CYTOGENET CELL GENET, V84, P150, DOI 10.1159/000015244; Stanyon R, 2003, GENOMICS, V82, P245, DOI 10.1016/S0888-7543(03)00109-5; STANYON R, 1991, B ZOOL, V58, P81, DOI 10.1080/11250009109355732; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Svartman M, 2005, GENOMICS, V85, P425, DOI 10.1016/j.ygeno.2004.12.004; TELENIUS H, 1991, CYTOGENET CELL GENET, V58, P2154; Ventura K, 2009, CHROMOSOME RES, V17, P1063, DOI 10.1007/s10577-009-9083-5; Veyrunes F, 2006, P ROY SOC B-BIOL SCI, V273, P2925, DOI 10.1098/rspb.2006.3670; Weimer J, 2000, CYTOGENET CELL GENET, V88, P114, DOI 10.1159/000015502; WHANGPENG J, 1976, J NATL CANCER I, V57, P897; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Yang F, 2000, CHROMOSOME RES, V8, P219, DOI 10.1023/A:1009200912436; ZENZES MT, 1977, CYTOGENET CELL GENET, V19, P368, DOI 10.1159/000130830	70	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127937	10.1371/journal.pone.0127937	http://dx.doi.org/10.1371/journal.pone.0127937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010445	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900167
J	Samson, K; Kostyszyn, P				Samson, Katarzyna; Kostyszyn, Patrycjusz			Effects of Cognitive Load on Trusting Behavior - An Experiment Using the Trust Game	PLOS ONE			English	Article							BUSYNESS; MIND	Last decades have witnessed a progressing decline of social trust, which has been predominantly linked to worsening economic conditions and increasing social inequality. In the present research we propose a different type of explanation for the observed decline cognitive load related to technological development and the accelerating pace of modern life. In an experimental study participants played the trust game while performing one of two different secondary tasks - listening to a disturbing noise or memorizing a sequence of characters - or with no additional task in the control condition. Results show that in both cognitive load conditions participants expressed significantly less trust in the trust game than in case of no cognitive load. Additionally, when cognitive resources were limited, participants' behavior was more impulsive than when their resources were fully available.	[Samson, Katarzyna] Univ Warsaw, Robert B Zajonc Inst Social Studies, Warsaw, Poland; [Kostyszyn, Patrycjusz] Univ Social Sci & Human, Warsaw, Poland	University of Warsaw; SWPS University of Social Sciences & Humanities	Samson, K (corresponding author), Univ Warsaw, Robert B Zajonc Inst Social Studies, Warsaw, Poland.	kasiasamson@gmail.com		Samson, Katarzyna/0000-0003-0248-8233	Narodowe Centrum Nauki (National Science Centre, Poland) grant Trust enhancing social factors - A dynamical perspective [2011/01/N/HS6/01903]	Narodowe Centrum Nauki (National Science Centre, Poland) grant Trust enhancing social factors - A dynamical perspective	This study was partially funded by Narodowe Centrum Nauki (National Science Centre, Poland) grant Trust enhancing social factors - A dynamical perspective no. 2011/01/N/HS6/01903, which financed the development of software used in this research. The rest of support for this research came from the authors' personal funds. No one, except the authors, had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock A. B, 2000, EFFECTS COGNITIVE LO; Alesina A, 2002, J PUBLIC ECON, V85, P207, DOI 10.1016/S0047-2727(01)00084-6; Arrow K. J., 1974, LIMITS ORG; Becker LC, 1996, ETHICS, V107, P43, DOI 10.1086/233696; Benjamin DJ, 2013, J EUR ECON ASSOC, V11, P1231, DOI 10.1111/jeea.12055; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Blind P. K., 2006, 7 GLOBAL FORUM REINV; Bohner G, 2002, BRIT J SOC PSYCHOL, V41, P495, DOI 10.1348/014466602321149858; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Coleman J., 1990, FDN SOCIAL THEORY; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Conway P, 2013, J PERS SOC PSYCHOL, V104, P216, DOI 10.1037/a0031021; Cook Karen, 2001, TRUST SOC; DEUTSCH M, 1960, HUM RELAT, V13, P123, DOI 10.1177/001872676001300202; Deutsch M., 1958, J CONFLICT RESOLUT, V2, P265, DOI [DOI 10.1177/002200275800200401, 10.1177/002200275800200401]; Duffy S, 2012, 38825 MPRA; Dyer Jeffrey H., 2006, ORG TRUST, P207; Erikson E., 1963, YOUTH CHANGE CHALLEN; Field J., 2008, SOCIAL CAPITAL, V2nd; Fukuyama F, 2001, THIRD WORLD Q, V22, P7; GILBERT D T, 1989, P189; GILBERT DT, 1989, J PERS SOC PSYCHOL, V57, P940, DOI 10.1037/0022-3514.57.6.940; GILBERT DT, 1988, J PERS SOC PSYCHOL, V54, P733, DOI 10.1037/0022-3514.54.5.733; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Hartford T., 2010, HARTFORD DATA; Hernandez I, 2013, J EXP SOC PSYCHOL, V49, P178, DOI 10.1016/j.jesp.2012.08.010; Hinson JM, 2002, COGN AFFECT BEHAV NE, V2, P341, DOI 10.3758/CABN.2.4.341; Hirsch F., 1978, SOCIAL LIMITS GROWTH; Jaworowska A, 1991, PODRECZNIK TESTU MAT; Johnson ND, 2011, J ECON PSYCHOL, V32, P865, DOI 10.1016/j.joep.2011.05.007; Johnson R, 2013, I NEW EC THINKING BL; Kenworthy L, 1997, AM BEHAV SCI, V40, P645, DOI 10.1177/0002764297040005010; Kirsh D., 2000, INTELLECTICA, V30, P19, DOI [DOI 10.3406/intel.2000.1592, 10.3406/intel.2000.1592]; Klingberg T., 2009, OVERFLOWING BRAIN IN; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Lalwani AK, 2009, J CONSUM RES, V36, P305, DOI 10.1086/597214; Lewicki R.J., 1995, C COOPERATION JUSTIC, P133, DOI DOI 10.1177/0149206306294405; LEWIS JD, 1985, SOC FORCES, V63, P967, DOI 10.2307/2578601; Lyon F, 2012, HANDBOOK OF RESEARCH METHODS ON TRUST, P1; MCALLISTER DJ, 1995, ACAD MANAGE J, V38, P24, DOI 10.2307/256727; Miller J, 2014, BBC             0807; Morrow J., 2004, J MANAGERIAL ISSUES, V16, P48; Ostrom E., 2003, TRUST RECIPROCITY IN; Papaioannou E., 2013, CTR EUROPEAN STUDIES; Pickett Kate, 2010, SPIRIT LEVEL WHY GRE; Putnam R., 2007, SCANDINAVIAN POLITIC, V30, P134, DOI [10.1111/j.1467-9477.2007.00176.x, DOI 10.1111/J.1467-9477.2007.00176.X, DOI 10.1111/j.1467-9477.2007.00176.x]; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; PUTNAM RD, 1995, J DEMOCRACY, V0006; Putnam RD., 2000, BOWLING ALONE COLLAP; Rahn WM, 1998, POLIT PSYCHOL, V19, P545, DOI 10.1111/0162-895X.00117; REMPEL JK, 1985, J PERS SOC PSYCHOL, V49, P95, DOI 10.1037/0022-3514.49.1.95; Rideout V.J., 2010, HENRY J KAIS FAM FOU; Rogers Y, 2009, LECT NOTES COMPUT SC, V5889, P1; Rotenberg KJ, 2010, PERS SOC PSYCHOL B, V36, P1086, DOI 10.1177/0146167210374957; Roth F., 2011, 343 CEPS; Rozycka J., 2012, ZYCIE SPOLECZNE JAKO; Rydval O, 2012, WP457 CERGEEI; Shiv B, 1999, J CONSUM RES, V26, P278, DOI 10.1086/209563; Short J, 2013, HOW MUCH MEDIA; Sparrow B, 2001, SCI, V333, P776; SWANN WB, 1990, J PERS SOC PSYCHOL, V59, P17, DOI 10.1037/0022-3514.59.1.17; Szalma JL, 2011, PSYCHOL BULL, V137, P682, DOI 10.1037/a0023987; Twenge JM, 2014, PSYCHOL SCI, V25, P1914, DOI 10.1177/0956797614545133; Uslaner E., 2002, MORAL FDN TRUST; van den Bos K, 2006, J EXP SOC PSYCHOL, V42, P273, DOI 10.1016/j.jesp.2005.04.003; Ward A, 2000, J PERS SOC PSYCHOL, V78, P753, DOI 10.1037/0022-3514.78.4.753; Yamagishi T., 2001, TRUST SOC, P121; Zak PJ, 2001, ECON J, V111, P295, DOI 10.1111/1468-0297.00609	68	24	25	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127680	10.1371/journal.pone.0127680	http://dx.doi.org/10.1371/journal.pone.0127680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010489	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900128
J	Xie, JJ; Lei, B; Niu, ML; Huang, Y; Kong, QS; Bie, ZL				Xie, Junjun; Lei, Bo; Niu, Mengliang; Huang, Yuan; Kong, Qiusheng; Bie, Zhilong			High Throughput Sequencing of Small RNAs in the Two Cucurbita Germplasm with Different Sodium Accumulation Patterns Identifies Novel MicroRNAs Involved in Salt Stress Response	PLOS ONE			English	Article							EXPRESSION; SALINITY; CUCUMBER; MECHANISMS; TOLERANCE; ROOTSTOCK; PROTEINS; PUMPKIN; ROLES; MELON	MicroRNAs (miRNAs), a class of small non-coding RNAs, recognize their mRNA targets based on perfect sequence complementarity. MiRNAs lead to broader changes in gene expression after plants are exposed to stress. High-throughput sequencing is an effective method to identify and profile small RNA populations in non-model plants under salt stresses, significantly improving our knowledge regarding miRNA functions in salt tolerance. Cucurbits are sensitive to soil salinity, and the Cucurbita genus is used as the rootstock of other cucurbits to enhance salt tolerance. Several cucurbit crops have been used for miRNA sequencing but salt stress-related miRNAs in cucurbit species have not been reported. In this study, we subjected two Cucurbita germplasm, namely, N12 (Cucurbita. maxima Duch.) and N15 (Cucurbita. moschata Duch.), with different sodium accumulation patterns, to Illumina sequencing to determine small RNA populations in root tissues after 4 h of salt treatment and control. A total of 21,548,326 and 19,394,108 reads were generated from the control and salt-treated N12 root tissues, respectively. By contrast, 19,108,240 and 20,546,052 reads were obtained from the control and salt-treated N15 root tissues, respectively. Fifty-eight conserved miRNA families and 33 novel miRNAs were identified in the two Cucurbita germplasm. Seven miRNAs (six conserved miRNAs and one novel miRNAs) were up-regulated in salt-treated N12 and N15 samples. Most target genes of differentially expressed novel miRNAs were transcription factors and salt stress-responsive proteins, including dehydration-induced protein, cation/H+ antiporter 18, and CBL-interacting serine/threonine-protein kinase. The differential expression of miRNAs between the two Cucurbita germplasm under salt stress conditions and their target genes demonstrated that novel miRNAs play an important role in the response of the two Cucurbita germplasm to salt stress. The present study initially explored small RNAs in the response of pumpkin to salt stress, and provided valuable information on novel miRNAs and their target genes in Cucurbita.	[Xie, Junjun; Lei, Bo; Niu, Mengliang; Huang, Yuan; Kong, Qiusheng; Bie, Zhilong] Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Bie, ZL (corresponding author), Huazhong Agr Univ, Key Lab Hort Plant Biol, Minist Educ, Coll Hort & Forestry, Wuhan 430070, Peoples R China.	biezhilong@hotmail.com	Kong, Qiusheng/F-7710-2012	Kong, Qiusheng/0000-0003-0939-4424	National Natural Science Foundation of China [31172000, 31372110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by National Natural Science Foundation of China (31172000, 31372110). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Edelstein M, 2011, J EXP BOT, V62, P177, DOI 10.1093/jxb/erq255; Fan ML, 2014, PLANTA, V239, P397, DOI 10.1007/s00425-013-1976-z; Gonzalez-Ibeas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-393; Hu JH, 2014, BIOCHIMIE, V102, P137, DOI 10.1016/j.biochi.2014.03.002; Huang Y, 2013, SCI HORTIC-AMSTERDAM, V149, P80, DOI 10.1016/j.scienta.2012.02.009; Huang Y, 2013, SCI HORTIC-AMSTERDAM, V149, P47, DOI 10.1016/j.scienta.2012.04.018; Huang Y, 2009, SCI HORTIC-AMSTERDAM, V122, P26, DOI 10.1016/j.scienta.2009.04.004; Ismail A, 2014, J EXP BOT, V65, P2963, DOI 10.1093/jxb/eru159; Jagadeeswaran G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-329; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kong QS, 2014, SCI HORTIC-AMSTERDAM, V175, P150, DOI 10.1016/j.scienta.2014.06.009; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumar R, 2014, APPL BIOCHEM BIOTECH, V174, P93, DOI 10.1007/s12010-014-0914-2; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Lei B, 2014, PHYSIOL PLANTARUM, V152, P738, DOI 10.1111/ppl.12223; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039650; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057359; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033040; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nam MH, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-25; Nie XZ, 2002, GENOME, V45, P905, DOI [10.1139/g02-062, 10.1139/G02-062]; Paul S, 2011, PLANT CELL TISS ORG, V105, P233, DOI 10.1007/s11240-010-9857-7; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Xie FL, 2014, PLANT BIOTECHNOL J, V12, P354, DOI 10.1111/pbi.12142; Yin ZJ, 2012, MOL BIOL REP, V39, P4961, DOI 10.1007/s11033-011-1292-2; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhu J, 2008, SOIL SCI PLANT NUTR, V54, P895, DOI 10.1111/j.1747-0765.2008.00306.x; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	47	20	21	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127412	10.1371/journal.pone.0127412	http://dx.doi.org/10.1371/journal.pone.0127412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010449	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900087
J	Zhang, L; Li, Y; Xie, XJ; Xu, HP; Xu, ZQ; Ma, JG; Li, BX; Lin, SD; Nie, QH; Luo, QB; Zhang, XQ				Zhang, Li; Li, Ying; Xie, Xiujuan; Xu, Haiping; Xu, Zhenqiang; Ma, Jinge; Li, Bixiao; Lin, Shudai; Nie, Qinghua; Luo, Qingbin; Zhang, Xiquan			A Systematic Analysis on mRNA and MicroRNA Expression in Runting and Stunting Chickens	PLOS ONE			English	Article							BROILER LINES; MALABSORPTION-SYNDROME; MIR-30; SUSCEPTIBILITY; FAMILY; GROWTH; GENE; BEHAVIOR; DELETION; DIFFER	Runting and stunting syndrome (RSS), which is characterized by lower body weight, widely occurs in broilers. Some RSS chickens simply exhibit slow growth without pathological changes. An increasing number of studies indicate that broiler strains differ in susceptibility to infectious diseases, most likely due to their genetic differences. The objective of this study was to detect the differentially expressed miRNAs and mRNAs in RSS and normal chickens. By integrating miRNA with mRNA expression profiling, potential molecular mechanisms involved in RSS could be further explored. Twenty-two known miRNAs and 1,159 genes were differentially expressed in RSS chickens compared with normal chickens (P < 0.05). qPCR validation results displayed similar patterns. The differentially expressed genes were primarily involved in energy metabolism pathways. The antisense transcripts were extensively expressed in chicken liver albeit with reduced abundance. Dual-luciferase reporter assay indicated that gga-miR-30b/c directly target CARS through binding to its 30UTR. The miR-30b/c: CARS regulation mainly occurred in liver. In thigh muscle and the hypothalamus, miR-30b/c are expressed at higher levels in RSS chickens compared with normal chickens from 2 to 6 w of age, and notably significant differences are observed at 4 w of age.	[Zhang, Li; Li, Ying; Xie, Xiujuan; Xu, Haiping; Xu, Zhenqiang; Ma, Jinge; Li, Bixiao; Lin, Shudai; Nie, Qinghua; Luo, Qingbin; Zhang, Xiquan] South China Agr Univ, Minist Agr, Guangdong Prov Key Lab Agroanim Genom & Mol Bree, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Li; Li, Ying; Xie, Xiujuan; Xu, Haiping; Xu, Zhenqiang; Ma, Jinge; Li, Bixiao; Lin, Shudai; Nie, Qinghua; Luo, Qingbin; Zhang, Xiquan] South China Agr Univ, Minist Agr, Key Lab Chicken Genet,Breeding & Reprod, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Li] Guangdong Ocean Univ, Coll Agr, Zhanjiang 524088, Peoples R China; [Li, Ying] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou 510640, Guangdong, Peoples R China	Ministry of Agriculture & Rural Affairs; South China Agricultural University; Ministry of Agriculture & Rural Affairs; South China Agricultural University; Guangdong Ocean University; Guangdong Academy of Agricultural Sciences	Zhang, XQ (corresponding author), South China Agr Univ, Minist Agr, Guangdong Prov Key Lab Agroanim Genom & Mol Bree, Guangzhou 510642, Guangdong, Peoples R China.	xqzhang@scau.edu.cn	xu, haiping/GSJ-1374-2022		Chinese Postdoctoral Science Foundation [2012M521611, 2013T60808]; National Natural Science Foundation [31301958]; Guangdong Provincial Natural Science Foundation [S2013010013382]; China Agriculture Research System [CARS-42-G05]	Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); China Agriculture Research System	This work was supported by the Chinese Postdoctoral Science Foundation (2012M521611, 2013T60808), the National Natural Science Foundation (31301958), the Guangdong Provincial Natural Science Foundation (S2013010013382) and the China Agriculture Research System (CARS-42-G05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolisetty MT, 2009, J VIROL, V83, P12009, DOI 10.1128/JVI.01182-09; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Choufani S, 2013, AM J MED GENET C, V163C, P131, DOI 10.1002/ajmg.c.31363; Costa V, 2013, EUR J HUM GENET, V21, P134, DOI 10.1038/ejhg.2012.129; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Gu LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086150; Hu J, 2013, AM J MED GENET A, V161A, P179, DOI 10.1002/ajmg.a.35658; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kaiser MG, 1998, POULTRY SCI, V77, P271, DOI 10.1093/ps/77.2.271; Kang KI, 2012, AVIAN PATHOL, V41, P41, DOI 10.1080/03079457.2011.632402; Kort YH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-12; KOUWENHOVEN B, 1978, AVIAN PATHOL, V7, P183, DOI 10.1080/03079457808418269; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; LILBURN MS, 1982, POULTRY SCI, V61, P608, DOI 10.3382/ps.0610608; Lin SM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-306; Ma Q, 2008, CELL SIGNAL, V20, P1044, DOI 10.1016/j.cellsig.2008.01.015; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Otto P, 2006, AVIAN DIS, V50, P411, DOI 10.1637/7511-020106R.1; Pfisterer L, 2015, CIRCULATION, V132; Rebel JMJ, 2005, BRIT POULTRY SCI, V46, P679, DOI 10.1080/00071660500395541; Rebel JMJ, 2004, BRIT POULTRY SCI, V45, P201, DOI 10.1080/00071660410001715803; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sissler M, 1999, P NATL ACAD SCI USA, V96, P8985, DOI 10.1073/pnas.96.16.8985; Songserm T, 2002, VET IMMUNOL IMMUNOP, V85, P51, DOI 10.1016/S0165-2427(01)00411-1; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Toyomizu M, 2011, COMP BIOCHEM PHYS A, V159, P75, DOI 10.1016/j.cbpa.2011.01.020; van Hemert S, 2004, POULTRY SCI, V83, P1675, DOI 10.1093/ps/83.10.1675; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-278; WINSTEAD CS, 1985, POULTRY SCI, V64, P499, DOI 10.3382/ps.0640499; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zekarias B, 2002, POULTRY SCI, V81, P1283, DOI 10.1093/ps/81.9.1283; Zhang L, 2013, GENE, V519, P77, DOI 10.1016/j.gene.2013.01.043; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	38	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127342	10.1371/journal.pone.0127342	http://dx.doi.org/10.1371/journal.pone.0127342			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010155	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900084
J	Brown, JR; Livesay, DR				Brown, Jenna R.; Livesay, Dennis R.			Flexibility Correlation between Active Site Regions Is Conserved across Four AmpC beta-Lactamase Enzymes	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ALLOSTERIC MODULATION; CITROBACTER-FREUNDII; ESCHERICHIA-COLI; OMEGA-LOOP; SPECTRUM; STABILITY; MECHANISM; EVOLUTION; RESISTANCE	beta-lactamases are bacterial enzymes that confer resistance to beta-lactam antibiotics, such as penicillins and cephalosporins. There are four classes of beta-lactamase enzymes, each with characteristic sequence and structure properties. Enzymes from class A are the most common and have been well characterized across the family; however, less is known about how physicochemical properties vary across the C and D families. In this report, we compare the dynamical properties of four AmpC (class C) beta-lactamases using our distance constraint model (DCM). The DCM reliably predicts thermodynamic and mechanical properties in an integrated way. As a consequence, quantitative stability/flexibility relationships (QSFR) can be determined and compared across the whole family. The DCM calculates a large number of QSFR metrics. Perhaps the most useful is the flexibility index (FI), which quantifies flexibility along the enzyme backbone. As typically observed in other systems, FI is well conserved across the four AmpC enzymes. Cooperativity correlation (CC), which quantifies intramolecular couplings within structure, is rarely conserved across protein families; however, it is in AmpC. In particular, the bulk of each structure is composed of a large rigid cluster, punctuated by three flexibly correlated regions located at the active site. These regions include several catalytic residues and the O-loop. This evolutionary conservation combined with active their site location strongly suggests that these coupled dynamical modes are important for proper functioning of the enzyme.	[Brown, Jenna R.] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28262 USA; [Livesay, Dennis R.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28262 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Livesay, DR (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28262 USA.	drlivesa@uncc.edu			National Institutes of Health [GM101570]; Charlotte Research Scholars summer research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM101570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Research Scholars summer research fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by a National Institutes of Health grant GM101570 to DRL and a Charlotte Research Scholars summer research fellowship to JRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; Azzaroni O, 2008, PHYS CHEM CHEM PHYS, V10, P7031, DOI 10.1039/b806445h; Banerjee S, 1998, BIOCHEMISTRY-US, V37, P3286, DOI 10.1021/bi972127f; Beadle BM, 1999, PROTEIN SCI, V8, P1816, DOI 10.1110/ps.8.9.1816; Blizzard TA, 2010, BIOORG MED CHEM LETT, V20, P918, DOI 10.1016/j.bmcl.2009.12.069; Bos F, 2009, BIOPHYS J, V97, P2550, DOI 10.1016/j.bpj.2009.08.031; Brown MC, 2014, METHODS MOL BIOL, V1084, P227, DOI 10.1007/978-1-62703-658-0_12; Bu, 2010, HLTH INF BIOINF HIBI; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Chen Y, 2006, J AM CHEM SOC, V128, P2970, DOI 10.1021/ja056806m; Chen Y, 2009, PROTEIN SCI, V18, P662, DOI 10.1002/pro.60; Crichlow GV, 2001, BIOCHEMISTRY-US, V40, P6233, DOI 10.1021/bi010131s; Dahiyat BI, 1997, PROTEIN SCI, V6, P1333, DOI 10.1002/pro.5560060622; Diaz N, 2006, BIOCHEMISTRY-US, V45, P439, DOI 10.1021/bi051600j; Donadio S, 2010, J ANTIBIOT, V63, P423, DOI 10.1038/ja.2010.62; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Emery CL, 1997, J CLIN MICROBIOL, V35, P2061, DOI 10.1128/JCM.35.8.2061-2067.1997; Goldberg SD, 2003, PROTEIN SCI, V12, P1633, DOI 10.1110/ps.0302903; HUDSON JW, 1993, J MOL BIOL, V234, P700, DOI 10.1006/jmbi.1993.1621; Jacobs D., 2012, BIOPHYSICS INTECH, P91; Jacobs DJ, 2005, BIOPHYS J, V88, P903, DOI 10.1529/biophysj.104.048496; Jacobs DJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061109; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 2006, RECENT RES DEV BIOPH, V5, P71; Jacobs DJ, 2012, METHODS MOL BIOL, V796, P279, DOI 10.1007/978-1-61779-334-9_15; Jacobs DJ, 2010, CURR OPIN PHARMACOL, V10, P760, DOI 10.1016/j.coph.2010.09.014; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jensen AA, 2004, EUR J PHARM SCI, V21, P407, DOI 10.1016/j.ejps.2003.11.007; Kato-Toma Y, 2003, BIOCHEM J, V371, P175, DOI 10.1042/BJ20021447; Kim JY, 2006, MOL MICROBIOL, V60, P907, DOI 10.1111/j.1365-2958.2006.05146.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li TJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0082499, 10.1371/journal.pone.0092870]; Li T, 2014, PROTEIN PEPTIDE LETT, V21, P752; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu CT, 2014, J AM CHEM SOC, V136, P10349, DOI 10.1021/ja5038947; Livesay DR, 2006, J CHEM THEORY COMPUT, V2, P927, DOI 10.1021/ct600066z; Livesay DR, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-17; Livesay DR, 2006, PROTEINS, V62, P130, DOI 10.1002/prot.20745; Livesay DR, 2004, FEBS LETT, V576, P468, DOI 10.1016/j.febslet.2004.09.057; MADGWICK PJ, 1987, BIOCHEM J, V248, P657, DOI 10.1042/bj2480657; Majiduddin FK, 2002, INT J MED MICROBIOL, V292, P127, DOI 10.1078/1438-4221-00198; May LT, 2004, CURR PHARM DESIGN, V10, P2003, DOI 10.2174/1381612043384303; MONNAIE D, 1994, BIOCHEM J, V302, P1; Mottonen JM, 2010, BIOPHYS J, V99, P2245, DOI 10.1016/j.bpj.2010.07.043; Mottonen JM, 2009, PROTEINS, V75, P610, DOI 10.1002/prot.22273; Nukaga M, 2004, J BIOL CHEM, V279, P9344, DOI 10.1074/jbc.M312356200; Nukaga M, 1998, BIOCHEMISTRY-US, V37, P10461, DOI 10.1021/bi980184i; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Rasheed JK, 1997, ANTIMICROB AGENTS CH, V41, P647, DOI 10.1128/AAC.41.3.647; Royer WE, 2005, J BIOL CHEM, V280, P27477, DOI 10.1074/jbc.R500006200; Royer WE, 2001, TRENDS BIOCHEM SCI, V26, P297, DOI 10.1016/S0968-0004(01)01811-4; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Teotico DG, 2009, P NATL ACAD SCI USA, V106, P7455, DOI 10.1073/pnas.0813029106; Thomas VL, 2010, J MOL BIOL, V396, P47, DOI 10.1016/j.jmb.2009.11.005; Verma D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003155; Verma D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002409; Vorov OK, 2011, BIOPHYS J, V100, P1129, DOI 10.1016/j.bpj.2011.01.027; Vorov OK, 2009, BIOPHYS J, V97, P3000, DOI 10.1016/j.bpj.2009.09.013; Wernli D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001022	65	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125832	10.1371/journal.pone.0125832	http://dx.doi.org/10.1371/journal.pone.0125832			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018804	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600036
J	Zhong, GC; Wang, Y; Zhang, Y; Zhao, Y				Zhong, GuoChao; Wang, Yi; Zhang, Yong; Zhao, Yong			Association between Benzodiazepine Use and Dementia: A Meta-Analysis	PLOS ONE			English	Article							PSYCHOTROPIC-DRUG USE; LONG-TERM USE; ALZHEIMERS-DISEASE; RISK; PREVALENCE; DISORDERS; HEALTH	Background The association between long-term benzodiazepine use and risk of dementia remains controversial. Therefore, current study aimed to quantify this association, and to explore a potential dose-response pattern. Methods We searched PubMed, Embase and the Cochrane Library through August 17, 2014. We included nested case-control or prospective cohort studies that provided risk estimates on the association of benzodiazepine use with risk of dementia, and a clear definition of status of benzodiazepine use. Overall effect size was calculated using a random-effects model. Findings Six studies were eligible for inclusion, involving 11,891 dementia cases and 45,391 participants. Compared with never users, pooled adjusted risk ratios (RRs) for dementia were 1.49 (95% confidence interval (CI) 1.30-1.72) for ever users, 1.55 (95% CI 1.31-1.83) for recent users, and 1.55 (95% CI 1.17-2.03) for past users. The risk of dementia increased by 22% for every additional 20 defined daily dose per year (RR, 1.22, 95% CI 1.18-1.25). When we restricted our meta-analyses to unadjusted RRs, all initial significant associations persisted. Conclusions Long-term benzodiazepine users have an increased risk of dementia compared with never users. However, findings from our study should be treated with caution due to limited studies and potential reverse causation. Large prospective cohort studies with long follow-up duration are warranted to confirm these findings.	[Zhong, GuoChao; Wang, Yi] Chongqing Med Univ, Student Off 2, Chongqing, Peoples R China; [Zhang, Yong; Zhao, Yong] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zhong, GC (corresponding author), Chongqing Med Univ, Student Off 2, Chongqing, Peoples R China.	gczhong1991@163.com; zhaoyong@cqmu.edu.cn	Zhang, Yong/B-7089-2016; Zhao, Yong/Z-3231-2019	Zhang, Yong/0000-0003-1436-5951; Zhao, Yong/0000-0001-9290-109X; Zhong, Guo-Chao/0000-0002-0280-7938				Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Ashton H, 2005, CURR OPIN PSYCHIATR, V18, P249, DOI 10.1097/01.yco.0000165594.60434.84; Barbui C, 2013, EPIDEMIOL PSYCH SCI, V22, P307, DOI 10.1017/S2045796013000358; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bennett S, 2014, MATURITAS; Bocti C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7986; Chen PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049113; de Gage SB, 2015, EXPERT OPIN DRUG SAF, V14, P733, DOI 10.1517/14740338.2015.1014796; de Gage SB, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5205; de Gage SB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6231; Dell'osso B, 2013, EUR PSYCHIAT, V28, P7, DOI 10.1016/j.eurpsy.2011.11.003; Dong JY, 2011, J AM COLL CARDIOL, V58, P1378, DOI 10.1016/j.jacc.2011.06.024; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; European Medicines Agency, 2012, SUMM PROD CHAR BENZ; Fastbom J, 1998, ALZ DIS ASSOC DIS, V12, P14, DOI 10.1097/00002093-199803000-00002; Froehlich TE, 2001, J AM GERIATR SOC, V49, P477, DOI 10.1046/j.1532-5415.2001.49096.x; Gallacher J, 2012, J EPIDEMIOL COMMUN H, V66, P869, DOI 10.1136/jech-2011-200314; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Griffiths RR, 1997, PSYCHOPHARMACOLOGY, V134, P1, DOI 10.1007/s002130050422; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hsiao F-Y, 2014, J AM MED DIRECTORS A; Lagnaoui R, 2002, J CLIN EPIDEMIOL, V55, P314, DOI 10.1016/S0895-4356(01)00453-X; Lesen E, 2011, INT PSYCHOGERIATR, V23, P1270, DOI 10.1017/S1041610211000524; Linden M, 2004, INT PSYCHOGERIATR, V16, P461, DOI 10.1017/S1041610204000420; Mamdani M, 2005, AM J GERIAT PSYCHIAT, V13, P892, DOI 10.1176/appi.ajgp.13.10.892; Mirza SS, 2014, ALZHEIMERS DEMENTIA; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Pariente A, 2008, DRUG AGING, V25, P61, DOI 10.2165/00002512-200825010-00007; Parikh NM, 2011, INT J GERIATR PSYCH, V26, P749, DOI 10.1002/gps.2604; Puustinen J, 2007, DRUG AGING, V24, P1045, DOI 10.2165/00002512-200724120-00007; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; SHORR RI, 1994, DRUG AGING, V4, P9, DOI 10.2165/00002512-199404010-00002; Smith AD, 2014, J ALZHEIMERS DIS, V38, P699, DOI 10.3233/JAD-132372; Ster MP, 2011, CROAT MED J, V52, P16, DOI 10.3325/cmj.2011.52.16; Vinkers CH, 2012, ADV PHARMACOL SCI, V2012, DOI 10.1155/2012/416864; Wells GA., 2015, NEWCASTLE OTTAWA SCA; World Health Organization, 2000, COLL CTR DRUG STAT M; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210; Xiang YT, 2008, SLEEP, V31, P1655, DOI 10.1093/sleep/31.12.1655	42	80	83	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127836	10.1371/journal.pone.0127836	http://dx.doi.org/10.1371/journal.pone.0127836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016483	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600097
J	Dey, P; Velazquez-Villegas, LA; Faria, M; Turner, A; Jonsson, P; Webb, P; Williams, C; Gustafsson, JA; Strom, AM				Dey, Prasenjit; Velazquez-Villegas, Laura A.; Faria, Michelle; Turner, Anthony; Jonsson, Philp; Webb, Paul; Williams, Cecilia; Gustafsson, Jan-Ake; Stroem, Anders M.			Estrogen Receptor beta 2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1 alpha in Prostate Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU PROTEIN; ANDROGEN RECEPTOR; ER-BETA; ALPHA; GROWTH; HIF; TRANSCRIPTION; METASTASIS; MECHANISM	The estrogen receptor (ER) beta variant ER beta 2 is expressed in aggressive castration-resistant prostate cancer and has been shown to correlate with decreased overall survival. Genome-wide expression analysis after ER beta 2 expression in prostate cancer cells revealed that hypoxia was an overrepresented theme. Here we show that ER beta 2 interacts with and stabilizes HIF-1 alpha protein in normoxia, thereby inducing a hypoxic gene expression signature. HIF-1 alpha is known to stimulate metastasis by increasing expression of Twist1 and increasing vascularization by directly activating VEGF expression. We found that ER beta 2 interacts with HIF-1 alpha and piggybacks to the HIF-1 alpha response element present on the proximal Twist1 and VEGF promoters. These findings suggest that at least part of the oncogenic effects of ER beta 2 is mediated by HIF-1 alpha and that targeting of this ER beta 2 -HIF-1 alpha interaction may be a strategy to treat prostate cancer.	[Dey, Prasenjit; Velazquez-Villegas, Laura A.; Faria, Michelle; Turner, Anthony; Jonsson, Philp; Williams, Cecilia; Gustafsson, Jan-Ake; Stroem, Anders M.] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Sci & Engn Res Ctr, Houston, TX 77204 USA; [Webb, Paul] Weill Cornell Med Coll, Houston Methodist Res Inst, Genom Med Program, Houston, TX 77030 USA; [Gustafsson, Jan-Ake] Karolinska Inst, Dept BioSci & Nutr, S-14157 Huddinge, Sweden; [Williams, Cecilia] KTH Royal Inst Technol, Dept Prote & Nanotechnol, Sci Life Lab, S-17121 Stockholm, Sweden	University of Houston System; University of Houston; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Karolinska Institutet; Royal Institute of Technology	Strom, AM (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Sci & Engn Res Ctr, 3605 Cullen Blvd,Bldg 545, Houston, TX 77204 USA.	amstrom@uh.edu	Williams, Cecilia/A-6677-2009	Williams, Cecilia/0000-0002-0602-2062; Velazquez-Villegas, Laura/0000-0002-5310-5637; Jonsson, Philip/0000-0002-1537-0624	Cancer Prevention & Research Institute of Texas (CPRIT) [HIRP100680, RP110444]; Texas Emerging Technology Fund [300-9-1958]; Robert A. Welch Foundation [E-0004]; Swedish Cancer Fund; Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility for Growth [GROWTH 291795]	Cancer Prevention & Research Institute of Texas (CPRIT); Texas Emerging Technology Fund; Robert A. Welch Foundation(The Welch Foundation); Swedish Cancer Fund; Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility for Growth	This work was supported by The Cancer Prevention & Research Institute of Texas (CPRIT) grants HIRP100680 and RP110444, the Texas Emerging Technology Fund under Agreement no. 300-9-1958, the Robert A. Welch Foundation (Grant E-0004), the Swedish Cancer Fund and Marie Curie Actions FP7-PEOPLE-2011-COFUND (GROWTH 291795) via the VINNOVA programme Mobility for Growth (to C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chantzi MI, 2013, J CANCER RES CLIN, V139, P1489, DOI 10.1007/s00432-013-1467-4; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Dey P, 2014, ONCOGENE, V33, P4213, DOI 10.1038/onc.2013.384; Dey P, 2012, MOL ENDOCRINOL, V26, P1991, DOI 10.1210/me.2012.1227; Fixemer T, 2003, PROSTATE, V54, P79, DOI 10.1002/pros.10171; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Horvath LG, 2001, CANCER RES, V61, P5331; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Latil A, 2001, CANCER RES, V61, P1919; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Leung YK, 2010, ENDOCR-RELAT CANCER, V17, P675, DOI 10.1677/ERC-09-0294; Li XF, 2007, CANCER RES, V67, P7646, DOI 10.1158/0008-5472.CAN-06-4353; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mak P, 2013, P NATL ACAD SCI USA, V110, P4708, DOI 10.1073/pnas.1221654110; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Ogawa S, 1998, NUCLEIC ACIDS RES, V26, P3505, DOI 10.1093/nar/26.15.3505; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Paatero I, 2012, J BIOL CHEM, V287, P9659, DOI 10.1074/jbc.M111.299537; Perlmutter Mark A, 2007, Rev Urol, V9 Suppl 1, pS3; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Ragnum HB, 2013, INT J RADIAT ONCOL, V87, P753, DOI 10.1016/j.ijrobp.2013.07.023; Richter K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-75; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	36	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128239	10.1371/journal.pone.0128239	http://dx.doi.org/10.1371/journal.pone.0128239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010887	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900212
J	Stobart, B; Diaz, D; Alvarez, F; Alonso, C; Mallol, S; Goni, R				Stobart, Ben; Diaz, David; Alvarez, Federico; Alonso, Cristina; Mallol, Sandra; Goni, Raquel			Performance of Baited Underwater Video: Does It Underestimate Abundance at High Population Densities?	PLOS ONE			English	Article							PALINURUS-ELEPHAS FABRICIUS; FISH ASSEMBLAGES; REEF FISH; RELATIVE DENSITY; IDENTIFICATION; BIODIVERSITY; VARIABILITY; ATTRACTION; CARCHARIAS; FISHERIES	Video survey techniques are now commonly used to estimate animal abundance under the assumption that estimates relate to true abundance, a key property needed to make video a valid survey tool. Using the spiny lobster Palinurus elephas as our model organism, we evaluate the effectiveness of baited underwater video (BUV) for estimating abundance in areas with widely different population density. We test three BUV abundance metrics and compare the results with an independently obtained abundance index from trammel-net surveys (Trammel). Video metrics used to estimate relative abundance include a value for total number of individuals per recording (TotN), the traditional maximum number of fish observed in a single video frame (MaxN), and the recently suggested alternative, the average of the mean MaxN from 5-minute periods throughout the duration of the recording (MeanN). This is the first video study of a wild population to include an estimate for TotN. Comparison of TotN with the other two BUV relative abundance metrics demonstrates that both of the latter lack resolution at high population densities. In spite of this, the three BUV metrics tested, as well as the independent estimate Trammel, distinguished high density areas from low density areas. Thus they could all be used to identify areas of differing population density, but MaxN and MeanN would not be appropriate metrics for studies aimed at documenting increases in abundance, such as those conducted to assess marine protected area effectiveness, as they are prone to sampling saturation. We also demonstrate that time of first arrival (T1) is highly correlated with all of the abundance indices; suggesting T1 may be a potentially useful index of abundance. However, these relationships require further investigation as our data suggests T1 may not adequately represent lobster abundance in areas of high density.	[Stobart, Ben; Diaz, David; Alvarez, Federico; Mallol, Sandra; Goni, Raquel] Ctr Oceanog Baleares, Inst Espanol Oceanog, Palma de Mallorca 07015, Spain; [Stobart, Ben] Port Lincoln Marine Sci Ctr, South Australian Res & Dev Inst, Port Lincoln, SA 5606, Australia; [Diaz, David] CSIC, Inst Ciencies Mar, E-08003 Barcelona, Spain; [Alonso, Cristina] Univ Alicante, IMEM Ramon Margalef, E-03080 Alicante, Spain	Spanish Institute of Oceanography; South Australian Research & Development Institute (SARDI); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universitat d'Alacant	Stobart, B (corresponding author), Ctr Oceanog Baleares, Inst Espanol Oceanog, Muelle Poniente S-N, Palma de Mallorca 07015, Spain.	ben.stobart@sa.gov.au	Ning, Yin/B-4034-2017; Ning〕, 宁印〔Yin/AAN-7682-2020; Ning, Yin/N-7040-2019; DIAZ, DAVID/AAS-8722-2021	Ning, Yin/0000-0003-1808-3513; Ning, Yin/0000-0003-1808-3513; DIAZ, DAVID/0000-0003-0611-2516; MALLOL, SANDRA/0000-0002-0394-9794	Spanish National Plan for Scientific and Technological Research and Innovation; RECMARE project [CTM2012-36982 MAR]; SGP (Spanish Ministry of Agriculture, Environment and Fisheries); South Australian Research Institute	Spanish National Plan for Scientific and Technological Research and Innovation; RECMARE project; SGP (Spanish Ministry of Agriculture, Environment and Fisheries); South Australian Research Institute	This work was supported by a grant from the Spanish National Plan for Scientific and Technological Research and Innovation, the RECMARE project (CTM2012-36982 MAR) and by the SGP (Spanish Ministry of Agriculture, Environment and Fisheries) for the ERICOL project. The South Australian Research Institute provided in-kind funding support.	Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Bacheler NM, 2013, FISH RES, V143, P81, DOI 10.1016/j.fishres.2013.01.013; Bernard ATF, 2012, MAR ECOL PROG SER, V471, P235, DOI 10.3354/meps10039; Birt MJ, 2012, J EXP MAR BIOL ECOL, V416, P92, DOI 10.1016/j.jembe.2012.02.011; Brooks Edward J., 2011, Endangered Species Research, V13, P231, DOI 10.3354/esr00331; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2007, CUTTINGEDGE TECHNOLO, V1, P101; Cappo M., 2002, AQUATIC PROTECTED AR, P455; Connolly RM, 2002, MAR FRESHWATER RES, V53, P777, DOI 10.1071/MF01168; Diaz D, 2011, MAR ECOL PROG SER, V433, P149, DOI 10.3354/meps09182; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; ELLIS DM, 1995, FISH B-NOAA, V93, P67; Farnsworth KD, 2007, MAR ECOL PROG SER, V350, P223, DOI 10.3354/meps07190; Frisch AJ, 2007, J EXP MAR BIOL ECOL, V351, P294, DOI 10.1016/j.jembe.2007.07.008; GOBERT B, 1992, FISH RES, V13, P353, DOI 10.1016/0165-7836(92)90057-Z; Goni R, 2005, CAH BIOL MAR, V46, P127; Goni R, 2003, FISH RES, V65, P295, DOI 10.1016/j.fishres.2003.09.021; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Jury SH, 2001, MAR FRESHWATER RES, V52, P1125, DOI 10.1071/MF01096; MacDiarmid AB, 2005, NEW ZEAL J MAR FRESH, V39, P551, DOI 10.1080/00288330.2005.9517333; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; McConney P, 2007, FISH RES, V87, P77, DOI 10.1016/j.fishres.2007.06.011; Merritt D, 2011, FISH B-NOAA, V109, P56; Meyer-Rochow V.B., 1984, ZOOLOGICA, V45, P1; SAINTE-MARIE B, 1987, MAR BIOL, V94, P431, DOI 10.1007/BF00428250; Schobernd ZH, 2014, CAN J FISH AQUAT SCI, V71, P464, DOI 10.1139/cjfas-2013-0086; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Stoner AW, 2008, J EXP MAR BIOL ECOL, V354, P202, DOI 10.1016/j.jembe.2007.11.008; Taylor MD, 2013, FISH RES, V140, P96, DOI 10.1016/j.fishres.2012.12.013; Tessier E, 2005, J EXP MAR BIOL ECOL, V315, P17, DOI 10.1016/j.jembe.2004.08.027; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Wilson SK, 2006, J FISH BIOL, V69, P928, DOI 10.1111/j.1095-8649.2006.01128.x; Wraith JA, 2007, ASSESSING REEF ASSEM; Wraith J, 2013, MAR ECOL PROG SER, V477, P189, DOI 10.3354/meps10137	40	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127559	10.1371/journal.pone.0127559	http://dx.doi.org/10.1371/journal.pone.0127559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010738	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900110
J	Szpila, BE; Ozrazgat-Baslanti, T; Zhang, JY; Lanz, J; Davis, R; Rebel, A; Vanzant, E; Gentile, LF; Cuenca, AG; Ang, DN; Liu, HZ; Lottenberg, L; Marker, P; Zumberg, M; Bihorac, A; Moore, FA; Brakenridge, S; Efron, PA				Szpila, Benjamin E.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Lanz, Jennifer; Davis, Ruth; Rebel, Annette; Vanzant, Erin; Gentile, Lori F.; Cuenca, Alex G.; Ang, Darwin N.; Liu, Huazhi; Lottenberg, Lawrence; Marker, Peggy; Zumberg, Marc; Bihorac, Azra; Moore, Frederick A.; Brakenridge, Scott; Efron, Philip A.			Successful Implementation of a Packed Red Blood Cell and Fresh Frozen Plasma Transfusion Protocol in the Surgical Intensive Care Unit	PLOS ONE			English	Article							PROTHROMBIN TIME; CARDIAC-SURGERY; CRITICALLY-ILL; INCREASED MORTALITY; ELDERLY-PATIENTS; REQUIREMENTS; MORBIDITY; TRAUMA; TRIAL	Background Blood product transfusions are associated with increased morbidity and mortality. The purpose of this study was to determine if implementation of a restrictive protocol for packed red blood cell (PRBC) and fresh frozen plasma (FFP) transfusion safely reduces blood product utilization and costs in a surgical intensive care unit (SICU). Study Design We performed a retrospective, historical control analysis comparing before (PRE) and after (POST) implementation of a restrictive PRBC/FFP transfusion protocol for SICU patients. Univariate analysis was utilized to compare patient demographics and blood product transfusion totals between the PRE and POST cohorts. Multivariate logistic regression models were developed to determine if implementation of the restrictive transfusion protocol is an independent predictor of adverse outcomes after controlling for age, illness severity, and total blood products received. Results 829 total patients were included in the analysis (PRE, n=372; POST, n=457). Despite higher mean age (56 vs. 52 years, p=0.01) and APACHE II scores (12.5 vs. 11.2, p=0.006), mean units transfused per patient were lower for both packed red blood cells (0.7 vs. 1.2, p=0.03) and fresh frozen plasma (0.3 vs. 1.2, p=0.007) in the POST compared to the PRE cohort, respectively. There was no difference in inpatient mortality between the PRE and POST cohorts (7.5% vs. 9.2%, p=0.39). There was a decreased risk of urinary tract infections (OR 0.47, 95% CI 0.28-0.80) in the POST cohort after controlling for age, illness severity and amount of blood products transfused. Conclusions Implementation of a restrictive transfusion protocol can effectively reduce blood product utilization in critically ill surgical patients with no increase in morbidity or mortality.	[Szpila, Benjamin E.; Zhang, Jianyi; Lanz, Jennifer; Davis, Ruth; Vanzant, Erin; Gentile, Lori F.; Cuenca, Alex G.; Lottenberg, Lawrence; Moore, Frederick A.; Brakenridge, Scott; Efron, Philip A.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA; [Ozrazgat-Baslanti, Tezcan; Bihorac, Azra] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32610 USA; [Marker, Peggy] Univ Florida, Coll Med, Dept Nursing, Gainesville, FL 32610 USA; [Zumberg, Marc] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA; [Rebel, Annette] Univ Kentucky, Coll Med, Dept Anesthesia, Lexington, KY 40506 USA; [Ang, Darwin N.; Liu, Huazhi] Univ S Florida, Dept Surg, Tampa, FL 33612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Kentucky; State University System of Florida; University of South Florida	Efron, PA (corresponding author), Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA.	philip.efron@surgery.ufl.edu	Brakenridge, Scott/AAD-6691-2019; Bihorac, Azra/Q-6500-2016; Ang, Darwin/AIA-3852-2022	Brakenridge, Scott/0000-0002-7327-3718; Bihorac, Azra/0000-0002-5745-2863; Zhang, Jianyi/0000-0002-1501-4822	NIGMS [T32 GM-008721, R01 GM-40586-24, R01 GM-80576-06]; NIH NIGMS [K23 GM087709]; P50 NIH grant [P50GM111152-01]; NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM111152, R01GM040586, T32GM008721, K23GM087709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); P50 NIH grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	BES, AGC, and LFG were supported by a T32 training grant (T32 GM-008721) in burns and trauma from the NIGMS. AB is supported by NIH NIGMS Grant K23 GM087709. Other support was provided by R01 GM-40586-24 and R01 GM-80576-06 awarded by the NIGMS. AB, FM, SB, and PE were supported by a P50 NIH grant P50GM111152-01. NIH funding had a role in the collection, management, analysis, and interpretation of the data; and preparation and review of the manuscript.	Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x; Bauer DF, 2011, J TRAUMA, V70, P1112, DOI 10.1097/TA.0b013e3181e7c2ae; Corwin HL, 2007, NEW ENGL J MED, V356, P1667, DOI 10.1056/NEJMe078019; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Gerber DR, 2008, CRIT CARE MED, V36, P1068, DOI 10.1097/CCM.0b013e318169251f; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 2004, VOX SANG, V87, P209, DOI 10.1111/j.1741-6892.2004.00497.x; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Juffermans NP, 2011, SHOCK, V35, P355, DOI 10.1097/SHK.0b013e3182086094; Kiraly LN, 2009, J TRAUMA, V67, P29, DOI 10.1097/TA.0b013e3181af6a8c; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Marik PE, 2008, CRIT CARE MED, V36, P3134; Matevosyan K, 2011, J NEUROSURG, V114, P3, DOI 10.3171/2010.7.JNS091699; Mica Ladislav, 2013, J Trauma Manag Outcomes, V7, P6, DOI 10.1186/1752-2897-7-6; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Napolitano LM, 2009, J TRAUMA, V67, P1439, DOI 10.1097/TA.0b013e3181ba7074; Pita-Ramirez L, 1999, REV INVEST CLIN, V51, P89; Qiao Q, 2012, J INT MED RES, V40, P1114, DOI 10.1177/147323001204000331; Raghavan M, 2005, CHEST, V127, P295, DOI 10.1378/chest.127.1.295; Robinson WP, 2005, J TRAUMA, V58, P437, DOI 10.1097/01.TA.0000153935.18997.14; Stanworth SJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10129; Stanworth SJ, 2004, BRIT J HAEMATOL, V126, P139, DOI 10.1111/j.1365-2141.2004.04973.x; Tavares M, 2011, TRANSFUSION, V51, P754, DOI 10.1111/j.1537-2995.2010.02900.x; Taylor RW, 2002, CRIT CARE MED, V30, P2249, DOI 10.1097/00003246-200210000-00012; Tinmouth AT, 2011, CRIT CARE, V15, DOI 10.1186/cc10215; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; [No title captured]	29	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126895	10.1371/journal.pone.0126895	http://dx.doi.org/10.1371/journal.pone.0126895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010247	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900045
J	Vaughan, K; Ponomarenko, J; Peters, B; Sette, A				Vaughan, Kerrie; Ponomarenko, Julia; Peters, Bjoern; Sette, Alessandro			Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and Present	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; HIGH-RISK INFANTS; FUSION GLYCOPROTEIN; MONOCLONAL-ANTIBODY; F-GLYCOPROTEIN; MEMBRANE-FUSION; MEASLES-VIRUS; INFECTION; VACCINE; PROTEIN	Human RSV is one of the most prevalent viral pathogens of early childhood for which no vaccine is available. Herein we provide an analysis of RSV epitope data to examine its application to vaccine design and development. Our objective was to provide an overview of antigenic coverage, identify critical antibody and T cell determinants, and then analyze the cumulative RSV epitope data from the standpoint of functional responses using a combinational approach to characterize antigenic structure and epitope location. A review of the cumulative data revealed, not surprisingly, that the vast majority of epitopes have been defined for the two major surface antigens, F and G. Antibody and T cell determinants have been reported from multiple hosts, including those from human subjects following natural infection, however human data represent a minority of the data. A structural analysis of the major surface antigen, F, showed that the majority of epitopes defined for functional antibodies (neutralizing and/or protective) were either shown to bind pre-F or to be accessible in both pre-and post-F forms. This finding may have has implications for on-going vaccine design and development. These interpretations are in agreement with previous work and can be applied in the larger context of functional epitopes on the F protein. It is our hope that this work will provide the basis for further RSV-specific epitope discovery and investigation into the nature of antigen conformation in immunogenicity.	[Vaughan, Kerrie; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Ponomarenko, Julia] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; University of California System; University of California San Diego	Vaughan, K (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	kvaughan@liai.org	Ponomarenko, Julia/K-8105-2015; Sette, Alessandro/AFO-8916-2022	Ponomarenko, Julia/0000-0002-1477-9444	NIAID [HHSN272201200010C]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, contract # HHSN272201200010C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA GL, 1981, IMMUNOL REV, V58, P5, DOI 10.1111/j.1600-065X.1981.tb00347.x; Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Anderson R, 2010, FUTURE MICROBIOL, V5, P585, DOI 10.2217/FMB.10.22; Apweiler R, 2010, NAT CHEM BIOL, V6, P785, DOI 10.1038/nchembio.460; ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; Bueno SM, 2008, INT IMMUNOPHARMACOL, V8, P1320, DOI 10.1016/j.intimp.2008.03.012; Cheon IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094269; Christiaansen AF, 2014, IMMUNOL RES, V59, P109, DOI 10.1007/s12026-014-8540-1; Collins PL, 2013, CURR TOP MICROBIOL, V372, P3, DOI 10.1007/978-3-642-38919-1_1; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gonzalez-Reyes L, 2001, P NATL ACAD SCI USA, V98, P9859, DOI 10.1073/pnas.151098198; Graham BS, 2013, CURR TOP MICROBIOL, V372, P391, DOI 10.1007/978-3-642-38919-1_20; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hubbard SJ, 1993, NACCESS COMPUTER PRO; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; KIM Y, 2012, PLOS COMPUT BIOL, V8, P38028, DOI [DOI 10.1371/, DOI 10.1371/JOURNAL.PONE.0038028]; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; LOPEZ JA, 1990, J VIROL, V64, P927; Lopez JA, 1998, J VIROL, V72, P6922; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, J VIROL, V84, P12236, DOI 10.1128/JVI.01579-10; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P197, DOI 10.1128/JCM.24.2.197-202.1986; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P894, DOI 10.1128/JCM.24.5.894-898.1986; NENCIONI L, 1991, INFECT IMMUN, V59, P625, DOI 10.1128/IAI.59.2.625-630.1991; NORRBY E, 1975, INFECT IMMUN, V11, P231, DOI 10.1128/IAI.11.2.231-239.1975; NORRBY E, 1975, J INFECT DIS, V132, P262, DOI 10.1093/infdis/132.3.262; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Openshaw PJ, 2013, CURR OPIN VIROL, V3, P468, DOI 10.1016/j.coviro.2013.05.005; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; Pizza M, 2003, METH MOLEC MED, V87, P133; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; PRINCE GA, 1986, J VIROL, V57, P721, DOI 10.1128/JVI.57.3.721-728.1986; Sakurai H, 1999, J VIROL, V73, P2956, DOI 10.1128/JVI.73.4.2956-2962.1999; Shaw CA, 2013, CURR OPIN VIROL, V3, P332, DOI 10.1016/j.coviro.2013.05.003; STOTT EJ, 1987, J VIROL, V61, P3855, DOI 10.1128/JVI.61.12.3855-3861.1987; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Zhu Q, 2011, J INFECT DIS, V203, P674, DOI 10.1093/infdis/jiq100; Zimmer G, 2005, J VIROL, V79, P10467, DOI 10.1128/JVI.79.16.10467-10477.2005	49	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127108	10.1371/journal.pone.0127108	http://dx.doi.org/10.1371/journal.pone.0127108			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001197	Green Published, gold, Green Submitted			2022-12-27	WOS:000354931700041
J	Bozic, D; Papaefthimiou, D; Bruckner, K; de Vos, RCH; Tsoleridis, CA; Katsarou, D; Papanikolaou, A; Pateraki, I; Chatzopoulou, FM; Dimitriadou, E; Kostas, S; Manzano, D; Scheler, U; Ferrer, A; Tissier, A; Makris, AM; Kampranis, SC; Kanellis, AK				Bozic, Dragana; Papaefthimiou, Dimitra; Brueckner, Kathleen; de Vos, Ric C. H.; Tsoleridis, Constantinos A.; Katsarou, Dimitra; Papanikolaou, Antigoni; Pateraki, Irini; Chatzopoulou, Fani M.; Dimitriadou, Eleni; Kostas, Stefanos; Manzano, David; Scheler, Ulschan; Ferrer, Albert; Tissier, Alain; Makris, Antonios M.; Kampranis, Sotirios C.; Kanellis, Angelos K.			Towards Elucidating Carnosic Acid Biosynthesis in Lamiaceae: Functional Characterization of the Three First Steps of the Pathway in Salvia fruticosa and Rosmarinus officinalis	PLOS ONE			English	Article							IN-VITRO ANTIOXIDANT; SUBCELLULAR-LOCALIZATION; DIPHOSPHATE SYNTHASE; PHENOLIC DITERPENES; ROSEMARY; GENE; L.; EXPRESSION; METABOLISM; CRETICUS	Carnosic acid (CA) is a phenolic diterpene with anti-tumour, anti-diabetic, antibacterial and neuroprotective properties that is produced by a number of species from several genera of the Lamiaceae family, including Salvia fruticosa (Cretan sage) and Rosmarinus officinalis (Rosemary). To elucidate CA biosynthesis, glandular trichome transcriptome data of S. fruticosa were mined for terpene synthase genes. Two putative diterpene synthase genes, namely SfCPSand SfKSL, showing similarities to copalyl diphosphate synthase and kaurene synthase-like genes, respectively, were isolated and functionally characterized. Recombinant expression in Escherichia coli followed by in vitro enzyme activity assays confirmed that SfCPS is a copalyl diphosphate synthase. Coupling of SfCPS with SfKSL, both in vitro and in yeast, resulted in the synthesis miltiradiene, as confirmed by 1D and 2D NMR analyses (H-1, C-13, DEPT, COSY H-H, HMQC and HMBC). Coupled transient in vivo assays of SfCPS and SfKSL in Nicotiana benthamiana further confirmed production of miltiradiene in planta. To elucidate the subsequent biosynthetic step, RNA-Seq data of S. fruticosa and R. officinalis were searched for cytochrome P450 (CYP) encoding genes potentially involved in the synthesis of the first phenolic compound in the CA pathway, ferruginol. Three candidate genes were selected, SfFS, RoFS1 and RoFS2. Using yeast and N. benthamiana expression systems, all three where confirmed to be coding for ferruginol synthases, thus revealing the enzymatic activities responsible for the first three steps leading to CA in two Lamiaceae genera.	[Bozic, Dragana; Papaefthimiou, Dimitra; Katsarou, Dimitra; Papanikolaou, Antigoni; Chatzopoulou, Fani M.; Dimitriadou, Eleni; Kanellis, Angelos K.] Aristotle Univ Thessaloniki, Dept Pharmaceut Sci, Lab Pharmacognosy, Grp Biotechnol Pharmaceut Plants, Thessaloniki 54124, Greece; [Brueckner, Kathleen; Scheler, Ulschan; Tissier, Alain] Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Germany; [de Vos, Ric C. H.] Wageningen Univ & Res Ctr, Plant Res Int, Wageningen, Netherlands; [Tsoleridis, Constantinos A.] Aristotle Univ Thessaloniki, Dept Chem, Organ Chem Lab, Thessaloniki 54124, Greece; [Pateraki, Irini; Ferrer, Albert] CSIC IRTA UAB UB, Ctr Res Agr Genom, Dept Mol Genet, Barcelona 08193, Spain; [Ferrer, Albert] Univ Barcelona, Fac Pharm, Dept Biochem & Mol Biol, Barcelona 08028, Spain; [Kostas, Stefanos] Aristotle Univ Thessaloniki, Sch Agr, Lab Floriculture, Thessaloniki 54124, Greece; [Makris, Antonios M.] Ctr Res & Technol Hellas, Inst Appl Biosci, Thermi, Greece; [Kampranis, Sotirios C.] Univ Crete, Sch Med, Dept Biochem, Iraklion 71003, Greece; [de Vos, Ric C. H.] Netherlands Metab Ctr, Leiden, Netherlands	Aristotle University of Thessaloniki; Leibniz Institut fur Pflanzenbiochemie; Wageningen University & Research; Aristotle University of Thessaloniki; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Aristotle University of Thessaloniki; Centre for Research & Technology Hellas; University of Crete	Kanellis, AK (corresponding author), Aristotle Univ Thessaloniki, Dept Pharmaceut Sci, Lab Pharmacognosy, Grp Biotechnol Pharmaceut Plants, Thessaloniki 54124, Greece.	kanellis@pharm.auth.gr	Chatzopoulou, Fani/AAK-1799-2021; Tissier, Alain F/B-2108-2017; Kampranis, Sotirios C/G-8374-2016; Ferrer, Albert/AAI-4595-2021; De Vos, Ric/F-5012-2017; Kanellis, Angelos/B-7998-2010; Pateraki, Irini/A-5957-2015	Tissier, Alain F/0000-0002-9406-4245; Kampranis, Sotirios C/0000-0001-6208-1684; Ferrer, Albert/0000-0002-0741-2388; Matekalo, Dragana/0000-0001-6565-4580; Chatzopoulou, Fani/0000-0003-4695-5753; Kanellis, Angelos/0000-0002-7653-440X; Pateraki, Irini/0000-0002-7526-2334; Bathe, Ulschan/0000-0002-0454-502X	EU [KBBE-227448]; Netherlands Metabolomics Centre, Netherlands Genomics Initiative/Netherlands Organization; Cost Action [FA1006]; European Commission	EU(European Commission); Netherlands Metabolomics Centre, Netherlands Genomics Initiative/Netherlands Organization; Cost Action(European Cooperation in Science and Technology (COST)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by EU Grant agreement KBBE-227448 for the TERPMED project (http://www.terpmed.eu). RCHdV acknowledges the Netherlands Metabolomics Centre, which is part of the Netherlands Genomics Initiative/Netherlands Organization for additional financial support. Support from Cost Action FA1006 is greatly appreciated. Funding for having this publication made available Open Access has been provided by the European Commission through its FP7 post-grant Gold Open Access Pilot. The funders had no role in the study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	[Anonymous], 1989, PLANT MOL BIOL MANUA; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Bauer J, 2012, J PHARMACOL EXP THER, V342, P169, DOI 10.1124/jpet.112.193847; Bruckner K, 2014, PHYTOCHEMISTRY, V101, P52, DOI 10.1016/j.phytochem.2014.01.021; Caniard A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-119; Chatzopoulou FM, 2010, PLANT CELL REP, V29, P523, DOI 10.1007/s00299-010-0841-9; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cvetkovikj I, 2013, J CHROMATOGR A, V1282, P38, DOI 10.1016/j.chroma.2012.12.068; Dilas S, 2012, INT J FOOD SCI TECH, V47, P2052, DOI 10.1111/j.1365-2621.2012.03069.x; El-Banna H., 2013, J PHYS PHARM ADV, V3, P41, DOI [10.5455/jppa.20130228054608, DOI 10.5455/JPPA.20130228054608]; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Falara V, 2008, PLANT MOL BIOL, V68, P633, DOI 10.1007/s11103-008-9399-0; Falara V, 2010, PLANT PHYSIOL, V154, P301, DOI 10.1104/pp.110.159566; Fischedick JT, 2013, BIOORGAN MED CHEM, V21, P2618, DOI 10.1016/j.bmc.2013.02.019; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Gaya M, 2013, BBA-GEN SUBJECTS, V1830, P3796, DOI 10.1016/j.bbagen.2013.03.021; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Hidalgo PJ, 1998, J AGR FOOD CHEM, V46, P2624, DOI 10.1021/jf970974j; Hillwig ML, 2011, PLANT J, V68, P1051, DOI 10.1111/j.1365-313X.2011.04756.x; Hofer R, 2014, PLANT PHYSIOL, V166, P1149, DOI 10.1104/pp.114.244814; Ignea C, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-162; Ignea C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-4; INATANI R, 1982, AGR BIOL CHEM TOKYO, V46, P1661, DOI 10.1080/00021369.1982.10865273; Iwamoto M, 2003, PLANTA MED, V69, P69, DOI 10.1055/s-2003-37037; Jordan MJ, 2012, J AGR FOOD CHEM, V60, P9603, DOI 10.1021/jf302881t; Karousou R., 1997, Willdenowia, V27, P113, DOI 10.3372/wi.27.2710; Kianbakht S, 2013, COMPLEMENT THER MED, V21, P441, DOI 10.1016/j.ctim.2013.07.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Jimenez A, 2013, EUR J NUTR, V52, P85, DOI 10.1007/s00394-011-0289-x; Masuda T, 2001, J AGR FOOD CHEM, V49, P5560, DOI 10.1021/jf010693i; Matsingou TC, 2003, J AGR FOOD CHEM, V51, P6696, DOI 10.1021/jf034516o; MUHAMMAD I, 1992, PHYTOTHER RES, V6, P261, DOI 10.1002/ptr.2650060508; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Ono M, 1999, J NAT PROD, V62, P1532, DOI 10.1021/np990204x; Park M, 2013, EXP DERMATOL, V22, P336, DOI 10.1111/exd.12138; Pateraki I, 2008, PHYTOCHEMISTRY, V69, P1641, DOI 10.1016/j.phytochem.2008.02.005; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Petiwala SM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00029; Pizzale L, 2002, J SCI FOOD AGR, V82, P1645, DOI 10.1002/jsfa.1240; Poeckel D, 2008, BIOCHEM PHARMACOL, V76, P91, DOI 10.1016/j.bcp.2008.04.013; Richheimer SL, 1996, J AM OIL CHEM SOC, V73, P507, DOI 10.1007/BF02523927; Ro DK, 2002, PLANT PHYSIOL, V130, P1837, DOI 10.1104/pp.008011; Rodriguez JA, 2006, LIFE SCI, V78, P2503, DOI 10.1016/j.lfs.2005.10.018; Sakamoto T, 2004, PLANT PHYSIOL, V134, P1642, DOI 10.1104/pp.103.033696; Sallaud C, 2012, PLANT J, V72, P1, DOI 10.1111/j.1365-313X.2012.05068.x; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Skoula M, 1999, BIOCHEM SYST ECOL, V27, P559, DOI 10.1016/S0305-1978(98)00122-7; Skoula M, 2000, BIOCHEM SYST ECOL, V28, P551, DOI 10.1016/S0305-1978(99)00095-2; Sugai Y, 2011, J BIOL CHEM, V286, P42840, DOI 10.1074/jbc.M111.302703; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Tounekti T, 2012, ENVIRON EXP BOT, V78, P146, DOI 10.1016/j.envexpbot.2011.12.037; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang Q, 2012, J BIOL CHEM, V287, P6159, DOI 10.1074/jbc.M111.305599; Zhou L, 1999, INDUCIBLE GENE EXPRESSION IN PLANTS, P127; Zi JC, 2013, ORG BIOMOL CHEM, V11, P7650, DOI 10.1039/c3ob41885e	59	42	47	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124106	10.1371/journal.pone.0124106	http://dx.doi.org/10.1371/journal.pone.0124106			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020634	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300006
J	Gargiulo, G; Sannino, A; Stabile, E; Perrino, C; Trimarco, B; Esposito, G				Gargiulo, Giuseppe; Sannino, Anna; Stabile, Eugenio; Perrino, Cinzia; Trimarco, Bruno; Esposito, Giovanni			New Cerebral Lesions at Magnetic Resonance Imaging after Carotid Artery Stenting Versus Endarterectomy: An Updated Meta-Analysis	PLOS ONE			English	Article							AORTIC-VALVE IMPLANTATION; ISCHEMIC BRAIN-LESIONS; PROTECTION; MORTALITY; OUTCOMES; REVASCULARIZATION; DISEASE; SURGERY; RISK	Background Carotid endarterectomy (CEA) or stenting (CAS) are associated with a relatively low rate of clinical events, but diffusion-weighted imaging (DWI) is increasingly being used to compare the incidence of new ischemic lesions. Therefore, we conducted an updated meta-analysis on the occurrence of post-procedural new DWI lesions after CAS versus CEA. Methods and Results MEDLINE, Cochrane, ISI Web of Science and SCOPUS databases were searched and 20 studies (2 randomized and 18 non-randomized) with a total of 2104 procedures (CAS = 989; CEA = 1115) were included. The incidence of new DWI cerebral lesions was significantly greater after CAS than CEA (40.3% vs 12.2%; 20 studies; 2104 patients; odds ratio [OR] 5.17; 95% confidence interval [CI], 3.31-8.06; p<0.00001). Also peri-procedural stroke (17 studies; 1833 patients; OR 2.01; 95% CI, 1.14-3.55; p=0.02) and stroke or TIA (17 studies; 1833 patients; OR 2.40; 95% CI, 1.42-4.08; p=0.001) were significantly increased after CAS. This latter clinical advantage in the CEA group over CAS was tempered when CEA procedures were performed with shunting in all instead of selective shunting or when CAS was performed with only closed cell stents instead of both closed and open cell stents, however, no significant differences between subgroups emerged. Conclusions CAS is associated with an increased incidence of post-procedural brain DWI lesions. This greater amount of ischemic burden may also reflect a higher rate of cerebral events after CAS. However, whether recent technical advances mainly for CAS could potentially reduce these ischemic events still remains to be evaluated.	[Gargiulo, Giuseppe; Sannino, Anna; Stabile, Eugenio; Perrino, Cinzia; Trimarco, Bruno; Esposito, Giovanni] Univ Naples Federico II, Dept Adv Biomed Sci, Div Cardiol, Naples, Italy	University of Naples Federico II	Esposito, G (corresponding author), Univ Naples Federico II, Dept Adv Biomed Sci, Div Cardiol, Naples, Italy.	espogiov@unina.it	Stefanadis, Christodoulos/ABH-2232-2020; Sannino, Anna/AAA-2412-2019; Perrino, Cinzia/K-3183-2016; Gargiulo, Giuseppe/AAC-2356-2022; GARGIULO, Giuseppe/AAC-2336-2022; Trimarco, Bruno BT/K-7851-2016; ESPOSITO, Giovanni/F-2880-2010	Stefanadis, Christodoulos/0000-0001-5974-6454; Perrino, Cinzia/0000-0002-2274-0048; GARGIULO, Giuseppe/0000-0003-4395-6742; Trimarco, Bruno BT/0000-0002-0701-6449; ESPOSITO, Giovanni/0000-0003-0565-7127; SANNINO, ANNA/0000-0003-4275-8066				Akutsu N, 2012, AM J NEURORADIOL, V33, P1557, DOI 10.3174/ajnr.A3002; Biondi-Zoccai G, 2012, J AM COLL CARDIOL, V59, P292, DOI 10.1016/j.jacc.2011.09.053; Bonati LH, 2010, LANCET NEUROL, V9, P353, DOI 10.1016/S1474-4422(10)70057-0; Capoccia L, 2010, J VASC SURG, V51, P584, DOI 10.1016/j.jvs.2009.10.079; Capodanno D, 2015, EUR HEART J ACUTE CA; Chaturvedi S, 2015, J AM COLL CARDIOL, V65, P1134, DOI 10.1016/j.jacc.2014.12.045; Cho AH, 2014, STROKE, V45, P602, DOI 10.1161/STROKEAHA.113.003792; Cremonesi A, 2015, EUR HEART J, V36, P13, DOI 10.1093/eurheartj/ehu446; Economopoulos KP, 2011, STROKE, V42, P687, DOI 10.1161/STROKEAHA.110.606079; Faraglia V, 2007, J CARDIOVASC SURG, V48, P683; Felli MMG, 2012, INT ANGIOL, V31, P420; Flach HZ, 2004, J ENDOVASC THER, V11, P251, DOI 10.1583/03-1128.1; Garcia-Sanchez S, 2004, REV NEUROLOGIA, V38, P1013, DOI 10.33588/rn.3811.2004003; Gargiulo G, 2015, CATHETER CARDIOVASC; Gargiulo G, 2015, INT J CARDIOL, V189, P77, DOI 10.1016/j.ijcard.2015.04.077; Gargiulo G, 2015, INT J CARDIOL, V187, P592, DOI 10.1016/j.ijcard.2015.03.435; Gargiulo G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002220; Iihara K, 2006, J NEUROSURG, V105, P546, DOI 10.3171/jns.2006.105.4.546; Kuliha M, 2015, BRIT J SURG, V102, P194, DOI 10.1002/bjs.9677; Lacroix V, 2007, EUR J VASC ENDOVASC, V33, P430, DOI 10.1016/j.ejvs.2006.11.012; Mitsuoka Hiroshi, 2011, Ann Vasc Dis, V4, P106, DOI 10.3400/avd.oa.11.00007; Poppert H, 2004, J NEUROL, V251, P1198, DOI 10.1007/s00415-004-0502-4; Posacioglu H, 2008, TEX HEART I J, V35, P395; Roh HG, 2005, AM J NEURORADIOL, V26, P376; Sannino A, 2014, AM J CARDIOL, V114, P875, DOI 10.1016/j.amjcard.2014.06.022; Sannino A, 2014, INT J CARDIOL, V176, P32, DOI 10.1016/j.ijcard.2014.06.017; Schnaudigel S, 2008, STROKE, V39, P1911, DOI 10.1161/STROKEAHA.107.500603; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; Skjelland M, 2009, STROKE, V40, P230, DOI 10.1161/STROKEAHA.107.513341; Stabile E, 2014, JACC-CARDIOVASC INTE, V7, P1177, DOI 10.1016/j.jcin.2014.05.019; Tedesco MM, 2007, J VASC SURG, V46, P244, DOI 10.1016/j.jvs.2007.04.049; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Wasser K, 2011, J VASC SURG, V53, P61, DOI 10.1016/j.jvs.2010.07.061; Yamada K, 2011, ATHEROSCLEROSIS, V215, P399, DOI 10.1016/j.atherosclerosis.2011.01.002; Zhou W, 2009, J VASC SURG, V50, P1314, DOI 10.1016/j.jvs.2009.07.105	35	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0129209	10.1371/journal.pone.0129209	http://dx.doi.org/10.1371/journal.pone.0129209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017678	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600126
J	Jahrling, N; Becker, K; Wegenast-Braun, BM; Grathwohl, SA; Jucker, M; Dodt, HU				Jaehrling, Nina; Becker, Klaus; Wegenast-Braun, Bettina M.; Grathwohl, Stefan A.; Jucker, Mathias; Dodt, Hans-Ulrich			Cerebral beta-Amyloidosis in Mice Investigated by Ultramicroscopy	PLOS ONE			English	Article							TRANSGENIC MICE; A-BETA; DISEASE; MODELS	Alzheimer's disease (AD) is the most common neurodegenerative disorder. AD neuropathology is characterized by intracellular neurofibrillary tangles and extracellular beta-amyloid deposits in the brain. To elucidate the complexity of AD pathogenesis a variety of transgenic mouse models have been generated. An ideal imaging system for monitoring beta-amyloid plaque deposition in the brain of these animals should allow 3D-reconstructions of beta-amyloid plaques via a single scan of an uncropped brain. Ultramicroscopy makes this possible by replacing mechanical slicing in standard histology by optical sectioning. It allows a time efficient analysis of the amyloid plaque distribution in the entire mouse brain with 3D cellular resolution. We herein labeled beta-amyloid deposits in a transgenic mouse model of cerebral beta-amyloidosis (APPPS1 transgenic mice) with two intraperitoneal injections of the amyloid-binding fluorescent dye methoxy-X04. Upon postmortem analysis the total number of beta-amyloid plaques, the beta-amyloid load (volume percent) and the amyloid plaque size distributions were measured in the frontal cortex of two age groups (2.5 versus 7-8.5 month old mice). Applying ultramicroscopy we found in a proof-of-principle study that the number of beta-amyloid plaques increases with age. In our experiments we further observed an increase of large plaques in the older age group of mice. We demonstrate that ultramicroscopy is a fast, and accurate analysis technique for studying beta-amyloid lesions in transgenic mice allowing the 3D staging of beta-amyloid plaque development. This in turn is the basis to study neural network degeneration upon cerebral beta-amyloidosis and to assess A beta-targeting therapeutics.	[Jaehrling, Nina; Becker, Klaus; Dodt, Hans-Ulrich] Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria; [Jaehrling, Nina; Becker, Klaus; Dodt, Hans-Ulrich] MUW, Ctr Brain Res, Sect Bioelect, Vienna, Austria; [Wegenast-Braun, Bettina M.; Grathwohl, Stefan A.; Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Tubingen, Germany; [Wegenast-Braun, Bettina M.; Grathwohl, Stefan A.; Jucker, Mathias] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany	Technische Universitat Wien; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Jahrling, N (corresponding author), Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria.	nina.jaehrling@tuwien.ac.at		Becker, Klaus/0000-0002-2406-0476	Hertie Foundation; Austrian "Fonds zur Forderung der wissenschaftlichen Forschung" (FWF) [P23102-N22]	Hertie Foundation; Austrian "Fonds zur Forderung der wissenschaftlichen Forschung" (FWF)(Austrian Science Fund (FWF))	This study was supported by the Hertie Foundation and by the Austrian "Fonds zur Forderung der wissenschaftlichen Forschung" (FWF; grant no. P23102-N22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2008, J BIOPHOTONICS, V1, P36, DOI 10.1002/jbio.200710011; Becker K, 2012, PLOS ONE; Bittner T, 2012, ACTA NEUROPATHOL, V124, P797, DOI 10.1007/s00401-012-1047-8; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Hefendehl JK, 2011, J NEUROSCI, V31, P624, DOI 10.1523/JNEUROSCI.5147-10.2011; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Klymkowsky M, 1991, METHODS CELL BIOL, V36; Maier FC, 2014, NAT MED, V20, P1485, DOI 10.1038/nm.3734; Manook A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031310; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Vettenburg T, 2014, NAT METHODS, V11, P541, DOI [10.1038/NMETH.2922, 10.1038/nmeth.2922]; Wegenast-Braun BM, 2009, AM J PATHOL, V175, P271, DOI 10.2353/ajpath.2009.090044	19	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125418	10.1371/journal.pone.0125418	http://dx.doi.org/10.1371/journal.pone.0125418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017149	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600022
J	Nyaga, JM; Neff, JC; Cramer, MD				Nyaga, Justine M.; Neff, Jason C.; Cramer, Michael D.			The Contribution of Occult Precipitation to Nutrient Deposition on the West Coast of South Africa	PLOS ONE			English	Article							ORGANIC NITROGEN; MARINE AEROSOLS; SPECTROPHOTOMETRIC DETERMINATION; FOLIAR APPLICATION; SOUTHWESTERN CAPE; FYNBOS ECOSYSTEM; RICINUS-COMMUNIS; RAIN-FOREST; FOG; NITRATE	The Strandveld mediterranean-ecosystem of the west coast of South Africa supports floristically diverse vegetation growing on mostly nutrient-poor aeolian sands and extending from the Atlantic Ocean tens of kilometers inland. The cold Benguela current upwelling interacts with warm onshore southerly winds in summer causing coastal fogs in this region. We hypothesized that fog and other forms of occult precipitation contribute moisture and nutrients to the vegetation. We measured occult precipitation over one year along a transect running inland in the direction of the prevailing wind and compared the nutrient concentrations with those in rainwater. Occult deposition rates of P, N, K, Mg, Ca, Na, Al and Fe all decreased with distance from the ocean. Furthermore, ratios of cations to Na were similar to those of seawater, suggesting a marine origin for these. In contrast, N and P ratios in occult precipitation were higher than in seawater. We speculate that this is due to marine foam contributing to occult precipitation. Nutrient loss in leaf litter from dominant shrub species was measured to indicate nutrient demand. We estimated that occult precipitation could meet the demand of the dominant shrubby species for annual N, P, K and Ca. Of these species, those with small leaves intercepted more moisture and nutrients than those with larger leaves and could take up foliar deposits of glycine, NO3-, NH4+ and Li (as tracer for K) through leaf surfaces. We conclude that occult deposition together with rainfall deposition are potentially important nutrient and moisture sources for the Strandveld vegetation that contribute to this vegetation being floristically distinct from neighbouring nutrient-poor Fynbos vegetation.	[Nyaga, Justine M.; Cramer, Michael D.] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa; [Nyaga, Justine M.] Embu Univ Coll, Dept Biol Sci, Embu, Kenya; [Neff, Jason C.] Univ Colorado, Geol Sci & Environm Studies, Boulder, CO 80309 USA	University of Cape Town; University of Colorado System; University of Colorado Boulder	Cramer, MD (corresponding author), Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa.	Michael.cramer@uct.ac.za	Cramer, Michael D/A-3213-2013	Cramer, Michael D/0000-0003-0989-3266; NEFF, JASON/0000-0002-8290-1472	Andrew Mellon Foundation; Oppenheimner Memorial Trust of South Africa	Andrew Mellon Foundation; Oppenheimner Memorial Trust of South Africa	This research was supported by the Andrew Mellon Foundation (www.mellon.org). The Oppenheimner Memorial Trust of South Africa provided additional doctoral bursary to JMN and sabbatical support to MDC.	Abanda PA, 2011, GEODERMA, V164, P128, DOI 10.1016/j.geoderma.2011.05.015; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; AZEVEDO J, 1974, ECOLOGY, V55, P1135, DOI 10.2307/1940364; BAILEY GW, 1991, PROG OCEANOGR, V28, P9, DOI 10.1016/0079-6611(91)90019-I; Bergh NG, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P1; BIRCH GF, 1977, T ROY SOC S AFR, V42, P223, DOI 10.1080/00359197709519915; Boyce RL, 1996, CAN J FOREST RES, V26, P1539, DOI 10.1139/x26-173; BROWN G, 1984, J ECOL, V72, P547, DOI 10.2307/2260065; BRUIJNZEEL LA, 1995, ECOL STU AN, V110, P38; Brunner U, 1998, TOXICOL ENVIRON CHEM, V67, P171, DOI DOI 10.1080/02772249809358612; Cape JN, 2010, ENVIRON POLLUT, V158, P2926, DOI 10.1016/j.envpol.2010.06.002; Castle SC, 2009, ECOSYSTEMS, V12, P101, DOI 10.1007/s10021-008-9210-8; Cavelier J, 1996, J TROP ECOL, V12, P357, DOI 10.1017/S026646740000955X; Chapin F. S. III, 1989, Plant physiological ecology: field methods and instrumentation., P185; Compton J., 2004, ROCKS MOUNTAINS CAPE; Cornell SE, 2003, ATMOS ENVIRON, V37, P2173, DOI 10.1016/S1352-2310(03)00133-X; Cowling RM, 1999, PLANT ECOL, V142, P3, DOI 10.1023/A:1009831308074; Cramer MD, 2009, PALAEOGEOGR PALAEOCL, V274, P125, DOI 10.1016/j.palaeo.2008.12.021; Cramer MD, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P248; Dawson TE, 1998, OECOLOGIA, V117, P476, DOI 10.1007/s004420050683; Derry LA, 2007, ELEMENTS, V3, P333, DOI 10.2113/gselements.3.5.333; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Doyle A, 2004, SOIL SCI SOC AM J, V68, P669, DOI 10.2136/sssaj2004.0669; Facchini MC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034210; FITZGERALD JW, 1991, ATMOS ENVIRON A-GEN, V25, P533, DOI 10.1016/0960-1686(91)90050-H; Franceschini G, 2006, J COASTAL RES, V22, P1158, DOI 10.2112/05-0576.1; FRANZEN LG, 1990, AMBIO, V19, P180; Garten CT, 1998, FOREST ECOL MANAG, V103, P211, DOI 10.1016/S0378-1127(97)00185-0; Gower ST, 1999, REMOTE SENS ENVIRON, V70, P29, DOI 10.1016/S0034-4257(99)00056-5; Heydoorn AE, 1980, 380 CSIR 1; Hutley LB, 1997, AUST J BOT, V45, P311, DOI 10.1071/BT96014; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Kawamura K, 1999, J GEOPHYS RES-ATMOS, V104, P3501, DOI 10.1029/1998JD100041; KEENE WC, 1986, J GEOPHYS RES-ATMOS, V91, P6647, DOI 10.1029/JD091iD06p06647; Kraaij T, 2014, FYNBOS ECOLOGY EVOLU, P248; Likens G. E., 2014, USDA FOREST SERVICE, P463; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; MADGWICK H. A. I., 1959, FORESTRY, V32, P14, DOI 10.1093/forestry/32.1.14; Majdi H, 2005, PLANT SOIL, V276, P1, DOI 10.1007/s11104-005-3104-8; Martorell C, 2007, OECOLOGIA, V151, P561, DOI 10.1007/s00442-006-0614-x; Mills A. J., 2012, South African Journal of Plant and Soil, V29, P191, DOI 10.1080/02571862.2012.730636; MINAGAWA M, 1984, ANAL CHEM, V56, P1859, DOI 10.1021/ac00275a023; MOTOMIZU S, 1983, ANALYST, V108, P361, DOI 10.1039/an9830800361; Mucina L., 2006, VEGETATION S AFRICA; Neff JC, 2003, FRONT ECOL ENVIRON, V1, P205, DOI 10.1890/1540-9295(2003)001[0205:BITCDO]2.0.CO;2; Nyaga JM, 2013, ATMOS ENVIRON, V81, P625, DOI 10.1016/j.atmosenv.2013.09.021; O'Dowd CD, 2007, PHILOS T R SOC A, V365, P1753, DOI 10.1098/rsta.2007.2043; Olivier J, 2002, WATER SA, V28, P349; Peuke AD, 1998, NEW PHYTOL, V140, P625, DOI 10.1046/j.1469-8137.1998.00304.x; Peuke AD, 1998, NEW PHYTOL, V138, P675, DOI 10.1046/j.1469-8137.1998.00158.x; Piketh SJ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002056; Radloff FGT, 2010, OECOLOGIA, V164, P567, DOI 10.1007/s00442-010-1731-0; Richardson SJ, 2005, ECOLOGY, V86, P20, DOI 10.1890/04-0524; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; Rollenbeck R, 2011, HYDROL PROCESS, V25, P344, DOI 10.1002/hyp.7799; Schilling K, 2011, WATER RES, V45, P4355, DOI 10.1016/j.watres.2011.06.004; SCHLESINGER WH, 1980, AM MIDL NAT, V103, P114, DOI 10.2307/2425045; Smith M, 2004, APPL GEOCHEM, V19, P645, DOI 10.1016/j.apgeochem.2003.10.003; Soderberg K, 2007, ECOSYSTEMS, V10, P550, DOI 10.1007/s10021-007-9032-0; Sparks JP, 2009, OECOLOGIA, V159, P1, DOI 10.1007/s00442-008-1188-6; Specht RL, 1988, MEDITERRANEAN TYPE E, P149; STAAF H, 1982, CAN J BOT, V60, P1561, DOI 10.1139/b82-199; STOCK WD, 1986, S AFR J BOT, V52, P273, DOI 10.1016/S0254-6299(16)31519-8; Tinley KL, 1985, 109 SANSP; Trudgill ST, 1988, SOIL VEGETATION SYST; TYREE MT, 1990, PLANT PHYSIOL, V92, P103, DOI 10.1104/pp.92.1.103; Unsworth MH, 1987, POLLUTANT TRANSPORT, P125; Uscola M, 2014, ENVIRON EXP BOT, V104, P34, DOI 10.1016/j.envexpbot.2014.03.004; VELIMIROV B, 1980, MAR BIOL, V58, P311, DOI 10.1007/BF00390779; VELIMIROV B, 1982, Marine Ecology, V3, P97, DOI 10.1111/j.1439-0485.1982.tb00376.x; Vogelmann H. W., 1973, BioScience, V23, P96, DOI 10.2307/1296569; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Weathers KC, 1997, ENVIRON SCI TECHNOL, V31, P210, DOI 10.1021/es9603416; Weathers KC, 2000, ECOSYSTEMS, V3, P590, DOI 10.1007/s100210000051; WITKOWSKI ETF, 1987, J ECOL, V75, P1159, DOI 10.2307/2260320; Wrzesinsky T, 2004, ECOL STU AN, V172, P191; YATES DJ, 1995, AUST J BOT, V43, P157, DOI 10.1071/BT9950157; Yates MJ, 2010, FUNCT ECOL, V24, P485, DOI 10.1111/j.1365-2435.2009.01678.x	79	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126225	10.1371/journal.pone.0126225	http://dx.doi.org/10.1371/journal.pone.0126225			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017747	Green Published, gold			2022-12-27	WOS:000355185600047
J	Slavik, O; Horky, P; Maciak, M				Slavik, Ondrej; Horky, Pavel; Maciak, Matus			Ostracism of an Albino Individual by a Group of Pigmented Catfish	PLOS ONE			English	Article							JUVENILE ATLANTIC SALMON; ODDITY; SIGNAL; COLOR; SHOAL	Physiological and behavioural constraints hinder albino individuals. Albino animals are rare in the wild; this trait is associated with easy detection by predators, non-native or damaged environments, and exclusively aphotic environments in total darkness. The social aspect of albinism is reported only for human beings, and the effect is distinguishable in time and space when social benefits, are used to a limited the extent. Thus far, the social consequences of albinism for animals remain unknown. We used socially established groups of the pigmented catfish, (Silurus glanis), to observe space and temporal distance detachment of albino specimens in laboratory conditions. The albino fish were separated at larger distances from the group than pigmented individuals with the same social status determined by familiarity, and this asymmetry also varied in time. Albinism-related ostracism results in a solitary existence, usually followed by enhanced predation risk. The motivation for an individual's exclusion from a group appears to be the avoidance of the predation risk that increases not only for an odd individual but also for conspecifics within a group. Our findings indicate a role for albinism in behavioural processes related to sociality in a group of conspecifics.	[Slavik, Ondrej; Horky, Pavel] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Maciak, Matus] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada	Czech University of Life Sciences Prague; University of Alberta	Slavik, O (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Kamycka 129, Prague, Czech Republic.	oslavik@af.czu.cz	Slavík, Ondrej/A-4732-2013; Maciak, Matus/D-7836-2016; Horký, Pavel/A-3857-2013; Slavík, Ondřej/P-4253-2019	Maciak, Matus/0000-0002-9414-2151; Horký, Pavel/0000-0002-1738-7753; Slavík, Ondřej/0000-0003-3443-4125	Czech Science Foundation [13-058725]	Czech Science Foundation(Grant Agency of the Czech Republic)	The work was supported by the Czech Science Foundation (no. 13-058725), www.gacr.cz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanara A, 2001, J ANIM ECOL, V70, P980, DOI 10.1046/j.0021-8790.2001.00550.x; Bolker JA, 2000, J FISH BIOL, V56, P1029, DOI 10.1111/j.1095-8649.2000.tb02121.x; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; Burnham K. P., 1998, MODEL SELECTION INFE; Carden SM, 1998, BRIT J OPHTHALMOL, V82, P189, DOI 10.1136/bjo.82.2.189; CHIVERS DP, 1995, CAN J ZOOL, V73, P955, DOI 10.1139/z95-111; DEFRIES JC, 1969, NATURE, V221, P65, DOI 10.1038/221065a0; Ellegren H, 1997, NATURE, V389, P593, DOI 10.1038/39303; Estrada-Hernandez N, 2007, REHABIL PSYCHOL, V52, P263, DOI 10.1037/0090-5550.52.3.263; Gomez-Laplaza LM, 2009, BEHAV PROCESS, V82, P39, DOI 10.1016/j.beproc.2009.04.002; Griffiths SW, 2004, P ROY SOC B-BIOL SCI, V271, P695, DOI 10.1098/rspb.2003.2648; GRUTER M, 1986, ETHOL SOCIOBIOL, V7, P149, DOI 10.1016/0162-3095(86)90043-9; Hoglund E, 2000, J EXP BIOL, V203, P1711; Hong ES, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-212; Hupfeld D, 2006, BEHAV BRAIN RES, V170, P29, DOI 10.1016/j.bbr.2006.01.022; Javangwe G, 2012, EARLY CHILD DEV CARE, V182, P1593, DOI 10.1080/03004430.2011.630074; Krause J, 2002, LIVING GROUPS; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Leclercq E, 2010, FISH FISH, V11, P159, DOI 10.1111/j.1467-2979.2009.00346.x; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McRobert SP, 1998, ANIM BEHAV, V56, P611, DOI 10.1006/anbe.1998.0846; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V259, P207, DOI 10.1098/rspb.1995.0030; Nakatani I, 1999, J CRUSTACEAN BIOL, V19, P380, DOI 10.2307/1549245; O'Connor KI, 1999, ANIM BEHAV, V58, P1269, DOI 10.1006/anbe.1999.1260; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prusky GT, 2002, BEHAV BRAIN RES, V136, P339, DOI 10.1016/S0166-4328(02)00126-2; Rodgers GM, 2013, J EXP BIOL, V216, P2760, DOI 10.1242/jeb.080879; Rodgers GM, 2010, ANIM BEHAV, V79, P1025, DOI 10.1016/j.anbehav.2010.01.017; Slavik O, 2011, AQUACULTURE, V313, P73, DOI 10.1016/j.aquaculture.2011.01.002; Slavik O, 2012, APPL ANIM BEHAV SCI, V142, P116, DOI 10.1016/j.applanim.2012.09.005; SMITH AP, 1977, NATURE, V266, P527, DOI 10.1038/266527a0; Spence R, 2007, ETHOLOGY, V113, P62, DOI 10.1111/j.1439-0310.2006.01295.x; Suter HC, 2002, J FISH BIOL, V61, P606, DOI 10.1006/jfbi.2002.2084; Tao J., 2002, MIXED SAS SYSTEM COU; THEODORAKIS CW, 1989, ANIM BEHAV, V38, P496, DOI 10.1016/S0003-3472(89)80042-9; Williams KD., 1997, PL S SOC CL, P133	36	16	17	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128279	10.1371/journal.pone.0128279	http://dx.doi.org/10.1371/journal.pone.0128279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018869	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600115
J	Chang, CJ; Jian, DY; Lin, MW; Zhao, JZ; Ho, LT; Juan, CC				Chang, Chi-Jen; Jian, Deng-Yuan; Lin, Ming-Wei; Zhao, Jun-Zhi; Ho, Low-Tone; Juan, Chi-Chang			Evidence in Obese Children: Contribution of Hyperlipidemia, Obesity-Inflammation, and Insulin Sensitivity	PLOS ONE			English	Article							FACTOR-ANALYSIS REVEALS; METABOLIC SYNDROME; RISK-FACTORS; SYSTEMIC INFLAMMATION; RESISTANCE SYNDROME; ADOLESCENTS; ADIPONECTIN; ASSOCIATION; LEPTIN; MARKERS	Background Evidence shows a high incidence of insulin resistance, inflammation and dyslipidemia in adult obesity. The aim of this study was to assess the relevance of inflammatory markers, circulating lipids, and insulin sensitivity in overweight/obese children. Methods We enrolled 45 male children (aged 6 to 13 years, lean control = 16, obese = 19, overweight = 10) in this study. The plasma total cholesterol, HDL cholesterol, triglyceride, glucose and insulin levels, the circulating levels of inflammatory factors, such as TNF-alpha, IL-6, and MCP-1, and the high-sensitive CRP level were determined using quantitative colorimetric sandwich ELISA kits. Results Compared with the lean control subjects, the obese subjects had obvious insulin resistance, abnormal lipid profiles, and low-grade inflammation. The overweight subjects only exhibited significant insulin resistance and low-grade inflammation. Both TNF-alpha and leptin levels were higher in the overweight/obese subjects. A concurrent correlation analysis showed that body mass index (BMI) percentile and fasting insulin were positively correlated with insulin resistance, lipid profiles, and inflammatory markers but negatively correlated with adiponectin. A factor analysis identified three domains that explained 74.08% of the total variance among the obese children (factor 1: lipid, 46.05%; factor 2: obesity-inflammation, 15.38%; factor 3: insulin sensitivity domains, 12.65%). Conclusions Our findings suggest that lipid, obesity-inflammation, and insulin sensitivity domains predominantly exist among obese children. These factors might be applied to predict the outcomes of cardiovascular diseases in the future.	[Chang, Chi-Jen; Zhao, Jun-Zhi] Shin Kong Wu Ho Hosp, Dept Surg, Div Pediat Surg, Taipei, Taiwan; [Chang, Chi-Jen] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Jian, Deng-Yuan; Ho, Low-Tone; Juan, Chi-Chang] Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei 112, Taiwan; [Jian, Deng-Yuan] Wen Lin Hemodialysis Unit, Div Nephrol, Taipei, Taiwan; [Lin, Ming-Wei] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei 112, Taiwan; [Lin, Ming-Wei; Ho, Low-Tone; Juan, Chi-Chang] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Juan, Chi-Chang] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital	Juan, CC (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Physiol, Taipei 112, Taiwan.	ccjuan@ym.edu.tw			Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan [SKH8302-99-DR-19]; Ministry of Education, Aim for the Top University Plan	Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by research grants from the Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan (SKH8302-99-DR-19) and from the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AR, 2009, METAB SYNDR RELAT D, V7, P17, DOI 10.1089/met.2008.0045; Agueda M, 2012, NUTR METAB CARDIOVAS, V22, P208, DOI 10.1016/j.numecd.2010.06.010; Anderson PJ, 2001, INT J OBESITY, V25, P1782, DOI 10.1038/sj.ijo.0801837; Angin Y, 2014, TURKISH J PEDIATR, V56, P259; Arrigo T, 2013, EUR J ENDOCRINOL, V168, P631, DOI 10.1530/EJE-13-0037; Aycan Z, 2005, J PEDIATR ENDOCR MET, V18, P275; Becton LJ, 2012, INDIAN J PEDIATR, V79, P1056, DOI 10.1007/s12098-012-0777-x; Breslin WL, 2012, PEDIATRICS, V129, pE1180, DOI 10.1542/peds.2011-2477; Brito N, 2010, J PEDIATR ENDOCR MET, V23, P97; Charlton R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-764; Cohen JI, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-26; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Da Costa LA, 2012, DIABET METAB SYND OB, V5, P347, DOI 10.2147/DMSO.S35115; DeBoer MD, 2013, NUTRITION, V29, P379, DOI 10.1016/j.nut.2012.07.003; Ding D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/709756; Edwards KL, 1998, AM J EPIDEMIOL, V147, P441, DOI 10.1093/oxfordjournals.aje.a009469; Finucane OM, 2012, P NUTR SOC, V22, P1; Flynn JT, 2011, J CLIN HYPERTENS, V13, P323, DOI 10.1111/j.1751-7176.2011.00452.x; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frost PH, 1996, CIRCULATION, V94, P2381, DOI 10.1161/01.CIR.94.10.2381; Garanty-Bogacka B, 2005, NEUROENDOCRINOL LETT, V26, P242; Garanty-Bogacka B, 2011, ENDOKRYNOL POL, V62, P499; Gong CD, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-129; Guo XF, 2012, INTERNAL MED, V51, P23, DOI 10.2169/internalmedicine.51.6347; Hanley AJG, 2004, DIABETES, V53, P1773, DOI 10.2337/diabetes.53.7.1773; Hobkirk JP, 2012, METAB SYNDR RELAT D, V10, P20, DOI 10.1089/met.2011.0050; Illan-Gomez F, 2012, OBES SURG, V22, P950, DOI 10.1007/s11695-012-0643-y; Jurimae J, 2011, J PEDIATR ENDOCR MET, V24, P419, DOI 10.1515/JPEM.2011.054; l'Allemand-Jander D, 2010, INT J OBESITY, V34, pS32, DOI 10.1038/ijo.2010.237; LaBresh KA, 2014, PEDIATRICS, V134, pE732, DOI 10.1542/peds.2014-0876; Lawlor DA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6224; Lin MW, 2006, AM J HYPERTENS, V19, P1118, DOI 10.1016/j.amjhyper.2006.04.003; Lopez KN, 2012, CONGENIT HEART DIS, V7, P189, DOI 10.1111/j.1747-0803.2011.00618.x; Lutgens E, 2011, THROMB HAEMOSTASIS, V106, P755, DOI 10.1160/TH11-10-0683; Maestu J, 2010, MED SPORT SCI, V55, P56, DOI 10.1159/000321972; Masuo K, 2010, CURR DIABETES REV, V6, P58, DOI 10.2174/157339910790909396; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Mertens Ilse, 2005, Semin Vasc Med, V5, P48, DOI 10.1055/s-2005-871741; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Mokha JS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-73; Montero D, 2012, OBES REV, V13, P441, DOI 10.1111/j.1467-789X.2011.00956.x; Nasreddine L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-798; Orsi CM, 2011, CURR OPIN ENDOCRINOL, V18, P14, DOI 10.1097/MED.0b013e3283423de1; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Panagopoulou P, 2008, J PEDIATR GASTR NUTR, V47, P356, DOI 10.1097/MPG.0b013e31817fcb67; Pyrzak B, 2010, EUR J MED RES, V15, P147; Raj Manu, 2012, Indian J Endocrinol Metab, V16, P13, DOI 10.4103/2230-8210.91176; Rana JS, 2007, DIABETES OBES METAB, V9, P218, DOI 10.1111/j.1463-1326.2006.00594.x; Rubin DA, 2010, MED SPORT SCI, V55, P43, DOI 10.1159/000321971; Saffari F, 2012, THER CLIN RISK MANAG, V8, P55, DOI 10.2147/TCRM.S26673; Stelzer I, 2012, TRANSL RES, V159, P118, DOI 10.1016/j.trsl.2011.10.001; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Utsal L, 2012, HORM RES PAEDIAT, V78, P31, DOI 10.1159/000339831; Valle M, 2005, DIABETES METAB, V31, P55, DOI 10.1016/S1262-3636(07)70167-2; van Vliet M, 2011, EUR J PEDIATR, V170, P589, DOI 10.1007/s00431-010-1323-3; Vykoukal D, 2012, VASCULAR, V20, P156, DOI 10.1258/vasc.2011.201201; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wasilewska A, 2012, ACTA PAEDIATR, V101, P497, DOI 10.1111/j.1651-2227.2011.02582.x	60	48	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125935	10.1371/journal.pone.0125935	http://dx.doi.org/10.1371/journal.pone.0125935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011530	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900019
J	Figuera-Losada, M; Stathis, M; Dorskind, JM; Thomas, AG; Bandaru, VVR; Yoo, SW; Westwood, NJ; Rogers, GW; McArthur, JC; Haughey, NJ; Slusher, BS; Rojas, C				Figuera-Losada, Mariana; Stathis, Marigo; Dorskind, Joelle M.; Thomas, Ajit G.; Bandaru, Veera Venkata Ratnam; Yoo, Seung-Wan; Westwood, Nicholas J.; Rogers, Graeme W.; McArthur, Justin C.; Haughey, Norman J.; Slusher, Barbara S.; Rojas, Camilo			Cambinol, a Novel Inhibitor of Neutral Sphingomyelinase 2 Shows Neuroprotective Properties	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN-IMMUNODEFICIENCY-VIRUS; ALZHEIMERS-DISEASE; SPHINGOLIPID METABOLISM; BIOLOGICAL EVALUATION; SELECTIVE INHIBITORS; SIRTUIN INHIBITORS; NMDA RECEPTORS; CERAMIDE; EXOSOMES	Ceramide is a bioactive lipid that plays an important role in stress responses leading to apoptosis, cell growth arrest and differentiation. Ceramide production is due in part to sphingomyelin hydrolysis by sphingomyelinases. In brain, neutral sphingomyelinase 2 (nSMase2) is expressed in neurons and increases in its activity and expression have been associated with pro-inflammatory conditions observed in Alzheimer's disease, multiple sclerosis and human immunodeficiency virus (HIV-1) patients. Increased nSMase2 activity translates into higher ceramide levels and neuronal cell death, which can be prevented by chemical or genetic inhibition of nSMase2 activity or expression. However, to date, there are no soluble, specific and potent small molecule inhibitor tool compounds for in vivo studies or as a starting point for medicinal chemistry optimization. Moreover, the majority of the known inhibitors were identified using bacterial, bovine or rat nSMase2. In an attempt to identify new inhibitor scaffolds, two activity assays were optimized as screening platform using the recombinant human enzyme. First, active hits were identified using a fluorescence-based high throughput compatible assay. Then, hits were confirmed using a C-14 sphingomyelin-based direct activity assay. Pharmacologically active compounds and approved drugs were screened using this strategy which led to the identification of cambinol as a novel uncompetitive nSMase2 inhibitor (K-i = 7 mu M). The inhibitory activity of cambinol for nSMase2 was approximately 10-fold more potent than for its previously known target, silence information regulator 1 and 2 (SIRT1/2). Cambinol decreased tumor necrosis factor-alpha or interleukin-1 beta-induced increases of ceramide and cell death in primary neurons. A preliminary study of cambinol structure and activity allowed the identification of the main structural features required for nSMase2 inhibition. Cambinol and its analogs may be useful as nSMase2 inhibitor tool compounds to prevent ceramide-dependent neurodegeneration.	[Figuera-Losada, Mariana; Stathis, Marigo; Thomas, Ajit G.; Slusher, Barbara S.; Rojas, Camilo] Johns Hopkins Univ, Sch Med, Brain Sci Inst Drug Discovery Program, Baltimore, MD 21205 USA; [Figuera-Losada, Mariana; Dorskind, Joelle M.; Bandaru, Veera Venkata Ratnam; Yoo, Seung-Wan; McArthur, Justin C.; Haughey, Norman J.; Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Westwood, Nicholas J.; Rogers, Graeme W.] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; [Westwood, Nicholas J.; Rogers, Graeme W.] Univ St Andrews, Biomed Sci Res Ctr, St Andrews KY16 9ST, Fife, Scotland; [Westwood, Nicholas J.; Rogers, Graeme W.] EaStCHEM, St Andrews KY16 9ST, Fife, Scotland; [Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Slusher, Barbara S.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Rojas, Camilo] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Haughey, Norman J.] Johns Hopkins Univ, Sch Med, Richard T Johnson Div Neuroimmunol & Neurol Infec, Baltimore, MD 21205 USA; [Figuera-Losada, Mariana; Stathis, Marigo; Dorskind, Joelle M.; Thomas, Ajit G.; Bandaru, Veera Venkata Ratnam; Yoo, Seung-Wan; McArthur, Justin C.; Haughey, Norman J.; Slusher, Barbara S.; Rojas, Camilo] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of St Andrews; University of St Andrews; University of St Andrews; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Haughey, NJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	nhaughe1@jhmi.edu; bslusher@jhmi.edu; crojas2@jhmi.edu		Westwood, Nicholas/0000-0003-0630-0138	National Institute of Mental Health [P30 MH075673-06, R01 MH096636, R01 MH077542]; Johns Hopkins Brain Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH075673, R01MH110246, P01MH105280, R01MH096636, R03MH103985, R01MH077542] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johns Hopkins Brain Science Institute(Johns Hopkins University); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grants: P30 MH075673-06 to BSS, CR, NJH and JCM; R01 MH096636 and R01 MH077542 to NJH (http://projectreporter.nih.gov/reporter.cfm); and The Johns Hopkins Brain Science Institute to BSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amtmann E, 2003, DRUG EXP CLIN RES, V29, P5; Arenz C, 2001, BIOORGAN MED CHEM, V9, P2901, DOI 10.1016/S0968-0896(01)00165-1; Bandaru VVR, 2007, NEUROLOGY, V68, P1481, DOI 10.1212/01.wnl.0000260610.79853.47; Barbone AG, 2000, METHOD ENZYMOL, V311, P168; Barth BM, 2012, J NEUROSCI RES, V90, P229, DOI 10.1002/jnr.22748; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x; Chang CW, 2013, NEUROSCI LETT, V548, P190, DOI 10.1016/j.neulet.2013.06.009; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Clarke CJ, 2011, BIOCHEM J, V435, P381, DOI 10.1042/BJ20101752; Clarke CJ, 2011, ADV ENZYME REGUL, V51, P51, DOI 10.1016/j.advenzreg.2010.09.016; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Cutler RG, 2002, ANN NEUROL, V52, P448, DOI 10.1002/ana.10312; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fleming A, 2014, PATHOG DIS; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Hakogi T, 2003, ORG LETT, V5, P2801, DOI 10.1021/ol034771u; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Haughey NJ, 2008, FRONT BIOSCI, V13, P5120, DOI 10.2741/3068; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kosicek M, 2013, INT J MOL SCI, V14, P1310, DOI 10.3390/ijms14011310; Lee DH, 2011, ARCH PHARM RES, V34, P229, DOI 10.1007/s12272-011-0208-y; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lugrin J, 2013, BBA-MOL CELL RES, V1833, P1498, DOI 10.1016/j.bbamcr.2013.03.004; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Martinez TN, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-45; Medda F, 2011, MEDCHEMCOMM, V2, P611, DOI 10.1039/c1md00023c; Medda F, 2009, J MED CHEM, V52, P2673, DOI 10.1021/jm8014298; Mielke MM, 2012, NEUROLOGY, V79, P633, DOI 10.1212/WNL.0b013e318264e380; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Mielke MM, 2010, J NEUROVIROL, V16, P445, DOI 10.3109/13550284.2010.525599; Mielke MM, 2010, ALZHEIMERS DEMENT, V6, P378, DOI 10.1016/j.jalz.2010.03.014; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Ogorevc E, 2013, RADIOL ONCOL, V47, P197, DOI 10.2478/raon-2013-0037; Onderwater RCA, 1999, CHEM RES TOXICOL, V12, P396, DOI 10.1021/tx980198p; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; SHAIKH NA, 1994, ANAL BIOCHEM, V216, P313, DOI 10.1006/abio.1994.1047; Soeda S, 2004, NEUROCHEM INT, V45, P619, DOI 10.1016/j.neuint.2004.04.001; SPENCE MW, 1978, J NEUROCHEM, V30, P917, DOI 10.1111/j.1471-4159.1978.tb10804.x; Taguchi M, 2003, BIOORG MED CHEM LETT, V13, P3681, DOI 10.1016/j.bmcl.2003.08.020; Taguchi M, 2003, BIOORG MED CHEM LETT, V13, P1963, DOI 10.1016/S0960-894X(03)00360-3; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Uchida R, 2001, J ANTIBIOT, V54, P882, DOI 10.7164/antibiotics.54.882; Uchida R, 1999, J ANTIBIOT, V52, P572, DOI 10.7164/antibiotics.52.572; Urbanelli L, 2013, GENES-BASEL, V4, P152, DOI 10.3390/genes4020152; van Echten-Deckert G, 2012, PROG LIPID RES, V51, P378, DOI 10.1016/j.plipres.2012.07.001; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Xu HX, 2011, J NEUROSCI, V31, P17074, DOI 10.1523/JNEUROSCI.4072-11.2011; Zeng C, 2005, J NEUROCHEM, V94, P703, DOI 10.1111/j.1471-4159.2005.03217.x	58	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0124481	10.1371/journal.pone.0124481	http://dx.doi.org/10.1371/journal.pone.0124481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010541	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900008
J	Navarathna, DHMLP; Stein, EV; Lessey-Morillon, EC; Nayak, D; Martin-Manso, G; Roberts, DD				Navarathna, Dhammika H. M. L. P.; Stein, Erica V.; Lessey-Morillon, Elizabeth C.; Nayak, Debasis; Martin-Manso, Gema; Roberts, David D.			CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis	PLOS ONE			English	Article							T-CELL-ACTIVATION; SIRP-ALPHA; NEUTROPHIL TRANSMIGRATION; DENDRITIC CELLS; ALBICANS; THROMBOSPONDIN-1; RESPONSES; INTEGRIN; PATHOGENESIS; EXPRESSION	CD47 is a widely expressed receptor that regulates immunity by engaging its counter-receptor SIRP alpha on phagocytes and its secreted ligand thrombospondin-1. Mice lacking CD47 can exhibit enhanced or impaired host responses to bacterial pathogens, but its role in fungal immunity has not been examined. cd47(-/-) mice on a C57BL/6 background showed significantly increased morbidity and mortality following Candida albicans infection when compared with wild-type mice. Despite normal fungal colonization at earlier times, cd47(-/-) mice at four days post-infection had increased colonization of brain and kidneys accompanied by stronger inflammatory reactions. Neutrophil and macrophage numbers were significantly elevated in kidneys and neutrophils in the brains of infected cd47(-/-) mice. However, no defect in phagocytic activity towards C. albicans was observed in cd47(-/-) bone-marrow-derived macrophages, and neutrophil and macrophage killing of C. albicans was not impaired. CD47-deficiency did not alter the early humoral immune response to C. albicans. Th1, Th2, and Th17 population of CD4(+) T cells were expanded in the spleen, and gene expression profiles of spleen and kidney showed stronger pro-inflammatory signaling in infected cd47(-/-) mice. The chemoattractant chemokines MIP-2 alpha and MIP-2 beta were highly expressed in infected spleens of cd47(-/-) mice. G-CSF, GM-CSF, and the inflammasome component NLRP3 were more highly expressed in infected cd47(-/-) kidneys than in infected wild-type controls. Circulating pro-(TNF-alpha, IL-6) and anti-inflammatory cytokines (IL-10) were significantly elevated, but IL-17 was decreased. These data indicate that CD47 plays protective roles against disseminated candidiasis and alters pro-inflammatory and immunosuppressive pathways known to regulate innate and T cell immunity.	[Navarathna, Dhammika H. M. L. P.; Stein, Erica V.; Lessey-Morillon, Elizabeth C.; Martin-Manso, Gema; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Nayak, Debasis] NINDS, NIH, Bethesda, MD 20892 USA; [Stein, Erica V.] George Washington Univ, Microbiol & Immunol Program, Inst Biomed Sci, Dept Microbiol, Washington, DC 20037 USA; [Stein, Erica V.] George Washington Univ, Microbiol & Immunol Program, Inst Biomed Sci, Dept Immunol, Washington, DC 20037 USA; [Nayak, Debasis] George Washington Univ, Microbiol & Immunol Program, Inst Biomed Sci, Dept Trop Med, Washington, DC 20037 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); George Washington University; George Washington University; George Washington University	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008; Navarathna, Dhammika/GXM-8674-2022	Roberts, David D./0000-0002-2481-2981; Stein, Erica/0000-0001-8778-8846; Nayak, Debasis/0000-0002-4762-4553	NIH, National Cancer Institute, Center for Cancer Research; National Institute of Neurological Disorders and Stroke; NATIONAL CANCER INSTITUTE [ZIASC009173] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (DDR) and the National Institute of Neurological Disorders and Stroke (DN).	Ashman RB, 2008, FRONT BIOSCI-LANDMRK, V13, P3334; Azcutia V, 2012, J IMMUNOL, V189, P2553, DOI 10.4049/jimmunol.1103606; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Bellocchio S, 2005, MED MYCOL, V43, pS181, DOI 10.1080/14789940500051417; Bian Z, 2013, J IMMUNOL, V190, P411, DOI 10.4049/jimmunol.1201963; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Cameron CM, 2005, VIROLOGY, V337, P55, DOI 10.1016/j.virol.2005.03.037; CASADEVALL A, 1995, INFECT IMMUN, V63, P4211, DOI 10.1128/IAI.63.11.4211-4218.1995; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; D'Angelo JA, 2010, J IMMUNOL, V185, P3217, DOI 10.4049/jimmunol.1001199; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Evans Scott E, 2010, Proc Am Thorac Soc, V7, P197, DOI 10.1513/pats.200907-075AL; Fortin G, 2009, J EXP MED, V206, P1995, DOI 10.1084/jem.20082805; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Garay J, 2010, J IMMUNOL, V185, P3227, DOI 10.4049/jimmunol.0903066; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Johansson U, 2004, SCAND J IMMUNOL, V59, P40, DOI 10.1111/j.0300-9475.2004.01355.x; Johansson U, 2004, SCAND J IMMUNOL, V59, P50, DOI 10.1111/j.0300-9475.2004.01354.x; Kaur S, 2014, J IMMUNOL, V193, P3914, DOI 10.4049/jimmunol.1303116; Kaur S, 2011, J BIOL CHEM, V286, P14991, DOI 10.1074/jbc.M110.179663; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Kim MJ, 2008, TUMOR BIOL, V29, P28, DOI 10.1159/000132568; Kullberg Bart Jan, 2002, P327; Kurihara H, 2010, AM J PHYSIOL-RENAL, V299, pF517, DOI 10.1152/ajprenal.00571.2009; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lionakis MS, 2013, J CLIN INVEST, V123, P5035, DOI 10.1172/JCI71307; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Liu Y, 2001, J BIOL CHEM, V276, P40156, DOI 10.1074/jbc.M104138200; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martin-Manso G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048775; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Miller TW, 2013, MATRIX BIOL, V32, P316, DOI 10.1016/j.matbio.2013.02.009; Mittal R, 2010, J IMMUNOL, V185, P2998, DOI 10.4049/jimmunol.1001296; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P4006, DOI 10.1128/IAI.00397-07; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P1609, DOI 10.1128/IAI.01182-06; Navarathna DHMLP, 2013, NMR BIOMED, V26, P1125, DOI 10.1002/nbm.2926; Navarathna DHMLP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048475; Navarathna DHMLP, 2010, FREE RADICAL BIO MED, V49, P1561, DOI 10.1016/j.freeradbiomed.2010.08.020; Navarathna DHMLP, 2005, J ANTIMICROB CHEMOTH, V56, P1156, DOI 10.1093/jac/dki383; NICKERSON WJ, 1953, J INFECT DIS, V93, P43, DOI 10.1093/infdis/93.1.43; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Overland G, 2005, SCAND J IMMUNOL, V62, P148, DOI 10.1111/j.1365-3083.2005.01653.x; RAAB SS, 1994, MODERN PATHOL, V7, P599; Raymond M, 2009, J ALLERGY CLIN IMMUN, V124, P1333, DOI 10.1016/j.jaci.2009.07.021; Reinhold MI, 1997, J EXP MED, V185, P1, DOI 10.1084/jem.185.1.1; Reinhold MI, 1999, INT IMMUNOL, V11, P707, DOI 10.1093/intimm/11.5.707; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244; Scott CL, 2014, EUR J IMMUNOL, V44, P3658, DOI 10.1002/eji.201444859; Shenderov K, 2013, J IMMUNOL, V190, P5722, DOI 10.4049/jimmunol.1203343; Soto Pantoja DR, 2013, UCSD MOL PAGES, V2, P1; Soto-Pantoja DR, 2013, EXPERT OPIN THER TAR, V17, P89, DOI 10.1517/14728222.2013.733699; Su X, 2008, J IMMUNOL, V180, P6947, DOI 10.4049/jimmunol.180.10.6947; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Traynor TR, 2001, MED MYCOL, V39, P41, DOI 10.1080/714030978; Van VQ, 2006, EMBO J, V25, P5560, DOI 10.1038/sj.emboj.7601415; Verdrengh M, 1999, MICROBES INFECT, V1, P745, DOI 10.1016/S1286-4579(99)80076-8; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	73	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128220	10.1371/journal.pone.0128220	http://dx.doi.org/10.1371/journal.pone.0128220			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010544	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900208
J	Ordano, M; Engelhard, I; Rempoulakis, P; Nemny-Lavy, E; Blum, M; Yasin, S; Lensky, IM; Papadopoulos, NT; Nestel, D				Ordano, Mariano; Engelhard, Izhar; Rempoulakis, Polychronis; Nemny-Lavy, Esther; Blum, Moshe; Yasin, Sami; Lensky, Itamar M.; Papadopoulos, Nikos T.; Nestel, David			Olive Fruit Fly (Bactrocera oleae) Population Dynamics in the Eastern Mediterranean: Influence of Exogenous Uncertainty on a Monophagous Frugivorous Insect	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; DIPTERA TEPHRITIDAE; DACUS-OLEAE; DENSITY-DEPENDENCE; CLIMATE-CHANGE; HEAT-STRESS; INFESTATION; PATTERNS; ROSSI; TIME	Despite of the economic importance of the olive fly (Bactrocera oleae) and the large amount of biological and ecological studies on the insect, the factors driving its population dynamics (i.e., population persistence and regulation) had not been analytically investigated until the present study. Specifically, our study investigated the autoregressive process of the olive fly populations, and the joint role of intrinsic and extrinsic factors molding the population dynamics of the insect. Accounting for endogenous dynamics and the influences of exogenous factors such as olive grove temperature, the North Atlantic Oscillation and the presence of potential host fruit, we modeled olive fly populations in five locations in the Eastern Mediterranean region. Our models indicate that the rate of population change is mainly shaped by first and higher order non-monotonic, endogenous dynamics (i.e., density-dependent population feedback). The olive grove temperature was the main exogenous driver, while the North Atlantic Oscillation and fruit availability acted as significant exogenous factors in one of the five populations. Seasonal influences were also relevant for three of the populations. In spite of exogenous effects, the rate of population change was fairly stable along time. We propose that a special reproductive mechanism, such as reproductive quiescence, allows populations of monophagous fruit flies such as the olive fly to remain stable. Further, we discuss how weather factors could impinge constraints on the population dynamics at the local level. Particularly, local temperature dynamics could provide forecasting cues for management guidelines. Jointly, our results advocate for establishing monitoring programs and for a major focus of research on the relationship between life history traits and populations dynamics.	[Ordano, Mariano] Fdn Miguel Lillo, San Miguel De Tucuman, Argentina; [Engelhard, Izhar; Rempoulakis, Polychronis; Nemny-Lavy, Esther; Nestel, David] Agr Res Org, Volcani Ctr, Inst Plant Protect, IL-50250 Bet Dagan, Israel; [Blum, Moshe; Lensky, Itamar M.] Bar Ilan Univ, Dept Geog & Environm, Ramat Gan, Israel; [Yasin, Sami] Agro Nippon Int Cooperat Community Dev NICCOD, Zababdeh Off, Tubas, Israel; [Papadopoulos, Nikos T.] Univ Thessaly, Lab Entomol & Agr Zool, Volos, Greece; [Ordano, Mariano] Consejo Nacl Invest Cient & Tecn, FML, CCT Tucuman, Unidad Ejecutora Lillo, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Bar Ilan University; University of Thessaly; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Nestel, D (corresponding author), Agr Res Org, Volcani Ctr, Inst Plant Protect, IL-50250 Bet Dagan, Israel.	nestel@volcani.agri.gov.il	Papadopoulos, Nikos/AAJ-1721-2020; Ordano, Mariano/H-8437-2019; Rempoulakis, Polychronis/P-2731-2019; Papadopoulos, Nikos T./B-9156-2011; Lensky, Itamar/B-5285-2014	Papadopoulos, Nikos/0000-0003-2480-8189; Ordano, Mariano/0000-0003-0962-973X; Rempoulakis, Polychronis/0000-0002-3947-0064; Papadopoulos, Nikos T./0000-0003-2480-8189; Lensky, Itamar/0000-0001-7594-5277; Nestel, 0000-0002-4042-9210 Other IDs Loop profile: 123122/0000-0003-4322-4648	Nippon International Cooperation for Community Development [131-1631]	Nippon International Cooperation for Community Development	This work was supported by the Nippon International Cooperation for Community Development (grant no. 131-1631 to DN). The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aluja M, 2012, J ECON ENTOMOL, V105, P823, DOI 10.1603/EC11353; Aluja M, 2009, J INSECT PHYSIOL, V55, P231, DOI 10.1016/j.jinsphys.2008.11.013; AVIDOV Z., 1954, Ktavim, V4, P39; Baldoni L, 2009, HANDB PLANT BREED, V4, P397, DOI 10.1007/978-0-387-77594-4_13; Berryman A, 2001, OIKOS, V92, P265, DOI 10.1034/j.1600-0706.2001.920208.x; Berryman A., 1999, PRINCIPLES POPULATIO; Blum M, 2013, AGR FOREST METEOROL, V176, P90, DOI 10.1016/j.agrformet.2013.03.007; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Burrack HJ, 2011, CALIF AGR, V65, P14, DOI 10.3733/ca.v065n01p14; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Delrio G., 1985, INTEGRATED PEST CONT, P394; ECONOMOPOULOS AP, 1982, Z ANGEW ENTOMOL, V93, P463; Engelhard I, 2012, THESIS HEBREW U JERU, P40; Estay SA, 2014, OIKOS, V123, P131, DOI 10.1111/j.1600-0706.2013.00607.x; Estay SA, 2010, POPUL ECOL, V52, P289, DOI 10.1007/s10144-009-0179-8; Fletcher B.S., 1989, World Crop Pests, V3A, P273; FLETCHER BS, 1978, ECOL ENTOMOL, V3, P99, DOI 10.1111/j.1365-2311.1978.tb00908.x; Fornaciari M, 2000, PLANT BIOSYST, V134, P199, DOI 10.1080/11263500012331358474; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Galecki A, 2013, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4614-3900-4; Giannini A, 2001, J CLIMATE, V14, P2867, DOI 10.1175/1520-0442(2001)014<2867:ICITET>2.0.CO;2; Goncalves F, 2013, INT J PEST MANAGE, V59, P279, DOI 10.1080/09670874.2013.851428; Gordo O, 2010, GLOBAL CHANGE BIOL, V16, P1082, DOI 10.1111/j.1365-2486.2009.02084.x; Gutierrez AP, 2009, CLIMATIC CHANGE, V95, P195, DOI 10.1007/s10584-008-9528-4; Haniotakis GE, 1982, P M EEC ETAT AVANCEM, P46; Hodar JA, 2012, CLIMATIC CHANGE, V113, P699, DOI 10.1007/s10584-011-0371-7; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Israely N, 1997, ENVIRON ENTOMOL, V26, P1263, DOI 10.1093/ee/26.6.1263; K?chenhoff H., 2006, R NEWS, V6, P26; Katsoyannos P, 1992, FAO PLANT PRODUCTION, V115; Kiritani K, 2013, APPL ENTOMOL ZOOL, V48, P97, DOI 10.1007/s13355-012-0158-y; Knape J, 2012, ECOL LETT, V15, P17, DOI 10.1111/j.1461-0248.2011.01702.x; Kounatidis I, 2008, J APPL ENTOMOL, V132, P722, DOI 10.1111/j.1439-0418.2008.01349.x; KOVEOS DS, 1990, ENTOMOL EXP APPL, V55, P161, DOI 10.1007/BF00352577; Lima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030569; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; National Weather Service. Climate Prediction Center, TEL IND CALC PROC; Nestel D, 2004, INSECT PEST MANAGEMENT, FIELD AND PROTECTED CROPS, P45; NEUENSCHWANDER P, 1978, Z ANGEW ENTOMOL, V86, P420; NICHOLSON AJ, 1958, ANNU REV ENTOMOL, V3, P107, DOI 10.1146/annurev.en.03.010158.000543; Papadopoulos NT, 2003, PHYTOMA ESPANA, V153, P149; Papanastasiou SA, 2011, J INSECT PHYSIOL, V57, P83, DOI 10.1016/j.jinsphys.2010.09.008; Pappas ML, 2011, J APPL ENTOMOL, V135, P359, DOI 10.1111/j.1439-0418.2010.01579.x; Parry M. L., 2007, CLIMATE CHANGE 2007; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro J, 2000, MIXED EFFECTS MODELS; Podgornik M, 2013, ENTOMOL NEWS, V123, P15, DOI 10.3157/021.123.0106; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramos P, 1983, P CEC IBOC INT S FRU, p[16, 38]; Royama T., 1992, Analytical population dynamics.; SOLOMON ME, 1957, ANNU REV ENTOMOL, V2, P121, DOI 10.1146/annurev.en.02.010157.001005; Stavrakis G.N., 1980, Mededelingen van de Faculteit Landbouwwetenschappen Rijksuniversiteit Gent, V45, P587; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Tzanakakis ME, 2003, NETH J ZOOL, V52, P87, DOI 10.1163/156854203764817670; Varikou K, 2013, PHYTOPARASITICA, V41, P105, DOI 10.1007/s12600-012-0270-0; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Volakakis NG, 2012, J SUSTAIN AGR, V36, P683, DOI 10.1080/10440046.2012.672377; Wang XG, 2009, ENVIRON ENTOMOL, V38, P1496, DOI 10.1603/022.038.0518; Wang XG, 2009, ANN ENTOMOL SOC AM, V102, P727, DOI 10.1603/008.102.0418; Weissman Z, 2009, DESERT OLIVE OIL CUL; Yasin S, 2014, CROP PROT, V57, P63, DOI 10.1016/j.cropro.2013.12.020; Yokoyama VY, 2012, J ECON ENTOMOL, V105, P186, DOI 10.1603/EC11255; Zuur Alain F., 2009, P1	64	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127798	10.1371/journal.pone.0127798	http://dx.doi.org/10.1371/journal.pone.0127798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010332	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900146
J	Si, W; Wu, ZW; Wang, LL; Yang, MM; Zhao, X				Si, Wei; Wu, ZhaoWei; Wang, LiangLiang; Yang, MingMing; Zhao, Xin			Enzymological Characterization of Atm, the First Laccase from Agrobacterium sp. S5-1, with the Ability to Enhance In Vitro digestibility of Maize Straw	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; WHEAT-STRAW; ENZYMES; POLYSACCHARIDES; PURIFICATION; FUNGAL	Laccase is an enzyme that catalyzes oxidation of phenolic compounds, diamines and aromatic amines. In this study, a novel laccase-like gene (atm) in a ligninolyitic isolate Agrobacterium sp. S5-1 from soil humus was identified and heterologously expressed in Escherichia coli. Atm exhibited its maximal activity at pH 4.5 and at 50 degrees C. This enzyme was tolerant to high temperature, a broad range of pH, heavy metal ions (Co3+, Mn2+, Cu2+ and Ni2+, 20 mM) and all tested organic solvents. Furthermore, Atm significantly (p<0.05) increased dry matter digestibility of maize straw from 23.44% to 27.96% and from 29.53% to 37.10% after 8 or 24 h of digestion and improved acid detergent fiber digestibility from 5.81% to 10.33% and from 12.80% to 19.07% after 8 or 24 h of digestion, respectively. The combination of Atm and fibrolytic enzymes significantly (p<0.05) enhanced neutral detergent fiber digestibility from 19.02% to 24.55% after 24 h of digestion respectively. Results showed treatment with Atm effectively improved in vitro digestibility of maize straw, thus suggesting that Atm has an application potential for bioconversion of lignin rich agricultural byproducts into animal feed and cellulosic ethanol.	[Si, Wei; Wu, ZhaoWei; Wang, LiangLiang; Yang, MingMing; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Montreal, PQ H3A 2T5, Canada	Northwest A&F University - China; McGill University	Zhao, X (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China.	biodna@126.com; xin.zhao@mcgill.ca	Zhao, Xin/M-4312-2015; Wang, Liangliang/ADF-9017-2022	Zhao, Xin/0000-0002-1078-7332; 	China Thousand Talents program; National Science Foundation of China [31372343]	China Thousand Talents program; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the China Thousand Talents program and a grant from the National Science Foundation of China (31372343).	Arora DS, 2009, BIORESOURCES, V4, P909; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen M, 2008, CARBOHYD POLYM, V71, P411, DOI 10.1016/j.carbpol.2007.06.011; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; DESCHAMPS AM, 1980, EUR J APPL MICROBIOL, V9, P45, DOI 10.1007/BF00500001; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Graminha EBN, 2008, ANIM FEED SCI TECH, V144, P1, DOI 10.1016/j.anifeedsci.2007.09.029; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; Komori H, 2009, FEBS LETT, V583, P1189, DOI 10.1016/j.febslet.2009.03.008; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Krueger NA, 2008, ANIM FEED SCI TECH, V145, P95, DOI 10.1016/j.anifeedsci.2007.05.042; Krueger NA, 2008, ANIM FEED SCI TECH, V145, P84, DOI 10.1016/j.anifeedsci.2007.05.041; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martins LO, 2015, CELL MOL LIFE SCI, V72, P911, DOI 10.1007/s00018-014-1822-x; MENKE KH, 1979, J AGR SCI, V93, P217, DOI 10.1017/S0021859600086305; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Nakamura K, 2003, FEBS LETT, V553, P239, DOI 10.1016/S0014-5793(03)01000-7; Parshetti GK, 2011, J ENVIRON SCI, V23, P1384, DOI 10.1016/S1001-0742(10)60547-5; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Rivera-Hoyos CM, 2013, FUNGAL BIOL REV, V27, P67, DOI 10.1016/j.fbr.2013.07.001; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Sharma RK, 2010, BIORESOURCE TECHNOL, V101, P9248, DOI 10.1016/j.biortech.2010.07.042; Shrivastava B, 2011, BIODEGRADATION, V22, P823, DOI 10.1007/s10532-010-9408-2; Singh G, 2007, ENZYME MICROB TECH, V41, P794, DOI 10.1016/j.enzmictec.2007.07.001; SUNDMAN V, 1964, J GEN MICROBIOL, V36, P185, DOI 10.1099/00221287-36-2-185; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Widsten P, 2008, ENZYME MICROB TECH, V42, P293, DOI 10.1016/j.enzmictec.2007.12.003; Wu YR, 2010, BIORESOURCE TECHNOL, V101, P9772, DOI 10.1016/j.biortech.2010.07.091; Yu P, 2005, J ANIM SCI, V83, P1133	34	10	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128204	10.1371/journal.pone.0128204	http://dx.doi.org/10.1371/journal.pone.0128204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010258	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900205
J	Zeng, C; Li, H; Wei, J; Yang, T; Deng, ZH; Yang, Y; Zhang, Y; Yang, TB; Lei, GH				Zeng, Chao; Li, Hui; Wei, Jie; Yang, Tuo; Deng, Zhen-han; Yang, Ye; Zhang, Yi; Yang, Tu-bao; Lei, Guang-hua			Association between Dietary Magnesium Intake and Radiographic Knee Osteoarthritis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; METABOLIC SYNDROME; RISK-FACTORS; WOMEN; DISEASE; INFLAMMATION; PREVALENCE; DEFICIENCY; CALCIUM; METAANALYSIS	Objective To examine the cross-sectional associations between dietary magnesium (Mg) intake and radiographic knee osteoarthritis (OA), joint space narrowing (JSN), and osteophytes (OST) respectively. Methods A total of 1626 subjects were included in the study. Dietary intake was assessed using a validated semi-quantitative food frequency questionnaire. Radiographic knee OA was defined as Kellgren-Lawrence (K-L) Grade 2 in at least one leg. JSN and OST were assessed individually according to the Osteoarthritis Research Society International (OARSI) atlas. A multivariable logistic analysis model was applied to test the various associations after adjusting for potentially confounding factors. Results The relative odds of radiographic knee OA were decreased by 0.53 times in the third quintile of Mg intake [odds ratio (OR) 0.53, 95% confidence interval (CI) 0.28-1.01], 0.40 times in the fourth quintile (OR 0.40, 95% CI 0.17-0.94) and 0.34 times in the fifth quintile (OR 0.34, 95% CI 0.11-1.00) compared with those in the lowest quintile, while P for trend was 0.111. The relative odds of JSN were decreased by 0.49 times in the third quintile of Mg intake (OR 0.49, 95% CI 0.28-0.88) and 0.37 times in the fifth quintile (OR 0.37, 95% CI 0.14-0.98) compared with those in the lowest quintile, while P for trend was 0.088. There was no significant relationship between dietary Mg intake and the presence of OST. Conclusions The findings of this cross-sectional study indicate that Mg intake is inversely associated with radiographic knee OA and JSN. It supports potential role of Mg in the prevention of knee OA.	[Zeng, Chao; Li, Hui; Yang, Tuo; Deng, Zhen-han; Yang, Ye; Zhang, Yi; Lei, Guang-hua] Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China; [Wei, Jie; Yang, Tu-bao] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University; Central South University	Lei, GH (corresponding author), Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China.	lgh9640@sina.cn	Wei, Jie/ACR-8087-2022; Deng, Zhenhan/AAB-4968-2021; Deng, Zhenhan/AAR-2420-2021	Wei, Jie/0000-0003-3510-8241; Deng, Zhenhan/0000-0003-0522-8269	Hunan Provincial Innovation Foundation for Postgraduate [CX2014A005]; Fundamental Research Funds for the Central Universities of Central South University; National Natural Science Foundation of China [81201420, 81272034, 81472130]; Provincial Science Foundation of Hunan [14JJ3032]; Scientific Research Project of the Development and Reform Commission of Hunan Province [[2013]1199]; Scientific Research Project of Science and Technology Office of Hunan Province [2013SK2018]; Ministry of Education of China [20120162110036]	Hunan Provincial Innovation Foundation for Postgraduate; Fundamental Research Funds for the Central Universities of Central South University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Science Foundation of Hunan; Scientific Research Project of the Development and Reform Commission of Hunan Province; Scientific Research Project of Science and Technology Office of Hunan Province; Ministry of Education of China(Ministry of Education, China)	This work was supported by Hunan Provincial Innovation Foundation for Postgraduate (CX2014A005), the Fundamental Research Funds for the Central Universities of Central South University, the National Natural Science Foundation of China (No. 81201420, 81272034, 81472130), the Provincial Science Foundation of Hunan (No. 14JJ3032), the Scientific Research Project of the Development and Reform Commission of Hunan Province ([2013]1199), the Scientific Research Project of Science and Technology Office of Hunan Province (2013SK2018), and the Doctoral Scientific Fund Project of the Ministry of Education of China (20120162110036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Berenbaum F, 2011, ANN RHEUM DIS, V70, P1354, DOI 10.1136/ard.2010.146399; Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344; Conaghan PG, 2005, ANN RHEUM DIS, V64, P1539, DOI 10.1136/ard.2005.039263; Dibaba DT, 2014, EUR J CLIN NUTR, V68, P510, DOI 10.1038/ejcn.2014.7; Du H, 2005, RHEUMATOL INT, V25, P585, DOI 10.1007/s00296-004-0492-7; Egerbacher M, 2001, VET PATHOL, V38, P143, DOI 10.1354/vp.38-2-143; Engstrom G, 2009, OSTEOARTHR CARTILAGE, V17, P168, DOI 10.1016/j.joca.2008.07.003; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Feyerabend F, 2006, TISSUE ENG, V12, P3545, DOI 10.1089/ten.2006.12.3545; FINCHAM JE, 1986, S AFR MED J, V70, P740; Gruber HE, 2004, BIOTECH HISTOCHEM, V79, P45, DOI 10.1080/10520290410001697913; Hejazi J, 2011, WOMENS HEALTH, V7, P599, DOI [10.2217/WHE.11.41, 10.2217/whe.11.41]; Ho-Pham LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094563; Hruby A, 2014, DIABETES CARE, V37, P419, DOI 10.2337/dc13-1397; Hunter DJ, 2003, RHEUMATOLOGY, V42, P1311, DOI 10.1093/rheumatology/keg373; Jin XZ, 2015, ANN RHEUM DIS, V74, P703, DOI 10.1136/annrheumdis-2013-204494; Kellgren JH, 1963, THE EPIDEMIOLOGY OF; King DE, 2007, MAGNESIUM RES, V20, P32; King DE, 2005, J AM COLL NUTR, V24, P166, DOI 10.1080/07315724.2005.10719461; Kremer JM, 1996, J RHEUMATOL, V23, P990; Lee CH, 2009, OSTEOARTHR CARTILAGE, V17, P1485, DOI 10.1016/j.joca.2009.05.006; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Mak IT, 1997, MOL CELL BIOCHEM, V176, P35, DOI 10.1023/A:1006814609769; Malpuech-Brugere C, 2000, BBA-MOL BASIS DIS, V1501, P91, DOI 10.1016/S0925-4439(00)00018-1; Marks Ray, 2002, Med Sci Monit, V8, pCR305; Morgan S L, 1993, Arthritis Care Res, V6, P4, DOI 10.1002/art.1790060103; Nanri A, 2010, EUR J CLIN NUTR, V64, P1244, DOI 10.1038/ejcn.2010.138; Nielsen FH, 2010, NUTR REV, V68, P333, DOI 10.1111/j.1753-4887.2010.00293.x; Puenpatom RA, 2009, POSTGRAD MED, V121, P9, DOI 10.3810/pgm.2009.11.2073; Qin B, 2012, ARTHRIT CARE RES, V64, P1306, DOI 10.1002/acr.21708; Salve Harshal, 2010, Indian J Public Health, V54, P155, DOI 10.4103/0019-557X.75739; Song YQ, 2007, AM J CLIN NUTR, V85, P1068, DOI 10.1093/ajcn/85.4.1068; Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59; Song YQ, 2005, DIABETES CARE, V28, P1438, DOI 10.2337/diacare.28.6.1438; Tam M, 2003, EUR J CLIN NUTR, V57, P1193, DOI 10.1038/sj.ejcn.1601689; Tangney CC, 2004, J NUTR, V134, P927, DOI 10.1093/jn/134.4.927; van Dam RM, 2006, DIABETES CARE, V29, P2238, DOI 10.2337/dc06-1014; WEGLICKI WB, 1992, MOL CELL BIOCHEM, V110, P169, DOI 10.1007/BF02454195; Yang YX., 2009, CHINA FOOD COMPOSITI; Yoshimura N, 2011, J RHEUMATOL, V38, P921, DOI 10.3899/jrheum.100569; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Zeng C, 2014, OSTEOARTHR CARTILAGE, V22, P1947, DOI 10.1016/j.joca.2014.06.039; Zeng QY, 2006, CHINESE MED J-PEKING, V119, P1522, DOI 10.1097/00029330-200609020-00004; Zhang Y, 2015, RHEUMATOL INT; Zheng JM, 2014, BIOL TRACE ELEM RES, V159, P8, DOI 10.1007/s12011-014-9961-3; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	47	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127666	10.1371/journal.pone.0127666	http://dx.doi.org/10.1371/journal.pone.0127666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010333	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900126
J	Buttmann-Schweiger, N; Klug, SJ; Luyten, A; Holleczek, B; Heitz, F; du Bois, A; Kraywinkel, K				Buttmann-Schweiger, Nina; Klug, Stefanie J.; Luyten, Alexander; Holleczek, Bernd; Heitz, Florian; du Bois, Andreas; Kraywinkel, Klaus			Incidence Patterns and Temporal Trends of Invasive Nonmelanotic Vulvar Tumors in Germany 1999-2011. A Population-Based Cancer Registry Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; RISK; WOMEN; SURVIVAL	Objectives Time trends on the incidence and characteristics of invasive vulvar cancer in Germany have so far been studied in few local population-and hospital based tumor registries. We aimed to provide an overview on recent developments of vulvar cancer in Germany, using population-based cancer registry data. Methods We analyzed the data on vulvar cancer of eight population-based German cancer registries for the period 1999-2011. ICD-10 codes and ICD-O-3 morphology codes were used to select site and histologic types. The annual percentage change was calculated on age-adjusted incidence rates with a joinpoint regression model. Results A total of 12,711 registered cases of invasive carcinoma of the vulva were included in the analyses, hereof were 12,205 of squamous cell origin. Age-standardized incidence rates of vulvar cancer annually increased by 6.7% (95% confidence limits: 5.6-7.9) from 1.7 per 100,000 women in 1999 to 3.6 per 100,000 women in 2011. An increase was observed among women of all ages, and especially between 30 and 69 years of age. Conclusion The annual incidence of invasive carcinoma of the vulva nearly doubled in the past decade in Germany, considerably exceeding the rates observed in other Western European countries. A combination of changes in risk factors, and documentation practice might have contributed to the observed substantial increase in vulvar cancer incidence.	[Buttmann-Schweiger, Nina; Kraywinkel, Klaus] German Ctr Canc Registry Data, Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Buttmann-Schweiger, Nina; Klug, Stefanie J.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Univ Canc Ctr Dresden, Canc Epidemiol, D-01062 Dresden, Germany; [Luyten, Alexander] Klinikum Wolfsburg, Dept Obstet & Gynaecol, Wolfsburg, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Heitz, Florian; du Bois, Andreas] Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany	Robert Koch Institute; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Kliniken Essen-Mitte	Buttmann-Schweiger, N (corresponding author), German Ctr Canc Registry Data, Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.	ButtmannN@rki.de		Kraywinkel, Klaus/0000-0002-9250-6003; Heitz, Florian/0000-0002-2412-0352; Klug, Stefanie J./0000-0003-3523-1362; Buttmann-Schweiger, Nina/0000-0001-6946-635X				Adami J, 2003, BRIT J CANCER, V89, P1221, DOI 10.1038/sj.bjc.6601219; Akhtar-Danesh N, 2014, GYNECOL ONCOL, V134, P314, DOI 10.1016/j.ygyno.2014.05.014; [Anonymous], 1999, GESUNDHEITSBERICHTER; [Anonymous], 1997, J CLIN PATHOL; Baandrup L, 2011, GYNECOL ONCOL, V122, P45, DOI 10.1016/j.ygyno.2011.03.016; Baumann KH, 2010, J ONCOL, V2010, DOI 10.1155/2010/512032; Bodelon C, 2009, CANCER CAUSE CONTROL, V20, P1779, DOI 10.1007/s10552-009-9418-8; Boyle P, 1991, IARC Sci Publ, P126; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Bruni L., HUMAN PAPILLOMAVIRUS; DALING JR, 1992, AM J EPIDEMIOL, V135, P180, DOI 10.1093/oxfordjournals.aje.a116270; de Sanjose S, 2013, EUR J CANCER, V49, P3450, DOI 10.1016/j.ejca.2013.06.033; Dittmer C, 2011, ARCH GYNECOL OBSTET, V284, P169, DOI 10.1007/s00404-011-1850-9; Ferenczy A, 2003, CAN MED ASSOC J, V169, P431; Ferlay J., 2013, IARC CANCERBASE, V11; Forman D, 2013, CANC INCIDENCE 5 CON, VX; German-Organ-Transplantation-Foundation, 2013, ORG DON TRANSPL GERM; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hampl M, 2008, GYNECOL ONCOL, V109, P340, DOI 10.1016/j.ygyno.2008.01.041; Joura EA, 2000, J REPROD MED, V45, P613; Klug SJ, 2007, J MED VIROL, V79, P616, DOI 10.1002/jmv.20863; Lai J, 2014, BJOG-INT J OBSTET GY, V121, P728, DOI 10.1111/1471-0528.12459; Lampert T, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1231, DOI 10.1007/s00103-005-1158-7; Lampert T, 2011, RAUCHEN AKTUELLE ENT, DOI [10.1016/j.etp.2008.01.014, DOI 10.1016/J.ETP.2008.01.014]; Madeleine MM, 1997, JNCI-J NATL CANCER I, V89, P1516, DOI 10.1093/jnci/89.20.1516; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Petry KU, 2003, BRIT J CANCER, V88, P1570, DOI 10.1038/sj.bjc.6600918; Robert Koch-Institut, 2013, EPID B, V26; Robert Koch-Institut die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V, 2017, KREBS DEUTSCHL 2013, V11; Schuurman MS, 2013, EUR J CANCER, V49, P3872, DOI 10.1016/j.ejca.2013.08.003; Sigusch Volkmar, 2004, Ger Med Sci, V2, pDoc07; Sobin, 2009, UICC TNM CLASSIFICAT; Stang A, 2005, GYNECOL ONCOL, V96, P216, DOI 10.1016/j.ygyno.2004.09.052; Tavassoli F, 2003, WHO CLASSIFICATION T, P314; US National Cancer Institute, 2013, SURV RES; Vogel M, 2011, EUR J MED RES, V16, P101, DOI 10.1186/2047-783X-16-3-101; Wilkinson E.J., 2003, WHO CLASSIFICATION T, P316; Wittekind C, 2010, TNM KLASSIFIKATION M; Zentrum fur Krebsregisterdaten, 2014, DAT QUER	39	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128073	10.1371/journal.pone.0128073	http://dx.doi.org/10.1371/journal.pone.0128073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020540	Green Published, gold			2022-12-27	WOS:000355187300077
J	Kumagai, H; Ikeda, Y; Motozawa, Y; Fujishiro, M; Okamura, T; Fujio, K; Okazaki, H; Nomura, S; Takeda, N; Harada, M; Toko, H; Takimoto, E; Akazawa, H; Morita, H; Suzuki, J; Yamazaki, T; Yamamoto, K; Komuro, I; Yanagisawa, M				Kumagai, Hidetoshi; Ikeda, Yuichi; Motozawa, Yoshihiro; Fujishiro, Mitsuhiro; Okamura, Tomohisa; Fujio, Keishi; Okazaki, Hiroaki; Nomura, Seitaro; Takeda, Norifumi; Harada, Mutsuo; Toko, Haruhiro; Takimoto, Eiki; Akazawa, Hiroshi; Morita, Hiroyuki; Suzuki, Jun-ichi; Yamazaki, Tsutomu; Yamamoto, Kazuhiko; Komuro, Issei; Yanagisawa, Masashi			Quantitative Measurement of GPCR Endocytosis via Pulse-Chase Covalent Labeling	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; PROTEIN-ANALYSIS; IN-VIVO; INTERNALIZATION; TRAFFICKING; TECHNOLOGY; MOUSE	G protein-coupled receptors (GPCRs) play a critical role in many physiological systems and represent one of the largest families of signal-transducing receptors. The number of GPCRs at the cell surface regulates cellular responsiveness to their cognate ligands, and the number of GPCRs, in turn, is dynamically controlled by receptor endocytosis. Recent studies have demonstrated that GPCR endocytosis, in addition to affecting receptor desensitization and resensitization, contributes to acute G protein-mediated signaling. Thus, endocytic GPCR behavior has a significant impact on various aspects of physiology. In this study, we developed a novel GPCR internalization assay to facilitate characterization of endocytic GPCR behavior. We genetically engineered chimeric GPCRs by fusing HaloTag (a catalytically inactive derivative of a bacterial hydrolase) to the N-terminal end of the receptor (HT-GPCR). HaloTag has the ability to form a stable covalent bond with synthetic HaloTag ligands that contain fluorophores or a high-affinity handle (such as biotin) and the HaloTag reactive linker. We selectively labeled HT-GPCRs at the cell surface with a HaloTag PEG ligand, and this pulse-chase covalent labeling allowed us to directly monitor the relative number of internalized GPCRs after agonist stimulation. Because the endocytic activities of GPCR ligands are not necessarily correlated with their agonistic activities, applying this novel methodology to orphan GPCRs, or even to already characterized GPCRs, will increase the likelihood of identifying currently unknown ligands that have been missed by conventional pharmacological assays.	[Kumagai, Hidetoshi; Ikeda, Yuichi; Motozawa, Yoshihiro; Nomura, Seitaro; Takeda, Norifumi; Harada, Mutsuo; Toko, Haruhiro; Takimoto, Eiki; Akazawa, Hiroshi; Morita, Hiroyuki; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kumagai, Hidetoshi; Ikeda, Yuichi; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75390 USA; [Kumagai, Hidetoshi; Suzuki, Jun-ichi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan; [Fujishiro, Mitsuhiro] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Okamura, Tomohisa; Fujio, Keishi] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Okamura, Tomohisa] Univ Tokyo, Max Plank Ctr Integrat Inflammol, Tokyo, Japan; [Okazaki, Hiroaki] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Yamazaki, Tsutomu] Univ Tokyo, Clin Res Support Ctr, Tokyo, Japan; [Yanagisawa, Masashi] Univ Tsukuba, Int WPI IIIS, Tsukuba, Ibaraki, Japan	University of Tokyo; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tsukuba	Kumagai, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	hdtshkmg@gmail.com	Takimoto, Eiki/AAC-5100-2021; 藤城, 光弘/AAN-3131-2020	Akazawa, Hiroshi/0000-0002-3574-9607; TAKEDA, NORIFUMI/0000-0003-4818-3347	Howard Hughes Medical Institute; Perot Family Foundation; Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (ERATO);  [14463492]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Perot Family Foundation; Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (ERATO); 	This research was supported by the Howard Hughes Medical Institute, the Perot Family Foundation, Exploratory Research for Advanced Technology of Japan Science and Technology Corporation (ERATO) (to MY), and Grant-in-Aid for Scientific Research C (# 14463492) (to HK).	Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Enquist J, 2011, J PHARMACOL EXP THER, V338, P633, DOI 10.1124/jpet.111.179754; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Los GV, 2007, METH MOL B, V356, P195; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Salahpour A, 2011, METHODS MOL BIOL, V756, P311, DOI 10.1007/978-1-61779-160-4_18; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; von Zastrow M, 2012, NEURON, V76, P22, DOI 10.1016/j.neuron.2012.09.022	16	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0129394	10.1371/journal.pone.0129394	http://dx.doi.org/10.1371/journal.pone.0129394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020647	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300126
J	Venot, M; Weis, L; Clec'h, C; Darmon, M; Allaouchiche, B; Goldgran-Toledano, D; Garrouste-Orgeas, M; Adrie, C; Timsit, JF; Azoulay, E				Venot, Marion; Weis, Lise; Clec'h, Christophe; Darmon, Michael; Allaouchiche, Bernard; Goldgran-Toledano, Dany; Garrouste-Orgeas, Maite; Adrie, Christophe; Timsit, Jean-Francois; Azoulay, Elie			Acute Kidney Injury in Severe Sepsis and Septic Shock in Patients with and without Diabetes Mellitus: A Multicenter Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; RISK; POPULATION; INFECTIONS; MORTALITY; DISEASE	Introduction Whether diabetes mellitus increases the risk of acute kidney injury (AKI) during sepsis is controversial. Materials and Methods We used a case-control design to compare the frequency of AKI, use of renal replacement therapy (RRT), and renal recovery in patients who had severe sepsis or septic shock with or without diabetes. The data were from the Outcomerea prospective multicenter database, in which 12 French ICUs enrolled patients admitted between January 1997 and June 2009. Results First, we compared 451 patients with severe sepsis or septic shock and diabetes to 3,277 controls with severe sepsis or septic shock and without diabetes. Then, we compared 318 cases (with diabetes) to 746 matched controls (without diabetes). Diabetic patients did not have a higher frequency of AKI (hazard ratio [HR], 1.18; P = 0.05]) or RRT (HR, 1.09; P = 0.6). However, at discharge, diabetic patients with severe sepsis or septic shock who experienced acute kidney injury during the ICU stay and were discharged alive more often required RRT (9.5% vs. 4.8%; P = 0.02), had higher serum creatinine values (134 vs. 103 mu moL/L; P<0.001) and had less often recovered a creatinine level less than 1.25 fold the basal creatinine (41.1% vs. 60.5%; P<0.001). Conclusions In patients with severe sepsis or septic shock, diabetes is not associated with occurrence of AKI or need for RRT but is an independent risk factor for persistent renal dysfunction in patients who experience AKI during their ICU stay.	[Venot, Marion; Azoulay, Elie] Hop St Louis, AP HP, Serv Reanimat Med, Paris, France; [Weis, Lise] Hop Europeen Georges Pompidou, AP HP, Serv Med Vasc & Hypertens Arterielle, Paris, France; [Clec'h, Christophe] Hop Avicenne, AP HP, Serv Reanimat, Paris, France; [Clec'h, Christophe] Univ Paris 13, Fac Med, Bobigny, France; [Darmon, Michael] CHU St Etienne, Serv Reanimat Med, St Etienne, France; [Darmon, Michael] Univ St Etienne, Fac Med Jacques Lisfranc, St Etienne, France; [Allaouchiche, Bernard] CHU Edouard Herriot, Serv Reanimat Chirurg, Lyon, France; [Goldgran-Toledano, Dany] Ctr Hosp Gonesse, Serv Reanimat Polyvalente, Gonesse, France; [Garrouste-Orgeas, Maite] Grp Hosp Paris St Joseph, Serv Reanimat Polyvalente, Paris, France; [Adrie, Christophe] Hop Cochin, AP HP, Serv Physiol, F-75674 Paris, France; [Timsit, Jean-Francois] CHU Grenoble, Serv Reanimat Polyvalente, F-38043 Grenoble, France; [Timsit, Jean-Francois] Univ Grenoble 1, U823, Grenoble, France; [Azoulay, Elie] Univ Paris 05, Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU de St Etienne; Universite Jean Monnet; CHU Lyon; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Cite	Venot, M (corresponding author), Hop St Louis, AP HP, Serv Reanimat Med, Paris, France.	marion.venot@aphp.fr		Darmon, Michael/0000-0003-4198-8038	Aventis Pharma; Wyeth; Pfizer; MSD; French agency (Centre National de la Recherche Scientifique [CNRS]); French agency (Institut National pour la Sante et la Recherche Medicale [INSERM]); French agency (French Ministry of Health)	Aventis Pharma; Wyeth(Wyeth); Pfizer(Pfizer); MSD; French agency (Centre National de la Recherche Scientifique [CNRS]); French agency (Institut National pour la Sante et la Recherche Medicale [INSERM]); French agency (French Ministry of Health)	Outcomerea is a nonprofit organization supported by public grants and nonexclusive grants from four pharmaceutical companies (Aventis Pharma, Wyeth, Pfizer, and MSD). Also, Outcomerea has been granted by three publicly funded French agencies (Centre National de la Recherche Scientifique [CNRS], Institut National pour la Sante et la Recherche Medicale [INSERM], and the French Ministry of Health). None of the co-authors are employed, consultants or part of any of these companies and none of their relationship with industrial companies are related to the topic covered by this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXIEWICZ JM, 1995, ANN INTERN MED, V123, P919, DOI 10.7326/0003-4819-123-12-199512150-00004; [Anonymous], 2012, WESTERN JOURNAL OF C, V76, P19, DOI DOI 10.2204/IODP.PR.340.2012; Bagshaw SM, 2008, CRIT CARE, V12, DOI [10.1186/cc6863, 10.1186/cc6268]; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; De Boer IH, 2011, JAMA, V305; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Doi K, 2008, KIDNEY INT, V74, P1017, DOI 10.1038/ki.2008.346; Esper AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7717; Harel Z, 2013, KIDNEY INT, V83, P901, DOI 10.1038/ki.2012.451; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; Macedo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036388; Michalia M, 2009, INTENS CARE MED, V35, P448, DOI 10.1007/s00134-008-1288-0; Neveu H, 1996, NEPHROL DIAL TRANSPL, V11, P293, DOI 10.1093/oxfordjournals.ndt.a027256; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Schuetz P, 2011, DIABETES CARE, V34, P771, DOI 10.2337/dc10-1185; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Stegenga ME, 2010, CRIT CARE MED, V38, P539, DOI 10.1097/CCM.0b013e3181c02726; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8866; Yegenaga I, 2004, AM J KIDNEY DIS, V43, P817, DOI 10.1053/j.ajkd.2003.12.045	24	42	47	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127411	10.1371/journal.pone.0127411	http://dx.doi.org/10.1371/journal.pone.0127411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020231	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300040
J	Zhu, WJ; Perez, EA; Hong, RX; Li, Q; Xu, BH				Zhu, Wenjie; Perez, Edith A.; Hong, Ruoxi; Li, Qing; Xu, Binghe			Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; INTERNATIONAL SOCIETY; WOMEN; SURVIVAL; OLDER; RECOMMENDATIONS; UNDERTREATMENT; MANAGEMENT; SUBTYPES; RACE	Background Triple-negative breast cancer (TNBC) has been demonstrated to carry poor prognosis, but whether or not there exists any age-related variation in TNBC outcomes has yet to be elucidated. The current population-based study investigated the early survival pattern of elderly women with TNBC and identified outcome-correlated factors. Patients and Methods We searched the Surveillance, Epidemiology, and End Results (SEER) database and enrolled female primary non-metastatic TNBC cases. The patients were subdivided into elderly (>= 70 years) and young groups (<70 years). The survival status of elderly patients was compared to that of the younger women. The primary and secondary endpoints were cancer-specific survival (CSS) and overall survival (OS) respectively. Results 9908 female TNBC patients diagnosed from 2010 to 2011 were included in the current study (20.4% elderly). Elderly patients with relatively advanced diseases exhibited distinctly worse cancer-specific (log-rank, p<0.001) and overall survival (log-rank, p<0.001) than their young counterparts. Advanced age at diagnosis (>= 70 years) was significantly predictive of poor outcome in terms of CSS (hazard ratio (HR), 2.125; 95% confidence interval (CI), 1.664 to 2.713; p<0.001) and OS (HR, 3.042; 95% CI, 2.474 to 3.740; p<0.001). Underuse of curative treatment especially radiotherapy was more prevalent in elderly women with stage II or III diseases than in younger patients. Conclusion Elderly patients with TNBC displayed elevated early mortality within the first two years of diagnosis compared to the younger individuals. The observed lower rate of loco-regional treatment might be associated with worse cancer-specific outcome for these patients.	[Zhu, Wenjie; Hong, Ruoxi; Li, Qing; Xu, Binghe] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Zhu, Wenjie; Hong, Ruoxi; Li, Qing; Xu, Binghe] Peking Union Med Coll, Beijing 100021, Peoples R China; [Perez, Edith A.] Mayo Clin, Jacksonville, FL 32224 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Mayo Clinic	Xu, BH (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China.	bhxu@hotmail.com						Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Biganzoli L, 2012, LANCET ONCOL, V13, pE148, DOI 10.1016/S1470-2045(11)70383-7; Billar JAY, 2010, ANN SURG ONCOL, V17, pS384, DOI 10.1245/s10434-010-1260-4; Bouchardy C, 2003, J CLIN ONCOL, V21, P3580, DOI 10.1200/JCO.2003.02.046; Boyle P, 2008, WORLD CANC REPORT 20; Cancello G, 2010, ANN ONCOL, V21, P1974, DOI 10.1093/annonc/mdq072; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cheung K, 2011, J CLIN ONCOL, V29; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Giordano SH, 2006, J CLIN ONCOL, V24, P2750, DOI 10.1200/JCO.2005.02.3028; International Agency of Research on Cancer, 2014, GLOBOCAN 2012 EST CA; Joerger M, 2013, J GERIATR ONCOL, V4, P39, DOI 10.1016/j.jgo.2012.08.002; Lavelle K, 2014, BRIT J CANCER, V110, P573, DOI 10.1038/bjc.2013.734; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Muss HB, 2005, JAMA-J AM MED ASSOC, V293, P1073, DOI 10.1001/jama.293.9.1073; Oakman C, 2010, BREAST, V19, P312, DOI 10.1016/j.breast.2010.03.026; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Rocco N, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S25; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; Thike AA, 2010, AM J SURG PATHOL, V34, P956, DOI 10.1097/PAS.0b013e3181e02f45; Wang SL, 2011, INT J RADIAT ONCOL, V80, P1095, DOI 10.1016/j.ijrobp.2010.03.038; Weiss A, 2013, ANN SURG ONCOL, V20, P3274, DOI 10.1245/s10434-013-3115-2; Wildiers H, 2007, LANCET ONCOL, V8, P1101, DOI 10.1016/S1470-2045(07)70378-9; Yu KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011035	28	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128345	10.1371/journal.pone.0128345	http://dx.doi.org/10.1371/journal.pone.0128345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020519	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300101
J	Tao, H; Yan, J; Zhao, JW; Tian, YQ; Jin, ZY; Xu, XM				Tao, Han; Yan, Juan; Zhao, Jianwei; Tian, Yaoqi; Jin, Zhengyu; Xu, Xueming			Effect of Multiple Freezing/Thawing Cycles on the Structural and Functional Properties of Waxy Rice Starch	PLOS ONE			English	Article							IN-VITRO DIGESTIBILITY; PHYSICOCHEMICAL PROPERTIES; RHEOLOGICAL PROPERTIES; CEREAL STARCHES; AMYLOSE CONTENT; DAMAGED STARCH; CHAIN-LENGTH; MAIZE STARCH; WHEAT-STARCH; GELATINIZATION	The structural and functional properties of non-gelatinized waxy rice starch were investigated after 1, 3, 7, and 10 freezing/thawing cycles. Freezing caused an increasing damaged starch from 1.36% in native waxy rice starch to 5.77% in 10 freezing/thawing-treated starch (FTS), as evidenced by the cracking surface on starch granules. More dry matter concentration was leached, which was characterized by high amylopectin concentration (4.34 mg/mL). The leaching was accompanied by a decrease in relative crystallinity from 35.19% in native starch to 31.34% in 10 FTS. Freezing treatment also led to significant deviations in the functional characteristics, for instance decreased gelatinization temperature range, enthalpy, and pasting viscosities. The resistant starch content of 10FTS significantly decreased from 58.9% to 19%, whereas the slowly digested starch content greatly increased from 23.8% in native starch to 50.3%. The increase in susceptibility to enzyme hydrolysis may be attributed to porous granular surface, amylopectin leaching, and the decrease in the relative crystallinity caused by freezing water.	[Tao, Han; Yan, Juan; Zhao, Jianwei; Jin, Zhengyu; Xu, Xueming] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China; [Tian, Yaoqi; Jin, Zhengyu] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Xu, Xueming] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi, Jiangsu, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Xu, XM (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Peoples R China.	xmxu@jiangnan.edu.cn	Tian, Yaoqi/E-7493-2010	Tian, Yaoqi/0000-0001-5693-8872	National "Twelfth Five-Year" Plan for Science & Technology Support of China [2012BAD37B06, 2012BAD37B07]; graduate student innovation project of Jiangsu province [KYLX_1165]	National "Twelfth Five-Year" Plan for Science & Technology Support of China; graduate student innovation project of Jiangsu province	This work was supported by the National "Twelfth Five-Year" Plan for Science & Technology Support of China (Nos. 2012BAD37B06 & 2012BAD37B07), and the graduate student innovation project of Jiangsu province (KYLX_1165).	American Association of Cereal Chemists, 2000, APPR METH AM ASS CER, V10th ed.; Anon M. C., 2004, Handbook of frozen foods, P571; AOAC, 1995, OFFICIAL METHODS ANA, V16th; Barrera GN, 2013, J FOOD ENG, V116, P233, DOI 10.1016/j.jfoodeng.2012.11.020; Cheetham NWH, 1998, CARBOHYD POLYM, V36, P277, DOI 10.1016/S0144-8617(98)00007-1; Chung HJ, 2006, J CEREAL SCI, V43, P353, DOI 10.1016/j.jcs.2005.12.001; Chung HJ, 2011, FOOD HYDROCOLLOID, V25, P968, DOI 10.1016/j.foodhyd.2010.09.011; COLONNA P, 1992, EUR J CLIN NUTR, V46, pS17; de la Hera E, 2013, CARBOHYD POLYM, V98, P421, DOI 10.1016/j.carbpol.2013.06.002; Giannou V, 2003, TRENDS FOOD SCI TECH, V14, P99, DOI 10.1016/S0924-2244(02)00278-9; GIDLEY MJ, 1987, CARBOHYD RES, V161, P291, DOI 10.1016/S0008-6215(00)90086-7; Goesaert H, 2005, TRENDS FOOD SCI TECH, V16, P12, DOI 10.1016/j.tifs.2004.02.011; Jacobson MR, 1998, CEREAL CHEM, V75, P22, DOI 10.1094/CCHEM.1998.75.1.22; Jane J, 1999, CEREAL CHEM, V76, P629, DOI 10.1094/CCHEM.1999.76.5.629; KOMIYA T, 1986, STARCH-STARKE, V38, P9, DOI 10.1002/star.19860380104; Leray G, 2010, J FOOD ENG, V100, P70, DOI 10.1016/j.jfoodeng.2010.03.029; Li EP, 2014, STARCH-STARKE, V66, P15, DOI 10.1002/star.201200224; Lorenzo G, 2009, J CEREAL SCI, V50, P255, DOI 10.1016/j.jcs.2009.06.003; Marston P, 1978, BAKERS DIG; Mezaize S, 2010, FOOD RES INT, V43, P2186, DOI 10.1016/j.foodres.2010.07.030; Meziani S, 2011, J FOOD ENG, V107, P358, DOI 10.1016/j.jfoodeng.2011.07.003; MORRISON WR, 1994, J CEREAL SCI, V20, P69, DOI 10.1006/jcrs.1994.1046; Pomeranz Y., 1971, WHEAT CHEM TECHNOL, V3, P385; Srichuwong S, 2007, FOOD SCI BIOTECHNOL, V16, P663; Szymonska J, 2000, INT J BIOL MACROMOL, V27, P307, DOI 10.1016/S0141-8130(00)00137-9; Szymonska J, 2005, FOOD HYDROCOLLOID, V19, P753, DOI 10.1016/j.foodhyd.2004.08.004; TESTER RF, 1990, CEREAL CHEM, V67, P551; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; TESTER RF, 1990, CEREAL CHEM, V67, P558; Wang SJ, 2014, J AGR FOOD CHEM, V62, P3636, DOI 10.1021/jf500249w; Warren FJ, 2011, CARBOHYD POLYM, V86, P1038, DOI 10.1016/j.carbpol.2011.05.062; Wei BX, 2013, INT J BIOL MACROMOL, V62, P652, DOI 10.1016/j.ijbiomac.2013.10.008; You SY, 2014, CARBOHYD POLYM, V112, P729, DOI 10.1016/j.carbpol.2014.06.065; Yu SF, 2010, LWT-FOOD SCI TECHNOL, V43, P1138, DOI 10.1016/j.lwt.2010.03.004	34	22	22	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127138	10.1371/journal.pone.0127138	http://dx.doi.org/10.1371/journal.pone.0127138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018506	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600071
J	Yang, YL; Wang, P; Baker, LA; Narr, KL; Joshi, SH; Hafzalla, G; Raine, A; Thompson, PM				Yang, Yaling; Wang, Pan; Baker, Laura A.; Narr, Katherine L.; Joshi, Shantanu H.; Hafzalla, George; Raine, Adrian; Thompson, Paul M.			Thicker Temporal Cortex Associates with a Developmental Trajectory for Psychopathic Traits in Adolescents	PLOS ONE			English	Article							MATTER MICROSTRUCTURAL ABNORMALITIES; CALIFORNIA TWIN REGISTER; OF-SOUTHERN-CALIFORNIA; PARALIMBIC GRAY-MATTER; CORTICAL SURFACE-AREA; ENVIRONMENTAL-INFLUENCES; PREFRONTAL CORTEX; CONDUCT PROBLEMS; CEREBRAL-CORTEX; GREY-MATTER	Psychopathy is a clinical condition characterized by a failure in normal social interaction and morality. Recent studies have begun to reveal brain structural abnormalities associated with psychopathic tendencies in children. However, little is known about whether variations in brain morphology are linked to the developmental trajectory of psychopathic traits over time. In this study, structural magnetic resonance imaging (sMRI) data from 108 14-year-old adolescents with no history of substance abuse (54 males and 54 females) were examined to detect cortical thickness variations associated with psychopathic traits and individual rates of change in psychopathic traits from ages 9 to 18. We found cortical thickness abnormalities to correlate with psychopathic traits both cross-sectionally and longitudinally. Specifically, at age 14, higher psychopathic scores were correlated with thinner cortex in the middle frontal gyrus, particularly in females, and thicker cortex in the superior temporal gyrus, middle temporal gyrus, and parahippocampal gyrus, particularly in males. Longitudinally, individual rates of change in psychopathic tendency over time were correlated with thicker cortex in the superior temporal gyrus, middle temporal gyrus, inferior temporal gyrus, parahippocampal gyrus, and posterior cingulate gyrus, particularly in males. Findings suggest that abnormal cortical thickness may reflect a delay in brain maturation, resulting in disturbances in frontal and temporal functioning such as impulsivity, sensation-seeking, and emotional dysregulation in adolescents. Thus, findings provide initial evidence supporting that abnormal cortical thickness may serve as a biomarker for the development of psychopathic propensity in adolescents.	[Yang, Yaling] Univ So Calif, Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90089 USA; [Wang, Pan; Baker, Laura A.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Narr, Katherine L.; Joshi, Shantanu H.; Hafzalla, George] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Raine, Adrian] Univ Penn, Dept Criminol, Philadelphia, PA 19104 USA; [Raine, Adrian] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Raine, Adrian] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Thompson, Paul M.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Thompson, Paul M.] Univ So Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Yang, YL (corresponding author), Univ So Calif, Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90089 USA.	yayang@chla.usc.edu	Thompson, Paul M/C-4194-2018; Joshi, Sudhanshu/L-2284-2019	Thompson, Paul M/0000-0002-4720-8867; Joshi, Sudhanshu/0000-0003-4748-5001; Wang, Pan/0000-0001-7376-2629	National Institutes of Health [R00 MH093388, R01MH58354, R01MH092301, R01AG040060, P41RR013642]; Brain and Creativity Institute, University of Southern California; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092301, R01MH058354, R00MH093388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Creativity Institute, University of Southern California; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (http://www.nih.org) including R00 MH093388 (YY) for data analysis and preparation of the manuscript, R01MH58354 (LAB) for study design and data collection and analysis, R01MH092301 (KLN) for data analysis and preparation of the manuscript, and R01AG040060 and P41RR013642 (PMT) for data analysis, and by a grant from the Brain and Creativity Institute, University of Southern California for data collection.	Baker LA, 2006, TWIN RES HUM GENET, V9, P933, DOI 10.1375/twin.9.6.933; Baker LA, 2013, TWIN RES HUM GENET, V16, P336, DOI 10.1017/thg.2012.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezdjian S, 2011, CLIN PSYCHOL REV, V31, P1209, DOI 10.1016/j.cpr.2011.07.005; Blair RJR, 2013, NAT REV NEUROSCI, V14, P786, DOI 10.1038/nrn3577; Blair RJR, 2006, J CHILD PSYCHOL PSYC, V47, P262, DOI 10.1111/j.1469-7610.2006.01596.x; Cope LM, 2014, J ABNORM CHILD PSYCH, V42, P659, DOI 10.1007/s10802-013-9810-4; De Brito SA, 2011, MOL PSYCHIATR, V16, P476, DOI 10.1038/mp.2010.74; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; de Oliveira-Souza R, 2008, NEUROIMAGE, V40, P1202, DOI 10.1016/j.neuroimage.2007.12.054; Decety J, 2014, SOC NEUROSCI-UK, V9, P36, DOI 10.1080/17470919.2013.866905; Ducharme S, 2012, J AM ACAD CHILD PSY, V51, P18, DOI 10.1016/j.jaac.2011.09.022; Ermer E, 2013, J AM ACAD CHILD PSY, V52, P94, DOI 10.1016/j.jaac.2012.10.013; Ermer E, 2012, J ABNORM PSYCHOL, V121, P649, DOI 10.1037/a0026371; Ermer E, 2010, PSYCHOL SCI, V21, P1399, DOI 10.1177/0956797610384148; Farrington DP, 2005, J ABNORM CHILD PSYCH, V33, P489, DOI 10.1007/s10802-005-5729-8; Fett AKJ, 2014, SOC COGN AFFECT NEUR, V9, P395, DOI 10.1093/scan/nss144; Frick PJ, 2008, J CHILD PSYCHOL PSYC, V49, P359, DOI 10.1111/j.1469-7610.2007.01862.x; Frick PJ, 2000, PSYCHOL ASSESSMENT, V12, P382, DOI 10.1037//1040-3590.12.4.382; Gao Y, 2009, CAN J PSYCHIAT, V54, P813, DOI 10.1177/070674370905401204; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Glenn AL, 2009, MOL PSYCHIATR, V14, P5, DOI 10.1038/mp.2008.104; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hare R.D, 2003, MANUAL REVISED PSYCH, V2nd; Harenski CL, 2012, DEV COGN NEUROS-NETH, V2, P162, DOI 10.1016/j.dcn.2011.09.002; Howner K, 2012, PSYCHIAT RES-NEUROIM, V203, P126, DOI 10.1016/j.pscychresns.2011.12.011; Hyde LW, 2010, J ABNORM CHILD PSYCH, V38, P197, DOI 10.1007/s10802-009-9358-5; Joshi AA, 2011, NEUROREPORT, V22, P101, DOI 10.1097/WNR.0b013e3283424c84; Kiehl KA, 2004, PSYCHIAT RES-NEUROIM, V130, P27, DOI 10.1016/S0925-4927(03)00106-9; Kiehl KA, 2006, PSYCHIAT RES, V142, P107, DOI 10.1016/j.psychres.2005.09.013; Koenigs M, 2012, REV NEUROSCIENCE, V23, P253, DOI 10.1515/revneuro-2012-0036; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Ly M, 2012, AM J PSYCHIAT, V169, P743, DOI 10.1176/appi.ajp.2012.11111627; Lynam DR, 2005, ANNU REV CLIN PSYCHO, V1, P381, DOI 10.1146/annurev.clinpsy.1.102803.144019; Lynam DR, 2005, J ABNORM CHILD PSYCH, V33, P431, DOI 10.1007/s10648-005-5724-0; Lynam DR, 1997, J ABNORM PSYCHOL, V106, P425, DOI 10.1037/0021-843X.106.3.425; Marsh AA, 2014, SOC COGN AFFECT NEUR, V9, P3, DOI 10.1093/scan/nss097; McArdle JJ, 2005, BEHAV GENET, V35, P631, DOI 10.1007/s10519-005-2868-1; McArdle JJ, 2006, TWIN RES HUM GENET, V9, P343, DOI 10.1375/183242706777591263; Mednick S, 1997, EXAMPLE BIOSOCIAL RE; Mier D, 2014, WORLD J BIOL PSYCHIA, V15, P479, DOI 10.3109/15622975.2014.902541; Molenberghs P, 2014, HUM BRAIN MAPP, V35, P4989, DOI 10.1002/hbm.22527; Motzkin JC, 2011, J NEUROSCI, V31, P17348, DOI 10.1523/JNEUROSCI.4215-11.2011; Muller JL, 2008, BEHAV SCI LAW, V26, P131, DOI 10.1002/bsl.796; Muthen B., 2010, MPLUS USERS GUIDE; Narayan VM, 2007, AM J PSYCHIAT, V164, P1418, DOI 10.1176/appi.ajp.2007.06101631; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pinheiro J, 2001, MIXED EFFECTS MODELS; Raine A, 2011, MOL PSYCHIATR, V16, P227, DOI 10.1038/mp.2009.136; Rijsdijsk FV, 2010, ARCH GEN PSYCHIAT, V67, P406, DOI 10.1001/archgenpsychiatry.2010.20; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Sadeh N, 2013, SOC COGN AFFECT NEUR, V8, P235, DOI 10.1093/scan/nsr092; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sarkar S, 2013, PSYCHOL MED, V43, P401, DOI 10.1017/S003329171200116X; Sato JR, 2011, SOC NEUROSCI-UK, V6, P627, DOI 10.1080/17470919.2011.562687; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Shaw P, 2012, BIOL PSYCHIAT, V72, P191, DOI 10.1016/j.biopsych.2012.01.031; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; Tiihonen J, 2008, PSYCHIAT RES-NEUROIM, V163, P201, DOI 10.1016/j.pscychresns.2007.08.012; Viding Essi, 2014, Curr Top Behav Neurosci, V17, P395, DOI 10.1007/7854_2013_266; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wang P, 2012, J ABNORM CHILD PSYCH, V40, P759, DOI 10.1007/s10802-011-9606-3; Wang YL, 2011, NEUROIMAGE, V56, P1993, DOI 10.1016/j.neuroimage.2011.03.040; Yakovlev PI, 1967, MYELOGENETIC CYCLES; Yang Y, 2009, MOL PSYCHIATR, V14, P561, DOI 10.1038/mp.2009.12; Yang Y., 2008, PSYCHIATRY, V7, P133, DOI DOI 10.1016/J.MPPSY.2008.01.001; Yang YL, 2012, NEUROREPORT, V23, P702, DOI 10.1097/WNR.0b013e328355a62a; Yang YL, 2012, CEREB CORTEX, V22, P1170, DOI 10.1093/cercor/bhr193; Yang YL, 2010, SCHIZOPHR RES, V123, P116, DOI 10.1016/j.schres.2010.08.005; Yang YL, 2010, J ABNORM PSYCHOL, V119, P546, DOI 10.1037/a0019611; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Zaki J, 2007, SOC NEUROSCI-UK, V2, P276, DOI 10.1080/17470910701401973	74	11	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127025	10.1371/journal.pone.0127025	http://dx.doi.org/10.1371/journal.pone.0127025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017779	gold, Green Submitted, Green Published			2022-12-27	WOS:000355185600067
J	Avaldi, VM; Lenzi, J; Castaldini, I; Urbinati, S; Di Pasquale, G; Morini, M; Protonotari, A; Maggioni, AP; Fantini, MP				Avaldi, Vera Maria; Lenzi, Jacopo; Castaldini, Ilaria; Urbinati, Stefano; Di Pasquale, Giuseppe; Morini, Mara; Protonotari, Adalgisa; Maggioni, Aldo Pietro; Fantini, Maria Pia			Hospital Readmissions of Patients with Heart Failure: The Impact of Hospital and Primary Care Organizational Factors in Northern Italy	PLOS ONE			English	Article							DISEASE MANAGEMENT PROGRAM; IMPROVING PRIMARY-CARE; MYOCARDIAL-INFARCTION; RANDOMIZED TRIAL; ELDERLY-PATIENTS; HIGH-RISK; INTERVENTION; METAANALYSIS; ADMISSION; EPIDEMIOLOGY	Background Primary health care is essential for an appropriate management of heart failure (HF), a disease which is a major clinical and public health issue and a leading cause of hospitalization. The aim of this study was to evaluate the impact of different organizational factors on readmissions of patients with HF. Methods The study population included elderly resident in the Local Health Authority of Bologna (Northern Italy) and discharged with a diagnosis of HF from January to December 2010. Unplanned hospital readmissions were measured in four timeframes: 30 (short-term), 90 (medium-term), 180 (mid-long-term), and 365 days (long-term). Using multivariable multilevel Poisson regression analyses, we investigated the association between readmissions and organizational factors (discharge from a cardiology department, general practitioners' monodisciplinary organizational arrangement, and implementation of a specific HF care pathway). Results The 1873 study patients had a median age of 83 years (interquartile range 77-87) and 55.5% were females; 52.0% were readmitted to the hospital for any reason after a year, while 20.1% were readmitted for HF. The presence of a HF care pathway was the only factor significantly associated with a lower risk of readmission for HF in the short-, medium-, mid-long-and long-term period (short-term: IRR [incidence rate ratio] = 0.57, 95% CI [confidence interval] = 0.35-0.92; medium-term: IRR = 0.70, 95% CI = 0.51-0.96; mid-long-term: IRR= 0.79, 95% CI= 0.64-0.98; long-term: IRR = 0.82, 95% CI = 0.67-0.99), and with a lower risk of all-cause readmission in the short-term period (IRR= 0.73, 95% CI = 0.57-0.94). Conclusion Our study shows that the HF care specific pathway implemented at the primary care level was associated with lower readmission rate for HF in each timeframe, and also with lower readmission rate for all causes in the short-term period. Our results suggest that the engagement of primary care professionals starting from the early post-discharge period may be relevant in the management of patients with HF.	[Avaldi, Vera Maria; Lenzi, Jacopo; Fantini, Maria Pia] Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Castaldini, Ilaria; Protonotari, Adalgisa] Bologna Local Healthcare Author, Dept Programming & Control, Bologna, Italy; [Urbinati, Stefano] Bellaria Hosp, Dept Cardiol, Bologna, Italy; [Di Pasquale, Giuseppe] Maggiore Hosp, Dept Cardiol, Bologna, Italy; [Morini, Mara] Bologna Local Healthcare Author, Dept Primary Care, Bologna, Italy; [Maggioni, Aldo Pietro] ANMCO Res Ctr, Florence, Italy	University of Bologna; AUSL di Bologna; AUSL di Bologna; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)	Fantini, MP (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Bologna, Italy.	mariapia.fantini@unibo.it	Lenzi, Jacopo/W-4835-2017; Maggioni, Aldo Pietro/AAL-5334-2020	Lenzi, Jacopo/0000-0003-2882-4223; Maggioni, Aldo Pietro/0000-0003-2764-6779; Avaldi, Vera Maria/0000-0003-0609-2439				Armeni P, 2014, MED CARE RES REV, V71, P315, DOI 10.1177/1077558714536618; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Blue L, 2001, BRIT MED J, V323, P715, DOI 10.1136/bmj.323.7315.715; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bottle A, 2014, EUR J HEART FAIL, V16, P846, DOI 10.1002/ejhf.129; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Capomolla S, 2002, J AM COLL CARDIOL, V40, P1259, DOI 10.1016/S0735-1097(02)02140-X; Clark AM, 2008, LANCET, V372, P784, DOI 10.1016/S0140-6736(08)61317-3; Clark RA, 2007, BMJ-BRIT MED J, V334, P942, DOI 10.1136/bmj.39156.536968.55; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Del Sindaco D, 2007, J CARDIOVASC MED, V8, P324, DOI 10.2459/JCM.0b013e32801164cb; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Ducharme A, 2005, CAN MED ASSOC J, V173, P40, DOI 10.1503/cmaj.1041137; Fantini MP, 2012, HEALTH CARE MANAGE R, V37, P67, DOI 10.1097/HMR.0b013e31822241cf; Garin N, 2012, EUR J INTERN MED, V23, P760, DOI 10.1016/j.ejim.2012.06.006; Gonseth J, 2004, EUR HEART J, V25, P1570, DOI 10.1016/j.ehj.2004.04.022; Ham C, 2010, HEALTH ECON POLICY L, V5, P71, DOI 10.1017/S1744133109990120; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Inglis SC, 2011, EUR J HEART FAIL, V13, P1028, DOI 10.1093/eurjhf/hfr039; Jaarsma T, 2013, EUR J CARDIOVASC NUR, V12, P230, DOI [10.1177/1474515113476605, 10.1177/1474515112449539]; Kasper EK, 2002, J AM COLL CARDIOL, V39, P471, DOI 10.1016/S0735-1097(01)01761-2; Kirchmayer U, 2012, J CLIN PHARM THER, V37, P37, DOI 10.1111/j.1365-2710.2010.01242.x; Kirchmayer U, 2013, PHARMACOEPIDEM DR S, V22, P649, DOI 10.1002/pds.3430; Klersy C, 2009, J AM COLL CARDIOL, V54, P1683, DOI 10.1016/j.jacc.2009.08.017; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; Kul S, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-81; Lenzi J, 2015, EUR J CLIN PHARMACOL, V71, P243, DOI 10.1007/s00228-014-1793-8; Linden A, 2014, AM J MANAG CARE, V20; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McAlister FA, 2013, CAN MED ASSOC J, V185, pE681, DOI 10.1503/cmaj.130048; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Michalsen A, 1998, HEART, V80, P437, DOI 10.1136/hrt.80.5.437; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Panella M, 2009, QUAL SAF HEALTH CARE, V18, P369, DOI 10.1136/qshc.2008.026559; Profili S., 2009, HLTH SYST TRANSIT, V11, P1; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Takeda A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub3; Tsuyuki RT, 2004, J CARD FAIL, V10, P473, DOI 10.1016/j.cardfail.2004.02.005; Tuppin P, 2014, ARCH CARDIOVASC DIS, V107, P158, DOI 10.1016/j.acvd.2014.01.012; Visca M, 2013, HEALTH POLICY, V113, P188, DOI 10.1016/j.healthpol.2013.05.016; Wagner E H, 1998, Eff Clin Pract, V1, P2; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206	44	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127796	10.1371/journal.pone.0127796	http://dx.doi.org/10.1371/journal.pone.0127796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010223	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900145
J	Efrati, S; Golan, H; Bechor, Y; Faran, Y; Daphna-Tekoah, S; Sekler, G; Fishlev, G; Ablin, JN; Bergan, J; Volkov, O; Friedman, M; Ben-Jacob, E; Buskila, D				Efrati, Shai; Golan, Haim; Bechor, Yair; Faran, Yifat; Daphna-Tekoah, Shir; Sekler, Gal; Fishlev, Gregori; Ablin, Jacob N.; Bergan, Jacob; Volkov, Olga; Friedman, Mony; Ben-Jacob, Eshel; Buskila, Dan			Hyperbaric Oxygen Therapy Can Diminish Fibromyalgia Syndrome - Prospective Clinical Trial	PLOS ONE			English	Article							HEALTH SURVEY SF-36; WIDESPREAD PAIN; CELLS; RATS; NEUROINFLAMMATION; ABNORMALITIES; DEPRESSION; PRESSURE; CRITERIA; PLACEBO	Background Fibromyalgia Syndrome (FMS) is a persistent and debilitating disorder estimated to impair the quality of life of 2-4% of the population, with 9: 1 female-to-male incidence ratio. FMS is an important representative example of central nervous system sensitization and is associated with abnormal brain activity. Key symptoms include chronic widespread pain, allodynia and diffuse tenderness, along with fatigue and sleep disturbance. The syndrome is still elusive and refractory. The goal of this study was to evaluate the effect of hyperbaric oxygen therapy (HBOT) on symptoms and brain activity in FMS. Methods and Findings A prospective, active control, crossover clinical trial. Patients were randomly assigned to treated and crossover groups: The treated group patients were evaluated at baseline and after HBOT. Patients in the crossover-control group were evaluated three times: baseline, after a control period of no treatment, and after HBOT. Evaluations consisted of physical examination, including tender point count and pain threshold, extensive evaluation of quality of life, and single photon emission computed tomography (SPECT) imaging for evaluation of brain activity. The HBOT protocol comprised 40 sessions, 5 days/week, 90 minutes, 100% oxygen at 2ATA. Sixty female patients were included, ag(e)d 21-67 years and diagnosed with FMS at least 2 years earlier. HBOT in both groups led to significant amelioration of all FMS symptoms, with significant improvement in life quality. Analysis of SPECT imaging revealed rectification of the abnormal brain activity: decrease of the hyperactivity mainly in the posterior region and elevation of the reduced activity mainly in frontal areas. No improvement in any of the parameters was observed following the control period. Conclusions The study provides evidence that HBOT can improve the symptoms and life quality of FMS patients. Moreover, it shows that HBOT can induce neuroplasticity and significantly rectify abnormal brain activity in pain related areas of FMS patients.	[Efrati, Shai; Ben-Jacob, Eshel] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Efrati, Shai; Bechor, Yair; Fishlev, Gregori; Bergan, Jacob; Friedman, Mony] Assaf Harofeh Med Ctr, Inst Hyperbar Med, IL-70300 Zerifin, Israel; [Efrati, Shai; Golan, Haim; Fishlev, Gregori; Ablin, Jacob N.; Bergan, Jacob; Volkov, Olga; Friedman, Mony] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Efrati, Shai; Ben-Jacob, Eshel] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Golan, Haim; Volkov, Olga] Assaf Harofeh Med Ctr, Inst Nucl Med, IL-70300 Zerifin, Israel; [Faran, Yifat; Daphna-Tekoah, Shir] Ashkelon Acad Coll, Sch Social Work, Ashqelon, Israel; [Daphna-Tekoah, Shir] Kaplan Med Ctr, Dept Social Work, Rehovot, Israel; [Sekler, Gal; Ben-Jacob, Eshel] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Ablin, Jacob N.] Tel Aviv Sourasky Med Ctr Israel, Inst Rheumatol, Tel Aviv, Israel; [Ben-Jacob, Eshel] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Buskila, Dan] BGU Univ Negev, Soroka Med Ctr, Dept Med H, Beer Sheva, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Hebrew University of Jerusalem; Kaplan Medical Center; Tel Aviv University; Rice University; Ben Gurion University; Soroka Medical Center	Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel.	efratishai@013.net; eshelbj@gmail.com	Ablin, Jacob/V-9716-2019; Golan, Haim/K-2831-2019	Ablin, Jacob/0000-0003-2523-4850	Assaf-Harofeh Medical Center; Tauber Family Funds; Maguy-Glass Chair in Physics of Complex Systems	Assaf-Harofeh Medical Center; Tauber Family Funds; Maguy-Glass Chair in Physics of Complex Systems	The study was supported by the research fund of Assaf-Harofeh Medical Center. EB-J and G-S were supported by a grant from the Tauber Family Funds and the Maguy-Glass Chair in Physics of Complex Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arnold LM, 2008, PATIENT EDUC COUNS, V73, P114, DOI 10.1016/j.pec.2008.06.005; Berman S, 2013, NEPHROLOGY, V18, P292, DOI 10.1111/nep.12043; BITTERMAN N, 1994, J APPL PHYSIOL, V77, P2355, DOI 10.1152/jappl.1994.77.5.2355; BITTERMAN N, 1993, UNDERSEA HYPERBAR M, V20, P197; Boussi-Gross R, 2014, NEUROPSYCHOLOGY; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Buskila D, 1996, J RHEUMATOL, V23, P903; Chen ZQ, 2010, J MAGN RESON IMAGING, V31, P1054, DOI 10.1002/jmri.22142; Chung E, 2010, J PAIN, V11, P847, DOI 10.1016/j.jpain.2009.12.004; Clauw DJ, 2011, MAYO CLIN PROC, V86, P907, DOI 10.4065/mcp.2011.0206; Dall'Era MA, 2006, J UROLOGY, V176, P87, DOI 10.1016/S0022-5347(06)00491-5; DiSabato F, 1997, UNDERSEA HYPERBAR M, V24, P117; Efrati S, 2014, EXPERT REV NEUROTHER; Efrati S, 2007, J HYPERTENS, V25, P1041, DOI 10.1097/HJH.0b013e32807fb09c; Efrati S, 2014, UNDERSEA HYPERBAR M, V41, P71; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Emad Y, 2008, J RHEUMATOL, V35, P1371; Etzion Y, 2000, EUR J NEUROSCI, V12, P4007, DOI 10.1046/j.1460-9568.2000.00303.x; Gibbons CR, 2013, BRAIN RES, V1537, P111, DOI 10.1016/j.brainres.2013.08.050; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; Goldenberg DL, 2008, J CLIN PSYCHIAT, V69, P30; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Gu N, 2012, EUR J PAIN, V16, P1094, DOI 10.1002/j.1532-2149.2012.00113.x; Guedj E, 2008, J NUCL MED, V49, P1798, DOI 10.2967/jnumed.108.053264; Guedj E, 2007, EUR J NUCL MED MOL I, V34, P130, DOI 10.1007/s00259-006-0174-7; Gunther A, 2005, EUR J NEUROSCI, V21, P3189, DOI 10.1111/j.1460-9568.2005.04151.x; Hanlo PW, 1997, DEV MED CHILD NEUROL, V39, P286; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Hui J, 2013, J PAIN, V14, P747, DOI 10.1016/j.jpain.2013.02.003; JASZCZAK RJ, 1979, PHYS MED BIOL, V24, P1123, DOI 10.1088/0031-9155/24/6/003; Johnson W, 2012, CARDIOL CLIN, V30, P533, DOI 10.1016/j.ccl.2012.07.011; Kanaan RAA, 2007, PSYCHOSOM MED, V69, P855, DOI 10.1097/PSY.0b013e31815b001a; Kiralp MZ, 2004, J INT MED RES, V32, P258, DOI 10.1177/147323000403200304; Lee YS, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/512978; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Matthey A, 2013, PAIN PHYSICIAN, V16, pE553; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mukherjee A, 2014, UNDERSEA HYPERB MED; Neubauer RA, 1998, NEUROL RES, V20, pS33; Neumann L, 2000, SEMIN ARTHRITIS RHEU, V29, P400, DOI 10.1053/sarh.2000.7171; PEACH G, 1995, UNDERSEA HYPERBAR M, V22, P407; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; PEVELER RC, 1990, PSYCHOL MED, V20, P873, DOI 10.1017/S0033291700036576; Sarzi-Puttini P, 2011, BEST PRACT RES CL RH, V25, P133, DOI 10.1016/j.berh.2011.04.001; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Smith HS, 2010, PAIN PHYSICIAN, V13, P295; Tai PA, 2010, J NEUROTRAUM, V27, P1121, DOI 10.1089/neu.2009.1162; Tuter NV, 1997, ZH NEVROPATOL PSIKH, V97, P33; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wilson JR, 1998, HEADACHE, V38, P112, DOI 10.1046/j.1526-4610.1998.3802112.x; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolfe F, 2009, ARTHRIT RHEUM-ARTHR, V61, P715, DOI 10.1002/art.24553; Wood PR, 2009, J PAIN, V10, P47, DOI 10.1016/j.jpain.2008.07.003; Yildiz S, 2004, J INT MED RES, V32, P263; Yildiz Senol, 2006, Curr Pain Headache Rep, V10, P95, DOI 10.1007/s11916-006-0019-x; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003	62	52	54	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127012	10.1371/journal.pone.0127012	http://dx.doi.org/10.1371/journal.pone.0127012			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010952	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900054
J	Kotani, H; Taimatsu, K; Ohga, R; Ota, S; Kawahara, A				Kotani, Hirohito; Taimatsu, Kiyohito; Ohga, Rie; Ota, Satoshi; Kawahara, Atsuo			Efficient Multiple Genome Modifications Induced by the crRNAs, tracrRNA and Cas9 Protein Complex in Zebrafish	PLOS ONE			English	Article							TARGET DNA; KNOCK-IN; RNA; SYSTEM; CRISPR; NUCLEASES; TALEN; CELL; IDENTIFICATION; GENERATION	The type II clustered regularly interspaced short palindromic repeats (CRISPR) associated with Cas9 endonuclease (CRISPR/Cas9) has become a powerful genetic tool for understanding the function of a gene of interest. In zebrafish, the injection of Cas9 mRNA and guide-RNA (gRNA), which are prepared using an in vitro transcription system, efficiently induce DNA double-strand breaks (DSBs) at the targeted genomic locus. Because gRNA was originally constructed by fusing two short RNAs CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA), we examined the effect of synthetic crRNAs and tracrRNA with Cas9 mRNA or Cas9 protein on the genome editing activity. We previously reported that the disruption of tyrosinase (tyr) by tyr-gRNA/Cas9 mRNA causes a retinal pigment defect, whereas the disruption of spns2 by spns2-gRNA1/Cas9 mRNA leads to a cardiac progenitor migration defect in zebrafish. Here, we found that the injection of spns2-crRNA1, tyr-crRNA and tracrRNA with Cas9 mRNA or Cas9 protein simultaneously caused a migration defect in cardiac progenitors and a pigment defect in retinal epithelial cells. A time course analysis demonstrated that the injection of crRNAs and tracrRNA with Cas9 protein rapidly induced genome modifications compared with the injection of crRNAs and tracrRNA with Cas9 mRNA. We further show that the crRNA-tracrRNA-Cas9 protein complex is functional for the visualization of endogenous gene expression; therefore, this is a very powerful, ready-to-use system in zebrafish.	[Kotani, Hirohito; Taimatsu, Kiyohito; Ohga, Rie; Ota, Satoshi; Kawahara, Atsuo] Univ Yamanashi, Grad Sch Med Sci, Dev Biol Lab, Ctr Med Educ & Sci, Chuo, Yamanashi, Japan	University of Yamanashi	Kawahara, A (corresponding author), Univ Yamanashi, Grad Sch Med Sci, Dev Biol Lab, Ctr Med Educ & Sci, Shimokato 1110, Chuo, Yamanashi, Japan.	akawahara@yamanashi.ac.jp			Japan Society for the Promotion of Science KAKENHI [26640064]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by the Japan Society for the Promotion of Science KAKENHI Grant Number 26640064, http://www.jsps.go.jp/english/index.html.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hisano Y, 2014, DEV GROWTH DIFFER, V56, P26, DOI 10.1111/dgd.12094; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Kawahara A, 2002, DEV BIOL, V248, P107, DOI 10.1006/dbio.2002.0709; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lee JS, 2014, G3-GENES GENOM GENET, V4, P1291, DOI 10.1534/g3.114.012179; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Page-McCaw PS, 2004, NAT NEUROSCI, V7, P1329, DOI 10.1038/nn1344; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	36	64	65	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128319	10.1371/journal.pone.0128319	http://dx.doi.org/10.1371/journal.pone.0128319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010089	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900223
J	Moncla, BJ; Chappell, CA; Mahal, LK; Debo, BM; Meyn, LA; Hillier, SL				Moncla, Bernard J.; Chappell, Catherine A.; Mahal, Lara K.; Debo, Brian M.; Meyn, Leslie A.; Hillier, Sharon L.			Impact of Bacterial Vaginosis, as Assessed by Nugent Criteria and Hormonal Status on Glycosidases and Lectin Binding in Cervicovaginal Lavage Samples	PLOS ONE			English	Article							RAPID PRESUMPTIVE IDENTIFICATION; SIALIDASE NEURAMINIDASE ACTIVITY; GARDNERELLA-VAGINALIS; MUCINS; EXPRESSION; IGA; OLIGOSACCHARIDES; DESIALYLATION; PATHOGENESIS; BARRIER	The objective of this study was to evaluate the impact of hormonal status and bacterial vaginosis (BV) on the glycosidases present and glycosylation changes as assessed by lectin binding to cervicovaginal lavage constituents. Frozen cervicovaginal lavage samples from a completed study examining the impact of reproductive hormones on the physicochemical properties of vaginal fluid were utilized for the present study. In the parent study, 165 women were characterized as having BV, intermediate or normal microflora using the Nugent criteria. The presence of glycosidases in the samples was determined using quantitative 4-methyl-umbelliferone based assays, and glycosylation was assessed using enzyme linked lectin assays (ELLA). Women with BV had elevated sialidase, alpha-galactosidase, beta-galactosidase and alpha-glucosidase activities compared to intermediate or normal women (P< 0.001, 0.003, 0.006 and 0.042 respectively). The amount of sialic acid (Sambucus nigra, P = 0.003) and high mannose (griffithsin, P< 0.001) were reduced, as evaluated by lectin binding, in women with BV. When the data were stratified according to hormonal status, alpha-glucosidase and griffithsin binding were decreased among postmenopausal women (P< 0.02) when compared to premenopausal groups. These data suggest that both hormonal status and BV impact the glycosidases and lectin binding sites present in vaginal fluid. The sialidases present at increased levels in women with BV likely reduce the number of sialic acid binding sites. Other enzymes likely reduce griffithsin binding. The alterations in the glycosidase content, high mannose and sialic acid binding sites in the cervicovaginal fluid associated with bacterial vaginosis may impact susceptibility to viruses, such as HIV, that utilize glycans as a portal of entry.	[Moncla, Bernard J.; Chappell, Catherine A.; Hillier, Sharon L.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Moncla, Bernard J.; Meyn, Leslie A.; Hillier, Sharon L.] Magee Womens Res Inst, Pittsburgh, PA USA; [Mahal, Lara K.] NYU, Dept Chem, Inst Biomed Chem, New York, NY 10003 USA; [Debo, Brian M.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; New York University; University of Pennsylvania	Moncla, BJ (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	bjm4@pitt.edu	Mahal, Lara/GRY-7287-2022	Mahal, Lara/0000-0003-4791-8524	National Institutes of Health [U19AI082639]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant U19AI082639.	Andersch-Bjorkman Y, 2007, MOL CELL PROTEOMICS, V6, P708, DOI 10.1074/mcp.M600439-MCP200; ANT J, 1991, Journal of Dental Research, V70, P584; AUDIE JP, 1995, HUM REPROD, V10, P98, DOI 10.1093/humrep/10.1.98; Bai XM, 2001, GLYCOBIOLOGY, V11, P621, DOI 10.1093/glycob/11.8.621; BRAHAM PH, 1992, J CLIN MICROBIOL, V30, P649, DOI 10.1128/JCM.30.3.649-654.1992; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Carson DD, 1998, HUM REPROD UPDATE, V4, P459, DOI 10.1093/humupd/4.5.459; Cauci S, 1998, AM J OBSTET GYNECOL, V178, P511, DOI 10.1016/S0002-9378(98)70430-2; Cauci S, 1998, J INFECT DIS, V178, P1698, DOI 10.1086/314505; Cauci S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.061; Cauci S, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.035; Chappell CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.041; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; ENGEL LD, 1988, J PERIODONTOL, V59, P841, DOI 10.1902/jop.1988.59.12.841; GEYER H, 1988, J BIOL CHEM, V263, P11760; Gipson IK, 1999, BIOL REPROD, V60, P58, DOI 10.1095/biolreprod60.1.58; Gipson IK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1245, DOI 10.2741/Gipson; HOADLEY ME, 1990, BIOCHEM J, V266, P757, DOI 10.1042/bj2660757; HOMER KA, 1994, J MED MICROBIOL, V41, P184, DOI 10.1099/00222615-41-3-184; Homer KA, 2001, J CLIN MICROBIOL, V39, P995, DOI 10.1128/JCM.39.3.995-1001.2001; Howe L, 1999, INT J STD AIDS, V10, P442, DOI 10.1258/0956462991914438; Hunter RHF, 2011, J ASSIST REPROD GEN, V28, P191, DOI 10.1007/s10815-010-9531-3; Keller MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P194, DOI 10.1097/QAI.0b013e31826867ae; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; Kutteh WH, 1996, CLIN EXP IMMUNOL, V104, P538, DOI 10.1046/j.1365-2249.1996.36742.x; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Moncla BJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-78; MONCLA BJ, 1991, J CLIN MICROBIOL, V29, P1955, DOI 10.1128/JCM.29.9.1955-1958.1991; MONCLA BJ, 1989, J CLIN MICROBIOL, V27, P182, DOI 10.1128/JCM.27.1.182-184.1989; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pluta K, 2012, PHYSIOL GENOMICS, V44, P1165, DOI 10.1152/physiolgenomics.00088.2012; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Stamatos NM, 1997, VIROLOGY, V228, P123, DOI 10.1006/viro.1996.8373; Stamatos NM, 2004, J LEUKOCYTE BIOL, V75, P307, DOI 10.1189/jlb.0503241; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vogel I, 2003, INT J GYNECOL OBSTET, V83, P307, DOI 10.1016/S0020-7292(03)00268-6; Wang L, 2015, PLOS ONE IN PRESS; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; YUREWICZ EC, 1987, J BIOL CHEM, V262, P4733	51	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127091	10.1371/journal.pone.0127091	http://dx.doi.org/10.1371/journal.pone.0127091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011704	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000355183900061
J	Zhang, XL; Guariglia, SR; McGlothan, JL; Stansfield, KH; Stanton, PK; Guilarte, TR				Zhang, Xiao-lei; Guariglia, Sara R.; McGlothan, Jennifer L.; Stansfield, Kirstie H.; Stanton, Patric K.; Guilarte, Tomas R.			Presynaptic Mechanisms of Lead Neurotoxicity: Effects on Vesicular Release, Vesicle Clustering and Mitochondria Number	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SCHAFFER COLLATERAL-CA1 SYNAPSES; PROBABILITY FLUCTUATION ANALYSIS; GABAERGIC TRANSMISSION; SYNAPTIC-TRANSMISSION; EXPOSURE; DEPRESSION; GLUTAMATE; DEFICITS; PB2+	Childhood lead (Pb2+) intoxication is a global public health problem and accounts for 0.6% of the global burden of disease associated with intellectual disabilities. Despite the recognition that childhood Pb2+ intoxication contributes significantly to intellectual disabilities, there is a fundamental lack of knowledge on presynaptic mechanisms by which Pb2+ disrupts synaptic function. In this study, using a well-characterized rodent model of developmental Pb2+ neurotoxicity, we show that Pb2+ exposure markedly inhibits presynaptic vesicular release in hippocampal Schaffer collateral-CA1 synapses in young adult rats. This effect was associated with ultrastructural changes which revealed a reduction in vesicle number in the readily releasable/docked vesicle pool, disperse vesicle clusters in the resting pool, and a reduced number of presynaptic terminals with multiple mitochondria with no change in presynaptic calcium influx. These studies provide fundamental knowledge on mechanisms by which Pb2+ produces profound inhibition of presynaptic vesicular release that contribute to deficits in synaptic plasticity and intellectual development.	[Zhang, Xiao-lei; Stanton, Patric K.] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Guariglia, Sara R.; McGlothan, Jennifer L.; Stansfield, Kirstie H.; Guilarte, Tomas R.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA	New York Medical College; Columbia University	Guilarte, TR (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	trguilarte@columbia.edu		Dziedzic, Jennifer/0000-0001-5577-0262	National Institute of Environmental Health Sciences [ES006189, ES020465]; NIEHS Center for Environmental Health in Northern Manhattan [ES009089]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006189, P30ES009089, R01ES020465] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Center for Environmental Health in Northern Manhattan; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants ES006189 and ES020465 from the National Institute of Environmental Health Sciences to TRG. The authors also acknowledge support from the metals core facilities of the NIEHS Center for Environmental Health in Northern Manhattan grant number ES009089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 1967, Prog Brain Res, V27, P400; BELLINGER DC, 1992, PEDIATRICS, V90, P855; Braga MFM, 1999, BRAIN RES, V826, P10, DOI 10.1016/S0006-8993(99)01193-2; Braga MFM, 1999, BRAIN RES, V826, P22, DOI 10.1016/S0006-8993(99)01194-4; Brustein E, 2003, PFLUG ARCH EUR J PHY, V446, P766, DOI 10.1007/s00424-003-1138-4; Burgdorf J, 2013, NEUROPSYCHOPHARMACOL, V38, P729, DOI 10.1038/npp.2012.246; Bykhovskaia M, 2011, SEMIN CELL DEV BIOL, V22, P387, DOI 10.1016/j.semcdb.2011.07.003; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Denker Annette, 2010, Front Synaptic Neurosci, V2, P135, DOI 10.3389/fnsyn.2010.00135; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Guilarte TR, 2003, ANN NEUROL, V53, P50, DOI 10.1002/ana.10399; Jusko TA, 2008, ENVIRON HEALTH PERSP, V116, P243, DOI 10.1289/ehp.10424; Kuhlmann AC, 1997, NEUROSCI LETT, V233, P101, DOI 10.1016/S0304-3940(97)00633-2; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lasley SM, 2002, TOXICOL SCI, V66, P139, DOI 10.1093/toxsci/66.1.139; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Ly CV, 2006, NEUROSCIENTIST, V12, P291, DOI 10.1177/1073858406287661; McGlothan JL, 2008, NEUROTOXICOLOGY, V29, P1127, DOI 10.1016/j.neuro.2008.06.010; Neal AP, 2010, MOL NEUROBIOL, V42, P151, DOI 10.1007/s12035-010-8146-0; Neal AP, 2010, TOXICOL SCI, V116, P249, DOI 10.1093/toxsci/kfq111; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nihei MK, 2000, NEUROSCIENCE, V99, P233, DOI 10.1016/S0306-4522(00)00192-5; Nikonenko AG, 2004, MICROSC RES TECHNIQ, V65, P287, DOI 10.1002/jemt.20134; Oleskevich S, 2000, J PHYSIOL-LONDON, V524, P513, DOI 10.1111/j.1469-7793.2000.00513.x; Pechstein A, 2011, FRONT SYNAPTIC NEURO, V2, P1; Peng SQ, 2002, MOL PHARMACOL, V62, P1418, DOI 10.1124/mol.62.6.1418; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Saghatelyan AK, 2004, MOL CELL NEUROSCI, V26, P191, DOI 10.1016/j.mcn.2004.01.008; Schwartz BS, 2000, NEUROLOGY, V55, P1144, DOI 10.1212/WNL.55.8.1144; Shupliakov O, 2011, SEMIN CELL DEV BIOL, V22, P393, DOI 10.1016/j.semcdb.2011.07.006; Silver RA, 2003, J NEUROSCI METH, V130, P127, DOI 10.1016/j.jneumeth.2003.09.030; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Stansfield K.H., 2015, TRANSL PSY; Stansfield KH, 2012, TOXICOL SCI, V127, P277, DOI 10.1093/toxsci/kfs090; Stanton PK, 2005, EUR J NEUROSCI, V22, P2451, DOI 10.1111/j.1460-9568.2005.04437.x; Stanton PK, 2003, J NEUROSCI, V23, P5936; Stewart WF, 2006, NEUROLOGY, V66, P1476, DOI 10.1212/01.wnl.0000216138.69777.15; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; Toscano CD, 2005, BRAIN RES REV, V49, P529, DOI 10.1016/j.brainresrev.2005.02.004; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Verina T, 2007, NEUROSCIENCE, V145, P1037, DOI 10.1016/j.neuroscience.2006.12.040; Verstegen AMJ, 2014, J NEUROSCI, V34, P7266, DOI 10.1523/JNEUROSCI.3973-13.2014; Vos M, 2010, FRONT SYNAPTIC NEURO, V2, P1, DOI [10.3389/neuro.19.001.2010, DOI 10.3389/NEURO.19.001.2010]; Xiao C, 2006, BRAIN RES, V1088, P93, DOI 10.1016/j.brainres.2006.03.005; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhang XL, 2006, J NEUROSCI, V26, P10270, DOI 10.1523/JNEUROSCI.3091-06.2006; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020500; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	53	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127461	10.1371/journal.pone.0127461	http://dx.doi.org/10.1371/journal.pone.0127461			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011056	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900095
J	Holgerson, PL; Ohman, C; Ronnlund, A; Johansson, I				Holgerson, Pernilla Lif; Ohman, Carina; Ronnlund, Agneta; Johansson, Ingegerd			Maturation of Oral Microbiota in Children with or without Dental Caries	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; GUT MICROBIOTA; HEALTH; ESTABLISHMENT; ANAEROBES; PROFILES; OBESITY	Background The aim of this longitudinal study was to evaluate the oral microbiota in children from age 3 months to 3 years, and to determine the association of the presence of caries at 3 years of age. Methods and findings Oral biofilms and saliva were sampled from children at 3 months (n = 207) and 3 years (n = 155) of age, and dental caries was scored at 3 years of age. Oral microbiota was assessed by culturing of total lactobacilli and mutans streptococci, PCR detection of Streptococcus mutans and Streptococcus sobrinus, 454 pyrosequencing and HOMIM (Human Oral Microbe Identification Microarray) microarray detection of more then 300 species/phylotypes. Species richness and taxa diversity significantly increased from 3 months to 3 years. Three bacterial genera, present in all the 3-month-old infants, persisted at 3 years of age, whereas three other genera had disappeared by this age. A large number of new taxa were also observed in the 3-year-olds. The microbiota at 3 months of age, except for lactobacilli, was unrelated to caries development at a later age. In contrast, several taxa in the oral biofilms of the 3-year-olds were linked with the presence or absence of caries. The main species/phylotypes associated with caries in 3-year-olds belonged to the Actinobaculum, Atopobium, Aggregatibacter, and Streptococcus genera, whereas those influencing the absence of caries belonged to the Actinomyces, Bergeyella, Campylobacter, Granulicatella, Kingella, Leptotrichia, and Streptococcus genera. Conclusions Thus, during the first years of life, species richness and taxa diversity in the mouth increase significantly. Besides the more prevalent colonization of lactobacilli, the composition of the overall microbiota at 3 months of age was unrelated to caries development at a later age. Several taxa within the oral biofilms of the 3-year-olds could be linked to the presence or absence of caries.	[Holgerson, Pernilla Lif; Ohman, Carina; Ronnlund, Agneta] Umea Univ, Dept Odontol, Sect Pedodont, Umea, Sweden; [Ohman, Carina; Ronnlund, Agneta; Johansson, Ingegerd] Umea Univ, Dept Odontol, Sect Cariol, Umea, Sweden	Umea University; Umea University	Holgerson, PL (corresponding author), Umea Univ, Dept Odontol, Sect Pedodont, Umea, Sweden.	pernilla.lif@umu.se			Swedish patent revenue foundation; Vasterbottens Lans landsting	Swedish patent revenue foundation; Vasterbottens Lans landsting	This work was supported by the Swedish patent revenue foundation (PLH) (http://www.pmf.se), and the Vasterbottens Lans landsting (PLH) (http://www.fou.nu/is/vll). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; de Soet JJ, 2000, CARIES RES, V34, P486, DOI 10.1159/000016628; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ettinger R, 2014, GUT MICROBES; Flint HJ, 2011, J CLIN GASTROENTEROL, V45, pS128, DOI 10.1097/MCG.0b013e31821f44c4; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; Haenlein M., 2004, UNDERSTANDING STAT, V3, P283, DOI [10.1207/s15328031us0304_4, DOI 10.1207/S15328031US0304_4]; Hasslof P, 2013, CARIES RES, V47, P559, DOI 10.1159/000350524; Holgerson PL, 2011, J DENT RES, V90, P1183, DOI 10.1177/0022034511418973; Holgerson PL, 2013, J PEDIATR GASTR NUTR, V56, P127, DOI 10.1097/MPG.0b013e31826f2bc6; Hughes CV, 2012, PEDIAT DENT, V34, P16; Isolauri E, 2012, J PAEDIATR CHILD H, V48, P1, DOI 10.1111/j.1440-1754.2012.02489.x; Jiang W, 2011, MICROB ECOL, V61, P342, DOI 10.1007/s00248-010-9753-z; Jiang W, 2013, CURR MICROBIOL, V67, P537, DOI 10.1007/s00284-013-0393-7; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; KAUL S S, 1992, Zeitschrift fuer Morphologie und Anthropologie, V79, P25; Kianoush N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092940; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kononen E, 2005, ANAEROBE, V11, P131, DOI 10.1016/j.anaerobe.2004.11.001; Kononen E, 1999, J DENT RES, V78, P1634, DOI 10.1177/00220345990780100801; Kononen E, 2000, ANN MED, V32, P107, DOI 10.3109/07853890009011759; Leroy R, 2003, COMMUNITY DENT ORAL, V31, P30, DOI 10.1034/j.1600-0528.2003.00023.x; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Lundqvist A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0373-3; Luo AH, 2012, ORAL DIS, V18, P595, DOI 10.1111/j.1601-0825.2012.01915.x; Luoto R, 2013, ANN NUTR METAB, V63, P17, DOI 10.1159/000354896; Mantzourani M, 2009, CARIES RES, V43, P308, DOI 10.1159/000222659; Munyaka PM, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00109; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Obata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103712; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Parisotto TM, 2010, ORAL HLTH PREV DENT, V8, P59; Preidis GA, 2012, FASEB J, V26, P1960, DOI 10.1096/fj.10-177980; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; Sjostrom M., 1986, PATTERN RECOGN, P461, DOI DOI 10.1016/B978-0-444-87877-9.50042-X; Stecksen-Blicks C, 2014, ACTA ODONTOL SCAND, V72, P852, DOI 10.3109/00016357.2014.914569; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tanner ACR, 2011, J DENT RES, V90, P1298, DOI 10.1177/0022034511421201; Torlakovic L, 2012, J ORAL MICROBIOL, V4, DOI [10.3402/jorn.v4i0.16125, DOI 10.3402/JORN.V4I0.16125]; West CE, 2014, CURR OPIN CLIN NUTR, V17, P261, DOI 10.1097/MCO.0000000000000044; World Health Organization, 1997, ORAL HEALTH SURVEYS; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089269; Yano A, 2002, FEMS MICROBIOL LETT, V217, P23, DOI 10.1111/j.1574-6968.2002.tb11451.x	48	59	60	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128534	10.1371/journal.pone.0128534	http://dx.doi.org/10.1371/journal.pone.0128534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020247	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300118
J	Navarro, C; Moore, J; Ott, A; Baumert, E; Mohan, A; Gill, KS; Sandhu, D				Navarro, Christopher; Moore, Jerott; Ott, Alina; Baumert, Eric; Mohan, Amita; Gill, Kulvinder S.; Sandhu, Devinder			Evolutionary, Comparative and Functional Analyses of the Brassinosteroid Receptor Gene, BRI1, in Wheat and Its Relation to Other Plant Genomes	PLOS ONE			English	Article							LEUCINE-RICH-REPEAT; STEROID-HORMONE; KINASE; GROWTH; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; ELONGATION; PERCEPTION; REGULATORS	Brassinosteroids (BRs) are plant hormones, fundamental for the growth and development of plants. A trans-membrane protein receptor kinase, Brassinosteroid-Insensitive 1 (BRI1), is known to interact with BRs and be directly involved in plant development. This study investigates the structural organization of BRI1 orthologs in several taxa, with a specific interest in Triticum aestivum. True orthologs of Arabidopsis thaliana BRI1 (AtBRI1) from seven-plant species showed sequence identity ranging from 54% to 95% at the protein level. All gene sequences lacked introns, leading to speculation that post-transcriptional processing in TaBRI1 is similar to AtBRI1. Based on in silico analysis, a single copy of BRI1 was present in each of the three wheat genomes on the long arm of chromosome 3. Domain structure of BRI1 orthologs among different taxa showed multiple leucine rich repeats (LRRs), an island domain (ID), a juxtamembrane/transmembrane domain (JTMD), a catalytic kinase domain (KD), C and N-Terminal domains. The KD showed the highest level of conservation while the LRRs and JTMD were most variable. Phosphorylation of residues in the juxtamembrane domain, known to be involved in the activation of the KD, is conserved in TaBRI1. While TaBRI1 has well-defined differences in the ID and LRR domains, many residues involved in ligand binding are conserved. The activation loop present in the KD showed 100% conservation in all taxa. Despite residue differences, hydrophobicity was conserved in the BR binding pocket across taxa, suggesting that function may not differ as drastically as residue identity may suggest. Predicted 3D structure of AtBRI1 and TaBRI1 showed a conserved super helical assembly, a feature essential in protein-protein interactions. An unrooted phylogram showed TaBRI1 in the monocot clade to be distinct from that of dicots. New insight in the structure and functions of BRI1 may help in targeting BR pathway for crop improvement.	[Navarro, Christopher; Moore, Jerott; Ott, Alina; Baumert, Eric; Sandhu, Devinder] Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA; [Mohan, Amita; Gill, Kulvinder S.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	University of Wisconsin System; University of Wisconsin Stevens Point; Washington State University	Sandhu, D (corresponding author), Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA.	dsandhu@uwsp.edu		Sandhu, Devinder/0000-0003-4193-3408; Ott, Alina/0000-0003-4830-8509	National Science Foundation - Basic Research to Enable Agricultural Development (NSF-BREAD) [ISO-0965533]; UWSP Student Research Fund	National Science Foundation - Basic Research to Enable Agricultural Development (NSF-BREAD)(National Science Foundation (NSF)NSF - Office of the Director (OD)); UWSP Student Research Fund	This research project was supported by the National Science Foundation - Basic Research to Enable Agricultural Development (NSF-BREAD) project (ISO-0965533) and the UWSP Student Research Funds.	Altmann T, 1999, PLANTA, V208, P1, DOI 10.1007/s004250050528; Bajguz A, 2003, PHYTOCHEMISTRY, V62, P1027, DOI 10.1016/S0031-9422(02)00656-8; Bajwa VS, 2013, PLANT PHYSIOL, V163, P30, DOI 10.1104/pp.113.221465; Bojar D, 2014, PLANT J, V78, P31, DOI 10.1111/tpj.12445; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chono M, 2003, PLANT PHYSIOL, V133, P1209, DOI 10.1104/pp.103.026195; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Dockter C, 2014, PLANT PHYSIOL, V166, P1912, DOI 10.1104/pp.114.250738; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fridman Y, 2013, PLANT SCI, V209, P24, DOI 10.1016/j.plantsci.2013.04.002; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; Jaillais Y, 2011, P NATL ACAD SCI USA, V108, P8503, DOI 10.1073/pnas.1103556108; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; Matsushima N, 2012, BIOMOLECULES, V2, P288, DOI 10.3390/biom2020288; Matsushima N, 2009, BBA-GEN SUBJECTS, V1790, P1217, DOI 10.1016/j.bbagen.2009.06.014; Montoya T, 2002, PLANT CELL, V14, P3163, DOI 10.1105/tpc.006379; Morinaka Y, 2006, PLANT PHYSIOL, V141, P924, DOI 10.1104/pp.106.077081; Morris ER, 2003, CURR OPIN PLANT BIOL, V6, P339, DOI 10.1016/S1369-5266(03)00055-4; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Nomura T, 2003, PLANT J, V36, P291, DOI 10.1046/j.1365-313X.2003.01863.x; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Peng P, 2008, MOL PLANT, V1, P338, DOI 10.1093/mp/ssn001; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Sreeramulu S, 2013, PLANT J, V74, P905, DOI 10.1111/tpj.12175; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong HN, 2014, PLANT CELL, V26, P4376, DOI 10.1105/tpc.114.132092; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Zhang D, 2014, PLANT CELL, V26, P2472, DOI 10.1105/tpc.113.121848; Zullo MA, 2002, BRAZ J PLANT PHYS, V14	58	11	11	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127544	10.1371/journal.pone.0127544	http://dx.doi.org/10.1371/journal.pone.0127544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020768	Green Submitted, gold, Green Published			2022-12-27	WOS:000355187300043
J	Corcoran, JA; Jordan, MD; Thrimawithana, AH; Crowhurst, RN; Newcomb, RD				Corcoran, Jacob A.; Jordan, Melissa D.; Thrimawithana, Amali H.; Crowhurst, Ross N.; Newcomb, Richard D.			The Peripheral Olfactory Repertoire of the Lightbrown Apple Moth, Epiphyas postvittana	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; IONOTROPIC GLUTAMATE RECEPTORS; CANDIDATE PHEROMONE RECEPTORS; SEX-PHEROMONE; BINDING-PROTEINS; FUNCTIONAL-CHARACTERIZATION; LEPIDOPTERA; ANTENNAE; TORTRICIDAE; RESPONSES	The lightbrown apple moth, Epiphyas postvittana is an increasingly global pest of horticultural crops. Like other moths, E. postvittana relies on olfactory cues to locate mates and oviposition sites. To detect these cues, moths have evolved families of genes encoding elements of the peripheral olfactory reception system, including odor carriers, receptors and degrading enzymes. Here we undertake a transcriptomic approach to identify members of these families expressed in the adult antennae of E. postvittana, describing open reading frames encoding 34 odorant binding proteins, 13 chemosensory proteins, 70 odorant receptors, 19 ionotropic receptors, nine gustatory receptors, two sensory neuron membrane proteins, 27 carboxylesterases, 20 glutathione-S-transferases, 49 cytochrome p450s and 18 takeout proteins. For the odorant receptors, quantitative RT-PCR corroborated RNAseq count data on steady state transcript levels. Of the eight odorant receptors that group phylogenetically with pheromone receptors from other moths, two displayed significant male-biased expression patterns, one displayed significant female-biased expression pattern and five were expressed equally in the antennae of both sexes. In addition, we found two male-biased odorant receptors that did not group with previously described pheromone receptors. This suite of olfaction-related genes provides a substantial resource for the functional characterization of this signal transduction system and the development of odor-mediated control strategies for horticultural pests.	[Corcoran, Jacob A.; Newcomb, Richard D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Corcoran, Jacob A.; Jordan, Melissa D.; Thrimawithana, Amali H.; Crowhurst, Ross N.; Newcomb, Richard D.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand	University of Auckland; New Zealand Institute for Plant & Food Research Ltd	Newcomb, RD (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	Richard.Newcomb@plantandfood.co.nz	Thrimawithana, Amali H/O-4702-2017; Crowhurst, Ross N/N-8892-2017; Newcomb, Richard/C-2067-2009	Thrimawithana, Amali H/0000-0001-6325-2334; Crowhurst, Ross N/0000-0003-0608-2134; Newcomb, Richard/0000-0002-7307-9755; Corcoran, Jacob/0000-0002-2698-850X	New Zealand Ministry of Business, Innovation and Employment [C06X0701]; Agricultural and Marketing Research and Development Trust of New Zealand [1161]	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Agricultural and Marketing Research and Development Trust of New Zealand	This work was supported by the New Zealand Ministry of Business, Innovation and Employment (C06X0701) to RDN (http://www.mbie.govt.nz/) and The Agricultural and Marketing Research and Development Trust of New Zealand (1161) to MDJ (http://www.agmardt.org.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Andrews S., 2010, FASTQC QUALITY CONTR; Aronesty E, UTILS COMMAND LINE T; Begum D, 2011, THESIS U AUCKLAND AU; BELLAS TE, 1983, J CHEM ECOL, V9, P503, DOI 10.1007/BF00990222; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, CHEM SENSES, V31, pA5; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Biomatters, GEN V6 0 6; Carraher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038391; Corcoran JA, 2014, INSECT BIOCHEM MOLEC, V54, P22, DOI 10.1016/j.ibmb.2014.08.005; Damberger FF, 2013, P NATL ACAD SCI USA, V110, P18680, DOI 10.1073/pnas.1317706110; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; El-Sayed AM, 2011, J CHEM ECOL, V37, P640, DOI 10.1007/s10886-011-9964-x; Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hamiaux C, 2009, J BIOL CHEM, V284, P3496, DOI 10.1074/jbc.M807467200; Hamiaux C, 2013, J STRUCT BIOL, V182, P259, DOI 10.1016/j.jsb.2013.03.013; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; KANAUJIA S, 1985, J INSECT PHYSIOL, V31, P71, DOI 10.1016/0022-1910(85)90044-7; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Masante-Roca I, 2005, J EXP BIOL, V208, P1147, DOI 10.1242/jeb.01508; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Newcomb RD, 2002, INSECT BIOCHEM MOLEC, V32, P1543, DOI 10.1016/S0965-1748(02)00075-9; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rambaut A, FIGTREE V1 4 0; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; RUMBO ER, 1983, PHYSIOL ENTOMOL, V8, P195, DOI 10.1111/j.1365-3032.1983.tb00349.x; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; Rytz R, 2013, INSECT BIOCHEM MOLEC, V43, P888, DOI 10.1016/j.ibmb.2013.02.007; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, CHEM SENSES, V33, pS74; SINGH P, 1974, New Zealand Journal of Zoology, V1, P241; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Suckling DM, 1996, NEW ZEAL J CROP HORT, V24, P323, DOI 10.1080/01140671.1996.9513969; Syed Z, 2010, P NATL ACAD SCI USA, V107, P9436, DOI 10.1073/pnas.1003881107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tooman LK, 2011, J ECON ENTOMOL, V104, P920, DOI 10.1603/EC10342; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varela N, 2009, CELL TISSUE RES, V337, P513, DOI 10.1007/s00441-009-0839-1; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 2005, MOL BASIS PHEROMONE; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Yasukochi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018843; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	69	36	39	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128596	10.1371/journal.pone.0128596	http://dx.doi.org/10.1371/journal.pone.0128596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017144	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600122
J	Pearse, WD; Chase, MW; Crawley, MJ; Dolphin, K; Fay, MF; Joseph, JA; Powney, G; Preston, CD; Rapacciuolo, G; Roy, DB; Purvis, A				Pearse, William D.; Chase, Mark W.; Crawley, Michael J.; Dolphin, Konrad; Fay, Michael F.; Joseph, Jeffrey A.; Powney, Gary; Preston, Chris D.; Rapacciuolo, Giovanni; Roy, David B.; Purvis, Andy			Beyond the EDGE with EDAM: Prioritising British Plant Species According to Evolutionary Distinctiveness, and Accuracy and Magnitude of Decline	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; DISTRIBUTION MODELS; CONSERVATION; TAXA; ESTABLISHMENT; BIODIVERSITY	Conservation biologists have only finite resources, and so must prioritise some species over others. The EDGE-listing approach ranks species according to their combined evolutionary distinctiveness and degree of threat, but ignores the uncertainty surrounding both threat and evolutionary distinctiveness. We develop a new family of measures for species, which we name EDAM, that incorporates evolutionary distinctiveness, the magnitude of decline, and the accuracy with which decline can be predicted. Further, we show how the method can be extended to explore phyogenetic uncertainty. Using the vascular plants of Britain as a case study, we find that the various EDAM measures emphasise different species and parts of Britain, and that phylogenetic uncertainty can strongly affect the prioritisation scores of some species.	[Pearse, William D.; Crawley, Michael J.; Dolphin, Konrad; Powney, Gary; Rapacciuolo, Giovanni; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [Pearse, William D.; Powney, Gary; Preston, Chris D.; Rapacciuolo, Giovanni; Roy, David B.; Purvis, Andy] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Pearse, William D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Chase, Mark W.; Fay, Michael F.; Joseph, Jeffrey A.] Jodrell Lab, Royal Bot Gardens Kew, Richmond TW7 3DS, Surrey, England; [Purvis, Andy] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Imperial College London; UK Centre for Ecology & Hydrology (UKCEH); University of Minnesota System; University of Minnesota Twin Cities; Royal Botanic Gardens, Kew; Natural History Museum London	Pearse, WD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England.	will.pearse@gmail.com	Chase, Mark W/A-6642-2011; Fay, Michael F/G-4741-2010; Purvis, Andy/A-7529-2008; Roy, David/A-6619-2009; Fay, Michael/AAU-5861-2021	Fay, Michael F/0000-0003-3491-9093; Purvis, Andy/0000-0002-8609-6204; Roy, David/0000-0002-5147-0331; Chase, Mark/0000-0002-9927-4938; Pearse, William D/0000-0002-6241-3164; Rapacciuolo, Giovanni/0000-0003-1494-9017; Powney, Gary/0000-0003-3313-7786	Natural Environment Research Council (NERC); NERC [ceh020002] Funding Source: UKRI; Natural Environment Research Council [ceh020002] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	WDP was funded by a Natural Environment Research Council (NERC) Collaborative Award in Science and Engineering (CASE) PhD studentship.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bennett JR, 2014, BIOL CONSERV, V174, P47, DOI 10.1016/j.biocon.2014.03.013; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bivand R., 2013, CLASSINT CHOOSE UNIV; Bossard M., 2000, 40 EEA; Braithwaite ME, 2006, CHANG BRIT FLORA 198; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cheffings C. M., 2005, SPECIES STATUS, V7, P1; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Fay MF, 1998, TAXON, V47, P43, DOI 10.2307/1224017; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; Hartmann K, 2013, BIODIVERS CONSERV, V22, P449, DOI 10.1007/s10531-012-0422-z; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hill M.O., 2004, PLANTATT ATTRIBUTES; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kharouba HM, 2009, ECOLOGY, V90, P2213, DOI 10.1890/08-1304.1; Kissling WD, 2012, J BIOGEOGR, V39, P2163, DOI 10.1111/j.1365-2699.2011.02663.x; Kores Paul J., 1997, Lindleyana, V12, P1; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Lledo MD, 1998, SYST BOT, V23, P21, DOI 10.2307/2419571; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Mooers AO, 2005, CONSERV BIOL SER, V8, P120; MYERS N, 1993, AMBIO, V22, P74; Orme D., 2013, CAPER COMP ANAL PHYL; Pearse WD, 2013, METHODS ECOL EVOL, V4, P692, DOI 10.1111/2041-210X.12055; Perring F.H., 1962, ATLAS BRIT FLORA; Phillips SJ, 2010, ECOLOGY, V91, P2476, DOI 10.1890/09-0760.1; Pilgrim ES, 2004, BIOL CONSERV, V120, P161, DOI 10.1016/j.biocon.2004.02.008; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Powney GD, 2014, BIODIVERS CONSERV, V23, P171, DOI 10.1007/s10531-013-0590-5; Preston C, 2002, NEW ATLAS BRIT IRISH; Rapacciuolo G, 2014, METHODS ECOL EVOL, V5, P407, DOI 10.1111/2041-210X.12181; Rapacciuolo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040212; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Ridgeway G., 2007, GBM GEN BOOSTED REGR; Rosindell J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001406; Safi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063582; Sanderson MJ, 2011, SCIENCE, V333, P448, DOI 10.1126/science.1206357; Southall H, 2009, VISION BRITAIN TIME; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Telfer MG, 2002, BIOL CONSERV, V107, P99, DOI 10.1016/S0006-3207(02)00050-2; Tingley R, 2011, AM NAT, V177, P382, DOI 10.1086/658342; UK Biodiversity Reporting and Information Group, 2007, TECHNICAL REPORT; Van Wilgen NJ, 2012, CONSERV BIOL, V26, P267, DOI 10.1111/j.1523-1739.2011.01804.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Weitzman ML, 1998, ECONOMETRICA, V66, P1279, DOI 10.2307/2999617; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015	57	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126524	10.1371/journal.pone.0126524	http://dx.doi.org/10.1371/journal.pone.0126524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018568	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000355185600053
J	Smith, RWA; Monroe, C; Bolnick, DA				Smith, Rick W. A.; Monroe, Cara; Bolnick, Deborah A.			Detection of Cytosine Methylation in Ancient DNA from Five Native American Populations Using Bisulfite Sequencing	PLOS ONE			English	Article							PRESERVATION; EXTRACTION; EVOLUTION; PATTERNS; BONES	While cytosine methylation has been widely studied in extant populations, relatively few studies have analyzed methylation in ancient DNA. Most existing studies of epigenetic marks in ancient DNA have inferred patterns of methylation in highly degraded samples using post-mortem damage to cytosines as a proxy for cytosine methylation levels. However, this approach limits the inference of methylation compared with direct bisulfite sequencing, the current gold standard for analyzing cytosine methylation at single nucleotide resolution. In this study, we used direct bisulfite sequencing to assess cytosine methylation in ancient DNA from the skeletal remains of 30 Native Americans ranging in age from approximately 230 to 4500 years before present. Unmethylated cytosines were converted to uracils by treatment with sodium bisulfite, bisulfite products of a CpG-rich retrotransposon were pyrosequenced, and C-to-T ratios were quantified for a single CpG position. We found that cytosine methylation is readily recoverable from most samples, given adequate preservation of endogenous nuclear DNA. In addition, our results indicate that the precision of cytosine methylation estimates is inversely correlated with aDNA preservation, such that samples of low DNA concentration show higher variability in measures of percent methylation than samples of high DNA concentration. In particular, samples in this study with a DNA concentration above 0.015 ng/mu L generated the most consistent measures of cytosine methylation. This study presents evidence of cytosine methylation in a large collection of ancient human remains, and indicates that it is possible to analyze epigenetic patterns in ancient populations using direct bisulfite sequencing approaches.	[Smith, Rick W. A.; Bolnick, Deborah A.] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [Monroe, Cara] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Monroe, Cara] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Bolnick, Deborah A.] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Washington State University; University of California System; University of California Santa Barbara; University of Texas System; University of Texas Austin	Smith, RWA (corresponding author), Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA.	rickwasmith@utexas.edu			University of Texas at Austin; Sigma Xi [G2012162144]	University of Texas at Austin; Sigma Xi	Research funds were provided to DAB by the University of Texas at Austin. Sigma Xi Grant-in-Aid of Research (Grant ID: G2012162144) was granted to RWAS (https://www.sigmaxi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CJ, 2011, J ARCHAEOL SCI, V38, P956, DOI 10.1016/j.jas.2010.11.010; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Bestor TH, 1998, CIBA F SYMP, V214, P187; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Bolnick DA, 2007, AM ANTIQUITY, V72, P627, DOI 10.2307/25470437; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Burger J, 1999, ELECTROPHORESIS, V20, P1722; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368; Grand A, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2290-9; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P1; Hummel S, 2002, INT J LEGAL MED, V116, P327, DOI 10.1007/s00414-002-0315-x; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaestle FA, 2002, YEARB PHYS ANTHROPOL, V45, P92, DOI 10.1002/ajpa.10179; Kazazian H, 1998, NAT GENET; Kemp BM, 2006, J ARCHAEOL SCI, V33, P1680, DOI 10.1016/j.jas.2006.02.015; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Llamas B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030226; Mata-Miguez J, 2012, AM J PHYS ANTHROPOL, V149, P504, DOI 10.1002/ajpa.22152; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Orlando L, 2014, SCIENCE, V345, P511, DOI 10.1126/science.1256515; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; R Core Team, 2013, LANG ENV STAT COMP, DOI [DOI 10.3758/S13428-013-0330-5, 10.3758/s13428-013-0330-5]; Rakotoarisoa G, 2006, MOL ECOL NOTES, V6, P1122, DOI 10.1111/j.1471-8286.2006.01458.x; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rusmintratip V, 2000, P NATL ACAD SCI USA, V97, P14183, DOI 10.1073/pnas.97.26.14183; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Sawyer S, 2012, PLOS ONE, V7, P1; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Shapiro B, 2012, METHODS MOL BIOL, V840, P1, DOI 10.1007/978-1-61779-516-9; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; Smith O, 2014, SCI REP-UK, V4, DOI 10.1038/srep05559; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Villanea FA, 2013, AM J PHYS ANTHROPOL, V151, P649, DOI 10.1002/ajpa.22292; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang FF, 2011, J NUTR, V141, P1165, DOI 10.3945/jn.110.134536	45	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125344	10.1371/journal.pone.0125344	http://dx.doi.org/10.1371/journal.pone.0125344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016479	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600017
J	Sugimoto, CR; Ni, CQ; West, JD; Lariviere, V				Sugimoto, Cassidy R.; Ni, Chaoqun; West, Jevin D.; Lariviere, Vincent			The Academic Advantage: Gender Disparities in Patenting	PLOS ONE			English	Article							SCIENCE; WOMEN; ENTREPRENEURSHIP; GAP	We analyzed gender disparities in patenting by country, technological area, and type of assignee using the 4.6 million utility patents issued between 1976 and 2013 by the United States Patent and Trade Office (USPTO). Our analyses of fractionalized inventorships demonstrate that women's rate of patenting has increased from 2.7% of total patenting activity to 10.8% over the nearly 40-year period. Our results show that, in every technological area, female patenting is proportionally more likely to occur in academic institutions than in corporate or government environments. However, women's patents have a lower technological impact than that of men, and that gap is wider in the case of academic patents. We also provide evidence that patents to which women-and in particular academic women-contributed are associated with a higher number of International Patent Classification (IPC) codes and co-inventors than men. The policy implications of these disparities and academic setting advantages are discussed.	[Sugimoto, Cassidy R.] Indiana Univ, Sch Informat & Comp, Bloomington, IN USA; [Ni, Chaoqun] Simmons Coll, Sch Lib & Informat Sci, Boston, MA 02115 USA; [West, Jevin D.] Univ Washington, Informat Sch, Seattle, WA 98195 USA; [Lariviere, Vincent] Univ Montreal, Ecole Bibliothecon & Sci Informat, Montreal, PQ, Canada; [Lariviere, Vincent] Univ Quebec, CIRST, OST, Montreal, PQ H3C 3P8, Canada	Indiana University System; Indiana University Bloomington; Simmons University; University of Washington; University of Washington Seattle; Universite de Montreal; University of Quebec; University of Quebec Montreal	Lariviere, V (corresponding author), Univ Montreal, Ecole Bibliothecon & Sci Informat, Pavillon Lionel Groulx,Succ Ctr Ville, Montreal, PQ, Canada.	vincent.lariviere@umontreal.ca	Lariviere, Vincent/AAF-3179-2019; Ni, Chaoqun/AAE-9178-2021; Sugimoto, Cassidy R/AAV-2705-2021	Ni, Chaoqun/0000-0002-4130-7602; Sugimoto, Cassidy R/0000-0001-8608-3203; West, Jevin/0000-0002-4118-0322	Canada Research Chairs program; Fonds de Recherche du Quebec-Societe et Culture (FRQSC); Social Sciences and Humanities Research Coucil of Canada; NSF-SciSIP Program	Canada Research Chairs program(Canada Research Chairs); Fonds de Recherche du Quebec-Societe et Culture (FRQSC); Social Sciences and Humanities Research Coucil of Canada; NSF-SciSIP Program(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by the Canada Research Chairs program (Vincent Lariviere), Fonds de Recherche du Quebec-Societe et Culture (FRQSC) (Vincent Lariviere), Social Sciences and Humanities Research Coucil of Canada (Vincent Lariviere), and the NSF-SciSIP Program (Cassidy Sugimoto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu M, 2013, RES POLICY, V42, P408, DOI 10.1016/j.respol.2012.10.005; BarNir A, 2012, MANAGE DECIS, V50, P399, DOI 10.1108/00251741211216205; Cozzens SE, 2008, SCI ENG ETHICS, V14, P345, DOI 10.1007/s11948-008-9061-x; de Melo-Martin I, 2013, SCI ENG ETHICS, V19, P491, DOI 10.1007/s11948-011-9344-5; Department of Commerce: United States Patent and Trademark Office, 2013, FED REG, V78, P72064; Ding WW, 2006, SCIENCE, V313, P665, DOI 10.1126/science.1124832; Duch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051332; European Commission, 2013, SHE FIG 2012 GEND RE; Fagerberg J, 2012, RES POLICY, V41, P1132, DOI 10.1016/j.respol.2012.03.008; Gicheva D, 2013, SMALL BUS ECON, V40, P199, DOI 10.1007/s11187-011-9411-y; Hunt J, 2013, RES POLICY, V42, P831, DOI 10.1016/j.respol.2012.11.004; Jaffe D., 2003, INGENIOUS WOMEN TINC; King M. M., 2014, WORKING PAPER; Klitkou A, 2010, SCIENTOMETRICS, V82, P93, DOI 10.1007/s11192-009-0050-x; Ledford H, 2013, NATURE, V501, P471, DOI 10.1038/501471a; Lissoni F, 2013, J ECON BEHAV ORGAN, V95, P49, DOI 10.1016/j.jebo.2013.08.016; Meng Y, 2011, YEARB NANOTECHNOL SO, V2, P23, DOI 10.1007/978-90-481-9615-9_2; National Science Board, 2014, 1401 NSB NAT SCI FDN; Rosser SV, 2010, FEMINISM AND WOMEN IN LEADERSHIP, P111; Schumpeter J. A., 2004, THEORY EC DEV INQUIR; Smith-Doerr Laurel, 2004, WOMENS WORK GENDER E; Stephan PE, 2007, J TECHNOL TRANSFER, V32, P475, DOI 10.1007/s10961-007-9033-3; Stephan PE, 2005, WHOS PATENTING U EVI; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Thursby J G, 2005, J TECHNOLOGY TRANSFE, V30, P343, DOI DOI 10.1007/S10961-005-2580-6; Whittington K., 2005, J TECHNOL TRANSFER, V30, P355, DOI DOI 10.1007/S10961-005-2581-5>; Whittington KB, 2008, GENDER SOC, V22, P194, DOI 10.1177/0891243207313928; Whittington KB, 2011, WORK OCCUPATION, V38, P417, DOI 10.1177/0730888411414529	28	44	47	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128000	10.1371/journal.pone.0128000	http://dx.doi.org/10.1371/journal.pone.0128000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017626	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600106
J	Teves, ME; Sundaresan, G; Cohen, DJ; Hyzy, SL; Kajan, I; Maczis, M; Zhang, ZB; Costanzo, RM; Zweit, J; Schwartz, Z; Boyan, BD; Strauss, JF				Teves, Maria Eugenia; Sundaresan, Gobalakrishnan; Cohen, David J.; Hyzy, Sharon L.; Kajan, Illya; Maczis, Melissa; Zhang, Zhibing; Costanzo, Richard M.; Zweit, Jamal; Schwartz, Zvi; Boyan, Barbara D.; Strauss, Jerome F., III			Spag17 Deficiency Results in Skeletal Malformations and Bone Abnormalities	PLOS ONE			English	Article							PRIMARY CILIUM; GROWTH; LOCI; PF6; PATTERN; COMPLEX; HEIGHT; CELLS	Height is the result of many growth and development processes. Most of the genes associated with height are known to play a role in skeletal development. Single-nucleotide polymorphisms in the SPAG17 gene have been associated with human height. However, it is not clear how this gene influences linear growth. Here we show that a targeted mutation in Spag17 leads to skeletal malformations. Hind limb length in mutants was significantly shorter than in wild-type mice. Studies revealed differences in maturation of femur and tibia suggesting alterations in limb patterning. Morphometric studies showed increased bone formation evidenced by increased trabecular bone area and the ratio of bone area to total area, leading to reductions in the ratio of marrow area/total area in the femur. Micro-CTs and von Kossa staining demonstrated increased mineral in the femur. Moreover, osteocalcin and osterix were more highly expressed in mutant mice than in wild-type mice femurs. These data suggest that femur bone shortening may be due to premature ossification. On the other hand, tibias appear to be shorter due to a delay in cartilage and bone development. Morphometric studies showed reduction in growth plate and bone formation. These defects did not affect bone mineralization, although the volume of primary bone and levels of osteocalcin and osterix were higher. Other skeletal malformations were observed including fused sternebrae, reduced mineralization in the skull, medial and metacarpal phalanges. Primary cilia from chondrocytes, osteoblasts, and embryonic fibroblasts (MEFs) isolated from knockout mice were shorter and fewer cells had primary cilia in comparison to cells from wild-type mice. In addition, Spag17 knockdown in wild-type MEFs by Spag17 siRNA duplex reproduced the shorter primary cilia phenotype. Our findings disclosed unexpected functions for Spag17 in the regulation of skeletal growth and mineralization, perhaps because of its role in primary cilia of chondrocytes and osteoblasts.	[Teves, Maria Eugenia; Zhang, Zhibing; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA; [Sundaresan, Gobalakrishnan; Zweit, Jamal] Virginia Commonwealth Univ, Dept Radiol, Richmond, VA USA; [Cohen, David J.; Hyzy, Sharon L.; Kajan, Illya; Maczis, Melissa; Schwartz, Zvi; Boyan, Barbara D.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Zhang, Zhibing; Boyan, Barbara D.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Costanzo, Richard M.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Strauss, JF (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Med Coll Virginia Campus, Richmond, VA 23284 USA.	jfstrauss@vcu.edu	Teves, Maria/AAJ-9523-2020	Teves, Maria/0000-0001-7035-2202; Costanzo, Richard/0000-0002-6839-3520; Gobalakrishnan, Sundaresan/0000-0002-9620-5611	National Institutes of Health [R01 HD-37416, R01 HD-076257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076257] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health [grant number R01 HD-37416 to J.F.S., R01 HD-076257 to Z.Z.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; BOYAN BD, 1988, ENDOCRINOLOGY, V122, P2851, DOI 10.1210/endo-122-6-2851; BOYAN BD, 1989, ANAT REC, V224, P211, DOI 10.1002/ar.1092240210; BRUDER SP, 1989, CONNECT TISSUE RES, V20, P65, DOI 10.3109/03008208909023875; CHEN JM, 1952, J ANAT, V86, P373; Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174; Delaine-Smith RM, 2014, FASEB J, V28, P430, DOI 10.1096/fj.13-231894; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goduti DJ, 2012, CYTOSKELETON, V69, P179, DOI 10.1002/cm.21010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hajihosseini MK, 2004, DEVELOPMENT, V131, P325, DOI 10.1242/dev.00940; Hoey DA, 2012, J BIOMECH, V45, P17, DOI 10.1016/j.jbiomech.2011.08.008; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Liakhovitskaia A, 2010, DEV BIOL, V340, P539, DOI 10.1016/j.ydbio.2010.02.005; Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169; Michigami T, 2013, CELL MOL LIFE SCI, V70, P4213, DOI 10.1007/s00018-013-1346-9; N'Diaye A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002298; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Ovchinnikov Dmitry, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5170; Rupp G, 2001, MOL BIOL CELL, V12, P739, DOI 10.1091/mbc.12.3.739; Schmidts M, 2014, J PEDIATR GENET, V3, P49, DOI 10.3233/PGE-14089; Silina K, 2011, J IMMUNOTHER, V34, P28, DOI 10.1097/CJI.0b013e3181fb64fa; Takeuchi F, 2009, J HUM GENET, V54, P749, DOI 10.1038/jhg.2009.99; Temiyasathit S, 2010, ANN NY ACAD SCI, V1192, P422, DOI 10.1111/j.1749-6632.2009.05243.x; Teves ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107271; Teves ME, 2013, AM J RESP CELL MOL, V48, P765, DOI 10.1165/rcmb.2012-0362OC; van der Valk RJP, 2015, HUM MOL GENET, V24, P1155, DOI 10.1093/hmg/ddu510; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112708; Wargo MJ, 2005, J CELL SCI, V118, P4655, DOI 10.1242/jcs.02585; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yuan X, 2015, ANN NY ACAD SCI, V1335, P78, DOI 10.1111/nyas.12463; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200; Zhao JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-96	37	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125936	10.1371/journal.pone.0125936	http://dx.doi.org/10.1371/journal.pone.0125936			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017218	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600043
J	Tunstall, H; Shortt, NK; Pearce, JR; Mitchell, RJ				Tunstall, Helena; Shortt, Niamh K.; Pearce, Jamie R.; Mitchell, Richard J.			Difficult Life Events, Selective Migration and Spatial Inequalities in Mental Health in the UK	PLOS ONE			English	Article							RESIDENTIAL-MOBILITY; NEIGHBORHOOD INEQUALITIES; MARITAL TRANSITIONS; MULTILEVEL ANALYSIS; SHORT-TERM; PEOPLE; PLACES; DEPRIVATION; DISORDERS; GEOGRAPHY	Objective Research has indicated that people moving towards neighbourhoods with disadvantaged socio-economic status have poor health, in particular mental health, but the reasons for this are unclear. This study aims to assess why people moving towards more socio-economically deprived areas have poor mental health. It focuses upon the role of difficult life events that may both trigger moves and damage mental health. This study investigates how mental health and socio-spatial patterns of mobility vary between people moving following difficult life events and for other reasons. Methods Longitudinal analysis of British Household Panel Survey data describing adults' moves between annual survey waves, pooled over ten years, 1996-2006 (N=122,892 observations). Respondents were defined as 'difficult life event movers' if they had experienced relationship breakdown, housing eviction/repossession, or job loss between waves. Respondents were categorised as moving to more or less deprived quintiles using their Census Area Statistic residential ward Carstairs score. Mental health was indicated by self-reported mental health problems. Binary logistic regression models of weighted data were adjusted for age, sex, education and social class. Results The migration rate over one year was 8.5%; 14.1% of movers had experienced a difficult life event during this time period. Adjusted regression model odds of mental health problems among difficult life event movers were 1.67 (95% CI 1.35-2.07) relative to other movers. Odds of difficult life events movers, compared to other movers, moving to a less deprived area, relative to an area with a similar level of deprivation, were 0.70 (95% CI 0.58-0.84). Odds of mental health problems among difficult life event movers relocating to more deprived areas were highly elevated at 2.40 (95% CI 1.63-3.53), relative to stayers. Conclusion Difficult life events may influence health selective patterns of migration and socio-spatial trajectories, reducing moves to less deprived neighbourhoods among people with mental illness.	[Tunstall, Helena; Shortt, Niamh K.; Pearce, Jamie R.] Univ Edinburgh, Environm Res Ctr, Inst Geog, Soc & Hlth, Edinburgh, Midlothian, Scotland; [Mitchell, Richard J.] Univ Glasgow, Environm Res Ctr, Inst Hlth & Wellbeing, Soc & Hlth, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Tunstall, H (corresponding author), Univ Edinburgh, Environm Res Ctr, Inst Geog, Soc & Hlth, Edinburgh, Midlothian, Scotland.	Helena.Tunstall@ed.ac.uk			European Research Council [263501]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Research Council (http://erc.europa.eu/) through grant number ERC-2010-StG Grant 263501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaya MC, 2014, P NATL ACAD SCI USA, V111, P16246, DOI 10.1073/pnas.1416950111; Bailey N., 2005, DETERMINANTS INDIVID; Bartley M., 2006, SOCIAL DETERMINANTS, P78, DOI [10.1093/acprof:oso/9780198565895.001.0001, DOI 10.1093/ACPROF:OSO/9780198565895.001.0001]; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; BENTHAM G, 1988, SOC SCI MED, V26, P49, DOI 10.1016/0277-9536(88)90044-5; Boyle P, 2004, PROG HUM GEOG, V28, P767, DOI 10.1191/0309132504ph518pr; Buck N., 2000, RES SOCIAL EC CHANGE, P250; Businelle MS, 2014, J PUBLIC HEALTH-UK, V36, P205, DOI 10.1093/pubmed/fdt060; Carr D, 2010, J MARRIAGE FAM, V72, P743, DOI 10.1111/j.1741-3737.2010.00728.x; Clark WAV, 2003, ENVIRON PLANN A, V35, P323, DOI 10.1068/a3542; Connolly S, 2007, SOC SCI MED, V65, P1004, DOI 10.1016/j.socscimed.2007.04.035; Curtis S, 2009, SOC SCI MED, V69, P1845, DOI 10.1016/j.socscimed.2009.08.004; Evandrou Maria, 2010, Popul Trends, P74, DOI 10.1057/pt.2010.22; FINDLEY SE, 1988, INT MIGR REV, V22, P4, DOI 10.2307/2546583; Flint E, 2013, J EPIDEMIOL COMMUN H, V67, P796, DOI 10.1136/jech-2013-202425; Fone D, 2007, SOC SCI MED, V64, P633, DOI 10.1016/j.socscimed.2006.09.020; Fone DL, 2006, HEALTH PLACE, V12, P332, DOI 10.1016/j.healthplace.2005.02.002; Halliday TJ, 2008, POP STUD-J DEMOG, V62, P321, DOI 10.1080/00324720802339806; Harkness J, 2002, HOUS POLICY DEBATE, V13, P597; Jokela M, 2014, AM J EPIDEMIOL, V180, P776, DOI 10.1093/aje/kwu233; Larson A, 2004, SOC SCI MED, V59, P2149, DOI 10.1016/j.socscimed.2004.03.015; Lorenz FO, 2006, J HEALTH SOC BEHAV, V47, P111, DOI 10.1177/002214650604700202; Magdol L, 2002, SEX ROLES, V47, P553, DOI 10.1023/A:1022025905755; Martikainen P, 2008, HEALTH PLACE, V14, P361, DOI 10.1016/j.healthplace.2007.07.004; McCulloch A, 2001, ENVIRON PLANN A, V33, P667, DOI 10.1068/a33205; McLeod H, 2000, REG ENVIRON CHANGE, V1, P78, DOI 10.1007/PL00011536; Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008; Nowok B, 2013, ENVIRON PLANN A, V45, P986, DOI 10.1068/a45287; Oakes JM, 2014, AM J EPIDEMIOL, V180, P785, DOI 10.1093/aje/kwu231; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Pevalin DJ, 2009, J EPIDEMIOL COMMUN H, V63, P949, DOI 10.1136/jech.2008.083477; Propper C, 2005, SOC SCI MED, V61, P2065, DOI 10.1016/j.socscimed.2005.04.013; Rabe B, 2010, J R STAT SOC A STAT, V173, P531, DOI 10.1111/j.1467-985X.2009.00626.x; Rogerson PA, 2002, SOC SCI MED, V55, P1817, DOI 10.1016/S0277-9536(01)00316-1; Smith SJ, 2005, T I BRIT GEOGR, V30, P173, DOI 10.1111/j.1475-5661.2005.00159.x; Strohschein L, 2005, SOC SCI MED, V61, P2293, DOI 10.1016/j.socscimed.2005.07.020; Taylor M.F., 2010, BRIT HOUSEHOLD PANEL; Taylor M. P., 2006, PSYCHOL COSTS UNSUST; Tulloch AD, 2011, HEALTH PLACE, V17, P859, DOI 10.1016/j.healthplace.2011.05.006; Tunstall H, 2014, J PUBLIC HLTH UK; Tunstall H, 2014, SOC SCI MED, V118, P97, DOI 10.1016/j.socscimed.2014.07.038; Tunstall H, 2012, HEALTH PLACE, V18, P657, DOI 10.1016/j.healthplace.2011.11.009; Tunstall H, 2010, SOC SCI MED, V71, P786, DOI 10.1016/j.socscimed.2010.04.013; van Lenthe FJ, 2007, HEALTH PLACE, V13, P123, DOI 10.1016/j.healthplace.2005.09.013; Van Zandt S, 2006, J URBAN AFF, V28, P491, DOI 10.1111/j.1467-9906.2006.00311.x; Verheij RA, 1998, J EPIDEMIOL COMMUN H, V52, P487, DOI 10.1136/jech.52.8.487; Wade TJ, 2004, J HEALTH SOC BEHAV, V45, P155, DOI 10.1177/002214650404500203; Wainwright NWJ, 2004, J EPIDEMIOL COMMUN H, V58, P333, DOI 10.1136/jech.2003.012518; Weich S, 2005, BRIT J PSYCHIAT, V187, P29, DOI 10.1192/bjp.187.1.29; Weich S, 2003, J EPIDEMIOL COMMUN H, V57, P616, DOI 10.1136/jech.57.8.616; Wu Z, 2002, J MARRIAGE FAM, V64, P420, DOI 10.1111/j.1741-3737.2002.00420.x	51	14	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126567	10.1371/journal.pone.0126567	http://dx.doi.org/10.1371/journal.pone.0126567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018595	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600054
J	Basile, LFH; Sato, JR; Pasquini, HA; Lozano, MD; Nucci, MP; Velasques, B; Ribeiro, P; Ramos, RT; Anghina, R				Basile, Luis F. H.; Sato, Joao R.; Pasquini, Henrique A.; Lozano, Mirna D.; Nucci, Mariana P.; Velasques, Bruna; Ribeiro, Pedro; Ramos, Renato T.; Anghina, Renato			Individual Topographic Variability Is Inherent to Cortical Physiology but Task-Related Differences May Be Noise	PLOS ONE			English	Article							INCIDENTAL FINDINGS; FUNCTIONAL MRI; BRAIN; GENERATION; ATTENTION; CORTEX; FMRI; POTENTIALS; NETWORK; AREAS	The observation of highly variable sets of association neocortical areas across individuals, containing the estimated generators of Slow Potentials (SPs) and beta oscillations, lead to the persistence in individual analyses. This brought to notice an unexpected within individual topographic similarity between task conditions, despite our original interest in task-related differences. A recent related work explored the quantification of the similarity in beta topography between largely differing tasks. In this article, we used Independent Component Analysis (ICA) for the decomposition of beta activity from a visual attention task, and compared it with quiet resting, recorded by 128-channel EEG in 62 subjects. We statistically tested whether each ICA component obtained in one condition could be explained by a linear regression model based on the topographic patterns from the other condition, in each individual. Results were coherent with the previous report, showing a high topographic similarity between conditions. From an average of 12 beta component maps obtained for each task, over 80% were satisfactorily explained by the complementary task. Once more, the component maps including those considered unexplained, putatively "task-specific", had their scalp distribution and estimated cortical sources highly variable across subjects. These findings are discussed along with other studies based on individual data and the present fMRI results, reinforcing the increasingly accepted view that individual variability in sets of active neocortical association areas is not noise, but intrinsic to cortical physiology. Actual 'noise', mainly stemming from group "brain averaging" and the emphasis on statistical differences as opposed to similarities, may explain the overall hardship in replication of the vast literature on supposed task-specific forms of activity, and the ever inconclusive status of a universal functional mapping of cortical association areas. A new hypothesis, that individuals may use the same idiosyncratic sets of areas, at least by their fraction of activity in the sub-delta and beta range, in various non-sensory-motor forms of conscious activities, is a corollary of the discussed variability.	[Basile, Luis F. H.; Pasquini, Henrique A.; Lozano, Mirna D.] UMESP, Fac Saude, Psychophysiol Lab, Sao Paulo, SP, Brazil; [Basile, Luis F. H.] Univ Sao Paulo, Sch Med, Dept Neurol, Div Neurosurg, Sao Paulo, SP, Brazil; [Sato, Joao R.] Fed Univ ABC, Ctr Math Computat & Cognit, Santo Andre, SP, Brazil; [Nucci, Mariana P.] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, SP, Brazil; [Velasques, Bruna; Ribeiro, Pedro] Univ Fed Rio de Janeiro, Dept Psychiat, Rio De Janeiro, RJ, Brazil; [Ramos, Renato T.] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, SP, Brazil; [Anghina, Renato] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, SP, Brazil	Universidade Metodista de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade de Sao Paulo	Basile, LFH (corresponding author), UMESP, Fac Saude, Psychophysiol Lab, Sao Paulo, SP, Brazil.	lbasile@usp.br	Ramos, Renato T/G-1566-2013; Nucci, Mariana/AAM-6841-2021; Nucci, Mariana/AAC-4990-2020	Nucci, Mariana/0000-0002-1502-9215; Sato, Joao Ricardo/0000-0002-7503-9781	FAPESP, Sao Paulo, Brazil [2013/07236-0]	FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grant 2013/07236-0 from FAPESP, Sao Paulo, Brazil.	Aziz-Zadeh L, 2008, SOC NEUROSCI-UK, V3, P229, DOI 10.1080/17470910701414604; Barbas H, 1992, Adv Neurol, V57, P91; Basile LFH, 2003, INT J PSYCHOPHYSIOL, V48, P55, DOI 10.1016/S0167-8760(03)00004-7; Basile LFH, 2002, INT J PSYCHOPHYSIOL, V45, P227, DOI 10.1016/S0167-8760(02)00014-4; Basile LFH, 2007, INT J PSYCHOPHYSIOL, V65, P238, DOI 10.1016/j.ijpsycho.2007.05.001; Basile LFH, 2006, INT J PSYCHOPHYSIOL, V61, P149, DOI 10.1016/j.ijpsycho.2005.09.004; Basile LFH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059595; Basile LFH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015022; Bibbig A, 2002, J NEUROPHYSIOL, V88, P1634, DOI 10.1152/jn.2002.88.4.1634; Brannen JH, 2001, AM J NEURORADIOL, V22, P1711; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Duffau H, 2012, Adv Tech Stand Neurosurg, V38, P3, DOI 10.1007/978-3-7091-0676-1_1; Duffau H, 2012, CORTEX, V48, P120, DOI 10.1016/j.cortex.2011.04.029; Ekstrom A, 2010, BRAIN RES REV, V62, P233, DOI 10.1016/j.brainresrev.2009.12.004; Epstein RA, 2006, NEUROPSYCHOLOGIA, V44, P1145, DOI 10.1016/j.neuropsychologia.2005.10.009; Eskandary H, 2005, SURG NEUROL, V63, P550, DOI 10.1016/j.surneu.2004.07.049; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Fuster J.M., 1989, PREFRONTAL CORTEX; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Haist F, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00181; He BJ, 2009, TRENDS COGN SCI, V13, P302, DOI 10.1016/j.tics.2009.04.004; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; Hinterberger T, 2003, EXP BRAIN RES, V152, P113, DOI 10.1007/s00221-003-1515-4; Hudson AJ, 2000, CAN J NEUROL SCI, V27, P2, DOI 10.1017/S0317167100051908; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaminski J, 2012, INT J PSYCHOPHYSIOL, V85, P125, DOI 10.1016/j.ijpsycho.2011.11.006; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Khader P, 2008, INT J PSYCHOPHYSIOL, V67, P252, DOI 10.1016/j.ijpsycho.2007.05.018; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Macko K A, 1985, Res Publ Assoc Res Nerv Ment Dis, V63, P73; Mazoyer, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; McCallum W., 1988, HDB ELECTROENCEPHALO, V3, P427; Mechelli A, 2002, NEUROIMAGE, V17, P1459, DOI 10.1006/nimg.2002.1231; Naito E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00594; Noppency U, 2004, J ANATOMY, V205, P6; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Pandya D.N., 1988, P39; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Seghier ML, 2007, NEUROIMAGE, V36, P594, DOI 10.1016/j.neuroimage.2007.03.021; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Xu YD, 2007, J NEUROSCI, V27, P5981, DOI 10.1523/JNEUROSCI.5527-06.2007; Zilles K, 2013, TRENDS COGN SCI, V17, P153, DOI 10.1016/j.tics.2013.02.003; [No title captured]	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128343	10.1371/journal.pone.0128343	http://dx.doi.org/10.1371/journal.pone.0128343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010428	Green Published, gold			2022-12-27	WOS:000355183900227
J	Bolotov, IN; Bespalaya, YV; Vikhrev, IV; Aksenova, OV; Aspholm, PE; Gofarov, MY; Klishko, OK; Kolosova, YS; Kondakov, AV; Lyubas, AA; Paltser, IS; Konopleva, ES; Tumpeesuwan, S; Bolotov, NI; Voroshilova, IS				Bolotov, Ivan N.; Bespalaya, Yulia V.; Vikhrev, Ilya V.; Aksenova, Olga V.; Aspholm, Paul E.; Gofarov, Mikhail Y.; Klishko, Olga K.; Kolosova, Yulia S.; Kondakov, Alexander V.; Lyubas, Artyom A.; Paltser, Inga S.; Konopleva, Ekaterina S.; Tumpeesuwan, Sakboworn; Bolotov, Nikita I.; Voroshilova, Irina S.			Taxonomy and Distribution of Freshwater Pearl Mussels (Unionoida: Margaritiferidae) of the Russian Far East	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; BIVALVIA MARGARITIFERIDAE; CONSERVATION GENETICS; DAHURICA MIDDENDORFF; MITOCHONDRIAL GENOME; COMPARATORY METHOD; GLOBAL DIVERSITY; SPECIES BIVALVIA; LAEVIS BIVALVIA; MOLLUSCA	The freshwater pearl mussel family Margaritiferidae includes 13 extant species, which are all listed by IUCN as endangered or vulnerable taxa. In this study, an extensive spatial sampling of Margaritifera spp. across the Russian Far East (Amur Basin, Kamchatka Peninsula, Kurile Archipelago and Sakhalin Island) was conducted for a revision of their taxonomy and distribution ranges. Based on their DNA sequences, shell and soft tissue morphology, three valid species were identified: Margaritifera dahurica (Middendorff, 1850), M. laevis (Haas, 1910) and M. middendorffi (Rosen, 1926). M. dahurica ranges across the Amur basin and some of the nearest river systems. M. laevis is distributed in Japan, Sakhalin Island and the Kurile Archipelago. M. middendorffi was previously considered an endemic species of the Kamchatka. However, it is widespread in the rivers of Kamchatka, Sakhalin Island, the Kurile Islands ( across the Bussol Strait, which is the most significant biogeographical boundary within the archipelago), and, likely, in Japan. The Japanese species M. togakushiensis Kondo & Kobayashi, 2005 seems to be conspecific with M. middendorffi because of similar morphological patterns, small shell size (<100 mm long) and overlapped ranges, but it is in need of a separate revision. Phylogenetic analysis reveals that two NW Pacific margaritiferid species, M. laevis and M. middendorffi, formed a monophyletic 18S rDNA clade together with the North American species M. marrianae and M. falcata. The patterns that were found in these Margaritifera spp. are similar to those of freshwater fishes, indicating multiple colonizations of Eastern Asia by different mitochondrial lineages, including an ancient Beringian exchange between freshwater faunas across the Pacific.	[Bolotov, Ivan N.; Bespalaya, Yulia V.; Vikhrev, Ilya V.; Aksenova, Olga V.; Gofarov, Mikhail Y.; Kolosova, Yulia S.; Kondakov, Alexander V.; Lyubas, Artyom A.; Paltser, Inga S.; Konopleva, Ekaterina S.; Bolotov, Nikita I.] Russian Acad Sci, Inst Ecol Problems North, Ural Branch, Arkhangelsk, Russia; [Aspholm, Paul E.] Svanhovd, Norwegian Inst Agr & Environm Res Bioforsk, Svanvik, Norway; [Klishko, Olga K.] Russian Acad Sci, Inst Nat Resources Ecol & Cryol, Siberian Branch, Chita, Russia; [Tumpeesuwan, Sakboworn] Maha Sarakham Univ, Fac Sci, Dept Biol, Maha Sarakham, Thailand; [Voroshilova, Irina S.] Russian Acad Sci, ID Papanin Inst Biol Inland Waters, Borok, Yaroslavl Oblas, Russia	N. Laverov Federal Center for Integrated Arctic Research; Institute of Ecological Problems of the North, Ural Branch of the RAS; Russian Academy of Sciences; Bioforsk; Russian Academy of Sciences; Mahasarakham University; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences	Vikhrev, IV (corresponding author), Russian Acad Sci, Inst Ecol Problems North, Ural Branch, Arkhangelsk, Russia.	vikhrevilja@gmail.com	Yulia, Bespalaya V/C-6844-2015; Vikhrev, Ilya V/F-2902-2017; Kondakov, Alexander V/C-9202-2018; Bolotov, Ivan N/P-2892-2015; Aksenova, Olga V./C-7734-2014; Gofarov, Mikhail Y/U-9024-2017; Kolosova, Yulia/J-4040-2018; Voroshilova, Irina S/R-4122-2016; Konopleva, Ekaterina S./D-1484-2018; Lyubas, Artem/AAF-3215-2021	Yulia, Bespalaya V/0000-0002-9066-4833; Vikhrev, Ilya V/0000-0002-8612-7736; Kondakov, Alexander V/0000-0002-6305-6496; Aksenova, Olga V./0000-0002-0817-7105; Gofarov, Mikhail Y/0000-0002-8532-0307; Voroshilova, Irina S/0000-0002-2257-1475; Bolotov, Ivan/0000-0002-3878-4192	Federal Agency for Scientific Organisations [0410-2014-0028]; Ural Branch of Russian Academy of Sciences [15-12-5-3, 15-2-5-7]; Russian Foundation for Basic Research [14-04-98801, 15-04-05638]; Ministry of Science and Education of Russia [P362];  [MD-6465.2014.5];  [MK-4735.2015.4]	Federal Agency for Scientific Organisations; Ural Branch of Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Science and Education of Russia; ; 	This study was supported by the Federal Agency for Scientific Organisations (no. 0410-2014-0028), the Ural Branch of Russian Academy of Sciences (nos. 15-12-5-3 and 15-2-5-7), grants from the President of Russia (no. MD-6465.2014.5 and MK-4735.2015.4) and the Russian Foundation for Basic Research (nos. 14-04-98801 and 15-04-05638) and the Ministry of Science and Education of Russia (no. P362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2007, ZOOL SCI, V24, P890, DOI 10.2108/zsj.24.890; Akiyama Yoshihiro B., 2013, Venus (Tokyo), V71, P191; Akiyama YB, 2009, FUND APPL LIMNOL, V175, P295, DOI 10.1127/1863-9135/2009/0175-0295; [Anonymous], 2014, TRACER V1 6; Araujo R, 2005, J MOLLUS STUD, V71, P25, DOI 10.1093/mollus/eyi002; Araujo R, 2009, J MOLLUS STUD, V75, P95, DOI 10.1093/mollus/eyn043; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baba Karoly, 2000, Bollettino Malacologico, V36, P133; Banarescu P, 1992, ZOOGEOGRAPHY FRESH W, V2; BOGAN AE, 1993, AM ZOOL, V33, P599; Bogan AE, 2008, J N AM BENTHOL SOC, V27, P349, DOI 10.1899/07-069.1; Bogatov VV, 2013, BIOL BULL+, V40, P488, DOI 10.1134/S1062359013050026; Bogatov VV, 2012, BIOL BULL+, V39, P672, DOI 10.1134/S1062359012080031; Bogatov V.V., 2001, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V5, P71; Bogatov Victor V., 2003, Ruthenica, V13, P41; Bogatov VV, 1988, P ZOOLOGICAL I USSR, V171, P155; Bogutskaya NG, 2008, ICHTHYOL EXPLOR FRES, V19, P301; Bohlen J, 2006, MOL PHYLOGENET EVOL, V40, P856, DOI 10.1016/j.ympev.2006.04.020; Bolotov IN, 2013, BIOL BULL+, V40, P221, DOI 10.1134/S1062359013020027; BRANDT R A M, 1974, Archiv fuer Molluskenkunde, V105, P1; Buldovsky AT, 1935, P FAR E BRANCH USSR, V12, P39; BUYANOVSKY AI, 1993, ZOOL ZH, V72, P29; Curole JP, 2004, CONSERV GENET, V5, P271, DOI 10.1023/B:COGE.0000030005.14751.76; Dashi-Dorgi A, 1953, THESIS IRKUTSK STATE; Eyerdam W. J., 1938, Nautilus Philadelphia, V52, P56; Fang Z-J, 2009, U KANSAS PALEONTOLOG, V17, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Geist J, 2010, HYDROBIOLOGIA, V644, P69, DOI 10.1007/s10750-010-0190-2; Graf DL, 2007, P ACAD NAT SCI PHILA, V156, P71, DOI 10.1635/0097-3157(2007)156[71:PFMMBU]2.0.CO;2; Graf DL, 2007, J MOLLUS STUD, V73, P291, DOI 10.1093/mollus/eym029; Graf DL, 2006, ZOOL J LINN SOC-LOND, V148, P343, DOI 10.1111/j.1096-3642.2006.00259.x; Graf DL, 2013, AM MALACOL BULL, V31, P135, DOI 10.4003/006.031.0106; Graf DL, 2013, FRESHWATER MUSSELS U; Grande T, 2004, COPEIA, P743; Haag Wendell R., 2009, P107; Haas F., 1910, Annals & Magazine of Natural History Series 8, V6; Haas F., 1969, TIERREICH, V88, P1; HAAS FRITZ, 1940, ZOOL SER [PUBL 464] FIELD MUS NAT HIST, V24, P115; Habe T, 1991, HITACHIOBI, V56, P3; HALL T., 2013, BIOEDIT VERSION 7 2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Honda Y, 1986, PALAEONTOLOGICAL SOC, P3, DOI [10.1186/1471-2148-11-118.Terrestrial, DOI 10.1186/1471-2148-11-118.TERRESTRIAL]; Huff SW, 2004, J MOLLUS STUD, V70, P379, DOI 10.1093/mollus/70.4.379; Imoto JM, 2013, GENE, V514, P112, DOI 10.1016/j.gene.2012.10.019; Inoue K, 2014, HEREDITY, V112, P282, DOI 10.1038/hdy.2013.104; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; JOHNSON R I, 1983, Occasional Papers on Mollusks Museum of Comparative Zoology Harvard University, V4, P299; Khalloufi N, 2011, J MOLLUS STUD, V77, P103, DOI 10.1093/mollus/eyq046; Klishko OK, 2014, BIOL BULL+, V41, P434, DOI 10.1134/S1062359014050057; Klishko O.K., 2012, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V15-1, P31; Klishko O. K., 2008, Vestnik Zoologii, V42, P291; Klishko Olga K., 2013, Ellipsaria, V15, P31; Klishko Olga K., 2009, Korean Journal of Malacology, V25, P237; Kobayashi Osamu, 2005, Venus (Tokyo), V64, P63; Kobayashi Osamu, 2009, Venus (Tokyo), V67, P189; Kobayashi Osamu, 2008, Venus (Tokyo), V67, P61; Kobayashi Osamu, 2007, Venus (Tokyo), V65, P355; Kobelt W, 1879, ABHANDLUNGEN SENCKEN, V11, P285; Kondo T, 2008, SPECIAL PUBLICATION, V3, P1; Kondo Takaki, 2005, Venus (Tokyo), V64, P135; Kurenkov II, 1966, QUESTIONS KAMCHATKA, V4, P110; Kurihara Yoshihiro, 2005, Venus (Tokyo), V64, P55; Liu X., 1981, B CHENGDU I GEOL MIN, V2, P121; Machordom A, 2003, BIOL J LINN SOC, V78, P235, DOI 10.1046/j.1095-8312.2003.00158.x; Melnychenko R. K., 2004, Vestnik Zoologii, V38, P19; Middendorff A. T., 1850, B ACAD IMPERIALE PM, V9, P108; Middendorff A. T., 1851, REISE AUSSERSTEN NOR, VII, P163, DOI DOI 10.1160/600TAXA.3795.4.10; Miyadi D., 1938, Internationale Revue der Hydrobiologie Leipzig, V37, P125; Moskvicheva I.M., 1973, Zoologicheskii Zh, V52, P1458; Noda H, 1970, T P PALAEONTOLOGICAL, V77, P235; Pietsch TW, 2003, J BIOGEOGR, V30, P1297, DOI 10.1046/j.1365-2699.2003.00956.x; Preston SJ, 2010, AQUAT CONSERV, V20, P568, DOI 10.1002/aqc.1121; Prozorova LA, 2004, FLORA FAUNA SAKHALIN, V1, P138; Rambaut A., 2012, FIGTREE VERSION 1 4; Reis J, 2009, J NAT HIST, V43, P1929, DOI 10.1080/00222930902993724; Reshetnikov YuS, 2010, FISHES NATURE RESERV, V1; Rosen OV, 1926, ANN MUSEE ZOOLOGIQUE, V27, P261; Sayenko E.M., 2007, Byulleten' Dal'nevostochnogo Malakologicheskogo Obshchestva, V11, P100; Scholz H, 2007, NEUES JAHRB GEOL P-A, V244, P43, DOI 10.1127/0077-7749/2007/0244-0043; Schrenck Lv, 1867, REISEN FORSCHUNGEN A, V2, P605; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simpson CT, 1895, P US NATL MUS, V28, P295; SMITH DG, 1983, ZOOL SCR, V12, P67, DOI 10.1111/j.1463-6409.1983.tb00550.x; Smith DG, 2001, ECOL STU AN, V145, P33; Smith DG, 2001, J CONCHOL, V37, P119; Suzuki K, 1944, J GEOLOGICAL SOC JAP, V51, P100, DOI DOI 10.5575/GEOSOC.51.100; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR DW, 1988, PALAEOGEOGR PALAEOCL, V62, P511, DOI 10.1016/0031-0182(88)90071-5; Tsalolikhin S. J., 2004, OPREDELITEL PRESNOVO, V6, P9; Uchiyama R, 2010, ANIMAL DISTRIBUTION, P43; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Yokoyama M., 1932, J Fac Sci Univ Tokyo Geol etc (2), V3, P221; Yokoyama M, 1959, SPECIAL PAPERS PALAE, V5; Zaki SAH, 2008, BIOL J LINN SOC, V95, P337, DOI 10.1111/j.1095-8312.2008.01050.x; ZATRAVKIN MN, 1984, ZOOL ZH, V63, P1785; Zatravkin MN, 1987, LARGE BIVALVE MOLLUS, P152; Zeng Q, 2011, MITOCHONDR DNA, V22, P162, DOI 10.3109/19401736.2011.636435; Zhadin V. I., 1938, FAUNA SSSR M, V4, P1, DOI DOI 10.1371/JOURNAL.PONE.0111546; Zhadin VI, 1952, ZOOLOGICAL I USSR AC, V46, P1; Zieritz A, 2009, BIOL J LINN SOC, V98, P814, DOI 10.1111/j.1095-8312.2009.01329.x; Zuiganov V., 1994, FRESHWATER PEARL MUS, P104, DOI [10.1086/419023, DOI 10.1086/419023]	101	25	33	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0122408	10.1371/journal.pone.0122408	http://dx.doi.org/10.1371/journal.pone.0122408			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011762	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900001
J	Cheng, Y; Lu, F; Lee, SK; Kong, DH; Ha, KS; Wang, B; Sattabongkot, J; Tsuboi, T; Han, ET				Cheng, Yang; Lu, Feng; Lee, Seong-Kyun; Kong, Deok-Hoon; Ha, Kwon-Soo; Wang, Bo; Sattabongkot, Jetsumon; Tsuboi, Takafumi; Han, Eun-Taek			Characterization of Plasmodium vivax Early Transcribed Membrane Protein 11.2 and Exported Protein 1	PLOS ONE			English	Article							HOST-CELL CYTOPLASM; ERYTHROCYTE-MEMBRANE; PARASITE INVASION; MALARIA; FALCIPARUM; FAMILY; INFECTION; IDENTIFICATION; ETRAMPS; COMPLEX	In Plasmodium, the membrane of intracellular parasites is initially formed during invasion as an invagination of the red blood cell surface, which forms a barrier between the parasite and infected red blood cells in asexual blood stage parasites. The membrane proteins of intracellular parasites of Plasmodium species have been identified such as early-transcribed membrane proteins (ETRAMPs) and exported proteins (EXPs). However, there is little or no information regarding the intracellular parasite membrane in Plasmodium vivax. In the present study, recombinant PvETRAMP11.2 (PVX_003565) and PvEXP1 (PVX_091700) were expressed and evaluated antigenicity tests using sera from P. vivax-infected patients. A large proportion of infected individuals presented with IgG antibody responses against PvETRAMP11.2 (76.8%) and PvEXP1 (69.6%). Both of the recombinant proteins elicited high antibody titers capable of recognizing parasites of vivax malaria patients. PvETRAMP11.2 partially co-localized with PvEXP1 on the intracellular membranes of immature schizont. Moreover, they were also detected at the apical organelles of newly formed merozoites of mature schizont. We first proposed that these proteins might be synthesized in the preceding schizont stage, localized on the parasite membranes and apical organelles of infected erythrocytes, and induced high IgG antibody responses in patients.	[Cheng, Yang; Lu, Feng; Lee, Seong-Kyun; Wang, Bo; Han, Eun-Taek] Kangwon Natl Univ, Sch Med, Dept Med Environm Biol & Trop Med, Chunchon, Gangwon Do, South Korea; [Cheng, Yang] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Lu, Feng] Jiangsu Inst Parasit Dis, Minist Hlth, Key Lab Parasit Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China; [Lu, Feng] Jiangsu Inst Parasit Dis, Jiangsu Prov Key Lab Parasite Mol Biol, Wuxi, Jiangsu, Peoples R China; [Kong, Deok-Hoon; Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Gangwon Do, South Korea; [Wang, Bo] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Unit, Bangkok 10700, Thailand; [Tsuboi, Takafumi] Ehime Univ, Proteosci Ctr, Div Malaria Res, Matsuyama, Ehime, Japan	Kangwon National University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Kangwon National University; Anhui Medical University; Mahidol University; Ehime University	Tsuboi, T (corresponding author), Ehime Univ, Proteosci Ctr, Div Malaria Res, Matsuyama, Ehime, Japan.	tsuboi.takafumi.mb@ehime-u.ac.jp; ethan@kangwon.ac.kr	Lu, Feng/AAW-7341-2021; Prachumsri, Jetsumon/AAZ-7732-2021; Cheng, Yang/AAN-2357-2020; Tsuboi, Takafumi/AAK-6145-2021; Ha, Kwon-Soo/AAU-4417-2020	Sattabongkot, Jetsumon/0000-0002-3938-4588; Tsuboi, Takafumi/0000-0002-7415-1325; Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation (NRF) of Korea Grant - Korean government (MEST) [2011-0016401]; Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A121180]; MEXT KAKENHI [23117008]; JSPS KAKENHI in Japan [23406007]	National Research Foundation (NRF) of Korea Grant - Korean government (MEST); Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Research Foundation (NRF) of Korea Grant funded by the Korean government (MEST) (2011-0016401) and a grant from the Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A121180). This work was also supported in part by MEXT KAKENHI (23117008) and JSPS KAKENHI (23406007) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; AIKAWA M, 1983, CIBA F SYMP, V94, P45; [Anonymous], 2008, METHODS MALARIA RES; Ansorge I, 1997, MOL BIOCHEM PARASIT, V84, P259, DOI 10.1016/S0166-6851(96)02806-X; Arevalo-Pinzon G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-60; Arumugam TU, 2011, INFECT IMMUN, V79, P4523, DOI 10.1128/IAI.05412-11; Birago C, 2003, MOL BIOCHEM PARASIT, V126, P209, DOI 10.1016/S0166-6851(02)00275-X; Blackman MJ, 2004, CELL MICROBIOL, V6, P893, DOI 10.1111/j.1462-5822.2004.00437.x; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; Cheng Y, 2014, PARASITOL RES, V113, P2559, DOI 10.1007/s00436-014-3907-8; Cheng Y, 2013, INFECT IMMUN, V81, P1585, DOI 10.1128/IAI.01117-12; Curra C, 2012, TRAFFIC, V13, P388, DOI 10.1111/j.1600-0854.2011.01313.x; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Fan YT, 2013, J PROTEOMICS, V78, P148, DOI 10.1016/j.jprot.2012.11.020; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Hiller NL, 2003, J BIOL CHEM, V278, P48413, DOI 10.1074/jbc.M307266200; JOHNSON D, 1994, PARASITOLOGY, V109, P1, DOI 10.1017/S0031182000077696; Li J, 2012, PARASITOL INT, V61, P443, DOI 10.1016/j.parint.2012.02.008; Lu F, 2014, J PROTEOMICS, V102, P66, DOI 10.1016/j.jprot.2014.02.029; LUSTIGMAN S, 1988, MOL BIOCHEM PARASIT, V30, P217, DOI 10.1016/0166-6851(88)90090-4; MacKellar DC, 2011, CELL MICROBIOL, V13, P1755, DOI 10.1111/j.1462-5822.2011.01656.x; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Pinder JC, 2000, PARASITOL TODAY, V16, P240, DOI 10.1016/S0169-4758(00)01664-1; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SIMMONS D, 1987, EMBO J, V6, P485, DOI 10.1002/j.1460-2075.1987.tb04779.x; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Spielmann T, 2003, MOL BIOL CELL, V14, P1529, DOI 10.1091/mbc.E02-04-0240; Spielmann T, 2000, MOL BIOCHEM PARASIT, V111, P453, DOI 10.1016/S0166-6851(00)00333-9; Spielmann T, 2012, INT J MED MICROBIOL, V302, P179, DOI 10.1016/j.ijmm.2012.07.011; STENZEL DJ, 1989, EUR J CELL BIOL, V49, P311; Tsuboi T, 2010, METHODS MOL BIOL, V607, P73, DOI 10.1007/978-1-60327-331-2_8; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127500	10.1371/journal.pone.0127500	http://dx.doi.org/10.1371/journal.pone.0127500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011536	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900099
J	Dosedelova, H; Dumkova, J; Lesot, H; Glocova, K; Kunova, M; Tucker, AS; Vesela, I; Krejci, P; Tichy, F; Hampl, A; Buchtova, M				Dosedelova, Hana; Dumkova, Jana; Lesot, Herve; Glocova, Kristyna; Kunova, Michaela; Tucker, Abigail S.; Vesela, Iva; Krejci, Pavel; Tichy, Frantisek; Hampl, Ales; Buchtova, Marcela			Fate of the Molar Dental Lamina in the Monophyodont Mouse	PLOS ONE			English	Article							STEM-CELLS; TOOTH REPLACEMENT; BASAL LAMINA; PROLIFERATION; HEDGEHOG; TEETH; MORPHOGENESIS; SOX2; INITIATION; DENTITION	The successional dental lamina (SDL) plays an essential role in the development of replacement teeth in diphyodont and polyphyodont animals. A morphologically similar structure, the rudimental successional dental lamina (RSDL), has been described in monophyodont (only one tooth generation) lizards on the lingual side of the developing functional tooth. This rudimentary lamina regresses, which has been proposed to play a role in preventing the formation of future generations of teeth. A similar rudimentary lingual structure has been reported associated with the first molar in the monophyodont mouse, and we show that this structure is common to all murine molars. Intriguingly, a lingual lamina is also observed on the non-replacing molars of other diphyodont mammals (pig and hedgehog), initially appearing very similar to the successional dental lamina on the replacing teeth. We have analyzed the morphological as well as ultrastructural changes that occur during the development and loss of this molar lamina in the mouse, from its initiation at late embryonic stages to its disappearance at postnatal stages. We show that loss appears to be driven by a reduction in cell proliferation, down-regulation of the progenitor marker Sox2, with only a small number of cells undergoing programmed cell death. The lingual lamina was associated with the dental stalk, a short epithelial connection between the tooth germ and the oral epithelium. The dental stalk remained in contact with the oral epithelium throughout tooth development up to eruption when connective tissue and numerous capillaries progressively invaded the dental stalk. The buccal side of the dental stalk underwent keratinisation and became part of the gingival epithelium, while most of the lingual cells underwent programmed cell death and the tissue directly above the erupting tooth was shed into the oral cavity.	[Dosedelova, Hana; Glocova, Kristyna; Vesela, Iva; Tichy, Frantisek; Buchtova, Marcela] Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Anat Histol & Embryol, Brno, Czech Republic; [Dosedelova, Hana; Vesela, Iva; Buchtova, Marcela] Acad Sci Czech Republ, Vvi, Inst Anim Physiol & Genet, Brno, Czech Republic; [Dumkova, Jana; Hampl, Ales] Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic; [Lesot, Herve] Univ Strasbourg, INSERM, Team Osteoarticular & Dent Regenerat NanoMed, UMR1109, Strasbourg, France; [Lesot, Herve] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France; [Kunova, Michaela; Krejci, Pavel] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Tucker, Abigail S.] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London, England; [Tucker, Abigail S.] Kings Coll London, Inst Dent, Dept Orthodont, London, England; [Buchtova, Marcela] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno, Czech Republic	University of Veterinary Sciences Brno; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Masaryk University Brno; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Masaryk University Brno; University of London; King's College London; University of London; King's College London; Masaryk University Brno	Buchtova, M (corresponding author), Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Anat Histol & Embryol, Brno, Czech Republic.	buchtova@iach.cz	Hampl, Ales/N-1632-2016; Krejčí, Pavel/I-4285-2014; Lesot, Herve/AAM-4523-2021; Tucker, Abigail S/K-1788-2016	Hampl, Ales/0000-0002-8963-9235; Tucker, Abigail S/0000-0001-8871-6094; Krejci, Pavel/0000-0003-0618-9134; Dumkova, Jana/0000-0002-2834-6316; Vesela, Iva/0000-0001-5751-0130; Bosakova, Michaela/0000-0002-7627-0344	Internal Grant Agency UVPS [96/2014/FVL]; Czech Science Foundation/GACR [14-37368G, 14-29273P]; Ministry of Education, Youth and Sports/OPVK [CZ.1.074/2.3.00/30.0053]; IRP IPAG [AVOZ 5045015]; Academy of Sciences of the Czech Republic [M200451201]	Internal Grant Agency UVPS; Czech Science Foundation/GACR(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports/OPVK; IRP IPAG; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The research was supported by Internal Grant Agency UVPS (96/2014/FVL), Czech Science Foundation/GACR (14-37368G to MB lab, 14-29273P to IV), Ministry of Education, Youth and Sports/OPVK (CZ.1.074/2.3.00/30.0053) and the labs run under IRP IPAG (No. AVOZ 5045015). International cooperation between the labs was supported by Academy of Sciences of the Czech Republic (M200451201).	Alibardi L, 2013, ACTA HISTOCHEM, V115, P879, DOI 10.1016/j.acthis.2013.04.008; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avery JK, 1994, ORAL DEVELOPMENT AND; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Buchtova M, 2012, J DENT RES, V91, P491, DOI 10.1177/0022034512442896; Buchtova M, 2008, DEV BIOL, V319, P132, DOI 10.1016/j.ydbio.2008.03.004; Buchtova M, 2007, ZOOLOGY, V110, P231, DOI 10.1016/j.zool.2007.01.006; Buchtova M, 2013, ARCH ORAL BIOL, V58, P118, DOI 10.1016/j.archoralbio.2012.10.019; COOPER JS, 1970, J ZOOL, V162, P85; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Fan YX, 2013, GENET MOL RES, V12, P6067, DOI 10.4238/2013.December.2.5; Gaete M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074484; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Handrigan GR, 2010, DEV BIOL, V348, P130, DOI 10.1016/j.ydbio.2010.09.003; Handrigan GR, 2010, DEVELOPMENT, V137, P3545, DOI 10.1242/dev.052415; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; Huysseune A, 2004, BIOESSAYS, V26, P665, DOI 10.1002/bies.20039; Jarvinen E, 2009, J EXP ZOOL PART B, V312B, P281, DOI 10.1002/jez.b.21275; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Jussila M, 2014, DIFFERENTIATION, V87, P32, DOI 10.1016/j.diff.2013.11.004; Juuri E, 2013, EUR J ORAL SCI, V121, P509, DOI 10.1111/eos.12095; Juuri E, 2013, DEVELOPMENT, V140, P1424, DOI 10.1242/dev.089599; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; KARCHERDJURICIC V, 1978, J BIOL BUCCALE, V6, P257; KHAEJORNBUT J, 1991, J ANAT, V179, P85; Lesot H, 1999, INT J DEV BIOL, V43, P245; Lesot H, 2002, CONNECT TISSUE RES, V43, P191, DOI 10.1080/03008200290000529; Martinez C, 2011, J DENT RES, V90, P483, DOI 10.1177/0022034510391797; Matalova E, 2004, J DENT RES, V83, P11, DOI 10.1177/154405910408300103; MEYER JM, 1995, CELL TISSUE RES, V279, P135, DOI 10.1007/BF00300700; MOSKOW BS, 1983, J CLIN PERIODONTOL, V10, P119, DOI 10.1111/j.1600-051X.1983.tb02200.x; Nadiri A, 2006, CELL TISSUE RES, V324, P33, DOI 10.1007/s00441-005-0120-1; Numakura C, 2010, AM J MED GENET A, V152A, P2355, DOI 10.1002/ajmg.a.33556; OSMAN M, 1981, J DENT RES, V60, P1015, DOI 10.1177/00220345810600060301; Peterkova R, 2014, AUST DENT J, V59, P55, DOI 10.1111/adj.12130; Richman JM, 2011, GENESIS, V49, P247, DOI 10.1002/dvg.20721; Rothova M, 2012, DEV BIOL, V366, P244, DOI 10.1016/j.ydbio.2012.03.018; RUCH JV, 1983, J BIOL BUCCALE, V11, P173; RUCH JV, 1995, INT J DEV BIOL, V39, P51; Setkova J, 2006, INT J DEV BIOL, V50, P481, DOI 10.1387/ijdb.052067js; Sire JY, 2002, MICROSC RES TECHNIQ, V59, P408, DOI 10.1002/jemt.10220; Smith MM, 2009, J EXP ZOOL PART B, V312B, P260, DOI 10.1002/jez.b.21272; Steinert PM, 1999, MOL BIOL CELL, V10, P4247, DOI 10.1091/mbc.10.12.4247; Stembirek J, 2010, EUR J ORAL SCI, V118, P547, DOI 10.1111/j.1600-0722.2010.00772.x; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; Wu P, 2013, P NATL ACAD SCI USA, V110, pE2009, DOI 10.1073/pnas.1213202110; Zahradnicek O, 2012, J ANAT, V221, P195, DOI 10.1111/j.1469-7580.2012.01531.x	50	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127543	10.1371/journal.pone.0127543	http://dx.doi.org/10.1371/journal.pone.0127543			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010446	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900107
J	Ispas, G; Koul, A; Verbeeck, J; Sheehan, J; Sanders-Beer, B; Roymans, D; Andries, K; Rouan, MC; De Jonghe, S; Bonfanti, JF; Vanstockem, M; Simmen, K; Verloes, R				Ispas, Gabriela; Koul, Anil; Verbeeck, Johan; Sheehan, Jennifer; Sanders-Beer, Brigitte; Roymans, Dirk; Andries, Koen; Rouan, Marie-Claude; De Jonghe, Sandra; Bonfanti, Jean-Francois; Vanstockem, Marc; Simmen, Kenneth; Verloes, Rene			Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model	PLOS ONE			English	Article							HIGH-RISK INFANTS; CLINICAL CANDIDATE; YOUNG-CHILDREN; INFECTION; BRONCHIOLITIS; PALIVIZUMAB; SELECTION; EFFICACY; ANTIBODY; MONKEYS	Background The study assessed the antiviral activity of TMC353121, a respiratory syncytial virus (RSV) fusion inhibitor, in a preclinical non-human primate challenge model with a viral shedding pattern similar to that seen in humans, following continuous infusion (CI). Methods African green monkeys were administered TMC353121 through CI, in 2 studies. Study 1 evaluated the prophylactic and therapeutic efficacy of TMC353121 at a target plasma level of 50 ng/mL (n= 15; Group 1: prophylactic arm [Px50], 0.033 mg/mL TMC353121, flow rate 2.5 mL/kg/h from 24 hours pre-infection to 10 days; Group 2: therapeutic arm [Tx50], 0.033mg/mL TMC353121 from 24 hours postinfection to 8 days; Group 3: control [Vh1] vehicle, 24 hours post-infection to 8 days). Study 2 evaluated the prophylactic efficacy of TMC353121 at target plasma levels of 5 and 500 ng/mL (n= 12; Group 1: prophylactic 5 arm [Px5], 0.0033 mg/mL TMC353121, flow rate 2.5 mL/kg/h from 72 hours pre-infection to 14 days; Group 2: prophylactic 500 arm [Px500], 0.33 mg/mL TMC353121; Group 3: control [Vh2] vehicle, 14 days). Bronchoalveolar lavage fluid and plasma were collected every 2 days from day 1 postinfection for pharmacokinetics and safety analysis. Findings TMC353121 showed a dose-dependent antiviral activity, varying from 1log(10) reduction of peak viral load to complete inhibition of the RSV replication. Complete inhibition of RSV shedding was observed for a relatively low plasma exposure (0.39 mu g/mL) and was associated with a dose-dependent reduction in INF gamma, IL6 and MIP1 alpha. TMC353121 administered as CI for 16 days was generally well-tolerated. Conclusion TMC353121 exerted dose-dependent antiviral effect ranging from full inhibition to absence of antiviral activity, in a preclinical model highly permissive for RSV replication. No new safety findings emerged from the study.	[Ispas, Gabriela; Koul, Anil; Roymans, Dirk; Andries, Koen; Vanstockem, Marc; Verloes, Rene] Janssen Infect Dis, Beerse, Belgium; [Verbeeck, Johan] Janssen Res & Dev, London, England; [Sheehan, Jennifer] Huntingdon Life Sci, Somerset, NJ 08873 USA; [Sanders-Beer, Brigitte] BIOQUAL Inc, Rockville, MD 20850 USA; [Rouan, Marie-Claude; De Jonghe, Sandra] Janssen Res & Dev, Beerse, Belgium; [Bonfanti, Jean-Francois] Janssen Res & Dev, Jan Cil France, Paris, France; [Simmen, Kenneth] J&J Pharmaceut Res & Dev, Jan Cil UK, High Wycombe, Bucks, England	BIOQUAL Inc.; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson	Ispas, G (corresponding author), Janssen Infect Dis, Beerse, Belgium.	gispas@its.jnj.com	Roymans, Dirk/AFQ-3892-2022		Janssen Pharmaceutical Companies of JJ	Janssen Pharmaceutical Companies of JJ	Janssen Pharmaceutical Companies of J&J funded the study and was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Huntigton Life Sciences and Bioqual were involved in study design, data collection and analysis and preparation of the manuscript.	Andries K, 2003, ANTIVIR RES, V60, P209, DOI 10.1016/j.antiviral.2003.07.004; Baker KA, 1999, POSTGRAD MED, V106, P97, DOI 10.3810/pgm.1999.12.803; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; Bonfanti JF, 2008, J MED CHEM, V51, P875, DOI 10.1021/jm701284j; Bonfanti JF, 2007, J MED CHEM, V50, P4572, DOI 10.1021/jm070143x; Cianci C, 2004, ANTIMICROB AGENTS CH, V48, P2448, DOI 10.1128/AAC.48.7.2448-2454.2004; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Durbin AP, 2003, CLIN INFECT DIS, V37, P1668, DOI 10.1086/379775; El Kholy AA, 2013, PEDIATR INT, V55, P283, DOI 10.1111/ped.12051; Falsey AR, 2014, J INFECT DIS, V209, P1873, DOI 10.1093/infdis/jit839; Garofalo RP, 2005, J MED VIROL, V75, P282, DOI 10.1002/jmv.20268; Geskey JM, 2007, BIOL-TARGETS THER, V1, P33; Gong EY, 2013, METHODS IN MOLECULAR; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Hashem M, 2003, J CLIN VIROL, V27, P14, DOI 10.1016/S1386-6532(03)00047-7; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Jin H, 2003, VACCINE, V21, P3647, DOI 10.1016/S0264-410X(03)00426-2; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Lee FEH, 2004, ANTIVIR RES, V63, P191, DOI 10.1016/j.antiviral.2004.04.005; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Olszewska W, 2011, EUR RESPIR J, V38, P401, DOI 10.1183/09031936.00005610; Player MR, 1998, P NATL ACAD SCI USA, V95, P8874, DOI 10.1073/pnas.95.15.8874; Rouan MC, 2010, ANTIMICROB AGENTS CH, V54, P4534, DOI 10.1128/AAC.00643-10; Roymans D, 2010, P NATL ACAD SCI USA, V107, P308, DOI 10.1073/pnas.0910108106; Tripp Ralph A, 2005, Proc Am Thorac Soc, V2, P147, DOI 10.1513/pats.200502-014AW; Wang D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15050; Weiss WJ, 2003, J MED PRIMATOL, V32, P82, DOI 10.1034/j.1600-0684.2003.00014.x; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Weltzin R, 1996, J INFECT DIS, V174, P256, DOI 10.1093/infdis/174.2.256	32	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126959	10.1371/journal.pone.0126959	http://dx.doi.org/10.1371/journal.pone.0126959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010881	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900052
J	Lee, C; Clark, SE				Lee, Chunghee; Clark, Steven E.			A WUSCHEL-Independent Stem Cell Specification Pathway Is Repressed by PHB, PHV and CNA in Arabidopsis	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; ZIPPER GENE FAMILY; ORGAN DEVELOPMENT; FATE; CLAVATA1; THALIANA; ARGONAUTE1; EXPRESSION; CLV3; REGULATOR	The homeostatic maintenance of stem cells that carry out continuous organogenesis at the shoot meristem is crucial for plant development. Key known factors act to signal between the stem cells and an underlying group of cells thought to act as the stem cell niche. In Arabidopsis thaliana the homeodomain transcription factor WUSCHEL (WUS) is essential for stem cell initiation and maintenance at shoot and flower meristems. Recent data suggest that the WUS protein may move from the niche cells directly into the stem cells to maintain stem cell identity. Here we provide evidence for a second, previously unknown, pathway for stem cell specification at shoot and flower meristems that bypasses the requirement for WUS. We demonstrate that this novel stem cell specification pathway is normally repressed by the activity of the HD-zip III transcription factors PHABULOSA (PHB), PHAVOLUTA (PHV) and CORONA (CNA). When de-repressed, this second stem cell pathway leads to an accumulation of stem cells and an enlargement of the stem cell niche. When de-repressed in a wus mutant background, this second stem cell pathway leads to functional meristems with largely normal cell layering and meristem morphology, activation of WUS cis regulatory elements, and extensive, but not indeterminate, organogenesis. Thus, WUS is largely dispensable for stem cell specification and meristem function, suggesting a set of key stem cell specification factors, competitively regulated by WUS and PHB/PHV/CNA, remain unidentified.	[Lee, Chunghee; Clark, Steven E.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Clark, SE (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	clarks@umich.edu			National Institutes of Health [R01GM62962]; US Department of Agriculture [2006-35304-17403]; University of Michigan MCubed program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); University of Michigan MCubed program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health (R01GM62962), the US Department of Agriculture (2006-35304-17403), and the University of Michigan MCubed program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; BARTON MK, 1993, DEVELOPMENT, V119, P823; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Baurle I, 2005, PLANT CELL, V17, P2271, DOI 10.1105/tpc.105.032623; Bowman JL, 2002, TRENDS GENET, V18, P134, DOI 10.1016/S0168-9525(01)02601-4; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, PLANT CELL, V9, P1067, DOI 10.1105/tpc.9.7.1067; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; Dievart A, 2003, PLANT CELL, V15, P1198, DOI 10.1105/tpc.010504; Dodsworth S, 2009, DEV BIOL, V336, P1, DOI 10.1016/j.ydbio.2009.09.031; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; FURNER IJ, 1992, DEVELOPMENT, V115, P755; Gagne JM, 2010, PLANT CELL, V22, P729, DOI 10.1105/tpc.109.068734; Gallois JL, 2002, DEVELOPMENT, V129, P3207; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Gross-Hardt R, 2002, GENE DEV, V16, P1129, DOI 10.1101/gad.225202; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Ha CM, 2010, CURR TOP DEV BIOL, V91, P103, DOI 10.1016/S0070-2153(10)91004-1; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; IRISH VF, 1992, DEVELOPMENT, V115, P745; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Ji LJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001358; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kerstetter RA, 1997, PLANT CELL, V9, P1001, DOI 10.1105/tpc.9.7.1001; Laux T, 1996, DEVELOPMENT, V122, P87; Lee CH, 2013, WIRES DEV BIOL, V2, P671, DOI 10.1002/wdev.110; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Liu QL, 2009, PLANT J, V58, P27, DOI 10.1111/j.1365-313X.2008.03757.x; Lynn K, 1999, DEVELOPMENT, V126, P469; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Ni J, 2006, PLANT PHYSIOL, V140, P726, DOI 10.1104/pp.105.072678; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Pogany JA, 1998, J PLANT RES, V111, P307, DOI 10.1007/BF02512189; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rojo E, 2002, PLANT CELL, V14, P969, DOI 10.1105/tpc.002196; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schuster C, 2014, DEV CELL, V28, P438, DOI 10.1016/j.devcel.2014.01.013; Song SK, 2006, DEVELOPMENT, V133, P4691, DOI 10.1242/dev.02652; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Stewart R. N., 1940, AM J BOT, V27, P875; STEWART RN, 1975, AM J BOT, V62, P935, DOI 10.2307/2441638; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2010, DEVELOPMENT, V137, P3581, DOI 10.1242/dev.054973; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yu LP, 2003, CURR BIOL, V13, P179, DOI 10.1016/S0960-9822(03)00042-3; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	65	28	31	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126006	10.1371/journal.pone.0126006	http://dx.doi.org/10.1371/journal.pone.0126006			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011610	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900020
J	McMahon, JH; Moore, R; Eu, B; Tee, BK; Chen, M; El-Hayek, C; Street, A; Woolley, I; Buggie, A; Collins, D; Medland, N; Hoy, J				McMahon, James H.; Moore, Richard; Eu, Beng; Tee, Ban-Kiem; Chen, Marcus; El-Hayek, Carol; Street, Alan; Woolley, Ian; Buggie, Andrew; Collins, Danielle; Medland, Nicholas; Hoy, Jennifer		VIPER Study Grp	Clinic Network Collaboration and Patient Tracing to Maximize Retention in HIV Care	PLOS ONE			English	Article							UNITED-STATES; ENGAGEMENT; INTERRUPTION; PREVENTION; INFECTION; DIAGNOSIS; AIDS	Background Understanding retention and loss to follow up in HIV care, in particular the number of people with unknown outcomes, is critical to maximise the benefits of antiretroviral therapy. Individual- level data are not available for these outcomes in Australia, which has an HIV epidemic predominantly focused amongst men who have sex with men. Methods and Findings A network of the 6 main HIV clinical care sites was established in the state of Victoria, Australia. Individuals who had accessed care at these sites between February 2011 and June 2013 as assessed by HIV viral load testing but not accessed care between June 2013 and February 2014 were considered individuals with potentially unknown outcomes. For this group an intervention combining cross-referencing of clinical data between sites and phone tracing individuals with unknown outcomes was performed. 4966 people were in care in the network and before the intervention estimates of retention ranged from85.9%-95.8% and the proportion with unknown outcomes ranged from 1.3-5.5%. After the intervention retention increased to 91.4-98.8% and unknown outcomes decreased to 0.1-2.4% (p < .01 for all sites for both outcomes). Most common reasons for disengagement from care were being too busy to attend or feeling well. For those with unknown outcomes prior to the intervention documented active psychiatric illness at last visit was associated with not re-entering care (p = 0.04) Conclusions The network demonstrated low numbers of people with unknown outcomes and high levels of retention in care. Increased levels of retention in care and reductions in unknown outcomes identified after the intervention largely reflected confirmation of clinic transfers while a smaller number were successfully re-engaged in care. Factors associated with disengagement from care were identified. Systems to monitor patient retention, care transfer and minimize disengagement will maximise individual and population-level outcomes for populations with HIV.	[McMahon, James H.; Woolley, Ian; Hoy, Jennifer] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [McMahon, James H.; Woolley, Ian; Hoy, Jennifer] Monash Univ, Melbourne, Vic 3004, Australia; [McMahon, James H.; Woolley, Ian] Monash Hlth, Infect Dis Unit, Melbourne, Vic, Australia; [McMahon, James H.; El-Hayek, Carol] Burnet Inst, Melbourne, Vic, Australia; [Moore, Richard] Northside Clin, Melbourne, Vic, Australia; [Eu, Beng] Prahran Market Clin, Melbourne, Vic, Australia; [Tee, Ban-Kiem; Collins, Danielle] Ctr Clin, Melbourne, Vic, Australia; [Chen, Marcus; Buggie, Andrew; Medland, Nicholas] Melbourne Sexual Hlth Ctr, Alfred Hlth, Melbourne, Vic, Australia; [Chen, Marcus] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Street, Alan] Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic 3050, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Burnet Institute; Monash University; Royal Melbourne Hospital; University of Melbourne	McMahon, JH (corresponding author), Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia.	ja.mcmahon@alfred.org.au	Hoy, Jennifer/AAK-7968-2020; El-Hayek, Carol/AAA-8666-2019; Eu, Beng/AAJ-7746-2021	El-Hayek, Carol/0000-0001-5743-5994; Eu, Beng/0000-0002-7009-9179; Medland, Nicholas Andrew/0000-0003-0403-8930; McMahon, James/0000-0003-1460-5572; Hoy, Jennifer/0000-0002-6948-7086; Woolley, Ian John/0000-0003-2928-1291	Gilead Fellowship Grant	Gilead Fellowship Grant	This work was funded by a Gilead Fellowship Grant (https://gileadfellowship.com.au/). The grant is a competitively funded award for investigator initiated proposals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ANN SURV REP 2014 S; Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113; Buskin SE, 2014, SEX TRANSM DIS, V41, P35, DOI 10.1097/OLQ.0000000000000072; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; DHHS, 2014, GUID US ANT AG HIV 1; Dombrowski JC, 2012, AIDS, V26, P77, DOI 10.1097/QAD.0b013e32834dcee9; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Hoy J, 2012, HIV SERVICE KEY PERF; Li XH, 2005, JAIDS-J ACQ IMM DEF, V38, P320; McMahon J, 2013, 317 AUSTR SOC HIV ME; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Nosyk B, 2014, LANCET INFECT DIS, V14, P40, DOI 10.1016/S1473-3099(13)70254-8; OECD, 2021, BETT LIF IND DAT; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Samji H, 2014, AIDS BEHAV, V18, P2240, DOI 10.1007/s10461-014-0776-1; Singh S, 2014, MMWR-MORBID MORTAL W, V63, P829; STEIN DS, 1992, J INFECT DIS, V165, P352, DOI 10.1093/infdis/165.2.352; Supervie V, 2013, 20 C RETR OPP INF AT; Udeagu CCN, 2013, AIDS, V27, P2271, DOI 10.1097/QAD.0b013e328362fdde; Van Beckhoven D, 2014, J INT AIDS SOC, V17, P30, DOI 10.7448/IAS.17.4.19534; Wilkinson AL, 2015, SEX HEALTH, V12, P34, DOI 10.1071/SH14144	23	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127726	10.1371/journal.pone.0127726	http://dx.doi.org/10.1371/journal.pone.0127726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011034	Green Published, gold			2022-12-27	WOS:000355183900136
J	Moreira, CA; Bando, SY; Bertonha, FB; Iamashita, P; Silva, FN; Costa, LD; Silva, AV; Castro, LHM; Wen, HT				Moreira-Filho, Carlos Alberto; Bando, Silvia Yumi; Bertonha, Fernanda Bernardi; Iamashita, Priscila; Silva, Filipi Nascimento; Costa, Luciano da Fontoura; Silva, Alexandre Valotta; Martins Castro, Luiz Henrique; Wen, Hung-Tzu			Community Structure Analysis of Transcriptional Networks Reveals Distinct Molecular Pathways for Early- and Late-Onset Temporal Lobe Epilepsy with Childhood Febrile Seizures	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; LONG-TERM POTENTIATION; FACTOR-KAPPA-B; OXIDATIVE STRESS; GENE-EXPRESSION; NERVOUS-SYSTEM; HIPPOCAMPAL SCLEROSIS; STATUS EPILEPTICUS; DNA FRAGMENTATION; COMPLEX NETWORKS	Age at epilepsy onset has a broad impact on brain plasticity and epilepsy pathomechanisms. Prolonged febrile seizures in early childhood (FS) constitute an initial precipitating insult (IPI) commonly associated with mesial temporal lobe epilepsy (MTLE). FS-MTLE patients may have early disease onset, i.e. just after the IPI, in early childhood, or late-onset, ranging from mid-adolescence to early adult life. The mechanisms governing early (E) or late (L) disease onset are largely unknown. In order to unveil the molecular pathways underlying E and L subtypes of FS-MTLE we investigated global gene expression in hippocampal CA3 explants of FS-MTLE patients submitted to hippocampectomy. Gene coexpression networks (GCNs) were obtained for the E and L patient groups. A network-based approach for GCN analysis was employed allowing: i) the visualization and analysis of differentially expressed (DE) and complete (CO) - all valid GO annotated transcripts - GCNs for the E and L groups; ii) the study of interactions between all the system's constituents based on community detection and coarse-grained community structure methods. We found that the E-DE communities with strongest connection weights harbor highly connected genes mainly related to neural excitability and febrile seizures, whereas in L-DE communities these genes are not only involved in network excitability but also playing roles in other epilepsy-related processes. Inversely, in E-CO the strongly connected communities are related to compensatory pathways (seizure inhibition, neuronal survival and responses to stress conditions) while in L-CO these communities harbor several genes related to pro-epileptic effects, seizure-related mechanisms and vulnerability to epilepsy. These results fit the concept, based on fMRI and behavioral studies, that early onset epilepsies, although impacting more severely the hippocampus, are associated to compensatory mechanisms, while in late MTLE development the brain is less able to generate adaptive mechanisms, what has implications for epilepsy management and drug discovery.	[Moreira-Filho, Carlos Alberto; Bando, Silvia Yumi; Bertonha, Fernanda Bernardi; Iamashita, Priscila] FMUSP, Dept Pediat, Sao Paulo, SP, Brazil; [Silva, Filipi Nascimento; Costa, Luciano da Fontoura] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Silva, Alexandre Valotta] FMUSP, Grad Program Expt Pathophysiol, Sao Paulo, SP, Brazil; [Martins Castro, Luiz Henrique] FMUSP, Dept Neurol, Sao Paulo, SP, Brazil; [Martins Castro, Luiz Henrique] FMUSP, Hosp Clin, Clin Neurol Div, Sao Paulo, SP, Brazil; [Wen, Hung-Tzu] FMUSP, Hosp Clin, Epilepsy Surg Grp, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Moreira, CA (corresponding author), FMUSP, Dept Pediat, Sao Paulo, SP, Brazil.	carlos.moreira@hc.fm.usp.br	Silva, Filipi Nascimento/C-7620-2012; Silva, Alexandre V/A-2634-2011; da F. Costa, Luciano/H-5475-2011; Bertonha, Fernanda Bernardi/H-3333-2015; moreira-filho, carlos alberto/J-2551-2014; Castro, Luiz H M/H-9427-2012	Silva, Filipi Nascimento/0000-0002-9151-6517; Silva, Alexandre V/0000-0001-7107-0864; da F. Costa, Luciano/0000-0001-5203-4366; Bertonha, Fernanda Bernardi/0000-0002-3675-1362; moreira-filho, carlos alberto/0000-0003-3433-4714; Castro, Luiz H M/0000-0003-1878-8548; Bando, Silvia Yumi/0000-0003-3794-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/53443-1, 2005/56446-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305635/2009-3]; FAPESP [2005/00587-5, 2011/50761-2]; CNPq [307333/2013-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPESP-MCT/CNPq/PRONEX [2011/50761-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP-MCT/CNPq/PRONEX	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) research grants 2009/53443-1 and 2005/56446-0 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant 305635/2009-3 to CAM-F. LdFC was funded by FAPESP grants 2005/00587-5 and 2011/50761-2 and CNPq grants 307333/2013-2. FNS and PI were funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). FNS, CAM-F and LdFC are funded by FAPESP-MCT/CNPq/PRONEX grant 2011/50761-2.	Ahmad S, 2010, SEMIN PEDIATR NEUROL, V17, P150, DOI 10.1016/j.spen.2010.06.004; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alegro MD, 2012, MAGN RESON MED, V68, P1647, DOI 10.1002/mrm.24174; [Anonymous], 1960, HIPPOCAMPUS, V18, P460, DOI [10.1002/hipo.20409, DOI 10.1002/HIP0.20409]; Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Bai DM, 2014, NUCLEIC ACIDS RES, V42, P1799, DOI 10.1093/nar/gkt971; Balosso S, 2013, EXP NEUROL, V247, P267, DOI 10.1016/j.expneurol.2013.05.010; Bando SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026268; Bando SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079913; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006; Baulac M, 2015, REV NEUROL, V26; Bernhardt BC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00624; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bhanot K, 2011, J PROTEOME RES, V10, P5118, DOI 10.1021/pr200564g; Bhargava S, 2014, MOL CELL BIOCHEM, V387, P55, DOI 10.1007/s11010-013-1869-2; Bianchi MG, 2014, CELL MOL LIFE SCI, V71, P2001, DOI 10.1007/s00018-013-1484-0; Bierhals T, 2013, EUR J MED GENET, V56, P325, DOI 10.1016/j.ejmg.2013.03.009; Bilevicius E, 2010, NEUROLOGY, V75, P1695, DOI 10.1212/WNL.0b013e3181fc29dd; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Bosio Y, 2012, EUR J CELL BIOL, V91, P662, DOI 10.1016/j.ejcb.2012.03.002; Brockmann D, 2009, REV NONLINEAR DYNAMI, P55, DOI DOI 10.1002/9783527628001.CH1; Broomfield A, 2013, JIMD REP, V11, P93, DOI 10.1007/8904_2013_227; Buchser WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038101; Burk K, 2013, INT J NEUROSCI, V123, P278, DOI 10.3109/00207454.2012.755180; Cai JJ, 2010, GENOME BIOL EVOL, V2, P815, DOI 10.1093/gbe/evq064; Cao GD, 2001, J NEUROSCI, V21, P4678, DOI 10.1523/JNEUROSCI.21-13-04678.2001; Carpentier C, 2014, BBA-MOL BASIS DIS, V1842, P654, DOI 10.1016/j.bbadis.2014.01.004; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Casanova JR, 2013, EUR J NEUROSCI, V38, P3115, DOI 10.1111/ejn.12315; Charong N, 2011, J CANCER RES CLIN, V137, P89, DOI 10.1007/s00432-010-0863-2; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chen ZL, 2003, MOL BIOL CELL, V14, P2665, DOI 10.1091/mbc.E02-12-0832; Cheung ZH, 2004, NEUROSCI LETT, V361, P47, DOI 10.1016/j.neulet.2003.12.117; Chiang S, 2014, CLIN NEUROPHYSIOL, V125, P1295, DOI 10.1016/j.clinph.2014.04.004; Choudhary S, 2011, J BIOL CHEM, V286, P37187, DOI 10.1074/jbc.M111.224923; Choy M, 2014, J NEUROSCI, V34, P8672, DOI 10.1523/JNEUROSCI.4806-13.2014; Chungath M, 2008, NAT CLIN PRACT NEURO, V4, P610, DOI 10.1038/ncpneuro0922; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cloix JF, 2009, CURR MED CHEM, V16, P841, DOI 10.2174/092986709787549316; Cornejo BJ, 2007, ANN NEUROL, V61, P411, DOI 10.1002/ana.21071; Costa LD, 2008, PHYSICA A, V387, P6201, DOI 10.1016/j.physa.2008.06.034; Costa LD, 2011, ADV PHYS, V60, P329, DOI 10.1080/00018732.2011.572452; Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y; Coxon CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049543; Crepaldi L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003699; Davies KG, 1996, EPILEPSY RES, V24, P119, DOI 10.1016/0920-1211(96)00008-3; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Doucet G, 2013, HUM BRAIN MAPP, V34, P2202, DOI 10.1002/hbm.22059; Doucet GE, 2015, BRAIN TOPOGR, V28, P113, DOI 10.1007/s10548-014-0366-6; Du YS, 2013, BRAIN RES, V1509, P79, DOI 10.1016/j.brainres.2013.03.005; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; El-Hattab AW, 2011, CLIN GENET, V79, P531, DOI 10.1111/j.1399-0004.2010.01496.x; Erck C, 2005, P NATL ACAD SCI USA, V102, P7853, DOI 10.1073/pnas.0409626102; Feliciano P, 2013, J NEUROSCI, V33, P18319, DOI 10.1523/JNEUROSCI.5293-12.2013; Francis JS, 2011, GLIA, V59, P1435, DOI 10.1002/glia.21187; Furukawa A, 2011, NEUROBIOL DIS, V43, P706, DOI 10.1016/j.nbd.2011.05.024; Gasteier JE, 2005, EXP CELL RES, V306, P192, DOI 10.1016/j.yexcr.2005.02.006; Ghanta KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017135; Glynn P, 2013, BBA-MOL CELL BIOL L, V1831, P633, DOI 10.1016/j.bbalip.2012.07.023; Gomez-Ospina N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060526; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Halder SK, 2012, CELL MOL NEUROBIOL, V32, P59, DOI 10.1007/s10571-011-9734-x; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Helmstaedter C, 2004, EPILEPSY BEHAV, V5, P696, DOI 10.1016/j.yebeh.2004.06.008; Heuser K, 2011, SEIZURE-EUR J EPILEP, V20, P163, DOI 10.1016/j.seizure.2010.11.015; Hinnebusch AG, 2014, ANN REV BIO IN PRESS; Hoang SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081972; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Huang CT, 2008, NEUROPSYCHOBIOLOGY, V58, P171, DOI 10.1159/000191123; Huang JH, 2011, FEBS J, V278, P1651, DOI 10.1111/j.1742-4658.2011.08085.x; Huang YY, 2012, SYNAPSE, V66, P151, DOI 10.1002/syn.20995; Huh YH, 2013, CELL MOL LIFE SCI, V70, P4841, DOI 10.1007/s00018-013-1447-5; Jacquemet G, 2013, J CELL SCI, V126, P4121, DOI 10.1242/jcs.121988; Janszky J, 2004, NEUROLOGY, V63, P1296, DOI 10.1212/01.WNL.0000140701.40447.88; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kanari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059026; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kim H, 2009, PHARMACOGENOMICS, V10, P171, DOI 10.2217/14622416.10.2.171; Kim JE, 2008, EXP NEUROL, V211, P128, DOI 10.1016/j.expneurol.2008.01.029; Kim JE, 2010, J COMP NEUROL, V518, P4612, DOI 10.1002/cne.22482; Kim KC, 2014, MOL NEUROBIOL, V49, P512, DOI 10.1007/s12035-013-8535-2; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Kobayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035820; Kobow K, 2012, EPILEPSIA, V53, P11, DOI 10.1111/epi.12031; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Krug A, 2014, EUR ARCH PSY CLIN N, V264, P103, DOI 10.1007/s00406-013-0428-x; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; Lauritzen F, 2013, BRAIN STRUC IN PRESS; Lauritzen F, 2012, NEUROBIOL DIS, V45, P165, DOI 10.1016/j.nbd.2011.08.001; Lauritzen F, 2011, NEUROBIOL DIS, V41, P577, DOI 10.1016/j.nbd.2010.11.005; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Lee CH, 2012, MOL CELL NEUROSCI, V51, P61, DOI 10.1016/j.mcn.2012.07.010; Lee MC, 2001, HUM PATHOL, V32, P643, DOI 10.1053/hupa.2001.24997; Lee TS, 2006, ACTA NEUROPATHOL, V111, P351, DOI 10.1007/s00401-005-0017-9; Lewerenz J, 2012, CELL DEATH DIFFER, V19, P847, DOI 10.1038/cdd.2011.165; Lewerenz J, 2014, ANTIOXID REDOX SIGN, V20, P2907, DOI 10.1089/ars.2013.5455; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Linnartz B, 2013, GLIA, V61, P37, DOI 10.1002/glia.22359; Linnartz-Gerlach B, 2014, NEUROSCIENCE, V275, P113, DOI 10.1016/j.neuroscience.2014.05.061; Liu G, 2002, ONCOGENE, V21, P7195, DOI 10.1038/sj.onc.1205862; Liu Y, 2008, J BIOL CHEM, V283, P6561, DOI 10.1074/jbc.M708096200; Lu CF, 2010, NEUROSCI LETT, V484, P139, DOI 10.1016/j.neulet.2010.08.036; Ludwig A, 2011, J NEUROSCI, V31, P644, DOI 10.1523/JNEUROSCI.2006-10.2011; Lum H, 2002, AM J PHYSIOL-CELL PH, V282, pC59, DOI 10.1152/ajpcell.00256.2001; Ma YY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-109; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Margineanu DG, 2012, EPILEPSY RES, V98, P104, DOI 10.1016/j.eplepsyres.2011.10.006; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; McClelland S, 2011, NEUROSCI LETT, V497, P155, DOI 10.1016/j.neulet.2011.02.032; Medrihan L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2515; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Millard CJ, 2014, CANCER METAST REV, V33, P857, DOI 10.1007/s10555-014-9513-5; Miller-Delaney SFC, 2012, J NEUROSCI, V32, P1577, DOI 10.1523/JNEUROSCI.5180-11.2012; Miyagi M, 2011, NEUROSCIENCE, V176, P93, DOI 10.1016/j.neuroscience.2010.12.027; Moorthamer M, 1999, BIOCHEM BIOPH RES CO, V255, P631, DOI 10.1006/bbrc.1999.0145; Moreira-Filho CA, 2014, TRANSCRIPTOMICS HLTH, P79; Mulley JC, 2013, EPILEPSIA, V54, pe122, DOI 10.1111/epi.12323; N'Gouemo P, 2011, EXPERT OPIN THER TAR, V15, P1283, DOI 10.1517/14728222.2011.620607; Nam J, 2011, SEMIN CELL DEV BIOL, V22, P492, DOI 10.1016/j.semcdb.2011.06.005; Narayanan T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067237; Naylor DE, 2013, NEUROBIOL DIS, V54, P225, DOI 10.1016/j.nbd.2012.12.015; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Otalora LFP, 2008, BRAIN RES, V1200, P116, DOI 10.1016/j.brainres.2008.01.017; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Parrish RR, 2013, NEUROSCIENCE, V248, P602, DOI 10.1016/j.neuroscience.2013.06.029; Patterson KP, 2014, NEUROTHERAPEUTICS, V11, P242, DOI 10.1007/s13311-014-0263-4; Pechenino AS, 2009, NEUROBIOL LEARN MEM, V91, P313, DOI 10.1016/j.nlm.2008.09.017; Perosa SR, 2002, BRAIN RES BULL, V58, P509, DOI 10.1016/S0361-9230(02)00822-5; Poppe R, 1997, J NEUROCHEM, V69, P84, DOI 10.1046/j.1471-4159.1997.69010084.x; Puskarjov M, 2014, EMBO REP, V15, P723, DOI 10.1002/embr.201438749; Putkonen N, 2011, EUR J NEUROSCI, V34, P1212, DOI 10.1111/j.1460-9568.2011.07858.x; Radzicki D, 2013, J NEUROSCI, V33, P9920, DOI 10.1523/JNEUROSCI.5482-12.2013; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Ravenall SJ, 2002, EUR J NEUROSCI, V15, P281, DOI 10.1046/j.0953-816x.2001.01862.x; Richardson RJ, 2013, CHEM-BIOL INTERACT, V203, P238, DOI 10.1016/j.cbi.2012.10.024; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rowley S, 2013, FREE RADICAL BIO MED, V62, P121, DOI 10.1016/j.freeradbiomed.2013.02.002; Russo I, 2013, NEUROMOL MED, V15, P324, DOI 10.1007/s12017-013-8221-6; Saha S, 2013, J BIOL CHEM, V288, P7815, DOI 10.1074/jbc.M112.417196; Sahni N, 2013, CURR OPIN GENET DEV, V23, P649, DOI 10.1016/j.gde.2013.11.002; Saitoh F, 2004, J BIOL CHEM, V279, P29461, DOI 10.1074/jbc.M401471200; Salat K, 2011, FUTURE MED CHEM, V3, P211, DOI 10.4155/FMC.10.298; Sanchez J, 2014, SEIZURE-EUR J EPILEP, V23, P448, DOI 10.1016/j.seizure.2014.03.003; Santos SD, 2012, J BIOL CHEM, V287, P6868, DOI 10.1074/jbc.M111.322909; Sasaki K, 2009, PEDIATR NEUROL, V41, P114, DOI 10.1016/j.pediatrneurol.2009.03.003; Sasaki N, 2005, BIOCHEM BIOPH RES CO, V333, P131, DOI 10.1016/j.bbrc.2005.05.082; Sato T, 2010, J COMP NEUROL, V518, P4513, DOI 10.1002/cne.22469; Sequeira KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053204; Sha L, 2014, MOL CELLULA IN PRESS; Shen AG, 2002, NEUROSCI LETT, V327, P45, DOI 10.1016/S0304-3940(02)00381-6; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Smirnova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065605; Soerensen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001813; Souchet B, 2014, NEUROBIOL DIS, V69, P65, DOI 10.1016/j.nbd.2014.04.016; Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004; Steinhoff BJ, 1999, EPILEPSY RES, V36, P75, DOI 10.1016/S0920-1211(99)00026-1; Teocchi MA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-53; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Troller U, 2004, CELL SIGNAL, V16, P245, DOI 10.1016/S0898-6568(03)00135-9; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Van Kuilenburg ABP, 1999, HUM GENET, V104, P1, DOI 10.1007/PL00008711; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Vielhaber S, 2008, EPILEPSIA, V49, P40, DOI 10.1111/j.1528-1167.2007.01280.x; Viggiano A, 2012, BRAIN RES, V1471, P66, DOI 10.1016/j.brainres.2012.06.048; Villarroel-Campos D, 2014, J NEUROCHEM, V129, P240, DOI 10.1111/jnc.12676; Wagnon JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003067; Wang Y, 2006, MOL MEMBR BIOL, V23, P377, DOI 10.1080/09687860600776734; Wang YJ, 2012, J CELL BIOCHEM, V113, P2696, DOI 10.1002/jcb.24145; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Weser S, 2004, J BIOL CHEM, V279, P27022, DOI 10.1074/jbc.M312790200; West S, 2008, NUCLEIC ACIDS RES, V36, P905, DOI 10.1093/nar/gkm1112; White HS, 2014, NEUROTHERAPEUTICS, V11, P373, DOI 10.1007/s13311-013-0250-1; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Woods JO, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-203; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11; Xiao F, 2008, BRAIN RES, V1233, P168, DOI 10.1016/j.brainres.2008.07.101; Yang F, 2008, HIPPOCAMPUS, V18, P460, DOI 10.1002/hipo.20409; Yang JW, 2006, AMINO ACIDS, V30, P477, DOI 10.1007/s00726-005-0281-y; Yang RQ, 2011, MOL CELL BIOL, V31, P542, DOI 10.1128/MCB.01162-10; Yoo DY, 2015, NEUROL RES, V37, P69, DOI 10.1179/1743132814Y.0000000416; You JJ, 2010, J BIOL CHEM, V285, P11652, DOI 10.1074/jbc.M109.051094; Zha QQ, 2008, J NEUROCHEM, V105, P68, DOI 10.1111/j.1471-4159.2007.05110.x; Zhang BL, 2007, BIOCHEM BIOPH RES CO, V356, P536, DOI 10.1016/j.bbrc.2007.02.160; Zhang C, 1999, J NEUROCHEM, V73, P1650, DOI 10.1046/j.1471-4159.1999.0731650.x; Zhang DM, 1998, J NEUROSCI, V18, P3314; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhou Yun, 2013, Front Endocrinol (Lausanne), V4, P165, DOI 10.3389/fendo.2013.00165; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	208	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128174	10.1371/journal.pone.0128174	http://dx.doi.org/10.1371/journal.pone.0128174			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011637	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900201
J	Srinivasan, PP; Parajuli, A; Price, C; Wang, LY; Duncan, RL; Kirn-Safran, CB				Srinivasan, Padma P.; Parajuli, Ashutosh; Price, Christopher; Wang, Liyun; Duncan, Randall L.; Kirn-Safran, Catherine B.			Inhibition of T-Type Voltage Sensitive Calcium Channel Reduces Load-Induced OA in Mice and Suppresses the Catabolic Effect of Bone Mechanical Stress on Chondrocytes	PLOS ONE			English	Article							SUBCHONDRAL BONE; FLUID-FLOW; CARTILAGE DEGENERATION; MC3T3-E1 OSTEOBLASTS; ARTICULAR-CARTILAGE; CA2+ CHANNELS; SHEAR-STRESS; ION-CHANNEL; IN-VIVO; OSTEOARTHRITIS	Voltage-sensitive calcium channels (VSCC) regulate cellular calcium influx, one of the earliest responses to mechanical stimulation in osteoblasts. Here, we postulate that T-type VSCCs play an essential role in bone mechanical response to load and participate in events leading to the pathology of load-induced OA. Repetitive mechanical insult was used to induce OA in Ca(v)3.2 T-VSCC null and wild-type control mouse knees. Osteoblasts (MC3T3-E1) and chondrocytes were treated with a selective T-VSCC inhibitor and subjected to fluid shear stress to determine how blocking of T-VSCCs alters the expression profile of each cell type upon mechanical stimulation. Conditioned-media (CM) obtained from static and sheared MC3T3-E1 was used to assess the effect of osteoblast-derived factors on the chondrocyte phenotype. T-VSCC null knees exhibited significantly lower focal articular cartilage damage than age-matched controls. In vitro inhibition of T-VSCC significantly reduced the expression of both early and late mechanoresponsive genes in osteoblasts but had no effect on gene expression in chondrocytes. Furthermore, treatment of chondrocytes with CM obtained from sheared osteoblasts induced expression of markers of hypertrophy in chondrocytes and this was nearly abolished when osteoblasts were pre-treated with the T-VSCC-specific inhibitor. These results indicate that T-VSCC plays a role in signaling events associated with induction of OA and is essential to the release of osteoblast-derived factors that promote an early OA phenotype in chondrocytes. Further, these findings suggest that local inhibition of T-VSCC may serve as a therapy for blocking load-induced bone formation that results in cartilage degeneration.	[Srinivasan, Padma P.; Duncan, Randall L.; Kirn-Safran, Catherine B.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Parajuli, Ashutosh; Price, Christopher; Duncan, Randall L.; Kirn-Safran, Catherine B.] Univ Delaware, Biomed Engn Program, Newark, DE 19716 USA; [Wang, Liyun; Duncan, Randall L.] Univ Delaware, Dept Mech Engn, Newark, DE 19716 USA	University of Delaware; University of Delaware; University of Delaware	Kirn-Safran, CB (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	ckirn@udel.edu	Price, Christopher/I-4851-2018; Duncan, Randall/AAK-3888-2020; Kirn-Safran, Catherine/AAB-9089-2022	Duncan, Randall/0000-0001-5733-6603	National Institutes of Health (USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103333] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (USA): CBKS RLD LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed E, 2009, MOL MEMBR BIOL, V26, P146, DOI 10.1080/09687680802612721; Alford AI, 2003, BONE, V33, P64, DOI 10.1016/S8756-3282(03)00167-4; Bergink AP, 2005, BONE, V37, P446, DOI 10.1016/j.bone.2005.05.001; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; CATTERALL WA, 1995, ANNU REV BIOCHEM, V64, P493, DOI 10.1146/annurev.biochem.64.1.493; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Choi S, 2007, GENES BRAIN BEHAV, V6, P425, DOI 10.1111/j.1601-183X.2006.00268.x; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; D'Angelo M, 2000, J CELL BIOCHEM, V77, P678, DOI 10.1002/(SICI)1097-4644(20000615)77:4<678::AID-JCB15>3.3.CO;2-G; DUNCAN R, 1989, FEBS LETT, V251, P17, DOI 10.1016/0014-5793(89)81420-6; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Duncan RL, 1998, SEMIN NEPHROL, V18, P178; Genetos DC, 2005, J BONE MINER RES, V20, P41, DOI 10.1359/jbmr.041009; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Herman BC, 2010, BONE, V47, P766, DOI 10.1016/j.bone.2010.07.006; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; HUNG CT, 1995, CLIN ORTHOP RELAT R, P256; Hunter David J, 2003, Curr Rheumatol Rep, V5, P15, DOI 10.1007/s11926-003-0078-5; Kapur S, 2010, J BIOL CHEM, V285, P37607, DOI 10.1074/jbc.M110.169714; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Ko FC, 2013, ARTHRITIS RHEUM-US, V65, P1569, DOI 10.1002/art.37906; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Kronbergs A, 2011, THESIS U DELAWARE; Li JL, 2002, J BONE MINER RES, V17, P1795, DOI 10.1359/jbmr.2002.17.10.1795; Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474; Martel-Pelletier J, 2010, EKLEM HAST CERRAHISI, V21, P2; McDonald J.H., 2009, HDB BIOL STAT; Mohtai M, 1996, J ORTHOP RES, V14, P67, DOI 10.1002/jor.1100140112; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Ohba S, 2010, OSTEOARTHR CARTILAGE, V18, P1620, DOI 10.1016/j.joca.2010.09.006; Pan J, 2012, BONE, V51, P212, DOI 10.1016/j.bone.2011.11.030; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Poulet B, 2011, ARTHRITIS RHEUM-US, V63, P137, DOI 10.1002/art.27765; Prasadam I, 2010, ARTHRITIS RHEUM-US, V62, P1349, DOI 10.1002/art.27397; Price C, 2011, J BONE MINER RES, V26, P277, DOI 10.1002/jbmr.211; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Ryder KD, 2001, J BONE MINER RES, V16, P240, DOI 10.1359/jbmr.2001.16.2.240; Shao Y, 2005, DEV DYNAM, V234, P54, DOI 10.1002/dvdy.20517; Smalt R, 1997, AM J PHYSIOL-ENDOC M, V273, pE751, DOI 10.1152/ajpendo.1997.273.4.E751; Srinivasan PP, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024109; Suzuki T, 2013, BONE, V54, P172, DOI 10.1016/j.bone.2013.01.001; Tat SK, 2010, BEST PRACT RES CL RH, V24, P51, DOI 10.1016/j.berh.2009.08.004; Todorovic SM, 2011, BRIT J PHARMACOL, V163, P484, DOI 10.1111/j.1476-5381.2011.01256.x; Todorovic SM, 2001, MOL PHARMACOL, V60, P603; Truong LH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2101; Westacott C., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P507; Zhou XZ, 2010, J BIOMECH, V43, P1598, DOI 10.1016/j.jbiomech.2009.12.028	54	17	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127290	10.1371/journal.pone.0127290	http://dx.doi.org/10.1371/journal.pone.0127290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011709	Green Published, gold			2022-12-27	WOS:000355183900079
J	Szeto, CC; Kwan, BCH; Chow, KM; Kwok, JSS; Lai, KB; Cheng, PMS; Pang, WF; Ng, JKC; Chan, MHM; Lit, LCW; Leung, CB; Li, PKT				Szeto, Cheuk-Chun; Kwan, Bonnie Ching-Ha; Chow, Kai-Ming; Kwok, Jeffrey Sung-Shing; Lai, Ka-Bik; Cheng, Phyllis Mei-Shan; Pang, Wing-Fai; Ng, Jack Kit-Chung; Chan, Michael Ho-Ming; Lit, Lydia Choi-Wan; Leung, Chi-Bon; Li, Philip Kam-Tao			Circulating Bacterial-Derived DNA Fragment Level Is a Strong Predictor of Cardiovascular Disease in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SYSTEMIC INFLAMMATION; RENAL-FAILURE; ALL-CAUSE; ENDOTOXEMIA; ATHEROSCLEROSIS; MORTALITY; HEMODIALYSIS; ASSOCIATION; EPIDEMIOLOGY	Background Circulating bacterial DNA fragment is related to systemic inflammatory state in peritoneal dialysis (PD) patients. We hypothesize that plasma bacterial DNA level predicts cardiovascular events in new PD patients. Methods We measured plasma bacterial DNA level in 191 new PD patients, who were then followed for at least a year for the development of cardiovascular event, hospitalization, and patient survival. Results The average age was 59.3 +/- 11.8 years; plasma bacterial DNA level 34.9 +/- 1.5 cycles; average follow up 23.2 +/- 9.7 months. At 24 months, the event-free survival was 86.1%, 69.8%, 55.4% and 30.8% for plasma bacterial DNA level quartiles I, II, III and IV, respectively (p < 0.0001). After adjusting for confounders, plasma bacterial DNA level, baseline residual renal function and malnutrition-inflammation score were independent predictors of composite cardiovascular end-point; each doubling in plasma bacterial DNA level confers a 26.9% (95% confidence interval, 13.0 - 42.5%) excess in risk. Plasma bacterial DNA also correlated with the number of hospital admission (r = -0.379, p < 0.0001) and duration of hospitalization for cardiovascular reasons (r = -0.386, p < 0.0001). Plasma bacterial DNA level did not correlate with baseline arterial pulse wave velocity (PWV), but with the change in carotid-radial PWV in one year (r = -0.238, p = 0.005). Conclusions Circulating bacterial DNA fragment level is a strong predictor of cardiovascular event, need of hospitalization, as well as the progressive change in arterial stiffness in new PD patients.	[Szeto, Cheuk-Chun; Kwan, Bonnie Ching-Ha; Chow, Kai-Ming; Lai, Ka-Bik; Cheng, Phyllis Mei-Shan; Pang, Wing-Fai; Ng, Jack Kit-Chung; Leung, Chi-Bon; Li, Philip Kam-Tao] Chinese Univ Hong Kong, Prince Wales Hosp, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Kwok, Jeffrey Sung-Shing; Chan, Michael Ho-Ming; Lit, Lydia Choi-Wan] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Szeto, CC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	ccszeto@cuhk.edu.hk	Kwan, Bonnie/N-3463-2015; Ming, Chow Kai/Y-5568-2019; Ng, Jack KC/L-6473-2019; Szeto, Cheuk Chun/N-4954-2015; Li, Philip K. T./D-4051-2017	Kwan, Bonnie/0000-0001-6742-8480; Ming, Chow Kai/0000-0001-5310-5197; Ng, Jack KC/0000-0002-9549-9611; Szeto, Cheuk Chun/0000-0002-8898-8505; Chan, Michael/0000-0003-1949-1666	Baxter Extramural Grant program; Richard Yu Chinese University of Hong Kong (CUHK) PD Research Fund; CUHK research account [6901031]	Baxter Extramural Grant program; Richard Yu Chinese University of Hong Kong (CUHK) PD Research Fund; CUHK research account(Chinese University of Hong Kong)	This study was supported in part by the Baxter Extramural Grant program, the Richard Yu Chinese University of Hong Kong (CUHK) PD Research Fund, and CUHK research account 6901031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; Bossola M, 2009, CLIN J AM SOC NEPHRO, V4, P379, DOI 10.2215/CJN.03490708; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; de Almeida Duarte Joan Bosco, 2004, Urol Res, V32, P266; Dumea R, 2014, INT UROL NEPHROL, V46, P461, DOI 10.1007/s11255-013-0542-8; ENIA G, 1993, NEPHROL DIAL TRANSPL, V8, P1094; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Harrison LEA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040209; John SG, 2011, CLIN J AM SOC NEPHRO, V6, P2389, DOI 10.2215/CJN.11211210; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; KREDIET R T, 1986, Blood Purification, V4, P194, DOI 10.1159/000169445; Kwan BCH, 2013, NEPHRON CLIN PRACT, V123, P246, DOI 10.1159/000354714; Kwan BCH, 2013, NEPHROL DIAL TRANSPL, V28, P2139, DOI 10.1093/ndt/gft100; Levin A, 2003, SEMIN DIALYSIS, V16, P101, DOI 10.1046/j.1525-139X.2003.16025.x; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; NOE DA, 1991, J PHARM SCI, V80, P501, DOI 10.1002/jps.2600800520; Owen WF, 1998, KIDNEY INT, V54, P627, DOI 10.1046/j.1523-1755.1998.00032.x; Parikh NI, 2006, ARCH INTERN MED, V166, P1884, DOI 10.1001/archinte.166.17.1884; Peritoneal Dialysis Adequacy Work Group, 2001, AM J KIDNEY DIS, V37, pS65; Ramezani A, 2014, J AM SOC NEPHROL, V25, P657, DOI 10.1681/ASN.2013080905; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Selgas R, 1996, Perit Dial Int, V16 Suppl 1, pS215; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2002, NEPHROL DIAL TRANSPL, V17, P33, DOI 10.1093/ndt/17.suppl_8.33; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Szeto CC, 2000, KIDNEY INT, V58, P400, DOI 10.1046/j.1523-1755.2000.00179.x; Szeto CC, 2003, J AM SOC NEPHROL, V14, P2119, DOI 10.1097/01.ASN.0000080316.37254.7A; Szeto CC, 2003, NEPHROL DIAL TRANSPL, V18, P977, DOI 10.1093/ndt/gfg027; Szeto CC, 2008, CLIN J AM SOC NEPHRO, V3, P431, DOI 10.2215/CJN.03600807; Szeto CC, 2007, J AM SOC NEPHROL, V18, P1966, DOI 10.1681/ASN.2006101184; Szeto CC, 2007, NEPHROL DIAL TRANSPL, V22, P552, DOI 10.1093/ndt/gfl559; Szeto CC, 2012, AM J NEPHROL, V35, P127, DOI 10.1159/000335580; Szeto CC, 2010, PERITON DIALYSIS INT, V30, P178, DOI 10.3747/pdi.2008.00242; Tripepi G, 2005, J AM SOC NEPHROL, V16, pS83, DOI 10.1681/ASN.2004110972; Wang Angela Y-M, 2005, Curr Opin Investig Drugs, V6, P879; Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Yeun JY, 1997, AM J KIDNEY DIS, V30, P923, DOI 10.1016/S0272-6386(97)90105-0	40	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125162	10.1371/journal.pone.0125162	http://dx.doi.org/10.1371/journal.pone.0125162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010741	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900010
J	Wang, LM; Lu, HB; Brown, PL; Rea, W; Vaupel, B; Yang, YH; Stein, E; Shepard, PD				Wang, Leiming; Lu, Hanbing; Brown, P. Leon; Rea, William; Vaupel, Bruce; Yang, Yihong; Stein, Elliot; Shepard, Paul D.			Manganese-Enhanced MRI Reflects Both Activity-Independent and Activity-Dependent Uptake within the Rat Habenulomesencephalic Pathway	PLOS ONE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; RESONANCE-IMAGING MEMRI; HABENULO-INTERPEDUNCULAR PATHWAY; IN-VIVO; GLUTAMATE RECEPTORS; CALCIUM-CHANNELS; TRANSFERRIN RECEPTOR; CA2+ PERMEABILITY; NEURONAL-ACTIVITY; BRAIN ACTIVATION	Manganese-enhanced magnetic resonance imaging (MEMRI) is a powerful technique for assessing the functional connectivity of neurons within the central nervous system. Despite the widely held proposition that MEMRI signal is dependent on neuronal activity, few studies have directly tested this implicit hypothesis. In the present series of experiments, MnCl2 was injected into the habenula of urethane-anesthetized rats alone or in combination with drugs known to alter neuronal activity by modulating specific voltage-and/or ligand-gated ion channels. Continuous quantitative T1 mapping was used to measure Mn2+ accumulation in the interpeduncular nucleus, a midline structure in which efferents from the medial habenula terminate. Microinjection of MnCl2 into the habenular complex using a protocol that maintained spontaneous neuronal activity resulted in a time-dependent increase in MEMRI signal intensity in the interpeduncular nucleus consistent with fast axonal transport of Mn2+ between these structures. Co-injection of the excitatory amino-acid agonist AMPA, increased the Mn2+-enhanced signal intensity within the interpeduncular nucleus. AMPA-induced increases in MEMRI signal were attenuated by co-injection of either the sodium channel blocker, TTX, or broad-spectrum Ca2+ channel blocker, Ni2+, and were occluded in the presence of both channel blockers. However, neither Ni2+ nor TTX, alone or in combination, attenuated the increase in signal intensity following injection of Mn2+ into the habenula. These results support the premise that changes in neuronal excitability are reflected by corresponding changes in MEMRI signal intensity. However, they also suggest that basal rates of Mn2+ uptake by neurons in the medial habenula may also occur via activity-independent mechanisms.	[Wang, Leiming; Lu, Hanbing; Rea, William; Vaupel, Bruce; Yang, Yihong; Stein, Elliot] Natl Inst Drug Abuse, Neuroimaging Res Branch, IRP, Baltimore, MD 21224 USA; [Wang, Leiming; Brown, P. Leon; Shepard, Paul D.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21228 USA; [Wang, Leiming; Brown, P. Leon; Shepard, Paul D.] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Shepard, PD (corresponding author), Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21228 USA.	shepard.paul@gmail.com	Brown, P. Leon/ABD-6581-2021; Shepard, Paul/AAF-1533-2021	Brown, P. Leon/0000-0001-5778-3921	Intramural Research Program of the National Institute on Drug Abuse, NIDA Residential Research Support Services [N01DA-5-9909]; National Institute of Mental Health [MH-094489]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000597, ZIADA000545] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse, NIDA Residential Research Support Services; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the Intramural Research Program of the National Institute on Drug Abuse, NIDA Residential Research Support Services Contract N01DA-5-9909 and a grant from the National Institute of Mental Health (MH-094489).	Aoki I, 2002, MAGNET RESON MED, V48, P927, DOI 10.1002/mrm.10320; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; Bearer EL, 2007, NEUROIMAGE, V37, pS37, DOI 10.1016/j.neuroimage.2007.04.053; Bock NA, 2009, NMR BIOMED, V22, P730, DOI 10.1002/nbm.1384; Bowie D, 1998, J NEUROSCI, V18, P8175; Canals S, 2008, NEUROIMAGE, V40, P458, DOI 10.1016/j.neuroimage.2007.12.007; CONTESTABILE A, 1981, J COMP NEUROL, V196, P253; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; FORNASIERO D, 1987, INVEST RADIOL, V22, P322, DOI 10.1097/00004424-198704000-00008; Fowler JH, 2004, J CEREBR BLOOD F MET, V24, P1098, DOI 10.1097/01.WCB.0000138665.25305.7C; Fuchs RA, 2002, PSYCHOPHARMACOLOGY, V160, P425, DOI 10.1007/s00213-001-0997-7; Gao M, 2007, J NEUROSCI, V27, P5414, DOI 10.1523/JNEUROSCI.5347-06.2007; GARLAND JC, 1983, BRAIN RES, V263, P33, DOI 10.1016/0006-8993(83)91197-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gunter TE, 2013, NEUROTOXICOLOGY, V34, P118, DOI 10.1016/j.neuro.2012.10.018; Haacke E. M., 1999, MAGNETIC RESONANCE I; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; HERKENHAM M, 1981, BRAIN RES, V210, P461, DOI 10.1016/0006-8993(81)90927-6; HODES JE, 1985, ANESTHESIOLOGY, V63, P633, DOI 10.1097/00000542-198512000-00013; Hsu YH, 2007, BRAIN, V130, P3124, DOI 10.1093/brain/awm207; Inoue T, 2011, REV NEUROSCIENCE, V22, P675, DOI 10.1515/RNS.2011.048; Ito M, 1984, No To Shinkei, V36, P1191; Kaku T, 2003, JPN J PHYSIOL, V53, P165, DOI 10.2170/jjphysiol.53.165; KANG YS, 1984, INVEST RADIOL, V19, P399, DOI 10.1097/00004424-198409000-00012; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; KITA H, 1981, BRAIN RES, V205, P111, DOI 10.1016/0006-8993(81)90723-X; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; Leergaard TB, 2003, NEUROIMAGE, V20, P1591, DOI 10.1016/j.neuroimage.2003.07.009; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Lowe AS, 2008, NMR BIOMED, V21, P859, DOI 10.1002/nbm.1272; Lu HB, 2007, P NATL ACAD SCI USA, V104, P2489, DOI 10.1073/pnas.0606983104; MARCHAND ER, 1980, BRAIN RES, V193, P339; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MCQUEEN JK, 1984, BRAIN RES, V300, P19, DOI 10.1016/0006-8993(84)91336-2; MENDONCADIAS MH, 1983, SEMIN NUCL MED, V13, P364, DOI 10.1016/S0001-2998(83)80048-8; Moldovan N, 2013, BIOMETALS, V26, P179, DOI 10.1007/s10534-012-9605-z; Moos T, 1999, MOL BRAIN RES, V72, P231, DOI 10.1016/S0169-328X(99)00226-0; Moos T, 1998, J COMP NEUROL, V398, P420; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Paxinos G., 2007, THE RAT BRAIN IN STE; Paxinos G., 1986, THE RAT BRAIN IN STE; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Robertson SJ, 1999, J PHYSIOL-LONDON, V518, P539, DOI 10.1111/j.1469-7793.1999.0539p.x; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Sakhi K, 2014, J PHYSIOL-LONDON, V592, P5025, DOI 10.1113/jphysiol.2014.280065; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; SAVAKI HE, 1983, J COMP NEUROL, V213, P36, DOI 10.1002/cne.902130104; Shin WY, 2009, MAGN RESON MED, V61, P899, DOI 10.1002/mrm.21836; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2008, SCHIZOPHRENIA BULLET, V34, P7; SLOOT WN, 1994, BRAIN RES, V657, P124, DOI 10.1016/0006-8993(94)90959-8; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; SUZUKI S, 1989, P NATL ACAD SCI USA, V86, P7228, DOI 10.1073/pnas.86.18.7228; Swerdlow NR, 2002, BRAIN RES, V953, P246, DOI 10.1016/S0006-8993(02)03298-5; Takeda A, 1998, BRAIN RES BULL, V45, P149, DOI 10.1016/S0361-9230(97)00330-4; Watanabe T, 2006, MAGN RESON IMAGING, V24, P209, DOI 10.1016/j.mri.2005.10.034; Weng JC, 2007, NEUROIMAGE, V36, P1179, DOI 10.1016/j.neuroimage.2007.04.010; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Zhao H, 2005, NEUROSCIENCE, V132, P519, DOI 10.1016/j.neuroscience.2005.01.012	62	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127773	10.1371/journal.pone.0127773	http://dx.doi.org/10.1371/journal.pone.0127773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009889	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900142
J	Xu, Y; Hu, B; Alnajm, SS; Lu, Y; Huang, YX; Allen-Gipson, D; Cheng, F				Xu, Yan; Hu, Brian; Alnajm, Sammy S.; Lu, Yin; Huang, Yangxin; Allen-Gipson, Diane; Cheng, Feng			SEGEL: A Web Server for Visualization of Smoking Effects on Human Lung Gene Expression	PLOS ONE			English	Article							CIGARETTE-SMOKE; INTERLEUKIN-8 RELEASE; ALVEOLAR MACROPHAGES; ADENOSINE; RECEPTOR; OVEREXPRESSION; PATHOGENESIS; INFLAMMATION; ACTIVATION; EPITHELIUM	Cigarette smoking is a major cause of death worldwide resulting in over six million deaths per year. Cigarette smoke contains complex mixtures of chemicals that are harmful to nearly all organs of the human body, especially the lungs. Cigarette smoking is considered the major risk factor for many lung diseases, particularly chronic obstructive pulmonary diseases (COPD) and lung cancer. However, the underlying molecular mechanisms of smoking- induced lung injury associated with these lung diseases still remain largely unknown. Expression microarray techniques have been widely applied to detect the effects of smoking on gene expression in different human cells in the lungs. These projects have provided a lot of useful information for researchers to understand the potential molecular mechanism (s) of smoke-induced pathogenesis. However, a user-friendly web server that would allow scientists to fast query these data sets and compare the smoking effects on gene expression across different cells had not yet been established. For that reason, we have integrated eight public expression microarray data sets from trachea epithelial cells, large airway epithelial cells, small airway epithelial cells, and alveolar macrophage into an online web server called SEGEL (Smoking Effects on Gene Expression of Lung). Users can query gene expression patterns across these cells from smokers and nonsmokers by gene symbols, and find the effects of smoking on the gene expression of lungs from this web server. Sex difference in response to smoking is also shown. The relationship between the gene expression and cigarette smoking consumption were calculated and are shown in the server. The current version of SEGEL web server contains 42,400 annotated gene probe sets represented on the Affymetrix Human Genome U133 Plus 2.0 platform. SEGEL will be an invaluable resource for researchers interested in the effects of smoking on gene expression in the lungs. The server also provides useful information for drug development against smoking-related diseases. The SEGEL web server is available online at http://www.chengfeng.info/smoking_database.html.	[Xu, Yan; Hu, Brian; Lu, Yin; Allen-Gipson, Diane; Cheng, Feng] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA; [Alnajm, Sammy S.] Univ Cologne, Fac Math & Nat Sci, Dept Biol, D-50931 Cologne, Germany; [Huang, Yangxin; Cheng, Feng] Univ S Florida, Coll Publ Hlth, Dept Dept Epidemiol & Biostat, Tampa, FL USA; [Allen-Gipson, Diane] Univ S Florida, Coll Med, Div Allergy & Clin Immunol, Tampa, FL USA	State University System of Florida; University of South Florida; University of Cologne; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Cheng, F (corresponding author), Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA.	fcheng1@health.usf.edu	Cheng, Feng/A-9760-2009	Cheng, Feng/0000-0003-3619-8090; Allen-Gipson, Diane/0000-0001-6976-3960	University of South Florida (USF) System Internal Awards Program under USF Women's Health Collaborative Grant [0095058]	University of South Florida (USF) System Internal Awards Program under USF Women's Health Collaborative Grant	The project was supported by the University of South Florida (USF) System Internal Awards Program under USF Women's Health Collaborative Grant No. 0095058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beukers MW, 2000, MOL PHARMACOL, V58, P1349, DOI 10.1124/mol.58.6.1349; Carolan BJ, 2008, J IMMUNOL, V181, P5760, DOI 10.4049/jimmunol.181.8.5760; Caruso M, 2006, CURR OPIN PHARMACOL, V6, P251, DOI 10.1016/j.coph.2006.02.002; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; DUBAR V, 1993, EXP LUNG RES, V19, P345, DOI 10.3109/01902149309064351; Edwards R, 2004, BRIT MED J, V328, P217, DOI 10.1136/bmj.328.7433.217; Feoktistov I, 1997, PHARMACOL REV, V49, P381; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Johnson Bankole A, 2011, Front Psychiatry, V2, P2, DOI 10.3389/fpsyt.2011.00002; Kazeros A, 2008, AM J RESP CELL MOL, V39, P747, DOI 10.1165/rcmb.2007-0306OC; King Brian A, 2012, Am J Public Health, V102, pe93, DOI 10.2105/AJPH.2012.301002; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Poliska S, 2011, RESPIRATION, V81, P499, DOI 10.1159/000324297; Rennard SI, 1999, AM J RESP CRIT CARE, V160, pS12, DOI 10.1164/ajrccm.160.supplement_1.5; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Richter P, 2008, PUBLIC HEALTH REP, V123, P30, DOI 10.1177/003335490812300105; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; SHOJI S, 1995, CLIN SCI, V88, P337, DOI 10.1042/cs0880337; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; Spicuzza L, 2006, EUR J PHARMACOL, V533, P77, DOI 10.1016/j.ejphar.2005.12.056; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; Turetz ML, 2009, CTS-CLIN TRANSL SCI, V2, P260, DOI 10.1111/j.1752-8062.2009.00129.x; Vanni H, 2009, CHEST, V135, P1197, DOI 10.1378/chest.08-1024; Vogelmeier C, 2007, AM J RESP CRIT CARE, V175, P1217, DOI 10.1164/rccm.200703-513ED; Wang R, 2012, J IMMUNOL, V189, P2217, DOI 10.4049/jimmunol.1101895	34	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128326	10.1371/journal.pone.0128326	http://dx.doi.org/10.1371/journal.pone.0128326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010234	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900225
J	Su, S; Cassey, P; Vall-Llosera, M; Blackburn, TM				Su, Shan; Cassey, Phillip; Vall-Llosera, Miquel; Blackburn, Tim M.			Going Cheap: Determinants of Bird Price in the Taiwanese Pet Market	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; EXTINCTION RISK; GLOBAL TRADE; BODY-SIZE; PATTERNS; PATHWAYS; TRENDS; NONRANDOMNESS; ESTABLISHMENT; INVASIONS	Background International wildlife trade is the largest emerging source of vertebrate invasive alien species. In order to prevent invasions, it is essential to understand the mechanics of trade and, in particular, which traded species are most likely to be released or escape into the wild. A species' economic value is a key factor, because we expect cheaper species to be less assiduously secured against escaping, and more likely to be deliberately released. Here, we investigate determinants of the price of species in the Taiwanese bird trade. Taiwan is an international hub for bird trade, and several native species are threatened by alien bird species. Methodology We investigated the relationship between the traded species sale price in Taiwan and the species availability for trade (the number of birds for sale, geographic range size and their origin, conservation and CITES status) and traits (body size, coloration, song attractiveness). We used phylogenetic generalized least squares models, with multi-model inference, to assess the variables that are best related to the price of birds in the Taiwanese pet trade. Principal Findings / Conclusions We found that species available for sale in larger numbers, native to Taiwan, not globally endangered, and small-bodied are all relatively cheaper, as too are species lacking yellow coloration and without attractive songs. Our models of price revealed high levels of phylogenetic correlation, and hence that closely related species tended to be sold for similar prices. We suggest that, on the basis of price, native species are more likely to be deliberately or accidentally released than alien species. Nevertheless, our survey of bird shops recorded 160 species alien to Taiwan (7,631 individuals), several of which are for sale cheaply and in large numbers. Alien bird species in trade therefore present an ongoing, non-trivial invasion risk on the island.	[Su, Shan] Zool Soc London, Inst Zool, London NW1 4RY, England; [Su, Shan; Blackburn, Tim M.] UCL, Res Dept Genet Evolut & Environm, London, England; [Su, Shan; Cassey, Phillip; Vall-Llosera, Miquel; Blackburn, Tim M.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Blackburn, Tim M.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa	Zoological Society of London; University of London; University College London; University of Adelaide; Stellenbosch University	Su, S (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	su.shan@ioz.ac.uk	Blackburn, Tim M/A-7685-2011; Vall-llosera, Miquel/AAM-8895-2020; Blackburn, Tim/AAC-3144-2019	Vall-llosera, Miquel/0000-0003-2644-2643; Blackburn, Tim/0000-0003-0152-2663; Cassey, Phillip/0000-0002-2626-0172	Institute of Zoology, Zoological Society of London; Invasive Animals CRC	Institute of Zoology, Zoological Society of London; Invasive Animals CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	PC is an ARC Future Fellow (FT0991420). This study received financial support from Institute of Zoology, Zoological Society of London (zsl.org), and from the Invasive Animals CRC (to MV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoramoorthy G., 2009, J INT WILDL LAW POLI, V12, P190, DOI DOI 10.1080/13880290903202690; Agoramoorthy G, 2007, HUM ECOL, V35, P251, DOI 10.1007/s10745-006-9068-3; [Anonymous], 2014, R LANG ENV STAT COMP; Bennett P. M., 2002, OX ECOL EV; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Blackburn TM, 2007, DIVERS DISTRIB, V13, P519, DOI 10.1111/j.1472-4642.2007.00358.x; Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Blackburn TM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001850; Blackburn TM, 2014, ETHOLOGY, V120, P305, DOI 10.1111/eth.12211; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; BLACKBURN TM, 1995, J BIOGEOGR, V22, P7, DOI 10.2307/2846069; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; BLACKBURN TM, 1994, OIKOS, V69, P336, DOI 10.2307/3546157; Blackburn TM, 2001, J BIOGEOGR, V28, P927, DOI 10.1046/j.1365-2699.2001.00597.x; Bohning-Gaese K, 1999, EVOL ECOL RES, V1, P347; Brooks-Moizer F, 2009, ECOL SOC, V14; Bush ER, 2014, CONSERV BIOL, V28, P663, DOI 10.1111/cobi.12240; C-T Yao, 2007, 9603804 END SPEC RES; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P207, DOI 10.1890/070075; Cassey P, 2004, GLOBAL CHANGE BIOL, V10, P417, DOI 10.1111/j.1529-8817.2003.00748.x; Chen G-M., 2007, CHINA MEDIA RES, V3, P102; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Colunga-Garcia M., 2013, NeoBiota, P103; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Davis M. A., 2009, INVASION BIOL; Ding T-S, 2012, 2012 CWBF CHECKLIST; Dunning Jr JB, 1992, CRC HDB AVIAN BODY M; Edmunds K, 2011, ECOHEALTH, V8, P63, DOI 10.1007/s10393-011-0691-0; Environment and Animal Society of Taiwan, 2009, INV PRAYER AN REL TA; Environment and Animal Society of Taiwan, 2004, REP PRAYER AN TAIW S; Environment and Animal Society of Taiwan (EAST) & Kaohsiung Teacher's Association, 2004, PRACT PRAYER AN REL; Forster P, 2014, ECOHEALTH, V11, P15, DOI 10.1007/s10393-013-0887-6; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Frynta D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012568; Garcia-Diaz P, 2015, GLOBAL CHANGE BIOL, V21, P1078, DOI 10.1111/gcb.12790; Garrett Valery, 2008, CHINESE DRESS QING D; Gaston K.J., 1994, RARITY, P1; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; GASTON KJ, 1991, OIKOS, V61, P434, DOI 10.2307/3545251; GASTON KJ, 1994, ECOGRAPHY, V17, P198, DOI 10.1111/j.1600-0587.1994.tb00094.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; International Traffic Network, 1992, PERC CONS MAN WILD B; IUCN, 2013, IUCN RED LIST THREAT; Jepson P, 2005, ORYX, V39, P442, DOI 10.1017/S0030605305001110; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kellert StephenR., 1984, ADV ANIMAL WELFARE S, P177; Knegtering E, 2011, ENVIRON CONSERV, V38, P28, DOI 10.1017/S0376892910000755; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lee TW, 2005, ENDEM SPECIES RES, V7, P1; Li SH, 2010, J AVIAN BIOL, V41, P64, DOI 10.1111/j.1600-048X.2009.04719.x; Liskova S, 2013, ANTHROZOOS, V26, P27, DOI 10.2752/175303713X13534238631399; Lockwood J, 2001, BIOTIC HOMOGENIZATIO; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Low BW, 2014, EMU, V114, P277, DOI 10.1071/MU13094; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Nash SV, 1993, SOLD SONG TRADE SE A; Nuwer R, 2014, AUDUBON          JAN; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Robinson JM, 2001, ENVIRON CONSERV, V28, P76, DOI 10.1017/S0376892901000078; Severinghaus LL, 1999, BIOL CONSERV, V89, P301, DOI 10.1016/S0006-3207(98)00155-4; Severinghaus LL, 2007, J NATL PARK, V17, P27; Shepherd C.R., 2012, EXPORT REEXPORT CITE; Regueira RFS, 2012, BIOL CONSERV, V149, P16, DOI 10.1016/j.biocon.2012.02.009; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Soma I, 1997, HDB JAPAN US ENV BEH, P101; Su S, 2014, BIOL INVASIONS, V16, P2563, DOI 10.1007/s10530-014-0686-1; Tella JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107546; Webb TJ, 2007, J ANIM ECOL, V76, P123, DOI 10.1111/j.1365-2656.2006.01192.x; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Wilson LH, 1998, J AM VET MED ASSOC, V212, P1222; Worthley R., 1990, INT MARKET REV, V8, P21, DOI [10.1108/02651339110137279, DOI 10.1108/02651339110137279]; Young AM, 2012, ANIM CONSERV, V15, P28, DOI 10.1111/j.1469-1795.2011.00477.x; Zhang S., 2008, FRONT BIOL CHINA, V3, P308, DOI DOI 10.1007/S11515-008-0042-X	80	38	38	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127482	10.1371/journal.pone.0127482	http://dx.doi.org/10.1371/journal.pone.0127482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017386	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600084
J	Yen, CY; Chiang, WF; Liu, SY; Lin, CC; Liao, KA; Lin, CY; Hsieh, WF; Cheng, YC; Hsu, KC; Lin, PY; Chen, TC; Lee, IL; Lin, MH; Liu, YC				Yen, Ching-Yu; Chiang, Wei-Fan; Liu, Shyun-Yeu; Lin, Chung-Chih; Liao, Kuo-An; Lin, Che-Yi; Hsieh, Wan-Fang; Cheng, Yon-Chi; Hsu, Kai-Cheng; Lin, Pin-Yen; Chen, Tai-Chi; Lee, I-Ling; Lin, Mei-Huei; Liu, Young-Chau			Impacts of Autophagy-Inducing Ingredient of Areca Nut on Tumor Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BECLIN 1-INDEPENDENT AUTOPHAGY; 30-100 KDA FRACTION; SIGNALING PATHWAY; CROSS-TALK; AMPK; CANCER; INDUCTION; ARECOLINE; APOPTOSIS	Areca nut (AN) is a popular carcinogen used by about 0.6-1.2 billion people worldwide. Although AN contains apoptosis-inducing ingredients, we previously demonstrated that both AN extract (ANE) and its 30-100 kDa fraction (ANE 30-100K) predominantly induce autophagic cell death in both normal and malignant cells. In this study, we further explored the action mechanism of ANE 30-100K-induced autophagy (AIA) in Jurkat T lymphocytes and carcinoma cell lines including OECM-1 (mouth), CE81T/VGH (esophagus), SCC25 (tongue), and SCC-15 (tongue). The results showed that chemical-and small hairpin RNA (shRNA)-mediated inhibition of AMP-activated protein kinase (AMPK) resulted in the attenuation of AIA in Jurkat T but not in OECM-1 cells. Knockdown of Atg5 and Beclin 1 expressions ameliorated AIA in OECM-1/CE81T/VGH/Jurkat T and OECM-1/SCC25/SCC-15, respectively. Furthermore, ANE 30-100K could activate caspase-3 after inhibition of Beclin 1 expression in OECM-1/SCC25/SCC15 cells. Meanwhile, AMPK was demonstrated to be the upstream activator of the extracellular-regulated kinase (ERK) in Jurkat T cells, and inhibition of MEK attenuated AIA in Jurkat T/OECM-1/CE81T/VGH cells. Finally, we also found that multiple myeloma RPMI8226, lymphoma U937, and SCC15 cells survived from long-term non-cytotoxic ANE 30-100K treatment exhibited stronger resistance against serum deprivation through upregulated autophagy. Collectively, our studies indicate that Beclin-1 and Atg5 but not AMPK are commonly required for AIA, and MEK/ERK pathway is involved in AIA. Meanwhile, it is also suggested that long-term AN usage might increase the resistance of survived tumor cells against serum-limited conditions.	[Yen, Ching-Yu; Liu, Shyun-Yeu] Taipei Med Univ, Dept Dent, Taipei, Taiwan; [Yen, Ching-Yu; Liu, Shyun-Yeu] Natl Def Med Ctr, Dept Dent, Taipei, Taiwan; [Yen, Ching-Yu; Liu, Shyun-Yeu] Chi Mei Med Ctr, Oral & Maxillofacial Surg Sect, Tainan, Taiwan; [Chiang, Wei-Fan; Liao, Kuo-An; Lin, Che-Yi; Lee, I-Ling] Chi Mei Hosp, Oral & Maxillofacial Surg Sect, Liouying, Taiwan; [Chiang, Wei-Fan] Natl Yang Ming Univ, Sch Dent, Taipei 112, Taiwan; [Lin, Chung-Chih] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lin, Che-Yi] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Hsieh, Wan-Fang; Cheng, Yon-Chi; Hsu, Kai-Cheng; Lin, Pin-Yen; Lin, Mei-Huei] Chia Nan Univ Pharm, Dept Biotechnol, Tainan, Taiwan; [Hsieh, Wan-Fang; Cheng, Yon-Chi; Hsu, Kai-Cheng; Lin, Pin-Yen; Chen, Tai-Chi; Lin, Mei-Huei; Liu, Young-Chau] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Liu, Young-Chau] Shu Te Univ, Coll Liberal Educ, Div Nat Sci, Kaohsiung, Taiwan	Taipei Medical University; National Defense Medical Center; Chi Mei Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Shu-Te University	Lin, MH (corresponding author), Chia Nan Univ Pharm, Dept Biotechnol, Tainan, Taiwan.	mhlin3224@mail.cnu.edu.tw; god15539@stu.edu.tw	Yen, Ching Yu/A-2771-2013; Chiang, Wei-Fan/L-6537-2019	Chiang, Wei-Fan/0000-0002-9240-1404	Ministry of Science and Technology [NSC98-2314-B384-002-MY3, NSC98-2314-B041-002, NSC99-2314-B-041-002, NSC101-2320-B-366-001, NSC102-2314-B-041-001-MY3]; Chi Mei Medical Center [CMFHR9903, CMFHR9936, CMFHR9948, CMFHR10051, CMFHR10055, CMFHR10159, CMFHR10203, CMFHR10209, CMFHR10307, CMFHR10301]; Chi Mei Hospital [CLFHR10107, CLFHR10223]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chi Mei Medical Center; Chi Mei Hospital	This study is supported by grants from Ministry of Science and Technology (previously named: National Science Council) (NSC98-2314-B384-002-MY3, NSC98-2314-B041-002, NSC99-2314-B-041-002, NSC101-2320-B-366-001, and NSC102-2314-B-041-001-MY3), Chi Mei Medical Center (CMFHR9903, CMFHR9936, CMFHR9948, CMFHR10051, CMFHR10055, CMFHR10159, CMFHR10203, CMFHR10209, CMFHR10307, and CMFHR10301), and Chi Mei Hospital (CLFHR10107 and CLFHR10223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Chen YB, 2012, J SURG ONCOL, V105, P542, DOI 10.1002/jso.22151; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Damm E, 2012, MOL ENDOCRINOL, V26, P643, DOI 10.1210/me.2011-1218; Gao P, 2010, J BIOL CHEM, V285, P25570, DOI 10.1074/jbc.M110.118125; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Gillis JM, 2011, TRAFFIC, V12, P1897, DOI 10.1111/j.1600-0854.2011.01270.x; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Honda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5004; Hwang SL, 2013, BRIT J PHARMACOL, V169, P69, DOI 10.1111/bph.12124; Juenemann Katrin, 2012, Int J Cell Biol, V2012, P189794, DOI 10.1155/2012/189794; Kayampilly PP, 2012, ENDOCRINOLOGY, V153, P2831, DOI 10.1210/en.2011-1967; Kim MJ, 2010, J BIOL CHEM, V285, P14617, DOI 10.1074/jbc.M109.085456; Klionsky DJ, 2014, AUTOPHAGY, V10, P715, DOI 10.4161/auto.28813; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Lee PH, 2006, TOXICOLOGY, V220, P81, DOI 10.1016/j.tox.2005.07.026; Lin HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060516; Lin MH, 2008, AUTOPHAGY, V4, P967, DOI 10.4161/auto.6821; Lin MH, 2010, ORAL ONCOL, V46, P822, DOI 10.1016/j.oraloncology.2010.08.002; Liu CY, 2013, BIOMED REP, V1, P855, DOI 10.3892/br.2013.171; Liu SY, 2008, J BIOMED SCI, V15, P823, DOI 10.1007/s11373-008-9273-8; Liu XN, 2014, MOL CANCER THER, V13, P596, DOI 10.1158/1535-7163.MCT-13-0579; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Seo G, 2011, FREE RADICAL RES, V45, P389, DOI 10.3109/10715762.2010.535530; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Sid B, 2014, BIOCHEM PHARMACOL, V91, P168, DOI 10.1016/j.bcp.2014.07.010; Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53; Steele S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003562; Tian SH, 2010, AUTOPHAGY, V6, P1032, DOI 10.4161/auto.6.8.13336; Wang CC, 2009, TOXICOL IN VITRO, V23, P1234, DOI 10.1016/j.tiv.2009.07.033; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Williams T, 2009, AUTOPHAGY, V5, P1155, DOI 10.4161/auto.5.8.10090; Wu XY, 2013, TUMOR BIOL, V34, P713, DOI 10.1007/s13277-012-0599-5; Yen CY, 2014, J ORAL PATHOL MED, V43, P91, DOI 10.1111/jop.12102; Yen CY, 2011, ORAL ONCOL, V47, P345, DOI 10.1016/j.oraloncology.2011.02.014; Yeung ED, 2012, PROSTATE, V72, P165, DOI 10.1002/pros.21417; Zhou WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080338; Zhu BL, 2012, J VIROL, V86, P12003, DOI 10.1128/JVI.01434-12	47	9	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128011	10.1371/journal.pone.0128011	http://dx.doi.org/10.1371/journal.pone.0128011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017803	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600107
J	Austin, KG; Kasibhatla, PS; Urban, DL; Stolle, F; Vincent, J				Austin, Kemen G.; Kasibhatla, Prasad S.; Urban, Dean L.; Stolle, Fred; Vincent, Jeffrey			Reconciling Oil Palm Expansion and Climate Change Mitigation in Kalimantan, Indonesia	PLOS ONE			English	Article							AGRICULTURAL LAND; TROPICAL REGIONS; DEFORESTATION; EMISSIONS; PERFORMANCE; REGRESSION; FORESTS; DEMAND; MODELS; MAP	Our society faces the pressing challenge of increasing agricultural production while minimizing negative consequences on ecosystems and the global climate. Indonesia, which has pledged to reduce greenhouse gas (GHG) emissions from deforestation while doubling production of several major agricultural commodities, exemplifies this challenge. Here we focus on palm oil, the world's most abundant vegetable oil and a commodity that has contributed significantly to Indonesia's economy. Most oil palm expansion in the country has occurred at the expense of forests, resulting in significant GHG emissions. We examine the extent to which land management policies can resolve the apparently conflicting goals of oil palm expansion and GHG mitigation in Kalimantan, a major oil palm growing region of Indonesia. Using a logistic regression model to predict the locations of new oil palm between 2010 and 2020 we evaluate the impacts of six alternative policy scenarios on future emissions. We estimate net emissions of 128.4-211.4 MtCO(2) yr(-1) under business as usual expansion of oil palm plantations. The impact of diverting new plantations to low carbon stock land depends on the design of the policy. We estimate that emissions can be reduced by 9-10% by extending the current moratorium on new concessions in primary forests and peat lands, 35% by limiting expansion on all peat and forestlands, 46% by limiting expansion to areas with moderate carbon stocks, and 55-60% by limiting expansion to areas with low carbon stocks. Our results suggest that these policies would reduce oil palm profits only moderately but would vary greatly in terms of cost-effectiveness of emissions reductions. We conclude that a carefully designed and implemented oil palm expansion plan can contribute significantly towards Indonesia's national emissions mitigation goal, while allowing oil palm area to double.	[Austin, Kemen G.; Kasibhatla, Prasad S.; Urban, Dean L.; Vincent, Jeffrey] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Stolle, Fred] World Resources Inst, Washington, DC 20006 USA	Duke University	Austin, KG (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	kemen.austin@duke.edu	Austin, Kemen G/AFL-1822-2022	Austin, Kemen G/0000-0002-7690-8774; Kasibhatla, Prasad/0000-0003-3562-3737	National Science Foundation [DGE-1106401]	National Science Foundation(National Science Foundation (NSF))	KGA is supported by the National Science Foundation's Graduate Research Fellowship Program (DGE-1106401 http://www.nsfgrfp.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abood SA, 2015, CONSERV LETT, V8, P58, DOI 10.1111/conl.12103; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2014, 2006 IPCC GUIDELIN S; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2013, OIL PALM LAND USE CH; Atmadja S, 2012, MITIG ADAPT STRAT GL, V17, P311, DOI 10.1007/s11027-011-9328-4; Austin Kemen., 2014, INDONESIAS FOREST MO; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; BPS, 2011, IND OIL PALM STAT; Butler R., 2015, PALM OIL MAJOR MAKES; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Chatterjee S., 2012, REGRESSION ANAL EXAM; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Dewi S., 2009, WORLD AGROFOR CENT I; DNPI and Government of Central Kalimantan, 2010, CREAT LOW C IN PRESS; DNPI and Government of East Kalimantan, 2011, E KAL ENV S IN PRESS; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; FARZIN YH, 1984, J POLIT ECON, V92, P841, DOI 10.1086/261261; Ferreira S, 2010, ENVIRON RESOUR ECON, V47, P241, DOI 10.1007/s10640-010-9374-5; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gingold B, 2012, IDENTIFY DEGRADED LA, P1; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Harris N.L., 2013, PROJECTIONS OIL PALM; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hartley CWS, 1967, OIL PALM, V3rd; Hertel TW, 2011, AM J AGR ECON, V93, P259, DOI 10.1093/ajae/aaq189; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Intergovernmental Panel on Climate Change (IPCC), 2014, CLIM CHANG 2014; Intergovernmental Panel on Climate Change (IPCC), 2006, 2006 IPCC GUIDELINES, V4; Koh LP, 2010, SPATIALLY EXPLICIT S, V107; Lee JSH, 2014, CONSERV LETT, V7, P25, DOI 10.1111/conl.12039; Mantel S, 2007, BIOPHYSICAL LAND SUI; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Maulia E, 2010, INDONESIA PLEDGES FE; McCarthy J, 2010, LAW POLICY, V32; McConnell WJ, 2004, AGR ECOSYST ENVIRON, V101, P171, DOI 10.1016/j.agee.2003.09.012; Ministry of Forestry, 2010, PERK AGR PLANT; Ministry of Forestry, 2013, IND MAP SUSP NEW LIC; Ministry of Forestry, 2010, LEG CLASS MAPS PROV; Minnemeyer S, 2009, INTERACTIVE ATLAS IN; Murdiyarso Daniel., 2011, INDONESIAS FOREST MO; Obidinski K, 2012, ECOLOGY SOC, V17; Page S. E., 2011, REV PEAT SURFACE GRE; Paoli G. D., 2013, OIL PALM INDONESIA G; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Peters J.A.H.W, 2012, TRENDS GLOBAL CO2 EM; R Core Team, 2012, R LANG ENV STAT COMP; Ramdani F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070323; RePPProT, 1990, REG PHYS PLANN PROGR; Rist L, 2010, BIODIVERS CONSERV, V19, P1009, DOI 10.1007/s10531-010-9815-z; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Schrier-Uijl A.P., 2013, ENV SOCIAL IMPACTS O; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sloan S, 2012, CONSERV LETT, V5, P222, DOI 10.1111/j.1755-263X.2012.00233.x; Stolle F, 2003, ENVIRON CONSERV, V30, P375, DOI 10.1017/S0376892903000390; Sukuwan S, 2012, CARBON ASSESSMENT TO; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; UKP4, 2012, REDD NAT STRAT; UNEP/GRID-Arendal, 2011, AR QUAL PROT IND LAW; USDA, 2014, OILS WORLD MARK TRAD; USDA, 2009, COMM INT REP IND PAL; USGS, 2004, SHUTTL RAD TOP MISS; Wetlands International, 2004, MAPS PEAT LAND DISTR; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th	69	39	39	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127963	10.1371/journal.pone.0127963	http://dx.doi.org/10.1371/journal.pone.0127963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011182	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900173
J	Bi, HS; Guo, ZH; Benfield, MC; Fan, CL; Ford, M; Shahrestani, S; Sieracki, JM				Bi, Hongsheng; Guo, Zhenhua; Benfield, Mark C.; Fan, Chunlei; Ford, Michael; Shahrestani, Suzan; Sieracki, Jeffery M.			A Semi-Automated Image Analysis Procedure for In Situ Plankton Imaging Systems	PLOS ONE			English	Article							CLASSIFICATION; RECOGNITION; ENUMERATION; RESOLUTION; ABUNDANCE; TIME; NET	Plankton imaging systems are capable of providing fine-scale observations that enhance our understanding of key physical and biological processes. However, processing the large volumes of data collected by imaging systems remains a major obstacle for their employment, and existing approaches are designed either for images acquired under laboratory controlled conditions or within clear waters. In the present study, we developed a semi-automated approach to analyze plankton taxa from images acquired by the ZOOplankton VISualization (ZOOVIS) system within turbid estuarine waters, in Chesapeake Bay. When compared to images under laboratory controlled conditions or clear waters, images from highly turbid waters are often of relatively low quality and more variable, due to the large amount of objects and nonlinear illumination within each image. We first customized a segmentation procedure to locate objects within each image and extracted them for classification. A maximally stable extremal regions algorithm was applied to segment large gelatinous zooplankton and an adaptive threshold approach was developed to segment small organisms, such as copepods. Unlike the existing approaches for images acquired from laboratory, controlled conditions or clear waters, the target objects are often the majority class, and the classification can be treated as a multi-class classification problem. We customized a two-level hierarchical classification procedure using support vector machines to classify the target objects (< 5%), and remove the non-target objects (> 95%). First, histograms of oriented gradients feature descriptors were constructed for the segmented objects. In the first step all non-target and target objects were classified into different groups: arrow-like, copepod-like, and gelatinous zooplankton. Each object was passed to a group-specific classifier to remove most non-target objects. After the object was classified, an expert or non-expert then manually removed the non-target objects that could not be removed by the procedure. The procedure was tested on 89,419 images collected in Chesapeake Bay, and results were consistent with visual counts with > 80% accuracy for all three groups.	[Bi, Hongsheng; Shahrestani, Suzan] Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA; [Guo, Zhenhua] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Broadband Network & Multimedia, Shenzhen 518057, Peoples R China; [Benfield, Mark C.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Fan, Chunlei] Morgan State Univ, Dept Biol, Patuxent Environm & Aquat Res Lab, St Leonard, MD 20685 USA; [Ford, Michael] Natl Ocean & Atmospher Adm, Silver Spring, MD 20910 USA; [Sieracki, Jeffery M.] SR2 Grp LLC, Laurel, MD 20707 USA	University System of Maryland; University of Maryland Center for Environmental Science; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Louisiana State University System; Louisiana State University; Morgan State University; National Oceanic Atmospheric Admin (NOAA) - USA	Bi, HS (corresponding author), Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA.	hbi@cbl.umces.edu	Bi, Hongsheng/B-9409-2012; /AAD-1578-2020	Bi, Hongsheng/0000-0003-2595-6271; 	North Pacific Research Board [1419]; BP Exploration and Production Company	North Pacific Research Board; BP Exploration and Production Company	This research was funded by the North Pacific Research Board (project no. 1419). Development of ZOOVIS was supported by a grant from BP Exploration and Production Company to LSU. SR2 Group LLC provided support in the form of salaries for author JMS, but neither the funder or SR2 Group LLC had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Babbar R, 2013, ADV NEUR IN, V26, P1824; Batuwita R, 2013, IMBALANCED LEARNING: FOUNDATIONS, ALGORITHMS, AND APPLICATIONS, P83; Benfield MC, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.63; Benfield MC, 1996, DEEP-SEA RES PT II, V43, P1925, DOI 10.1016/S0967-0645(96)00044-6; Bhutada GG, 2011, DIGIT SIGNAL PROCESS, V21, P118, DOI 10.1016/j.dsp.2010.09.002; Bi HS, 2013, J PLANKTON RES, V35, P270, DOI 10.1093/plankt/fbs094; Buskey EJ, 2006, HARMFUL ALGAE, V5, P685, DOI 10.1016/j.hal.2006.02.003; Chang CY, 2012, CONT SHELF RES, V36, P19, DOI 10.1016/j.csr.2012.01.005; Cowen RK, 2008, LIMNOL OCEANOGR-METH, V6, P126, DOI 10.4319/lom.2008.6.126; Culverhouse PF, 1996, MAR ECOL PROG SER, V139, P281, DOI 10.3354/meps139281; Culverhouse PF, 2003, MAR ECOL PROG SER, V247, P17, DOI 10.3354/meps247017; Culverhouse PF, 2006, MAR ECOL PROG SER, V312, P297, DOI 10.3354/meps312297; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Davis CS, 1996, DEEP-SEA RES PT II, V43, P1947, DOI 10.1016/S0967-0645(96)00051-3; Fefilatyev S., 2011, 2011 IEEE International Conference on Data Mining Workshops, P741, DOI 10.1109/ICDMW.2011.65; Gorsky G, 2002, J MARINE SYST, V33, P289, DOI 10.1016/S0924-7963(02)00063-5; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Grosjean P, 2004, ICES J MAR SCI, V61, P518, DOI 10.1016/j.icesjms.2004.03.012; Hu Q, 2006, MAR ECOL PROG SER, V306, P51, DOI 10.3354/meps306051; Hu Q, 2005, MAR ECOL PROG SER, V295, P21, DOI 10.3354/meps295021; Kohavi R., 1998, MACH LEARN, V30-2, P271, DOI [DOI 10.1023/A:1017181826899, 10.1023/A:1017181826899]; Luo T, 2005, J MACH LEARN RES, V6, P589; Luo T, 2004, IEEE T SYST MAN CY B, V34, P1753, DOI 10.1109/TSMCB.2004.830340; Luo T, 2003, IEEE SYS MAN CYBERN, P888; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Matas J., 2002, Electronic Proceedings of the 13th British Machine Vision Conference, P384; Nister D, 2008, LECT NOTES COMPUT SC, V5303, P183, DOI 10.1007/978-3-540-88688-4_14; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Panetta K, 2011, IEEE T SYST MAN CY B, V41, P460, DOI 10.1109/TSMCB.2010.2058847; Pang YW, 2011, SIGNAL PROCESS, V91, P773, DOI 10.1016/j.sigpro.2010.08.010; Picheral M, 2010, LIMNOL OCEANOGR-METH, V8, P462, DOI 10.4319/lom.2010.8.462; Samson S, 2001, IEEE J OCEANIC ENG, V26, P671, DOI 10.1109/48.972110; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Schulz J, 2010, J EUR OPT SOC-RAPID, V5, DOI 10.2971/jeos.2010.10017s; Shapiro L., 2001, COMPUTER VISION; Sieracki CK, 1998, MAR ECOL PROG SER, V168, P285, DOI 10.3354/meps168285; Trevorrow MV, 2005, J ACOUST SOC AM, V117, P3574, DOI 10.1121/1.1920087; Vapnik V., 2013, NATURE STAT LAERNING; Vapnik V., 1998, STAT LEARNING THEORY; Wiebe PH, 2003, PROG OCEANOGR, V56, P7, DOI 10.1016/S0079-6611(02)00140-4; Ye L, 2011, MAR ECOL PROG SER, V441, P185, DOI 10.3354/meps09387; Zhu XJ, 2013, OPT LETT, V38, P275, DOI 10.1364/OL.38.000275	42	34	35	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127121	10.1371/journal.pone.0127121	http://dx.doi.org/10.1371/journal.pone.0127121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010260	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900065
J	Buck, AKW; Ding, ZH; Elder, CP; Towse, TF; Damon, BM				Buck, Amanda K. W.; Ding, Zhaohua; Elder, Christopher P.; Towse, Theodore F.; Damon, Bruce M.			Anisotropic Smoothing Improves DT-MRI-Based Muscle Fiber Tractography	PLOS ONE			English	Article							AXONAL PROJECTIONS; SKELETAL-MUSCLE; DIFFUSION; NOISE; TRACKING; BRAIN; ARCHITECTURE; IMAGES	Purpose To assess the effect of anisotropic smoothing on fiber tracking measures, including pennation angle, fiber tract length, and fiber tract number in the medial gastrocnemius (MG) muscle in healthy subjects using diffusion-weighted magnetic resonance imaging (DW-MRI). Materials and Methods 3T DW-MRI data were used for muscle fiber tractography in the MG of healthy subjects. Anisotropic smoothing was applied at three levels (5%, 10%, 15%), and pennation angle, tract length, fiber tract number, fractional anisotropy, and principal eigenvector orientation were quantified for each smoothing level. Results Fiber tract length increased with pre-fiber tracking smoothing, and local heterogeneities in fiber direction were reduced. However, pennation angle was not affected by smoothing. Conclusion Modest anisotropic smoothing (10%) improved fiber-tracking results, while preserving structural features.	[Buck, Amanda K. W.; Ding, Zhaohua; Elder, Christopher P.; Towse, Theodore F.; Damon, Bruce M.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Buck, Amanda K. W.; Ding, Zhaohua; Elder, Christopher P.; Towse, Theodore F.; Damon, Bruce M.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Buck, Amanda K. W.; Ding, Zhaohua; Damon, Bruce M.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Ding, Zhaohua] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA; [Towse, Theodore F.] Vanderbilt Univ, Dept Phys Med & Rehabil, Nashville, TN 37235 USA; [Damon, Bruce M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Damon, BM (corresponding author), Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	bruce.m.damon@vanderbilt.edu	Buck, Amanda Kathleen Wake/GYK-0734-2022; Ding, Zhaohua/AHC-7551-2022	Ding, Zhaohua/0000-0002-1805-2955; Buck, Amanda/0000-0003-1042-6374	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR050101]; National Institutes of Health; National Center for Research Resources [2 ULI TR000445-06]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001628] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	AKWB, ZD, CPE, TFT, and BMD received support from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases; www.niams.nih.gov; R01 AR050101. TFT received support from the National Institutes of Health; National Center for Research Resources; www.nih.gov; 2 ULI TR000445-06	Alexander R.M., 1975, J HUMAN MOVEMENT STU, V1, P115; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Basser PJ, 2000, MAGNET RESON MED, V44, P41, DOI 10.1002/1522-2594(200007)44:1<41::AID-MRM8>3.0.CO;2-O; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Damon BM, 2008, MAGN RESON MED, V60, P934, DOI 10.1002/mrm.21707; Damon BM, 2012, MAGN RESON IMAGING, V30, P589, DOI 10.1016/j.mri.2012.02.003; Ding ZH, 2005, MAGN RESON MED, V53, P485, DOI 10.1002/mrm.20339; Englund EK, 2011, AM J PHYSIOL-REG I, V300, pR1079, DOI 10.1152/ajpregu.00474.2010; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; Froeling M, 2013, NMR BIOMED, V26, P1339, DOI 10.1002/nbm.2959; Haldar JP, 2013, MAGN RESON MED, V69, P277, DOI 10.1002/mrm.24229; Heemskerk AM, 2005, MAGNET RESON MED, V53, P1333, DOI 10.1002/mrm.20476; Koay CG, 2006, J MAGN RESON, V182, P115, DOI 10.1016/j.jmr.2006.06.020; Lansdown DA, 2007, J APPL PHYSIOL, V103, P673, DOI 10.1152/japplphysiol.00290.2007; Lohmann G, 2010, MAGN RESON MED, V64, P15, DOI 10.1002/mrm.22488; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Moraschi M, 2010, J MAGN RESON IMAGING, V31, P690, DOI 10.1002/jmri.22040; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Nagy Z, 2008, MAGN RESON MED, V60, P1256, DOI 10.1002/mrm.21746; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Sinha U, 2011, J APPL PHYSIOL, V110, P807, DOI 10.1152/japplphysiol.00923.2010; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Xu Q, 2010, MAGN RESON IMAGING, V28, P200, DOI 10.1016/j.mri.2009.10.001; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	28	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126953	10.1371/journal.pone.0126953	http://dx.doi.org/10.1371/journal.pone.0126953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010830	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900051
J	Cunniff, B; Newick, K; Nelson, KJ; Wozniak, AN; Beuschel, S; Leavitt, B; Bhave, A; Butnor, K; Koenig, A; Chouchani, ET; James, AM; Haynes, AC; Lowther, WT; Murphy, MP; Shukla, A; Heintz, NH				Cunniff, Brian; Newick, Kheng; Nelson, Kimberly J.; Wozniak, Alexandra N.; Beuschel, Stacie; Leavitt, Bruce; Bhave, Anant; Butnor, Kelly; Koenig, Andreas; Chouchani, Edward T.; James, Andrew M.; Haynes, Alexina C.; Lowther, W. Todd; Murphy, Michael P.; Shukla, Arti; Heintz, Nicholas H.			Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma	PLOS ONE			English	Article							OXIDATIVE STRESS; CANCER-CELLS; ANTIOXIDANT DEFENSE; MELANOMA-CELLS; COMPLEX-I; THIOSTREPTON; FOXM1; EXPRESSION; REDUCTASE; TUMOR	Dysregulation of signaling pathways and energy metabolism in cancer cells enhances production of mitochondrial hydrogen peroxide that supports tumorigenesis through multiple mechanisms. To counteract the adverse effects of mitochondrial peroxide many solid tumor types up-regulate the mitochondrial thioredoxin reductase 2-thioredoxin 2 (TRX2)-peroxiredoxin 3 (PRX3) antioxidant network. Using malignant mesothelioma cells as a model, we show that thiostrepton (TS) irreversibly disables PRX3 via covalent crosslinking of peroxidatic and resolving cysteine residues in homodimers, and that targeting the oxidoreductase TRX2 with the triphenylmethane gentian violet (GV) potentiates adduction by increasing levels of disulfide-bonded PRX3 dimers. Due to the fact that activity of the PRX3 catalytic cycle dictates the rate of adduction by TS, immortalized and primary human mesothelial cells are significantly less sensitive to both compounds. Moreover, stable knockdown of PRX3 reduces mesothelioma cell proliferation and sensitivity to TS. Expression of catalase in shPRX3 mesothelioma cells restores defects in cell proliferation but not sensitivity to TS. In a SCID mouse xenograft model of human mesothelioma, administration of TS and GV together reduced tumor burden more effectively than either agent alone. Because increased production of mitochondrial hydrogen peroxide is a common phenotype of malignant cells, and TS and GV are well tolerated in mammals, we propose that targeting PRX3 is a feasible redox-dependent strategy for managing mesothelioma and other intractable human malignancies.	[Cunniff, Brian; Wozniak, Alexandra N.; Beuschel, Stacie; Butnor, Kelly; Shukla, Arti; Heintz, Nicholas H.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Newick, Kheng] Univ Penn, Sch Med, Div Pulm, Thorac Oncol Res Lab, Philadelphia, PA 19147 USA; [Nelson, Kimberly J.; Haynes, Alexina C.; Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Leavitt, Bruce] Univ Vermont, Coll Med, Dept Surg, Burlington, VT 05405 USA; [Bhave, Anant] Univ Vermont, Coll Med, Dept Radiol, Burlington, VT 05405 USA; [Koenig, Andreas] Univ Vermont, Dept Immunol Med, Burlington, VT 05405 USA; [Chouchani, Edward T.; James, Andrew M.; Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Chouchani, Edward T.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	University of Vermont; University of Pennsylvania; Wake Forest University; University of Vermont; University of Vermont; University of Vermont; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Cunniff, B (corresponding author), Univ Vermont, Coll Med, Dept Pathol, 149 Beaumont Ave, Burlington, VT 05405 USA.	Nicholas.Heintz@uvm.edu	James, Andrew M/A-2639-2015; Chouchani, Edward T./HCH-3775-2022; Murphy, Michael/C-2120-2009	James, Andrew M/0000-0002-0515-9649; Nelson, Kimberly/0000-0003-2464-7696; Murphy, Michael/0000-0003-1115-9618	National Institute of General Medical Sciences of the National Institutes of Health [P20GM103449]; Mini-Fellowship from the Society for Free Radical Biology and Medicine; UVM Department of Pathology; NIEHS [T32 ES 007122]; National Institutes of Health [GM072866, GM050389]; Comprehensive Cancer Center of Wake Forest University [NCI CCSG P30CA012197]; Vermont Cancer Center; Gates Cambridge Trust; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021110, T32ES007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449, R01GM050389, R01GM072866] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Mini-Fellowship from the Society for Free Radical Biology and Medicine; UVM Department of Pathology; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center of Wake Forest University; Vermont Cancer Center; Gates Cambridge Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	UVM Proteomics facility supported by the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103449 provided technical assistance. Nicole Bishop and Doug Taatjes of the UVM Microscopy Imaging Center provided technical expertise for IHC of tumor sections. The Advanced Genomic Technologies Center of the Vermont Cancer Center performed the quantitative RT-PCR. BC was supported for work at the MRC, Cambridge in MM's lab by a Mini-Fellowship from the Society for Free Radical Biology and Medicine, and a graduate fellowship from the UVM Department of Pathology. KN was supported by a training grant in Environmental Pathology from the NIEHS (T32 ES 007122). Studies by WTL and KJN were supported in part by grants from the National Institutes of Health (GM072866, GM050389) and the Comprehensive Cancer Center of Wake Forest University (NCI CCSG P30CA012197). ESI-TOF-MS analysis was performed by Cristina Furdui, Julie Reisz Haines and Nelmi Devarie Baez at Wake Forest School of Medicine. Studies by NHH were supported by a 40 pilot project award from the Vermont Cancer Center. ETC was supported by the Gates Cambridge Trust (doctoral scholarship) and the Canadian Institutes of Health Research (postdoctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON WS, 1976, ACCOUNTS CHEM RES, V9, P293, DOI 10.1021/ar50104a003; Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; Bausch SL, 2005, J BIOL CHEM, V280, P29956, DOI 10.1074/jbc.M504182200; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Bowling BD, 2008, CANCER CHEMOTH PHARM, V63, P37, DOI 10.1007/s00280-008-0705-y; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; Chan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052578; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chappell J. B., 1972, SUBCELLULAR COMPONEN; Cheng CW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.204; Chiu ML, 1996, BIOCHEMISTRY-US, V35, P2332, DOI 10.1021/bi952073e; Chua PJ, 2010, INT J ONCOL, V36, P359, DOI 10.3892/ijo_00000507; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Cunniff B, 2014, REDOX BIOL, V3, P79, DOI 10.1016/j.redox.2014.11.003; Cunniff B, 2014, REDOX BIOL, V2, P475, DOI 10.1016/j.redox.2014.01.021; Cunniff B, 2013, ANAL BIOCHEM, V443, P34, DOI 10.1016/j.ab.2013.08.013; Cunniff B, 2013, J CELL PHYSIOL, V228, P835, DOI 10.1002/jcp.24232; Diers AR, 2010, BIOCHEM J, V426, P31, DOI 10.1042/BJ20091293; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x; Friedman M, 1977, Adv Exp Med Biol, V86B, P213; FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x; Gartel AL, 2010, EXPERT OPIN INV DRUG, V19, P235, DOI 10.1517/13543780903563364; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Ho JCM, 2001, CANCER RES, V61, P8578; Hurd TR, 2007, J BIOL CHEM, V282, P22040, DOI 10.1074/jbc.M703591200; Jonsson TJ, 2009, J BIOL CHEM, V284, P33305, DOI 10.1074/jbc.M109.036400; Jones DP, 2010, J INTERN MED, V268, P432, DOI 10.1111/j.1365-2796.2010.02268.x; Karihtala P, 2003, CLIN CANCER RES, V9, P3418; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Newick K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039404; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Qiao SX, 2012, BIOCHEM PHARMACOL, V83, P1229, DOI 10.1016/j.bcp.2012.01.027; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Song IS, 2011, INT J MOL SCI, V12, P7163, DOI 10.3390/ijms12107163; Ummanni R, 2012, J PROTEOME RES, V11, P2452, DOI 10.1021/pr201172n; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang M, 2012, CELL CYCLE, V11, P3370, DOI 10.4161/cc.21290; Wang M, 2011, MOL CANCER THER, V10, P2287, DOI 10.1158/1535-7163.MCT-11-0536; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; WENNER CE, 1956, J BIOL CHEM, V222, P399; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xiang XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014640; Younis IR, 2008, J PHARMACOL EXP THER, V327, P770, DOI 10.1124/jpet.108.142208; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zhang L, 2005, FEBS LETT, V579, P6423, DOI 10.1016/j.febslet.2005.09.103; Zhang X, 2011, FREE RADICAL BIO MED, V50, P811, DOI 10.1016/j.freeradbiomed.2010.12.036; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	70	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127310	10.1371/journal.pone.0127310	http://dx.doi.org/10.1371/journal.pone.0127310			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011724	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900080
J	Guo, HY; Chamberlain, SA; Elhaik, E; Jalli, I; Lynes, AR; Marczak, L; Sabath, N; Vargas, A; Wieski, K; Zelig, EM; Pennings, SC				Guo, Hongyu; Chamberlain, Scott A.; Elhaik, Eran; Jalli, Inder; Lynes, Alana-Rose; Marczak, Laurie; Sabath, Niv; Vargas, Amy; Wieski, Kazimierz; Zelig, Emily M.; Pennings, Steven C.			Geographic Variation in Plant Community Structure of Salt Marshes: Species, Functional and Phylogenetic Perspectives	PLOS ONE			English	Article							DISTANCE-DECAY; BETA-DIVERSITY; FRESH-WATER; SIMILARITY; ECOLOGY; HETEROGENEITY; MAINTENANCE; DISPERSAL; INSIGHTS; ZONATION	In general, community similarity is thought to decay with distance; however, this view may be complicated by the relative roles of different ecological processes at different geographical scales, and by the compositional perspective (e.g. species, functional group and phylogenetic lineage) used. Coastal salt marshes are widely distributed worldwide, but no studies have explicitly examined variation in salt marsh plant community composition across geographical scales, and from species, functional and phylogenetic perspectives. Based on studies in other ecosystems, we hypothesized that, in coastal salt marshes, community turnover would be more rapid at local versus larger geographical scales; and that community turnover patterns would diverge among compositional perspectives, with a greater distance decay at the species level than at the functional or phylogenetic levels. We tested these hypotheses in salt marshes of two regions: The southern Atlantic and Gulf Coasts of the United States. We examined the characteristics of plant community composition at each salt marsh site, how community similarity decayed with distance within individual salt marshes versus among sites in each region, and how community similarity differed among regions, using species, functional and phylogenetic perspectives. We found that results from the three compositional perspectives generally showed similar patterns: there was strong variation in community composition within individual salt marsh sites across elevation; in contrast, community similarity decayed with distance four to five orders of magnitude more slowly across sites within each region. Overall, community dissimilarity of salt marshes was lowest on the southern Atlantic Coast, intermediate on the Gulf Coast, and highest between the two regions. Our results indicated that local gradients are relatively more important than regional processes in structuring coastal salt marsh communities. Our results also suggested that in ecosystems with low species diversity, functional and phylogenetic approaches may not provide additional insight over a species-based approach.	[Guo, Hongyu; Elhaik, Eran; Jalli, Inder; Lynes, Alana-Rose; Marczak, Laurie; Sabath, Niv; Vargas, Amy; Wieski, Kazimierz; Zelig, Emily M.; Pennings, Steven C.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Chamberlain, Scott A.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA	University of Houston System; University of Houston; Rice University	Pennings, SC (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	spennings@uh.edu	Elhaik, Eran/H-6838-2019; Pennings, Steven C/A-8326-2013	Elhaik, Eran/0000-0003-4795-1084; Pennings, Steven C/0000-0003-4757-7125; Marczak, Laurie/0000-0001-5979-4261	Environmental Institute of Houston; NSF [OCE06-20959, OCE12-37140, EF-0553768]; University of California, Santa Barbara; State of California; Division Of Ocean Sciences [1237140] Funding Source: National Science Foundation	Environmental Institute of Houston; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors thank the Environmental Institute of Houston and the NSF (OCE06-20959; OCE12-37140) for funding. This work resulted from a Distributed Graduate Seminar (Ushering in a New Era of Functional Ecology: Dynamics in a Changing Environment), conducted through the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (EF-0553768), the University of California, Santa Barbara, and the State of California.	Adam P., 1990, SALTMARSH ECOLOGY; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Bahram M, 2013, J ECOL, V101, P1335, DOI 10.1111/1365-2745.12120; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; BERTNESS MD, 1991, ECOLOGY, V72, P138, DOI 10.2307/1938909; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; BERTNESS MD, 1991, ECOLOGY, V72, P125, DOI 10.2307/1938908; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chapman VJ, 1960, SALT MARSHES SALT DE; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Duckworth JC, 2000, PROG PHYS GEOG, V24, P515, DOI 10.1177/030913330002400403; ELEUTERIUS L N, 1976, Chesapeake Science, V17, P289, DOI 10.2307/1350516; ELEUTERIUS LN, 1979, B MAR SCI, V29, P394; Epstein HE, 2001, OIKOS, V95, P239, DOI 10.1034/j.1600-0706.2001.950206.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Garcillan PP, 2003, J VEG SCI, V14, P859, DOI 10.1111/j.1654-1103.2003.tb02219.x; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hubbell Stephen P., 2001, V32, pi; Judd FW, 2004, TEX J SCI, V56, P103; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kunza AE, 2008, ESTUAR COAST, V31, P673, DOI 10.1007/s12237-008-9058-3; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Morlon H, 2008, ECOL LETT, V11, P904, DOI 10.1111/j.1461-0248.2008.01202.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Pavoine S, 2013, J VEG SCI, V24, P781, DOI 10.1111/jvs.12051; Pennings SC, 2005, J ECOL, V93, P159, DOI 10.1111/j.1365-2745.2004.00959.x; Pennings SC, 2001, MARINE COMMUNITY ECOLOGY, P289; Purschke O, 2013, J ECOL, V101, P857, DOI 10.1111/1365-2745.12098; Rajaniemi TK, 2006, ECOL LETT, V9, P121, DOI 10.1111/j.1461-0248.2005.00855.x; Rasser MK, 2013, WETLANDS, V33, P575, DOI 10.1007/s13157-013-0398-9; Rowe N, 2005, NEW PHYTOL, V166, P61, DOI 10.1111/j.1469-8137.2004.01309.x; Stout J.P., 1984, US FISH WILDLIFE SER; Suchrow S, 2010, WETLANDS, V30, P735, DOI 10.1007/s13157-010-0073-3; Sullivan G, 1999, OIKOS, V84, P246, DOI 10.2307/3546719; Tessier M, 2002, J VEG SCI, V13, P115, DOI 10.1658/1100-9233(2002)013[0115:TROSTH]2.0.CO;2; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; USDA [ US Department of Agriculture], 2014, THE PLANTS DAT; VivianSmith G, 1997, J ECOL, V85, P71, DOI 10.2307/2960628; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiegert RG, 1990, US FISH WILDLIFE SER, V85, P1; ZETLER BD, 1970, B MAR SCI, V20, P57	51	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127781	10.1371/journal.pone.0127781	http://dx.doi.org/10.1371/journal.pone.0127781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010135	Green Accepted, Green Published, gold			2022-12-27	WOS:000355183900144
J	Gururani, MA; Venkatesh, J; Ganesan, M; Strasser, RJ; Han, Y; Kim, JI; Lee, HY; Song, PS				Gururani, Mayank Anand; Venkatesh, Jelli; Ganesan, Markkandan; Strasser, Reto Joerg; Han, Yunjeong; Kim, Jeong-Il; Lee, Hyo-Yeon; Song, Pill-Soon			In Vivo Assessment of Cold Tolerance through Chlorophyll-a Fluorescence in Transgenic Zoysiagrass Expressing Mutant Phytochrome A	PLOS ONE			English	Article							ABIOTIC STRESS TOLERANCE; ELECTRON-TRANSPORT; CHILLING TOLERANCE; HYDROGEN-PEROXIDE; FREEZING TOLERANCE; OXIDATIVE STRESS; SALINITY STRESS; SALICYLIC-ACID; LIGHT-QUALITY; POTATO PLANTS	Chlorophyll-a fluorescence analysis provides relevant information about the physiology of plants growing under abiotic stress. In this study, we evaluated the influence of cold stress on the photosynthetic machinery of transgenic turfgrass, Zoysia japonica, expressing oat phytochrome A (PhyA) or a hyperactive mutant phytochrome A (S599A) with post-translational phosphorylation blocked. Biochemical analysis of zoysiagrass subjected to cold stress revealed reduced levels of hydrogen peroxide, increased proline accumulation, and enhanced specific activities of antioxidant enzymes compared to those of control plants. Detailed analyses of the chlorophyll-a fluorescence data through the so-called OJIP test exhibited a marked difference in the physiological status among transgenic and control plants. Overall, these findings suggest an enhanced level of cold tolerance in S599A zoysiagrass cultivars as reflected in the biochemical and physiological analyses. Further, we propose that chlorophyll-a fluorescence analysis using OJIP test is an efficient tool in determining the physiological status of plants under cold stress conditions.	[Gururani, Mayank Anand; Ganesan, Markkandan; Lee, Hyo-Yeon; Song, Pill-Soon] Jeju Natl Univ, Fac Biotechnol, Subtrop Hort Res Inst, Jeju 690756, South Korea; [Venkatesh, Jelli] Konkuk Univ, Dept Mol Biotechnol, Seoul 143701, South Korea; [Ganesan, Markkandan] Presidency Univ, Dept Biol Sci, Kolkata 700073, W Bengal, India; [Strasser, Reto Joerg] Univ Geneva, Bioenerget Lab, CH-1254 Geneva, Switzerland; [Han, Yunjeong; Kim, Jeong-Il] Chonnam Natl Univ, Dept Biotechnol, Gwangju 500757, South Korea; [Han, Yunjeong; Kim, Jeong-Il] Chonnam Natl Univ, Kumho Life Sci Lab, Gwangju 500757, South Korea; [Gururani, Mayank Anand] Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, Gyeongbook, South Korea	Jeju National University; Konkuk University; Presidency University, Kolkata; University of Geneva; Chonnam National University; Chonnam National University; Yeungnam University	Song, PS (corresponding author), Jeju Natl Univ, Fac Biotechnol, Subtrop Hort Res Inst, Jeju 690756, South Korea.	pssong@gmail.com	Venkatesh, Jelli/E-7887-2018; Venkatesh, Jelli/O-8942-2019; Gururani, Mayank/E-9978-2012	Venkatesh, Jelli/0000-0002-8896-0385; Venkatesh, Jelli/0000-0002-8896-0385; Gururani, Mayank/0000-0003-4254-6450; Markkandan, Ganesan/0000-0002-3402-9747	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education (NRF) [2012R1A1A2000706, 2009-0094059, PJ00949101]; Science and Technology, Next-Generation Biogreen 21 Program, Rural Development Administration, Korea [PJ009499012014]; Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea [309017-5]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education (NRF); Science and Technology, Next-Generation Biogreen 21 Program, Rural Development Administration, Korea; Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF Grant No. 2012R1A1A2000706 to PSS, 2009-0094059, PJ00949101), Science and Technology, Next-Generation Biogreen 21 Program, Rural Development Administration, Korea (Grant No. PJ009499012014), and by the Technology Development Program for Agriculture and Forestry, Ministry for Agriculture, Forestry and Fisheries, Republic of Korea (to J.-I Kim, grant no. 309017-5).	Agati G, 1996, J PLANT PHYSIOL, V148, P384, DOI 10.1016/S0176-1617(96)80270-7; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bae TW, 2008, J ENVIRON QUAL, V37, P207, DOI 10.2134/jeq2007.0128; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; Camejo D, 2010, J HORTIC SCI BIOTECH, V85, P137, DOI 10.1080/14620316.2010.11512644; Cheeseman JM, 2006, J EXP BOT, V57, P2435, DOI 10.1093/jxb/erl004; Chen LS, 2009, PHOTOSYNTHETICA, V47, P112, DOI 10.1007/s11099-009-0017-4; Chen LS, 2009, ENVIRON EXP BOT, V66, P110, DOI 10.1016/j.envexpbot.2008.12.017; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; Dechaine JM, 2009, PLANT CELL ENVIRON, V32, P1297, DOI 10.1111/j.1365-3040.2009.01998.x; Donohue K, 2008, NEW PHYTOL, V177, P367, DOI 10.1111/j.1469-8137.2007.02281.x; Elavarthi S, 2010, METHODS MOL BIOL, V639, P273, DOI 10.1007/978-1-60761-702-0_16; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Franklin KA, 2007, NAT GENET, V39, P1410, DOI 10.1038/ng.2007.3; Ganesan M, 2012, PLANTA, V236, P1135, DOI 10.1007/s00425-012-1662-6; Goltsev V, 2012, BBA-BIOENERGETICS, V1817, P1490, DOI 10.1016/j.bbabio.2012.04.018; Govindjee, 2004, ADV PHOTOSYNTH RESP, V19, P1; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Govindjee, 2010, ENCY LIFE SCI ELS; Gururani MA, 2016, J PLANT GROWTH REGUL, V35, P11, DOI 10.1007/s00344-015-9502-0; Gururani MA, 2015, BIOTECHNOL ADV, V33, P53, DOI 10.1016/j.biotechadv.2014.12.005; Gururani MA, 2013, J PLANT GROWTH REGUL, V32, P245, DOI 10.1007/s00344-012-9292-6; Gururani MA, 2013, PLANT SCI, V198, P7, DOI 10.1016/j.plantsci.2012.09.014; Gururani MA, 2012, PLANT PHYSIOL BIOCH, V58, P182, DOI 10.1016/j.plaphy.2012.07.003; Heschel MS, 2007, NEW PHYTOL, V174, P735, DOI 10.1111/j.1469-8137.2007.02044.x; HUANG J, 2009, J PLANT PHYSL, V389, P556, DOI DOI 10.1016/J.BBRC.2009.09.032; Kautsky H., 1931, NATURWISSENSCHAFTEN, V19, P964, DOI [DOI 10.1007/BF01516164, 10.1007/BF01516164]; Kim J, 2004, PLANT CELL, V16, P2629, DOI 10.1105/tpc.104.023879; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kruger GHJ, 2014, S AFR J BOT, V95, P85, DOI 10.1016/j.sajb.2014.07.010; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mora-Herrera ME, 2005, PHYSIOL PLANTARUM, V125, P430, DOI 10.1111/j.1399-3054.2005.00572.x; OKane D, 1996, PLANTA, V198, P371, DOI 10.1007/BF00620053; PAILLOTIN G, 1976, J THEOR BIOL, V58, P237, DOI 10.1016/0022-5193(76)90150-8; Papageorgiou GC, 2014, ADV PHOTOSYNTH RESP, V40, P1, DOI 10.1007/978-94-017-9032-1_1; Qian YL, 2000, CROP SCI, V40, P488, DOI 10.2135/cropsci2000.402488x; Ranjan S, 2014, PLANT PHYSIOL BIOCH, V79, P48, DOI 10.1016/j.plaphy.2014.03.007; Redondo-Gomez S., 2013, MOL STRESS PHYSL PLA, P1; Rochaix JD, 2011, BBA-BIOENERGETICS, V1807, P375, DOI 10.1016/j.bbabio.2010.11.010; Schansker G, 2014, PHOTOSYNTH RES, V120, P43, DOI 10.1007/s11120-013-9806-5; Stirbet A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P291, DOI 10.1134/S0006297914040014; Stirbet A, 2012, PHOTOSYNTH RES, V113, P15, DOI 10.1007/s11120-012-9754-5; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser R.J., 1981, PHOTOSYNTHESIS STRUC, P727; Strasser R.J., 2000, PROBING PHOTOSYNTHES, P445; Strasser R.J., 2001, CHIMIE NOUVELLE SRC, V75, P3321; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; STRASSER RJ, 1992, NATO ADV SCI I A-LIF, V226, P423; Strauss AJ, 2006, ENVIRON EXP BOT, V56, P147, DOI 10.1016/j.envexpbot.2005.01.011; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Toth SZ, 2011, PLANT PHYSIOL, V156, P382, DOI 10.1104/pp.110.171918; Upadhyaya CP, 2011, BIOTECHNOL LETT, V33, P2297, DOI 10.1007/s10529-011-0684-7; Venkatesh J, 2012, HORTIC ENVIRON BIOTE, V53, P320, DOI 10.1007/s13580-012-0035-1; Wang Y, 2009, BIOL PLANTARUM, V53, P179, DOI 10.1007/s10535-009-0030-2; Warnke S., 2003, TURFGRASS BIOL GENET, P175; Yan BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080770; Yusuf MA, 2010, BBA-BIOENERGETICS, V1797, P1428, DOI 10.1016/j.bbabio.2010.02.002; Zhou J, 2012, PLANT PHYSIOL BIOCH, V60, P141, DOI 10.1016/j.plaphy.2012.07.010; Zivcak M, 2014, J PHOTOCH PHOTOBIO B, V137, P107, DOI 10.1016/j.jphotobiol.2014.01.007; Zivcak M, 2014, PHOTOSYNTH RES, V119, P339, DOI 10.1007/s11120-014-9969-8; Zurek G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091475; Zushi K, 2012, SCI HORTIC-AMSTERDAM, V148, P39, DOI 10.1016/j.scienta.2012.09.022	69	51	53	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127200	10.1371/journal.pone.0127200	http://dx.doi.org/10.1371/journal.pone.0127200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010864	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900071
J	Huan, YJ; Xie, BT; Liu, SC; Kong, QR; Liu, ZH				Huan, Yanjun; Xie, Bingteng; Liu, Shichao; Kong, Qingran; Liu, Zhonghua			A Novel Role for DNA Methyltransferase 1 in Regulating Oocyte Cytoplasmic Maturation in Pigs	PLOS ONE			English	Article							IN-VITRO MATURATION; DEVELOPMENTAL COMPETENCE; PREIMPLANTATION DEVELOPMENT; DNA METHYLTRANSFERASE-1; EMBRYONIC LETHALITY; DNMT1; LOCALIZATION; CELLS; METHYLATION; EXPRESSION	Maternal factors are required for oocyte maturation and embryo development. To better understand the role of DNA methyltransferase 1 (Dnmt1) in oocyte maturation and embryo development, small interfering RNA (siRNA) was conducted in porcine oocytes. In this study, our results showed that Dnmt1 localized in oocyte cytoplasm and its expression displayed no obvious change during oocyte maturation. When siRNAs targeting Dnmt1 were injected into germinal vesicle (GV) stage oocytes, Dnmt1 transcripts significantly decreased in matured oocytes (P<0.05). After Dnmt1 knockdown in GV stage oocytes, the significant reduction of glutathione content, mitochondrial DNA copy number, glucose-6-phosphate dehydrogenase activity and expression profiles of maternal factors and the severely disrupted distribution of cortical granules were observed in MII stage oocytes (P<0.05), leading to the impaired oocyte cytoplasm. Further study displayed that Dnmt1 knockdown in GV stage oocytes significantly reduced the development of early embryos generated through parthenogenetic activation, in vitro fertilization and somatic cell nuclear transfer (P< 0.05). In conclusion, Dnmt1 was indispensable for oocyte cytoplasmic maturation, providing a novel role for Dnmt1 in the regulation of oocyte maturation.	[Huan, Yanjun; Xie, Bingteng; Liu, Shichao; Kong, Qingran; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China; [Huan, Yanjun] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Shandong, Peoples R China	Northeast Agricultural University - China; Shandong Academy of Agricultural Sciences	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China.	liu086@126.com	Liu, Shichao/J-2954-2019; Liu, Zhonghua/AAO-3590-2021; Liu, Zhunghua/F-2485-2010	Liu, Shichao/0000-0002-4156-3876; Liu, Zhonghua/0000-0002-9199-6493; Liu, Zhunghua/0000-0002-9199-6493; , Yanjun/0000-0001-7334-4582	National Basic Research Program of China, Program 973 [2011CB944202]; National Natural Science Foundation of China, NSFC [31101035]; China Postdoctoral Science Foundation [2014M551943]; special foundation of Postdoctoral Innovation Project in Shandong Province of China [201402044]	National Basic Research Program of China, Program 973(National Basic Research Program of China); National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); special foundation of Postdoctoral Innovation Project in Shandong Province of China	National Basic Research Program of China, Program 973 (2011CB944202) to ZHL, http://www.most.gov.cn/; National Natural Science Foundation of China, NSFC (31101035) to ZHL, http://www.nsfc.gov.cn/; China Postdoctoral Science Foundation (2014M551943) to YJH, http://bg.chinapostdoctor.org.cn/; the special foundation of Postdoctoral Innovation Project in Shandong Province of China (201402044) to YJH, http://www.sdhrss.gov.cn/cm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Brevini TAL, 2007, ANIM REPROD SCI, V98, P23, DOI 10.1016/j.anireprosci.2006.10.018; Choi JY, 2013, J REPROD DEVELOP, V59, P450, DOI 10.1262/jrd.2012-134; Georgia S, 2013, GENE DEV, V27, P372, DOI 10.1101/gad.207001.112; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Huan YJ, 2012, AGR SCI TECHNOLOGY, V13, P1368; Jeong YS, 2009, DEV DYNAM, V238, P1666, DOI 10.1002/dvdy.21975; Laget S, 2014, EPIGENETICS-US, V9, P546, DOI 10.4161/epi.27695; Lee SK, 2014, J REPROD DEVELOP, V60, P128, DOI 10.1262/jrd.2013-098; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin SB, 2014, NAT CELL BIOL, V16, P129, DOI 10.1038/ncb2914; Lodde V, 2009, EUR J HISTOCHEM, V53, P199, DOI 10.4081/ejh.2009.e24; Luberda Zofia, 2005, Reprod Biol, V5, P5; Martin SE, 2007, ANNU REV GENOM HUM G, V8, P81, DOI 10.1146/annurev.genom.8.080706.092424; McGraw S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003873; Oliveri RS, 2007, REPRODUCTION, V134, P549, DOI 10.1530/REP-06-0315; Petrussa L, 2014, MOL HUM REPROD, V20, P861, DOI 10.1093/molehr/gau049; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Watson AJ, 2007, J ANIM SCI, V85, pE1, DOI 10.2527/jas.2006-432; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020154; Yamanaka K, 2011, J REPROD DEVELOP, V57, P393, DOI 10.1262/jrd.10-181A; Zhang X, 2010, J ANIM SCI, V88, P2604, DOI 10.2527/jas.2009-2714; Zhou P, 2010, BIOL REPROD, V82, P759, DOI 10.1095/biolreprod.109.082206; Zuccotti M, 2011, HUM REPROD UPDATE, V17, P525, DOI 10.1093/humupd/dmr009	29	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127512	10.1371/journal.pone.0127512	http://dx.doi.org/10.1371/journal.pone.0127512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009894	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900102
J	Salloum-Asfar, S; Boelen, A; Reitsma, PH; van Vlijmen, BJM				Salloum-Asfar, Salam; Boelen, Anita; Reitsma, Pieter H.; van Vlijmen, Bart J. M.			The Immediate and Late Effects of Thyroid Hormone (Triiodothyronine) on Murine Coagulation Gene Transcription	PLOS ONE			English	Article							IN-VIVO; MICE; EXPRESSION; BETA; ANTAGONISTS; MODULATION; DISORDERS; PROTEINS; BINDING; LIVER	Thyroid dysfunction is associated with changes in coagulation. The aim of our study was to gain more insight into the role of thyroid hormone in coagulation control. C57Black/6J mice received a low-iodine diet and drinking water supplemented with perchlorate to suppress endogenous triiodothyronine (T-3) and thyroxine (T-4) production. Under these conditions, the impact of exogenous T-3 on plasma coagulation, and hepatic and vessel-wall-associated coagulation gene transcription was studied in a short-(4 hours) and long-term (14 days) setting. Comparing euthyroid conditions (normal mice), with hypothyroidism (conditions of a shortage of thyroid hormone) and those with replacement by incremental doses of T3, dosages of 0 and 0.5 mu g T-3/mouse/day were selected to study the impact of T-3 on coagulation gene transcription. Under these conditions, a single injection of T-3 injection increased strongly hepatic transcript levels of the well-characterized T-3-responsive genes deiodinase type 1 (Dio1) and Spot14 within 4 hours. This coincided with significantly reduced mRNA levels of Fgg, Serpinc1, Proc, Proz, and Serpin10, and the reduction of the latter three persisted upon daily treatment with T-3 for 14 days. Prolonged T-3 treatment induced a significant down-regulation in factor (F) 2, F9 and F10 transcript levels, while F11 and F12 levels increased. Activity levels in plasma largely paralleled these mRNA changes. Thbd transcript levels in the lung (vessel-wall-associated coagulation) were significantly up-regulated after a single T3 injection, and persisted upon prolonged T-3 exposure. Two-week T-3 administration also resulted in increased Vwf and Tfpi mRNA levels, whereas Tf levels decreased. These data showed that T-3 has specific effects on coagulation, with Fgg, Serpinc1, Proc, Proz, Serpin10 and Thbd responding rapidly, making these likely direct thyroid hormone receptor targets. F2, F9, F10, F11, F12, Vwf, Tf and Tfpi are late responding genes and probably indirectly modulated by T-3.	[Salloum-Asfar, Salam; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Salloum-Asfar, Salam] Univ Murcia, IMIB Arrixaca, Ctr Reg Hemodonac, Dept Hematol & Med Oncol, Murcia, Spain; [Boelen, Anita] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Amsterdam; Academic Medical Center Amsterdam	van Vlijmen, BJM (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	b.j.m.van_vlijmen@lumc.nl	Salloum-Asfar, Salam/AAQ-4772-2021	Salloum-Asfar, Salam/0000-0002-8357-2180	Netherlands Heart Foundation [2006B0045]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported by grant 2006B0045 from the Netherlands Heart Foundation (https://www.hartstichting.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burggraaf J, 2001, THYROID, V11, P153, DOI 10.1089/105072501300042820; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; Debeij J, 2014, J THROMB HAEMOST, V12, P839, DOI 10.1111/jth.12573; Dong HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012136; Erem C, 2011, SEMIN THROMB HEMOST, V37, P17, DOI 10.1055/s-0030-1270067; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P288, DOI 10.1055/s-0029-1222607; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Lin KH, 2003, J ENDOCRINOL, V179, P367, DOI 10.1677/joe.0.1790367; NIESSEN RWLM, 1995, THROMB HAEMOSTASIS, V74, P686; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Selva DM, 2009, J MOL ENDOCRINOL, V43, P19, DOI 10.1677/JME-09-0025; Shih CH, 2004, ENDOCRINOLOGY, V145, P2804, DOI 10.1210/en.2003-1372; Takeuchi Y, 2002, ENDOCRINOLOGY, V143, P1346, DOI 10.1210/en.143.4.1346; van Beeren HC, 2003, ENDOCRINOLOGY, V144, P552, DOI 10.1210/en.2002-220604; van Beeren HC, 2012, THYROID, V22, P1275, DOI 10.1089/thy.2012.0135; van Zaane B, 2010, BLOOD, V115, P4344, DOI 10.1182/blood-2009-11-253724; WIERSINGA WM, 1982, METHOD ENZYMOL, V84, P272; Wikstrom L, 1998, EMBO J, V17, P455, DOI 10.1093/emboj/17.2.455; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862	24	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127469	10.1371/journal.pone.0127469	http://dx.doi.org/10.1371/journal.pone.0127469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011296	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900097
J	Schuck, PF; Milanez, AP; Felisberto, F; Galant, LS; Machado, JL; Furlanetto, CB; Petronilho, F; Dal-Pizzol, F; Streck, EL; Ferreira, GC				Schuck, Patricia Fernanda; Milanez, Ana Paula; Felisberto, Francine; Galant, Leticia Selinger; Machado, Jessica Luca; Furlanetto, Camila Brulezi; Petronilho, Fabricia; Dal-Pizzol, Felipe; Streck, Emilio Luiz; Ferreira, Gustavo Costa			Brain and Muscle Redox Imbalance Elicited by Acute Ethylmalonic Acid Administration	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; CREATINE-KINASE ACTIVITY; LIPID-PEROXIDATION; OXIDATIVE DAMAGE; MITOCHONDRIA; INHIBITION; STRESS	Ethylmalonic acid (EMA) accumulates in tissues and biological fluids of patients affected by short-chain acyl-CoA dehydrogenase deficiency (SCADD) and ethylmalonic encephalopathy, illnesses characterized by neurological and muscular symptoms. Considering that the mechanisms responsible for the brain and skeletal muscle damage in these diseases are poorly known, in the present work we investigated the effects of acute EMA administration on redox status parameters in cerebral cortex and skeletal muscle from 30-day-old rats. Animals received three subcutaneous injections of EMA (6 mu mol/g; 90 min interval between injections) and were killed 1 h after the last administration. Control animals received saline in the same volumes. EMA administration significantly increased thiobarbituric acid-reactive substances levels in cerebral cortex and skeletal muscle, indicating increased lipid peroxidation. In addition, carbonyl content was increased in EMA-treated animal skeletal muscle when compared to the saline group. EMA administration also significantly increased 2', 7'-dihydrodichlorofluorescein oxidation and superoxide production (reactive species markers), and decreased glutathione peroxidase activity in cerebral cortex, while glutathione levels were decreased only in skeletal muscle. On the other hand, respiratory chain complex I-III activity was altered by acute EMA administration neither in cerebral cortex nor in skeletal muscle. The present results show that acute EMA administration elicits oxidative stress in rat brain and skeletal muscle, suggesting that oxidative damage may be involved in the pathophysiology of the brain and muscle symptoms found in patients affected by SCADD and ethylmalonic encephalopathy.	[Schuck, Patricia Fernanda; Milanez, Ana Paula; Machado, Jessica Luca; Furlanetto, Camila Brulezi] Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Erros Inatos Metabolismo, Criciuma, SC, Brazil; [Felisberto, Francine; Galant, Leticia Selinger; Dal-Pizzol, Felipe] Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Fisiopatol Expt, Criciuma, SC, Brazil; [Petronilho, Fabricia] Univ Sul Santa Catarina, Programa Posgrad Ciencias Saude, Lab Imunopatol Clin & Expt, Tubarao, SC, Brazil; Univ Extremo Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Erros Inatos Metabolismo, Criciuma, SC, Brazil; [Streck, Emilio Luiz] Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Bioenerget, Criciuma, SC, Brazil; [Ferreira, Gustavo Costa] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas, Lab Neuroquim, Rio De Janeiro, Brazil	Universidade do Extremo Sul Catarinense; Universidade do Extremo Sul Catarinense; Universidade do Sul de Santa Catarina; Universidade do Extremo Sul Catarinense; Universidade Federal do Rio de Janeiro	Schuck, PF (corresponding author), Univ Extremo Sul Catarinense, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Erros Inatos Metabolismo, Criciuma, SC, Brazil.	patricia.schuck@pq.cnpq.br	Petronilho, Fabricia/D-8822-2013; Galant, Letícia Selinger/AAJ-9163-2020; Schuck, Patricia Fernanda/O-1344-2013	Schuck, Patricia Fernanda/0000-0003-3148-4952; SELINGER GALANT, LETICIA/0000-0001-7965-5648	Universidade do Extremo Sul Catarinense; Nucleo de Excelencia em Neurociencias Aplicada de Santa Catarina; Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina	Universidade do Extremo Sul Catarinense; Nucleo de Excelencia em Neurociencias Aplicada de Santa Catarina; Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	Universidade do Extremo Sul Catarinense: PFS GCF ELS FDP LSG FF CBF JLM Nucleo de Excelencia em Neurociencias Aplicada de Santa Catarina: PFS ELS FDP; Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico: PFS GCF ELS FDP; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina: PFS ELS FDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140; Aebi H, 1984, Methods Enzymol, V105, P121; Aksenov MY, 2001, NEUROSCI LETT, V302, P141, DOI 10.1016/S0304-3940(01)01636-6; BANNISTER JV, 1987, METHOD BIOCHEM ANAL, V32, P279; Barschak AG, 2006, METAB BRAIN DIS, V21, P11, DOI 10.1007/s11011-006-9000-y; BENZI G, 1995, FREE RADICAL BIO MED, V19, P77, DOI 10.1016/0891-5849(94)00244-E; Browne R W, 1998, Methods Mol Biol, V108, P347; Campos D, 2012, METAB BRAIN DIS, V27, P121, DOI 10.1007/s11011-012-9302-1; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Ferreira GD, 2006, METAB BRAIN DIS, V21, P29, DOI 10.1007/s11011-006-9004-7; Di Meo I, 2012, EMBO MOL MED, V4, P1008, DOI 10.1002/emmm.201201433; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Evelson P, 2001, ARCH BIOCHEM BIOPHYS, V388, P261, DOI 10.1006/abbi.2001.2292; Jafari P, 2011, MOL GENET METAB, V104, P425, DOI 10.1016/j.ymgme.2011.08.027; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Leipnitz G, 2003, NEUROCHEM RES, V28, P771, DOI 10.1023/A:1022874103630; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nowaczyk MJM, 1998, METABOLISM, V47, P836, DOI 10.1016/S0026-0495(98)90122-6; Pedersen CB, 2010, J INHERIT METAB DIS, V33, P211, DOI 10.1007/s10545-010-9086-6; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Roe CR, 2001, METABOLIC MOL BASES; Schapira AHV, 1998, ARCH NEUROL-CHICAGO, V55, P1293, DOI 10.1001/archneur.55.10.1293; Schuck PF, 2013, SYNAPSE, V67, P111, DOI 10.1002/syn.21618; Schuck PF, 2010, NEUROCHEM RES, V35, P298, DOI 10.1007/s11064-009-0055-0; Schuck PF, 2009, BEHAV BRAIN RES, V197, P364, DOI 10.1016/j.bbr.2008.09.031; Schuck PF, 2002, NEUROCHEM RES, V27, P1633, DOI 10.1023/A:1021682910373; Strassburger M, 2005, FREE RADICAL BIO MED, V38, P1458, DOI 10.1016/j.freeradbiomed.2005.02.009; Tiranti V, 2011, AM J HUM GENET, V74, P239; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Vargas CR, 2011, MOL GENET METAB, V104, pS97, DOI 10.1016/j.ymgme.2011.07.010; Vazquez MC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/205713; Wendel A, 1981, Methods Enzymol, V77, P325; Zolkipli Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017534	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126606	10.1371/journal.pone.0126606	http://dx.doi.org/10.1371/journal.pone.0126606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010931	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900035
J	Wang, B; Xie, XB; Yin, JQ; Zou, CY; Wang, J; Huang, G; Wang, YQ; Shen, JN				Wang, Bo; Xie, Xianbiao; Yin, Junqiang; Zou, Changye; Wang, Jin; Huang, Gang; Wang, Yongqian; Shen, Jingnan			Reconstruction with Modular Hemipelvic Endoprosthesis after Pelvic Tumor Resection: A Report of 50 Consecutive Cases	PLOS ONE			English	Article							INTERNAL HEMIPELVECTOMY	Purpose To evaluate the effectiveness of reconstruction with a modular hemipelvic endoprosthesis after pelvic tumor resection. Methods We retrospectively studied 50 consecutive patients diagnosed with pelvic tumor from 2003 to 2013. All patients received limb-salvage surgery and reconstruction with modular hemipelvic endoprosthesis. Results Patients were followed for an average of 54 months. At the most recent follow-up, 32 patients were alive with an estimated three-year and five-year survival rate of 66.3% and 57.5% according to the Kaplan-Meier survival analysis. Eighteen patients died from the tumor, with a mean survival of 28 months, and 9 patients experienced local recurrence at an average of 19.6 months after surgery. Patients with marginal or intracapsular surgical margins had a significantly higher recurrence rate than those with wide margins (p=0.02). Metastasis occurred in 12 cases at an average of 16 months after surgery. The perioperative complication rate was 48.0%, and the most common complications were wound healing disturbance (28.0%) and deep infection (14.0%). The endoprosthetic complication rate was 16.0%, and breakage of the pubic connection plate was the most common complication. The mean Musculoskeletal Tumor Society score was 61.4%. Conclusion Reconstruction with a modular hemipelvic endoprosthesis after pelvic tumor resection can improve function, with an acceptable complication rate.	[Wang, Bo; Xie, Xianbiao; Yin, Junqiang; Zou, Changye; Wang, Jin; Huang, Gang; Wang, Yongqian; Shen, Jingnan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Musculoskeletal Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Shen, JN (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Musculoskeletal Oncol, Guangzhou 510275, Guangdong, Peoples R China.	shenjingnan@126.com						Ayvaz M, 2014, SCI WORLD J, DOI 10.1155/2014/605019; Bruns J, 1997, ARCH ORTHOP TRAUM SU, V116, P27, DOI 10.1007/BF00434096; ENNEKING W, 1990, Chirurgia degli Organi di Movimento, V75, P217; ENNEKING WF, 1978, J BONE JOINT SURG AM, V60, P731, DOI 10.2106/00004623-197860060-00002; ENNEKING WF, 1986, CLIN ORTHOP RELAT R, P9; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Falkinstein Y, 2008, J BONE JOINT SURG BR, V90B, P371, DOI 10.1302/0301-620X.90B3.20144; Guo W, 2007, CLIN ORTHOP RELAT R, P180, DOI 10.1097/BLO.0b013e31806165d5; Ham SJ, 1997, EUR J SURG ONCOL, V23, P540, DOI 10.1016/S0748-7983(97)93173-5; HARRINGTON KD, 1992, J BONE JOINT SURG AM, V74A, P331, DOI 10.2106/00004623-199274030-00003; Jaiswal PK, 2008, J BONE JOINT SURG BR, V90B, P1222, DOI 10.1302/0301-620X.90B9.20758; Ji T, 2013, EJSO-EUR J SURG ONC, V39, P53, DOI 10.1016/j.ejso.2012.10.002; Langlais F, 2001, CLIN ORTHOP RELAT R, P178; Mankin Henry J, 2005, Surg Oncol Clin N Am, V14, P381, DOI 10.1016/j.soc.2004.11.010; Muller PE, 2002, INT ORTHOP, V26, P76, DOI 10.1007/s00264-001-0322-4; Ozaki T, 2002, CLIN ORTHOP RELAT R, P197; Refaat Y, 2002, CLIN ORTHOP RELAT R, P298; Tunn PU, 2007, Z ORTHOP UNFALLCHIR, V145, P753, DOI 10.1055/s-2007-965757; Witte D, 2009, EJSO-EUR J SURG ONC, V35, P1318, DOI 10.1016/j.ejso.2009.04.011	19	30	36	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127263	10.1371/journal.pone.0127263	http://dx.doi.org/10.1371/journal.pone.0127263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011448	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900076
J	Ito, H; Uchida, T; Makita, K				Ito, Hiroyuki; Uchida, Tokujiro; Makita, Koshi			Ketamine Causes Mitochondrial Dysfunction in Human Induced Pluripotent Stem Cell-Derived Neurons	PLOS ONE			English	Article							APOPTOTIC NEURODEGENERATION; CORTICAL-NEURONS; DEVELOPING BRAIN; DRUG DISCOVERY; EARLY EXPOSURE; PATHWAY; FUSION; INHIBITION; FISSION; CULTURE	Purpose Ketamine toxicity has been demonstrated in nonhuman mammalian neurons. To study the toxic effect of ketamine on human neurons, an experimental model of cultured neurons from human induced pluripotent stem cells (iPSCs) was examined, and the mechanism of its toxicity was investigated. Methods Human iPSC-derived dopaminergic neurons were treated with 0, 20, 100 or 500 mu M ketamine for 6 and 24 h. Ketamine toxicity was evaluated by quantification of caspase 3/7 activity, reactive oxygen species (ROS) production, mitochondrial membrane potential, ATP concentration, neurotransmitter reuptake activity and NADH/NAD(+) ratio. Mitochondrial morphological change was analyzed by transmission electron microscopy and confocal microscopy. Results Twenty-four-hour exposure of iPSC-derived neurons to 500 mu M ketamine resulted in a 40% increase in caspase 3/7 activity (P < 0.01), 14% increase in ROS production (P < 0.01), and 81% reduction in mitochondrial membrane potential (P < 0.01), compared with untreated cells. Lower concentration of ketamine (100 mu M) decreased the ATP level (22%, P < 0.01) and increased the NADH/NAD(+) ratio (46%, P < 0.05) without caspase activation. Transmission electron microscopy showed enhanced mitochondrial fission and autophagocytosis at the 100 mu M ketamine concentration, which suggests that mitochondrial dysfunction preceded ROS generation and caspase activation. Conclusions We established an in vitro model for assessing the neurotoxicity of ketamine in iPSC-derived neurons. The present data indicate that the initial mitochondrial dysfunction and autophagy may be related to its inhibitory effect on the mitochondrial electron transport system, which underlies ketamine-induced neural toxicity. Higher ketamine concentration can induce ROS generation and apoptosis in human neurons.	[Ito, Hiroyuki; Uchida, Tokujiro; Makita, Koshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Ito, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol, Bunkyo Ku, Tokyo, Japan.	hiro-ito.mane@tmd.ac.jp			Japan Society for the Promotion of Science, Japan [25670666]; Grants-in-Aid for Scientific Research [25670759, 15H05004] Funding Source: KAKEN	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is funded by Grant-in-Aid 25670666 (KM) from the Japan Society for the Promotion of Science, Japan (https://www.jsps.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE WN, 1960, BIOCHEM J, V76, P47, DOI 10.1042/bj0760047; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bai XW, 2013, ANESTH ANALG, V116, P869, DOI 10.1213/ANE.0b013e3182860fc9; Bosnjak ZJ, 2012, CURR DRUG SAF, V7, P106, DOI 10.2174/157488612802715663; Braun S, 2010, BRIT J ANAESTH, V105, P347, DOI 10.1093/bja/aeq169; CHANCE B, 1963, J BIOL CHEM, V238, P418; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Colleoni M, 1996, PHARMACOL TOXICOL, V78, P69, DOI 10.1111/j.1600-0773.1996.tb00182.x; Deng WB, 2010, EMBO REP, V11, P161, DOI 10.1038/embor.2010.15; DOMINO EF, 1982, ANESTH ANALG, V61, P87; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Fredriksson A, 2004, BEHAV BRAIN RES, V153, P367, DOI 10.1016/j.bbr.2003.12.026; GRANT IS, 1983, BRIT J ANAESTH, V55, P1107, DOI 10.1093/bja/55.11.1107; Hanley PJ, 1998, J PHYSIOL-LONDON, V506, P231, DOI 10.1111/j.1469-7793.1998.231bx.x; Hroudova J, 2012, TOXICOL LETT, V213, P345, DOI 10.1016/j.toxlet.2012.07.017; Huang LN, 2012, BRAIN RES, V1476, P164, DOI 10.1016/j.brainres.2012.07.059; Ichinose S, 2010, LAB INVEST, V90, P210, DOI 10.1038/labinvest.2009.125; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; KISSIN I, 1983, ANESTHESIOLOGY, V59, P447, DOI 10.1097/00000542-198311000-00016; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kumar KK, 2012, NEUROTOXICOLOGY, V33, P518, DOI 10.1016/j.neuro.2012.02.005; Lee ST, 2009, BRIT J ANAESTH, V102, P80, DOI 10.1093/bja/aen322; Leist M, 2008, ALTEX-ALTERN TIEREXP, V25, P163; Liu WW, 2013, J BIOCHEM MOL TOXIC, V27, P17, DOI 10.1002/jbt.21470; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; McLean RF, 1996, CAN J ANAESTH, V43, P580, DOI 10.1007/BF03011770; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Rintoul GL, 2010, BBA-MOL BASIS DIS, V1802, P143, DOI 10.1016/j.bbadis.2009.09.005; Slikker W, 2007, TOXICOL SCI, V98, P145, DOI 10.1093/toxsci/kfm084; STONG LJ, 1975, ANESTHESIOLOGY, V42, P123, DOI 10.1097/00000542-197502000-00003; Takadera T, 2006, TOXICOL APPL PHARM, V210, P100, DOI 10.1016/j.taap.2005.10.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Venancio C, 2015, ANESTH ANALG, V120, P320, DOI 10.1213/ANE.0000000000000539; Venancio C, 2013, LIFE SCI, V93, P464, DOI 10.1016/j.lfs.2013.08.001; Vojnits K, 2010, TOXICOLOGY, V270, P10, DOI 10.1016/j.tox.2009.12.003; Wang C, 2006, TOXICOL SCI, V91, P192, DOI 10.1093/toxsci/kfj144; Wang C, 2005, NEUROSCIENCE, V132, P967, DOI 10.1016/j.neuroscience.2005.01.053; Wang C, 2010, THESCIENTIFICWORLDJO, V10, P1473, DOI 10.1100/tsw.2010.118; Wei HF, 2011, ANESTH ANALG, V113, P972, DOI 10.1213/ANE.0b013e3182323261; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Young C, 2005, BRIT J PHARMACOL, V146, P189, DOI 10.1038/sj.bjp.0706301; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010	47	38	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128445	10.1371/journal.pone.0128445	http://dx.doi.org/10.1371/journal.pone.0128445			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020236	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300112
J	Kotomura, N; Harada, N; Ishihara, S				Kotomura, Naoe; Harada, Nobuhiro; Ishihara, Satoru			The Proportion of Chromatin Graded between Closed and Open States Determines the Level of Transcripts Derived from Distinct Promoters in the CYP19 Gene	PLOS ONE			English	Article							MAMMALIAN-CELLS; HUMAN GENOME; AROMATASE; EXPRESSION; BINDING; TISSUES; RECOGNITION; METHYLATION; TARGET	The human CYP19 gene encodes aromatase, which converts androgens to estrogens. CYP19 mRNA variants are transcribed mainly from three promoters. Quantitative RT-PCR was used to measure the relative amounts of each of the three transcripts and determine the on/off state of the promoters. While some of the promoters were silent, CYP19 mRNA production differed among the other promoters, whose estimated transcription levels were 0.001% to 0.1% of that of the TUBB control gene. To investigate the structural aspects of chromatin that were responsible for this wide range of activity of the CYP19 promoters, we used a fractionation protocol, designated SEVENS, which sequentially separates densely packed nucleosomes from dispersed nucleosomes. The fractional distribution of each inactive promoter showed a similar pattern to that of the repressed reference loci; the inactive regions were distributed toward lower fractions, in which closed chromatin comprising packed nucleosomes was enriched. In contrast, active CYP19 promoters were raised toward upper fractions, including dispersed nucleosomes in open chromatin. Importantly, these active promoters were moderately enriched in the upper fractions as compared to active reference loci, such as the TUBB promoter; the proportion of open chromatin appeared to be positively correlated to the promoter strength. These results, together with ectopic transcription accompanied by an increase in the proportion of open chromatin in cells treated with an H3K27me inhibitor, indicate that CYP19 mRNA could be transcribed from a promoter in which chromatin is shifted toward an open state in the equilibrium between closed and open chromatin.	[Kotomura, Naoe; Harada, Nobuhiro; Ishihara, Satoru] Fujita Hlth Univ, Sch Med, Dept Biochem, Toyoake, Aichi 47011, Japan	Fujita Health University	Ishihara, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Biochem, Toyoake, Aichi 47011, Japan.	satorui@fujita-hu.ac.jp			Japan Society for the Promotion of Science KAKENHI [22570006, 22591019, 22510219, 26430188]; Fujita Gakuen; Grants-in-Aid for Scientific Research [25461398] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fujita Gakuen; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI grants (#22570006 to NK, #22591019 to NH, #22510219 and #26430188 to SI, URL: http://kaken.nii.ac.jp/) and Fujita Gakuen (to NH and SI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Harada N, 1997, J STEROID BIOCHEM, V61, P175; Harada N, 2003, J STEROID BIOCHEM, V86, P327, DOI 10.1016/S0960-0760(03)00375-3; Hihara S, 2012, CELL REP, V2, P1645, DOI 10.1016/j.celrep.2012.11.008; Ishihara S, 2011, J IMMUNOL, V187, P3292, DOI 10.4049/jimmunol.1003173; Ishihara S, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq203; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MEANS GD, 1991, MOL ENDOCRINOL, V5, P2005, DOI 10.1210/mend-5-12-2005; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Stehr R, 2008, BIOPHYS J, V95, P3677, DOI 10.1529/biophysj.107.120543; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Torchia J, 1998, CURR OPIN CELL BIOL, V10, P373, DOI 10.1016/S0955-0674(98)80014-8; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128282	10.1371/journal.pone.0128282	http://dx.doi.org/10.1371/journal.pone.0128282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020632	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300096
J	Cautain, B; de Pedro, N; Schulz, C; Pascual, J; Sousa, TD; Martin, J; Perez-Victoria, I; Asensio, F; Gonzalez, I; Bills, GF; Reyes, F; Genilloud, O; Vicente, F				Cautain, Bastien; de Pedro, Nuria; Schulz, Christian; Pascual, Javier; Sousa, Thiciana da S.; Martin, Jesus; Perez-Victoria, Ignacio; Asensio, Francisco; Gonzalez, Ignacio; Bills, Gerald F.; Reyes, Fernando; Genilloud, Olga; Vicente, Francisca			Identification of the Lipodepsipeptide MDN-0066, a Novel Inhibitor of VHL/HIF Pathway Produced by a New Pseudomonas Species	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; VON-HIPPEL-LINDAU; DNA-DAMAGE; NATURAL-PRODUCTS; PROLIFERATION; HIF; CHECKPOINTS; METABOLISM; REPAIR; DRUGS	Throughout recent history, metabolites of microbial origin have had an extraordinary impact on the welfare of humanity. In fact, natural products have largely been - and still are-considered an exceedingly valuable platform for the discovery of new drugs against diverse pathologies. Such value is partly due to their higher complexity and chemical diversity as compared to those of synthetic and combinatorial compounds. Mutations in the Von Hippel-Lindau (vhl) gene are responsible for VHL disease, congenital polycythemia, and are found in many sporadic tumor types. The primary cause of morbidity and mortality for these patients arises from progression of Renal Cell Carcinoma (RCC) or end-stage renal disease. Inactivation of the Von Hippel-Lindau (vhl) tumor suppressor gene arises in the majority of Renal Cell Carcinoma (RCC) as well as in other types of cancer and is associated with a high degree of vascularization and poor prognosis. Loss of pVHL function thus represents a pathognomonic molecular defect for therapeutic exploitation. In this study, renal carcinoma cell lines with naturally occurring vhl mutations (RCC4 VA) and their genetically matched wild-type vhl (RCC4 VHL) counterparts were seeded onto 96-well plates and treated with a collection of 1,040 organic extracts obtained from 130 bacterial strains belonging to at least 25 genera of the phyla Actinobacteria, Firmicutes, Proteobacteria and Bacteroidetes. This strategy allowed us to identify several extracts obtained from bacterial strain F-278,770(T), the type strain of the recently proposed new species Pseudomonas granadensis, showing biological activities not associated with previously known bioactive metabolites. The fractionation and structural elucidation of one of these extracts led to the discovery of a new lipodepsipeptide (MDN-0066) with specific toxicity in pVHL deficient cells that is not detectable in cells with pVHL expression rescue. This specific toxicity is associated with apoptosis induction in VHL deficient cell line as demonstrated with PARP activation and Annexin V staining. Our study demonstrated the feasibility of selectively targeting the loss of the vhl tumor suppressor gene for potential clinical benefit. Our results may have great impact on the development of new targeted therapies from natural products for the treatment of cancer and other genetic diseases.	[Cautain, Bastien; de Pedro, Nuria; Schulz, Christian; Pascual, Javier; Sousa, Thiciana da S.; Martin, Jesus; Perez-Victoria, Ignacio; Asensio, Francisco; Gonzalez, Ignacio; Bills, Gerald F.; Reyes, Fernando; Genilloud, Olga; Vicente, Francisca] Fdn MEDINA, Granada 18016, Spain		Cautain, B (corresponding author), Fdn MEDINA, Parque Tecnol Ciencias Salud,Avda Conocimiento 3, Granada 18016, Spain.	bastien.cautain@medinaandalucia.es	vicente, francisca/N-5126-2014; González, Ignacio/I-1089-2015; Reyes, Fernando/G-4027-2013; pascual, javier/M-5964-2019; Pérez-Victoria, Ignacio/I-1559-2015; Genilloud, Olga/I-2779-2015; Cautain, Bastien/W-1948-2018; Martín-Serrano, Jesús/M-1937-2014	vicente, francisca/0000-0003-3198-9205; González, Ignacio/0000-0002-8490-2401; Reyes, Fernando/0000-0003-1607-5106; pascual, javier/0000-0002-1900-7099; Pérez-Victoria, Ignacio/0000-0002-4556-688X; Genilloud, Olga/0000-0002-4202-1219; Martín-Serrano, Jesús/0000-0001-7487-2790; Cautain, Bastien/0000-0002-1324-3576; Bills, Gerald/0000-0003-2352-8417	Non-Oriented Basic Research Program of the Spanish Ministry of Science [SAF2010-15010]; Fundacion MEDINA; Merck Sharp & Dohme de Espana S.A./Universidad de Granada/Junta de Andalucia; MICINN [PCT-010000-2010-3, PCT-010000-2010-4, INP-2011-0016-PCT-010000-ACT7]	Non-Oriented Basic Research Program of the Spanish Ministry of Science; Fundacion MEDINA; Merck Sharp & Dohme de Espana S.A./Universidad de Granada/Junta de Andalucia; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This research was supported by the Non-Oriented Basic Research Program of the Spanish Ministry of Science (Project SAF2010-15010) and by Fundacion MEDINA, a public-private partnership of Merck Sharp & Dohme de Espana S.A./Universidad de Granada/Junta de Andalucia. In addition, the equipment used in this work was supported by MICINN (Grants PCT-010000-2010-3, PCT-010000-2010-4 and INP-2011-0016-PCT-010000-ACT7). The authors thank the administration of the Tejeda, Almijara and Alhama Natural Parks and the Sierra Nevada National Park for their permission to collect soil.	Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Beutler JA, 2009, CURR PROTOC PHARM, V9; Cautain B, 2013, ADV BIOSCIENCE BIOTE, V4, P398; Coleman ML, 2009, CURR PHARM DESIGN, V15, P3904, DOI 10.2174/138161209789649448; Demain AL, 2009, J ANTIBIOT, V62, P5, DOI 10.1038/ja.2008.16; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Genilloud O, 2012, RSC SERIES; GNARRA JR, 1995, SEMIN ONCOL, V22, P3; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gossage L, 2010, NAT REV CLIN ONCOL, V7, P277, DOI 10.1038/nrclinonc.2010.42; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill R, 2014, ONCOTARGET, V5, P11, DOI 10.18632/oncotarget.1457; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Matsui S, 2002, MAMM GENOME, V13, P680, DOI 10.1007/s00335-002-2197-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Newman DJ, 2009, CURR OPIN INVEST DR, V10, P1280; Nordstrom-O'Brien M, 2010, HUM MUTAT, V31, P521, DOI 10.1002/humu.21219; Pascual J, 2015, INT J SYST EVOL MICR, V65, P625, DOI 10.1099/ijs.0.069260-0; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Singh SB, 2013, J NAT PROD, V76, P334, DOI 10.1021/np300704s; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Zhang Y, 2007, RADIAT RES, V168, P115, DOI 10.1667/RR0811.1; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	34	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125221	10.1371/journal.pone.0125221	http://dx.doi.org/10.1371/journal.pone.0125221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018559	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600012
J	Matsuo, Y; Watanabe, M; Taniike, M; Mohri, I; Kobashi, S; Tachibana, M; Kobayashi, Y; Kitamura, Y				Matsuo, Yuka; Watanabe, Masayuki; Taniike, Masako; Mohri, Ikuko; Kobashi, Syoji; Tachibana, Masaya; Kobayashi, Yasushi; Kitamura, Yuri			Gap Effect Abnormalities during a Visually Guided Pro-Saccade Task in Children with Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							MONKEY SUPERIOR COLLICULUS; DEFICIT/HYPERACTIVITY DISORDER; EYE-MOVEMENTS; BASAL GANGLIA; VOLITIONAL ACTIONS; VOLUNTARY CONTROL; DOPAMINE THEORY; REACTION-TIME; NEUROBIOLOGY; ADHD	Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that starts in early childhood and has a comprehensive impact on psychosocial activity and education as well as general health across the lifespan. Despite its prevalence, the current diagnostic criteria for ADHD are debated. Saccadic eye movements are easy to quantify and may be a quantitative biomarker for a wide variety of neurological and psychiatric disorders, including ADHD. The goal of this study was to examine whether children with ADHD exhibit abnormalities during a visually guided pro-saccadic eye-movement and to clarify the neurophysiological mechanisms associated with their behavioral impairments. Thirty-seven children with ADHD (aged 5-11 years) and 88 typically developing (TD) children (aged 5-11 years) were asked to perform a simple saccadic eye-movement task in which step and gap conditions were randomly interleaved. We evaluated the gap effect, which is the difference in the reaction time between the two conditions. Children with ADHD had a significantly longer reaction time than TD children (p < 0.01) and the gap effect was markedly attenuated (p < 0.01). These results suggest that the measurement of saccadic eye movements may provide a novel method for evaluating the behavioral symptoms and clinical features of ADHD, and that the gap effect is a potential biomarker for the diagnosis of ADHD in early childhood.	[Matsuo, Yuka; Kitamura, Yuri] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka, Japan; [Watanabe, Masayuki] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Taniike, Masako; Mohri, Ikuko] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Kobashi, Syoji] Univ Hyogo, Grad Sch Engn, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712201, Japan; [Tachibana, Masaya] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA; [Kobayashi, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Visual Neurosci Lab, Suita, Osaka, Japan; [Kobayashi, Yasushi] Natl Inst Informat & Communicat Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan; [Kobayashi, Yasushi] Osaka Univ, Suita, Osaka, Japan	Osaka University; Queens University - Canada; Osaka University; University of Hyogo; Mayo Clinic; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Kitamura, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka, Japan.	ytkitamura@envi.med.osaka-u.ac.jp	Tachibana, Masaya/AAW-3526-2020; Kobashi, Syoji/O-7773-2016	Tachibana, Masaya/0000-0002-6761-7158; Kobashi, Syoji/0000-0003-3659-4114; Kobayashi, Yasushi/0000-0002-2690-6527	Japan Society for the Promotion of Science (JSPS) KAKENHI [21610011]; Precursory Research for Embryonic Science and Technology (PRESTO) of Japan Science and Technology (JST); Kato Memorial Trust for NAMBYO Research; Grants-in-Aid for Scientific Research [15H02669] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Precursory Research for Embryonic Science and Technology (PRESTO) of Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Kato Memorial Trust for NAMBYO Research(Kato Memorial Trust for Nambyo Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 21610011 and Precursory Research for Embryonic Science and Technology (PRESTO) of Japan Science and Technology (JST) and The Kato Memorial Trust for NAMBYO Research 2010 to Yuri Kitamura, Yasushi Kobayashi, and Yuri Kitamura, respectively. The funders had no role in study design, data collection and analylsis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2000, MANUAL ASEBA SCH AGE; American Psychiatric, 2000, DIAGN STAT MAN MENT; Arnsten AF, 2009, J PEDIAT, V154; Banaschewski T, 2008, BIOL PSYCHOL, V77, P53, DOI 10.1016/j.biopsycho.2007.09.003; Biederman J, 2002, J Atten Disord, V6 Suppl 1, pS7; Biederman J, 2001, J CLIN CHILD PSYCHOL, V30, P492, DOI 10.1207/S15374424JCCP3004_06; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Cairney S, 2001, EXP BRAIN RES, V141, P507, DOI 10.1007/s002210100890; Carpenter RHS, 2000, CURR BIOL, V10, pR291, DOI 10.1016/S0960-9822(00)00430-9; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Connor DF, 2002, J DEV BEHAV PEDIATR, V23, pS1, DOI 10.1097/00004703-200202001-00002; Curatolo P, 2009, EUR J PAEDIATR NEURO, V13, P299, DOI 10.1016/j.ejpn.2008.06.003; Dorris MC, 2002, J COGNITIVE NEUROSCI, V14, P1256, DOI 10.1162/089892902760807249; Dorris MC, 1997, J NEUROSCI, V17, P8566; DuPaul GJ, 2003, PSYCHOL ASSESSMENT, V15, P115, DOI 10.1037/1040-3590.15.1.115; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Faraone SV, 1998, BIOL PSYCHIAT, V44, P951, DOI 10.1016/S0006-3223(98)00240-6; Feifel D, 2004, BIOL PSYCHIAT, V56, P333, DOI 10.1016/j.biopsych.2004.06.019; Fukushima J, 2000, BRAIN DEV-JPN, V22, P173, DOI 10.1016/S0387-7604(00)00101-7; Gooding DC, 2008, BRAIN COGNITION, V68, P371, DOI 10.1016/j.bandc.2008.08.024; Goto Y, 2010, BRAIN DEV-JPN, V32, P347, DOI 10.1016/j.braindev.2009.04.017; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Hikosaka O, 1998, ADV BIOPHYS, V35, P81, DOI 10.1016/S0065-227X(98)80004-X; Himelstein J, 2000, FRONT BIOSCI, V5, pD461, DOI 10.2741/Himelste; Karatekin C, 2010, SCHIZOPHRENIA BULL, V36, P1167, DOI 10.1093/schbul/sbp035; Klein C, 2003, PSYCHOPHYSIOLOGY, V40, P17, DOI 10.1111/1469-8986.00003; Klein C, 2002, EXP BRAIN RES, V145, P121, DOI 10.1007/s00221-002-1105-x; Levy F, 2001, AUST NZ J PSYCHIAT, V35, P504, DOI 10.1046/j.1440-1614.2001.00923.x; LEVY F, 1991, AUST NZ J PSYCHIAT, V25, P277, DOI 10.3109/00048679109077746; Mahone EM, 2009, J AM ACAD CHILD PSY, V48, P749, DOI 10.1097/CHI.0b013e3181a565f1; MATTES JA, 1980, COMPR PSYCHIAT, V21, P358, DOI 10.1016/0010-440X(80)90017-6; McLoughlin G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-66; MIYASHITA Y, 1980, BRAIN RES, V198, P210, DOI 10.1016/0006-8993(80)90357-1; Mostofsky SH, 2001, J AM ACAD CHILD PSY, V40, P1464, DOI 10.1097/00004583-200112000-00018; MUNOZ DP, 1992, J NEUROPHYSIOL, V67, P1000, DOI 10.1152/jn.1992.67.4.1000; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 2002, PROG BRAIN RES, V140, P3; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Narbona-Garcia J, 1999, Rev Neurol, V28 Suppl 2, pS160; O'Driscoll GA, 2005, BIOL PSYCHIAT, V57, P1452, DOI 10.1016/j.biopsych.2005.02.029; Ohnishi M, 2010, RES DEV DISABIL, V31, P1305, DOI 10.1016/j.ridd.2010.07.011; Pare M, 2001, EXP BRAIN RES, V137, P354, DOI 10.1007/s002210000647; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Peltsch A, 2008, EXP BRAIN RES, V186, P457, DOI 10.1007/s00221-007-1248-x; Renner TJ, 2008, NERVENARZT, V79, P771, DOI 10.1007/s00115-008-2513-3; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Russell VA, 2007, J NEUROSCI METH, V161, P185, DOI 10.1016/j.jneumeth.2006.12.005; Tani I, 2010, RES DEV DISABIL, V31, P1426, DOI 10.1016/j.ridd.2010.06.016; Tannock R, 1998, J CHILD PSYCHOL PSYC, V39, P65, DOI 10.1017/S0021963097001777; Temel Y, 2009, EXP NEUROL, V216, P481, DOI 10.1016/j.expneurol.2009.01.007; Tinsley CJ, 2002, PROG BRAIN RES, V140, P61; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Watanabe M, 2014, EUR J NEUROSCI, V39, P2098, DOI 10.1111/ejn.12566; Watanabe M, 2010, J NEUROSCI, V30, P10144, DOI 10.1523/JNEUROSCI.1738-10.2010; Watanabe M, 2009, EUR J NEUROSCI, V30, P2165, DOI 10.1111/j.1460-9568.2009.06998.x; Wickens JR, 2007, J NEUROSCI METH, V166, P293, DOI 10.1016/j.jneumeth.2007.09.011; World Health Organization, 1990, INT CLASS DIS, V10th; Zwicker JG, 2009, J CHILD NEUROL, V24, P1273, DOI 10.1177/0883073809333537	63	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125573	10.1371/journal.pone.0125573	http://dx.doi.org/10.1371/journal.pone.0125573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018057	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600028
J	Quillfeldt, P; Cherel, Y; Masello, JF; Delord, K; McGill, RAR; Furness, RW; Moodley, Y; Weimerskirch, H				Quillfeldt, Petra; Cherel, Yves; Masello, Juan F.; Delord, Karine; McGill, Rona A. R.; Furness, Robert W.; Moodley, Yoshan; Weimerskirch, Henri			Half a World Apart? Overlap in Nonbreeding Distributions of Atlantic and Indian Ocean Thin-Billed Prions	PLOS ONE			English	Article							TRANS-EQUATORIAL MIGRATION; THEMISTO-GAUDICHAUDII; PACHYPTILA-BELCHERI; ROUND DISTRIBUTION; WINTERING AREAS; STABLE-ISOTOPES; FEEDING ECOLOGY; FORAGING AREAS; SMALL PETREL; FOOD-WEB	Distant populations of animals may share their non-breeding grounds or migrate to distinct areas, and this may have important consequences for population differentiation and dynamics. Small burrow-nesting seabirds provide a suitable case study, as they are often restricted to safe breeding sites on islands, resulting in a patchy breeding distribution. For example, Thin-billed prions Pachyptila belcheri have two major breeding colonies more than 8,000 km apart, on the Falkland Islands in the south-western Atlantic and in the Kerguelen Archipelago in the Indian Ocean. We used geolocators and stable isotopes to compare at-sea movements and trophic levels of these two populations during their nonbreeding season, and applied ecological niche models to compare environmental conditions in the habitat. Over three winters, birds breeding in the Atlantic showed a high consistency in their migration routes. Most individuals migrated more than 3000 km eastwards, while very few remained over the Patagonian Shelf. In contrast, all Indian Ocean birds migrated westwards, resulting in an overlapping nonbreeding area in the eastern Atlantic sector of the Southern Ocean. Geolocators and isotopic signature of feathers indicated that prions from the Falklands moulted at slightly higher latitudes than those from Kerguelen Islands. All birds fed on low trophic level prey, most probably crustaceans. The phenology differed notably between the two populations. Falkland birds returned to the Patagonian Shelf after 2-3 months, while Kerguelen birds remained in the nonbreeding area for seven months, before returning to nesting grounds highly synchronously and at high speed. Habitat models identified sea surface temperature and chlorophyll a concentration as important environmental parameters. In summary, we show that even though the two very distant populations migrate to roughly the same area to moult, they have distinct wintering strategies: They had significantly different realized niches and timing which may contribute to spatial niche partitioning.	[Quillfeldt, Petra; Masello, Juan F.] Univ Giessen, Dept Anim Ecol & Systemat, D-35392 Giessen, Germany; [Quillfeldt, Petra; Cherel, Yves; Delord, Karine; Weimerskirch, Henri] Univ La Rochelle, CNRS, Ctr Etud Biol Chize, UMR 7372, F-79360 Villiers En Bois, France; [McGill, Rona A. R.] Scottish Univ, Environm Res Ctr, Life Sci Mass Spectrometry Facil, Glasgow G75 0QF, Lanark, Scotland; [Furness, Robert W.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Moodley, Yoshan] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, A-1160 Vienna, Austria	Justus Liebig University Giessen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Scottish Universities Research & Reactor Center; University of Glasgow; University of Veterinary Medicine Vienna	Quillfeldt, P (corresponding author), Univ Giessen, Dept Anim Ecol & Systemat, D-35392 Giessen, Germany.	Petra.Quillfeldt@bio.uni-giessen.de	Quillfeldt, Petra/A-9549-2009; McGill, Rona/F-1793-2010; Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013; Masello, Juan/C-7133-2009	Quillfeldt, Petra/0000-0002-4450-8688; McGill, Rona/0000-0003-0400-7288; Weimerskirch, Henri/0000-0002-0457-586X; Masello, Juan/0000-0002-6826-4016; Moodley, Yoshan/0000-0003-4216-2924	German Science Foundation DFG [Qu 148/5]; IPEV [109]; NERC Grant [NE/I02237X/1]; Natural Environment Research Council [NE/I02237X/1, lsmsf010002] Funding Source: researchfish; NERC [lsmsf010002, NE/I02237X/1] Funding Source: UKRI	German Science Foundation DFG(German Research Foundation (DFG)); IPEV; NERC Grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Grants were provided by the German Science Foundation DFG (Qu 148/5). Fieldwork at Kerguelen was supported by IPEV (Programme 109 to HW). RWF was supported by NERC Grant NE/I02237X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; [Anonymous], 2014, R LANG ENV STAT COMP; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Becker BH, 2007, CONDOR, V109, P451, DOI 10.1650/0010-5422(2007)109[451:DSINAC]2.0.CO;2; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bocher P, 2001, MAR ECOL PROG SER, V223, P261, DOI 10.3354/meps223261; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Brooke ML., 2004, ALBATROSSES PETRELS; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Cherel Y, 2014, MAR ECOL PROG SER, V505, P267, DOI 10.3354/meps10795; Cherel Y, 2010, LIMNOL OCEANOGR, V55, P324, DOI 10.4319/lo.2010.55.1.0324; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Dong SF, 2006, J PHYS OCEANOGR, V36, P2075, DOI 10.1175/JPO2973.1; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hedd A, 2012, MAR ECOL PROG SER, V449, P277, DOI 10.3354/meps09538; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; Kane J. E., 1966, Discovery Reports, V34, P163; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; Mateos M, 2011, MAR BIOL, V158, P329, DOI 10.1007/s00227-010-1561-y; Michalik A, 2010, RAPID COMMUN MASS SP, V24, P875, DOI 10.1002/rcm.4462; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Newton I., 2010, BIRD MIGRATION; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Padovani LN, 2012, J SEA RES, V67, P85, DOI 10.1016/j.seares.2011.10.007; Pakhomov EA, 2000, DEEP-SEA RES PT I, V47, P1663, DOI 10.1016/S0967-0637(99)00122-3; Pakhomov EA, 1996, POLAR BIOL, V16, P271, DOI 10.1007/s003000050054; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Putz K, 2006, POLAR BIOL, V29, P735, DOI 10.1007/s00300-006-0110-0; Quillfeldt P, 2003, POLAR BIOL, V26, P746, DOI 10.1007/s00300-003-0544-6; Quillfeldt P, 2014, J AVIAN BIOL, V45, P315, DOI 10.1111/jav.00307; Quillfeldt P, 2013, J BIOGEOGR, V40, P430, DOI 10.1111/jbi.12008; Quillfeldt P, 2012, MAR BIOL, V159, P1809, DOI 10.1007/s00227-012-1971-0; Quillfeldt P, 2010, MAR BIOL, V157, P2043, DOI 10.1007/s00227-010-1472-y; Quillfeldt P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-15; Quillfeldt P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1157, DOI 10.1007/s00265-010-0931-2; Quillfeldt P, 2008, MAR ECOL PROG SER, V373, P137, DOI 10.3354/meps07751; Rayner MJ, 2012, EMU, V112, P107, DOI 10.1071/MU11066; RIDOUX V, 1989, POLAR BIOL, V9, P137, DOI 10.1007/BF00297168; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Sprintall J, 2008, PROG OCEANOGR, V77, P316, DOI 10.1016/j.pocean.2006.06.004; Thiebot JB, 2012, ECOLOGY, V93, P122, DOI 10.1890/11-0385.1; THOMPSON KR, 1992, IBIS, V134, P11, DOI 10.1111/j.1474-919X.1992.tb07223.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Weiss F, 2009, POLAR BIOL, V32, P1753, DOI 10.1007/s00300-009-0674-6	55	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125007	10.1371/journal.pone.0125007	http://dx.doi.org/10.1371/journal.pone.0125007			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018194	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000355185600009
J	Verde, Z; Reinoso, L; Chicharro, LM; Resano, P; Sanchez-Hernandez, I; Gonzalez-Moro, JMR; Bandres, F; Gomez-Gallego, F; Santiago, C				Verde, Zoraida; Reinoso, Luis; Chicharro, Luis Miguel; Resano, Pilar; Sanchez-Hernandez, Ignacio; Gonzalez-Moro, Jose Miguel Rodriguez; Bandres, Fernando; Gomez-Gallego, Felix; Santiago, Catalina			Are SNP-Smoking Association Studies Needed in Controls? DNA Repair Gene Polymorphisms and Smoking Intensity	PLOS ONE			English	Article							LUNG-CANCER RISK; ENVIRONMENT INTERACTIONS; APE1 ASP148GLU; XPD; VARIANTS; XRCC1; POPULATION; ADDUCTS; PATHWAY; ERCC2	Variations in tobacco-related cancers, incidence and prevalence reflect differences in tobacco consumption in addition to genetic factors. Besides, genes related to lung cancer risk could be related to smoking behavior. Polymorphisms altering DNA repair capacity may lead to synergistic effects with tobacco carcinogen-induced lung cancer risk. Common problems in genetic association studies, such as presence of gene-by-environment (G x E) correlation in the population, may reduce the validity of these designs. The main purpose of this study was to evaluate the independence assumption for selected SNPs and smoking behaviour in a cohort of 320 healthy Spanish smokers. We found an association between the wild type alleles of XRCC3 Thr241Met or KLC3 Lys751Gln and greater smoking intensity (OR = 12.98, 95% CI = 2.86-58.82 and OR=16.90, 95% CI=2.09-142.8; respectively). Although preliminary, the results of our study provide evidence that genetic variations in DNA-repair genes may influence both smoking habits and the development of lung cancer. Population-specific G x E studies should be carried out when genetic and environmental factors interact to cause the disease.	[Verde, Zoraida; Reinoso, Luis; Chicharro, Luis Miguel] Univ Europea, Dept Morphol Sci & Biomed, Madrid, Spain; [Reinoso, Luis] Dept Occupat Hlth, Grp Banco Popular, Madrid, Spain; [Resano, Pilar] Hosp Guadalajara, Dept Neumol, Guadalajara, Spain; [Sanchez-Hernandez, Ignacio] Hosp Carlos III, Dept Neumol, Madrid, Spain; [Gonzalez-Moro, Jose Miguel Rodriguez] Hosp Gregorio Maranon, Dept Neumol, Madrid, Spain; [Bandres, Fernando] Univ Complutense, Dept Toxicol & Hlth Sanit, E-28040 Madrid, Spain; [Gomez-Gallego, Felix; Santiago, Catalina] Univ Europea, Sch Doctoral Studies & Res, Madrid, Spain	Hospital Carlos III; General University Gregorio Maranon Hospital; Complutense University of Madrid	Verde, Z (corresponding author), Univ Europea, Dept Morphol Sci & Biomed, Madrid, Spain.	zoraida.verde@uem.es	Gomez-Gallego, Felix/H-6925-2013; Santiago, Catalina/P-8177-2019; Gomez-Gallego, Felix/AAD-9617-2020; VERDE, ZORAIDA/A-9914-2012	Gomez-Gallego, Felix/0000-0002-1968-1761; Santiago, Catalina/0000-0003-3852-8217; VERDE, ZORAIDA/0000-0002-9260-7672; Rodriguez Gonzalez-Moro, Jose Miguel/0000-0002-8446-3373; BANDRES MOYA, FERNANDO/0000-0002-4675-8226	Universidad Europea, Madrid [2012/UEM17]; Catedra Florencio Tejerina-UEM [2010/UEM19]	Universidad Europea, Madrid; Catedra Florencio Tejerina-UEM	This study was supported by a grant from Universidad Europea, Madrid (project number 2012/UEM17) and Catedra Florencio Tejerina-UEM (project number 2010/UEM19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2001, AM J EPIDEMIOL, V154, P687, DOI 10.1093/aje/154.8.687; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P304, DOI 10.1001/jama.2008.993; Buch SC, 2012, MOL CARCINOGEN, V51, pE11, DOI 10.1002/mc.20858; Cai LY, 2014, TUMOR BIOL, V35, P5237, DOI 10.1007/s13277-014-1681-y; CAPORASO N, 1991, PHARMACOGENETICS, V1, P4, DOI 10.1097/00008571-199110000-00003; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Dong ZM, 2008, J CLIN GASTROENTEROL, V42, P910, DOI 10.1097/MCG.0b013e3180f6262c; Duell EJ, 2000, CARCINOGENESIS, V21, P965, DOI 10.1093/carcin/21.5.965; Lopez-Cima MF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-433; Frosina G, 2004, FREE RADICAL RES, V38, P1037, DOI 10.1080/10715760400011445; Hafeman DM, 2011, EPIDEMIOLOGY, V22, P753, DOI 10.1097/EDE.0b013e3181c311b2; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hodgson ME, 2010, CANCER EPIDEM BIOMAR, V19, P3055, DOI 10.1158/1055-9965.EPI-10-0877; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hoffmann H, 2005, MUTAGENESIS, V20, P455, DOI 10.1093/mutage/gei064; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Ito H, 2004, CARCINOGENESIS, V25, P1395, DOI 10.1093/carcin/bgh153; Kazma R, 2012, HUM HERED, V74, P205, DOI 10.1159/000346825; Kazma R, 2012, CARCINOGENESIS, V33, P1059, DOI 10.1093/carcin/bgs116; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kogevinas M, 2005, CANC LAB ESPANA; Lazary Judit, 2011, Neuropsychopharmacol Hung, V13, P7; Leitch DN, 2005, RESP MED, V99, P32, DOI 10.1016/j.rmed.2004.03.027; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; Letkova L, 2013, MOL BIOL REP, V40, P5261, DOI 10.1007/s11033-013-2626-z; Li WY, 2014, ONCOL LETT, V8, P1725, DOI 10.3892/ol.2014.2351; Li WS, 2014, GENE, V538, P361, DOI 10.1016/j.gene.2013.12.028; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lopez-Cima MF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-162; Lu XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060006; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Matullo G, 2006, CARCINOGENESIS, V27, P997, DOI 10.1093/carcin/bgi280; Matullo G, 2001, INT J CANCER, V92, P562, DOI 10.1002/ijc.1228; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; Mohrenweiser Harvey W, 2004, Toxicol Pathol, V32 Suppl 1, P136, DOI 10.1080/01926230490424671; Peluso M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/386798; Popanda O, 2004, CARCINOGENESIS, V25, P2433, DOI 10.1093/carcin/bgh264; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Uppal Vibha, 2014, J Clin Diagn Res, V8, pCC17, DOI 10.7860/JCDR/2014/10061.5132; US Department of Health Human Services, 2014, HLTH CONSMOK 50 YE, P17, DOI DOI 10.1037/E510072014-001; Verde Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026668; Verde Z, 2009, THROMB HAEMOSTASIS, V101, P591, DOI 10.1160/TH08-09-0578; Vineis P, 2009, JNCI-J NATL CANCER I, V101, P24, DOI 10.1093/jnci/djn437; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang R, 2014, SCIENCE, V346, P1127, DOI 10.1126/science.1258973; Wang RT, 2014, TUMOR BIOL, V35, P1739, DOI 10.1007/s13277-013-1435-2; Wilding CS, 2005, MUTAT RES-FUND MOL M, V570, P137, DOI 10.1016/j.mrfmmm.2004.11.002; Wilson DM, 2003, J MOL BIOL, V330, P1027, DOI 10.1016/S0022-2836(03)00712-5; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; World Health Organization, 2008, WHO REP GLOB TOB EP; Xing DY, 2002, LUNG CANCER-J IASLC, V38, P123, DOI 10.1016/S0169-5002(02)00184-8; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	52	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0129374	10.1371/journal.pone.0129374	http://dx.doi.org/10.1371/journal.pone.0129374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017978	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600128
J	Ye, J; Nielsen, S; Joseph, S; Thomas, T				Ye, Jun; Nielsen, Shaun; Joseph, Stephen; Thomas, Torsten			High-Resolution and Specific Detection of Bacteria on Complex Surfaces Using Nanoparticle Probes and Electron Microscopy	PLOS ONE			English	Article							SITU HYBRIDIZATION FISH; PHYLOGENETIC IDENTIFICATION; COMBINING FLUORESCENCE; MICROBIAL-CELLS; SOIL; MICROORGANISMS; NANOGOLD	The study of the interaction of bacteria with surfaces requires the detection of specific bacterial groups with high spatial resolution. Here, we describe a method to rapidly and efficiently add nanogold particles to oligonucleotide probes, which target bacterial ribosomal RNA. These nanogold-labeled probes are then used in an in situ hybridization procedure that ensures both cellular integrity and high specificity. Electron microscopy subsequently enables the visualization of specific cells with high local precision on complex surface structures. This method will contribute to an increased understanding of how bacteria interact with surface structures on a sub-micron scale.	[Ye, Jun; Nielsen, Shaun; Thomas, Torsten] Univ New S Wales, Ctr Marine Bioinnovat, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Joseph, Stephen] Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Thomas, T (corresponding author), Univ New S Wales, Ctr Marine Bioinnovat, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	t.thomas@unsw.edu.au	YE, JUN/B-1801-2018	YE, JUN/0000-0002-6476-6406; Thomas, Torsten/0000-0001-9557-3001	Australian Research Council	Australian Research Council(Australian Research Council)	The study was supported by the Australian Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Binder BJ, 1998, APPL ENVIRON MICROB, V64, P3346; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; de la Torre BG, 2002, HELV CHIM ACTA, V85, P2594, DOI 10.1002/1522-2675(200209)85:9<2594::AID-HLCA2594>3.0.CO;2-R; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Ehrhardt CJ, 2009, J MICROSC-OXFORD, V236, P5, DOI 10.1111/j.1365-2818.2009.03207.x; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1883, DOI 10.1016/j.soilbio.2008.03.024; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1284, DOI 10.1016/j.soilbio.2007.06.019; Emmanuelle G, 2005, JOURNAL OF MICROBIOL, V63, P20, DOI [10.1016/j.mimet.2005.02.018, DOI 10.1016/J.MIMET.2005.02.018]; Hazrin-Chong NH, 2012, J MICROBIOL METH, V90, P96, DOI 10.1016/j.mimet.2012.04.014; Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Kenzaka T, 2005, APPL ENVIRON MICROB, V71, P5523, DOI 10.1128/AEM.71.9.5523-5531.2005; Kubota K, 2014, SYST APPL MICROBIOL, V37, P261, DOI 10.1016/j.syapm.2014.02.003; Kubota K, 2013, MICROBES ENVIRON, V28, P3, DOI 10.1264/jsme2.ME12107; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Luef B, 2013, ISME J, V7, P338, DOI 10.1038/ismej.2012.103; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Melton ED, 2014, NAT REV MICROBIOL, V12, P797, DOI 10.1038/nrmicro3347; Schmidt H, 2014, FEMS MICROBIOL ECOL, V87, P390, DOI 10.1111/1574-6941.12232; Schmidt H, 2012, SYST APPL MICROBIOL, V35, P518, DOI 10.1016/j.syapm.2012.04.006; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Weipoltshammer K, 2000, HISTOCHEM CELL BIOL, V114, P489; Williams DB, 1996, THE TRANSMISSION ELE; Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e	32	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126404	10.1371/journal.pone.0126404	http://dx.doi.org/10.1371/journal.pone.0126404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018431	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600051
J	Anton, BP; Mongodin, EF; Agrawal, S; Fomenkov, A; Byrd, DR; Roberts, RJ; Raleigh, EA				Anton, Brian P.; Mongodin, Emmanuel F.; Agrawal, Sonia; Fomenkov, Alexey; Byrd, Devon R.; Roberts, Richard J.; Raleigh, Elisabeth A.			Complete Genome Sequence of ER2796, a DNA Methyltransferase-Deficient Strain of Escherichia coli K-12	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEM; METHYLASE DAM MUTANTS; HELICOBACTER-PYLORI; CYTOSINE METHYLATION; STATIONARY-PHASE; GENE CONVERSION; SINGLE-MOLECULE; MUTATIONS; RECOMBINATION; EXPRESSION	We report the complete sequence of ER2796, a laboratory strain of Escherichia coli K-12 that is completely defective in DNA methylation. Because of its lack of any native methylation, it is extremely useful as a host into which heterologous DNA methyltransferase genes can be cloned and the recognition sequences of their products deduced by Pacific Biosciences Single-Molecule Real Time (SMRT) sequencing. The genome was itself sequenced from a long-insert library using the SMRT platform, resulting in a single closed contig devoid of methylated bases. Comparison with K-12 MG1655, the first E. coli K-12 strain to be sequenced, shows an essentially co-linear relationship with no major rearrangements despite many generations of laboratory manipulation. The comparison revealed a total of 41 insertions and deletions, and 228 single base pair substitutions. In addition, the long-read approach facilitated the surprising discovery of four gene conversion events, three involving rRNA operons and one between two cryptic prophages. Such events thus contribute both to genomic homogenization and to bacteriophage diversification. As one of relatively few laboratory strains of E. coli to be sequenced, the genome also reveals the sequence changes underlying a number of classical mutant alleles including those affecting the various native DNA methylation systems.	[Anton, Brian P.; Fomenkov, Alexey; Byrd, Devon R.; Roberts, Richard J.; Raleigh, Elisabeth A.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Mongodin, Emmanuel F.; Agrawal, Sonia] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	New England Biolabs; University System of Maryland; University of Maryland Baltimore	Raleigh, EA (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	raleigh@neb.com	Mongodin, Emmanuel/AAF-1850-2020; Agrawal, Sonia/AAC-6273-2020	Mongodin, Emmanuel/0000-0003-3833-7437; Agrawal, Sonia/0000-0003-4484-7433; Roberts, Richard/0000-0002-4348-0169; Raleigh, Elisabeth A./0000-0003-0745-9925				Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9; Bachmann B. J., 1987, ESCHERICHIA COLI SAL, V2, P807; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Beckwith J, 1978, THE OPERON, P11; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Broadbent SE, 2007, J BACTERIOL, V189, P4325, DOI 10.1128/JB.01854-06; BROOKS JE, 1989, NUCLEIC ACIDS RES, V17, P979, DOI 10.1093/nar/17.3.979; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; DAR ME, 1993, MOL MICROBIOL, V9, P823, DOI 10.1111/j.1365-2958.1993.tb01741.x; DRYDEN DTF, 1993, J BIOL CHEM, V268, P13228; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; FRAM RJ, 1985, MOL PHARMACOL, V28, P51; Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469; GARRICKS.L, 1970, GENETICS, V66, P231; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARAYAMA S, 1983, J BACTERIOL, V153, P408, DOI 10.1128/JB.153.1.408-415.1983; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; INOKUCHI H, 1979, J MOL BIOL, V132, P663, DOI 10.1016/0022-2836(79)90381-4; Jensen KF, 1993, J BACTERIOL, V175, P3401; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Kahramanoglou C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1878; KARRAN P, 1982, NATURE, V296, P868, DOI 10.1038/296868a0; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; KLECKNER N, 1979, J MOL BIOL, V127, P89, DOI 10.1016/0022-2836(79)90461-3; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; Krebes J, 2014, NUCLEIC ACIDS RES, V42, P2415, DOI 10.1093/nar/gkt1201; Kusano K, 1997, J BACTERIOL, V179, P5380, DOI 10.1128/jb.179.17.5380-5390.1997; Laehnemann D, 2014, GENOME BIOL EVOL, V6, P1287, DOI 10.1093/gbe/evu106; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Lieb M, 1996, MOL MICROBIOL, V20, P467, DOI 10.1046/j.1365-2958.1996.5291066.x; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P56, DOI 10.1093/nar/gkt747; LOW B, 1968, P NATL ACAD SCI USA, V60, P160, DOI 10.1073/pnas.60.1.160; MACNEIL DJ, 1988, J BACTERIOL, V170, P5607, DOI 10.1128/jb.170.12.5607-5612.1988; MARINUS MG, 1974, J MOL BIOL, V85, P309, DOI 10.1016/0022-2836(74)90366-0; MARINUS MG, 1976, MOL GEN GENET, V149, P273, DOI 10.1007/BF00268528; Marinus MG, 2000, J BACTERIOL, V182, P463, DOI 10.1128/JB.182.2.463-468.2000; MARINUS MG, 1973, J BACTERIOL, V114, P1143, DOI 10.1128/JB.114.3.1143-1150.1973; Militello KT, 2012, FEMS MICROBIOL LETT, V328, P78, DOI 10.1111/j.1574-6968.2011.02482.x; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Neidhardt, 1996, ESCHERICHIA COLIAND, V2, P2460; Nichols BP, 1998, J BACTERIOL, V180, P6408; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; PALMER BR, 1994, GENE, V143, P1, DOI 10.1016/0378-1119(94)90597-5; PARKER B, 1988, GENE, V73, P531, DOI 10.1016/0378-1119(88)90517-3; Parker BW, 2013, J BIOL CHEM, V288, P32574, DOI 10.1074/jbc.M113.503516; PETERSON KR, 1985, MOL GEN GENET, V201, P14, DOI 10.1007/BF00397979; PETERSON KR, 1993, J BACTERIOL, V175, P7505, DOI 10.1128/JB.175.22.7505-7508.1993; Raghavan R, 2011, J BACTERIOL, V193, P2871, DOI 10.1128/JB.00398-11; RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x; RALEIGH EA, 1984, J MOL BIOL, V173, P437, DOI 10.1016/0022-2836(84)90390-5; RALEIGH EA, 1989, GENETICS, V122, P279; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Santoyo G, 2005, J BACTERIOL, V187, P4116, DOI 10.1128/JB.187.12.4116-4126.2005; Sibley MH, 2004, NUCLEIC ACIDS RES, V32, P522, DOI 10.1093/nar/gkh194; Singaravelan B, 2010, J BACTERIOL, V192, P6039, DOI 10.1128/JB.00474-10; SINGER M, 1989, MICROBIOL REV, V53, P1; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Suzuki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019534; Talarico S, 2012, MOL MICROBIOL, V84, P1050, DOI 10.1111/j.1365-2958.2012.08073.x; Turner PC, 2012, J IND MICROBIOL BIOT, V39, P629, DOI 10.1007/s10295-011-1052-2; Visick JE, 1997, J BACTERIOL, V179, P4158, DOI 10.1128/jb.179.13.4158-4163.1997; Zhou J, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI DOI 10.1093/NAR/GKS1235; ZIPSER D, 1967, J MOL BIOL, V25, P567, DOI 10.1016/0022-2836(67)90209-4; ZIPSER D, 1970, J MOL BIOL, V49, P251, DOI 10.1016/0022-2836(70)90392-X	72	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127446	10.1371/journal.pone.0127446	http://dx.doi.org/10.1371/journal.pone.0127446			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010885	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900092
J	Berge, LI; Riise, T; Tell, GS; Iversen, MM; Ostbye, T; Lund, A; Knudsen, AK				Berge, Line I.; Riise, Trond; Tell, Grethe S.; Iversen, Marjolein M.; Ostbye, Truls; Lund, Anders; Knudsen, Ann Kristin			Depression in Persons with Diabetes by Age and Antidiabetic Treatment: A Cross-Sectional Analysis with Data from the Hordaland Health Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; MENTAL-DISORDERS; GLYCEMIC CONTROL; RISK-FACTOR; METAANALYSIS; PREVALENCE; METFORMIN; SYMPTOMS; DISEASES; ATHEROSCLEROSIS	Background Persons with diabetes have increased risk of depression, however, studies addressing whether the risk varies by age and type of antidiabetic treatment have yielded conflicting results. The aim of this study was to investigate if the association between diabetes and depression varied by type of antidiabetic treatment in a large community based sample of middle-aged (40-47 years) and older adults (70-72 years). Methods Data from 21845 participants in the Hordaland Health Study (HUSK) were analyzed in a cross-sectional design. Diabetes was assessed by self-report and classified as un-medicated, treated by oral antidiabetic agents or by insulin. Depression was defined as a score >= 8 on the depression subscale of the Hospital Anxiety and Depression Scale and/or self-reported use of antidepressant agents. Associations between diabetes and depression were estimated using logistic regression. Results Persons in their forties with diabetes had a doubled prevalence of depression (OR: 1.96 (95% C. I.: 1.35, 2.83)) compared to persons without diabetes, while a lower and non-significant association was found among persons in their seventies. Persons in their forties with orally treated diabetes had about three times higher prevalence of depression (OR: 2.92 (95% C. I.: 1.48, 5.77)) after adjustment for gender, BMI, physical activity, alcohol consumption and education, compared to non-diabetic persons in the same age-group. No association between depression and insulin or un-medicated diabetes was found. Conclusions Clinicians should be aware that persons in their forties with orally treated diabetes are at a marked increased risk of depression.	[Berge, Line I.; Riise, Trond; Tell, Grethe S.; Ostbye, Truls; Knudsen, Ann Kristin] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Berge, Line I.; Lund, Anders] Univ Bergen, Sect Psychiat, Dept Clin Med 1, Bergen, Norway; [Berge, Line I.; Lund, Anders] Univ Bergen, Haukeland Univ Hosp, Mood Net Res Grp, Bergen, Norway; [Iversen, Marjolein M.] Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway; [Iversen, Marjolein M.] Stavanger Univ Hosp, Endocrinol Sect, Dept Med, Stavanger, Norway; [Ostbye, Truls] Duke Univ, Global Hlth Inst, Durham, NC 27706 USA; [Knudsen, Ann Kristin] Norwegian Inst Publ Hlth, Dept Hlth Registries, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Western Norway University of Applied Sciences; Stavanger University Hospital; Duke University; Norwegian Institute of Public Health (NIPH)	Berge, LI (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	line.iden.berge@gmail.com	Knudsen, Ann Kristin/AAB-2465-2019; Riise, Trond/H-1390-2018; Tell, Grethe/G-5639-2015	Riise, Trond/0000-0001-9644-5140; Tell, Grethe/0000-0003-1386-1638; Knudsen, Ann Kristin/0000-0002-1218-798X; Iversen, Marjolein Memelink/0000-0001-9954-171X	University of Bergen	University of Bergen	The authors received no specific funding for this particular work. This work is a part of a PHD funded by the University of Bergen.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; [Anonymous], 2013, DIABETES ATLAS; Anstey KJ, 2009, PSYCHOSOM MED, V71, P937, DOI 10.1097/PSY.0b013e3181beab60; Barnard K, 2013, DIABETES CARE, V36, P3337, DOI 10.2337/dc13-0560; Berge LI, 2012, DIABETIC MED, V29, P509, DOI 10.1111/j.1464-5491.2011.03530.x; Berkowitz SA, 2013, DIABETOLOGIA, V56, P2593, DOI 10.1007/s00125-013-3036-4; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Chen PC, 2013, DIABETES CARE, V36, P376, DOI 10.2337/dc12-0473; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Engum A, 2007, J PSYCHOSOM RES, V62, P31, DOI 10.1016/j.jpsychores.2006.07.009; Gendelman N, 2009, DIABETES CARE, V32, P575, DOI 10.2337/dc08-1835; Golden SH, 2007, PSYCHOSOM MED, V69, P529, DOI 10.1097/PSY.0b013e3180f61c5c; Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Heckbert SR, 2010, J GEN INTERN MED, V25, P524, DOI 10.1007/s11606-010-1272-6; Hessler DM, 2011, PATIENT EDUC COUNS, V85, P154, DOI 10.1016/j.pec.2010.10.030; Hsu CC, 2011, J ALZHEIMERS DIS, V24, P485, DOI 10.3233/JAD-2011-101524; Institute for Health Metrics and Evaluation, 2013, THE GLOBAL BURDEN OF; Klungel OH, 1999, NETH J MED, V55, P177, DOI 10.1016/S0300-2977(99)00045-5; Knol MJ, 2007, PSYCHOSOM MED, V69, P300, DOI 10.1097/PSY.0b013e31805f48b9; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Li CY, 2008, DIABETES CARE, V31, P105, DOI 10.2337/dc07-1154; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lin EHB, 2008, J PSYCHOSOM RES, V65, P571, DOI 10.1016/j.jpsychores.2008.06.007; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Pan A, 2010, ARCH INTERN MED, V170, P1884, DOI 10.1001/archinternmed.2010.356; Park M, 2013, GEN HOSP PSYCHIAT, V35, P217, DOI 10.1016/j.genhosppsych.2013.01.006; Roy T, 2012, DIABETIC MED, V29, P164, DOI 10.1111/j.1464-5491.2011.03401.x; Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6; Rubin RR, 2005, DIABETES CARE, V28, P830; Schneider ALC, 2012, AM J EPIDEMIOL, V176, P738, DOI 10.1093/aje/kws156; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; Schumann G, 2014, EUR NEUROPSYCHOPHARM, V24, P5, DOI 10.1016/j.euroneuro.2013.09.010; Stringhini S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001479; Wahlqvist ML, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-150; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Waitzfelder B, 2010, PRIM CARE DIABETES, V4, P215, DOI 10.1016/j.pcd.2010.07.002; Yoon JM, 2013, KOREAN J FAM MED, V34, P228, DOI 10.4082/kjfm.2013.34.4.228	42	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127161	10.1371/journal.pone.0127161	http://dx.doi.org/10.1371/journal.pone.0127161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010615	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900069
J	Brar, S; Tsui, CKM; Dhillon, B; Bergeron, MJ; Joly, DL; Zambino, PJ; El-Kassaby, YA; Hamelin, RC				Brar, Simren; Tsui, Clement K. M.; Dhillon, Braham; Bergeron, Marie-Josee; Joly, David L.; Zambino, P. J.; El-Kassaby, Yousry A.; Hamelin, Richard C.			Colonization History, Host Distribution, Anthropogenic Influence and Landscape Features Shape Populations of White Pine Blister Rust, an Invasive Alien Tree Pathogen	PLOS ONE			English	Article							CRONARTIUM-RIBICOLA; NORTH-AMERICA; AERIAL DISPERSAL; LIMBER PINE; GENE; EPIDEMIOLOGY; RESISTANCE; EASTERN; SPECIALIZATION; MANAGEMENT	White pine blister rust is caused by the fungal pathogen Cronartium ribicola J.C. Fisch (Basidiomycota, Pucciniales). This invasive alien pathogen was introduced into North America at the beginning of the 20th century on pine seedlings imported from Europe and has caused serious economic and ecological impacts. In this study, we applied a population and landscape genetics approach to understand the patterns of introduction and colonization as well as population structure and migration of C. ribicola. We characterized 1,292 samples of C. ribicola from 66 geographic locations in North America using single nucleotide polymorphisms (SNPs) and evaluated the effect of landscape features, host distribution, and colonization history on the structure of these pathogen populations. We identified eastern and western genetic populations in North America that are strongly differentiated. Genetic diversity is two to five times higher in eastern populations than in western ones, which can be explained by the repeated accidental introductions of the pathogen into northeastern North America compared with a single documented introduction into western North America. These distinct genetic populations are maintained by a barrier to gene flow that corresponds to a region where host connectivity is interrupted. Furthermore, additional cryptic spatial differentiation was identified in western populations. This differentiation corresponds to landscape features, such as mountain ranges, and also to host connectivity. We also detected genetic differentiation between the pathogen populations in natural stands and plantations, an indication that anthropogenic movement of this pathogen still takes place. These results highlight the importance of monitoring this invasive alien tree pathogen to prevent admixture of eastern and western populations where different pathogen races occur.	[Brar, Simren; Tsui, Clement K. M.; Dhillon, Braham; El-Kassaby, Yousry A.; Hamelin, Richard C.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Bergeron, Marie-Josee; Hamelin, Richard C.] Nat Resources Canada, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [Joly, David L.] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada; [Zambino, P. J.] US Forest Serv, USDA, Coeur dAlene Field Off, Coeur Dalene, ID USA	University of British Columbia; Natural Resources Canada; University of Moncton; United States Department of Agriculture (USDA); United States Forest Service	Hamelin, RC (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	Richard.hamelin@ubc.ca	El-Kassaby, Yousry A/K-9856-2016; Joly, David/ABC-5640-2020; Tsui, Clement/F-6416-2013; Hamelin, Richard/F-7006-2010; Joly, David/B-4612-2012	El-Kassaby, Yousry A/0000-0002-4887-8977; Tsui, Clement/0000-0001-5129-1037; Hamelin, Richard/0000-0003-4006-532X; Joly, David/0000-0001-8411-5558	NSERC; Genome Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada)	This study was funded by an NSERC Discovery grant to RCH that supported a research assistant-ship to SB, and by a Genome Canada Large Scale Applied Genomics grant to RCH that supported BD and CKMT, (http://www.genomecanada.ca/en/portfolio/research/2010-competition.aspx).	ANDERSON R. L., 1955, Forest Science, V1, P38; Archie EA, 2009, TRENDS ECOL EVOL, V24, P21, DOI 10.1016/j.tree.2008.08.008; Arsdel E. P., 2006, P 53 W INT FOR DIS W, P49; Biek R, 2010, MOL ECOL, V19, P3515, DOI 10.1111/j.1365-294X.2010.04679.x; BROWN DH, 1978, PLANT DIS REP, V62, P905; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; CLOSE RC, 1978, INT J BIOMETEOROL, V22, P1, DOI 10.1007/BF01553136; Cummins G, 2003, THE AMERICAN PHYTOPA; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; DIAMOND JM, 1976, SCIENCE, V193, P1027, DOI 10.1126/science.193.4257.1027; Dong SM, 2014, SCIENCE, V343, P552, DOI 10.1126/science.1246300; DRAPER MA, 1993, PLANT DIS, V77, P952, DOI 10.1094/PD-77-0952C; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Geils BW, 2010, FOREST PATHOL, V40, P147, DOI 10.1111/j.1439-0329.2010.00654.x; Hamelin RC, 2000, PHYTOPATHOLOGY, V90, P1073, DOI 10.1094/PHYTO.2000.90.10.1073; Hamelin RC, 1995, THEOR APPL GENET, V91, P1214, DOI 10.1007/BF00220932; HAWKSWORTH FG, 1990, PLANT DIS, V74, P938, DOI 10.1094/PD-74-0938A; Hunt RS, 2009, FOREST CHRON, V85, P516, DOI 10.5558/tfc85516-4; HUNT RS, 1991, FOREST CHRON, V67, P284, DOI 10.5558/tfc67284-3; Johnson D. W., 2000, Plant Disease, V84, P595, DOI 10.1094/PDIS.2000.84.5.595D; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kinloch BB, 2004, PHYTOPATHOLOGY, V94, P751, DOI 10.1094/PHYTO.2004.94.7.751; Kinloch BB, 2003, PHYTOPATHOLOGY, V93, P1044, DOI 10.1094/PHYTO.2003.93.8.1044; Kinloch BB, 2003, PHYTOPATHOLOGY, V93, P691, DOI 10.1094/PHYTO.2003.93.6.691; KINLOCH BB, 1981, PLANT DIS, V65, P604, DOI 10.1094/PD-65-604; Loo J, 2009, BIOL INVASIONS, V11, P81, DOI 10.1007/s10530-008-9321-3; LUNDQUIST JE, 1992, PLANT DIS, V76, P538, DOI 10.1094/PD-76-0538A; Maloy OC, 1997, ANNU REV PHYTOPATHOL, V35, P87, DOI 10.1146/annurev.phyto.35.1.87; McDonald GI, 2006, FOREST PATHOL, V36, P73, DOI 10.1111/j.1439-0329.2006.00432.x; MIELKE J. L., 1943, Bull. Sch. For. Yale Univ., V52; Milgroom MG, 2003, PLANT DIS, V87, P608, DOI 10.1094/PDIS.2003.87.6.608; MOIR W. S., 1924, Bulletin. United States Department of Agriculture; Mulvey RL, 2011, FOREST PATHOL, V41, P453, DOI 10.1111/j.1439-0329.2010.00702.x; NAGARAJAN S, 1990, ANNU REV PHYTOPATHOL, V28, P139, DOI 10.1146/annurev.py.28.090190.001035; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richardson BA, 2007, CAN J BOT, V85, P299, DOI 10.1139/B07-031; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Schoettle AW, 2007, J FOREST RES-JPN, V12, P327, DOI 10.1007/s10310-007-0024-x; Schwandt JW, 2010, FOREST PATHOL, V40, P226, DOI 10.1111/j.1439-0329.2010.00656.x; Smith JA, 2006, PHYTOPATHOLOGY, V96, P171, DOI 10.1094/PHYTO-96-0171; Sniezko RA, 2004, BREEDING AND GENETIC, V2, P203; Spaulding P, 1929, USDA TECHNICAL BULLE, V87, P58; Spaulding P., 1911, USDA BUR PLANT IND B, V206, P88; SPIERS AG, 1994, MYCOL RES, V98, P889, DOI 10.1016/S0953-7562(09)80260-8; Stewart FC, 1906, NY AGR EXP STN TECH, P61; Tanguay P, 2013, PHYTOPATHOLOGY, V103, P143; Tomback DF, 2007, PHYS GEOGR, V28, P397, DOI 10.2747/0272-3646.28.5.397; Vialle A, 2013, MOL PHYLOGENET EVOL, V66, P628, DOI 10.1016/j.ympev.2012.10.021; Washburn LF, 1917, WORK ON PINE BLISTER; Zambino PJ, 2007, PLANT DIS, V91, P467, DOI 10.1094/PDIS-91-4-0467A; Zambino PJ, 2010, FOREST PATHOL, V40, P264, DOI 10.1111/j.1439-0329.2010.00658.x	56	13	13	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127916	10.1371/journal.pone.0127916	http://dx.doi.org/10.1371/journal.pone.0127916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010250	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900165
J	Chen, LX; Zhou, ZR; Li, YL; Ning, GZ; Zhang, TS; Zhang, D; Feng, SQ				Chen, Ling-Xiao; Zhou, Zhi-Rui; Li, Yu-Lin; Ning, Guang-Zhi; Zhang, Tian-Song; Zhang, Di; Feng, Shi-Qing			Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis	PLOS ONE			English	Article							ESTABLISHED PRIMARY OSTEOPOROSIS; PARATHYROID-HORMONE; DOUBLE-BLIND; ALENDRONATE TREATMENT; VERTEBRAL FRACTURES; POSTMENOPAUSAL OSTEOPOROSIS; IDIOPATHIC OSTEOPOROSIS; SECONDARY OSTEOPOROSIS; STRONTIUM RANELATE; EFFICACY	Context The preferred treatment for osteoporosis in men is debated, and pairwise meta-analysis cannot obtain hierarchies of these treatments. Objective The objective of this study was to integrate the evidence and provide hierarchies of eight drugs based on their effect on the bone mineral density in the lumbar spine (BMD in LS) and the fracture rate. Data Sources Eligible studies were identified by searching Amed, British Nursing Index, EMBASE, PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), Google Scholar, SIGLE, the National Technical Information Service, the National Research Register (UK), and the Current Controlled Trials databases. Study Selection RCTs or quasi-RCTs reporting at least two drugs (two active drugs or one active drug and a placebo) used to treat osteoporosis in men were selected by two authors. Data Extraction Two authors independently extracted the data. Data Synthesis Thirteen studies involving 3647 patients were included. Compared with placebo therapy, zoledronate (SMDs 13.48, 95% credible intervals 11.88-15.08) yielded the most significant effect on increasing the BMD in LS, followed by alendronate (11.04, 9.68-12.41), teriparatide (20mcg) + risedronate (10.98, 8.55-13.48), risedronate (10.33, 8.68-12.01), teriparatide (20mcg) (9.33, 6.87-11.76), strontium ranelate (8.88, 7.51-10.24), ibandronate (5.49, 3.82-7.16), parathyroid hormone (1-84) (4.89, 3.12-6.62) and alfacalcidol (3.42, 1.7-5.2). Placebo therapy had a significantly higher fracture rate in contrast to risedronate (OR 2.51, 95% CrI 1.23-4.24) or zoledronate (2.92, 1.29-5.62) or teriparatide (20mcg) (4.04, 1.36-8.49) or teriparatide (40mcg) (3.5, 1.14-8.34). Zoledronate ranked first for increasing the BMD in LS, and teriparatide (20mg) was ranked first for decreasing the fracture rate. Conclusions Zoledronate might be the best choice to increase the BMD in LS and teriparatide (20mg) might lead to the lowest fracture rate.	[Chen, Ling-Xiao; Li, Yu-Lin; Ning, Guang-Zhi; Zhang, Di; Feng, Shi-Qing] Tianjin Med Univ, Gen Hosp, Dept Orthopaed, Tianjin, Peoples R China; [Zhou, Zhi-Rui] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Radiat Oncol,Dept Oncol, Shanghai 200032, Peoples R China; [Zhang, Tian-Song] Jing Dist Cent Hosp Shanghai, Internal Med Tradit Chinese Med Dept, Shanghai 200040, Peoples R China	Tianjin Medical University; Fudan University	Feng, SQ (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Orthopaed, 154 Anshan Rd, Tianjin, Peoples R China.	fengsq321@gmail.com	Chen, Lingxiao/M-7806-2019	Chen, Lingxiao/0000-0001-7721-0493				Adami S, 2001, CALCIFIED TISSUE INT, V69, P239, DOI 10.1007/s00223-001-1066-2; Boonen S, 2012, NEW ENGL J MED, V367, P1714, DOI 10.1056/NEJMoa1204061; Boonen S, 2012, BONE, V51, P383, DOI 10.1016/j.bone.2012.06.016; Boonen S, 2009, J BONE MINER RES, V24, P719, DOI 10.1359/JBMR.081214; Cosman F, 2005, NEW ENGL J MED, V353, P566, DOI 10.1056/NEJMoa050157; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Felsenberg D, 2011, J MUSCULOSKEL NEURON, V11, P34; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Freemantle N, 2013, OSTEOPOROSIS INT, V24, P209, DOI 10.1007/s00198-012-2068-9; Fujita T, 2007, J BONE MINER METAB, V25, P130, DOI 10.1007/s00774-006-0738-4; Gillberg P, 2002, J CLIN ENDOCR METAB, V87, P4900, DOI 10.1210/jc.2002-020231; Gonnelli S, 2003, CALCIFIED TISSUE INT, V73, P133, DOI 10.1007/s00223-002-1085-7; Guven Z, 2007, AGING MALE, V10, P197, DOI 10.1080/13685530701661051; Guyatt GH, 2002, ENDOCRIN METAB CLIN, V31, P659, DOI 10.1016/S0889-8529(02)00024-5; Hamdy R C, 1998, Am J Ther, V5, P89, DOI 10.1097/00045391-199803000-00006; Ho YV, 2000, OSTEOPOROSIS INT, V11, P98, DOI 10.1007/PL00004182; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Hwang JS, 2010, J BONE MINER METAB, V28, P328, DOI 10.1007/s00774-009-0136-9; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Serrano AJ, 2013, GYNECOL ENDOCRINOL, V29, P1005, DOI 10.3109/09513590.2013.813468; Kaufman JM, 2013, J CLIN ENDOCR METAB, V98, P592, DOI 10.1210/jc.2012-3048; Kaufman JM, 2005, OSTEOPOROSIS INT, V16, P510, DOI 10.1007/s00198-004-1713-3; Kurland ES, 2000, J CLIN ENDOCR METAB, V85, P3069, DOI 10.1210/jc.85.9.3069; Leslie WD, 2014, CURR OPIN RHEUMATOL, V26, P440, DOI 10.1097/BOR.0000000000000064; Leslie WD, 2014, J BONE MINER RES, V29, P952, DOI 10.1002/jbmr.2099; Looker AC, 2012, OSTEOPOROSIS INT, V23, P771, DOI 10.1007/s00198-011-1623-0; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Majima T, 2008, INTERNAL MED, V47, P717, DOI 10.2169/internalmedicine.47.0591; Migliore A, 2013, EUR REV MED PHARMACO, V17, P658; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Orwoll ES, 2010, J BONE MINER RES, V25, P2239, DOI 10.1002/jbmr.119; Orwoll ES, 2010, BONE, V46, P970, DOI 10.1016/j.bone.2009.12.034; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Ringe JD, 1998, OSTEOPOROSIS INT, V8, P47, DOI 10.1007/s001980050047; Ringe JD, 2006, RHEUMATOL INT, V26, P427, DOI 10.1007/s00296-005-0004-4; Ringe JD, 2004, RHEUMATOL INT, V24, P110, DOI 10.1007/s00296-003-0388-y; Ringe JD, 2001, J CLIN ENDOCR METAB, V86, P5252, DOI 10.1210/jc.86.11.5252; Ringe JD, 2010, ARZNEIMITTELFORSCH, V60, P267; Ringe JD, 2009, RHEUMATOL INT, V29, P311, DOI 10.1007/s00296-008-0689-2; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schwarz P, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/259818; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586; Sun YP, 2002, CHINESE MED J-PEKING, V115, P402; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Tajeu GS, 2014, J GERONTOL A-BIOL, V69, P346, DOI 10.1093/gerona/glt105; Walker MD, 2013, ENDOCRINE, V44, P237, DOI 10.1007/s12020-012-9819-4; Watts Nelson B, 2010, Endocr Pract, V16 Suppl 3, P1	49	20	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128032	10.1371/journal.pone.0128032	http://dx.doi.org/10.1371/journal.pone.0128032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010450	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900187
J	Chen, Q; Xu, HG; Tan, LD				Chen, Qiang; Xu, Hongguo; Tan, Lidong			Application of Composite Small Calibration Objects in Traffic Accident Scene Photogrammetry	PLOS ONE			English	Article							SELF-CALIBRATION	In order to address the difficulty of arranging large calibration objects and the low measurement accuracy of small calibration objects in traffic accident scene photogrammetry, a photogrammetric method based on a composite of small calibration objects is proposed. Several small calibration objects are placed around the traffic accident scene, and the coordinate system of the composite calibration object is given based on one of them. By maintaining the relative position and coplanar relationship of the small calibration objects, the local coordinate system of each small calibration object is transformed into the coordinate system of the composite calibration object. The two-dimensional direct linear transformation method is improved based on minimizing the reprojection error of the calibration points of all objects. A rectified image is obtained using the nonlinear optimization method. The increased accuracy of traffic accident scene photogrammetry using a composite small calibration object is demonstrated through the analysis of field experiments and case studies.	[Chen, Qiang; Xu, Hongguo; Tan, Lidong] Jilin Univ, Sch Transportat, Changchun 130023, Jilin, Peoples R China	Jilin University	Tan, LD (corresponding author), Jilin Univ, Sch Transportat, Changchun 130023, Jilin, Peoples R China.	tanld@jlu.edu.cn			National Natural Science Foundation of China [51078167]; National High Technology Research and Development Program of China (863 Program) [2009AA11Z201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	The authors extend their gratitude to the National Natural Science Foundation of China (No. 51078167) and the National High Technology Research and Development Program of China (863 Program No. 2009AA11Z201) for their assistance with this project.	Abdel-Aziz Y. I., 1971, P ASP UI S CLOS RANG, P1, DOI [DOI 10.1080/10671188.1967.10616517, 10.14358/PERS.81.2.103]; DeChant L, 2012, AE TECHNICAL PAPER, DOI [10.4271/2012-01-0612, DOI 10.4271/2012-01-0612]; DeMa S, 1996, IEEE T ROBOTIC AUTOM, V12, P114, DOI 10.1109/70.481755; Du XG, 2009, ADV ENG SOFTW, V40, P497, DOI 10.1016/j.advengsoft.2008.09.002; Fenton S, 1997, SAE PUBLICATIONS, VV, P29, DOI [10.4271/970944, DOI 10.4271/970944]; Fraser C.S., 2008, INT ARCH PHOTOGRAMME, VXXXVII, P125; Hartley RI, 1997, INT J COMPUT VISION, V22, P5, DOI 10.1023/A:1007957826135; Hovey C, 2013, SAE TECHNICAL PAPER, DOI [10.4271/2013-01-0780, DOI 10.4271/2013-01-0780]; Huo Ju, 2013, Infrared and Laser Engineering, V42, P1474; Jin J, 2013, J OPT SOC AM A, V30, P287, DOI 10.1364/JOSAA.30.000287; Lin PD, 2007, OPT EXPRESS, V15, P3012, DOI 10.1364/OE.15.003012; Ma Y, 2004, AN INVITATION TO 3 D, DOI [10.1007/978-0-387-21779-6, DOI 10.1007/978-0-387-21779-6]; Massa D, 1999, SAE TECHNICAL PAPER, DOI [10.4271/1999-01-0093, DOI 10.4271/1999-01-0093]; MAYBANK SJ, 1992, INT J COMPUT VISION, V8, P123, DOI 10.1007/BF00127171; Neale W. T., 2011, SAE TECHNICAL PAPER, DOI [10.4271/2011-01-0286, DOI 10.4271/2011-01-0286]; Rahman T, 2012, IEEE T IMAGE PROCESS, V21, P626, DOI 10.1109/TIP.2011.2164421; Randles B, 2010, 2010010065 SAE, DOI [10.4271/2010-01-0065, DOI 10.4271/2010-01-0065]; Rucoba R, 2008, SAE TECHNICAL PAPER, DOI [10.4271/2008-01-0163, DOI 10.4271/2008-01-0163]; Shang Y, 2013, OPTIK, V124, P6553, DOI 10.1016/j.ijleo.2013.05.121; Toglia A, 2005, Proceedings of the ASME Computers and Information in Engineering Division, P21; Topolsek D, 2014, J TRANSPORT TECHNOL, V4, P84, DOI [10.4236/jtts.2014.41008, DOI 10.4236/JTTS.2014.41008]; TSAI RY, 1987, IEEE T ROBOTIC AUTOM, V3, P323, DOI 10.1109/JRA.1987.1087109; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	23	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127018	10.1371/journal.pone.0127018	http://dx.doi.org/10.1371/journal.pone.0127018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011052	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900055
J	Eggers, M; Enders, M; Terletskaia-Ladwig, E				Eggers, Maren; Enders, Martin; Terletskaia-Ladwig, Elena			Evaluation of the Becton Dickinson Rapid Influenza Diagnostic Tests in Outpatients in Germany during Seven Influenza Seasons	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PCR; METAANALYSIS; PERFORMANCE; INFECTION	Background An extensive retrospective study spanning several seasons was undertaken to evaluate the diagnostic performance of the BD rapid influenza diagnostic test (RIDT) in comparison with the RT-PCR assay. Methods A total of 2,179 respiratory samples were tested in parallel by in-house RT-PCR and the RIDT. During the 2003-2004, 2006-2007, 2007-2008, and 2008-2009 (n= 1671) seasons, the BD Directigen Flu A+B test was used, and during the 2010-2011, 2011-2012 and 2012-2013 (n= 508) seasons, the BD Directigen EZ Flu A+B test b was used. Results The sensitivity, specificity, PPV and NPV for the BD Directigen Flu A+B test calculated for types A and B together were 39%, 99%, 98%, and 56%, respectively. For the BD Directigen EZ Flu A+B test, these values were 47%, 100%, 100%, 55%, respectively. The sensitivity of the BD Directigen Flu A+B test did not differ significantly from season to season or between types A (44%) and B (37%). The sensitivity of the BD Directigen EZ Flu A+B test calculated for type A only was 59%, which was considerably higher than the sensitivity of this test for type B (23%). The sensitivity of the RIDT was approximately 40-50% in children and teenagers, but it was only 18.% in adults aged 20 years and older. The specificity of both RIDTs was very high (> 99%) during all seasons. Conclusions Due to their rapid turnaround time, RIDTs can help guide decisions about the clinical management of influenza. Because of the high specificity, a positive result can be interpreted as a true positive, and antiviral therapy as well as appropriate measures to prevent the transmission of influenza can be initiated. The best sensitivity of the RIDT is achieved in children. However, even in this group, the RIDT will only recognize influenza infection in approximately half of the cases, and influenza should still be considered in patients with negative results; negative RIDT results must be confirmed by PCR.	[Eggers, Maren] Prof Gisela Enders & Kollegen MVZ GbR, Stuttgart, Germany; Inst Virol Infect Dis & Epidemiol eV, Stuttgart, Germany		Eggers, M (corresponding author), Prof Gisela Enders & Kollegen MVZ GbR, Rosenbergstr 85, Stuttgart, Germany.	eggers@labor-enders.de		Eggers, Maren/0000-0001-8485-9485				Al Johani S M, 2011, J Infect Public Health, V4, P7, DOI 10.1016/j.jiph.2010.10.004; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Blazquez D, 2010, ENFERM INFEC MICR CL, V28, P698, DOI 10.1016/j.eimc.2010.02.018; Centers for Disease Control and Prevention (CDC), 2014, HAVE YOU HEARD CDC R; Centers for Disease Control and Prevention (CDC), 2011, GUIDANCE FOR CLINICI; CHAKRAVERTY P, 1971, B WORLD HEALTH ORGAN, V45, P755; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; Cheng XD, 2011, J CLIN VIROL, V50, P153, DOI 10.1016/j.jcv.2010.10.002; Effler PV, 2002, EMERG INFECT DIS, V8, P23, DOI 10.3201/eid0801.010067; Eggers M, 2012, EUR J CLIN MICROBIOL, V31, P1257, DOI 10.1007/s10096-011-1437-1; Grondahl B, 2005, CLIN MICROBIOL INFEC, V11, P848, DOI 10.1111/j.1469-0691.2005.01223.x; Heinonen S, 2010, CLIN INFECT DIS, V51, P887, DOI 10.1086/656408; Heneghan CJ, 2014, ZANAMIVIR FOR INFLUE; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Jefferson T, 2014, OSELTAMIVIR FOR INFL; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; Liao RS, 2009, J CLIN MICROBIOL, V47, P527, DOI 10.1128/JCM.01213-08; Medimmune, 2012, FLUMIST PRESCRIBING; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Pebody RG, 2011, EMERG INFECT DIS, V17, P990, DOI [10.3201/eid1706.101161, 10.3201/eid/1706.101161]; Schueler S, 2014, ECCMID 2014; Tanei M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003885; Terletskaia-Ladwig E, 2009, INFECTION, V37, P401, DOI 10.1007/s15010-009-8434-7; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7	29	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127070	10.1371/journal.pone.0127070	http://dx.doi.org/10.1371/journal.pone.0127070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011531	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900059
J	de Moraes, ACF; Cassenote, AJF; Leclercq, C; Dallongeville, J; Androutsos, O; Torok, K; Gonzalez-Gross, M; Widhalm, K; Kafatos, A; Carvalho, HB; Moreno, LA				Ferreira de Moraes, Augusto Cesar; Cassenote, Alex Jones Flores; Leclercq, Catherine; Dallongeville, Jean; Androutsos, Odysseas; Toeroek, Katalin; Gonzalez-Gross, Marcela; Widhalm, Kurt; Kafatos, Anthony; Carvalho, Heraclito Barbosa; Alberto Moreno, Luis			Resting Heart Rate Is Not a Good Predictor of a Clustered Cardiovascular Risk Score in Adolescents: The HELENA Study	PLOS ONE			English	Article							SYMPATHETIC NEURAL ACTIVATION; HEALTHY LIFE-STYLE; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; OBESITY; HYPERTENSION; PREVALENCE; OVERWEIGHT; NUTRITION; EUROPE	Background Resting heart rate (RHR) reflects sympathetic nerve activity a significant association between RHR and all-cause and cardiovascular mortality has been reported in some epidemiologic studies. Methods To analyze the predictive power and accuracy of RHR as a screening measure for individual and clustered cardiovascular risk in adolescents. The study comprised 769 European adolescents (376 boys) participating in the HELENA cross-sectional study (2006-2008) were included in this study. Measurements on systolic blood pressure, HOMA index, triglycerides, TC/HDL-c, VO(2)max and the sum of four skinfolds were obtained, and a clustered cardiovascular disease (CVD) risk index was computed. The receiver operating characteristics curve was applied to calculate the power and accuracy of RHR to predict individual and clustered CVD risk factors. Results RHR showed low accuracy for screening CVD risk factors in both sexes (range 38.5%-54.4% in boys and 45.5%-54.3% in girls). Low specificity's (15.6%-19.7% in boys; 18.1%-20.0% in girls) were also found. Nevertheless, the sensitivities were moderate-to-high (61.4%-89.1% in boys; 72.9%-90.3% in girls). Conclusion RHR is a poor predictor of individual CVD risk factors and of clustered CVD and the estimates based on RHR are not accurate. The use of RHR as an indicator of CVD risk in adolescents may produce a biased screening of cardiovascular health in both sexes.	[Ferreira de Moraes, Augusto Cesar; Carvalho, Heraclito Barbosa] Univ Sao Paulo, Sch Med, YCARE Youth Child & cARdiovasc Risk & Environm Re, Sao Paulo, Brazil; [Ferreira de Moraes, Augusto Cesar; Alberto Moreno, Luis] Univ Zaragoza, Fac Ciencias Salud, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Cassenote, Alex Jones Flores] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil; [Ferreira de Moraes, Augusto Cesar; Carvalho, Heraclito Barbosa; Alberto Moreno, Luis] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil; [Leclercq, Catherine] Natl Inst Food & Nutr Res, Rome, Italy; [Dallongeville, Jean] Inst Pasteur, F-59019 Lille, France; [Androutsos, Odysseas] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Toeroek, Katalin] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [Gonzalez-Gross, Marcela] Tech Univ Madrid, Fac Phys Act & Sport INEF, Dept Hlth & Human Performance, Madrid, Spain; [Gonzalez-Gross, Marcela] Univ Bonn, Rhein Friedrich Wilhelms, Inst Ernahrungs & Lebensmittelwissensch Humanemah, Dortmund, Germany; [Widhalm, Kurt] Private Med Univ Salzburg, Dept Paediat, Salzburg, Austria; [Kafatos, Anthony] Univ Crete Herakl, Sch Med, Prevent Med & Nutr Unit, Iraklion, NE, Greece	Universidade de Sao Paulo; University of Zaragoza; Universidade de Sao Paulo; Universidade de Sao Paulo; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Harokopio University Athens; University of Pecs; Universidad Politecnica de Madrid; University of Bonn; University of Crete	de Moraes, ACF (corresponding author), Univ Sao Paulo, Sch Med, YCARE Youth Child & cARdiovasc Risk & Environm Re, Sao Paulo, Brazil.	augustocesar.demoraes@usp.br	Gonzalez-Gross, Marcela/W-8000-2018; Cassenote, Alex/C-4220-2013; Androutsos, Odysseas/ABF-8670-2021; Ferreira De Moraes, Augusto César/D-2198-2009; Carvalho, Heráclito/C-1334-2012; Moreno, Luis/S-1780-2019	Ferreira De Moraes, Augusto César/0000-0002-5763-435X; Carvalho, Heráclito/0000-0002-7037-5655; Moreno, Luis/0000-0003-0454-653X; Gonzalez-Gross, Marcela/0000-0001-7757-3235; Leclercq, Catherine/0000-0002-9416-7738	European Community Sixth RTD Framework Programme [FOOD-CT-2005-007034]; Spanish Ministry of Health: Maternal, Child Health and Development Network [RD08/0072]; Spanish Ministry of Education [EX-2008-0641]; Swedish Heart-Lung Foundation [20090635]; Sao Paulo Research Foundation - FAPESP [proc. 2011/11137-1, 2011/20662-2, proc. 2014/13367-2, proc. 2013/18158-1]; Post-Doctoral scholarship from the Brazilian Government from the National Counsel of Technological and Scientific Development - CNPq [proc. 471266/2013-2, 313772/2014-2]; Brazilian government by Science without Borders Program by CNPq (National Counsel of Technological and Scientific Development); CAPES (Coordination of Improvement of Higher Education Personnel) [proc. 007/2012]; European Regional Development Fund (MICINN-FEDER)	European Community Sixth RTD Framework Programme(European Commission); Spanish Ministry of Health: Maternal, Child Health and Development Network(Spanish Government); Spanish Ministry of Education(Spanish Government); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Post-Doctoral scholarship from the Brazilian Government from the National Counsel of Technological and Scientific Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Brazilian government by Science without Borders Program by CNPq (National Counsel of Technological and Scientific Development); CAPES (Coordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); European Regional Development Fund (MICINN-FEDER)	The HELENA Study takes place with the financial support of the European Community Sixth RTD Framework Programme (contract FOOD-CT-2005-007034). The writing group takes sole responsibility for the content of this article. This study was also supported by granta from the Spanish Ministry of Health: Maternal, Child Health and Development Network (number RD08/0072), the Spanish Ministry of Education (EX-2008-0641) and the Swedish Heart-Lung Foundation (20090635). Augusto Cesar F. de Moraes was given a PhD Student scholarship from the Sao Paulo Research Foundation - FAPESP (proc. 2011/11137-1 and 2011/20662-2) and a Post-Doctoral scholarship from the Brazilian Government from the National Counsel of Technological and Scientific Development - CNPq (proc. 471266/2013-2 and 313772/2014-2) and the Sao Paulo Research Foundation - FAPESP (proc. 2014/13367-2). Alex Jones Flores Cassenote was given a PhD Student scholarship from the Sao Paulo Research Foundation - FAPESP (proc. 2013/18158-1). Luis A. Moreno was given a visiting professor scholarship from the Brazilian government by Science without Borders Program by CNPq (National Counsel of Technological and Scientific Development) and CAPES (Coordination of Improvement of Higher Education Personnel) (proc. 007/2012). The GENUD Research Group was co-financed by the European Regional Development Fund (MICINN-FEDER).	Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Beghin L, 2008, INT J OBESITY, V32, pS12, DOI 10.1038/ijo.2008.179; Bemelmans RHH, 2013, INT J CARDIOL, V168, P1410, DOI 10.1016/j.ijcard.2012.12.043; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49; Falkner B, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0449-5; Fernandes RA, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-48; Fernandes RA, 2011, J PEDIATR-US, V158, P634, DOI 10.1016/j.jpeds.2010.10.007; de Moraes ACF, 2009, CAD SAUDE PUBLICA, V25, P1195, DOI 10.1590/S0102-311X2009000600002; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grassi G, 1998, J HYPERTENS, V16, P1635, DOI 10.1097/00004872-199816110-00010; Guidolin M, 2012, SLEEP MED, V13, P779, DOI 10.1016/j.sleep.2012.03.016; Huggett RJ, 2004, HYPERTENSION, V44, P847, DOI 10.1161/01.HYP.0000147893.08533.d8; Iliescu C, 2008, INT J OBESITY, V32, pS19, DOI 10.1038/ijo.2008.178; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moreno LA, 2008, INT J OBESITY, V32, pS4, DOI 10.1038/ijo.2008.177; Moreno LA, 2008, PUBLIC HEALTH NUTR, V11, P288, DOI 10.1017/S1368980007000535; Ortega FB, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.183; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Palatini P, 2004, CLIN EXP HYPERTENS, V26, P637, DOI 10.1081/CEH-200031959; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rey-Lopez JP, 2013, NUTR METAB CARDIOVAS, V23, P1017, DOI 10.1016/j.numecd.2012.06.006; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syme C, 2008, ARCH PEDIAT ADOL MED, V162, P453, DOI 10.1001/archpedi.162.5.453; Topouchian JA, 2006, BLOOD PRESS MONIT, V11, P165, DOI 10.1097/01.mbp.0000209078.17246.34; Weise M, 2002, J CLIN ENDOCR METAB, V87, P5038, DOI 10.1210/jc.2002-020590	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127530	10.1371/journal.pone.0127530	http://dx.doi.org/10.1371/journal.pone.0127530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010248	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900105
J	Wu, Q				Wu, Qun			Pulling Mobile Assisted Language Learning (MALL) into the Mainstream: MALL in Broad Practice	PLOS ONE			English	Article							PHONES; SMS	The researcher designed a smartphone app to help college students to learn English (L2) vocabulary. The app contained 3,402 English words that were compiled into an alphabetic wordlist with each word displayed on three features; namely: spelling, pronunciation and Chinese definitions. To test the effectiveness of the app, an experimental group (with app) was compared with a control group (without app) and knowledge of words was tested before and after the research. The study revealed that the students using the program significantly outperformed those in the control group in vocabulary acquisition. This paper introduced a research design method and set up a pedagogical paradigm which can be followed as a way to practice MALL.	Jiujiang Univ, Sch Foreign Languages, Jiujiang, Jiangxi, Peoples R China	Jiujiang University	Wu, Q (corresponding author), Jiujiang Univ, Sch Foreign Languages, Jiujiang, Jiangxi, Peoples R China.	perry20008@sohu.com						Ballance OJ, 2012, LANG LEARN TECHNOL, V16, P21; Bromley K, 2012, READ TEACH, V66, P340, DOI 10.1002/TRTR.01130; Burston J, 2014, CALICO J, V31, P103, DOI 10.11139/cj.31.1.103-125; Cavus N, 2009, BRIT J EDUC TECHNOL, V40, P78, DOI 10.1111/j.1467-8535.2007.00801.x; Dai JH, 2013, J CHONGQING U TECHNO, V27, P118; Editorial, 2005, LANGUAGE TEACHER, V29, P3; Gao TX, 2011, SURVEYS ENGLISH LEAR; Godwin-Jones R, 2011, LANG LEARN TECHNOL, V15, P2; Graham-Smith D, 2013, WRITE SEL ANDROID AP; Hayati A, 2013, BRIT J EDUC TECHNOL, V44, P66, DOI 10.1111/j.1467-8535.2011.01260.x; Kukulska-Hulme Agnes, 2008, Journal of Eurocall, V20, P271, DOI 10.1017/S0958344008000335; Li X., 2004, THESIS U SUNDERLAND; Lu M, 2008, J COMPUT ASSIST LEAR, V24, P515, DOI 10.1111/j.1365-2729.2008.00289.x; Ma GH, 2001, FOREIGN LANGUAGE ED, V22, P48; Mehrpour S., 2008, ASIAN EFL J Q, V10, P192; Qian DD, 1996, CAN MOD LANG REV, V53, P120, DOI 10.3138/cmlr.53.1.120; Read J., 2000, ASSESSING VOCABULARY; Schmitt N, 2008, LANG TEACH RES, V12, P329, DOI 10.1177/1362168808089921; Song F. Y., 2004, CELEA J, V27, P18; Stockwell Glenn, 2007, Computer Assisted Language Learning, V20, P365, DOI 10.1080/09588220701745817; Stockwell Glenn, 2008, Journal of Eurocall, V20, P253, DOI 10.1017/S0958344008000232; Stockwell G, 2010, LANG LEARN TECHNOL, V14, P95; Tai YM, 2012, EDUC TECHNOL SOC, V15, P220; Thornton P, 2005, J COMPUT ASSIST LEAR, V21, P217, DOI 10.1111/j.1365-2729.2005.00129.x; Thornton P, 2004, 2ND IEEE INTERNATIONAL WORKSHOP ON WIRELESS AND MOBILE TECHNOLOGIES IN EDUCATION, P3, DOI 10.1109/WMTE.2004.1281326; Thornton P., 2001, P ED MEDIA TAMP FINL, P1846; TYLER SW, 1979, J EXP PSYCHOL-HUM L, V5, P607, DOI 10.1037/0278-7393.5.6.607; Ushioda E, 2013, LANG LEARN TECHNOL, V17, P1; Viberg O, 2013, CEUR; Waring R., 2003, READING FOREIGN LANG, V15, P130, DOI DOI 10.1177/003368828501600214; Webb S, 2007, APPL LINGUIST, V28, P46, DOI 10.1093/applin/aml048; Wikipedia, 2013, ANDR OP SYST; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; Yuan ZY, 2005, J HEBEI U EC TRADE C, V5, P91	34	20	20	7	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128762	10.1371/journal.pone.0128762	http://dx.doi.org/10.1371/journal.pone.0128762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010606	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900249
J	Xiong, FZ; Obholzer, ND; Noche, RR; Megason, SG				Xiong, Fengzhu; Obholzer, Nikolaus D.; Noche, Ramil R.; Megason, Sean G.			Multibow: Digital Spectral Barcodes for Cell Tracing	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; FLUORESCENT PROTEINS; STEM-CELLS; ZEBRAFISH; EXPRESSION; BRAINBOW; LINEAGE; PROMOTER; SYSTEM; IDENTIFICATION	We introduce a multicolor labeling strategy (Multibow) for cell tracing experiments in developmental and regenerative processes. Building on Brainbow-based approaches that produce colors by differential expression levels of different fluorescent proteins, Multibow adds a layer of label diversity by introducing a binary code in which reporters are initially OFF and then probabilistically ON or OFF following Cre recombination. We have developed a library of constructs that contains seven different colors and three different subcellular localizations. Combining constructs from this library in the presence of Cre generates cells labeled with multiple independently expressed colors based on if each construct is ON or OFF following recombination. These labels form a unique "barcode" that allows the tracking of the cell and its clonal progenies in addition to expression level differences of each color. We tested Multibow in zebrafish which validates its design concept and suggests its utility for cell tracing applications in development and regeneration.	[Xiong, Fengzhu; Obholzer, Nikolaus D.; Noche, Ramil R.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Megason, SG (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	megason@hms.harvard.edu	XIONG, FENGZHU/A-9590-2015	XIONG, FENGZHU/0000-0002-6153-0254; Noche, Ramil R./0000-0002-4894-5682	NIH [R01 DC010791]; Biological Sciences in Dental Medicine at Harvard University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biological Sciences in Dental Medicine at Harvard University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01 DC010791 from NIH. F.X. is also supported by the graduate program of Biological Sciences in Dental Medicine at Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Boulina M, 2013, DEVELOPMENT, V140, P1605, DOI 10.1242/dev.088930; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Card JP, 2011, P NATL ACAD SCI USA, V108, P3377, DOI 10.1073/pnas.1015033108; Casco-Robles MM, 2010, DEV DYNAM, V239, P3275, DOI 10.1002/dvdy.22463; Garcia-Marques J, 2013, CEREB CORTEX, V23, P1463, DOI 10.1093/cercor/bhs134; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gupta V, 2012, NATURE, V484, P479, DOI 10.1038/nature11045; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Loulier K, 2014, NEURON, V81, P505, DOI 10.1016/j.neuron.2013.12.016; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Mosaliganti KR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002780; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Pan YA, 2011, COLD SPRING HARB PRO, V2011; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Swoger J, 2011, J BIOPHOTONICS, V4, P122, DOI 10.1002/jbio.201000087; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Urasaki A, 2008, GENE, V425, P64, DOI 10.1016/j.gene.2008.08.008; Wachsman G, 2011, PLANT CELL, V23, P2581, DOI 10.1105/tpc.111.086199; Weber K, 2012, NAT PROTOC, V7, P839, DOI 10.1038/nprot.2012.026; Worley MI, 2013, DEVELOPMENT, V140, P3275, DOI 10.1242/dev.096057; Xiong FZ, 2014, CELL, V159, P415, DOI 10.1016/j.cell.2014.09.007; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023	31	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127822	10.1371/journal.pone.0127822	http://dx.doi.org/10.1371/journal.pone.0127822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010570	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900149
J	Li, JY; Wang, QH; Cui, Y; Yang, XQ; Li, Y; Zhang, XY; Qiu, MS; Zhang, Z; Zhang, ZY				Li, Jianying; Wang, Qihui; Cui, Ying; Yang, Xueqin; Li, Yan; Zhang, Xiaoyun; Qiu, Mengsheng; Zhang, Ze; Zhang, Zunyi			Suppressor of Fused Is Required for Determining Digit Number and Identity via Gli3/Fgfs/Gremlin	PLOS ONE			English	Article							LIMB-BUD; VERTEBRATE LIMB; INDEPENDENT REGULATION; TARGETED DISRUPTION; ACTIVATOR FUNCTION; MOUSE LIMB; GLI3; HEDGEHOG; SHH; REPRESSOR	The anterior-posterior patterning of the vertebrate limb bud requires closely coordinated signaling interactions, including Sonic Hedgehog (Shh)-mediated counteraction of the Gli3 transcription factor in the distal and posterior mesenchyme of the limb bud. Suppressor of Fused (Sufu), an intracellular negative regulator of Shh signaling via Gli2 and Gli3, is implicated in early development of the mouse limb bud. However, how Sufu is involved in the genetic regulation of limb bud patterning still remains elusive. In this study, we show that the conditional deletion of Sufu in the mesenchyme of the early limb bud results in polydactyly with loss of digit identity and supernumerary bones in the wrist and the ankle. These pattern alterations are associated with anterior expansion of HoxD genes located at the 5' end of the cluster. By focusing on gene expression analysis of Shh/Gremlin1/Fgf signaling critical for the establishment and maintenance of anterior-posterior patterning, we show that early response to loss of Sufu involves anterior prolongation of Fgf4 and Fgf8 expression in the apical ectodermal ridge at E10.5. We also reveal the anterior activation of Shh-dependent posterior markers Ptc1, Gli1 and Gremlin in limb buds lacking Sufu. Furthermore, we find that loss of Sufu leads to attenuated levels of repressor Gli2 and repressor Gli3 in the early limb bud. Moreover, expression of Hand2 is activated in the entire limb bud at the early outgrowth stage in the mutant lacking Sufu. Thus, we provide evidence that Sufu is involved in the genetic network that restricts the posterior expression of Gli2/3/Hand2 and Gremlin/Fgf in limb bud patterning.	[Li, Jianying; Wang, Qihui; Cui, Ying; Yang, Xueqin; Li, Yan; Zhang, Xiaoyun; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Zhejiang Key Lab Organogenesis & Regenerat Techno, Hangzhou 310036, Zhejiang, Peoples R China; [Qiu, Mengsheng] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Zhang, Ze] Tulane Univ, Med Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA	Hangzhou Normal University; University of Louisville; Tulane University	Zhang, ZY (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Zhejiang Key Lab Organogenesis & Regenerat Techno, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi.zhang@idrbio.org		Li, Jianying/0000-0003-1488-8322	National Natural Science Foundation of China [31201089, 31071287, 31371471]; Natural Science Foundation of Zhejiang Province [LZ12C12002]; Science and Technology Support of Zhejing [2013C37024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Science and Technology Support of Zhejing	This work was supported by the following grants: The National Natural Science Foundation of China (31201089),(31071287) and (31371471); The Natural Science Foundation of Zhejiang Province (LZ12C12002); and Science and Technology Support of Zhejing (2013C37024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; Bowers M, 2012, DEV BIOL, V370, P110, DOI 10.1016/j.ydbio.2012.07.017; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; Hill P, 2007, HUM MOL GENET, V16, P2089, DOI 10.1093/hmg/ddm156; Hill P, 2009, DEV BIOL, V328, P506, DOI 10.1016/j.ydbio.2009.02.017; Hsu SHC, 2012, J BIOL CHEM, V287, P36222, DOI 10.1074/jbc.M112.382275; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kim JJ, 2011, J NEUROSCI, V31, P1825, DOI 10.1523/JNEUROSCI.2166-10.2011; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu JL, 2012, DEV BIOL, V362, P141, DOI 10.1016/j.ydbio.2011.11.022; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Park HL, 2000, DEVELOPMENT, V127, P1593; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ruel L, 2009, GENE DEV, V23, P1843, DOI 10.1101/gad.1838109; Simon-Chazottes D, 2000, MAMM GENOME, V11, P614, DOI 10.1007/s003350010144; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhang ZY, 2000, DEV BIOL, V220, P154, DOI 10.1006/dbio.2000.9637; Zhu X, 2014, J DENT RES, V93, P582, DOI 10.1177/0022034514531985; Zhu XJ, 2013, J BIOL CHEM, V288, P12080, DOI 10.1074/jbc.M113.462473; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002; Zuniga A, 1999, DEVELOPMENT, V126, P13	42	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128006	10.1371/journal.pone.0128006	http://dx.doi.org/10.1371/journal.pone.0128006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001200	Green Published, Green Submitted, gold			2022-12-27	WOS:000354931700097
J	Amend, SR; Wilson, WC; Chu, L; Lu, L; Liu, PY; Serie, D; Su, XM; Xu, YL; Wang, DY; Gramolini, A; Wen, XY; O'Neal, J; Hurchla, M; Vachon, CM; Colditz, G; Vij, R; Weilbaecher, KN; Tomasson, MH				Amend, Sarah R.; Wilson, William C.; Chu, Liang; Lu, Lan; Liu, Pengyuan; Serie, Daniel; Su, Xinming; Xu, Yalin; Wang, Dingyan; Gramolini, Anthony; Wen, Xiao-Yan; O'Neal, Julie; Hurchla, Michelle; Vachon, Celine M.; Colditz, Graham; Vij, Ravi; Weilbaecher, Katherine N.; Tomasson, Michael H.			Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types	PLOS ONE			English	Article							UNDETERMINED SIGNIFICANCE MGUS; MONOCLONAL GAMMOPATHY; GENE-EXPRESSION; MODEL; HACS1; RISK	Monoclonal gammopathy of undetermined significance (MGUS) is the requisite precursor to multiple myeloma (MM), a malignancy of antibody-producing plasma B-cells. The genetic basis of MGUS and its progression to MM remains poorly understood. C57BL/KaLwRij (KaLwRij) is a spontaneously-derived inbred mouse strain with a high frequency of benign idiopathic paraproteinemia (BIP), a phenotype with similarities to MGUS including progression to MM. Using mouse haplotype analysis, human MM SNP array data, and whole exome and whole genome sequencing of KaLwRij mice, we identified novel KaLwRij gene variants, including deletion of Samsn1 and deleterious point mutations in Tnfrsf22 and Tnfrsf23. These variants significantly affected multiple cell types implicated in MM pathogenesis including B-cells, macrophages, and bone marrow stromal cells. These data demonstrate that multiple cell types contribute to MM development prior to the acquisition of somatic driver mutations in KaLwRij mice, and suggest that MM may an inherently non-cell autonomous malignancy.	[Amend, Sarah R.; Wilson, William C.; Chu, Liang; Lu, Lan; Su, Xinming; Xu, Yalin; O'Neal, Julie; Hurchla, Michelle; Vij, Ravi; Weilbaecher, Katherine N.; Tomasson, Michael H.] Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA; [Liu, Pengyuan] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Colditz, Graham] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Wang, Dingyan; Gramolini, Anthony; Wen, Xiao-Yan] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Serie, Daniel; Vachon, Celine M.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA	Washington University (WUSTL); Medical College of Wisconsin; Washington University (WUSTL); University of Toronto; Mayo Clinic	Tomasson, MH (corresponding author), Washington Univ, Sch Med, Div Oncol, St Louis, MO 63130 USA.	tomasson@dom.wustl.edu	Wilson, William/Y-8857-2019; Su, Xinming/G-1643-2012; Colditz, Graham/A-3963-2009	Wilson, William/0000-0002-7877-9224; Colditz, Graham/0000-0002-7307-0291; Wen, Xiao-Yan/0000-0001-6728-0025; Wilson, William/0000-0002-1526-5939; Tomasson, Michael/0000-0003-4518-7123; Amend, Sarah R./0000-0002-5606-1262	National Institute on Aging [R21AG040777]; National Cancer Institute [1F31CA174096-01A1, R01 CA097250, 2P01 CA100730]; St. Louis Men's Group against Cancer; Washington University Musculoskeletal Research Center (National Institutes of Health) [P30 AR057235]; Barnes Jewish Foundation; NATIONAL CANCER INSTITUTE [P01CA100730, R01CA097250, F31CA174096, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG040777] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Louis Men's Group against Cancer; Washington University Musculoskeletal Research Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes Jewish Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging R21AG040777 (to MHT), the National Cancer Institute 1F31CA174096-01A1 (to SRA), the National Cancer Institute R01 CA097250, 2P01 CA100730 (to KNW, MH, YX, SRA, and XS), the St. Louis Men's Group against Cancer and Barnes Jewish Foundation (to KNW, MH, YX, SRA, and XS), and the Washington University Musculoskeletal Research Center (National Institutes of Health P30 AR057235) (to MH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Claudio J, 2001, ONCOGENE, V20, P5373, DOI 10.1038/sj.onc.1204698; Colucci S, 2004, BLOOD, V104, P3722, DOI 10.1182/blood-2004-02-0474; Davies FE, 2003, BLOOD, V102, P4504, DOI 10.1182/blood-2003-01-0016; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Epstein J, 1543, SCID HU MYELOMA MODE; Fowler JA, 2011, BLOOD, V118, P5872, DOI 10.1182/blood-2011-01-330407; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Landgren O, 2006, BLOOD, V107, P904, DOI 10.1182/blood-2005-08-3449; Lohr JG, 1878, WIDESPREAD GENETIC H; RADL J, 1978, CLIN EXP IMMUNOL, V33, P395; Sarah Amend LC, 2013, 55 AM SOC HEM ANN M; Schneider P, IDENTIFICATION NEW M; von Holleben M, 2011, J BIOL CHEM, V286, P13489, DOI 10.1074/jbc.M110.155184; Wang DY, 2010, FASEB J, V24, P947, DOI 10.1096/fj.09-140806; Weinhold N, 2014, BLOOD, V123, P2513, DOI 10.1182/blood-2013-10-532283; Zhu YX, 2004, J EXP MED, V200, P737, DOI 10.1084/jem.20031816	21	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127828	10.1371/journal.pone.0127828	http://dx.doi.org/10.1371/journal.pone.0127828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020268	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300058
J	Llorente, A; Garcia-Herranz, M; Cebrian, M; Moro, E				Llorente, Alejandro; Garcia-Herranz, Manuel; Cebrian, Manuel; Moro, Esteban			Social Media Fingerprints of Unemployment	PLOS ONE			English	Article							MOBILITY; SCALE	Recent widespread adoption of electronic and pervasive technologies has enabled the study of human behavior at an unprecedented level, uncovering universal patterns underlying human activity, mobility, and interpersonal communication. In the present work, we investigate whether deviations from these universal patterns may reveal information about the socio-economical status of geographical regions. We quantify the extent to which deviations in diurnal rhythm, mobility patterns, and communication styles across regions relate to their unemployment incidence. For this we examine a country-scale publicly articulated social media dataset, where we quantify individual behavioral features from over 19 million geo-located messages distributed among more than 340 different Spanish economic regions, inferred by computing communities of cohesive mobility fluxes. We find that regions exhibiting more diverse mobility fluxes, earlier diurnal rhythms, and more correct grammatical styles display lower unemployment rates. As a result, we provide a simple model able to produce accurate, easily interpretable reconstruction of regional unemployment incidence from their social-media digital fingerprints alone. Our results show that cost-effective economical indicators can be built based on publicly-available social media datasets.	[Llorente, Alejandro; Moro, Esteban] Univ Autonoma Madrid, Inst Ingn Conocimiento, E-28049 Madrid, Spain; [Llorente, Alejandro; Moro, Esteban] Univ Carlos III Madrid, Dept Matemat, Leganes 28911, Spain; [Llorente, Alejandro; Moro, Esteban] Univ Carlos III Madrid, GISC, Leganes 28911, Spain; [Garcia-Herranz, Manuel] UNICEF Innovat Unit, New York, NY 10017 USA; [Cebrian, Manuel] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Cebrian, Manuel] Natl Informat & Commun Technol Australia, Melbourne, Vic 3003, Australia	Autonomous University of Madrid; Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; UNICEF; University of California System; University of California San Diego	Moro, E (corresponding author), Univ Autonoma Madrid, Inst Ingn Conocimiento, E-28049 Madrid, Spain.	emoro@math.uc3m.es	Moro, Esteban/AAB-1159-2019; Garcia-Herranz, Manuel/ABB-2617-2021	Moro, Esteban/0000-0003-2894-1024; 	Spanish Ministry of Economy and Competitiveness [FIS2013-47532-C3-3-P]; Australian Government; Australian Research Council	Spanish Ministry of Economy and Competitiveness(Spanish Government); Australian Government(Australian GovernmentCGIAR); Australian Research Council(Australian Research Council)	Partial funding came from the Spanish Ministry of Economy and Competitiveness through grant FIS2013-47532-C3-3-P, the Australian Government, and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADigital, 2013, US TWITT ESP 2012; Antenucci Dolan, 2014, TECHNICAL REPORT; Baker S, 2013, PREPRINT; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Becker G., 1976, EC APPROACH HUMAN BE; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Calabrese F, 2013, TRANSPORT RES C-EMER, V26, P301, DOI 10.1016/j.trc.2012.09.009; Camerer Colin F, 2011, ADV BEHAV EC; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Davenport JR, 2014, READABILITY TWEETS T; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Erlander S, 1990, VSP, V3; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Frias-Martinez V, 2010, QUAL MEETS QUANT WOR; Glaeser EL, 1991, TECHNICAL REPORT; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Groves RM, 2011, SURVEY METHODOLOGY, V561; Gutierrez T, 2013, PREPRINT; Hawelka B, 2013, GEOLOCATED TWITTER P; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Lathia Neal, 2012, Pervasive Computing. Proceedings of the 10th International Conference, Pervasive 2012, P91, DOI 10.1007/978-3-642-31205-2_6; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lenormand M, 2014, CROSS CHECKING DIFFE; MILGRAM S, 1970, SCIENCE, V167, P1461, DOI 10.1126/science.167.3924.1461; Pan W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2961; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rutherford Alex, 2013, Proc Natl Acad Sci U S A, V110, P6281, DOI 10.1073/pnas.1216338110; Schneider F, 2011, HANDBOOK ON THE SHADOW ECONOMY, P9; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Smith C, 2013, ORANGE D4D CHA UNPUB; Smith  Chris, 2013, P 2013 C COMP SUPP C, P683, DOI DOI 10.1145/2441776.2441852; Sobolevsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081707; Soto V, 2011, LECT NOTES COMPUT SC, V6787, P377, DOI 10.1007/978-3-642-22362-4_35; Sui DZ, 2011, ICWSM, P81, DOI DOI 10.1109/WCSP.2011.6096843; Sun L, 2014, QUANTIFYING LONG TER; van Deursen AJAM, 2014, NEW MEDIA SOC, V16, P507, DOI 10.1177/1461444813487959	41	53	58	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128692	10.1371/journal.pone.0128692	http://dx.doi.org/10.1371/journal.pone.0128692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0SC	26020628	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300120
J	Stevanovic, A; Schmitz, S; Rossaint, R; Schurholz, T; Coburn, M				Stevanovic, Ana; Schmitz, Sabine; Rossaint, Rolf; Schuerholz, Tobias; Coburn, Mark			CONSORT Item Reporting Quality in the Top Ten Ranked Journals of Critical Care Medicine in 2011: A Retrospective Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; INTERVENTION; STATEMENT; ADHERENCE; GUIDELINES; REVIEWS	Introduction Reporting randomised controlled trials is a key element in order to disseminate research findings. The CONSORT statement was introduced to improve the reporting quality. We assessed the adherence to the CONSORT statement of randomised controlled trials published 2011 in the top ten ranked journals of critical care medicine (ISI Web of Knowledge 2011, Thomson Reuters, London UK). Methods Design. We performed a retrospective cross sectional data analysis. Setting. This study was executed at the University Hospital of RWTH, Aachen. Participants. We selected the following top ten listed journals according to ISI Web of Knowledge (Thomson Reuters, London, UK) critical care medicine ranking in the year 2011: American Journal of Respiratory and Critical Care Medicine, Critical Care Medicine, Intensive Care Medicine, CHEST, Critical Care, Journal of Neurotrauma, Resuscitation, Pediatric Critical Care Medicine, Shock and Minerva Anestesiologica. Main outcome measures. We screened the online table of contents of each included journal, to identify the randomised controlled trials. The adherence to the items of the CONSORT Checklist in each trial was evaluated. Additionally we correlated the citation frequency of the articles and the impact factor of the respective journal with the amount of reported items per trial. Results We analysed 119 randomised controlled trials and found, 15 years after the implementation of the CONSORT statement, that a median of 61,1% of the checklist-items were reported. Only 55.5% of the articles were identified as randomised trials in their titles. The citation frequency of the trials correlated significantly (rs = 0,433; p<0,001 and r = 0,331; p<0,001) to the CONSORT statement adherence. The impact factor showed also a significant correlation to the CONSORT adherence (r = 0,386; p<0,001). Conclusion The reporting quality of randomised controlled trials in the field of critical care medicine remains poor and needs considerable improvement.	[Stevanovic, Ana; Schmitz, Sabine; Rossaint, Rolf; Coburn, Mark] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Schuerholz, Tobias] Univ Hosp Aachen, Dept Intens Care & Intermediate Care, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Coburn, M (corresponding author), Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany.	mcoburn@ukaachen.de	Schuerholz, Tobias/E-8071-2011	Schuerholz, Tobias/0000-0003-3830-3499; Coburn, Mark/0000-0002-7930-0270				Ahmadzadeh J., 2013, Shiraz E Medical Journal, V14, P130; Altman DG, 2005, BMJ-BRIT MED J, V330, P1056, DOI 10.1136/bmj.330.7499.1056; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Dechartres A, 2011, J CLIN EPIDEMIOL, V64, P136, DOI 10.1016/j.jclinepi.2010.04.015; Elia N, 2011, EUR J ANAESTH, V28, P478, DOI 10.1097/EJA.0b013e3283461868; Geha NN, 2013, RESP CARE, V58, P1899, DOI 10.4187/respcare.02379; Gray R, 2012, ANN ROY COLL SURG, V94, P388, DOI 10.1308/003588412X13171221592339; Hill CL, 2002, J CLIN EPIDEMIOL, V55, P783, DOI 10.1016/S0895-4356(02)00440-7; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Latronico N, 2013, INTENS CARE MED, V39, P1386, DOI 10.1007/s00134-013-2947-3; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Munter NH, 2015, EUR J ANAESTH, V32, P117, DOI 10.1097/EJA.0000000000000176; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sibbald B, 1998, BRIT MED J, V316, P201; Silverman BW., 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; To MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084779; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wager E, 2014, EUR J ANAESTH, V31, P397, DOI 10.1097/EJA.0000000000000084	29	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128061	10.1371/journal.pone.0128061	http://dx.doi.org/10.1371/journal.pone.0128061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020246	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300076
J	Yang, J; Yang, XD; Lin, YH; Ng, TB; Lin, J; Ye, XY				Yang, Jie; Yang, Xiaodan; Lin, Yonghui; Ng, Tzi Bun; Lin, Juan; Ye, Xiuyun			Laccase-Catalyzed Decolorization of Malachite Green: Performance Optimization and Degradation Mechanism	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; TRIPHENYLMETHANE DYES; BIODEGRADATION; DETOXIFICATION; PURIFICATION; REDUCTION; GENE	Malachite green (MG) was decolorized by laccase (LacA) of white-rot fungus Cerrena sp. with strong decolorizing ability. Decolorization conditions were optimized with response surface methodology. A highly significant quadratic model was developed to investigate MG decolorization with LacA, and the maximum MG decolorization ratio of 91.6% was predicted under the conditions of 2.8 U mL(-1) LacA, 109.9 mg L-1 MG and decolorization for 172.4 min. Kinetic studies revealed the Km and kcat values of LacA toward MG were 781.9 mM and 9.5 s(-1), respectively. UV-visible spectra confirmed degradation of MG, and the degradation mechanism was explored with liquid chromatography-mass spectrometry (LC-MS) analysis. Based on the LC-MS spectra of degradation products, LacA catalyzed MG degradation via two simultaneous pathways. In addition, the phytotoxicity of MG, in terms of inhibition on seed germination and seedling root elongation of Nicotiana tabacum and Lactuca sativa, was reduced after laccase treatment. These results suggest that laccase of Cerrena was effective in decolorizing MG and promising in bioremediation of wastewater in food and aquaculture industries.	[Yang, Jie; Yang, Xiaodan; Lin, Juan; Ye, Xiuyun] Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350002, Fujian, Peoples R China; [Yang, Jie; Yang, Xiaodan; Lin, Juan; Ye, Xiuyun] Fujian Key Lab Marine Enzyme Engn, Fuzhou, Fujian, Peoples R China; [Lin, Yonghui] Fujian Entry Exit Inspect & Quarantine Bur, Ctr Tech, Fuzhou, Fujian, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Fuzhou University; Chinese University of Hong Kong	Lin, J (corresponding author), Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350002, Fujian, Peoples R China.	ljuan@fzu.edu.cn; xiuyunye@fzu.edu.cn			Natural Science Foundation of China [41306120]; Oceanic Public Welfare Industry Special Research Project of China [2013418015]; Fujian Provincial Development and Reform Commission Bio-industry Special Project [[2011]1598]; Fuzhou Science and Technology Bureau [2012-G-125]; Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China [YRWEF201506]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oceanic Public Welfare Industry Special Research Project of China; Fujian Provincial Development and Reform Commission Bio-industry Special Project; Fuzhou Science and Technology Bureau; Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China	The work was funded by grants from Natural Science Foundation of China (41306120), Oceanic Public Welfare Industry Special Research Project of China (2013418015), Fujian Provincial Development and Reform Commission Bio-industry Special Project ([2011]1598), Fuzhou Science and Technology Bureau (2012-G-125) and the Foundation of Key Laboratory of Yangtze River Water Environment, Ministry of Education (Tongji University), China, (No. YRWEF201506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; Balan K, 2012, J TAIWAN INST CHEM E, V43, P776, DOI 10.1016/j.jtice.2012.04.005; Ben Younes S, 2011, EUR FOOD RES TECHNOL, V233, P751, DOI 10.1007/s00217-011-1569-7; Berberidou C, 2007, APPL CATAL B-ENVIRON, V74, P63, DOI 10.1016/j.apcatb.2007.01.013; Bergwerff AA, 2003, J CHROMATOGR B, V788, P351, DOI 10.1016/S1570-0232(03)00042-4; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; Chen CC, 2007, J HAZARD MATER, V141, P520, DOI 10.1016/j.jhazmat.2006.07.011; Chhabra M, 2009, J BIOTECHNOL, V143, P69, DOI 10.1016/j.jbiotec.2009.06.011; Couto SR, 2006, BIOTECHNOL ADV, V24, P500, DOI 10.1016/j.biotechadv.2006.04.003; Daassi D, 2012, J ENVIRON MANAGE, V108, P84, DOI 10.1016/j.jenvman.2012.04.039; Du LN, 2011, ECOTOXICOLOGY, V20, P438, DOI 10.1007/s10646-011-0595-3; Eggert C, 1998, APPL ENVIRON MICROB, V64, P1766; Fischer AR, 2011, CHEMOSPHERE, V82, P210, DOI 10.1016/j.chemosphere.2010.10.019; Forgacs E, 2004, ENVIRON INT, V30, P953, DOI 10.1016/j.envint.2004.02.001; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; Jasinska A, 2012, INT BIODETER BIODEGR, V73, P33, DOI 10.1016/j.ibiod.2012.06.025; Kalyani DC, 2008, BIORESOURCE TECHNOL, V99, P4635, DOI 10.1016/j.biortech.2007.06.058; Kang HW, 2014, BIOTECHNOL BIOPROC E, V19, P519, DOI 10.1007/s12257-013-0663-z; Kumar VV, 2012, J MOL CATAL B-ENZYM, V74, P63, DOI 10.1016/j.molcatb.2011.08.015; Maalej-Kammoun M, 2009, INT BIODETER BIODEGR, V63, P600, DOI 10.1016/j.ibiod.2009.04.003; Morozova OV, 2007, APPL BIOCHEM MICRO+, V43, P523, DOI 10.1134/S0003683807050055; Murugesan K, 2009, APPL MICROBIOL BIOT, V82, P341, DOI 10.1007/s00253-008-1819-1; Papinutti VL, 2004, FEMS MICROBIOL LETT, V231, P205, DOI 10.1016/S0378-1097(03)00957-1; Parshetti G, 2006, ACTA CHIM SLOV, V53, P492; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Pogni R, 2015, CELL MOL LIFE SCI, V72, P885, DOI 10.1007/s00018-014-1825-7; Rahman IA, 2005, BIORESOURCE TECHNOL, V96, P1578, DOI 10.1016/j.biortech.2004.12.015; Roriz MS, 2009, J HAZARD MATER, V169, P691, DOI 10.1016/j.jhazmat.2009.03.150; Saravanakumar T, 2013, APPL BIOCHEM BIOTECH, V171, P1178, DOI 10.1007/s12010-013-0220-4; Sathishkumar P, 2013, CLEAN-SOIL AIR WATER, V41, P665, DOI 10.1002/clen.201100521; Solomon EI, 2001, ANGEW CHEM INT EDIT, V40, P4570, DOI 10.1002/1521-3773(20011217)40:24<4570::AID-ANIE4570>3.0.CO;2-4; Srivastava S, 2004, AQUAT TOXICOL, V66, P319, DOI 10.1016/j.aquatox.2003.09.008; Tamayo-Ramos JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-165; Wang JY, 2012, INT CONF INFORM SCI, P7, DOI 10.1109/ISISE.2012.11; Wong DWS, 2009, APPL BIOCHEM BIOTECH, V157, P174, DOI 10.1007/s12010-008-8279-z; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110834; Zhang C, 2013, J AGR FOOD CHEM, V61, P5468, DOI 10.1021/jf4010498	37	35	41	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127714	10.1371/journal.pone.0127714	http://dx.doi.org/10.1371/journal.pone.0127714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020270	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300052
J	Ahsan, MR; Islam, MT; Ullah, MH; Singh, MJ; Ali, MT				Ahsan, Md Rezwanul; Islam, Mohammad Tariqul; Ullah, Mohammad Habib; Singh, Mandeep Jit; Ali, Mohd Tarmizi			Metasurface Reflector (MSR) Loading for High Performance Small Microstrip Antenna Design	PLOS ONE			English	Article							BANDWIDTH ENHANCEMENT; BAND; GAIN; PARAMETERS	A meander stripline feed multiband microstrip antenna loaded with metasurface reflector (MSR) structure has been designed, analyzed and constructed that offers the wireless communication services for UHF/microwave RFID and WLAN/WiMAX applications. The proposed MSR assimilated antenna comprises planar straight forward design of circular shaped radiator with horizontal slots on it and 2D metasurface formed by the periodic square metallic element that resembles the behavior of metamaterials. A custom made high dielectric bio-plastic substrate (epsilon(r) = 15) is used for fabricating the prototype of the MSR embedded planar monopole antenna. The details of the design progress through numerical simulations and experimental results are presented and discussed accordingly. The measured impedance bandwidth, radiation patterns and gain of the proposed MSR integrated antenna are compared with the obtained results from numerical simulation, and a good compliance can be observed between them. The investigation shows that utilization of MSR structure has significantly broadened the -10dB impedance bandwidth than the conventional patch antenna: from 540 to 632 MHz (17%), 467 to 606 MHz (29%) and 758 MHz to 1062 MHz (40%) for three distinct operating bands centered at 0.9, 3.5 and 5.5 GHz. Additionally, due to the assimilation of MSR, the overall realized gains have been upgraded to a higher value of 3.62 dBi, 6.09 dBi and 8.6 dBi for lower, middle and upper frequency band respectively. The measured radiation patterns, impedance bandwidths (S11<-10 dB) and gains from the MSR loaded antenna prototype exhibit reasonable characteristics that can satisfy the requirements of UHF/microwave (5.8 GHz) RFID, WiMAX (3.5/5.5 GHz) and WLAN (5.2/5.8 GHz) applications.	[Ahsan, Md Rezwanul; Islam, Mohammad Tariqul; Singh, Mandeep Jit] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia; [Ullah, Mohammad Habib] Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur, Malaysia; [Ali, Mohd Tarmizi] Univ Teknol Mara UiTM, Fac Elect Engn FKE, MTC, ARG, Shah Alam, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaya; Universiti Teknologi MARA	Ahsan, MR (corresponding author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Bangi 43600, Selangor, Malaysia.	rezwanul.ahsan@yahoo.com	Islam, Mohammad Tariqul/M-7377-2016; singh, mandeep/W-7242-2019; Ahsan, Md. Rezwanul/A-8152-2012; Singh, Mandeep/AAC-8680-2020; Islam, Mohammad Tariqul/E-6380-2012	Islam, Mohammad Tariqul/0000-0002-4929-3209; Ahsan, Md. Rezwanul/0000-0003-3624-5803; Islam, Mohammad Tariqul/0000-0002-4929-3209	Universiti Kebangsaan Malaysia [DIP-2014-029]	Universiti Kebangsaan Malaysia	This work was supported by the Universiti Kebangsaan Malaysia through university research grant code no. DIP-2014-029. The funders had no role in study design, data collection and analysis, decision to preparation or publication of the manuscript.	Ahsan MR, 2015, APPL COMPUT ELECTROM, V30, P213; Ahsan MR, 2014, SCI WORLD J, DOI 10.1155/2014/856504; Aksun MI, 2008, IEEE T MICROW THEORY, V56, P1423, DOI 10.1109/TMTT.2008.923870; Antoniades MA, 2008, IEEE ANTENN WIREL PR, V7, P652, DOI 10.1109/LAWP.2008.2007813; Balanis CA, 2005, ANTENNA THEORY ANAL, V3rd, P816; Booker H. G., 1946, J I ELECT ENG 3A, V93, P620, DOI DOI 10.1049/JI-3A-1.1946.0150; Burns R. W., 1993, Engineering Science and Education Journal, V2, P114, DOI 10.1049/esej:19930036; Chaimool S., 2010, Progress In Electromagnetics Research B, V22, P23, DOI 10.2528/PIERB10031901; Chaimool S, 2013, APPL PHYS A-MATER, V112, P669, DOI 10.1007/s00339-013-7703-6; Chen XD, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016608; Chung K. L., 2011, 2011 5th European Conference on Antennas and Propagation (EuCAP), P48; Chung KL, 2012, MICROW OPT TECHN LET, V54, P529, DOI 10.1002/mop.26574; Cui TJ, 2010, METAMATERIALS: THEORY, DESIGN, AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-0573-4; Devireddy B, 2011, APPL COMPUT ELECTROM, V26, P170; Enoch S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213902; Fang DG, 2010, ANTENNA THEORY AND MICROSTRIP ANTENNAS, P1; Fiedziuszko SJ, 2002, IEEE T MICROW THEORY, V50, P706, DOI 10.1109/22.989956; Finkenzeller Klaus, 2010, RFID HDB FUNDAMENTAL, V3rd; Ge YH, 2012, IEEE T ANTENN PROPAG, V60, P743, DOI 10.1109/TAP.2011.2173113; Goussetis G, 2006, IEEE T ANTENN PROPAG, V54, P82, DOI 10.1109/TAP.2005.861575; Holloway CL, 2012, IEEE ANTENN PROPAG M, V54, P10, DOI 10.1109/MAP.2012.6230714; Honari MM, 2011, IEEE ANTENN WIREL PR, V10, P1413, DOI 10.1109/LAWP.2011.2178998; Krishna DD, 2008, PROG ELECTROMAGN RES, V83, P245, DOI 10.2528/PIER08052201; Lee KF, 2011, IEEE ANTENN PROPAG M, V53, P60, DOI 10.1109/MAP.2011.6028422; Liberal I, 2012, IEEE T ANTENN PROPAG, V60, P3020, DOI 10.1109/TAP.2012.2194836; Liu HJ, 2014, IEEE T ANTENN PROPAG, V62, P2856, DOI 10.1109/TAP.2014.2308525; Liu Y, 2013, INT J ANTENNAS PROPA, V2013; Lu JH, 2003, IEEE T ANTENN PROPAG, V51, P1126, DOI 10.1109/TAP.2003.811481; Maci S, 1997, IEEE ANTENNAS PROPAG, V39, P13, DOI 10.1109/74.646798; Maddani GP, 2010, MICROW OPT TECHN LET, V52, P2841, DOI 10.1002/mop.25612; Munk B. A., 2000, FREQUENCY SELECTIVE, DOI 10.1002/0471723770; Numan AB, 2013, IEEE ANTENN PROPAG M, V55, P202, DOI 10.1109/MAP.2013.6735515; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Rehman SU, 2011, APPL COMPUT ELECTROM, V26, P624; Saenz E, 2007, ELECTRON LETT, V43, P850, DOI 10.1049/el:20071591; Smith DR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195104; Tiang JJ, 2011, J ELECTROMAGNET WAVE, V25, P1851, DOI 10.1163/156939311797454042; Ullah MH, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/8/085015; Ullah MH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4833496; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; WANG BF, 1984, IEEE T ANTENN PROPAG, V32, P938, DOI 10.1109/TAP.1984.1143459; Wang S, 2004, ELECTRON LETT, V40, P405, DOI 10.1049/el:20040306; Wong K. L., 2004, COMPACT BROADBAND MI, V168; Xiong H, 2012, RADIOENGINEERING, V21; Yang F, 2005, MICROW OPT TECHN LET, V47, P240, DOI 10.1002/mop.21136; Zarifi D, 2012, PROG ELECTROMAGN RES, V123, P337, DOI 10.2528/PIER11110506; Zhai HQ, 2013, IEEE ANTENN WIREL PR, V12, P65, DOI 10.1109/LAWP.2013.2238881; Zhang RQ, 2012, IEEE MICROW WIREL CO, V22, P233, DOI 10.1109/LMWC.2012.2192419; Zhao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103945	49	13	13	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127185	10.1371/journal.pone.0127185	http://dx.doi.org/10.1371/journal.pone.0127185			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018795	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600074
J	Arizzi, A; Brummer, M; Martin-Sanchez, I; Cultrone, G; Viles, H				Arizzi, Anna; Bruemmer, Monika; Martin-Sanchez, Ines; Cultrone, Giuseppe; Viles, Heather			The Influence of the Type of Lime on the Hygric Behaviour and Bio-Receptivity of Hemp Lime Composites Used for Rendering Applications in Sustainable New Construction and Repair Works	PLOS ONE			English	Article							FIBERS; CONCRETE	The benefits of using sustainable building materials are linked not only to the adoption of manufacturing processes that entail reduced pollution, CO2 emissions and energy consumption, but also to the onset of improved performance in the building. In particular, hemplime composite shows low shrinkage and high thermal and acoustic insulating properties. However, this material also shows a great ability to absorb water, an aspect that can turn out to be negative for the long-term durability of the building. For this reason, the hygric properties of hemp-based composites need to be studied to ensure the correct use of this material in construction and repair works. The water absorption, drying and transpirability of hemp composites made with aerial (in the form of dry powder and putty) and hydraulic limes were investigated here and related to the microbial growth induced by the water movements within the material. Results show that hemp-natural hydraulic lime mixes exhibit the highest transpirability and drying rate, the lowest water absorption by immersion and capillary uptake and the least intense microbial attack and chromatic change. A microscopical study of the hemp shives also related their great ability to absorb water to the near-irreversible swelling of their structure under dry-wet conditions.	[Arizzi, Anna; Viles, Heather] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Bruemmer, Monika] CANNABRIC, E-18500 Granada, Spain; [Martin-Sanchez, Ines] Univ Granada, Dept Microbiol, Granada 18002, Spain; [Cultrone, Giuseppe] Univ Granada, Dept Mineral & Petrol, Granada 18002, Spain	University of Oxford; University of Granada; University of Granada	Arizzi, A (corresponding author), Univ Oxford, Sch Geog & Environm, Dyson Perrins Bldg,South Parks Rd, Oxford OX1 3QY, England.	anna.arizzi@ouce.ox.ac.uk	Cultrone, Giuseppe/ABF-7168-2021; Arizzi, Anna/A-8608-2019	Arizzi, Anna/0000-0002-8996-0205; Viles, Heather/0000-0002-2444-1295	European Union [326983]; Spanish project of the Ministerio de Ciencia y Competitividad [MAT-2012-34473]	European Union(European Commission); Spanish project of the Ministerio de Ciencia y Competitividad	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 326983 (NaturALiMe), and the Spanish project MAT-2012-34473 of the Ministerio de Ciencia y Competitividad. Author MB, owner of the CANNABRIC company, had some role in the design and preparation of mortar samples and in the preparation of this manuscript, but did not have any additional role in data collection and analysis. The specific role of this author is articulated in the author contributions section.	Amziane S, 2013, BIOAGGREGATE BASED B, p[83, 122]; Anna A, 2014, ENVIRON EARTH SCI, V71, P1699, DOI 10.1007/s12665-013-2574-x; [Anonymous], 2000, 1971 EN; [Anonymous], 2011, 15886 UNEEN; [Anonymous], 2008, 13755 UNIEN CNRICR; [Anonymous], 1988, 2988 NORMAL CNRICR; [Anonymous], 2010, 4591 BSEN; [Anonymous], 2000, 1925 UNIEN CNRICR; Arandigoyen M, 2006, APPL SURF SCI, V252, P8077, DOI 10.1016/j.apsusc.2005.10.019; Arnaud L, 2012, CONSTR BUILD MATER, V28, P50, DOI 10.1016/j.conbuildmat.2011.07.052; Benavente D, 2009, ENVIRON GEOL, V56, P1495, DOI 10.1007/s00254-008-1246-8; Bevan R, 2008, HEMP LIME CONSTRUCTI, P9; Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5; Colinart T, 2012, CONSTR BUILD MATER, V30, P372, DOI 10.1016/j.conbuildmat.2011.12.030; Collet F, 2008, CONSTR BUILD MATER, V22, P1271, DOI 10.1016/j.conbuildmat.2007.01.018; Cutler N, 2010, GEOMICROBIOL J, V27, P630, DOI 10.1080/01490451003702933; Faruk O, 2012, PROG POLYM SCI, V37, P1552, DOI 10.1016/j.progpolymsci.2012.04.003; Faure P, 2012, CEMENT CONCRETE RES, V42, P1468, DOI 10.1016/j.cemconres.2012.07.007; Groot C, 2010, TC203RHM RILEM ITAM; Groot C.J.W.P., 2010, HERON, V55, P141; Hall C, 2007, P R SOC A, V463, P1871, DOI 10.1098/rspa.2007.1855; Lawrence M, 2013, PROC INST CIV ENG-CO, V166, P257, DOI 10.1680/coma.12.00031; Le Troedec M, 2009, J EUR CERAM SOC, V29, P1861, DOI 10.1016/j.jeurceramsoc.2008.11.016; Mwaikambo LY, 2002, J APPL POLYM SCI, V84, P2222, DOI 10.1002/app.10460; Newman G, 2008, EUROPEAN DECORTICATI; Nozahic V, 2012, CEMENT CONCRETE COMP, V34, P231, DOI 10.1016/j.cemconcomp.2011.09.002; Pejic BM, 2008, BIORESOURCE TECHNOL, V99, P7152, DOI 10.1016/j.biortech.2007.12.073; SCHERER GW, 1990, J AM CERAM SOC, V73, P3, DOI 10.1111/j.1151-2916.1990.tb05082.x; Sgriccia N, 2008, COMPOS PART A-APPL S, V39, P1632, DOI 10.1016/j.compositesa.2008.07.007; Valadez-Gonzalez A, 1999, COMPOS PART B-ENG, V30, P309, DOI 10.1016/S1359-8368(98)00054-7; Veniale F, 2002, CEMENT CONCRETE COMP, V25, P1123; Walker P, 2005, RAMMED EARTH DESIGN, P14; Wood C, 2010, THESIS U OXFORD	33	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125520	10.1371/journal.pone.0125520	http://dx.doi.org/10.1371/journal.pone.0125520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017563	Green Published, gold			2022-12-27	WOS:000355185600025
J	Gordon, T; Hendry, M; Lafontaine, CA; Cartar, H; Zhang, JJ; Borschel, GH				Gordon, Tessa; Hendry, Michael; Lafontaine, Christine A.; Cartar, Holliday; Zhang, Jennifer J.; Borschel, Gregory H.			Nerve Cross-Bridging to Enhance Nerve Regeneration in a Rat Model of Delayed Nerve Repair	PLOS ONE			English	Article							TO-SIDE NEURORRHAPHY; NEUROTROPHIC FACTOR EXPRESSION; POOR FUNCTIONAL RECOVERY; SCHWANN-CELLS; AXONAL REGENERATION; MOTOR UNITS; WALLERIAN DEGENERATION; IMPAIRED REGENERATION; CONTRIBUTING FACTORS; PARTIAL DENERVATION	There are currently no available options to promote nerve regeneration through chronically denervated distal nerve stumps. Here we used a rat model of delayed nerve repair asking of prior insertion of side-to-side cross-bridges between a donor tibial (TIB) nerve and a recipient denervated common peroneal (CP) nerve stump ameliorates poor nerve regeneration. First, numbers of retrogradely-labelled TIB neurons that grew axons into the nerve stump within three months, increased with the size of the perineurial windows opened in the TIB and CP nerves. Equal numbers of donor TIB axons regenerated into CP stumps either side of the cross-bridges, not being affected by target neurotrophic effects, or by removing the perineurium to insert 5-9 cross-bridges. Second, CP nerve stumps were coapted three months after inserting 0-9 cross-bridges and the number of 1) CP neurons that regenerated their axons within three months or 2) CP motor nerves that reinnervated the extensor digitorum longus (EDL) muscle within five months was determined by counting and motor unit number estimation (MUNE), respectively. We found that three but not more cross-bridges promoted the regeneration of axons and reinnervation of EDL muscle by all the CP motoneurons as compared to only 33% regenerating their axons when no cross-bridges were inserted. The same 3-fold increase in sensory nerve regeneration was found. In conclusion, side-to-side cross-bridges ameliorate poor regeneration after delayed nerve repair possibly by sustaining the growth-permissive state of denervated nerve stumps. Such autografts may be used in human repair surgery to improve outcomes after unavoidable delays.	[Gordon, Tessa; Hendry, Michael; Lafontaine, Christine A.; Cartar, Holliday; Zhang, Jennifer J.; Borschel, Gregory H.] Univ Toronto, Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gordon, T (corresponding author), Univ Toronto, Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada.	tessat.gordon@gmail.com			Canadian Institutes of Health Research [253172]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research #253172.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Akeda K, 2006, PLAST RECONSTR SURG, V117, P1194, DOI 10.1097/01.prs.0000201460.54187.d7; Al-Qattan MM, 1998, BRIT J PLAST SURG, V51, P238, DOI 10.1054/bjps.1997.0188; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bain JR, 2001, NEUROSCIENCE, V103, P503, DOI 10.1016/S0306-4522(00)00577-7; BEUCHE W, 1984, J NEUROCYTOL, V13, P767, DOI 10.1007/BF01148493; Boyd JG, 2001, J NEUROBIOL, V49, P314, DOI 10.1002/neu.10013; Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P792, DOI 10.1111/j.1460-9568.1995.tb00682.x; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; Brushart TM, 2013, EXP NEUROL, V247, P272, DOI 10.1016/j.expneurol.2013.05.007; Brushart TM, 2002, J NEUROSCI, V22, P6631; CHEN S, 1993, J COMP NEUROL, V335, P576, DOI 10.1002/cne.903350409; Fricker FR, 2011, FUTUR NEUROL, V6, P809, DOI 10.2217/FNL.11.45; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Furey MJ, 2007, NEUROSURGERY, V60, P723, DOI 10.1227/01.NEU.0000255412.63184.CC; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Goheen-Robillard B, 2002, LARYNGOSCOPE, V112, P899, DOI 10.1097/00005537-200205000-00022; GORDON T, 1993, BRAIN RES BULL, V30, P477, DOI 10.1016/0361-9230(93)90281-F; GORDON T, 1982, J PHYSIOL-LONDON, V323, P307, DOI 10.1113/jphysiol.1982.sp014074; Gordon T, 2014, EXP NEUROL, V254, P99, DOI 10.1016/j.expneurol.2014.01.012; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Gordon T, 2010, J COMMUN DISORD, V43, P265, DOI 10.1016/j.jcomdis.2010.04.003; Groves ML, 2005, EXP NEUROL, V195, P278, DOI 10.1016/j.expneurol.2005.04.007; Hall SM, 1999, ANN NY ACAD SCI, V883, P215, DOI 10.1111/j.1749-6632.1999.tb08584.x; Haninec P, 2007, J NEUROSURG, V106, P391, DOI 10.3171/jns.2007.106.3.391; Hart AM, 2002, EXP BRAIN RES, V142, P308, DOI 10.1007/s00221-001-0929-0; Hayashi A, 2008, EXP NEUROL, V211, P539, DOI 10.1016/j.expneurol.2008.02.031; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hendry JM, 2015, NEUROSURG IN PRESS; Hirata K, 1999, J NEUROCYTOL, V28, P685, DOI 10.1023/A:1007012916530; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; HOFFER JA, 1979, BRAIN RES, V178, P347, DOI 10.1016/0006-8993(79)90698-X; Hoke A, 2006, J NEUROSCI, V26, P9646, DOI 10.1523/JNEUROSCI.1620-06.2006; Hoke A, 2002, EXP NEUROL, V173, P77, DOI 10.1006/exnr.2001.7826; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Hudson A R, 1977, Clin Neurosurg, V24, P391; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1479, DOI 10.1002/glia.20779; Kemp SWP, 2013, J PERIPHER NERV SYST, V18, P220, DOI 10.1111/jns5.12035; Knott EP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/651625; Ladak A, 2011, NEUROSURGERY, V68, P1654, DOI 10.1227/NEU.0b013e31821246a8; Liu K, 1999, J ORTHOP RES, V17, P293, DOI 10.1002/jor.1100170220; Lundborg G., 2004, NERVE INJURY REPAIR; MACKINNON SE, 1991, MUSCLE NERVE, V14, P1116, DOI 10.1002/mus.880141113; Magill CK, 2010, ARCH FACIAL PLAST S, V12, P315, DOI 10.1001/archfacial.2010.71; Major LA, 2007, J NEUROPHYSIOL, V97, P1846, DOI 10.1152/jn.00904.2006; MILNER TE, 1981, J NEUROL NEUROSUR PS, V44, P485, DOI 10.1136/jnnp.44.6.485; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Moore AM, 2012, J NEUROSCI METH, V204, P19, DOI 10.1016/j.jneumeth.2011.10.011; More HL, 2011, J NEUROSCI METH, V201, P149, DOI 10.1016/j.jneumeth.2011.07.026; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Oyamatsu H, 2012, J PLAST SURG HAND SU, V46, P299, DOI 10.3109/2000656X.2012.696264; RAFUSE VF, 1992, J NEUROPHYSIOL, V68, P1261, DOI 10.1152/jn.1992.68.4.1261; Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031; Rotshenker S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-109; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; Stoll G, 1999, BRAIN PATHOL, V9, P313; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3; Tam S.L., 2011, ENCL NEUROSCI, P1; Tam SL, 2003, J NEUROCYTOL, V32, P961, DOI 10.1023/B:NEUR.0000020635.41233.0f; Tarasidis G, 1997, ANN OTO RHINOL LARYN, V106, P506, DOI 10.1177/000348949710600612; Udina E, 2010, EXP NEUROL, V223, P143, DOI 10.1016/j.expneurol.2009.08.026; Veltri K, 2005, J RECONSTR MICROSURG, V21, P57, DOI 10.1055/s-2005-862783; Viterbo F, 1998, Sao Paulo Med J, V116, P1808; VITERBO F, 1994, BRIT J PLAST SURG, V47, P75, DOI 10.1016/0007-1226(94)90162-7; Viterbo F, 1992, Rev Paul Med, V110, P267; Viterbo Fausto, 2009, Plast Reconstr Surg, V124, pe351, DOI 10.1097/PRS.0b013e3181bf8471; Walker JC, 2004, J NEUROTRAUM, V21, P217, DOI 10.1089/089771504322778677; Wang XX, 2012, EXP NEUROL, V237, P55, DOI 10.1016/j.expneurol.2012.06.009; Witzel C, 2005, J COMP NEUROL, V485, P183, DOI 10.1002/cne.20436; Yan JG, 2002, J HAND SURG-AM, V27A, P484, DOI 10.1053/jhsu.2002.32953; You SJ, 1997, GLIA, V20, P87, DOI 10.1002/(SICI)1098-1136(199706)20:2<87::AID-GLIA1>3.0.CO;2-1; Yuksel F, 1999, PLAST RECONSTR SURG, V104, P2092; Zhang ZJ, 1999, MICROSURG, V19, P281; Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922; Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.3.CO;2-4	84	16	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127397	10.1371/journal.pone.0127397	http://dx.doi.org/10.1371/journal.pone.0127397			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016986	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600081
J	Henschell, MA; Webster, CR; Flaspohler, DJ; Fortin, CR				Henschell, Max A.; Webster, Christopher R.; Flaspohler, David J.; Fortin, Chad R.			Influence of Plant Community Composition on Biomass Production in Planted Grasslands	PLOS ONE			English	Article							FLORISTIC QUALITY ASSESSMENT; SPECIES COMPOSITION; CONSUMERS GUIDE; DIVERSITY; BIODIVERSITY; SWITCHGRASS; BIOENERGY; INVASION; EVENNESS; IMPACTS	United States energy policy mandates increased use of renewable fuels. Restoring grasslands could contribute to a portion of this requirement through biomass harvest for bioenergy use. We investigated which plant community characteristics are associated with differences in biomass yield from a range of realistic native prairie plantings (n = 11; i.e., conservation planting, restoration, and wildlife cover). Our primary goal was to understand whether patterns in plant community composition and the Floristic Quality Index (FQI) were related to productivity as evidenced by dormant season biomass yield. FQI is an objective measure of how closely a plant community represents that of a pre-European settlement community. Our research was conducted in planted fields of native tallgrass prairie species, and provided a gradient in floristic quality index, species richness, species diversity, and species evenness in south-central Wisconsin during 2008 and 2009. We used a network of 15 randomly located 1 m(2) plots within each field to characterize the plant community and estimate biomass yield by clipping the plots at the end of each growing season. While plant community composition and diversity varied significantly by planting type, biomass yield did not vary significantly among planting types (ANOVA; P > 0.05). Biomass yield was positively correlated with plant community evenness, richness, C4 grass cover, and floristic quality index, but negatively correlated with plant species diversity in our multi-season multiple linear mixed effects models. Concordantly, plots with biomass yield in the lowest quartile (biomass yield <3500 kh/ha) had 8% lower plant community evenness and 9% lower FQI scores than those in the upper quartile (biomass yield > 5800 kh/ha). Our results suggest that promoting the establishment of fields with high species evenness and floristic quality may increase biomass yield, while simultaneously supporting biodiversity.	[Henschell, Max A.; Webster, Christopher R.; Flaspohler, David J.; Fortin, Chad R.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University	Henschell, MA (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	henschell@wisc.edu			National Science Foundation Materials Use: Science, Engineering, and Society [0524872]; Wisconsin Focus on Energy [08-13]	National Science Foundation Materials Use: Science, Engineering, and Society; Wisconsin Focus on Energy	This work was funded by the National Science Foundation (www.nsf.gov) Materials Use: Science, Engineering, and Society grant #0524872 and from the Wisconsin Focus on Energy (https://focusonenergy.com) grant # 08-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2006, AGRON J, V98, P1518, DOI 10.2134/agronj2005.0351; Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1; Anderson D, 2004, MODEL SELECTION MULT, V2nd; Baer SG, 2002, ECOL APPL, V12, P1688, DOI 10.1890/1051-0761(2002)012[1688:CIESAF]2.0.CO;2; Bernthal TW, 2003, DEV FLORISTIC QUALIT, P22; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; CAMARGO JA, 1992, B ENVIRON CONTAM TOX, V48, P428; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Chalcraft DR, 2009, BIODIVERS CONSERV, V18, P91, DOI 10.1007/s10531-008-9457-6; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cohen MJ, 2004, ECOL APPL, V14, P784, DOI 10.1890/02-5378; Di Virgilio N, 2007, FIELD CROP RES, V101, P232, DOI 10.1016/j.fcr.2006.11.009; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Garlock RJ, 2012, BIOMASS BIOENERG, V37, P49, DOI 10.1016/j.biombioe.2011.12.036; Gorley C.K., 2006, GETTING STARTED PRIM; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Herman KD, 1997, NAT AREA J, V17, P265; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Johnson MVV, 2010, BIOENERG RES, V3, P353, DOI 10.1007/s12155-010-9094-2; Jungers JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061209; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee D, 2013, GCB BIOENERGY, V5, P6, DOI 10.1111/j.1757-1707.2012.01177.x; Liebman M, 2013, RENEW AGR FOOD SYST, V28, P115, DOI 10.1017/S1742170512000300; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; Mitchell R, 2008, BIOFUEL BIOPROD BIOR, V2, P530, DOI 10.1002/bbb.106; Monti A, 2009, BIOMASS BIOENERG, V33, P841, DOI 10.1016/j.biombioe.2009.01.006; Mushet DM, 2002, WETLANDS, V22, P126, DOI 10.1672/0277-5212(2002)022[0126:FQAOON]2.0.CO;2; Naeem S, 2000, OIKOS, V91, P97, DOI 10.1034/j.1600-0706.2000.910108.x; Paine LK, 1996, BIOMASS BIOENERG, V10, P231, DOI 10.1016/0961-9534(95)00072-0; Peet RK, 1998, FLEXIBLE MULTIPURPOS, P63; R Core Development Team, 2013, R LANG ENV STAT COMP; Robertson BA, 2013, BIOENERG RES, V6, P311, DOI 10.1007/s12155-012-9258-3; Robertson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016941; Roscher C, 2009, ACTA OECOL, V35, P206, DOI 10.1016/j.actao.2008.10.003; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Stevens MHH, 2001, OIKOS, V92, P291, DOI 10.1034/j.1600-0706.2001.920211.x; Swink F, 1979, PLANTS CHICAGO REGIO; Taft JB, 2006, BIOL CONSERV, V131, P42, DOI 10.1016/j.biocon.2006.02.006; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; U. S. Energy Information Administration. Monthly Energy Review February 2015, 2015, DOEEIA0035 OFF EN ST, P224; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Webster CR, 2010, BIOFUELS-UK, V1, P451, DOI 10.4155/BFS.10.18; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; White R.P., 2000, GRASSLAND ECOSYSTEMS; Wilsey BJ, 2011, PERSPECT PLANT ECOL, V13, P265, DOI 10.1016/j.ppees.2011.07.002; Yurkonis KA, 2005, J ECOL, V93, P1053, DOI 10.1111/j.1365-2745.2005.01029.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	55	5	5	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125758	10.1371/journal.pone.0125758	http://dx.doi.org/10.1371/journal.pone.0125758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018412	gold, Green Submitted, Green Published			2022-12-27	WOS:000355185600030
J	Khatib, MN; Shankar, A; Kirubakaran, R; Agho, K; Simkhada, P; Gaidhane, S; Saxena, D; Unnikrishnan, B; Gode, D; Gaidhane, A; Quazi Syed, Z				Khatib, Mahalaqua Nazli; Shankar, Anuraj; Kirubakaran, Richard; Agho, Kingsley; Simkhada, Padam; Gaidhane, Shilpa; Saxena, Deepak; Unnikrishnan, B.; Gode, Dilip; Gaidhane, Abhay; Quazi Syed, Zahiruddin			Effect of Ghrelin on Mortality and Cardiovascular Outcomes in Experimental Rat and Mice Models of Heart Failure: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CARDIAC SYMPATHETIC TONE; DES-OCTANOYL GHRELIN; MYOCARDIAL-INFARCTION; INDUCED INJURY; PREVENTS; ANGIOGENESIS; INFUSION; PEPTIDE; ISOPROTERENOL; APOPTOSIS	Background Heart failure (HF) continues to be a challenging condition in terms of prevention and management of the disease. Studies have demonstrated various cardio-protective effects of Ghrelin. The aim of the study is to determine the effect of Ghrelin on mortality and cardiac function in experimental rats/mice models of HF. Methods Data sources: PUBMED, Scopus. We searched the Digital Dissertations and conference proceedings on Web of Science. Search methods: We systematically searched for all controlled trials (upto November 2014) which assessed the effects of Ghrelin (irrespective of dose, form, frequency, duration and route of administration) on mortality and cardiac function in rats/mice models of HF. Ghrelin administration irrespective of dose, form, frequency, duration and route of administration. Data collection and analysis: Two authors independently assessed each abstract for eligibility and extracted data on characteristics of the experimental model used, intervention and outcome measures. We assessed the methodological quality by SYRCLE's risk of bias tool for all studies and the quality of evidence by GRADEpro. We performed meta-analysis using RevMan 5.3. Results A total of 325 animals (rats and mice) were analyzed across seven studies. The meta-analysis revealed that the mortality in Ghrelin group was 31.1% and in control group was 40% (RR 0.83, 95% CI 0.46 to 1.47) i.e Ghrelin group had 68 fewer deaths per 1000 (from 216 fewer to 188 more) as compared to the control group. The meta-analysis reveals that the heart rate in rats/mice on Ghrelin was higher (MD 13.11, 95% CI 1.14 to 25.08, P=0.66) while the mean arterial blood pressure (MD - 1.38, 95% CI - 5.16 to 2.41, P=0.48) and left ventricular end diastolic pressure (MD - 2.45, 95% CI - 4.46 to - 0.43, P=0.02) were lower as compared to the those on placebo. There were insignificant changes in cardiac output (SMD 0.28, 95% CI - 0.24 to 0.80, P=0.29) and left ventricular end systolic pressure (MD 1.48, 95% CI - 3.86 to 6.82, P=0.59). Conclusions The existing data provides evidence to suggest that Ghrelin may lower the risk of mortality and improve cardiovascular outcomes. However; the quality of evidence as assessed by GRADEpro is low to very low. Clinical judgments to administer Ghrelin to patients with HF must be made on better designed animal studies.	[Khatib, Mahalaqua Nazli] Datta Meghe Inst Med Sci, Dept Physiol, Wardha, Maharashtra, India; [Shankar, Anuraj] Harvard Univ, Sch Publ Hlth, Dept Nutr, Cambridge, MA 02138 USA; [Kirubakaran, Richard] Christian Med Coll & Hosp, South Asian Cochrane Ctr, Vellore, Tamil Nadu, India; [Agho, Kingsley] Univ Western Sydney, Dept Biostat, Sydney, NSW, Australia; [Simkhada, Padam] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 5UX, Merseyside, England; [Gaidhane, Shilpa] Datta Meghe Inst Med Sci, Dept Med, Wardha, Maharashtra, India; [Saxena, Deepak] Indian Inst Publ Health Gandhinagar, Publ Hlth Fdn India, New Delhi, India; [Unnikrishnan, B.] Manipal Univ, Dept Community Med, Manipal, Karnataka, India; [Gode, Dilip] Datta Meghe Inst Med Sci, Wardha, Maharashtra, India; [Gaidhane, Abhay; Quazi Syed, Zahiruddin] Datta Meghe Inst Med Sci, Dept Community Med, Wardha, Maharashtra, India	Datta Meghe Institute of Medical Sciences - Deemed to be University; Jawaharlal Nehru Medical College Wardha; Harvard University; Harvard T.H. Chan School of Public Health; Christian Medical College & Hospital (CMCH) Vellore; Western Sydney University; Liverpool John Moores University; Datta Meghe Institute of Medical Sciences - Deemed to be University; Jawaharlal Nehru Medical College Wardha; Public Health Foundation of India; Manipal Academy of Higher Education (MAHE); Datta Meghe Institute of Medical Sciences - Deemed to be University; Datta Meghe Institute of Medical Sciences - Deemed to be University; Jawaharlal Nehru Medical College Wardha	Quazi Syed, Z (corresponding author), Datta Meghe Inst Med Sci, Dept Community Med, Wardha, Maharashtra, India.	zahirquazi@gmail.com	Agho, Kingsley/AAW-5622-2021; Agho, Kingsley/AAE-9971-2020; Unnikrishnan, Bhaskaran/O-1025-2015; Syed, ZQ/K-2887-2018; Gaidhane, Abhay/AAK-7144-2020; Gaidhane, Shilpa/AAL-2089-2020; Kirubakaran, Richard/AAI-5947-2021; Saxena, Deepak/AAH-7395-2019; Khatib, Mahalaqua Nazli/E-7308-2010; Shankar, Anuraj/U-3764-2018	Agho, Kingsley/0000-0003-4111-3207; Unnikrishnan, Bhaskaran/0000-0003-0892-8551; Syed, ZQ/0000-0002-1435-899X; Gaidhane, Abhay/0000-0002-4814-2695; Gaidhane, Shilpa/0000-0002-3012-7438; Kirubakaran, Richard/0000-0002-5799-0303; Saxena, Deepak/0000-0003-0563-4259; Khatib, Mahalaqua Nazli/0000-0001-5875-8277; Simkhada, Padam/0000-0002-5706-6479; Shankar, Anuraj/0000-0001-7268-6708	Department for International Development (DFID) [201400] Funding Source: researchfish	Department for International Development (DFID)		Akashi YJ, 2009, INT J CARDIOL, V137, P267, DOI 10.1016/j.ijcard.2008.06.094; [Anonymous], 2014, REV MAN REVMAN; Chang L, 2004, ACTA PHARMACOL SIN, V25, P1131; Chen Y, 2014, ARCH MED RES, V45, P263, DOI 10.1016/j.arcmed.2014.01.004; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Du CK, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.64; Freeman JN, 2013, PEPTIDES, V42, P35, DOI 10.1016/j.peptides.2013.02.003; Goldstone AP, 2014, AM J CLIN NUTR, V99, P1319, DOI 10.3945/ajcn.113.075291; Granata R, 2011, EXP BIOL MED, V236, P505, DOI 10.1258/ebm.2011.010365; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Huang CX, 2009, PEPTIDES, V30, P2286, DOI 10.1016/j.peptides.2009.09.004; Isgaard J, 2013, ENDOCR DEV, V25, P83, DOI 10.1159/000346056; Kemp BA, 2014, ENDOCRINOLOGY, V155, P2658, DOI 10.1210/en.2013-2177; Khatib MN, 2014, ANN TROP MED PUBLIC, V7, P30, DOI 10.4103/1755-6783.145008; Khatib Mahalaqua Nazli, 2014, Heart Views, V15, P74, DOI 10.4103/1995-705X.144792; Khatib MN, 2014, NATL J PHYSL PHARM P, V4, P101, DOI DOI 10.5455/NJPPP.2014.4.230420141; Khatib N, 2014, J CLIN DIAGN RES, V8, pMC13, DOI 10.7860/JCDR/2014/9863.4767; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Li L, 2006, ACTA PHARMACOL SIN, V27, P527, DOI 10.1111/j.1745-7254.2006.00319.x; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035265; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mao Y, 2014, HYPERTENSION; Mao YJ, 2014, PEPTIDES, V56, P156, DOI 10.1016/j.peptides.2014.04.004; Mao YJ, 2013, ENDOCRINOLOGY, V154, P3847, DOI 10.1210/en.2013-1291; Mao YJ, 2013, ENDOCRINOLOGY, V154, P1854, DOI 10.1210/en.2012-2132; Mao YJ, 2012, ENDOCRINOLOGY, V153, P3426, DOI 10.1210/en.2012-1065; Miki K, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-37; Miki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035708; Mitacchione G, 2014, CIRC-HEART FAIL, V7, P643, DOI 10.1161/CIRCHEARTFAILURE.114.001167; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Nagaya N, 2006, DRUGS, V66, P439, DOI 10.2165/00003495-200666040-00004; Nagaya N, 2004, CIRCULATION, V110, P3674, DOI 10.1161/01.CIR.0000149746.62908.BB; Nagaya N, 2003, REGUL PEPTIDES, V114, P71, DOI 10.1016/S0167-0115(03)00117-4; Nagaya N, 2001, J CLIN ENDOCR METAB, V86, P5854, DOI 10.1210/jc.86.12.5854; Nagaya N, 2001, CIRCULATION, V104, P1430, DOI 10.1161/hc3601.095575; Ohta K, 2011, J DENT RES, V90, P1286, DOI 10.1177/0022034511420431; Rizzo M, 2013, CURR PHARM DESIGN, V19, P4953, DOI 10.2174/1381612811319270018; Robertson J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-103; Schunemann HJ OA, 2008, CHAPTER 12 INTERPRET; Schwenke DO, 2008, ENDOCRINOLOGY, V149, P5172, DOI 10.1210/en.2008-0472; Schwenke DO, 2012, ENDOCRINOLOGY, V153, P2436, DOI 10.1210/en.2011-2057; Shimada T, 2014, METABOLISM, V63, P469, DOI 10.1016/j.metabol.2013.12.011; Shu ZW, 2013, CARDIOVASC DRUG THER, V27, P309, DOI 10.1007/s10557-013-6453-1; Stewart S, 2003, HEART, V89, P49, DOI 10.1136/heart.89.1.49; Strasser F, 2012, CURR PHARM DESIGN, V18, P4800, DOI 10.2174/138161212803216870; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Tokudome T, 2014, FRONT HORM RES, V43, P125, DOI 10.1159/000360593; Tully Phillip J, 2013, J Extra Corpor Technol, V45, P8; van Luijk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089981; Vestergaard ET, 2007, AM J PHYSIOL-HEART C, V293, pH3020, DOI 10.1152/ajpheart.00496.2007; Vila G, 2012, DIABETES, V61, P2592, DOI 10.2337/db11-1466; Wang Li, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P50; Wang L, 2012, PEPTIDES, V33, P92, DOI 10.1016/j.peptides.2011.11.001; Wang X, 2014, BIOCHEM PHARMACOL, V88, P334, DOI 10.1016/j.bcp.2014.01.040; Yang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085785; Yano Y, 2014, AM J HYPERTENS, V27, P727, DOI 10.1093/ajh/hpt232; Yuan MJ, 2014, ONCOL LETT, V8, P969, DOI 10.3892/ol.2014.2245; Yuan MJ, 2012, REGUL PEPTIDES, V179, P39, DOI 10.1016/j.regpep.2012.08.013; Yuan MJ, 2011, PEPTIDES, V32, P2357, DOI 10.1016/j.peptides.2011.10.004; Yuan MJ, 2014, REGUL PEPT; Zaniolo K, 2011, INVEST OPHTH VIS SCI, V52, P5376, DOI 10.1167/iovs.10-7152; Zhang GG, 2013, PEPTIDES, V48, P156, DOI 10.1016/j.peptides.2013.08.015; Zhang GG, 2010, CURR CARDIOL REV, V6, P62, DOI 10.2174/157340310790231662	64	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126697	10.1371/journal.pone.0126697	http://dx.doi.org/10.1371/journal.pone.0126697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016489	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600057
J	Teichert, T; Hellwig, A; Pessler, A; Hellwig, M; Vossoughi, M; Sugiri, D; Vierkotter, A; Schulte, T; Freund, J; Roden, M; Hoffmann, B; Schikowski, T; Luckhaus, C; Kramer, U; Henle, T; Herder, C				Teichert, Tom; Hellwig, Anne; Pessler, Annette; Hellwig, Michael; Vossoughi, Mohammad; Sugiri, Dorothea; Vierkoetter, Andrea; Schulte, Thomas; Freund, Juliane; Roden, Michael; Hoffmann, Barbara; Schikowski, Tamara; Luckhaus, Christian; Kraemer, Ursula; Henle, Thomas; Herder, Christian			Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study	PLOS ONE			English	Article							METHYLGLYOXAL-DERIVED HYDROIMIDAZOLONE; EPSILON-CARBOXYMETHYL-LYSINE; INCREASED SERUM-LEVELS; OXIDATIVE STRESS; ENDPRODUCTS AGES; MONOCLONAL-ANTIBODY; INSULIN-RESISTANCE; RENAL FIBROSIS; PROTEIN; PLASMA	Advanced glycation end products (AGEs) may contribute to the development of type 2 diabetes and related complications, whereas their role in the early deterioration of glycaemia is unknown. While previous studies used antibody-based methods to quantify AGEs, data from tandem mass spectrometry coupled liquid chromatography (LC-MS/MS)-based measurements are limited to patients with known diabetes. Here, we used the LC-MS/MSmethod to test the hypothesis that plasma AGE levels are higher in individuals with impaired fasting glucose (IFG) than in those with normal fasting glucose (NFG). Secondary aims were to assess correlations of plasma AGEs with quantitative markers of glucose metabolism and biomarkers of subclinical inflammation. This study included on 60 women with NFG or IFG (n = 30 each, mean age 74 years) from the German SALIA cohort. Plasma levels of free metabolites (3-deoxyfructose, 3-deoxypentosone, 3-deoxypentulose), two hydroimidazolones, oxidised adducts (carboxymethyllysine, carboxyethyllysine, methionine sulfoxide) and Ne-fructosyllysine were measured using LC-MS/MS. Plasma concentrations of all tested AGEs did not differ between the NFG and IFG groups (all p>0.05). Associations between plasma levels of AGEs and fasting glucose, insulin and HOMA-IR as a measure of insulin resistance were weak (r between -0.2 and 0.2, all p>0.05). The association between 3-deoxyglucosone-derived hydroimidazolone with several proinflammatory biomarkers disappeared upon adjustment for multiple testing. In conclusion, plasma AGEs assessed by LC-MS/MS were neither increased in IFG nor associated with parameters of glucosemetabolism and subclinical inflammation in our study. Thus, these data argue against strong effects of AGEs in the early stages of deterioration of glucosemetabolism.	[Teichert, Tom; Roden, Michael; Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Teichert, Tom; Roden, Michael; Herder, Christian] DZD eV, Partner Dusseldorf, German Ctr Diabet Res, Dusseldorf, Germany; [Hellwig, Anne; Pessler, Annette; Hellwig, Michael; Freund, Juliane; Henle, Thomas] Tech Univ Dresden, Inst Food Chem, D-01062 Dresden, Germany; [Vossoughi, Mohammad; Sugiri, Dorothea; Vierkoetter, Andrea; Hoffmann, Barbara; Schikowski, Tamara; Kraemer, Ursula] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Schulte, Thomas; Luckhaus, Christian] Univ Dusseldorf, Dept Psychiat & Psychotherapy, Dusseldorf, Germany; [Roden, Michael] Univ Dusseldorf, Fac Med, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Hoffmann, Barbara] Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Schikowski, Tamara] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schikowski, Tamara] Univ Basel, Basel, Switzerland	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Technische Universitat Dresden; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Herder, C (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	christian.herder@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019	Hellwig, Michael/0000-0001-8528-6893	Deutsche Forschungsgemeinschaft (DFG) [HE-4510/2-1, KR 1938/3-1, LU 691/4-1]; Ministry of the Environment of the State of North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) VT [266.1]; Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of the Environment of the State of North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) VT; Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by research grants from the Deutsche Forschungsgemeinschaft (DFG; HE-4510/2-1, KR 1938/3-1, LU 691/4-1). SALIA received funds from the Ministry of the Environment of the State of North Rhine-Westphalia (Dusseldorf, Germany) and the Federal Ministry of the Environment (Berlin, Germany). The follow-up investigation was funded by the DGUV (German statutory accident assurance) VT 266.1. This work was supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW), the German Federal Ministry of Health (BMG) and in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2005, ATHEROSCLEROSIS, V178, P115, DOI 10.1016/j.atherosclerosis.2004.08.007; Accacha S, 2013, HORM RES PAEDIAT, V80, P318, DOI 10.1159/000354831; Ahmed N, 2002, BIOCHEM J, V364, P1; Ahmed N, 2005, DIABETES CARE, V28, P2465, DOI 10.2337/diacare.28.10.2465; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Beisswenger PJ, 2014, AMINO ACIDS, V46, P311, DOI 10.1007/s00726-013-1533-x; Beisswenger PJ, 2012, AMINO ACIDS, V42, P1171, DOI 10.1007/s00726-010-0784-z; Cai WJ, 2008, AM J PATHOL, V173, P327, DOI 10.2353/ajpath.2008.080152; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Davis KE, 2014, NUTR RES, V34, P478, DOI 10.1016/j.nutres.2014.04.012; Degen J, 2014, J AGR FOOD CHEM, V62, P2449, DOI 10.1021/jf405546q; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Forbes JM, 2003, FASEB J, V17, P1762, DOI 10.1096/fj.02-1102fje; Forbes JM, 2014, AMINO ACIDS, V46, P321, DOI 10.1007/s00726-013-1542-9; Fosmark DS, 2006, METABOLISM, V55, P232, DOI 10.1016/j.metabol.2005.08.017; GRANDHEE SK, 1991, J BIOL CHEM, V266, P11649; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; HAYWARD LD, 1977, CARBOHYD RES, V53, P13; Heier M, 2015, DIABETES VASC DIS RE, V12, P139, DOI 10.1177/1479164114560910; Hellwig M, 2011, CHEMBIOCHEM, V12, P1270, DOI 10.1002/cbic.201000759; Henle T, 2005, AMINO ACIDS, V29, P313, DOI 10.1007/s00726-005-0200-2; Henle T, 2003, KIDNEY INT, V63, pS145, DOI 10.1046/j.1523-1755.63.s84.16.x; Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155; Herder C, 2014, DIABETOLOGIA, V57, P16, DOI 10.1007/s00125-013-3061-3; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Jakus V, 2014, PHYSIOL RES, V63, P297, DOI 10.33549/physiolres.932672; Kellow NJ, 2013, EUR J CLIN NUTR, V67, P239, DOI 10.1038/ejcn.2012.220; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; KNECHT KJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P130, DOI 10.1016/0003-9861(92)90146-N; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Kusunoki H, 2003, DIABETES CARE, V26, P1889, DOI 10.2337/diacare.26.6.1889; Lacinov? K., 2010, ADV MOL MECH PHARM D, P17; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Mera K, 2010, J PHARM SCI-US, V99, P1614, DOI 10.1002/jps.21927; MIYATA S, 1992, J CLIN INVEST, V89, P1102, DOI 10.1172/JCI115690; Nagai R, 2003, BIOCHEM SOC T, V31, P1438; Nicholl ID, 1998, MOL MED, V4, P594, DOI 10.1007/BF03401759; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; SCHRAY KJ, 1978, ACCOUNTS CHEM RES, V11, P136, DOI 10.1021/ar50124a002; Semba RD, 2011, J NUTR, V141, P1726, DOI 10.3945/jn.111.143172; Sjogren P, 2007, ATHEROSCLEROSIS, V195, pE168, DOI 10.1016/j.atherosclerosis.2007.06.003; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tahara N, 2012, CARDIOVASC THER, V30, P42, DOI 10.1111/j.1755-5922.2010.00177.x; Tan KCB, 2011, DIABETES-METAB RES, V27, P488, DOI 10.1002/dmrr.1188; Tan KCB, 2004, DIABETES CARE, V27, P223, DOI 10.2337/diacare.27.1.223; Teichert T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083042; Thornalley P., 2011, DRUG METABOL DRUG IN, V23, P125; Thornalley PJ, 2014, BBA-GEN SUBJECTS, V1840, P818, DOI 10.1016/j.bbagen.2013.03.025; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Turk Z, 2009, CLIN LAB, V55, P431; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P2465, DOI 10.1271/bbb.70229; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Vlassara H, 2010, US ENDOCRINOL, V6, P14; Wang TN, 2012, J AM CHEM SOC, V134, P8958, DOI 10.1021/ja301994d; WELLSKNECHT KJ, 1994, DIABETES, V43, P1152, DOI 10.2337/diabetes.43.9.1152; Zhou GH, 2004, AM J PATHOL, V165, P2033, DOI 10.1016/S0002-9440(10)63254-3	62	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128293	10.1371/journal.pone.0128293	http://dx.doi.org/10.1371/journal.pone.0128293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018950	gold, Green Published, Green Accepted			2022-12-27	WOS:000355185600116
J	Guajardo, V; Solis, S; Sagredo, B; Gainza, F; Munoz, C; Gasic, K; Hinrichsen, P				Guajardo, Vernoica; Solis, Simon; Sagredo, Boris; Gainza, Felipe; Munoz, Carlos; Gasic, Ksenija; Hinrichsen, Patricio			Construction of High Density Sweet Cherry (Prunus avium L.) Linkage Maps Using Microsatellite Markers and SNPs Detected by Genotyping-by-Sequencing (GBS)	PLOS ONE			English	Article							GENETIC DIVERSITY; GENOME; PEACH; SOFTWARE	Linkage maps are valuable tools in genetic and genomic studies. For sweet cherry, linkage maps have been constructed using mainly microsatellite markers (SSRs) and, recently, using single nucleotide polymorphism markers (SNPs) from a cherry 6K SNP array. Genotyping-by-sequencing (GBS), a new methodology based on high-throughput sequencing, holds great promise for identification of high number of SNPs and construction of high density linkage maps. In this study, GBS was used to identify SNPs from an intra-specific sweet cherry cross. A total of 8,476 high quality SNPs were selected for mapping. The physical position for each SNP was determined using the peach genome, Peach v1.0, as reference, and a homogeneous distribution of markers along the eight peach scaffolds was obtained. On average, 65.6% of the SNPs were present in genic regions and 49.8% were located in exonic regions. In addition to the SNPs, a group of SSRs was also used for construction of linkage maps. Parental and consensus high density maps were constructed by genotyping 166 siblings from a 'Rainier' x 'Rivedel' (Ra x Ri) cross. Using Ra x Ri population, 462, 489 and 985 markers were mapped into eight linkage groups in 'Rainier', 'Rivedel' and the Ra x Ri map, respectively, with 80% of mapped SNPs located in genic regions. Obtained maps spanned 549.5, 582.6 and 731.3 cM for 'Rainier', 'Rivedel' and consensus maps, respectively, with an average distance of 1.2 cM between adjacent markers for both 'Rainier' and 'Rivedel' maps and of 0.7 cM for Ra x Ri map. High synteny and co-linearity was observed between obtained maps and with Peach v1.0. These new high density linkage maps provide valuable information on the sweet cherry genome, and serve as the basis for identification of QTLs and genes relevant for the breeding of the species.	[Guajardo, Vernoica; Solis, Simon; Gainza, Felipe] CEAF, Los Choapinos, Rengo, Chile; [Sagredo, Boris] INIA Rayentue, Inst Invest Agr, Rengo, Chile; [Munoz, Carlos] Univ Chile, Fac Ciencias Agron, Santiago, Chile; [Gasic, Ksenija] Clemson Univ, Dept Agr & Environm Sci, Clemson, SC USA; [Hinrichsen, Patricio] INIA La Platina, Inst Invest Agr, Santiago, Chile	Universidad de Chile; Clemson University	Hinrichsen, P (corresponding author), INIA La Platina, Inst Invest Agr, Santiago, Chile.	phinrichsen@inia.cl	Guajardo, Verónica/J-8190-2017; Munoz, Carlos E/A-8260-2011; Gasic, Ksenija/AAN-6234-2021; Gasic, Ksenija/H-8254-2017	Guajardo, Verónica/0000-0002-8756-628X; Gasic, Ksenija/0000-0003-4391-5262; Gasic, Ksenija/0000-0003-4391-5262; gainza, felipe/0000-0003-2513-2504	CONICYT [24121618]; FONDECYT [1121117]; FONDEF-Chile [G09I1008]; University of Chile Doctoral Program;  [CONICYT/REGIONAL/GORE/O'HIGGINS/CEAF/R08I1001]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDEF-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); University of Chile Doctoral Program; 	This work was funded by CONICYT/REGIONAL/GORE/O'HIGGINS/CEAF/R08I1001, CONICYT fellowship 24121618, FONDECYT 1121117, FONDEF-Chile (G09I1008), and the University of Chile Doctoral Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranzana MJ, 2002, PLANT BREEDING, V121, P87, DOI 10.1046/j.1439-0523.2002.00656.x; Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Boskovic R, 1998, EUPHYTICA, V103, P273, DOI 10.1023/A:1018664600714; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Cabrera A, 2012, TREE GENET GENOMES, V8, P237, DOI 10.1007/s11295-011-0436-9; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; Cantini C, 2001, J AM SOC HORTIC SCI, V126, P205, DOI 10.21273/JASHS.126.2.205; Carrasco B, 2013, BIOL RES, V46, P219, DOI 10.4067/S0716-97602013000300001; Clarke JB, 2009, TREE GENET GENOMES, V5, P41, DOI 10.1007/s11295-008-0166-9; Clarke JB, 2003, MOL ECOL NOTES, V3, P578, DOI 10.1046/j.1471-8286.2003.00517.x; Di Genova A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-7; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Eduardo I, 2013, TREE GENET GENOMES, V9, P189, DOI 10.1007/s11295-012-0546-z; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fresnedo-Ramirez J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-750; Gardner Kyle M, 2014, G3 (Bethesda), V4, P1681, DOI 10.1534/g3.114.011023; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guajardo V, 2013, ACTA HORTIC IN PRESS; Klagges C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054743; Koepke T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-18; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XH, 2014, G3-GENES GENOM GENET, V4, P1971, DOI 10.1534/g3.114.012245; Ma XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033821; Olmstead JW, 2008, TREE GENET GENOMES, V4, P897, DOI 10.1007/s11295-008-0161-1; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Rauh B, 2013, 21 PLANT AN GEN C JA; Rojas G, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue5-fulltext-1; Russell J, 2014, MOL BREEDING, V33, P835, DOI 10.1007/s11032-013-9996-8; Sanchez G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-137; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Sonneveld T, 2003, THEOR APPL GENET, V107, P1059, DOI 10.1007/s00122-003-1274-4; Spindel J, 2013, THEOR APPL GENET, V126, P2699, DOI 10.1007/s00122-013-2166-x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stockinger EJ, 1996, J HERED, V87, P214, DOI 10.1093/oxfordjournals.jhered.a022987; Struss D, 2002, HORTSCIENCE, V37, P191, DOI 10.21273/HORTSCI.37.1.191; Struss D, 2003, J AM SOC HORTIC SCI, V128, P904, DOI 10.21273/JASHS.128.6.0904; Tavassolian I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-551; Van Ooijen J., 2006, SOFTWARE CALCULATION; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2	46	62	66	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127750	10.1371/journal.pone.0127750	http://dx.doi.org/10.1371/journal.pone.0127750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011256	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900138
J	Munns, JJ; Lee, JYB; Orias, AAE; Takatori, R; Andersson, GBJ; An, HS; Inoue, N				Munns, Justin J.; Lee, Joe Y. B.; Orias, Alejandro A. Espinoza; Takatori, Ryota; Andersson, Gunnar B. J.; An, Howard S.; Inoue, Nozomu			Ligamentum Flavum Hypertrophy in Asymptomatic and Chronic Low Back Pain Subjects	PLOS ONE			English	Article							SEGMENTAL MOTION; SPINAL STENOSIS; LUMBAR; PATHOMECHANISM; TISSUE	Purpose To examine ligamentum flavum thickness using magnetic resonance (MR) images to evaluate its association with low back pain symptoms, age, gender, lumbar level, and disc characteristics. Materials and Methods Sixty-three individuals were part of this IRB-approved study: twenty-seven with chronic low back pain, and thirty-six as asymptomatic. All patients underwent MR imaging and computed tomography (CT) of the lumbar spine. The MR images at the mid-disc level were captured and enlarged 800% using a bilinear interpolation size conversion algorithm that allowed for enhanced image quality. Ligamentum flavum thickness was assessed using bilateral medial and lateral measurements. Disc height at each level was measured by the least-distance measurement method in three-dimensional models created by CT images taken of the same subject. Analysis of variance and t-tests were carried out to evaluate the relationship between ligamentum flavum thickness and patient variables. Results Ligamentum flavum thickness was found to significantly increase with older age, lower lumbar level, and chronic low back pain (p < 0.03). No difference in ligamentum flavum thickness was observed between right and left sided measurements, or between male and female subjects. Disc height and both ligamentum flavum thickness measurements showed low to moderate correlations that reached significance (p < 0.01). Additionally, a moderate and significant correlation between disc degeneration grade and ligamentum flavum thickness does exist (p < 0.001). Conclusion By measuring ligamentum flavum thickness on MR images at two different sites and comparing degrees of disc degeneration, we found that ligamentum flavum thickness may be closely related to the pathogenesis of pain processes in the spine.	[Munns, Justin J.; Lee, Joe Y. B.; Orias, Alejandro A. Espinoza; Takatori, Ryota; Andersson, Gunnar B. J.; An, Howard S.; Inoue, Nozomu] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA	Rush University	Inoue, N (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	Nozomu_Inoue@rush.edu		Takatori, Ryota/0000-0002-0867-3918	National Institutes of Health grant: National Institute for Arthritis and Musculoskeletal and Skin Diseases [P01-AR48152-10]; National Institutes of Health grant: National Center for Complementary and Alternative Medicine [R01-AT006692-01A1]; National Center for Complementary & Integrative Health [R01AT006692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048152] Funding Source: NIH RePORTER	National Institutes of Health grant: National Institute for Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health grant: National Center for Complementary and Alternative Medicine; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by two National Institutes of Health grants: National Institute for Arthritis and Musculoskeletal and Skin Diseases (www.niams.nih.gov) Grant No. P01-AR48152-10; National Center for Complementary and Alternative Medicine (nccam.nih.gov) Grant No. R01-AT006692-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas J, 2010, SPINE, V35, P1225, DOI 10.1097/BRS.0b013e3181bfca15; Altinkaya N, 2011, SPINE, V36, pE1093, DOI 10.1097/BRS.0b013e318203e2b5; Chen JW, 2014, DIS MARKERS, V2014, P1, DOI 10.1155/2014/786543; Chen YT, 2011, SPINE, V36, pE1193, DOI 10.1097/BRS.0b013e3182053f58; Crane B, 2006, 52 ANN M ORTH RES SO; Cui GY, 2011, J ORTHOP SCI, V16, P785, DOI 10.1007/s00776-011-0135-2; Duan CY, 2011, OSTEOARTHR CARTILAGE, V19, P96, DOI 10.1016/j.joca.2010.10.015; FUKUYAMA S, 1995, J SPINAL DISORD, V8, P126; Hansson T, 2009, EUR SPINE J, V18, P679, DOI 10.1007/s00586-009-0919-7; Kosaka H, 2007, SPINE, V32, P2805, DOI 10.1097/BRS.0b013e31815b650f; Miyamoto Kei, 2006, Spine J, V6, P692, DOI 10.1016/j.spinee.2006.04.014; Moon HJ, 2012, SPINE, V37, pE147, DOI 10.1097/BRS.0b013e3182269b19; NACHEMSON A L, 1968, Journal of Biomechanics, V1, P211, DOI 10.1016/0021-9290(68)90006-7; Ochia RS, 2007, SPINE, V32, P1394, DOI 10.1097/BRS.0b013e318060122b; Ochia RS, 2006, SPINE, V31, P2073, DOI 10.1097/01.brs.0000231435.55842.9e; Okuda T, 2004, SPINE, V29, P1689, DOI 10.1097/01.BRS.0000132510.25378.8C; Park J B, 2001, Spine (Phila Pa 1976), V26, pE492, DOI 10.1097/00007632-200111010-00007; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; POSTACCHINI F, 1994, SPINE, V19, P917, DOI 10.1097/00007632-199404150-00009; Safak AA, 2010, CLIN ANAT, V23, P79, DOI 10.1002/ca.20883; Sairyo K, 2005, SPINE, V30, P2649, DOI 10.1097/01.brs.0000188117.77657.ee; Sairyo K, 2007, SPINE, V32, pE340, DOI 10.1097/01.brs.0000263407.25009.6e; Sakamaki T, 2009, ARCH ORTHOP TRAUM SU, V129, P1415, DOI 10.1007/s00402-009-0849-1; Schrader PK, 1999, EUR SPINE J, V8, P323, DOI 10.1007/s005860050181; Watanabe S, 2012, EUR SPINE J, V21, P946, DOI 10.1007/s00586-011-2090-1; Zhong ZM, 2011, J ORTHOP RES, V29, P1592, DOI 10.1002/jor.21431	26	25	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128321	10.1371/journal.pone.0128321	http://dx.doi.org/10.1371/journal.pone.0128321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010138	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900224
J	Ondoa, P; Gautam, R; Rusine, J; Lutter, R; Jurriaans, S; Kootstra, N; Karita, E; van de Wijgert, J				Ondoa, Pascale; Gautam, Raju; Rusine, John; Lutter, Rene; Jurriaans, Suzanne; Kootstra, Neeltje; Karita, Etienne; van de Wijgert, Janneke			Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BACTERIAL VAGINOSIS; TRACT; RNA; TRANSMISSION; INFLAMMATION; TRICHOMONAS; MODULATION; ACTIVATION; EXPRESSION	Background Genital viral load (GVL) is the main determinant of sexual transmission of human immune-deficiency virus (HIV). The effect of antiretroviral therapy (ART) on local cervico-vaginal immunological factors associated with GVL is poorly described. We aimed to identify the risk factors of detectable GVL, and the impact of ART on HIV genital shedding and its correlates in a cohort of HIV-infected women, attending HIV care in Kigali, Rwanda. Materials and Methods All participants were evaluated for GVL, plasma viral load (PVL), CD4 count, various sexually-transmitted infections (STIs) at baseline and at month 12. Genital concentration of 19 cytokines and mRNA expression of APOBEC3G and BST2, two host HIV restriction factors, were evaluated at baseline in all participants. Cytokine levels were re-assessed at month 12 only in participants eligible for ART at baseline. Risk factors of GVL >= 40copies/mL at baseline and month 12 were assessed using logistic regression. Effect of 12-month ART on various local and systemic immunological parameters was examined using a paired t-test and McNemar as appropriate. Results 96 of the 247 women enrolled in the study were eligible for ART. After 12 months of ART, PVL and GVL decreased to undetectable level in respectively 74 and 88% of treated participants. ART did not affect cytokine levels. HIV genital shedding occurred only when PVL was detectable. At baseline, GVL was independently associated with IL-1 beta after controlling for PVL, age and N. gonorrhea infection ( 95% CI 1.32-2.15) and at month 12 with MIP-1 beta ( 95% CI 0.96-21.32) after controlling for baseline GVL, PVL and month 12 IL-8. Conclusion Suppressive ART does not necessarily reduce genital level of immune activation. Minimizing all conditions favoring genital inflammation, including active detection and treatment of STIs, might reduce the risk of HIV transmission as supplement to the provision of potent ART.	[Ondoa, Pascale] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, AIGHD, NL-1105 AZ Amsterdam, Netherlands; [Gautam, Raju; van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Rusine, John] INTERACT Program, Kigali, Rwanda; [Rusine, John] Natl Reference Lab, Kigali, Rwanda; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, NL-1105 AZ Amsterdam, Netherlands; [Lutter, Rene; Kootstra, Neeltje] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Jurriaans, Suzanne] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Karita, Etienne] Project San Francisco, Kigali, Rwanda	University of Amsterdam; Academic Medical Center Amsterdam; University of Liverpool; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Ondoa, P (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, AIGHD, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.ondoa@aighd.org		van de Wijgert, Janneke H.H.M./0000-0003-2728-4560; Kootstra, Neeltje A./0000-0001-9429-7754	Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP) [W 0705 201 00]; European Developing Countries Clinical Trials Partnership (EDCTP) [CT-ct-05-33070-001]	Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP); European Developing Countries Clinical Trials Partnership (EDCTP)	This study was funded by The Netherlands-African partnership for Capacity development and Clinical interventions against Poverty-related diseases (NACCAP, grant number W 0705 201 00) and the European Developing Countries Clinical Trials Partnership (EDCTP). NACCAP: http://www.nwo.nl/en/research-and-results/programmes/NACCAP. EDCTP: http://www.edctp.org/ (grant number CT-ct-05-33070-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton G, 2008, INFECTION, V36, P147, DOI 10.1007/s15010-007-7152-2; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Blish CA, 2012, JAIDS-J ACQ IMM DEF, V61, P436, DOI 10.1097/QAI.0b013e31826c2edd; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Cohn MA, 2001, J INFECT DIS, V184, P410, DOI 10.1086/322780; Cu-Uvin S, 2006, JAIDS-J ACQ IMM DEF, V42, P584, DOI 10.1097/01.qai.0000229997.52246.95; Cu-Uvin S, 2010, AIDS, V24, P2486, DOI 10.1097/QAD.0b013e32833e5043; Ferreira VH, 2014, AM J REPROD IMMUNOL, V71, P543, DOI 10.1111/aji.12221; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Ghanem KG, 2005, J INFECT DIS, V191, P358, DOI 10.1086/427190; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jarvis GA, 2012, CURR HIV RES, V10, P211, DOI 10.2174/157016212800618138; Jimenez VC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00763; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Kedzierska K, 2003, REV MED VIROL, V13, P39, DOI 10.1002/rmv.369; Kovacs A, 2001, LANCET, V358, P1593, DOI 10.1016/S0140-6736(01)06653-3; Lamkanfi M, 2011, J IMMUNOL, V187, P597, DOI 10.4049/jimmunol.1100229; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Mirmonsef P, 2012, CURR HIV RES, V10, P202, DOI 10.2174/157016212800618165; Mitchell C, 2011, AIDS RES HUM RETROV, V27, P35, DOI 10.1089/aid.2010.0129; Mkhize NN, 2010, J VIROL, V84, P10765, DOI 10.1128/JVI.00518-10; Natividad-Villanueva GU, 2003, INT J STD AIDS, V14, P826, DOI 10.1258/095646203322556165; Neely MN, 2007, JAIDS-J ACQ IMM DEF, V44, P38, DOI 10.1097/01.qai.0000248352.18007.1f; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Politch JA, 2012, AIDS, V26, P1535, DOI 10.1097/QAD.0b013e328353b11b; Rebbapragada A, 2008, JAIDS-J ACQ IMM DEF, V49, P520, DOI 10.1097/QAI.0b013e318189a7ca; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064345; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063303; *RWAND MIN HLTH, 2011, NAT HIV CAR TREATM G; Sachdeva RK, 2010, J INTERF CYTOK RES, V30, P299, DOI 10.1089/jir.2009.0056; Salter JD, 2014, TRENDS BIOCHEM SCI, V39, P373, DOI 10.1016/j.tibs.2014.07.001; Sawada M, 2006, INT J GYNECOL OBSTET, V92, P117, DOI 10.1016/j.ijgo.2005.10.004; Simhan HN, 2007, AM J OBSTET GYNECOL, V196, P59, DOI 10.1016/j.ajog.2006.08.035; Spear GT, 2008, J REPROD IMMUNOL, V78, P76, DOI 10.1016/j.jri.2007.11.001; Spear GT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019560; Tokarev A, 2009, AIDS RES HUM RETROV, V25, P1197, DOI 10.1089/aid.2009.0253; Vettore MV, 2006, J INFECTION, V52, P290, DOI 10.1016/j.jinf.2005.06.002; WHO, 2010, ANT THER HIV INF AD	42	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127201	10.1371/journal.pone.0127201	http://dx.doi.org/10.1371/journal.pone.0127201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010956	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900072
J	Reynolds, KA; Grindler, NM; Rhee, JS; Cooper, AR; Ratts, VS; Carson, KR; Jungheim, ES				Reynolds, Kasey A.; Grindler, Natalia M.; Rhee, Julie S.; Cooper, Amber R.; Ratts, Valerie S.; Carson, Kenneth R.; Jungheim, Emily S.			Variability in the Practice of Fertility Preservation for Patients with Cancer	PLOS ONE			English	Article							BREAST-CANCER; OVARIAN STIMULATION; EMBRYO CRYOPRESERVATION; AMERICAN-SOCIETY; WOMEN; RECOMMENDATIONS; ONCOLOGISTS; TAMOXIFEN; LETROZOLE; LYMPHOMA	Fertility is important to women and men with cancer. While options for fertility preservation (FP) are available, knowledge regarding the medical application of FP is lacking. Therefore we examined FP practices for cancer patients among reproductive endocrinologists (REs). A 36 item survey was sent to board-certified REs. 98% of respondents reported counseling women with cancer about FP options. Oocyte and embryo cryopreservation were universally offered by these providers, but variability was noted in reported management of these cases -particularly for women with breast cancer. 86% of the respondents reported using letrozole during controlled ovarian stimulation (COS) in patients with estrogen receptor positive (ER+) breast cancer to minimize patient exposure to estrogen. 49% of respondents who reported using letrozole in COS for patients with ER+ breast cancer reported that they would also use letrozole in COS for women with ER negative breast cancer. Variability was also noted in the management of FP for men with cancer. 83% of participants reported counseling men about sperm banking with 22% recommending against banking for men previously exposed to chemotherapy. Overall, 79% of respondents reported knowledge of American Society for Clinical Oncology FP guidelines-knowledge that was associated with providers offering gonadal tissue cryopreservation (RR 1.82, 95% CI 1.14-2.90). These findings demonstrate that RE management of FP in cancer patients varies. Although some variability may be dictated by local resources, standardization of FP practices and communication with treating oncologists may help ensure consistent recommendations and outcomes for patients seeking FP.	[Reynolds, Kasey A.; Grindler, Natalia M.; Rhee, Julie S.; Cooper, Amber R.; Ratts, Valerie S.; Jungheim, Emily S.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, St Louis, MO 63110 USA; [Carson, Kenneth R.] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO USA; [Carson, Kenneth R.] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA; [Carson, Kenneth R.] St Louis Vet Affairs Med Ctr, Res Serv, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Jungheim, ES (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, St Louis, MO 63110 USA.	jungheime@wustl.edu			National Institutes of Health [T32 HD0040135, K12 HD063086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD063086, T32HD040135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grants: T32 HD0040135 (KAR, JSR), and K12 HD063086 (ESJ, ARC).	Adams E, 2013, BRIT J CANCER, V108, P1602, DOI 10.1038/bjc.2013.139; Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS241, DOI 10.1016/j.fertnstert.2008.08.039; Azim AA, 2008, J CLIN ONCOL, V26, P2630, DOI 10.1200/JCO.2007.14.8700; Cakmak H, 2013, FERTIL STERIL, V99, P1476, DOI 10.1016/j.fertnstert.2013.03.029; Dobson R, 2009, BMJ-BRIT MED J, P339; Forman EJ, 2010, FERTIL STERIL, V94, P1652, DOI 10.1016/j.fertnstert.2009.10.008; Jungheim ES, 2015, SEMIN REPROD MED, V33, P77, DOI 10.1055/s-0035-1546424; Kim SS, 2012, J ASSIST REPROD GEN, V29, P465, DOI 10.1007/s10815-012-9786-y; King JW, 2012, ONCOLOGIST, V17, P910, DOI 10.1634/theoncologist.2012-0064; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Oktay K, 2003, HUM REPROD, V18, P90, DOI 10.1093/humrep/deg045; Oktay K, 2005, J CLIN ONCOL, V23, P4347, DOI 10.1200/JCO.2005.05.037; Oktay K, 2010, REPROD BIOMED ONLINE, V20, P783, DOI 10.1016/j.rbmo.2010.03.004; Omurtag K, 2012, FERTIL STERIL, V97, P1095, DOI 10.1016/j.fertnstert.2012.02.026; Partridge AH, 2008, J CLIN ONCOL, V26, P2612, DOI 10.1200/JCO.2008.16.1976; Pfeifer S, 2014, FERTIL STERIL, V101, P1237, DOI 10.1016/j.fertnstert.2014.02.052; Quinn GP, 2011, J NATL COMPR CANC NE, V9, P1219, DOI 10.6004/jnccn.2011.0102; Quinn GP, 2009, J CLIN ONCOL, V27, P5952, DOI 10.1200/JCO.2009.23.0250; Rodriguez-Wallberg KA, 2012, CANCER TREAT REV, V38, P354, DOI 10.1016/j.ctrv.2011.10.002; SART, 2013, 2011 DAT SOC ASS REP; Sheth KR, 2012, J UROLOGY, V187, P979, DOI 10.1016/j.juro.2011.10.154; Sonmezer M, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2011.01.030; Sunderam S, 2012, MMWR SURVEILL SUMM, V61, P1; Vadaparampil ST, 2013, J ONCOL PRACT, V9, P300, DOI 10.1200/JOP.2013.001097; von Wolff M, 2011, ARCH GYNECOL OBSTET, V284, P427, DOI 10.1007/s00404-011-1874-1; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127335	10.1371/journal.pone.0127335	http://dx.doi.org/10.1371/journal.pone.0127335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010087	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900083
J	Verma, M; Beaulieu-Abdelahad, D; Ait-Ghezala, G; Li, RN; Crawford, F; Mullan, M; Paris, D				Verma, Megha; Beaulieu-Abdelahad, David; Ait-Ghezala, Ghania; Li, Rena; Crawford, Fiona; Mullan, Michael; Paris, Daniel			Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; BETA OLIGOMERS; SYNAPTIC PLASTICITY; PLAQUE-FORMATION; SOCIAL MEMORY; IN-VIVO; MICE; GENE; CYCLOOXYGENASE-2; EXPRESSION	Anatabine is a minor tobacco alkaloid, which is also found in plants of the Solanaceae family and displays a chemical structure similarity with nicotine. We have shown previously that anatabine displays some anti-inflammatory properties and reduces microgliosis and tau phosphorylation in a pure mouse model of tauopathy. We therefore investigated the effects of a chronic oral treatment with anatabine in a transgenic mouse model (Tg PS1/APPswe) of Alzheimer's disease (AD) which displays pathological A beta deposits, neuroinflammation and behavioral deficits. In the elevated plus maze, Tg PS1/APPswe mice exhibited hyperactivity and disinhibition compared to wild-type mice. Six and a half months of chronic oral anatabine treatment, suppressed hyperactivity and disinhibition in Tg PS1/APPswe mice compared to Tg PS1/APPswe receiving regular drinking water. Tg PS1/APPswe mice also elicited profound social interaction and social memory deficits, which were both alleviated by the anatabine treatment. We found that anatabine reduces the activation of STAT3 and NF kappa B in the vicinity of A beta deposits in Tg PS1/APPswe mice resulting in a reduction of the expression of some of their target genes including Bace1, iNOS and Cox-2. In addition, a significant reduction in microgliosis and pathological deposition of A beta was observed in the brain of Tg PS1/APPswe mice treated with anatabine. This is the first study to investigate the impact of chronic anatabine treatment on AD-like pathology and behavior in a transgenic mouse model of AD. Overall, our data show that anatabine reduces beta-amyloidosis, neuroinflammation and alleviates some behavioral deficits in Tg PS1/APPswe, supporting further exploration of anatabine as a possible disease modifying agent for the treatment of AD.	[Verma, Megha; Beaulieu-Abdelahad, David; Ait-Ghezala, Ghania; Li, Rena; Crawford, Fiona; Mullan, Michael; Paris, Daniel] Roskamp Inst, Sarasota, FL 34243 USA; [Verma, Megha] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Mullan, Michael] Rock Creek Pharmaceut, Sarasota, FL 34243 USA	Open University - UK	Verma, M (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.	mverma@roskampinstitute.net	Verma, Megha/I-3172-2019	Verma, Megha/0000-0001-7767-612X; Ait-Ghezala, Ghania/0000-0002-9836-8617; Paris, Daniel/0000-0002-9622-0846	Rock Creek Pharmaceuticals	Rock Creek Pharmaceuticals	Rock Creek Pharmaceuticals provided support in the form of salary for author MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Alkadhi KA, 2012, INT J NEUROPSYCHOPH, V15, P223, DOI 10.1017/S1461145711000162; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; Babcock AA, 2015, BRAIN BEHAV IMMUN; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Baron R, 2014, AGING CELL, V13, P584, DOI 10.1111/acel.12210; BECKER JT, 1994, ARCH NEUROL-CHICAGO, V51, P585, DOI 10.1001/archneur.1994.00540180063015; Bediou B, 2009, J GERIATR PSYCH NEUR, V22, P130, DOI 10.1177/0891988709332939; Bitner RS, 2010, J PHARMACOL EXP THER, V334, P875, DOI 10.1124/jpet.110.167213; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; Caturegli P, 2012, ENDOCRINOLOGY, V153, P4580, DOI 10.1210/en.2012-1452; Chami L, 2012, J BIOL CHEM, V287, P24573, DOI 10.1074/jbc.M111.333054; Cheng D, 2013, BEHAV BRAIN RES, V245, P120, DOI 10.1016/j.bbr.2013.02.008; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chung JA, 2000, NEUROL CLIN, V18, P829, DOI 10.1016/S0733-8619(05)70228-0; Court JA, 2005, NEUROPATH APPL NEURO, V31, P522, DOI 10.1111/j.1365-2990.2005.00674.x; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Cui YQ, 2012, CNS NEUROSCI THER, V18, P827, DOI 10.1111/j.1755-5949.2012.00372.x; Echeverria V, 2011, J ALZHEIMERS DIS, V24, P817, DOI 10.3233/JAD-2011-102136; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; FILE SE, 1985, BRIT J PHARMACOL, V86, P729, DOI 10.1111/j.1476-5381.1985.tb08952.x; Font-Nieves M, 2012, J BIOL CHEM, V287, P6454, DOI 10.1074/jbc.M111.327874; Frisoni GB, 1999, DEMENT GERIATR COGN, V10, P130, DOI 10.1159/000017113; Hanzel CE, 2014, NEUROBIOL AGING, V35, P2249, DOI 10.1016/j.neurobiolaging.2014.03.026; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hellstrom-Lindahl E, 2004, NEUROBIOL DIS, V15, P351, DOI 10.1016/j.nbd.2003.11.024; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Inestrosa NC, 2013, NEUROMOL MED, V15, P549, DOI 10.1007/s12017-013-8242-1; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kitamura Y, 1999, BIOCHEM BIOPH RES CO, V254, P582, DOI 10.1006/bbrc.1998.9981; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Kroker KS, 2013, BRAIN RES BULL, V96, P28, DOI 10.1016/j.brainresbull.2013.04.006; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lanier RK, 2015, DRUG ALCOHOL DEPEN, V146, pe167, DOI DOI 10.1016/J.DRUGALCDEP.2014.09.371; Levin ED, 2014, J PSYCHOPHARMACOL, V28, P915, DOI 10.1177/0269881114543721; Liu Q, 2007, FASEB J, V21, P61, DOI 10.1096/fj.06-5841com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Maciuk A, 2008, J PHARMACEUT BIOMED, V48, P238, DOI 10.1016/j.jpba.2007.11.024; Medeiros R, 2014, AM J PATHOL, V184, P520, DOI 10.1016/j.ajpath.2013.10.010; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Mrak Robert E, 2012, Int J Alzheimers Dis, V2012, P165021, DOI 10.1155/2012/165021; Newhouse P, 2012, NEUROLOGY, V78, P91, DOI 10.1212/WNL.0b013e31823efcbb; Nie HZ, 2011, NEUROCHEM RES, V36, P904, DOI 10.1007/s11064-011-0420-7; Ognibene E, 2005, BEHAV BRAIN RES, V156, P225, DOI 10.1016/j.bbr.2004.05.028; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Paris D, 2014, BRAIN DISORDERS THER; Paris D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055392; Paris D, 2013, EUR J PHARMACOL, V698, P145, DOI 10.1016/j.ejphar.2012.11.017; Paris D, 2011, EUR J PHARMACOL, V670, P384, DOI 10.1016/j.ejphar.2011.09.019; Sambamurti K, 2004, FASEB J, V18, P1034, DOI 10.1096/fj.03-1378fje; Srivareerat M, 2011, NEUROBIOL AGING, V32, P834, DOI 10.1016/j.neurobiolaging.2009.04.015; Takata K, 2012, J PHARMACOL SCI, V118, P331, DOI 10.1254/jphs.11R10FM; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Viggiano D, 2008, BEHAV BRAIN RES, V194, P1, DOI 10.1016/j.bbr.2008.06.033; Wan J, 2010, J NEUROSCI, V30, P6873, DOI 10.1523/JNEUROSCI.0519-10.2010; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; Yang LY, 2013, J NEUROSCI, V33, P5275, DOI 10.1523/JNEUROSCI.3200-12.2013; Yasojima K, 1999, BRAIN RES, V830, P226, DOI 10.1016/S0006-8993(99)01389-X	64	22	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128224	10.1371/journal.pone.0128224	http://dx.doi.org/10.1371/journal.pone.0128224			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010758	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900210
J	Goswami, N; Evans, J; Schneider, S; von der Wiesche, M; Mulder, E; Rossler, A; Hinghofer-Szalkay, H; Blaber, AP				Goswami, Nandu; Evans, Joyce; Schneider, Stefan; von der Wiesche, Melanie; Mulder, Edwin; Roessler, Andreas; Hinghofer-Szalkay, Helmut; Blaber, Andrew P.			Effects of Individualized Centrifugation Training on Orthostatic Tolerance in Men and Women	PLOS ONE			English	Article							BODY NEGATIVE-PRESSURE; HEAD-DOWN TILT; BLOOD-VOLUME; SINGLE BOUT; MAXIMAL EXERCISE; AMBULATORY MEN; PLASMA-VOLUME; FLOW; RESPONSIVENESS; SPACEFLIGHT	Aims Exposure to artificial gravity (AG) at different G loads and durations on human centrifuges has been shown to improve orthostatic tolerance in men. However, the effects on women and of an individual-specific AG training protocol on tolerance are not known. Methods We examined the effects of 90 minutes of AG vs. 90 minutes of supine rest on the orthostatic tolerance limit (OTL), using head up tilt and lower body negative pressure until presyncope of 7 men and 5 women. Subjects were placed in the centrifuge nacelle while instrumented and after one-hour they underwent either: 1) AG exposure (90 minutes) in supine position [protocol 1, artificial gravity exposure], or 2) lay supine on the centrifuge for 90 minutes in supine position without AG exposure [protocol 2, control]. The AG training protocol was individualized, by first determining each subject's maximum tolerable G load, and then exposing them to 45 minutes of ramp training at sub-presyncopal levels. Results Both sexes had improved OTL (14 minutes vs 11 minutes, p < 0.0019) following AG exposure. When cardiovascular (CV) variables at presyncope in the control test were compared with the CV variables at the same tilt-test time (isotime) during post-centrifuge, higher blood pressure, stroke volume and cardiac output and similar heart rates and peripheral resistance were found post-centrifuge. Conclusions These data suggest a better-maintained central circulating blood volume post-centrifugation across gender and provide an integrated insight into mechanisms of blood pressure regulation and the possible implementation of in-flight AG countermeasure profiles during spaceflights.	[Goswami, Nandu; Roessler, Andreas; Hinghofer-Szalkay, Helmut] Med Univ Graz, Inst Physiol, Graz, Austria; [Evans, Joyce] Univ Kentucky, Lexington, KY 40506 USA; [Schneider, Stefan] German Sports Univ, Cologne, Germany; [Schneider, Stefan] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Marrochydore, Qld, Australia; [von der Wiesche, Melanie; Mulder, Edwin] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Blaber, Andrew P.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	Medical University of Graz; University of Kentucky; German Sport University Cologne; University of the Sunshine Coast; Helmholtz Association; German Aerospace Centre (DLR); Simon Fraser University	Goswami, N (corresponding author), Med Univ Graz, Inst Physiol, Graz, Austria.	nandu.goswami@medunigraz.at	Roessler, Andreas/A-5751-2008; Schneider, Stefan/AAH-7418-2020	Roessler, Andreas/0000-0001-9543-8870; Schneider, Stefan/0000-0002-4563-9890	European Space Agency's CORA-GBF program	European Space Agency's CORA-GBF program	The European Space Agency's CORA-GBF program supported this study. Land Steiermark, Austria, also supported Dr. Nandu Goswami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaber AP, 2013, EUR J APPL PHYSIOL, V113, P1909, DOI 10.1007/s00421-012-2539-x; Blaber AP, 2013, AVIAT SPACE ENVIR MD, V84, P59, DOI 10.3357/ASEM.3424.2013; Blaber AP, 2011, STROKE, V42, P1844, DOI 10.1161/STROKEAHA.110.610576; Convertino VA, 1996, AM J PHYSIOL-REG I, V270, pR3, DOI 10.1152/ajpregu.1996.270.1.R3; Convertino VA, 2003, J APPL PHYSIOL, V95, P192, DOI 10.1152/japplphysiol.00123.2003; DELP MD, 1995, MED SCI SPORT EXER, V27, P1152; Engelke KA, 1996, AM J PHYSIOL-REG I, V271, pR837, DOI 10.1152/ajpregu.1996.271.4.R837; ENGELKE KA, 1995, AM J PHYSIOL-REG I, V269, pR614, DOI 10.1152/ajpregu.1995.269.3.R614; Evans JM, 2004, AVIAT SPACE ENVIR MD, V75, P850; Fong KJ, 2007, J GRAVIT PHYSL, V14, pP15; FritschYelle JM, 1996, J APPL PHYSIOL, V81, P2134, DOI 10.1152/jappl.1996.81.5.2134; Goswami N, 2009, PHYSIOL RES, V58, P311, DOI 10.33549/physiolres.931431; Goswami N, 2009, ACTA PHYSIOL HUNG, V96, P157, DOI 10.1556/APhysiol.96.2009.2.2; Goswami N, 2013, EUR J APPL PHYSIOL, V113, P1645, DOI 10.1007/s00421-012-2507-5; Grasser EK, 2009, PHYSIOL RES, V58, P817, DOI 10.33549/physiolres.931591; Hinghofer-Szalkay H, 2011, EUR J CLIN INVEST, V41, P1180, DOI 10.1111/j.1365-2362.2011.02523.x; Hinghofer-Szalkay HG, 2008, AM J PHYSIOL-GASTR L, V295, pG332, DOI 10.1152/ajpgi.00042.2008; Iwase Satoshi, 2002, Environmental Medicine (Nagoya), V46, P29; Leonetti P, 2004, CLIN AUTON RES, V14, P176, DOI 10.1007/s10286-004-0191-1; LIEBERMAN EH, 1994, ANN INTERN MED, V121, P936, DOI 10.7326/0003-4819-121-12-199412150-00005; Meendering JR, 2005, AM J PHYSIOL-HEART C, V289, pH631, DOI 10.1152/ajpheart.00029.2005; Stenger MB, 2007, ACTA ASTRONAUT, V60, P267, DOI 10.1016/j.actaastro.2006.08.008; Stenger MB, 2012, EUR J APPL PHYSIOL, V112, P605, DOI 10.1007/s00421-011-2005-1; Taneja I, 2007, AM J PHYSIOL-HEART C, V292, pH1420, DOI 10.1152/ajpheart.01096.2006; Waters WW, 2002, J APPL PHYSIOL, V92, P586, DOI 10.1152/japplphysiol.00544.2001	25	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125780	10.1371/journal.pone.0125780	http://dx.doi.org/10.1371/journal.pone.0125780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020542	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000355187300017
J	Kim, A; Im, M; Hwang, YH; Yang, HJ; Ma, JY				Kim, Aeyung; Im, Minju; Hwang, Youn-Hwan; Yang, Hye Jin; Ma, Jin Yeul			Jaeumganghwa-Tang Induces Apoptosis via the Mitochondrial Pathway and Lactobacillus Fermentation Enhances Its Anti-Cancer Activity in HT1080 Human Fibrosarcoma Cells	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; SIGNALING PATHWAY; HERBAL MEDICINES; CANCER; THERAPY	Jaeumganghwa-tang (JGT, Zi-yin-jiang-huo-tang in Chinese and Jiin-koka-to in Japanese) is an oriental herbal formula that has long been used as a traditional medicine to treat respiratory and kidney diseases. Recent studies revealed that JGT exhibited potent inhibitory effects on allergies, inflammation, pain, convulsions, and prostate hyperplasia. Several constituent herbs in JGT induce apoptotic cancer cell death. However, the anti-cancer activity of JGT has not been examined. In this study, we investigated the anti-cancer effects of JGT using highly tumorigenic HT1080 human fibrosarcoma cells and elucidated the underlying mechanisms. In addition, we examined whether the Lactobacillus fermentation of JGT enhanced its anti-cancer activity using an in vivo xenograft model because fermentation of herbal extracts is thought to strengthen their therapeutic effects. Data revealed that JGT suppressed the growth of cancer cells efficiently by stimulating G1 cell cycle arrest and then inducing apoptotic cell death by causing mitochondrial damage and activating caspases. The phosphorylation of p38 and ERK also played a role in JGT-induced cell death. In vitro experiments demonstrated that JGT fermented with Lactobacillus acidophilus, designated fJGT162, elicited similar patterns of cell death as did non-fermented JGT. Meanwhile, the daily oral administration of 120 mg/kg fJGT162 to HT1080-bearing BALB/c nude mice suppressed tumor growth dramatically (up to 90%) compared with saline treatment, whereas the administration of non-fermented JGT suppressed tumor growth by similar to 70%. Collectively, these results suggest that JGT and fJGT162 are safe and useful complementary and alternative anti-cancer herbal therapies, and that Lactobacillus fermentation improves the in vivo anti-cancer efficacy of JGT significantly.	[Kim, Aeyung; Im, Minju; Hwang, Youn-Hwan; Yang, Hye Jin; Ma, Jin Yeul] KIOM, KM Based Herbal Drug Dev Ctr, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Ma, JY (corresponding author), KIOM, KM Based Herbal Drug Dev Ctr, Taejon, South Korea.	jyma@kiom.re.kr	Hwang, Youn-Hwan/AAU-9373-2021		Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea [K15280]	Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea	This work has been supported by the Grant K15280 awarded to Korea Institute of Oriental Medicine (KIOM) from Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea.	Bae EA, 2004, ARCH PHARM RES, V27, P61, DOI 10.1007/BF02980048; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Eum HA, 2011, AFR J TRADIT COMPLEM, V8, P312; Hambright HG, 2015, MOL CARCINOGEN, V54, P1227, DOI 10.1002/mc.22192; Hsiao WLW, 2010, PLANTA MED, V76, P1118, DOI 10.1055/s-0030-1250186; Jang DS, 2003, J NAT PROD, V66, P1166, DOI 10.1021/np0302100; Jang YS, 2009, CHINESE SCI BULL, V54, P227, DOI 10.1007/s11434-008-0567-z; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Joo SS, 2009, PHYTOTHER RES, V23, P913, DOI 10.1002/ptr.2758; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kang SH, 2009, ENVIRON TOXICOL PHAR, V28, P430, DOI 10.1016/j.etap.2009.07.007; Kim A, 2014, PHARMACOGN MAG, V10, P463, DOI 10.4103/0973-1296.139774; Kim A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098703; Kim A, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-233; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim YK, 2004, KOREAN J ORIEN INTER, V25, P174; Konkimalla VB, 2008, J ETHNOPHARMACOL, V116, P207, DOI 10.1016/j.jep.2007.12.009; Kwon KB, 2006, BIOL PHARM BULL, V29, P1082, DOI 10.1248/bpb.29.1082; Lee HJ, 2006, CARCINOGENESIS, V27, P2455, DOI 10.1093/carcin/bgl104; Lee JE, 2011, AM J CHINESE MED, V39, P1235, DOI 10.1142/S0192415X11009524; Lee JH, 2013, KOREAN J ORIEN INTER, V34, P155; Lee JJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-78; Lee Kwang Jin, 2013, Journal of Applied Biological Chemistry, V56, P131, DOI 10.3839/jabc.2013.021; Li M, 2014, ONCOL REP, V32, P2845, DOI 10.3892/or.2014.3543; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Lu W, 2015, MOL MED REP, V11, P3920, DOI 10.3892/mmr.2014.3139; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Ng CC, 2011, J BIOSCI BIOENG, V111, P289, DOI 10.1016/j.jbiosc.2010.11.011; Oh YC, 2014, PHARMACOGN MAG, V10, P645, DOI 10.4103/0973-1296.139815; Oh YC, 2012, AM J CHINESE MED, V40, P813, DOI 10.1142/S0192415X12500619; Oh YC, 2012, AM J CHINESE MED, V40, P611, DOI 10.1142/S0192415X12500462; Oh YC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-17; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Seo I, 2011, IMMUNOPHARM IMMUNOT, V33, P682, DOI 10.3109/08923973.2011.560159; Shim KS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-106; Shim KS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/325791; Shin IS, 2012, J KOREAN SOC APPL BI, V55, P205, DOI 10.1007/s13765-012-1174-x; Sohn Y, 2012, FOOD CHEM TOXICOL, V50, P2987, DOI 10.1016/j.fct.2012.06.001; Thirugnanam S, 2008, ONCOL REP, V20, P1387, DOI 10.3892/or_00000157; Xu W, 2006, EUR J CANCER CARE, V15, P397, DOI 10.1111/j.1365-2354.2006.00685.x; Zheng Hong-mei, 2010, [The Journal of Korean Oriental Internal Medicine, 대한한방내과학회지], V31, P395	42	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127898	10.1371/journal.pone.0127898	http://dx.doi.org/10.1371/journal.pone.0127898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020238	gold, Green Submitted, Green Published			2022-12-27	WOS:000355187300064
J	Lou, HF; Fang, JG; Li, PD; Zhou, WG; Wang, Y; Fan, EZ; Li, Y; Wang, H; Liu, ZY; Xiao, L; Wang, CS; Zhang, L				Lou, Hongfei; Fang, Jugao; Li, Pingdong; Zhou, Weiguo; Wang, Yang; Fan, Erzhong; Li, Ying; Wang, Hong; Liu, Zhongyan; Xiao, Lei; Wang, Chengshuo; Zhang, Luo			Frequency, Suppressive Capacity, Recruitment and Induction Mechanisms of Regulatory T Cells in Sinonasal Squamous Cell Carcinoma and Nasal Inverted Papilloma	PLOS ONE			English	Article							PERIPHERAL-CIRCULATION; TUMOR MICROENVIRONMENT; CCL22 CHEMOKINES; NECK-CANCER; HEAD; LYMPHOCYTES; EXPRESSION; MANAGEMENT; SURVIVAL; BREAST	Background Sinonasal squamous cell carcinoma (SSCC) and nasal inverted papilloma (NIP) represent the predominant type of malignant and benign tumors in sinonasal tract, respectively. CD4(+)CD25(+)Foxp3(+) natural regulatory T (Treg) cells might play critical role(s) in the suppression of anti-tumor immune response and thus shed light on tumor progression from benign to malignant. Objective This study aimed to evaluate the frequency and suppressive capacity of Treg cells in SSCC compared to NIP and further to explore the underlying mechanisms. Patients and Methods Frequencies of Treg, Th1 and Th2 cells were evaluated by flow cytometry in tissue homogenate and peripheral blood from 31 SSCC patients, 32 NIP patients and 35 normal controls. Treg cells were tested for regulatory function by co-culture with effector T cells. CCR4 and its ligands, CCL22 and CCL17, were analyzed by flow cytometry and Luminex, respectively. The chemoattractant properties of CCR4/CCL22 and CCR4/CCL17 for Treg cells were assessed using the Boyden chamber technique, to elucidate the potential mechanisms of Treg recruitment in tumor microenvironment. Treg cells induction via TGF-beta was assessed with transwells after local CD4(+)Foxp3(+) T cells were assessed by immunohistochemistry and TGF-beta concentration was measured by Luminex. Results Tumor-infiltrating Treg cells increased significantly from normal to NIP to SSCC (P <= 0.001 for normal vs. NIP and P = 0.004 for NIP vs. SSCC). Significantly elevated frequency and enhanced suppression capacity of circulating Treg cells in SSCC were detected compared to NIP and healthy controls, concomitant with Th1 decrease and Th2 increase. Apparently increased CCL22 attracted CCR4-expressing Treg cells to tumor microenvironment in SSCC, compared to NIP. SSCC produced significantly more TGF-beta than NIP and thus possessed greater potential for Treg cell induction. Conclusion Frequency and suppressive capacity of Treg cells enhanced with progression of malignancy from NIP to SSCC. Circulating Treg cells were recruited to tumor tissue via CCR4/CCL22 signalling, whereas tumor-synthesised TGF-beta contributed to induction of peripheral Treg cells.	[Lou, Hongfei; Fang, Jugao; Li, Pingdong; Zhou, Weiguo; Wang, Chengshuo; Zhang, Luo] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Lou, Hongfei; Wang, Yang; Fan, Erzhong; Li, Ying; Wang, Hong; Liu, Zhongyan; Zhang, Luo] Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing, Peoples R China; [Xiao, Lei] Univ Illinois, Sect Pulm, Chicago, IL USA; [Xiao, Lei] Univ Illinois, Cardiol Sect, Chicago, IL USA	Capital Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, CS (corresponding author), Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	wangcs830@126.com; dr.luozhang@gmail.com	wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793; Zhang, Luo/0000-0002-0910-9884	Program for Changjiang Scholars and Innovative Research Team [IRT13082]; National Science Fund for the Major International Joint Research Program [81420108009]; Beijing Natural Science Foundation [7131006]; Ministry of Health Foundation [201202005]; Capital Health Research and Development of Special [2011-1017-06]; Special Fund of Sanitation Elite Reconstruction of Beijing [2009-2-007]; Beijing Health Bureau Program for high level talents [2009-2-007, 2011-3-043]	Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science Fund for the Major International Joint Research Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Health Foundation; Capital Health Research and Development of Special; Special Fund of Sanitation Elite Reconstruction of Beijing; Beijing Health Bureau Program for high level talents	This work was supported by grants from the Program for Changjiang Scholars and Innovative Research Team (IRT13082), the National Science Fund for the Major International Joint Research Program (81420108009), Beijing Natural Science Foundation (7131006), Ministry of Health Foundation (201202005), the Capital Health Research and Development of Special (2011-1017-06), the Special Fund of Sanitation Elite Reconstruction of Beijing (2009-2-007) and Beijing Health Bureau Program for high level talents (2009-2-007 and 2011-3-043).	Alhamarneh O, 2011, HEAD NECK-J SCI SPEC, V33, P415, DOI 10.1002/hed.21464; Ansa B, 2013, CANCER-AM CANCER SOC, V119, P2602, DOI 10.1002/cncr.28108; Apostolou I, 2008, J CLIN IMMUNOL, V28, P619, DOI 10.1007/s10875-008-9254-8; Bose Anamika, 2008, Cancer Immun, V8, P10; Boucek J, 2010, J CELL MOL MED, V14, P426, DOI 10.1111/j.1582-4934.2008.00650.x; CHRISTENSEN WN, 1986, HUM PATHOL, V17, P393, DOI 10.1016/S0046-8177(86)80463-4; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Deng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063777; Drennan S, 2013, IMMUNOLOGY; Erfani N, 2013, IMMUNOL INVEST, V42, P81, DOI 10.3109/08820139.2012.708376; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Gu YL, 2011, HEAD NECK-J SCI SPEC, V33, P1005, DOI 10.1002/hed.21581; Lal A, 2013, BREAST CANCER RES TR, V139, P381, DOI 10.1007/s10549-013-2556-4; Lathers DMR, 2004, CYTOKINE, V25, P220, DOI 10.1016/j.cyto.2003.11.005; LAWSON W, 1995, LARYNGOSCOPE, V105, P282, DOI 10.1288/00005537-199503000-00011; Lawson W, 2003, LARYNGOSCOPE, V113, P1548, DOI 10.1097/00005537-200309000-00026; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Maruyama T, 2010, DIS ESOPHAGUS, V23, P422, DOI 10.1111/j.1442-2050.2009.01029.x; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; MYERS EN, 1990, LARYNGOSCOPE, V100, P481; Pere H, 2012, ONCOIMMUNOLOGY, V1, P326, DOI 10.4161/onci.18852; Pere H, 2011, BLOOD, V118, P4853, DOI 10.1182/blood-2011-01-329656; Schaefer C, 2005, BRIT J CANCER, V92, P913, DOI 10.1038/sj.bjc.6602407; Schott AK, 2010, INT J MOL MED, V26, P67, DOI 10.3892/ijmm_00000436; Sheu BC, 2001, J IMMUNOL, V167, P2972, DOI 10.4049/jimmunol.167.5.2972; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Sun W, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-35; Toulza F, 2010, J IMMUNOL, V185, P183, DOI 10.4049/jimmunol.0903846; VRABEC DP, 1975, LARYNGOSCOPE, V85, P186, DOI 10.1288/00005537-197501000-00014; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Yokokawa J, 2008, CLIN CANCER RES, V14, P1032, DOI 10.1158/1078-0432.CCR-07-2056; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005	32	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126463	10.1371/journal.pone.0126463	http://dx.doi.org/10.1371/journal.pone.0126463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020249	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300022
J	Chen, XH; Motani, R; Cheng, L; Jiang, DY; Rieppel, O				Chen, Xiao-hong; Motani, Ryosuke; Cheng, Long; Jiang, Da-yong; Rieppel, Olivier			A New Specimen of Carroll's Mystery Hupehsuchian from the Lower Triassic of China	PLOS ONE			English	Article								A new specimen of an enigmatic hupehsuchian genus is reported. The genus was first recognized by Robert L. Carroll and Zhi-ming Dong in 1991, who refrained from naming it because of the poor quality of the only specimen known at the time. After more than two decades, we finally report a second specimen of this genus, which remained unprepared until recently. The new specimen preserves most of the skeleton except the skull, allowing us to erect a new genus and species, Eretmorhipis carrolldongi. The new species shares many characters with Parahupehsuchus longus, including the strange axial skeleton that forms a bony body tube. However, the body tube is short in the new species, being limited to the pectoral region. The vertebral count and limb morphology considerably differ between the new species and P. longus. The forelimb of E. carrolldongi is markedly larger than its hind limb as in Hupehsuchus nanchangensis but unlike in P. longus. The new species is unique among hupehsuchians in a list of features. It has manual and pedal digits that spread radially, forming manus and pes that are almost as wide as long. The third-layer elements of the dermal armor are unusually large, spanning four vertebral segments, yet there are substantial gaps among them. With the addition of the unique paddle, it is now clear that Hupehsuchia had diverse forelimb morphologies spanning from paddles to flippers, unlike ichthyopterygians that were taxonomically more diverse yet only had flippers.	[Chen, Xiao-hong; Cheng, Long] Wuhan Ctr China Geol Survey, Wuhan, Hubei, Peoples R China; [Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-yong] Peking Univ, Dept Geol, Lab Orogen Belt & Crustal Evolut, MOE, Beijing 100871, Peoples R China; [Jiang, Da-yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Rieppel, Olivier] Ctr Integrat Res, Field Museum, Chicago, IL USA	China Geological Survey; University of California System; University of California Davis; Peking University; Peking University; Field Museum of Natural History (Chicago)	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	Ministry of Land and Resources, China [201311062]; China Geological Survey [1212011120148]; National Natural Science Foundation of China [40920124002, 41372016]; Ministry of Education, China; Research Fund for the Doctoral Program of Higher Education Project [20120001110072]	Ministry of Land and Resources, China; China Geological Survey(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education Project	Funding provided by Ministry of Land and Resources, China (http://www.mlr.gov.cn/mlrenglish/), Special project for scientific research Project 201311062 to Xiao-hong Chen, China Geological Survey (http://en.cgs.gov.cn/), Project 1212011120148 to Long Cheng, National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/), Projects 40920124002 and 41372016 to Da-yong Jiang and Ministry of Education, China (http://en.ustc.edu.cn/dictionary/201105/t20110509_111375.html), Research Fund for the Doctoral Program of Higher Education Project 20120001110072 to Da-yong Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115244; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094396; Delfino M, 2010, ORG DIVERS EVOL, V10, P69, DOI 10.1007/s13127-010-0019-x; GOLOBOFF P, 2000, TNT TREE ANAL USING; Laurenti J. N, 1768, SPECIMEN MEDICUM EXH; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; Maxwell EE, 2012, J EXP ZOOL PART B, V318B, P545, DOI 10.1002/jez.b.22459; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Osborn HF, 1903, MEMOIRS AM MUSEUM NA, V1, P449; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Wang K., 1959, Acta Palaeontologica Sinica, V7, P367; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Young C, 1972, AQUATIC REPTILES TRI, P1	15	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126024	10.1371/journal.pone.0126024	http://dx.doi.org/10.1371/journal.pone.0126024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017585	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600046
J	Duan, AG; Zhang, JG; Zhang, XQ; He, CY				Duan, Aiguo; Zhang, Jianguo; Zhang, Xiongqing; He, Caiyun			Relationship between Modelling Accuracy and Inflection Point Attributes of Several Equations while Modelling Stand Diameter Distributions	PLOS ONE			English	Article							GROWTH; HEIGHTS	In this study, seven popular equations, including 3-parameter Weibull, 2-parameter Weibull, Gompertz, Logistic, Mitscherlich, Korf and R distribution, were used to model stand diameter distributions for exploring the relationship between the equations' inflection point attributes and model accuracy. A database comprised of 146 diameter frequency distributions of Chinese fir (Cunninghamia lanceolata (Lamb.) Hook.) plantations was used to demonstrate model fitting and comparison. Results showed that the inflection points of the stand diameter cumulative percentage distribution ranged from 0.4 to 0.6, showing a 1/2 close rule. The equation's inflection point attribute was strongly related to its model accuracy. Equation with an inflection point showed much higher accuracy than that without an inflection point. The larger the effective inflection point interval of the fitting curve of the equation was, and the closer the inflection point was to 0.5 for the equations with fixed inflection points, the higher the equation's accuracy was. It could be found that the equation's inflection point had close relationship with skewness of diameter distribution and stand age, stand density, which provided a scientific basis for model selection of a stand diameter distribution for Chinese fir plantations and other tree species.	[Duan, Aiguo; Zhang, Jianguo; Zhang, Xiongqing; He, Caiyun] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Zhang, JG (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat State Forestry A, Beijing, Peoples R China.	zhangjg@caf.ac.cn	Zhang, Xiongqing/AAW-6171-2020	Zhang, Xiongqing/0000-0001-5592-6730	Scientific and Technological Task in China [2015BAD09B01, 2012BAD01B01]; National Natural Science Foundation of China [31370629]; Collaborative Innovation Center of Sustaintable Forestry in Southern China, Nanjing Forestry University	Scientific and Technological Task in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Innovation Center of Sustaintable Forestry in Southern China, Nanjing Forestry University	This study was supported by the Scientific and Technological Task in China (No. 2015BAD09B01, 2012BAD01B01), the National Natural Science Foundation of China (31370629) and Collaborative Innovation Center of Sustaintable Forestry in Southern China, Nanjing Forestry University.	Aaron RW, 2009, FOREST ECOL MANAG, V258, P323; BAILEY RL, 1973, FOREST SCI, V19, P97; Birch CPD, 1999, ANN BOT-LONDON, V83, P713, DOI 10.1006/anbo.1999.0877; Brooks J. R., 1992, Southern Journal of Applied Forestry, V16, P130; Burgess D, 2005, FOREST ECOL MANAG, V209, P117, DOI 10.1016/j.foreco.2005.01.006; Burkhart HE, 1974, ROYAL COLL FOR RES N, V30, P128; Calegario N, 2005, FOREST ECOL MANAG, V204, P11, DOI 10.1016/j.foreco.2004.07.051; Duan AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062605; Gadow K.V., 1998, MODELLING FOREST DEV; Garcia O, 1997, WORKING PAPER; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; HAFLEY WL, 1977, CAN J FOREST RES, V7, P481, DOI 10.1139/x77-062; HUANG SM, 1992, CAN J FOREST RES, V22, P1297, DOI 10.1139/x92-172; Ishikawa Y, 1998, J PLANN, V31, P15; Kerman SC, 2013, STAT PROBABIL LETT, V83, P2129, DOI 10.1016/j.spl.2013.05.028; Kilkki P., 1989, Silva Fennica, V23, P311; Kilkki P., 1986, Silva Fennica, V20, P149; Kiviste AK, 1988, MATH FUNCTIONS FORES; Lei YC, 2001, SE10 USDA FOR SERV S; Li FS, 2002, FOREST SCI, V48, P47; LITTLE SN, 1983, CAN J FOREST RES, V13, P85, DOI 10.1139/x83-012; Mitscherlich EA, 1919, LANDW JB, V53, P167; Monness E. N., 1982, Meddelelser fra Norsk Institutt for Skogforskning, V36; Monness E, 2011, CAN J FOREST RES, V41, P707, DOI [10.1139/x10-246, 10.1139/X10-246]; Newton PF, 2005, FOREST ECOL MANAG, V209, P181, DOI 10.1016/j.foreco.2005.01.020; Rennolls K, 2005, CAN J FOREST RES, V35, P575, DOI [10.1139/x05-006, 10.1139/X05-006]; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; SAS Institute Inc, 1999, SAS STAT US GUID VER; Sun HG, 2011, FOREST ECOL MANAG, V261, P1010, DOI 10.1016/j.foreco.2010.12.019; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Wang ML, 2008, FOREST ECOL MANAG, V255, P2659, DOI 10.1016/j.foreco.2008.01.030; WEST PW, 1987, ANN BOT-LONDON, V60, P571, DOI 10.1093/oxfordjournals.aob.a087480; ZEIDE B, 1989, CAN J FOREST RES, V19, P1283, DOI 10.1139/x89-195; ZEIDE B, 1993, FOREST SCI, V39, P594, DOI 10.1093/forestscience/39.3.594	34	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126831	10.1371/journal.pone.0126831	http://dx.doi.org/10.1371/journal.pone.0126831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016995	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600061
J	Gallardo, B; Zieritz, A; Aldridge, DC				Gallardo, Belinda; Zieritz, Alexandra; Aldridge, David C.			The Importance of the Human Footprint in Shaping the Global Distribution of Terrestrial, Freshwater and Marine Invaders	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; PLANT INVASIONS; GREAT-BRITAIN; MODELS; PREDICTION; HABITAT; RISK; PERFORMANCE; ABILITY	Human activities such as transport, trade and tourism are likely to influence the spatial distribution of non-native species and yet, Species Distribution Models (SDMs) that aim to predict the future broad scale distribution of invaders often rely on environmental (e.g. climatic) information only. This study investigates if and to what extent do human activities that directly or indirectly influence nature (hereafter the human footprint) affect the global distribution of invasive species in terrestrial, freshwater and marine ecosystems. We selected 72 species including terrestrial plants, terrestrial animals, freshwater and marine invasive species of concern in a focus area located in NW Europe (encompassing Great Britain, France, The Netherlands and Belgium). Species Distribution Models were calibrated with the global occurrence of species and a set of high-resolution (9x9 km) environmental (e.g. topography, climate, geology) layers and human footprint proxies (e.g. the human influence index, population density, road proximity). Our analyses suggest that the global occurrence of a wide range of invaders is primarily limited by climate. Temperature tolerance was the most important factor and explained on average 42% of species distribution. Nevertheless, factors related to the human footprint explained a substantial amount (23% on average) of species distributions. When global models were projected into the focus area, spatial predictions integrating the human footprint featured the highest cumulative risk scores close to transport networks (proxy for invasion pathways) and in habitats with a high human influence index (proxy for propagule pressure). We conclude that human related information-currently available in the form of easily accessible maps and databases-should be routinely implemented into predictive frameworks to inform upon policies to prevent and manage invasions. Otherwise we might be seriously underestimating the species and areas under highest risk of future invasions.	[Gallardo, Belinda; Zieritz, Alexandra; Aldridge, David C.] Univ Cambridge, Dept Zool, Aquat Ecol Grp, Cambridge, England; [Gallardo, Belinda] CSIC, IPE, Dept Biodivers & Restorat, Appl & Restorat Ecol Grp, Zaragoza, Spain	University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Gallardo, B (corresponding author), Univ Cambridge, Dept Zool, Aquat Ecol Grp, Cambridge, England.	galla82@hotmail.com	Gallardo, Belinda/H-9038-2013	Gallardo, Belinda/0000-0002-1552-8233; Zieritz, Alexandra/0000-0002-0305-8270	European Regional Development Fund through RINSE (Reducing the Impacts of Non-native Species in Europe); RINSE; Spanish Ministerio de Economia y Competitividad, through the Severo Ochoa Program for Centres of Excellence in R+D+I [SEV-2012-0262]	European Regional Development Fund through RINSE (Reducing the Impacts of Non-native Species in Europe); RINSE; Spanish Ministerio de Economia y Competitividad, through the Severo Ochoa Program for Centres of Excellence in R+D+I	Research leading to this study has been funded by the European Regional Development Fund through RINSE (Reducing the Impacts of Non-native Species in Europe, http://www.rinse-europe.eu/). BG received financial support from RINSE and the Spanish Ministerio de Economia y Competitividad, through the Severo Ochoa Program for Centres of Excellence in R+D+I (SEV-2012-0262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022985; [Anonymous], 2014, R LANG ENV STAT COMP; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bellard C, 2013, GLOBAL CHANGE BIOL, V19, P3740, DOI 10.1111/gcb.12344; Chytry M, 2009, DIVERS DISTRIB, V15, P98, DOI 10.1111/j.1472-4642.2008.00515.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Ferreira JG, 2011, ESTUAR COAST SHELF S, V93, P117, DOI 10.1016/j.ecss.2011.03.014; Flory SL, 2009, BIOL CONSERV, V142, P2531, DOI 10.1016/j.biocon.2009.05.024; Gallardo B, 2014, ETHOL ECOL EVOL, V26, P130, DOI 10.1080/03949370.2014.896417; Gallardo B, 2013, J BIOGEOGR, V40, P2274, DOI 10.1111/jbi.12170; Gallardo B, 2013, J APPL ECOL, V50, P757, DOI 10.1111/1365-2664.12079; Gallardo B, 2013, ECOL APPL, V23, P352, DOI 10.1890/12-1018.1; Gallardo B, 2012, BIOL INVASIONS, V14, P1265, DOI 10.1007/s10530-011-0154-0; Gonzalez-Moreno P, 2015, GLOBAL ECOL BIOGEOGR, V24, P360, DOI 10.1111/geb.12271; Gonzalez-Moreno P, 2014, DIVERS DISTRIB, V20, P720, DOI 10.1111/ddi.12206; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jimenez-Valverde A, 2014, BIODIVERS CONSERV, V23, P369, DOI 10.1007/s10531-013-0606-1; Keller RP, 2009, CONSERV BIOL, V23, P1526, DOI 10.1111/j.1523-1739.2009.01249.x; Kiritani K, 2003, INVASIVE SPECIES VEC, P518; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Barbosa AM, 2013, DIVERS DISTRIB, V19, P1188, DOI 10.1111/ddi.12106; McNeely, 2001, GREAT RESHUFFLING HU; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Mortensen DA, 2009, INVAS PLANT SCI MANA, V2, P191, DOI 10.1614/IPSM-08-125.1; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Real R, 2008, DIVERS DISTRIB, V14, P364, DOI 10.1111/j.1472-4642.2007.00419.x; Rodriguez-Castaneda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044402; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Taylor BW, 2004, P NATL ACAD SCI USA, V101, P17725, DOI 10.1073/pnas.0405176101; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Vila M, 2001, BIOL CONSERV, V100, P397, DOI 10.1016/S0006-3207(01)00047-7; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zerebecki RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014806; Zieritz Alexandra, 2014, NeoBiota, V23, P65; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	55	103	106	5	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125801	10.1371/journal.pone.0125801	http://dx.doi.org/10.1371/journal.pone.0125801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018575	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600033
J	Suzuki, H; Watari, A; Hashimoto, E; Yonemitsu, M; Kiyono, H; Yagi, K; Kondoh, M; Kunisawa, J				Suzuki, Hidehiko; Watari, Akihiro; Hashimoto, Eri; Yonemitsu, Miki; Kiyono, Hiroshi; Yagi, Kiyohito; Kondoh, Masuo; Kunisawa, Jun			C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine	PLOS ONE			English	Article							PROTEIN-A PSPA; PATCH M CELLS; STREPTOCOCCUS-PNEUMONIAE; INTRANASAL IMMUNIZATION; PROTECTIVE IMMUNITY; CLAUDIN MODULATOR; HETEROLOGOUS PSPA; ANTIBODIES; MICE; FRAGMENT	Efficient vaccine delivery to mucosal tissues including mucosa-associated lymphoid tissues is essential for the development of mucosal vaccine. We previously reported that claudin-4 was highly expressed on the epithelium of nasopharynx-associated lymphoid tissue (NALT) and thus claudin-4-targeting using C-terminal fragment of Clostridium perfringens enterotoxin (C-CPE) effectively delivered fused antigen to NALT and consequently induced antigen-specific immune responses. In this study, we applied the C-CPE-based vaccine delivery system to develop a nasal pneumococcal vaccine. We fused C-CPE with pneumococcal surface protein A (PspA), an important antigen for the induction of protective immunity against Streptococcus pneumoniae infection, (PspA-C-CPE). PspA-C-CPE binds to claudin-4 and thus efficiently attaches to NALT epithelium, including antigen-sampling M cells. Nasal immunization with PspA-C-CPE induced PspA-specific IgG in the serum and bronchoalveolar lavage fluid (BALF) as well as IgA in the nasal wash and BALF. These immune responses were sufficient to protect against pneumococcal infection. These results suggest that C-CPE is an efficient vaccine delivery system for the development of nasal vaccines against pneumococcal infection.	[Suzuki, Hidehiko; Hashimoto, Eri; Yonemitsu, Miki; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr, Lab Vaccine Mat, Osaka 5670085, Japan; [Suzuki, Hidehiko; Watari, Akihiro; Yagi, Kiyohito; Kondoh, Masuo] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Bio Funct Mol Chem, Suita, Osaka 5650871, Japan; [Hashimoto, Eri; Kiyono, Hiroshi; Kunisawa, Jun] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo 1088639, Japan; [Kiyono, Hiroshi; Kunisawa, Jun] Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Inst Med Sci, Tokyo 1088639, Japan; [Kiyono, Hiroshi; Kunisawa, Jun] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Kunisawa, Jun] Kobe Univ, Grad Sch Med, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan; [Kunisawa, Jun] Osaka Univ, Grad Sch Pharmaceut Sci, Grad Sch Med, Osaka 5650871, Japan; [Kunisawa, Jun] Osaka Univ, Grad Sch Dent, Osaka 5650871, Japan	Osaka University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kobe University; Osaka University; Osaka University	Kondoh, M (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Bio Funct Mol Chem, Suita, Osaka 5650871, Japan.	masuo@phs.osaka-u.ac.jp; kunisawa@nibiohn.go.jp	Kiyono, Hiroshi/AAC-6735-2022		Ministry of Health and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST); Kowa Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Kowa Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported by grants from the Ministry of Health and Welfare of Japan (J.K., H.K., and M.K.); from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (J.K., H.K., and M.K.); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry (J.K.); the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (J.K.); from Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST; to H.K.); Kowa Life Science Foundation (J.K.); and Mochida Memorial Foundation for Medical and Pharmaceutical Research (J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Nguyen CT, 2011, VACCINE, V29, P5731, DOI 10.1016/j.vaccine.2011.05.095; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; CRAIN MJ, 1990, INFECT IMMUN, V58, P3293, DOI 10.1128/IAI.58.10.3293-3299.1990; Dlugonska Henryka, 2012, Annals of Parasitology, V58, P1; Fujkuyama Y, 2012, EXPERT REV VACCINES, V11, P367, DOI [10.1586/erv.11.196, 10.1586/ERV.11.196]; Fukuyama Y, 2010, J IMMUNOL, V185, P1755, DOI 10.4049/jimmunol.1000831; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Goulart C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059605; Goulart C, 2011, VACCINE, V29, P1634, DOI 10.1016/j.vaccine.2010.12.074; Grevers G, 2010, INT J PEDIATR OTORHI, V74, P572, DOI 10.1016/j.ijporl.2010.03.049; HANNA PC, 1991, J BIOL CHEM, V266, P11037; Harboe ZB, 2014, CLIN INFECT DIS; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Helander A, 2003, J VIROL, V77, P7964, DOI 10.1128/JVI.77.14.7964-7977.2003; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jensen VB, 1998, INFECT IMMUN, V66, P3758, DOI 10.1128/IAI.66.8.3758-3766.1998; Kakutani H, 2010, BIOMATERIALS, V31, P5463, DOI 10.1016/j.biomaterials.2010.03.047; KokaiKun JF, 1997, INFECT IMMUN, V65, P1014, DOI 10.1128/IAI.65.3.1014-1022.1997; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; Kong IG, 2013, INFECT IMMUN, V81, P1625, DOI 10.1128/IAI.00240-13; Kunisawa J, 2008, TRENDS IMMUNOL, V29, P505, DOI 10.1016/j.it.2008.07.008; Kunisawa J, 2012, ADV DRUG DELIVER REV, V64, P523, DOI 10.1016/j.addr.2011.07.003; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Miyaji EN, 2013, CELL MOL LIFE SCI, V70, P3303, DOI 10.1007/s00018-012-1234-8; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Shima H, 2014, INT IMMUNOL, V26, P619, DOI 10.1093/intimm/dxu061; Smedley JG, 2007, INFECT IMMUN, V75, P2381, DOI 10.1128/IAI.01737-06; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Suzuki H, 2011, PHARMAZIE, V66, P543, DOI 10.1691/ph.2011.0365; Suzuki H, 2010, PHARMAZIE, V65, P766, DOI 10.1691/ph.2010.0097; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Wang XH, 2003, J IMMUNOL, V171, P4717, DOI 10.4049/jimmunol.171.9.4717; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zhao AS, 2014, INT J PEDIATR OTORHI, V78, P499, DOI 10.1016/j.ijporl.2013.12.028	48	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126352	10.1371/journal.pone.0126352	http://dx.doi.org/10.1371/journal.pone.0126352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018248	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600050
J	Tang, WJ; Dong, WW; Xie, P; Cheng, PF; Bai, SJ; Ren, YF; Wang, G; Chen, XY; Cui, C; Zhuang, YX; Huang, W				Tang, Weiju; Dong, Weiwei; Xie, Peng; Cheng, Pengfei; Bai, Shunjie; Ren, Yifei; Wang, Gong; Chen, Xiuying; Cui, Chun; Zhuang, Yuxiang; Huang, Wen			The Effect of Pre-Condition Cerebella Fastigial Nucleus Electrical Stimulation within and beyond the Time Window of Thrombolytic on Ischemic Stroke in the Rats	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CEREBRAL-ARTERY OCCLUSION; HIPPOCAMPAL-NEURONS; BRAIN-INJURY; NEUROPROTECTION; EXPRESSION; MECHANISM; ALTEPLASE	Objective To investigate the effect of neurogenic neuroprotection conferred by cerebellar fastigial nucleus stimulation (FNS) and the role of PPAR gamma-mediated inflammation in a rat model of cerebral ischemia reperfusion. Methods After a continuous 1 hour fastigial nucleus electric stimulation, the male Sprague Dawley (SD) rats were given middle cerebral artery occlusion (MCAO) for 1, 3, 6, 9, 12 and 15 hours undergoing reperfusion with intravenous recombinant tissue plasminogen activator (rt-PA), while the control group received without FNS. After 72h of reperfusion, the neurological deficits, infarct volume and brain edema were evaluated. The brain tissue in ischemic penumbra was determined the myeloperoxidase (MPO) activity by a spectrophotometer and expression of PPAR. was measured by Rt-PCR and Western blotting. Results Our findings showed that FNS group had significantly reduced infarct volume and brain edema, and improved neurological deficits compared with the control group, especially in 6h and 9h reperfusion subgroups(p<0.05). The expression levels of PPAR. increased gradually and the peak may be before and after 9h reperfusion, the 3h, 6h, 9h, 12h and 15h reperfusion subgroups were higher than each control group(p<0.05). The MPO activity of 6h, 12h and 15h reperfusion subgroups were higher than each control group(p<0.05). Conclusions The neuroprotective effects of FNS have been shown to prolong the therapeutic window in cerebral ischemia/reperfusion, which might be related to the PPAR gamma mediated-inflammation in penumbral region.	[Tang, Weiju; Wang, Gong; Chen, Xiuying; Huang, Wen] Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China; [Dong, Weiwei; Xie, Peng; Cheng, Pengfei; Bai, Shunjie; Ren, Yifei] Third Mil Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Cui, Chun; Zhuang, Yuxiang] Third Mil Med Univ, Xinqiao Hosp, Dept Radiol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Huang, W (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China.	bosshuangwen@126.com			National Natural Science Foundation of China [81171113]; Natural Science Foundation of Chongqing, China [CSTC 2011BA5012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing)	This work was supported by research grants from the National Natural Science Foundation of China (Grant # 81171113), the Natural Science Foundation of Chongqing, China (Grant # CSTC 2011BA5012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto GE, 2012, EXP NEUROL, V238, P284, DOI 10.1016/j.expneurol.2012.08.015; Busch E, 1997, BRAIN RES, V778, P16, DOI 10.1016/S0006-8993(97)01008-1; Chen JG, 2007, J PHARMACOL SCI, V103, P317, DOI 10.1254/jphs.FP0061235; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Golanov EV, 2003, CELL MOL NEUROBIOL, V23, P651, DOI 10.1023/A:1025088516742; Golanov EV, 1998, NEUROREPORT, V9, P819, DOI 10.1097/00001756-199803300-00010; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Kinouchi T, 2012, STROKE, V43, P478, DOI 10.1161/STROKEAHA.111.618926; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Lee CH, 2014, ANAT CELL BIOL, V47, P111, DOI 10.5115/acb.2014.47.2.111; Liu JL, 2014, NEURAL REGEN RES, V9, P727, DOI 10.4103/1673-5374.131577; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; Majid Arshad, 2014, ISRN Neurol, V2014, P515716, DOI 10.1155/2014/515716; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Mohammadi A, 2014, IRAN J BASIC MED SCI, V17, P263; Nour M, 2012, INTERV NEUROL, V1, P185, DOI 10.1159/000353125; Okami N, 2013, J CEREBR BLOOD F MET, V33, P106, DOI 10.1038/jcbfm.2012.138; Owens B, 2014, NATURE, V510, pS1, DOI 10.1038/510S1a; Reis DJ, 1990, STROKE, V21, P172; Rupadevi M, 2011, J PHARMACOL PHARMACO, V2, P36, DOI 10.4103/0976-500X.77113; Sun H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041716; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Zhao XR, 2009, J NEUROSCI, V29, P6186, DOI 10.1523/JNEUROSCI.5857-08.2009; Zhou P, 2005, J NEUROCHEM, V95, P221, DOI 10.1111/j.1471-4159.2005.03358.x; 夏一鲁, 1999, [中风与神经疾病杂志, Journal of Apoplexy and Nervous Diseases], V16, P3	32	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128447	10.1371/journal.pone.0128447	http://dx.doi.org/10.1371/journal.pone.0128447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016630	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600118
J	Imai, N; Yasuda, T; Kamijo-Ikemori, A; Shibagaki, Y; Kimura, K				Imai, Naohiko; Yasuda, Takashi; Kamijo-Ikemori, Atsuko; Shibagaki, Yugo; Kimura, Kenjiro			Distinct Roles of Urinary Liver-Type Fatty Acid-Binding Protein in Non-Diabetic Patients with Anemia	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; L-FABP; ERYTHROPOIETIN; BIOMARKER; EXCRETION; REFLECTS	Background Various stresses including ischemia are known to up-regulate renal L-FABP gene expression and increase the urinary excretion of L-FABP. In diabetic patients with anemia, the urinary excretion of L-FABP is significantly increased. We studied the clinical significance of urinary L-FABP and its relationship with anemia in non-diabetic patients. Subjects and Methods A total of 156 patients were studied in this retrospective cross-sectional analysis. The associations between anemia and urinary L-FABP levels, and the predictors of urinary L-FABP levels in non-diabetic patients were evaluated. Results Urinary L-FABP levels were significantly higher in patients with anemia compared to those in patients without anemia. Similarly, the urinary L-FABP levels were significantly higher in patients with albuminuria compared to those in patients without albuminuria. Urinary L-FABP levels correlated with urinary albumin-to-creatinine ratios, estimated glomerular filtration rates, body mass index, and hemoglobin levels. Multivariate linear regression analysis determined that hemoglobin levels (beta = -0.249, P = 0.001) and urinary albumin-to-creatinine ratios (beta = 0.349, P < 0.001) were significant predictors of urinary L-FABP levels. Conclusions Urinary L-FABP is strongly associated with anemia in non-diabetic patients.	[Imai, Naohiko; Yasuda, Takashi; Kamijo-Ikemori, Atsuko; Shibagaki, Yugo] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan; [Kimura, Kenjiro] Tokyo Takanawa Hosp, Dept Internal Med, Tokyo, Japan	Saint Marianna University	Imai, N (corresponding author), St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan.	naohiko.imai@gmail.com		Imai, Naohiko/0000-0001-9984-2889				Babazono T, 2006, DIABETOLOGIA, V49, P1387, DOI 10.1007/s00125-006-0247-y; Dikow R, 2002, NEPHROL DIAL TRANSPL, V17, P67, DOI 10.1093/ndt/17.suppl_1.67; Erturk S, 1996, NEPHROL DIAL TRANSPL, V11, P396, DOI 10.1093/oxfordjournals.ndt.a027287; Hayashi K, 2001, KIDNEY INT, V60, P1910, DOI 10.1046/j.1523-1755.2001.00028.x; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Izuhara Y, 2005, J AM SOC NEPHROL, V16, P3631, DOI 10.1681/ASN.2005050522; Kamijo A, 2004, AM J PATHOL, V165, P1243, DOI 10.1016/S0002-9440(10)63384-6; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Kamijo A, 2006, MOL CELL BIOCHEM, V284, P175, DOI 10.1007/s11010-005-9047-9; Kamijo-Ikemori A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0513-1; Lawrence JW, 2000, J LIPID RES; MAATMAN RGHJ, 1991, BIOCHEM J, V273, P759, DOI 10.1042/bj2730759; Matsui K, 2011, AM J PATHOL, V178, P1021, DOI 10.1016/j.ajpath.2010.12.002; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mayer GL, 2006, FATS OF LIFE, V20, P4; McCullough Peter A, 2005, Rev Cardiovasc Med, V6, P1; Nakamura T, 2007, DIABETOLOGIA, V50, P490, DOI 10.1007/s00125-006-0545-4; Nakamura T, 2005, DIABETES CARE, V28, P2728, DOI 10.2337/diacare.28.11.2728; Nakamura T, 2006, AM J NEPHROL, V26, P276, DOI 10.1159/000093934; Nangaku M, 2005, J AM SOC NEPHROL, V16, P1195, DOI 10.1681/ASN.2004121098; Nielsen SE, 2009, DIABETES CARE, V32, P1684, DOI 10.2337/dc09-0429; Portilla D, 2008, KIDNEY INT, V73, P465, DOI 10.1038/sj.ki.5002721; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; von Eynatten M, 2010, EUR J CLIN INVEST, V40, P95, DOI 10.1111/j.1365-2362.2009.02220.x; Vrtovsnik F, 1999, KIDNEY INT, V56, pS92, DOI 10.1046/j.1523-1755.1999.07123.x; World Health Organization, 2011, SER FERR CONC ASS IR; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Yokoyama T, 2009, AM J PATHOL, V174, P2096, DOI 10.2353/ajpath.2009.080780	28	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126990	10.1371/journal.pone.0126990	http://dx.doi.org/10.1371/journal.pone.0126990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010898	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900053
J	Ito, A; Nagai, M; Tajino, J; Yamaguchi, S; Iijima, H; Zhang, XK; Aoyama, T; Kuroki, H				Ito, Akira; Nagai, Momoko; Tajino, Junichi; Yamaguchi, Shoki; Iijima, Hirotaka; Zhang, Xiangkai; Aoyama, Tomoki; Kuroki, Hiroshi			Culture Temperature Affects Human Chondrocyte Messenger RNA Expression in Monolayer and Pellet Culture Systems	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; OXYGEN-TENSION; OSTEOARTHRITIC CHONDROCYTES; HYDROSTATIC-PRESSURE; CARTILAGE FORMATION; GENE-EXPRESSION; RETINOIC ACID; 3D CULTURES; STEM-CELLS; REDIFFERENTIATION	Cell-based therapy has been explored for articular cartilage regeneration. Autologous chondrocyte implantation is a promising cell-based technique for repairing articular cartilage defects. However, there are several issues such as chondrocyte de-differentiation. While numerous studies have been designed to overcome some of these issues, only a few have focused on the thermal environment that can affect chondrocyte metabolism and phenotype. In this study, the effects of different culture temperatures on human chondrocyte metabolism-and phenotype-related gene expression were investigated in 2D and 3D environments. Human chondrocytes were cultured in a monolayer or in a pellet culture system at three different culture temperatures (32 degrees C, 37 degrees C, and 41 degrees C) for 3 days. The results showed that the total RNA level, normalized to the threshold cycle value of internal reference genes, was higher at lower temperatures in both culture systems. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and citrate synthase (CS), which are involved in glycolysis and the citric acid cycle, respectively, were expressed at similar levels at 32 degrees C and 37 degrees C in pellet cultures, but the levels were significantly lower at 41 degrees C. Expression of the chondrogenic markers, collagen type IIA1 (COL2A1) and aggrecan (ACAN), was higher at 37 degrees C than at 32 degrees C and 41 degrees C in both culture systems. However, this phenomenon did not coincide with SRY (sex-determining region Y)-box 9 (SOX9), which is a fundamental transcription factor for chondrogenesis, indicating that a SOX9-independent pathway might be involved in this phenomenon. In conclusion, the expression of chondrocyte metabolism-related genes at 32 degrees C was maintained or enhanced compared to that at 37 degrees C. However, chondrogenesis-related genes were further induced at 37 degrees C in both culture systems. Therefore, manipulating the culture temperature may be an advantageous approach for regulating human chondrocyte metabolic activity and chondrogenesis.	[Ito, Akira; Nagai, Momoko; Tajino, Junichi; Yamaguchi, Shoki; Iijima, Hirotaka; Zhang, Xiangkai; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal Human Hlth Sci, Kyoto, Japan; [Ito, Akira; Yamaguchi, Shoki] Japan Soc Promot Sci, Tokyo, Japan; [Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Dev & Rehabil Motor Funct Human Hlth Sci, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Kyoto University	Kuroki, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal Human Hlth Sci, Kyoto, Japan.	kuroki.hiroshi.6s@kyoto-u.ac.jp	Ito, Akira/AAA-4872-2021; Iijima, Hirotaka/AAV-9480-2020	Ito, Akira/0000-0002-9645-9777; 	JSPS KAKENHI [25242055, 25560258];  [253611]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This study was supported in part by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/index.html) Research Fellows (no. 253611) to AI, a JSPS KAKENHI Grant-in-Aid for Scientific Research (A) (no. 25242055) and a JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research (no. 25560258) to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Babur BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058865; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BENYA PD, 1988, J CELL BIOL, V106, P161, DOI 10.1083/jcb.106.1.161; Bernstein P, 2009, BIOTECHNOL PROGR, V25, P1146, DOI 10.1002/btpr.186; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Blain EJ, 2009, INT J EXP PATHOL, V90, P1, DOI 10.1111/j.1365-2613.2008.00625.x; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004; Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091561; Chuppa S, 1997, BIOTECHNOL BIOENG, V55, P328, DOI 10.1002/(SICI)1097-0290(19970720)55:2<328::AID-BIT10>3.0.CO;2-D; Dehne T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2800; DEWEY WC, 1977, RADIOLOGY, V123, P463, DOI 10.1148/123.2.463; Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477; Elder SH, 2006, J ORTHOP RES, V24, P740, DOI 10.1002/jor.20086; Foldager CB, 2011, ACTA ORTHOP, V82, P234, DOI 10.3109/17453674.2011.566135; Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3; Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035; Gallagher S, 2001, Curr Protoc Protein Sci, VAppendix 4, p4K, DOI 10.1002/0471140864.psa04ks13; Gigante A, 2008, EUR J HISTOCHEM, V52, P169; Hendrick V, 2001, CYTOTECHNOLOGY, V36, P71, DOI 10.1023/A:1014088919546; Hojo Tatsuya, 2003, J Orthop Sci, V8, P396, DOI 10.1007/s10776-002-0643-2; Idowu BD, 2000, HISTOCHEM J, V32, P165, DOI 10.1023/A:1004095207330; Ito Akira, 2014, J Jpn Phys Ther Assoc, V17, P14, DOI 10.1298/jjpta.Vol17_003; Ito A, 2014, INT J HYPERTHER, V30, P210, DOI 10.3109/02656736.2014.906048; Ito A, 2014, INT J HYPERTHER, V30, P96, DOI 10.3109/02656736.2014.880857; Ito A, 2012, ULTRASOUND MED BIOL, V38, P1726, DOI 10.1016/j.ultrasmedbio.2012.06.005; Jeon JE, 2012, OSTEOARTHR CARTILAGE, V20, P906, DOI 10.1016/j.joca.2012.04.019; KIM HKW, 1991, J BONE JOINT SURG AM, V73A, P1301, DOI 10.2106/00004623-199173090-00004; Kocaoglu B, 2011, ARTHROSCOPY, V27, P526, DOI 10.1016/j.arthro.2010.10.019; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443; Li S, 2014, BIOTECHNOL BIOENG, V111, P1876, DOI 10.1002/bit.25241; Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007; MALLEINGERIN F, 1991, EUR J CELL BIOL, V56, P364; MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022; Moore A, 1997, CYTOTECHNOLOGY, V23, P47, DOI 10.1023/A:1007919921991; Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; Ono Y, 2013, BIOCHEM BIOPH RES CO, V435, P733, DOI 10.1016/j.bbrc.2013.05.052; OOSTERVELD FGJ, 1994, SEMIN ARTHRITIS RHEU, V24, P82, DOI 10.1016/S0049-0172(05)80002-2; PARKKINEN JJ, 1995, J ORTHOPAED RES, V13, P495, DOI 10.1002/jor.1100130404; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; Roberts S, 2009, KNEE, V16, P398, DOI 10.1016/j.knee.2009.02.004; Roelofs AJ, 2013, OSTEOARTHR CARTILAGE, V21, P892, DOI 10.1016/j.joca.2013.04.008; Sanchez-Inchausti G, 2005, ARTHROSCOPY, V21, P552, DOI 10.1016/j.arthro.2005.01.011; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Schrobback K, 2012, CELL TISSUE RES, V347, P649, DOI 10.1007/s00441-011-1193-7; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Siu PM, 2003, J APPL PHYSIOL, V94, P555, DOI 10.1152/japplphysiol.00821.2002; Tan GK, 2011, BIOMATERIALS, V32, P5600, DOI 10.1016/j.biomaterials.2011.04.033; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wang LM, 2010, BIOMATERIALS, V31, P1612, DOI 10.1016/j.biomaterials.2009.11.024; WHEATLEY DN, 1989, INT J HYPERTHER, V5, P145, DOI 10.3109/02656738909140444; Ylarinne JH, 2014, CELL TISSUE RES, V358, P541, DOI 10.1007/s00441-014-1970-1; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246	62	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128082	10.1371/journal.pone.0128082	http://dx.doi.org/10.1371/journal.pone.0128082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010859	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900191
J	Leng, YQ; Zhong, SB				Leng, Yueqiang; Zhong, Shaobin			The Role of Mitogen-Activated Protein (MAP) Kinase Signaling Components in the Fungal Development, Stress Response and Virulence of the Fungal Cereal Pathogen Bipolaris sorokiniana	PLOS ONE			English	Article							COCHLIOBOLUS-SATIVUS; MYCOSPHAERELLA-GRAMINICOLA; MAGNAPORTHE-GRISEA; OXIDATIVE STRESS; CRYPHONECTRIA-PARASITICA; CHLAMYDOSPORE FORMATION; APPRESSORIUM FORMATION; FUSARIUM-GRAMINEARUM; CANDIDA-ALBICANS; PLANT INFECTION	Mitogen-activated protein kinases (MAPKs) have been demonstrated to be involved in fungal development, sexual reproduction, pathogenicity and/or virulence in many filamentous plant pathogenic fungi, but genes for MAPKs in the fungal cereal pathogen Bipolaris sorokiniana have not been characterized. In this study, orthologues of three MAPK genes (CsSLT2, CsHOG1 and CsFUS3) and one MAPK kinase kinase (MAPKKK) gene (CsSTE11) were identified in the whole genome sequence of the B. sorokiniana isolate ND90Pr, and knockout mutants were generated for each of them. The Delta Csfus3 and Delta Csste11 mutants were defective in conidiation and formation of appressoria-like structures, showed hypersensitivity to oxidative stress and lost pathogenicity on non-wounded leaves of barley cv. Bowman. When inoculated on wounded leaves of Bowman, the Delta Csfus3 and Delta Csste11 mutants were reduced in virulence compared to the wild type. No morphological changes were observed in the Delta Cshog1 mutants in comparison with the wild type; however, they were slightly reduced in growth under oxidative stress and were hypersensitive to hyperosmotic stress. The Delta Cshog1 mutants formed normal appressoria-like structures but were reduced in virulence when inoculated on Bowman leaves. The Delta Csslt2 mutants produced more vegetative hyphae, had lighter pigmentation, were more sensitive to cell wall degrading enzymes, and were reduced in virulence on Bowman leaves, although they formed normal appressoria like the wild type. Root infection assays indicated that the Delta Cshog1 and Delta Csslt2 mutants were able to infect barley roots while the Delta Csfus3 and Delta Csste11 failed to cause any symptoms. However, no significant difference in virulence was observed for Delta Cshog1 mutants while Delta Csslt2 mutants showed significantly reduced virulence on barley roots in comparison with the wild type. Our results indicated that all of these MAPK and MAPKKK genes are involved in the regulation of fungal development under normal and stress conditions and required for full virulence on barley plants.	[Leng, Yueqiang; Zhong, Shaobin] N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA	North Dakota State University Fargo	Zhong, SB (corresponding author), N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA.	shaobin.zhong@ndsu.edu			Triticeae-CAP project from the USDA National Institute of Food and Agriculture [2011-68002-30029]; North Dakota State University	Triticeae-CAP project from the USDA National Institute of Food and Agriculture; North Dakota State University	This study was partially supported by the Triticeae-CAP project (2011-68002-30029) from the USDA National Institute of Food and Agriculture. Additional funding was provided by North Dakota State University. The authors received no specific funding from other sources for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Choi ES, 2005, MICROBIOL-SGM, V151, P1349, DOI 10.1099/mic.0.27796-0; Condon BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003233; Cousin A, 2006, MOL PLANT PATHOL, V7, P269, DOI [10.1111/j.1364-3703.2006.00337.x, 10.1111/J.1364-3703.2006.00337.X]; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Eliahu N, 2007, EUKARYOT CELL, V6, P421, DOI 10.1128/EC.00264-06; Fetch TG, 1999, PLANT DIS, V83, P213, DOI 10.1094/PDIS.1999.83.3.213; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; Heinisch JJ, 2005, BBA-PROTEINS PROTEOM, V1754, P171, DOI 10.1016/j.bbapap.2005.07.032; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Igbaria A, 2008, MOL PLANT MICROBE IN, V21, P769, DOI 10.1094/MPMI-21-6-0769; Izumitsu K, 2009, CURR GENET, V55, P439, DOI 10.1007/s00294-009-0257-7; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Leng YQ, 2012, MOL PLANT PATHOL, V13, P375, DOI 10.1111/j.1364-3703.2011.00756.x; Lev S, 1999, P NATL ACAD SCI USA, V96, P13542, DOI 10.1073/pnas.96.23.13542; LILJEROTH E, 1993, PHYTOPATHOLOGY, V83, P1484, DOI 10.1094/Phyto-83-1484; Mathre D. E., 1997, COMPENDIUM BARLEY DI; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P389, DOI 10.1094/MPMI-19-0389; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P1262, DOI 10.1094/MPMI-19-1262; Mey G, 2002, MOL MICROBIOL, V46, P305, DOI 10.1046/j.1365-2958.2002.03133.x; Moriwaki A, 2006, FEMS MICROBIOL LETT, V257, P253, DOI 10.1111/j.1574-6968.2006.00178.x; Moriwaki A, 2007, MICROBIOL RES, V162, P108, DOI 10.1016/j.micres.2006.01.014; Park SM, 2004, MOL MICROBIOL, V51, P1267, DOI 10.1111/j.1365-2958.2004.03919.x; Ruiz-Roldan MC, 2001, MOL PLANT MICROBE IN, V14, P116, DOI 10.1094/MPMI.2001.14.2.116; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Solomon PS, 2005, CURR GENET, V48, P60, DOI 10.1007/s00294-005-0588-y; Takano Y, 2000, MOL PLANT MICROBE IN, V13, P374, DOI 10.1094/MPMI.2000.13.4.374; TINLINE R. D., 1960, CANADIAN JOUR BOT, V38, P275, DOI 10.1139/b60-028; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; ValjavecGratian M, 1997, PLANT DIS, V81, P1275, DOI 10.1094/PDIS.1997.81.11.1275; Wiese M.V., 1977, COMPENDIUM WHEAT DIS; WINDELS CE, 1988, PHYTOPATHOLOGY, V78, P107, DOI 10.1094/Phyto-78-107; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yoshimi A, 2005, EUKARYOT CELL, V4, P1820, DOI 10.1128/EC.4.11.1820-1828.2005; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; Zhong SB, 2002, MOL PLANT MICROBE IN, V15, P481, DOI 10.1094/MPMI.2002.15.5.481	44	23	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128291	10.1371/journal.pone.0128291	http://dx.doi.org/10.1371/journal.pone.0128291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011429	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900218
J	Lin, WY; Lee, CC; Hsu, CW; Huang, KY; Lyu, SR				Lin, Wen-Yan; Lee, Ching-Chih; Hsu, Chia-Wen; Huang, Kuang-Yung; Lyu, Shaw-Ruey			Patients with Knee Osteoarthritis Undergoing Total Knee Arthroplasty Have a Lower Risk of Subsequent Severe Cardiovascular Events: Propensity Score and Instrumental Variable Analysis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; MYOCARDIAL-INFARCTION; NATIONAL-HEALTH; OUTCOMES; PREVALENCE; PREVENTION; NUTRITION; MORTALITY	Objective This population-based study investigated the subsequent cardiovascular risk of patients with knee osteoarthritis underwent total knee arthroplasty in Taiwan. Materials and methods This was a population-based follow-up study of 22931 patients diagnosed with knee osteoarthritis between 2008 and 2011. Each patient was followed for 3 years or until death. Treatment was dichotomized into conservative treatment and TKA. The association between TKA and cardiovascular disease (CVD) events was analyzed using propensity score analysis and instrumental variable analysis and two-stage least-squares regression model. Results Patients with knee osteoarthritis who underwent TKA had a lower 3-year cumulative risk of stroke and acute myocardial infarction (AMI). After adjusting for measured risk and confounding factors, propensity score showed a 0.56 fold (adjusted OR = 0.56; 95% CI, 0.51-0.61; p<0.001) risk for CVD in those with TKA. Use of instrumental variable analysis for adjusting measured and unmeasured factors and two-stage least squares regression model revealed that the average treatment effect of TKA was statistically associated with a decreased 7% risk of CVD events (95% CI, 0.2%-13.6%). Conclusion Our study revealed that patients with knee osteoarthritis who underwent TKA had a lower risk of suffering from a future severe cardiovascular event. This benefit may be attributed to an improvement in physical activity, reduction of psychosocial stress, and/or a decreased use of NSAIDs as a result of having undergone TKA.	[Lin, Wen-Yan] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Orthoped, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih; Lyu, Shaw-Ruey] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Educ, Chiayi, Taiwan; [Lee, Ching-Chih; Huang, Kuang-Yung; Lyu, Shaw-Ruey] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Hsu, Chia-Wen] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Huang, Kuang-Yung] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Huang, Kuang-Yung] Natl Chung Cheung Univ, Dept Life Sci, Chiayi, Taiwan; [Huang, Kuang-Yung] Natl Chung Cheung Univ, Inst Mol Biol, Chiayi, Taiwan; [Lyu, Shaw-Ruey] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Joint Ctr, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Lyu, SR (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Educ, Chiayi, Taiwan.	srlyu@seed.net.tw	Lyu, Shaw-Ruey/AAC-5480-2022; Lyu, Shaw-Ruey/AAD-9397-2022	Lyu, Shaw-Ruey/0000-0003-3797-4848; 				Andersen RE, 1999, J AM GERIATR SOC, V47, P1435, DOI 10.1111/j.1532-5415.1999.tb01563.x; [Anonymous], 2007, PREV CARD DIS GUID A; Brown GA, 2013, J AM ACAD ORTHOP SUR, V21, P577, DOI [10.5435/00124635-201309020-00009, 10.5435/JAAOS-21-09-577]; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Clays E, 2013, EUR J EPIDEMIOL, V28, P241, DOI 10.1007/s10654-013-9764-4; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Davies NM, 2013, EPIDEMIOLOGY, V24, P352, DOI 10.1097/EDE.0b013e318289e024; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dowsey MM, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/506518; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Haapanen N, 1997, INT J EPIDEMIOL, V26, P739, DOI 10.1093/ije/26.4.739; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Hawker GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091286; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Iwashyna Theodore J, 2013, Ann Am Thorac Soc, V10, P255, DOI 10.1513/AnnalsATS.201303-054FR; Kane RL, 2005, J BONE JOINT SURG AM, V87A, P1719, DOI 10.2106/JBJS.D.02714; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; Marks R., 2013, AM J MED STUD SCI ED, V1, P11, DOI [10.12691/ajms-1-3-1], DOI 10.12691/AJMS-1-3-1]; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Ravi B, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6187; Ries MD, 1996, J BONE JOINT SURG AM, V78A, P1696, DOI 10.2106/00004623-199611000-00009; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Tu Karen, 2007, Open Med, V1, pe18; Yeh RW, 2014, CIRC-CARDIOVASC QUAL, V7, P118, DOI 10.1161/CIRCOUTCOMES.113.000476	29	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127454	10.1371/journal.pone.0127454	http://dx.doi.org/10.1371/journal.pone.0127454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010912	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900093
J	Mafurah, JJ; Ma, HF; Zhang, MX; Xu, J; He, F; Ye, TY; Shen, DY; Chen, YY; Rajput, NA; Dou, DL				Mafurah, Joseph Juma; Ma, Huifei; Zhang, Meixiang; Xu, Jing; He, Feng; Ye, Tingyue; Shen, Danyu; Chen, Yanyu; Rajput, Nasir Ahmed; Dou, Daolong			A Virulence Essential CRN Effector of Phytophthora capsici Suppresses Host Defense and Induces Cell Death in Plant Nucleus	PLOS ONE			English	Article							RXLR EFFECTOR; SOJAE; RESISTANCE; PROTEINS; NICOTIANA; AVIRULENCE; SEQUENCE; TOMATO; SIGNAL	Phytophthora capsici is a soil-borne plant pathogen with a wide range of hosts. The pathogen secretes a large array of effectors during infection of host plants, including Crinkler (CRN) effectors. However, it remains largely unknown on the roles of these effectors in virulence especially in P. capsici. In this study, we identified a cell death-inducing CRN effector PcCRN4 using agroinfiltration approach. Transient expression of PcCRN4 gene induced cell death in N. benthamiana, N. tabacum and Solanum lycopersicum. Overexpression of the gene in N. benthamiana enhanced susceptibility to P. capsici. Subcellular localization results showed that PcCRN4 localized to the plant nucleus, and the localization was required for both of its cell death-inducing activity and virulent function. Silencing PcCRN4 gene in P. capsici significantly reduced pathogen virulence. The expression of the pathogenesis-related gene PR1b in N. benthamiana was significantly induced when plants were inoculated with PcCRN4-silenced P. capsici transformant compared to the wilt-type. Callose deposits were also abundant at sites inoculated with PcCRN4-silenced transformant, indicating that silencing of PcCRN4 in P. capsici reduced the ability of the pathogen to suppress plant defenses. Transcriptions of cell death-related genes were affected when PcCRN4-silenced line were inoculated on Arabidopsis thaliana, suggesting that PcCRN4 may induce cell death by manipulating cell death-related genes. Overall, our results demonstrate that PcCRN4 is a virulence essential effector and it needs target to the plant nucleus to suppress plant immune responses.	[Mafurah, Joseph Juma; Ma, Huifei; Zhang, Meixiang; Xu, Jing; He, Feng; Ye, Tingyue; Shen, Danyu; Chen, Yanyu; Rajput, Nasir Ahmed; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Dou, DL (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing 210095, Jiangsu, Peoples R China.	ddou@njau.edu.cn	Shen, Danyu/AAF-1644-2019; Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642	National Natural Science Foundation of China [31371894]; Natural Science Foundation of Jiangsu Province [BK2012027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China, (31371894), http://www.nsfc.gov.cn/; and Natural Science Foundation of Jiangsu Province, (BK2012027), www.jstd.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Chen XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074588; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Dong SM, 2008, PLANT CELL REP, V27, P1559, DOI 10.1007/s00299-008-0554-5; Dong SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002353; Dong SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005556; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Hogenhout SA, 2009, MOL PLANT MICROBE IN, V22, P115, DOI 10.1094/MPMI-22-2-0115; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jupe J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r63; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lamour KH, 2012, MOL PLANT PATHOL, V13, P329, DOI 10.1111/j.1364-3703.2011.00754.x; Liu TL, 2011, PLANT PHYSIOL, V155, P490, DOI 10.1104/pp.110.166470; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; Nasir KHB, 2005, PLANT J, V43, P491, DOI 10.1111/j.1365-313X.2005.02472.x; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Rajput NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098114; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Schornack S, 2010, P NATL ACAD SCI USA, V107, P17421, DOI 10.1073/pnas.1008491107; Shen DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070036; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Stam R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00387; Stam R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059517; Takemoto D, 2005, PLANT PHYSIOL, V138, P1491, DOI 10.1104/pp.104.058388; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Damme M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002875; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wang YL, 2009, MICROB PATHOGENESIS, V47, P78, DOI 10.1016/j.micpath.2009.04.013; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yu XL, 2012, NEW PHYTOL, V196, P247, DOI 10.1111/j.1469-8137.2012.04241.x	45	27	31	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127965	10.1371/journal.pone.0127965	http://dx.doi.org/10.1371/journal.pone.0127965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011314	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900174
J	Vega, Y; Delgado, E; Fernandez-Garcia, A; Cuevas, MT; Thomson, MM; Montero, V; Sanchez, M; Sanchez, AM; Perez-Alvarez, L				Vega, Yolanda; Delgado, Elena; Fernandez-Garcia, Aurora; Teresa Cuevas, Maria; Thomson, Michael M.; Montero, Vanessa; Sanchez, Monica; Maria Sanchez, Ana; Perez-Alvarez, Lucia		Spanish Grp Study New HIV-1 Diag G	Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; NEWLY-DIAGNOSED PATIENTS; NON-B SUBTYPES; INFECTED INDIVIDUALS; PREVALENCE; PREVENTION; VIRUS	Our objectives were to carry out an epidemiological surveillance study on transmitted drug resistance (TDR) among individuals newly diagnosed of HIV-1 infection during a nine year period in Spain and to assess the role of transmission clusters (TC) in the propagation of resistant strains. An overall of 1614 newly diagnosed individuals were included in the study from January 2004 through December 2012. Individuals come from two different Spanish regions: Galicia and the Basque Country. Resistance mutations to reverse transcriptase inhibitors (RTI) and protease inhibitors (PI) were analyzed according to mutations included in the surveillance drug-resistance mutations list updated in 2009. TC were defined as those comprising viruses from five or more individuals whose sequences clustered in maximum likelihood phylogenetic trees with a bootstrap value >= 90%. The overall prevalence of TDR to any drug was 9.9%: 4.9% to nucleoside RTIs (NRTIs), 3.6% to non-nucleoside RTIs (NNRTIs), and 2.7% to PIs. A significant decrease of TDR to NRTIs over time was observed [from 10% in 2004 to 2% in 2012 (p=0.01)]. Sixty eight (42.2%) of 161 sequences with TDR were included in 25 TC composed of 5 or more individuals. Of them, 9 clusters harbored TDR associated with high level resistance to antiretroviral drugs. T215D revertant mutation was transmitted in a large cluster comprising 25 individuals. The impact of epidemiological networks on TDR frequency may explain its persistence in newly diagnosed individuals. The knowledge of the populations involved in TC would facilitate the design of prevention programs and public health interventions.	[Vega, Yolanda; Delgado, Elena; Fernandez-Garcia, Aurora; Teresa Cuevas, Maria; Thomson, Michael M.; Montero, Vanessa; Sanchez, Monica; Maria Sanchez, Ana; Perez-Alvarez, Lucia] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Biol & Variabilidad VIH, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Cuevas, MT (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Biol & Variabilidad VIH, Madrid, Spain.	tcuevas@isciii.es	Thomson, Michael M/P-8949-2017; gonzalez-nico, maria teresa cuevas/E-2001-2014; Delgado, Elena/E-2785-2019	Thomson, Michael M/0000-0002-0622-7527; gonzalez-nico, maria teresa cuevas/0000-0002-4195-1975; Coira Nieto, Amparo/0000-0003-1412-4242; Delgado, Elena/0000-0002-0754-8533; OCAMPO HERMIDA, ANTONIO/0000-0002-3176-9758; Lopez-Soria, Leyre/0000-0003-2335-8665; Matilde, Trigo Dapota/0000-0001-7006-2854	Conselleria de Sanidade, Government of Galicia, Spain [MVI - 1291/08]; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain [MVI-1255-08]; Ministerio de Sanidad, Servicios Sociales e Igualdad, Direccion General de Salud Publica, Cohesion e Innovacion [PI EC11-272]	Conselleria de Sanidade, Government of Galicia, Spain; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain; Ministerio de Sanidad, Servicios Sociales e Igualdad, Direccion General de Salud Publica, Cohesion e Innovacion	This work was supported by Conselleria de Sanidade, Government of Galicia, Spain (MVI - 1291/08), Osakidetza-Servicio Vasco de Salud, Basque Country, Spain (MVI-1255-08) and Ministerio de Sanidad, Servicios Sociales e Igualdad, Direccion General de Salud Publica, Cohesion e Innovacion (PI EC11-272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Chilton DN, 2010, ANTIVIR THER, V15, P985, DOI 10.3851/IMP1658; de Mendoza C, 2005, CLIN INFECT DIS, V41, P1350, DOI 10.1086/496982; Dolling D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5253; Drescher SM, 2014, CLIN INFECT DIS, V58, P285, DOI 10.1093/cid/cit694; Frentz D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-407; Frentz D, 2012, AIDS REV, V14, P17; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Grgic I, 2013, AIDS RES HUM RETROV, V29, P329, DOI [10.1089/aid.2012.0191, 10.1089/AID.2012.0191]; Hunt GM, 2012, CLIN INFECT DIS, V54, pS334, DOI 10.1093/cid/cir1017; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Jordan MR, 2008, ANTIVIR THER, V13, P15; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kaye M, 2008, JAIDS-J ACQ IMM DEF, V49, P9, DOI 10.1097/QAI.0b013e318180c8af; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Monge S, 2012, CLIN MICROBIOL INFEC, V18, pE485, DOI 10.1111/1469-0691.12011; Perez-Alvarez L, 2003, ANTIVIR THER, V8, P355; Pineda-Pena AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101738; Romero A, 2011, ENFERM INFEC MICR CL, V29, P482, DOI 10.1016/j.eimc.2011.03.001; Schmidt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104474; Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P833, DOI [10.1089/aid.2011.0348, 10.1089/AID.2011.0348]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sungkanuparph S, 2012, JAIDS-J ACQ IMM DEF, V59, pE3, DOI 10.1097/QAI.0b013e31823ac978; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757; Turner D, 2012, HIV MED, V13, P202, DOI 10.1111/j.1468-1293.2011.00960.x; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Yebra G, 2014, ARCH VIROL, V159, P1079, DOI 10.1007/s00705-013-1933-y; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	37	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125699	10.1371/journal.pone.0125699	http://dx.doi.org/10.1371/journal.pone.0125699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010948	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900014
J	Vega-Rodriguez, J; Pastrana-Mena, R; Crespo-Llado, KN; Ortiz, JG; Ferrer-Rodriguez, I; Serrano, AE				Vega-Rodriguez, Joel; Pastrana-Mena, Rebecca; Crespo-Llado, Keila N.; Ortiz, Jose G.; Ferrer-Rodriguez, Ivan; Serrano, Adelfa E.			Implications of Glutathione Levels in the Plasmodium berghei Response to Chloroquine and Artemisinin	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; FERRIPROTOPORPHYRIN-IX; MALARIA PARASITES; FALCIPARUM MALARIA; RODENT MALARIA; INTRACELLULAR GLUTATHIONE; ANTIMALARIAL ACTION; DRUG-RESISTANCE; INHIBITION; MECHANISM	Malaria is one of the most devastating parasitic diseases worldwide. Plasmodium drug resistance remains a major challenge to malaria control and has led to the re-emergence of the disease. Chloroquine (CQ) and artemisinin (ART) are thought to exert their anti-malarial activity inducing cytotoxicity in the parasite by blocking heme degradation (for CQ) and increasing oxidative stress. Besides the contribution of the CQ resistance transporter (PfCRT) and the multidrug resistant gene (pfmdr), CQ resistance has also been associated with increased parasite glutathione (GSH) levels. ART resistance was recently shown to be associated with mutations in the K13-propeller protein. To analyze the role of GSH levels in CQ and ART resistance, we generated transgenic Plasmodium bergheiparasites either deficient in or overexpressing the gamma-glutamylcysteine synthetase gene (pbggcs) encoding the rate-limiting enzyme in GSH biosynthesis. These lines produce either lower (pbggcs-ko) or higher (pbggcs-oe) levels of GSH than wild type parasites. In addition, GSH levels were determined in P. berghei parasites resistant to CQ and mefloquine (MQ). Increased GSH levels were detected in both, CQ and MQ resistant parasites, when compared to the parental sensitive clone. Sensitivity to CQ and ART remained unaltered in both pgggcs-ko and pbggcs-oe parasites when tested in a 4 days drug suppressive assay. However, recrudescence assays after the parasites have been exposed to a sub-lethal dose of ART showed that parasites with low levels of GSH are more sensitive to ART treatment. These results suggest that GSH levels influence Plasmodium berghei response to ART treatment.	[Vega-Rodriguez, Joel; Pastrana-Mena, Rebecca; Crespo-Llado, Keila N.; Ferrer-Rodriguez, Ivan; Serrano, Adelfa E.] Univ Puerto Rico, Dept Microbiol & Med Zool, San Juan, PR 00936 USA; [Ortiz, Jose G.] Univ Puerto Rico, Sch Med, Dept Pharmacol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Serrano, AE (corresponding author), Univ Puerto Rico, Dept Microbiol & Med Zool, San Juan, PR 00936 USA.	adelfa.serrano@upr.edu			National Institute of Health (AES): National Institute of General Medicine [S06GM008224]; National Institute on Minority Health and Health Disparities [G12-MD 007600]; National Center on Minority Health and Health Disparities [T37 MD001477]; National Institute of Allergy and Infectious Diseases [F31A1056662]; Fogarty International Center; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [T37MD001477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, S06GM008224] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institute of Health (AES): National Institute of General Medicine; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was partially supported by the following awards of the National Institute of Health (AES): National Institute of General Medicine S06GM008224, National Institute on Minority Health and Health Disparities G12-MD 007600, The Fogarty International Center and National Center on Minority Health and Health Disparities T37 MD001477, and the National Institute of Allergy and Infectious Diseases F31A1056662 (Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship award to JVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2014, STAT REP ART RES; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; BAGGALEY VC, 1972, T ROY SOC TROP MED H, V66, P4, DOI 10.1016/0035-9203(72)90005-3; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Birago C, 2001, J PHARMACEUT BIOMED, V25, P759, DOI 10.1016/S0731-7085(01)00379-X; CHOU AC, 1980, BIOCHEMISTRY-US, V19, P1543, DOI 10.1021/bi00549a600; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P727, DOI 10.1016/S0006-2952(97)00510-8; DUBOIS VL, 1995, EXP PARASITOL, V81, P117, DOI 10.1006/expr.1995.1099; Egan TJ, 1997, J INORG BIOCHEM, V68, P137, DOI 10.1016/S0162-0134(97)00086-X; Famin O, 1999, BIOCHEM PHARMACOL, V58, P59, DOI 10.1016/S0006-2952(99)00059-3; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Ginsburg H, 1998, BIOCHEM PHARMACOL, V56, P1305, DOI 10.1016/S0006-2952(98)00184-1; Gonzalez-Pons M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-1; Haynes RK, 2010, CHEMMEDCHEM, V5, P1282, DOI 10.1002/cmdc.201000225; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; KILLICKKENDRICK R, 1974, PARASITOLOGY, V69, P225, DOI 10.1017/S0031182000048071; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Leed A, 2002, BIOCHEMISTRY-US, V41, P10245, DOI 10.1021/bi020195i; Lehane AM, 2012, INT J PARASITOL-DRUG, V2, P47, DOI 10.1016/j.ijpddr.2011.11.001; Lim P, 2003, ANTIMICROB AGENTS CH, V47, P87, DOI 10.1128/AAC.47.1.87-94.2003; MANSOOR MA, 1992, ANAL BIOCHEM, V200, P218, DOI 10.1016/0003-2697(92)90456-H; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; MOREAU S, 1982, BIOCHIMIE, V64, P1015, DOI 10.1016/S0300-9084(82)80382-9; Mukanganyama S, 2001, FREE RADICAL RES, V35, P427, DOI 10.1080/10715760100300941; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Paitayatat S, 1997, J MED CHEM, V40, P633, DOI 10.1021/jm960767v; Pandey AV, 2001, BIOCHEM J, V355, P333, DOI 10.1042/0264-6021:3550333; Pastrana-Mena R, 2010, J BIOL CHEM, V285, P27045, DOI 10.1074/jbc.M110.122275; Patzewitz EM, 2013, ANTIOXID REDOX SIGN, V19, P683, DOI 10.1089/ars.2012.4625; Perez-Rosado J, 2002, EXP PARASITOL, V101, P175, DOI 10.1016/S0014-4894(02)00138-8; PETERS W, 1975, ANN TROP MED PARASIT, V69, P155, DOI 10.1080/00034983.1975.11686997; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; PETERS W, 1977, ANN TROP MED PARASIT, V71, P419, DOI 10.1080/00034983.1977.11687207; Peters W, 1987, CHEMOTHERAPY DRUG RE; Platel DFN, 1999, MOL BIOCHEM PARASIT, V98, P215, DOI 10.1016/S0166-6851(98)00170-4; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Rodriguez JF, 1998, PEDIATR INFECT DIS J, V17, P236, DOI 10.1097/00006454-199803000-00012; Safeukui I, 2004, BIOCHEM PHARMACOL, V68, P1903, DOI 10.1016/j.bcp.2004.05.049; SEELIG GF, 1985, METHOD ENZYMOL, V113, P379; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Srivastava P, 1999, TROP MED INT HEALTH, V4, P251, DOI 10.1046/j.1365-3156.1999.00387.x; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Sullivan DJ, 2002, INT J PARASITOL, V32, P1645, DOI 10.1016/S0020-7519(02)00193-5; Summers RL, 2014, P NATL ACAD SCI USA, V111, pE1759, DOI 10.1073/pnas.1322965111; TEW KD, 1994, CANCER RES, V54, P4313; Vega-Rodriguez J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000302; Wang DY, 2000, CHEM COMMUN, P2193, DOI 10.1039/b006906j; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wichmann O, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-17	56	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128212	10.1371/journal.pone.0128212	http://dx.doi.org/10.1371/journal.pone.0128212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010448	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900207
J	Kondratiuk, I; Plucinska, G; Miszczuk, D; Wozniak, G; Szydlowska, K; Kaczmarek, L; Filipkowski, RK; Lukasiuk, K				Kondratiuk, Ilona; Plucinska, Gabriela; Miszczuk, Diana; Wozniak, Grazyna; Szydlowska, Kinga; Kaczmarek, Leszek; Filipkowski, Robert K.; Lukasiuk, Katarzyna			Epileptogenesis following Kainic Acid-Induced Status Epilepticus in Cyclin D2 Knock-Out Mice with Diminished Adult Neurogenesis	PLOS ONE			English	Article							SEIZURE-INDUCED NEUROGENESIS; ECTOPIC GRANULE CELLS; HIPPOCAMPAL NEUROGENESIS; BRAIN NEUROGENESIS; DENTATE GYRUS; PROLIFERATION; ATTENUATION; INTEGRATION; NEURONS; MODELS	The goal of this study was to determine whether a substantial decrease in adult neurogenesis influences epileptogenesis evoked by the intra-amygdala injection of kainic acid (KA). Cyclin D2 knockout (cD2 KO) mice, which lack adult neurogenesis almost entirely, were used as a model. First, we examined whether status epilepticus (SE) evoked by an intra-amygdala injection of KA induces cell proliferation in cD2 KO mice. On the day after SE, we injected BrdU into mice for 5 days and evaluated the number of DCX- and DCX/BrdU-immunopositive cells 3 days later. In cD2 KO control animals, only a small number of DCX+ cells was observed. The number of DCX+ and DCX/BrdU+ cells/mm of subgranular layer in cD2 KO mice increased significantly following SE (p<0.05). However, the number of newly born cells was very low and was significantly lower than in KA-treated wild type (wt) mice. To evaluate the impact of diminished neurogenesis on epileptogenesis and early epilepsy, we performed video-EEG monitoring of wt and cD2 KO mice for 16 days following SE. The number of animals with seizures did not differ between wt (11 out of 15) and cD2 KO (9 out of 12) mice. The median latency to the first spontaneous seizure was 4 days (range 2 - 10 days) in wt mice and 8 days (range 2 - 16 days) in cD2 KO mice and did not differ significantly between groups. Similarly, no differences were observed in median seizure frequency (wt: 1.23, range 0.1 - 3.4; cD2 KO: 0.57, range 0.1 - 2.0 seizures/day) or median seizure duration (wt: 51 s, range 23 -103; cD2 KO: 51 s, range 23 - 103). Our results indicate that SE-induced epileptogenesis is not disrupted in mice with markedly reduced adult neurogenesis. However, we cannot exclude the contribution of reduced neurogenesis to the chronic epileptic state.	[Kondratiuk, Ilona; Wozniak, Grazyna; Kaczmarek, Leszek; Filipkowski, Robert K.] Polish Acad Sci, Nencki Inst Expt Biol, Neurobiol Lab, Warsaw, Poland; [Plucinska, Gabriela; Miszczuk, Diana; Szydlowska, Kinga; Lukasiuk, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Lab Epileptogenesis, Warsaw, Poland; [Filipkowski, Robert K.] Univ Finance & Management Warsaw, Lab Biol Psychol, Warsaw, Poland; [Filipkowski, Robert K.] Polish Acad Sci, Mossakowski Med Res Ctr, Behav & Metab Res Lab, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Lukasiuk, K (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Lab Epileptogenesis, Warsaw, Poland.	k.lukasiuk@nencki.gov.pl	Kaczmarek, Leszek/AHA-0076-2022; Szydlowska, Kinga/D-1301-2016; Lukasiuk, Katarzyna/F-4636-2010; Kaczmarek, Leszek/B-6171-2008; Kondratiuk, Ilona/M-7078-2018	Kaczmarek, Leszek/0000-0002-7207-3490; Szydlowska, Kinga/0000-0001-9019-7676; Kaczmarek, Leszek/0000-0002-7207-3490; Lukasiuk, Katarzyna/0000-0002-1582-0920; Kondratiuk, Ilona/0000-0002-7740-8923; Miszczuk, Diana/0000-0001-9798-6088	Polish Ministry of Science and Higher Education [190/6, PR UE/2006/7]; Polish Science Foundation [MPD/2009/4]; University of Finance and Management in Warsaw; European Union structural funds Innovative Economy Operational Program [POIG.01.01.02-00-109/09]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish Science Foundation(Foundation for Polish Science); University of Finance and Management in Warsaw; European Union structural funds Innovative Economy Operational Program	The study was supported by Polish Ministry of Science and Higher Education grant 190/6, PR UE/2006/7 (KL), Polish Science Foundation grant MPD/2009/4 (DM, IK), statutory funds of the University of Finance and Management in Warsaw (RKF), and by the European Union structural funds Innovative Economy Operational Program - Project No. POIG.01.01.02-00-109/09 (LK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Ansorg A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-46; Ben Abdallah NMB, 2013, BEHAV BRAIN RES, V252, P275, DOI 10.1016/j.bbr.2013.05.034; Bielefeld P, 2014, EUR J NEUROSCI, V39, P1, DOI 10.1111/ejn.12387; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Drexel M, 2011, NEUROSCIENCE, V189, P316, DOI 10.1016/j.neuroscience.2011.05.021; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Filipkowski RK, 2005, ACTA BIOCHIM POL, V52, P359; Frankland PW, 2013, BEHAV NEUROSCI, V127, P126, DOI 10.1037/a0031512; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Glickstein SB, 2007, DEVELOPMENT, V134, P4083, DOI 10.1242/dev.008524; Gray WP, 1998, BRAIN RES, V790, P52, DOI 10.1016/S0006-8993(98)00030-4; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Jaholkowski P, 2011, GENES BRAIN BEHAV, V10, P551, DOI 10.1111/j.1601-183X.2011.00692.x; Jaholkowski P, 2009, LEARN MEMORY, V16, P439, DOI 10.1101/lm.1459709; Jedynak P, 2014, J PSYCHIATR RES, V56, P106, DOI 10.1016/j.jpsychires.2014.05.009; Jedynak P, 2012, BEHAV BRAIN RES, V227, P159, DOI 10.1016/j.bbr.2011.11.007; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Jung KH, 2004, EUR J NEUROSCI, V19, P3219, DOI 10.1111/j.0953-816X.2004.03412.x; Kokaia M, 2011, EUR J NEUROSCI, V33, P1133, DOI 10.1111/j.1460-9568.2011.07612.x; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Ledergerber D, 2006, EXP NEUROL, V199, P130, DOI 10.1016/j.expneurol.2006.02.010; Murphy BL, 2011, J NEUROSCI, V31, P105, DOI 10.1523/JNEUROSCI.2728-10.2011; Parent J. M., 2012, NEUROGENESIS EPILEPS; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 1997, J NEUROSCI, V17, P3727; Pekcec A, 2010, HIPPOCAMPUS; Raedt R, 2007, EPILEPSIA, V48, P1952, DOI 10.1111/j.1528-1167.2007.01146.x; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Tanaka K, 2010, EPILEPSY RES, V88, P151, DOI 10.1016/j.eplepsyres.2009.10.012; Wood JC, 2011, EXP NEUROL, V229, P484, DOI 10.1016/j.expneurol.2011.03.019	36	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128285	10.1371/journal.pone.0128285	http://dx.doi.org/10.1371/journal.pone.0128285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020770	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300097
J	Stamler, RA; Holguin, O; Dungan, B; Schaub, T; Sanogo, S; Goldberg, N; Randall, JJ				Stamler, Rio A.; Holguin, Omar; Dungan, Barry; Schaub, Tanner; Sanogo, Soumaila; Goldberg, Natalie; Randall, Jennifer J.			BABA and Phytophthora nicotianae Induce Resistance to Phytophthora capsici in Chile Pepper (Capsicum annuum)	PLOS ONE			English	Article							ACID-INDUCED RESISTANCE; CELL-WALL INVERTASE; ARABIDOPSIS; GLYCEROL-3-PHOSPHATE; ACCUMULATION; INHIBITION; INFECTION; PATHOGENS; BLIGHT; LEAVES	Induced resistance in plants is a systemic response to certain microorganisms or chemicals that enhances basal defense responses during subsequent plant infection by pathogens. Inoculation of chile pepper with zoospores of non-host Phytophthora nicotianae or the chemical elicitor beta-aminobutyric acid (BABA) significantly inhibited foliar blight caused by Phytophthora capsici. Tissue extract analyses by GC/MS identified conserved change in certain metabolite concentrations following P. nicotianae or BABA treatment. Induced chile pepper plants had reduced concentrations of sucrose and TCA cycle intermediates and increased concentrations of specific hexose-phosphates, hexose-disaccharides and amino acids. Galactose, which increased significantly in induced chile pepper plants, was shown to inhibit growth of P. capsici in a plate assay.	[Stamler, Rio A.; Sanogo, Soumaila; Randall, Jennifer J.] New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA; [Holguin, Omar] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA; [Goldberg, Natalie] New Mexico State Univ, Dept Extens Plant Sci, Las Cruces, NM 88003 USA; [Dungan, Barry; Schaub, Tanner] New Mexico State Univ, Chem Anal & Instrumentat Lab, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University; New Mexico State University; New Mexico State University	Randall, JJ (corresponding author), New Mexico State Univ, Dept Entomol Plant Pathol & Weed Sci, Las Cruces, NM 88003 USA.	jrandall@nmsu.edu		Schaub, Tanner/0000-0002-5747-4237	New Mexico Chile Association	New Mexico Chile Association	This work was partially funded through the New Mexico Chile Association. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andres JL, 2003, J PLANT PATHOL, V85, P91; Andres JL, 2014, SPAN J AGRIC RES, V4, P248; Broeckling CD, 2005, J EXP BOT, V56, P323, DOI 10.1093/jxb/eri058; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; de Jongh WA, 2008, BIOTECHNOL BIOENG, V101, P317, DOI 10.1002/bit.21890; Diaz J, 2005, PLANT PATHOL, V54, P773, DOI 10.1111/j.1365-3059.2005.01285.x; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Evers D, 2006, BIOL PLANTARUM, V50, P265, DOI 10.1007/s10535-006-0017-1; Fotopoulos V, 2003, PLANT PHYSIOL, V132, P821, DOI 10.1104/pp.103.021428; French JM, 2011, PLANT DIS, V95, P1028, DOI 10.1094/PDIS-01-11-0048; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Jakab G, 2001, EUR J PLANT PATHOL, V107, P29, DOI 10.1023/A:1008730721037; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Lee SC, 2005, PLANTA, V221, P790, DOI 10.1007/s00425-005-1488-6; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; MARCAN H, 1979, PHYSIOL PLANT PATHOL, V14, P1, DOI 10.1016/0048-4059(79)90018-3; Martins MCM, 2013, PLANT PHYSIOL, V163, P1142, DOI 10.1104/pp.113.226787; Monroy-Barbosa A, 2010, HORTSCIENCE, V45, P1563, DOI 10.21273/HORTSCI.45.10.1563; Pastor V, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00295; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Sanogo S, 2012, CAN J PLANT PATHOL, V34, P479, DOI 10.1080/07060661.2012.732117; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Voll LM, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00039; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xie JH, 1999, AGR WATER MANAGE, V42, P127, DOI 10.1016/S0378-3774(99)00038-4; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	28	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128327	10.1371/journal.pone.0128327	http://dx.doi.org/10.1371/journal.pone.0128327			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020237	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300100
J	Han, S; Lee, JH; Kim, G; Ko, JS; Choi, SJ; Kwon, JH; Heo, BY; Gwak, MS				Han, Sangbin; Lee, Jong Hwan; Kim, Gaabsoo; Ko, Justin Sangwook; Choi, Soo Joo; Kwon, Ji Hae; Heo, Burn Young; Gwak, Mi Sook			Bioreactance Is Not Interchangeable with Thermodilution for Measuring Cardiac Output during Adult Liver Transplantation	PLOS ONE			English	Article							PULMONARY-ARTERY CATHETER; SURGERY; MONITORS; SYSTEM; FLUID	Background Thermodilution technique using a pulmonary artery catheter is widely used for the assessment of cardiac output (CO) in patients undergoing liver transplantation. However, the unclearness of the risk-benefit ratio of this method has led to an interest in less invasive modalities. Thus, we evaluated whether noninvasive bioreactance CO monitoring is interchangeable with thermodilution technique. Methods Nineteen recipients undergoing adult-to-adult living donor liver transplantation were enrolled in this prospective observational study. COs were recorded automatically by the two devices and compared simultaneously at 3-minute intervals. The Bland-Altman plot was used to evaluate the agreement between bioreactance and thermodilution. Clinically acceptable agreement was defined as a percentage error of limits of agreement <30%. The four quadrant plot was used to evaluate concordance between bioreactance and thermodilution. Clinically acceptable concordance was defined as a concordance rate >92%. Results A total of 2640 datasets were collected. The mean CO difference between the two techniques was 0.9 l/min, and the 95% limits of agreement were -3.5 l/min and 5.4 l/min with a percentage error of 53.9%. The percentage errors in the dissection, anhepatic, and reperfusion phase were 50.6%, 56.1%, and 53.5%, respectively. The concordance rate between the two techniques was 54.8%. Conclusion Bioreactance and thermodilution failed to show acceptable interchangeability in terms of both estimating CO and tracking CO changes in patients undergoing liver transplantation. Thus, the use of bioreactance as an alternative CO monitoring to thermodilution, in spite of its noninvasiveness, would be hard to recommend in these surgical patients.	[Han, Sangbin; Lee, Jong Hwan; Kim, Gaabsoo; Ko, Justin Sangwook; Choi, Soo Joo; Kwon, Ji Hae; Heo, Burn Young; Gwak, Mi Sook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Gwak, MS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	gwakms@skku.edu		Han, Sangbin/0000-0002-4129-301X				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bottiger BW, 1997, ANAESTHESIA, V52, P207, DOI 10.1111/j.1365-2044.1997.079-az0077.x; Cheung HY, 2015, J ANESTH, V29, P416, DOI 10.1007/s00540-014-1938-z; Conway DH, 2013, EUR J ANAESTH, V30, P501, DOI 10.1097/EJA.0b013e3283603250; Critchley LAH, 2005, ANESTH ANALG, V100, P1708, DOI 10.1213/01.ANE.0000150602.40554.EB; Critchley LAH, 1999, J CLIN MONIT COMPUT, V15, P85, DOI 10.1023/A:1009982611386; Critchley LA, 2010, ANESTH ANALG, V111, P1180, DOI 10.1213/ANE.0b013e3181f08a5b; De Wolf AM, 2006, INT ANESTHESIOL CLIN, V44, P59, DOI 10.1097/01.aia.0000210818.85287.de; De Wolf AM, 2008, LIVER TRANSPLANT, V14, P917, DOI 10.1002/lt.21543; Feltracco P, 2012, MINERVA ANESTESIOL, V78, P1372; Greim CA, 1997, ANESTH ANALG, V85, P483, DOI 10.1097/00000539-199709000-00003; Gwak MS, 2007, LIVER TRANSPLANT, V13, P1451, DOI 10.1002/lt.21300; Han SB, 2014, TRANSPL P, V46, P705, DOI 10.1016/j.transproceed.2013.11.091; Han SB, 2013, TRANSPL P, V45, P251, DOI 10.1016/j.transproceed.2012.05.088; Kang WS, 2012, J INT MED RES, V40, P2295, DOI 10.1177/030006051204000627; Keren H, 2007, AM J PHYSIOL-HEART C, V293, pH583, DOI 10.1152/ajpheart.00195.2007; Kober D, 2013, J CLIN MONIT COMPUT, V27, P621, DOI 10.1007/s10877-013-9478-x; Kossari N, 2009, HEMODIAL INT, V13, P512, DOI 10.1111/j.1542-4758.2009.00386.x; Krejci V, 2010, LIVER TRANSPLANT, V16, P773, DOI 10.1002/lt.22056; Kupersztych-Hagege E, 2013, BRIT J ANAESTH, V111, P961, DOI 10.1093/bja/aet282; Marik PE, 2013, J CARDIOTHOR VASC AN, V27, P121, DOI 10.1053/j.jvca.2012.03.022; Moller S, 2006, WORLD J GASTROENTERO, V12, P526, DOI 10.3748/wjg.v12.i4.526; Newby DE, 2002, QJM-INT J MED, V95, P827, DOI 10.1093/qjmed/95.12.827; Peng ZY, 2005, BRIT J ANAESTH, V95, P458, DOI 10.1093/bja/aei206; Rich JD, 2013, EUR RESPIR J, V42, P125, DOI 10.1183/09031936.00102212; Schumann R, 2013, J CLIN ANESTH, V25, P542, DOI 10.1016/j.jclinane.2013.04.017; Vergnaud E, 2015, PEDIATR ANESTH, V25, P160, DOI 10.1111/pan.12412; Weisz DE, 2012, NEONATOLOGY, V102, P61, DOI 10.1159/000337295; Wong LSG, 2008, LIVER TRANSPLANT, V14, P1038, DOI 10.1002/lt.21483	29	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127981	10.1371/journal.pone.0127981	http://dx.doi.org/10.1371/journal.pone.0127981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017364	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600104
J	Parag, T; Chakraborty, A; Plaza, S; Scheffer, L				Parag, Toufiq; Chakraborty, Anirban; Plaza, Stephen; Scheffer, Louis			A Context-Aware Delayed Agglomeration Framework for Electron Microscopy Segmentation	PLOS ONE			English	Article								Electron Microscopy (EM) image (or volume) segmentation has become significantly important in recent years as an instrument for connectomics. This paper proposes a novel agglomerative framework for EM segmentation. In particular, given an over-segmented image or volume, we propose a novel framework for accurately clustering regions of the same neuron. Unlike existing agglomerative methods, the proposed context-aware algorithm divides superpixels (over-segmented regions) of different biological entities into different subsets and agglomerates them separately. In addition, this paper describes a "delayed" scheme for agglomerative clustering that postpones some of the merge decisions, pertaining to newly formed bodies, in order to generate a more confident boundary prediction. We report significant improvements attained by the proposed approach in segmentation accuracy over existing standard methods on 2D and 3D datasets.	[Parag, Toufiq; Plaza, Stephen; Scheffer, Louis] HHMI, Ashburn, VA USA; [Chakraborty, Anirban] Natl Univ Singapore, Dept Diagnost Radiol, Singapore 117548, Singapore	Howard Hughes Medical Institute; National University of Singapore	Parag, T (corresponding author), HHMI, Ashburn, VA USA.	paragt@janelia.hhmi.org						Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Andres Bjoern, 2012, ECCV; [Anonymous], 2014, ARXIV14091801; Arbelaez P, 2011, IEEE T PATTERN ANAL, V33, P898, DOI 10.1109/TPAMI.2010.161; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Ciresan D, 2012, NIPS, V2012, P2852; Funke J., 2012, CVPR; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Jain V., 2011, ADV NEURAL INFORM PR, P648; Jain V., 2010, CVPR; Jurrus E, 2010, MED IMAGE ANAL, V14, P770, DOI 10.1016/j.media.2010.06.002; Krahenbuhl P., 2011, ADV NEURAL INFORM PR, P109; Ladicky L, 2009, IEEE I CONF COMP VIS, P739, DOI 10.1109/ICCV.2009.5459248; Liu T., 2012, ICPR; Liu T, 2014, J NEUROSCI METH, V226, P88, DOI 10.1016/j.jneumeth.2014.01.022; Lucchi A, 2012, IEEE T MED IMAGING, V31, P474, DOI 10.1109/TMI.2011.2171705; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Nunez-Iglesias J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071715; Parag T., 2014, MICCAI; Sommer C., 2011, ISBI; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Uzunbas M., 2014, MICCAI; Vazquez-Reina A., 2011, ICCV	26	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125825	10.1371/journal.pone.0125825	http://dx.doi.org/10.1371/journal.pone.0125825			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018659	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600035
J	Rabna, P; Ramos, J; Ponce, G; Sanca, L; Mane, M; Armada, A; Machado, D; Vieira, F; Gomes, VF; Martins, E; Colombatti, R; Riccardi, F; Perdigao, J; Sotero, J; Portugal, I; Couto, I; Atouguia, J; Rodrigues, A; Viveiros, M				Rabna, Paulo; Ramos, Jorge; Ponce, Gema; Sanca, Lilica; Mane, Morto; Armada, Ana; Machado, Diana; Vieira, Fina; Gomes, Victor F.; Martins, Elisabete; Colombatti, Raffaella; Riccardi, Fabio; Perdigao, Joao; Sotero, Joana; Portugal, Isabel; Couto, Isabel; Atouguia, Jorge; Rodrigues, Amabelia; Viveiros, Miguel			Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RAPID IDENTIFICATION; MIRU-VNTRPLUS; COMPLEX; DATABASE; IMPACT	Background This study aimed to evaluate the usefulness of the Xpert MTB/RIF assay for the rapid direct detection of M. tuberculosis complex (MTBC) strains and rifampicin resistance associated mutations in a resource-limited setting such as Guinea-Bissau and its implications in the management of tuberculosis (TB) and drug resistant tuberculosis, complementing the scarce information on resistance and genotypic diversity of MTBC strains in this West African country. Methods and Results This cross-sectional prospective study included 100 consecutive TB patients with positive acid-fast smears at two months of anti-tuberculosis treatment or in a re-treatment situation, between May and December 2012. Resistance to rifampicin was detected using the Gen-eXpert system and the Xpert MTB/RIF assay. MTBC isolates obtained with the BACTEC MGIT 960 system were tested for susceptibility to first- and second-line anti-tuberculosis drugs. Overall, the prevalence of multidrug-resistant tuberculosis (MDR-TB) was found to be 9 cases. Of these, 67% (6 patients) of confirmed MDR-TB cases had no past history of TB treatment and 33% (3 patients) were previously treated cases. Extensively drug-resistant TB was not found. Molecular typing of the MDR-TB strains revealed recent transmission patterns of imported MDR strains. Conclusions The Xpert MTB/RIF assay was reliable for the detection of rifampicin resistant MTBC strains directly from sputum samples of patients undergoing first-line treatment for two months, being more trustworthy than the simple presence of acid-fast bacilli in the smear. Its implementation is technically simple, does not require specialized laboratory infrastructures and is suitable for resource-limited settings when a regular source of electricity and maintenance is available as well as financial and operation sustainability is guaranteed by the health authorities. A high prevalence of MDR-TB among patients at risk of MDR-TB after two months of first-line treatment was found, in support of the WHO recommendations for its use in the management of this risk group.	[Rabna, Paulo; Sanca, Lilica; Mane, Morto; Rodrigues, Amabelia] Inst Nacl Saude Publ Projecto Saude Bandim INASA, Bissau, Guinea Bissau; [Ramos, Jorge; Armada, Ana; Machado, Diana; Couto, Isabel; Viveiros, Miguel] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Grp Micobacterias,GHTM,IHMT,UNL, P-1200 Lisbon, Portugal; [Ponce, Gema; Atouguia, Jorge] Univ Nova Lisboa, Unidade Clin Trop, Inst Higiene & Med Trop Lisboa, IHMT,UNL, P-1200 Lisbon, Portugal; [Armada, Ana; Atouguia, Jorge; Viveiros, Miguel] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais CMDT, Inst Higiene & Med Trop Lisboa, IHMT,UNL, P-1200 Lisbon, Portugal; [Vieira, Fina; Martins, Elisabete] Hosp Raoul Follereau, Bissau, Guinea Bissau; [Gomes, Victor F.] Minist Saude, Programa Nacl Luta Tuberculose, Bissau, Guinea Bissau; [Colombatti, Raffaella; Riccardi, Fabio] Aid Hlth & Dev Onlus Ahead Onlus, Rome, Italy; [Perdigao, Joao; Sotero, Joana; Portugal, Isabel] Univ Lisbon, Fac Farm, URIA, Ctr Patogenese Mol, P-1699 Lisbon, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa	Viveiros, M (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiol Med, Grp Micobacterias,GHTM,IHMT,UNL, P-1200 Lisbon, Portugal.	mviveiros@ihmt.unl.pt	Machado, Diana/L-7027-2013; Armada, Ana/I-2113-2012; Viveiros, Miguel/A-7326-2008; Couto, Isabel/I-2640-2012; Portugal, Isabel/B-1491-2008; Perdigão, João/L-6893-2013; iMed.ULisboa, M2B/B-5277-2014; Colombatti, Raffaella/D-2910-2017; Atouguia, Jorge M/J-2877-2012	Machado, Diana/0000-0003-2375-2726; Armada, Ana/0000-0001-5066-9982; Viveiros, Miguel/0000-0001-9676-6251; Couto, Isabel/0000-0003-3536-2733; Portugal, Isabel/0000-0002-7843-0006; Perdigão, João/0000-0002-0339-1305; iMed.ULisboa, M2B/0000-0002-1245-3715; Colombatti, Raffaella/0000-0001-9797-0457; Atouguia, Jorge/0000-0001-9854-0854; RICCARDI, Fabio/0000-0003-4523-3556; Sanca, Lilica Hulile/0000-0002-1787-2396; Ramos, Jorge/0000-0001-6419-5351	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through Global Program for Science of UNESCO [SFRH/BPD/5148/2011]; Gulbenkian Foundation; FCT, Portugal [SFRH/BD/65060/2009, PTDC/SAU-EPI/122400/2010, SFRH/BPD/95406/2013]	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through Global Program for Science of UNESCO; Gulbenkian Foundation; FCT, Portugal(Portuguese Foundation for Science and Technology)	The Pos-Doc study project of Paulo Rabna was funded by Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) through a grant of the Global Program for Science of UNESCO (SFRH/BPD/5148/2011). Gulbenkian Foundation is acknowledged for a clinical research grant to Gema Ponce. Diana Machado was supported by grant SFRH/BD/65060/2009 from FCT, Portugal. Joao Perdigao was supported by post-doctoral fellowships from Project PTDC/SAU-EPI/122400/2010 and SFRH/BPD/95406/2013 from FCT, Portugal. The funding Institutions had no role in study design, data collection, analysis, interpretation, preparation of the manuscript, or decision to publish.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Atun RA, 2005, INT J STD AIDS, V16, P560, DOI 10.1258/0956462054679124; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Drobniewski FA, 2008, EUR RESPIR J, V26, P298; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; International Air Transport Association, 2006, INF SUBST SHIPP GUID; Kallenius G, 1999, J CLIN MICROBIOL, V37, P3872; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kent PT, 1985, MYCOBACTERIOLOGY GUI; Machado D, 2013, J ANTIMICROB CHEMOTH, V68, P1728, DOI 10.1093/jac/dkt090; McNerney R, 2015, CURR OPIN PULM MED, V21, P304, DOI 10.1097/MCP.0000000000000161; Ministerio da Saude da Republica da Guine-Bissau, 2009, PROGR NAC LUT TUB RE; Ministerio da Saude da Republica da Guine-Bissau, 2013, MAN GEST PROGR NAC L; Olaru ID, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106075; Imperiale BR, 2014, J ANTIBIOT, V67, P749, DOI 10.1038/ja.2014.61; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Siddiqi S, 2006, MGIT960 PROCEDURE MA; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Vieira F, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.049; Viveiros M, 2005, J CLIN MICROBIOL, V43, P4880, DOI 10.1128/JCM.43.9.4880-4884.2005; Viveiros M, 2010, EXPERT REV ANTI-INFE, V8, P465, DOI [10.1586/eri.10.20, 10.1586/ERI.10.20]; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2011, AUT REAL TIM NUCL AC; World Health Organization, 2011, WHOHTMTB20116; World Health Organization, 2014, XPERT MTB RIF IMPL M; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2008, WHOHTHTB2008; World Health Organization, 2013, WHOHTMTB201311; World Health Organization & Stop TB Partnership, 2010, WHOHTMSTB20102; World Health Organization (WHO), 2009, WHOHTMTB2009420	33	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127536	10.1371/journal.pone.0127536	http://dx.doi.org/10.1371/journal.pone.0127536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017968	Green Published, gold			2022-12-27	WOS:000355185600088
J	Strofer, S; Noordzij, ML; Ufkes, EG; Giebels, E				Strofer, Sabine; Noordzij, Matthijs L.; Ufkes, Elze G.; Giebels, Ellen			Deceptive Intentions: Can Cues to Deception Be Measured before a Lie Is Even Stated?	PLOS ONE			English	Article							INTERPERSONAL DECEPTION; DETECTING DECEPTION; PREFRONTAL CORTEX; SKIN-CONDUCTANCE; COGNITIVE LOAD; DIFFERENTIATION; STRATEGIES; RESPONSES; AROUSAL; LIARS	Can deceitful intentions be discriminated from truthful ones? Previous work consistently demonstrated that deceiving others is accompanied by nervousness/stress and cognitive load. Both are related to increased sympathetic nervous system (SNS) activity. We hypothesized that SNS activity already rises during intentions to lie and, consequently, cues to deception can be detected before stating an actual lie. In two experiments, controlling for prospective memory, we monitored SNS activity during lying, truth telling, and truth telling with the aim of lying at a later instance. Electrodermal activity (EDA) was used as an indicator of SNS. EDA was highest during lying, and compared to the truth condition, EDA was also raised during the intention to deceive. Moreover, the switch from truth telling toward lying in the intention condition evoked higher EDA than switching toward non-deception related tasks in the lie or truth condition. These results provide first empirical evidence that increased SNS activity related to deception can be monitored before a lie is stated. This implies that cues to deception are already present during the mere intention to lie.	[Strofer, Sabine; Ufkes, Elze G.; Giebels, Ellen] Univ Twente, Dept Psychol Conflict Risk & Safety, NL-7500 AE Enschede, Netherlands; [Noordzij, Matthijs L.] Univ Twente, Dept Cognit Psychol & Ergon, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente	Strofer, S (corresponding author), Univ Twente, Dept Psychol Conflict Risk & Safety, POB 217, NL-7500 AE Enschede, Netherlands.	s.strofer@utwente.nl	Ufkes, Elze/G-2264-2015; Noordzij, Matthijs/AAC-4097-2019	Ufkes, Elze/0000-0002-9568-6310; Noordzij, Matthijs/0000-0002-5013-9225				Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Aikins DE, 2010, PSYCHOPHYSIOLOGY, V47, P633, DOI 10.1111/j.1469-8986.2010.00976.x; BANKART CP, 1974, PSYCHOPHYSIOLOGY, V11, P160; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; Boucsein W, 2012, PSYCHOPHYSIOLOGY, V49, P1017, DOI 10.1111/j.1469-8986.2012.01384.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Buller DB, 1996, COMMUN THEOR, V6, P203, DOI 10.1111/j.1468-2885.1996.tb00127.x; BURGOON JK, 1994, J NONVERBAL BEHAV, V18, P155, DOI 10.1007/BF02170076; Carlson JR, 2004, GROUP DECIS NEGOT, V13, P5, DOI 10.1023/B:GRUP.0000011942.31158.d8; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Cunha MG, 2010, SPIE DEFENSE SECURIT; DAWSON ME, 1980, PSYCHOPHYSIOLOGY, V17, P8, DOI 10.1111/j.1469-8986.1980.tb02452.x; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Dotsch R, 2008, J EXP SOC PSYCHOL, V44, P1194, DOI 10.1016/j.jesp.2008.03.003; EKMAN P, 1989, NATO ADV SCI I D-BEH, V47, P71; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Ekman P., 2009, TELLING LIES CLUES D; Engstrom J, 2005, TRANSPORT RES F-TRAF, V8, P97, DOI 10.1016/j.trf.2005.04.012; Fiedler K, 2002, BASIC APPL SOC PSYCH, V24, P313, DOI 10.1207/S15324834BASP2404_6; Field A., 2013, DISCOVERING STAT USI; Figner B., 2010, HDB PROCESS TRACING, P163; FUREDY JJ, 1991, PSYCHOPHYSIOLOGY, V28, P163, DOI 10.1111/j.1469-8986.1991.tb00407.x; FUREDY JJ, 1988, PSYCHOPHYSIOLOGY, V25, P683, DOI 10.1111/j.1469-8986.1988.tb01908.x; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; Godert HW, 2001, INT J PSYCHOPHYSIOL, V40, P61, DOI 10.1016/S0167-8760(00)00149-5; Granhag P. A., 2010, OPEN CRIMINOLOGY J, V3, P37, DOI DOI 10.2174/1874917801003010037; Granhag PA, 2008, FORENSIC PSYCHOL; Granhag PA, 2011, APPL COGNITIVE PSYCH, V25, P274, DOI 10.1002/acp.1674; Hartwig M, 2011, PSYCHOL BULL, V137, P643, DOI 10.1037/a0023589; Honts C. R., 2004, DETECTION DECEPTION, P103; Horrey WJ, 2009, J SAFETY RES, V40, P7, DOI 10.1016/j.jsr.2008.10.011; Howells FM, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-39; Ikehara CS, 2005, ASSESSING COGNITIVE, P295; Jung KH, 2012, SOC BEHAV PERSONAL, V40, P575, DOI 10.2224/sbp.2012.40.4.575; Kuikkaniemi K, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P859; Lacey J.I., 1963, EXPRESSION EMOTIONS, P161; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Leal S, 2008, ACTA PSYCHOL, V129, P1, DOI 10.1016/j.actpsy.2008.03.015; Leins DA, 2013, LEGAL CRIMINOL PSYCH, V18, P141, DOI 10.1111/j.2044-8333.2011.02041.x; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Malle BF, 2001, INTENTIONS INTENTION; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nourbakhsh N, 2012, P 24 AUSTR COMP HUM, P420, DOI DOI 10.1145/2414536.2414602; Nunez JM, 2005, NEUROIMAGE, V25, P267, DOI 10.1016/j.neuroimage.2004.10.041; Page Martin, 2007, Br J Nurs, V16, P622; Park J, 2011, J CATARACT REFR SURG, V37, P1517, DOI 10.1016/j.jcrs.2011.01.031; PENNEBAKER JW, 1985, J PERS SOC PSYCHOL, V49, P1427, DOI 10.1037/0022-3514.49.5.1427; PODLESNY JA, 1977, PSYCHOL BULL, V84, P782, DOI 10.1037/0033-2909.84.4.782; Porter S, 2010, LEGAL CRIMINOL PSYCH, V15, P57, DOI 10.1348/135532509X433151; Schmeichel BJ, 2006, J EXP SOC PSYCHOL, V42, P95, DOI 10.1016/j.jesp.2005.02.005; Schweitzer ME, 2002, INT J CONFL MANAGE, V13, P258, DOI 10.1108/eb022876; Seitz M, 2013, P FISITA 2012 WORLD, P245; Setz C, 2010, IEEE T INF TECHNOL B, V14, P410, DOI 10.1109/TITB.2009.2036164; Shi Y, 2007, CHI 07 EXTENDED ABST, P2651, DOI [10.1145/1240866.1241057, DOI 10.1145/1240866.1241057]; Sip KE, 2008, TRENDS COGN SCI, V12, P48, DOI 10.1016/j.tics.2007.11.008; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Stromwall LA, 2011, J INVEST PSYCHOL OFF, V8, P271, DOI 10.1002/jip.148; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Van den Hout MA, 2000, PSYCHOPHYSIOLOGY, V37, P283, DOI 10.1017/S0048577200980673; Van Impe A, 2011, NEUROPSYCHOLOGIA, V49, P2400, DOI 10.1016/j.neuropsychologia.2011.04.016; VINCENT A, 1992, INT J PSYCHOPHYSIOL, V13, P129, DOI 10.1016/0167-8760(92)90052-D; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; Vrij A, 2006, TRENDS COGN SCI, V10, P141, DOI 10.1016/j.tics.2006.02.003; Vrij A., 2008, DETECTING LIES DECEI; Vrij A., 2004, DETECTION DECEPTION, P287, DOI DOI 10.1017/CB09780511490071.013; Vrij A., 2010, OPEN ACCESS J FORENS, V2, P6; Vrij A., 2000, DETECTING LIES DECEI; Vrij A, 2008, LAW HUMAN BEHAV, V32, P253, DOI 10.1007/s10979-007-9103-y; Vrij A, 2011, CURR DIR PSYCHOL SCI, V20, P28, DOI 10.1177/0963721410391245; Vrij A, 2010, PSYCHOL CRIME LAW, V16, P327, DOI 10.1080/10683160902740633; Walczyk JJ, 2005, PERS PSYCHOL, V58, P141, DOI 10.1111/j.1744-6570.2005.00484.x; WALLIN BG, 1981, PSYCHOPHYSIOLOGY, V18, P470, DOI 10.1111/j.1469-8986.1981.tb02483.x; Warmelink L, 2012, ACTA PSYCHOL, V141, P178, DOI 10.1016/j.actpsy.2012.07.011; WATSON DC, 1993, PERS INDIV DIFFER, V15, P75, DOI 10.1016/0191-8869(93)90043-3; Wilson GF, 2002, INT J AVIAT PSYCHOL, V12, P3, DOI 10.1207/S15327108IJAP1201_2; Zuckerman M., 1981, ADV EXP SOC PSYCHOL, VVolume 14, P1, DOI [10.1002/aic.690020228, DOI 10.1016/S0065-2601(08)60369-X]	78	13	13	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125237	10.1371/journal.pone.0125237	http://dx.doi.org/10.1371/journal.pone.0125237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018573	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600013
J	Uitdehaag, JCM; de Roos, JADM; van Doornmalen, AM; Prinsen, MBW; Spijkers-Hagelstein, JAP; de Vetter, JRF; de Man, J; Buijsman, RC; Zaman, GJR				Uitdehaag, Joost C. M.; de Roos, Jeroen A. D. M.; van Doornmalen, Antoon M.; Prinsen, Martine B. W.; Spijkers-Hagelstein, Jill A. P.; de Vetter, Judith R. F.; de Man, Jos; Buijsman, Rogier C.; Zaman, Guido J. R.			Selective Targeting of CTNBB1-, KRAS-or MYC-Driven Cell Growth by Combinations of Existing Drugs	PLOS ONE			English	Article							SYNTHETIC LETHAL INTERACTION; KINASE INHIBITOR; BETA-CATENIN; COLON-CANCER; TYROSINE KINASE; MEK INHIBITION; BRAF; EGFR; RESISTANCE; MELANOMA	The aim of combination drug treatment in cancer therapy is to improve response rate and to decrease the probability of the development of drug resistance. Preferably, drug combinations are synergistic rather than additive, and, ideally, drug combinations work synergistically only in cancer cells and not in non-malignant cells. We have developed a workflow to identify such targeted synergies, and applied this approach to selectively inhibit the proliferation of cell lines with mutations in genes that are difficult to modulate with small molecules. The approach is based on curve shift analysis, which we demonstrate is a more robust method of determining synergy than combination matrix screening with Bliss-scoring. We show that the MEK inhibitor trametinib is more synergistic in combination with the BRAF inhibitor dabrafenib than with vemurafenib, another BRAF inhibitor. In addition, we show that the combination of MEK and BRAF inhibitors is synergistic in BRAF-mutant melanoma cells, and additive or antagonistic in, respectively, BRAF-wild type melanoma cells and nonmalignant fibroblasts. This combination exemplifies that synergistic action of drugs can depend on cancer genotype. Next, we used curve shift analysis to identify new drug combinations that specifically inhibit cancer cell proliferation driven by difficult-to-drug cancer genes. Combination studies were performed with compounds that as single agents showed preference for inhibition of cancer cells with mutations in either the CTNNB1 gene (coding for beta-catenin), KRAS, or cancer cells expressing increased copy numbers of MYC. We demonstrate that the Wnt-pathway inhibitor ICG-001 and trametinib acted synergistically in Wnt-pathway-mutant cell lines. The ERBB2 inhibitor TAK-165 was synergistic with trametinib in KRAS-mutant cell lines. The EGFR/ERBB2 inhibitor neratinib acted synergistically with the spindle poison docetaxel and with the Aurora kinase inhibitor GSK-1070916 in cell lines with MYC amplification. Our approach can therefore efficiently discover novel drug combinations that selectively target cancer genes.	[Uitdehaag, Joost C. M.; de Roos, Jeroen A. D. M.; van Doornmalen, Antoon M.; Prinsen, Martine B. W.; Spijkers-Hagelstein, Jill A. P.; de Vetter, Judith R. F.; de Man, Jos; Buijsman, Rogier C.; Zaman, Guido J. R.] Netherlands Translat Res Ctr BV, Oss, Netherlands		Zaman, GJR (corresponding author), Netherlands Translat Res Ctr BV, Oss, Netherlands.	guido.zaman@ntrc.nl			Innovation Office of the Ministry of Economic Affairs of the Netherlands [INT 111039]; Netherlands Translational Research Center B. V.	Innovation Office of the Ministry of Economic Affairs of the Netherlands; Netherlands Translational Research Center B. V.	This research was supported by a grant from the Innovation Office of the Ministry of Economic Affairs of the Netherlands (INT 111039). Netherlands Translational Research Center B. V. provided support in the form of salaries for authors JCNU, JADMR, AMVD, MBWP, JAPSH, JDM, RCB and GJRZ, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams ND, 2010, J MED CHEM, V53, P3973, DOI 10.1021/jm901870q; Addepalli MK, 2010, GENE THER, V17, P352, DOI 10.1038/gt.2009.155; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Babij C, 2011, CANCER RES, V71, P5818, DOI 10.1158/0008-5472.CAN-11-0778; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Chow LWC, 2013, BRIT J CANCER, V108, P1985, DOI 10.1038/bjc.2013.178; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Evan G, 2012, SCIENCE, V335, P293, DOI 10.1126/science.1217819; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Griner LAM, 2014, P NATL ACAD SCI USA, V111, P2349, DOI 10.1073/pnas.1311846111; Haagensen EJ, 2012, BRIT J CANCER, V106, P1386, DOI 10.1038/bjc.2012.70; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hoellein A, 2011, ONCOTARGET, V2, P599; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Hynes NE, 2001, J MAMMARY GLAND BIOL, V6, P141, DOI 10.1023/A:1009528918064; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067583; Li FF, 2014, INT J CANCER, V134, P1257, DOI 10.1002/ijc.28261; Liu DX, 2008, THYROID, V18, P853, DOI 10.1089/thy.2007.0357; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Mitsui F, 2007, MODERN PATHOL, V20, P622, DOI 10.1038/modpathol.3800777; Nagasawa J, 2006, INT J UROL, V13, P587, DOI 10.1111/j.1442-2042.2006.01342.x; Naik S, 2009, CLIN CANCER RES, V15, P7529, DOI 10.1158/1078-0432.CCR-09-0336; Nair R, 2014, ONCOGENE, V33, P3992, DOI 10.1038/onc.2013.368; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; R Core Team, 2018, R LANG ENV STAT COMP; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Singh A, 2009, CELL CYCLE, V8, P2676, DOI 10.4161/cc.8.17.9336; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Straetemans R, 2005, BIOMETRICAL J, V47, P299, DOI 10.1002/bimj.200410124; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Uitdehaag JCM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092146; Uitdehaag JCM, 2012, BRIT J PHARMACOL, V166, P858, DOI 10.1111/j.1476-5381.2012.01859.x; Uitdehaag JCM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-94; Vasan N, 2014, CLIN CANCER RES, V20, P3921, DOI 10.1158/1078-0432.CCR-13-1762; Violette S, 2002, INT J CANCER, V98, P498, DOI 10.1002/ijc.10146; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yap TA, 2013, J CLIN ONCOL, V31, P1592, DOI 10.1200/JCO.2011.37.6418; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087	61	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125021	10.1371/journal.pone.0125021	http://dx.doi.org/10.1371/journal.pone.0125021			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018524	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600011
J	Fugmann, M; Uhl, O; Hellmuth, C; Hetterich, H; Kammer, NN; Ferrari, U; Parhofer, KG; Koletzko, B; Seissler, J; Lechner, A				Fugmann, Marina; Uhl, Olaf; Hellmuth, Christian; Hetterich, Holger; Kammer, Nora N.; Ferrari, Uta; Parhofer, Klaus G.; Koletzko, Berthold; Seissler, Jochen; Lechner, Andreas			Differences in the Serum Nonesterified Fatty Acid Profile of Young Women Associated with a Recent History of Gestational Diabetes and Overweight/Obesity	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FETUIN-A; LINKING OBESITY; PLASMA; RISK; DESATURATION; INFLAMMATION; BIOMARKERS	Background Nonesterified fatty acids (NEFA) play pathophysiological roles in metabolic syndrome and type 2 diabetes (T2D). In this study, we analyzed the fasting NEFA profiles of normoglycemic individuals at risk for T2D (women with a recent history of gestational diabetes (GDM)) in comparison to controls (women after a normoglycemic pregnancy). We also examined the associations of NEFA species with overweight/obesity, body fat distribution and insulin sensitivity. Subjects and Methods Using LC-MS/MS, we analyzed 41 NEFA species in the fasting sera of 111 women (62 post-GDM, 49 controls). Clinical characterization included a five-point oral glucose tolerance test (OGTT), biomarkers and anthropometrics, magnetic resonance imaging (n = 62) and a food frequency questionnaire. Nonparametric tests with Bonferroni correction, binary logistic regression analyses and rank correlations were used for statistical analysis. Results Women after GDM had a lower molar percentage of total saturated fatty acids (SFA; 38.55% vs. 40.32%, p = 0.0002) than controls. At an explorative level of significance several NEFA species were associated with post-GDM status (with and without adjustment for body mass index (BMI) and HbA1c): The molar percentages of 14: 0, 16: 0, 18: 0 and 18: 4 were reduced, whereas those of 18: 1, 18: 2, 20: 2, 24: 4, monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA) and total n-6 NEFA were increased. BMI and the amount of body fat correlated inversely with several SFA and MUFA and positively with various PUFA species over the whole study cohort (abs(rho)>= 0.3 for all). 14: 0 was inversely and BMI-independently associated with abdominal visceral adiposity. We saw no correlations of NEFA species with insulin sensitivity and the total NEFA concentration was similar in the post-GDM and the control group. Conclusion In conclusion, we found alterations in the fasting NEFA profile associated with a recent history of gestational diabetes, a risk marker for T2D. NEFA composition also varied with overweight/obesity and with body fat distribution, but not with insulin sensitivity.	[Fugmann, Marina; Ferrari, Uta; Seissler, Jochen; Lechner, Andreas] Univ Munich, Diabet Res Grp, Med Klin & Poliklin 4, Klinikum Univ Munchen, Munich, Germany; [Fugmann, Marina; Ferrari, Uta; Seissler, Jochen; Lechner, Andreas] Helmholtz Zentrum Munchen, Clin Cooperat Grp Type Diabet 2, Munich, Germany; [Fugmann, Marina; Ferrari, Uta; Seissler, Jochen; Lechner, Andreas] German Ctr Diabet Res DZD, Munich, Germany; [Uhl, Olaf; Hellmuth, Christian; Koletzko, Berthold] Univ Munich, Klinikum Univ Munchen, Div Metabol & Nutrit Med, Dr Von Hauner Childrens Hosp, Munich, Germany; [Hetterich, Holger; Kammer, Nora N.] Univ Munich, Klinikum Univ Munchen, Inst Clin Radiol, Munich, Germany; [Parhofer, Klaus G.] Univ Munich, Klinikum Univ Munchen, Med Klin & Poliklin 2, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Lechner, A (corresponding author), Univ Munich, Diabet Res Grp, Med Klin & Poliklin 4, Klinikum Univ Munchen, Munich, Germany.	andreas.lechner@med.uni-muenchen.de	; Hellmuth, Christian/C-2575-2017	Uhl, Olaf/0000-0001-8064-7717; Hellmuth, Christian/0000-0001-9778-497X	Helmholtz Zentrum Munchen; Klinikum der Universitat Munchen; German Center for Diabetes Research	Helmholtz Zentrum Munchen(Helmholtz Association); Klinikum der Universitat Munchen; German Center for Diabetes Research	This work was supported by Helmholtz Zentrum Munchen: http://www.helmholtz-muenchen.de/en/ (AL, JS), Klinikum der Universitat Munchen: http://www.klinikum.uni-muenchen.de/de/index.html (AL, JS), and German Center for Diabetes Research: http://www.dzd-ev.de/index.html (AL, JS).	Abdul-Ghani MA, 2008, ACTA DIABETOL, V45, P147, DOI 10.1007/s00592-008-0033-z; Baylin A, 2002, AM J CLIN NUTR, V76, P750, DOI 10.1093/ajcn/76.4.750; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13; Heinrichsdorff J, 2012, NAT MED, V18, P1182, DOI 10.1038/nm.2869; Hellmuth C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074927; Hellmuth C, 2012, ANAL CHEM, V84, P1483, DOI 10.1021/ac202602u; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Iggman D, 2010, DIABETOLOGIA, V53, P850, DOI 10.1007/s00125-010-1669-0; Il'yasova D, 2010, DIABETOLOGIA, V53, P866, DOI 10.1007/s00125-010-1657-4; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Koutsari C, 2008, DIABETES, V57, P1186, DOI 10.2337/db07-0664; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Liu XQ, 2011, ADV NUTR, V2, P15, DOI 10.3945/an.110.000125; Lorenzo C, 2010, DIABETES CARE, V33, P2098, DOI 10.2337/dc10-0165; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matsuzaka T, 2009, J MOL MED, V87, P379, DOI 10.1007/s00109-009-0449-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Novgorodtseva TP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-82; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Roden M, 2012, DIABETES, V61, P2397, DOI 10.2337/db12-0662; Rottenkolber M, 2015, J CLIN ENDOCR METAB, V100, pE910, DOI 10.1210/jc.2014-3898; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sjogren P, 2008, DIABETOLOGIA, V51, P328, DOI 10.1007/s00125-007-0876-9; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Sun Q, 2013, DIABETES, V62, P49, DOI 10.2337/db12-0372; Verma A, 2002, J CLIN ENDOCR METAB, V87, P3227, DOI 10.1210/jc.87.7.3227; Vessby B, 2002, ANN NY ACAD SCI, V967, P183	43	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128001	10.1371/journal.pone.0128001	http://dx.doi.org/10.1371/journal.pone.0128001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011768	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900181
J	Hyun, JW; Kim, SH; Jeong, IH; Ahn, SW; Huh, SY; Park, MS; Eom, YI; Joo, IS; Cho, JY; Bin Cho, E; Min, JH; Kim, BJ; Kim, NH; Oh, J; Park, KD; Kim, HJ				Hyun, Jae-Won; Kim, Su-Hyun; Jeong, In Hye; Ahn, Suk-Won; Huh, So-Young; Park, Min Su; Eom, Young In; Joo, In Soo; Cho, Joong-Yang; Bin Cho, Eun; Min, Ju-Hong; Kim, Byoung Joon; Kim, Nam-Hee; Oh, Jeeyoung; Park, Kee Duk; Kim, Ho Jin			Utility of the Rio Score and Modified Rio Score in Korean Patients with Multiple Sclerosis	PLOS ONE			English	Article							INTERFERON-BETA; DISEASE; DISABILITY; THERAPIES; CRITERIA	Objectives Early identification of suboptimal responders to multiple sclerosis (MS) treatment is critical for optimizing therapeutic decisions. The Rio score (RS) and modified Rio score (MRS) were developed to discriminate the responses to interferon-beta (IFNB) treatment in MS patients. This study was performed to evaluate the utility of RS and MRS in daily clinical practice in Korea. Methods This was a real-world setting, multicenter, retrospective study of MS patients treated with IFNB from 10 hospitals in Korea. We investigated whether the RS and MRS at the early stage of IFNB therapy could predict treatment responses over 3 years. Suboptimal treatment responses at 3 years were defined as the presence of clinical relapse and/or EDSS progression and/or patients who had been treated with INFB for at least for 1 year and therapy was switched due to perceived treatment failure during the 2 years of follow-up. Results Seventy patients (50 females and 20 males) were enrolled; 92% (12/13) of patients with high RS and 86% (12/14) of patients with high MRS (score 2 or 3) were suboptimal responders, whereas 93% (53/57) of patients with low RS and 93% (52/56) patients with low MRS (score 0 or 1) showed optimal responses. New active lesions on MRI with clinical relapse in high RS and MRS were the most common combination in suboptimal responders. Conclusions We confirmed that RS and MRS at 6-15 months of IFNB therapy were useful for predicting poor responders over 3 years.	[Hyun, Jae-Won; Kim, Su-Hyun; Jeong, In Hye; Kim, Ho Jin] Natl Canc Ctr, Res Inst & Hosp, Dept Neurol, Goyang, South Korea; [Ahn, Suk-Won] Chung Ang Univ, Coll Med, Seoul 156756, South Korea; [Huh, So-Young] Kosin Univ, Coll Med, Busan, South Korea; [Park, Min Su] Yeungnam Univ, Coll Med, Taegu, South Korea; [Eom, Young In; Joo, In Soo] Ajou Univ, Sch Med, Suwon 441749, South Korea; [Cho, Joong-Yang] Inje Univ, Ilsan Paik Hosp, Coll Med, Goyang, South Korea; [Bin Cho, Eun; Min, Ju-Hong; Kim, Byoung Joon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Kim, Nam-Hee] Dongguk Univ, Ilsan Hosp, Goyang, South Korea; [Oh, Jeeyoung] Konkuk Univ, Sch Med, Seoul, South Korea; [Park, Kee Duk] Ewha Womans Univ, Grad Sch Med, Seoul, South Korea; [Kim, Byoung Joon] Samsung Med Ctr, Ctr Neurosci, Seoul, South Korea	National Cancer Center - Korea (NCC); Chung Ang University; Chung Ang University Hospital; Yeungnam University; Ajou University; Inje University; Sungkyunkwan University (SKKU); Samsung Medical Center; Dongguk University; NHIS Ilsan Hospital; Konkuk University; Konkuk University Medical Center; Ewha Womans University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, HJ (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Dept Neurol, Goyang, South Korea.	hojinkim@ncc.re.kr			Genzyme; Merck Serono; Kael-GemVax	Genzyme(Sanofi-AventisGenzyme Corporation); Merck Serono(Merck & Company); Kael-GemVax	Financial Disclosure: Drs. Hyun, SH Kim, Jeong, Ahn, Huh, MS Park, Eom, Joo, JY Cho, EB Cho, Min, BJ Kim, KD Park report no disclosures. Dr. HJ Kim has received honoraria for speaking or consulting from Bayer Schering Pharma, Biogen Idec, Genzyme, Merck Serono, Novartis, MedImmune, and Teva-Handok and has received research grants from Genzyme, Merck Serono, and Kael-GemVax. He serves on a steering committee for MedImmune and serves as an editorial board member of Multiple Sclerosis Journal-Experimental, Translational and Clinical. Dr. NH Kim has received honoraria for speaking or consulting from Bayer Schering Pharma, UCB, Merck Serono, and Novartis. Dr. J Oh has received honoraria for speaking or consulting from Genzyme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Havrdova E, 2010, NEUROLOGY, V74, pS3, DOI 10.1212/WNL.0b013e3181dbb51c; Huh SY, 2014, MULT SCLER J, V20, P492, DOI 10.1177/1352458513496881; Jarernsook B, 2013, MULT SCLER J, V19, P585, DOI 10.1177/1352458512459290; Kim NH, 2010, NEUROLOGY, V75, P1432, DOI 10.1212/WNL.0b013e3181f88191; Kim SH, 2013, MULT SCLER J, V19, P1493, DOI 10.1177/1352458513477712; NOSEWORTHY JH, 1990, NEUROLOGY, V40, P971, DOI 10.1212/WNL.40.6.971; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Rio J, 2008, MULT SCLER J, V14, P479, DOI 10.1177/1352458507085555; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Rio J, 2009, MULT SCLER, V15, P848, DOI 10.1177/1352458509104591; Rio J, 2009, NAT REV NEUROL, V5, P553, DOI 10.1038/nrneurol.2009.139; Rudick RA, 2004, ANN NEUROL, V56, P548, DOI 10.1002/ana.20224; Rudick RA, 2009, LANCET NEUROL, V8, P545, DOI 10.1016/S1474-4422(09)70082-1; Saida T, 2012, MULT SCLER J, V18, P1782, DOI 10.1177/1352458512442261; Sormani MP, 2013, MULT SCLER J, V19, P1246, DOI 10.1177/1352458513483892; Sormani MP, 2013, MULT SCLER J, V19, P605, DOI 10.1177/1352458512460605; Sormani MP, 2011, NEUROLOGY, V77, P1684, DOI 10.1212/WNL.0b013e31823648b9; Sormani MP, 2005, J NEUROL, V252, P1455, DOI 10.1007/s00415-005-0885-x; Wingerchuk DM, 2014, MAYO CLIN PROC, V89, P225, DOI 10.1016/j.mayocp.2013.11.002	22	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0129243	10.1371/journal.pone.0129243	http://dx.doi.org/10.1371/journal.pone.0129243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010897	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900253
J	Kato, T				Kato, Tsukasa			The Impact of Coping Flexibility on the Risk of Depressive Symptoms	PLOS ONE			English	Article							RACE/ETHNICITY; SCALE	Objective According to the dual-process theory, coping flexibility is defined as the ability to produce and implement a new coping strategy in place of an ineffective coping strategy. Specifically, coping flexibility includes two processes: evaluation coping and adaptive coping. Evaluation coping refers to sensitivity to feedback about the efficacy of a coping strategy, and adaptive coping involves the willingness to implement alternative coping strategies. The coping flexibility hypothesis (CFH) postulates that more flexible coping will be associated with more adaptive outcomes; importantly, there are numerous theories and studies that support the CFH. The main purpose of this study was to test the CFH based on dual-process theory. Methods A total of 1,770 Japanese college students participated and, completed a set of questionnaires that measured coping flexibility (evaluation coping and adaptive coping) and depressive symptoms. Depressive symptoms were measured via the Center for Epidemiologic Studies Depression Scale. Results The proportions of women and men who reported depressive symptoms were 58.69% (95% CIs [55.74, 61.66]) and 54.17% (95% CIs [50.37, 57.95]), respectively when a cut-off score of 16 on the CES-D was used. A multivariable logistic regression analysis revealed that evaluation coping (OR = 0.86, 95% CIs [0.83, 0.0.89]) and adaptive coping (OR = 0.91, 95% CIs [0.88, 0.93]) were significantly associated with lower levels of depressive symptoms. Conclusion The results of the present study indicated that the CFH based on dual-process theory was supported in a Japanese sample.	Toyo Univ, Dept Social Psychol, Tokyo, Japan	Toyo University	Kato, T (corresponding author), Toyo Univ, Dept Social Psychol, Tokyo, Japan.	mtsukasa@hotmail.com	Kato, Tsukasa/C-2066-2014	Kato, Tsukasa/0000-0002-0827-0051	Japan Society for the Promotion of Science [C-25380948]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by the Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research C-25380948. (http://www.jsps.go.jp/english/index.html) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach SM, 1998, STRESS MANAGEMENT PS; Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6; Bonanno GA, 2013, PERSPECT PSYCHOL SCI, V8, P591, DOI 10.1177/1745691613504116; Bonanno GA, 2013, MEMORY, V21, P150, DOI 10.1080/09658211.2012.745572; Cheng C, 2014, PSYCHOL BULL, V140, P1582, DOI 10.1037/a0037913; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Iwata N, 2002, SOC SCI MED, V55, P2243, DOI 10.1016/S0277-9536(02)00003-5; Iwata N, 1998, PSYCHOL MED, V28, P153, DOI 10.1017/S0033291797005898; Kato T, 2015, INT J BEHAV MED, V22, P506, DOI 10.1007/s12529-014-9443-1; Kato T, 2012, J COUNS PSYCHOL, V59, P262, DOI 10.1037/a0027770; Kim G, 2011, CULT DIVERS ETHN MIN, V17, P381, DOI 10.1037/a0025434; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus RS, 1991, STRESS EMOTION NEW S; Ng HKS, 2014, PERS INDIV DIFFER, V70, P7, DOI 10.1016/j.paid.2014.06.006; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; North West Adelaide Health Study, 2007, 200706 N W AD HLTH S, V2007-06; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Shahar G, 2014, WILEY-BL HB BEHAV SC, P3; Shima S., 1998, CES D SCALE; Van Noorden R, 2014, NATURE, V514, P550, DOI 10.1038/514550a; WHO, 2001, WORLD HLTH REP MENT; Worz R., 2003, PAIN CLIN UPDATES, V11; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	24	23	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128307	10.1371/journal.pone.0128307	http://dx.doi.org/10.1371/journal.pone.0128307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011626	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900220
J	Lukaszewicz, AC; Faivre, V; Bout, H; Gayat, E; Lagergren, T; Damoisel, C; Bresson, D; Paugam, C; Mantz, J; Payen, D				Lukaszewicz, Anne-Claire; Faivre, Valerie; Bout, Helene; Gayat, Etienne; Lagergren, Tina; Damoisel, Charles; Bresson, Damien; Paugam, Catherine; Mantz, Jean; Payen, Didier			Multicenter Testing of the Rapid Quantification of Radical Oxygen Species in Cerebrospinal Fluid to Diagnose Bacterial Meningitis	PLOS ONE			English	Article								Purpose Meningitis is a serious concern after traumatic brain injury (TBI) or neurosurgery. This study tested the level of reactive oxygen species (ROS) in cerebrospinal fluid (CSF) to diagnose meningitis in febrile patients several days after trauma or surgery. Methods Febrile patients (temperature > 38 degrees C) after TBI or neurosurgery were included prospectively. ROS were measured in CSF within 4 hours after sampling using luminescence in the basal state and after cell stimulation with phorbol 12-myristate 13-acetate (PMA). The study was conducted in a single-center cohort 1 (n = 54, training cohort) and then in a multicenter cohort 2 (n = 136, testing cohort) in the Intensive Care and Neurosurgery departments of two teaching hospitals. The performance of the ROS test was compared with classical CSF criteria, and a diagnostic decision for meningitis was made by two blinded experts. Results The production of ROS was higher in the CSF of meningitis patients than in non-infected CSF, both in the basal state and after PMA stimulation. In cohort 1, ROS production was associated with a diagnosis of meningitis with an AUC of 0.814 (95% confidence interval (CI) [0.684-0.820]) for steady-state and 0.818 (95% CI [0.655-0.821]) for PMA-activated conditions. The best threshold value obtained in cohort 1 was tested in cohort 2 and showed high negative predictive values and low negative likelihood ratios of 0.94 and 0.36 in the basal state, respectively, and 0.96 and 0.24 after PMA stimulation, respectively. Conclusion The ROS test in CSF appeared suitable for eliminating a diagnosis of bacterial meningitis.	[Lukaszewicz, Anne-Claire; Faivre, Valerie; Gayat, Etienne; Lagergren, Tina; Damoisel, Charles; Payen, Didier] Univ Paris Diderot, Sorbonne Paris Cite, Lariboisiere Hosp, Dept Anesthesiol & Crit Care, Paris, France; [Bout, Helene; Paugam, Catherine; Mantz, Jean] Univ Paris Diderot, Sorbonne Paris Cite, Beaujon Hosp, Dept Anesthesiol & Crit Care, Paris, France; [Bresson, Damien] Univ Paris Diderot, Sorbonne Paris Cite, Lariboisiere Hosp, Dept Neurosurg, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Lukaszewicz, AC (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Lariboisiere Hosp, Dept Anesthesiol & Crit Care, Paris, France.	aclukaszewicz@hotmail.com	Gayat, Etienne/ABG-5308-2021; Lukaszewicz, Anne-Claire/GXG-4590-2022	GAYAT, Etienne/0000-0002-3334-3849; Bresson, Damien/0000-0001-6250-8932; Paugam-Burtz, Catherine/0000-0002-8168-7152	French Ministry of Health	French Ministry of Health	This work was supported by the "Plan quadriennal 2010-2014" from the French Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger C, 2002, CRIT CARE MED, V30, P1778, DOI 10.1097/00003246-200208000-00017; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; de Menezes CC, 2009, NEUROCHEM RES, V34, DOI [10.1007/s11064-008-9909-0, DOI 10.1007/S11064-008-9909-0]; Druel B, 1996, CLIN MICROBIOL INFEC, V1; Freitas M, 2009, ANAL CHIM ACTA, V649, DOI [10.1016/j.aca.2009.07.012, DOI 10.1016/J.ACA.2009.07.012]; Horan TC, 2008, AM J INFECT CONTROL, V36, DOI [10.1016/j.ajic.2007.10.015, DOI 10.1016/J.AJIC.2007.10.015]; Korinek AM, 2005, ACTA NEUROCHIR WIEN, V147; Lopez-Cortes LF, 2000, CRIT CARE MED, V28, P215, DOI 10.1097/00003246-200001000-00035; Lozier AP, 2008, NEUROSURGERY S2, V62; Lukaszewicz AC, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-10; Martinez R, 2002, INTENSIVE CARE MED, V28; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Segal AW, 2005, ANN REV IMMUNOL, V23; Steinmann U, 2013, J NEUROINFLAMM, V10, DOI [10.1186/1742-2094-10-106, DOI 10.1186/1742-2094-10-106]; Tavares WM, 2006, ARQ NEURO-PSIQUIAT, V64, P592, DOI 10.1590/S0004-282X2006000400012; Tsukahara H, 2000, REDOX REP, V5; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Zarrouk V, 2007, CLIN INFECT DIS, V44, P1555, DOI 10.1086/518169; Zarrouk V, 2010, J CLIN MICROBIOL, V48, P3331, DOI 10.1128/JCM.00008-10	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128286	10.1371/journal.pone.0128286	http://dx.doi.org/10.1371/journal.pone.0128286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011286	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900217
J	Pan, HH; Zhao, XY; Zhang, XW; Abouelsoud, M; Sun, JL; April, C; Amleh, A; Fan, JB; Hu, YF; Li, R				Pan, Haihui; Zhao, Xiayan; Zhang, Xiaowen; Abouelsoud, Mohamed; Sun, Jianlong; April, Craig; Amleh, Asma; Fan, Jian-Bing; Hu, Yanfen; Li, Rong			Translational Initiation at a Non-AUG Start Codon for Human and Mouse Negative Elongation Factor-B	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION; P-TEFB; EUKARYOTIC RIBOSOMES; ACTIVE PROMOTERS; MAMMALIAN-CELLS; POL-II; NELF; DROSOPHILA; COMPLEX	Negative elongation factor (NELF), a four-subunit protein complex in metazoan, plays an important role in regulating promoter-proximal pausing of RNA polymerase II (RNAPII). Genetic studies demonstrate that the B subunit of mouse NELF (NELF-B) is critical for embryonic development and homeostasis in adult tissue. We report here that both human and mouse NELF-B proteins are translated from a non-AUG codon upstream of the annotated AUG. This non-AUG codon sequence is conserved in mammalian NELF-B but not NELF-B orthologs of lower metazoan. The full-length and a truncated NELF-B that starts at the first AUG codon both interact with the other three NELF subunits. Furthermore, these two forms of NELF-B have a similar impact on the transcriptomics and proliferation of mouse embryonic fibroblasts. These results strongly suggest that additional amino acid sequence upstream of the annotated AUG is dispensable for the essential NELF function in supporting cell growth in vitro. The majority of mouse adult tissues surveyed express the full-length NELF-B protein, and some contain a truncated NELF-B protein with the same apparent size as the AUG-initiated version. This result raises the distinct possibility that translational initiation of mouse NELF-B is regulated in a tissue-dependent manner.	[Pan, Haihui; Zhao, Xiayan; Zhang, Xiaowen; Sun, Jianlong; Hu, Yanfen; Li, Rong] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Abouelsoud, Mohamed; Amleh, Asma] Amer Univ Cairo, Sch Sci & Engn, Dept Biol, New Cairo 11835, Egypt; [April, Craig; Fan, Jian-Bing] Illumina Inc, San Diego, CA 92121 USA	University of Texas System; University of Texas Health San Antonio; Egyptian Knowledge Bank (EKB); American University Cairo; Illumina	Li, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.	lir3@uthscsa.edu			National Institutes of Health [NIH CA170306, CA161349, CA191837]; Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio [P30CA054174]; DoD Breast Cancer Research Predoctoral Fellowship; Al Alfi Foundation Biotechnology Fellowship Program at the American University at Cairo; NATIONAL CANCER INSTITUTE [P30CA054174, R21CA191837, R01CA161349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio; DoD Breast Cancer Research Predoctoral Fellowship; Al Alfi Foundation Biotechnology Fellowship Program at the American University at Cairo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by grants to Y.H. from the National Institutes of Health (NIH CA170306), to R.L. from NIH (CA161349 and CA191837) and Cancer Therapy and Research Center at University of Texas Health Science Center at San Antonio (P30CA054174), to H.P. from the DoD Breast Cancer Research Predoctoral Fellowship, and to M.A. from the Al Alfi Foundation Biotechnology Fellowship Program at the American University at Cairo. The genomic data are available at NIH Gene Expression Omnibus site (GSE62248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Pan HH, 2014, CELL REP, V7, P79, DOI 10.1016/j.celrep.2014.02.028; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; PORTIS JL, 1994, J VIROL, V68, P3879, DOI 10.1128/JVI.68.6.3879-3887.1994; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Saunders A, 2013, GENE DEV, V27, P1146, DOI 10.1101/gad.215459.113; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Sun J, 2007, J STEROID BIOCHEM, V107, P131, DOI 10.1016/j.jsbmb.2007.05.031; Sun JL, 2011, J BIOL CHEM, V286, P36248, DOI 10.1074/jbc.M111.269167; Wada T, 2000, MOL CELL, V5, P1067, DOI 10.1016/S1097-2765(00)80272-5; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011498; Williams LH, 2015, MOL CELL IN PRESS; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127422	10.1371/journal.pone.0127422	http://dx.doi.org/10.1371/journal.pone.0127422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010750	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900090
J	Qin, B; Zhou, JL				Qin, Bo; Zhou, Junlan			Src Family Kinases (SFK) Mediate Angiotensin II-Induced Myosin Light Chain Phosphorylation and Hypertension	PLOS ONE			English	Article							RECEPTOR	Angiotensin (Ang) II is the major bioactive peptide of the renin-angiotensin system (RAS); it contributes to the pathogenesis of hypertension by inducing vascular contraction and adverse remodeling, thus elevated peripheral resistance. Ang II also activates Src family kinases (SFK) in the vascular system, which has been implicated in cell proliferation and migration. However, the role of SFK in Ang II-induced hypertension is largely unknown. In this study, we found that administration of a SFK inhibitor SU6656 markedly lowered the level of systemic BP in Ang II-treated mice, which was associated with an attenuated phosphorylation of the smooth-muscle myosin-light-chain (MLC) in the mesenteric resistant arteries. In the cultured human coronary artery smooth muscle cells (SMCs), pretreatment with SU6656 blocked Ang II-induced MLC phosphorylation and contraction. These results for the first time demonstrate that SFK directly regulate vascular contractile machinery to influence BP. Thus our study provides an additional mechanistic link between Ang II and vasoconstriction via SFK-enhanced MLC phosphorylation in SMCs, and suggests that targeted inhibition of Src may provide a new therapeutic opportunity in the treatment of hypertension.	[Qin, Bo] Northwestern Univ, Weinberg Coll Arts & Sci, Chicago, IL 60611 USA; [Zhou, Junlan] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Feinberg School of Medicine	Zhou, JL (corresponding author), Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.	junlan-zhou@northwestern.edu			American Heart Association [13SDG17120011]	American Heart Association(American Heart Association)	This work was supported by the American Heart Association (Grant# 13SDG17120011 to J.Z.).	Abe K, 2008, HYPERTENS RES, V31, P987, DOI 10.1291/hypres.31.987; Aurelie NDC, 2011, CURR HYPERTENS REP, V13, P122, DOI 10.1007/s11906-011-0187-x; Cheng M, 2015, J MOL CELL CARDIOL, V81, P49, DOI 10.1016/j.yjmcc.2015.01.024; Corey SJ, 2013, BLOOD, V122, P4009, DOI 10.1182/blood-2013-10-533158; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Ikebe R, 1999, J BIOL CHEM, V274, P30122, DOI 10.1074/jbc.274.42.30122; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mugabe BE, 2010, J PHARMACOL EXP THER, V332, P116, DOI 10.1124/jpet.109.157552; Oda Y, 1999, CAN J PHYSIOL PHARM, V77, P606, DOI 10.1139/cjpp-77-8-606; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Sever PS, 2011, EUR HEART J, V32, P2499, DOI 10.1093/eurheartj/ehr177; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Tatton L, 2003, J BIOL CHEM, V278, P4847, DOI 10.1074/jbc.M209321200; Touyz RM, 2001, J HYPERTENS, V19, P441, DOI 10.1097/00004872-200103000-00012; Walsh MP, 2011, IUBMB LIFE, V63, P987, DOI 10.1002/iub.527; Zhou JL, 2009, CIRCULATION, V120, P1213, DOI 10.1161/CIRCULATIONAHA.109.859207	19	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127891	10.1371/journal.pone.0127891	http://dx.doi.org/10.1371/journal.pone.0127891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011449	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900159
J	Tsai, S; Yen, W; Chavanich, S; Viyakarn, V; Lin, C				Tsai, Sujune; Yen, Wish; Chavanich, Suchana; Viyakarn, Voranop; Lin, Chiahsin			Development of Cryopreservation Techniques for Gorgonian (Junceella juncea) Oocytes through Vitrification	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; ICE-FREE CRYOPRESERVATION; EMBRYOS; CORAL; CRYOPROTECTANT; FRAGILIS; STAGE; TEMPERATURE; PROGRESS; AGENTS	Gorgonian corals are slowly declining due to human interaction and environmental impacts. Cryopreservation of gorgonian corals is an ex-situ method of conservation, ensuring future reproduction. The present study assessed the vitrification properties of cryoprotectant (CPT) mixtures using the cryotop, cryoloop and open pulled straw (OPS) cryopereservation methods prior to experimentation on gorgonian (Junceella juncea) oocytes. Investigations of the equilibration and vitrification solutions' (ES and VS) effect on oocytes throughout different incubation periods were conducted. The cryotop method was found to be the most successful in ensuring vitrification. The most favourable VS was composed of propylene glycol (PG), ethylene glycol (EG) and methanol with concentrations of 3.5M, 1.5M and 2M respectively. Experiments were performed using the cryotop method to cryopreserve Junceella juncea oocytes using VS2, the solution had the least impact on oocytes at 5 degrees C rather than at 26 degrees C. The success of the vitrification procedures was determined by adenosine triphosphate (ATP) levels in cooled-thaw oocytes and the highest viability obtained from the present study was 76.6 +/- 6.2%. This study provides information regarding gorgonian corals' tolerance and viability throughout vitrification to further advance the vitrification protocol on whip corals.	[Tsai, Sujune] Mingdao Univ, Dept Biotechnol, Changhua, Taiwan; [Tsai, Sujune] Mingdao Univ, Dept Post Modern Agr, Peetow, Changhua, Taiwan; [Yen, Wish] Univ Ottawa, Inst Biochem & Environm Sci, Ottawa, ON, Canada; [Lin, Chiahsin] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Lin, Chiahsin] Natl Dong Hwa Univ, Inst Marine Biol, Checheng, Pingtung, Taiwan; [Chavanich, Suchana; Viyakarn, Voranop] Chulalongkorn Univ, Fac Sci, Dept Marine Sci, Reef Biol Res Grp, Bangkok, Thailand	Mingdao University; Mingdao University; University of Ottawa; National Museum of Marine Biology & Aquarium; National Dong Hwa University; Chulalongkorn University	Lin, C (corresponding author), Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan.	chiahsin@nmmba.gov.tw	Viyakarn, Voranop/Q-9182-2019; Chavanich, Suchana/AAU-8266-2020		National Science Council [NSC 102-2313-B-291 -002]	National Science Council(Ministry of Science and Technology, Taiwan)	Funding was provided by the National Science Council (NSC 102-2313-B-291 -002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI J, 1993, J REPROD FERTIL, V99, P471, DOI 10.1530/jrf.0.0990471; Edashige K, 2006, CRYOBIOLOGY, V53, P96, DOI 10.1016/j.cryobiol.2006.04.002; El-Battawy KA, 2009, REPROD DOMEST ANIM, V44, P718, DOI 10.1111/j.1439-0531.2007.01059.x; GAKHOVA E N, 1988, Ontogenez, V19, P175; Guan M, 2010, CRYOLETTERS, V31, P230; Hajarian H, 2011, J ANIM VET ADV, V10, P2541, DOI 10.3923/javaa.2011.2541.2545; Higaki S, 2010, J REPROD, V56, P12; Isachenko V, 2005, REPROD BIOMED ONLINE, V10, P350, DOI 10.1016/S1472-6483(10)61795-6; Kuiter R.H., 2001, ZOONETICS, V2001, P1; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Lin C, 2012, THERIOGENOLOGY, V77, P1257, DOI 10.1016/j.theriogenology.2011.09.021; Lin C, 2011, CRYOLETTERS, V32, P141; Lin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092812; Lin CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057823; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038689; Lin TT, 2000, CRYOPRESERVATION AQU, P240; MAZUR P, 1993, CRYOBIOLOGY, V30, P45, DOI 10.1006/cryo.1993.1006; O'Neil L, 1998, CRYOBIOLOGY, V37, P59, DOI 10.1006/cryo.1998.2098; Olive PJW, 1997, CRYOBIOLOGY, V34, P284, DOI 10.1006/cryo.1997.2006; Paniagua-Chavez CG, 2001, CRYOBIOLOGY, V43, P211, DOI 10.1006/cryo.2001.2346; PATTON WK, 1972, B MAR SCI, V22, P419; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Robles V, 2005, THERIOGENOLOGY, V64, P1633, DOI 10.1016/j.theriogenology.2005.04.014; Robles V, 2004, THERIOGENOLOGY, V61, P1367, DOI 10.1016/j.theriogenology.2003.08.010; Ruppert EE, 1988, SEASHORE ANIMALS SE, P429; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Song YC, 2000, J INVEST SURG, V13, P279; Tsai S, 2014, CRYOLETTERS, V35, P1; Tsai S, 2012, BRAZ ARCH BIOL TECHN, V55, P425, DOI 10.1590/S1516-89132012000300014; Tsai S, 2011, CRYOLETTERS, V32, P1; Tsai S, 2010, THERIOGENOLOGY, V73, P605, DOI 10.1016/j.theriogenology.2009.10.016; Tsai S, 2009, THERIOGENOLOGY, V71, P1226, DOI 10.1016/j.theriogenology.2009.01.014; Tsai S, 2014, MITOCHONDRIAL DNA; Tsai SJ, 2014, TISSUE CELL, V46, P225, DOI 10.1016/j.tice.2014.05.002; Vrana NE, 2012, J TISSUE ENG REGEN M, V6, P280, DOI 10.1002/term.431; Wowk B, 2000, CRYOBIOLOGY, V40, P228, DOI 10.1006/cryo.2000.2243; Wusteman M, 2004, CRYOBIOLOGY, V48, P179, DOI 10.1016/j.cryobiol.2004.01.002; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c	38	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0123409	10.1371/journal.pone.0123409	http://dx.doi.org/10.1371/journal.pone.0123409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010144	Green Published, gold			2022-12-27	WOS:000355183900004
J	van der Meer, E; van Oers, K				van der Meer, Esther; van Oers, Kees			Gender and Personality Differences in Response to Social Stressors in Great Tits (Parus major)	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; HORMONAL RESPONSES; IMMUNE FUNCTION; ANNUAL CYCLE; REALIZED HERITABILITY; DOMINANCE HIERARCHIES; EXPLORATORY-BEHAVIOR; COPING STRATEGIES; HANDLING STRESS; MICE	In response to stressors, animals can increase the activity of the hypothalamic-pituitary-adrenocortical axis, resulting in elevated glucocorticoid concentrations. An increase in glucocorticoids results in an increase in heterophils and a decrease in lymphocytes, which ratio (H/L-ratio) is an indicator of stress in birds. The physiological response to a stressor can depend on individual characteristics, like dominance rank, sex and personality. Although the isolated effects of these characteristics on the response to a stressor have been well studied, little is known about the response in relation to a combination of these characteristics. In this study we investigate the relationship between social stress, dominance rank, sex and exploratory behaviour as a validated operational measure of personality in great tits (Parus major). Great tits show consistent individual differences in behaviour and physiology in response to stressors, and exploratory behaviour can be classified as fast or slow exploring. We group-housed four birds, two fast and two slow explorers, of the same sex that were previously singly housed, in an aviary and compared the H/L-ratio, lymphocyte and heterophil count before and after group housing. After experiencing the social context all birds increased their H/L-ratio and heterophil count. Females showed a stronger increase in H/Lratio and heterophil count than males, which seemed to be related to a higher number of agonistic interactions compared to males. Dominance rank and exploration type did not affect the H/L-ratio or heterophil count. Contrary to our expectations, all birds increased their lymphocyte count. However, this increase was slower for fast than for slow explorers. Our study suggests that personality and sex related differences, but not dominance rank, are associated with changes in an individual's physiological response due to a social context.	[van der Meer, Esther; van Oers, Kees] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [van der Meer, Esther] Cheetah Conservat Project Zimbabwe, Victoria Falls, Zimbabwe	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	van der Meer, E (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	esther@cheetahzimbabwe.org	van Oers, Kees/B-2562-2009; KNAW, NIOO-KNAW/A-4320-2012	van Oers, Kees/0000-0001-6984-906X; KNAW, NIOO-KNAW/0000-0002-3835-159X				APPLEBY MC, 1983, ANIM BEHAV, V31, P600, DOI 10.1016/S0003-3472(83)80084-0; Azpiroz A, 2008, BRAIN BEHAV IMMUN, V22, P690, DOI 10.1016/j.bbi.2007.10.007; Baugh AT, 2013, GEN COMP ENDOCR, V189, P96, DOI 10.1016/j.ygcen.2013.04.030; Baugh AT, 2012, GEN COMP ENDOCR, V175, P488, DOI 10.1016/j.ygcen.2011.12.012; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; BERCOVITCH FB, 1995, PHYSIOL BEHAV, V58, P215, DOI 10.1016/0031-9384(95)00055-N; Bergman TJ, 2005, ANIM BEHAV, V70, P703, DOI 10.1016/j.anbehav.2004.12.017; Bolivar VJ, 2009, NEUROBIOL LEARN MEM, V92, P206, DOI 10.1016/j.nlm.2009.02.002; BURLEY N, 1981, SCIENCE, V211, P721, DOI 10.1126/science.211.4483.721; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Cartledge CA, 2005, COMP BIOCHEM PHYS A, V141, P100, DOI 10.1016/j.cbpb.2005.04.008; Cirule D, 2012, J ORNITHOL, V153, P161, DOI 10.1007/s10336-011-0719-9; Colleter M, 2011, ANIM BEHAV, V81, P1231, DOI 10.1016/j.anbehav.2011.03.011; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Davis AK, 2005, J FIELD ORNITHOL, V76, P334, DOI 10.1648/0273-8570-76.4.334; DAWSON A, 1983, GEN COMP ENDOCR, V51, P303, DOI 10.1016/0016-6480(83)90085-0; de Boer SF, 2003, BEHAV GENET, V33, P485, DOI 10.1023/A:1025766415159; DELAET J, 1984, ORNIS SCAND, V15, P73, DOI 10.2307/3675940; DEUSTER PA, 1989, METABOLISM, V38, P141, DOI 10.1016/0026-0495(89)90253-9; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Drent P.J, 1983, THESIS U GRONINGEN; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Dugatkin LA, 1997, BEHAV ECOL, V8, P583, DOI 10.1093/beheco/8.6.583; Eeva T, 2005, J AVIAN BIOL, V36, P405, DOI 10.1111/j.0908-8857.2005.03449.x; Everly Jr GS, 2012, CLIN GUIDE TREATMENT, P17; Filby AL, 2010, PHYSIOL BEHAV, V101, P576, DOI 10.1016/j.physbeh.2010.09.004; Fucikova E, 2009, ETHOLOGY, V115, P366, DOI 10.1111/j.1439-0310.2009.01618.x; Fukushiro DF, 2011, PHARMACOL BIOCHEM BE, V100, P180, DOI 10.1016/j.pbb.2011.08.015; Gallo L, 2013, AVIAN DIS, V57, P737, DOI 10.1637/10521-022713-Reg.1; Gesquiere LR, 2011, SCIENCE, V333, P357, DOI 10.1126/science.1207120; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Hegemann A, 2012, OECOLOGIA, V170, P605, DOI 10.1007/s00442-012-2339-3; HESSING MJC, 1994, PHYSIOL BEHAV, V55, P39, DOI 10.1016/0031-9384(94)90007-8; Ros AFH, 2006, J EXP ZOOL PART A, V305A, P986, DOI 10.1002/jez.a.349; Huntingford FA, 1987, CHAPMAN HALL ANIMAL; Ingolfsdottir HB, 2008, APPL ANIM BEHAV SCI, V114, P485, DOI 10.1016/j.applanim.2008.04.014; Jakubas D, 2011, ANN ZOOL FENN, V48, P243, DOI 10.5735/086.048.0405; Jawale CV, 2014, VACCINE, V32, P1093, DOI 10.1016/j.vaccine.2013.12.053; Jones BC, 1998, PSYCHONEUROENDOCRINO, V23, P505; Krams I, 1998, J AVIAN BIOL, V29, P55, DOI 10.2307/3677341; Krams I, 2013, ETHOLOGY, V119, P397, DOI 10.1111/eth.12075; Krams I, 2011, J ORNITHOL, V152, P889, DOI 10.1007/s10336-011-0672-7; Lange H, 2004, BEHAV ECOL, V15, P549, DOI 10.1093/beheco/arh044; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Maxwell MH, 1998, WORLD POULTRY SCI J, V54, P155, DOI 10.1079/WPS19980012; Moller AP, 2005, BEHAV ECOL SOCIOBIOL, V58, P534, DOI 10.1007/s00265-005-0962-2; Morales J, 2014, BEHAV ECOL SOCIOBIOL, V68, P1195, DOI 10.1007/s00265-014-1730-y; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Noujaim JC, 2008, POULTRY SCI, V87, P927, DOI 10.3382/ps.2007-00476; OSBORNE B, 1980, J COMP PHYSIOL PSYCH, V94, P536, DOI 10.1037/h0077688; Pap PL, 2010, ARDEA, V98, P105, DOI 10.5253/078.098.0113; Puerta M, 1996, COMP HAEMATOL INT, V6, P102, DOI 10.1007/BF00426050; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rivier C, 1999, PHARMACOL BIOCHEM BE, V64, P739; Romero LM, 2000, GEN COMP ENDOCR, V119, P52, DOI 10.1006/gcen.2000.7491; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Salomons AR, 2010, BEHAV BRAIN RES, V215, P95, DOI 10.1016/j.bbr.2010.06.035; SCHWABL H, 1988, BEHAVIOUR, V107, P107, DOI 10.1163/156853988X00223; Setchell JM, 2010, HORM BEHAV, V58, P720, DOI 10.1016/j.yhbeh.2010.07.004; SIEGEL HS, 1995, BRIT POULTRY SCI, V36, P3, DOI 10.1080/00071669508417748; Sloman KA, 2000, FISH PHYSIOL BIOCHEM, V22, P11, DOI 10.1023/A:1007837400713; Stefanski V, 2000, PSYCHONEUROENDOCRINO, V25, P389, DOI 10.1016/S0306-4530(99)00066-9; Tamashiro KLK, 2005, FRONT NEUROENDOCRIN, V26, P27, DOI 10.1016/j.yfrne.2005.03.001; TERRY WS, 1979, ANIM LEARN BEHAV, V7, P525, DOI 10.3758/BF03209714; Trainor BC, 2010, HORM BEHAV, V58, P506, DOI 10.1016/j.yhbeh.2010.04.008; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; van Oers K, 2011, ANIM BEHAV, V81, P1055, DOI 10.1016/j.anbehav.2011.02.014; Veenema AH, 2003, HORM BEHAV, V43, P197, DOI 10.1016/S0018-506X(02)00013-2; Verbeek MEM, 1996, BEHAVIOUR, V133, P945, DOI 10.1163/156853996X00314; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Verbeek MEM, 1999, BEHAVIOUR, V136, P23, DOI 10.1163/156853999500659; VOIGT K, 1990, PSYCHONEUROENDOCRINO, V15, P173, DOI 10.1016/0306-4530(90)90028-8; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	81	9	9	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127984	10.1371/journal.pone.0127984	http://dx.doi.org/10.1371/journal.pone.0127984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011633	Green Published, gold			2022-12-27	WOS:000355183900177
J	Veiga, N; Pereira, C; Resende, C; Amaral, O; Ferreira, M; Nelas, P; Chaves, C; Duarte, J; Cirnes, L; Machado, JC; Ferreira, P; Correia, IJ				Veiga, Nelio; Pereira, Carlos; Resende, Carlos; Amaral, Odete; Ferreira, Manuela; Nelas, Paula; Chaves, Claudia; Duarte, Joao; Cirnes, Luis; Machado, Jose Carlos; Ferreira, Paula; Correia, Ilidio J.			Oral and Gastric Helicobacter Pylori: Effects and Associations	PLOS ONE			English	Article							DENTAL PLAQUE; CAVITY; INFECTION; HEALTH; CHILDREN; SALIVA; VACA; SEROPREVALENCE; PREVALENCE; HYGIENE	Introduction This study consisted in the comparison of the prevalence of Helicobacter pylori (H. pylori) present in the stomach and in saliva of a sample of Portuguese adolescents and the assessment of the association between H. pylori infection with socio-demographic variables and prevalence of dental caries. Materials and Methods A cross-sectional study was designed including a sample of 447 adolescents aged 12 to 19 years old, attending a public school in Satao, Portugal. A questionnaire about socio-demographic variables and oral health behaviors was applied. Gastric H. pylori infection was determined using the urease breath test (UBT). Saliva collection was obtained and DNA was extracted by Polymerase Chain Reaction (PCR) in order to detect the presence of oral H. pylori. Results The prevalence of gastric H. pylori detected by UBT was 35.9%. Within the adolescents with a gastric UBT positive, only 1.9% were positive for oral H. pylori. The presence of gastric H. pylori was found to be associated with age (> 15years, Odds ratio(OR)= 1.64,95% CI= 1.08-2.52), residence area (urban, OR= 1.48,95% CI= 1.03-2.29) and parents' professional situation (unemployed, OR= 1.22,95% CI= 1.02-1.23). Among those with detected dental caries during the intra-oral observation, 37.4% were positive for gastric H. pylori and 40.2% negative for the same bacterial strain (p=0.3). Conclusions The oral cavity cannot be considered a reservoir for infection of H. pylori. Gastric H. pylori infection was found to be associated with socio-demographic variables such as age, residence area and socioeconomic status.	[Veiga, Nelio; Correia, Ilidio J.] Beira Interior Univ, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal; [Veiga, Nelio; Pereira, Carlos; Amaral, Odete; Ferreira, Manuela; Nelas, Paula; Chaves, Claudia; Duarte, Joao] Polytech Inst Viseu, Res Ctr Educ Technol & Hlth Studies, Viseu, Portugal; [Veiga, Nelio; Ferreira, Paula] Univ Coimbra, Dept Chem Engn, Chem Proc Engn & Forest Prod Res Ctr, Coimbra, Portugal; [Veiga, Nelio] Portuguese Catholic Porto, Dept Hlth Sci, Viseu, Portugal; [Resende, Carlos; Cirnes, Luis; Machado, Jose Carlos] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal	Universidade da Beira Interior; Instituto Politecnico de Viseu; Universidade de Coimbra; Universidade Catolica Portuguesa; Universidade do Porto	Veiga, N (corresponding author), Beira Interior Univ, Fac Hlth Sci, Hlth Sci Res Ctr, Covilha, Portugal.	nelioveiga@gmail.com	Amaral, Odete P/C-1451-2016; Correia, Ilidio/S-8295-2016; Ferreira, Paula/ABD-5826-2020; Machado, Jose Carlos/C-5907-2009; Ferreira, Paula/I-6288-2013; Ferreira, Paula/GQP-0550-2022; Correia, I. J./AAE-2400-2020; Chaves, Claudia/E-9556-2018; Veiga, Nelio/F-5279-2017; Ferreira, Manuela/N-1236-2013	Amaral, Odete P/0000-0002-3382-6074; Correia, Ilidio/0000-0003-1613-9675; Machado, Jose Carlos/0000-0003-4741-8415; Ferreira, Paula/0000-0003-3393-4427; Ferreira, Paula/0000-0003-3393-4427; Correia, I. J./0000-0003-1613-9675; Chaves, Claudia/0000-0002-8103-7221; Veiga, Nelio/0000-0001-6288-0435; Resende, Carlos/0000-0001-7143-7099; Nelas, Paula/0000-0003-0043-3597; Ferreira, Manuela/0000-0002-8452-2222	Fundacao para a Ciencia e Tecnologia; CIDETS (Portugal)	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); CIDETS (Portugal)	This study was funded by the Fundacao para a Ciencia e Tecnologia and CI&DETS (Portugal).	Adler I, 2014, WORLD J GASTROENTERO, V20, P9922, DOI 10.3748/wjg.v20.i29.9922; Al Sayed A, 2014, ISRN GASTROENTEROL, V2014, P1; Almeida M, 2012, ACTA PEDIAT PORT, V43, pS37; Assumpcao MB, 2010, WORLD J GASTROENTERO, V16, P3033, DOI 10.3748/wjg.v16.i24.3033; Atherton JC, 1997, GASTROENTEROLOGY, V112, P92, DOI 10.1016/S0016-5085(97)70223-3; Berroteran A, 2002, J MED MICROBIOL, V51, P764, DOI 10.1099/0022-1317-51-9-764; Bharath T Sreenivasa, 2014, J Oral Maxillofac Pathol, V18, P19, DOI 10.4103/0973-029X.131885; Boyanova L, 2013, DIAGN MICR INFEC DIS, V77, P287, DOI 10.1016/j.diagmicrobio.2013.06.030; Buergers R, 2008, EUR J ORAL SCI, V116, P297, DOI 10.1111/j.1600-0722.2008.00543.x; Camargo MC, 2004, HELICOBACTER, V9, P106, DOI 10.1111/j.1083-4389.2004.00206.x; Chaudhry S, 2011, JCPSP-J COLL PHYSICI, V21, P589, DOI 10.2011/JCPSP.589592; Chen YYM, 1996, INFECT IMMUN, V64, P585, DOI 10.1128/IAI.64.2.585-592.1996; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Dus I, 2013, POSTEP HIG MED DOSW, V67, P261; El-Fakhfakh Effat Abd El-Monem, 2014, J Egypt Soc Parasitol, V44, P275; Fernando N, 2001, HELICOBACTER, V6, P169, DOI 10.1046/j.1523-5378.2001.00025.x; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Kabir S, 2004, HELICOBACTER, V9, P115, DOI 10.1111/j.1083-4389.2004.00207.x; Kignel S, 2005, ORAL DIS, V11, P17, DOI 10.1111/j.1601-0825.2004.01043.x; Kilmartin Catherine M, 2002, J Can Dent Assoc, V68, P489; Kodaira MS, 2002, REV SAUDE PUBL, V36, P356, DOI 10.1590/S0034-89102002000300017; Liu P, 2013, ASIA-PAC J PUBLIC HE, V25, p49S, DOI 10.1177/1010539513495555; Loster BW, 2006, J PHYSIOL PHARMACOL, V57, P91; Mana F, 2013, ACTA GASTRO-ENT BELG, V76, P381; Medina ML, 2010, MED ORAL PATOL ORAL, V15, pE38, DOI 10.4317/medoral.15.e38; Momtaz H, 2012, WORLD J GASTROENTERO, V18, P2105, DOI 10.3748/wjg.v18.i17.2105; Monno R, 2008, INFECTION, V36, P345, DOI 10.1007/s15010-008-6338-6; Namiot DB, 2010, ADV MED SCI-POLAND, V55, P167, DOI 10.2478/v10039-010-0032-5; Nisha KJ, 2016, J INVESTIG CLIN DENT, V7, P37, DOI 10.1111/jicd.12122; Panahi O, 2011, JPCS, V2, P13; Miranda ACP, 2010, SAO PAULO MED J, V128, P187, DOI 10.1590/S1516-31802010000400002; Roman-Roman A, 2013, ENFERM INFEC MICR CL, V31, P130, DOI 10.1016/j.eimc.2012.09.002; Salazar CR, 2012, CARCINOGENESIS, V33, P399, DOI 10.1093/carcin/bgr284; Satheehkumar P, 2013, ORAL ONCOL, V49, P20; Sepulveda E, 2012, REV CHIL INFECTOL, V29, P278, DOI 10.4067/S0716-10182012000300005; Rossi-Aguiar VPS, 2009, ORAL MICROBIOL IMMUN, V24, P255, DOI 10.1111/j.1399-302X.2008.00491.x; Sousa M B, 2001, Arq Gastroenterol, V38, P132; Vahedi M, 2011, J Dent (Tehran), V8, P165; WHO World Health Organization, 2003, OR HLTH SURV BAS MET; Wichelhaus A, 2011, J OROFAC ORTHOP, V72, P187, DOI 10.1007/s00056-011-0024-5; Zou QH, 2011, J ORAL PATHOL MED, V40, P317, DOI 10.1111/j.1600-0714.2011.01006.x	41	8	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126923	10.1371/journal.pone.0126923	http://dx.doi.org/10.1371/journal.pone.0126923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010595	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900049
J	Zucca, S; Pasotti, L; Politi, N; Casanova, M; Mazzini, G; De Angelis, MGC; Magni, P				Zucca, Susanna; Pasotti, Lorenzo; Politi, Nicolo; Casanova, Michela; Mazzini, Giuliano; De Angelis, Maria Gabriella Cusella; Magni, Paolo			Multi-Faceted Characterization of a Novel LuxR-Repressible Promoter Library for Escherichia coli	PLOS ONE			English	Article							CELL-CELL COMMUNICATION; TUNING GENETIC-CONTROL; VIBRIO-FISCHERI; LOGIC GATES; QUORUM; EXPRESSION; CONSTRUCTION; BACTERIA; PARTS	The genetic elements regulating the natural quorum sensing (QS) networks of several microorganisms are widely used in synthetic biology to control the behaviour of single cells and engineered bacterial populations via ad-hoc constructed synthetic circuits. A number of novel engineering-inspired biological functions have been implemented and model systems have also been constructed to improve the knowledge on natural QS systems. Synthetic QS-based parts, such as promoters, have been reported in literature, to provide biological components with functions that are not present in nature, like modified induction logic or activation/repression by additional molecules. In this work, a library of promoters that can be repressed by the LuxR protein in presence of the QS autoinducer N-3-oxohexanoyl-L-homoserine lactone (AHL) was reported for Escherichia coli, to expand the toolkit of genetic parts that can be used to engineer novel synthetic QS-based systems. The library was constructed via polymerase chain reaction with highly constrained degenerate oligonucleotides, designed according to the consensus -35 and -10 sequences of a previously reported constitutive promoter library of graded strength, to maximize the probability of obtaining functional clones. All the promoters have a lux box between the -35 and -10 regions, to implement a LuxR-repressible behaviour. Twelve unique library members of graded strength (about 100-fold activity range) were selected to form the final library and they were characterized in several genetic contexts, such as in different plasmids, via different reporter genes, in presence of a LuxR expression cassette in different positions and in response to different AHL concentrations. The new obtained regulatory parts and corresponding data can be exploited by synthetic biologists to implement an artificial AHL-dependent repression of transcription in genetic circuits. The target transcriptional activity can be selected among the available library members to meet the design specifications of the biological system.	[Zucca, Susanna; Pasotti, Lorenzo; Politi, Nicolo; Casanova, Michela; Magni, Paolo] Univ Pavia, Dipartimento Ingn Ind Informaz, I-27100 Pavia, Italy; [Zucca, Susanna; Pasotti, Lorenzo; Politi, Nicolo; Casanova, Michela; De Angelis, Maria Gabriella Cusella; Magni, Paolo] Univ Pavia, Ctr Ingn Tissutale, I-27100 Pavia, Italy; [Mazzini, Giuliano] Univ Pavia, IGM CNR, I-27100 Pavia, Italy	University of Pavia; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Pavia	Magni, P (corresponding author), Univ Pavia, Dipartimento Ingn Ind Informaz, Via Palestro 3, I-27100 Pavia, Italy.	paolo.magni@unipv.it	Pasotti, Lorenzo/AAA-5215-2022; Zucca, Susanna/G-7087-2018	Pasotti, Lorenzo/0000-0002-5431-3083; Zucca, Susanna/0000-0001-8465-632X; Magni, Paolo/0000-0002-8931-4676; Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346	University of Pavia	University of Pavia	This project was supported by the University of Pavia. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BL, 2014, ACS SYNTH BIOL, V3, P210, DOI 10.1021/sb400068z; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Egland KA, 2000, J BACTERIOL, V182, P805, DOI 10.1128/JB.182.3.805-811.2000; Ellis T, 2009, NATURE PROTOCOL EXCH, DOI [10.1038/nprot.2009.79, DOI 10.1038/NPROT.2009.79]; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Fischer CR, 2006, TRENDS BIOTECHNOL, V24, P55, DOI 10.1016/j.tibtech.2005.12.001; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GRAY KM, 1994, J BACTERIOL, V176, P3076, DOI 10.1128/JB.176.10.3076-3080.1994; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Haseltine EL, 2008, APPL ENVIRON MICROB, V74, P437, DOI 10.1128/AEM.01688-07; Kelly JR, 2009, J BIOL ENG, V3, DOI [10.1186/1754-1611-3-20, DOI 10.1186/1754-1611-3-20]; Knight T., 2003, IDEMPOTENT VECTOR DE; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Martin L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007569; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Nistala Goutam J, 2010, J Biol Eng, V4, P4, DOI 10.1186/1754-1611-4-4; Pai A, 2014, ACS SYNTH BIOL, V3, P220, DOI 10.1021/sb400069w; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Pasotti L, 2013, MODELING METHODOLOGY, P545, DOI [10.1016/B978-0-12-411557-6.00023-9, DOI 10.1016/B978-0-12-411557-6.00023-9]; Pasotti L, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/369681; Pasotti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039407; Pasotti L, 2011, BIOTECHNOL J, V6, P784, DOI 10.1002/biot.201100080; Pasotti L, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-8; Payne S, 2014, ADV BIOCHEM ENG BIOT, V146, P97, DOI 10.1007/10_2013_249; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Politi N, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-5; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Riccione KA, 2012, ACS SYNTH BIOL, V1, P389, DOI 10.1021/sb300044r; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shong J, 2014, ACS SYNTH BIOL, V3, P238, DOI 10.1021/sb4000965; Shong J, 2013, ACS SYNTH BIOL, V2, P568, DOI 10.1021/sb4000433; Sifri CD, 2008, CLIN INFECT DIS, V47, P1070, DOI 10.1086/592072; Solem C, 2002, APPL ENVIRON MICROB, V68, P2397, DOI 10.1128/AEM.68.5.2397-2403.2002; Stevens AM, 1997, J BACTERIOL, V179, P557, DOI 10.1128/jb.179.2.557-562.1997; Swift S, 1996, TRENDS BIOCHEM SCI, V21, P214; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Zucca S, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-12; Zucca S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S11	55	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126264	10.1371/journal.pone.0126264	http://dx.doi.org/10.1371/journal.pone.0126264			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010244	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900025
J	Ismail, MZB; Hodges, MD; Boylan, M; Achall, R; Shirras, A; Broughton, SJ				Ismail, Mohd Zamri Bin Haji; Hodges, Matt D.; Boylan, Michael; Achall, Rajesh; Shirras, Alan; Broughton, Susan J.			The Drosophila Insulin Receptor Independently Modulates Lifespan and Locomotor Senescence	PLOS ONE			English	Article							AGE-RELATED IMPAIRMENT; OXIDATIVE STRESS; CENTRAL COMPLEX; FUNCTIONAL SENESCENCE; NEGATIVE GEOTAXIS; GROWTH; GLUTAMATE; EXPRESSION; LONGEVITY; CELLS	The Insulin/IGF-like signalling (IIS) pathway plays an evolutionarily conserved role in ageing. In model organisms reduced IIS extends lifespan and ameliorates some forms of functional senescence. However, little is known about IIS in nervous system ageing and behavioural senescence. To investigate this role in Drosophila melanogaster, we measured the effect of reduced IIS on senescence of two locomotor behaviours, negative geotaxis and exploratory walking. Two long-lived fly models with systemic IIS reductions (daGAL4/UAS-InRDN (ubiquitous expression of a dominant negative insulin receptor) and d2GAL/UAS-rpr (ablation of insulin-like peptide producing cells)) showed an amelioration of negative geotaxis senescence similar to that previously reported for the long-lived IIS mutant chico. In contrast, exploratory walking in daGAL4/UAS-InRDN and d2GAL/UAS-rpr flies declined with age similarly to controls. To determine the contribution of IIS in the nervous system to these altered senescence patterns and lifespan, the InRDN was targeted to neurons (elavGAL4/UAS-InRDN), which resulted in extension of lifespan in females, normal negative geotaxis senescence in males and females, and detrimental effects on age-specific exploratory walking behaviour in males and females. These data indicate that the Drosophila insulin receptor independently modulates lifespan and age-specific function of different types of locomotor behaviour. The data suggest that ameliorated negative geotaxis senescence of long-lived flies with systemic IIS reductions is due to ageing related effects of reduced IIS outside the nervous system. The lifespan extension and coincident detrimental or neutral effects on locomotor function with a neuron specific reduction (elavGAL4/UAS-InRDN) indicates that reduced IIS is not beneficial to the neural circuitry underlying the behaviours despite increasing lifespan.	[Ismail, Mohd Zamri Bin Haji; Hodges, Matt D.; Boylan, Michael; Achall, Rajesh; Shirras, Alan; Broughton, Susan J.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England	Lancaster University	Broughton, SJ (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YQ, England.	s.j.broughton@lancaster.ac.uk	Hodges, Matthew/GZB-0433-2022	Hodges, Matthew David John/0000-0002-6815-751X; Shirras, Alan/0000-0002-1377-5134; Broughton, Sue/0000-0001-8168-5387	Lancaster University; Government of Brunei Darussalam's Studentship	Lancaster University; Government of Brunei Darussalam's Studentship	Funding was provided by Lancaster University to SJB and AS, and by Government of Brunei Darussalam's Studentship to MZBHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Alic N, 2014, CELL REP, V6, P608, DOI 10.1016/j.celrep.2014.01.015; Bai H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003941; Barnes C, 2011, SCIENTIST, V25, P30; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bhandari P, 2007, AGING CELL, V6, P631, DOI 10.1111/j.1474-9726.2007.00320.x; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Burger JMS, 2008, EVOLUTION, V62, P1294, DOI 10.1111/j.1558-5646.2008.00376.x; Burger JMS, 2006, EXP GERONTOL, V41, P1108, DOI 10.1016/j.exger.2006.08.008; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cook-Wiens E, 2002, EXP GERONTOL, V37, P1347, DOI 10.1016/S0531-5565(02)00096-7; Costello DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031124; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Donahue AN, 2006, MECH AGEING DEV, V127, P57, DOI 10.1016/j.mad.2005.09.003; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; Fedele G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5391; Garcia-Galloway E, 2003, MOL CELL NEUROSCI, V24, P1027, DOI 10.1016/j.mcn.2003.08.005; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Jones MA, 2011, EXP GERONTOL, V46, P320, DOI 10.1016/j.exger.2010.08.012; Jones MA, 2009, EXP GERONTOL, V44, P532, DOI 10.1016/j.exger.2009.05.007; Kahsai L, 2012, NEUROSCIENCE, V208, P11, DOI 10.1016/j.neuroscience.2012.02.007; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Keller A, 2002, J NEUROBIOL, V50, P221, DOI 10.1002/neu.10029; Kerr F, 2011, NEUROBIOL AGING, V32, P1977, DOI 10.1016/j.neurobiolaging.2009.10.015; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654; Martin I, 2006, EXP GERONTOL, V41, P877, DOI 10.1016/j.exger.2006.06.052; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin-Pena A, 2007, J NEUROCHEM, V102, P15; Rakshit K, 2013, AGING CELL, V12, P752, DOI 10.1111/acel.12100; Rhodenizer D, 2008, EXP GERONTOL, V43, P739, DOI 10.1016/j.exger.2008.04.011; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Robie AA, 2010, J EXP BIOL, V213, P2494, DOI 10.1242/jeb.041749; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Selman C, 2008, SCIENCE, V320, DOI 10.1126/science.1152366; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Simon AF, 2006, MECH AGEING DEV, V127, P647, DOI 10.1016/j.mad.2006.02.006; Skorokhod A, 1999, BIOL BULL-US, V197, P198, DOI 10.2307/1542615; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Sun LY, 2005, NEUROBIOL AGING, V26, P929, DOI 10.1016/j.neurobiolaging.2004.07.010; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Vellai T, 2006, GENETICS, V174, P309, DOI 10.1534/genetics.106.061499; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yang JL, 2011, MECH AGEING DEV, V132, P405, DOI 10.1016/j.mad.2011.06.005	54	21	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125312	10.1371/journal.pone.0125312	http://dx.doi.org/10.1371/journal.pone.0125312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020640	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000355187300012
J	Shankar, M; Mohapatra, SS; Biswas, S; Biswas, I				Shankar, Manoharan; Mohapatra, Saswat S.; Biswas, Saswati; Biswas, Indranil			Gene Regulation by the LiaSR Two-Component System in Streptococcus mutans	PLOS ONE			English	Article							ENVELOPE STRESS-RESPONSE; BACILLUS-SUBTILIS; STAPHYLOCOCCUS-AUREUS; KINETIC CHARACTERIZATION; LIAFSR SYSTEM; PROTEINS; PHOSPHORYLATION; EXPRESSION; VIRULENCE; OPERON	The LiaSR two-component signal transduction system regulates cellular responses to several environmental stresses, including those that induce cell envelope damages. Downstream regulons of the LiaSR system have been implicated in tolerance to acid, antibiotics and detergents. In the dental pathogen Streptococcus mutans, the LiaSR system is necessary for tolerance against acid, antibiotics, and cell wall damaging stresses during growth in the oral cavity. To understand the molecular mechanisms by which LiaSR regulates gene expression, we created a mutant LiaR in which the conserved aspartic acid residue (the phosphorylation site), was changed to alanine residue (D58A). As expected, the LiaR-D58A variant was unable to acquire the phosphate group and bind to target promoters. We also noted that the predicted LiaR-binding motif upstream of the lia operon does not appear to be well conserved. Consistent with this observation, we found that LiaR was unable to bind to the promoter region of lia; however, we showed that LiaR was able to bind to the promoters of SMU. 753, SMU. 2084 and SMU. 1727. Based on sequence analysis and DNA binding studies we proposed a new 25-bp conserved motif essential for LiaR binding. Introducing alterations at fully conserved positions in the 25-bp motif affected LiaR binding, and the binding was dependent on the combination of positions that were altered. By scanning the S. mutans genome for the occurrence of the newly defined LiaR binding motif, we identified the promoter of hrcA (encoding a key regulator of the heat shock response) that contains a LiaR binding motif, and we showed that hrcA is negatively regulated by the LiaSR system. Taken together our results suggest a putative role of the LiaSR system in heat shock responses of S. mutans.	[Shankar, Manoharan; Mohapatra, Saswat S.; Biswas, Saswati; Biswas, Indranil] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Biswas, I (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA.	ibiswas@kumc.edu	Mohapatra, Saswat Sourav/B-6487-2011; Manoharan, Shankar/M-9826-2016; Manoharan, Shankar/AAG-4459-2020	Mohapatra, Saswat Sourav/0000-0003-2776-1363; Manoharan, Shankar/0000-0001-8030-2073; Manoharan, Shankar/0000-0001-8030-2073	NIH (NIDCR) [DE22660]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022660] Funding Source: NIH RePORTER	NIH (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH (NIDCR), DE22660 (www.nih.gov).	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Banerjee A, 2008, APPL ENVIRON MICROB, V74, P2037, DOI 10.1128/AEM.02346-07; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Belcheva A, 2008, J BIOL CHEM, V283, P12354, DOI 10.1074/jbc.M710010200; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Boll JM, 2011, P NATL ACAD SCI USA, V108, P20160, DOI 10.1073/pnas.1113013108; Butcher BG, 2007, J BACTERIOL, V189, P8616, DOI 10.1128/JB.01181-07; Chong P, 2008, INFECT IMMUN, V76, P3093, DOI 10.1128/IAI.01627-07; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Dmitriev A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020127; Eldholm V, 2010, J BACTERIOL, V192, P1761, DOI 10.1128/JB.01489-09; Fritsch F, 2011, MICROBIOL-SGM, V157, P373, DOI 10.1099/mic.0.044776-0; Galbusera E, 2011, ANTIMICROB AGENTS CH, V55, P1008, DOI 10.1128/AAC.00720-10; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Jordan S, 2007, MICROBIOL-SGM, V153, P2530, DOI 10.1099/mic.0.2007/006817-0; Jordan S, 2006, J BACTERIOL, V188, P5153, DOI 10.1128/JB.00310-06; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Klinzing DC, 2013, MICROBIOL-SGM, V159, P1521, DOI 10.1099/mic.0.064444-0; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lemos JAC, 2001, J BACTERIOL, V183, P6074, DOI 10.1128/JB.183.20.6074-6084.2001; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Mascher T, 2004, ANTIMICROB AGENTS CH, V48, P2888, DOI 10.1128/AAC.48.8.2888-2896.2004; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; McCallum N, 2011, ANTIMICROB AGENTS CH, V55, P1391, DOI 10.1128/AAC.01213-10; Munita JM, 2014, CLIN INFECT DIS, V59, P1277, DOI 10.1093/cid/ciu642; Perry JA, 2008, LETT APPL MICROBIOL, V47, P439, DOI 10.1111/j.1472-765X.2008.02455.x; Qureshi NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085873; Roces C, 2009, INT J FOOD MICROBIOL, V133, P279, DOI 10.1016/j.ijfoodmicro.2009.06.002; Schachern PA, 2014, INT J PEDIATR OTORHI, V78, P1517, DOI 10.1016/j.ijporl.2014.06.024; Scharf BE, 2010, CURR OPIN MICROBIOL, V13, P246, DOI 10.1016/j.mib.2010.01.006; Schrecke K, 2013, MOL MICROBIOL, V87, P769, DOI 10.1111/mmi.12130; Schulz A, 1996, J BACTERIOL, V178, P1088, DOI 10.1128/jb.178.4.1088-1093.1996; Silversmith RE, 1997, BIOCHEMISTRY-US, V36, P14965, DOI 10.1021/bi9715573; Suntharalingam P, 2009, J BACTERIOL, V191, P2973, DOI 10.1128/JB.01563-08; Worthington RJ, 2013, FUTURE MED CHEM, V5, P1265, DOI 10.4155/fmc.13.58; Wu ZC, 2013, J BACTERIOL, V195, P4545, DOI 10.1128/JB.00792-13; Yin SH, 2006, ANTIMICROB AGENTS CH, V50, P336, DOI 10.1128/AAC.50.1.336-343.2006; Zhang JQ, 2009, MICROBIOL-SGM, V155, P61, DOI 10.1099/mic.0.023077-0	43	21	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128083	10.1371/journal.pone.0128083	http://dx.doi.org/10.1371/journal.pone.0128083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020679	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300078
J	Eiri, DM; Suwannapong, G; Endler, M; Nieh, JC				Eiri, Daren M.; Suwannapong, Guntima; Endler, Matthew; Nieh, James C.			Nosema ceranae Can Infect Honey Bee Larvae and Reduces Subsequent Adult Longevity	PLOS ONE			English	Article							APIS-MELLIFERA; MICROSPORIDIA; VIRULENCE; COLONIES; PARASITE; DISEASE; BOMBI; SUSCEPTIBILITY; HYMENOPTERA; PATHOGEN	Nosema ceranae causes a widespread disease that reduces honey bee health but is only thought to infect adult honey bees, not larvae, a critical life stage. We reared honey bee (Apis mellifera) larvae in vitro and provide the first demonstration that N. ceranae can infect larvae and decrease subsequent adult longevity. We exposed three-day-old larvae to a single dose of 40,000 (40K), 10,000 (10K), zero (control), or 40K autoclaved (control) N. ceranae spores in larval food. Spores developed intracellularly in midgut cells at the pre-pupal stage (8 days after egg hatching) of 41% of bees exposed as larvae. We counted the number of N. ceranae spores in dissected bee midguts of pre-pupae and, in a separate group, upon adult death. Pre-pupae exposed to the 10K or 40K spore treatments as larvae had significantly elevated spore counts as compared to controls. Adults exposed as larvae had significantly elevated spore counts as compared to controls. Larval spore exposure decreased longevity: a 40K treatment decreased the age by which 75% of adult bees died by 28%. Unexpectedly, the low dose (10K) led to significantly greater infection (1.3 fold more spores and 1.5 fold more infected bees) than the high dose (40K) upon adult death. Differential immune activation may be involved if the higher dose triggered a stronger larval immune response that resulted in fewer adult spores but imposed a cost, reducing lifespan. The impact of N. ceranae on honey bee larval development and the larvae of naturally infected colonies therefore deserve further study.	[Eiri, Daren M.; Endler, Matthew; Nieh, James C.] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; [Suwannapong, Guntima] Burapha Univ, Fac Sci, Dept Biol, Chon Buri 20131, Thailand	University of California System; University of California San Diego; Burapha University	Eiri, DM (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, 9500 Gilman Dr,MC 0116, La Jolla, CA 92093 USA.	dareneiri@gmail.com	Nieh, James C/H-8705-2014; Suwannapong, Guntima/AAV-8447-2021	Nieh, James C/0000-0001-6237-0726; Suwannapong, Guntima/0000-0002-3180-4103	University of California San Diego Academic Senate; National Honey Board; North American Pollinator Protection Campaign	University of California San Diego Academic Senate; National Honey Board; North American Pollinator Protection Campaign	This research was made possible by funding from the University of California San Diego Academic Senate (https://senate.ucsd.edu/), National Honey Board (http://www.honey.com/honey-industry/honey-and-bee-research/honey-bee-research/c/2012-research-projects), and the North American Pollinator Protection Campaign (http://www.pollinator.org/honeybee_health.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; BAILEY L, 1955, PARASITOLOGY, V45, P86, DOI 10.1017/S0031182000027451; Blaser M, 2005, J INVERTEBR PATHOL, V89, P251, DOI 10.1016/j.jip.2005.04.004; Botias C, 2012, RES VET SCI, V93, P150, DOI 10.1016/j.rvsc.2011.08.002; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Cameron SA, 2001, SYST BIOL, V50, P194, DOI 10.1080/10635150151125851; CANTWELL G E, 1970, American Bee Journal, V110, P222; Chaimanee V, 2013, VET PARASITOL, V193, P260, DOI 10.1016/j.vetpar.2012.12.004; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Crailsheim K, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.05; da Cruz-Landim C, 2003, ZOOL SCI, V20, P1099, DOI 10.2108/zsj.20.1099; Dadant, 1975, HIV HON; Dainat B, 2012, ENV MICROBIOL REP, V4, P123, DOI 10.1111/j.1758-2229.2011.00312.x; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; FISHER FM, 1962, J PARASITOL, V48, P926, DOI 10.2307/3275124; Fontbonne R, 2013, INFECT GENET EVOL, V17, P188, DOI 10.1016/j.meegid.2013.04.016; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Fujiwara T., 1979, Journal of Sericultural Science of Japan, V48, P376; Fukuda H., 1968, Researches on Population Ecology Kyoto University, V10, P31, DOI 10.1007/BF02514731; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2013, J INVERTEBR PATHOL, V113, P1, DOI 10.1016/j.jip.2013.01.004; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; HASSANEIN MH, 1951, ANN APPL BIOL, V38, P844, DOI 10.1111/j.1744-7348.1951.tb07854.x; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2008, J INVERTEBR PATHOL, V97, P76, DOI 10.1016/j.jip.2007.06.002; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Huang Q, 2014, APIDOLOGIE, V45, P248, DOI 10.1007/s13592-013-0243-4; Huang Q, 2012, J INVERTEBR PATHOL, V109, P297, DOI 10.1016/j.jip.2012.01.004; Huang WF, 2007, APIDOLOGIE, V38, P30, DOI 10.1051/apido:2006054; Huang WF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003185; Huang WF, 2013, J INVERTEBR PATHOL, V113, P35, DOI 10.1016/j.jip.2013.01.001; Huang Z, 2009, STANDARDIZED PROCEDU; HUANG ZY, 1991, J INSECT BEHAV, V4, P305, DOI 10.1007/BF01048280; Kaftanoglu O, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.9601; KELLEN WR, 1968, J INVERTEBR PATHOL, V11, P104, DOI 10.1016/0022-2011(68)90059-1; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Maiolino P., 2014, VET MED ANIM SCI, V2, P4, DOI [10.7243/2054-3425-2-4, DOI 10.7243/2054-3425-2-4]; Martin-Hernandez R, 2011, PARASITOL RES, V109, P605, DOI 10.1007/s00436-011-2292-9; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Meana A, 2010, J APICULT RES, V49, P212, DOI 10.3896/IBRA.1.49.2.12; Neumann P, 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.1.04, DOI 10.3896/IBRA.1.52.1.04]; Otti O, 2008, ECOL ENTOMOL, V33, P577, DOI 10.1111/j.1365-2311.2008.00998.x; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rennich K, 2012, NATL HONEY BEE PESTS; Rueppell O, 2010, J EVOLUTION BIOL, V23, P1538, DOI 10.1111/j.1420-9101.2010.02022.x; Rutrecht ST, 2008, APIDOLOGIE, V39, P504, DOI 10.1051/apido:2008031; Schmid-Hempel P, 1998, APIDOLOGIE, V29, P525, DOI 10.1051/apido:19980605; Smart MD, 2012, J INVERTEBR PATHOL, V109, P148, DOI 10.1016/j.jip.2011.09.009; Smith ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043319; SOLTER LF, 1990, J INVERTEBR PATHOL, V55, P337, DOI 10.1016/0022-2011(90)90076-I; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Suwannapong G, 2011, J INVERTEBR PATHOL, V106, P236, DOI 10.1016/j.jip.2010.10.003; Suwannapong G, 2010, J ASIA-PAC ENTOMOL, V13, P361, DOI 10.1016/j.aspen.2010.07.003; Swanson JAI, 2009, J CHEM ECOL, V35, P1108, DOI 10.1007/s10886-009-9683-8; Traver BE, 2012, J INVERTEBR PATHOL, V110, P408, DOI 10.1016/j.jip.2012.04.001; Traver BE, 2011, J INVERTEBR PATHOL, V107, P234, DOI 10.1016/j.jip.2011.05.016; UNDEEN AH, 1973, J INVERTEBR PATHOL, V22, P258, DOI 10.1016/0022-2011(73)90143-2; van der Steen JJM, 2008, APIDOLOGIE, V39, P273, DOI 10.1051/apido:2008006; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Webster TC, 2004, APIDOLOGIE, V35, P49, DOI 10.1051/apido:2003063; Winfree R, 2011, ECOL ECON, V71, P80, DOI 10.1016/j.ecolecon.2011.08.001; Winston M., 1987, The biology of the honey bee.; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	77	58	63	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126330	10.1371/journal.pone.0126330	http://dx.doi.org/10.1371/journal.pone.0126330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018139	Green Published, gold			2022-12-27	WOS:000355185600049
J	Gong, M; Yang, JT; Liu, YQ; Tang, LH; Wang, Y; Wang, LJ; Zhang, FJ; Yan, M				Gong, Ming; Yang, Jin-Ting; Liu, Yun-Qing; Tang, Li-Hui; Wang, Yin; Wang, Lie-Ju; Zhang, Feng-Jiang; Yan, Min			Irradiation Can Selectively Kill Tumor Cells while Preserving Erythrocyte Viability in a Co-Culture System	PLOS ONE			English	Article							INTRAOPERATIVE BLOOD SALVAGE; LEUKOCYTE DEPLETION FILTERS; CANCER-SURGERY; HEPATOCELLULAR-CARCINOMA; RADICAL PROSTATECTOMY; EFFICIENT ELIMINATION; AUTOTRANSFUSION; TRANSFUSION; MODELS; MOUSE	An understanding of how to safely apply intraoperative blood salvage (IBS) in cancer surgery has not yet been obtained. Here, we investigated the optimal dose of Cs-137 gamma-ray irradiation for killing human hepatocarcinoma (HepG2), gastrocarcinoma (SGC7901), and colonic carcinoma (SW620) tumor cells while preserving co-cultured erythrocytes obtained from 14 healthy adult volunteers. HepG2, SGC7901, or SW620 cells were mixed into the aliquots of erythrocytes. After the mixed cells were treated with Cs-137 gamma-ray irradiation (30, 50, and 100 Gy), tumor cells and erythrocytes were separated by density gradient centrifugation in Percoll with a density of 1.063 g/ml. The viability, clonogenicity, DNA synthesis, tumorigenicity, and apoptosis of the tumor cells were determined by MTT assay, plate colony formation, 5-ethynyl-2'-deoxyuridine (EdU) incorporation, subcutaneous xenograft implantation into immunocompromised mice, and annexin V/7-AAD staining, respectively. The ATP concentration, 2,3-DPG level, free Hb concentration, osmotic fragility, membrane phosphatidylserine externalization, blood gas variables, reactive oxygen species levels, and superoxide dismutase levels in erythrocytes were analyzed. We found that Cs-137 gamma-ray irradiation at 50 Gy effectively inhibited the viability, proliferation, and tumorigenicity of HepG2, SGC7901, and SW620 cells without markedly damaging the oxygen-carrying ability or membrane integrity or increasing the oxidative stress of erythrocytes in vitro. These results demonstrated that 50 Gy irradiation in a standard Cs-137 blood irradiator might be a safe and effective method of inactivating HepG2, SGC7901, and SW620 cells mixed with erythrocytes, which might help to safely allow IBS in cancer surgery.	[Gong, Ming; Yang, Jin-Ting; Tang, Li-Hui; Zhang, Feng-Jiang; Yan, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310009, Zhejiang, Peoples R China; [Liu, Yun-Qing; Wang, Yin; Wang, Lie-Ju] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Peoples R China	Zhejiang University; Xuzhou Medical University	Yan, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310009, Zhejiang, Peoples R China.	zryanmin@zju.edu.cn			Chinese Ministry of Health-Zhejiang Health Department, China [WKJ2008-2-021, WKJ2013-2-019]	Chinese Ministry of Health-Zhejiang Health Department, China	This work was supported by grants for Scientific Research from Chinese Ministry of Health-Zhejiang Health Department, China (WKJ2008-2-021 and WKJ2013-2-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adias TC, 2006, S AFR J SURG, V44, P114; Bosman GJCGM, 2011, TRANSFUSION, V51, P1072, DOI 10.1111/j.1537-2995.2010.02929.x; Bower MR, 2011, ANN SURG ONCOL, V18, P166, DOI 10.1245/s10434-010-1228-4; BUTTON LN, 1981, TRANSFUSION, V21, P419, DOI 10.1046/j.1537-2995.1981.21481275998.x; Catling S, 2008, ANAESTHESIA, V63, P1332, DOI 10.1111/j.1365-2044.2008.05637.x; Choi ES, 2013, ANAESTHESIA, V68, P1259, DOI 10.1111/anae.12420; d'Almeida MS, 2000, TRANSFUSION MED, V10, P291, DOI 10.1046/j.1365-3148.2000.00267.x; Eriksson D, 2010, TUMOR BIOL, V31, P363, DOI 10.1007/s13277-010-0042-8; Futamura N, 2005, AM SURGEON, V71, P585; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Gobbel GT, 2001, J NEUROCHEM, V76, P520, DOI 10.1046/j.1471-4159.2001.00070.x; Gorin MA, 2012, WORLD J UROL, V30, P379, DOI 10.1007/s00345-011-0746-4; Gu YJ, 2009, EUR J CARDIO-THORAC, V36, P877, DOI 10.1016/j.ejcts.2009.04.058; Gwak MS, 2005, LIVER TRANSPLANT, V11, P331, DOI 10.1002/lt.20346; Hansen E, 1999, TRANSFUSION, V39, P608, DOI 10.1046/j.1537-2995.1999.39060608.x; HANSEN E, 1995, ARCH SURG-CHICAGO, V130, P387; Hansen E, 2002, TRANSFUS APHER SCI, V27, P153, DOI 10.1016/S1473-0502(02)00037-X; Hasegawa A, 2012, BLOOD, V119, P2615, DOI 10.1182/blood-2011-09-382473; Hod EA, 2010, VOX SANG, V99, P99, DOI 10.1111/j.1423-0410.2010.01327.x; Holzapfel BM, 2013, CANCER METAST REV, V32, P129, DOI 10.1007/s10555-013-9437-5; Ishihara C, 2003, J VET MED SCI, V65, P831, DOI 10.1292/jvms.65.831; ISHIHARA C, 1994, J VET MED SCI, V56, P1149, DOI 10.1292/jvms.56.1149; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kessack LK, 2010, ANAESTHESIA, V65, P745, DOI 10.1111/j.1365-2044.2010.06301.x; Kumar N, 2014, LANCET ONCOL, V15, pE33, DOI 10.1016/S1470-2045(13)70245-6; Liang TB, 2008, TRANSPLANTATION, V85, P863, DOI 10.1097/TP.0b013e3181671f2e; Martin RCG, 2005, ANN SURG ONCOL, V12, P1017, DOI 10.1245/ASO.2005.12.018; Pietraforte D, 2007, FREE RADICAL BIO MED, V42, P202, DOI 10.1016/j.freeradbiomed.2006.10.035; Poli M, 2008, VOX SANG, V95, P308, DOI 10.1111/j.1423-0410.2008.01109.x; Puchala M, 2004, J RADIAT RES, V45, P275, DOI 10.1269/jrr.45.275; Raval JS, 2012, TRANSFUSION, V52, P2590, DOI 10.1111/j.1537-2995.2012.03682.x; Shi L, 2014, TRANSFUSION, V54, P471, DOI 10.1111/trf.12273; Sojka BN, 2008, VOX SANG, V94, P56, DOI 10.1111/j.1423-0410.2007.00990.x; Sreelakshmi TR, 2010, ANAESTHESIA, V65, P742, DOI 10.1111/j.1365-2044.2009.06190.x; SUDA BA, 1993, TRANSFUSION, V33, P389, DOI 10.1046/j.1537-2995.1993.33593255598.x; Tamulevicius P, 2007, RADIAT RES, V167, P1, DOI 10.1667/RR0751.1; Ubee S, 2011, ANN ROY COLL SURG, V93, P157, DOI 10.1308/003588411X561044; Wang XH, 2012, ARTIF ORGANS, V36, P931, DOI 10.1111/j.1525-1594.2012.01494.x; Waters JH, 2012, TRANSFUSION, V52, P2167, DOI 10.1111/j.1537-2995.2011.03555.x; Winslow RM, 2007, RESP PHYSIOL NEUROBI, V158, P121, DOI 10.1016/j.resp.2007.03.011; Yang SH, 2011, BIOL REPROD, V84, P1182, DOI 10.1095/biolreprod.110.087569; Yonar SM, 2014, ECOTOX ENVIRON SAFE, V102, P202, DOI 10.1016/j.ecoenv.2014.01.007; Zbikowska HM, 2012, INT J RADIAT BIOL, V88, P654, DOI 10.3109/09553002.2012.705223; Zhu ZC, 2013, J NEURO-ONCOL, V112, P17, DOI 10.1007/s11060-012-1032-z; Zimring JC, 2014, TRANSFUSION, V54, P137, DOI 10.1111/trf.12264	45	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127181	10.1371/journal.pone.0127181	http://dx.doi.org/10.1371/journal.pone.0127181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018651	gold, Green Submitted, Green Published			2022-12-27	WOS:000355185600073
J	Lee, JR; Maggini, R; Taylor, MFJ; Fuller, RA				Lee, Jasmine R.; Maggini, Ramona; Taylor, Martin F. J.; Fuller, Richard A.			Mapping the Drivers of Climate Change Vulnerability for Australia's Threatened Species	PLOS ONE			English	Article							MOUNTAIN PYGMY-POSSUM; BURRAMYS-PARVUS; DISPERSAL; HABITAT; FRAGMENTATION; CONSEQUENCES; MARSUPIALIA; FRAMEWORK; IMPACTS; DEBATE	Effective conservation management for climate adaptation rests on understanding the factors driving species' vulnerability in a spatially explicit manner so as to direct on-ground action. However, there have been only few attempts to map the spatial distribution of the factors driving vulnerability to climate change. Here we conduct a species-level assessment of climate change vulnerability for a sample of Australia's threatened species and map the distribution of species affected by each factor driving climate change vulnerability across the continent. Almost half of the threatened species assessed were considered vulnerable to the impacts of climate change: amphibians being the most vulnerable group, followed by plants, reptiles, mammals and birds. Species with more restricted distributions were more likely to show high climate change vulnerability than widespread species. The main factors driving climate change vulnerability were low genetic variation, dependence on a particular disturbance regime and reliance on a particular moisture regime or habitat. The geographic distribution of the species impacted by each driver varies markedly across the continent, for example species impacted by low genetic variation are prevalent across the human-dominated south-east of the country, while reliance on particular moisture regimes is prevalent across northern Australia. Our results show that actions to address climate adaptation will need to be spatially appropriate, and that in some regions a complex suite of factors driving climate change vulnerability will need to be addressed. Taxonomic and geographic variation in the factors driving climate change vulnerability highlights an urgent need for a spatial prioritisation of climate adaptation actions for threatened species.	[Lee, Jasmine R.; Maggini, Ramona; Fuller, Richard A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Maggini, Ramona] Univ Queensland, Australian Res Council, CEED, Brisbane, Qld, Australia; [Taylor, Martin F. J.] WWF Australia, Brisbane, Qld, Australia	University of Queensland; University of Queensland; World Wildlife Fund	Lee, JR (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	jasmine.lee1@uqconnect.edu.au	Fuller, Richard/B-7971-2008	Fuller, Richard/0000-0001-9468-9678	WWF-Australia; National Climate Change Adaptation Research Facility; Australian Government's National Environmental Research Program; Australian Research Council Centre of Excellence for Environmental Decisions	WWF-Australia; National Climate Change Adaptation Research Facility; Australian Government's National Environmental Research Program(Australian Government); Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council)	This research was funded by a scholarship to J. R. L. from WWF-Australia, a grant from the National Climate Change Adaptation Research Facility, and additional funding from the Australian Government's National Environmental Research Program and the Australian Research Council Centre of Excellence for Environmental Decisions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Arribas P, 2012, GLOBAL CHANGE BIOL, V18, P2135, DOI 10.1111/j.1365-2486.2012.02691.x; Bagne KE, 2011, RMRSGTR257 USDA; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; BRERETON R, 1995, BIOL CONSERV, V72, P339, DOI 10.1016/0006-3207(94)00016-J; Broome LS, 2001, AUSTRAL ECOL, V26, P275, DOI 10.1046/j.1442-9993.2001.01114.x; Cardoso MJ, 2011, THESIS U NEW S WALES; Carvalho SB, 2010, GLOBAL CHANGE BIOL, V16, P3257, DOI 10.1111/j.1365-2486.2010.02212.x; Cary GJ, 2000, ADV GLOB CHANGE RES, V3, P233; Crossman ND, 2012, DIVERS DISTRIB, V18, P60, DOI 10.1111/j.1472-4642.2011.00851.x; Department of Sustainability Environment Water Population and Communities, 2012, INT BIOG REG AUSTR I; Department of Sustainability Environment Water Population and Communities, 2008, SPEC NAT ENV SIGN DA; Department of Sustainability Environment Water Population and Communities, 2011, SPEC PROF THREATS DA; Duarte H, 2012, GLOBAL CHANGE BIOL, V18, P412, DOI 10.1111/j.1365-2486.2011.02518.x; Erasmus BFN, 2002, GLOBAL CHANGE BIOL, V8, P679, DOI 10.1046/j.1365-2486.2002.00502.x; Evans MC, 2011, BIOSCIENCE, V61, P281, DOI 10.1525/bio.2011.61.4.8; FODEN W, 2008, 2008 REV IUCN RED LI; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Galbraith H, 2009, FRAMEWORK C IN PRESS; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Hagger V, 2013, AUSTRAL ECOL, V38, P465, DOI 10.1111/j.1442-9993.2012.02437.x; He TH, 2009, NEW PHYTOL, V181, P725, DOI 10.1111/j.1469-8137.2008.02686.x; Hennessy K., 2005, CLIMATE CHANGE IMPAC; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Hunter ML, 2007, CONSERV BIOL, V21, P1356, DOI 10.1111/j.1523-1739.2007.00780.x; Johnson JE, 2007, CLIMATE CHANGE GREAT; Kittel TGF, 2011, REG ENVIRON CHANGE, V11, pS249, DOI 10.1007/s10113-010-0180-y; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Mackey Brendan G., 2008, Biodiversity (Ottawa), V9, P11; Martin TG, 2012, CONSERV LETT, V5, P274, DOI 10.1111/j.1755-263X.2012.00239.x; Matthes M., 2000, ALLOCASUARINA PORTUE; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Midgley GF, 2002, GLOBAL ECOL BIOGEOGR, V11, P445, DOI 10.1046/j.1466-822X.2002.00307.x; Mitrovski P, 2007, MOL ECOL, V16, P75, DOI 10.1111/j.1365-294X.2006.03125.x; Mooney P.A., 2005, RECOVERY PLAN S AUST; Murray KA, 2011, P ROY SOC B-BIOL SCI, V278, P1515, DOI 10.1098/rspb.2010.1872; Nakicenovic N, 2000, SPECIAL REPORT EMISS, DOI [10.1073/pnas.1119787109, DOI 10.1073/PNAS.1119787109]; National Geophysical Data Center, 2011, DIG EL MOD DEM; Osborne MJ, 2000, MOL ECOL, V9, P609, DOI 10.1046/j.1365-294x.2000.00908.x; Paull David C., 2009, Pacific Conservation Biology, V15, P254; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perry LG, 2012, GLOBAL CHANGE BIOL, V18, P821, DOI 10.1111/j.1365-2486.2011.02588.x; Pimm SL, 2008, CURR BIOL, V18, pR117, DOI 10.1016/j.cub.2007.11.055; PRIMACK RB, 1992, CONSERV BIOL, V6, P513, DOI 10.1046/j.1523-1739.1992.06040513.x; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Core Team, 2018, R LANG ENV STAT COMP; Reside AE, 2012, ECOL EVOL, V2, P705, DOI 10.1002/ece3.197; Sattler P., 2002, AUSTR TERRESTRIAL BI; Schneider SH, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P779; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Soderquist TR, 2000, AUST J ZOOL, V48, P551, DOI 10.1071/ZO00029; Steffen, 2009, AUSTR BIODIVERSITY C; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P2335, DOI 10.1111/j.1365-2486.2012.02700.x; Thomas CD, 2011, TRENDS ECOL EVOL, V26, P216, DOI 10.1016/j.tree.2011.02.006; Tokushima H, 2008, AUST J ZOOL, V56, P363, DOI 10.1071/ZO08042; Williams RJ., 2009, INTERACTIONS CLIMATE; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Woinarski JCZ, 2004, FALCUNCULUS FRONTATU; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Young B., 2011, GUIDELINES USING NAT; Young BE, 2013, CONSERVING WILDLIFE, P129	63	9	9	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124766	10.1371/journal.pone.0124766	http://dx.doi.org/10.1371/journal.pone.0124766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017785	gold, Green Published			2022-12-27	WOS:000355185600007
J	Reeuwijk, KG; Robroek, SJW; Niessen, MAJ; Kraaijenhagen, RA; Vergouwe, Y; Burdorf, A				Reeuwijk, Kerstin G.; Robroek, Suzan J. W.; Niessen, Maurice A. J.; Kraaijenhagen, Roderik A.; Vergouwe, Yvonne; Burdorf, Alex			The Prognostic Value of the Work Ability Index for Sickness Absence among Office Workers	PLOS ONE			English	Article							DISABILITY PENSION; PREDICTION MODELS; JOB TERMINATION; RISK-FACTOR; LIFE-STYLE; EMPLOYEES; HEALTH; LEAVE; UNEMPLOYMENT; IMPACT	Background The work ability index (WAI) is a frequently used tool in occupational health to identify workers at risk for a reduced work performance and for work-related disability. However, information about the prognostic value of the WAI to identify workers at risk for sickness absence is scarce. Objectives To investigate the prognostic value of the WAI for sickness absence, and whether the discriminative ability differs across demographic subgroups. Methods At baseline, the WAI (score 7-49) was assessed among 1,331 office workers from a Dutch financial service company. Sickness absence was registered during 12-months follow-up and categorised as 0 days, 0< days< 5, 5 <= days< 15, and >= 15 days in one year. Associations between WAI and sickness absence were estimated by multinomial regression analyses. Discriminative ability of the WAI was assessed by the Area Under the Curve (AUC) and Ordinal c-index (ORC). Test characteristics were determined for dichotomised outcomes. Additional analyses were performed for separate WAI dimensions, and subgroup analyses for demographic groups. Results A lower WAI was associated with sickness absence (>= 15 days vs. 0 days: per point lower WAI score OR=1.27; 95% CI 1.21-1.33). The WAI showed reasonable ability to discriminate between categories of sickness absence (ORC=0.65; 95% CI 0.63-0.68). Highest discrimination was found for comparing workers with >= 15 sick days with 0 sick days (AUC=0.77) or with 1-5 sick days (AUC=0.69). At the cut-off for poor work ability (WAI <= 27) the sensitivity to identify workers at risk for >= 15 sick days was 7.5%, the specificity 99.6%, and the positive predictive value 82%. The performance was similar across demographic subgroups. Conclusions The WAI could be used to identify workers at high risk for prolonged sickness absence. However, due to low sensitivity many workers will be missed. Hence, additional factors are required to better identify workers at highest risk.	[Reeuwijk, Kerstin G.; Robroek, Suzan J. W.; Vergouwe, Yvonne; Burdorf, Alex] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Niessen, Maurice A. J.; Kraaijenhagen, Roderik A.] NIPED Res Fdn, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Robroek, SJW (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	s.robroek@erasmusmc.nl	Burdorf, Alex/A-2226-2008	Burdorf, Alex/0000-0003-3129-2862; Robroek, Suzan/0000-0002-9427-9676	Netherland Organisation for Health Research and Development (ZonMw) [208031003]; Netherlands Organisation for Scientific Research (NWO) [917.11.383]	Netherland Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The current study was conducted with financial support from The Netherland Organisation for Health Research and Development (ZonMw) http://www.zonmw.nl/en/ (Project Number 208031003). YV is supported by the Netherlands Organisation for Scientific Research (NWO) http://www.nwo.nl/en (Grant 917.11.383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom L, 2010, SCAND J WORK ENV HEA, V36, P404, DOI 10.5271/sjweh.2917; Alavinia SM, 2009, OCCUP MED-OXFORD, V59, P32, DOI 10.1093/occmed/kqn148; Alavinia SM, 2009, SCAND J WORK ENV HEA, V35, P325, DOI 10.5271/sjweh.1340; Alexanderson K, 2012, J EPIDEMIOL COMMUN H, V66, P155, DOI 10.1136/jech.2010.126789; Beemsterboer W, 2009, INT J OCCUP MED ENV, V22, P169, DOI 10.2478/v10001-009-0013-8; Bethge M, 2013, ARCH PHYS MED REHAB, V94, P2262, DOI 10.1016/j.apmr.2013.05.003; Colkesen EB, 2011, J OCCUP MED TOXICOL,, V6, DOI 10.1186/1745-6673-6-5; de Croon EM, 2005, SCAND J RHEUMATOL, V34, P277, DOI 10.1080/03009740510018615; de Zwart BCH, 2002, OCCUP MED-OXFORD, V52, P177, DOI 10.1093/occmed/52.4.177; Federation of Biomedical Scientific Societies, 2004, CODE OF CONDUCT FOR; Ferrie JE, 2005, OCCUP ENVIRON MED, V62, P74, DOI 10.1136/oem.2004.013896; Hultin H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-861; Hultin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035614; Jahkola, 1998, WORK ABILITY INDEX; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Koopmans PC, 2008, OCCUP ENVIRON MED, V65, P494, DOI 10.1136/oem.2007.034322; Kujala V, 2006, SCAND J WORK ENV HEA, V32, P75, DOI 10.5271/sjweh.979; Lund T, 2009, EUR J PUBLIC HEALTH, V19, P343, DOI 10.1093/eurpub/ckn128; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; Ministery of Work and Social Affairs, ZIEKTEVERZUIM VAN HE; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Niessen MAJ, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2387; Niessen MAJ, 2012, J OCCUP ENVIRON MED, V54, P404, DOI 10.1097/JOM.0b013e31824d2e43; Pedersen J, 2012, SCAND J WORK ENV HEA, V38, P516, DOI 10.5271/sjweh.3293; Radkiewicz P, 2005, INT CONGR SER, V1280, P304, DOI 10.1016/j.ics.2005.02.089; Robroek SJW, 2011, OCCUP ENVIRON MED, V68, P134, DOI 10.1136/oem.2010.055962; Roelen CAM, 2011, OCCUP MED-OXFORD, V61, P96, DOI 10.1093/occmed/kqq181; Roelen CA, 2013, EUR J PUBLIC HEALTH, V23, P128, DOI 10.1093/eurpub/cks036; Roelen CAM, 2014, J OCCUP REHABIL, V24, P747, DOI 10.1007/s10926-014-9505-x; Roelen CAM, 2014, SCAND J WORK ENV HEA, V40, P428, DOI 10.5271/sjweh.3428; Schouten LS, 2015, SCAND J WORK ENV HEA, V41, P36, DOI 10.5271/sjweh.3465; Sell L, 2009, INT ARCH OCC ENV HEA, V82, P1133, DOI 10.1007/s00420-009-0417-6; TUOMI K, 1991, SCAND J WORK ENV HEA, V17, P67; Tuomi K, 2001, OCCUP MED-OXFORD, V51, P318, DOI 10.1093/occmed/51.5.318; UWV, STAPPENPLAN BIJ ZIEK; Van Calster B, 2012, EUR J EPIDEMIOL, V27, P761, DOI 10.1007/s10654-012-9733-3; Van Calster B, 2012, BIOMETRICAL J, V54, P674, DOI 10.1002/bimj.201200026; van de Vijfeijke H, 2013, J OCCUP ENVIRON MED, V55, P1238, DOI 10.1097/JOM.0b013e3182a2a5e1; van den Berg TIJ, 2009, OCCUP ENVIRON MED, V66, P211, DOI 10.1136/oem.2008.039883; van den Berg TI, 2011, INT ARCH OCC ENV HEA, V84, P705, DOI 10.1007/s00420-010-0588-1; Virtanen M, 2006, OCCUP ENVIRON MED, V63, P212, DOI 10.1136/oem.2005.020297; Voss M, 2008, OCCUP ENVIRON MED, V65, P61, DOI 10.1136/oem.2006.031427	43	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126969	10.1371/journal.pone.0126969	http://dx.doi.org/10.1371/journal.pone.0126969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017387	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600064
J	Vecino, E; Heller, JP; Veiga-Crespo, P; Martin, KR; Fawcett, JW				Vecino, Elena; Heller, Janosch P.; Veiga-Crespo, Patricia; Martin, Keith R.; Fawcett, James W.			Influence of Extracellular Matrix Components on the Expression of Integrins and Regeneration of Adult Retinal Ganglion Cells	PLOS ONE			English	Article							IN-VITRO; RAT RETINA; LAMININ; SURVIVAL; GLAUCOMA; AXONS; RECEPTORS; NEUROTROPHINS; FIBERS; INVIVO	Purpose Retinal ganglion cells (RGCs) are exposed to injury in a variety of optic nerve diseases including glaucoma. However, not all cells respond in the same way to damage and the capacity of individual RGCs to survive or regenerate is variable. In order to elucidate factors that may be important for RGC survival and regeneration we have focussed on the extracellular matrix (ECM) and RGC integrin expression. Our specific questions were: (1) Do adult RGCs express particular sets of integrins in vitro and in vivo? (2) Can the nature of the ECM influence the expression of different integrins? (3) Can the nature of the ECM affect the survival of the cells and the length or branching complexity of their neurites? Methods Primary RGC cultures from adult rat retina were placed on glass coverslips treated with different substrates: Poly-L-Lysine (PL), or PL plus laminin (L), collagen I (CI), collagen IV (CIV) or fibronectin (F). After 10 days in culture, we performed double immunostaining with an antibody against beta III-Tubulin to identify the RGCs, and antibodies against the integrin subunits: alpha V, alpha 1, alpha 3, alpha 5, beta 1 or beta 3. The number of adhering and surviving cells, the number and length of the neurites and the expression of the integrin subunits on the different substrates were analysed. Results PL and L were associated with the greatest survival of RGCs while CI provided the least favourable conditions. The type of substrate affected the number and length of neurites. L stimulated the longest growth. We found at least three different types of RGCs in terms of their capacity to regenerate and extend neurites. The different combinations of integrins expressed by the cells growing on different substrata suggest that RGCs expressed predominantly alpha 1 beta 1 or alpha 3 beta 1 on L, alpha 1 beta 1 on CI and CIV, and alpha 5 beta 3 on F. The activity of the integrins was demonstrated by the phosphorylation of focal adhesion kinase (FAK). Conclusions Adult rat RGCs can survive and grow in the presence of different ECM tested. Further studies should be done to elucidate the different molecular characteristics of the RGCs subtypes in order to understand the possible different sensitivity of different RGCs to damage in diseases like glaucoma in which not all RGCs die at the same time.	[Vecino, Elena; Veiga-Crespo, Patricia] Univ Basque Country, UPV EHU, Dept Cell Biol & Histol, Leioa, Vizcaya, Spain; [Vecino, Elena; Heller, Janosch P.; Martin, Keith R.; Fawcett, James W.] Univ Cambridge, Dept Clin Neurosci, John van Geest Ctr Brain Repair, Cambridge, England; [Martin, Keith R.] Univ Cambridge, Welcome Trust MRC Cambridge Stem Cell Inst, Cambridge, England	University of Basque Country; University of Cambridge; University of Cambridge	Vecino, E (corresponding author), Univ Basque Country, Dept Cell Biol & Histol, Leioa, Vizcaya, Spain.	elena.vecino@ehu.es	Vecino, Elena/AAO-3462-2021; Heller, Janosch/GVT-5921-2022; Heller, Janosch/J-7509-2019; Veiga-Crespo, Patricia/A-1402-2012	Vecino, Elena/0000-0002-1672-5132; Heller, Janosch/0000-0002-8825-3787; Veiga-Crespo, Patricia/0000-0001-8595-3553; Fawcett, James/0000-0002-7990-4568	Grupos Consolidados Gobierno Vasco [IT437-10]; Basque Country Goberment/Clare Hall Fellowship; Fight for Sight; Jukes Glaucoma Research Foundation; Medical Reseach Council (GB); Medical Research Council [G1000864] Funding Source: researchfish; Fight for Sight [1867/68] Funding Source: researchfish; International Spinal Research Trust [NRB110] Funding Source: researchfish; MRC [G1000864] Funding Source: UKRI	Grupos Consolidados Gobierno Vasco; Basque Country Goberment/Clare Hall Fellowship; Fight for Sight; Jukes Glaucoma Research Foundation; Medical Reseach Council (GB); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; International Spinal Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support was provided by Grupos Consolidados Gobierno Vasco (IT437-10), Basque Country Goberment/Clare Hall Fellowship to EV, Fight for Sight and the Jukes Glaucoma Research Foundation to KRM, and Medical Reseach Council (GB) to JWF.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Bates CA, 1997, DEV BIOL, V181, P91, DOI 10.1006/dbio.1996.8438; Bauch H, 1998, J NEUROSCI, V18, P1774; Brocco MA, 1999, DEV BRAIN RES, V118, P23, DOI 10.1016/S0165-3806(99)00120-0; BURKE JM, 1980, EXP EYE RES, V31, P213, DOI 10.1016/0014-4835(80)90079-2; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chierzi S, 1999, J NEUROSCI, V19, P8367; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; COHEN J, 1986, NATURE, V322, P465, DOI 10.1038/322465a0; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; ELICES MJ, 1989, P NATL ACAD SCI USA, V86, P9906, DOI 10.1073/pnas.86.24.9906; Franze K, 2013, DEVELOPMENT, V140, P3069, DOI 10.1242/dev.079145; Fukada Y, 1977, BRAIN RES, V119, P327; Garcia M, 2003, INVEST OPHTH VIS SCI, V44, P4532, DOI 10.1167/iovs.03-0419; Garcia M, 2002, INVEST OPHTH VIS SCI, V43, P3735; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GLOVINSKY Y, 1992, ARCH OPHTHALMOL-CHIC, V110, P486, DOI 10.1001/archopht.1992.01080160064031; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Grimpe B, 2002, J NEUROSCI, V22, P3144, DOI 10.1523/JNEUROSCI.22-08-03144.2002; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; HUNTER DD, 1992, NEURON, V8, P399, DOI 10.1016/0896-6273(92)90269-J; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; LETOURNEAU PC, 1975, DEV BIOL, V44, P92, DOI 10.1016/0012-1606(75)90379-6; Lodovichi C, 2001, EUR J NEUROSCI, V13, P833, DOI 10.1046/j.1460-9568.2001.01440.x; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P1096; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; MORGAN JE, 1994, BRIT J OPHTHALMOL, V78, P875, DOI 10.1136/bjo.78.11.875; Morgan JE, 1994, BR J OPHTHALMOL, V78, P879; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; Ruiz-Ederra J, 2004, MOL VIS, V10, P83; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Vecino E, 2002, VISION RES, V42, P151, DOI 10.1016/S0042-6989(01)00251-6; Vecino E, 1998, GEN PHARMACOL-VASC S, V30, P305, DOI 10.1016/S0306-3623(97)00361-3; Vecino E, 1999, NEUROREPORT, V10, P1103, DOI 10.1097/00001756-199904060-00036; Vecino E., 2015, PROGR RETIN IN PRESS	38	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125250	10.1371/journal.pone.0125250	http://dx.doi.org/10.1371/journal.pone.0125250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018803	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600016
J	Baboota, RK; Sarma, SM; Boparai, RK; Kondepudi, KK; Mantri, S; Bishnoi, M				Baboota, Ritesh K.; Sarma, Siddhartha M.; Boparai, Ravneet K.; Kondepudi, Kanthi Kiran; Mantri, Shrikant; Bishnoi, Mahendra			Microarray Based Gene Expression Analysis of Murine Brown and Subcutaneous Adipose Tissue: Significance with Human	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ENERGY-EXPENDITURE; COLD-EXPOSURE; FAT-CELL; WHITE; ADIPOCYTES; MICE; TRANSCRIPTION; AGONISTS; DISTINCT	Background Two types of adipose tissues, white (WAT) and brown (BAT) are found in mammals. Increasingly novel strategies are being proposed for the treatment of obesity and its associated complications by altering amount and/or activity of BAT using mouse models. Methodology/Principle Findings The present study was designed to: (a) investigate the differential expression of genes in LACA mice subcutaneous WAT (sWAT) and BAT using mouse DNA microarray, (b) to compare mouse differential gene expression with previously published human data; to understand any inter-species differences between the two and (c) tomake a comparative assessment with C57BL/6 mouse strain. In mouse microarray studies, over 7003, 1176 and 401 probe sets showedmore than two-fold, five-fold and ten-fold change respectively in differential expression between murine BAT andWAT. Microarray data was validated using quantitative RT-PCR of key genes showing high expression in BAT (Fabp3, Ucp1, Slc27a1) and sWAT (Ms4a1, H2-Ob, Bank1) or showing relatively low expression in BAT (Pgk1, Cox6b1) and sWAT (Slc20a1, Cd74). Multi-omic pathway analysis was employed to understand possible links between the organisms. When murine two fold data was compared with published human BAT and sWAT data, 90 genes showed parallel differential expression in bothmouse and human. Out of these 90 genes, 46 showed same pattern of differential expression whereas the pattern was opposite for the remaining 44 genes. Based on our microarray results and its comparison with human data, we were able to identify genes (targets) (a) which can be studied inmouse model systems to extrapolate results to human (b) where caution should be exercised before extrapolation of murine data to human. Conclusion Our study provides evidence for inter species (mouse vs human) differences in differential gene expression between sWAT and BAT. Critical understanding of this data may help in development of novel ways to engineer one form of adipose tissue to another using murine model with focus on human.	[Baboota, Ritesh K.; Sarma, Siddhartha M.; Kondepudi, Kanthi Kiran; Mantri, Shrikant; Bishnoi, Mahendra] Natl Agri Food Biotechnol Inst NABI, Sas Nagar, Punjab, India; [Boparai, Ravneet K.] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University	Mantri, S (corresponding author), Natl Agri Food Biotechnol Inst NABI, Sas Nagar, Punjab, India.	shrikant@nabi.res.in; mbishnoi@gmail.com	Bishnoi, Mahendra/CAG-3229-2022; Baboota, Ritesh Kumar/AAQ-2606-2020; Kondepudi, Kanthi Kiran/P-8336-2014	Kondepudi, Kanthi Kiran/0000-0001-8036-7555; Mantri, Shrikant/0000-0002-7493-459X; Bishnoi, Mahendra/0000-0002-7785-1204; boparai, ravneet/0000-0002-0520-768X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors would like to thank the Department of Biotechnology, Government of India for research grants given to National Agri-Food Biotechnology Institute (NABI).	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carey AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091997; Cinti S, 2000, Eat Weight Disord, V5, P132; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FAWCETT DW, 1952, J MORPHOL, V90, P363, DOI 10.1002/jmor.1050900208; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kanzleiter T, 2009, BBA-MOL BASIS DIS, V1792, P777, DOI 10.1016/j.bbadis.2009.05.002; Klingenberg M, 1999, J BIOENERG BIOMEMBR, V31, P419, DOI 10.1023/A:1005440221914; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Mitschke MM, 2013, FASEB J, V27, P1621, DOI 10.1096/fj.12-221580; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Murholm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008458; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nookaew I, 2013, J CLIN ENDOCR METAB, V98, pE370, DOI 10.1210/jc.2012-2764; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scheele C, 2014, ADIPOCYTE, V3, P54, DOI 10.4161/adip.26520; Scheffler Immo E., 1999, MITOCHONDRIA, P266; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shen W, 2013, J LIPID RES, V54, P909, DOI 10.1194/jlr.M030924; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Svensson P., 2011, INT J MOL MED, V27; Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Voshol PJ, 2009, BBA-MOL CELL BIOL L, V1791, P479, DOI 10.1016/j.bbalip.2008.12.015; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yadav H, 2012, FRONT ENDOCRINOL, V3; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127701	10.1371/journal.pone.0127701	http://dx.doi.org/10.1371/journal.pone.0127701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010905	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900134
J	Billioux, A; Nakigozi, G; Newell, K; Chang, LW; Quinn, TC; Gray, RH; Ndyanabo, A; Galiwango, R; Kiggundu, V; Serwadda, D; Reynolds, SJ				Billioux, Alexander; Nakigozi, Gertrude; Newell, Kevin; Chang, Larry W.; Quinn, Thomas C.; Gray, Ron H.; Ndyanabo, Anthony; Galiwango, Ronald; Kiggundu, Valerian; Serwadda, David; Reynolds, Steven J.			Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VIRAL LOAD; THERAPY; OUTCOMES; ADULTS; PREDICTORS; PREVENTION; MORTALITY; COUNTRIES; FAILURE	Objectives HIV viral load is recommended for monitoring antiretroviral treatment and identifying treatment failure. We assessed the durability of viral suppression after viral load-triggered adherence counseling among patients with HIV viremia 6 months after ART initiation. Design Observational cohort enrolled in an antiretroviral treatment program in rural Uganda. Methods Participants who underwent routine viral load determination every 24 weeks and had at least 48 weeks of follow-up were included in this analysis. Patients with viral loads > 400 copies/ml at 24 weeks of treatment were given additional adherence counseling, and all patients were followed to assess the duration of viral suppression and development of virologic failure. Results 1,841 participants initiating antiretroviral therapy were enrolled in the Rakai Health Sciences Program between June 2005 and June 2011 and were followed with viral load monitoring every 24 weeks. 148 (8%) of patients did not achieve viral suppression at 24 weeks and were given additional adherence counseling. 85 (60%) of these patients had undetectable viral loads at 48 weeks, with a median duration of viral suppression of 240 weeks (IQR 193-288 weeks). Failure to achieve an undetectable viral load at 48 weeks was associated with age < 30 years and 24 week viral load > 2,000 copies/ml in multivariate logistic regression analysis. Conclusions The majority of patients with persistent viremia who were provided adherence counseling achieved robust viral suppression for a median 4.6 years. Access to virologic monitoring and adherence counseling is a priority in resource-limited settings.	[Billioux, Alexander; Chang, Larry W.; Quinn, Thomas C.; Reynolds, Steven J.] Johns Hopkins Sch Med, Baltimore, MD 21205 USA; [Billioux, Alexander; Nakigozi, Gertrude; Chang, Larry W.; Quinn, Thomas C.; Ndyanabo, Anthony; Galiwango, Ronald; Kiggundu, Valerian; Serwadda, David; Reynolds, Steven J.] Rakai Hlth Sci Program, Rakai, Uganda; [Newell, Kevin] Leidos Biomed Res Inc, Clin Monitoring Res Program, Clin Res Directorate, Frederick Natl Lab Canc Res, Frederick, MD USA; [Quinn, Thomas C.; Reynolds, Steven J.] NIAID, NIH, Bethesda, MD 20892 USA; [Chang, Larry W.; Gray, Ron H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Serwadda, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda	Johns Hopkins University; Johns Hopkins Medicine; Rakai Health Sciences Program; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Makerere University	Reynolds, SJ (corresponding author), Johns Hopkins Sch Med, Baltimore, MD 21205 USA.	sjr@jhmi.edu		Reynolds, Steven/0000-0002-5403-2759	National Cancer Institute [HHSN261200800001E]; National Institute of Mental Health [K23MH086338]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Leidos Biomedical Research, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, ZIAAI000361, ZIAAI001040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH086338] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Leidos Biomedical Research, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project has been funded in whole or in part with federal funds from the National Cancer Institute under Contract No. HHSN261200800001E, the National Institute of Mental Health under contract K23MH086338, and by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Leidos Biomedical Research, Inc., provided support in the form of a salary for author KN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; Almeida JM, 2011, AIDS RES HUM RETROV, V27, P705, DOI [10.1089/aid.2010.0200, 10.1089/AID.2010.0200]; Alvarez-Uria G, 2012, TROP MED INT HEALTH, V17, P1152, DOI 10.1111/j.1365-3156.2012.02982.x; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; De Beaudrap P, 2008, EUR J EPIDEMIOL, V23, P227, DOI 10.1007/s10654-007-9221-3; Enriquez M, 2011, HIV AIDS-RES PALLIAT, V3, P45, DOI 10.2147/HIV.S8993; Fregonese F, 2012, JAIDS-J ACQ IMM DEF, V60, P91, DOI 10.1097/QAI.0b013e31824bd33f; Grabar S, 2005, JAIDS-J ACQ IMM DEF, V39, P284, DOI 10.1097/01.qai.0000160925.33935.72; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jourdain G, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001494; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; McNabb J, 2001, CLIN INFECT DIS, V33, P700, DOI 10.1086/322590; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Metzner KJ, 2007, AIDS, V21, P703, DOI 10.1097/QAD.0b013e3280121ac6; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pirkle CM, 2009, HIV MED, V10, P152, DOI 10.1111/j.1468-1293.2008.00664.x; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Townsend David, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P314, DOI 10.1177/1545109709343966; von Wyl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077691; Wilson D, 2009, T ROY SOC TROP MED H, V103, P601, DOI 10.1016/j.trstmh.2008.11.007	29	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127235	10.1371/journal.pone.0127235	http://dx.doi.org/10.1371/journal.pone.0127235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011158	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900074
J	Charolidi, N; Schilling, T; Eder, C				Charolidi, Nicoletta; Schilling, Tom; Eder, Claudia			Microglial Kv1.3 Channels and P2Y12 Receptors Differentially Regulate Cytokine and Chemokine Release from Brain Slices of Young Adult and Aged Mice	PLOS ONE			English	Article							NEURONAL NMDA RECEPTORS; POTASSIUM CHANNELS; INFLAMMATORY RESPONSES; ACTIVATED MICROGLIA; EXPRESSION; ASTROCYTES; CULTURE; MODEL	Brain tissue damage following stroke or traumatic brain injury is accompanied by neuroinflammatory processes, while microglia play a central role in causing and regulating neuroinflammation via production of proinflammatory substances, including cytokines and chemokines. Here, we used brain slices, an established in situ brain injury model, from young adult and aged mice to investigate cytokine and chemokine production with particular focus on the role of microglia. Twenty four hours after slice preparation, higher concentrations of proinflammatory cytokines, i.e. TNF-alpha and IL-6, and chemokines, i.e. CCL2 and CXCL1, were released from brain slices of aged mice than from slices of young adult mice. However, maximal microglial stimulation with LPS for 24 h did not reveal age-dependent differences in the amounts of released cytokines and chemokines. Mechanisms underlying microglial cytokine and chemokine production appear to be similar in young adult and aged mice. Inhibition of microglial Kv1.3 channels with margatoxin reduced release of IL-6, but not release of CCL2 and CXCL1. In contrast, blockade of microglial P2Y12 receptors with PSB0739 inhibited release of CCL2 and CXCL1, whereas release of IL-6 remained unaffected. Cytokine and chemokine production was not reduced by inhibitors of Kir2.1 K+ channels or adenosine receptors. In summary, our data suggest that brain tissue damage-induced production of cytokines and chemokines is age-dependent, and differentially regulated by microglial Kv1.3 channels and P2Y12 receptors.	[Charolidi, Nicoletta; Schilling, Tom; Eder, Claudia] Univ London, Inst Infect & Immun, London SW17 0RE, England	University of London	Eder, C (corresponding author), Univ London, Inst Infect & Immun, Cranmer Terrace, London SW17 0RE, England.	ceder@sgul.ac.uk		Schilling, Tom/0000-0002-0274-5482; Charolidi, Nicoletta/0000-0002-5721-5155	EU-FP7 grant "TargetBraIn" [279017]	EU-FP7 grant "TargetBraIn"	Funding provided by EU-FP7 grant "TargetBraIn" (#279017).	Bartok A, 2014, TOXICON, V87, P6, DOI 10.1016/j.toxicon.2014.05.002; Benakis C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00461; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dissing-Olesen L, 2014, J NEUROSCI, V34, P10511, DOI 10.1523/JNEUROSCI.0405-14.2014; Duque A, 2013, DEV NEUROBIOL, V73, P841, DOI 10.1002/dneu.22105; Eder C, 2005, J NEUROSCI RES, V81, P314, DOI 10.1002/jnr.20476; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Huuskonen J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-25; Jaerve A, 2012, CELL TISSUE RES, V349, P229, DOI 10.1007/s00441-012-1427-3; Kawabori M, 2015, CURR MED CHEM, V22, P1258, DOI 10.2174/0929867322666150209154036; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Lyons SA, 2000, J CEREBR BLOOD F MET, V20, P1537, DOI 10.1097/00004647-200011000-00003; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Menteyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006770; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; NORENBERG W, 1994, J PHYSIOL-LONDON, V475, P15; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Peng Y, 2014, NEURO-ONCOLOGY, V16, P528, DOI 10.1093/neuonc/not221; Quick ED, 2014, J VIROL, V88, P13005, DOI 10.1128/JVI.01994-14; Rangaraju S, 2015, J ALZHEIMERS DIS, V44, P797, DOI 10.3233/JAD-141704; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Schilling T, 2015, GLIA, V63, P664, DOI 10.1002/glia.22776; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stock C, 2006, J IMMUNOL, V177, P8560, DOI 10.4049/jimmunol.177.12.8560; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Streit WJ, 2014, CURR OPIN IMMUNOL, V29, P93, DOI 10.1016/j.coi.2014.05.005; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Wang HR, 2011, ACS CHEM BIOL, V6, P845, DOI 10.1021/cb200146a; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022	43	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128463	10.1371/journal.pone.0128463	http://dx.doi.org/10.1371/journal.pone.0128463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011191	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900237
J	Faraone, N; Hillier, NK; Cutler, GC				Faraone, Nicoletta; Hillier, N. Kirk; Cutler, G. Christopher			Plant Essential Oils Synergize and Antagonize Toxicity of Different Conventional Insecticides against Myzus persicae (Hemiptera: Aphididae)	PLOS ONE			English	Article							AEDES-AEGYPTI; BOTANICAL INSECTICIDES; MAJOR CONSTITUENTS; SPODOPTERA-LITURA; AGRICULTURE; PYRETHRUM; PRODUCTS; BLENDS; REPELLENTS; RESISTANCE	Plant-derived products can play an important role in pest management programs. Essential oils from Lavandula angustifolia (lavender) and Thymus vulgaris (thyme) and their main constituents, linalool and thymol, respectively, were evaluated for insecticidal activity and synergistic action in combination with insecticides against green peach aphid, Myzus persicae (Sulzer) (Hemiptera: Aphididae). The essential oils and their main constituents exerted similar insecticidal activity when aphids were exposed by direct sprays, but were non-toxic by exposure to treated leaf discs. In synergism experiments, the toxicity of imidacloprid was synergized 16- to 20-fold by L. angustifolia and T. vulgaris essential oils, but far less synergism occurred with linalool and thymol, indicating that secondary constituents of the oils were probably responsible for the observed synergism. In contrast to results with imidacloprid, the insecticidal activity of spirotetramat was antagonized by L. angustifolia and T. vulgaris essential oils, and linalool and thymol. Our results demonstrate the potential of plant essential oils as synergists of insecticides, but show that antagonistic action against certain insecticides may occur.	[Faraone, Nicoletta; Cutler, G. Christopher] Dalhousie Univ, Fac Agr, Dept Environm Sci, Truro, NS B2N 5E3, Canada; [Hillier, N. Kirk] Acadia Univ, Dept Biol, Wolfville, NS B4P 2R6, Canada	Dalhousie University; Acadia University	Cutler, GC (corresponding author), Dalhousie Univ, Fac Agr, Dept Environm Sci, Truro, NS B2N 5E3, Canada.	chris.cutler@dal.ca	Hillier, Neil/AAM-7270-2020	Cutler, Chris/0000-0002-4666-9987	Atlantic Canada Opportunities Agency, Atlantic Innovation Fund [197853]	Atlantic Canada Opportunities Agency, Atlantic Innovation Fund	This research was supported by an Atlantic Canada Opportunities Agency, Atlantic Innovation Fund to NKH (No. 197853).	Abbassy MA, 2009, ENTOMOL EXP APPL, V131, P225, DOI 10.1111/j.1570-7458.2009.00854.x; Adams RP, 2007, IDENTIFICATION ESSEN, DOI [10.1002/cbdv.201100039, DOI 10.1002/CBDV.201100039]; Athanassiou CG, 2013, J ECON ENTOMOL, V106, P1902, DOI 10.1603/EC12474; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; BBERNARD C, 1993, J TOXICOL ENV HEALTH, V38, P199, DOI 10.1080/15287399309531712; Berenbaum M., 1985, Recent Advances in Phytochemistry, V19, P139; BLACKMAN R.L., 1984, ORIENT INSECTS; Bozin B, 2006, J AGR FOOD CHEM, V54, P1822, DOI 10.1021/jf051922u; Bruck E, 2009, CROP PROT, V28, P838, DOI 10.1016/j.cropro.2009.06.015; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; Cloyd RA, 2009, J ECON ENTOMOL, V102, P1567, DOI 10.1603/029.102.0422; Enan EE, 2005, INSECT BIOCHEM MOLEC, V35, P309, DOI 10.1016/j.ibmb.2004.12.007; Ghadamyari M, 2012, J PLANT PROT, V26, P29; Gonzalez-Coloma A, 2011, BIOCHEM SYST ECOL, V39, P1, DOI 10.1016/j.bse.2010.08.010; Halbert SE, 2009, ANN APPL BIOL, V154, P303, DOI 10.1111/j.1744-7348.2008.00300.x; Hori M, 1999, APPL ENTOMOL ZOOL, V34, P113, DOI 10.1303/aez.34.113; Hori M, 1998, J CHEM ECOL, V24, P1425, DOI 10.1023/A:1020947414051; Hummelbrunner LA, 2001, J AGR FOOD CHEM, V49, P715, DOI 10.1021/jf000749t; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470; Isman MB, 2012, PHARM BIOL, V50, P621; Isman MB, 2011, PHYTOCHEM REV, V10, P197, DOI 10.1007/s11101-010-9170-4; Ramirez GIJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048698; Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x; Jiang ZL, 2009, J AGR FOOD CHEM, V57, P4833, DOI 10.1021/jf900274r; Joffe T, 2012, PEST MANAG SCI, V68, P178, DOI 10.1002/ps.2241; Koul O, 2013, IND CROP PROD, V49, P428, DOI 10.1016/j.indcrop.2013.05.032; Liu SQ, 2014, J ECON ENTOMOL, V107, P797, DOI 10.1603/EC13440; Lopez MD, 2010, IND CROP PROD, V31, P284, DOI 10.1016/j.indcrop.2009.11.005; Danh LT, 2013, FOOD BIOPROCESS TECH, V6, P3481, DOI 10.1007/s11947-012-1026-z; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; METCALF RL, 1967, ANNU REV ENTOMOL, V12, P229, DOI 10.1146/annurev.en.12.010167.001305; Miresmailli S, 2006, PEST MANAG SCI, V62, P366, DOI 10.1002/ps.1157; Nauen R, 1996, B ENTOMOL RES, V86, P165, DOI 10.1017/S0007485300052408; Nguyen SN, 2007, J ECON ENTOMOL, V100, P534, DOI 10.1603/0022-0493(2007)100[534:TSANEO]2.0.CO;2; Nikolic M, 2014, IND CROP PROD, V61, P225, DOI 10.1016/j.indcrop.2014.07.011; Omolo MO, 2005, PHYTOMEDICINE, V12, P241, DOI 10.1016/j.phymed.2003.10.004; Pavela R., 2006, Journal of Essential Oil-Bearing Plants, V9, P99; Petrakis EA, 2014, IND CROP PROD, V62, P272, DOI 10.1016/j.indcrop.2014.08.041; PMRA, 2008, 1568427 PMRA HLTH CA; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Priestley CM, 2003, BRIT J PHARMACOL, V140, P1363, DOI 10.1038/sj.bjp.0705542; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; SAS, 2008, SAS VERS 9 2; Scott J.G., 1990, PESTICIDE RESISTANCE, P39, DOI DOI 10.1007/978-1-4684-6429-0_3; Shaalan EAS, 2005, J VECTOR ECOL, V30, P284; SUN YP, 1960, J AGR FOOD CHEM, V8, P261, DOI 10.1021/jf60110a003; Tomlin C.D.S., 2004, E PESTICIDE MANUAL, Vthirteenth; Tong F, 2013, J MED ENTOMOL, V50, P826, DOI 10.1603/ME13002; Waliwitiya R, 2012, J MED ENTOMOL, V49, P614, DOI 10.1603/ME10272; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Yu DY, 2011, AFR J BIOTECHNOL, V10, P3424	53	58	63	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127774	10.1371/journal.pone.0127774	http://dx.doi.org/10.1371/journal.pone.0127774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010088	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900143
J	Martins, HA; Simas, RC; Brolio, MP; Ferreira, CR; Perecin, F; Nogueira, GD; Miglino, MA; Martins, DS; Eberlin, MN; Ambrosio, CE				Martins-Junior, Helio A.; Simas, Rosineide C.; Brolio, Marina P.; Ferreira, Christina R.; Perecin, Felipe; Nogueira, Guilherme de P.; Miglino, Maria A.; Martins, Daniele S.; Eberlin, Marcos N.; Ambrosio, Carlos E.			Profiles of Steroid Hormones in Canine X-Linked Muscular Dystrophy via Stable Isotope Dilution LC-MS/MS	PLOS ONE			English	Article							MASS-SPECTROMETRY; GRMD DOGS; MUSCLE; MODEL; ENHANCEMENT; CARRIERS; LOCUS; GENE	Golden retriever muscular dystrophy (GRMD) provides the best animal model for characterizing the disease progress of the human disorder, Duchenne muscular dystrophy (DMD). The purpose of this study was to determine steroid hormone concentration profiles in healthy golden retriever dogs (control group - CtGR) versus GRMD-gene carrier (CaGR) and affected female dogs (AfCR). Therefore, a sensitive and specific analytical method was developed and validated to determine the estradiol, progesterone, cortisol, and testosterone levels in the canine serum by isotope dilution liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). To more accurately understand the dynamic nature of the serum steroid profile, the fluctuating levels of these four steroid hormones over the estrous cycle were compared across the three experimental groups using a multivariate statistical analysis. The concentration profiles of estradiol, cortisol, progesterone, and testosterone revealed a characteristic pattern for each studied group at each specific estrous phase. Additionally, several important changes in the serum concentrations of cortisol and estradiol in the CaGR and AfCR groups seem to be correlated with the status and progression of the muscular dystrophy. A comprehensive and quantitative monitoring of steroid profiles throughout the estrous cycle of normal and GRMD dogs were achieved. Significant differences in these profiles were observed between GRMD and healthy animals, most notably for estradiol. These findings contribute to a better understanding of both dog reproduction and the muscular dystrophy pathology. Our data open new venues for hormonal behavior studies in dystrophinopathies and that may affect the quality of life of DMD patients.	[Martins-Junior, Helio A.; Simas, Rosineide C.; Ferreira, Christina R.; Eberlin, Marcos N.] Univ Campinas UNICAMP, Inst Chem, ThoMSon Mass Spectrometry Lab, Campinas, SP, Brazil; [Martins-Junior, Helio A.] AB SCIEX Brazil, Sao Paulo, SP, Brazil; [Simas, Rosineide C.; Nogueira, Guilherme de P.] Sao Paulo State Univ UNESP, Fac Vet Med, DAPSA, Aracatuba, SP, Brazil; [Brolio, Marina P.; Perecin, Felipe; Martins, Daniele S.; Ambrosio, Carlos E.] Univ Sao Paulo, FZEA, Pirassununga, SP, Brazil; [Miglino, Maria A.] Univ Sao Paulo, Fac Vet Med & Anim Sci FMVZ, Sao Paulo, SP, Brazil; [Ferreira, Christina R.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ambrosio, CE (corresponding author), Univ Sao Paulo, FZEA, Pirassununga, SP, Brazil.	ceambrosio@usp.br	Ambrosio, Carlos Eduardo/F-3402-2010; Martins-Júnior, Helio A/B-7769-2015; Miglino, Maria Angelica/B-9519-2012; Ferreira, Christina Ramires/F-4744-2012; dos Santos Martins, Daniele/ABH-1262-2020; de Paula Nogueira, Guilherme/I-3595-2012; Perecin, Felipe/C-7268-2012; dos Santos Martins, Daniele/C-9004-2013; Simas, Rosineide Costa/J-2729-2015	Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Miglino, Maria Angelica/0000-0003-4979-115X; Ferreira, Christina Ramires/0000-0003-3988-6454; dos Santos Martins, Daniele/0000-0002-6277-4664; de Paula Nogueira, Guilherme/0000-0002-5277-7220; Perecin, Felipe/0000-0003-2009-5863; dos Santos Martins, Daniele/0000-0002-6277-4664; Simas, Rosineide Costa/0000-0002-2018-0403; Eberlin, Marcos Nogueira/0000-0003-4868-0618	FAPESP [2007/51222-2, 2010/15167-0, 2010/51677-2]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to thank FAPESP projects 2007/51222-2, 2010/15167-0, and 2010/51677-2.	Ambrosio CE, 2009, GENET MOL RES, V8, P389, DOI 10.4238/vol8-2gmr581; Araujo KPC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061367; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Brinkmeyer-Langford C, 2013, CURR GENOMICS, V14, P330, DOI 10.2174/13892029113149990004; Brolio MP, 2014, ANIM REPROD SCI, V150, P56, DOI 10.1016/j.anireprosci.2014.08.005; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; David ON, 2007, VERTEBRATE ENDOCRINO; Etter ML, 2006, J CHROMATOGR B, V840, P69, DOI 10.1016/j.jchromb.2006.04.038; Fanelli F, 2011, STEROIDS, V76, P244, DOI 10.1016/j.steroids.2010.11.005; Feldman EN, 2003, CANINE FELINE ENDOCR; Fortin T, 2009, ANAL CHEM, V81, P9343, DOI 10.1021/ac901447h; Gaiad TP, 2011, RES VET SCI, V91, P188, DOI 10.1016/j.rvsc.2011.01.007; Giton F, 2010, CLIN CHIM ACTA, V411, P1208, DOI 10.1016/j.cca.2010.04.022; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Gust M, 2010, J CHROMATOGR B, V878, P1487, DOI 10.1016/j.jchromb.2010.03.046; GUYTON AC, 2006, TXB MED PHYSL, P944; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hydbring-Sandberg E, 2004, J ENDOCRINOL, V180, P439, DOI 10.1677/joe.0.1800439; Inaba T, 2002, NEUROSCI LETT, V333, P107, DOI 10.1016/S0304-3940(02)01001-7; Isabelle GT, 2007, RES VET SCI, V82, P195, DOI 10.1016/j.rvsc.2006.07.010; Janssen PML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088360; Jones AC, 2006, HORM BEHAV, V50, P393, DOI 10.1016/j.yhbeh.2006.04.007; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Koal T, 2012, J STEROID BIOCHEM, V129, P129, DOI 10.1016/j.jsbmb.2011.12.001; Kushnir MM, 2011, CLIN BIOCHEM, V44, P77, DOI 10.1016/j.clinbiochem.2010.07.008; Liang HR, 2003, RAPID COMMUN MASS SP, V17, P2815, DOI 10.1002/rcm.1268; Morini AC, 2011, PESQUI VET BRASIL, V31, P94, DOI 10.1590/S0100-736X2011000100015; Nghiem PP, 2013, AM J PATHOL, V183, P1411, DOI 10.1016/j.ajpath.2013.07.013; Nguyen F, 2002, J COMP PATHOL, V126, P100, DOI 10.1053/jcpa.2001.0526; Nozoe KT, 2014, SEX MED-UK, V2, P133, DOI 10.1002/sm2.29; Peres MA, 2014, ANDROLOGIA, V46, P277, DOI 10.1111/and.12079; Pfaff DW, 2004, PRINCIPLES HORMONAL, P61; Samsa M, 2004, LAUR048575; Selk Ghaffari M., 2009, COMP CLIN PATHOL, V18, P341, DOI 10.1007/s00580-009-0815-x; SHARP NJH, 1989, SEMIN VET MED SURG, V4, P133; Stanczyk FZ, 2010, J STEROID BIOCHEM, V121, P491, DOI 10.1016/j.jsbmb.2010.05.001; Stapleton DI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091514; VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7	39	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126585	10.1371/journal.pone.0126585	http://dx.doi.org/10.1371/journal.pone.0126585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010907	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900034
J	Ostensson, E; Alder, S; Elfstrom, KM; Sundstrom, K; Zethraeus, N; Arbyn, M; Andersson, S				Ostensson, Ellinor; Alder, Susanna; Elfstrom, K. Miriam; Sundstrom, Karin; Zethraeus, Niklas; Arbyn, Marc; Andersson, Sonia			Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years	PLOS ONE			English	Article							PAPILLOMAVIRUS VACCINE UPTAKE; HPV VACCINATION; SCHOOL-STUDENTS; AWARENESS; PREVENTION; KNOWLEDGE; ATTITUDES; BEHAVIOR; SWEDEN; COST	Objective This study aims to identify possible barriers to and facilitators of cervical cancer screening by (a) estimating time and travel costs and other direct non-medical costs incurred in attending clinic-based cervical cancer screening, (b) investigating screening compliance and reasons for noncompliance, (c) determining women's knowledge of human papillomavirus (HPV), its relationship to cervical cancer, and HPV and cervical cancer prevention, and (d) investigating correlates of HPV knowledge and screening compliance. Materials and Methods 1510 women attending the clinic-based cervical cancer screening program in Stockholm, Sweden were included. Data on sociodemographic characteristics, time and travel costs and other direct non-medical costs incurred in attending (e.g., indirect cost of time needed for the screening visit, transportation costs, child care costs, etc.), mode(s) of travel, time, distance, companion's attendance, HPV knowledge, and screening compliance were obtained via self-administered questionnaire. Results Few respondents had low socioeconomic status. Mean total time and travel costs and direct non-medical cost per attendance, including companion (if any) were (sic)55.6. Over half (53%) of the respondents took time off work to attend screening (mean time 147 minutes). A large portion (44%) of the respondents were noncompliant (i.e., did not attend screening within 1 year of the initial invitation), 51% of whom stated difficulties in taking time off work. 64% of all respondents knew that HPV vaccination was available; only 34% knew it was important to continue to attend screening following vaccination. Age, education, and income were the most important correlates of HPV knowledge and compliance; and additional factors associated with compliance were time off work, accompanying companion and HPV knowledge. Conclusion Time and travel costs and other direct non-medical costs for clinic-based screening can be considerable, may affect the cost-effectiveness of a screening program, and may constitute barriers to screening while HPV knowledge may facilitate compliance with screening.	[Ostensson, Ellinor; Alder, Susanna; Andersson, Sonia] Karolinska Univ Hosp Solna, Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Elfstrom, K. Miriam] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sundstrom, Karin] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Zethraeus, Niklas] Karolinska Inst, Dept Learning Informat Management & Eth LIME, MMC, Stockholm, Sweden; [Arbyn, Marc] Sci Inst Publ Hlth, Canc Epidemiol Unit, Belgian Canc Ctr, B-1050 Brussels, Belgium	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Ostensson, E (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden.	ellinor.ostensson@ki.se	Alder, Susanna/HGD-0525-2022; Sundström, Karin/V-5714-2017	Sundström, Karin/0000-0002-6865-0224; Ostensson, Ellinor/0000-0003-0668-088X	Swedish Cancer Foundation [070623, CAN 2007/1044, 11 0544, CAN 2011/471]; Karolinska Institutet Cancer Strategic grants [5888/05-722]; Swedish Research Council [521-2008-2899]; Stockholm County Council [20130097]	Swedish Cancer Foundation; Karolinska Institutet Cancer Strategic grants; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council)	Swedish Cancer Foundation (070623, CAN 2007/1044, 11 0544, CAN 2011/471) URL: www.cancerfonden.se, SA; Karolinska Institutet Cancer Strategic grants (5888/05-722) URL: www.ki.se, SA; Swedish Research Council (521-2008-2899) URL: www.vr.se, SA; Stockholm County Council (20130097) URL www.skl.se, SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Arbyn M, 2010, ANN ONCOL, V21, P448, DOI 10.1093/annonc/mdp471; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Association SA, 2012, MOT COST; Bauch CT, 2010, LANCET INFECT DIS, V10, P133, DOI 10.1016/S1473-3099(10)70004-9; Bech M, 2000, HEALTH POLICY, V54, P125, DOI 10.1016/S0168-8510(00)00104-4; Blomberg K, 2008, PSYCHO-ONCOLOGY, V17, P561, DOI 10.1002/pon.1270; Chao C, 2009, AM J PUBLIC HEALTH, V99, P1137, DOI 10.2105/AJPH.2008.147876; Dahlstrom LA, 2012, J ADOLESCENT HEALTH, V50, P204, DOI 10.1016/j.jadohealth.2011.05.009; Dillner J, 2013, SWEDISH NATL QUALITY, DOI [10.1111/aogs.12561, DOI 10.1111/AOGS.12561]; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Dranove D, 1995, VALUING HLTH CARE, P61; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dyson S, 2010, SEX HEALTH, V7, P49, DOI 10.1071/SH09059; Farzaneh Farah, 2011, Med J Malaysia, V66, P468; Fylan F, 1998, BRIT J GEN PRACT, V48, P1509; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Gold M, 1996, MED CARE, V34, pDS197; Gottvall M, 2009, EUR J CONTRACEP REPR, V14, P399, DOI 10.3109/13625180903229605; Hoglund AT, 2009, INT J STD AIDS, V20, P102, DOI 10.1258/ijsa.2008.008200; IARC, 2005, CANC PREV HDB, V10; KIEFE CI, 1994, ARCH INTERN MED, V154, P1217, DOI 10.1001/archinte.154.11.1217; Kulasingam SL, 2007, VACCINE, V25, P8110, DOI 10.1016/j.vaccine.2007.09.035; Lancucki L, 2010, J MED SCREEN, V17, P91, DOI 10.1258/jms.2010.010017; Lefevere E, 2011, VACCINE, V29, P8390, DOI 10.1016/j.vaccine.2011.08.039; Leval A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020624; Link BG, 1998, MILBANK Q, V76, P375, DOI 10.1111/1468-0009.00096; Lloyd GP, 2009, J ADOLESCENT HEALTH, V45, P532, DOI 10.1016/j.jadohealth.2009.06.003; MAHLCK CG, 1994, INT J GYNECOL OBSTET, V44, P267, DOI 10.1016/0020-7292(94)90177-5; Marek E, 2012, VACCINE, V30, P6824, DOI 10.1016/j.vaccine.2012.09.012; Marlow LAV, 2007, BRIT J CANCER, V97, P691, DOI 10.1038/sj.bjc.6603927; Mather T, 2012, VACCINE, V30, P3196, DOI 10.1016/j.vaccine.2012.02.081; NEILSON AR, 1995, SOC SCI MED, V41, P365, DOI 10.1016/0277-9536(94)00329-R; Nohr B, 2008, ACTA OBSTET GYN SCAN, V87, P1048, DOI 10.1080/00016340802326373; Ostensson E, 2010, ACTA OBSTET GYN SCAN, V89, P1316, DOI 10.3109/00016349.2010.512066; Papa D, 2009, J LOW GENIT TRACT DI, V13, P66, DOI 10.1097/LGT.0b013e31818a53f0; Racey CS, 2013, CAN J PUBLIC HEALTH, V104, pE159, DOI 10.1007/BF03405681; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sach TH, 2005, INT J PEDIATR OTORHI, V69, P929, DOI 10.1016/j.ijporl.2005.01.037; Sach Tracey H, 2003, Appl Health Econ Health Policy, V2, P135; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sculpher M J, 1992, Health Econ, V1, P39, DOI 10.1002/hec.4730010107; Sendi Pedram, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P1, DOI 10.1586/14737167.4.1.1; Steens A, 2013, INT J CANCER, V132, P932, DOI 10.1002/ijc.27671; Stockholms Lokaltrafik [SL], 2014, STOCKHOLM PUBLIC TRA; Thompson S, 2001, 0301 HERU; Tillgren P, 2011, INT J CANCER, V130, P937, DOI [10.1002/ijc.26084, DOI 10.1002/IJC.26084]; Tornberg S, 2014, AVGIFTSFRI MAMMOGRAF, V111, pCM7X; Trafikanalys, 2011, ARB STORST NUL; Tristram A, 2006, BEST PRACT RES CL OB, V20, P267, DOI 10.1016/j.bpobgyn.2005.10.006; Woolley C, 2007, INT J TECHNOL ASSESS, V23, P232, DOI 10.1017/S026646230707016X; WSP Sverige AB, 2010, TRAF VARD TID NAT TI; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	55	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128270	10.1371/journal.pone.0128270	http://dx.doi.org/10.1371/journal.pone.0128270			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011051	Green Published, gold			2022-12-27	WOS:000355183900215
J	Panicker, IS; Browning, GF; Markham, PF				Panicker, Indu S.; Browning, Glenn F.; Markham, Philip F.			The Effect of an Alternate Start Codon on Heterologous Expression of a PhoA Fusion Protein in Mycoplasma gallisepticum	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSLATIONAL EFFICIENCY; BACILLUS-SUBTILIS; INITIATION CODON; MESSENGER-RNA; GENE-EXPRESSION; GENOME SEQUENCE; PROKARYOTES; EUKARYOTES; PNEUMONIAE	While the genomes of many Mycoplasma species have been sequenced, there are no collated data on translational start codon usage, and the effects of alternate start codons on gene expression have not been studied. Analysis of the annotated genomes found that ATG was the most prevalent translational start codon among Mycoplasma spp. However in Mycoplasma gallisepticum a GTG start codon is commonly used in the vlhA multigene family, which encodes a highly abundant, phase variable lipoprotein adhesin. Therefore, the effect of this alternate start codon on expression of a reporter PhoA lipoprotein was examined in M. gallisepticum. Mutation of the start codon from ATG to GTG resulted in a 2.5 fold reduction in the level of transcription of the phoA reporter, but the level of PhoA activity in the transformants containing phoA with a GTG start codon was only 63% of that of the transformants with a phoA with an ATG start codon, suggesting that GTG was a more efficient translational initiation codon. The effect of swapping the translational start codon in phoA reporter gene expression was less in M. gallisepticum than has been seen previously in Escherichia coli or Bacillus subtilis, suggesting the process of translational initiation in mycoplasmas may have some significant differences from those used in other bacteria. This is the first study of translational start codon usage in mycoplasmas and the impact of the use of an alternate start codon on expression in these bacteria.	[Panicker, Indu S.; Browning, Glenn F.; Markham, Philip F.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic, Australia	University of Melbourne	Browning, GF (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic, Australia.	glenfb@unimelb.edu.au	Somasundara Panicker, Indu/K-6010-2015; Browning, Glenn Francis/P-4459-2014	Somasundara Panicker, Indu/0000-0003-4395-5096; Browning, Glenn Francis/0000-0002-0903-2469	International Postgraduate Research Scholarship from the Commonwealth of Australia	International Postgraduate Research Scholarship from the Commonwealth of Australia	ISP was in receipt of an International Postgraduate Research Scholarship from the Commonwealth of Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengaud J, 2009, CURR OPIN MICROBIOL, V12, P292, DOI 10.1016/j.mib.2009.03.005; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Dybvig K, 1996, ANNU REV MICROBIOL, V50, P25, DOI 10.1146/annurev.micro.50.1.25; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; GUILLEREZ J, 1991, NUCLEIC ACIDS RES, V19, P6743, DOI 10.1093/nar/19.24.6743; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; INAMINE JM, 1990, J BACTERIOL, V172, P504, DOI 10.1128/JB.172.1.504-506.1990; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Li WC, 2007, ANTON LEEUW INT J G, V92, P417, DOI 10.1007/s10482-007-9170-6; LOOMAN AC, 1986, FEBS LETT, V197, P315, DOI 10.1016/0014-5793(86)80349-0; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Mazin PV, 2014, NUCLEIC ACIDS RES, V42, P13254, DOI 10.1093/nar/gku976; MUTO A, 2002, MOL BIOL PATHOGENICI, P323; Panicker IS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-138; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; Rocha EPC, 1999, NUCLEIC ACIDS RES, V27, P3567, DOI 10.1093/nar/27.17.3567; Sharp JS, 2003, J BACTERIOL, V185, P5372, DOI 10.1128/JB.185.18.5372-5379.2003; Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Villegas A, 2008, MICROBIOL-SGM, V154, P2559, DOI 10.1099/mic.0.2008/021360-0; YAMAO F, 1985, P NATL ACAD SCI USA, V82, P2306, DOI 10.1073/pnas.82.8.2306; Yeh CM, 1997, J APPL MICROBIOL, V83, P758, DOI 10.1046/j.1365-2672.1997.00306.x; Zalucki YM, 2009, TRENDS MICROBIOL, V17, P146, DOI 10.1016/j.tim.2009.01.005	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127911	10.1371/journal.pone.0127911	http://dx.doi.org/10.1371/journal.pone.0127911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010086	Green Published, gold			2022-12-27	WOS:000355183900163
J	Yong, HEJ; Melton, PE; Johnson, MP; Freed, KA; Kalionis, B; Murthi, P; Brennecke, SP; Keogh, RJ; Moses, EK				Yong, Hannah E. J.; Melton, Phillip E.; Johnson, Matthew P.; Freed, Katy A.; Kalionis, Bill; Murthi, Padma; Brennecke, Shaun P.; Keogh, Rosemary J.; Moses, Eric K.			Genome-Wide Transcriptome Directed Pathway Analysis of Maternal Pre-Eclampsia Susceptibility Genes	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2 AND-9; 1ST TRIMESTER PLACENTAS; HYPERTENSIVE DISORDERS; CARDIOVASCULAR-DISEASE; GROWTH RESTRICTION; FETAL INTERFACE; PRETERM BIRTH; RISK-FACTORS; ACTIVIN-A; PREGNANCY	Background Preeclampsia (PE) is a serious hypertensive pregnancy disorder with a significant genetic component. Numerous genetic studies, including our own, have yielded many susceptibility genes from distinct functional groups. Additionally, transcriptome profiling of tissues at the maternal-fetal interface has likewise yielded many differentially expressed genes. Often there is little overlap between these two approaches, although genes identified in both approaches are significantly associated with PE. We have thus taken a novel integrative bioinformatics approach of analysing pathways common to the susceptibility genes and the PE transcriptome. Methods Using Illumina Human Ht12v4 and Wg6v3 BeadChips, transcriptome profiling was conducted on n = 65 normotensive and n = 60 PE decidua basalis tissues collected at delivery. The R software package libraries lumi and limma were used to preprocess transcript data for pathway analysis. Pathways were analysed and constructed using Pathway Studio. We examined ten candidate genes, which are from these functional groups: activin/inhibin signalling-ACVR1, ACVR1C, ACVR2A, INHA, INHBB; structural components-COL4A1, COL4A2 and M1 family aminopeptidases-ERAP1, ERAP2 and LNPEP. Results/Conclusion Major common regulators/targets of these susceptibility genes identified were AGT, IFNG, IL6, INHBA, SERPINE1, TGFB1 and VEGFA. The top two categories of pathways associated with the susceptibility genes, which were significantly altered in the PE decidual transcriptome, were apoptosis and cell signaling (p < 0.001). Thus, susceptibility genes from distinct functional groups share similar downstream pathways through common regulators/targets, some of which are altered in PE. This study contributes to a better understanding of how susceptibility genes may interact in the development of PE. With this knowledge, more targeted functional analyses of PE susceptibility genes in these key pathways can be performed to examine their contributions to the pathogenesis and severity of PE.	[Yong, Hannah E. J.; Kalionis, Bill; Murthi, Padma; Brennecke, Shaun P.; Keogh, Rosemary J.] Pregnancy Res Ctr, Dept Perinatal Med, Parkville, Vic 3052, Australia; [Yong, Hannah E. J.; Kalionis, Bill; Murthi, Padma; Brennecke, Shaun P.; Keogh, Rosemary J.] Univ Melbourne, Dept Obstet & Gynaecol, Royal Womens Hosp, Parkville, Vic 3052, Australia; [Melton, Phillip E.; Moses, Eric K.] Univ Western Australia, Ctr Genet Origins Hlth & Dis, Crawley, WA 6009, Australia; [Johnson, Matthew P.; Freed, Katy A.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA	University of Melbourne; University of Western Australia; Texas Biomedical Research Institute	Yong, HEJ (corresponding author), Pregnancy Res Ctr, Dept Perinatal Med, Locked Bag 300,Corner Grattan St & Flemington Rd, Parkville, Vic 3052, Australia.	ejyong@student.unimelb.edu.au	Yong, Hannah Ee Juen/GPS-8941-2022; Brennecke, Shaun/AFV-3919-2022; KALIONIS, BILL/B-4766-2011; Melton, Phillip/A-5012-2013; Murthi, Padma/AAY-5395-2021	Yong, Hannah Ee Juen/0000-0002-8814-752X; Brennecke, Shaun/0000-0003-3070-6971; Melton, Phillip/0000-0003-4026-2964; Moses, Eric/0000-0001-7781-4465	National Institutes of Health [HD049847]; National Health and Medical Research Council [APP1053152]; Faye L. and William L. Cowden Charitable Foundation; Australian Society for Medical Research; University of Melbourne's Melbourne International Fee Remission Scholarship; Felix Meyer Scholarship in Obstetrics and Gynaecology; National Center for Research Resources, National Institutes of Health [RR017515]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049847] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Faye L. and William L. Cowden Charitable Foundation; Australian Society for Medical Research; University of Melbourne's Melbourne International Fee Remission Scholarship; Felix Meyer Scholarship in Obstetrics and Gynaecology; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health [HD049847 to E.K.M. and S.P.B.], the National Health and Medical Research Council [APP1053152 to E.K.M. and S.P.B.], and the Faye L. and William L. Cowden Charitable Foundation (to M. P.J.). H.E.J.Y. was supported by the Australian Society for Medical Research 2013 Domestic Research Travel Award, the University of Melbourne's Melbourne International Fee Remission Scholarship, and the Felix Meyer Scholarship in Obstetrics and Gynaecology. Transcriptional profiling was conducted in facilities constructed with support from Research Facilities Improvement Program grant RR017515 from the National Center for Research Resources, National Institutes of Health. National Institutes of Health: grants.nih.gov; National Health and Medical Research Council: http://www.nhmrc.gov.au/; Faye L. and William L. Cowden Charitable Foundation: http://www.broadwaybank.com/wealthmanagement/FoundationFayeLWilliamLCowden.html; Australian Society for Medical Research: www.asmr.org.au; The University of Melbourne: www.unimelb.edu.au.	Aggarwal PK, 2012, J HUM HYPERTENS, V26, P236, DOI 10.1038/jhh.2011.29; Anderson CM, 2007, JOGNN-J OBST GYN NEO, V36, P3, DOI [10.1111/j.1552-6909.2006.00115.x, 10.1111/J.1552-6909.2006.00115.x]; Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Arngrimsson R, 1997, AM J HUM GENET, V61, P354, DOI 10.1086/514843; Bauer V, 2010, GEN PHYSIOL BIOPHYS, V29, P319, DOI 10.4149/gpb_2010_04_319; Brown DW, 2006, STROKE, V37, P1055, DOI 10.1161/01.STR.0000206284.96739.ee; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P133, DOI 10.1111/j.1479-828X.2000.tb01136.x; BROWN MA, 1993, MED J AUSTRALIA, V158, P700; Chang SD, 2011, TAIWAN J OBSTET GYNE, V50, P283, DOI 10.1016/j.tjog.2011.07.005; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; Colorado PC, 2000, CANCER RES, V60, P2520; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Eide IP, 2008, ACTA OBSTET GYN SCAN, V87, P272, DOI 10.1080/00016340701763015; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Founds SA, 2011, J PERINAT MED, V39, P361, DOI [10.1515/JPM.2011.045, 10.1515/jpm.2011.045]; Guo GL, 1999, HUM GENET, V105, P641, DOI 10.1007/s004390051156; Herse F, 2007, HYPERTENSION, V49, P604, DOI 10.1161/01.HYP.0000257797.49289.71; Hsu P, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00125; Jebbink J, 2012, BBA-MOL BASIS DIS, V1822, P1960, DOI 10.1016/j.bbadis.2012.08.004; Johnson MP, 2007, MOL HUM REPROD, V13, P61, DOI 10.1093/molehr/gal095; Johnson MP, 2013, MOL HUM REPROD, V19, P423, DOI 10.1093/molehr/gat011; Johnson MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033666; Kalkunte S, 2010, AM J PATHOL, V177, P2387, DOI 10.2353/ajpath.2010.100475; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Kleinrouweler CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068991; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Kumar A, 2013, CELL IMMUNOL, V283, P70, DOI 10.1016/j.cellimm.2013.06.012; Laivuori H, 2003, AM J HUM GENET, V72, P168, DOI 10.1086/345311; Li W, 2014, BIOCHEM PHARMACOL, V89, P370, DOI 10.1016/j.bcp.2014.03.017; Lian IA, 2011, PLACENTA, V32, P823, DOI 10.1016/j.placenta.2011.08.005; Lian IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069848; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Louwen F, 2012, ONCOTARGET, V3, P759; Mangos GJ, 2006, J HYPERTENS, V24, P639, DOI 10.1097/01.hjh.0000217844.57466.85; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; Monboisse JC, 2014, BBA-GEN SUBJECTS, V1840, P2589, DOI 10.1016/j.bbagen.2013.12.029; Mori T, 2010, HYPERTENS RES, V33, P250, DOI 10.1038/hr.2009.222; Moses EK, 2006, MOL HUM REPROD, V12, P505, DOI 10.1093/molehr/gal056; Muetze S, 2008, J PERINAT MED, V36, P38, DOI 10.1515/JPM.2008.004; Munaut C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033475; Muttukrishna S, 1997, LANCET, V349, P1285, DOI 10.1016/S0140-6736(96)09264-1; Myatt L, 2013, BJOG-INT J OBSTET GY, V120, P1183, DOI 10.1111/1471-0528.12128; Nilsson E, 2004, BJOG-INT J OBSTET GY, V111, P200, DOI 10.1111/j.1471-0528.2004.00042x.x; Ozkan ZS, 2014, J MATERN-FETAL NEO M, V27, P1513, DOI 10.3109/14767058.2013.861415; Palei ACT, 2012, EXP MOL PATHOL, V92, P217, DOI 10.1016/j.yexmp.2012.01.008; Petrou S, 2011, ARCH DIS CHILD-FETAL, V96, pF225, DOI 10.1136/adc.2009.161117; Plaks V, 2013, P NATL ACAD SCI USA, V110, P11109, DOI 10.1073/pnas.1309561110; Prins JR, 2012, J REPROD IMMUNOL, V95, P1, DOI 10.1016/j.jri.2012.05.004; Ros HS, 2000, AM J MED GENET, V91, P256; Sahay AS, 2014, HYPERTENS RES, DOI [10.1038/hr.2014.71, DOI 10.1038/HR.2014.71HR201471]; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sharp AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087621; Silver HM, 1999, AM J OBSTET GYNECOL, V180, P1131, DOI 10.1016/S0002-9378(99)70606-X; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Dijk M, 2005, NAT GENET, V37, P514, DOI 10.1038/ng1541; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Whitley GSJ, 2009, J ANAT, V215, P21, DOI 10.1111/j.1469-7580.2008.01039.x; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Yong HEJ, 2014, PLACENTA, V35, P117, DOI 10.1016/j.placenta.2013.11.008; Zhang Z, 2013, MOL CELL BIOCHEM, V381, P31, DOI 10.1007/s11010-013-1685-8; Zhao LL, 2013, ANN HUM GENET, V77, P277, DOI 10.1111/ahg.12021; Zhao LL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-61	68	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128230	10.1371/journal.pone.0128230	http://dx.doi.org/10.1371/journal.pone.0128230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010865	Green Published, gold			2022-12-27	WOS:000355183900211
J	Yu, XK; He, L; Cao, P; Yu, Q				Yu, Xiaokui; He, Li; Cao, Peng; Yu, Qiang			Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3	PLOS ONE			English	Article							CELL-CYCLE ARREST; ANTITUMOR-ACTIVITY; TYROSINE KINASES; LEUKEMIA-CELLS; DNA-BINDING; TRANSCRIPTION; APOPTOSIS; PROTEIN; TRANSDUCERS; PATHWAY	Activated STAT3 plays an important role in oncogenesis by stimulating cell proliferation and resisting apoptosis. STAT3 therefore is an attractive target for cancer therapy. We have screened a traditional Chinese herb medicine compound library and found Eriocalyxin B (EB), a diterpenoid from Isodon eriocalyx, as a specific inhibitor of STAT3. EB selectively inhibited constitutive as well as IL-6-induced phosphorylation of STAT3 and induced apoptosis of STAT3-dependent tumor cells. EB did not affect the upstream protein tyrosine kinases or the phosphatase (PTPase) of STAT3, but rather interacted directly with STAT3. The effects of EB could be abolished by DTT or GSH, suggesting a thiol-mediated covalent linkage between EB and STAT3. Site mutagenesis of cysteine in and near the SH2 domain of STAT3 identified Cys712 to be the critical amino acid for the EB-induced inactivation of STAT3. Furthermore, LC/MS/MS analyses demonstrated that an a, beta-unsaturated carbonyl of EB covalently interacted with the Cys712 of STAT3. Computational modeling analyses also supported a direct interaction between EB and the Cys712 of STAT3. These data strongly suggest that EB directly targets STAT3 through a covalent linkage to inhibit the phosphorylation and activation of STAT3 and induces apoptosis of STAT3-dependent tumor cells.	[Yu, Xiaokui; He, Li; Yu, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 200031, Peoples R China; [Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Nanjing University of Chinese Medicine	Yu, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 200031, Peoples R China.	qyu@sibs.ac.cn		, Peng/0000-0002-2044-3074	China Ministry of Science & Technology "Key New Drug Creation and Manufacturing Program" [2013ZX09102015]; China Ministry of Science and Technology [2013ZX10002010-009]; China National Natural Science Foundation [81373447, 91129701, 91213304, 81274150]; National Science and Technology 973 grants [2012CB910704, 2013CB910900]	China Ministry of Science & Technology "Key New Drug Creation and Manufacturing Program"; China Ministry of Science and Technology(Ministry of Science and Technology, China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology 973 grants	This work was supported by the China Ministry of Science & Technology "Key New Drug Creation and Manufacturing Program" Grant 2013ZX09102015; the China Ministry of Science and Technology Research Grant 2013ZX10002010-009; the China National Natural Science Foundation Grants 81373447, 91129701, 91213304, and 81274150; the National Science and Technology 973 grants 2012CB910704 and 2013CB910900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkova L, 2007, FOLIA BIOL-PRAGUE, V53, P1; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Buettner R, 2011, ACS CHEM BIOL, V6, P432, DOI 10.1021/cb100253e; Cao D, 2007, AM J PHYSIOL-LUNG C, V292, pL422, DOI 10.1152/ajplung.00204.2006; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; Chen Z, 2012, ACTA PHARMACOL SIN, V33, P101, DOI 10.1038/aps.2011.164; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Heidelberger S, 2013, BIOORG MED CHEM LETT, V23, P4719, DOI 10.1016/j.bmcl.2013.05.066; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Inghirami G, 2005, CELL CYCLE, V4, P1131, DOI 10.4161/cc.4.9.1985; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Klampfer L, 2006, CURR CANCER DRUG TAR, V6, P107, DOI 10.2174/156800906776056491; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Li L, 2012, TOXICOL APPL PHARM, V262, P80, DOI 10.1016/j.taap.2012.04.021; Liu DB, 2012, ACTA PHARMACOL SIN, V33, P682, DOI 10.1038/aps.2012.18; Lu Y, 2013, P NATL ACAD SCI USA, V110, P2258, DOI 10.1073/pnas.1222426110; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Pellegrini S, 1997, EUR J BIOCHEM, V248, P615, DOI 10.1111/j.1432-1033.1997.00615.x; Qi Qian-Rong, 2014, World J Biol Chem, V5, P231, DOI 10.4331/wjbc.v5.i2.231; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Sareila O, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/16161; Schuringa JJ, 2000, BLOOD, V95, P3765, DOI 10.1182/blood.V95.12.3765; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; SUN HD, 1995, PHYTOCHEMISTRY, V38, P1451, DOI 10.1016/0031-9422(94)00815-B; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Urn HJ, 2012, BIOCHEM BIOPH RES CO, V427, P24, DOI 10.1016/j.bbrc.2012.08.133; Wang L, 2007, CELL DEATH DIFFER, V14, P306, DOI 10.1038/sj.cdd.4401996; Wang Y, 2009, CANCER RES, V69, P7302, DOI 10.1158/0008-5472.CAN-09-0462; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Xu XL, 1998, CANCER RES, V58, P2832; Ye YC, 2012, ACTA PHARMACOL SIN, V33, P1055, DOI 10.1038/aps.2012.53; Zhang YW, 2010, EXP HEMATOL, V38, P191, DOI 10.1016/j.exphem.2009.12.005; Zhao Y, 2007, EUR J MED CHEM, V42, P494, DOI 10.1016/j.ejmech.2006.11.004	53	28	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128406	10.1371/journal.pone.0128406	http://dx.doi.org/10.1371/journal.pone.0128406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010889	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900233
J	Liu, TX; Wu, HY; Cao, DN; Li, QY; Zhang, YQ; Li, N; Hu, XX				Liu, Tongxin; Wu, Hanyu; Cao, Dainan; Li, Qingyuan; Zhang, Yaqiong; Li, Ning; Hu, Xiaoxiang			Oviduct-Specific Expression of Human Neutrophil Defensin 4 in Lentivirally Generated Transgenic Chickens	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; ANTIMICROBIAL PEPTIDES; NONDIVIDING CELLS; OVALBUMIN GENE; MILK; PROTEIN; VECTOR; TRANSMISSION; PURIFICATION; KNOCKOUT	The expression of oviduct-specific recombinant proteins in transgenic chickens is a promising technology for the production of therapeutic biologics in eggs. In this study, we constructed a lentiviral vector encoding an expression cassette for human neutrophil defensin 4 (HNP4), a compound that displays high activity against Escherichia coli, and produced transgenic chickens that expressed the recombinant HNP4 protein in egg whites. After the antimicrobial activity of the recombinant HNP4 protein was tested at the cellular level, a 2.8-kb ovalbumin promoter was used to drive HNP4 expression specifically in oviduct tissues. From 669 injected eggs, 218 chickens were successfully hatched. Ten G(0) roosters, with semens identified as positive for the transgene, were mated with wild-type hens to generate G(1) chickens. From 1,274 total offspring, fifteen G1 transgenic chickens were positive for the transgene, which was confirmed by PCR and Southern blotting. The results of the Southern blotting and genome walking indicated that a single copy of the HNP4 gene was integrated into chromosomes 1, 2, 3, 4, 6 and 24 of the chickens. As expected, HNP4 expression was restricted to the oviduct tissues, and the levels of both transcriptional and translational HNP4 expression varied greatly in transgenic chickens with different transgene insertion sites. The amount of HNP4 protein expressed in the eggs of G(1) and G(2) heterozygous transgenic chickens ranged from 1.65 mu g/ml to 10.18 mu g/ml. These results indicated that the production of transgenic chickens that expressed HNP4 protein in egg whites was successful.	[Liu, Tongxin; Wu, Hanyu; Cao, Dainan; Li, Qingyuan; Zhang, Yaqiong; Li, Ning; Hu, Xiaoxiang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Hu, XX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	huxx@cau.edu.cn		Cao, Dainan/0000-0001-6119-9357	948 Program of the Ministry of Agriculture of China [2012-G1]; National High Technology Research and Development Program of China [2011AA100301]; Key Technology Research and Development Program of Guangdong Emerging Strategic Industries [2012A020800005]	948 Program of the Ministry of Agriculture of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Technology Research and Development Program of Guangdong Emerging Strategic Industries	This work was supported by a grant from 948 Program of the Ministry of Agriculture of China (2012-G1), the National High Technology Research and Development Program of China (2011AA100301) and Key Technology Research and Development Program of Guangdong Emerging Strategic Industries (2012A020800005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan MS, 2005, ANESTHESIOLOGY, V102, P276, DOI 10.1097/00000542-200502000-00007; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Borwornpinyo S, 2005, POULTRY SCI, V84, P1477, DOI 10.1093/ps/84.9.1477; BOSSELMAN RA, 1989, SCIENCE, V243, P533, DOI 10.1126/science.2536194; Brophy B, 2003, NAT BIOTECHNOL, V21, P157, DOI 10.1038/nbt783; Byun SJ, 2011, BIOSCI BIOTECH BIOCH, V75, P646, DOI 10.1271/bbb.100721; Chapman SC, 2005, DEVELOPMENT, V132, P935, DOI 10.1242/dev.01652; de Lucca AJ, 1999, ANTIMICROB AGENTS CH, V43, P1, DOI 10.1093/jac/43.1.1; DENMAN J, 1991, BIO-TECHNOL, V9, P839, DOI 10.1038/nbt0991-839; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; HAECKER SAE, 1995, MOL ENDOCRINOL, V9, P1113, DOI 10.1210/me.9.9.1113; Hancock REW, 1997, J MED MICROBIOL, V46, P1; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Ko JH, 2000, TRANSGENIC RES, V9, P215, DOI 10.1023/A:1008972010351; Kwon SC, 2010, BIOL REPROD, V82, P1057, DOI 10.1095/biolreprod.109.081687; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonberg N., 2008, V181, P69; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Paleyanda RK, 1997, NAT BIOTECHNOL, V15, P971, DOI 10.1038/nbt1097-971; Park HM, 2000, BIOCHEMISTRY-US, V39, P8537, DOI 10.1021/bi0005862; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; RYAN TM, 1990, SCIENCE, V247, P566, DOI 10.1126/science.2154033; SALTER DW, 1986, POULTRY SCI, V65, P1445, DOI 10.3382/ps.0651445; Schambach A, 2006, GENE THER, V13, P641, DOI 10.1038/sj.gt.3302698; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Vakili N, 2011, MOL CELL ENDOCRINOL, V345, P48, DOI 10.1016/j.mce.2011.07.010; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; WILDE CG, 1989, J BIOL CHEM, V264, P11200; WRIGHT G, 1991, BIO-TECHNOL, V9, P830, DOI 10.1038/nbt0991-830; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062	39	15	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127922	10.1371/journal.pone.0127922	http://dx.doi.org/10.1371/journal.pone.0127922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020529	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300065
J	Mils, V; Bosch, S; Roy, J; Bel-Vialar, S; Belenguer, P; Pituello, F; Miquel, MC				Mils, Valerie; Bosch, Stephanie; Roy, Julie; Bel-Vialar, Sophie; Belenguer, Pascale; Pituello, Fabienne; Miquel, Marie-Christine			Mitochondrial Reshaping Accompanies Neural Differentiation in the Developing Spinal Cord	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; STEM-CELL DIFFERENTIATION; DYNAMIN-RELATED PROTEIN; EMBRYONIC-DEVELOPMENT; ENERGY-METABOLISM; SYNAPSE FORMATION; OPA1; FUSION; PLASTICITY; MORPHOLOGY	Mitochondria, long known as the cell powerhouses, also regulate redox signaling and arbitrate cell survival. The organelles are now appreciated to exert additional critical roles in cell state transition from a pluripotent to a differentiated state through balancing glycolytic and respiratory metabolism. These metabolic adaptations were recently shown to be concomitant with mitochondrial morphology changes and are thus possibly regulated by contingencies of mitochondrial dynamics. In this context, we examined, for the first time, mitochondrial network plasticity during the transition from proliferating neural progenitors to post-mitotic differentiating neurons. We found that mitochondria underwent morphological reshaping in the developing neural tube of chick and mouse embryos. In the proliferating population, mitochondria in the mitotic cells lying at the apical side were very small and round, while they appeared thick and short in interphase cells. In differentiating neurons, mitochondria were reorganized into a thin, dense network. This reshaping of the mitochondrial network was not specific of a subtype of progenitors or neurons, suggesting that this is a general event accompanying neurogenesis in the spinal cord. Our data shed new light on the various changes occurring in the mitochondrial network during neurogenesis and suggest that mitochondrial dynamics could play a role in the neurogenic process.	[Mils, Valerie; Bosch, Stephanie; Roy, Julie; Bel-Vialar, Sophie; Belenguer, Pascale; Pituello, Fabienne; Miquel, Marie-Christine] Univ Toulouse 3, Univ Toulouse, CNRS, Ctr Biol Dev,UMR5547, Toulouse, France; [Miquel, Marie-Christine] Univ Paris 06, Sorbonne Univ, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Sorbonne Universite	Miquel, MC (corresponding author), Univ Toulouse 3, Univ Toulouse, CNRS, Ctr Biol Dev,UMR5547, Toulouse, France.	marie-christine.miquel@univ-tlse3.fr		Miquel, Marie-Christine/0000-0002-9332-2572; Belenguer, Pascale/0000-0003-0229-5554	French CNRS; French Universite Toulouse 3; French AMMI [5841174]	French CNRS(Centre National de la Recherche Scientifique (CNRS)); French Universite Toulouse 3; French AMMI	This work was funded by French CNRS, perennial grants (http://www.cnrs.fr/), French Universite Toulouse 3, perennial grants (http://www.univ-tlse3.fr/), and French AMMI, grant 5841174 (http://www.association-ammi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Basak NP, 2014, J BIOL CHEM, V289, P7320, DOI 10.1074/jbc.M113.519405; Bertholet AM, 2013, BRAIN, V136, P1518, DOI 10.1093/brain/awt060; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013; Chen CT, 2010, BBA-GEN SUBJECTS, V1800, P257, DOI 10.1016/j.bbagen.2009.09.001; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Choi SY, 2013, FASEB J, V27, P51, DOI 10.1096/fj.12-211920; Cohen M, 2013, CURR OPIN GENET DEV, V23, P423, DOI 10.1016/j.gde.2013.04.003; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Folmes CDL, 2012, ANN NY ACAD SCI, V1254, P82, DOI 10.1111/j.1749-6632.2012.06487.x; Galloway CA, 2012, FREE RADICAL BIO MED, V53, P2218, DOI 10.1016/j.freeradbiomed.2012.09.035; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Horn SR, 2011, MOL BIOL CELL, V22, P1207, DOI 10.1091/mbc.E10-07-0567; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kasahara A, 2014, TRENDS CELL BIOL; Kasahara A, 2013, SCIENCE, V342, P734, DOI 10.1126/science.1241359; Kosodo Y, 2012, CELL MOL LIFE SCI, V69, P2727, DOI 10.1007/s00018-012-0952-2; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Le Dreau G, 2013, CELL MOL LIFE SCI, V70, P4293, DOI 10.1007/s00018-013-1354-9; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lobjois V, 2004, DEV BIOL, V273, P195, DOI 10.1016/j.ydbio.2004.05.031; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Shimojo H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00078; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wagatsuma A, 2013, THESCIENTIFICWORLDJO, V2013, DOI DOI 10.1155/2013/593267; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128130	10.1371/journal.pone.0128130	http://dx.doi.org/10.1371/journal.pone.0128130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020522	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300083
J	Zhao, XY; Wang, SM; Wu, JJ; Li, XY; Wang, X; Gao, ZQ; Wu, WT; Wang, HJ; Wang, JC; Qian, J; Ma, K; Li, H; Han, BH; Bai, CX; Li, Q; Liu, WB; Lu, DR				Zhao, Xueying; Wang, Shiming; Wu, Junjie; Li, Xiaoying; Wang, Xun; Gao, Zhiqiang; Wu, Wenting; Wang, Haijian; Wang, Jiucun; Qian, Ji; Ma, Ke; Li, Hui; Han, Baohui; Bai, Chunxue; Li, Qiang; Liu, Wenbin; Lu, Daru			Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; PLATINUM-BASED CHEMOTHERAPY; PROGRESSION-FREE SURVIVAL; SURROGATE END-POINT; GENETIC-VARIANTS; SEVERE TOXICITY; NEVER-SMOKERS; EXPRESSION; HTERT; LOCUS	TERT is of great importance in cancer initiation and progression. Many studies have demonstrated the TERT polymorphisms as risk factors for many cancer types, including lung cancer. However, the impacts of TERT variants on cancer progression and treatment efficacy have remained controversial. This study aimed to investigate the association of TERT polymorphisms with clinical outcome of advanced non-small cell lung cancer (NSCLC) patients receiving first-line platinum-based chemotherapy, including response rate, clinical benefit, progression-free survival (PFS), overall survival (OS), and grade 3 or 4 toxicity. Seven polymorphisms of TERT were assessed, and a total of 1004 inoperable advanced NSCLC patients treated with platinum-based chemotherapy were enrolled. It is exhibited that the variant heterozygote of rs4975605 showed significant association with a low rate of clinical benefit, and displayed a much stronger effect in never-smoking female subset, leading to the clinical benefit rate decreased from 82.9% (C/C genotype) to 56.4% (C/A genotype; adjusted OR, 3.58; P=1.40x10(-4)). It is also observed that the polymorphism rs2736109 showed significant correlation with PFS (log-rank P=0.023). In age > 58 subgroup, patients carrying the heterozygous genotype had a longer median PFS than those carrying the wildtype genotypes (P=0.002). The results from the current study, for the first time to our knowledge, provide suggestive evidence of an effect of TERT polymorphisms on disease progression variability among Chinese patients with platinum-treated advanced NSCLC.	[Zhao, Xueying; Wang, Shiming; Wu, Junjie; Li, Xiaoying; Wu, Wenting; Wang, Haijian; Wang, Jiucun; Qian, Ji; Lu, Daru] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhao, Xueying; Wang, Shiming; Wu, Junjie; Li, Xiaoying; Wu, Wenting; Wang, Haijian; Wang, Jiucun; Qian, Ji; Lu, Daru] Fudan Univ, Sch Life Sci, Inst Genet, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wu, Junjie; Li, Qiang] Second Mil Med Univ, Changhai Hosp Shanghai, Dept Pneumol, Shanghai, Peoples R China; [Wang, Xun; Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Gao, Zhiqiang; Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Resp Dis, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Naval Medical University; Fudan University; Shanghai Jiao Tong University	Liu, WB (corresponding author), Shanghai Res Inst Criminal Sci & Technol, Shanghai Key Lab Crime Scene Evidence, Shanghai, Peoples R China.	wbliu1981@163.com; drlu@fudan.edu.cn	wu, wenting/Q-4979-2016	wu, wenting/0000-0003-0982-771X; Bai, Chunxue/0000-0001-5798-3130				Beck S, 2011, MOL CELLS, V31, P9, DOI 10.1007/s10059-011-0008-8; Bertorelle R, 2013, BRIT J CANCER, V108, P278, DOI 10.1038/bjc.2012.602; Cecchin E, 2009, J CLIN ONCOL, V27, P2457, DOI 10.1200/JCO.2008.19.0314; Chen D, 2008, CARCINOGENESIS, V29, P342, DOI 10.1093/carcin/bgm285; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Colangelo D, 2005, CURR MED CHEM, V12, P3091, DOI 10.2174/092986705774933416; Ding DQ, 2013, FEBS J, V280, P3205, DOI 10.1111/febs.12258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garon EB, 2012, LUNG CANCER, V77, P475, DOI 10.1016/j.lungcan.2012.06.007; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Han BH, 2011, LUNG CANCER, V72, P238, DOI 10.1016/j.lungcan.2010.09.001; Han KL, 2014, NEURO-ONCOLOGY, V16, P696, DOI 10.1093/neuonc/not236; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsiung CA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001051; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Lantuejoul S, 2004, BRIT J CANCER, V90, P1222, DOI 10.1038/sj.bjc.6601643; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Peng Y, 2014, INT J CANCER, V135, P2687, DOI 10.1002/ijc.28892; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rudin CM, 2009, CLIN CANCER RES, V15, P5646, DOI 10.1158/1078-0432.CCR-09-0377; Ruzzo A, 2006, J CLIN ONCOL, V24, P1883, DOI 10.1200/JCO.2005.04.8322; Sidhu R, 2013, CLIN CANCER RES, V19, P969, DOI 10.1158/1078-0432.CCR-12-2502; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Tchirkov A, 2003, BRIT J CANCER, V88, P516, DOI 10.1038/sj.bjc.6600754; Wang L, 2002, CLIN CANCER RES, V8, P2883; Wang YF, 2010, CARCINOGENESIS, V31, P234, DOI 10.1093/carcin/bgp287; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wright WE, 1996, DEV GENET, V18, P173; Wu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033200; Wu WT, 2009, CLIN CANCER RES, V15, P3889, DOI 10.1158/1078-0432.CCR-08-2715	36	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0129232	10.1371/journal.pone.0129232	http://dx.doi.org/10.1371/journal.pone.0129232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020272	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300124
J	Heininga, VE; Oldehinkel, AJ; Veenstra, R; Nederhof, E				Heininga, Vera E.; Oldehinkel, Albertine J.; Veenstra, Rene; Nederhof, Esther			I Just Ran a Thousand Analyses: Benefits of Multiple Testing in Understanding Equivocal Evidence on Gene-Environment Interactions	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; STRESSFUL LIFE EVENTS; 5-HTTLPR GENOTYPE; SENSITIVE PERIODS; DEPRESSION; POLYMORPHISM; ADVERSITY; REPLICATION; MODERATION; BRAIN	Background In psychiatric genetics research, the volume of ambivalent findings on gene-environment interactions (G x E) is growing at an accelerating pace. In response to the surging suspicions of systematic distortion, we challenge the notion of chance capitalization as a possible contributor. Beyond qualifying multiple testing as a mere methodological issue that, if uncorrected, leads to chance capitalization, we advance towards illustrating the potential benefits of multiple tests in understanding equivocal evidence in genetics literature. Method We focused on the interaction between the serotonin-transporter-linked promotor region (5-HTTLPR) and childhood adversities with regard to depression. After testing 2160 interactions with all relevant measures available within the Dutch population study of adolescents TRAILS, we calculated percentages of significant (p < .05) effects for several subsets of regressions. Using chance capitalization (i.e. overall significance rate of 5% alpha and randomly distributed findings) as a competing hypothesis, we expected more significant effects in the subsets of regressions involving: 1) interview-based instead of questionnaire-based measures; 2) abuse instead of milder childhood adversities; and 3) early instead of later adversities. Furthermore, we expected equal significance percentages across 4) male and female subsamples, and 5) various genotypic models of 5-HTTLPR. Results We found differences in the percentages of significant interactions among the subsets of analyses, including those regarding sex-specific subsamples and genetic modeling, but often in unexpected directions. Overall, the percentage of significant interactions was 7.9% which is only slightly above the 5% that might be expected based on chance. Conclusion Taken together, multiple testing provides a novel approach to better understand equivocal evidence on G x E, showing that methodological differences across studies are a likely reason for heterogeneity in findings - but chance capitalization is at least equally plausible.	[Heininga, Vera E.; Oldehinkel, Albertine J.; Nederhof, Esther] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Veenstra, Rene] Univ Groningen, Dept Sociol, Groningen, Netherlands	University of Groningen; University of Groningen	Heininga, VE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	v.e.heininga@umcg.nl	Veenstra, René/G-6696-2011; Heininga, Vera/AAA-3738-2020	Veenstra, René/0000-0001-6686-6307; Heininga, Vera/0000-0003-0889-8524	VICI grant from the Netherlands Organization for Scientific Research [NWO Vici 016.001/002]; Netherlands Organization for Scientific Research NWO (Medical Research Council) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant) [100-001-004]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behaviour and Dependence grants) [60-60600-97-118]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant) [261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants) [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Netherlands Organization for Scientific Research NWO (Social Sciences Council project) [GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant) [175.010.2003.005]; Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding) [481-08-013]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]; Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL [CP 32]; Accare Center for Child and Adolescent Psychiatry	VICI grant from the Netherlands Organization for Scientific Research; Netherlands Organization for Scientific Research NWO (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behaviour and Dependence grants); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants); Netherlands Organization for Scientific Research NWO (Social Sciences Council project); Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant); Netherlands Organization for Scientific Research NWO (NWO Longitudinal Survey and Panel Funding)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project); Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL; Accare Center for Child and Adolescent Psychiatry	This research was made possible by a VICI grant from the Netherlands Organization for Scientific Research (NWO Vici 016.001/002) to Dr. Oldehinkel. The data used were collected as part of the TRacking Adolescents' Individual Lives Survey (TRAILS). Participating centers of TRAILS include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behaviour and Dependence grants 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 452-04-314 and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), Biobanking and Biomolecular Resources Research Infrastructure BBMRI-NL (CP 32), the participating universities, and Accare Center for Child and Adolescent Psychiatry.	Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Achenbach TM, 2001, MANUAL ASEBA SCH AGE, DOI [10.1007/s00127-013-0685-z, DOI 10.1007/S00127-013-0685-Z]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Eaves LJ, 2006, TWIN RES HUM GENET, V9, P1, DOI 10.1375/183242706776403073; Fergusson DM, 2011, BRIT J PSYCHIAT, V198, P129, DOI 10.1192/bjp.bp.110.085993; Flint J, 2013, CURR OPIN NEUROBIOL, V23, P57, DOI 10.1016/j.conb.2012.07.005; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Homberg JR, 2012, PROG NEUROBIOL, V99, P117, DOI 10.1016/j.pneurobio.2012.08.003; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; IBM Corp, 2013, IBM SPSS STAT WINDOW; Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010; Ioannidis JPA, 2007, PLOS MED, V4, P1132, DOI 10.1371/journal.pmed.0040215; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2009, INT J METH PSYCH RES, V18, P69, DOI 10.1002/mpr.279; Laucht M, 2009, INT J NEUROPSYCHOPH, V12, P737, DOI 10.1017/S1461145708009875; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Markus CR, 2013, PSYCHIAT GENET, V23, P108, DOI 10.1097/YPG.0b013e32835fe3e1; Martel MM, 2013, PSYCHOL BULL, V139, P1221, DOI 10.1037/a0032247; Martin J, 2007, MOL PSYCHIATR, V12, P421, DOI 10.1038/sj.mp.4001952; McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monroe SM, 2008, ANNU REV CLIN PSYCHO, V4, P33, DOI 10.1146/annurev.clinpsy.4.022007.141207; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Munafo MR, 2009, INT J NEUROPSYCHOPH, V12, P727, DOI 10.1017/S1461145709000479; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Nederhof E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-93; Nederhof E, 2010, BIOL PSYCHIAT, V68, P209, DOI 10.1016/j.biopsych.2010.04.006; Ormel J, 2012, J AM ACAD CHILD PSY, V51, P1020, DOI 10.1016/j.jaac.2012.08.004; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Roisman GI, 2012, DEV PSYCHOPATHOL, V24, P389, DOI 10.1017/S0954579412000065; Sheikh HI, 2008, PERS INDIV DIFFER, V45, P425, DOI 10.1016/j.paid.2008.05.020; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123; Williams RB, 2003, NEUROPSYCHOPHARMACOL, V28, P533, DOI 10.1038/sj.npp.1300054; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zalsman G, 2010, EUR PSYCHIAT, V25, P284, DOI 10.1016/j.eurpsy.2010.01.007	48	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125383	10.1371/journal.pone.0125383	http://dx.doi.org/10.1371/journal.pone.0125383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016887	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600020
J	Liao, HB; Cheng, XJ; Zhu, DK; Wang, MS; Jia, RY; Chen, S; Chen, XY; Biville, F; Liu, MF; Cheng, AC				Liao, HeBin; Cheng, XingJun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Chen, XiaoYue; Biville, Francis; Liu, MaFeng; Cheng, AnChun			TonB Energy Transduction Systems of Riemerella anatipestifer Are Required for Iron and Hemin Utilization	PLOS ONE			English	Article							OUTER-MEMBRANE; VIBRIO-CHOLERAE; UPTAKE GENES; PSEUDOMONAS-AERUGINOSA; VIRULENCE; ACQUISITION; TRANSPORT; PROTEIN; IDENTIFICATION; EXBB	Riemerella anatipestifer (R. anatipestifer) is one of the most important pathogens in ducks. The bacteria causes acute or chronic septicemia characterized by fibrinous pericarditis and meningitis. The R. anatipestifer genome encodes multiple iron/hemin-uptake systems that facilitate adaptation to iron-limited host environments. These systems include several TonB-dependent transporters and three TonB proteins responsible for energy transduction. These three tonB genes are present in all the R. anatipestifer genomes sequenced so far. Two of these genes are contained within the exbB-exbD-tonB1 and exbB-exbD-exbD-tonB2 operons. The third, tonB3, forms a monocistronic transcription unit. The inability to recover derivatives deleted for this gene suggests its product is essential for R. anatipestifer growth. Here, we show that deletion of tonB1 had no effect on hemin uptake of R. anatipestifer, though disruption of tonB2 strongly decreases hemin uptake, and disruption of both tonB1 and tonB2 abolishes the transport of exogenously added hemin. The ability of R. anatipestifer to grow on iron-depleted medium is decreased by tonB2 but not tonB1 disruption. When expressed in an E. coli model strain, the TonB1 complex, TonB2 complex, and TonB3 protein from R. anatipestifer cannot energize heterologous hemin transporters. Further, only the TonB1 complex can energize a R. anatipestifer hemin transporter when co-expressed in an E. coli model strain.	[Liao, HeBin; Cheng, XingJun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Chen, XiaoYue; Liu, MaFeng; Cheng, AnChun] Sichuan Agr Univ, Coll Vet Med, Avian Dis Res Ctr, Yaan, Sichuan, Peoples R China; [Liao, HeBin; Cheng, XingJun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Chen, XiaoYue; Liu, MaFeng; Cheng, AnChun] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu, Sichuan, Peoples R China; [Liao, HeBin; Cheng, XingJun; Zhu, DeKang; Wang, MingShu; Jia, RenYong; Chen, Shun; Chen, XiaoYue; Liu, MaFeng; Cheng, AnChun] Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Biville, Francis] Inst Pasteur, Unite Infect Bacteriennes Invas, Paris, France	Sichuan Agricultural University; Sichuan Agricultural University; Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Liu, MF (corresponding author), Sichuan Agr Univ, Coll Vet Med, Avian Dis Res Ctr, Yaan, Sichuan, Peoples R China.	liumafengra@163.com; chenganchun@vip.163.com	Zhu, Dekang/A-2292-2014	Zhu, Dekang/0000-0002-7314-1088	National Natural Science Foundation of China [31302131]; Research Fund for the Doctoral Program of Higher Education of China [20135103120006]; China Postdoctoral Science Foundation [2014M552378]; National science and technology support program [2015BAD12B05]; National Special Fund for Agro-scientific Research in the Public Interest [201003012]; China Agricultural Research System [CARS-43-8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National science and technology support program; National Special Fund for Agro-scientific Research in the Public Interest; China Agricultural Research System	Funding for this work comes from the following sources: National Natural Science Foundation of China (Grant No. 31302131, http://www.nsfc.gov.cn/), Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20135103120006, http://www.cutech.edu.cn/cn/index.htm), China Postdoctoral Science Foundation (Grant No. 2014M552378, http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), National science and technology support program (No. 2015BAD12B05, http://www.most.gov.cn/kjjh/gjkjjh/), National Special Fund for Agro-scientific Research in the Public Interest (No. 201003012, http://www.moa.gov.cn/), and China Agricultural Research System (CARS-43-8, http://www.moa.gov.cn/).	Abbas A, 2007, FEMS MICROBIOL LETT, V274, P269, DOI 10.1111/j.1574-6968.2007.00845.x; Alvarez B, 2008, MICROBIOL-SGM, V154, P1144, DOI 10.1099/mic.0.2007/010900-0; Benevides-Matos N, 2008, J BACTERIOL, V190, P21, DOI 10.1128/JB.01389-07; Benson DR, 2013, METAL IONS LIFE SCI, V12, P279, DOI 10.1007/978-94-007-5561-1_9; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chu BCH, 2007, BIOMETALS, V20, P467, DOI 10.1007/s10534-006-9049-4; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Crasta KC, 2002, J BACTERIOL, V184, P1932, DOI 10.1128/JB.184.7.1932-1939.2002; Fournier C, 2011, MOL MICROBIOL, V80, P133, DOI 10.1111/j.1365-2958.2011.07562.x; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; GrayOwen SD, 1996, TRENDS MICROBIOL, V4, P185, DOI 10.1016/0966-842X(96)10025-1; Hess C, 2013, AVIAN PATHOL, V42, P151, DOI 10.1080/03079457.2013.775401; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Holden KM, 2012, COMP IMMUNOL MICROB, V35, P129, DOI 10.1016/j.cimid.2011.12.004; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039805; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Huynh C, 2008, CELL MICROBIOL, V10, P293, DOI 10.1111/j.1462-5822.2007.01095.x; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Lu FY, 2013, VET MICROBIOL, V167, P713, DOI 10.1016/j.vetmic.2013.08.020; Luan BQ, 2010, PROTEINS, V78, P1153, DOI 10.1002/prot.22635; Maniatis T., 1989, LAB MANUAL, Vsecond; Mey AR, 2003, J BACTERIOL, V185, P1195, DOI 10.1128/JB.185.4.1195-1207.2003; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Najimi M, 2008, ARCH MICROBIOL, V190, P439, DOI 10.1007/s00203-008-0391-5; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Nijssen E, 2009, CLIN MICROBIOL INFEC, V15, P118, DOI 10.1111/j.1469-0691.2008.02193.x; Occhino DA, 1998, MOL MICROBIOL, V29, P1493, DOI 10.1046/j.1365-2958.1998.01034.x; PATHANASOPHON P, 1995, AVIAN PATHOL, V24, P195, DOI 10.1080/03079459508419059; Pathanasophon P, 2002, AVIAN PATHOL, V31, P267, DOI 10.1080/03079450220136576; Pauer H, 2013, J MED MICROBIOL, V62, P1524, DOI 10.1099/jmm.0.054692-0; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Peacock RS, 2005, J MOL BIOL, V345, P1185, DOI 10.1016/j.jmb.2004.11.026; Reeves SA, 2000, INFECT IMMUN, V68, P6329, DOI 10.1128/IAI.68.11.6329-6336.2000; Rio SJ, 2005, ARCH MICROBIOL, V183, P347, DOI 10.1007/s00203-005-0779-4; Runyen-Janecky LJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00055; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; Seliger SS, 2001, MOL MICROBIOL, V39, P801, DOI 10.1046/j.1365-2958.2001.02273.x; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Stork M, 2004, INFECT IMMUN, V72, P7326, DOI 10.1128/IAI.72.12.7326-7329.2004; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Tu J, 2014, VET MICROBIOL, V168, P395, DOI 10.1016/j.vetmic.2013.11.027; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wang QY, 2008, ARCH MICROBIOL, V190, P595, DOI 10.1007/s00203-008-0407-1; Wang XJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-630, 10.1186/1471-2164-15-479]; Weng SC, 1999, FEMS MICROBIOL LETT, V179, P11, DOI 10.1111/j.1574-6968.1999.tb08701.x; Wiggerich HG, 2000, MICROBIOL-UK, V146, P1053, DOI 10.1099/00221287-146-5-1053; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Zeng XM, 2013, FEMS MICROBIOL LETT, V347, P83, DOI 10.1111/1574-6968.12221; Zhao QX, 2000, FEMS MICROBIOL LETT, V184, P127, DOI 10.1111/j.1574-6968.2000.tb09002.x; Zimbler DL, 2013, INFECT IMMUN, V81, P3382, DOI 10.1128/IAI.00540-13	56	19	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127506	10.1371/journal.pone.0127506	http://dx.doi.org/10.1371/journal.pone.0127506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017672	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600086
J	Sholler, GLS; Gerner, EW; Bergendahl, G; MacArthur, RB; VanderWerff, A; Ashikaga, T; Bond, JP; Ferguson, W; Roberts, W; Wada, RK; Eslin, D; Kraveka, JM; Kaplan, J; Mitchell, D; Parikh, NS; Neville, K; Sender, L; Higgins, T; Kawakita, M; Hiramatsu, K; Moriya, S; Bachmann, AS				Sholler, Giselle L. Saulnier; Gerner, Eugene W.; Bergendahl, Genevieve; MacArthur, Robert B.; VanderWerff, Alyssa; Ashikaga, Takamaru; Bond, Jeffrey P.; Ferguson, William; Roberts, William; Wada, Randal K.; Eslin, Don; Kraveka, Jacqueline M.; Kaplan, Joel; Mitchell, Deanna; Parikh, Nehal S.; Neville, Kathleen; Sender, Leonard; Higgins, Timothy; Kawakita, Masao; Hiramatsu, Kyoko; Moriya, Shunsuke; Bachmann, Andre S.			A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma	PLOS ONE			English	Article							EFLORNITHINE COMBINATION THERAPY; ORNITHINE-DECARBOXYLASE GENE; ALPHA-DIFLUOROMETHYLORNITHINE; DIAMINE EXPORTER; DOUBLE-BLIND; N-MYC; CANCER; POLYMORPHISM; MECHANISMS; P27(KIP1)	Background Neuroblastoma (NB) is the most common cancer in infancy and most frequent cause of death from extracranial solid tumors in children. Ornithine decarboxylase (ODC) expression is an independent indicator of poor prognosis in NB patients. This study investigated safety, response, pharmacokinetics, genetic and metabolic factors associated with ODC in a clinical trial of the ODC inhibitor difluoromethylornithine (DFMO) +/- etoposide for patients with relapsed or refractory NB. Methods and Findings Twenty-one patients participated in a phase I study of daily oral DFMO alone for three weeks, followed by additional three-week cycles of DFMO plus daily oral etoposide. No dose limiting toxicities (DLTs) were identified in patients taking doses of DFMO between 500-1500 mg/m2 orally twice a day. DFMO pharmacokinetics, single nucleotide polymorphisms (SNPs) in the ODC gene and urinary levels of substrates for the tissue polyamine exporter were measured. Urinary polyamine levels varied among patients at baseline. Patients with the minor T-allele at rs2302616 of the ODC gene had higher baseline levels (p=0.02) of, and larger decreases in, total urinary polyamines during the first cycle of DFMO therapy (p=0.003) and had median progression free survival (PFS) that was over three times longer, compared to patients with the major G allele at this locus although this last result was not statistically significant (p=0.07). Six of 18 evaluable patients were progression free during the trial period with three patients continuing progression free at 663, 1559 and 1573 days after initiating treatment. Median progression-free survival was less among patients having increased urinary polyamines, especially diacetylspermine, although this result was not statistically significant (p= 0.056). Conclusions DFMO doses of 500-1500mg/m2/day are safe and well tolerated in children with relapsed NB. Children with the minor T-allele at rs2302616 of the ODC gene with relapsed or refractory NB had higher levels of urinary polyamine markers and responded better to therapy containing DFMO, compared to those with the major G allele at this locus. These findings suggest that this patient subset may display dependence on polyamines and be uniquely susceptible to therapies targeting this pathway.	[Sholler, Giselle L. Saulnier; Bergendahl, Genevieve; VanderWerff, Alyssa; Mitchell, Deanna] Helen DeVos Childrens Hosp, Grand Rapids, MI 49503 USA; [Sholler, Giselle L. Saulnier; Bachmann, Andre S.] Michigan State Univ, Coll Human Med, Grand Rapids, MI USA; [Gerner, Eugene W.; MacArthur, Robert B.] Canc Prevent Pharmaceut, Tucson, AZ USA; [Ashikaga, Takamaru; Higgins, Timothy] Univ Vermont, Med Biostat, Burlington, VT USA; [Bond, Jeffrey P.] Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA; [Ferguson, William] Cardinal Glennon Childrens Hosp, St Louis, MO USA; [Roberts, William] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Roberts, William] Rady Childrens Hosp, San Diego, CA USA; [Wada, Randal K.] Kapiolani Med Ctr Women & Children, Honolulu, HI USA; [Eslin, Don] Arnold Palmer Hosp Children, Orlando, FL USA; [Kraveka, Jacqueline M.] Med Univ S Carolina, Charleston, SC 29425 USA; [Kaplan, Joel] Levine Childrens Hosp, Charlotte, NC USA; [Parikh, Nehal S.] Connecticut Childrens Med Ctr, Hartford, CT USA; [Neville, Kathleen] Childrens Mercy Hosp & Clin, Kansas City, MO USA; [Sender, Leonard] Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Kawakita, Masao; Hiramatsu, Kyoko; Moriya, Shunsuke] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Bachmann, Andre S.] Univ Hawaii, Daniel K Inouye Coll Pharm, Hilo, HI 96720 USA	Michigan State University; Michigan State University College of Human Medicine; University of Vermont; University of Vermont; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Medical University of South Carolina; Connecticut Children's Medical Center; Children's Mercy Hospital; Childrens Hospital of Orange County; Tokyo Metropolitan Institute of Medical Science; University of Hawaii System; University Hawaii Hilo	Sholler, GLS (corresponding author), Helen DeVos Childrens Hosp, Grand Rapids, MI 49503 USA.	giselle.sholler@helendevoschildrens.org; andre.bachmann@hc.msu.edu			Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC); Cancer Prevention Pharmaceuticals; Beat NB Foundation; Max's Ring of Fire; Meryl and Charles Witmer Foundation; Owen Moscone Foundation; NIH [CA095060, CA123065]; NATIONAL CANCER INSTITUTE [R01CA123065, P50CA095060] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25460714] Funding Source: KAKEN	Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC); Cancer Prevention Pharmaceuticals; Beat NB Foundation; Max's Ring of Fire; Meryl and Charles Witmer Foundation; Owen Moscone Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) supported this work in collaboration with Cancer Prevention Pharmaceuticals. This trial was funded by the Beat NB Foundation, Max's Ring of Fire, Meryl and Charles Witmer Foundation, Owen Moscone Foundation and many other donations from the families of children with neuroblastoma. PD measurements were supported in part by NIH grants CA095060 (EWG PI) and CA123065 (EWG PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2013, CLIN INFECT DIS, V56, P195, DOI 10.1093/cid/cis886; Auvinen M, 2003, INT J BIOCHEM CELL B, V35, P496, DOI 10.1016/S1357-2725(02)00305-9; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; AUVINEN M, 1995, MOL CELL BIOL, V15, P6513; Babbar N, 2007, BIOCHEM SOC T, V35, P300, DOI 10.1042/BST0350300; Bachmann Andre S, 2004, Hawaii Med J, V63, P371; Bachmann AS, 2012, PED CANCER, V1, P91, DOI 10.1007/978-94-007-2418-1_9; Bailey HH, 2010, CANCER PREV RES, V3, P35, DOI 10.1158/1940-6207.CAPR-09-0096; Ben-Yosef T, 1998, ONCOGENE, V17, P165, DOI 10.1038/sj.onc.1201939; Blume-Peytavi U, 2008, DERMATOL THER, V21, P329, DOI 10.1111/j.1529-8019.2008.00215.x; Brown I, 2009, FAM CANCER, V8, P307, DOI 10.1007/s10689-009-9237-9; Carbone PP, 2000, CLIN CANCER RES, V6, P3850; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Choi PS, 2014, P NATL ACAD SCI US; Davison AC, 1997, BOOTSTRAP METHODS TH; DORR RT, 1986, CANCER RES, V46, P3891; Evageliou NF, 2009, CLIN CANCER RES, V15, P5956, DOI 10.1158/1078-0432.CCR-08-3213; Gamble LD, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00162; Garcia-Huidobro JM, 2014, NUCL ACIDS RES UNPUB; Garcia-Huidobro JT, 2014, CANCER RESEARCH SUBM; Geerts D, 2010, INT J CANCER, V126, P2012, DOI 10.1002/ijc.25074; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Hayes CS, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27360; Hiramatsu K, 2005, CLIN CANCER RES, V11, P2986, DOI 10.1158/1078-0432.CCR-04-2275; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Kablfleisch RL, 1980, STAT ANAL FAILURE TI; Kareva I, 2014, CANC LETT; Kawakita M, 2011, METHODS MOL BIOL, V720, P367, DOI 10.1007/978-1-61779-034-8_23; Koomoa DLT, 2013, INT J ONCOL, V42, P1219, DOI 10.3892/ijo.2013.1835; Koomoa DLT, 2008, CANCER RES, V68, P9825, DOI 10.1158/0008-5472.CAN-08-1865; Kushner BH, 1999, J CLIN ONCOL, V17, P3221, DOI 10.1200/JCO.1999.17.10.3221; Lange I, 2014, J MOL BIOL, V426, P332, DOI 10.1016/j.jmb.2013.09.037; Lu XH, 2003, CANCER LETT, V197, P125, DOI 10.1016/S0304-3835(03)00096-X; Lutz W, 1996, ONCOGENE, V13, P803; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Martinez ME, 2003, P NATL ACAD SCI USA, V100, P7859, DOI 10.1073/pnas.1332465100; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Modak S, 2010, CANCER TREAT REV, V36, P307, DOI 10.1016/j.ctrv.2010.02.006; Norris MDG, 2014, ADV NEUROBLASTOMA RE, P140; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Pegg AE, 2007, BIOCHEM SOC T, V35, P295, DOI 10.1042/BST0350295; PENDYALA L, 1993, CANCER EPIDEM BIOMAR, V2, P235; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Robison NJ, 2014, PEDIATR BLOOD CANCER, V61, P636, DOI 10.1002/pbc.24794; Rounbehler RJ, 2009, CANCER RES, V69, P547, DOI 10.1158/0008-5472.CAN-08-2968; RUSSELL DH, 1971, CANCER RES, V31, P248; Samal K, 2013, INT J CANC IN PRESS; Sholler GL, 2013, P AACR; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; Team RC, 2014, R LANG ENV STAT COMP; Therneau TM, 2000, MODELING SURVIVAL DA, pxiii; Thompson PA, 2010, GASTROENTEROLOGY, V139, P797, DOI 10.1053/j.gastro.2010.06.005; Uemura T, 2008, J BIOL CHEM, V283, P26428, DOI 10.1074/jbc.M804714200; Uemura T, 2010, AM J PHYSIOL-GASTR L, V299, pG517, DOI 10.1152/ajpgi.00169.2010; Visvanathan K, 2004, J UROLOGY, V171, P652, DOI 10.1097/01.ju.0000108384.74718.73; Wallick CJ, 2005, ONCOGENE, V24, P5606, DOI 10.1038/sj.onc.1208808; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Witherspoon M, 2013, CANCER DISCOV, V3, P1072, DOI 10.1158/2159-8290.CD-12-0305; Xie XZ, 1997, J BIOL CHEM, V272, P20484, DOI 10.1074/jbc.272.33.20484; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zell JA, 2009, CLIN CANCER RES, V15, P6208, DOI 10.1158/1078-0432.CCR-09-0592	64	83	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127246	10.1371/journal.pone.0127246	http://dx.doi.org/10.1371/journal.pone.0127246			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018967	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600076
J	Cortes, X; Borras-Blasco, J; Moles, JR; Bosca, M; Cortes, E				Cortes, Xavier; Borras-Blasco, Joaquin; Ramon Moles, Jose; Bosca, Maia; Cortes, Ernesto			Safety of Ferric Carboxymaltose Immediately after Infliximab Administration, in a Single Session, in Inflammatory Bowel Disease Patients with Iron Deficiency: A Pilot Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ANEMIA; METAANALYSIS; PREVALENCE; DIAGNOSIS; THERAPY	Aim To obtain preliminary safety and efficacy data on intravenous (IV) administration of infliximab (IFX) and ferric carboxymaltose (FCM) to inflammatory bowel disease (IBD) patients in a single treatment session. Methods A two-phase non-interventional, observational, prospective pilot study was performed to evaluate safety and efficacy of FCM given immediately after IFX. IBD patients were recruited consecutively in the outpatient clinic in two groups. Control group patients (n = 12) received FCM on a separate day from IFX. Subsequently, single-session group patients (n = 33) received FCM after IFX on the same day. All patients received 5mg/kg IFX and 1000mg FCM for iron-restricted anemia (IRA) or 500mg FCM for iron deficiency without anemia. Safety assessment was performed by recording adverse events (AEs) during and immediately after infusion, 30 minutes afterwards, and via follow-up at 7 days and 8 weeks. For efficacy assessment, hematological parameters were assessed prior to FCM infusion (pre-FCM) and after 8 weeks. Economic impact of FCM given immediately after IFX was assessed. Results All 45 patients (35 Crohn's disease, 10 ulcerative colitis) received IFX 5mg/kg. 21 patients received 500mg FCM and 24 received 1000mg. FCM administration immediately after IFX corrected iron deficiency or IRA as shown by increases in hematological parameters. No AEs were reported during the safety evaluation at the end of FCM or IFX administration, 30 minutes, 7 days and 8 weeks afterwards, in either control or single-session groups. Total cost per patient for single-session administration was 354.63(sic); for patients receiving IFX and FCM on separate days, it was 531.94(sic), giving a 177.31 (sic) per-patient cost saving. Conclusion Single-session administration of FCM after IFX was safe and effective in IBD patients and can offer a good cost-benefit ratio and improve treatment adherence. To our knowledge, this study is the first to evaluate FCM and IFX administration in a single treatment session.	[Cortes, Xavier; Ramon Moles, Jose] Internal Med Hosp Sagunto, Gastroenterol Sect, IBD Unit, Sagunto, Spain; [Cortes, Xavier] Univ Cardenal Herrera CEU, Castellon de La Plana, Spain; [Borras-Blasco, Joaquin] Hosp Sagunto, Serv Pharm, Sagunto, Spain; [Bosca, Maia] Univ Clin Hosp Valencia, Dept Gastroenterol, IBD Unit, Valencia, Spain; [Cortes, Ernesto] Miguel Hernandez Univ, Pharmacol Paediat & Organ Chem Dept, Alacant, Spain	Universidad CEU Cardenal Herrera; Universidad Miguel Hernandez de Elche	Cortes, X (corresponding author), Internal Med Hosp Sagunto, Gastroenterol Sect, IBD Unit, Sagunto, Spain.	xacori@gmail.com		cortes, xavier/0000-0002-8032-8211; BOSCA-WATTS, MARTA MAIA/0000-0001-7495-8797				Avni T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075540; Befrits R, 2013, SCAND J GASTROENTERO, V48, P1027, DOI 10.3109/00365521.2013.819442; Bergamaschi G, 2010, HAEMATOL-HEMATOL J, V95, P199, DOI 10.3324/haematol.2009.009985; Biggar P, 2013, MMW Fortschr Med, V155 Suppl 1, P18; Calvet X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045604; Dignass AU, 2015, J CROHNS COLITIS, V9, P211, DOI 10.1093/ecco-jcc/jju009; Evstatiev R, 2011, GASTROENTEROLOGY, V141, P846, DOI 10.1053/j.gastro.2011.06.005; Filmann N, 2014, INFLAMM BOWEL DIS, V20, P936, DOI 10.1097/01.MIB.0000442728.74340.fd; Gasche C, 2001, AM J GASTROENTEROL, V96, P2382; HARVEY RF, 1980, LANCET, V1, P514; Katsanos K, 2007, J CROHNS COLITIS, V1, P97, DOI 10.1016/j.crohns.2007.08.005; Keating GM, 2015, DRUGS, V75, P101, DOI 10.1007/s40265-014-0332-3; Kulnigg S, 2008, AM J GASTROENTEROL, V103, P1182, DOI 10.1111/j.1572-0241.2007.01744.x; Lee TW, 2012, J CROHNS COLITIS, V6, P267, DOI 10.1016/j.crohns.2011.09.010; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Price General Index from S. I. E. (Sistema de Informacion Economica), 2014, PRIC GEN IND SIE SIS; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Vifor Ltd, FER SUMM PROD CHAR	18	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128156	10.1371/journal.pone.0128156	http://dx.doi.org/10.1371/journal.pone.0128156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011514	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900199
J	Du, W; Pang, CH; Wang, DL; Zhang, QJ; Xue, YK; Jiao, HL; Zhan, L; Ma, Q; Wei, XT				Du, Wei; Pang, Changhe; Wang, Dongliang; Zhang, Qingjun; Xue, Yake; Jiao, Hongliang; Zhan, Lei; Ma, Qian; Wei, Xinting			Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXD3; TUMOR-SUPPRESSOR; MURINE MODEL; PROGRESSION; REQUIREMENT; DISEASE	Background The transcription factor forkhead box D3 (FOXD3) plays important roles in the development of neural crest and has been shown to suppress the development of various cancers. However, the expression and its potential biological roles of FOXD3 in high-grade gliomas (HGGs) remain unknown. Methods The mRNA and protein expression levels of FOXD3 were examined using real-time quantitative PCR and western blotting in 23 HGG and 13 normal brain samples, respectively. Immunohistochemistry was used to validate the expression FOXD3 protein in 184 HGG cases. The association between FOXD3 expression and the prognosis of HGG patients were analyzed using Kaplan-Meier survival curves and Cox proportional hazards regression models. In addition, we further examined the effects of FOXD3 on the proliferation and serum starvation-induced apoptosis of glioma cells. Results In comparison to normal brain tissues, FOXD3 expression was significantly decreased in HGG tissues at both mRNA and protein levels. Immunohistochemistry further validated the expression of FOXD3 in HGG tissues. Moreover, low FOXD3 expression was significantly associated with poor prognosis in HGG patients. Depletion of FOXD3 expression promoted glioma cell proliferation and inhibited serum starvation-induced apoptosis, whereas overexpression of FOXD3 inhibited glioma cell proliferation and promoted serum starvation-induced apoptosis. Conclusions Our results indicated that FOXD3 might serve as an independent prognostic biomarker and a potential therapeutic target for HGGs, which warrant further investigation.	[Du, Wei; Pang, Changhe; Xue, Yake; Jiao, Hongliang; Wei, Xinting] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, Zhengzhou 450052, Peoples R China; [Wang, Dongliang; Zhang, Qingjun] Peking Univ, Peoples Hosp, Dept Neurosurg, Beijing 100044, Peoples R China; [Zhan, Lei] Harbin Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Harbin 150086, Peoples R China; [Ma, Qian] Zhengzhou Univ, Affiliated Hosp 1, Prenatal Diag Ctr, Dept Gynecol & Obstet, Zhengzhou 450052, Peoples R China	Zhengzhou University; Peking University; Harbin Medical University; Zhengzhou University	Wei, XT (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, Zhengzhou 450052, Peoples R China.	weixinting777@163.com			First Affiliated Hospital of Zhengzhou University	First Affiliated Hospital of Zhengzhou University	The present study was supported by the First Affiliated Hospital of Zhengzhou University Research and Development Funds.	Abel EV, 2010, CANCER RES, V70, P2891, DOI 10.1158/0008-5472.CAN-09-3139; Blaes J, 2014, J NEURO-ONCOL, V117, P25, DOI 10.1007/s11060-013-1357-2; Chen SS, 2009, CELL CYCLE, V8, P3663, DOI 10.4161/cc.8.22.9957; Cheng ASL, 2013, GASTROENTEROLOGY, V144, P122, DOI 10.1053/j.gastro.2012.10.002; Chu TL, 2014, BIOCHEM BIOPH RES CO, V446, P580, DOI 10.1016/j.bbrc.2014.03.019; Dottori M, 2001, DEVELOPMENT, V128, P4127; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Katiyar P, 2011, MOL CANCER RES, V9, P545, DOI 10.1158/1541-7786.MCR-10-0454; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kos R, 2001, DEVELOPMENT, V128, P1467; Li D, 2013, ONCOTARGET, V4, P2021, DOI 10.18632/oncotarget.1579; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Schmid CA, 2013, GASTROENTEROLOGY, V144, P22, DOI 10.1053/j.gastro.2012.11.014; Sun BQ, 2009, J NEURO-ONCOL, V94, P213, DOI 10.1007/s11060-009-9859-7; Teng L, 2008, DEVELOPMENT, V135, P1615, DOI 10.1242/dev.012179; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; van Roon EH, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-2; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Xu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048415; Zhao H, 2014, INT J CLIN EXP PATHO, V7, P670	24	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127976	10.1371/journal.pone.0127976	http://dx.doi.org/10.1371/journal.pone.0127976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011451	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900175
J	Favaretto, A; Poggiali, D; Lazzarotto, A; Rolma, G; Causin, F; Gallo, P				Favaretto, Alice; Poggiali, Davide; Lazzarotto, Andrea; Rolma, Giuseppe; Causin, Francesco; Gallo, Paolo			The Parallel Analysis of Phase Sensitive Inversion Recovery (PSIR) and Double Inversion Recovery (DIR) Images Significantly Improves the Detection of Cortical Lesions in Multiple Sclerosis (MS) since Clinical Onset	PLOS ONE			English	Article							INTRACORTICAL LESIONS; COGNITIVE IMPAIRMENT; MRI; DEMYELINATION; ATROPHY	Background Double inversion recovery (DIR) detects only a minority (<20%) of cortical lesions (CL) in multiple sclerosis (MS). Phase-sensitive inversion recovery (PSIR) was suggested to be substantially superior to DIR in the detection of cortical lesions (CL). These two sequences might be complementary. Objectives To analyze CL frequency and type in MS patients having different disease duration and disability, including patients at clinical onset, and to discern more correctly the artifacts, by combining DIR and PSIR images. Patients and Methods 40 patients were enrolled in the study: 10 clinically isolated syndrome/early relapsing remitting MS (CIS/eRRMS), 24 relapsing remitting MS (RRMS), 6 secondary progressive MS (SPMS). DIR and PSIR images were jointly used to classify lesions as purely intracortical (IC), leukocortical (LC) and juxtacortical (JC). Results PSIR disclosed CL in 100% of the patients and was capable of identifying more than four times lesions (455.5%, p<0.00001), especially IC (mean numbers: 36.5 in CIS/eRRMS, 45.0 in RRMS and 52.3 in SPMS) and LC (mean numbers: 10.9 in CIS/eRRMS, 20.1 in RRMS and 25.3 in SPMS), compared to DIR (p<0.00001). CL number was significantly higher in SPMS compared to RRMS (p<0.0001). Artifacts were more accurately identified by comparing the two sequences. Conclusions Our study confirms the higher ability of PSIR in disclosing and classifying CL. The presence of CL in all CIS patients further points out the relevance of cortical pathology in MS. Whether the parallel analysis of DIR and PSIR images may be useful for diagnostic purposes, especially when a diagnosis of MS is suspected but not confirmed by routine MRI, needs to be evaluated in larger patient series. The analysis of the cortex by DIR and PSIR may also allow a better stratification of the patients for prognostic and counseling purposes, as well as for their inclusion in clinical studies.	[Favaretto, Alice; Poggiali, Davide; Lazzarotto, Andrea; Gallo, Paolo] Multiple Sclerosis Ctr Veneto Reg CeSMuV, Dept Neurosci SNPSRR, Padua, Italy; [Rolma, Giuseppe; Causin, Francesco] Univ Hosp Padova, Neuroradiol Unit, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova	Gallo, P (corresponding author), Multiple Sclerosis Ctr Veneto Reg CeSMuV, Dept Neurosci SNPSRR, Padua, Italy.	paolo.gallo@unipd.it	Causin, Francesco/AAR-4624-2021; Poggiali, Davide/AAR-2478-2020	Causin, Francesco/0000-0001-6491-7027; Poggiali, Davide/0000-0002-2894-0825	 [GR-2010-2313255]		This research was supported by grants from the Italian Minister of Public Health, Project GR-2010-2313255.	Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Calabrese M, 2009, MULT SCLER J, V15, P933, DOI 10.1177/1352458509106510; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2012, BRAIN, V135, P2952, DOI 10.1093/brain/aws246; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Ciccarelli O, 2012, NEUROLOGY, V78, P296, DOI 10.1212/WNL.0b013e318245296f; de Graaf WL, 2013, EUR RADIOL, V23, P528, DOI 10.1007/s00330-012-2619-7; Filippi M, 2010, NEUROLOGY, V75, P1988, DOI 10.1212/WNL.0b013e3181ff96f6; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2005, AM J NEURORADIOL, V26, P572; Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Miller DH, 2012, LANCET NEUROL, V11, P157, DOI 10.1016/S1474-4422(11)70274-5; Nelson F, 2008, MULT SCLER J, V14, P1214, DOI 10.1177/1352458508094644; Nelson F, 2007, AM J NEURORADIOL, V28, P1645, DOI 10.3174/ajnr.A0645; Nelson F, 2011, MULT SCLER J, V17, P1122, DOI 10.1177/1352458511405561; Nielsen AS, 2013, NEUROLOGY, V81, P641, DOI 10.1212/WNL.0b013e3182a08ce8; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu BFG, 2011, NEUROLOGY, V76, P1705, DOI 10.1212/WNL.0b013e31821a44f1; Popescu Bogdan F Gh, 2013, Continuum (Minneap Minn), V19, P901, DOI 10.1212/01.CON.0000433291.23091.65; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0; Sethi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078879; Sethi V, 2012, J NEUROL NEUROSUR PS, V83, P877, DOI 10.1136/jnnp-2012-303023; Simon B, 2010, EUR RADIOL, V20, P1675, DOI 10.1007/s00330-009-1705-y	29	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127805	10.1371/journal.pone.0127805	http://dx.doi.org/10.1371/journal.pone.0127805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010425	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900147
J	Hosoki, K; Ying, S; Corrigan, C; Qi, HB; Kurosky, A; Jennings, K; Sun, Q; Boldogh, I; Sur, S				Hosoki, Koa; Ying, Sun; Corrigan, Christopher; Qi, Huibin; Kurosky, Alexander; Jennings, Kristofer; Sun, Qian; Boldogh, Istvan; Sur, Sanjiv			Analysis of a Panel of 48 Cytokines in BAL Fluids Specifically Identifies IL-8 Levels as the Only Cytokine that Distinguishes Controlled Asthma from Uncontrolled Asthma, and Correlates Inversely with FEV1	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; BRONCHIAL EPITHELIAL-CELLS; ATOPIC ASTHMA; ALLERGEN CHALLENGE; AIRWAY HYPERRESPONSIVENESS; MESSENGER-RNA; T-CELLS; EOSINOPHILIC BRONCHITIS; PERIPHERAL-BLOOD; CLUSTER-ANALYSIS	We sought to identify cells and cytokines in bronchoalveolar lavage (BAL) fluids that distinguish asthma from healthy control subjects and those that distinguish controlled asthma from uncontrolled asthma. Following informed consent, 36 human subjects were recruited for this study. These included 11 healthy control subjects, 15 subjects with controlled asthma with FEV1 >= 80% predicted and 10 subjects with uncontrolled asthma with FEV1<80% predicted. BAL fluid was obtained from all subjects. The numbers of different cell types and the levels of 48 cytokines were measured in these fluids. Compared to healthy control subjects, patients with asthma had significantly more percentages of eosinophils and neutrophils, IL-1RA, IL-1 alpha, IL-1 beta, IL-2R alpha, IL-5, IL-6, IL-7, IL-8, G-CSF, GRO alpha (CXCL1), MIP-1 beta (CCL4), MIG (CXCL9), RANTES (CCL5) and TRAIL in their BAL fluids. The only inflammatory markers that distinguished controlled asthma from uncontrolled asthma were neutrophil percentage and IL-8 levels, and both were inversely correlated with FEV1. We examined whether grouping asthma subjects on the basis of BAL eosinophil % or neutrophil % could identify specific cytokine profiles. The only differences between neutrophil-normal asthma (neutrophil <= 2.4%) and neutrophil-high asthma (neutrophils%>2.4%) were a higher BAL fluid IL-8 levels, and a lower FEV1 in the latter group. By contrast, compared to eosinophil-normal asthma (eosinophils <= 0.3%), eosinophil-high asthma (eosinophils>0.3%) had higher levels of IL-5, IL-13, IL-16, and PDGF-bb, but same neutrophil percentage, IL-8, and FEV1. Our results identify neutrophils and IL-8 are the only inflammatory components in BAL fluids that distinguish controlled asthma from uncontrolled asthma, and both correlate inversely with FEV1.	[Hosoki, Koa; Qi, Huibin; Sun, Qian; Sur, Sanjiv] Univ Texas Med Branch, Dept Internal Med, Div Allergy & Immunol, Galveston, TX 77555 USA; [Ying, Sun; Corrigan, Christopher] Kings Coll London, Div Asthma Allergy & Lung Biol, London SE1 9RT, England; [Ying, Sun; Corrigan, Christopher] Kings Coll London, MRC, London SE1 9RT, England; [Ying, Sun; Corrigan, Christopher] Kings Coll London, Asthma UK Ctr Allerg Mech, London SE1 9RT, England; [Kurosky, Alexander] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Jennings, Kristofer] Univ Texas Med Branch, Off Biostat Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Sur, S (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Allergy & Immunol, Galveston, TX 77555 USA.	sasur@UTMB.EDU		Jennings, Kristofer/0000-0002-5442-9326; Hosoki, Koa/0000-0003-4228-2176; Corrigan, Chris/0000-0002-0706-6534	NAID [P01 AI062885-06A1]; NHLBI Proteomic Center [N01HV00245]; NIEHS [RO1 ES18948]; Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948] Funding Source: NIH RePORTER	NAID; NHLBI Proteomic Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NAID P01 AI062885-06A1, NHLBI Proteomic Center, N01HV00245. NIEHS RO1 ES18948, Leon Bromberg Professorship, UTMB.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Anagnostou K, 2012, PRIM CARE RESP J, V21, P71, DOI 10.4104/pcrj.2011.00097; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Arron JR, 2014, EUR RESPIR J, V43, P627, DOI 10.1183/09031936.00117013; Bossley CJ, 2012, J ALLERGY CLIN IMMUN, V129, P974, DOI 10.1016/j.jaci.2012.01.059; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brasier AR, 2008, J ALLERGY CLIN IMMUN, V121, P30, DOI 10.1016/j.jaci.2007.10.015; Brightling CE, 2003, THORAX, V58, P528, DOI 10.1136/thorax.58.6.528; Chu HW, 2000, J ALLERGY CLIN IMMUN, V106, P1115; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; COX G, 1995, J IMMUNOL, V154, P4719; COX G, 1991, AM J RESP CELL MOL, V4, P525, DOI 10.1165/ajrcmb/4.6.525; Emadi S, 2005, BLOOD, V105, P464, DOI 10.1182/blood-2003-12-4415; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Fitzpatrick AM, 2010, J ALLERGY CLIN IMMUN, V125, P851, DOI 10.1016/j.jaci.2010.01.048; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; Godard P, 2002, EUR RESPIR J, V19, P61, DOI 10.1183/09031936.02.00232001; Gras D, 2012, J ALLERGY CLIN IMMUN, V129, P1259, DOI 10.1016/j.jaci.2012.01.073; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Grosse-Steffen T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/720768; GUNDEL RH, 1991, J CLIN INVEST, V87, P1470, DOI 10.1172/JCI115155; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HUANG SK, 1995, J IMMUNOL, V155, P2688; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Justice JP, 2003, AM J PHYSIOL-LUNG C, V284, pL169, DOI 10.1152/ajplung.00260.2002; Kotsimbos TC, 1996, P ASSOC AM PHYSICIAN, V108, P368; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; Kuo PL, 2011, TOXICOL SCI, V121, P177, DOI 10.1093/toxsci/kfr030; Lamblin C, 1998, AM J RESP CRIT CARE, V157, P394, DOI 10.1164/ajrccm.157.2.97-02099; Lamkhioued B, 1997, J IMMUNOL, V159, P4593; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; LEUNG DYM, 1995, J EXP MED, V181, P33, DOI 10.1084/jem.181.1.33; Lilly CM, 2001, AM J RESP CRIT CARE, V163, P1669, DOI 10.1164/ajrccm.163.7.9812044; Moller GM, 1996, AM J RESP CELL MOL, V14, P439; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Moore WC, 2014, J ALLERGY CLIN IMMUN, V133, P1557, DOI 10.1016/j.jaci.2013.10.011; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nair P, 2012, CLIN EXP ALLERGY, V42, P1097, DOI 10.1111/j.1365-2222.2012.04014.x; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Park SJ, 2006, J IMMUNOL, V176, P2538, DOI 10.4049/jimmunol.176.4.2538; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sakamoto N, 2005, AM J PHYSIOL-LUNG C, V288, pL508, DOI 10.1152/ajplung.00076.2004; Sevin CM, 2013, AM J RESP CELL MOL, V49, P396, DOI 10.1165/rcmb.2012-0442OC; SUR S, 1995, J ALLERGY CLIN IMMUN, V96, P661, DOI 10.1016/S0091-6749(95)70265-2; Sur S, 1996, J ALLERGY CLIN IMMUN, V97, P1272, DOI 10.1016/S0091-6749(96)70195-1; SUR S, 1993, AM REV RESPIR DIS, V148, P713, DOI 10.1164/ajrccm/148.3.713; Suzuki T, 1996, AM J RESP CRIT CARE, V153, P1405, DOI 10.1164/ajrccm.153.4.8616573; Tillie-Leblond I, 2000, AM J RESP CRIT CARE, V162, P586, DOI 10.1164/ajrccm.162.2.9907014; Vega A, 2011, J INVEST ALLERG CLIN, V21, P38; Verbout NG, 2009, AM J PHYSIOL-LUNG C, V297, pL228, DOI 10.1152/ajplung.90540.2008; VIRCHOW JC, 1995, AM J RESP CRIT CARE, V151, P960; WALKER C, 1994, AM J RESP CRIT CARE, V150, P1038, DOI 10.1164/ajrccm.150.4.7921434; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Woodman L, 2006, CHEST, V130, P371, DOI 10.1378/chest.130.2.371; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; XIU Q, 1995, CLIN EXP ALLERGY, V25, P51, DOI 10.1111/j.1365-2222.1995.tb01002.x; Ying S, 1997, J IMMUNOL, V158, P3539; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Ying S, 2008, J IMMUNOL, V181, P2790, DOI 10.4049/jimmunol.181.4.2790	67	61	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126035	10.1371/journal.pone.0126035	http://dx.doi.org/10.1371/journal.pone.0126035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011707	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900021
J	Le Guen, M; Naline, E; Grassin-Delyle, S; Devillier, P; Faisy, C				Le Guen, Morgan; Naline, Emmanuel; Grassin-Delyle, Stanislas; Devillier, Philippe; Faisy, Christophe			Effectiveness of a Load-Imposing Device for Cyclic Stretching of Isolated Human Bronchi: A Validation Study	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; EPITHELIAL-CELLS; IN-VITRO; MECHANICAL STRETCH; MYOSIN PHOSPHATASE; RHO-KINASE; RESPONSIVENESS; CONTRACTION; ACTIVATION; BINDING	Background Mechanical ventilation may induce harmful effects in the airways of critically ill patients. Nevertheless, the effects of cyclic stretching caused by repetitive inflation-deflation of the bronchial compartment have not been well characterized in humans. The objective of the present study was to assess the effectiveness of a load-imposing device for the cyclic stretching of human bronchi. Methods Intact bronchial segments were removed from 128 thoracic surgery patients. After preparation and equilibration in an organ bath, bronchi were stretched repetitively and cyclically with a motorized transducer. The peak force imposed on the bronchi was set to 80% of each individual maximum contraction in response to acetylcholine and the minimal force corresponded to the initial basal tone before stretching. A 1-min cycle (stretching for 15 sec, relaxing for 15 sec and resting for 30 sec) was applied over a time period ranging from 5 to 60 min. The device's performance level was assessed and the properties of the stretched bronchi were compared with those of paired, non-stretched bronchi. Results Despite the intrinsic capacities of the device, the targets of the tension adjustments remained variable for minimal tension (156-178%) while the peak force set point was unchanged (87-115%). In the stretched bronchi, a time-dependent rise in basal tone (P < .05 vs. non-stretched) was apparent after as little as 5 min of cyclic stretching. The stretch-induced rise in basal tone continued to increase (P < .01) after the stretching had ended. Only 60 min of cyclic stretching was associated with a significant (P < .05) increase in responsiveness to acetylcholine, relative to non-stretched bronchi. Conclusions Low-frequency, low-force, cyclic loading of human bronchi is associated with elevated basal tone and acetylcholine responsiveness. The present experimental model is likely to be a useful tool for future investigations of the bronchial response to repetitive stress during mechanical ventilation.	[Le Guen, Morgan; Naline, Emmanuel; Grassin-Delyle, Stanislas; Devillier, Philippe; Faisy, Christophe] Univ Versailles St Quentin, Hop Foch, Res Unit UPRES EA220, F-92150 Suresnes, France; [Le Guen, Morgan] Hop Foch, Dept Anesthesiol, F-92150 Suresnes, France; [Faisy, Christophe] Univ Sorbonne Paris Cite, Hop Europeen Georges Pompidou, AP HP, Med Intens Care Unit, F-75908 Paris 15, France	Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP	Faisy, C (corresponding author), Univ Versailles St Quentin, Hop Foch, Res Unit UPRES EA220, 40 Rue Worth, F-92150 Suresnes, France.	christophe.faisy@egp.aphp.fr	Grassin-Delyle, Stanislas/AAC-5921-2021	Grassin-Delyle, Stanislas/0000-0001-5747-4432	Research Unit UPRES EA220, University Versailles Saint-Quentin; Medical Intensive Care Unit, Hopital Europeen Georges Pompidou, Assistance Publique-Hopitaux de Paris, University Sorbonne Paris Cite, France	Research Unit UPRES EA220, University Versailles Saint-Quentin; Medical Intensive Care Unit, Hopital Europeen Georges Pompidou, Assistance Publique-Hopitaux de Paris, University Sorbonne Paris Cite, France	This research was funded by the Research Unit UPRES EA220, University Versailles Saint-Quentin, and the Medical Intensive Care Unit, Hopital Europeen Georges Pompidou, Assistance Publique-Hopitaux de Paris, University Sorbonne Paris Cite, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey EF, 2006, J APPL PHYSIOL, V101, P609, DOI 10.1152/japplphysiol.00204.2006; Bosse Y, 2010, AM J PHYSIOL-LUNG C, V298, pL277, DOI 10.1152/ajplung.00275.2009; Bosse Ynuk, 2008, Proc Am Thorac Soc, V5, P62, DOI 10.1513/pats.200705-056VS; Bosse Y, 2009, AM J RESP CELL MOL, V40, P13, DOI 10.1165/rcmb.2008-0150OC; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Ciobanasu C, 2013, EUR J CELL BIOL, V92, P339, DOI 10.1016/j.ejcb.2013.10.009; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Deng LH, 2009, PULM PHARMACOL THER, V22, P407, DOI 10.1016/j.pupt.2009.04.008; Dimopoulos GJ, 2007, CIRC RES, V100, P121, DOI 10.1161/01.RES.0000253902.90489.df; Faisy C, 2011, CRIT CARE, V15, DOI 10.1186/cc10443; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959, DOI 10.1164/ajrccm.159.3.9804060; Hernandez JM, 2008, J PHARMACOL EXP THER, V327, P503, DOI 10.1124/jpet.108.141176; Ito S, 2008, AM J RESP CELL MOL, V38, P407, DOI 10.1165/rcmb.2007-0259OC; Ito S, 2006, EUR J PHARMACOL, V552, P135, DOI 10.1016/j.ejphar.2006.08.067; Kelley K, 2003, PSYCHOL METHODS, V8, P305, DOI 10.1037/1082-989X.8.3.305; Krishnan R, 2008, RESP PHYSIOL NEUROBI, V163, P17, DOI 10.1016/j.resp.2008.04.006; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kuo KH, 2001, J APPL PHYSIOL, V90, P1811, DOI 10.1152/jappl.2001.90.5.1811; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Mijailovich SM, 2000, BIOPHYS J, V79, P2667, DOI 10.1016/S0006-3495(00)76505-2; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Nickles HT, 2014, AM J PHYSIOL-LUNG C, V307, pL27, DOI 10.1152/ajplung.00288.2013; Noble Peter B, 2012, J Allergy (Cairo), V2012, P157047, DOI 10.1155/2012/157047; Noble PB, 2011, J APPL PHYSIOL, V110, P1510, DOI 10.1152/japplphysiol.01226.2010; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Tepper RS, 2005, J APPL PHYSIOL, V98, P1949, DOI 10.1152/japplphysiol.00952.2004; Thomas RA, 2006, RESP MED, V100, P1588, DOI 10.1016/j.rmed.2005.12.008; Vlahakis NE, 1999, AM J PHYSIOL-LUNG C, V277, pL167, DOI 10.1152/ajplung.1999.277.1.L167; Waters CM, 2002, AM J PHYSIOL-LUNG C, V283, pL503, DOI 10.1152/ajplung.00141.2002; Watson N, 1998, BRIT J PHARMACOL, V123, P694, DOI 10.1038/sj.bjp.0701637; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127765	10.1371/journal.pone.0127765	http://dx.doi.org/10.1371/journal.pone.0127765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011598	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900141
J	Rose, SJ; Babrak, LM; Bermudez, LE				Rose, Sasha J.; Babrak, Lmar M.; Bermudez, Luiz E.			Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to Antibiotics	PLOS ONE			English	Article							COMPLEX MAC; RELEASE; ROLES; FORM; IDENTIFICATION; ABILITY; GROWTH	Mycobacterium avium subsp. hominissuis is an opportunistic pathogen that is associated with biofilm-related infections of the respiratory tract and is difficult to treat. In recent years, extracellular DNA (eDNA) has been found to be a major component of bacterial biofilms, including many pathogens involved in biofilm-associated infections. To date, eDNA has not been described as a component of mycobacterial biofilms. In this study, we identified and characterized eDNA in a high biofilm-producing strain of Mycobacterium avium subsp. hominissuis (MAH). In addition, we surveyed for presence of eDNA in various MAH strains and other nontuberculous mycobacteria. Biofilms of MAH A5 (high biofilm-producing strain) and MAH 104 (reference strain) were established at 22 degrees C and 37 degrees C on abiotic surfaces. Acellular biofilm matrix and supernatant from MAH A5 7 day-old biofilms both possess abundant eDNA, however very little eDNA was found in MAH 104 biofilms. A survey of MAH clinical isolates and other clinically relevant nontuberculous mycobacterial species revealed many species and strains that also produce eDNA. RAPD analysis demonstrated that eDNA resembles genomic DNA. Treatment with DNase I reduced the biomass of MAH A5 biofilms when added upon biofilm formation or to an already established biofilm both on abiotic surfaces and on top of human pharyngeal epithelial cells. Furthermore, co-treatment of an established biofilm with DNase 1 and either moxifloxacin or clarithromycin significantly increased the susceptibility of the bacteria within the biofilm to these clinically used antimicrobials. Collectively, our results describe an additional matrix component of mycobacterial biofilms and a potential new target to help treat biofilm-associated nontuberculous mycobacterial infections.	[Rose, Sasha J.; Babrak, Lmar M.; Bermudez, Luiz E.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Rose, Sasha J.; Babrak, Lmar M.; Bermudez, Luiz E.] Oregon State Univ, Coll Sci, Dept Microbiol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Bermudez, LE (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Luiz.Bermudez@oregonstate.edu			NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by a NIH grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Asally M, 2012, P NATL ACAD SCI USA, V109, P18891, DOI 10.1073/pnas.1212429109; Barnes AMT, 2012, MBIO, V3, DOI 10.1128/mBio.00193-12; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Chen JM, 2006, J BACTERIOL, V188, P633, DOI 10.1128/JB.188.2.633-641.2006; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h; Falkinham JO, 2008, J WATER HEALTH, V6, P209, DOI [10.2166/wh.2008.232, 10.2166/wh.2008.032]; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Freeman R, 2006, APPL ENVIRON MICROB, V72, P7554, DOI 10.1128/AEM.01633-06; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Godeke J, 2011, APPL ENVIRON MICROB, V77, P5342, DOI 10.1128/AEM.00643-11; Grande R, 2011, J APPL MICROBIOL, V110, P490, DOI 10.1111/j.1365-2672.2010.04911.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hannan S, 2010, FEMS IMMUNOL MED MIC, V59, P345, DOI 10.1111/j.1574-695X.2010.00661.x; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Hymes SR, 2013, J INFECT DIS, V207, P1491, DOI 10.1093/infdis/jit047; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Kaplan JB, 2012, J ANTIBIOT, V65, P73, DOI 10.1038/ja.2011.113; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Liao SM, 2014, J BACTERIOL, V196, P2355, DOI 10.1128/JB.01493-14; Liu RY, 2012, SCI TOTAL ENVIRON, V435, P124, DOI 10.1016/j.scitotenv.2012.07.022; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; McNabe M, 2011, CLIN MICROBIOL INFEC, V17, P697, DOI 10.1111/j.1469-0691.2010.03307.x; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Nessar R, 2011, MICROBIOL-SGM, V157, P1187, DOI 10.1099/mic.0.046557-0; Nishiuchi Y, 2007, CLIN INFECT DIS, V45, P347, DOI 10.1086/519383; Nishiuchi Y, 2009, JPN J INFECT DIS, V62, P182; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Pillai SR, 2001, VET MICROBIOL, V79, P275, DOI 10.1016/S0378-1135(00)00358-8; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramasoota P, 2001, VET MICROBIOL, V78, P251, DOI 10.1016/S0378-1135(00)00302-3; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rose SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108703; Rose SJ, 2014, INFECT IMMUN, V82, P405, DOI 10.1128/IAI.00820-13; Sahu Praveen K, 2012, ScientificWorldJournal, V2012, P973436, DOI 10.1100/2012/973436; Seper A, 2011, MOL MICROBIOL, V82, P1015, DOI 10.1111/j.1365-2958.2011.07867.x; Tetz GV, 2009, ANTIMICROB AGENTS CH, V53, P1204, DOI 10.1128/AAC.00471-08; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Whiley H, 2012, J APPL MICROBIOL, V113, P223, DOI 10.1111/j.1365-2672.2012.05298.x; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wu CW, 2009, MICROB PATHOGENESIS, V46, P222, DOI 10.1016/j.micpath.2009.01.010; Yamazaki Y, 2006, APPL ENVIRON MICROB, V72, P819, DOI 10.1128/AEM.72.1.819-825.2006; Yamazaki Y, 2006, CELL MICROBIOL, V8, P806, DOI 10.1111/j.1462-5822.2005.00667.x; Zambrano MM, 2005, CELL, V123, P762, DOI 10.1016/j.cell.2005.11.011	54	44	45	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128772	10.1371/journal.pone.0128772	http://dx.doi.org/10.1371/journal.pone.0128772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010725	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900250
J	Vinberg, M; Miskowiak, K; Hoejman, P; Pedersen, M; Kessing, LV				Vinberg, Maj; Miskowiak, Kamilla; Hoejman, Pernille; Pedersen, Maria; Kessing, Lars Vedel			The Effect of Recombinant Erythropoietin on Plasma Brain Derived Neurotrophic Factor Levels in Patients with Affective Disorders: A Randomised Controlled Study	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; BIPOLAR DISORDER; FACTOR BDNF; DECREASED LEVELS; MOOD EPISODES; RATING-SCALE; SERUM-LEVELS; RELEASE; RELIABILITY; SEVERITY	The study aims to investigate the effect of repeated infusions of recombinant erythropoietin (EPO) on plasma brain derived neurotrophic factor (BDNF) levels in patients with affective disorders. In total, 83 patients were recruited: 40 currently depressed patients with treatment-resistant depression (TRD) (Hamilton Depression Rating Scale-17 items (HDRS-17) score >17) (study 1) and 43 patients with bipolar disorder (BD) in partial remission (HDRS-17 and Young Mania Rating Scale (YMRS) <= 14) (study 2). In both studies, patients were randomised to receive eight weekly EPO (Eprex; 40,000 IU) or saline (0.9% NaCl) infusions in a double-blind, placebo-controlled, parallel-group design. Plasma BDNF levels were measured at baseline and at weeks 5, 9 and at follow up, week 14. In contrast with our hypothesis, EPO down regulated plasma BDNF levels in patients with TRD (mean reduction at week 9 (95% CI): EPO 10.94 ng/l (4.51-21.41 ng/l); mean increase at week 9: Saline 0.52 ng/l, p = 0.04 (-5.88-4.48 ng/l) p = 0.04, partial eta(2) = 0.12). No significant effects were found on BDNF levels in partially remitted patients with BD (p = 0.35). The present effects of EPO on BDNF levels in patients with TRD point to a role of neurotrophic factors in the potential effects of EPO seen in TRD and BD. The neurobiological mechanisms underlying these effects and the interaction between EPO and peripheral levels on BDNF need to be further elucidated in human studies including a broad range of biomarkers.	[Vinberg, Maj; Miskowiak, Kamilla; Kessing, Lars Vedel] Univ Copenhagen Hosp, Rigshosp, Psychiat Ctr Copenhagen, DK-2100 Copenhagen, Denmark; [Hoejman, Pernille; Pedersen, Maria] Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Hoejman, Pernille; Pedersen, Maria] Rigshosp, Ctr Phys Act Res, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Vinberg, M (corresponding author), Univ Copenhagen Hosp, Rigshosp, Psychiat Ctr Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	maj.vinberg@regionh.dk	Vinberg/ABC-7493-2021	Vinberg/0000-0002-5982-1335; Kessing, Lars/0000-0001-9377-9436; Miskowiak, Kamilla/0000-0003-2572-1384	Danish Ministry of Science, Innovation and Higher Education; Novo Nordisk Foundation; Beckett Fonden; Sawaerksejer Juhl's Mindefond; Augustinus Foundation	Danish Ministry of Science, Innovation and Higher Education; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Beckett Fonden; Sawaerksejer Juhl's Mindefond; Augustinus Foundation	The study was funded by the Danish Ministry of Science, Innovation and Higher Education, Novo Nordisk Foundation, Beckett Fonden, Sawaerksejer Juhl's Mindefond, and the Augustinus Foundation. The funding source had no role in the study design, in the collection, analyses, and interpretation of data, in writing the manuscript, or in the decision to submit the paper for publication.	Barbosa IG, 2013, REV BRAS PSIQUIATR, V35, P67, DOI 10.1016/j.rbp.2012.05.011; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Birkenhager TK, 2012, J PSYCHIATR RES, V46, P285, DOI 10.1016/j.jpsychires.2011.12.006; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brunoni AR, 2014, WORLD J BIOL PSYCHIA; Chao MV, 2004, J ALZHEIMERS DIS, V6, pS7; Chong ZZ, 2013, EXPERT OPIN THER TAR, V17, P707, DOI 10.1517/14728222.2013.780599; de Oliveira GS, 2009, J PSYCHIATR RES, V43, P1171, DOI 10.1016/j.jpsychires.2009.04.002; Dell'Osso L, 2010, NEUROPSYCHOBIOLOGY, V62, P207, DOI 10.1159/000319946; Diniz BS, 2014, J PSYCHIATR RES, V49, P96, DOI 10.1016/j.jpsychires.2013.11.004; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Fava M, 2009, PSYCHOTHER PSYCHOSOM, V78, P91, DOI 10.1159/000201934; Fernandes BS, 2014, MOL PSYCHIATR, V19, P749, DOI 10.1038/mp.2013.172; Fernandes BS, 2011, J PSYCHIATR RES, V45, P995, DOI 10.1016/j.jpsychires.2011.03.002; Forsgren S, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/650685; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Geslain R, 2013, CYTOKINE, V61, P329, DOI 10.1016/j.cyto.2012.10.017; Girgenti MJ, 2009, BIOL PSYCHIAT, V66, P267, DOI 10.1016/j.biopsych.2008.12.005; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Goldstein BI, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0425-9; Grande I, 2012, J PSYCHIATR RES, V46, P1511, DOI 10.1016/j.jpsychires.2012.08.017; Green MJ, 2011, MOL PSYCHIATR, V16, P960, DOI 10.1038/mp.2010.88; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hasselbalch BJ, 2012, ACTA PSYCHIAT SCAND, V126, P157, DOI 10.1111/j.1600-0447.2012.01831.x; Hayley S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00218; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Lee BH, 2007, J AFFECT DISORDERS, V101, P239, DOI 10.1016/j.jad.2006.11.005; Maiese K, 2012, INT J MOL SCI, V13, P11102, DOI 10.3390/ijms130911102; Mengozzi M, 2012, P NATL ACAD SCI USA, V109, P9617, DOI 10.1073/pnas.1200554109; Miskowiak K., 2014, J CLIN PSYCHIAT; Miskowiak K, 2015, BIOL PSYCHI IN PRESS; Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007; Miskowiak KW, 2014, NEUROPSYCHOPHARMACOL, V39, P1399, DOI 10.1038/npp.2013.335; Miskowiak KW, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-97; Molendijk ML, 2013, MOL PSYCHIAT; Monteleone P, 2008, BIPOLAR DISORD, V10, P95, DOI 10.1111/j.1399-5618.2008.00459.x; Muller GC, 2010, CLIN EXP ALLERGY, V40, P1755, DOI 10.1111/j.1365-2222.2010.03618.x; Munkholm K, 2014, PSYCHONEUROENDOCRINO, V47, P199, DOI 10.1016/j.psyneuen.2014.05.011; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nettiksimmons J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091339; Nofuji Y, 2008, NEUROSCI LETT, V437, P29, DOI 10.1016/j.neulet.2008.03.057; Oral E, 2012, BRAIN RES BULL, V88, P454, DOI 10.1016/j.brainresbull.2012.03.005; Pedersen BK, 2009, EXP PHYSIOL, V94, P1153, DOI 10.1113/expphysiol.2009.048561; Posternak MA, 2004, J NERV MENT DIS, V192, P95, DOI 10.1097/01.nmd.0000110280.19284.47; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Ricken R, 2013, J CLIN PSYCHOPHARM, V33, P806, DOI 10.1097/JCP.0b013e3182a412b8; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Schuch FB, 2014, EUR ARCH PSYCHIAT CL; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Sodersten K, 2014, J AFFECT DISORDERS, V160, P1, DOI 10.1016/j.jad.2014.01.009; Teixeira AL, 2010, BIOMARK MED, V4, P871, DOI 10.2217/BMM.10.111; van der Meij A, 2014, PSYCHONEUROENDOCRINO, V43, P81, DOI 10.1016/j.psyneuen.2014.02.001; Vinberg M, 2013, PSYCHIAT RES; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Watanabe K, 2010, PROG NEURO-PSYCHOPH, V34, P1450, DOI 10.1016/j.pnpbp.2010.07.036; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Yoshimura R, 2006, HUM PSYCHOPHARM CLIN, V21, P433, DOI 10.1002/hup.804; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069620	61	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127629	10.1371/journal.pone.0127629	http://dx.doi.org/10.1371/journal.pone.0127629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011424	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900118
J	Grosse-Wilde, A; d'Herouel, AF; McIntosh, E; Ertaylan, G; Skupin, A; Kuestner, RE; del Sol, A; Walters, KA; Huang, S				Grosse-Wilde, Anne; d'Herouel, Aymeric Fouquier; McIntosh, Ellie; Ertaylan, Gokhan; Skupin, Alexander; Kuestner, Rolf E.; del Sol, Antonio; Walters, Kathie-Anne; Huang, Sui			Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION SIGNATURE; IN-VITRO PROPAGATION; TUMOR-CELLS; METASTATIC COLONIZATION; PROGNOSTIC-SIGNIFICANCE; SUBTYPES; DIFFERENTIATION; IDENTIFICATION; PROGENITORS	Breast cancer stem cells (CSCs) are thought to drive recurrence and metastasis. Their identity has been linked to the epithelial to mesenchymal transition (EMT) but remains highly controversial since-depending on the cell-line studied-either epithelial (E) or mesenchymal (M) markers, alone or together have been associated with stemness. Using distinct transcript expression signatures characterizing the three different E, M and hybrid E/M cell-types, our data support a novel model that links a mixed EM signature with stemness in 1) individual cells, 2) luminal and basal cell lines, 3) in vivo xenograft mouse models, and 4) in all breast cancer subtypes. In particular, we found that co-expression of E and M signatures was associated with poorest outcome in luminal and basal breast cancer patients as well as with enrichment for stem-like cells in both E and M breast cell-lines. This link between a mixed EM expression signature and stemness was explained by two findings: first, mixed cultures of E and M cells showed increased cooperation in mammosphere formation (indicative of stemness) compared to the more differentiated E and M cell-types. Second, singlecell qPCR analysis revealed that E and M genes could be co-expressed in the same cell. These hybrid E/M cells were generated by both E or M cells and had a combination of several stem-like traits since they displayed increased plasticity, self-renewal, mammosphere formation, and produced ALDH1+ progenies, while more differentiated M cells showed less plasticity and E cells showed less self-renewal. Thus, the hybrid E/M state reflecting stemness and its promotion by E-M cooperation offers a dual biological rationale for the robust association of the mixed EM signature with poor prognosis, independent of cellular origin. Together, our model explains previous paradoxical findings that breast CSCs appear to be M in luminal cell-lines but E in basal breast cancer cell-lines. Our results suggest that targeting E/M heterogeneity by eliminating hybrid E/M cells and cooperation between E and M cell-types could improve breast cancer patient survival independent of breast cancer-subtype.	[Grosse-Wilde, Anne; d'Herouel, Aymeric Fouquier; McIntosh, Ellie; Skupin, Alexander; Kuestner, Rolf E.; Walters, Kathie-Anne; Huang, Sui] Inst Syst Biol, Seattle, WA 98109 USA; [d'Herouel, Aymeric Fouquier; Ertaylan, Gokhan; Skupin, Alexander; del Sol, Antonio] Luxembourg Ctr Syst Biomed, L-4362 Esch Sur Alzette, Luxembourg	Institute for Systems Biology (ISB); University of Luxembourg	Grosse-Wilde, A (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	anne@grwil.de; shuang@systemsbiology.org		Ertaylan, Gokhan/0000-0001-5602-6435; SKUPIN, Alexander/0000-0002-8955-8304	Institute for Systems Biology; University of Luxembourg; NIH Center for Systems Biology [2P50GM075647]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109964] Funding Source: NIH RePORTER	Institute for Systems Biology; University of Luxembourg; NIH Center for Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the strategic partnership between the Institute for Systems Biology and the University of Luxembourg, and the NIH Center for Systems Biology/2P50GM075647.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Azzam DJ, 2013, EMBO MOL MED, V5, P1502, DOI 10.1002/emmm.201302558; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Granit RZ, 2014, WIRES SYST BIOL MED, V6, P93, DOI 10.1002/wsbm.1252; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Jolly MK, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0962; Jones Robin L, 2012, Surg Pathol Clin, V5, P701, DOI 10.1016/j.path.2012.06.008; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Kim HJ, 2011, BREAST, V20, P78, DOI 10.1016/j.breast.2010.08.001; Kim J, 2012, P NATL ACAD SCI USA, V109, P6124, DOI 10.1073/pnas.1203203109; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Li CI, 2009, CANCER RES, V69, P6865, DOI 10.1158/0008-5472.CAN-09-1355; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Lu MY, 2014, CANCER RES, V74, P4574, DOI 10.1158/0008-5472.CAN-13-3367; Lu M, 2013, P NATL ACAD SCI USA, V110, P18144, DOI 10.1073/pnas.1318192110; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcus JS, 2006, ANAL CHEM, V78, P3084, DOI 10.1021/ac0519460; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Mihaly Zsuzsanna, 2013, Microarrays (Basel), V2, P228, DOI 10.3390/microarrays2030228; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Ombrato Luigi, 2014, Critical Reviews in Oncogenesis, V19, P349; Patsialou A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3344; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002	68	218	222	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126522	10.1371/journal.pone.0126522	http://dx.doi.org/10.1371/journal.pone.0126522			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020648	Green Submitted, gold, Green Published			2022-12-27	WOS:000355187300024
J	Wang, C; Lai, DYF; Tong, C; Wang, WQ; Huang, JF; Zeng, CS				Wang, Chun; Lai, Derrick Y. F.; Tong, Chuan; Wang, Weiqi; Huang, Jiafang; Zeng, Chongsheng			Variations in Temperature Sensitivity (Q(10)) of CH4 Emission from a Subtropical Estuarine Marsh in Southeast China	PLOS ONE			English	Article							CARBON-DIOXIDE FLUX; MIN RIVER ESTUARY; SOIL RESPIRATION; METHANE EMISSIONS; ORGANIC-CARBON; ECOSYSTEM RESPIRATION; VEGETATION ZONES; NITROGEN; WETLANDS; CO2	Understanding the functional relationship between greenhouse gas fluxes and environmental variables is crucial for predicting the impacts of wetlands on future climate change in response to various perturbations. We examined the relationships between methane (CH4) emission and temperature in two marsh stands dominated by the Phragmites australis and Cyperus malaccensis, respectively, in a subtropical estuarine wetland in southeast China based on three years of measurement data (2007-2009). We found that the Q(10) coefficient of CH4 emission to soil temperature (Qs(10)) from the two marsh stands varied slightly over the three years (P > 0.05), with a mean value of 3.38 +/- 0.46 and 3.89 +/- 0.41 for the P. australis and C. malaccensis stands, respectively. On the other hand, the three-year mean Q(a10) values (Q(10) coefficients of CH4 emission to air temperature) were 3.39 +/- 0.59 and 4.68 +/- 1.10 for the P. australis and C. malaccensis stands, respectively, with a significantly higher Q(a10) value for the C. malaccensis stand in 2008 (P < 0.05). The seasonal variations of Q(10) (Q(s10) and Q(a10)) differed among years, with generally higher values in the cold months than those in the warm months in 2007 and 2009. We found that the Q(s10) values of both stands were negatively correlated with soil conductivity, but did not obtain any conclusive results about the difference in Q(10) of CH4 emission between the two tidal stages (before flooding and after ebbing). There were no significant differences in both Q(s10) and Q(a10) values of CH4 emission between the P. australis stand and the C. malaccensis stands (P > 0.05). Our results show that the Q(10) values of CH4 emission in this estuarine marsh are highly variable across space and time. Given that the overall CH4 flux is governed by a suite of environmental factors, the Q(10) values derived from field measurements should only be considered as a semi-empirical parameter for simulating CH4 emissions.	[Wang, Chun; Tong, Chuan; Wang, Weiqi; Huang, Jiafang; Zeng, Chongsheng] Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Fuzhou, Peoples R China; [Wang, Chun] Fujian Normal Univ, Sch Geog Sci, Fuzhou, Peoples R China; [Lai, Derrick Y. F.] Chinese Univ Hong Kong, Dept Geog & Resource Management, Shatin, Hong Kong, Peoples R China; [Lai, Derrick Y. F.] Chinese Univ Hong Kong, Ctr Environm Policy & Resource Management, Shatin, Hong Kong, Peoples R China; [Tong, Chuan; Wang, Weiqi; Huang, Jiafang; Zeng, Chongsheng] Fujian Normal Univ, Inst Geog, Fuzhou, Peoples R China	Fujian Normal University; Fujian Normal University; Chinese University of Hong Kong; Chinese University of Hong Kong; Fujian Normal University	Tong, C (corresponding author), Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc, Minist Educ, Fuzhou, Peoples R China.	tongch@fjnu.edu.cn	Lai, Derrick Y.F./B-1387-2009; Wang, weiqi/AAN-8209-2020	Lai, Derrick Y.F./0000-0002-1225-9904; wang, weiqi/0000-0001-8503-0978	National Science Foundation of China [40671174, 41071148]; Program for Innovative Research Team in Fujian Normal University [IRTL1205]; Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK458913]; Chinese University of Hong Kong [SS12434]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Fujian Normal University; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was financially supported by the National Science Foundation of China (Grant No: 40671174 and 41071148), the Program for Innovative Research Team in Fujian Normal University IRTL1205), Research Grants Council of the Hong Kong Special Administrative Region, China (CUHK458913), and The Chinese University of Hong Kong (SS12434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JA, 2000, SOIL BIOL BIOCHEM, V32, P699, DOI 10.1016/S0038-0717(99)00206-0; Arkebauer TJ, 2001, AM J BOT, V88, P653, DOI 10.2307/2657065; Bai JH, 2005, GEODERMA, V124, P181, DOI 10.1016/j.geoderma.2004.04.012; Bergman I, 1998, SOIL BIOL BIOCHEM, V30, P729, DOI 10.1016/S0038-0717(97)00181-8; Biswas H, 2007, J MARINE SYST, V68, P55, DOI 10.1016/j.jmarsys.2006.11.001; Chambers LG, 2013, BIOGEOCHEMISTRY, V115, P363, DOI 10.1007/s10533-013-9841-5; Chang TC, 2003, ATMOS ENVIRON, V37, P4551, DOI 10.1016/S1352-2310(03)00588-0; Chen BY, 2010, SOIL BIOL BIOCHEM, V42, P1735, DOI 10.1016/j.soilbio.2010.06.010; Chen H, 2005, J INTEGR PLANT BIOL, V47, P1288, DOI 10.1111/j.1744-7909.2005.00211.x; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Crill PM, 1988, GLOBAL BIOGEOCHEM CY, V2, P371, DOI 10.1029/GB002i004p00371; Cusack DF, 2010, GLOBAL CHANGE BIOL, V16, P2555, DOI 10.1111/j.1365-2486.2009.02131.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DISE NB, 1993, J GEOPHYS RES-ATMOS, V98, P10583, DOI 10.1029/93JD00160; Drewitt GB, 2002, AGR FOREST METEOROL, V110, P299, DOI 10.1016/S0168-1923(01)00294-5; Duan Xiao-nan, 2007, Huanjing Kexue, V28, P455; DUNFIELD P, 1993, SOIL BIOL BIOCHEM, V25, P321, DOI 10.1016/0038-0717(93)90130-4; Gunther A, 2014, ENVIRON MONIT ASSESS, V186, P2151, DOI 10.1007/s10661-013-3524-5; HARRISS RC, 1982, NATURE, V297, P673, DOI 10.1038/297673a0; Hirota M, 2004, SOIL BIOL BIOCHEM, V36, P737, DOI 10.1016/j.soilbio.2003.12.009; Inglett KS, 2012, BIOGEOCHEMISTRY, V108, P77, DOI 10.1007/s10533-011-9573-3; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Koch O, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002983; Lai DYF, 2014, ATMOS ENVIRON, V89, P249, DOI 10.1016/j.atmosenv.2014.02.034; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Ma AN, 2012, J COASTAL RES, V28, P1319, DOI 10.2112/JCOASTRES-D-11-00001.1; Macdonald JA, 1998, ATMOS ENVIRON, V32, P3219, DOI 10.1016/S1352-2310(97)00464-0; Magenheimer JF, 1996, ESTUARIES, V19, P139, DOI 10.2307/1352658; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Miller RL, 2011, WETLANDS, V31, P1055, DOI 10.1007/s13157-011-0215-2; Min K, 2014, SOIL BIOL BIOCHEM, V76, P193, DOI 10.1016/j.soilbio.2014.05.021; Moore TR, 2011, ECOSYSTEMS, V14, P646, DOI 10.1007/s10021-011-9435-9; MOORE TR, 1990, BIOGEOCHEMISTRY, V11, P45; Neubauer SC, 2013, ESTUAR COAST, V36, P491, DOI 10.1007/s12237-011-9455-x; Olefeldt D, 2013, GLOBAL CHANGE BIOL, V19, P589, DOI 10.1111/gcb.12071; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rask H, 2002, SOIL BIOL BIOCHEM, V34, P435, DOI 10.1016/S0038-0717(01)00197-3; ROULET NT, 1992, J GEOPHYS RES-ATMOS, V97, P3739, DOI 10.1029/91JD03109; SANSONE FJ, 1981, SCIENCE, V211, P707, DOI 10.1126/science.211.4483.707; Schipper LA, 2014, GLOBAL CHANGE BIOL, V20, P3578, DOI 10.1111/gcb.12596; SCHUTZ H, 1990, BIOGEOCHEMISTRY, V11, P77; Segers R, 1998, BIOGEOCHEMISTRY, V41, P23, DOI 10.1023/A:1005929032764; Shangguan XJ, 1994, J GRADUATE SCH ACAD, V11, P214; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Song Chang-chun, 2006, Huanjing Kexue, V27, P2369; Song CC, 2009, GLOBAL CHANGE BIOL, V15, P692, DOI 10.1111/j.1365-2486.2008.01821.x; Sun ZG, 2013, PLANT SOIL, V369, P317, DOI 10.1007/s11104-012-1564-1; Tong C, 2014, WETLANDS, V34, P225, DOI 10.1007/s13157-013-0478-x; Tong C, 2012, BIOGEOCHEMISTRY, V111, P677, DOI 10.1007/s10533-012-9712-5; Tong C, 2010, J ENVIRON SCI HEAL A, V45, P506, DOI 10.1080/10934520903542261; Treat CC, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000210; UPDEGRAFF K, 1995, ECOL APPL, V5, P151, DOI 10.2307/1942060; VALENTINE DW, 1994, J GEOPHYS RES-ATMOS, V99, P1563, DOI 10.1029/93JD00391; Van der Nat FJ, 2000, BIOGEOCHEMISTRY, V49, P103, DOI 10.1023/A:1006333225100; van Winden JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039614; Verville JH, 1998, BIOGEOCHEMISTRY, V41, P215, DOI 10.1023/A:1005984701775; Wallenstein MD, 2009, GLOBAL CHANGE BIOL, V15, P1631, DOI 10.1111/j.1365-2486.2008.01819.x; Wang CK, 2006, GLOBAL CHANGE BIOL, V12, P2103, DOI 10.1111/j.1365-2486.2006.01234.x; WESTERMANN P, 1989, APPL ENVIRON MICROB, V55, P1262, DOI 10.1128/AEM.55.5.1262-1266.1989; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013	61	18	19	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125227	10.1371/journal.pone.0125227	http://dx.doi.org/10.1371/journal.pone.0125227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020528	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300011
J	Arriaza, MC; Dominguez-Rodrigo, M; Martinez-Maza, C; Mabulla, A; Baquedano, E				Carmen Arriaza, Mari; Dominguez-Rodrigo, Manuel; Martinez-Maza, Cayetana; Mabulla, Audax; Baquedano, Enrique			Differential Predation by Age and Sex Classes in Blue Wildebeest in Serengeti: Study of a Modern Carnivore Den in Olduvai Gorge (Tanzania)	PLOS ONE			English	Article							POPULATION-DYNAMICS; PREY; CONSEQUENCES; PATTERNS; BEHAVIOR; SEASON; LION	Age and sex selection of prey is an aspect of predator ecology which has been extensively studied in both temperate and African ecosystems. This dimension, along with fecundity, survival rates of prey and mortality factors other than predation are important in laying down the population dynamics of prey and have important implications in the management of species. A carnivore den located in the short-grassland ecological unit of the Serengeti was studied. Sex-and age-class (using five age categories) of the wildebeest remains recovered were analyzed through horn morphology, biometrics of the bones and tooth wear patterns. We compared our results with previous studies from lion and hyaena kills through multivariate analyses. Seasonality of the accumulation was analyzed through tooth histology. PCA and CVA results show that age class selection by predators depends on season, habitat-type, and growth rate of the wildebeest population. Female-biased predation was found to contradict classical hypotheses based on territorial male behaviour. The lion and spotted hyaena showed strong selection on age classes, contrary to previous studies. Migratory wildebeest sex ratio is regulated through differential predation by seasons and female deaths in the wet season are a trade-off for population stability. These data are crucial for an effective management of the species and the new method created may be useful for different carnivore species and their prey.	[Carmen Arriaza, Mari] Univ Alcala De Henares, Dept Geol Geog & Med Ambiente, Madrid 28871, Spain; [Carmen Arriaza, Mari; Dominguez-Rodrigo, Manuel; Baquedano, Enrique] Inst Evoluc Africa IDEA, Madrid, Spain; [Dominguez-Rodrigo, Manuel] Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; [Martinez-Maza, Cayetana] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Mabulla, Audax] Univ Dar Es Salaam, Dept Archaeol, Dar Es Salaam, Tanzania; [Baquedano, Enrique] Museo Arqueol Reg Comunidad Madrid, Madrid, Spain	Universidad de Alcala; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Dar es Salaam	Arriaza, MC (corresponding author), Univ Alcala De Henares, Dept Geol Geog & Med Ambiente, Edificio Ciencia,Campus ExternoCtra A-2 Km 33 600, Madrid 28871, Spain.	mcarmen.arriaza@uah.es	Mabulla, Audax ZP/ABE-2455-2020; Baquedano, Enrique/ABE-9997-2020; del Carmen Arriaza Dorado, María/AAB-3468-2021	del Carmen Arriaza Dorado, María/0000-0003-1393-4323	Spanish Ministry of Science and Innovation through the European project I + D [HAR2013-45246-C3-1P]; Spanish Ministry of Culture through the Heritage Institute; Program of Funding for Archaeological Projects Abroad; JAE-DOC postdoctoral contract (CSIC); European Social Fund; Comunidad de Madrid through the I + D project [S2010/BMD-2330]	Spanish Ministry of Science and Innovation through the European project I + D(Ministry of Science and Innovation, Spain (MICINN)); Spanish Ministry of Culture through the Heritage Institute(Spanish Government); Program of Funding for Archaeological Projects Abroad; JAE-DOC postdoctoral contract (CSIC); European Social Fund(European Social Fund (ESF)); Comunidad de Madrid through the I + D project(Comunidad de Madrid)	The authors greatly appreciate the major funding provided by the Spanish Ministry of Science and Innovation through the European project I + D HAR2013-45246-C3-1P and the Spanish Ministry of Culture through the Heritage Institute and the Program of Funding for Archaeological Projects Abroad. CMM was supported by a JAE-DOC postdoctoral contract (CSIC) co-funded by the European Social Fund. The authors also thank the Comunidad de Madrid for funding provided through the I + D project S2010/BMD-2330 (I+D activities programme for research groups of the Consejeria de Educacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arceredillo D, 2011, J ARCHAEOL SCI, V38, P2450, DOI 10.1016/j.jas.2011.05.013; ATTWELL CAM, 1980, S AFR J ZOOL, V15, P121; Boukal DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002687; Bunn HT, 2010, QUATERNARY RES, V74, P395, DOI 10.1016/j.yqres.2010.07.012; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Creel S., 2002, AFRICAN WILD DOG BEH; Davidson Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055182; Dennis B., 1989, Natural Resource Modeling, V3, P481; DOEBELI M, 1994, P ROY SOC B-BIOL SCI, V257, P17, DOI 10.1098/rspb.1994.0088; Dominguez-Rodrigo M, 2007, DECONSTRUCTING OLDUV; Dominguez-Rodrigo M, 2012, ARCHAEOL ANTHROP SCI, V4, P47, DOI 10.1007/s12520-011-0082-z; ELLIOTT JP, 1978, CAN J ZOOL, V56, P1726, DOI 10.1139/z78-237; ESTES R D, 1976, East African Wildlife Journal, V14, P135; ESTES RD, 1966, NATURE, V212, P999, DOI 10.1038/212999a0; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fryxell John M., 1995, P257; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; Hopcraft JGC., 2010, ECOLOGICAL IMPLICATI; Jarman P. J., 1979, SERENGETI DYNAMICS E, P185; Kingdom J, 1982, E AFRICAN MAMMALS AT; Klevezal G., 1996, RECORDING STRUCTURES; KLEVEZAL GA, 1987, ACTA THERIOL, V32, P115, DOI 10.4098/AT.arch.87-10; Kruuk H., 1972, SPOTTED HYENA STUDY; Lehmann MB, 2008, S AFR J WILDL RES, V38, P66, DOI 10.3957/0379-4369-38.1.66; Lindstrom J, 1998, P ROY SOC B-BIOL SCI, V265, P483, DOI 10.1098/rspb.1998.0320; McCarthy MA, 1997, ECOL MODEL, V103, P99, DOI 10.1016/S0304-3800(97)00104-X; Mduma SAR, 1999, J ANIM ECOL, V68, P1101, DOI 10.1046/j.1365-2656.1999.00352.x; Mduma SAR, 1996, THESIS U BRIT COLUMB; MILLS MGL, 1992, J ANIM ECOL, V61, P693, DOI 10.2307/5624; Mills MGL, 1990, KALAHARY HYAENAS; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Ndibalema VG, 2009, AFR J ECOL, V47, P574, DOI 10.1111/j.1365-2028.2008.00994.x; Ndibalema VG, 2007, THESIS U SCI TECHNOL; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; Pienaar U. de V., 1969, Koedoe, VNo. 12, P108; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Schaller G. B., 1972, SERENGETI LION STUDY; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; SINCLAIR ARE, 1977, NATURE, V267, P832, DOI 10.1038/267832a0; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; SINCLAIR ARE, 1995, ECOLOGY, V76, P882, DOI 10.2307/1939353; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stiner M.C., 1994, HONOR THIEVES ZOOARC; STINER MC, 1990, J ANTHROPOL ARCHAEOL, V9, P305, DOI 10.1016/0278-4165(90)90010-B; Talbot LM., 1963, E AFRICA, P3; von den Driesch A, 1972, OSTEOARCHAOLOGISCHE, V3; Watson R.M., 1967, THESIS CAMBRIDGE U; Wilson B, 1982, OXFORD BAR BRIT SERI, V109; Yravedra J, 2009, J QUATERNARY SCI, V24, P85, DOI 10.1002/jqs.1164	51	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125944	10.1371/journal.pone.0125944	http://dx.doi.org/10.1371/journal.pone.0125944			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017363	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600044
J	Lu, GW; Zhang, JL; Zhang, CT; Li, XL; Shi, DW; Yang, ZP; Wang, CM				Lu, Guangwu; Zhang, Jilei; Zhang, Chuntao; Li, Xiaolu; Shi, Dawei; Yang, Zhaopeng; Wang, Chengming			One-Step Reverse-Transcription FRET-PCR for Differential Detection of Five Ebolavirus Species	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; VIRUS; FILOVIRUSES; STRAIN; ZAIRE; ASSAY; PANEL	Ebola is an emerging infectious disease caused by a deadly virus belonging to the family Filoviridae, genus Ebolavirus. Based on their geographical distribution, Ebolavirus has been classified into total five species so far, mainly Zaire, Sudan, Tai Forest, Bundibugyo and Reston. It is important to be able to differentiate the Ebolavirus species as they significantly differ in pathogenicity and more than one species can be present in an area. We have developed a one-step step-down RT-PCR detecting all five Ebolavirus species with high sensitivity (1 copy of Ebolavirus DNA, 10 copies of RNA and 320 copies of RNA spiked in 1 ml whole blood). The primers and FRET-probes we designed enabled us to differentiate five Ebolavirus species by distinct T-m (Zaire: flat peaks between 53.0 degrees C and 56.9 degrees C; Sudan: 51.6 degrees C; Reston: flat peaks between 47.5 degrees C and 54.9 degrees C; Tai Forest: 52.8 degrees C; Bundibugyo: dual peaks at 48.9 degrees C and 53.5 degrees C), and by different amplicon sizes (Zaire 255bp, Sudan 211bp, Reston 192bp, Tai Forest 166bp, Bundibugyo 146bp). This one-size-fit-all assay enables the rapid detection and discrimination of the five Ebolavirus species in a single reaction.	[Lu, Guangwu; Zhang, Jilei; Wang, Chengming] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Chuntao; Shi, Dawei; Yang, Zhaopeng] China Food & Drug Adm, Natl Inst Food & Drug Control NIFDC, Beijing 100050, Peoples R China; [Li, Xiaolu] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China	Yangzhou University; National Institute of Food & Drug Control - China; Donghua University	Wang, CM (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.	wangcm@yzu.edu.cn	Zhang, Jilei/L-8672-2019	Zhang, Jilei/0000-0002-9589-1162	National Natural Science Foundation of China [31472225]; Priority Academic Program Development of Jiangsu Higher Education Institutions, Yangzhou, Jiangsu, P. R. China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions, Yangzhou, Jiangsu, P. R. China	This project was supported by grant from the National Natural Science Foundation of China (NO: 31472225; http://www.nsfc.gov.cn/publish/portal1/) and the Priority Academic Program Development of Jiangsu Higher Education Institutions, Yangzhou, Jiangsu, P. R. China (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Bhaumik S, 2012, NATL MED J INDIA, V25, P317; Burd EM, 2015, J CLIN MICROBIOL, V53, P4, DOI 10.1128/JCM.03115-14; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Drosten C, 2001, J CLIN MICROBIOL, V39, P4302, DOI 10.1128/JCM.39.12.4302-4308.2001; Fajfr M, 2014, EPIDEMIOL MIKROBI IM, V63, P238; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Gibb TR, 2001, J CLIN MICROBIOL, V39, P4125, DOI 10.1128/JCM.39.11.4125-4130.2001; Goeijenbier M, 2014, NETH J MED, V72, P442; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; HEYMANN DL, 1980, J INFECT DIS, V142, P372, DOI 10.1093/infdis/142.3.372; Huang Yi, 2012, Virologica Sinica, V27, P273, DOI 10.1007/s12250-012-3252-y; JOHNSON KM, 1977, LANCET, V1, P569; Joshi SM, 2000, J VIROL, V74, P10260, DOI 10.1128/JVI.74.21.10260-10268.2000; Kelly PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053450; Kuhn JH, 2014, ARCH VIROL, V159, P1229, DOI 10.1007/s00705-013-1877-2; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Li YH, 2014, EPIDEMIOL INFECT, V142, P1138, DOI 10.1017/S0950268813002215; Liu Yang, 2012, Chinese Journal of Virology, V28, P567; Ogawa H, 2011, J VIROL METHODS, V171, P310, DOI 10.1016/j.jviromet.2010.11.010; Panning M, 2007, J INFECT DIS, V196, pS199, DOI 10.1086/520600; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Ross AGP, 2014, INT J INFECT DIS, V28, P217, DOI 10.1016/j.ijid.2014.09.001; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636; Wang CM, 2010, VET PARASITOL, V168, P11, DOI 10.1016/j.vetpar.2009.10.015; World Health Organization, 2015, EBOLA CURRENT SITUAT; Xiang JH, 2002, J MED VIROL, V68, P537, DOI 10.1002/jmv.10237; Yang Yu, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P313	31	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126281	10.1371/journal.pone.0126281	http://dx.doi.org/10.1371/journal.pone.0126281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017916	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600048
J	McFadden, BR; Lusk, JL; Crespi, JM; Cherry, JBC; Martin, LE; Aupperle, RL; Bruce, AS				McFadden, Brandon R.; Lusk, Jayson L.; Crespi, John M.; Cherry, J. Bradley C.; Martin, Laura E.; Aupperle, Robin L.; Bruce, Amanda S.			Can Neural Activation in Dorsolateral Prefrontal Cortex Predict Responsiveness to Information? An Application to Egg Production Systems and Campaign Advertising	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DECISION-MAKING; ORBITOFRONTAL CORTEX; RESPONSES; BRAIN; RISK; VALUATION; AMBIGUITY; CHOICE; LOGOS	Consumers prefer to pay low prices and increase animal welfare; however consumers are typically forced to make tradeoffs between price and animal welfare. Campaign advertising (i.e., advertising used during the 2008 vote on Proposition 2 in California) may affect how consumers make tradeoffs between price and animal welfare. Neuroimaging data was used to determine the effects of brain activation in dorsolateral prefrontal cortex (dlPFC) on choices making a tradeoff between price and animal welfare and responsiveness to campaign advertising. Results indicated that activation in the dlPFC was greater when making choices that forced a tradeoff between price and animal welfare, compared to choices that varied only by price or animal welfare. Furthermore, greater activation differences in right dlPFC between choices that forced a tradeoff and choices that did not, indicated greater responsiveness to campaign advertising.	[McFadden, Brandon R.] Univ Florida, Dept Food & Resource Econ, Gainesville, FL 32611 USA; [Lusk, Jayson L.] Oklahoma State Univ, Dept Agr Econ, Stillwater, OK 74078 USA; [Crespi, John M.] Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA; [Cherry, J. Bradley C.; Bruce, Amanda S.] Univ Kansas, Med Ctr, Dept Behav Pediat, Kansas City, KS 66103 USA; [Martin, Laura E.] Univ Kansas, Med Ctr, Dept Prevent Med & Publ Hlth, Kansas City, KS 66103 USA; [Aupperle, Robin L.] Univ Tulsa, Laureate Inst Brain Res, Tulsa, OK 74104 USA	State University System of Florida; University of Florida; Oklahoma State University System; Oklahoma State University - Stillwater; Kansas State University; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Laureate Institute for Brain Research, Inc.; University of Tulsa	McFadden, BR (corresponding author), Univ Florida, Dept Food & Resource Econ, Gainesville, FL 32611 USA.	brandon.mcfadden@ufl.edu	Aupperle, Robin/AAU-8550-2020		United States Department of Agriculture National Institute of Food and Agriculture, Agricultural and Food Research Initiative [2011-67023-30047]	United States Department of Agriculture National Institute of Food and Agriculture, Agricultural and Food Research Initiative	This work was supported by the United States Department of Agriculture National Institute of Food and Agriculture, Agricultural and Food Research Initiative grant number 2011-67023-30047.	Allender WJ, 2010, J AGR RESOUR ECON, V35, P424; [Anonymous], 2008, YES PROP 2 ADVERTISE; [Anonymous], 2008, NO PROP 2 ADVERTISEM; Bach DR, 2009, J NEUROSCI, V29, P1648, DOI 10.1523/JNEUROSCI.4578-08.2009; Baltzer K., 2004, Acta Agricultura Scandinavica. Section C, Economy, V1, P78, DOI 10.1080/16507540410024506; Bruce AS, 2014, J NEUROSCI PSYCHOL E, V7, P164, DOI 10.1037/npe0000023; Bruce AS, 2014, SOC COGN AFFECT NEUR, V9, P118, DOI 10.1093/scan/nss109; Bruce AS, 2013, J PEDIATR-US, V162, P759, DOI 10.1016/j.jpeds.2012.10.003; Camerer CF, 2013, J ECON LIT, V51, P1155, DOI 10.1257/jel.51.4.1155; Camus M, 2009, EUR J NEUROSCI, V30, P1980, DOI 10.1111/j.1460-9568.2009.06991.x; Chang JB, 2010, J AGR RESOUR ECON, V35, P406; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Hutcherson CA, 2012, J NEUROSCI, V32, P13543, DOI 10.1523/JNEUROSCI.6387-11.2012; Kahnt T, 2011, NEUROIMAGE, V56, P709, DOI 10.1016/j.neuroimage.2010.05.058; Karipidis P., 2005, Journal of Food Distribution Research, V36, P68; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Linder NS, 2010, NEUROIMAGE, V53, P215, DOI 10.1016/j.neuroimage.2010.05.077; Lusk J.L., 2010, J AGR FOOD IND ORG, V8, P3, DOI [DOI 10.2202/1542-0485.1296, 10.2202/1542-0485.1296]; Norwood FB, 2011, J ENVIRON ECON MANAG, V62, P80, DOI 10.1016/j.jeem.2011.04.001; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Talairach J., 1988, COPLANAR STEREOTAXIC; Tonsor GT, 2009, FOOD POLICY, V34, P492, DOI 10.1016/j.foodpol.2009.06.008; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Volz KG, 2005, BRAIN RES BULL, V67, P403, DOI 10.1016/j.brainresbull.2005.06.011; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Webb R, 2013, WORKING PAPER, P1	32	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125243	10.1371/journal.pone.0125243	http://dx.doi.org/10.1371/journal.pone.0125243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018592	Green Published, gold			2022-12-27	WOS:000355185600014
J	Orge, GO; Dellavechia, TR; Cameiro-Neto, JA; Araujo-de-Freitas, L; Daltro, CHC; Santos, CT; Quarantini, LC				Orge, Gloria O.; Dellavechia, Thais R.; Cameiro-Neto, Jose Abraao; Araujo-de-Freitas, Lucas; Daltro, Carla H. C.; Santos, Carlos T.; Quarantini, Lucas C.			Psychiatric Disorders in HTLV-1-Infected Individuals with Bladder Symptoms	PLOS ONE			English	Article							QUALITY-OF-LIFE; MAJOR DEPRESSION; HTLV-I; VIROLOGICAL RESPONSE; MENTAL-DISORDERS; IMPACT; HCV; PREVALENCE; ANXIETY; MANIFESTATIONS	Background Previous studies have reported high rates of depression and anxiety in HTLV-1 infected individuals with the neurological disease and in the asymptomatic phase. No study has investigated the rates in individuals that already show bladder symptoms without severe neurological changes; that is, during the oligosymptomatic phase. The present study investigated patients in this intermediate form on the spectrum of the infection. Methodology/Principal Findings Participants answered a sociodemographic questionnaire, the Mini International Neuropsychiatric Interview Brazilian Version 5.0.0 (MINI PLUS) and the Hospital Anxiety and Depression Scale (HADS). Data analysis was performed in STATA statistical software (version 12.0). Depressive disorder was the most frequent comorbidity. Current depressive disorder was higher in the group of overactive bladder subjects (11.9%), and lifelong depression was more frequent in the HAM/TSP group (35%). The three groups had similar frequencies of anxiety disorders. Increased frequency and severity of anxiety and depression symptoms were observed in the overactive bladder group. Conclusion/Significance The results suggest that individuals with overactive bladders need a more thorough assessment from the mental health perspective. These patients remain an understudied group regarding psychiatric comorbidities.	Univ Fed Bahia, Programa Posgrad Med & Saude, Salvador, BA, Brazil; [Cameiro-Neto, Jose Abraao] Univ Fed Bahia, Programa Posgrad Ciencias Saude, Salvador, BA, Brazil; [Quarantini, Lucas C.] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Dept Neurociencias, Salvador, BA, Brazil; [Daltro, Carla H. C.] Univ Fed Bahia, Escola Nutr, Salvador, BA, Brazil; [Santos, Carlos T.] Univ Estadual Feira de Santana, Dept Ciencias Exatas, Feira De Santana, BA, Brazil; [Santos, Carlos T.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Estadual de Feira de Santana; Universidade Federal da Bahia	Quarantini, LC (corresponding author), Univ Fed Bahia, Programa Posgrad Med & Saude, Salvador, BA, Brazil.	lcq@ufba.br	quarantini, l/K-8483-2014		National Council of Technological and Scientific Development (CNPq): Edital Universal MCT/CNPq [14/2010, 474869/2010-5]	National Council of Technological and Scientific Development (CNPq): Edital Universal MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This project was supported by the National Council of Technological and Scientific Development (CNPq): Edital Universal MCT/CNPq 14/2010, Grant number: (474869/2010-5) (URL: www.cnpq.br). Author LCQ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida N, 1997, BRIT J PSYCHIAT, V171, P524, DOI 10.1192/bjp.171.6.524; Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Asch SM, 2003, J GEN INTERN MED, V18, P450, DOI 10.1046/j.1525-1497.2003.20938.x; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Batista-Neves S, 2009, BRAZ J INFECT DIS, V13, P40, DOI 10.1590/S1413-86702009000100009; Batista-Neves SC, 2008, GEN HOSP PSYCHIAT, V30, P80, DOI 10.1016/j.genhosppsych.2007.08.014; Caskey MF, 2007, AIDS RES HUM RETROV, V23, P365, DOI 10.1089/aid.2006.0140; Castro N, 2005, INT J IMPOT RES, V17, P364, DOI 10.1038/sj.ijir.3901335; Castro Neviton M., 2007, Int. braz j urol., V33, P238, DOI 10.1590/S1677-55382007000200016; Coughlin SS, 2012, PUBLIC HEALTH REV, V34, DOI 10.1007/BF03391675; Coyne KS, 2011, BJU INT, V108, P1459, DOI 10.1111/j.1464-410X.2010.10013.x; Daltron-Oliveira R, 2013, ANN HEPATOL, V12, P399, DOI 10.1016/S1665-2681(19)31002-6; Druss B, 2000, ARCH INTERN MED, V160, P1522, DOI 10.1001/archinte.160.10.1522; Galvao-Castro AV, 2012, QUAL LIFE RES, V21, P1545, DOI 10.1007/s11136-011-0066-6; Garlet GP, 2010, CLIN INFECT DIS, V50, pE11, DOI 10.1086/649871; GESSAIN A, 1985, LANCET, V2, P407; Guiltinan AM, 1998, TRANSFUSION, V38, P1056, DOI 10.1046/j.1537-2995.1998.38111299056317.x; Guiltinan AM, 2013, TRANSFUSION, V53, P60, DOI 10.1111/j.1537-2995.2012.03677.x; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Irwin DE, 2006, BJU INT, V97, P96, DOI 10.1111/j.1464-410X.2005.05889.x; de Carvalho AGJ, 2009, BRAZ J INFECT DIS, V13, P5, DOI 10.1590/S1413-86702009000100003; Kaplan MS, 2007, AM J ORTHOPSYCHIAT, V77, P56, DOI 10.1037/0002-9432.77.1.56; Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008; Katon WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7; Kimmel PL, 2002, J PSYCHOSOM RES, V53, P951, DOI 10.1016/S0022-3999(02)00310-0; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LAGRENADE L, 1990, LANCET, V336, P1345; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Marcolino José Álvaro Marques, 2007, Rev. Bras. Anestesiol., V57, P52, DOI 10.1590/S0034-70942007000100006; Milsom I, 2012, UROLOGY, V80, P90, DOI 10.1016/j.urology.2012.04.004; MOCHIZUKI M, 1992, LANCET, V339, P1110, DOI 10.1016/0140-6736(92)90699-4; Morais-de-Jesus M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110529; Oliveira P, 2007, CLINICS, V62, P191, DOI 10.1590/S1807-59322007000200015; OSAME M, 1986, LANCET, V1, P1031; OSAME M, 1990, HUMAN RETROVIROLOGY : HTLV, P191; Poetker SKW, 2011, J CLIN VIROL, V51, P54, DOI 10.1016/j.jcv.2011.02.004; Gascon MRP, 2011, BRAZ J INFECT DIS, V15, P578, DOI 10.1590/S1413-86702011000600013; Quarantini LC, 2008, J MED VIROL, V80, P419, DOI 10.1002/jmv.21094; Quarantini LC, 2007, LIVER INT, V27, P1098, DOI 10.1111/j.1478-3231.2007.01532.x; Quarantini LC, 2009, J MED VIROL, V81, P1184, DOI 10.1002/jmv.21508; Radcliffe J, 2007, AIDS PATIENT CARE ST, V21, P501, DOI 10.1089/apc.2006.0144; Rocha-Leite CI, 2014, J PSYCHOSOM RES, V76, P422, DOI 10.1016/j.jpsychores.2014.02.006; Souza AR, 2009, JORNAL BRASILEIRO DO, V21, P163; Stumpf BP, 2008, INT J PSYCHIAT MED, V38, P345, DOI 10.2190/PM.38.3.i; Tanajura D, 2013, CLIN EXP MED SCI, V1, P1	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128103	10.1371/journal.pone.0128103	http://dx.doi.org/10.1371/journal.pone.0128103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018525	gold, Green Submitted, Green Published			2022-12-27	WOS:000355185600111
J	Walsh, JC; Angstmann, CN; Duggin, IG; Curmi, PMG				Walsh, James C.; Angstmann, Christopher N.; Duggin, Iain G.; Curmi, Paul M. G.			Molecular Interactions of the Min Protein System Reproduce Spatiotemporal Patterning in Growing and Dividing Escherichia coli Cells	PLOS ONE			English	Article							TOPOLOGICAL SPECIFICITY FACTOR; DIVISION SITE; MEMBRANE INTERACTION; PREVENT FORMATION; PROPER PLACEMENT; POLE OSCILLATION; SURFACE-WAVES; RAPID POLE; ATP; LOCALIZATION	Oscillations of the Min protein system are involved in the correct midcell placement of the divisome during Escherichia coli cell division. Based on molecular interactions of the Min system, we formulated a mathematical model that reproduces Min patterning during cell growth and division. Specifically, the increase in the residence time of MinD attached to the membrane as its own concentration increases, is accounted for by dimerisation of membrane-bound MinD and its interaction with MinE. Simulation of this system generates unparalleled correlation between the waveshape of experimental and theoretical MinD distributions, suggesting that the dominant interactions of the physical system have been successfully incorporated into the model. For cells where MinD is fully-labelled with GFP, the model reproduces the stationary localization of MinD-GFP for short cells, followed by oscillations from pole to pole in larger cells, and the transition to the symmetric distribution during cell filamentation. Cells containing a secondary, GFP-labelled MinD display a contrasting pattern. The model is able to account for these differences, including temporary midcell localization just prior to division, by increasing the rate constant controlling MinD ATPase and heterotetramer dissociation. For both experimental conditions, the model can explain how cell division results in an equal distribution of MinD and MinE in the two daughter cells, and accounts for the temperature dependence of the period of Min oscillations. Thus, we show that while other interactions may be present, they are not needed to reproduce the main characteristics of the Min system in vivo.	[Walsh, James C.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Walsh, James C.; Duggin, Iain G.] Univ Technol Sydney, ithree Inst, Sydney, NSW 2007, Australia; [Angstmann, Christopher N.] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of Technology Sydney; University of New South Wales Sydney	Curmi, PMG (corresponding author), Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia.	p.curmi@unsw.edu.au	Duggin, Iain/B-3904-2011; Angstmann, Christopher N/G-1990-2015; Curmi, Paul/G-7185-2011	Duggin, Iain/0000-0003-4868-7350; Angstmann, Christopher N/0000-0002-6688-9346; Curmi, Paul/0000-0001-5762-7638; Walsh, James/0000-0003-0447-2323	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	JCW was the recipient of an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon JL, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026201; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Berg H. C., 1983, RANDOM WALKS BIOL; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Di Ventura B, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.44; Di Ventura B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.111; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Fischer-Friedrich E, 2007, PHYS BIOL, V4, P38, DOI 10.1088/1478-3975/4/1/005; Fischer-Friedrich E, 2010, P NATL ACAD SCI USA, V107, P6134, DOI 10.1073/pnas.0911708107; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani Houman, 2011, Commun Integr Biol, V4, P101, DOI 10.4161/cib.4.1.14162; Ghosal D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6341; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Halatek J, 2012, CELL REP, V1, P741, DOI 10.1016/j.celrep.2012.04.005; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang KC, 2004, PHYS BIOL, V1, P229, DOI 10.1088/1478-3967/1/4/005; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; Juarez JR, 2010, J BACTERIOL, V192, P4134, DOI 10.1128/JB.00364-10; Kang GB, 2010, MOL MICROBIOL, V76, P1222, DOI 10.1111/j.1365-2958.2010.07160.x; Kelly C., 2011, EFFECT ANTIMICROBIAL; Kerr RA, 2006, P NATL ACAD SCI USA, V103, P347, DOI 10.1073/pnas.0505825102; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Knight JD, 2010, BIOPHYS J, V99, P2879, DOI 10.1016/j.bpj.2010.08.046; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Meacci G, 2005, PHYS BIOL, V2, P89, DOI 10.1088/1478-3975/2/2/002; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Park KT, 2012, MOL MICROBIOL, V85, P271, DOI 10.1111/j.1365-2958.2012.08110.x; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; PICHOFF S, 1995, MOL MICROBIOL, V18, P321, DOI 10.1111/j.1365-2958.1995.mmi_18020321.x; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rh Stokes RAR., 2002, ELECTROLYTE SOLUTION, P76; Sengupta S, 2007, PHYS BIOL, V4, P145, DOI 10.1088/1478-3975/4/3/001; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Taghbalout A, 2006, J BACTERIOL, V188, P2993, DOI 10.1128/JB.188.8.2993-3001.2006; Tostevin F, 2006, PHYS BIOL, V3, P1, DOI 10.1088/1478-3975/3/1/001; Touhami A, 2006, J BACTERIOL, V188, P7661, DOI 10.1128/JB.00911-06; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	57	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128148	10.1371/journal.pone.0128148	http://dx.doi.org/10.1371/journal.pone.0128148			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018614	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600113
J	Erdoes, G; Gerster, G; Colucci, G; Kaiser, H; Alberio, L; Eberle, B				Erdoes, Gabor; Gerster, Germaine; Colucci, Giuseppe; Kaiser, Heiko; Alberio, Lorenzo; Eberle, Balthasar			Prediction of Post-Weaning Fibrinogen Status during Cardiopulmonary Bypass: An Observational Study in 110 Patients	PLOS ONE			English	Article							COAGULATION MANAGEMENT; CARDIAC-SURGERY; MAJOR TRAUMA; ROTATIONAL THROMBOELASTOMETRY; BLOOD-LOSS; ON-PUMP; CONCENTRATE; HEMODILUTION; REPLACEMENT; TRANSFUSION	Background After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often leads to post-CPB bleeding. Though multifactorial in origin, this coagulopathy is often aggravated by deficient fibrinogen levels. Objective To assess whether laboratory and thrombelastometric testing on CPB can predict plasma fibrinogen immediately after CPB weaning. Patients / Methods This prospective study in 110 patients undergoing major cardiovascular surgery at risk of post-CPB bleeding compares fibrinogen level (Clauss method) and function (fibrin-specific thrombelastometry) in order to study the predictability of their course early after termination of CPB. Linear regression analysis and receiver operating characteristics were used to determine correlations and predictive accuracy. Results Quantitative estimation of post-CPB Clauss fibrinogen from on-CPB fibrinogen was feasible with small bias (+0.19 g/l), but with poor precision and a percentage of error >30%. A clinically useful alternative approach was developed by using on-CPB A10 to predict a Clauss fibrinogen range of interest instead of a discrete level. An on-CPB A10 <= 10 mm identified patients with a post-CPB Clauss fibrinogen of <= 1.5 g/l with a sensitivity of 0.99 and a positive predictive value of 0.60; it also identified those without a post-CPB Clauss fibrinogen <2.0 g/l with a specificity of 0.83. Conclusions When measured on CPB prior to weaning, a FIBTEM A10 <= 10 mm is an early alert for post-CPB fibrinogen levels below or within the substitution range (1.5-2.0 g/l) recommended in case of post-CPB coagulopathic bleeding. This helps to minimize the delay to data-based hemostatic management after weaning from CPB.	[Erdoes, Gabor; Gerster, Germaine; Kaiser, Heiko; Eberle, Balthasar] Univ Hosp Bern, Dept Anesthesiol & Pain Therapy, CH-3010 Bern, Switzerland; [Colucci, Giuseppe] Clin Luganese Moncucco, Lugano, Switzerland; [Alberio, Lorenzo] Univ Lausanne Hosp, Serv & Lab Cent Hematol, Hematol Nonmaligne & Hemostase, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Erdoes, G (corresponding author), Univ Hosp Bern, Dept Anesthesiol & Pain Therapy, CH-3010 Bern, Switzerland.	gabor.erdoes@insel.ch	Colucci, Giuseppe/AAJ-2178-2020; Kaiser, Heiko/AAB-1198-2021	Colucci, Giuseppe/0000-0002-2379-8751; Kaiser, Heiko/0000-0002-6082-9510; Alberio, Lorenzo/0000-0001-9686-9920	Department of Anaesthesiology and Pain Therapy, University Hospital Bern, Bern, Switzerland (Freiburgstr., CH Bern, Switzerland); CSL Behring (Wankdorfstr., CH Bern, Switzerland)	Department of Anaesthesiology and Pain Therapy, University Hospital Bern, Bern, Switzerland (Freiburgstr., CH Bern, Switzerland); CSL Behring (Wankdorfstr., CH Bern, Switzerland)	Funding was received for GE, GG, HK, BE from the Department of Anaesthesiology and Pain Therapy, University Hospital Bern, Bern, Switzerland (Freiburgstr., CH-3010 Bern, Switzerland). GC was supported by a research grant of CSL Behring (Wankdorfstr. 10, CH-3000 Bern, Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam S, 2010, CLIN APPL THROMB-HEM, V16, P461, DOI 10.1177/1076029609342090; Adam S, 2010, CLIN APPL THROMB-HEM, V16, P454, DOI 10.1177/1076029609336855; Amann G, 2012, CLIN CHEM LAB MED, V50, P1335, DOI 10.1515/cclm-2011-0800; Blome M, 2005, THROMB HAEMOSTASIS, V93, P1101, DOI 10.1160/TH04-12-0799; Bolliger D, 2009, BRIT J ANAESTH, V102, P793, DOI 10.1093/bja/aep098; Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Bolliger D, 2010, ANESTHESIOLOGY, V113, P1205, DOI 10.1097/ALN.0b013e3181f22b5a; Cannesson M, 2011, ANESTHESIOLOGY, V115, P231, DOI 10.1097/ALN.0b013e318225b80a; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Colucci G, 2011, INT J LAB HEMATOL, V33, P441, DOI 10.1111/j.1751-553X.2011.01303.x; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Davidson S, 2014, BRIT J HAEMATOL, V164, P779, DOI 10.1111/bjh.12746; Despotis GJ, 2001, ANN THORAC SURG, V72, pS1821, DOI 10.1016/S0003-4975(01)03211-8; Engberink RHGO, 2014, J CARDIOTHOR VASC AN, V28, P210, DOI 10.1053/j.jvca.2013.12.004; Faraoni D, 2014, EUR J ANAESTH, V31, P317, DOI 10.1097/EJA.0000000000000043; Fassl J, 2015, BRIT J ANAESTH, V114, P225, DOI 10.1093/bja/aeu364; Fries D, 2010, ANASTH INTENSIV NOTF, V45, P552, DOI 10.1055/s-0030-1265746; Ganter MT, 2008, ANESTH ANALG, V106, P1366, DOI 10.1213/ane.0b013e318168b367; Gertler R, 2011, J CARDIOTHOR VASC AN, V25, P981, DOI 10.1053/j.jvca.2010.11.020; Gorlinger K, 2013, BRIT J ANAESTH, V110, P222, DOI 10.1093/bja/aes374; Hiippala ST, 1995, BLOOD COAGUL FIBRIN, V6, P743; Karkouti K, 2013, ANESTH ANALG, V117, P14, DOI 10.1213/ANE.0b013e318292efa4; Karkouti K, 2010, ANESTH ANALG, V110, P1533, DOI 10.1213/ANE.0b013e3181db7991; Karlsson M, 2008, TRANSFUSION, V48, P2152, DOI 10.1111/j.1537-2995.2008.01827.x; Kozek-Langenecker SA, 2013, EUR J ANAESTH, V30, P270, DOI 10.1097/EJA.0b013e32835f4d5b; Kreuz W, 2005, TRANSFUS APHER SCI, V32, P239, DOI 10.1016/j.transci.2004.04.003; Lang Q, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-207; Lang T, 2005, BLOOD COAGUL FIBRIN, V16, P301, DOI 10.1097/01.mbc.0000169225.31173.19; Momeni M, 2013, J CARDIOTHOR VASC AN, V27, P5, DOI 10.1053/j.jvca.2012.07.008; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Ogawa S, 2013, BRIT J ANAESTH, V111, P1013, DOI 10.1093/bja/aet229; Ogawa S, 2012, ANESTH ANALG, V115, P16, DOI 10.1213/ANE.0b013e31824d523b; Ogawa S, 2012, TRANSFUSION, V52, P14, DOI 10.1111/j.1537-2995.2011.03241.x; Paparella D, 2004, INTENS CARE MED, V30, P1873, DOI 10.1007/s00134-004-2388-0; Rahe-Meyer N, 2013, J THORAC CARDIOV SUR, V145, pS178, DOI 10.1016/j.jtcvs.2012.12.083; Rahe-Meyer N, 2011, THROMB RES, V128, pS17, DOI 10.1016/S0049-3848(12)70005-1; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Skhirtladze K, 2014, BRIT J ANAESTH, V112, P255, DOI 10.1093/bja/aet348; Solomon C, 2013, BRIT J ANAESTH, V110, P947, DOI 10.1093/bja/aes576; Solomon C, 2010, BRIT J ANAESTH, V104, P555, DOI 10.1093/bja/aeq058; Solomon C, 2014, THROMB HAEMOSTASIS, V112, P109, DOI 10.1160/TH13-12-0997; Solomon C, 2011, TRANSFUSION, V51, P1695, DOI 10.1111/j.1537-2995.2011.03066.x; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Stanzel RDP, 2014, PERFUSION-UK, V29, P369, DOI 10.1177/0267659113513312; Swarowska M, 2014, INFLAMMATION, V37, P1142, DOI 10.1007/s10753-014-9838-9; Tanaka KA, 2014, TRANSFUSION, V54, P109, DOI 10.1111/trf.12248; Tanaka KA, 2012, J CARDIOTHOR VASC AN, V26, P1083, DOI 10.1053/j.jvca.2012.06.015; Ucar HI, 2007, HEART SURG FORUM, V10, pE392, DOI 10.1532/HSF98.20071065; Urwyler N, 2012, MINERVA ANESTESIOL, V78, P550; Van der Linden P, 2013, ANESTHESIOLOGY, V119, P1296, DOI 10.1097/ALN.0b013e3182a6b387; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Walden K, 2014, ANN THORAC SURG, V97, P1199, DOI 10.1016/j.athoracsur.2013.11.064; Wikkelso A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008864.pub2	56	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126692	10.1371/journal.pone.0126692	http://dx.doi.org/10.1371/journal.pone.0126692			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011420	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900039
J	Kletting, P; Maass, C; Reske, S; Beer, AJ; Glatting, G				Kletting, Peter; Maass, Christian; Reske, Sven; Beer, Ambros J.; Glatting, Gerhard			Physiologically Based Pharmacokinetic Modeling Is Essential in Y-90-Labeled Anti-CD66 Radioimmunotherapy	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; BIODISTRIBUTION; SOFTWARE; AFFINITY	Introduction Radioimmunotherapy (RIT) with Y-90-labeled anti-CD66 antibody is used to selectively irradiate the red marrow (RM) before blood stem cell transplantation of acute leukemia patients. To calculate the activity to administer, time-integrated activity coefficients are required. These are estimated prior to therapy using gamma camera and serum measurements after injection of In-111 labeled anti-CD66 antibody. Equal pre-therapeutic and therapeutic biodistributions are usually assumed to calculate the coefficients. However, additional measurements during therapy had shown that this assumption had to be abandoned. A physiologically based pharmacokinetic (PBPK) model was developed to allow the prediction of therapeutic time-integrated activity coefficients in eight patients. Aims The aims of the study were to demonstrate using a larger patient group 1) the need to perform patient-specific dosimetry in Y-90-labeled anti-CD66 RIT, 2) that pre-therapeutic and therapeutic biodistributions differ, and most importantly 3) that this difference in biodistributions can be accurately predicted using a refined model. Materials and Methods Two new PBPK models were developed considering fully, half and non-immunoreactive antibodies and constraints for estimating the RM antigen number. Both models were fitted to gamma camera and serum measurements of 27 patients. Akaike weights were used for model averaging. Time-integrated activity coefficients for total body, liver, spleen, RM and serum were calculated. Model-based predictions of the serum biokinetics during therapy were compared to actual measurements. Results Variability of the RM time-integrated activity coefficients ((37.3 +/- 7.5) h) indicates the need for patient-specific dosimetry. The relative differences between pre-therapeutic and therapeutic serum time-activity curves were (-25 +/- 16)%. The prediction accuracy of these differences using the refined PBPK models was (-3 +/- 20)%. Conclusion Individual treatment is needed due to biological differences between patients in RIT with Y-90-labeled anti-CD66 antibody. Differences in pre-therapeutic and therapeutic biokinetics are predominantly caused by different degrees of saturation due to different amounts of administered antibody. These differences could be predicted using the PBPK models.	[Kletting, Peter; Reske, Sven; Beer, Ambros J.] Univ Ulm, Dept Nucl Med, D-89070 Ulm, Germany; [Maass, Christian; Glatting, Gerhard] Heidelberg Univ, Med Fac Mannheim, Med Radiat Phys Radiat Protect, D-68167 Mannheim, Germany	Ulm University; Ruprecht Karls University Heidelberg	Maass, C (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Radiat Phys Radiat Protect, D-68167 Mannheim, Germany.	christian.maass@medma.uni-heidelberg.de	Beer, Ambros J./AAA-5539-2022; Glatting, Gerhard/ABF-2506-2020	Beer, Ambros J./0000-0001-9042-7806; Glatting, Gerhard/0000-0001-7916-1576; Kletting, Peter/0000-0003-3654-3667; Maass, Christian/0000-0001-7618-0421	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) [BMBF 02NUK008F]; Bundesamt fur Strahlenschutz (Federal Office for Radiation Protection) [BfS 3608S04001]; German Research Foundation (DFG) [BE 4393/1-1, GL 236/11-2, KL 2742/2-1]	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Bundesamt fur Strahlenschutz (Federal Office for Radiation Protection); German Research Foundation (DFG)(German Research Foundation (DFG))	The authors gratefully acknowledge grants by the Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research, BMBF 02NUK008F, http://www.bmbf.de/) and Bundesamt fur Strahlenschutz (Federal Office for Radiation Protection, BfS 3608S04001, http://www.bfs.de/bfs) for the establishment of the endowed professorship Medizinische Strahlenphysik/Strahlenschutz (Medical Radiation Physics/Radiation Protection). The authors would also like to gratefully thank the German Research Foundation (DFG) for support (BE 4393/1-1, GL 236/11-2 and KL 2742/2-1, http://dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalib SA, 2006, CURR PHARM BIOTECHNO, V7, P343, DOI 10.2174/138920106778521578; Barrett PHR, 1998, METABOLISM, V47, P484, DOI 10.1016/S0026-0495(98)90064-6; Buchmann I, 2003, EUR J NUCL MED MOL I, V30, P667, DOI 10.1007/s00259-002-1106-9; DONOHUE DM, 1958, J CLIN INVEST, V37, P1571, DOI 10.1172/JCI103750; EGER RR, 1987, CANCER RES, V47, P3328; Elghetany MT, 2002, BLOOD CELL MOL DIS, V28, P260, DOI 10.1006/bcmd.2002.0513; Ferl GZ, 2006, MOL CANCER THER, V5, P1550, DOI 10.1158/1535-7163.MCT-06-0072; Forrer F, 2009, EUR J NUCL MED MOL I, V36, P1443, DOI 10.1007/s00259-009-1120-2; Glatting G, 2006, CANCER BIOTHER RADIO, V21, P15, DOI 10.1089/cbr.2006.21.15; Glatting G, 2005, MED PHYS, V32, P2399, DOI 10.1118/1.1945348; Graff CP, 2003, CANCER RES, V63, P1288; Harris A, 2010, EUR J RADIOL, V75, pE97, DOI 10.1016/j.ejrad.2009.08.013; HOUSTON AS, 1979, INT J NUCL MED BIOL, V6, P85, DOI 10.1016/0047-0740(79)90002-0; Johnson TN, 2005, LIVER TRANSPLANT, V11, P1481, DOI 10.1002/lt.20519; KAUFMAN EN, 1992, CANCER RES, V52, P4157; Kletting P, 2013, MED PHYS, V40, DOI 10.1118/1.4820367; Kletting P, 2010, 23 ANN C EUR ASS NUC; Kletting P, 2011, MED PHYS, V38, P2572, DOI 10.1118/1.3581059; Kletting P, 2011, PHYS MED BIOL, V56, P73, DOI 10.1088/0031-9155/56/1/005; Kletting P, 2010, J NUCL MED, V51, P484, DOI 10.2967/jnumed.109.067546; Kletting P, 2009, Z MED PHYS, V19, P200, DOI 10.1016/j.zemedi.2009.05.003; Minarik D, 2010, J NUCL MED, V51, P1974, DOI 10.2967/jnumed.110.079897; PETERS AM, 1985, SCAND J HAEMATOL, V34, P111; Phillips KG, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118105; Ringhoffer M, 2005, BRIT J HAEMATOL, V130, P604, DOI 10.1111/j.1365-2141.2005.05663.x; Schulz AS, 2011, BLOOD, V117, P4642, DOI 10.1182/blood-2010-06-284349; Sharkey RM, 2011, IMMUNOTHERAPY-UK, V3, P349, DOI 10.2217/IMT.10.114	27	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127934	10.1371/journal.pone.0127934	http://dx.doi.org/10.1371/journal.pone.0127934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010360	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900166
J	Sim, JH; Chung, D; Lim, JS; Lee, MY; Chung, CH; Shin, JY; Huh, JH				Sim, Jeong Han; Chung, Dawn; Lim, Jung Soo; Lee, Mi Young; Chung, Choon Hee; Shin, Jang Yel; Huh, Ji Hye			Maternal Age at First Delivery Is Associated with the Risk of Metabolic Syndrome in Postmenopausal Women: From 2008-2010 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							REPRODUCTIVE FACTORS; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; MENARCHE; PARITY; AMERICAN; HORMONES; DISEASE	Background Recent cross-sectional studies demonstrated that earlier maternal age at first childbirth is correlated with a higher risk of diabetes in postmenopausal women. In this study, we evaluated whether the age at first delivery is associated with the risk of metabolic syndrome (MetS) in postmenopausal women. Methods A total of 4,261 postmenopausal women aged 45 years or older were analyzed using data generated from Korea National Health and Nutrition Examination Surveys (2008-2010). Subjects were divided into three groups according to the maternal age at first delivery as follows: <= 20 years (n=878), 21-25 years (n=2314), and >= 26 years (n=1069). Results Approximately 37% of subjects had MetS. The prevalence of MetS showed a gradual increase as maternal age at first delivery decreased (>= 26 years = 30.9% vs. 21-25 years = 39.9% vs. <= 20 years = 50.8%, respectively, p < 0.001). Central obesity indices such as trunk fat mass and waist circumference were significantly higher in the group aged <= 20 years than other groups. After adjustments for confounding factors, the odds ratios (ORs) for predicting the presence of MetS increased gradually as first delivery age decreased (>= 26 years vs. 21-25 years vs. <= 20 years: OR [95% CI] = 1 vs. 1.324 [1.118-1.567] vs. 1.641 [1.322-2.036], respectively). Among components of MetS, younger maternal age at first delivery (<= 20 years) was significantly associated with increased waist circumference (OR [95% CI] = 1.735 [1.41-2.13]), elevated blood pressure (1.261 [1.02-1.57]), high triglyceride (1.333 [1.072-1.659]), and low HDL-cholesterol (1.335[1.084-1.643]). Conclusions Our findings suggest that younger maternal age at first delivery is independently associated with a higher risk of central obesity and MetS in postmenopausal women.	[Sim, Jeong Han; Lim, Jung Soo; Lee, Mi Young; Chung, Choon Hee; Shin, Jang Yel; Huh, Ji Hye] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, Gwangwondo, South Korea; [Chung, Dawn] Yonsei Univ, Wonju Coll Med, Dept Obstet & Gynecol, Wonju, Gwangwondo, South Korea	Yonsei University; Yonsei University	Huh, JH (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, Gwangwondo, South Korea.	png1212@yonsei.ac.kr		Chung, Choon/0000-0003-1144-7206; Chung, Dawn/0000-0002-4495-1559				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; BERAL V, 1985, J EPIDEMIOL COMMUN H, V39, P343, DOI 10.1136/jech.39.4.343; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; Cernaro V, 2014, MED RES REV, V34, P77, DOI 10.1002/med.21277; Cohen A, 2006, J WOMENS HEALTH, V15, P763, DOI 10.1089/jwh.2006.15.763; DESPRES JP, 1995, INT J OBESITY, V19, pS76; Dreyfus JG, 2012, DIABETOLOGIA, V55, P2371, DOI 10.1007/s00125-012-2616-z; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Kaaja RJ, 2005, JAMA-J AM MED ASSOC, V294, P2751, DOI 10.1001/jama.294.21.2751; Kim JH, 2014, DIABETES CARE, V37, P671, DOI 10.2337/dc13-1784; Kirchengast S, 1998, COLLEGIUM ANTROPOL, V22, P393; KRITZSILVERSTEIN D, 1989, NEW ENGL J MED, V321, P1214, DOI 10.1056/NEJM198911023211802; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lao XQ, 2006, CLIN ENDOCRINOL, V65, P460, DOI 10.1111/j.1365-2265.2006.02615.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; PALMER JR, 1992, AM J EPIDEMIOL, V136, P408, DOI 10.1093/oxfordjournals.aje.a116513; Parikh NI, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.017; Ryan EA, 2003, LANCET, V362, P1777, DOI 10.1016/S0140-6736(03)14942-2; RYAN EA, 1988, J CLIN ENDOCR METAB, V67, P341, DOI 10.1210/jcem-67-2-341; Salamone LM, 2000, J APPL PHYSIOL, V89, P345, DOI 10.1152/jappl.2000.89.1.345; Saquib N, 2005, CLIMACTERIC, V8, P76, DOI 10.1080/13697130500062688; Stockl D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026076; SYMONDS EM, 1995, ARCH DIS CHILD-FETAL, V72, pF139, DOI 10.1136/fn.72.2.F139; Wen W, 2003, INT J OBESITY, V27, P933, DOI 10.1038/sj.ijo.0802318	27	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127860	10.1371/journal.pone.0127860	http://dx.doi.org/10.1371/journal.pone.0127860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010910	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900154
J	Teramoto, M; Moonie, S; Cross, CL; Chino, M; Alpert, PT				Teramoto, Masaru; Moonie, Sheniz; Cross, Chad L.; Chino, Michelle; Alpert, Patricia T.			Association of Leisure-Time Physical Activity to Cardiovascular Disease Prevalence in Relation to Smoking among Adult Nevadans	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CIGARETTE-SMOKING; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; MORTALITY; CESSATION; EXERCISE; MEN; FITNESS; STROKE	It is well known that cigarette smoking and physical activity have significant impacts on cardiovascular disease (CVD) mortality and morbidity. Meanwhile, it is of interest to understand whether physical activity protects against CVD for smokers in a similar manner as it does for non-smokers. The present study examined how leisure-time physical activity (LTPA) is associated with the prevalence of CVD in relation to smoking status among adult Nevadans, using data from the 2010 Nevada Behavioral Risk Factor Surveillance System. Of the 3,913 survey respondents, 8.5% self-reported that they had ever been diagnosed with CVD. People with a history of CVD were significantly less likely to engage in LTPA than those with no history of CVD (p < 0.05). After adjusting for common sociodemographic variables, it was revealed that people with CVD were twice more likely to not engage in LTPA than their counterparts independent of smoking status. Without taking LTPA into account, the odds of having CVD for current and former smokers was 1.87-2.25 times higher than the odds for non-smokers. Interestingly, however, if LTPA was accounted for, there was no significant difference in the odds of having CVD between current and non-smokers. These results indicate that LTPA is inversely associated with the prevalence of CVD independent of smoking status, and that regular physical activity may protect against CVD for smokers as well as for non-smokers. Physical activity, along with smoking cessation, should be promoted to better prevent and control CVD among smokers.	[Teramoto, Masaru] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA; [Moonie, Sheniz; Chino, Michelle] Univ Nevada, Sch Community Hlth Sci, Las Vegas, NV 89154 USA; [Cross, Chad L.] Nevada State Coll, Dept Phys & Life Sci, Henderson, NV USA; [Alpert, Patricia T.] Univ Nevada, Sch Nursing, Las Vegas, NV 89154 USA	Utah System of Higher Education; University of Utah; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); Nevada State College; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Teramoto, M (corresponding author), Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA.	teramot4@gmail.com	Moonie, Sheniz/R-6215-2016	Moonie, Sheniz/0000-0002-3192-9205; Cross, Chad/0000-0002-8756-5607				Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Bullen Christopher, 2008, Expert Rev Cardiovasc Ther, V6, P883, DOI 10.1586/14779072.6.6.883; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Centers for Disease Control and Prevention, 2013, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2011, BEH RISK FACT SURV S; Colberg SR, 2010, DIABETES CARE, V33, P2692, DOI [10.2337/dc10-1548, 10.2337/dc10-9990]; Department of Health and Human Services Nevada State Health Division Bureau of Health Statistics Planning Epidemiology and Response Office of Public Health Informatics and Epidemiology, 2012, NEV BEH RISK FACT SU; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Garrett Bridgette E., 2011, Morbidity and Mortality Weekly Report, V60, P109; Gregg EW, 2003, JAMA-J AM MED ASSOC, V289, P2379, DOI 10.1001/jama.289.18.2379; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Imamura H, 2002, METABOLISM, V51, P1313, DOI 10.1053/meta.2002.34040; Jacobs DR, 1999, ARCH INTERN MED, V159, P733, DOI 10.1001/archinte.159.7.733; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; Mendis S., 2011, GLOB ATL CARD DIS PR; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; Papathanasiou G, 2007, EUR J CARDIOV PREV R, V14, P646, DOI 10.1097/HJR.0b013e3280ecfe2c; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Slentz CA, 2007, J APPL PHYSIOL, V103, P432, DOI 10.1152/japplphysiol.01314.2006; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Syamlal Girija, 2011, Morbidity and Mortality Weekly Report, V60, P1305; Teramoto M, 2009, RES Q EXERCISE SPORT, V80, P138, DOI 10.1080/02701367.2009.10599547; Thun MJ, 1997, CHANGES CIGARETTE RE, V8, P383; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; U.S. Department of Health and Human Services, 2012, HLTH PEOPL 2020; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P863, DOI 10.1097/EDE.0b013e3181ba333c; WANNAMETHEE SG, 1995, JAMA-J AM MED ASSOC, V274, P155; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; Wilson K, 2000, ARCH INTERN MED, V160, P939, DOI 10.1001/archinte.160.7.939; World Health Organization, 2007, PREV CARD DIS GUID A	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128424	10.1371/journal.pone.0128424	http://dx.doi.org/10.1371/journal.pone.0128424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010914	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900234
J	Chen, LC; Cheng, LJ; Zhang, Y; He, X; Knaggs, RD				Chen, Li-Chia; Cheng, Li-Jen; Zhang, Yan; He, Xin; Knaggs, Roger D.			Acupuncture or Low Frequency Infrared Treatment for Low Back Pain in Chinese Patients: A Discrete Choice Experiment	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; ALTERNATIVE MEDICINE; PREFERENCES; CARE; COMPLEMENTARY; PREVALENCE; PHYSICIANS; BURDEN	Acupuncture is a popular but controversial treatment option for low back pain. In China, it is practised as traditional Chinese medicine; other treatment strategies for low back pain are commonly practised as Western medicine. Research on patient preference for low backpain treatment options has been mainly conducted in Western countries and is limited to a willingness-to-pay approach. A stated-preference, discrete choice experiment was conducted to determine Chinese patient preferences and trade-offs for acupuncture and low frequency infrared treatment in low back pain from September 2011 to August 2012 after approval from the Department of Scientific Research in the study settings. Eight-six adult outpatients who visited the 'traditional medicine department' at a traditional Chinese medicine hospital and the 'rehabilitation department' at a Western medicine hospital in Guangdong Province of China for chronic low back pain during study period participated in an interview survey. A questionnaire containing 10 scenarios (5 attributes in each scenario) was used to ask participants' preference for acupuncture, low frequency infrared treatment or neither option. Validated responses were analysed using a nested-logit model. The decision on whether to receive a therapy was not associated with the expected utility of receiving therapy, female gender and higher out-of-pocket payment significantly decreased chance to receive treatments. Of the utility of receiving either acupuncture or low frequency infrared treatment, the treatment sensation was the most important attribute as an indicator of treatment efficacy, followed by the maximum efficacy, maintenance duration and onset of efficacy, and the out-of-pocket payment. The willingness-to-pay for acupuncture and low frequency infrared treatment were about $618.6 and $592.4 USD per course respectively, demonstrated patients' demand of pain management. The treatment sensation was regarded as an indicator of treatment efficacy and the most important attribute for choosing acupuncture or low frequency infrared treatment. The high willingness-to-pay demonstrated patients' demand of pain management. However, there may be other factors influencing patients' preference to receive treatments.	[Chen, Li-Chia; Knaggs, Roger D.] Univ Nottingham, Sch Pharm, Div Social Res Med & Hlth, Nottingham, England; [Cheng, Li-Jen; Zhang, Yan; He, Xin] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Zhang, Yan] Univ Iowa, Coll Pharm Pharm Practice & Sci, Iowa City, IA USA; [Knaggs, Roger D.] Nottingham Univ Hosp NHS Trust, Dept Pharm, Nottingham, England	University of Nottingham; University of Macau; University of Iowa; Nottingham University Hospital NHS Trust	Cheng, LJ (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	chenglijen@gmail.com		Zhang, Yan/0000-0002-8526-9599; Chen, Li-Chia/0000-0002-6158-6645	Research Committee of the University of Macau [RG087]	Research Committee of the University of Macau	This research was funded by the Research Committee of the University of Macau (grant reference number RG087)(www.umac.mo)(YZ and XH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assendelft W, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000447.PUB2; Barnes Patricia M, 2004, Adv Data, P1; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Chancellor J, 2012, VALUE HEALTH, V15, P106, DOI 10.1016/j.jval.2011.07.002; Chen W, 2003, J ANHUI TCM COLL, V22, P38; Chenot JF, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-149; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chuck A, 2009, VALUE HEALTH, V12, P498, DOI 10.1111/j.1524-4733.2008.00457.x; Croft P, 1997, LOW BACK PAIN HLTH C; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Foltz V, 2005, JOINT BONE SPINE, V72, P571, DOI 10.1016/j.jbspin.2005.03.018; FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506; FURLAN AD, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001929; Gao M, 2006, J PREV MED CHIN PLA, V24, P339; Gaul C, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-89; Gureje O, 2001, PAIN, V92, P195, DOI 10.1016/S0304-3959(00)00483-8; Hamelsky SW, 2005, CEPHALALGIA, V25, P87, DOI 10.1111/j.1468-2982.2005.00797.x; Harmsworth K, 2001, SOC SCI MED, V52, P149, DOI 10.1016/S0277-9536(00)00124-6; Hauber AB, 2013, OSTEOARTHR CARTILAGE, V21, P289, DOI 10.1016/j.joca.2012.11.007; Ho KY, 2009, PAIN PHYSICIAN, V12, P685; Hopton AK, 2010, ACUPUNCT MED, V28, P185, DOI 10.1136/aim.2010.002279; Hopton AK, 2011, CHIN J INTEGR MED, V17, P173, DOI 10.1007/s11655-011-0663-9; Klojgaard ME, 2014, VALUE HEALTH, V17, P390, DOI 10.1016/j.jval.2014.01.005; Kroner-Herwig B, 2009, CURR OPIN PSYCHIATR, V22, P200, DOI 10.1097/YCO.0b013e3283252d5a; Lenert LA, 2003, MED CARE, V41, P299, DOI 10.1097/00005650-200302000-00011; Lipton RB., 1999, HEADACHE, V39, pS20, DOI [10.1111/j.1526-4610.1999.00006.x, DOI 10.1111/J.1526-4610.1999.00006.X]; MacPherson Hugh, 2005, Acupunct Med, V23, P112; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Paterson C., 2007, J HLTH SERV RES P S1, V12, P39, DOI [10.1258/135581907780318356, DOI 10.1258/135581907780318356]; Pearmain D, 1991, STATED PREFERENCE TE; Phillips Ceri J, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P591, DOI 10.1586/14737167.6.5.591; Ratcliffe J, 2004, RHEUMATOLOGY, V43, P337, DOI 10.1093/rheumatology/keh038; Ryan M, 2004, HEALTH ECON, V13, P397, DOI 10.1002/hec.821; Sherman Karen J, 2004, BMC Complement Altern Med, V4, P9, DOI 10.1186/1472-6882-4-9; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; [石学峰 SHI Xuefeng], 2011, [中国全科医学, Chinese General Practice], V14, P1938; Sternbach RA, 1986, CLIN J PAIN, V2, P49, DOI DOI 10.1097/00002508-198602010-00008; Sweeting KR, 2011, PATIENT, V4, P45, DOI 10.2165/11532830-000000000-00000; Trenkwalder C, 2013, LANCET NEUROL, V12, P1141, DOI 10.1016/S1474-4422(13)70239-4; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; van Middelkoop M, 2011, EUR SPINE J, V20, P19, DOI 10.1007/s00586-010-1518-3; van Tulder Maurits, 2003, Clin Evid, P1359; Viney Rosalie, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P319, DOI 10.1586/14737167.2.4.319; Wolsko PM, 2003, SPINE, V28, P292, DOI 10.1097/00007632-200302010-00018; Wood L, 2012, EUR J ONCOL NURS, V16, P432, DOI 10.1016/j.ejon.2011.10.002; World Health Organisation, 2005, PREP HEALTHC WORKF 2; Yan M, 2011, J SHAANXI COLL TRAD, V34, P87	50	9	10	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126912	10.1371/journal.pone.0126912	http://dx.doi.org/10.1371/journal.pone.0126912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020251	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300028
J	Millow, CJ; Mackintosh, SA; Lewison, RL; Dodder, NG; Hoh, E				Millow, Christopher J.; Mackintosh, Susan A.; Lewison, Rebecca L.; Dodder, Nathan G.; Hoh, Eunha			Identifying Bioaccumulative Halogenated Organic Compounds Using a Nontargeted Analytical Approach: Seabirds as Sentinels	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; EGGS; PERSISTENT; MERCURY; POLLUTANTS; TRICLOSAN; TRIS(4-CHLOROPHENYL)METHANOL; ORGANOCHLORINES; IDENTIFICATION; CONTAMINANTS	Persistent organic pollutants (POPs) are typically monitored via targeted mass spectrometry, which potentially identifies only a fraction of the contaminants actually present in environmental samples. With new anthropogenic compounds continuously introduced to the environment, novel and proactive approaches that provide a comprehensive alternative to targeted methods are needed in order to more completely characterize the diversity of known and unknown compounds likely to cause adverse effects. Nontargeted mass spectrometry attempts to extensively screen for compounds, providing a feasible approach for identifying contaminants that warrant future monitoring. We employed a nontargeted analytical method using comprehensive two-dimensional gas chromatography coupled to time-of-flight mass spectrometry (GCxGC/TOF-MS) to characterize halogenated organic compounds (HOCs) in California Black skimmer (Rynchops niger) eggs. Our study identified 111 HOCs; 84 of these compounds were regularly detected via targeted approaches, while 27 were classified as typically unmonitored or unknown. Typically unmonitored compounds of note in bird eggs included tris(4-chlorophenyl) methane (TCPM), tris(4-chlorophenyl) methanol (TCPMOH), triclosan, permethrin, heptachloro-1'-methyl-1,2'-bipyrrole (MBP), as well as four halogenated unknown compounds that could not be identified through database searching or the literature. The presence of these compounds in Black skimmer eggs suggests they are persistent, bioaccumulative, potentially biomagnifying, and maternally transferring. Our results highlight the utility and importance of employing nontargeted analytical tools to assess true contaminant burdens in organisms, as well as to demonstrate the value in using environmental sentinels to proactively identify novel contaminants.	[Millow, Christopher J.; Lewison, Rebecca L.] San Diego State Univ, Dept Biol, Ecol Program Area, San Diego, CA 92182 USA; [Mackintosh, Susan A.; Hoh, Eunha] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Mackintosh, Susan A.] San Diego State Univ, Res Fdn, San Diego, CA 92182 USA; [Dodder, Nathan G.] Southern Calif Coastal Water Res Project Author, Costa Mesa, CA USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University; Southern California Coastal Water Research Project	Millow, CJ (corresponding author), San Diego State Univ, Dept Biol, Ecol Program Area, San Diego, CA 92182 USA.	cmillow@gmail.com	Dodder, Nathan/C-7971-2015	Dodder, Nathan/0000-0001-5913-1767; Lewison, Rebecca/0000-0003-3065-2926; Hoh, Eunha/0000-0002-4075-040X	Environmental Protection Agency Science to Achieve Results Graduate Fellowship [FP-91748601-0]; San Diego State University Grant Program; California State University Program for Education and Research in Biotechnology; National Institute of Environmental Health Sciences - Oceans and Human Health Program [P01-ES021921]; California State University Council on Ocean Affairs, Science, and Technology Graduate Research Award; Waterbird Society, Nisbet Award; Association of Field Ornithologists, Bergstrom Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021921] Funding Source: NIH RePORTER	Environmental Protection Agency Science to Achieve Results Graduate Fellowship; San Diego State University Grant Program; California State University Program for Education and Research in Biotechnology; National Institute of Environmental Health Sciences - Oceans and Human Health Program; California State University Council on Ocean Affairs, Science, and Technology Graduate Research Award; Waterbird Society, Nisbet Award; Association of Field Ornithologists, Bergstrom Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was funded in part by the following entities and organizations: Environmental Protection Agency Science to Achieve Results Graduate Fellowship: FP-91748601-0, (http://www.epa.gov/ncer/fellowships/CJM), San Diego State University Grant Program, (http://newscenter.sdsu.edu/researchaffairs/ugp.aspx RLL, EH), California State University Program for Education and Research in Biotechnology, (http://www.calstate.edu/csuperb/grants/ EH); National Institute of Environmental Health Sciences - Oceans and Human Health Program: P01-ES021921, (http://www.niehs.nih.gov/research/supported/dert/programs/oceans/EH), California State University Council on Ocean Affairs, Science, and Technology Graduate Research Award (http://www.calstate.edu/coast/funding/internal_funding.shtml#studentAward CJM), the Waterbird Society, Nisbet Award (http://www.waterbirds.org/grants/nisbet-research-award CJM), and the Association of Field Ornithologists, Bergstrom Award(http:/www.afonet.org/grants/Bergstrom/Bergstrom.html CJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2007, SCI TOTAL ENVIRON, V384, P452, DOI 10.1016/j.scitotenv.2007.04.027; Alonso MB, 2012, ENVIRON INT, V47, P99, DOI 10.1016/j.envint.2012.06.010; Braune BM, 2001, ENVIRON POLLUT, V114, P39, DOI 10.1016/S0269-7491(00)00210-4; Brown FR, 2006, CHEMOSPHERE, V64, P276, DOI 10.1016/j.chemosphere.2005.12.012; Burger J, 2002, ENVIRON RES, V90, P33, DOI 10.1006/enrs.2002.4381; Burger J., 1990, BLACK SKIMMER SOCIAL; BUSER HR, 1995, ENVIRON SCI TECHNOL, V29, P2133, DOI 10.1021/es00008a036; Celo V, 2006, SCI TOTAL ENVIRON, V368, P126, DOI 10.1016/j.scitotenv.2005.09.043; Corsolini S, 2007, ENVIRON SCI POLLUT R, V14, P421, DOI 10.1065/espr2006.01.017; Crosse JD, 2012, ENVIRON POLLUT, V161, P93, DOI 10.1016/j.envpol.2011.10.003; Elliott JE, 2013, SCIENCE, V340, P556, DOI 10.1126/science.1235197; Falandysz J, 1999, ENVIRON SCI TECHNOL, V33, P517, DOI 10.1021/es980548u; Fernie KJ, 2009, ENVIRON SCI TECHNOL, V43, P2124, DOI 10.1021/es8027346; Finkelstein ME, 2007, ENVIRON TOXICOL CHEM, V26, P1896, DOI 10.1897/06-505R.1; Foster CR, 2009, ESTUAR COAST, V32, P1079, DOI 10.1007/s12237-009-9224-2; Gilbertson M., 1987, International Council for Bird Preservation Technical Publication, P231; Halden AN, 2010, AQUAT TOXICOL, V100, P30, DOI 10.1016/j.aquatox.2010.07.010; Harris HH, 2003, SCIENCE, V301, P1203, DOI 10.1126/science.1085941; Hoh E, 2012, ENVIRON SCI TECHNOL, V46, P8001, DOI 10.1021/es301139q; Hoh E, 2009, ENVIRON SCI TECHNOL, V43, P3240, DOI 10.1021/es803486x; Holmstrand H, 2010, APPL GEOCHEM, V25, P1301, DOI 10.1016/j.apgeochem.2010.06.001; Howard PH, 2010, ENVIRON SCI TECHNOL, V44, P2277, DOI 10.1021/es903383a; JARMAN WM, 1992, ENVIRON SCI TECHNOL, V26, P1770, DOI 10.1021/es00033a009; Johansson AK, 2009, ENVIRON TOXICOL CHEM, V28, P9, DOI 10.1897/08-142.1; Kannan K, 2004, ENVIRON POLLUT, V131, P425, DOI 10.1016/j.envpol.2004.03.004; Karlsson H, 1999, ENVIRON SCI TECHNOL, V33, P1353, DOI 10.1021/es9809962; Komoroske LM, 2011, CHEMOSPHERE, V84, P544, DOI 10.1016/j.chemosphere.2011.04.023; Koschier F, 2011, FOOD CHEM TOXICOL, V49, P2074, DOI 10.1016/j.fct.2011.05.019; Lavoie RA, 2010, ENVIRON POLLUT, V158, P2189, DOI 10.1016/j.envpol.2010.02.016; Lebeuf M, 2014, SCI TOTAL ENVIRON, V485, P377, DOI 10.1016/j.scitotenv.2014.03.097; Long ER, 2000, ECOL APPL, V10, P338, DOI 10.1890/1051-0761(2000)010[0338:DSQIUS]2.0.CO;2; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mathews S, 2014, ENVIRON SCI POLLUT R, V21, P6025, DOI 10.1007/s11356-013-2474-3; Molina KC, 2008, CALIFORNIA BIRD SPEC, P199; Muir DCG, 2006, ENVIRON SCI TECHNOL, V40, P7157, DOI 10.1021/es061677a; Nash SMB, 2008, SCI TOTAL ENVIRON, V407, P304, DOI 10.1016/j.scitotenv.2008.08.034; Owen TM, 2013, WATERBIRDS, V36, P342, DOI 10.1675/063.036.0311; Pangallo K, 2008, CHEMOSPHERE, V71, P1557, DOI 10.1016/j.chemosphere.2007.11.051; Perron MM, 2012, ENVIRON TOXICOL CHEM, V31, P1861, DOI 10.1002/etc.1884; Prosser RS, 2014, ENVIRON TOXICOL CHEM, V33, P975, DOI 10.1002/etc.2505; Reddy CM, 2004, ENVIRON SCI TECHNOL, V38, P1992, DOI 10.1021/es030568i; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Shaul NJ, 2015, ENVIRON SCI TECHNOL, V49, P1328, DOI 10.1021/es505156q; Skarphedinsdottir H, 2010, ARCH ENVIRON CON TOX, V58, P800, DOI 10.1007/s00244-009-9376-x; Tittlemier SA, 1999, ENVIRON SCI TECHNOL, V33, P26, DOI 10.1021/es980646f; Van den Steen E, 2009, ENVIRON POLLUT, V157, P430, DOI 10.1016/j.envpol.2008.09.031; Vetter W, 2002, ANAL CHEM, V74, P4287, DOI 10.1021/ac025696o; Vetter W, 2008, ANAL BIOANAL CHEM, V392, P489, DOI 10.1007/s00216-008-2277-4; Vetter W, 2006, REV ENVIRON CONTAM T, V188, P1, DOI 10.1007/978-0-387-32964-2_1; WALKER W, 1989, CHEMOSPHERE, V18, P1799, DOI 10.1016/0045-6535(89)90463-3; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zeeman C, 2008, CHARACTERIZING EXPOS; Zeeman CQT, 2004, ECOLOGICAL RISK BASE; ZOOK DR, 1992, AMBIO, V21, P557	54	31	31	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127205	10.1371/journal.pone.0127205	http://dx.doi.org/10.1371/journal.pone.0127205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020245	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300034
J	Brenndorfer, J; Altmann, A; Widner-Andra, R; Putz, B; Czamara, D; Tilch, E; Kam-Thong, T; Weber, P; Rex-Haffner, M; Bettecken, T; Bultmann, A; Muller-Myhsok, B; Binder, EE; Landgraf, R; Czibere, L				Brenndoerfer, Julia; Altmann, Andre; Widner-Andrae, Regina; Puetz, Benno; Czamara, Darina; Tilch, Erik; Kam-Thong, Tony; Weber, Peter; Rex-Haffner, Monika; Bettecken, Thomas; Bultmann, Andrea; Mueller-Myhsok, Bertram; Binder, Elisabeth E.; Landgraf, Rainer; Czibere, Ludwig			Connecting Anxiety and Genomic Copy Number Variation: A Genome-Wide Analysis in CD-1 Mice	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; GLYOXALASE-I; STRUCTURAL VARIATION; CANDIDATE GENES; ANIMAL-MODEL; DE-NOVO; MOUSE; KINASE; DISORDER	Genomic copy number variants (CNVs) have been implicated in multiple psychiatric disorders, but not much is known about their influence on anxiety disorders specifically. Using next-generation sequencing (NGS) and two additional array-based genotyping approaches, we detected CNVs in a mouse model consisting of two inbred mouse lines showing high (HAB) and low (LAB) anxiety-related behavior, respectively. An influence of CNVs on gene expression in the central (CeA) and basolateral (BLA) amygdala, paraventricular nucleus (PVN), and cingulate cortex (Cg) was shown by a two-proportion Z-test (p = 1.6 x 10(-31)), with a positive correlation in the CeA (p = 0.0062), PVN (p = 0.0046) and Cg (p = 0.0114), indicating a contribution of CNVs to the genetic predisposition to trait anxiety in the specific context of HAB/LAB mice. In order to confirm anxiety-relevant CNVs and corresponding genes in a second mouse model, we further examined CD-1 outbred mice. We revealed the distribution of CNVs by genotyping 64 CD 1 individuals using a high-density genotyping array (Jackson Laboratory). 78 genes within those CNVs were identified to show nominally significant association (48 genes), or a statistical trend in their association (30 genes) with the time animals spent on the open arms of the elevated plus-maze (EPM). Fifteen of them were considered promising candidate genes of anxiety-related behavior as we could show a significant overlap (permutation test, p = 0.0051) with genes within HAB/LAB CNVs. Thus, here we provide what is to our knowledge the first extensive catalogue of CNVs in CD-1 mice and potential corresponding candidate genes linked to anxiety-related behavior in mice.	[Brenndoerfer, Julia; Widner-Andrae, Regina; Bettecken, Thomas; Bultmann, Andrea; Landgraf, Rainer; Czibere, Ludwig] Max Planck Inst Psychiat, Dept Behav Neuroendocrinol, Munich, Germany; [Altmann, Andre; Puetz, Benno; Czamara, Darina; Kam-Thong, Tony; Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, Dept Stat Genet, D-80804 Munich, Germany; [Weber, Peter; Rex-Haffner, Monika; Binder, Elisabeth E.] Max Planck Inst Psychiat, Dept Mol Genet Affect Disorders, D-80804 Munich, Germany; [Tilch, Erik] Helmholtz Zentrum Munchen, Inst Human Genet, Munich, Germany; [Tilch, Erik] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Brenndorfer, J (corresponding author), Max Planck Inst Psychiat, Dept Behav Neuroendocrinol, Munich, Germany.	jbrenndoerfer@mpipsykl.mpg.de	Altmann, Andre/ABF-1675-2020	Altmann, Andre/0000-0002-9265-2393; Czibere, Ludwig/0000-0002-7508-5841	Max Planck Institute of Psychiatry	Max Planck Institute of Psychiatry(Max Planck Society)	This study was funded by the Max Planck Institute of Psychiatry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Altmann A, 2012, HUM GENET, V131, P1541, DOI 10.1007/s00439-012-1213-z; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo V, 2013, ANAL BIOCHEM, V432, P131, DOI 10.1016/j.ab.2012.09.029; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Brasch-Andersen C, 2004, HUM MUTAT, V24, P208, DOI 10.1002/humu.20074; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Czibere L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023604; Di Benedetto B, 2009, NEUROPSYCHOPHARMACOL, V34, P356, DOI 10.1038/npp.2008.57; Diekstra FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035333; Distler Margaret G., 2012, Frontiers in Genetics, V3, P250, DOI 10.3389/fgene.2012.00250; Distler MG, 2012, J CLIN INVEST, V122, P2306, DOI 10.1172/JCI61319; Farber CR, 2013, G3-GENES GENOM GENET, V3, P119, DOI 10.1534/g3.112.004788; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fujimoto M, 2008, NEUROSCI LETT, V438, P196, DOI 10.1016/j.neulet.2008.04.024; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Hambsch B, 2010, J NEUROCHEM, V113, P1240, DOI 10.1111/j.1471-4159.2010.06693.x; Haraksingh RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027859; Hayashi A, 2004, J BIOL CHEM, V279, P29450, DOI 10.1074/jbc.M400950200; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; HOLM S, 1979, SCAND J STAT, V6, P65; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jeon JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-426; Jurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037060; Kam-Thong T, 2012, HUM HERED, V73, P220, DOI 10.1159/000341885; Kam-Thong T, 2011, EUR J HUM GENET, V19, P465, DOI 10.1038/ejhg.2010.196; Kawamura Y, 2011, J HUM GENET, V56, P852, DOI 10.1038/jhg.2011.117; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kollmannsberger LK, 2013, G3-GENES GENOM GENET, V3, P1311, DOI 10.1534/g3.113.006445; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Landgraf R, 2002, BEHAV GENET, V32, P301, DOI 10.1023/A:1020258104318; Landgraf R, 2007, NEUROSCI BIOBEHAV R, V31, P89, DOI 10.1016/j.neubiorev.2006.07.003; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Levy RJ, 2012, METHODS MOL BIOL, V838, P97, DOI 10.1007/978-1-61779-507-7_4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liebsch G, 1998, BEHAV BRAIN RES, V94, P301, DOI 10.1016/S0166-4328(97)00198-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Roberts PC, 2008, BIOTECHNOL ANN REV, V14, P29, DOI 10.1016/S1387-2656(08)00002-1; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Rucker JJH, 2013, MOL PSYCHIATR, V18, P183, DOI 10.1038/mp.2011.144; Sartori SB, 2011, FUTUR NEUROL, V6, P531, DOI 10.2217/FNL.11.34; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; St Clair D, 2009, SCHIZOPHRENIA BULL, V35, P9, DOI 10.1093/schbul/sbn147; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thornalley PJ, 2006, TRENDS MOL MED, V12, P195, DOI 10.1016/j.molmed.2006.03.004; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; van de Wiel MA, 2011, BRIEF BIOINFORM, V12, P10, DOI 10.1093/bib/bbq004; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Warden M, 2011, METHODS MOL BIOL, V719, P235, DOI 10.1007/978-1-61779-027-0_11; Wefers B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035035; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Widner-Andra R, 2011, THESIS; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004649; Wu CT, 1999, CURR OPIN GENET DEV, V9, P237, DOI 10.1016/S0959-437X(99)80035-5; Xi RB, 2010, BRIEF FUNCT GENOMICS, V9, P405, DOI 10.1093/bfgp/elq025; Yang H, 2011, MOUSEDIVGENO VIGNETT; Yang H, 2010, MOUSEDIVGENO TOOLS A; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511	91	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128465	10.1371/journal.pone.0128465	http://dx.doi.org/10.1371/journal.pone.0128465			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011321	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900238
J	Bumrungthai, S; Ekalaksananan, T; Evans, MF; Chopjitt, P; Tangsiriwatthana, T; Patarapadungkit, N; Kleebkaow, P; Luanratanakorn, S; Kongyingyoes, B; Worawichawong, S; Pientong, C				Bumrungthai, Sureewan; Ekalaksananan, Tipaya; Evans, Mark Francis; Chopjitt, Peechanika; Tangsiriwatthana, Thumwadee; Patarapadungkit, Natcha; Kleebkaow, Pilaiwan; Luanratanakorn, Sanguanchoke; Kongyingyoes, Bunkerd; Worawichawong, Suchin; Pientong, Chamsai			Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; TUMOR-GROWTH; MICRORNA EXPRESSION; COLORECTAL-CANCER; INTERLEUKIN-6; CARCINOMA; PDCD4; PROMOTE; CELLS; INVASION	MicroRNA-21 (miR-21) is recognized as an oncomir and shows up-regulation in many types of human malignancy. The aim of this study was to investigate the association of miR-21 expression associated with HPV infection in normal and abnormal cervical tissues. Cervical tissue samples with different cytological or histopathological grades were investigated for HPV by PCR and for miR-21 and programmed cell death, protein 4 (PDCD4) expression using quantitative real-time PCR (qRT-PCR). Laser capture microdissection (LCM) of stromal and epithelial tissues and in situ hybridization (ISH) using locked nucleic acid (LNA) probes were performed on a subset of fixed specimens. Cell line experiments were conducted on fibroblasts stimulated in culture media from HeLa cells, which were then assessed for miR-21, PDCD4, IL-6 and alpha-SMA expression by qRT-PCR. Twenty normal cervical cell, 12 cervicitis, 14 cervical intraepithelial neoplastic I (CIN I), 22 CIN II-III and 43 cervical squamous cell carcinoma (SCC) specimens were investigated. miR-21 levels were significantly lower in normal than in abnormal tissues. The expression of miR-21 in HPV negative normal cytology was significantly lower than in HPV positive samples in abnormal tissue and SCC. The miR-21 expression was significantly higher in HPV negative cervicitis than HPV negative normal cells. LCM and ISH data showed that miR-21 is primarily expressed in the tumor-associated stromal cell microenvironment. Fibroblasts treated with HeLa cell culture media showed up-regulated expression of miR-21, which correlated with increased expression of alpha-SMA and IL-6 and with down-regulation of PDCD4. These results demonstrate that miR-21 is associated with HPV infection and involved in cervical lesions as well as cervicitis and its up-regulation in tumor-stroma might be involved in the inflammation process and cervical cancer progression.	[Bumrungthai, Sureewan; Ekalaksananan, Tipaya; Chopjitt, Peechanika; Pientong, Chamsai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Evans, Mark Francis] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT USA; [Tangsiriwatthana, Thumwadee] Khon Kaen Hosp, Dept Obstet & Gynecol, Khon Kaen, Thailand; [Patarapadungkit, Natcha] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Kleebkaow, Pilaiwan; Luanratanakorn, Sanguanchoke] Khon Kaen Univ, Fac Med, Dept Obstet & Gynecol, Khon Kaen, Thailand; [Kongyingyoes, Bunkerd] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand; [Worawichawong, Suchin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand; [Bumrungthai, Sureewan; Ekalaksananan, Tipaya; Chopjitt, Peechanika; Tangsiriwatthana, Thumwadee; Patarapadungkit, Natcha; Kleebkaow, Pilaiwan; Pientong, Chamsai] Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand	Khon Kaen University; University of Vermont; Khon Kaen University; Khon Kaen University; Khon Kaen University; Mahidol University; Khon Kaen University	Pientong, C (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	chapie@kku.ac.th	Evans, Mark/GYU-3450-2022; Chopjitt, Peechanika/ABD-4917-2020	Chopjitt, Peechanika/0000-0001-5010-4682	Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0212/2550]; Faculty of Medicine, Khon Kaen University [I54225, I57210]; Khon Kaen University, Thailand [551601, 564101, 573001]; Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA	Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Faculty of Medicine, Khon Kaen University; Khon Kaen University, Thailand; Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA	Financial support was from the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0212/2550) to student S. B. and advisor C.P. The research was supported by Faculty of Medicine, Khon Kaen University (Grant No. I54225 and I57210); Khon Kaen University, Thailand (Grant No. 551601, 564101 and 573001) and Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2012, INT IMMUNOPHARMACOL, V12, P594, DOI 10.1016/j.intimp.2012.01.014; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bauknecht T, 1999, VIROLOGY, V258, P344, DOI 10.1006/viro.1999.9722; Bon MAM, 2000, CLIN CHEM, V46, P1000; Castrilli G, 1997, BRIT J CANCER, V75, P855, DOI 10.1038/bjc.1997.152; Chan JK, 2014, GYNECOL ONCOL, V132, P739, DOI 10.1016/j.ygyno.2014.01.034; Deftereos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028423; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Hopman AHN, 1998, J HISTOCHEM CYTOCHEM, V46, P771, DOI 10.1177/002215549804600611; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; IGLESIAS M, 1995, AM J PATHOL, V146, P944; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jimenez-Wences H, 2014, ONCOL REP, V31, P2467, DOI 10.3892/or.2014.3142; Kenngott RAM, 2011, J HISTOCHEM CYTOCHEM, V59, P312, DOI 10.1369/0022155410397995; Kinoshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060914; Kyo S, 2000, GYNECOL ONCOL, V78, P383, DOI 10.1006/gyno.2000.5904; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Reis PP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-238; Ren CX, 2013, EUR J CANCER, V49, P3889, DOI 10.1016/j.ejca.2013.07.140; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057652; Tang T, 2013, GYNECOL ONCOL, V129, P199, DOI 10.1016/j.ygyno.2012.12.043; TARTOUR E, 1994, CANCER RES, V54, P6243; Tjiong MY, 1999, GYNECOL ONCOL, V73, P285, DOI 10.1006/gyno.1999.5358; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wei LH, 2001, GYNECOL ONCOL, V82, P49, DOI 10.1006/gyno.2001.6235; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yao Q, 2011, INT J CANCER, V128, P1783, DOI 10.1002/ijc.25506; Yao Q, 2009, BIOCHEM BIOPH RES CO, V388, P539, DOI 10.1016/j.bbrc.2009.08.044; Yeung CLA, 2011, ONCOGENE, V30, P2401, DOI 10.1038/onc.2010.613; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032	44	43	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127109	10.1371/journal.pone.0127109	http://dx.doi.org/10.1371/journal.pone.0127109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010154	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900064
J	Chikan, NA; Bukhari, S; Shabir, N; Amin, A; Shafi, S; Qadri, RA; Patel, TNC				Chikan, Naveed Anjum; Bukhari, Shoiab; Shabir, Nadeem; Amin, Asif; Shafi, Sheikh; Qadri, Raies Ahmad; Patel, Trupti Navin Chandra			Atomic Insight into the Altered O-6-Methylguanine-DNA Methyltransferase Protein Architecture in Gastric Cancer	PLOS ONE			English	Article							N-NITROSO COMPOUNDS; HUMAN O(6)-ALKYLGUANINE-DNA ALKYLTRANSFERASE; AMINO-ACID SUBSTITUTIONS; LUNG-CANCER; DNA-REPAIR; MOLECULAR-DYNAMICS; RISK; POLYMORPHISMS; MUTATIONS; KASHMIR	O-6-methylguanine-DNA methyltransferase (MGMT) is one of the major DNA repair protein that counteracts the alkalyting agent-induced DNA damage by replacing O-6-methylguanine (mutagenic lesion) back to guanine, eventually suppressing the mismatch errors and double strand crosslinks. Exonic alterations in the form of nucleotide polymorphism may result in altered protein structure that in turn can lead to the loss of function. In the present study, we focused on the population feared for high exposure to alkylating agents owing to their typical and specialized dietary habits. To this end, gastric cancer patients pooled out from the population were selected for the mutational screening of a specific error prone region of MGMT gene. We found that nearly 40% of the studied neoplastic samples harbored missense mutation at codon(151) resulting into Serine to Isoleucine variation. This variation resulted in bringing about the structural disorder, subsequently ensuing into a major stoichiometric variance in recognition domain, substrate binding and selectivity loop of the active site of the MGMT protein, as observed under virtual microscope of molecular dynamics simulation (MDS). The atomic insight into MGMT protein by computational approach showed a significant change in the intra molecular hydrogen bond pattern, thus leading to the observed structural anomalies. To further examine the mutational implications on regulatory plugs of MGMT that holds the protein in a DNA-Binding position, a MDS based analysis was carried out on, all known physically interacting amino acids essentially clustered into groups based on their position and function. The results generated by physical-functional clustering of protein indicated that the identified mutation in the vicinity of the active site of MGMT protein causes the local and global destabilization of a protein by either eliminating the stabilizing salt bridges in cluster C3, C4, and C5 or by locally destabilizing the "protein stabilizing hing" mapped on C3-C4 cluster, preceding the active site.	[Chikan, Naveed Anjum; Patel, Trupti Navin Chandra] VIT Univ, Sch Biosci & Technol, Div Med Biotechnol, Vellore 632014, Tamil Nadu, India; [Chikan, Naveed Anjum; Bukhari, Shoiab; Amin, Asif; Qadri, Raies Ahmad] Univ Kashmir, Dept Biotechnol, Srinagar 190006, Kashmir, India; [Shabir, Nadeem] Anand Agr Univ, Coll Vet Sci, Dept Anim Biotechnol, Anand 388001, Gujarat, India; [Shafi, Sheikh] Sherikashmir Inst Med Sci, Dept Clin Biochem, Srinagar 190011, Kashmir, India	Vellore Institute of Technology; University of Kashmir; Anand Agricultural University; Sher-i-Kashmir Institute of Medical Sciences	Patel, TNC (corresponding author), VIT Univ, Sch Biosci & Technol, Div Med Biotechnol, Vellore 632014, Tamil Nadu, India.	tnpatel@vit.ac.in	Shabir, Nadeem/AAY-9151-2020; Patel, Trupti N/F-6301-2017; Patel, Trupti/AAR-3277-2021; CHIKAN, NAVEED/N-5912-2014	Shabir, Nadeem/0000-0001-6358-5251; Patel, Trupti N/0000-0002-7941-602X; Patel, Trupti/0000-0002-7941-602X; CHIKAN, NAVEED/0000-0002-5977-0531; Bukhari, Shoiab/0000-0002-1172-7139; Qadri, Raies A./0000-0001-6018-4786	VIT University research associate grant	VIT University research associate grant	The research was funded by VIT University research associate grant and the funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, 2012, DISC STUD MOD ENV RE; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amadei A, 1996, J BIOMOL STRUCT DYN, V13, P615, DOI 10.1080/07391102.1996.10508874; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Bukhari S, 2015, MOL BIOSYST, V11, P159, DOI 10.1039/c4mb00506f; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chikan NA, 2012, ASIAN PAC J CANCER P, V13, P1077, DOI 10.7314/APJCP.2012.13.3.1077; Cohet C, 2004, CANCER EPIDEM BIOMAR, V13, P320, DOI 10.1158/1055-9965.EPI-03-0120; Daniels DS, 2000, MUTAT RES-DNA REPAIR, V460, P151, DOI 10.1016/S0921-8777(00)00024-0; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DHAR GM, 1993, J EPIDEMIOL COMMUN H, V47, P290, DOI 10.1136/jech.47.4.290; Doss CGP, 2014, ADV PROTEIN CHEM STR, V94, P177, DOI 10.1016/B978-0-12-800168-4.00006-8; Duguid EM, 2005, J MOL BIOL, V350, P657, DOI 10.1016/j.jmb.2005.05.028; Edara S, 1999, CARCINOGENESIS, V20, P103, DOI 10.1093/carcin/20.1.103; Egyhazi S, 2002, Hum Mutat, V20, P408, DOI 10.1002/humu.9078; El-Rifai W, 2002, SEMIN RADIAT ONCOL, V12, P128, DOI 10.1053/srao.2002.30815; Engelbergs J, 2000, MUTAT RES-FUND MOL M, V450, P139, DOI 10.1016/S0027-5107(00)00021-X; Ferlay J, 2014, INT J CANC; Fiocca R, 2001, HEPATO-GASTROENTEROL, V48, P1523; Ford BN, 2000, CARCINOGENESIS, V21, P1977, DOI 10.1093/carcin/21.11.1977; George Doss C Priya, 2014, Theranostics, V4, P366, DOI 10.7150/thno.7473; George P. D. C., 2014, SCI REPORTS, V4; Gonnelli G, 2012, J BIOTECHNOL, V161, P287, DOI 10.1016/j.jbiotec.2012.06.020; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ITO T, 1994, MUTAT RES, V314, P273, DOI 10.1016/0921-8777(94)90071-X; Kaur TB, 2000, CANCER EPIDEM BIOMAR, V9, P339; KHUROO MS, 1992, GUT, V33, P11, DOI 10.1136/gut.33.1.11; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; KUMAR R, 1990, CANCER LETT, V54, P61, DOI 10.1016/0304-3835(90)90092-C; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li CP, 2005, CANCER LETT, V227, P49, DOI 10.1016/j.canlet.2005.03.043; MONTESANO R, 1985, BIOCHIMIE, V67, P919, DOI 10.1016/S0300-9084(85)80288-1; NAKATSURU Y, 1991, MUTAT RES, V254, P225, DOI 10.1016/0921-8777(91)90060-3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PEGG AE, 1992, FASEB J, V6, P2302, DOI 10.1096/fasebj.6.6.1544541; PEGG AE, 1990, CANCER RES, V50, P6119; Petsko G., 2004, PROTEIN STRUCTURE FU; Priyadharshini C. J., 2014, FRONTIERS BIOSCIENCE, V20, P335; Sakumi K, 1997, CANCER RES, V57, P2415; Sekiguchi M, 1996, J CANCER RES CLIN, V122, P199, DOI 10.1007/BF01209646; SIDDIQI M, 1988, CANCER LETT, V39, P37, DOI 10.1016/0304-3835(88)90038-9; SIDDIQI M, 1988, CANCER LETT, V39, P259, DOI 10.1016/0304-3835(88)90068-7; Turner, 2005, XMGRACE VERSION 51 1; Wang L, 2006, CANCER EPIDEM BIOMAR, V15, P2364, DOI 10.1158/1055-9965.EPI-06-0437; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Wibley JEA, 2000, NUCLEIC ACIDS RES, V28, P393, DOI 10.1093/nar/28.2.393; Yang MH, 2004, LUNG CANCER, V44, P281, DOI 10.1016/j.lungcan.2003.12.003; Zheng Leizhen, 2004, Gastric Cancer, V7, P61	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127741	10.1371/journal.pone.0127741	http://dx.doi.org/10.1371/journal.pone.0127741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011121	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900137
J	Dubey, A; Goswami, M; Yadav, K; Chaudhary, D				Dubey, Akhilesh; Goswami, Mukunda; Yadav, Kamalendra; Chaudhary, Dharmendra			Oxidative Stress and Nano-Toxicity Induced by TiO2 and ZnO on WAG Cell Line	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; IN-VITRO; MANUFACTURED NANOPARTICLES; SILVER NANOPARTICLES; PARTICLE-SIZE; CATLA-CATLA; GILL TISSUE; FISH; CYTOTOXICITY; ECOTOXICOLOGY	Metallic nanoparticles are widely used in cosmetics, food products and textile industry. These particles are known to cause respiratory toxicity and epithelial inflammation. They are eventually released to aquatic environment necessitating toxicity studies in cells from respiratory organs of aquatic organisms. Hence, we have developed and characterized a new cell line, WAG, from gill tissue of Wallago attu for toxicity assessment of TiO2 and ZnO nanoparticles. The efficacy of the cell line as an in vitro system for nanoparticles toxicity studies was established using electron microscopy, cytotoxicity assays, genotoxicity assays and oxidative stress biomarkers. Results obtained with MTT assay, neutral red uptake assay and lactate dehydrogenase assay showed acute toxicity to WAG cells with IC50 values of 25.29+/-0.12, 34.99+/-0.09 and 35.06+/-0.09 mg/l for TiO2 and 5.716+/-0.1, 3.160+/-0.1 and 5.57+/-0.12 mg/l for ZnO treatment respectively. The physicochemical properties and size distribution of nanoparticles were characterized using electron microscopy with integrated energy dispersive X-ray spectroscopy and Zetasizer. Dose dependent increase in DNA damage, lipid peroxidation and protein carbonylation along with a significant decrease in activity of Superoxide Dismutase, Catalase, total Glutathione levels and total antioxidant capacity with increasing concentration of exposed nanoparticles indicated that the cells were under oxidative stress. The study established WAG cell line as an in vitro system to study toxicity mechanisms of nanoparticles on aquatic organisms.	[Dubey, Akhilesh; Goswami, Mukunda; Chaudhary, Dharmendra] Natl Bur Fish Genet Resources, Lucknow, Uttar Pradesh, India; [Yadav, Kamalendra] Natl Agri Food Biotechnol Inst, Mohali, Punjab, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Fish Genetic Resources; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Goswami, M (corresponding author), Natl Bur Fish Genet Resources, Lucknow, Uttar Pradesh, India.	mukugoswami@gmail.com			Department of Biotechnology, India [BT/PR13538/AAQ/03/506/2010]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	Department of Biotechnology, India is deeply acknowledged for the financial support. Grant number: BT/PR13538/AAQ/03/506/2010; dated 09.11.2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 1996, INTERCONNECTIONS HUM, P91; Aitken RJ, 2006, OCCUP MED-OXFORD, V56, P300, DOI 10.1093/occmed/kql051; ALVAREZ MC, 1991, J FISH BIOL, V39, P817, DOI 10.1111/j.1095-8649.1991.tb04411.x; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; BeruBe K, 2007, CLIN EXP PHARMACOL P, V34, P1044, DOI 10.1111/j.1440-1681.2007.04733.x; Bols NC, 2005, BIOCH MOLEC, V6, P43; Bols NC, 2001, DEV COMP IMMUNOL, V25, P853, DOI 10.1016/S0145-305X(01)00040-4; Braydich-Stolle LK, 2009, J NANOPART RES, V11, P1361, DOI 10.1007/s11051-008-9523-8; Cadet J, 1999, MUTAT RES-FUND MOL M, V424, P9, DOI 10.1016/S0027-5107(99)00004-4; Castano A, 2003, ATLA-ALTERN LAB ANIM, V31, P317, DOI 10.1177/026119290303100314; Chen JS, 2004, J ENVIRON MANAGE, V70, P43, DOI 10.1016/j.jenvman.2003.09.019; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Dayeh VR, 2002, WATER RES, V36, P3727, DOI 10.1016/S0043-1354(02)00078-7; Dechsakulthorn F., 2007, AATEX, V14, P397, DOI DOI 10.1021/NL0517480; Dubey A, 2014, MOL BIOL REP, V41, P915, DOI 10.1007/s11033-013-2936-1; Evans DH, 1987, ENV HLTH PERSPECT, V71, P54, DOI DOI 10.2307/3430412; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; FERIN J, 1985, AM IND HYG ASSOC J, V46, P69, DOI 10.1202/0002-8894(1985)046<0069:BEATAO>2.3.CO;2; Freshney R.I, 2010, CULTURE ANIMAL CELLS, Vsixth, P732; Goswami M, 2014, DRUG CHEM TOXICOL, V37, P48, DOI 10.3109/01480545.2013.806531; Handy RD, 2007, HEALTH RISK SOC, V9, P125, DOI 10.1080/13698570701306807; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; Hussain S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-10; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Kreuter J, 2008, TUMORI J, V94, P271; Kumar C, 2006, NANOMATERIALS TOXICI, V5; Lee LEJ, 2009, IN VITRO CELL DEV-AN, V45, P127, DOI 10.1007/s11626-008-9173-2; Majeed SA, 2013, CELL BIOL TOXICOL, V29, P59, DOI 10.1007/s10565-012-9237-7; Monserrat JM, 2007, COMP BIOCHEM PHYS C, V146, P221, DOI 10.1016/j.cbpc.2006.08.012; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Notter DA, 2014, ENVIRON TOXICOL CHEM, V33, P2733, DOI 10.1002/etc.2732; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; Ogino C, 2007, J BIOSCI BIOENG, V104, P339, DOI 10.1263/jbb.104.339; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pan D, 2015, NANOMEDICINE: A SOFT MATTER PERSPECTIVE, P131; Pujalte I, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-10; Raisuddin S, 2004, ENVIRON MOL MUTAGEN, V44, P83, DOI 10.1002/em.20027; Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011; Schirmer K, 2006, TOXICOLOGY, V224, P163, DOI 10.1016/j.tox.2006.04.042; Setyan A, 2009, PHYS CHEM CHEM PHYS, V11, P6205, DOI 10.1039/b902509j; Skubal LR, 2002, J PHOTOCH PHOTOBIO A, V148, P393, DOI 10.1016/S1010-6030(02)00069-2; Song L, 2014, NANOTOXICOLOGY, V8, P383, DOI 10.3109/17435390.2013.790997; Su JF, 2008, J NANOSCI NANOTECHNO, V8, P1174, DOI 10.1166/jnn.2008.317; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Taju G, 2014, COMP BIOCHEM PHYS C, V161, P41, DOI 10.1016/j.cbpc.2014.01.007; Taju G, 2013, CHEMOSPHERE, V90, P2172, DOI 10.1016/j.chemosphere.2012.11.027; Tan WB, 2007, BIOMATERIALS, V28, P1565, DOI 10.1016/j.biomaterials.2006.11.018; Ternes TA, 2004, ENVIRON SCI TECHNOL, V38, p392A, DOI 10.1021/es040639t; WANG R, 1995, FISH SHELLFISH IMMUN, V5, P329, DOI 10.1006/fsim.1995.0032; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Warheit DB, 2006, TOXICOL SCI, V91, P227, DOI 10.1093/toxsci/kfj140; Warheit DB, 2005, TOXICOL SCI, V88, P514, DOI 10.1093/toxsci/kfi331; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Xiong DW, 2011, SCI TOTAL ENVIRON, V409, P1444, DOI 10.1016/j.scitotenv.2011.01.015; Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385; Yoon KY, 2007, SCI TOTAL ENVIRON, V373, P572, DOI 10.1016/j.scitotenv.2006.11.007; Zelikoff JT, 1998, TOXICOLOGY, V129, P63, DOI 10.1016/S0300-483X(98)00064-X; Zhao Y., 2006, NANOTOXICOLOGY INTER	60	68	71	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127493	10.1371/journal.pone.0127493	http://dx.doi.org/10.1371/journal.pone.0127493			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011447	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900098
J	Garciadiego-Cazares, D; Aguirre-Sanchez, HI; Abarca-Buis, RF; Kouri, JB; Velasquillo, C; Ibarra, C				Garciadiego-Cazares, David; Aguirre-Sanchez, Hilda I.; Abarca-Buis, Rene F.; Kouri, Juan B.; Velasquillo, Cristina; Ibarra, Clemente			Regulation of alpha 5 and alpha V Integrin Expression by GDF-5 and BMP-7 in Chondrocyte Differentiation and Osteoarthritis	PLOS ONE			English	Article							DEVELOPING APPENDICULAR SKELETON; INDIAN HEDGEHOG; ARTICULAR-CARTILAGE; HYPERTROPHIC DIFFERENTIATION; JOINT FORMATION; SYNOVIAL JOINT; PROLIFERATION; MATRIX; ALPHA(V)BETA(3); COLLAGEN	The Integrin beta 1 family is the major receptors of the Extracellular matrix (ECM), and the synthesis and degradation balance of ECM is seriously disrupted during Osteoarthritis (OA). In this scenario, integrins modify their pattern expression and regulate chondrocyte differentiation in the articular cartilage. Members of the Transforming growth factor beta (Tgf-beta) Superfamily, such as Growth differentiation factor 5 (Gdf-5) and Bone morphogenetic protein 7 (Bmp-7), play a key role in joint formation and could regulate the integrin expression during chondrocyte differentiation and osteoarthritis progression in an experimental OA rat model. Decrease of alpha 5 integrin expression in articular cartilage was related with chondrocyte dedifferentiation during OA progression, while increase of alpha 1, alpha 2, and alpha 3 integrin expression was related with fibrous areas in articular cartilage during OA. Hypertrophic chondrocytes expressed alpha V integrin and was increased in the articular cartilage of rats with OA. Integrin expression during chondrocyte differentiation was also analyzed in a micromass culture system of mouse embryo mesenchymal cells, micromass cultures was treated with Gdf-5 or Bmp-7 for 4 and 6 days, respectively. Gdf-5 induced the expression of the alpha 5 sub-unit, while Bmp-7 induced the expression of the alpha V sub-unit. This suggests a switch in signaling for prehypertrophic chondrocyte differentiation towards hypertrophy, where Gdf-5 could maintain the articular chondrocyte phenotype and Bmp-7 would induce hypertrophy. Decrease of Ihh expression during late stages of OA in rat model suggest that the ossification in OA rat knees and endochondral ossification could be activated by Bmp-7 and alpha V integrin in absence of Ihh. Thus, chondrocyte phenotype in articular cartilage is similar to prehypetrophic chondrocyte in growth plate, and is preserved due to the presence of Indian hedgehog (Ihh), Gdf-5 and alpha 5 integrin to maintain articular cartilage and prevent hy-pertrophy.	[Garciadiego-Cazares, David; Aguirre-Sanchez, Hilda I.; Velasquillo, Cristina; Ibarra, Clemente] INR, Secretaria Salud SSA, Unidad Ingn Tejidos Terapia Celular & Med Regener, Mexico City, DF, Mexico; [Abarca-Buis, Rene F.] INR, Secretaria Salud SSA, Lab Tejido Conjunt, Mexico City, DF, Mexico; [Kouri, Juan B.] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Dept Infectom & Patogenesis Mol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Garciadiego-Cazares, D (corresponding author), INR, Secretaria Salud SSA, Unidad Ingn Tejidos Terapia Celular & Med Regener, Mexico City, DF, Mexico.	dgarciadiego@ciencias.unam.mx	Garciadiego-Cazares, David/AAA-9452-2022	Garciadiego-Cazares, David/0000-0002-7668-4133; kouri, juan/0000-0002-0155-9418; Abarca-Buis, Rene Fernando/0000-0003-3372-813X	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [CB-84683-2007]; CONACyT	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was supported by grant CB-84683-2007 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico, awarded to DG-C. HIA-S (14689), and RFA-B received a scholarship from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudd-Lozoya KA, 2000, PATHOL RES PRACT, V196, P729; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Buckwalter JA, 1999, ARTICULAR CARTILAGE, V1st; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Eerola I, 1998, ARTHRITIS RHEUM-US, V41, P1287, DOI 10.1002/1529-0131(199807)41:7<1287::AID-ART20>3.0.CO;2-D; EnomotoIwamoto M, 1997, J BONE MINER RES, V12, P1124, DOI 10.1359/jbmr.1997.12.7.1124; Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345; Goldring Mary B, 2012, HSS J, V8, P7, DOI 10.1007/s11420-011-9250-z; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hirsch MS, 1997, DEV DYNAM, V210, P249, DOI 10.1002/(SICI)1097-0177(199711)210:3<249::AID-AJA6>3.0.CO;2-G; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Klatt AR, 2009, FEBS LETT, V583, P3611, DOI 10.1016/j.febslet.2009.10.035; Lai TH, 2009, J CELL PHYSIOL, V218, P334, DOI 10.1002/jcp.21601; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Macias D, 1997, DEVELOPMENT, V124, P1109; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Pulai JI, 2002, ARTHRITIS RHEUM, V46, P1528, DOI 10.1002/art.10334; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; SALTER DM, 1995, J HISTOCHEM CYTOCHEM, V43, P447, DOI 10.1177/43.4.7897185; Segat D, 2002, J BIOL CHEM, V277, P31612, DOI 10.1074/jbc.M203471200; Shakibaei M, 1999, CELL TISSUE RES, V296, P565, DOI 10.1007/s004410051318; Sharma AR, 2013, INT J MOL SCI, V14, P19805, DOI 10.3390/ijms141019805; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Storgard CM, 1999, J CLIN INVEST, V103, P47, DOI 10.1172/JCI3756; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Tanaka K, 2007, MATRIX BIOL, V26, P409, DOI 10.1016/j.matbio.2007.04.005; Tarui T, 2001, J BIOL CHEM, V276, P39562, DOI 10.1074/jbc.M101815200; van der Weyden L, 2006, AM J PATHOL, V169, P515, DOI 10.2353/ajpath.2006.050981; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang ZP, 2010, J BIOL CHEM, V285, P20806, DOI 10.1074/jbc.M110.118521; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Wu QQ, 2001, J BIOL CHEM, V276, P35290, DOI 10.1074/jbc.M101055200; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Zemmyo M, 2003, ARTHRITIS RHEUM-US, V48, P2873, DOI 10.1002/art.11246	43	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127166	10.1371/journal.pone.0127166	http://dx.doi.org/10.1371/journal.pone.0127166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010756	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900070
J	Gothwal, VK; Bharani, S; Kekunnaya, R; Chhablani, P; Sachdeva, V; Pehere, NK; Narasaiah, A; Gunturu, R				Gothwal, Vijaya K.; Bharani, Seelam; Kekunnaya, Ramesh; Chhablani, PreetiPatil; Sachdeva, Virender; Pehere, Niranjan K.; Narasaiah, Asa; Gunturu, Rekha			Measuring Health-Related Quality of Life in Strabismus: A Modification of the Adult Strabismus-20 (AS-20) Questionnaire Using Rasch Analysis	PLOS ONE			English	Article							CATARACT-SURGERY OUTCOMES; DAILY VISION SCALE; PSYCHOSOCIAL-ASPECTS; DEPRESSION SCALE; CHINESE VERSION; YOUNG-ADULTS; SELF-ESTEEM; IMPACT; INSTRUMENTS; AMBLYOPIA	Purpose To evaluate the psychometric properties of the Adult Strabismus-20 (AS-20)-a health-related quality of life (HRQoL) questionnaire in adults with strabismus, and if flawed, to revise the AS-20 and its subscales creating valid measurement scales. Methods 584 adults (meanage, 27.5 years) with strabismus were recruited from an outpatient clinic at a South Indian tertiary eye care centre and were administered the AS-20 questionnaire. The AS-20 was translated and back translated into two Indian languages. The AS-20 and its two 10-item subscales - 'psychosocial' and 'function'were assessed separately for fit to the Rasch model, including an assessment of the rating scale, unidimensionality (by principal components analysis), measurement precision by person separation reliability, PSR, targeting, and differential item functioning (DIF; notable > 1.0 logits). Results Response categories were not used as intended, thereby, required re-organization and reducing their number from 5 to 3. The AS-20 had adequate measurement precision (PSR = 0.87) but lacked unidimensionality; however, deletion of the six multi-dimensionality causing items and an additional three misfitting items resulted in 11-item unidimensional questionnaire (AS-11). Two items failed to satisfy the model expectations in the 'psychosocial' subscale and were deleted - resulting in an 8-item unidimensional scale with adequate PSR (0.81) and targeting (0.23 logits). One item misfit in the 'function' subscale and was deleted-resulting in a 9 item Rasch-revised unidimensional subscale with acceptable PSR (0.80) and targeting (0.97 logits). None of the items displayed notable DIF by age, gender and level of education. Conclusions The AS-11 and its two Rasch-revised subscales - 8-item psychosocial and 9-item function subscale may be more appropriate than the original AS-20 and its two 10-item subscales for use as unidimensional measures of HRQoL in adults with strabismus in India. Further work is required to establish the validity of the revised rating scale.	[Gothwal, Vijaya K.; Bharani, Seelam] LV Prasad Eye Inst, Meera & LB Deshpande Ctr Sight Enhancement, Hyderabad, Andhra Pradesh, India; [Kekunnaya, Ramesh; Chhablani, PreetiPatil] LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, Andhra Pradesh, India; [Sachdeva, Virender; Gunturu, Rekha] LV Prasad Eye Inst, Nimmagadda Prasad Childrens Eye Care Ctr, Vishakapatnam, India; [Pehere, Niranjan K.; Narasaiah, Asa] David Brown Childrens Eye Care Ctr, Vijayawada, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Gothwal, VK (corresponding author), LV Prasad Eye Inst, Meera & LB Deshpande Ctr Sight Enhancement, KallamAnji Reddy Campus, Hyderabad, Andhra Pradesh, India.	vijayagothwal@gmail.com	Gothwal, Vijaya/AAY-4526-2020		Hyderabad Eye Research Foundation, Hyderabad, India	Hyderabad Eye Research Foundation, Hyderabad, India	This study was supported by the Hyderabad Eye Research Foundation, Hyderabad, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Alam D, 2014, INDIAN J OPHTHALMOL, V62, P799, DOI 10.4103/0301-4738.138620; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Beauchamp CL, 2006, J AAPOS, V10, P394, DOI 10.1016/j.jaapos.2006.06.004; Bez Y, 2009, J AAPOS, V13, P249, DOI 10.1016/j.jaapos.2009.02.010; Bond TG, 2013, APPL RASCH MODEL FUN, DOI [10.1186/1471-2377-13-78, DOI 10.1186/1471-2377-13-78]; Burke JH, 1997, AM J CARDIOL, V79, P178, DOI 10.1016/S0002-9149(96)00707-2; Burke JP, 1997, J PEDIAT OPHTH STRAB, V34, P159; Carlton J, 2011, BRIT J OPHTHALMOL, V95, P325, DOI 10.1136/bjo.2009.178889; CHAO RK, 1995, ETHOS, V23, P328, DOI 10.1525/eth.1995.23.3.02a00030; CHEN C, 1995, PSYCHOL SCI, V6, P170, DOI 10.1111/j.1467-9280.1995.tb00327.x; Coats DK, 2005, ARCH OPHTHALMOL-CHIC, V123, P497, DOI 10.1001/archopht.123.4.497; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Gothwal VK, 2009, BRIT J OPHTHALMOL, V93, P1652, DOI 10.1136/bjo.2009.159806; Gothwal VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101295; Gothwal VK, 2012, INVEST OPHTH VIS SCI, V53, P6081, DOI 10.1167/iovs.12-9885; Gothwal VK, 2010, INVEST OPHTH VIS SCI, V51, P694, DOI 10.1167/iovs.09-3448; Gothwal VK, 2009, CLIN EXP OPHTHALMOL, V37, P785, DOI 10.1111/j.1442-9071.2009.02133.x; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P1160, DOI 10.1097/OPX.0b013e3181bab10c; Gothwal VK, 2009, J CATARACT REFR SURG, V35, P1509, DOI 10.1016/j.jcrs.2009.03.056; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P836, DOI 10.1097/OPX.0b013e3181ae1ec7; Gunton KB, 2014, CURR OPIN OPHTHALMOL, V25, P406, DOI 10.1097/ICU.0000000000000087; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hatt SR, 2007, AM J OPHTHALMOL, V144, P643, DOI 10.1016/j.ajo.2007.06.032; Hatt SR, 2012, OPHTHALMOLOGY, V119, P1930, DOI 10.1016/j.ophtha.2012.02.035; Hatt SR, 2012, AM J OPHTHALMOL, V153, P614, DOI 10.1016/j.ajo.2011.10.001; Hatt SR, 2010, OPHTHALMOLOGY, V117, P2322, DOI 10.1016/j.ophtha.2010.03.042; Hatt SR, 2009, AM J OPHTHALMOL, V148, P558, DOI 10.1016/j.ajo.2009.05.009; Hatt SR, 2009, OPHTHALMOLOGY, V116, P139, DOI 10.1016/j.ophtha.2008.08.043; Jackson S, 2006, BRIT J OPHTHALMOL, V90, P883, DOI 10.1136/bjo.2005.089516; Kim H, 1999, J PERS SOC PSYCHOL, V77, P785, DOI 10.1037/0022-3514.77.4.785; Lambert S, 2011, PSYCHO-ONCOLOGY, V20, P919, DOI 10.1002/pon.1803; Leske DA, 2012, INVEST OPHTH VIS SCI, V53, P2630, DOI 10.1167/iovs.11-8308; Linacre J. M., 2009, USERS GUIDE WINSTEPS; Linacre JM, 2008, WINSTEPS RASCH MEASU; LONG VO, 1991, J PSYCHOL, V125, P263, DOI 10.1080/00223980.1991.10543290; Mallinson T, 2004, MED CARE, V42, P17, DOI 10.1097/01.mlr.0000103522.78233.c3; Mallinson T, 2007, OPTOMETRY VISION SCI, V84, P675, DOI 10.1097/OPX.0b013e3181339f44; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Massof RW, 2002, OPTOMETRY VISION SCI, V79, P516, DOI 10.1097/00006324-200208000-00015; McKenzie JA, 2009, ARCH OPHTHALMOL-CHIC, V127, P743, DOI 10.1001/archophthalmol.2009.68; Menon V, 2002, J PEDIAT OPHTH STRAB, V39, P203, DOI 10.3928/0191-3913-20020701-07; Middleton KL, 2000, PSYCHOL MARKET, V17, P149, DOI 10.1002/(SICI)1520-6793(200002)17:2<149::AID-MAR6>3.0.CO;2-L; Mohney BG, 2008, PEDIATRICS, V122, P1033, DOI 10.1542/peds.2007-3484; Nelson BA, 2008, J AAPOS, V12, P72, DOI 10.1016/j.jaapos.2007.08.006; Pallant JF, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-28; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Pesudovs K, 2003, INVEST OPHTH VIS SCI, V44, P2892, DOI 10.1167/iovs.02-1075; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pickard AS, 2006, VALUE HEALTH, V9, P59, DOI 10.1111/j.1524-4733.2006.00082.x; Rasch G., 1960, PROBABILISTIC MODELS; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; SCHUMACHER M, 1991, STAT MED, V10, P1915, DOI 10.1002/sim.4780101207; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Tennant A, 2004, VALUE HEALTH, V7, pS22, DOI 10.1111/j.1524-4733.2004.7s106.x; Twenge JM, 2002, PSYCHOL BULL, V128, P371, DOI 10.1037//0033-2909.128.3.371; van de Graaf E S, 2004, Strabismus, V12, P181; Velozo C A, 2000, J Outcome Meas, V4, P667; Vianya-Estopa M, 2010, INVEST OPHTH VIS SCI, V51, P2496, DOI 10.1167/iovs.09-4381; Wang ZW, 2014, APPL GEOPHYS, V11, P139, DOI 10.1007/s11770-014-0440-6; Wang ZH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-180; WRIGHT B, 1975, 19 MESA U CHIC DEP E; Wright B. D., 1976, 21 MESA U CHIC DEP E; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; Yu HY, 2013, OPHTHAL EPIDEMIOL, V20, P239, DOI 10.3109/09286586.2013.809771	65	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127064	10.1371/journal.pone.0127064	http://dx.doi.org/10.1371/journal.pone.0127064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011430	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900058
J	Hong, JW; Ku, CR; Noh, JH; Ko, KS; Rhee, BD; Kim, DJ				Hong, Jae Won; Ku, Cheol Ryong; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Association between Self-Reported Smoking and Hemoglobin A1c in a Korean Population without Diabetes: The 2011-2012 Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							MODERATE ALCOHOL INTAKE; CIGARETTE-SMOKING; INSULIN SENSITIVITY; GLYCOSYLATED HEMOGLOBIN; GLYCATED HEMOGLOBIN; CONSUMPTION; GLUCOSE; NICOTINE; HBA(1C); A(1C)	Background Several Western studies have revealed that among non-diabetics, glycosylated hemoglobin A1c (HbA1c) levels are higher in smokers than non-smokers. While studies conducted in Western populations consistently support this association, a recent meta-analysis reported that studies carried out in non-Western populations, including studies of Chinese, Egyptian, and Japanese-Americans, did not detect any significant differences in HbA1c levels between smokers and non-smokers. Objectives We assessed the association between smoking habits and HbA1c levels in the general Korean adult population using data from the Korean National Health and Nutrition Examination Survey (KNHANES) performed in 2011-2012. Methods A total of 10,241 participants (weighted n=33,946,561 including 16,769,320 men and 17,177,241 women) without diabetes were divided into four categories according to their smoking habits: never smokers (unweighted n/weighted n=6,349/19,105,564), ex-smokers (unweighted n/weighted n=1,912/6,207,144), current light smokers (< 15 cigarettes per day, unweighted n/weighted n=1,205/5,130,073), and current heavy smokers (>= 15 cigarettes per day, unweighted n/weighted n=775/3,503,781). Results In age- and gender-adjusted comparisons, the HbA1c levels of each group were 5.52 +/- 0.01% in non-smokers, 5.49 +/- 0.01% in ex-smokers, 5.53 +/- 0.01% in light smokers, and 5.61 +/- 0.02% in heavy smokers. HbA1c levels were significantly higher in light smokers than in ex-smokers (p = 0.033), and in heavy smokers compared with light smokers (p < 0.001). The significant differences remained after adjusting for age, gender, fasting plasma glucose, heavy alcohol drinking, hematocrit, college graduation, and waist circumference. Linear regression analyses for HbA1c using the above-mentioned variables as covariates revealed that a significant association between current smoking and HbA1c (coefficient 0.021, 95% CI 0.003-0.039, p = 0.019). Conclusions Current smoking was independently associated with higher HbA1c levels in a cigarette exposure-dependent manner in a representative population of Korean non-diabetic adults. In this study, we have observed an association between smoking status and HbA1c levels in non-diabetics drawn from a non-Western population, consistent with previous findings in Western populations.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea; [Ku, Cheol Ryong] Yonsei Univ, Coll Med, Endocrinol, Seoul 120749, South Korea; [Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Coll Med, Dept Internal Med, Sanggye Paik Hosp,Cardiovasc & Metab Dis Ctr, Koyang, Gyeonggi Do, South Korea	Inje University; Yonsei University; Yonsei University Health System; Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/ABD-9067-2021; Noh, Junghyun/AAU-8113-2020	Noh, Junghyun/0000-0002-7964-0515; Ku, Cheol Ryong/0000-0001-8693-9630				ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Axelsson T, 2001, J INTERN MED, V249, P539, DOI 10.1046/j.1365-2796.2001.00840.x; Bajaj M, 2012, DIABETES, V61, P3078, DOI 10.2337/db12-1100; Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Boeing H, 2000, AM J CLIN NUTR, V71, P1115; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Chiolero A, 2007, OBESITY, V15, P1311, DOI 10.1038/oby.2007.153; Cho NH, 2009, CLIN ENDOCRINOL, V71, P679, DOI 10.1111/j.1365-2265.2009.03586.x; Clair C, 2011, DIABETES CARE, V34, P2250, DOI 10.2337/dc11-0710; DAVIE SJ, 1992, DIABETES, V41, P167, DOI 10.2337/diabetes.41.2.167; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878; Eliasson B, 2003, PROG CARDIOVASC DIS, V45, P405, DOI 10.1053/pcad.2003.00103; FACCHINI F, 1994, DIABETES CARE, V17, P115, DOI 10.2337/diacare.17.2.115; Foy CG, 2005, DIABETES CARE, V28, P2501, DOI 10.2337/diacare.28.10.2501; Harding AH, 2002, EUR J CLIN NUTR, V56, P882, DOI 10.1038/sj.ejcn.1601408; HASHIMOTO Y, 1995, DIABETES CARE, V18, P1337, DOI 10.2337/diacare.18.10.1337; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Higgins Trefor, 2009, J Diabetes Sci Technol, V3, P644; Jansen H, 2013, J INTERN MED, V273, P283, DOI 10.1111/joim.12010; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Korea Centers for Disease Control and Prevention, 2013, KOR NAT HLTH NUTR EX; Kroenke CH, 2003, DIABETES CARE, V26, P1971, DOI 10.2337/diacare.26.7.1971; Krone CA, 2004, MED HYPOTHESES, V62, P275, DOI 10.1016/S0306-9877(03)00313-X; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nielsen TL, 2006, INT J OBESITY, V30, P805, DOI 10.1038/sj.ijo.0803197; NILSSON PM, 1995, METABOLISM, V44, P557, DOI 10.1016/0026-0495(95)90110-8; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Sargeant LA, 2001, INT J EPIDEMIOL, V30, P547, DOI 10.1093/ije/30.3.547; Soulimane S, 2014, DIABETOLOGIA, V57, P30, DOI 10.1007/s00125-013-3058-y; URBERG M, 1989, J FAM PRACTICE, V28, P529; Vlassopoulos A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1013; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wolffenbuttel BHR, 2013, DIABETES CARE, V36, P2931, DOI 10.2337/dc12-2711; Xie XT, 2009, ACTA PHARMACOL SIN, V30, P784, DOI 10.1038/aps.2009.49; Yang YC, 1997, DIABETES CARE, V20, P988, DOI 10.2337/diacare.20.6.988; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	43	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126746	10.1371/journal.pone.0126746	http://dx.doi.org/10.1371/journal.pone.0126746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011526	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900040
J	Osathanunkul, M; Madesis, P; de Boer, H				Osathanunkul, Maslin; Madesis, Panagiotis; de Boer, Hugo			Bar-HRM for Authentication of Plant-Based Medicines: Evaluation of Three Medicinal Products Derived from Acanthaceae Species	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; DNA BARCODES; FORENSIC USES; SUBSTITUTION; GENUS	Medicinal plants are used as a popular alternative to synthetic drugs, both in developed and developing countries. The economic importance of the herbal and natural supplement industry is increasing every year. As the herbal industry grows, consumer safety is one issue that cannot be overlooked. Herbal products in Thai local markets are commonly sold without packaging or labels. Plant powders are stored in large bags or boxes, and therefore buying local herbal products poses a high risk of acquiring counterfeited, substituted and/or adulterated products. Due to these issues, a reliable method to authenticate products is needed. Here DNA barcoding was used in combination with High Resolution Melting analysis (Bar-HRM) to authenticate three medicinal Acanthaceae species (Acanthus ebracteatus, Andrographis paniculata and Rhinacanthus nasutus) commonly used in Thailand. The rbcL barcode was selected for use in primers design for HRM analysis to produce standard melting profiles of the selected species. Melting data from the HRM assay using the designed rbcL primers showed that the three chosen species could be distinguished from each other. HRM curves of all fifteen test samples indicated that three of tested products did not contain the indicated species. Two closely related species (A. paniculata and R. nasutus), which have a high level of morphological similarity, were interchanged with one another in three tested products. Incorrect information on packaging and labels of the tested herbal products was the cause of the results shown here. Morphological similarity among the species of interest also hindered the collection process. The Bar-HRM method developed here proved useful in aiding in the identification and authentication of herbal species in processed samples. In the future, species authentication through Bar-HRM could be used to promote consumer trust, as well as raising the quality of herbal products.	[Osathanunkul, Maslin] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Madesis, Panagiotis] Ctr Res & Technol Hellas CERTH, Inst Appl Biosci, Thessaloniki, Greece; [de Boer, Hugo] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Uppsala, Sweden; [de Boer, Hugo] Naturalis Biodivers Ctr, Leiden, Netherlands; [de Boer, Hugo] Univ Oslo, Nat Hist Museum, Oslo, Norway	Chiang Mai University; Centre for Research & Technology Hellas; Naturalis Biodiversity Center; University of Oslo	Osathanunkul, M (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand.	omaslin@gmail.com	de Boer, Hugo Joris/AAS-7585-2020; Madesis, Panagiotis/AAL-5980-2020	de Boer, Hugo Joris/0000-0003-1985-7859; Madesis, Panagiotis/0000-0003-1447-3514	Thailand Research Fund [TRG5780027]	Thailand Research Fund(Thailand Research Fund (TRF))	This work was financially supported by the new researcher grant from the Thailand Research Fund (grant number TRG5780027). URL: http://academic.trf.or.th/index.php/fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Baker DA, 2012, J AOAC INT, V95, P1023, DOI 10.5740/jaoacint.11-261; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Bosmali I, 2012, FOOD RES INT, V46, P141, DOI 10.1016/j.foodres.2011.12.013; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Calixto JB, 2000, BRAZ J MED BIOL RES, V33, P179, DOI 10.1590/S0100-879X2000000200004; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Crawford AJ, 2012, MOL ECOL RESOUR; de Boer HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084291; DeSmet PAGM, 1997, DRUGS, V54, P801, DOI 10.2165/00003495-199754060-00003; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Ganopoulos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060945; Ganopoulos I, 2013, J SCI FOOD AGR, V93, P2281, DOI 10.1002/jsfa.6040; Ganopoulos I, 2012, PLANT MOL BIOL REP, V30, P1322, DOI 10.1007/s11105-012-0453-3; Ganopoulos I, 2012, FOOD CHEM, V133, P505, DOI 10.1016/j.foodchem.2012.01.015; GIA, 2013, HERB SUPPL REM GLOB; Gurib-Fakim A., 2006, MOL ASPECTS MED, V27, P1, DOI [10.1016/j.mam.2005.07.008, DOI 10.1016/J.MAM.2005.07.008]; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Ize-Ludlow D, 2004, PEDIATRICS, V114, pE653, DOI 10.1542/peds.2004-0058; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Madesis P, 2014, FOOD RES INT, V60, P163, DOI 10.1016/j.foodres.2013.10.042; Madesis P, 2013, FOOD RES INT, V50, P351, DOI 10.1016/j.foodres.2012.10.038; Madesis P, 2012, FOOD CONTROL, V25, P576, DOI 10.1016/j.foodcont.2011.11.034; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Ouarghidi A, 2012, ECON BOT, V66, P370, DOI 10.1007/s12231-012-9215-2; Rates SMK, 2001, TOXICON, V39, P603, DOI 10.1016/S0041-0101(00)00154-9; Silva-Brandao KL, 2009, NEOTROP ENTOMOL, V38, P441, DOI 10.1590/S1519-566X2009000400001; Skalli S, 2002, B SOC PATHOL EXOT, V95, P284; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Veldman S, 2014, NOVEL PLANT BIORESOURCES: APPLICATIONS IN FOOD, MEDICINE AND COSMETICS, P81; Wallace LJ, 2012, FOOD RES INT, V49, P446, DOI 10.1016/j.foodres.2012.07.048; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; World Health Organization, 2003, TRADITIONAL MED	44	47	51	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128476	10.1371/journal.pone.0128476	http://dx.doi.org/10.1371/journal.pone.0128476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011474	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900239
J	Saksono, B; Dewi, BE; Nainggolan, L; Suda, Y				Saksono, Budi; Dewi, Beti Ernawati; Nainggolan, Leonardo; Suda, Yasuo			A Highly Sensitive Diagnostic System for Detecting Dengue Viruses Using the Interaction between a Sulfated Sugar Chain and a Virion	PLOS ONE			English	Article							ENVELOPE PROTEIN; ANTIVIRAL ACTIVITY; SEROTYPE; INFANTS; CHIPS	We propose a novel method of detecting trace amounts of dengue virus (DENVs) from serum. Our method is based on the interaction between a sulfated sugar chain and a DENV surface glycoprotein. After capturing DENV with the sulfated sugar chain-immobilized gold nanoparticles (SGNPs), the resulting complex is precipitated and viral RNA content is measured using the reverse-transcription quantitative polymerase chain reaction SYBR Green I (RT-qPCR-Syb) method. Sugar chains that bind to DENVs were identified using the array-type sugar chain immobilized chip (Sugar Chip) and surface plasmon resonance (SPR) imaging. Heparin and low-molecular-weight dextran sulfate were identified as binding partners, and immobilized on gold nanoparticles to prepare 3 types of SGNPs. The capacity of these SGNPs to capture and concentrate trace amounts of DENVs was evaluated in vitro. The SGNP with greatest sensitivity was tested using clinical samples in Indonesia in 2013-2014. As a result, the novel method was able to detect low concentrations of DENVs using only 6 mu L of serum, with similar sensitivity to that of a Qiagen RNA extraction kit using 140 mu L of serum. In addition, this method allows for multiplex-like identification of serotypes of DENVs. This feature is important for good healthcare management of DENV infection in order to safely diagnose the dangerous, highly contagious disease quickly, with high sensitivity.	[Saksono, Budi; Suda, Yasuo] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Saksono, Budi] Biotechnol Res Ctr, Indonesian Inst Sci, Cibinong 16911, Indonesia; [Dewi, Beti Ernawati] Univ Indonesia, Fac Med, Dept Microbiol, Jakarta 10320, Indonesia; [Nainggolan, Leonardo] RSUPN Cipto Mangukusumo, Fac Med, Dept Internal Med, Jakarta, Indonesia	Kagoshima University; Indonesian Institute of Sciences; University of Indonesia	Saksono, B (corresponding author), Kagoshima Univ, Grad Sch Sci & Engn, 1-21-40 Kohrimoto, Kagoshima 8900065, Japan.	saksonobudi@yahoo.com; ysuda@eng.kagoshima-u.ac.jp		Saksono, Budi/0000-0001-8934-0914	Japan Science and Technology Agency [V07-05, AS2416907P]; Japan Ministry of Health, Labour and Welfare [H21-Nano-Ippan-002]; Japan Society for the Promotion of Science [SG2504]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Science and Technology Agency (V07-05 and AS2416907P to YS), the Japan Ministry of Health, Labour and Welfare (H21-Nano-Ippan-002 to YS), and the Japan Society for the Promotion of Science (SG2504 to YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; Chutinimitkul S, 2005, J VIROL METHODS, V129, P8, DOI 10.1016/j.jviromet.2005.05.006; Hernandez SID, 2013, J CLIN VIROL, V58, P258, DOI 10.1016/j.jcv.2013.06.016; Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hidari KIPJ, 2008, BIOCHEM BIOPH RES CO, V376, P91, DOI 10.1016/j.bbrc.2008.08.100; Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Hung SL, 1999, VIROLOGY, V257, P156, DOI 10.1006/viro.1999.9633; Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x; Kato D, 2010, ANTIVIR RES, V88, P236, DOI 10.1016/j.antiviral.2010.09.002; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nakamura-Tsuruta S, 2008, J BIOCHEM, V143, P833, DOI 10.1093/jb/mvn038; Pal T, 2014, J CLIN VIROL, V61, P365, DOI 10.1016/j.jcv.2014.09.003; Patramool S, 2013, J VIROL METHODS, V193, P55, DOI 10.1016/j.jviromet.2013.04.016; Prado I, 2005, J VIROL METHODS, V125, P75, DOI 10.1016/j.jviromet.2005.01.001; Qiu H, 2007, CARBOHYD RES, V342, P2230, DOI 10.1016/j.carres.2007.06.021; Soda Y, 2006, POLYM PREPRINTS, V47, P156; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Suda Y, 2006, BIOCONJUGATE CHEM, V17, P1125, DOI 10.1021/bc0600620; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; Thais MC, 2010, J VIROL METHODS, V163, P1, DOI [10.1016/j.jviromet.2009.10.001, DOI 10.1016/J.JVIROMET.2009.10.001]; Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309; VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004; Wakao M, 2008, BIOORG MED CHEM LETT, V18, P2499, DOI 10.1016/j.bmcl.2008.01.069; World Health Organization, 2009, DENGUE GUIDELINES DI; Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597	38	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0123981	10.1371/journal.pone.0123981	http://dx.doi.org/10.1371/journal.pone.0123981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010246	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900005
J	Sampath, S; Klimas, M; Feng, D; Baumgartner, R; Manigbas, E; Liang, AL; Evelhoch, JL; Chin, CL				Sampath, Smita; Klimas, Michael; Feng, Dai; Baumgartner, Richard; Manigbas, Elaine; Liang, Ai-Leng; Evelhoch, Jeffrey L.; Chin, Chih-Liang			Characterization of Regional Left Ventricular Function in Nonhuman Primates Using Magnetic Resonance Imaging Biomarkers: A Test-Retest Repeatability and Inter-Subject Variability Study	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITION; CONGESTIVE-HEART-FAILURE; TYPE-2 DIABETES-MELLITUS; MYOCARDIAL-INFARCTION; NONINVASIVE ASSESSMENT; DIASTOLIC DYSFUNCTION; SYSTOLIC FUNCTION; CARDIAC-FUNCTION; GENE-TRANSFER; STEM-CELLS	Pre-clinical animal models are important to study the fundamental biological and functional mechanisms involved in the longitudinal evolution of heart failure (HF). Particularly, large animal models, like nonhuman primates (NHPs), that possess greater physiological, biochemical, and phylogenetic similarity to humans are gaining interest. To assess the translatability of these models into human diseases, imaging biomarkers play a significant role in non-invasive phenotyping, prediction of downstream remodeling, and evaluation of novel experimental therapeutics. This paper sheds insight into NHP cardiac function through the quantification of magnetic resonance (MR) imaging biomarkers that comprehensively characterize the spatiotemporal dynamics of left ventricular (LV) systolic pumping and LV diastolic relaxation. MR tagging and phase contrast (PC) imaging were used to quantify NHP cardiac strain and flow. Temporal inter-relationships between rotational mechanics, myocardial strain and LV chamber flow are presented, and functional biomarkers are evaluated through test-retest repeatability and inter subject variability analyses. The temporal trends observed in strain and flow was similar to published data in humans. Our results indicate a dominant dimension based pumping during early systole, followed by a torsion dominant pumping action during late systole. Early diastole is characterized by close to 65% of untwist, the remainder of which likely contributes to efficient filling during atrial kick. Our data reveal that moderate to good intra-subject repeatability was observed for peak strain, strain-rates, E/circumferential strain-rate (CSR) ratio, E/longitudinal strain-rate (LSR) ratio, and deceleration time. The inter-subject variability was high for strain dyssynchrony, diastolic strain-rates, peak torsion and peak untwist rate. We have successfully characterized cardiac function in NHPs using MR imaging. Peak strain, average systolic strain-rate, diastolic E/CSR and E/LSR ratios, and deceleration time were identified as robust biomarkers that could potentially be applied to future pre-clinical drug studies.	[Sampath, Smita; Liang, Ai-Leng; Chin, Chih-Liang] Merck Sharp & Dohme Ltd, Merck Res Labs, Imaging, Singapore, Singapore; [Klimas, Michael; Evelhoch, Jeffrey L.] Merck & Co Inc, Merck Res Labs, Imaging, West Point, PA USA; [Feng, Dai; Baumgartner, Richard] Merck & Co Inc, Merck Res Labs, Biostat & Res Decis Sci, Biometr Res, Rahway, NJ 07065 USA; [Manigbas, Elaine] Maccine Pte Ltd, MRI Dept, Singapore, Singapore	Merck & Company; Merck & Company	Sampath, S (corresponding author), Merck Sharp & Dohme Ltd, Merck Res Labs, Imaging, Singapore, Singapore.	smita.sampath@merck.com	Evelhoch, Jeffrey/R-2619-2019		Merck Co.	Merck Co.(Merck & Company)	This research was funded by Merck & Co. The authors would like to declare that the following individuals are current or former employees of the funder: Smita Sampath, Michael Klimas, Dai Feng, Richard Baumgartner, Ai-Leng Liang, Jeffrey L. Evelhoch, Chih-Liang Chin. Their roles include study design, data collection and analysis, decision to publish and preparation of the manuscript.	Akkan D, 2008, EUR J HEART FAIL, V10, P689, DOI 10.1016/j.ejheart.2008.05.007; AXEL L, 1989, RADIOLOGY, V172, P349, DOI 10.1148/radiology.172.2.2748813; Brok HPM, 2001, IMMUNOL REV, V183, P173, DOI 10.1034/j.1600-065x.2001.1830114.x; Brotman D, 2013, MAGN RESON MED, V69, P1421, DOI 10.1002/mrm.24373; Capitanio JP, 2008, LANCET, V371, P1126, DOI 10.1016/S0140-6736(08)60489-4; Castillo E, 2005, J CARDIOVASC MAGN R, V7, P783, DOI 10.1080/10976640500295417; Cefalu WT, 2006, ILAR J, V47, P186, DOI 10.1093/ilar.47.3.186; Chetboul V, 2008, J VET INTERN MED, V22, P342, DOI 10.1111/j.1939-1676.2007.0037.x; Chu GX, 2002, J CARD FAIL, V8, pS432, DOI 10.1054/jcaf.2002.129284; De Marchi SF, 2000, HEART, V83, P678, DOI 10.1136/heart.83.6.678; Ding SY, 2007, METABOLISM, V56, P838, DOI 10.1016/j.metabol.2007.01.015; Edvardsen T, 2006, AM HEART J, V151, P109, DOI 10.1016/j.ahj.2005.02.018; Epstein FH, 2004, MAGN RESON MED, V52, P774, DOI 10.1002/mrm.20232; Eriksson J, 2011, AM J PHYSIOL-HEART C, V300, pH2135, DOI 10.1152/ajpheart.00993.2010; FEINBERG DA, 1985, MAGNET RESON MED, V2, P555, DOI 10.1002/mrm.1910020606; FIRMIN DN, 1987, J COMPUT ASSIST TOMO, V11, P751, DOI 10.1097/00004728-198709000-00001; FLETCHER PJ, 1981, CIRC RES, V49, P618, DOI 10.1161/01.RES.49.3.618; Ginis I, 2004, DEV BIOL, V269, P360, DOI 10.1016/j.ydbio.2003.12.034; Gorman JH, 1998, J THORAC CARDIOV SUR, V115, P615, DOI 10.1016/S0022-5223(98)70326-5; Gotte MJW, 2006, J AM COLL CARDIOL, V48, P2002, DOI 10.1016/j.jacc.2006.07.048; HAENDCHEN RV, 1983, CIRCULATION, V67, P1234, DOI 10.1161/01.CIR.67.6.1234; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hayashi N, 1997, ARZNEIMITTELFORSCH, V47, P625; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Janiczek RL, 2011, MAGN RESON MED, V66, P1382, DOI 10.1002/mrm.22937; Jugdutt BI, 2004, J CARD FAIL, V10, P74, DOI 10.1016/S1071-9164(03)00584-0; Jung B, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-87; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; King Gerard J, 2003, Cardiovasc Ultrasound, V1, P9, DOI 10.1186/1476-7120-1-9; Korosoglou G, 2012, J MAGN RESON IMAGING, V35, P804, DOI 10.1002/jmri.22879; Kraitchman DL, 1998, MAGN RESON MED, V40, P311, DOI 10.1002/mrm.1910400217; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Mewton N, 2008, INVEST RADIOL, V43, P219, DOI 10.1097/RLI.0b013e318161613e; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Moerman KM, 2011, MED PHYS, V38, P1248, DOI 10.1118/1.3533942; Moore C C, 2000, Top Magn Reson Imaging, V11, P359, DOI 10.1097/00002142-200012000-00005; Morita H, 2006, AM J PHYSIOL-HEART C, V290, pH2522, DOI 10.1152/ajpheart.00932.2005; Mukherjee R, 2003, CIRCULATION, V107, P618, DOI 10.1161/01.CIR.0000046449.36178.00; Narayanan A, 2009, CIRC-CARDIOVASC IMAG, V2, P382, DOI 10.1161/CIRCIMAGING.108.811620; Okura H, 2009, CIRC J, V73, P86, DOI 10.1253/circj.CJ-08-0457; Onishi T, 2010, CIRC-CARDIOVASC IMAG, V3, P134, DOI 10.1161/CIRCIMAGING.109.888354; Osman NF, 1999, MAGN RESON MED, V42, P1048, DOI 10.1002/(SICI)1522-2594(199912)42:6<1048::AID-MRM9>3.0.CO;2-M; Osman NF, 2004, IEEE T BIO-MED ENG, V51, P1428, DOI 10.1109/TBME.2004.827932; Osman NF, 2000, PHYS MED BIOL, V45, P1665, DOI 10.1088/0031-9155/45/6/318; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Parthasarathy V., 2006, CHARACTERIZATION HAR; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Pleger ST, 2007, CIRCULATION, V115, P2506, DOI 10.1161/CIRCULATIONAHA.106.671701; Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5; PRZYKLENK K, 1986, CARDIOVASC RES, V20, P403, DOI 10.1093/cvr/20.6.403; REIMER KA, 1979, LAB INVEST, V40, P633; Russel IK, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-26; Shen YT, 2000, CURR OPIN INVEST DR, V11, P1025; Sironi AM, 2008, HYPERTENSION, V51, P282, DOI 10.1161/HYPERTENSIONAHA.107.098640; SMITS JFM, 1992, J CARDIOVASC PHARM, V20, P772, DOI 10.1097/00005344-199211000-00013; Stuber M, 1999, MAGN RESON MATER PHY, V9, P85; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Wagner JD, 2001, TOXICOL PATHOL, V29, P142, DOI 10.1080/019262301301418955; WEBER KT, 1987, CIRCULATION, V75, P40; WEINBERG EO, 1994, CIRCULATION, V90, P1410, DOI 10.1161/01.CIR.90.3.1410; WHITE FC, 1986, LAB ANIM SCI, V36, P351; Yarbrough WM, 2003, CIRCULATION, V108, P1753, DOI 10.1161/01.CIR.0000091087.78630.79; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; ZERHOUNI EA, 1988, RADIOLOGY, V169, P59, DOI 10.1148/radiology.169.1.3420283; Zhang H, 2007, J THORAC CARDIOV SUR, V134, P1234, DOI 10.1016/j.jtcvs.2007.07.019; Zhong J, 2010, MAGN RESON MED, V64, P1315, DOI 10.1002/mrm.22530	67	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127947	10.1371/journal.pone.0127947	http://dx.doi.org/10.1371/journal.pone.0127947			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010607	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900169
J	Todorovic, M; Newman, JRB; Shan, JG; Bentley, S; Wood, SA; Silburn, PA; Mellick, GD				Todorovic, Michael; Newman, Jeremy R. B.; Shan, Jianguo; Bentley, Steven; Wood, Stephen A.; Silburn, Peter A.; Mellick, George D.			Comprehensive Assessment of Genetic Sequence Variants in the Antioxidant 'Master Regulator' Nrf2 in Idiopathic Parkinson's Disease	PLOS ONE			English	Article							OXIDATIVE STRESS; ASSOCIATION; RISK; NEUROTOXICITY; POLYMORPHISMS; TRANSCRIPTION; ACTIVATION; EXPRESSION; ALZHEIMERS; INCREASE	Parkinson's disease (PD) is a complex neurodegenerative disorder influenced by a combination of genetic and environmental factors. The molecular mechanisms that underlie PD are unknown; however, oxidative stress and impairment of antioxidant defence mechanisms have been implicated as major contributors to disease pathogenesis. Previously, we have reported a PD patient-derived cellular model generated from biopsies of the olfactory mucosa, termed hONS cells, in which the NRF2-mediated antioxidant response pathway genes were among the most differentially-expressed. To date, few studies have examined the role of the NRF2 encoding gene, NFE2L2, and PD. In this study, we comprehensibly assessed whether rare and common NFE2L2 genetic variations modify susceptibility to PD using a large Australian case-control sample (PD = 1338, controls = 1379). We employed a haplotype-tagging approach that identified an association with the tagging SNP rs2364725 and PD (OR = 0.849 (0.760-0.948), P = 0.004). Further genetic screening in hONS cell lines produced no obvious pathogenic variants in the coding regions of NFE2L2. Finally, we investigated the relationship between xenobiotic exposures and NRF2 function, through gene-environment interactions, between NFE2L2 SNPs and smoking or pesticide exposure. Our results demonstrated a significant interaction between rs2706110 and pesticide exposure (OR = 0.597 (0.393-0.900), P = 0.014). In addition, we were able to identify some age-at-onset modifying SNPs and replicate an 'early-onset' haplotype that contains a previously identified 'functional promoter' SNP (rs6721961). Our results suggest a role of NFE2L2 genetic variants in modifying PD susceptibility and onset. Our findings also support the utility of testing gene-environment interactions in genetic studies of PD.	[Todorovic, Michael; Newman, Jeremy R. B.; Shan, Jianguo; Bentley, Steven; Wood, Stephen A.; Mellick, George D.] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia; [Silburn, Peter A.; Mellick, George D.] Univ Queensland, UQCCR, Asia Pacific Ctr Neuromodulat, Herston, Qld, Australia	Griffith University; University of Queensland	Mellick, GD (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia.	G.Mellick@griffith.edu.au	Mellick, George D./A-7650-2010; Wood, Stephen A/E-8357-2011; Newman, Jeremy/L-9938-2013	Mellick, George D./0000-0002-7211-4651; Wood, Stephen A/0000-0002-2576-7457; Todorovic, Michael/0000-0003-0806-5610; Bentley, Steven/0000-0002-1888-8488; Newman, Jeremy/0000-0001-8486-2801	National Health and Medical Council of Australia [APP1010225]; Parkinson's Queensland PhD Project Grant; Geriatric Medical Foundation of Queensland	National Health and Medical Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Parkinson's Queensland PhD Project Grant; Geriatric Medical Foundation of Queensland	Support for this study came from the National Health and Medical Council of Australia (Project Grant APP1010225), Parkinson's Queensland PhD Project Grant (No Grant Number), and Geriatric Medical Foundation of Queensland (no Grant Number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1326; Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; Chen YC, 2013, PARKINSONISM RELAT D, V19, P247, DOI 10.1016/j.parkreldis.2012.10.018; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Cook AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021907; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Gartner CE, 2005, PARKINSONISM RELAT D, V11, P287, DOI 10.1016/j.parkreldis.2005.04.002; Hampel R, 2010, ENVIRON HEALTH PERSP, V118, P1755, DOI 10.1289/ehp.1001995; Innamorato NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011838; Kaidery NA, 2013, ANTIOXID REDOX SIGN, V18, P139, DOI 10.1089/ars.2011.4491; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lou HY, 2014, NEUROPHARMACOLOGY, V79, P380, DOI 10.1016/j.neuropharm.2013.11.026; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mellick GD, 2006, J NEURAL TRANSM-SUPP, P159; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Payami H, 2010, GENET EPIDEMIOL, V34, P92, DOI 10.1002/gepi.20439; Settivari R, 2013, NEUROTOXICOLOGY, V38, P51, DOI 10.1016/j.neuro.2013.05.014; Song Juhyun, 2014, Exp Neurobiol, V23, P93, DOI 10.5607/en.2014.23.1.93; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Sutherland GT, 2009, MOVEMENT DISORD, V24, P833, DOI 10.1002/mds.22214; Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2; von Otter M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-36; Xiao HB, 2011, TOXICOLOGY, V290, P286, DOI 10.1016/j.tox.2011.10.007	25	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128030	10.1371/journal.pone.0128030	http://dx.doi.org/10.1371/journal.pone.0128030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010367	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900186
J	Tuesta, EF; Delgado, KV; Mugnaini, R; Digiampietri, LA; Mena-Chalco, JP; Perez-Alcazar, JJ				Tuesta, Esteban F.; Delgado, Karina V.; Mugnaini, Rogerio; Digiampietri, Luciano A.; Mena-Chalco, Jesus P.; Perez-Alcazar, Jose J.			Analysis of an Advisor-Advisee Relationship: An Exploratory Study of the Area of Exact and Earth Sciences in Brazil	PLOS ONE			English	Article							RESEARCH SUPERVISION; PHD STUDENTS; PUBLICATION; THESES; COLLABORATION; INFORMATION	Scientific collaboration has been studied by researchers for decades. Several approaches have been adopted to address the question of how collaboration has evolved in terms of publication output, numbers of coauthors, and multidisciplinary trends. One particular type of collaboration that has received very little attention concerns advisor and advisee relationships. In this paper, we examine this relationship for the researchers who are involved in the area of Exact and Earth Sciences in Brazil and its eight subareas. These pairs are registered in the Lattes Platform that manages the individual curricula vitae of Brazilian researchers. The individual features of these academic researchers and their coauthoring relationships were investigated. We have found evidence that there exists positive correlation between time of advisor-advisee relationship with the advisee's productivity. Additionally, there has been a gradual decline in advisor-advisee coauthoring over a number of years as measured by the Kulczynski index, which could be interpreted as decline of the dependence.	[Tuesta, Esteban F.; Delgado, Karina V.; Digiampietri, Luciano A.; Perez-Alcazar, Jose J.] Univ Sao Paulo, Sch Arts Sci & Humanities EACH, Informat Syst Program, Sao Paulo, Brazil; [Mugnaini, Rogerio] Univ Sao Paulo, Sch Commun & Arts ECA, Sao Paulo, Brazil; [Mena-Chalco, Jesus P.] Fed Univ ABC, CMCC, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Delgado, KV (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities EACH, Informat Syst Program, Sao Paulo, Brazil.	kvd@usp.br	Mugnaini, Rogério/G-3844-2011; Digiampietri, Luciano Antonio/B-8597-2012; DELGADO, KARINA V/N-4940-2018; Tuesta, Esteban F Fernandez/K-6028-2016; Mena-Chalco, Jesus P./C-7550-2014	Mugnaini, Rogério/0000-0001-9334-3448; Digiampietri, Luciano Antonio/0000-0003-4890-1548; DELGADO, KARINA V/0000-0003-3835-3859; Tuesta, Esteban F Fernandez/0000-0002-0087-3405; Mena-Chalco, Jesus P./0000-0001-7509-5532	Coordination for the Improvement of Higher Education Personnel (CAPES) [N.BEX 8354/13-8]; Brazilian National Council for Scientific and Technological Development (CNPq) [306046/2013-0, 477246/2013-3]	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research project was partially funded by Coordination for the Improvement of Higher Education Personnel (CAPES, http://www.capes.gov.br/) grant N.BEX 8354/13-8 and the Brazilian National Council for Scientific and Technological Development (CNPq, www.cnpq.br) grants 306046/2013-0 and 477246/2013-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar MA, 2004, J LIBR INF SCI, V36, P151, DOI 10.1177/0961000604050565; Arriola-Quiroz I, 2010, HEALTH INFO LIBR J, V27, P148, DOI 10.1111/j.1471-1842.2010.00878.x; Bin A, 2014, SCIENTOMETRICS, P1; Coutinho RX, 2012, SCIENTOMETRICS, V92, P697, DOI 10.1007/s11192-012-0645-5; de Meis L, 2007, IUBMB LIFE, V59, P227, DOI 10.1080/15216540701258140; Vanz SAD, 2010, PERSPECT CIENC INF, V15, P42, DOI 10.1590/S1413-99362010000200004; Digiampietri LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094541; Digiampietri LA, 2014, EM QUESTAO, V20, P88; Fonseca L, 1998, SCIENTOMETRICS, V41, P299, DOI 10.1007/BF02459047; Franceschet M., 2010, COMMUNICATIONS ACM, V53, P129; Frkovic V, 2003, CROAT MED J, V44, P107; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Golde CM, 2000, REV HIGH EDUC, V23, P199; Halpern JY, 2011, COMMUN ACM, V54, P36, DOI 10.1145/1978542.1978555; Huang XY, 2010, PROCEEDINGS OF INTERNATIONAL FORUM OF KNOWLEDGE AS A SERVICE, P203; Kam BH, 1997, HIGH EDUC, V34, P81; Kamler B, 2008, STUD HIGH EDUC, V33, P283, DOI 10.1080/03075070802049236; Lariviere V, 2012, SCIENTOMETRICS, V90, P463, DOI 10.1007/s11192-011-0495-6; Lee WM, 2000, J AM SOC INFORM SCI, V51, P139, DOI 10.1002/(SICI)1097-4571(2000)51:2<139::AID-ASI5>3.0.CO;2-1; Leta J, 2005, ASLIB PROC, V57, P217, DOI 10.1108/00012530510599181; Mainhard T, 2009, HIGH EDUC, V58, P359, DOI 10.1007/s10734-009-9199-8; Mallette LA, 2006, THESIS PEPPERDINE U; Marsh HW, 2002, J HIGH EDUC-UK, V73, P313, DOI 10.1353/jhe.2002.0028; McAlpine L., 2006, HIGHER ED RES DEV, V25, P3, DOI [10.1080/07294360500453012, DOI 10.1080/07294360500453012]; Mena-Chalco Jesus P., 2011, Proceedings of the 2011 IEEE Seventh International Conference on e-Science Workshops (eScienceW 2011), P53, DOI 10.1109/eScienceW.2011.31; Mena-Chalco JP, 2014, J ASSOC INF SCI TECH, V65, P1424, DOI 10.1002/asi.23010; Myers JL, 2003, RES DESIGN STAT ANAL; Netting FE, 1997, J SOC WORK EDUC, V33, P555, DOI 10.1080/10437797.1997.10778893; Pinheiro D, 2014, TECHNOL FORECAST SOC, V81, P56, DOI 10.1016/j.techfore.2012.09.008; RAMOS, 2009, BRAZILIAN J BIOMOTRI, V3, P315; Sacardo MS, 2011, RBPG REV BRASILEIRA, V8, P111; Salmi LR, 2001, MED EDUC, V35, P18, DOI 10.1046/j.1365-2923.2001.00768.x; SAYERS MK, 1991, J INFORM SCI, V17, P307, DOI 10.1177/016555159101700507; Struppa DC, 2012, NOT AM MATH SOC, V59, P670; Vardi M, 2009, COMMUNICATIONS ACM, V52; Wang C., 2012, P 12 SIAM INT C DAT, P516; Wu TY, 2007, LECT NOTES ARTIF INT, V4702, P621; Wu TY, 2010, DATA MIN KNOWL DISC, V21, P371, DOI 10.1007/s10618-009-0161-2; Igami MPZ, 2014, J SCIENTOMETR RES, V3, P3, DOI 10.4103/2320-0057.143660	39	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0129065	10.1371/journal.pone.0129065	http://dx.doi.org/10.1371/journal.pone.0129065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010822	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900251
J	Tynyakov, J; Bentov, S; Abehsera, S; Khalaila, I; Manor, R; Abilevich, LK; Weil, S; Aflalo, ED; Sagi, A				Tynyakov, Jenny; Bentov, Shmuel; Abehsera, Shai; Khalaila, Isam; Manor, Rivka; Abilevich, Lihie Katzir; Weil, Simy; Aflalo, Eliahu D.; Sagi, Amir			A Novel Chitin Binding Crayfish Molar Tooth Protein with Elasticity Properties	PLOS ONE			English	Article							TRANSCRIPT EXPRESSION PATTERNS; CHERAX-QUADRICARINATUS; CUTICULAR PROTEINS; MATRIX PROTEINS; OVO GENE; EXTRACELLULAR-MATRIX; PROCAMBARUS-CLARKII; ANDROGENIC GLAND; BIOLOGICAL ROLES; CROSS-LINKING	The molar tooth of the crayfish Cherax quadricarinatus is part of the mandible, and is covered by a layer of apatite (calcium phosphate). This tooth sheds and is regenerated during each molting cycle together with the rest of the exoskeleton. We discovered that molar calcification occurs at the pre-molt stage, unlike calcification of the rest of the new exoskeleton. We further identified a novel molar protein from C. quadricarinatus and cloned its transcript from the molar-forming epithelium. We termed this protein Cq-M13. The temporal level of transcription of Cq-M13 in an NGS library of molar-forming epithelium at different molt stages coincides with the assembly and mineralization pattern of the molar tooth. The predicted protein was found to be related to the pro-resilin family of cuticular proteins. Functionally, in vivo silencing of the transcript caused molt cycle delay and a recombinant version of the protein was found to bind chitin and exhibited elastic properties.	[Tynyakov, Jenny; Bentov, Shmuel; Abehsera, Shai; Manor, Rivka; Abilevich, Lihie Katzir; Weil, Simy; Aflalo, Eliahu D.; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Tynyakov, Jenny; Bentov, Shmuel; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Khalaila, Isam] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Sagi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	khalaila, Isam/F-1498-2012	khalaila, Isam/0000-0003-3250-5778; Sagi, Amir/0000-0002-4229-1059; Aflalo, Eli/0000-0003-1385-2387	Israel Science Foundation (ISF) [613/13]; National Institute for Biotechnology in the Negev (NIBN)	Israel Science Foundation (ISF)(Israel Science Foundation); National Institute for Biotechnology in the Negev (NIBN)	This study was supported in part by grants from the Israel Science Foundation (ISF, Grant 613/13) and the National Institute for Biotechnology in the Negev (NIBN).	Addadi L, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/9/098003; Alexander R. McNeill, 2003, P1, DOI 10.1017/CBO9780511546327.003; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen SO, 2000, INSECT BIOCHEM MOLEC, V30, P569, DOI 10.1016/S0965-1748(00)00029-1; ANDERSEN SVEND OLAV, 1964, ADVANCES INSECT PHYSIOL, V2, P1, DOI 10.1016/S0065-2806(08)60071-5; Andersen Svend Olav, 2003, P259, DOI 10.1017/CBO9780511546327.015; Andersen SO, 2011, INSECT BIOCHEM MOLEC, V41, P620, DOI 10.1016/j.ibmb.2011.03.015; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P541, DOI 10.1016/j.ibmb.2010.05.002; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beniash E, 2011, WIRES NANOMED NANOBI, V3, P47, DOI 10.1002/wnan.105; Bentov S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1839; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornman RS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008345; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; DENNY M, 1976, J EXP BIOL, V65, P483; Deshpande AS, 2010, J BIOL CHEM, V285, P19277, DOI 10.1074/jbc.M109.079939; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; Fujisawa R, 2012, FRONT BIOSCI-LANDMRK, V17, P1891, DOI 10.2741/4026; Futahashi R, 2008, DEV GENES EVOL, V218, P491, DOI 10.1007/s00427-008-0243-y; GARFINKEL MD, 1994, MOL CELL BIOL, V14, P6809, DOI 10.1128/MCB.14.10.6809; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gilman JJ, 1973, SCI HARDNESS TESTING, P51; Glazer L, 2013, J EXP BIOL, V216, P1898, DOI 10.1242/jeb.080945; Glazer L, 2012, INVERTEBR REPROD DEV, V56, P57, DOI 10.1080/07924259.2011.588010; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; Iconomidou VA, 2005, INSECT BIOCHEM MOLEC, V35, P553, DOI 10.1016/j.ibmb.2005.01.017; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Luquet G, 2012, ZOOKEYS, P103, DOI 10.3897/zookeys.176.2318; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; Manor R, 2007, GEN COMP ENDOCR, V150, P326, DOI 10.1016/j.ygcen.2006.09.006; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; MEVELNINIO M, 1991, EMBO J, V10, P2259, DOI 10.1002/j.1460-2075.1991.tb07762.x; MEVELNINIO M, 1995, MECH DEVELOP, V49, P83, DOI 10.1016/0925-4773(94)00305-7; Nagasawa Hiromichi, 2011, P315, DOI 10.1007/978-3-642-21230-7_11; NEVILLE AC, 1963, J INSECT PHYSIOL, V9, P265, DOI 10.1016/0022-1910(63)90103-3; OBRIEN JJ, 1991, BIOL BULL, V181, P427, DOI 10.2307/1542363; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Pamuru RR, 2012, GEN COMP ENDOCR, V178, P227, DOI 10.1016/j.ygcen.2012.05.007; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POLLOCK M, 1994, AM J PHYSIOL, V266, pR1016, DOI 10.1152/ajpregu.1994.266.3.R1016; Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rosen O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015281; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shechter A, 2005, BIOL REPROD, V73, P72, DOI 10.1095/biolreprod.104.038554; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shechter A, 2008, BIOL BULL-US, V214, P122, DOI 10.2307/25066669; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; SHIMIZU S, 1989, J CLIN INVEST, V84, P1990, DOI 10.1172/JCI114389; Sievers F, FAST SCALABLE GENERA, DOI [10.1038/msb.2011.75, DOI 10.1038/MSB.2011.75]; Suderman RJ, 2006, INSECT BIOCHEM MOLEC, V36, P353, DOI 10.1016/j.ibmb.2006.01.012; Suzuki M, 2013, BIOSCI BIOTECH BIOCH, V77, P361, DOI 10.1271/bbb.120787; Tabor D, 1986, INDENTATION HARDNESS; Tatham AS, 2000, TRENDS BIOCHEM SCI, V25, P567, DOI 10.1016/S0968-0004(00)01670-4; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Ventura T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097261; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; WEISFOGH T, 1961, J MOL BIOL, V3, P648, DOI 10.1016/S0022-2836(61)80028-4; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275; Yudkovski Y, 2007, INSECT MOL BIOL, V16, P661, DOI 10.1111/j.1365-2583.2007.00762.x; Yudkovski Y, 2010, COMP BIOCHEM PHYS D, V5, P171, DOI 10.1016/j.cbd.2010.03.010	72	6	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127871	10.1371/journal.pone.0127871	http://dx.doi.org/10.1371/journal.pone.0127871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010981	Green Published, gold			2022-12-27	WOS:000355183900155
J	Vogiatzoglou, A; Mulligan, AA; Lentjes, MAH; Luben, RN; Spencer, JPE; Schroeter, H; Khaw, KT; Kuhnle, GGC				Vogiatzoglou, Anna; Mulligan, Angela A.; Lentjes, Marleen A. H.; Luben, Robert N.; Spencer, Jeremy P. E.; Schroeter, Hagen; Khaw, Kay-Tee; Kuhnle, Gunter G. C.			Flavonoid Intake in European Adults (18 to 64 Years)	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE MORTALITY; DIETARY FLAVONOIDS; ANTHOCYANIN INTAKE; TOPOISOMERASE-II; BLOOD-PRESSURE; RISK; CANCER; FLAVAN-3-OLS; PROANTHOCYANIDINS; DETERMINANTS	Background Flavonoids are a group of phenolic secondary plant metabolites that are ubiquitous in plant-based diets. Data from anthropological, observational and intervention studies have shown that many flavonoids are bioactive. For this reason, there is an increasing interest in investigating the potential health effects of these compounds. The translation of these findings into the context of the health of the general public requires detailed information on habitual dietary intake. However, only limited data are currently available for European populations. Objective The objective of this study is to determine the habitual intake and main sources of anthocyanidins, flavanols, flavanones, flavones, flavonols, proanthocyanidins, theaflavins and thearubigins in the European Union. Design We use food consumption data from the European Food Safety Authority (EFSA) and the FLAVIOLA Food Composition Database to estimate intake of flavonoids. Results Mean (+/- SEM) intake of total flavonoids in Europe was 428 +/- 49 mg/d, of which 136 +/- 14 mg/d were monomeric compounds. Gallated flavan-3-ols (53 +/- 12 mg/d) were the main contributor. The lowest flavonoid intake was observed in Mediterranean countries (monomeric compounds: 95 +/- 11 mg/d). The distribution of intake was skewed in many countries, especially in Germany (monomeric flavonoids; mean intake: 181 mg/d; median intake: 3 mg/d). Conclusions The habitual intake of flavonoids in Europe is below the amounts found to have a significant health effect.	[Vogiatzoglou, Anna; Spencer, Jeremy P. E.; Kuhnle, Gunter G. C.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Mulligan, Angela A.; Lentjes, Marleen A. H.; Luben, Robert N.; Kuhnle, Gunter G. C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Schroeter, Hagen] Mars Inc, Mclean, VA 22101 USA; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Clin Gerontol Unit, Cambridge, England	University of Reading; University of Cambridge; Mars; University of Cambridge	Kuhnle, GGC (corresponding author), Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England.	g.g.kuhnle@reading.ac.uk	Spencer, Jeremy P. E./F-4757-2010; Khaw, Kay-Tee/AAZ-3209-2021; Kuhnle, Gunter/AAG-5264-2019; Luben, Robert N/H-5519-2015	Spencer, Jeremy P. E./0000-0003-2931-7274; Kuhnle, Gunter/0000-0002-8081-8931; Luben, Robert N/0000-0002-5088-6343; Lentjes, Marleen/0000-0003-4713-907X; Schroeter, Hagen/0000-0001-6569-382X	European Union [226588]; Mars, Inc., a member of the FLAVIOLA research consortium; MRC [G0801534] Funding Source: UKRI; Cancer Research UK [14136] Funding Source: researchfish; Medical Research Council [G0401527, G1000143, UD99999933, G0801534] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114] Funding Source: researchfish	European Union(European Commission); Mars, Inc., a member of the FLAVIOLA research consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was supported by the European Union (grant 226588, "Flaviola"). Mars, Inc., a member of the FLAVIOLA research consortium, provided support in the form of salaries for author HS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	[Anonymous], 2011, FOOD CLASSIFICATION; [Anonymous], 2011, EFSA COMPREHENSIVE E; Armentano L, 1936, DEUT MED WOCHENSCHR, V62, P1325, DOI 10.1055/s-0028-1141260; Bai W, 2014, INT J FOOD SCI NUTR, V65, P9, DOI 10.3109/09637486.2013.832170; Bandele OJ, 2008, CHEM RES TOXICOL, V21, P1253, DOI 10.1021/tx8000785; Beking K, 2011, INT J FOOD SCI NUTR, V62, P17, DOI 10.3109/09637486.2010.511165; Berends KAW, 1829, HDB PRAKTISCHEN ARZN; Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408; Cassidy A, 2012, STROKE, V43, P946, DOI 10.1161/STROKEAHA.111.637835; Cassidy A, 2011, AM J CLIN NUTR, V93, P338, DOI 10.3945/ajcn.110.006783; Chang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054318; Commenges D, 2000, EUR J EPIDEMIOL, V16, P357, DOI 10.1023/A:1007614613771; Crozier A, 1997, J AGR FOOD CHEM, V45, P590, DOI 10.1021/jf960339y; Davies, 2012, FLAVONOID PHARMACOKI, P281; Ellinger S, 2012, AM J CLIN NUTR, V95, P1365, DOI 10.3945/ajcn.111.029330; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Holland B., 1991, COMPOSITION FOODS; Hollenberg NK, 1997, HYPERTENSION, V29, P171, DOI 10.1161/01.HYP.29.1.171; Hollman PCH, 1996, FOOD CHEM, V57, P43, DOI 10.1016/0308-8146(96)00065-9; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; Jaeger A, 1988, Prog Clin Biol Res, V280, P379; Jennings A, 2012, AM J CLIN NUTR, V96, P781, DOI 10.3945/ajcn.112.042036; Johannot L, 2006, PUBLIC HEALTH NUTR, V9, P1045, DOI 10.1017/PHN2006971; Justesen U, 1997, CANCER LETT, V114, P165, DOI 10.1016/S0304-3835(97)04651-X; Keli SO, 1996, ARCH INTERN MED, V156, P637, DOI 10.1001/archinte.156.6.637; Lentjes MAH, 2013, BRIT J NUTR IN PRESS; Lupton JR, 2014, EUR J NUTR, V53, P1, DOI 10.1007/s00394-014-0666-3; Martinez SE., 2012, FLAVONOID PHARMACOKI; Max Rubner-Institut, 2008, ERG NAT VERZ 2; Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7; McCullough ML, 2012, AM J CLIN NUTR, V95, P454, DOI 10.3945/ajcn.111.016634; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Neveu V, 2010, DATABASE-OXFORD, DOI 10.1093/database/bap024; Pendleton M, 2014, ANN NY ACAD SCI, V1310, P98, DOI 10.1111/nyas.12358; Quadri F, 1987, Schweiz Rundsch Med Prax, V76, P1338; Ried K, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008893.pub2, 10.1002/14651858.CD008893.pub3]; Schroeder I, 1655, PHARMACOPOEIA MED CH; Strack D., 1997, PLANT BIOCH, P387, DOI DOI 10.1016/B978-012214674-9/50011-4; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Tang NP, 2009, JPN J CLIN ONCOL, V39, P352, DOI 10.1093/jjco/hyp028; Team RC, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Tresserra-Rimbau A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-77; USDA, 2011, USDA DAT FLAV CONT S, DOI [10.1080/21551197.2012.702530, DOI 10.1080/21551197.2012.702530]; USDA, 2007, USDA DAT PROANTH CON; Vogiatzoglou A, 2015, FREE RADICAL BIO MED, V84, P1, DOI 10.1016/j.freeradbiomed.2015.03.005; Vogiatzoglou A, 2014, BRIT J NUTR, V111, P1463, DOI 10.1017/S0007114513003930; WALTI M, 1986, SCHWEIZ MED WSCHR, V116, P98; Wang L, 2009, AM J CLIN NUTR, V89, P905, DOI 10.3945/ajcn.2008.26913; Wang X, 2014, BRIT J NUTR, V111, P1, DOI 10.1017/S000711451300278X; Ward HA, 2010, ARCH BIOCHEM BIOPHYS, V501, P170, DOI 10.1016/j.abb.2010.05.018; Wasson AP, 2006, PLANT CELL, V18, P1617, DOI 10.1105/tpc.105.038232; Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894; Welch AA, 2001, PUBLIC HEALTH NUTR, V4, P1253, DOI 10.1079/PHN2001196; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Woo Hae Dong, 2013, PLoS One, V8, pe75604, DOI 10.1371/journal.pone.0075604; Woo HD, 2013, WORLD J GASTROENTERO, V19, P1011, DOI 10.3748/wjg.v19.i7.1011; Zamora-Ros R, 2013, EUR J CLIN NUTR, V67, P779, DOI 10.1038/ejcn.2013.89; Zamora-Ros R, 2014, J NUTR, V144, P335, DOI 10.3945/jn.113.184945; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1915, DOI 10.1017/S000711451100239X; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1090, DOI [10.1017/S0007114511001437, 10.1017/S0007114511006386]; ZILVA SS, 1949, BIOCHEM J, V45, P79, DOI 10.1042/bj0450079	62	111	113	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128132	10.1371/journal.pone.0128132	http://dx.doi.org/10.1371/journal.pone.0128132			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010916	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900194
J	Cheng, J; Wang, LX; Zhang, H; Xia, YY				Cheng, Jun; Wang, Lixia; Zhang, Hui; Xia, Yinyin			Diagnostic Value of Symptom Screening for Pulmonary Tuberculosis in China	PLOS ONE			English	Article							PREVALENCE; HIV; THERAPY	Objective To evaluate the diagnostic value of symptom screening for tuberculosis (TB) case finding defined in National Tuberculosis Control Program in China (China NTP) among elderly people( >= 65 years) and younger people(< 65 years). Methods We made a secondary analysis in a population-based TB prevalence survey in China in 2010. Questionnaire including information for cough and haemoptysis was completed by face to face interview, and then chest radiography was conducted in all eligible participants. Sputum smear and culture were followed for all TB suspects. We calculated the odds ratios (OR), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and the area under the receiver operating characteristic curve (AUC) of using different symptoms for screening to detect bacteriologically positive TB in subpopulations stratified by age 65, to evaluate the performance of symptom screening for TB. Findings Of 315 newly diagnosed bacteriologically positive TB, 131 patients (41.59%) were elderly, and 48.57% of TB patients were asymptomatic. Nearly 50% patients did not present cough of any duration, and less than half present cough more than 2 weeks, a defined suspected symptom in China NTP. Cough of any duration was reported more in patients aged under 65 than those in elderly, especially for the acute cough (9.78% vs 6.87%). Those symptoms defined by China NTP were reported by less than half participants in two subpopulations. Acute cough (< 2 weeks) was an independent predictor of TB in people aged under 65 (adjusted OR: 3.3, 95% CI: 2.0-5.5), but not in those aged 65 and above (adjusted OR: 1.4, 95% CI: 0.7-2.9). The specificity for each symptom was significantly higher in participants aged under 65 (P<0.01), and sensitivities of most symptoms were significantly higher among elderly (P<0.05 or P<0.01). When compared with cough for 2 weeks and more, using cough of any duration for symptom screening increased the sensitivity from 42.9% to 51.% for all participants, and the AUC increased from 0.70 to 0.74 for participants aged under 65 without significant difference. Conclusions There is a high percent of asymptomatic TB patients, and those symptoms adopted in China NTP for screening is poorly predictive for TB. The presence of TB symptoms, the sensitivities and specificities of symptoms for TB were distinct between two subpopulations cut by age 65, implying different case finding strategies should be established for them. The current case finding strategy should be improved, and further studies should be done to evaluate the performance and cost-effectiveness of different symptom screening strategy.	[Cheng, Jun; Wang, Lixia; Zhang, Hui; Xia, Yinyin] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Xia, YY (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.	xiayinyin@chinatb.org						Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Department of disease control Chinese Ministry of Health, 2008, GUID IMPL NAT TUB CO; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Hoffmann CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062211; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Murhekar MV, 2004, B WORLD HEALTH ORGAN, V82, P836; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Nishikiori N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-97; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2004, INT POL COLL TB HIV; World Health Organization, 2013, SYST SCREEN TUB PRIN	20	20	25	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127725	10.1371/journal.pone.0127725	http://dx.doi.org/10.1371/journal.pone.0127725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001190	Green Published, gold, Green Submitted			2022-12-27	WOS:000354931700076
J	Garcia-Basteiro, AL; Lopez-Varela, E; Augusto, OJ; Gondo, K; Munoz, J; Sacarlal, J; Marais, B; Alonso, PL; Ribo, JL				Garcia-Basteiro, Alberto L.; Lopez-Varela, Elisa; Augusto, Orvalho Joaquim; Gondo, Kizito; Munoz, Jose; Sacarlal, Jahit; Marais, Ben; Alonso, Pedro L.; Ribo, Jose L.			Radiological Findings in Young Children Investigated for Tuberculosis in Mozambique	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; HIGH-BURDEN; CLASSIFICATION; DIAGNOSIS; CT	Introduction Chest radiography remains a critical tool for diagnosing intrathoracic tuberculosis (TB) in young children who are unable to expectorate. We describe the radiological findings in children under 3 years of age investigated for TB in the district of Manhica, southern Mozambique, an area with a high prevalence of TB and HIV. Methods Digital antero-posterior and lateral projections were performed and reviewed by two independent readers, using a standardized template. Readers included a local pediatrician and a pediatric radiologist blinded to all clinical information. International consensus case definitions for intra-thoracic TB in children were applied. Results A total of 766 children were evaluated of whom 43 (5.6%) had TB. The most frequent lesion found in TB cases was air space consolidation (65.1%), followed by suggestive hilar lymphadenopathy (17.1%) and pleural effusion (7.0%). Air space consolidation was significantly more common in TB cases than in non-TB cases (odds ratio 8.9; 95% CI: 1.6-50.5), as were hilar lymphadenopathy (OR 17.2; 95% CI: 5.7-52.1). The only case with miliary infiltrates and 3 with pleural effusions occurred in HIV-infected children. Conclusion Frequent air space consolidation complicates radiological distinction between TB and bacterial pneumonia in young children, underscoring the need for epidemiological contextualization and consideration of all relevant signs and symptoms.	[Garcia-Basteiro, Alberto L.; Lopez-Varela, Elisa; Gondo, Kizito; Sacarlal, Jahit; Alonso, Pedro L.] CISM, Maputo 1929, Mozambique; [Garcia-Basteiro, Alberto L.; Lopez-Varela, Elisa; Augusto, Orvalho Joaquim; Munoz, Jose; Alonso, Pedro L.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, E-08036 Barcelona, Spain; [Marais, Ben] Univ Sydney, Marie Bashir Inst, Infect Dis & Biosecur Inst MBI, Westmead, NSW 2145, Australia; [Marais, Ben] Univ Sydney, Childrens Hosp Westmead, Westmead, NSW 2145, Australia; [Ribo, Jose L.] Hosp San Juan Dios, Dept Radiol, Barcelona, Spain	Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Sydney; University of Sydney	Lopez-Varela, E (corresponding author), CISM, Rua 12, Maputo 1929, Mozambique.	elisa.lopez@manhica.net	Marais, Ben/AAX-2626-2021; Alonso, Pedro L/AAZ-3645-2020; Augusto, Orvalho/J-8767-2019; Gutiérrez, José/GSJ-1846-2022; Sacarlal, Jahit/R-3172-2016; varela, elisa lopez/ABE-4092-2020; Gutiérrez, Jose Muñoz/X-5917-2018; Gutierrez, Jose Muñoz/AAH-6954-2020	Alonso, Pedro L/0000-0003-3292-3443; Augusto, Orvalho/0000-0002-0005-3968; Sacarlal, Jahit/0000-0003-1059-217X; varela, elisa lopez/0000-0002-6725-5687; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Fernandez, Ivette/0000-0001-5179-0477	European and Developing Countries Clinical Trial Partnership (EDCTP)	European and Developing Countries Clinical Trial Partnership (EDCTP)	This study is an ancillary study of a larger project funded by European and Developing Countries Clinical Trial Partnership (EDCTP). The funders had no no role in the study design, data collection and analysis.	Boloursaz MR, 2009, ACTA MED IRAN, V48, P244; Bosch-Marcet J, 2004, PEDIATR RADIOL, V34, P895, DOI 10.1007/s00247-004-1251-3; Consonni Dario, 2013, Tuberc Res Treat, V2013, P312065, DOI 10.1155/2013/312065; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Garcia-Basteiro AL, 2015, EUR RESPIR J, V45, P547, DOI 10.1183/09031936.00145714; Gie R., 2003, DIAGNOSTIC ATLAS INT; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Kim WS, 2006, AM J ROENTGENOL, V187, P1024, DOI 10.2214/AJR.04.0751; LEUNG AN, 1992, RADIOLOGY, V182, P87, DOI 10.1148/radiology.182.1.1727316; Looez-Varela E, 2015, PEDIATR INFECT DIS J, V34, P686, DOI 10.1097/INF.0000000000000710; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Marais BJ, 2004, PEDIATR RADIOL, V34, P886, DOI 10.1007/s00247-004-1238-0; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nicol MP, 2011, PAEDIATR RESPIR REV, V12, P16, DOI 10.1016/j.prrv.2010.09.008; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Pinto LM, 2013, EUR RESPIR J, V42, P480, DOI 10.1183/09031936.00107412; Pinto LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054235; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Salazar GE, 2001, PEDIATRICS, V108, P448, DOI 10.1542/peds.108.2.448; Schaaf HS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-140; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Theart AC, 2005, INT J TUBERC LUNG D, V9, P1210; World Health Organization, 2014, WHOHTMTB2014082014; World Health Organization, 2013, WHOHTMTB201311; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd	26	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127323	10.1371/journal.pone.0127323	http://dx.doi.org/10.1371/journal.pone.0127323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020541	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300035
J	Hwang, J; Lee, S; Lee, JH; Kang, WH; Kang, JH; Kang, MY; Oh, CS; Kang, BC				Hwang, Jeena; Lee, Seonhee; Lee, Joung-Ho; Kang, Won-Hee; Kang, Jin-Ho; Kang, Min-Young; Oh, Chang-Sik; Kang, Byoung-Cheorl			Plant Translation Elongation Factor 1B beta Facilitates Potato Virus X (PVX) Infection and Interacts with PVX Triple Gene Block Protein 1	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; MOSAIC-VIRUS; FACTOR 1A; RECESSIVE RESISTANCE; ACTIN CYTOSKELETON; ECTOPIC EXPRESSION; FACTOR 1B-GAMMA; CELL-DEATH; STEM-LOOP; REPLICATION	The eukaryotic translation elongation factor 1 (eEF1) has two components: the G-protein eEF1A and the nucleotide exchange factor eEF1B. In plants, eEF1B is itself composed of a structural protein (eEF1B.) and two nucleotide exchange subunits (eEF1B alpha and eEF1B beta). To test the effects of elongation factors on virus infection, we isolated eEF1A and eEF1B genes from pepper (Capsicum annuum) and suppressed their homologs in Nicotiana benthamiana using virus-induced gene silencing (VIGS). The accumulation of a green fluorescent protein (GFP)-tagged Potato virus X (PVX) was significantly reduced in the eEF1B beta-or eEF1B gamma-silenced plants as well as in eEF1A-silenced plants. Yeast two-hybrid and co-immunoprecipitation analyses revealed that eEF1B alpha and eEF1B beta interacted with eEF1A and that eEF1A and eEF1B beta interacted with triple gene block protein 1 (TGBp1) of PVX. These results suggest that both eEF1A and eEF1B beta play essential roles in the multi-plication of PVX by physically interacting with TGBp1. Furthermore, using eEF1B beta deletion constructs, we found that both N-(1-64 amino acids) and C-terminal (150-195 amino acids) domains of eEF1B beta are important for the interaction with PVX TGBp1 and that the C-terminal domain of eEF1B beta is involved in the interaction with eEF1A. These results suggest that eEF1B beta could be a potential target for engineering virus-resistant plants.	[Hwang, Jeena; Lee, Seonhee; Lee, Joung-Ho; Kang, Won-Hee; Kang, Jin-Ho; Kang, Min-Young; Kang, Byoung-Cheorl] Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul 151921, South Korea; [Hwang, Jeena; Lee, Seonhee; Lee, Joung-Ho; Kang, Won-Hee; Kang, Jin-Ho; Kang, Min-Young; Kang, Byoung-Cheorl] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Hwang, Jeena] Korea Inst Sci & Technol Informat, Seoul 130741, South Korea; [Kang, Jin-Ho; Kang, Byoung-Cheorl] Seoul Natl Univ, Crop Biotechnol Inst GreenBio Sci & Technol, Pyeongchang 232916, South Korea; [Oh, Chang-Sik] Kyung Hee Univ, Dept Hort Biotechnol, Yongin 446701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology Information (KISTI); Seoul National University (SNU); Kyung Hee University	Kang, BC (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul 151921, South Korea.	bk54@snu.ac.kr	Kang, Byoung-Cheorl/Q-6174-2019; Oh, Chang-Sik/AAK-7131-2020	Oh, Chang-Sik/0000-0002-2123-862X	Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS); Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA) Republic of Korea [710001-07]	Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS); Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA) Republic of Korea	This research was supported by the Golden Seed Project, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS) and a grant (Project No. 710001-07) from the Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA) Republic of Korea. The authors thank S.P. Dinesh-Kumar (University of California, Davis) for the TRV-LIC vector, K.H. Kim (Seoul National University) for PVX-GFP and D. Choi (Seoul National University) for access to the C. annuum sequence database.	Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Angell SM, 1996, VIROLOGY, V216, P197, DOI 10.1006/viro.1996.0046; BASTIN M, 1976, J VIROL, V20, P117, DOI 10.1128/JVI.20.1.117-122.1976; BECK DL, 1991, VIROLOGY, V183, P695, DOI 10.1016/0042-6822(91)90998-Q; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; CHAPMAN S, 1992, VIROLOGY, V191, P223, DOI 10.1016/0042-6822(92)90183-P; Cho SY, 2012, VIROLOGY, V427, P166, DOI 10.1016/j.virol.2012.02.005; Corbi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014481; Cotton S, 2009, J VIROL, V83, P10460, DOI 10.1128/JVI.00819-09; Das T, 1998, P NATL ACAD SCI USA, V95, P1449, DOI 10.1073/pnas.95.4.1449; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Dong Y, 2007, PLANT PHYSIOL, V145, P1161, DOI 10.1104/pp.107.107391; Dufresne PJ, 2008, VIROLOGY, V374, P217, DOI 10.1016/j.virol.2007.12.014; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Esposito AM, 2010, J BIOL CHEM, V285, P37995, DOI 10.1074/jbc.M110.160887; Esposito AM, 2007, FREE RADICAL BIO MED, V43, pS150; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; HUISMAN MJ, 1988, J GEN VIROL, V69, P1789, DOI 10.1099/0022-1317-69-8-1789; Hwang J, 2013, VIROLOGY, V439, P105, DOI 10.1016/j.virol.2013.02.004; JOSHI RL, 1986, EMBO J, V5, P1143, DOI 10.1002/j.1460-2075.1986.tb04339.x; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; Kang BC, 2007, PLANT BIOTECHNOL J, V5, P526, DOI 10.1111/j.1467-7652.2007.00262.x; Kang WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043136; Kidmose RT, 2010, P NATL ACAD SCI USA, V107, P10884, DOI 10.1073/pnas.1003015107; Kim J, 2014, MOL PLANT PATHOL, V15, P615, DOI 10.1111/mpp.12120; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Li DS, 2013, MICROBIOL MOL BIOL R, V77, P253, DOI 10.1128/MMBR.00059-12; Li ZH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001175; Li ZH, 2009, VIROLOGY, V385, P245, DOI 10.1016/j.virol.2008.11.041; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Mazier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029595; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Oh CS, 2013, FEBS LETT, V587, P1460, DOI 10.1016/j.febslet.2013.03.033; Park MR, 2009, VIROLOGY, V386, P257, DOI 10.1016/j.virol.2008.12.044; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Pomerening JR, 2003, MOL GENET GENOMICS, V269, P776, DOI 10.1007/s00438-003-0888-1; Rodnina MV, 2009, CURR OPIN CELL BIOL, V21, P435, DOI 10.1016/j.ceb.2009.01.023; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Sasvari Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002438; Schaad MC, 1997, EMBO J, V16, P4049, DOI 10.1093/emboj/16.13.4049; Seo E, 2012, MOL CELLS, V33, P415, DOI 10.1007/s10059-012-0017-2; Takeshita D, 2010, P NATL ACAD SCI USA, V107, P15733, DOI 10.1073/pnas.1006559107; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thivierge K, 2008, VIROLOGY, V377, P216, DOI 10.1016/j.virol.2008.04.015; Tilsner J, 2013, J CELL BIOL, V201, P981, DOI 10.1083/jcb.201304003; Tilsner J, 2012, PLANT PHYSIOL, V158, P1359, DOI 10.1104/pp.111.189605; Truniger V, 2009, ADV VIRUS RES, V75, P119, DOI 10.1016/S0065-3527(09)07504-6; Verchot-Lubicz J, 2005, MOL PLANT MICROBE IN, V18, P283, DOI 10.1094/MPMI-18-0283; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Yamaji Y, 2006, VIROLOGY, V347, P100, DOI 10.1016/j.virol.2005.11.031; Yeom SI, 2012, PLANT J, V69, P755, DOI 10.1111/j.1365-313X.2011.04828.x; Zeenko VV, 2002, J VIROL, V76, P5678, DOI 10.1128/JVI.76.11.5678-5691.2002	59	7	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128014	10.1371/journal.pone.0128014	http://dx.doi.org/10.1371/journal.pone.0128014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020533	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300071
J	Li, CL; Wang, ZJ; Wang, CX; Ma, Q; Zhao, YX				Li, Changlong; Wang, Zhijian; Wang, Chunxiao; Ma, Qian; Zhao, Yingxin			Perivascular Adipose Tissue-Derived Adiponectin Inhibits Collar-Induced Carotid Atherosclerosis by Promoting Macrophage Autophagy	PLOS ONE			English	Article							APOLIPOPROTEIN-E-DEFICIENT; OXIDATIVE STRESS; CANCER CELLS; PATHWAY; MICE; ATHEROGENESIS; ACTIVATION; MECHANISMS; DISEASE; PLAQUES	Objectives Adiponectin (APN) secreted from perivascular adipose tissue (PVAT) is one of the important anti-inflammatory adipokines to inhibit the development of atherosclerosis, but the underlying mechanism has not been clarified. In this study, we aimed to elucidate how APN regulates plaque formation in atherosclerosis. Methods and Results To assess the role of APN secreted by PVAT in atherosclerosis progression, we performed PVAT transplantation experiments on carotid artery atherosclerosis model: ApoE knockout (ApoE(-/-)) mice with a perivascular collar placement around the left carotid artery in combination with a high-fat diet feeding. Our results show that the ApoE(-/-) mice with PVAT derived from APN knockout (APN(-/-)) mice exhibited accelerated plaque volume formation compared to ApoE(-/-) mice transplanted with wild-type littermate tissue. Conversely, autophagy in macrophages was significantly attenuated in ApoE(-/-) mice transplanted with APN(-/-) mouse-derived PVAT compared to controls. Furthermore, in vitro studies indicate that APN treatment increased autophagy in primary macrophages, as evidenced by increased LC3-I processing and Beclin1 expression, which was accompanied by down-regulation of p62. Moreover, our results demonstrate that APN promotes macrophage autophagy via suppressing the Akt/FOXO3a signaling pathway. Conclusions Our results indicate that PVAT-secreted APN suppresses plaque formation by inducing macrophage autophagy.	[Li, Changlong; Wang, Zhijian; Ma, Qian; Zhao, Yingxin] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Wang, Chunxiao; Zhao, Yingxin] Capital Med Univ, Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China	Capital Medical University	Zhao, YX (corresponding author), Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China.	zyingxinmi@126.com	wang, jie/GRS-0942-2022; WANG, JINGYI/GSJ-1241-2022		National Natural Science Foundation of China [81170265]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by grants from a National Natural Science Foundation of China (Grant No. 81170265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barb D, 2007, ENDOCR-RELAT CANCER, V14, P995, DOI 10.1677/ERC-06-0091; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.380; De Meyer I, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0269-1; Errafiy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083318; Essick EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068697; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Farini D, 2007, DEV BIOL, V306, P572, DOI 10.1016/j.ydbio.2007.03.031; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Guo R, 2013, BBA-MOL BASIS DIS, V1832, P1136, DOI 10.1016/j.bbadis.2013.03.013; Huypens PR, 2007, MED HYPOTHESES, V68, P1134, DOI 10.1016/j.mehy.2006.09.046; Iacobellis G, 2008, CURR DIABETES REP, V8, P20, DOI 10.1007/s11892-008-0005-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kawahito H, 2013, AM J PHYSIOL-HEART C, V305, pH667, DOI 10.1152/ajpheart.00053.2013; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Li BH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.146; Li L, 2010, CIRC J, V74, P552, DOI 10.1253/circj.CJ-09-0304; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Maiuri M. C., 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/584715; Miao CY, 2012, BRIT J PHARMACOL, V165, P643, DOI 10.1111/j.1476-5381.2011.01404.x; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Muller C, 2011, AUTOPHAGY, V7, P541, DOI 10.4161/auto.7.5.15003; Nawrocki AR, 2010, ARTERIOSCL THROM VAS, V30, P1159, DOI 10.1161/ATVBAHA.109.195826; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Ohman MK, 2011, ATHEROSCLEROSIS, V219, P33, DOI 10.1016/j.atherosclerosis.2011.07.012; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; Peng N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05519; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Sobiesiak M, 2009, J IMMUNOL, V183, P4395, DOI 10.4049/jimmunol.0803017; Strozyk E, 2013, INT J MOL SCI, V14, P15260, DOI 10.3390/ijms140815260; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Tsubakio-Yamamoto K, 2008, BIOCHEM BIOPH RES CO, V375, P390, DOI 10.1016/j.bbrc.2008.08.009; Verheye S, 2007, J AM COLL CARDIOL, V49, P706, DOI 10.1016/j.jacc.2006.09.047; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wang XM, 2014, MED SCI MONITOR, V20, P1792, DOI 10.12659/MSM.892299; Yang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095935	44	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124031	10.1371/journal.pone.0124031	http://dx.doi.org/10.1371/journal.pone.0124031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020520	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300005
J	McNeilly, TN; Mitchell, MC; Corbishley, A; Nath, M; Simmonds, H; McAteer, SP; Mahajan, A; Low, JC; Smith, DGE; Huntley, JF; Gally, DL				McNeilly, Tom N.; Mitchell, Mairi C.; Corbishley, Alexander; Nath, Mintu; Simmonds, Hannah; McAteer, Sean P.; Mahajan, Arvind; Low, J. Christopher; Smith, David G. E.; Huntley, John F.; Gally, David L.			Optimizing the Protection of Cattle against Escherichia coli O157:H7 Colonization through Immunization with Different Combinations of H7 Flagellin, Tir, Intimin-531 or EspA	PLOS ONE			English	Article							III SECRETED PROTEINS; FEEDLOT CATTLE; SIDEROPHORE RECEPTOR; DOMESTIC RUMINANTS; TERMINAL RECTUM; O157-H7; VACCINATION; INFECTION; REDUCE; FECES	Enterohemorrhagic Escherichia coli (EHEC) are important human pathogens, causing hemorrhagic colitis and hemolytic uraemic syndrome in humans. E. coli O157:H7 is the most common serotype associated with EHEC infections worldwide, although other non-O157 serotypes cause life-threatening infections. Cattle are a main reservoir of EHEC and intervention strategies aimed at limiting EHEC excretion from cattle are predicted to lower the risk of human infection. We have previously shown that immunization of calves with recombinant versions of the type III secretion system (T3SS)-associated proteins EspA, intimin and Tir from EHEC O157: H7 significantly reduced shedding of EHEC O157 from experimentally-colonized calves, and that protection could be augmented by the addition of H7 flagellin to the vaccine formulation. The main aim of the present study was to optimize our current EHEC O157 subunit vaccine formulations by identifying the key combinations of these antigens required for protection. A secondary aim was to determine if vaccine-induced antibody responses exhibited cross-reactive potential with antigens from other EHEC serotypes. Immunization with EspA, intimin and Tir resulted in a reduction in mean EHEC O157 shedding following challenge, but not the mean proportion of calves colonized. Removal of Tir resulted in more prolonged shedding compared with all other groups, whereas replacement of Tir with H7 flagellin resulted in the highest levels of protection, both in terms of reducing both mean EHEC O157 shedding and the proportion of colonized calves. Immunization of calves with recombinant EHEC O157 EspA, intimin and Tir resulted in the generation of antibodies capable of cross-reacting with antigens from non-O157 EHEC serotypes, suggesting that immunization with these antigens may provide a degree of cross-protection against other EHEC serotypes. Further studies are now required to test the efficacy of these vaccines in the field, and to formally test the cross-protective potential of the vaccines against other non-O157 EHEC.	[McNeilly, Tom N.; Mitchell, Mairi C.; Corbishley, Alexander; Huntley, John F.] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [Corbishley, Alexander; Simmonds, Hannah; McAteer, Sean P.; Mahajan, Arvind; Low, J. Christopher; Gally, David L.] Univ Edinburgh, Roslin Inst, Div Immun & Infect, Edinburgh, Midlothian, Scotland; [Nath, Mintu] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Smith, David G. E.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Moredun Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; James Hutton Institute; University of Glasgow	McNeilly, TN (corresponding author), Moredun Res Inst, 408 Gilmerton Rd, Edinburgh EH17 7JH, Midlothian, Scotland.	Tom.McNeilly@moredun.ac.uk	Corbishley, Alexander/AAP-9466-2021; McNeilly, Tom/AAC-8264-2019; Smith, David/N-9743-2018	Corbishley, Alexander/0000-0002-7902-0914; McNeilly, Tom/0000-0001-6469-0512; Smith, David/0000-0002-2484-2603; Gally, David/0000-0002-2566-0844	Department for Environment, Food and Rural Affairs-NOVARTIS LINK [LK0666]; Scottish Government; BBSRC; Bioniche Life Sciences Ltd.; BBSRC [BB/I013954/1, BB/I011625/1, BBS/E/D/20231761] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231761, BB/I013954/1, BB/I011625/1] Funding Source: researchfish	Department for Environment, Food and Rural Affairs-NOVARTIS LINK; Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bioniche Life Sciences Ltd.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Department for Environment, Food and Rural Affairs-NOVARTIS LINK project number LK0666 (http://randd.defra.gov.uk) to TNM, MCM, AM, JCL, DGES, JFH, DLG; Scottish Government (http://www.scotland.gov.uk/) to TNM, MN, DGES; BBSRC (http://www.bbsrc.ac.uk) to DLG, SM; Bioniche Life Sciences Ltd. (http://www.bioniche.com) PhD studentship to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KJ, 2011, CAN J VET RES, V75, P98; Asper DJ, 2007, VACCINE, V25, P8262, DOI 10.1016/j.vaccine.2007.09.054; Asper DJ, 2011, CLIN VACCINE IMMUNOL, V18, P1052, DOI 10.1128/CVI.00068-11; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanco M, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-23; Brady MJ, 2007, CELL MICROBIOL, V9, P2242, DOI 10.1111/j.1462-5822.2007.00954.x; BUTLER JE, 1983, VET IMMUNOL IMMUNOP, V4, P43, DOI 10.1016/0165-2427(83)90056-9; Cernicchiaro N, 2014, J FOOD PROTECT, V77, P732, DOI 10.4315/0362-028X.JFP-13-358; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Cook SR, 2005, CAN J ANIM SCI, V85, P291, DOI 10.4141/A04-076; Corbishley A, 2014, INFECT IMMUN, V82, P5117, DOI 10.1128/IAI.02462-14; Dean-Nystrom EA, 2002, INFECT IMMUN, V70, P2414, DOI 10.1128/IAI.70.5.2414-2418.2002; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Dziva F, 2007, VET MICROBIOL, V123, P254, DOI 10.1016/j.vetmic.2007.02.016; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Harriff MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097515; Hoffman MA, 2006, CLIN VACCINE IMMUNOL, V13, P1322, DOI 10.1128/CVI.00205-06; Hurd HS, 2012, FOODBORNE PATHOG DIS, V9, P952, DOI 10.1089/fpd.2012.1150; Johnson R. P., 2008, Animal Health Research Reviews, V9, P201, DOI 10.1017/S1466252308001576; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Lai YS, 2013, CELL MICROBIOL, V15, P1796, DOI 10.1111/cmi.12179; Mahajan A, 2009, CELL MICROBIOL, V11, P121, DOI 10.1111/j.1462-5822.2008.01244.x; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Matthews L, 2013, P NATL ACAD SCI USA, V110, P16265, DOI 10.1073/pnas.1304978110; McNeilly TN, 2008, INFECT IMMUN, V76, P2594, DOI 10.1128/IAI.01452-07; McNeilly TN, 2010, VACCINE, V28, P1422, DOI 10.1016/j.vaccine.2009.10.076; Menge C, 1999, INFECT IMMUN, V67, P2209, DOI 10.1128/IAI.67.5.2209-2217.1999; Menge C, 2003, EXP BIOL MED, V228, P377, DOI 10.1177/153537020322800408; Moxley RA, 2009, FOODBORNE PATHOG DIS, V6, P879, DOI 10.1089/fpd.2009.0297; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Neves BC, 2003, INFECT IMMUN, V71, P2262, DOI 10.1128/IAI.71.4.2262-2265.2003; Paddock ZD, 2014, FOODBORNE PATHOG DIS, V11, P186, DOI 10.1089/fpd.2013.1659; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Potter AA, 2004, VACCINE, V22, P362, DOI 10.1016/j.vaccine.2003.08.007; R Development Core Team, 2014, R LANG ENV STAT COMP; Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x; Sheng HQ, 2005, J CLIN MICROBIOL, V43, P3213, DOI 10.1128/JCM.43.7.3213-3220.2005; Sinclair JF, 2006, INFECT IMMUN, V74, P1255, DOI 10.1128/IAI.74.2.1255-1265.2006; Snedeker KG, 2012, ZOONOSES PUBLIC HLTH, V59, P126, DOI 10.1111/j.1863-2378.2011.01426.x; Stanford K, 2014, FOODBORNE PATHOG DIS, V11, P379, DOI 10.1089/fpd.2013.1693; Thomson DU, 2009, FOODBORNE PATHOG DIS, V6, P871, DOI 10.1089/fpd.2009.0290; Thornton AB, 2009, J FOOD PROTECT, V72, P866, DOI 10.4315/0362-028X-72.4.866; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Vilte DA, 2011, VACCINE, V29, P3962, DOI 10.1016/j.vaccine.2011.03.079; Waddell N, 2012, COMMUNICATION; Wang D, 2008, MOL MICROBIOL, V69, P1499, DOI 10.1111/j.1365-2958.2008.06377.x; Yekta MA, 2011, VET IMMUNOL IMMUNOP, V140, P42, DOI 10.1016/j.vetimm.2010.11.010; Zhang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091632; Zhao T, 1998, J CLIN MICROBIOL, V36, P641, DOI 10.1128/JCM.36.3.641-647.1998	53	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128391	10.1371/journal.pone.0128391	http://dx.doi.org/10.1371/journal.pone.0128391			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020530	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000355187300107
J	Pitts, T; Gayagoy, AG; Rose, MJ; Poliacek, I; Condrey, JA; Musslewhite, MN; Shen, TY; Davenport, PW; Bolser, DC				Pitts, Teresa; Gayagoy, Albright G.; Rose, Melanie J.; Poliacek, Ivan; Condrey, Jillian A.; Musslewhite, M. Nicholas; Shen, Tabitha Y.; Davenport, Paul W.; Bolser, Donald C.			Suppression of Abdominal Motor Activity during Swallowing in Cats and Humans	PLOS ONE			English	Article							EXPIRATORY THRESHOLD LOAD; MEDULLARY NUCLEI; RISK-FACTORS; LUNG-VOLUME; PHARYNGEAL; COORDINATION; ASPIRATION; PRESSURE; COUGH; MANOFLUOROGRAPHY	Diseases affecting pulmonary mechanics often result in changes to the coordination of swallow and breathing. We hypothesize that during times of increased intrathoracic pressure, swallow suppresses ongoing expiratory drive to ensure bolus transport through the esophagus. To this end, we sought to determine the effects of swallow on abdominal electromyographic (EMG) activity during expiratory threshold loading in anesthetized cats and in awake-healthy adult humans. Expiratory threshold loads were applied to recruit abdominal motor activity during breathing, and swallow was triggered by infusion of water into the mouth. In both anesthetized cats and humans, expiratory cycles which contained swallows had a significant reduction in abdominal EMG activity, and a greater percentage of swallows were produced during inspiration and/or respiratory phase transitions. These results suggest that: a) spinal expiratory motor pathways play an important role in the execution of swallow, and b) a more complex mechanical relationship exists between breathing and swallow than has previously been envisioned.	[Pitts, Teresa] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40292 USA; [Gayagoy, Albright G.; Rose, Melanie J.; Poliacek, Ivan; Condrey, Jillian A.; Musslewhite, M. Nicholas; Shen, Tabitha Y.; Davenport, Paul W.; Bolser, Donald C.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA	University of Louisville; State University System of Florida; University of Florida	Pitts, T (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40292 USA.	t.pitts@louisville.edu	Bolser, Donald/CAI-2644-2022	Rose, Melanie/0000-0003-0021-3498; Pitts, Teresa/0000-0001-9448-2175; Musselwhite, Matthew/0000-0002-5116-8669	National Institutes of Health [HL103415, HL109025, HL111215]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL111215, K99HL111215, R01HL109025, R01HL103415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this study included National Institutes of Health HL103415, HL109025, and HL111215. There are no other financial disclosures to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker S, 2005, J SPEECH LANG HEAR R, V48, P1325, DOI 10.1044/1092-4388(2005/092); BASMAJIAN JV, 1962, J APPL PHYSIOL, V17, P849, DOI 10.1152/jappl.1962.17.5.849; Bautista TG, 2014, J PHYSIOL-LONDON, V592, P2605, DOI 10.1113/jphysiol.2014.272468; Bolser DC, 2000, J APPL PHYSIOL, V88, P1207, DOI 10.1152/jappl.2000.88.4.1207; Bonis JM, 2011, RESP PHYSIOL NEUROBI, V175, P272, DOI 10.1016/j.resp.2010.12.002; Cedborg AIH, 2009, EXP PHYSIOL, V94, P459, DOI 10.1113/expphysiol.2008.045724; CERENKO D, 1989, OTOLARYNG HEAD NECK, V100, P57, DOI 10.1177/019459988910000109; Chiara T, 2007, NEUROREHAB NEURAL RE, V21, P239, DOI 10.1177/1545968306294737; Chiara T, 2006, ARCH PHYS MED REHAB, V87, P468, DOI 10.1016/j.apmr.2005.12.035; Clayton NA, 2014, INT J SPEECH-LANG PA, V16, P615, DOI 10.3109/17549507.2014.882987; Cvejic L, 2011, RESPIROLOGY, V16, P269, DOI 10.1111/j.1440-1843.2010.01875.x; DICK TE, 1993, J PHYSIOL-LONDON, V465, P715, DOI 10.1113/jphysiol.1993.sp019702; Feroah TR, 2002, J APPL PHYSIOL, V92, P1923, DOI 10.1152/japplphysiol.01079.2000; Feroah TR, 2002, J APPL PHYSIOL, V93, P581, DOI 10.1152/japplphysiol.01268.2001; GOLDSTEIN I, 1975, J APPL PHYSIOL, V39, P697, DOI 10.1152/jappl.1975.39.5.697; Hegland KMW, 2009, J SPEECH LANG HEAR R, V52, P178, DOI 10.1044/1092-4388(2008/07-0165); Hegland KW, 2011, J SPEECH LANG HEAR R, V54, P777, DOI [10.1044/1092-4388(2010/09-0237), 10.1044/1092-4388(2010/09-0237]; HELLEMANS J, 1967, AM J DIG DIS, V12, P1240, DOI 10.1007/BF02233925; Hibberd J, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-39; HOWARD PJ, 1989, GUT, V30, P1179, DOI 10.1136/gut.30.9.1179; HUNT PS, 1970, GUT, V11, P303, DOI 10.1136/gut.11.4.303; Iscoe S, 1998, PROG NEUROBIOL, V56, P433, DOI 10.1016/S0301-0082(98)00046-X; JAMMES Y, 1983, J APPL PHYSIOL, V55, P316, DOI 10.1152/jappl.1983.55.2.316; JAMMES Y, 1983, J APPL PHYSIOL, V55, P307, DOI 10.1152/jappl.1983.55.2.307; JEAN A, 1984, J AUTONOM NERV SYST, V10, P225, DOI 10.1016/0165-1838(84)90017-1; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Kennedy J G 3rd, 1988, Dysphagia, V3, P24, DOI 10.1007/BF02406277; Kim J, 2005, J REHABIL RES DEV, V42, P211, DOI 10.1682/JRRD.2004.07.0077; KU DN, 1990, ANN BIOMED ENG, V18, P655, DOI 10.1007/BF02368453; LEEVERS AM, 1995, J PHYSIOL-LONDON, V488, P471, DOI 10.1113/jphysiol.1995.sp020981; Martin-Harris B, 2003, J APPL PHYSIOL, V94, P1735, DOI 10.1152/japplphysiol.00806.2002; Martin-Harris B, 2013, COORDINATION OF DEGL, P25; McConnel F M, 1988, Dysphagia, V2, P187, DOI 10.1007/BF02414425; McConnel F. M. S., 1994, Acta Oto-Rhino-Laryngologica Belgica, V48, P157; MCCONNEL FMS, 1986, HEAD NECK-J SCI SPEC, V9, P3, DOI 10.1002/hed.2890090103; MCCONNEL FMS, 1988, OTOLARYNG CLIN N AM, V21, P625; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P71; MCCONNEL FMS, 1994, LARYNGOSCOPE, V104, P571, DOI 10.1002/lary.5541040512; MCCONNEL FMS, 1988, ARCH OTOLARYNGOL, V114, P1413; MCCONNEL FMS, 1992, OTOLARYNG HEAD NECK, V106, P169, DOI 10.1177/019459989210600219; MCCONNEL FMS, 1987, HEAD NECK-J SCI SPEC, V9, P142, DOI 10.1002/hed.2890090303; MCCONNEL FMS, 1988, LARYNGOSCOPE, V98, P705; MCCONNEL FMS, 1988, PLAST RECONSTR SURG, V81, P346, DOI 10.1097/00006534-198803000-00005; MCCONNEL FMS, 1991, LARYNGOSCOPE, V101, P510; MENDELSOHN MS, 1987, LARYNGOSCOPE, V97, P483; Miller JD, 2006, J APPL PHYSIOL, V101, P213, DOI 10.1152/japplphysiol.00862.2005; Negus V, 1948, ACTA OTOLARYNGOL S, V49, P79; Nishino T, 2011, FRONT PHYSIOL, V3, P489; Pace CC, 2010, DYSPHAGIA, V25, P307, DOI 10.1007/s00455-010-9298-9; Pitts T, 2013, RESPIRATORY PHYSIOLO; Pitts T, 2013, RESP PHYSIOL NEUROBI, V189, P543, DOI 10.1016/j.resp.2013.08.009; Pitts T, 2009, CHEST, V135, P1301, DOI 10.1378/chest.08-1389; Saleemb AF, 2005, NEUROREHABILITATION, V20, P323; Singh B, 2011, RESPIROLOGY, V16, P185, DOI 10.1111/j.1440-1843.2010.01903.x; Starling E, 1902, ERGEBN PHYSL, V1, P446; Taylor JK, 2013, AM J MED, V126, P995, DOI 10.1016/j.amjmed.2013.07.012; Teramoto S, 2002, CHEST, V122, P1104, DOI 10.1378/chest.122.3.1104; Troche MS, 2010, NEUROLOGY, V75, P1912, DOI 10.1212/WNL.0b013e3181fef115; Tsuzuki A, 2012, J AM GERIATR SOC, V60, P1580, DOI 10.1111/j.1532-5415.2012.04067.x; Vaishnavi A, 2011, THORAX, V66, pA31, DOI 10.1136/thoraxjnl-2011-201054b.64; van der Maarel-Wierink CD, 2011, J AM MED DIR ASSOC, V12, P344, DOI 10.1016/j.jamda.2010.12.099; VANTRAPPEN G, 1967, AM J DIG DIS, V12, P255, DOI 10.1007/BF02233643; Wheeler KM, 2007, DYSPHAGIA, V22, P108, DOI 10.1007/s00455-006-9061-4; WILSON SL, 1981, J APPL PHYSIOL, V50, P851, DOI 10.1152/jappl.1981.50.4.851	64	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128245	10.1371/journal.pone.0128245	http://dx.doi.org/10.1371/journal.pone.0128245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020240	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300094
J	Ding, N; Dear, K; Guo, SY; Xiang, F; Lucas, R				Ding, Ning; Dear, Keith; Guo, Shuyu; Xiang, Fan; Lucas, Robyn			Tightrope Walking: Using Predictors of 25 (OH)D Concentration Based on Multivariable Linear Regression to Infer Associations with Health Risks	PLOS ONE			English	Article							VITAMIN-D STATUS; PLASMA 25-HYDROXYVITAMIN D; CANCER; MORTALITY; PROSTATE	The debate on the causal association between vitamin D status, measured as serum concentration of 25-hydroxyvitamin D (25[OH] D), and various health outcomes warrants investigation in large-scale health surveys. Measuring the 25(OH) D concentration for each participant is not always feasible, because of the logistics of blood collection and the costs of vitamin D testing. To address this problem, past research has used predicted 25(OH) D concentration, based on multivariable linear regression, as a proxy for unmeasured vitamin D status. We restate this approach in a mathematical framework, to deduce its possible pitfalls. Monte Carlo simulation and real data from the National Health and Nutrition Examination Survey 2005-06 are used to confirm the deductions. The results indicate that variables that are used in the prediction model (for 25[OH] D concentration) but not in the model for the health outcome (called instrumental variables), play an essential role in the identification of an effect. Such variables should be unrelated to the health outcome other than through vitamin D; otherwise the estimate of interest will be biased. The approach of predicted 25 (OH) D concentration derived from multivariable linear regression may be valid. However, careful verification that the instrumental variables are unrelated to the health outcome is required.	[Ding, Ning] Univ Canberra, Fac Hlth, Canberra, ACT 2601, Australia; [Ding, Ning; Guo, Shuyu; Xiang, Fan; Lucas, Robyn] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 2600, Australia; [Dear, Keith] Duke Kunshan Univ, Duke Global Hlth Inst, Kunshan 215316, Jiangsu, Peoples R China; [Lucas, Robyn] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	University of Canberra; Australian National University; Duke Kunshan University; Telethon Kids Institute; University of Western Australia	Ding, N (corresponding author), Univ Canberra, Fac Hlth, Canberra, ACT 2601, Australia.	ning.ding@canberra.edu.au		Lucas, Robyn/0000-0003-2736-3541; Dear, Keith/0000-0002-0788-7404	NHMRC Career Development Fellowship [1024898]	NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The authors received no specific funding for this work. Dr. Robyn Lucas would like to acknowledge that she is supported by a NHMRC Career Development Fellowship (1024898), https://www.nhmrc.gov.au/grants-funding/apply-funding/career-development-fellows hips.	Ananthakrishnan AN, 2012, GASTROENTEROLOGY, V142, P482, DOI 10.1053/j.gastro.2011.11.040; Bertrand KA, 2012, BRIT J NUTR, V108, P1889, DOI 10.1017/S0007114511007409; Bhaskaran K, 2014, INT J EPIDEMIOL, P1, DOI [10.1093/ije/dyuu080, DOI 10.1093/IJE/DYUU080]; Bilinski KL, 2012, MED J AUSTRALIA, V197, P90, DOI 10.5694/mja12.10561; Centers for Disease Control and Prevention, 2014, NAT CTR HLTH STAT NA; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; GARLAND FC, 1990, PREV MED, V19, P614, DOI 10.1016/0091-7435(90)90058-R; Gilbert R, 2012, CANCER CAUSE CONTROL, V23, P575, DOI 10.1007/s10552-012-9919-8; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Grant WB, 2009, ANN EPIDEMIOL, V19, P446, DOI 10.1016/j.annepidem.2008.12.014; Greene W, 2012, ECONOMETRIC ANAL; Harris HR, 2013, AM J EPIDEMIOL, V177, P420, DOI 10.1093/aje/kws247; Heckman JJ, 2008, INT STAT REV, V76, P1, DOI 10.1111/j.1751-5823.2007.00024.x; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Hoggatt KJ, 2003, INT J EPIDEMIOL, V32, P553, DOI 10.1093/ije/dyg222; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620; Jimenez M, 2014, PUBLIC HEALTH NUTR, V17, P844, DOI 10.1017/S1368980013000177; Joh HK, 2013, JNCI-J NATL CANCER I, V105, P726, DOI 10.1093/jnci/djt082; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318; Liu EJ, 2010, AM J CLIN NUTR, V91, P1627, DOI 10.3945/ajcn.2009.28441; Liu JJ, 2013, ANN ONCOL, V24, P687, DOI 10.1093/annonc/mds509; McCullagh P, 1989, GEN LINEAR MODELS; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ng K, 2009, BRIT J CANCER, V101, P916, DOI 10.1038/sj.bjc.6605262; Sattar N, 2012, LANCET, V379, P95, DOI 10.1016/S0140-6736(11)61816-3; SchmidtGayk H, 1997, SCAND J CLIN LAB INV, V57, P35; Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5	29	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125551	10.1371/journal.pone.0125551	http://dx.doi.org/10.1371/journal.pone.0125551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017695	Green Published, gold			2022-12-27	WOS:000355185600026
J	Elhelw, AM; Badran, EF				Elhelw, Amr M.; Badran, Ehab F.			Semi-Blind Error Resilient SLM for PAPR Reduction in OFDM Using Spread Spectrum Codes	PLOS ONE			English	Article							SIDE INFORMATION; SYSTEMS	High peak to average power ratio (PAPR) is one of the major problems of OFDM systems. Selected mapping (SLM) is a promising choice that can elegantly tackle this problem. Nevertheless, side information (SI) index is required to be transmitted which reduces the overall throughput. This paper proposes a semi-blind error resilient SLM system that utilizes spread spectrum codes for embedding the SI index in the transmitted symbols. The codes are embedded in an innovative manner which does not increase the average energy per symbol. The use of such codes allows the correction of probable errors in the SI index detection. A new receiver, which does not require perfect channel state information (CSI) for the detection of the SI index and has relatively low computational complexity, is proposed. Simulations results show that the proposed system performs well both in terms SI index detection error and bit error rate.	[Elhelw, Amr M.; Badran, Ehab F.] Arab Acad & Sci & Technol & Maritime Transport, Coll Engn & Technol, Dept Elect & Commun Engn, Alexandria 21937, Egypt	Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport	Elhelw, AM (corresponding author), Arab Acad & Sci & Technol & Maritime Transport, Coll Engn & Technol, Dept Elect & Commun Engn, Alexandria 21937, Egypt.	elhelw@aast.edu	Badran, Ehab Farouk/C-5103-2016	Badran, Ehab Farouk/0000-0001-9984-2475				Aburakhia SA, 2009, IEEE T BROADCAST, V55, P155, DOI 10.1109/TBC.2009.2013987; Badran EF, 2011, IEEE SIGNAL PROC LET, V18, P493, DOI 10.1109/LSP.2011.2160720; El-Helw AM, 2006, ELECTRON LETT, V42, P908, DOI 10.1049/el:20061290; El-Helw AM, 2012, JAP EG C EL COMM COM, P53; Hong E, 2013, IEEE T WIREL COMMUN, V12, P3140, DOI 10.1109/TWC.2013.061713.120280; Hu WW, 2012, IEEE COMMUN LETT, V16, P1056, DOI 10.1109/LCOMM.2012.050412.120482; Krongold BS, 2003, IEEE T BROADCAST, V49, P258, DOI 10.1109/TBC.2003.817088; Le Goff SY, 2009, IEEE T WIREL COMMUN, V8, P3320, DOI 10.1109/TWC.2009.070463; Rapp C., 1991, Proceedings of the Second European Conference on Satellite Communications. ECSC-2 (ESA SP-332), P179; Tellado J., 2000, MULTICARRIER MODULAT; Tellado J, 2000, PEAK AVERAGE POWER R	11	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127639	10.1371/journal.pone.0127639	http://dx.doi.org/10.1371/journal.pone.0127639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018504	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600091
J	Ho-Pham, LT; Lai, TQ; Nguyen, MTT; Nguyen, TV				Ho-Pham, Lan T.; Lai, Thai Q.; Nguyen, Mai T. T.; Nguyen, Tuan V.			Relationship between Body Mass Index and Percent Body Fat in Vietnamese: Implications for the Diagnosis of Obesity	PLOS ONE			English	Article							RISK-FACTORS; WAIST CIRCUMFERENCE; FOOD-CONSUMPTION; OVERWEIGHT; BMI; PREVALENCE; CHINESE; ADULTS; MORTALITY; POINTS	Background The burden of obesity in Vietnam has not been well defined because there is a lack of reference data for percent body fat (PBF) in Asians. This study sought to define the relationship between PBF and body mass index (BMI) in the Vietnamese population. Methods The study was designed as a comparative cross-sectional investigation that involved 1217 individuals of Vietnamese background (862 women) aged 20 years and older (average age 47 yr) who were randomly selected from the general population in Ho Chi Minh City. Lean mass (LM) and fat mass (FM) were measured by DXA (Hologic QDR 4500). PBF was derived as FM over body weight. Results Based on BMI >= 30, the prevalence of obesity was 1.1% and 1.3% for men and women, respectively. The prevalence of overweight and obesity combined (BMI >= 25) was similar to 24% and similar to 19% in men and women, respectively. Based on the quadratic relationship between BMI and PBF, the approximate PBF corresponding to the BMI threshold of 30 (obese) was 30.5 in men and 41 in women. Using the criteria of PBF > 30 in men and PBF > 40 in women, approximately 15% of men and women were considered obese. Conclusion These data suggest that body mass index underestimates the prevalence of obesity. We suggest that a PBF > 30 in men or PBF > 40 in women is used as criteria for the diagnosis of obesity in Vietnamese adults. Using these criteria, 15% of Vietnamese adults in Ho Chi Minh City was considered obese.	[Ho-Pham, Lan T.; Nguyen, Tuan V.] Ton Duc Thang Univ, Fac Sci Appl, Bone & Muscle Res Div, Ho Chi Minh City, Vietnam; [Ho-Pham, Lan T.] Pham Ngoc Thach Univ Med, Dept Internal Med, Ho Chi Minh City, Vietnam; [Ho-Pham, Lan T.; Lai, Thai Q.] Peoples Hosp 115, Dept Rheumatol, Ho Chi Minh City, Vietnam; [Nguyen, Mai T. T.] Pham Ngoc Thach Univ Med, Dept Med Eth Behav Sci, Ho Chi Minh City, Vietnam; [Nguyen, Tuan V.] Garvan Inst Med Res, Osteoporosis & Bone Biol, Sydney, NSW, Australia; [Nguyen, Tuan V.] UNSW Australia, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Nguyen, Tuan V.] Univ Technol Sydney, Ctr Hlth Technol, Sydney, NSW 2007, Australia	Ton Duc Thang University; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Technology Sydney	Ho-Pham, LT (corresponding author), Ton Duc Thang Univ, Fac Sci Appl, Bone & Muscle Res Div, Ho Chi Minh City, Vietnam.	hophamthuclan@tdt.edu.vn			Department of Science and Technology, Ho Chi Minh City; University Commission for Development (CUD) program, Belgium	Department of Science and Technology, Ho Chi Minh City(Department of Science & Technology (India)); University Commission for Development (CUD) program, Belgium	The study was partially supported by a grant from the Department of Science and Technology, Ho Chi Minh City and a grant from the University Commission for Development (CUD) program, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; [Anonymous], 2000, WHO TECH REP SER, P894; Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Cole TJ, 2008, AM J CLIN NUTR, V87, P1959, DOI 10.1093/ajcn/87.6.1959; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Deurenberg P, 2001, BRIT J NUTR, V85, P135, DOI 10.1079/BJN2000273; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Ha DTP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-62; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Ho-Pham LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094563; Ho-Pham LT, 2011, MAYO CLIN PROC, V86, P584, DOI 10.4065/mcp.2011.0097; Ho-Pham LT, 2010, OBESITY, V18, P1242, DOI 10.1038/oby.2010.19; Ho-Pham LT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-59; Jitnarin N, 2011, EAT WEIGHT DISORD-ST, V16, pE242, DOI 10.1007/BF03327467; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Kim CH, 2011, AM J CLIN NUTR, V94, P34, DOI 10.3945/ajcn.110.001867; Ko GTC, 2001, BRIT J NUTR, V85, P239, DOI 10.1079/BJN2000251; Kodama S, 2012, AM J EPIDEMIOL, V176, P959, DOI 10.1093/aje/kws172; Lee K, 2007, ASIA PAC J CLIN NUTR, V16, P649; Lin WY, 2011, CAN MED ASSOC J, V183, pE329, DOI 10.1503/cmaj.101303; Martin AD, 2011, J STAT SOFTW, V42, P1; Mohamud WNW, 2011, ASIA PAC J CLIN NUTR, V20, P35; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Odegaard AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014000; Pasco JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029580; R Development Core Team, 2008, LANG ENV STAT COMP; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Thang NM, 2004, EUR J CLIN NUTR, V58, P145, DOI 10.1038/sj.ejcn.1601761; Tuan NT, 2008, EUR J CLIN NUTR, V62, P78, DOI 10.1038/sj.ejcn.1602675; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Weisell RC, 2002, ASIA PAC J CLIN NUTR, V11, pS681, DOI 10.1046/j.1440-6047.11.s8.5.x; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Bank, 2018, WORLD DEV IND; World Health Organization, 1995, PHYS STAT US INT ANT; Yajnik CS, 2004, LANCET, V363, P163, DOI 10.1016/S0140-6736(03)15269-5; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	45	40	41	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127198	10.1371/journal.pone.0127198	http://dx.doi.org/10.1371/journal.pone.0127198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018910	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600075
J	Malvankar-Mehta, MS; Chen, YN; Iordanous, Y; Wang, WW; Costella, J; Hutnik, CML				Malvankar-Mehta, Monali S.; Chen, Yufeng Nancy; Iordanous, Yiannis; Wang, Wan Wendy; Costella, John; Hutnik, Cindy M. L.			iStent as a Solo Procedure for Glaucoma Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; MICRO-BYPASS STENT; OCULAR SURFACE; TIMOLOL; MEDICATIONS; ADHERENCE	Background Glaucoma is a leading cause of irreversible blindness. It is firmly entrenched in the traditional treatment paradigm to start with pharmacotherapy. However, pharmacotherapy is not benign and has been well documented to have a number of significant challenges. Minimally invasive glaucoma surgery (MIGS) that targets the outflow pathway with minimal to no scleral dissection has resulted in the need to reconsider the glaucoma treatment paradigm. Purpose To perform a systematic review and meta-analysis to evaluate and quantify the effect on post-operative intraocular pressure (IOP) and number of topical glaucoma medications, in patients receiving the iStent MIGS device as the solo procedure without concurrent cataract surgery. Methods A systematic review was conducted by searching various databases between January 1, 2000, and June 30, 2014. Studies reporting up to a maximum follow-up period of 24 months were retrieved and screened using the EPPI-Reviewer 4 gateway. Percentage reduction in IOP (IOPR%), and mean reduction in topical glaucoma medications after surgery were computed. Meta-analysis was performed using STATA v. 13.0. The standardized mean difference (SMD) was calculated as the effect size for continuous scale outcomes. Heterogeneity was determined using the I-2 statistics, Z-value, and chi(2) statistics. Fixed-effect and random-effect models were developed based on heterogeneity. Sub-group analysis was performed based on the number of iStents implanted and the follow-up period. The outcome measures were changes in the IOP and number of glaucoma medications. Results The search strategy identified 105 records from published literature and 9 records from the grey literature. Five studies with 248 subjects were included for quantitative synthesis. A 22% IOP reduction (IOPR%) from baseline occurred at 18-months after one iStent implant, 30% at 6-months after two iStents implantations, and 40% at 6-months after implantation of three iStents. A mean reduction of 1.2 bottles per patient of topical glaucoma medications occurred at 18-months after one iStent implant, 1.45 bottles per patient at 6-months after two iStents, and one bottle of medication per patient was reduced at 6-months following placement of three iStents implants. Meta-analysis results showed a significant reduction in the IOP after one iStent (SMD = -1.68, 95% CI: [-2.7, -0.61]), two iStents (SMD = -1.88, 95% CI: [-2.2, -1.56]), and three iStents (SMD = -2, 95% CI: [-2.62, -1.38]) implantation. Results showed a significant drop in the topical glaucoma medications after one iStent (SMD = -2.11, CI: [-3.95, -0.27]), two iStent (SMD = -1.88, CI: [-2.20, -1.56]), and three iStents (SMD = -2.00, CI: [-2.62, -1.38]) implantation. The maximum reduction in IOP occurred at 12-months (SMD = -2.21, CI: [-2.53, -1.88]) and a significant reduction in post-operative topical glaucoma medications occurred even after 18-months of iStent implantation (SMD = -0.71, CI: [-1.15, -0.26]). Conclusion iStent implantation as a solo procedure without concurrent cataract extraction does lower IOP, and reduces the dependency on glaucoma medications. This effect seems to last at least 18 months.	[Malvankar-Mehta, Monali S.; Iordanous, Yiannis; Hutnik, Cindy M. L.] Western Univ, Schulich Sch Med & Dent, Dept Ophthalmol, London, ON, Canada; [Malvankar-Mehta, Monali S.] Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada; [Chen, Yufeng Nancy; Wang, Wan Wendy] Western Univ, Schulich Sch Med & Dent, London, ON, Canada; [Costella, John] Western Univ, Ctr Nat Sci, Allyn & Betty Taylor Lib, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Malvankar-Mehta, MS (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Ophthalmol, London, ON, Canada.	Monali.Malvankar@schulich.uwo.ca	Costella, John/L-9241-2013	Costella, John/0000-0001-6542-6000				Ahmed SH, 2012, PROSPECTIVE RANDOMIZ, DOI [10.1016/j.jcrs.2012.03.006, DOI 10.1016/J.JCRS.2012.03.006]; American Academy of Ophthalmology (AAO), 2011, EYE HLTH STAT AM ACA; Ammar DA, 2011, ADV THER, V28, P501, DOI 10.1007/s12325-011-0029-x; Bates D., 1988, NONLINEAR REGRESSION; Baudouin C, 2008, OPHTHALMOLOGY, V115, P109, DOI 10.1016/j.ophtha.2007.01.036; Buchacra O, 2011, CLIN OPHTHALMOL, V5, P321, DOI 10.2147/OPTH.S15025; Buznego C, 2008, TECH OPHTHALMOL, V6, P114, DOI DOI 10.1097/ITO.0b013e318194e8c6; Center for Devices and Radiological Health, 2015, PREM STUD IMPL MIN I; Charters L, 2013, OPHTHALMOLOGY TIMES, P1, DOI [10.1186/1687-9856-2013-1, DOI 10.1186/1687-9856-2013-1]; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EVERITT DE, 1990, ANN INTERN MED, V112, P120, DOI 10.7326/0003-4819-112-2-120; Fea AM, 2010, J CATARACT REFR SURG, V36, P407, DOI 10.1016/j.jcrs.2009.10.031; Fingeret M, 1998, J Am Optom Assoc, V69, P115; Foundation BrightFocus, 2013, GLAUC FACTS STAT; Francis BA, 2011, OPHTHALMOLOGY, V118, P1466, DOI 10.1016/j.ophtha.2011.03.028; Glaucoma Research Foundation, 2013, GLAUC FACTS STATS; International Federation on Ageing, 2013, HIGH COST LOW VIS EV; Iordanous Y, 2013, J GLAUCOMA; KASS MA, 1987, AM J OPHTHALMOL, V103, P188, DOI 10.1016/S0002-9394(14)74225-4; Kholdebarin R, 2008, CAN J OPHTHALMOL, V43, P454, DOI [10.1139/i08-076, 10.3129/i08-076]; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Motulsky Harvey J., 2004, P1; Muller ME, 2006, BMJ-BRIT MED J, V332, P960, DOI 10.1136/bmj.332.7547.960; Nichamin LD, 2009, MIDDLE EAST AFR J OP, V16, P138, DOI 10.4103/0974-9233.56227; Okeke CO, 2009, OPHTHALMOLOGY, V116, P191, DOI 10.1016/j.ophtha.2008.09.004; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ratkowsky D.A, 1990, HDB NONLINEAR REGRES; Robin AL, 2007, AM J OPHTHALMOL, V144, P533, DOI 10.1016/j.ajo.2007.06.012; Saheb H, 2012, CURR OPIN OPHTHALMOL, V23, P96, DOI 10.1097/ICU.0b013e32834ff1e7; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Singh H, 2012, ISTENT GLAUCOMA DEVI; Spiegel D, 2002, BRIT J OPHTHALMOL, V86, P1228, DOI 10.1136/bjo.86.11.1228; Spiegel D, 2007, ADV THER, V24, P161, DOI 10.1007/BF02850004; Stone JL, 2009, ARCH OPHTHALMOL-CHIC, V127, P732, DOI 10.1001/archophthalmol.2009.96; The National Coalition for Vision Health, 2010, VIS LOSS CAN 2011; Tsai JC, 2009, OPHTHALMOLOGY, V116, pS30, DOI 10.1016/j.ophtha.2009.06.024; Vandewalle E, 2009, Bull Soc Belge Ophtalmol, P23; Voskanyan L, 2014, ADV THER, V31, P189, DOI 10.1007/s12325-014-0095-y; WHO Media Centre, 2013, VIS IMP BLINDN; Zhang WY, 2001, BRIT J OPHTHALMOL, V85, P983, DOI 10.1136/bjo.85.8.983	42	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128146	10.1371/journal.pone.0128146	http://dx.doi.org/10.1371/journal.pone.0128146			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018579	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600112
J	Mika, A; Van Treuren, W; Gonzalez, A; Herrera, JJ; Knight, R; Fleshner, M				Mika, Agnieszka; Van Treuren, Will; Gonzalez, Antonio; Herrera, Jonathan J.; Knight, Rob; Fleshner, Monika			Exercise Is More Effective at Altering Gut Microbial Composition and Producing Stable Changes in Lean Mass in Juvenile versus Adult Male F344 Rats	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; UNCONTROLLABLE STRESS; WEIGHT; EXPRESSION; DIVERSITY; BUTYRATE; BACTERIA; AGE; CONSEQUENCES; MICROFLORA	The mammalian intestine harbors a complex microbial ecosystem that influences many aspects of host physiology. Exposure to specific microbes early in development affects hostmetabolism, immune function, and behavior across the lifespan. Just as the physiology of the developing organism undergoes a period of plasticity, the developing microbial ecosystem is characterized by instability and may also be more sensitive to change. Early life thus presents a window of opportunity for manipulations that produce adaptive changes in microbial composition. Recent insights have revealed that increasing physical activity can increase the abundance of beneficial microbial species. We therefore investigated whether six weeks of wheel running initiated in the juvenile period (postnatal day 24) would produce more robust and stable changes in microbial communities versus exercise initiated in adulthood (postnatal day 70) in male F344 rats. 16S rRNA gene sequencing was used to characterize the microbial composition of juvenile versus adult runners and their sedentary counterparts across multiple time points during exercise and following exercise cessation. Alpha diversity measures revealed that the microbial communities of young runners were less even and diverse, a community structure that reflects volatility and malleability. Juvenile onset exercise altered several phyla and, notably, increased Bacteroidetes and decreased Firmicutes, a configuration associated with leanness. At the genus level of taxonomy, exercise altered more genera in juveniles than in the adults and produced patterns associated with adaptive metabolic consequences. Given the potential of these changes to contribute to a lean phenotype, we examined body composition in juvenile versus adult runners. Interestingly, exercise produced persistent increases in lean body mass in juvenile but not adult runners. Taken together, these results indicate that the impact of exercise on gut microbiota composition as well as body composition may depend on the developmental stage during which exercise is initiated.	[Mika, Agnieszka; Herrera, Jonathan J.; Fleshner, Monika] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80301 USA; [Mika, Agnieszka; Herrera, Jonathan J.; Fleshner, Monika] Univ Colorado, Ctr Neurosci, Boulder, CO 80301 USA; [Van Treuren, Will] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Gonzalez, Antonio; Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego	Fleshner, M (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80301 USA.	fleshner@colorado.edu	Knight, Rob/D-1299-2010; Gonzalez, Antonio/A-6421-2018	Fleshner, Monika/0000-0002-0470-0827; Knight, Rob/0000-0002-0975-9019	National Institutes of Health [R01-MH068283]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding provided by National Institutes of Health R01-MH068283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH EF, 1947, AM J PHYSIOL, V151, P110, DOI 10.1152/ajplegacy.1947.151.1.110; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; BERG RD, 1979, INFECT IMMUN, V23, P403, DOI 10.1128/IAI.23.2.403-411.1979; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke SF, 2014, GUT; CONLY JM, 1994, AM J GASTROENTEROL, V89, P915; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Desbonnet L, 2008, J PSYCHIATR RES, V43, P164, DOI 10.1016/j.jpsychires.2008.03.009; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Greenwood BN, 2008, NEUROMOL MED, V10, P81, DOI 10.1007/s12017-008-8029-y; Greenwood BN, 2012, BEHAV BRAIN RES, V233, P314, DOI 10.1016/j.bbr.2012.05.017; Greenwood BN, 2011, BEHAV BRAIN RES, V217, P354, DOI 10.1016/j.bbr.2010.11.005; Greenwood BN, 2005, BRAIN RES, V1033, P164, DOI 10.1016/j.brainres.2004.11.037; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Haange SB, 2012, J PROTEOME RES, V11, P5406, DOI 10.1021/pr3006364; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Korecka A, 2013, AM J PHYSIOL-GASTR L, V304, pG1025, DOI 10.1152/ajpgi.00293.2012; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mai V, 2007, MOL CARCINOGEN, V46, P42, DOI 10.1002/mc.20233; Mann PB, 2010, CARCINOGENESIS, V31, P1279, DOI 10.1093/carcin/bgq063; Maslanik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050636; Matsumoto M, 2008, BIOSCI BIOTECH BIOCH, V72, P572, DOI 10.1271/bbb.70474; McAllan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088904; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Meijer JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0210; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Million M, 2013, INT J OBESITY, V37, P1460, DOI 10.1038/ijo.2013.20; Murphy R, 2014, INT J OBESITY, V38, P1115, DOI 10.1038/ijo.2013.218; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Ohara Y, 2000, ACT NEUR S, V76, P117; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Petriz BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-511; Rao A. Ravishankar, 2009, P1; RESTREPO C, 1987, PSYCHONEUROENDOCRINO, V12, P393, DOI 10.1016/0306-4530(87)90068-0; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Salonen A., 2014, ISME J; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shindo D, 2014, J APPL PHYSIOL, V116, P674, DOI 10.1152/japplphysiol.00405.2013; Smith Dl Jr, 2009, Int J Body Compos Res, V7, P21; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Speaker KJ, 2014, BRAIN BEHAV IMMUN, V39, P87, DOI 10.1016/j.bbi.2013.10.028; STEVENSON JA, 1966, J APPL PHYSIOL, V21, P118, DOI 10.1152/jappl.1966.21.1.118; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sudo N, 1997, J IMMUNOL, V159, P1739; TAKEMOTO TI, 1975, TOHOKU J EXP MED, V117, P153, DOI 10.1620/tjem.117.153; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wall R, 2009, CLIN MED INSIGHTS-PE, V3, P45; Wilson M., 2005, MICROBIAL INHABITANT; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	80	110	116	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125889	10.1371/journal.pone.0125889	http://dx.doi.org/10.1371/journal.pone.0125889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016739	gold, Green Published			2022-12-27	WOS:000355185600039
J	Shim, DW; Heo, KH; Kim, YK; Sim, EJ; Kang, TB; Choi, JW; Sim, DW; Cheong, SH; Lee, SH; Bang, JK; Won, HS; Lee, KH				Shim, Do-Wan; Heo, Kang-Hyuck; Kim, Young-Kyu; Sim, Eun-Jeong; Kang, Tae-Bong; Choi, Jae-Wan; Sim, Dae-Won; Cheong, Sun-Hee; Lee, Seung-Hong; Bang, Jeong-Kyu; Won, Hyung-Sik; Lee, Kwang-Ho			Anti-Inflammatory Action of an Antimicrobial Model Peptide That Suppresses the TRIF-Dependent Signaling Pathway via Inhibition of Toll-Like Receptor 4 Endocytosis in Lipopolysaccharide-Stimulated Macrophages	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; FROG-SKIN; INNATE; EXPRESSION; INDUCTION; LPS; TOLL-LIKE-RECEPTOR-4; ACTIVATION; BINDING	Antimicrobial peptides (AMPs), also called host defense peptides, particularly those with amphipathic helical structures, are emerging as target molecules for therapeutic development due to their immunomodulatory properties. Although the antimicrobial activity of AMPs is known to be exerted primarily by permeation of the bacterial membrane, the mechanism underlying its anti-inflammatory activity remains to be elucidated. We report potent anti-inflammatory activity of WALK11.3, an antimicrobial model peptide with an amphipathic helical conformation, in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. This peptide inhibited the expression of inflammatory mediators, including nitric oxide, COX-2, IL-1 beta, IL-6, INF-beta, and TNF-alpha. Although WALK11.3 did not exert a major effect on all downstream signaling in the MyD88-dependent pathway, toll-like receptor 4 (TLR4)-mediated pro-inflammatory signals were markedly attenuated in the TRIF-dependent pathway due to inhibition of the phosphorylation of STAT1 by attenuation of IRF3 phosphorylation. WALK11.3 specifically inhibited the endocytosis of TLR4, which is essential for triggering TRIF-mediated signaling in macrophage cells. Hence, we suggest that specific interference with TLR4 endocytosis could be one of the major modes of the anti-inflammatory action of AMPs. Our designed WALK11 peptides, which possess both antimicrobial and anti-inflammatory activities, may be promising molecules for the development of therapies for infectious inflammation.	[Shim, Do-Wan; Heo, Kang-Hyuck; Kim, Young-Kyu; Sim, Eun-Jeong; Kang, Tae-Bong; Choi, Jae-Wan; Sim, Dae-Won; Cheong, Sun-Hee; Won, Hyung-Sik; Lee, Kwang-Ho] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, Chungbuk, South Korea; [Lee, Seung-Hong] Konkuk Univ, Coll Biomed & Hlth Sci, Div Food Biosci, Chungju, Chungbuk, South Korea; [Bang, Jeong-Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang, Chungbuk, South Korea	Konkuk University; Konkuk University; Korea Basic Science Institute (KBSI)	Won, HS (corresponding author), Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju, Chungbuk, South Korea.	wonhs@kku.ac.kr; kwangho@kku.ac.kr	kang, Tae-bong/AAD-7950-2022	kang, Tae-bong/0000-0003-1441-9470	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012-A419-0040]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092006]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012-A419-0040) and in part by the Korea Healthcare Technology R&D Project (no. A092006), Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Conlon JM, 2014, PEPTIDES, V57, P67, DOI 10.1016/j.peptides.2014.04.019; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Ge L, 2014, SCI WORLD J, V2014; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jacob B, 2014, AMINO ACIDS, V46, P187, DOI 10.1007/s00726-013-1616-8; Jacobs AT, 2001, J BIOL CHEM, V276, P47950, DOI 10.1074/jbc.M106639200; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim SJ, 2013, MOLECULES, V18, P859, DOI 10.3390/molecules18010859; Lee E, 2013, BBA-BIOMEMBRANES, V1828, P271, DOI 10.1016/j.bbamem.2012.10.028; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074194; Lee SH, 2011, REGUL PEPTIDES, V166, P36, DOI 10.1016/j.regpep.2010.08.010; Meng P, 2012, BIOCHIMIE, V94, P2508, DOI 10.1016/j.biochi.2012.06.029; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Moynagh PN, 2005, TRENDS IMMUNOL, V26, P469, DOI 10.1016/j.it.2005.06.009; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Shim DW, 2013, J ETHNOPHARMACOL, V150, P1007, DOI 10.1016/j.jep.2013.09.056; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wang JX, 2009, ACTA PHARMACOL SIN, V30, P1428, DOI 10.1038/aps.2009.138; Wei L, 2013, J MED CHEM, V56, P3546, DOI 10.1021/jm4004158; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	34	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126871	10.1371/journal.pone.0126871	http://dx.doi.org/10.1371/journal.pone.0126871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017270	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600063
J	Bednarczyk-Cwynar, B; Partyka, D; Zaprutko, L				Bednarczyk-Cwynar, Barbara; Partyka, Danuta; Zaprutko, Lucjusz			Simple Amides of Oleanolic Acid as Effective Penetration Enhancers	PLOS ONE			English	Article							STRUCTURE ELUCIDATION; DERIVATIVES; MEMBRANES; SKIN; TRITERPENOIDS; MECHANISMS; TRANSPORT; DELIVERY	Transdermal transport is now becoming one of the most convenient and safe pathways for drug delivery. In some cases it is necessary to use skin penetration enhancers in order to allow for the transdermal transport of drugs that are otherwise insufficiently skin-permeable. A series of oleanolic acid amides as potential transdermal penetration enhancers was formed by multistep synthesis and the synthesis of all newly prepared compounds is presented. The synthetized amides of oleanolic acid were tested for their in vitro penetration promoter activity. The above activity was evaluated by means of using the Furst Method. The relationships between the chemical structure of the studied compounds and penetration activity are presented.	[Bednarczyk-Cwynar, Barbara; Zaprutko, Lucjusz] Poznan Univ Med Sci, Fac Pharm, Dept Organ Chem, PL-60780 Poznan, Poland; [Partyka, Danuta] Poznan Univ Med Sci, Fac Pharm, Dept Technol Drug Forms, PL-60780 Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Bednarczyk-Cwynar, B (corresponding author), Poznan Univ Med Sci, Fac Pharm, Dept Organ Chem, Grunwaldzka Str 6, PL-60780 Poznan, Poland.	bcwynar@ump.edu.pl	Partyka, Danuta/P-5766-2015; 张, 张鑫月/AAP-1001-2020	Zaprutko, Lucjusz/0000-0003-1121-6272				Asbill Charles S., 2000, Pharmaceutical Science and Technology Today, V3, P36, DOI 10.1016/S1461-5347(99)00225-4; Barry BW, 2001, EUR J PHARM SCI, V14, P101, DOI 10.1016/S0928-0987(01)00167-1; Bednarczyk-Cwynar B, 2013, J MOL STRUCT, V1053, P115, DOI 10.1016/j.molstruc.2013.09.006; Chen Y, 2011, CHINA J CHIN MAT MED, V36, P4; Demir YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077289; FURST W, 1980, PHARMAZIE, V35, P106; Godwin DA, 1997, INT J PHARM, V155, P241, DOI 10.1016/S0378-5173(97)00163-4; Hadgraft J, 1996, INT J PHARM, V141, P17, DOI 10.1016/0378-5173(96)04609-1; Han SK, 1997, LIPIDS, V32, P769, DOI 10.1007/s11745-997-0098-9; Harrison JE, 1996, J CONTROL RELEASE, V41, P283, DOI 10.1016/0168-3659(96)01348-X; Honeywell-Nguyen P Loan, 2005, Drug Discov Today Technol, V2, P67, DOI 10.1016/j.ddtec.2005.05.003; Ibrahim SA, 2010, INT J PHARMACEUT, V383, P89, DOI 10.1016/j.ijpharm.2009.09.014; Jaworska M, 2013, ACTA BIOCHIM POL, V60, P779; Karande P, 2009, BBA-BIOMEMBRANES, V1788, P2362, DOI 10.1016/j.bbamem.2009.08.015; Kim N, 2001, J CONTROL RELEASE, V73, P183, DOI 10.1016/S0168-3659(01)00350-9; Marepally S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082581; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Pino CJ, 2014, DRUG DELIV TRANSL RE, V4, P131, DOI 10.1007/s13346-013-0186-3; Pino CJ, 2012, P NATL ACAD SCI USA, V109, P21283, DOI 10.1073/pnas.1200942109; Pungitore CR, 2005, J STORED PROD RES, V41, P433, DOI 10.1016/j.jspr.2004.07.001; RICHTER H, 1978, PHARMAZIE, V33, P523; Sinico C, 2005, J CONTROL RELEASE, V103, P123, DOI 10.1016/j.jconrel.2004.11.020; Vogel A. I., 1989, VOGELS TXB PRACTICAL, P395; Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025; WRZECIONO U, 1984, PHARMAZIE, V39, P683; WRZECIONO U, 1985, PHARMAZIE, V40, P542; Yan G, 2005, J CONTROL RELEASE, V110, P141, DOI 10.1016/j.jconrel.2005.09.006; YASUE M, 1974, YAKUGAKU ZASSHI, V94, P1468, DOI 10.1248/yakushi1947.94.11_1468; Zaprutko L, 2004, BIOORG MED CHEM LETT, V14, P4723, DOI 10.1016/j.bmcl.2004.06.087; ZAPRUTKO L, 1995, POL J CHEM, V69, P1003	30	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0122857	10.1371/journal.pone.0122857	http://dx.doi.org/10.1371/journal.pone.0122857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010090	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900003
J	Bermudez, M; Imaz-Rosshandler, I; Rangel-Escareno, C; Zeichner-David, M; Arzate, H; Mercado-Celis, GE				Bermudez, Mercedes; Imaz-Rosshandler, Ivan; Rangel-Escareno, Claudia; Zeichner-David, Margarita; Arzate, Higinio; Mercado-Celis, Gabriela E.			CEMP1 Induces Transformation in Human Gingival Fibroblasts	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PERIODONTAL-LIGAMENT CELLS; PROSTATE-CANCER; BREAST-CANCER; E-CADHERIN; CEMENTUM; EXPRESSION; CARCINOMA; PROTEIN; OVEREXPRESSION	Cementum Protein 1 (CEMP1) is a key regulator of cementogenesis. CEMP1 promotes cell attachment, differentiation, deposition rate, composition, and morphology of hydroxyapatite crystals formed by human cementoblastic cells. Its expression is restricted to cementoblasts and progenitor cell subpopulations present in the periodontal ligament. CEMP1 transfection into non-osteogenic cells such as adult human gingival fibroblasts results in differentiation of these cells into a "mineralizing" cell phenotype. Other studies have shown evidence that CEMP1 could have a therapeutic potential for the treatment of bone defects and regeneration of other mineralized tissues. To better understand CEMP1's biological effects in vitro we investigated the consequences of its expression in human gingival fibroblasts (HGF) growing in non-mineralizing media by comparing gene expression profiles. We identified several mRNAs whose expression is modified by CEMP1 induction in HGF cells. Enrichment analysis showed that several of these newly expressed genes are involved in oncogenesis. Our results suggest that CEMP1 causes the transformation of HGF and NIH3T3 cells. CEMP1 is overexpressed in cancer cell lines. We also determined that the region spanning the CEMP1 locus is commonly amplified in a variety of cancers, and finally we found significant overexpression of CEMP1 in leukemia, cervix, breast, prostate and lung cancer. Our findings suggest that CEMP1 exerts modulation of a number of cellular genes, cellular development, cellular growth, cell death, and cell cycle, and molecules associated with cancer.	[Bermudez, Mercedes; Arzate, Higinio] Univ Nacl Autonoma Mexico, Fac Odontol, Lab Biol Periodontal, Mexico City 04510, DF, Mexico; [Imaz-Rosshandler, Ivan; Rangel-Escareno, Claudia; Mercado-Celis, Gabriela E.] SSA, Inst Nacl Med Genom, Mexico City, DF, Mexico; [Zeichner-David, Margarita] Univ So Calif, Ostrow Sch Dent, Los Angeles, CA USA	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; University of Southern California	Mercado-Celis, GE (corresponding author), Univ Nacl Autonoma Mexico, Fac Odontol, Lab Genom, Mexico City 04510, DF, Mexico.	gemercadoc@unam.mx	Mercado-Celis, Gabriela E./AAR-7836-2020; Rangel-Escareno, Claudia/F-4587-2012; Arzate, Higinio/K-1934-2019	Mercado-Celis, Gabriela E./0000-0003-3113-0687; Rangel-Escareno, Claudia/0000-0003-1303-0834; Imaz Rosshandler, Ivan/0000-0001-5975-0138	Consejo Nacional de Ciencia y Tecnologia [224081, 142158]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [IT200414]; Internal Research Program Instituto Nacional de Medicina Genomica	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Internal Research Program Instituto Nacional de Medicina Genomica	This work was supported by Consejo Nacional de Ciencia y Tecnologia (224081) (HA); Consejo Nacional de Ciencia y Tecnologia (142158) (GEM) (www.conacyt.mx); Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (IT200414) (HA); and Internal Research Program Instituto Nacional de Medicina Genomica (GEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Perez MA, 2006, BONE, V38, P409, DOI 10.1016/j.bone.2005.09.009; Arzate H, 2002, J DENT RES, V81, P541, DOI 10.1177/154405910208100808; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x; Benjamini Y, CONTROLLING FALSE DI; Brannon RB, 2002, ORAL SURG ORAL MED O, V93, P311, DOI 10.1067/moe.2002.121993; Carmona-Rodriguez B, 2007, BIOCHEM BIOPH RES CO, V358, P763, DOI 10.1016/j.bbrc.2007.04.204; Chen W, 2012, STEM CELLS DEV, V21, P3372, DOI 10.1089/scd.2012.0121; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Choucair KA, 2012, TRANSL ONCOL, V5, P453, DOI 10.1593/tlo.12286; Fan M, 2013, TUMORI J, V99, P689, DOI 10.1700/1390.15457; Feng S, 2014, HISTOL HISTOPATHOL; Paula-Silva FWG, 2010, CALCIFIED TISSUE INT, V87, P144, DOI 10.1007/s00223-010-9368-x; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Giunti L, 2014, AM J CANCER RES, V4, P293; Gonzalez-Alva P, 2013, J ORAL RES, P2; Gonzalez-Perez A, 2013, NAT METHODS, V10, P723, DOI 10.1038/nmeth.2562; Grzesik WJ, 2002, CRIT REV ORAL BIOL M, V13, P474, DOI 10.1177/154411130201300605; Hoz L, 2012, CELL BIOL INT, V36, P129, DOI 10.1042/CBI20110168; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Komaki M, 2012, J CELL PHYSIOL, V227, P649, DOI 10.1002/jcp.22770; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Lacle MM, 2013, MODERN PATHOL, V26, P1461, DOI 10.1038/modpathol.2013.94; Lee BK, 2013, J KOR ASSOC ORAL MAX, V39, P255, DOI 10.5125/jkaoms.2013.39.6.255; Lerch JK, 2014, MOL CELL NEUROSCI, V59, P97, DOI 10.1016/j.mcn.2014.02.002; Lu Y, 2005, BIOINFORMATICS, V21, P3105, DOI 10.1093/bioinformatics/bti496; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; MCCARTHY SA, 1995, GENE DEV, V9, P1953, DOI 10.1101/gad.9.16.1953; MORELLO D, 1990, ONCOGENE, V5, P1511; Nakamura K, 2006, GASTROENTEROLOGY, V131, P1530, DOI 10.1053/j.gastro.2006.08.030; NARAYANAN AS, 1976, J BIOL CHEM, V251, P5464; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Neves F S, 2009, Minerva Stomatol, V58, P55; Nunez J, 2012, J PERIODONTAL RES, V47, P33, DOI 10.1111/j.1600-0765.2011.01402.x; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Raphael BJ, 2014, GENOME MED, V6, DOI 10.1186/gm524; Rodini CO, 2012, INT J ONCOL, V40, P1180, DOI 10.3892/ijo.2011.1321; Saha B, 2008, PROSTATE, V68, P78, DOI 10.1002/pros.20670; Saha B, 2007, ANTICANCER RES, V27, P3903; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Serrano J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078807; Sharma A, 2008, CANCER INVEST, V26, P843, DOI 10.1080/07357900801954210; Shen H, 2008, CANCER GENET CYTOGEN, V181, P100, DOI 10.1016/j.cancergencyto.2007.11.012; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tai YC, 2005, STAT ANAL MICROARRAY; De Hoyos AV, 2012, J DENT RES, V91, P203, DOI 10.1177/0022034511428155; Villarreal-Ramirez E, 2009, BIOCHEM BIOPH RES CO, V384, P49, DOI 10.1016/j.bbrc.2009.04.072; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang W, 2013, ONCOL LETT, V5, P884, DOI 10.3892/ol.2012.1091; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824	55	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127286	10.1371/journal.pone.0127286	http://dx.doi.org/10.1371/journal.pone.0127286			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011628	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900078
J	Iessi, E; Zischler, L; Etringer, A; Bergeret, M; Morle, A; Jacquemin, G; Morizot, A; Shirley, S; Lalaoui, N; Elifio-Esposito, SL; Fais, S; Garrido, C; Solary, E; Micheau, O				Iessi, Elisabetta; Zischler, Luciana; Etringer, Aurelie; Bergeret, Marion; Morle, Aymeric; Jacquemin, Guillaume; Morizot, Alexandre; Shirley, Sarah; Lalaoui, Najoua; Elifio-Esposito, Selene L.; Fais, Stefano; Garrido, Carmen; Solary, Eric; Micheau, Olivier			Death Receptor-Induced Apoptosis Signalling Regulation by Ezrin Is Cell Type Dependent and Occurs in a DISC-Independent Manner in Colon Cancer Cells	PLOS ONE			English	Article							MEDIATED APOPTOSIS; PHOSPHORYLATION; IDENTIFICATION; TRAIL; SENSITIVITY; MECHANISM; REVEALS; FADD	Ezrin belongs to the ERM (ezrin-radixin-moesin) protein family and has been demonstrated to regulate early steps of Fas receptor signalling in lymphoid cells, but its contribution to TRAIL-induced cell death regulation in adherent cancer cells remains unknown. In this study we report that regulation of FasL and TRAIL-induced cell death by ezrin is cell type dependant. Ezrin is a positive regulator of apoptosis in T-lymphoma cell line Jurkat, but a negative regulator in colon cancer cells. Using ezrin phosphorylation or actin-binding mutants, we provide evidence that negative regulation of death receptor-induced apoptosis by ezrin occurs in a cytoskeleton-and DISC-independent manner, in colon cancer cells. Remarkably, inhibition of apoptosis induced by these ligands was found to be tightly associated with regulation of ezrin phosphorylation on serine 66, the tumor suppressor gene WWOX and activation of PKA. Deficiency in WWOX expression in the liver cancer SK-HEP1 or the pancreatic Mia PaCa-2 cell lines as well as WWOX silencing or modulation of PKA activation by pharmacological regulators, in the colon cancer cell line SW480, abrogated regulation of TRAIL signalling by ezrin. Altogether our results show that death receptor pro-apoptotic signalling regulation by ezrin can occur downstream of the DISC in colon cancer cells.	[Iessi, Elisabetta; Zischler, Luciana; Etringer, Aurelie; Bergeret, Marion; Morle, Aymeric; Jacquemin, Guillaume; Morizot, Alexandre; Shirley, Sarah; Lalaoui, Najoua; Garrido, Carmen; Micheau, Olivier] INSERM, U866, F-21079 Dijon, France; [Iessi, Elisabetta; Etringer, Aurelie; Bergeret, Marion; Morle, Aymeric; Jacquemin, Guillaume; Morizot, Alexandre; Shirley, Sarah; Lalaoui, Najoua; Garrido, Carmen; Micheau, Olivier] Univ Bourgogne, UFR Sci Sante, F-21079 Dijon, France; [Zischler, Luciana; Elifio-Esposito, Selene L.] Pontificia Univ Catolica Parana, Escola Med, Posgrad Ciencias Saude, BR-80215901 Curitiba, Parana, Brazil; [Fais, Stefano] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Antitumor Drugs Sect, I-00161 Rome, Italy; [Solary, Eric] INSERM, U1009, F-94805 Villejuif, France; [Solary, Eric] Univ Paris 11, Inst Gustave Roussy, F-94805 Villejuif, France; [Garrido, Carmen; Micheau, Olivier] Ctr Georges Francois Leclerc, F-21000 Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Pontificia Universidade Catolica do Parana; Istituto Superiore di Sanita (ISS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Centre Georges-Francois Leclerc	Micheau, O (corresponding author), INSERM, U866, F-21079 Dijon, France.	olivier.micheau@inserm.fr	Esposito, Selene/AAR-3671-2021; Garrido, carmen/G-1633-2018; Lalaoui, Najoua/C-1410-2014; Garrido, Carolina/GWM-5557-2022; micheau, olivier/C-3574-2011; Fais, Stefano/J-8638-2016; Iessi, Elisabetta/O-2460-2017	Garrido, carmen/0000-0003-1368-1493; Lalaoui, Najoua/0000-0002-0165-3324; micheau, olivier/0000-0001-8499-7984; Fais, Stefano/0000-0001-9060-2766; Iessi, Elisabetta/0000-0001-7221-9173; Elifio-Esposito, Selene/0000-0002-8676-134X; Solary, Eric/0000-0002-8629-1341; Zischler, PhD, Dr. Luciana/0000-0001-8169-7601	European Community (ApopTrain Marie Curie RTN); program "Investissements d'Avenir" [ANR-11-LABX-0021-01-LipSTIC Labex]; University of Bourgogne; Conseil Regional de Bourgogne; INCa (Institut National du Cancer) [POLYNOM-174]; Canceropole Grand-Est; Ligue Nationale contre le Cancer; ARC (Association pour la Recherche sur le Cancer); Ministry of Research and Education; Marie Curie RTN; INCa; CAPES [BEX4938/14-3]	European Community (ApopTrain Marie Curie RTN)(European Commission); program "Investissements d'Avenir"(French National Research Agency (ANR)); University of Bourgogne; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); Canceropole Grand-Est(Region Grand-Est); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ministry of Research and Education; Marie Curie RTN(European Commission); INCa(Institut National du Cancer (INCA) France); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from the European Community (ApopTrain Marie Curie RTN), the program "Investissements d'Avenir" with reference ANR-11-LABX-0021-01-LipSTIC Labex, the University of Bourgogne, the Conseil Regional de Bourgogne, the INCa (Institut National du Cancer, POLYNOM-174), the Canceropole Grand-Est, the Ligue Nationale contre le Cancer, ARC (Association pour la Recherche sur le Cancer), and Ministry of Research and Education. EI, SS, LZ and AM were supported by fellowships from the Marie Curie RTN, INCa, CAPES (No BEX4938/14-3) and the Ligue Nationale Contre le Cancer, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Fluur C, 2007, J IMMUNOL, V178, P5340, DOI 10.4049/jimmunol.178.8.5340; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; KRIEG J, 1992, J BIOL CHEM, V267, P19258; Kuo WC, 2010, ONCOGENE, V29, P1374, DOI 10.1038/onc.2009.417; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; Luciani F, 2004, CELL DEATH DIFFER, V11, P574, DOI 10.1038/sj.cdd.4401374; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Merino D, 2007, EXPERT OPIN THER TAR, V11, P1299, DOI 10.1517/14728222.11.10.1299; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Piazzolla D, 2005, J CELL BIOL, V171, P1013, DOI 10.1083/jcb.200504137; Ramaswamy M, 2007, J IMMUNOL, V179, P6384, DOI 10.4049/jimmunol.179.10.6384; Saleh HS, 2009, J MOL BIOL, V385, P1015, DOI 10.1016/j.jmb.2008.11.051; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 1997, FEBS LETT, V416, P329, DOI 10.1016/S0014-5793(97)01231-3; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Zhang P, 2012, MOL MED REP, V6, P121, DOI 10.3892/mmr.2012.860; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	31	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126526	10.1371/journal.pone.0126526	http://dx.doi.org/10.1371/journal.pone.0126526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010871	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900032
J	Ji, F; Li, JA; Hong, MD; Chen, AT; Jiao, QS; Sun, L; Liang, SC; Yang, SM				Ji, Fei; Li, Jianan; Hong, Mengdi; Chen, Aiting; Jiao, Qingshan; Sun, Li; Liang, Sichao; Yang, Shiming			Determination of Benefits of Cochlear Implantation in Children with Auditory Neuropathy	PLOS ONE			English	Article							SPEECH-PERCEPTION; SPECTRUM DISORDER; HEARING; PERFORMANCE; MANAGEMENT; SYNCHRONY; DIAGNOSIS; OUTCOMES; PATIENT	Background Auditory neuropathy (AN) is a recently recognized hearing disorder characterized by intact outer hair cell function, disrupted auditory nerve synchronization and poor speech perception and recognition. Cochlear implants (CIs) are currently the most promising intervention for improving hearing and speech in individuals with AN. Although previous studies have shown optimistic results, there was large variability concerning benefits of CIs among individuals with AN. The data indicate that different criteria are needed to evaluate the benefit of CIs in these children compared to those with sensorineural hearing loss. We hypothesized that a hierarchic assessment would be more appropriate to evaluate the benefits of cochlear implantation in AN individuals. Methods Eight prelingual children with AN who received unilateral CIs were included in this study. Hearing sensitivity and speech recognition were evaluated pre- and postoperatively within each subject. The efficacy of cochlear implantation was assessed using a stepwise hierarchic evaluation for achieving: (1) effective audibility, (2) improved speech recognition, (3) effective speech, and (4) effective communication. Results The postoperative hearing and speech performance varied among the subjects. According to the hierarchic assessment, all eight subjects approached the primary level of effective audibility, with an average implanted hearing threshold of 43.8 +/- 10.2 dB HL. Five subjects (62.5%) attained the level of improved speech recognition, one (12.5%) reached the level of effective speech, and none of the subjects (0.0%) achieved effective communication. Conclusion CIs benefit prelingual children with AN to varying extents. A hierarchic evaluation provides a more suitable method to determine the benefits that AN individuals will likely receive from cochlear implantation.	[Ji, Fei; Li, Jianan; Hong, Mengdi; Chen, Aiting; Jiao, Qingshan; Sun, Li; Liang, Sichao; Yang, Shiming] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital	Yang, SM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing 100853, Peoples R China.	yangsm301@263.net			National Basic Research Program of China (973 Program) [2012CB967900]; Science and Technology Innovation Nursery Foundation of PLA General Hospital [12KMM29]; Clinical Research Supporting Foundation of PLA General Hospital [2012FC-TSYS-3056]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Science and Technology Innovation Nursery Foundation of PLA General Hospital; Clinical Research Supporting Foundation of PLA General Hospital	This work was supported by grants from the National Basic Research Program of China (973 Program) (#2012CB967900), Science and Technology Innovation Nursery Foundation of PLA General Hospital (12KMM29), and Clinical Research Supporting Foundation of PLA General Hospital (2012FC-TSYS-3056).	Allen MC, 1998, AM J OTOL, V19, P742; ASHA, 2003, NATIONAL OUTCOMES ME; Berlin CI, 2010, INT J AUDIOL, V49, P30, DOI 10.3109/14992020903160892; Berlin CI, 2003, MENT RETARD DEV D R, V9, P225, DOI 10.1002/mrdd.10084; Berlin CI, 1999, HEARING RES, V65, P40; BOND M, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI DOI 10.3310/HTA13440; Bradley Jane, 2008, Cochlear Implants Int, V9, P34, DOI 10.1179/cim.2008.9.1.34; Breneman AI, 2012, J AM ACAD AUDIOL, V23, P5, DOI 10.3766/jaaa.23.1.2; Brookes JT, 2008, INT J PEDIATR OTORHI, V72, P121, DOI 10.1016/j.ijporl.2007.08.019; Buss E, 2002, OTOL NEUROTOL, V23, P328, DOI 10.1097/00129492-200205000-00017; Dowley AC, 2009, DEV MED CHILD NEUROL, V51, P642, DOI 10.1111/j.1469-8749.2009.03298.x; Ferreira K, 2011, J APPL ORAL SCI, V19, P586, DOI 10.1590/S1678-77572011000600008; Fulmer SL, 2011, OTOLARYNG HEAD NECK, V144, P274, DOI 10.1177/0194599810391603; Gibson William P R, 2008, Cochlear Implants Int, V9, P1, DOI 10.1179/cim.2008.9.1.1; Gibson WPR, 2007, EAR HEARING, V28, p102S, DOI 10.1097/AUD.0b013e3180315392; Jeong SW, 2007, ACTA OTO-LARYNGOL, V127, P36, DOI 10.1080/03655230701624848; Ji F, 2014, ACTA OTO-LARYNGOL, V134, P280, DOI 10.3109/00016489.2013.852689; [冀飞 Ji Fei], 2004, [中华耳鼻咽喉科杂志, Chinese Journal of Otorhinolaryngology], V39, P584; Jung KH, 2012, AUDIOL NEURO-OTOL, V17, P189, DOI 10.1159/000336407; Katada A, 2005, EUR ARCH OTO-RHINO-L, V262, P449, DOI 10.1007/s00405-004-0863-4; Leigh J, 2003, PERSPECTIVES ON HEAR, V1240, P423; Mason JC, 2003, LARYNGOSCOPE, V113, P45, DOI 10.1097/00005537-200301000-00009; Miyamoto RT, 1999, LARYNGOSCOPE, V109, P181, DOI 10.1097/00005537-199902000-00002; Peterson Ann, 2003, J Am Acad Audiol, V14, P188; Postelmans JTF, 2006, J LARYNGOL OTOL, V120, P508, DOI 10.1017/S0022215106000727; Rance G, 1999, EAR HEARING, V20, P238, DOI 10.1097/00003446-199906000-00006; Rance G, 2008, OTOL NEUROTOL, V29, P179, DOI 10.1097/mao.0b013e31815e92fd; Raveh E, 2007, AM J OTOLARYNG, V28, P302, DOI 10.1016/j.amjoto.2006.09.006; ROBBINS AM, 1991, AM J OTOL, V12, P144; Roush P, 2011, AM J AUDIOL, V20, P159, DOI 10.1044/1059-0889(2011/10-0032); Shallop JK, 2001, LARYNGOSCOPE, V111, P555, DOI 10.1097/00005537-200104000-00001; Shallop Jon K., 2002, Seminars in Hearing, V23, P215, DOI 10.1055/s-2002-34474; SHANNON RV, 1993, PROG BRAIN RES, V97, P261; Sininger Y, 2002, AUDIOLOGY TODAY, V14, P16; Sininger Y, 2008, GUIDELINES FOR IDENT; STARR A, 1991, BRAIN, V114, P1157, DOI 10.1093/brain/114.3.1157; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Starr A., 2008, SENSES COMPREHENSIVE, P397; Talaat HS, 2009, INT J PEDIATR OTORHI, V73, P937, DOI 10.1016/j.ijporl.2009.03.009; Teagle HFB, 2010, EAR HEARING, V31, P325, DOI 10.1097/AUD.0b013e3181ce693b; Trautwein P G, 2000, J Am Acad Audiol, V11, P309; Walton J, 2008, OTOL NEUROTOL, V29, P302, DOI 10.1097/MAO.0b013e318164d0f6; Wang NY, 2008, OTOL NEUROTOL, V29, P240, DOI 10.1097/MAO.0b013e3181627a37; Wong LLN, 2008, INT J AUDIOL, V47, P393, DOI 10.1080/14992020701870221; Zdanski C, 2006, PERSPECTIVES ON HEAR, V16, P12; Zeng FG, 2006, J SPEECH LANG HEAR R, V49, P367, DOI 10.1044/1092-4388(2006/029); Zeng FG, 1999, NEUROREPORT, V10, P3429, DOI 10.1097/00001756-199911080-00031; Zheng Y, 2009, INT J AUDIOL, V48, P718, DOI 10.1080/14992020902902658; Zheng Y, 2009, EAR HEARING, V30, P600, DOI 10.1097/AUD.0b013e3181b4aba8; ZHOU RZ, 1995, HEARING RES, V88, P98, DOI 10.1016/0378-5955(95)00105-D	50	5	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127566	10.1371/journal.pone.0127566	http://dx.doi.org/10.1371/journal.pone.0127566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010832	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900111
J	Kurushima, Y; Ikebe, K; Matsuda, K; Enoki, K; Ogata, S; Yamashita, M; Murakami, S; Maeda, Y				Kurushima, Yuko; Ikebe, Kazunori; Matsuda, Ken-ichi; Enoki, Kaori; Ogata, Soshiro; Yamashita, Motozo; Murakami, Shinya; Maeda, Yoshinobu		Osaka Twin Res Grp	Examination of the Relationship between Oral Health and Arterial Sclerosis without Genetic Confounding through the Study of Older Japanese Twins	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; TOOTH LOSS; MASTICATORY PERFORMANCE; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; ASYMPTOMATIC SUBJECTS; PERIODONTAL-DISEASE; WALL THICKNESS; HEART-DISEASE; RISK	Objective Although researchers have recently demonstrated a relationship between oral health and arterial sclerosis, the genetic contribution to this relationship has been ignored even though genetic factors are expected to have some effect on various diseases. The aim of this study was to evaluate oral health as a significant risk factor related to arterial sclerosis after eliminating genetic confounding through study of older Japanese twins. Subjects and Methods Medical and dental surveys were conducted individually for 106 Japanese twin pairs over the age of 50 years. Maximal carotid intima-media thickness (IMT-Cmax) was measured as a surrogate marker of arterial sclerosis. IMT-Cmax > 1.0 mm was diagnosed as arterial sclerosis. All of the twins were examined for the number of remaining teeth, masticatory performance, and periodontal status. We evaluated each measurement related with IMT-Cmax and arterial sclerosis using generalized estimating equations analysis adjusted for potential risk factors. For non-smoking monozygotic twins, a regression analysis using a "between within" model was conducted to evaluate the relationship between IMT-Cmax and the number of teeth as the environmental factor controlling genetic and familial confounding. Results We examined 91 monozygotic and 15 dizygotic twin pairs (males: 42, females: 64) with a mean (+/- standard deviation) age of 67.4 +/- 10.0 years. Out of all of the oral health-related measurements collected, only the number of teeth was significantly related to arterial sclerosis (odds ratio: 0.72, 95% confidence interval: 0.52-0.99 per five teeth). Regression analysis showed a significant association between the IMT-Cmax and the number of teeth as an environmental factor (p = 0.037). Conclusions Analysis of monozygotic twins older than 50 years of age showed that having fewer teeth could be a significant environmental factor related to arterial sclerosis, even after controlling for genetic and familial confounding.	[Kurushima, Yuko; Ikebe, Kazunori; Matsuda, Ken-ichi; Enoki, Kaori; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka, Japan; [Ogata, Soshiro; Osaka Twin Res Grp] Osaka Univ, Grad Sch Med, Ctr Twin Res, Suita, Osaka, Japan; [Yamashita, Motozo; Murakami, Shinya] Osaka Univ, Dept Periodontol, Grad Sch Dent, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Ikebe, K (corresponding author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka, Japan.	ikebe@dent.osaka-u.ac.jp	Gao, Jing/M-8264-2018	Murakami, Shinya/0000-0002-5230-452X	Japan Society of Science Promotion	Japan Society of Science Promotion	This study was funded by the Japan Society of Science Promotion (http://www.jsps.go.jp/english/e-grants/index.html). The funder had a role in data collection and analysis, as well as in preparing the manuscript.	Abnet CC, 2005, INT J EPIDEMIOL, V34, P467, DOI 10.1093/ije/dyh375; Beck JD, 2001, ARTERIOSCL THROM VAS, V21, P1816, DOI 10.1161/hq1101.097803; Bots ML, 2003, STROKE, V34, P2985, DOI 10.1161/01.STR.0000102044.27905.B5; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Christensen K, 2001, J EPIDEMIOL COMMUN H, V55, P583, DOI 10.1136/jech.55.8.583; Enoki K, 2013, J ORAL REHABIL, V40, P252, DOI 10.1111/joor.12031; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Hayakawa K, 2013, TWIN RES HUM GENET, V16, P217, DOI 10.1017/thg.2012.141; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Ikebe K, 2007, INT J PROSTHODONT, V20, P161; Ikebe K, 2006, INT J PROSTHODONT, V19, P475; Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C; Kato K, 2006, ARCH GEN PSYCHIAT, V63, P1267, DOI 10.1001/archpsyc.63.11.1267; Krenke BE, 2002, J FORENSIC SCI, V47, P773; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Lopez-Jornet P, 2012, J PERIODONTOL, V83, P690, DOI 10.1902/jop.2011.110412; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Medda E, 2014, NUTR METAB CARDIOVAS, V24, P511, DOI 10.1016/j.numecd.2013.10.031; Pinho MM, 2013, J PERIODONTAL RES, V48, P452, DOI 10.1111/jre.12026; Mucci LA, 2005, J DENT RES, V84, P800, DOI 10.1177/154405910508400904; Nokubi T, 2013, GERODONTOLOGY, V30, P76, DOI 10.1111/j.1741-2358.2012.00647.x; Nowjack-Raymer RE, 2003, J DENT RES, V82, P123, DOI 10.1177/154405910308200209; Padilha DMP, 2008, J GERONTOL A-BIOL, V63, P739, DOI 10.1093/gerona/63.7.739; Sacco RL, 2009, STROKE, V40, P2307, DOI 10.1161/STROKEAHA.109.554121; Shah PK, 2010, J AM COLL CARDIOL, V56, P98, DOI 10.1016/j.jacc.2009.09.081; Song C, 2014, J INTERN MED, V275, P631, DOI 10.1111/joim.12177; Sun Y, 2002, ATHEROSCLEROSIS, V164, P89, DOI 10.1016/S0021-9150(02)00017-5; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Wakai K, 2010, COMMUNITY DENT ORAL, V38, P43, DOI 10.1111/j.1600-0528.2009.00512.x; Watt RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030797; Yang MJ, 2006, HUM REPROD, V21, P2175, DOI 10.1093/humrep/del133	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127642	10.1371/journal.pone.0127642	http://dx.doi.org/10.1371/journal.pone.0127642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009883	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900122
J	Lin, Y; Long, JJ; Huang, F; Duim, WC; Kirschbaum, S; Zhang, YD; Schroeder, LK; Rebane, AA; Velasco, MGM; Virrueta, A; Moonan, DW; Jiao, JY; Hernandez, SY; Zhang, YL; Bewersdorf, J				Lin, Yu; Long, Jane J.; Huang, Fang; Duim, Whitney C.; Kirschbaum, Stefanie; Zhang, Yongdeng; Schroeder, Lena K.; Rebane, Aleksander A.; Velasco, Mary Grace M.; Virrueta, Alejandro; Moonan, Daniel W.; Jiao, Junyi; Hernandez, Sandy Y.; Zhang, Yongli; Bewersdorf, Joerg			Quantifying and Optimizing Single-Molecule Switching Nanoscopy at High Speeds	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; SUPERRESOLUTION MICROSCOPY; LOCALIZATION MICROSCOPY; FLUORESCENT-PROBES; SCMOS CAMERA; DARK STATES; LIVE CELLS; RESOLUTION; FLUOROPHORES; EMITTERS	Single-molecule switching nanoscopy overcomes the diffraction limit of light by stochastically switching single fluorescent molecules on and off, and then localizing their positions individually. Recent advances in this technique have greatly accelerated the data acquisition speed and improved the temporal resolution of super-resolution imaging. However, it has not been quantified whether this speed increase comes at the cost of compromised image quality. The spatial and temporal resolution depends on many factors, among which laser intensity and camera speed are the two most critical parameters. Here we quantitatively compare the image quality achieved when imaging Alexa Fluor 647-immunolabeled micro-tubules over an extended range of laser intensities and camera speeds using three criteria-localization precision, density of localized molecules, and resolution of reconstructed images based on Fourier Ring Correlation. We found that, with optimized parameters, single-molecule switching nanoscopy at high speeds can achieve the same image quality as imaging at conventional speeds in a 5-25 times shorter time period. Furthermore, we measured the photoswitching kinetics of Alexa Fluor 647 from single-molecule experiments, and, based on this kinetic data, we developed algorithms to simulate single-molecule switching nanoscopy images. We used this software tool to demonstrate how laser intensity and camera speed affect the density of active fluorophores and influence the achievable resolution. Our study provides guidelines for choosing appropriate laser intensities for imaging Alexa Fluor 647 at different speeds and a quantification protocol for future evaluations of other probes and imaging parameters.	[Lin, Yu; Huang, Fang; Duim, Whitney C.; Zhang, Yongdeng; Schroeder, Lena K.; Velasco, Mary Grace M.; Jiao, Junyi; Zhang, Yongli; Bewersdorf, Joerg] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Lin, Yu; Velasco, Mary Grace M.; Hernandez, Sandy Y.; Bewersdorf, Joerg] Yale Univ, Dept Biomed Engn, New Haven, CT 06510 USA; [Lin, Yu; Rebane, Aleksander A.; Velasco, Mary Grace M.; Virrueta, Alejandro; Moonan, Daniel W.; Jiao, Junyi; Hernandez, Sandy Y.; Zhang, Yongli; Bewersdorf, Joerg] Yale Univ, Integrated Grad Program Phys & Engn Biol, New Haven, CT 06510 USA; [Long, Jane J.] Yale Univ, Yale Coll, New Haven, CT 06510 USA; [Kirschbaum, Stefanie] Jackson Lab, Inst Mol Biophys, Bar Harbor, ME 04609 USA; [Rebane, Aleksander A.] Yale Univ, Dept Phys, New Haven, CT 06510 USA; [Virrueta, Alejandro] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06510 USA; [Moonan, Daniel W.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Jackson Laboratory; Yale University; Yale University; Yale University	Bewersdorf, J (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	joerg.bewersdorf@yale.edu	Rebane, Aleksander/ABC-5510-2020; Zhang, Yongdeng/L-6333-2016	Rebane, Aleksander/0000-0002-0777-6165; Zhang, Yongdeng/0000-0002-4569-8137; Bewersdorf, Joerg/0000-0002-4085-7020; Lin, Yu/0000-0001-5109-0972	Wellcome Trust [095927/A/11/Z]; NIH [P30 DK45735]; Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences; James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship; Direct For Biological Sciences [1458609] Funding Source: National Science Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences; James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the Wellcome Trust (095927/A/11/Z), the NIH (P30 DK45735) and the Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences. FH received funding from a James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley D, 2009, BIOPHYS J, V96, pL22, DOI 10.1016/j.bpj.2008.11.002; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Colquhoun D, 2009, SINGLE CHANNEL RECOR, V2nd, P403; Cox S, 2012, NAT METHODS, V9, P195, DOI [10.1038/NMETH.1812, 10.1038/nmeth.1812]; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dempsey GT, 2009, J AM CHEM SOC, V131, P18192, DOI 10.1021/ja904588g; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Heilemann M, 2005, J AM CHEM SOC, V127, P3801, DOI 10.1021/ja044686x; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Holden SJ, 2014, P NATL ACAD SCI USA, V111, P4566, DOI 10.1073/pnas.1313368111; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Huang ZL, 2011, OPT EXPRESS, V19, P19156, DOI 10.1364/OE.19.019156; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Klein T, 2014, HISTOCHEM CELL BIOL, V141, P561, DOI 10.1007/s00418-014-1184-3; Lee SF, 2013, ANGEW CHEM INT EDIT, V52, P8948, DOI 10.1002/anie.201302341; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Olivier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069004; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Steinhauer C, 2008, J AM CHEM SOC, V130, P16840, DOI 10.1021/ja806590m; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]; Vogelsang J, 2010, CHEMPHYSCHEM, V11, P2475, DOI 10.1002/cphc.201000189; Vogelsang J, 2009, P NATL ACAD SCI USA, V106, P8107, DOI 10.1073/pnas.0811875106; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108; Zanacchi FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067667	38	31	32	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128135	10.1371/journal.pone.0128135	http://dx.doi.org/10.1371/journal.pone.0128135			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011109	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900196
J	Shen, YP; Zheng, YM; Jiang, JT; Liu, YM; Luo, XM; Shen, Z; Chen, X; Wang, Y; Dai, YH; Zhao, J; Liang, H; Chen, AM; Yuan, W				Shen, Yueping; Zheng, Yanmin; Jiang, Jingting; Liu, Yinmei; Luo, Xiaoming; Shen, Zongji; Chen, Xin; Wang, Yan; Dai, Yiheng; Zhao, Jing; Liang, Hong; Chen, Aimin; Yuan, Wei			Higher Urinary Bisphenol A Concentration Is Associated with Unexplained Recurrent Miscarriage Risk: Evidence from a Case-Control Study in Eastern China	PLOS ONE			English	Article							POLYCARBONATE DRINKING BOTTLES; IN-VITRO FERTILIZATION; SPONTANEOUS-ABORTION; LIQUID-CHROMATOGRAPHY; TEMPORAL VARIABILITY; MATERNAL SERUM; UNITED-STATES; NORMAL WOMEN; EXPOSURE; INFERTILITY	Background Evidence about the association between Bisphenol A (BPA) and the risk of recurrent miscarriage (RM) in human being is still limited. Objective We evaluated the association of urinary BPA concentrations with RM in human being. Methods A hospital-based 1: 2 matched case-control study on RM was carried out in Suzhou and Kunshan in Jiangsu Province in China between August 2008 and November 2011. Total urinary BPA concentrations in 264 eligible urine samples (102 RM patients and 162 controls) were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The Wilcoxon test and conditional logistic regression were used to estimate the differences between the groups and odds ratios (OR) with 95% confidence intervals (CI), respectively. Results The median +/- IQR (interquartile range) (P-75-P-25) values of non-creatinine-adjusted total urinary BPA levels in the RM patients and the controls were 1.66 +/- 3.69ng/ml and 0.58 +/- 1.07ng/ml, respectively (0.98 +/- 2.67 mu g/g Cr (creatinine) and 0.40 +/- 0.77 mu g/g Cr. The adjusted BPA level was significantly higher in the RM patients than in the controls (Wilcoxon test, Z = 4.476, P<0.001). Higher level of urinary BPA was significantly associated with an increased risk of RM (P-trend <0.001). Compared to the groups with urinary BPA levels less than 0.16 mu g/g Cr, the women with levels of 0.40-0.93 mu g/g Cr and 0.93 mu g/g Cr or above had a significantly higher risk of RM (OR = 3.91, 95% CI: 1.23-12.45 and OR = 9.34, 95% CI: 3.06-28.44) that persisted after adjusting for confounding factors. The time from recently RM date to recruitment does not significantly influence the urinary BPA level (P = 0.090). Conclusion Exposure to BPA may be associated with RM risk.	[Shen, Yueping] Soochow Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Peoples R China; [Zheng, Yanmin] Suzhou Ctr Dis Prevent & Control, Suzhou 215004, Peoples R China; [Jiang, Jingting] Suzhou Univ, Affiliated Hosp 3, Changzhou 213003, Peoples R China; [Liu, Yinmei] Shanghai Tenth Peoples Hosp, Dept Nosocomial Infect & Dis Control, Shanghai 200072, Peoples R China; [Luo, Xiaoming] Maternal & Child Hlth Bur Kunshan, Kunshan 215301, Peoples R China; [Shen, Zongji] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynaecol, Suzhou 215006, Peoples R China; [Chen, Xin] Soochow Univ, Affiliated Hosp 2, Dept Obstet & Gynaecol, Suzhou 215004, Peoples R China; [Wang, Yan; Dai, Yiheng; Zhao, Jing] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Suzhou 215123, Peoples R China; [Liang, Hong; Yuan, Wei] Shanghai Inst Planned Parenthood Res, Dept Reprod Epidemiol & Social Sci, Shanghai 200032, Peoples R China; [Chen, Aimin] Univ Cincinnati, Coll Med, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH 45221 USA; [Yuan, Wei] NPFPC Lab Contracept & Devices, Shanghai 200032, Peoples R China; [Yuan, Wei] Fudan Univ, Inst Reprod & Dev, Shanghai 200032, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; University System of Ohio; University of Cincinnati; Fudan University	Yuan, W (corresponding author), Shanghai Inst Planned Parenthood Res, Dept Reprod Epidemiol & Social Sci, Shanghai 200032, Peoples R China.	yuanwei11@yahoo.com		liang, hong/0000-0002-3430-9167; Chen, Aimin/0000-0001-9713-6438	National Natural Science Foundation of China [30872176]; Soochow University Medical Development Foundation [EE126705]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, R01ES020349, RC4ES019755] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Soochow University Medical Development Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by the National Natural Science Foundation of China (Grant No. 30872176) and the Soochow University Medical Development Foundation (EE126705). YP Shen received the funding and he had a role in study design, data collection and analysis.	Balakrishnan B, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.025; Bellver J, 2003, FERTIL STERIL, V79, P1136, DOI 10.1016/S0015-0282(03)00176-6; Bloom MS, 2011, ENVIRON TOXICOL PHAR, V32, P319, DOI 10.1016/j.etap.2011.06.003; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979; Brock JW, 2001, J EXPO ANAL ENV EPID, V11, P323, DOI 10.1038/sj.jea.7500174; Calafat AM, 2009, ENVIRON HEALTH PERSP, V117, P639, DOI 10.1289/ehp.0800265; Cantonwine D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-62; Chao HH, 2012, HISTOCHEM CELL BIOL, V137, P249, DOI 10.1007/s00418-011-0894-z; Chen XJ, 2013, CHEMOSPHERE, V93, P217, DOI 10.1016/j.chemosphere.2013.04.067; CLIFFORD K, 1994, HUM REPROD, V9, P1328, DOI 10.1093/oxfordjournals.humrep.a138703; Daya S, 1994, OBSTET GYNECOLOGY, V6, P153; Duan Z-H, 2008, CHINA ENV SCI, V3, P018; Ehrlich S, 2012, ENVIRON HEALTH PERSP, V120, P978, DOI 10.1289/ehp.1104307; Garcia-Prieto A, 2008, ANAL CHIM ACTA, V630, P19, DOI 10.1016/j.aca.2008.09.060; Greaves M, 2000, BRIT J HAEMATOL, V109, P704, DOI 10.1046/j.1365-2141.2000.02069.x; He YH, 2009, ENVIRON RES, V109, P629, DOI 10.1016/j.envres.2009.04.003; Herath CB, 2004, ENDOCRINE, V25, P163, DOI 10.1385/ENDO:25:2:163; Hiroi H, 2004, ENDOCR J, V51, P595, DOI 10.1507/endocrj.51.595; Homer HA, 2000, FERTIL STERIL, V73, P1, DOI 10.1016/S0015-0282(99)00480-X; Honma S, 2002, REPROD TOXICOL, V16, P117, DOI 10.1016/S0890-6238(02)00006-0; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Kang JH, 2003, J FOOD PROTECT, V66, P1444, DOI 10.4315/0362-028X-66.8.1444; Kubwabo C, 2009, FOOD ADDIT CONTAM A, V26, P928, DOI 10.1080/02652030802706725; LaKind JS, 2012, J EXPO SCI ENV EPID, V22, P219, DOI 10.1038/jes.2012.1; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lathi RB, 2014, FERTIL STERIL, V102, P123, DOI 10.1016/j.fertnstert.2014.03.024; Le HH, 2008, TOXICOL LETT, V176, P149, DOI 10.1016/j.toxlet.2007.11.001; Lemos MFL, 2010, CHEMOSPHERE, V78, P907, DOI 10.1016/j.chemosphere.2009.10.063; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575; Ouchi K, 2002, J CHROMATOGR B, V780, P365, DOI 10.1016/S1570-0232(02)00547-0; Politch JA, 2006, ENVIRON HEALTH PERSP, V114, pA16, DOI 10.1289/ehp.114-a16a; REGAN L, 1990, LANCET, V336, P1141, DOI 10.1016/0140-6736(90)92765-A; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Sakurai K, 2000, Nihon Rinsho, V58, P2508; STIRRAT GM, 1990, LANCET, V336, P673, DOI 10.1016/0140-6736(90)92159-F; Sugiura-Ogasawara M, 2003, AM J REPROD IMMUNOL, V50, P485, DOI 10.1046/j.8755-8920.2003.00106.x; Sugiura-Ogasawara M, 2005, HUM REPROD, V20, P2325, DOI 10.1093/humrep/deh888; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; TULPPALA M, 1993, HUM REPROD, V8, P764, DOI 10.1093/oxfordjournals.humrep.a138137; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Wang JX, 2002, OBES RES, V10, P551, DOI 10.1038/oby.2002.74; Watts MM, 2001, AQUAT TOXICOL, V55, P113, DOI 10.1016/S0166-445X(01)00148-5; Weiss A, 2005, HUM REPROD, V20, P2628, DOI 10.1093/humrep/dei081; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007; Yamada H, 2002, REPROD TOXICOL, V16, P735, DOI 10.1016/S0890-6238(02)00051-5; Yang MH, 2003, ARCH ENVIRON CON TOX, V44, P546, DOI 10.1007/s00244-002-2124-0; Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014; Zhang HQ, 2012, MOL BIOL REP, V39, P5651, DOI 10.1007/s11033-011-1372-3	57	37	41	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127886	10.1371/journal.pone.0127886	http://dx.doi.org/10.1371/journal.pone.0127886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011304	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900158
J	Smolina, K; Hanley, GE; Mintzes, B; Oberlander, TF; Morgan, S				Smolina, Kate; Hanley, Gillian E.; Mintzes, Barbara; Oberlander, Tim F.; Morgan, Steve			Trends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002-2011: A Population-Based Cohort Study	PLOS ONE			English	Article							MEDICATION USE; PRIMARY-CARE; WOMEN; LACTATION; ANTIDEPRESSANTS; TERATOGENICITY; NETHERLANDS; PREVALENCE; DEPRESSION; EXPOSURE	Purpose To describe trends, patterns, and determinants of prescription drug use during pregnancy and postpartum. Methods This is a retrospective, population-based study of all women who gave birth between January 2002 and 31 December 2011 in British Columbia, Canada. Study population consisted of 225,973 women who had 322,219 pregnancies. We examined administrative datasets containing person-specific information on filled prescriptions, hospitalizations, and medical services. Main outcome measures were filled prescriptions during pregnancy and postpartum. We used logistic regressions to examine associations between prescription drug use and maternal characteristics. Results Approximately two thirds of women filled a prescription during pregnancy, increasing from 60% in 2002 to 66% in 2011. The proportion of pregnant women using medicines in all three trimesters of pregnancy increased from 20% in 2002 to 27% in 2011. Use of four or more different types of prescription drug during at least one trimester increased from 8.4% in 2002 to 11.7% in 2011. Higher BMI, smoking during pregnancy, age under 25, carrying multiples, and being diagnosed with a chronic condition all significantly increased the odds of prescription drug use during pregnancy. Conclusions The observed increase in the number of prescriptions and number of different drugs being dispensed suggests a trend in prescribing practices with potentially important implications for mothers, their neonates, and caregivers. Monitoring of prescribing practices and further research into the safety of most commonly prescribed medications is crucial in better understanding risks and benefits to the fetus and the mother.	[Smolina, Kate; Morgan, Steve] Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada; [Hanley, Gillian E.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Mintzes, Barbara] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Oberlander, Tim F.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia	Smolina, K (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada.	kate.smolina@ubc.ca	Mintzes, Barbara/AFK-6613-2022	Mintzes, Barbara/0000-0002-8671-915X; Morgan, Steven/0000-0002-7529-0028; Oberlander, Tim/0000-0003-4781-6579; Hanley, Gillian/0000-0001-9594-0545	Canadian Institutes of Health Research [CIHR DC0190GP]; Canadian Institutes of Health Research Banting Postdoctoral Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Banting Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) (CIHR DC0190GP). Dr. Smolina is funded, in part, by a Canadian Institutes of Health Research Banting Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MP, 2011, AM J MED GENET C, V157C, P175, DOI 10.1002/ajmg.c.30313; Administration; UFaD, 2007, PUBL HLTH ADV US COD; Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; [Anonymous], 2012, VIT STAT DEATHS; Arsenault Marc-Yvon, 2002, J Obstet Gynaecol Can, V24, P817; Bakker MK, 2006, BJOG-INT J OBSTET GY, V113, P559, DOI 10.1111/j.1471-0528.2006.00927.x; Berard A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093870; Bjorn Anne-Mette Bay, 2011, Clin Epidemiol, V3, P149, DOI 10.2147/CLEP.S17747; British Columbia Ministry of Health, 2013, DISCH ABSTR DAT HOSP; Chan M, 2012, OBSTET GYNAECOL, V14, P87, DOI 10.1111/j.1744-4667.2012.00096.x; Chin JW, 2013, AM J PERINATOL; Cleary BJ, 2010, PHARMACOEPIDEM DR S, V19, P408, DOI 10.1002/pds.1906; Colvin L, 2009, PHARMACOEPIDEM DR S, V18, P211, DOI 10.1002/pds.1705; Daw JR, 2011, PHARMACOEPIDEM DR S, V20, P895, DOI 10.1002/pds.2184; Daw JR, 2011, CLIN THER; Egen-Lappe V, 2004, EUR J CLIN PHARMACOL, V60, P659, DOI 10.1007/s00228-004-0817-1; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; Food U, 1999, FED REGISTER, V64, P43190; Gagne JJ, 2008, EUR J CLIN PHARMACOL, V64, P1125, DOI 10.1007/s00228-008-0546-y; Hanley GE, 2010, MED CARE, V48, P402, DOI 10.1097/MLR.0b013e3181ca3d5d; Hanley GE, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-79; Health Canada, 2005, IMP SAF INF PAX PAR; Irvine L, 2010, DRUG SAFETY, V33, P593, DOI 10.2165/11532330-000000000-00000; Joseph KS, 2009, J OBSTET GYNAECOL CA, V31, P422, DOI 10.1016/S1701-2163(16)34173-1; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Koren G, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.030; Lacroix I, 2009, EUR J CLIN PHARMACOL, V65, P839, DOI 10.1007/s00228-009-0647-2; Lagoy CT, 2005, J WOMENS HEALTH, V14, P104, DOI 10.1089/jwh.2005.14.104; Lo WY, 2002, OBSTET GYNECOL, V100, P465, DOI 10.1016/S0029-7844(02)02122-1; Lupattelli A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004365; Malm H, 2003, EUR J CLIN PHARMACOL, V59, P127, DOI 10.1007/s00228-003-0584-4; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Olesen C, 1999, EUR J CLIN PHARMACOL, V55, P139, DOI 10.1007/s002280050608; Olesen C, 2006, EUR J CLIN PHARMACOL, V62, P547, DOI 10.1007/s00228-006-0119-x; Parisi MA, 2011, AM J MED GENET C, V157C, P247, DOI 10.1002/ajmg.c.30309; Persaud N, 2014, J OBSTET GYNAECOL CA, V36, P343, DOI 10.1016/S1701-2163(15)30611-3; Riley EH, 2005, J WOMENS HEALTH, V14, P401, DOI 10.1089/jwh.2005.14.401; Schirm E, 2004, EUR J OBSTET GYN R B, V114, P182, DOI 10.1016/j.ejogrb.2003.10.024; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Swanson LM, 2011, J WOMENS HEALTH, V20, P553, DOI 10.1089/jwh.2010.2371; Tamblyn R, 2014, ANN INTERN MED, V160, P441, DOI 10.7326/M13-1705; World Health Organization, 2011, AN THER CLASS STRUCT; Yang TB, 2008, PHARMACOEPIDEM DR S, V17, P270, DOI 10.1002/pds.1538	46	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128312	10.1371/journal.pone.0128312	http://dx.doi.org/10.1371/journal.pone.0128312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011706	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900221
J	Gurke, J; Hirche, F; Thieme, R; Haucke, E; Schindler, M; Stangl, GI; Fischer, B; Santos, AN				Guerke, Jacqueline; Hirche, Frank; Thieme, Rene; Haucke, Elisa; Schindler, Maria; Stangl, Gabriele I.; Fischer, Bernd; Santos, Anne Navarrete			Maternal Diabetes Leads to Adaptation in Embryonic Amino Acid Metabolism during Early Pregnancy	PLOS ONE			English	Article							INSULIN; CHAIN; BLASTOCYST; LEUCINE; RABBIT; EXPRESSION; GLUCOSE; GROWTH; TROPHECTODERM; TRANSPORTER	During pregnancy an adequate amino acid supply is essential for embryo development and fetal growth. We have studied amino acid composition and branched chain amino acid (BCAA) metabolism at day 6 p.c. in diabetic rabbits and blastocysts. In the plasma of diabetic rabbits the concentrations of 12 amino acids were altered in comparison to the controls. Notably, the concentrations of the BCAA leucine, isoleucine and valine were approximately three-fold higher in diabetic rabbits than in the control. In the cavity fluid of blastocysts from diabetic rabbits BCAA concentrations were twice as high as those from controls, indicating a close link between maternal diabetes and embryonic BCAA metabolism. The expression of BCAA oxidizing enzymes and BCAA transporter was analysed in maternal tissues and in blastocysts. The RNA amounts of three oxidizing enzymes, i.e. branched chain aminotransferase 2 (Bcat2), branched chain ketoacid dehydrogenase (Bckdha) and dehydrolipoyl dehydrogenase (Dld), were markedly increased in maternal adipose tissue and decreased in liver and skeletal muscle of diabetic rabbits than in those of controls. Blastocysts of diabetic rabbits revealed a higher Bcat2 mRNA and protein abundance in comparison to control blastocysts. The expression of BCAA transporter LAT1 and LAT2 were unaltered in endometrium of diabetic and healthy rabbits, whereas LAT2 transcripts were increased in blastocysts of diabetic rabbits. In correlation to high embryonic BCAA levels the phosphorylation amount of the nutrient sensor mammalian target of rapamycin (mTOR) was enhanced in blastocysts caused by maternal diabetes. These results demonstrate a direct impact of maternal diabetes on BCAA concentrations and degradation in mammalian blastocysts with influence on embryonic mTOR signalling.	[Guerke, Jacqueline; Thieme, Rene; Haucke, Elisa; Schindler, Maria; Fischer, Bernd; Santos, Anne Navarrete] Univ Halle Wittenberg, Fac Med, Dept Anat & Cell Biol, D-06108 Halle, Germany; [Hirche, Frank; Stangl, Gabriele I.] Univ Halle Wittenberg, Dept Agr & Nutr Sci, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Gurke, J (corresponding author), Univ Halle Wittenberg, Fac Med, Dept Anat & Cell Biol, D-06108 Halle, Germany.	jacqueline.guerke@medizin.uni-halle.de	Gürke, Jacqueline/L-6610-2019		EU FP7 EpiHealth [278418]; EpiConcept [FA1201]; RGB-Net [TD1101]; Wilhelm Roux Programme of the MLU Faculty of Medicine	EU FP7 EpiHealth; EpiConcept; RGB-Net; Wilhelm Roux Programme of the MLU Faculty of Medicine	This work was supported by EU FP7 EpiHealth (N<SUP>o</SUP> 278418), EpiConcept FA1201, RGB-Net TD1101, and the Wilhelm Roux Programme of the MLU Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTAGLIA FC, 1988, ANNU REV NUTR, V8, P43, DOI 10.1146/annurev.nu.08.070188.000355; BAVISTER BD, 1983, BIOL REPROD, V28, P235, DOI 10.1095/biolreprod28.1.235; Bavister BD, 1991, SER S PREIM IN PRESS; BERGER M, 1978, METABOLISM, V27, P793, DOI 10.1016/0026-0495(78)90214-7; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Chung M, 1998, AM J PHYSIOL-ENDOC M, V274, pE13, DOI 10.1152/ajpendo.1998.274.1.E13; CipcicSchmidt S, 1996, EUR J PEDIATR, V155, pS173, DOI 10.1007/PL00014241; Devreker F, 2001, HUM REPROD, V16, P749, DOI 10.1093/humrep/16.4.749; Eckert JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052791; FELIG P, 1970, DIABETES, V19, P727, DOI 10.2337/diab.19.10.727; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Fleming TP, 2012, ANIM REPROD SCI, V130, P193, DOI 10.1016/j.anireprosci.2012.01.015; FORLANI G, 1984, METABOLISM, V33, P147, DOI 10.1016/0026-0495(84)90127-6; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; GARDNER DK, 1994, BIOL REPROD, V50, P390, DOI 10.1095/biolreprod50.2.390; GARDNER DK, 1993, BIOL REPROD, V48, P377, DOI 10.1095/biolreprod48.2.377; Gaull GE, 1975, BIOL BRAIN DYSFUNCTI, P47; GELFAND RA, 1986, AM J PHYSIOL, V250, pE407, DOI 10.1152/ajpendo.1986.250.4.E407; Gopichandran N, 2003, REPRODUCTION, V126, P299, DOI 10.1530/rep.0.1260299; Gwatkin R, 1966, ANN N Y ACAD SCI, V139, P79; HANNA AK, 1980, METABOLISM, V29, P321, DOI 10.1016/0026-0495(80)90005-0; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; ICHIHARA A, 1966, J BIOCHEM-TOKYO, V59, P160, DOI 10.1093/oxfordjournals.jbchem.a128277; Jozwik M, 2001, AM J OBSTET GYNECOL, V185, P487, DOI 10.1067/mob.2001.116096; KALKHOFF RK, 1988, METABOLISM, V37, P234, DOI 10.1016/0026-0495(88)90101-1; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kim J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105080; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Leese HJ, 2008, REPROD FERT DEVELOP, V20, P1, DOI 10.1071/RD07153; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; LOUARD RJ, 1990, CLIN SCI, V79, P457, DOI 10.1042/cs0790457; Luetscher JA, 1942, J CLIN INVEST, V21, P275, DOI 10.1172/JCI101300; Martin PM, 2003, BIOL REPROD, V69, P1101, DOI 10.1095/biolreprod.103.018010; Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461; Maurer R. R., 1978, Methods in mammalian reproduction., P259; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; POZEFSKY T, 1969, J CLIN INVEST, V48, P2273, DOI 10.1172/JCI106193; Ramin N, 2010, ENDOCRINOLOGY, V151, P4158, DOI 10.1210/en.2010-0187; Teodoro GFR, 2012, J NUTR, V142, P924, DOI 10.3945/jn.111.146266; Santos AN, 2000, BIOL REPROD, V62, P1, DOI 10.1095/biolreprod62.1.1; Santos AN, 2008, ENDOCRINOLOGY, V149, P515, DOI 10.1210/en.2007-0821; SAUDUBRAY JM, 1984, J INHERIT METAB DIS, V7, P2, DOI 10.1007/BF03047365; SCHUSTER R, 1988, J CHROMATOGR-BIOMED, V431, P271, DOI 10.1016/S0378-4347(00)83096-0; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; STYRUD J, 1995, PEDIATR RES, V37, P343, DOI 10.1203/00006450-199503000-00015; TAKAHASHI Y, 1992, THERIOGENOLOGY, V37, P963, DOI 10.1016/0093-691X(92)90096-A; TEERLINK T, 1994, CLIN CHEM, V40, P245; Thieme R, 2012, MOL CELL ENDOCRINOL, V348, P112, DOI 10.1016/j.mce.2011.07.044; Tonack S, 2004, ANAT EMBRYOL, V208, P225, DOI 10.1007/s00429-004-0388-z; Torrazza RM, 2010, J NUTR, V140, P2145, DOI 10.3945/jn.110.128421; VANNINI P, 1982, DIABETOLOGIA, V22, P217, DOI 10.1007/BF00283757; VANWINKLE LJ, 1983, J REPROD FERTIL, V68, P437, DOI 10.1530/jrf.0.0680437; WAHREN J, 1976, J CLIN INVEST, V57, P987, DOI 10.1172/JCI108375; WAHREN J, 1972, J CLIN INVEST, V51, P1870, DOI 10.1172/JCI106989; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Zheng C, 2009, ASIAN AUSTRAL J ANIM, V22, P1495, DOI 10.5713/ajas.2009.90127	60	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127465	10.1371/journal.pone.0127465	http://dx.doi.org/10.1371/journal.pone.0127465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020623	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300042
J	Shafagati, N; Lundberg, L; Baer, A; Patanarut, A; Fite, K; Lepene, B; Kehn-Hall, K				Shafagati, Nazly; Lundberg, Lindsay; Baer, Alan; Patanarut, Alexis; Fite, Katherine; Lepene, Benjamin; Kehn-Hall, Kylene			The Use of Nanotrap Particles in the Enhanced Detection of Rift Valley Fever Virus Nucleoprotein	PLOS ONE			English	Article							HYDROGEL PARTICLES; DIAGNOSTICS; DISCOVERY; PROTEINS	Background Rift Valley fever virus (RVFV) is a highly pathogenic arthropod-borne virus that has a detrimental effect on both livestock and human populations. While there are several diagnostic methodologies available for RVFV detection, many are not sensitive enough to diagnose early infections. Furthermore, detection may be hindered by high abundant proteins such as albumin. Previous findings have shown that Nanotrap particles can be used to significantly enhance detection of various small analytes of low abundance. We have expanded upon this repertoire to show that this simple and efficient sample preparation technology can drastically improve the detection of the RVFV nucleoprotein (NP), the most abundant and widely used viral protein for RVFV diagnostics. Results After screening multiple Nanotrap particle architectures, we found that one particle, NT45, was optimal for RVFV NP capture, as demonstrated by western blotting. NT45 significantly enhanced detection of the NP at levels undetectable without the technology. Importantly, we demonstrated that Nanotrap particles are capable of concentrating NP in a number of matrices, including infected cell lysates, viral supernatants, and animal sera. Specifically, NT45 enhanced detection of NP at various viral titers, multiplicity of infections, and time points. Our most dramatic results were observed in spiked serum samples, where high abundance serum proteins hindered detection of NP without Nanotrap particles. Nanotrap particles allowed for sample cleanup and subsequent detection of RVFV NP. Finally, we demonstrated that incubation of our samples with Nanotrap particles protects the NP from degradation over extended periods of time (up to 120 hours) and at elevated temperatures (at 37 degrees C). Conclusion This study demonstrates that Nanotrap particles are capable of drastically lowering the limit of detection for RVFV NP by capturing, concentrating, and preserving RVFV NP in clinically relevant matrices. These studies can be extended to a wide range of pathogens and their analytes of diagnostic interest.	[Shafagati, Nazly; Lundberg, Lindsay; Baer, Alan; Fite, Katherine; Kehn-Hall, Kylene] George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA; [Patanarut, Alexis; Lepene, Benjamin] Ceres Nanosci, Manassas, VA USA	George Mason University	Kehn-Hall, K (corresponding author), George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA 20110 USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013		Institute for Infectious Animal Diseases (IIAD), Texas AM/DHS; IIAD, HS-STEM Career Development Program; U.S. Department of Homeland Security [20011-ST-104-000002]	Institute for Infectious Animal Diseases (IIAD), Texas AM/DHS; IIAD, HS-STEM Career Development Program; U.S. Department of Homeland Security(United States Department of Homeland Security (DHS))	This work was supported by a grant from The Institute for Infectious Animal Diseases (IIAD), Texas A&M/DHS to BL and KKH. NS was supported through a graduate student fellowship provided through the IIAD, HS-STEM Career Development Program. This material is based upon work supported by the U.S. Department of Homeland Security under Grant Award Number 20011-ST-104-000002. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Homeland Security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; [Anonymous], TRANSM RIFT VALL FEV; Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; *CDCP, 2006, MMWR-MORBID MORTAL W, V56, P73; Douglas TA, 2011, BIOMATERIALS, V32, P1157, DOI 10.1016/j.biomaterials.2010.10.004; Faburay B, 2013, VECTOR-BORNE ZOONOT, V13, P619, DOI 10.1089/vbz.2012.1285; Ferron F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002030; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Isaacson M, 2001, CLIN INFECT DIS, V33, P1707, DOI 10.1086/322620; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Liu L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-82; Longo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004763; Luchini A, 2010, CURR MOL MED, V10, P133, DOI 10.2174/156652410790963268; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; Narayanan A, 2014, VIROLOGY, V449, P270, DOI 10.1016/j.virol.2013.11.023; Patanarut A, 2010, COLLOID SURFACE A, V362, P8, DOI 10.1016/j.colsurfa.2010.03.023; Paul D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/783131; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Shafagati N, 2014, PATHOG DIS, V71, P162, DOI 10.1111/2049-632X.12136; Shafagati N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002296; Stellwagen E, 2001, DYE AFFINITY CHROMAT; SUBRAMANIAN S, 1984, CRC CR REV BIOCH MOL, V16, P169, DOI 10.3109/10409238409102302; Tamburro D, 2011, J AM CHEM SOC, V133, P19178, DOI 10.1021/ja207515j; Thomas PC, 2011, SOFT MATTER, V7, P8192, DOI 10.1039/c1sm05369h; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q	27	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128215	10.1371/journal.pone.0128215	http://dx.doi.org/10.1371/journal.pone.0128215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020252	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300088
J	Ubeda, A; Hortal, E; Ianez, E; Perez-Vidal, C; Azorin, JM				Ubeda, Andres; Hortal, Enrique; Ianez, Eduardo; Perez-Vidal, Carlos; Azorin, Jose M.			Assessing Movement Factors in Upper Limb Kinematics Decoding from EEG Signals	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; ELECTROENCEPHALOGRAPHIC SIGNALS; TETRAPLEGIA; PEOPLE; GRASP; REACH; ARM	The past decades have seen the rapid development of upper limb kinematics decoding techniques by performing intracortical recordings of brain signals. However, the use of noninvasive approaches to perform similar decoding procedures is still in its early stages. Recent studies show that there is a correlation between electroencephalographic (EEG) signals and hand-reaching kinematic parameters. From these studies, it could be concluded that the accuracy of upper limb kinematics decoding depends, at least partially, on the characteristics of the performed movement. In this paper, we have studied upper limb movements with different speeds and trajectories in a controlled environment to analyze the influence of movement variability in the decoding performance. To that end, low frequency components of the EEG signals have been decoded with linear models to obtain the position of the volunteer's hand during performed trajectories grasping the end effector of a planar manipulandum. The results confirm that it is possible to obtain kinematic information from low frequency EEG signals and show that decoding performance is significantly influenced by movement variability and tracking accuracy as continuous and slower movements improve the accuracy of the decoder. This is a key factor that should be taken into account in future experimental designs.	[Ubeda, Andres; Hortal, Enrique; Ianez, Eduardo; Perez-Vidal, Carlos; Azorin, Jose M.] Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Elche 03202, Spain	Universidad Miguel Hernandez de Elche	Ubeda, A (corresponding author), Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Av Univ S-N, Elche 03202, Spain.	aubeda@umh.es	Hortal, Enrique/R-9176-2018; Iáñez, Eduardo/J-9765-2014; Azorin, Jose M./M-8956-2019; Azorin, Jose M/G-2157-2011; Ubeda, Andres/E-9811-2018; Ubeda, Andres/K-4883-2015	Hortal, Enrique/0000-0003-2119-4169; Iáñez, Eduardo/0000-0001-8057-5952; Azorin, Jose M./0000-0001-5548-9657; Azorin, Jose M/0000-0001-5548-9657; Ubeda, Andres/0000-0003-3223-025X	Ministry of Economy and Competitiveness of Spain [DPI2011-27022-C02-01]; Conselleria d'Educacio, Cultura i Esport of Generalitat Valenciana through grant VALi+d [ACIF/2012/135]	Ministry of Economy and Competitiveness of Spain(Spanish Government); Conselleria d'Educacio, Cultura i Esport of Generalitat Valenciana through grant VALi+d	AU, JMA, EH, and EI have been supported by the Ministry of Economy and Competitiveness of Spain through the project DPI2011-27022-C02-01 (http://www.mineco.gob.es/portal/site/mineco/?lang_choosen=en). AU has also been supported by Conselleria d'Educacio, Cultura i Esport of Generalitat Valenciana through grant VALi+d ACIF/2012/135 (http://www.cece.gva.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe HA, 2011, IEEE ENG MED BIO, P5444, DOI 10.1109/IEMBS.2011.6091389; Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; Antelis JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061976; BRADBERRY TJ, 2011, J NEURAL ENG, V8, DOI DOI 10.1088/1741-2560/8/5/; Bradberry TJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/058002; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Grosse-Wentrup M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025004; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Ianez E, 2010, ROBOT AUTON SYST, V58, P1238, DOI 10.1016/j.robot.2010.08.007; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Kim SP, 2011, IEEE T NEUR SYS REH, V19, P193, DOI 10.1109/TNSRE.2011.2107750; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Muller-Putz GR, 2006, BIOMED TECH, V51, P57, DOI 10.1515/BMT.2006.011; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Poli R, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/058001; Blasco JLS, 2012, EXPERT SYST APPL, V39, P7908, DOI 10.1016/j.eswa.2012.01.110; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	24	17	17	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128456	10.1371/journal.pone.0128456	http://dx.doi.org/10.1371/journal.pone.0128456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020525	Green Submitted, gold, Green Published			2022-12-27	WOS:000355187300113
J	Altukhov, AV; Andrews, RD; Calkins, DG; Gelatt, TS; Gurarie, ED; Loughlin, TR; Mamaev, EG; Nikulin, VS; Permyakov, PA; Ryazanov, SD; Vertyankin, VV; Burkanov, VN				Altukhov, Alexey V.; Andrews, Russel D.; Calkins, Donald G.; Gelatt, Thomas S.; Gurarie, Eliezer D.; Loughlin, Thomas R.; Mamaev, Evgeny G.; Nikulin, Victor S.; Permyakov, Peter A.; Ryazanov, Sergey D.; Vertyankin, Vladimir V.; Burkanov, Vladimir N.			Age Specific Survival Rates of Steller Sea Lions at Rookeries with Divergent Population Trends in the Russian Far East	PLOS ONE			English	Article							NUTRITIONAL STRESS HYPOTHESIS; EUMETOPIAS-JUBATUS; ATTENDANCE PATTERNS; BIGHORN SHEEP; ALEUTIAN ISLANDS; ALASKA; DECLINE; VERTEBRATES; MORTALITY; RECOVERY	After a dramatic population decline, Steller sea lions have begun to recover throughout most of their range. However, Steller sea lions in the Western Aleutians and Commander Islands are continuing to decline. Comparing survival rates between regions with different population trends may provide insights into the factors driving the dynamics, but published data on vital rates have been extremely scarce, especially in regions where the populations are still declining. Fortunately, an unprecedented dataset of marked Steller sea lions at rookeries in the Russian Far East is available, allowing us to determine age and sex specific survival in sea lions up to 22 years old. We focused on survival rates in three areas in the Russian range with differing population trends: the Commander Islands (Medny Island rookery), Eastern Kamchatka (Kozlov Cape rookery) and the Kuril Islands (four rookeries). Survival rates differed between these three regions, though not necessarily as predicted by population trends. Pup survival was higher where the populations were declining (Medny Island) or not recovering (Kozlov Cape) than in all Kuril Island rookeries. The lowest adult (> 3 years old) female survival was found on Medny Island and this may be responsible for the continued population decline there. However, the highest adult survival was found at Kozlov Cape, not in the Kuril Islands where the population is increasing, so we suggest that differences in birth rates might be an important driver of these divergent population trends. High pup survival on the Commander Islands and Kamchatka Coast may be a consequence of less frequent (e. g. biennial) reproduction there, which may permit females that skip birth years to invest more in their offspring, leading to higher pup survival, but this hypothesis awaits measurement of birth rates in these areas.	[Altukhov, Alexey V.; Andrews, Russel D.] Univ Alaska Fairbanks, Fairbanks, AK 99775 USA; [Altukhov, Alexey V.; Ryazanov, Sergey D.; Burkanov, Vladimir N.] RAS, FEB, Pacific Geog Inst, Kamchatka Branch, Petropavlovsk Kamchatski, Kamchatsky Kray, Russia; [Andrews, Russel D.] Alaska SeaLife Ctr, Seward, AK USA; [Calkins, Donald G.; Burkanov, Vladimir N.] North Pacific Wildlife Consulting LLC, Anchorage, AK USA; [Gelatt, Thomas S.; Burkanov, Vladimir N.] NOAA, NMFS, AFSC, Natl Marine Mammal Lab, Seattle, WA USA; [Gurarie, Eliezer D.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Gurarie, Eliezer D.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Loughlin, Thomas R.] TRL Wildlife Consulting, NMML, Seattle, WA USA; [Mamaev, Evgeny G.] State Nat Reserve Komandorsky, Nikolskoe, Kamchatsky Kray, Russia; [Nikulin, Victor S.] Kamchatka Res Inst Fisheries & Oceanog, Petropavlovsk Kamchatski, Kamchatsky Kray, Russia; [Permyakov, Peter A.; Ryazanov, Sergey D.] RAS, FEB, VI Il Iichev Pacific Oceanol Inst, Vladivostok, Primorsky Kray, Russia; [Vertyankin, Vladimir V.] Kronotsky Reserve, Yelizovo, Kamchatsky Kray, Russia	University of Alaska System; University of Alaska Fairbanks; Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Maryland; University of Maryland College Park; University of Washington; University of Washington Seattle; Research lnstitute of Fisheries & Oceanography; Ilichev Pacific Oceanological Institute; Russian Academy of Sciences	Altukhov, AV (corresponding author), Univ Alaska Fairbanks, Fairbanks, AK 99775 USA.	aaltukhov@gmail.com	Permyakov, Petr/AAO-2623-2020; Gurarie, Eliezer/AGI-0958-2022; Ryazanov, Sergey/GWV-6301-2022; Burkanov, Vladimir/C-3116-2012	Gurarie, Eliezer/0000-0002-8666-9674; Ryazanov, Sergey/0000-0001-6586-5759; Andrews, Russel/0000-0002-4545-137X; Burkanov, Vladimir/0000-0002-0129-7884; Altukhov, Alexey/0000-0001-8532-0596	NOAA Fisheries; North Pacific Wildlife Consulting; Alaska Sea Life Center; Kamchatrybvod Agency; Russian Academy of Sciences; Pollock Conservation Cooperative Research Center; North Pacific Wildlife Consulting LLC; TRL Wildlife Consulting	NOAA Fisheries(National Oceanic Atmospheric Admin (NOAA) - USA); North Pacific Wildlife Consulting; Alaska Sea Life Center; Kamchatrybvod Agency; Russian Academy of Sciences(Russian Academy of Sciences); Pollock Conservation Cooperative Research Center; North Pacific Wildlife Consulting LLC; TRL Wildlife Consulting	Funding for this research was provided by grants from NOAA Fisheries, North Pacific Wildlife Consulting, Alaska Sea Life Center, Kamchatrybvod Agency, and Russian Academy of Sciences, with additional support from the Pollock Conservation Cooperative Research Center. Although one of the coauthors is employed by NOAA Fisheries, the work and results presented are collaborative and partial funding by NOAA Fisheries of the work presented here did not influence study design, data collection and analysis, decision to publish, or preparation of this manuscript. None of the other funding agencies influenced any aspects of this manuscript. North Pacific Wildlife Consulting LLC and TRL Wildlife Consulting provided support in the form of salaries for authors (DGC, TRL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Altukhov AV, 2008, ZOOL ZH, V87, P876; Altukhov AV, 2012, RUSS J MAR BIOL+, V38, P442, DOI 10.1134/S106307401206003X; Altukhov AV, 2012, THESIS MOSCOW STATE; [Anonymous], 2000, MAR FISH REV; [Anonymous], 2014, R LANG ENV STAT COMP; Atkinson S, 2008, MAMMAL REV, V38, P1, DOI 10.1111/j.1365-2907.2008.00128.x; Baker AR, 2005, J MAMMAL, V86, P1075, DOI 10.1644/04-MAMM-A-113R1.1; Becker RA, 2013, MAPS DRAW GEOGRAPHIC; BRAHAM HW, 1980, J WILDLIFE MANAGE, V44, P25, DOI 10.2307/3808347; Burkanov V N., 2005, MAR FISH REV, V67, P1; Burkanov V, 2011, J MAMMAL, V92, P352, DOI 10.1644/10-MAMM-A-194.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; CLINTON WL, 1993, ECOLOGY, V74, P1884, DOI 10.2307/1939945; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Cooch E. G., 2014, PROGRAM MARK GENTLE; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Fay G, 2013, ECOL APPL, V23, P1455, DOI 10.1890/12-1645.1; Festa-Bianchet M, 1998, BEHAV ECOL, V9, P144, DOI 10.1093/beheco/9.2.144; FestaBianchet M, 1997, CAN J ZOOL, V75, P1372, DOI 10.1139/z97-763; Fiscus CH, 1961, J MAMMAL, V42, P218, DOI [10.2307/1376831, DOI 10.2307/1376831]; Fowler C.W., 1981, P437; Fritz L, 2013, NMFSAFSC251 NOAA US; Fritz LW, 2014, ENDANGER SPECIES RES, V26, P13, DOI 10.3354/esr00634; Fritz LW, 2005, MAR MAMMAL SCI, V21, P476, DOI 10.1111/j.1748-7692.2005.tb01245.x; Gaillard JM, 2003, ECOLOGY, V84, P3294, DOI 10.1890/02-0409; Gisiner R, 1985, THESIS U CALIFORNIA; Hastie T, 2009, ELEMENTS STAT LEARNI, P43; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Heath RB, 1997, J WILDLIFE DIS, V33, P206, DOI 10.7589/0090-3558-33.2.206; Hogg JT, 1997, BEHAV ECOL SOCIOBIOL, V41, P33, DOI 10.1007/s002650050361; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Horning M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030173; Jorgenson JT, 1997, ECOLOGY, V78, P1019, DOI 10.1890/0012-9658(1997)078[1019:EOASDA]2.0.CO;2; Laake J, 2014, PROGRAM MARK GENTLE, P1; Laake JL., 2013, RMARK R INTERFACE AN; Laskina NB, 2012, MARINE MAMMALS HOLAR, P376; Loughlin Thomas R., 1997, Society for Marine Mammalogy Special Publication, V3, P159; LOUGHLIN TR, 1992, MAR MAMMAL SCI, V8, P220, DOI 10.1111/j.1748-7692.1992.tb00406.x; Mamaev E, 1999, THESIS MOSCOW STATE; Mamaev E.G., 2004, P359; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096328; Maniscalco JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010076; Marakov SV, 1966, PRIRODA, V8, P67; Merrick R, 1996, NMFSAFSC68 NOAA US D; Merrick RL, 1997, CAN J ZOOL, V75, P776, DOI 10.1139/z97-099; National Marine Fisheries Service, 2008, REC PLAN STELL SEA L; Nikulin VS, 2010, RES AQUATIC BIOL RES, V19, P90; PASCUAL MA, 1994, ECOL APPL, V4, P393, DOI 10.2307/1941942; Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Permyakov P, 2012, MARINE MAMMALS HOLAR, V2, P181; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Pitcher KW, 1998, CAN J ZOOL, V76, P2075, DOI 10.1139/cjz-76-11-2075; Ryazanov SD, 2013, RES AQUATIC BIOL RES, V28, P36; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winship AJ, 2006, MAR MAMMAL SCI, V22, P124, DOI 10.1111/j.1748-7692.2006.00009.x; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	61	15	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127292	10.1371/journal.pone.0127292	http://dx.doi.org/10.1371/journal.pone.0127292			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016772	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600079
J	Fontes, JD; Ramsey, J; Polk, JM; Koop, A; Denisova, JV; Belousov, AB				Fontes, Joseph D.; Ramsey, Jon; Polk, Jeremy M.; Koop, Andre; Denisova, Janna V.; Belousov, Andrei B.			Death of Neurons following Injury Requires Conductive Neuronal Gap Junction Channels but Not a Specific Connexin	PLOS ONE			English	Article							CELL-DEATH; BRAIN; HEMICHANNELS; VULNERABILITY; EXPRESSION; GLUTAMATE; ISCHEMIA; PERMEABILITY; MECHANISMS; ASTROCYTES	Pharmacological blockade or genetic knockout of neuronal connexin 36 (Cx36)-containing gap junctions reduces neuronal death caused by ischemia, traumatic brain injury and NMDA receptor (NMDAR)-mediated excitotoxicity. However, whether Cx36 gap junctions contribute to neuronal death via channel-dependent or channel-independent mechanism remains an open question. To address this, we manipulated connexin protein expression via lentiviral transduction of mouse neuronal cortical cultures and analyzed neuronal death twenty-four hours following administration of NMDA (a model of NMDAR excitotoxicity) or oxygen-glucose deprivation (a model of ischemic injury). In cultures prepared from wildtype mice, over-expression and knockdown of Cx36-containing gap junctions augmented and prevented, respectively, neuronal death from NMDAR-mediated excitotoxicity and ischemia. In cultures obtained form from Cx36 knockout mice, re-expression of functional gap junction channels, containing either neuronal Cx36 or non-neuronal Cx43 or Cx31, resulted in increased neuronal death following insult. In contrast, the expression of communication-deficient gap junctions (containing mutated connexins) did not have this effect. Finally, the absence of ethidium bromide uptake in non-transduced wild-type neurons two hours following NMDAR excitotoxicity or ischemia suggested the absence of active endogenous hemichannels in those neurons. Taken together, these results suggest a role for neuronal gap junctions in cell death via a connexin type-independent mechanism that likely relies on channel activities of gap junctional complexes among neurons. A possible contribution of gap junction channel-permeable death signals in neuronal death is discussed.	[Fontes, Joseph D.; Ramsey, Jon] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA; [Polk, Jeremy M.; Koop, Andre; Denisova, Janna V.; Belousov, Andrei B.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Belousov, AB (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	abelousov@kumc.edu		Fontes, Joseph/0000-0003-4796-343X	National Institutes of Health (NIH) [R21 NS076925]; University of Kansas Medical Center; NIH [P20 GM104936, P30 AG035982, UL1 TR000001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health (NIH) (R21 NS076925) and the University of Kansas Medical Center funds to A. B. B. The study also was supported in part by NIH P20 GM104936, P30 AG035982 and UL1 TR000001. Core support was provided by NIH HD002528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam H, 2005, NAT NEUROSCI, V8, P1720, DOI 10.1038/nn1588; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bargiotas P, 2012, BRAIN RES, V1479, P80, DOI 10.1016/j.brainres.2012.08.046; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; Bedner P, 2012, BBA-BIOMEMBRANES, V1818, P1971, DOI 10.1016/j.bbamem.2011.10.016; Belousov AB, 2014, J NEURAL TRANSM, V121, P837, DOI 10.1007/s00702-013-1109-7; Belousov AB, 2013, TRENDS NEUROSCI, V36, P227, DOI 10.1016/j.tins.2012.11.001; Belousov AB, 2012, NEUROSCI LETT, V524, P16, DOI 10.1016/j.neulet.2012.06.065; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Chang QA, 2000, J NEUROSCI, V20, P674, DOI 10.1523/JNEUROSCI.20-02-00674.2000; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cusato K, 2006, CELL DEATH DIFFER, V13, P1707, DOI 10.1038/sj.cdd.4401876; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Decrock E, 2013, BBA-MOL CELL RES, V1833, P1772, DOI 10.1016/j.bbamcr.2012.12.016; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Ek-Vitorin JF, 2013, BBA-BIOMEMBRANES, V1828, P51, DOI 10.1016/j.bbamem.2012.02.003; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; Garrett FG, 2008, NEURON GLIA BIOL, V4, P295, DOI 10.1017/S1740925X09990093; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Lynn BD, 2012, J MEMBRANE BIOL, V245, P303, DOI 10.1007/s00232-012-9451-5; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Park WM, 2011, J NEUROSCI, V31, P5909, DOI 10.1523/JNEUROSCI.6787-10.2011; Paschon V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045449; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Ramsey JE, 2013, MOL IMMUNOL, V56, P768, DOI 10.1016/j.molimm.2013.07.001; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Roscoe W, 2005, J BIOL CHEM, V280, P11458, DOI 10.1074/jbc.M409564200; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Srinivas M, 1999, J NEUROSCI, V19, P9848; Stauch K, 2012, J BIOL CHEM, V287, P27771, DOI 10.1074/jbc.M112.382572; Striedinger K, 2005, EUR J NEUROSCI, V22, P605, DOI 10.1111/j.1460-9568.2005.04228.x; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Udawatte C, 2005, APOPTOSIS, V10, P1019, DOI 10.1007/s10495-005-0776-8; Vaccari JCDR, 2007, J NEUROPHYSIOL, V98, P2878, DOI 10.1152/jn.00362.2007; Wang XJ, 2008, NEUROCHEM RES, V33, P826, DOI 10.1007/s11064-007-9514-7; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Wang YF, 2010, J NEUROPHYSIOL, V104, P3551, DOI 10.1152/jn.00656.2010	51	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125395	10.1371/journal.pone.0125395	http://dx.doi.org/10.1371/journal.pone.0125395			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017008	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600021
J	Ravanbakhsh, S; Liu, P; Bjordahl, TC; Mandal, R; Grant, JR; Wilson, M; Eisner, R; Sinelnikov, I; Hu, XY; Luchinat, C; Greiner, R; Wishart, DS				Ravanbakhsh, Siamak; Liu, Philip; Bjordahl, Trent C.; Mandal, Rupasri; Grant, Jason R.; Wilson, Michael; Eisner, Roman; Sinelnikov, Igor; Hu, Xiaoyu; Luchinat, Claudio; Greiner, Russell; Wishart, David S.			Accurate, Fully-Automated NMR Spectral Profiling for Metabolomics	PLOS ONE			English	Article							QUANTITATIVE METABOLOMICS; PHASE CORRECTION; METABONOMICS; H-1-NMR	Many diseases cause significant changes to the concentrations of small molecules (a.k.a. metabolites) that appear in a person's biofluids, which means such diseases can often be readily detected from a person's "metabolic profile"-i.e., the list of concentrations of those metabolites. This information can be extracted from a biofluids Nuclear Magnetic Resonance (NMR) spectrum. However, due to its complexity, NMR spectral profiling has remained manual, resulting in slow, expensive and error-prone procedures that have hindered clinical and industrial adoption of metabolomics via NMR. This paper presents a system, BAYESIL, which can quickly, accurately, and autonomously produce a person's metabolic profile. Given a 1D H-1 NMR spectrum of a complex biofluid (specifically serum or cerebrospinal fluid), BAYESIL can automatically determine the metabolic profile. This requires first performing several spectral processing steps, then matching the resulting spectrum against a reference compound library, which contains the "signatures" of each relevant metabolite. BAYESIL views spectral matching as an inference problem within a probabilistic graphical model that rapidly approximates the most probable metabolic profile. Our extensive studies on a diverse set of complex mixtures including real biological samples (serum and CSF), defined mixtures and realistic computer generated spectra; involving >50 compounds, show that BAYESIL can autonomously find the concentration of NMR-detectable metabolites accurately (similar to 90% correct identification and similar to 10% quantification error), in less than 5 minutes on a single CPU. These results demonstrate that BAYESIL is the first fully-automatic publicly-accessible system that provides quantitative NMR spectral profiling effectively-with an accuracy on these biofluids that meets or exceeds the performance of trained experts. We anticipate this tool will usher in high-throughput metabolomics and enable a wealth of new applications of NMR in clinical settings. BAYESIL is accessible at http://www.bayesil.ca.	[Ravanbakhsh, Siamak; Liu, Philip; Bjordahl, Trent C.; Mandal, Rupasri; Grant, Jason R.; Wilson, Michael; Eisner, Roman; Greiner, Russell; Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Ravanbakhsh, Siamak; Greiner, Russell] Alberta Innovates Ctr Machine Learning, Edmonton, AB, Canada; [Liu, Philip; Bjordahl, Trent C.; Mandal, Rupasri; Sinelnikov, Igor; Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hu, Xiaoyu] Fiorgen Fdn, I-50019 Florence, Italy; [Luchinat, Claudio] Univ Florence, Ctr Risonanze Magnet, Florence, Italy; [Wishart, David S.] CNR, Natl Inst Nanotechnol, Edmonton, AB, Canada	University of Alberta; Alberta Innovates; University of Alberta; University of Florence; National Research Council Canada	Wishart, DS (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.	david.wishart@ualberta.ca	Wishart, David Scott/ABI-3181-2020; Greiner, Russell/AAQ-4502-2020	Greiner, Russell/0000-0001-8327-934X; Wishart, David S/0000-0002-3207-2434	Alberta Innovates-Health Solutions; Alberta/Pfizer Translational Research Fund; Metabolomics Innovation Centre by Genome Canada; Genome Alberta; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Alberta Innovates Technology Futures scholarship; Queen Elizabeth II graduate scholarship; Alberta Innovates Centre for Machine Learning; CIHR [111062]; Alberta Innovates [201201143] Funding Source: researchfish	Alberta Innovates-Health Solutions; Alberta/Pfizer Translational Research Fund; Metabolomics Innovation Centre by Genome Canada; Genome Alberta; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures scholarship; Queen Elizabeth II graduate scholarship; Alberta Innovates Centre for Machine Learning; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	Funding for the whole project was provided by Alberta Innovates-Health Solutions and Alberta/Pfizer Translational Research Fund (http://www.aihealthsolutions.ca), and Metabolomics Innovation Centre (funded by Genome Canada and Genome Alberta, http://www.metabolomicscentre.ca). RG was supported by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) and Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca). SR was supported by Alberta Innovates Technology Futures (http://www.albertatechfutures.ca) and Queen Elizabeth II graduate scholarships. RG and SR were supported by Alberta Innovates Centre for Machine Learning (http://www.aicml.ca). DW was supported by CIHR grant reference number 111062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2009, NATURE, V457, P799, DOI 10.1038/457799a; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Biais B, 2009, ANAL CHEM, V81, P2884, DOI 10.1021/ac9001996; Blow N, 2008, NATURE, V455, P697, DOI 10.1038/455697a; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; BROWN DE, 1989, J MAGN RESON, V85, P15, DOI 10.1016/0022-2364(89)90315-6; de Brouwer H, 2009, J MAGN RESON, V201, P230, DOI 10.1016/j.jmr.2009.09.017; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; DIETRICH W, 1991, J MAGN RESON, V91, P1, DOI 10.1016/0022-2364(91)90402-F; Doucet A., 2001, SEQUENTIAL MONTE CAR; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; FRITSCH FN, 1980, SIAM J NUMER ANAL, V17, P238, DOI 10.1137/0717021; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Gibbs J. W., 2010, ELEMENTARY PRINCIPLE; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Griffin JL, 2011, NAT REV CARDIOL, V8, P630, DOI 10.1038/nrcardio.2011.138; Hao J, 2012, BIOINFORMATICS, V28, P2088, DOI 10.1093/bioinformatics/bts308; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; KOLLER D., 2009, PROBABILISTIC GRAPHI; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; MacKay DJC, 1996, ELECTRON LETT, V32, P1645, DOI 10.1049/el:19961141; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Mercier P, 2011, J BIOMOL NMR, V49, P307, DOI 10.1007/s10858-011-9480-x; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; Morris GA, 1997, PROG NUCL MAG RES SP, V31, P197, DOI 10.1016/S0079-6565(97)00011-3; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Ravanbakhsh S, 2009, THESIS; Ravanbakhsh S, 2010, PROC CONF AAAI ARTIF; Rubinstein RY, 2004, THE CROSS ENTROPY ME; Saleem F, 2013, METABOLOMICS, V9, P360, DOI 10.1007/s11306-012-0458-9; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sundekilde UK, 2013, METABOLITES, V3, P204, DOI 10.3390/metabo3020204; Takeda I, 2009, NMR BIOMED, V22, P577, DOI 10.1002/nbm.1369; TANG CG, 1994, J MAGN RESON SER A, V109, P232, DOI 10.1006/jmra.1994.1160; Tredwell GD, 2011, ANAL CHEM, V83, P8683, DOI 10.1021/ac202123k; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Whittaker E.T., 1922, P EDINBURGH MATH SOC, V41, P63, DOI [DOI 10.1017/S0013091500077853, 10.1017/S0013091500077853]; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wishart DS, 2008, TRAC-TREND ANAL CHEM, V27, P228, DOI 10.1016/j.trac.2007.12.001; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923	47	153	157	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124219	10.1371/journal.pone.0124219	http://dx.doi.org/10.1371/journal.pone.0124219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017271	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600003
J	Sala, N; Arsuaga, JL; Pantoja-Perez, A; Pablos, A; Martinez, I; Quam, RM; Gomez-Olivencia, A; de Castro, JMB; Carbonell, E				Sala, Nohemi; Arsuaga, Juan Luis; Pantoja-Perez, Ana; Pablos, Adrian; Martinez, Ignacio; Quam, Rolf M.; Gomez-Olivencia, Asier; Bermudez de Castro, Jose Marea; Carbonell, Eudald			Lethal Interpersonal Violence in the Middle Pleistocene	PLOS ONE			English	Article							BLUNT HEAD TRAUMA; LOS HUESOS ATAPUERCA; BREAKAGE PATTERNS; POSTMORTEM INTERVAL; FRACTURE PATTERNS; BONE-FRACTURES; FORCE TRAUMA; SIMA; CANNIBALISM; DISCRIMINATION	Evidence of interpersonal violence has been documented previously in Pleistocene members of the genus Homo, but only very rarely has this been posited as the possible manner of death. Here we report the earliest evidence of lethal interpersonal violence in the hominin fossil record. Cranium 17 recovered from the Sima de los Huesos Middle Pleistocene site shows two clear perimortem depression fractures on the frontal bone, interpreted as being produced by two episodes of localized blunt force trauma. The type of injuries, their location, the strong similarity of the fractures in shape and size, and the different orientations and implied trajectories of the two fractures suggest they were produced with the same object in face-to-face interpersonal conflict. Given that either of the two traumatic events was likely lethal, the presence of multiple blows implies an intention to kill. This finding shows that the lethal interpersonal violence is an ancient human behavior and has important implications for the accumulation of bodies at the site, supporting an anthropic origin.	[Sala, Nohemi; Arsuaga, Juan Luis; Pantoja-Perez, Ana; Pablos, Adrian; Martinez, Ignacio; Quam, Rolf M.; Gomez-Olivencia, Asier] UCM, Ctr Mixto, ISCIII, Evoluc Comportamiento Humanos, Madrid, Spain; [Arsuaga, Juan Luis] Univ Complutense Madrid, Fac Ciencias Geol, Dept Palaeontol, Madrid, Spain; [Pablos, Adrian; Martinez, Ignacio] Univ Alcala, Dept Ciencias Vida, Area Antropol Fis, Madrid, Spain; [Quam, Rolf M.] SUNY Binghamton, Dept Anthropol, Binghamton, NY 13902 USA; [Quam, Rolf M.] Amer Museum Nat Hist, Div Anthropol, New York, NY 10024 USA; [Gomez-Olivencia, Asier] Euskal Herriko Unibertsitatea, Fac Ciencias & Tecnol, Dept Estratig & Paleontol, Bilbao, Spain; [Gomez-Olivencia, Asier] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Gomez-Olivencia, Asier] Museum Natl Hist Nat, Musee Homme, Dept Prehist, Equipe Paleontol Humaine, F-75231 Paris, France; [Bermudez de Castro, Jose Marea] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Carbonell, Eudald] Univ Rovira & Virgili, Dept Hist & Hist Art, Area Prehist, E-43007 Tarragona, Spain; [Carbonell, Eudald] Inst Catala Paleoecol Humana & Evoluc Social, Tarragona, Spain; [Carbonell, Eudald] Inst Vertebrate Paleontol & Paleoanthropol Beijin, Beijing, Peoples R China	Complutense University of Madrid; Instituto de Salud Carlos III; Complutense University of Madrid; Universidad de Alcala; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; American Museum of Natural History (AMNH); University of Basque Country; Basque Foundation for Science; Museum National d'Histoire Naturelle (MNHN); Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Universitat Rovira i Virgili; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Sala, N (corresponding author), UCM, Ctr Mixto, ISCIII, Evoluc Comportamiento Humanos, Madrid, Spain.	nsala@isciii.es	Pérez, Ana Pantoja/AAG-7145-2019; Pablos, Adrián/H-4751-2015; Gómez-Olivencia, Asier/D-6531-2015; Pablos, Adrián/N-7531-2019; Sala, Nohemi/N-9961-2014; Sala, Nohemi/AAA-8881-2020	Pérez, Ana Pantoja/0000-0001-9302-1756; Pablos, Adrián/0000-0003-1630-4941; Gómez-Olivencia, Asier/0000-0001-7831-3902; Pablos, Adrián/0000-0003-1630-4941; Sala, Nohemi/0000-0002-0896-1493; Arsuaga, Juan Luis/0000-0001-5361-2295; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; martinez, ignacio/0000-0002-1835-9199	Ministerio de Economia y Competitividad of the government of Spain [CGL2012-38434-C03-01, CGL2012-38434-C03-02, CGL2012-38434-C03-03]; Junta de Castilla y Leon [BU005A09]; Junta de Castilla y Leon; Fundacion Atapuerca; Binghamton University (SUNY)	Ministerio de Economia y Competitividad of the government of Spain(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Atapuerca; Binghamton University (SUNY)	This research was supported by the Ministerio de Economia y Competitividad of the government of Spain (Project Nos. CGL2012-38434-C03-01, 02 & 03). CT scanning was carried out in collaboration with the Laboratorio de la Evolucion Humana at the Universidad de Burgos (Spain) with funding provided by the Junta de Castilla y Leon Project No. BU005A09. Fieldwork at the Atapuerca sites was funded by the Junta de Castilla y Leon and the Fundacion Atapuerca. N.S and A.P.P. have received postdoctoral and predoctoral respectively grants from the Fundacion Atapuerca. R.M.Q. has received financial support from Binghamton University (SUNY).	Aguirre E, 2000, TENDENCIAS ACTUALES, P31; Andrews P, 1997, J HUM EVOL, V33, P191, DOI 10.1006/jhev.1997.0137; Aranburu A, 2017, QUATERN INT, V433, P5, DOI 10.1016/j.quaint.2015.02.044; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Arsuaga JL, 1997, J HUM EVOL, V33, P109, DOI 10.1006/jhev.1997.0132; ARSUAGA JL, 1990, HUM EVOL, V5, P505; BERGER TD, 1995, J ARCHAEOL SCI, V22, P841, DOI 10.1016/0305-4403(95)90013-6; BERRYMAN HE, 1996, INT J OSTEOARCHAEOL, V6, P2; Brink O, 1998, INJURY, V29, P705, DOI 10.1016/S0020-1383(98)00176-4; Brink O, 2009, J TRAUMA, V67, P147, DOI 10.1097/TA.0b013e318182f77f; Caceres I, 2007, AM J PHYS ANTHROPOL, V133, P899, DOI 10.1002/ajpa.20610; Carbonell E, 2010, CURR ANTHROPOL, V51, P539, DOI 10.1086/653807; de Bakker BS, 2013, J FORENSIC RADIOL IM, V1, P176, DOI 10.1016/j.jofri.2013.07.005; de Castro JMB, 2004, J ANTHROPOL RES, V60, P5; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; Diez JC, 1990, I JORNADAS BURGALESA, P517; Fernandez-Jalvo Y, 1996, SCIENCE, V271, P277, DOI 10.1126/science.271.5247.277; Fleming-Farrell D, 2013, FORENSIC SCI INT, V229, DOI 10.1016/j.forsciint.2013.03.032; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; Galloway A, 1999, BROKEN BONES ANTHR A, P35; GURDJIAN ES, 1950, J NEUROSURG, V7, P106, DOI 10.3171/jns.1950.7.2.0106; Guyomarc'h P, 2010, J FORENSIC SCI, V55, P423, DOI 10.1111/j.1556-4029.2009.01310.x; HUSSAIN K, 1994, J TRAUMA, V36, P34, DOI 10.1097/00005373-199401000-00006; Jimenez-Brobeil SA, 2009, AM J PHYS ANTHROPOL, P140; Johnson E., 1985, ADV ARCHAEOLOGICAL M, P157, DOI [DOI 10.1016/B978-0-12-003108-5.50010-5, 10.1016/B978-0-12-003108-5.50010-5]; Jordana F, 2013, ROM J LEG MED, V21, P287, DOI 10.4323/rjlm.2013.287; Jordana F, 2013, J FORENSIC SCI, V58, pS156, DOI 10.1111/1556-4029.12012; Kremer C, 2008, J FORENSIC SCI, V53, P716, DOI 10.1111/j.1556-4029.2008.00725.x; Kremer C, 2009, J FORENSIC SCI, V54, P923, DOI 10.1111/j.1556-4029.2009.01072.x; Lovell NC, 1997, YEARB PHYS ANTHROPOL, V40, P139; Lozano M, 2009, EVOL HUM BEHAV, V30, P369, DOI 10.1016/j.evolhumbehav.2009.03.001; Martin DL, 2015, AM J PHYS ANTHROPOL, V156, P116, DOI 10.1002/ajpa.22662; Otterbein KF, 2011, CURR ANTHROPOL, V52, P439, DOI 10.1086/659742; Outram AK, 2005, J ARCHAEOL SCI, V32, P1699, DOI 10.1016/j.jas.2005.05.008; Perez PJ, 1997, J HUM EVOL, V33, P409, DOI 10.1006/jhev.1997.0139; Raul JS, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P21; Sala N, 2015, J ARCHAEOL SCI, V55, P113, DOI 10.1016/j.jas.2015.01.002; Sala N, 2014, QUATERNARY SCI REV, V97, P71, DOI 10.1016/j.quascirev.2014.05.004; Saladie P, 2012, J HUM EVOL, V63, P682, DOI 10.1016/j.jhevol.2012.07.004; Smith MO, 2003, AM J PHYS ANTHROPOL, V121, P303, DOI 10.1002/ajpa.10232; Spencer SD, 2012, INT J PALEOPATHOL, V2, P112, DOI 10.1016/j.ijpp.2012.09.007; Symes S.A., 2002, ADV FORENSIC TAPHONO, P403, DOI [10.1201/9781420058352-26, DOI 10.1201/9781420058352-26]; Thomas LM, 1984, MAXILLOFACIAL TRAUMA, P74; TRINKAUS E, 1982, AM J PHYS ANTHROPOL, V57, P61, DOI 10.1002/ajpa.1330570108; Trinkaus E, 2012, INT J OSTEOARCHAEOL, V22, P655, DOI 10.1002/oa.1227; Trinkaus E, 1983, THE SHANIDAR NEANDER; Trinkaus E, 2012, J ARCHAEOL SCI, V39, P3691, DOI 10.1016/j.jas.2012.05.039; Turner C.G., 1999, MAN CORN CANNIBALISM; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; VILLA P, 1986, SCIENCE, V233, P431, DOI 10.1126/science.233.4762.431; Villa P., 1992, EVOLUTIONARY ANTHR, V1, P93, DOI DOI 10.1002/EVAN.1360010307; WALKER PL, 1989, AM J PHYS ANTHROPOL, V80, P313, DOI 10.1002/ajpa.1330800305; Waters CJ, 2008, SKELETAL TRAUMA: IDENTIFICATION OF INJURIES RESULTING FROM HUMAN RIGHTS ABUSE AND ARMED CONFLICT, P321; Wedel V, 2014, BROKEN BONES ANTHROP; Wheatley BP, 2008, J FORENSIC SCI, V53, P69, DOI 10.1111/j.1556-4029.2008.00593.x; White T.D., 1992, PREHISTORIC CANNIBAL; Wieberg DAM, 2008, J FORENSIC SCI, V53, P1028, DOI 10.1111/j.1556-4029.2008.00801.x; Wu XJ, 2011, P NATL ACAD SCI USA, V108, P19558, DOI 10.1073/pnas.1117113108; Zollikofer CPE, 2002, P NATL ACAD SCI USA, V99, P6444, DOI 10.1073/pnas.082111899	59	59	61	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126589	10.1371/journal.pone.0126589	http://dx.doi.org/10.1371/journal.pone.0126589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018668	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600055
J	Weintrob, A; Bebu, I; Agan, B; Diem, A; Johnson, E; Lalani, T; Wang, X; Bavaro, M; Ellis, M; Mende, K; Crum-Cianflone, N				Weintrob, Amy; Bebu, Ionut; Agan, Brian; Diem, Alona; Johnson, Erica; Lalani, Tahaniyat; Wang, Xun; Bavaro, Mary; Ellis, Michael; Mende, Katrin; Crum-Cianflone, Nancy			Randomized, Double-Blind, Placebo-Controlled Study on Decolonization Procedures for Methicillin-Resistant Staphylococcus aureus (MRSA) among HIV-Infected Adults	PLOS ONE			English	Article							SOFT-TISSUE INFECTION; RISK-FACTORS; NASAL COLONIZATION; INTRANASAL MUPIROCIN; CARRIAGE; SKIN; ERADICATION; OUTPATIENTS; PREVALENCE; EMERGENCE	Background HIV-infected persons have increased risk of MRSA colonization and skin and soft-tissue infections (SSTI). However, no large clinical trial has examined the utility of decolonization procedures in reducing MRSA colonization or infection among community-dwelling HIV-infected persons. Methods 550 HIV-infected adults at four geographically diverse US military HIV clinics were prospectively screened for MRSA colonization at five body locations every 6 months during a 2-year period. Those colonized were randomized in a double-blind fashion to nasal mupirocin (Bactroban) twice daily and hexachlorophene (pHisoHex) soaps daily for 7 days compared to placeboes similar in appearance but without specific antibacterial activity. The primary endpoint was MRSA colonization at 6-months post-randomization; secondary endpoints were time to MRSA clearance, subsequent MRSA infections/SSTI, and predictors for MRSA clearance at the 6-month time point. Results Forty-nine (9%) HIV-infected persons were MRSA colonized and randomized. Among those with 6-month colonization data (80% of those randomized), 67% were negative for MRSA colonization in both groups (p = 1.0). Analyses accounting for missing 6-month data showed no significant differences could have been achieved. In the multivariate adjusted models, randomization group was not associated with 6-month MRSA clearance. The median time to MRSA clearance was similar in the treatment vs. placebo groups (1.4 vs. 1.8 months, p = 0.35). There was no difference on subsequent development of MRSA infections/SSTI (p = 0.89). In a multivariable model, treatment group, demographics, and HIV-specific factors were not predictive of MRSA clearance at the 6-month time point. Conclusion A one-week decolonization procedure had no effect on MRSA colonization at the 6-month time point or subsequent infection rates among community-dwelling HIV-infected persons. More aggressive or novel interventions may be needed to reduce the burden of MRSA in this population.	[Weintrob, Amy; Bebu, Ionut; Agan, Brian; Diem, Alona; Johnson, Erica; Lalani, Tahaniyat; Wang, Xun; Bavaro, Mary; Mende, Katrin; Crum-Cianflone, Nancy] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Weintrob, Amy] Walter Reed Natl Mil Med Ctr, Infect Dis Clin, Bethesda, MD USA; [Diem, Alona; Bavaro, Mary; Crum-Cianflone, Nancy] Naval Med Ctr San Diego, Infect Dis Clin, San Diego, CA USA; [Johnson, Erica; Mende, Katrin] San Antonio Mil Med Ctr, Infect Dis Serv, San Antonio, TX USA; [Lalani, Tahaniyat] Naval Med Ctr, Infect Dis Clin, Portsmouth, VA USA; [Ellis, Michael] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; Naval Medical Center San Diego; San Antonio Military Medical Center; Uniformed Services University of the Health Sciences - USA	Crum-Cianflone, N (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.	nancy32red@yahoo.com	Lalani, Tahaniyat/HCI-8313-2022	Lalani, Tahaniyat/0000-0002-9361-2991; Agan, Brian/0000-0002-5114-1669	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences [IDCRP-003]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work (IDCRP-003) was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072.	Ammerlaan HSM, 2009, CLIN INFECT DIS, V48, P922, DOI 10.1086/597291; Bending M, 1996, J AM SOC NEPHROL, V7, P2403; Brown DFJ, 2005, J ANTIMICROB CHEMOTH, V56, P1000, DOI 10.1093/jac/dki372; Crum-Cianflone NF, 2007, INT J STD AIDS, V18, P521, DOI 10.1258/095646207781439702; Datta R, 2008, CLIN INFECT DIS, V47, P176, DOI 10.1086/589241; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; DOEBBELING BN, 1994, ARCH INTERN MED, V154, P1505, DOI 10.1001/archinte.154.13.1505; Ellis MW, 2007, ANTIMICROB AGENTS CH, V51, P3591, DOI 10.1128/AAC.01086-06; Ellis MW, 2004, CLIN INFECT DIS, V39, P971, DOI 10.1086/423965; Gordon RJ, 2010, JAIDS-J ACQ IMM DEF, V55, P466, DOI 10.1097/QAI.0b013e3181ec2a68; Hidron AI, 2005, CLIN INFECT DIS, V41, P159, DOI 10.1086/430910; Hidron AI, 2011, AIDS, V25, P1001, DOI 10.1097/QAD.0b013e328343c595; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Lee LK, 2013, AIDS RES HUM RETROV, V29, P796, DOI [10.1089/aid.2012.0074, 10.1089/AID.2012.0074]; Lee NE, 2005, CLIN INFECT DIS, V40, P1529, DOI 10.1086/429827; Lobbedez T, 2004, NEPHROL DIAL TRANSPL, V19, P3140, DOI 10.1093/ndt/gfh494; Madariaga MG, 2009, CLIN INFECT DIS, V48, P1485, DOI 10.1086/598511; Martin JN, 1999, J INFECT DIS, V180, P896, DOI 10.1086/314949; Mathews WC, 2005, JAIDS-J ACQ IMM DEF, V40, P155, DOI 10.1097/01.qai.0000179464.40948.b9; McDonald LC, 2003, INT J STD AIDS, V14, P473, DOI 10.1258/095646203322025786; Miller M, 2007, CLIN INFECT DIS, V45, P343, DOI 10.1086/519429; Mody L, 2003, CLIN INFECT DIS, V37, P1467, DOI 10.1086/379325; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Padoveze MC, 2008, AM J INFECT CONTROL, V36, P187, DOI 10.1016/j.ajic.2007.05.012; Pegues DA, 2013, CLIN INFECT DIS, V57, P185, DOI 10.1093/cid/cit214; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Peters PJ, 2013, EMERG INFECT DIS, V19, P623, DOI 10.3201/eid1904.121353; Popovich KJ, 2013, CLIN INFECT DIS, V56, P1067, DOI 10.1093/cid/cit010; Rahimian J, 2007, INFECT CONT HOSP EP, V28, P1415, DOI 10.1086/523273; Ramsetty SK, 2010, HIV MED, V11, P389, DOI 10.1111/j.1468-1293.2009.00802.x; Robicsek A, 2009, CLIN INFECT DIS, V48, P910, DOI 10.1086/597296; Sandri AM, 2006, INFECT CONT HOSP EP, V27, P185, DOI 10.1086/500625; Seybold U, 2009, SCAND J INFECT DIS, V41, P63, DOI 10.1080/00365540802460000; Shet A, 2009, J INFECT DIS, V200, P88, DOI 10.1086/599315; Szumowski JD, 2009, CLIN INFECT DIS, V49, P118, DOI 10.1086/599608; van Rijen MML, 2008, J ANTIMICROB CHEMOTH, V61, P254, DOI 10.1093/jac/dkm480; Villacian JS, 2004, INFECT CONT HOSP EP, V25, P438, DOI 10.1086/502420; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2005, ANTIMICROB AGENTS CH, V49, P1465, DOI 10.1128/AAC.49.4.1465-1467.2005; Yang ES, 2010, CLIN MICROBIOL INFEC, V16, P425, DOI 10.1111/j.1469-0691.2009.02836.x	43	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128071	10.1371/journal.pone.0128071	http://dx.doi.org/10.1371/journal.pone.0128071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018036	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600108
J	Dalpiaz, PLM; Lamas, AZ; Caliman, IF; Ribeiro, RF; Abreu, GR; Moyses, MR; Andrade, TU; Gouvea, SA; Alves, MF; Carmona, AK; Bissoli, NS				Dalpiaz, P. L. M.; Lamas, A. Z.; Caliman, I. F.; Ribeiro, R. F., Jr.; Abreu, G. R.; Moyses, M. R.; Andrade, T. U.; Gouvea, S. A.; Alves, M. F.; Carmona, A. K.; Bissoli, N. S.			Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; II-INDUCED HYPERTENSION; GENDER-DIFFERENCES; BLOOD-PRESSURE; HEART-FAILURE; CONVERTING ENZYME-2; TYPE-2 RECEPTOR; EXPRESSION; PHOSPHOLAMBAN; MODULATION	Background There is growing interest in sex differences and RAS components. However, whether gender influences cardiac angiotensin I-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE2) activity is still unknown. In the present work, we determined the relationship between ACE and ACE2 activity, left ventricular function and gender in spontaneously hypertensive rats (SHRs). Methodology / Principal Findings Twelve-week-old female (F) and male (M) SHRs were divided into 2 experimental groups (n = 7 in each group): sham (S) and gonadectomized (G). Fifty days after gonadectomy, we measured positive and negative first derivatives (dP/dt maximum left ventricle (LV) and dP/dt minimum LV, respectively), hypertrophy (morphometric analysis) and ACE and ACE2 catalytic activity (fluorimetrically). Expression of calcium handling proteins was measured by western blot. Male rats exhibited higher cardiac ACE and ACE2 activity as well as hypertrophy compared to female rats. Orchiectomy decreased the activity of these enzymes and hypertrophy, while ovariectomy increased hypertrophy and ACE2, but did not change ACE activity. For cardiac function, the male sham group had a lower +dP/dt than the female sham group. After gonadectomy, the +dP/dt increased in males and reduced in females. The male sham group had a lower -dP/dt than the female group. After gonadectomy, the -dP/dt increased in the male and decreased in the female groups when compared to the sham group. No difference was observed among the groups in SERCA2a protein expression. Gonadectomy increased protein expression of PLB (phospholamban) and the PLB to SERCA2a ratio in female rats, but did not change in male rats. Conclusion Ovariectomy leads to increased cardiac hypertrophy, ACE2 activity, PLB expression and PLB to SERCA2a ratio, and worsening of hemodynamic variables, whereas in males the removal of testosterone has the opposite effects on RAS components.	[Dalpiaz, P. L. M.; Lamas, A. Z.; Caliman, I. F.; Ribeiro, R. F., Jr.; Abreu, G. R.; Moyses, M. R.; Bissoli, N. S.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Andrade, T. U.] Univ Vila Velha, Dept Pharm, Vila Velha, ES, Brazil; [Gouvea, S. A.] Univ Fed Espirito Santo, Nucleus Biotechnol, Vitoria, ES, Brazil; [Alves, M. F.; Carmona, A. K.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, Sao Paulo, Brazil	Universidade Federal do Espirito Santo; Centro Universitario Vila Velha; Universidade Federal do Espirito Santo; Universidade Federal de Sao Paulo (UNIFESP)	Dalpiaz, PLM (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	polyvitoria@yahoo.com.br	Ribeiro, Rogerio/F-7116-2012; Bissoli, Nazare/ABA-2679-2021; Carmona, Adriana K/D-2240-2012; Andrade, Tadeu U/M-4616-2016; dalpiaz, Polyana/AFK-3054-2022	Ribeiro, Rogerio/0000-0002-9725-3869; Carmona, Adriana K/0000-0003-3311-5456; Andrade, Tadeu U/0000-0001-6387-7895; Caliman, Izabela/0000-0002-6357-1375	FAPES Casadinho/Procad [54688175/2011]	FAPES Casadinho/Procad	FAPES Casadinho/Procad, 54688175/2011; http://www.fapes.es.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MF, 2005, BRAZ J MED BIOL RES, V38, P861, DOI 10.1590/S0100-879X2005000600007; BACHMANN J, 1993, J HYPERTENS, V11, pS226; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Bhatia K, 2013, AM J HYPERTENS, V26, P591, DOI 10.1093/ajh/hps088; Brosnihan KB, 1997, AM J PHYSIOL-REG I, V273, pR1908, DOI 10.1152/ajpregu.1997.273.6.R1908; Bubb KJ, 2012, BRIT J PHARMACOL, V167, P298, DOI 10.1111/j.1476-5381.2012.02036.x; Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Burrell LM, 2004, TRENDS ENDOCRIN MET, V15, P166, DOI 10.1016/j.tem.2004.03.001; Campbell DJ, 2004, HYPERTENSION, V43, P854, DOI 10.1161/01.HYP.0000119190.06968.f1; Campbell DJ, 2003, HYPERTENSION, V41, P383, DOI 10.1161/01.HYP.0000054215.71691.16; Chappell MC, 2003, HYPERTENSION, V42, P781, DOI 10.1161/01.HYP.0000085210.66399.A3; Chen J, 2003, AM J PHYS HEAR CIRC, V27709, P2657; CHEN YF, 1992, HYPERTENSION, V19, P456, DOI 10.1161/01.HYP.19.5.456; Chu SH, 2005, LIFE SCI, V76, P2735, DOI 10.1016/j.lfs.2004.12.013; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Crowley SD, 2012, EXP CELL RES, V318, P1049, DOI 10.1016/j.yexcr.2012.02.023; Dalpiaz PLM, 2013, BRAZ J MED BIOL RES, V46, P171, DOI 10.1590/1414-431X20122472; Dias DPM, 2010, BRAZ J MED BIOL RES, V43, P969, DOI 10.1590/S0100-879X2010001000008; Dong B, 2012, J AM COLL CARDIOL, V59, P739, DOI 10.1016/j.jacc.2011.09.071; Duarte DR, 2009, CLINICS, V64, P691, DOI 10.1590/S1807-59322009000700014; ELLISON KE, 1989, J CLIN INVEST, V83, P1941, DOI 10.1172/JCI114102; Fabris B, 2011, J HYPERTENS, V29, P273, DOI 10.1097/HJH.0b013e328340d0d3; Falcon BL, 2004, PHYSIOL GENOMICS, V19, P255, DOI 10.1152/physiolgenomics.00170.2004; Ferreira AJ, 2010, HYPERTENSION, V55, P207, DOI 10.1161/HYPERTENSIONAHA.109.140145; Ferreira C, 2010, CLINICS, V65, P723, DOI 10.1590/S1807-59322010000700012; Gallagher PE, 2006, AM J PHYSIOL-CELL PH, V290, pC420, DOI 10.1152/ajpcell.00409.2004; Hayasaki-Kajiwara Y, 1999, J MOL CELL CARDIOL, V31, P1559, DOI 10.1006/jmcc.1999.0993; Hilliard LM, 2013, CURR HYPERTENS REP, V15, P71, DOI 10.1007/s11906-012-0319-y; Hudson M, 2007, EUR J HEART FAIL, V9, P602, DOI 10.1016/j.ejheart.2007.02.001; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; Khalil RA, 2005, HYPERTENSION, V46, P249, DOI 10.1161/01.HYP.0000172945.06681.a4; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Koss KL, 1997, BASIC RES CARDIOL, V92, P17, DOI 10.1007/BF00794064; Li L, 2008, PHARMACOL RES, V58, P196, DOI 10.1016/j.phrs.2008.06.009; Lim YK, 2002, ATHEROSCLEROSIS, V160, P311, DOI 10.1016/S0021-9150(01)00576-7; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Maric-Bilkan C, 2012, GENDER MED, V9, P287, DOI 10.1016/j.genm.2012.06.005; Os I, 2008, HYPERTENSION, V51, P1103, DOI 10.1161/HYPERTENSIONAHA.107.105296; Pelzer T, 2005, CARDIOVASC RES, V67, P604, DOI 10.1016/j.cardiores.2005.04.035; Pendergrass KD, 2008, AM J PHYSIOL-HEART C, V295, pH10, DOI 10.1152/ajpheart.01277.2007; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; R Jr RF, 2010, LIPIDS HLTH DIS, V9, P1, DOI 10.1186/1476-511X-9-1; Reckelhoff JF, 1998, HYPERTENSION, V31, P435, DOI 10.1161/01.HYP.31.1.435; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Reckelhoff JF, 1999, HYPERTENSION, V34, P920, DOI 10.1161/01.HYP.34.4.920; Reckelhoff JF, 2000, HYPERTENSION, V35, P480, DOI 10.1161/01.HYP.35.1.480; Remme WJ, 2003, CARDIOVASC DRUG THER, V17, P349, DOI 10.1023/A:1027351808326; Riviere G, 2005, HYPERTENSION, V46, P1169, DOI 10.1161/01.HYP.0000185148.27901.fe; Sarkissian SD, 2008, HYPERTENSION, V51, P712, DOI 10.1161/HYPERTENSIONAHA.107.100693; Sarkissian SD, 2013, J AM SOC HYPERTENS, V7, P118, DOI 10.1016/j.jash.2013.01.002; Shenoy V, 2009, PEPTIDES, V30, P2309, DOI 10.1016/j.peptides.2009.09.005; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Sullivan JC, 2008, AM J PHYSIOL-REG I, V294, pR1220, DOI 10.1152/ajpregu.00864.2007; Sullivan JC, 2010, HYPERTENSION, V56, P658, DOI 10.1161/HYPERTENSIONAHA.110.153668; Tatchum-Talom R, 2011, J CARDIOVASC PHARM, V57, P357, DOI 10.1097/FJC.0b013e31820b7dc9; VALLOTTON MB, 1987, TRENDS PHARMACOL SCI, V8, P69, DOI 10.1016/0165-6147(87)90013-7; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang X, 2003, J APPL PHYSIOL, V94, P752, DOI 10.1152/japplphysiol.00248.2002; Xue BJ, 2005, AM J PHYSIOL-HEART C, V288, pH2177, DOI 10.1152/ajpheart.00969.2004; Yanes LL, 2009, AM J PHYSIOL-HEART C, V297, pH1583, DOI 10.1152/ajpheart.00901.2009; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Zhao YX, 2010, HUM GENE THER, V21, P1545, DOI 10.1089/hum.2009.160; Zimmerman MA, 2013, PHYSIOLOGY, V28, P234, DOI 10.1152/physiol.00013.2013	65	78	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127515	10.1371/journal.pone.0127515	http://dx.doi.org/10.1371/journal.pone.0127515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010093	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900103
J	Domnich, A; Panatto, D; Signori, A; Lai, PL; Gasparini, R; Amicizia, D				Domnich, Alexander; Panatto, Donatella; Signori, Alessio; Lai, Piero Luigi; Gasparini, Roberto; Amicizia, Daniela			Age-Related Differences in the Accuracy of Web Query-Based Predictions of Influenza-Like Illness	PLOS ONE			English	Article							PANDEMIC INFLUENZA; DISEASE SURVEILLANCE; INFORMATION-SEEKING; HEALTH INFORMATION; INTERNET; SEARCH; CHILDREN; INFODEMIOLOGY; COMMUNICATION; EPIDEMIC	Background Web queries are now widely used for modeling, nowcasting and forecasting influenza-like illness (ILI). However, given that ILI attack rates vary significantly across ages, in terms of both magnitude and timing, little is known about whether the association between ILI morbidity and ILI-related queries is comparable across different age-groups. The present study aimed to investigate features of the association between ILI morbidity and ILI-related query volume from the perspective of age. Methods Since Google Flu Trends is unavailable in Italy, Google Trends was used to identify entry terms that correlated highly with official ILI surveillance data. All-age and age-class-specific modeling was performed by means of linear models with generalized least-square estimation. Hold-out validation was used to quantify prediction accuracy. For purposes of comparison, predictions generated by exponential smoothing were computed. Results Five search terms showed high correlation coefficients of >.6. In comparison with exponential smoothing, the all-age query-based model correctly predicted the peak time and yielded a higher correlation coefficient with observed ILI morbidity (. 978 vs..929). However, query-based prediction of ILI morbidity was associated with a greater error. Age-class-specific query-based models varied significantly in terms of prediction accuracy. In the 0-4 and 25-44-year age-groups, these did well and outperformed exponential smoothing predictions; in the 15-24 and >= 65-year age-classes, however, the query-based models were inaccurate and highly overestimated peak height. In all but one age-class, peak timing predicted by the query-based models coincided with observed timing. Conclusions The accuracy of web query-based models in predicting ILI morbidity rates could differ among ages. Greater age-specific detail may be useful in flu query-based studies in order to account for age-specific features of the epidemiology of ILI.	[Domnich, Alexander; Panatto, Donatella; Signori, Alessio; Lai, Piero Luigi; Gasparini, Roberto; Amicizia, Daniela] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Panatto, Donatella; Lai, Piero Luigi; Gasparini, Roberto; Amicizia, Daniela] Inter Univ Ctr Res Influenza & Other Transmissibl, Genoa, Italy	University of Genoa	Domnich, A (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	alexander.domnich@gmail.com	Bragazzi, Nicola Luigi/G-1672-2011; Signori, Alessio/L-3081-2016	Bragazzi, Nicola Luigi/0000-0001-8409-868X; Signori, Alessio/0000-0001-6289-9144	Inter-University Centre of Research on Influenza and other Transmissible Infections (CIRI-IT), Genoa, Italy	Inter-University Centre of Research on Influenza and other Transmissible Infections (CIRI-IT), Genoa, Italy	The study was supported by the Inter-University Centre of Research on Influenza and other Transmissible Infections (CIRI-IT), Genoa, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258; Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P2634, DOI 10.4161/hv.26010; [Anonymous], SEARCH ENGINE USE 20; [Anonymous], 2014, R LANG ENV STAT COMP; Ansaldi F, 2008, J Prev Med Hyg, V49, P131; Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740; Bernhardt JM, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.1.e7; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Cho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081422; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cohen R. A., 2011, USE INTERNET HLTH IN; Cook AR, 2010, EMERG INFECT DIS, V16, P1647, DOI 10.3201/eid1610.100840; Lange MMA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-881; Debin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073675; Domnich A, 2014, INT J PUBLIC HEALTH, V59, P841, DOI 10.1007/s00038-014-0581-7; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Elliot A, 2009, EURO SURVEILL, V14; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; Fowlkes A, 2013, INFLUENZA OTHER RESP, V7, P694, DOI 10.1111/irv.12014; FOX J, 2002, TIME SERIES REGRESSI; Gasparini R, 2013, HUM VACC IMMUNOTHER, V9, P561, DOI 10.4161/hv.23235; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Glatman-Freedman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050228; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Jayasundara K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0670-5; Kang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055205; Khoo K, 2008, J PAEDIATR CHILD H, V44, P419, DOI 10.1111/j.1440-1754.2008.01322.x; Lai P L, 2011, J Prev Med Hyg, V52, P142; Lazer D, GOOGLE FLU TRENDS ST; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5; Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Paolotti D, 2010, P 3 INT ICST C EL HE; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Santos JC, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-S1-S6; Schanzer D, 2011, AM J EPIDEMIOL, V174, P109, DOI 10.1093/aje/kwr037; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Signorelli C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h116; Sim NZ, 2007, J PEDIATR SURG, V42, P305, DOI 10.1016/j.jpedsurg.2006.10.003; Skranes LP, 2014, J PUBLIC HEALTH-HEID, V22, P423, DOI 10.1007/s10389-014-0631-x; Viboud C, 2004, INT CONGR SER, V1263, P291, DOI 10.1016/j.ics.2004.01.013; Wainstein BK, 2006, J PAEDIATR CHILD H, V42, P528, DOI 10.1111/j.1440-1754.2006.00916.x; Yuan QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064323; Zhou XC, 2010, J ZHEJIANG U-SCI C, V11, P241, DOI 10.1631/jzus.C0910371	55	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127754	10.1371/journal.pone.0127754	http://dx.doi.org/10.1371/journal.pone.0127754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011418	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900139
J	Ma, JL; Liang, LM; Jiang, H; Gu, B				Ma, Junli; Liang, Limin; Jiang, Hua; Gu, Bin			Gap Arthroplasty versus Interpositional Arthroplasty for Temporomandibular Joint Ankylosis: A Meta-Analysis	PLOS ONE			English	Article							TEMPORALIS MUSCLE; SURGICAL-TREATMENT; TMJ ANKYLOSIS; FASCIA FLAP; FOLLOW-UP; FAT GRAFT; MANAGEMENT; EXPERIENCE; SURGERY	Gap arthroplasty (GA) and interpositional arthroplasty (IA) are widely used for the treatment of temporomandibular joint ankylosis (TMJA). However, controversy remains as to whether IA is superior to GA. PubMed, EMBASE, the Cochrane Library, the Web of science and the China National Knowledge Infrastructure were searched for literature regarding these procedures (published from 1946 to July 28, 2014). A study was included in this analysis if it was: (1) a randomized controlled trial or non-randomized observational cohort study; (2) comparing the clinical outcomes between GA and IA with respect to the maximal incisal opening (MIO) and reankylosis; (3) with a follow-up period of at least 12 months. The methodological quality of the included studies was evaluated according to the Newcastle-Ottawa Scale Eight non-randomized observational cohort studies with 272 patients were included. All the statistical analyses were performed using the RevMan 5.3 and Stat 12. The pooled analysis showed no significant difference in the incidence of reankylosis between the IA group (13/120) and the GA group (29/163) (RR= 0.67, 95% CI = 0.38 to 1.16; Z = 1.43, p = 0.15). The IA group showed a significantly larger MIO than the GA group (MD = 1.96, 95% CI = 0.21 to 3.72, Z = 2.19, p = 0.03, I-2 = 0%). In conclusion, patients with TMJA could benefit more from IA than GA, with a larger MIO and a similar incidence of reankylosis. IA shows to be an adequate option in the treatment of TMJA based on the results of maximal incisal opening.	[Ma, Junli] Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Stomatol, Guangzhou, Guangdong, Peoples R China; [Liang, Limin; Jiang, Hua; Gu, Bin] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China	Southern Theater Command General Hospital; Chinese People's Liberation Army General Hospital	Ma, JL (corresponding author), Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Stomatol, Guangzhou, Guangdong, Peoples R China.	skyring@126.com						Abdelrahman TF, 2010, J CRANIOFAC SURG, V21, P1301, DOI 10.1097/SCS.0b013e3181e1e69a; Akhtar Muhammad Usman, 2006, J Ayub Med Coll Abbottabad, V18, P73; Babu L, 2013, BRIT J ORAL MAX SURG, V51, P473, DOI 10.1016/j.bjoms.2012.11.004; Bayat M, 2009, ORAL MAXILLOFAC SURG, V13, P207, DOI 10.1007/s10006-009-0174-4; BERLIN JA, 1995, AM J EPIDEMIOL, V142, P383, DOI 10.1093/oxfordjournals.aje.a117645; Chidzonga MM, 1999, BRIT J ORAL MAX SURG, V37, P123, DOI 10.1054/bjom.1997.0089; Chossegros C, 1997, BRIT J ORAL MAX SURG, V35, P157, DOI 10.1016/S0266-4356(97)90554-4; Danda AK, 2009, J ORAL MAXIL SURG, V67, P1425, DOI 10.1016/j.joms.2008.12.049; Dean A, 1999, PLAST RECONSTR SURG, V104, P2021, DOI 10.1097/00006534-199912000-00012; Vasconcelos BCD, 2009, MED ORAL PATOL ORAL, V14, pE34; Driemel O, 2009, INT J ORAL MAX SURG, V38, P909, DOI 10.1016/j.ijom.2009.01.022; El-Sheikh MM, 1999, ANN ROY COLL SURG, V81, P12; Elgazzar RF, 2010, INT J ORAL MAX SURG, V39, P333, DOI 10.1016/j.ijom.2010.01.005; Erol B, 2006, J CRANIO MAXILL SURG, V34, P100, DOI 10.1016/j.jcms.2005.07.008; FEINBERG SE, 1989, J ORAL MAXIL SURG, V47, P142, DOI 10.1016/S0278-2391(89)80104-1; Guven O, 2000, Auris Nasus Larynx, V27, P27, DOI 10.1016/S0385-8146(99)00045-0; Holmlund A, 2013, BRIT J ORAL MAX SURG, V51, P206, DOI 10.1016/j.bjoms.2012.05.011; Hu Tie-xia, 2005, Zhonghua Zheng Xing Wai Ke Za Zhi, V21, P408; Humprey GW., 1826, ASSOC MED J, V160, P61; Jain G, 2008, ORAL MAXILLOFAC SURG, V12, P61, DOI 10.1007/s10006-008-0103-y; KABAN LB, 1990, J ORAL MAXIL SURG, V48, P1145, DOI 10.1016/0278-2391(90)90529-B; Karamese M, 2013, J CRANIO MAXILL SURG, V41, P789, DOI 10.1016/j.jcms.2013.01.027; Katsnelson A, 2012, J ORAL MAXIL SURG, V70, P531, DOI 10.1016/j.joms.2011.10.003; Manganello-Souza LC, 2003, INT J ORAL MAX SURG, V32, P24, DOI 10.1054/ijom.2002.0308; Mehrotra D, 2008, BRIT J ORAL MAX SURG, V46, P521, DOI 10.1016/j.bjoms.2008.03.002; Obiechina AE, 1999, E AFR MED J, V76, P683; Ortak T, 2001, J CRANIOFAC SURG, V12, P232, DOI 10.1097/00001665-200105000-00007; Rajasekhar A, 2011, J THROMB THROMBOLYS, V32, P40, DOI 10.1007/s11239-010-0544-7; Ramezanian M, 2006, ACTA MED IRAN, V44, P391; RAVEH J, 1989, J ORAL MAXIL SURG, V47, P900, DOI 10.1016/0278-2391(89)90371-6; Roychoudhury A, 1999, ORAL SURG ORAL MED O, V87, P166, DOI 10.1016/S1079-2104(99)70267-2; Sidebottom AJ, 2013, BRIT J ORAL MAX SURG, V51, P191, DOI 10.1016/j.bjoms.2012.04.271; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su-Gwan K, 2001, INT J ORAL MAX SURG, V30, P189, DOI 10.1054/ijom.2001.0047; Tanrikulu R, 2005, TURKISH J PEDIATR, V47, P261; Thangavelu A, 2011, INT J ORAL MAX SURG, V40, P50, DOI 10.1016/j.ijom.2010.06.025; TOPAZIAN RG, 1966, J ORAL SURG, V24, P405; Topazian RG, 2001, ORAL SURG ORAL MED O, V91, P388, DOI 10.1067/moe.2001.114623; Valentini V, 2002, J CRANIOFAC SURG, V13, P59, DOI 10.1097/00001665-200201000-00013; Vasconcelos Belmiro Cavalcanti do Egito, 2006, Med Oral Patol Oral Cir Bucal, V11, pE66; Yazdani J, 2010, J CRANIOFAC SURG, V21, P1218, DOI 10.1097/SCS.0b013e3181e1b4f6; Zhi KQ, 2009, ORAL SURG ORAL MED O, V108, P687, DOI 10.1016/j.tripleo.2009.06.041	42	19	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127652	10.1371/journal.pone.0127652	http://dx.doi.org/10.1371/journal.pone.0127652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010224	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900125
J	Ranthe, MF; Petersen, JA; Bundgaard, H; Wohlfahrt, J; Melbye, M; Boyd, HA				Ranthe, Mattis Flyvholm; Petersen, Jonathan Aavang; Bundgaard, Henning; Wohlfahrt, Jan; Melbye, Mads; Boyd, Heather A.			A Detailed Family History of Myocardial Infarction and Risk of Myocardial Infarction - A Nationwide Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; DEATH; ASSOCIATION; POPULATION	Background Family history of myocardial infarction (MI) is an independent risk factor for MI. Several genetic variants are associated with increased risk of MI and family history of MI in a first-degree relative doubles MI risk. However, although family history of MI is not a simple dichotomous risk factor, the impact of specific, detailed family histories has not received much attention, despite its high clinical relevance. We examined risk of MI by MIs in first-and second-degree relatives and by number and age of affected relatives. Methods and Findings Using Danish national registers, we established a nationwide cohort of persons born between 1930 and 1992 with identifiable first-or second- degree relatives. Incident MIs in both cohort members and relatives aged >= 20 years were identified. We calculated incidence rate ratios (IRRs) for MI by family history of MI, by Poisson regression. In 4.4 million persons followed for 104 million person-years, we identified 128,384 incident MIs. IRRs with 95% confidence intervals [CIs] for MI by history of MI in 1, 2 or >= 3 first-degree relatives were 1.46 (1.42-1.49), 2.38 ( 2.22-2.56) and 3.58 (2.66-4.81), respectively. Corresponding estimates for second- degree relatives were 1.17 (1.05-1.30), 1.87 (1.46-2.38) and 2.18 (1.09-4.36). A history of MI in combinations of first-and second- degree relatives increased risks 1.8- to 7-fold in middle-aged persons (36 to 55 years). Estimates were robust to adjustment for diabetes, hypertension, dyslipidemia and use of cardiovascular medications. Conclusion A detailed family history, particularly number of affected first-and second- degree relatives, contributes meaningfully to risk assessment, especially in middle-aged persons. Future studies should test for potential improvement of risk algorithm prediction using detailed family histories.	[Ranthe, Mattis Flyvholm; Petersen, Jonathan Aavang; Wohlfahrt, Jan; Melbye, Mads; Boyd, Heather A.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Bundgaard, Henning] Copenhagen Univ Hosp, Ctr Heart, Unit Inherited Cardiac Dis, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen	Ranthe, MF (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark.	mfrante@gmail.com	Bundgaard, Henning/AAA-4381-2020; Aavang Petersen, jonathan/ABG-7320-2021	Bundgaard, Henning/0000-0002-0563-7049; melbye, mads/0000-0001-8264-6785; Boyd, Heather/0000-0001-6849-9985; Aavang Petersen, Jonathan/0000-0003-0635-4144; Ranthe, Mattis Flyvholm/0000-0002-6363-6386	Danish Heart Foundation [10-04-R78-A2799-22615]; Dagmar Marshall's Foundation; Novo Nordisk Fonden [NNF14OC0012809] Funding Source: researchfish	Danish Heart Foundation; Dagmar Marshall's Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The Danish Heart Foundation: Grant 10-04-R78-A2799-22615 (http://www.hjerteforeningen.dk/om_os/in_english/) Dagmar Marshall's Foundation: In 2011 this Foundation granted 40,000 DKR (similar to 6,820 USD) for regular salary for Dr. Ranthe while he was employed at the Department of Epidemiology Research, Statens Serum Institut. Dagmar Marshall's Foundation is a small private fund managed by a local Danish law firm, Dagmar Marshall's Foundation do not provide grant numbers and has no webpage. None of the funding sources had any role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Bachmann JM, 2012, CIRCULATION, V125, P3092, DOI 10.1161/CIRCULATIONAHA.111.065490; BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; Chow CK, 2007, BMJ-BRIT MED J, V335, P481, DOI 10.1136/bmj.39253.577859.BE; Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dent THS, 2010, ATHEROSCLEROSIS, V213, P345, DOI 10.1016/j.atherosclerosis.2010.06.019; Di Angelantonio E, 2012, CIRC-CARDIOVASC GENE, V5, P387, DOI 10.1161/CIRCGENETICS.112.964148; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Framingham Heart Study, 2010, RISK SCOR PROF; Germano G, 2012, EUR HEART J, V33, P137; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Nielsen M, 2013, EUR HEART J, V34, P1198, DOI 10.1093/eurheartj/ehs475; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Prabhakaran D, 2012, MT SINAI J MED, V79, P721, DOI 10.1002/msj.21348; Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002; Ranthe MF, 2012, J AM COLL CARDIOL, V60, P814, DOI 10.1016/j.jacc.2012.06.018; Roberts R, 2014, CIRC RES, V114, P1890, DOI 10.1161/CIRCRESAHA.114.302692; Roberts R, 2012, J AM COLL CARDIOL, V60, P1715, DOI 10.1016/j.jacc.2011.12.062; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sivapalaratnam S, 2010, HEART, V96, P1985, DOI 10.1136/hrt.2010.210740; Valdez R, 2010, ANNU REV PUBL HEALTH, V31, P69, DOI 10.1146/annurev.publhealth.012809.103621; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	29	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125896	10.1371/journal.pone.0125896	http://dx.doi.org/10.1371/journal.pone.0125896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011129	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900016
J	Wendel, SO; Menon, S; Alshetaiwi, H; Shrestha, TB; Chlebanowski, L; Hsu, WW; Bossmann, SH; Narayanan, S; Troyer, DL				Wendel, Sebastian O.; Menon, Sailesh; Alshetaiwi, Hamad; Shrestha, Tej B.; Chlebanowski, Lauren; Hsu, Wei-Wen; Bossmann, Stefan H.; Narayanan, Sanjeev; Troyer, Deryl L.			Cell Based Drug Delivery: Micrococcus luteus Loaded Neutrophils as Chlorhexidine Delivery Vehicles in a Mouse Model of Liver Abscesses in Cattle	PLOS ONE			English	Article							FUSOBACTERIUM-NECROPHORUM LEUKOTOXIN; FEEDLOT CATTLE; RESISTANCE; ANTISEPTICS; BACTERIA	The recent WHO report on antibiotic resistances shows a dramatic increase of microbial resistance against antibiotics. With only a few new antibiotics in the pipeline, a different drug delivery approach is urgently needed. We have obtained evidence demonstrating the effectiveness of a cell based drug delivery system that utilizes the innate immune system as targeting carrier for antibacterial drugs. In this study we show the efficient loading of neutrophil granulocytes with chlorhexidine and the complete killing of E. coli as well as Fusobacterium necrophorum in in-vitro studies. Fusobacterium necrophorum causes hepatic abscesses in cattle fed high grain diets. We also show in a mouse model that this delivery system targets infections of F. necrophorum in the liver and reduces the bacterial burden by an order of magnitude from approximately 2.10(6) to 1.10(5).	[Wendel, Sebastian O.] Kansas State Univ, Dept Chem Engn, Manhattan, KS 66506 USA; [Menon, Sailesh; Narayanan, Sanjeev] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Alshetaiwi, Hamad; Shrestha, Tej B.; Troyer, Deryl L.] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Hsu, Wei-Wen] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA; [Bossmann, Stefan H.] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA; [Alshetaiwi, Hamad] Univ Hail, Hail, Saudi Arabia; [Chlebanowski, Lauren] Augustana Coll, Dept Chem, Rock Isl, IL 61201 USA	Kansas State University; Kansas State University; Kansas State University; Kansas State University; Kansas State University; University Ha'il	Narayanan, S (corresponding author), Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.	sanjeev@vet.k-state.edu	Bossmann, Stefan/AAG-9881-2020	Wendel, Sebastian/0000-0002-5515-0968	National Science Foundation Division of Material Research [1242765]; National Science Foundation Major Research Instrumentation [NSF-13-517]; Direct For Mathematical & Physical Scien [1242765] Funding Source: National Science Foundation	National Science Foundation Division of Material Research(National Science Foundation (NSF)); National Science Foundation Major Research Instrumentation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work was supported by National Science Foundation Division of Material Research-1242765 (SHB, DLT) and National Science Foundation Major Research Instrumentation NSF-13-517 (SHB, DLT, SN).	Alhariri M, 2013, EXPERT OPIN DRUG DEL, V10, P1515, DOI 10.1517/17425247.2013.822860; Baldridge CW, 1933, AM J PHYSIOL, V103, P235, DOI 10.1152/ajplegacy.1932.103.1.235; Bolhuis A, 2014, BIOORG CHEM, V55, P51, DOI 10.1016/j.bioorg.2014.03.009; BRINK DR, 1990, J ANIM SCI, V68, P1201; Brooks SE, 2002, INFECT CONT HOSP EP, V23, P692, DOI 10.1086/501996; Checkley SL, 2005, CAN VET J, V46, P1002; COOKSON BD, 1991, ANTIMICROB AGENTS CH, V35, P1997, DOI 10.1128/AAC.35.10.1997; CRITCHLOW DE, 1991, COMMUN STAT THEORY, V20, P127, DOI 10.1080/03610929108830487; Dhandapani N V, 2013, INT J RES PHARM SCI, V4, P187; Dwass M., 1960, CONTRIBUTIONS PROBAB, P198; Genuit T, 2001, Surg Infect (Larchmt), V2, P5, DOI 10.1089/109629601750185316; Hurst JK, 2012, FREE RADICAL BIO MED, V53, P508, DOI 10.1016/j.freeradbiomed.2012.05.008; Jones CG, 1997, PERIODONTOL 2000, V15, P55, DOI 10.1111/j.1600-0757.1997.tb00105.x; Leikin J.B., 2008, POISONING TOXICOLOGY, DOI [10.3109/9781420044805, DOI 10.3109/9781420044805]; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; MARTIN AR, 1959, J CLIN PATHOL, V12, P48, DOI 10.1136/jcp.12.1.48; Maruyama K, 2011, ADV DRUG DELIVER REV, V63, P161, DOI 10.1016/j.addr.2010.09.003; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; Nagaraja TG, 2007, VET CLIN N AM-FOOD A, V23, P351, DOI 10.1016/j.cvfa.2007.05.002; Nagaraja TG, 1998, J ANIM SCI, V76, P287; Nagaraja TG, 1999, J ANIM SCI, V77, P973; Narayanan S, 2002, INFECT IMMUN, V70, P4609, DOI 10.1128/IAI.70.8.4609-4620.2002; Narayanan SK, 2003, VET MICROBIOL, V93, P335, DOI 10.1016/S0378-1135(03)00045-2; Nuzzi Paul A, 2007, Methods Mol Biol, V370, P23; Perera AS, 2013, LANGMUIR, V29, P308, DOI 10.1021/la3037296; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Puig-Silla M, 2008, MED ORAL PATOL ORAL, V13, pE257; REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959; ROWE R, 1977, APPL ENVIRON MICROB, V33, P675, DOI 10.1128/AEM.33.3.675-680.1977; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Steel R.G.D., 1960, TECHNOMETRICS, VVol. 2, P197, DOI [DOI 10.1080/00401706.1960.10489894, 10.1080/00401706.1960.10489894]; Tadepalli S, 2008, J MED MICROBIOL, V57, P225, DOI 10.1099/jmm.0.47598-0; TAN ZL, 1994, APPL ENVIRON MICROB, V60, P1387, DOI 10.1128/AEM.60.4.1387-1389.1994; TAN ZL, 1994, J ANIM SCI, V72, P502, DOI 10.2527/1994.722502x; Timar CI, 2013, PFLUG ARCH EUR J PHY, V465, P1521, DOI 10.1007/s00424-013-1285-1; VanDonkersgoed J, 1997, CAN VET J, V38, P217; World Health Organization, 2014, ANT RES GLOB REP SUR; Young M, 2010, J BACTERIOL, V192, P841, DOI 10.1128/JB.01254-09	38	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128144	10.1371/journal.pone.0128144	http://dx.doi.org/10.1371/journal.pone.0128144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011247	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900197
J	Zhou, SR; Xiong, L; Xie, PX; Ambalavanan, A; Bourassa, CV; Dionne-Laporte, A; Spiegelman, D; Gauthier, MT; Henrion, E; Diallo, O; Dion, PA; Rouleau, GA				Zhou, Sirui; Xiong, Lan; Xie, Pingxing; Ambalavanan, Amirthagowri; Bourassa, Cynthia V.; Dionne-Laporte, Alexandre; Spiegelman, Dan; Gauthier, Maude Turcotte; Henrion, Edouard; Diallo, Ousmane; Dion, Patrick A.; Rouleau, Guy A.			Increased Missense Mutation Burden of Fatty Acid Metabolism Related Genes in Nunavik Inuit Population	PLOS ONE			English	Article							CARNITINE PALMITOYLTRANSFERASE 1A; SEQUENCE VARIANT; INFANT-MORTALITY; FUEL UTILIZATION; ENCEPHALOPATHY; DEFICIENCY; P479L; VISUALIZATION; ASSOCIATION; PREVALENCE	Background Nunavik Inuit (northern Quebec, Canada) reside along the arctic coastline where for generations their daily energy intake has mainly been derived from animal fat. Given this particular diet it has been hypothesized that natural selection would lead to population specific allele frequency differences and unique variants in genes related to fatty acid metabolism. A group of genes, namely CPT1A, CPT1B, CPT1C, CPT2, CRAT and CROT, encode for three carnitine acyltransferases that are important for the oxidation of fatty acids, a critical step in their metabolism. Methods Exome sequencing and SNP array genotyping were used to examine the genetic variations in the six genes encoding for the carnitine acyltransferases in 113 Nunavik Inuit individuals. Results Altogether ten missense variants were found in genes CPT1A, CPT1B, CPT1C, CPT2 and CRAT, including three novel variants and one Inuit specific variant CPT1A p.P479L (rs80356779). The latter has the highest frequency (0.955) compared to other Inuit populations. We found that by comparison to Asians or Europeans, the Nunavik Inuit have an increased mutation burden in CPT1A, CPT2 and CRAT; there is also a high level of population differentiation based on carnitine acyltransferase gene variations between Nunavik Inuit and Asians. Conclusion The increased number and frequency of deleterious variants in these fatty acid metabolism genes in Nunavik Inuit may be the result of genetic adaptation to their diet and/or the extremely cold climate. In addition, the identification of these variants may help to understand some of the specific health risks of Nunavik Inuit.	[Zhou, Sirui; Xie, Pingxing; Ambalavanan, Amirthagowri; Bourassa, Cynthia V.; Dionne-Laporte, Alexandre; Spiegelman, Dan; Gauthier, Maude Turcotte; Henrion, Edouard; Diallo, Ousmane; Dion, Patrick A.; Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Zhou, Sirui] McGill Univ, Fac Med, Dept Med, Montreal, PQ, Canada; [Xiong, Lan] McGill Univ, Fac Med, Dept Psychiat, Montreal, PQ H3A 2T5, Canada; [Xiong, Lan] Inst Univ Sante Mentale, Ctr Rech, Montreal, PQ, Canada; [Xie, Pingxing; Ambalavanan, Amirthagowri] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Dion, Patrick A.; Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Laval University; McGill University; McGill University	Rouleau, GA (corresponding author), McGill Univ, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada.	guy.rouleau@mcgill.ca	Xie, Pingxing/AAK-1965-2020	spiegelman, dan/0000-0003-4971-8868	Heart & Stroke Foundation [13-08]	Heart & Stroke Foundation(Heart & Stroke Foundation of Canada)	Support was provided by the Heart & Stroke Foundation grant No. 13-08 [http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2014, NHLBI GO EX SEQ PROJ; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bennett MJ, 1993, GENEREVIEWS; Brown NF, 2001, J LIPID RES, V42, P1134; Chen Y, 2005, FEBS LETT, V579, P2040, DOI 10.1016/j.febslet.2005.02.050; Collins SA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-190; Collins SA, 2010, MOL GENET METAB, V101, P200, DOI 10.1016/j.ymgme.2010.07.013; Colonna V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-234; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Gessner BD, 2011, J PEDIATR-US, V158, P46, DOI 10.1016/j.jpeds.2010.07.031; Gessner BD, 2010, PEDIATRICS, V126, P945, DOI 10.1542/peds.2010-0687; Gillingham MB, 2011, MOL GENET METAB, V104, P261, DOI 10.1016/j.ymgme.2011.06.017; Gobin S, 2002, HUM GENET, V111, P179, DOI 10.1007/s00439-002-0752-0; Greenberg CR, 2009, MOL GENET METAB, V96, P201, DOI 10.1016/j.ymgme.2008.12.018; Illsinger S, 2008, AM J MED GENET A, V146A, P2925, DOI 10.1002/ajmg.a.32545; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Labonte ME, 2014, J ACAD NUTR DIET, V114, P1208, DOI 10.1016/j.jand.2013.12.017; Lemas DJ, 2012, J LIPID RES, V53, P175, DOI 10.1194/jlr.P018952; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Macaulay Alexander, 2004, Int J Circumpolar Health, V63 Suppl 2, P80; Mak CM, 2011, J HUM GENET, V56, P617, DOI 10.1038/jhg.2011.63; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Miyagawa T, 2011, SLEEP, V34, P349, DOI 10.1093/sleep/34.3.349; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; MURTHY MSR, 1987, P NATL ACAD SCI USA, V84, P378, DOI 10.1073/pnas.84.2.378; Orngreen MC, 2005, ANN NEUROL, V57, P60, DOI 10.1002/ana.20320; Patricia Gadsby LS, 2004, INUIT PARADOX DISCOV; Proust F, 2014, PROSTAG LEUKOTR ESS, V90, P159, DOI 10.1016/j.plefa.2014.02.001; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rajakumar C, 2009, J LIPID RES, V50, P1223, DOI 10.1194/jlr.P900001-JLR200; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Taggart RT, 1999, HUM MUTAT, V13, P210; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wieser T., 1993, GENEREVIEWS; Yao DB, 2008, HUM MUTAT, V29, P718, DOI 10.1002/humu.20717	45	13	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128255	10.1371/journal.pone.0128255	http://dx.doi.org/10.1371/journal.pone.0128255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010953	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900214
J	Lledo, LD; Badesa, FJ; Almonacid, M; Cano-Izquierdo, JM; Sabater-Navarro, JM; Fernandez, E; Garcia-Aracil, N				Lledo, Luis D.; Badesa, Francisco J.; Almonacid, Miguel; Cano-Izquierdo, Jose M.; Sabater-Navarro, Jose M.; Fernandez, Eduardo; Garcia-Aracil, Nicolas			Supervised and Dynamic Neuro-Fuzzy Systems to Classify Physiological Responses in Robot-Assisted Neurorehabilitation	PLOS ONE			English	Article							SUBSERVING VALENCE; CIRCUMPLEX MODEL; AROUSAL; INTENSITY; EMOTION; FMRI	This paper presents the application of an Adaptive Resonance Theory ( ART) based on neural networks combined with Fuzzy Logic systems to classify physiological reactions of subjects performing robot-assisted rehabilitation therapies. First, the theoretical background of a neuro-fuzzy classifier called S-dFasArt is presented. Then, the methodology and experimental protocols to perform a robot-assisted neurorehabilitation task are described. Our results show that the combination of the dynamic nature of S-dFasArt classifier with a supervisory module are very robust and suggest that this methodology could be very useful to take into account emotional states in robot-assisted environments and help to enhance and better understand human-robot interactions.	[Lledo, Luis D.; Badesa, Francisco J.; Sabater-Navarro, Jose M.; Fernandez, Eduardo; Garcia-Aracil, Nicolas] Univ Miguel Hernandez, Biomed Neuroengn Grp, Alicante, Spain; [Almonacid, Miguel; Cano-Izquierdo, Jose M.] Univ Politecn Cartagena, Syst Engn & Automat Dept, Murcia, Spain	Universidad Miguel Hernandez de Elche; Universidad Politecnica de Cartagena	Lledo, LD (corresponding author), Univ Miguel Hernandez, Biomed Neuroengn Grp, Alicante, Spain.	llledo@umh.es	IZQUIERDO, JOSE MANUEL/ABE-6770-2021; Garcia-Aracil, Nicolas/G-2112-2011; Sabater-Navarro, Jose M./A-5583-2008; Bertomeu-Motos, Arturo/P-9501-2016; Almonacid-Kroeger, Miguel/P-5866-2014; Badesa, Francisco Javier/K-4477-2014; Garcia-Aracil, Nicolas/ABE-1945-2021; Fernandez, Eduardo/S-8206-2016; Lledo Perez, Luis Daniel/I-4793-2018	IZQUIERDO, JOSE MANUEL/0000-0002-2748-5269; Garcia-Aracil, Nicolas/0000-0002-2510-3829; Sabater-Navarro, Jose M./0000-0002-3890-6225; Bertomeu-Motos, Arturo/0000-0003-1921-0422; Badesa, Francisco Javier/0000-0003-0149-6469; Garcia-Aracil, Nicolas/0000-0002-2510-3829; Fernandez, Eduardo/0000-0002-7052-6011; Almonacid Kroeger, Miguel/0000-0002-5415-8677; Lledo Perez, Luis Daniel/0000-0003-0175-208X	European Commission [ICT-22-2014, 645322]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission (ICT-22-2014: Multimodal and Natural computer interaction) through the project AIDE: "Adaptive Multimodal Interfaces to Assist Disabled People in Daily Activities" (grant agreement no: 645322).	Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Badesa FJ, 2014, COMPUT METH PROG BIO, V116, P123, DOI 10.1016/j.cmpb.2013.09.011; Cano-Izquierdo JM, 2012, IEEE T NEUR SYS REH, V20, P2, DOI 10.1109/TNSRE.2011.2169991; Cano-Izquierdo JM, 2009, NEURAL NETWORKS, V22, P479, DOI 10.1016/j.neunet.2008.09.018; CARPENTER GA, 1992, IEEE T NEURAL NETWOR, V3, P698, DOI 10.1109/72.159059; Colibazzi T, 2010, EMOTION, V10, P377, DOI 10.1037/a0018484; Gerber AJ, 2008, NEUROPSYCHOLOGIA, V46, P2129, DOI 10.1016/j.neuropsychologia.2008.02.032; Izquierdo JMC, 2001, NEURAL NETWORKS, V14, P407, DOI 10.1016/S0893-6080(01)00031-4; Management of Stroke Rehabilitation Working Group, VA DOD CLIN PRACT GU; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Nielen MMA, 2009, BRAIN COGNITION, V71, P387, DOI 10.1016/j.bandc.2009.05.007; Novak D, 2012, INTERACT COMPUT, V24, P154, DOI 10.1016/j.intcom.2012.04.003; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Posner J, 2009, HUM BRAIN MAPP, V30, P883, DOI 10.1002/hbm.20553; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Shu F, 2012, NEUR NETW IJCNN 2012; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Toledo-Moreo R, 2010, IEEE T INTELL TRANSP, V11, P498, DOI 10.1109/TITS.2009.2039011	19	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127777	10.1371/journal.pone.0127777	http://dx.doi.org/10.1371/journal.pone.0127777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001214	Green Published, Green Submitted, gold			2022-12-27	WOS:000354931700083
J	Balazik, MT; Musick, JA				Balazik, Matthew T.; Musick, John A.			Dual Annual Spawning Races in Atlantic Sturgeon	PLOS ONE			English	Article							ACIPENSER-OXYRINCHUS; SUWANNEE RIVER; SOUTH-CAROLINA; GULF STURGEON; NORTH-AMERICA; LIFE-HISTORY; JAMES RIVER; MANAGEMENT; VIRGINIA; ESTUARY	Atlantic sturgeon (Acipenser oxyrinchus oxyrinchus, Acipenseridae) populations in the United States were listed as either endangered or threatened under the Endangered Species Act in 2012. Because of the endangered/threatened status, a better understanding of Atlantic sturgeon life-history behavior and habitat use is important for effective management. It has been widely documented that Atlantic sturgeon reproduction occurs from late winter to early summer, varying clinally with latitude. However, recent data show Atlantic sturgeon also spawn later in the year. The group that spawns later in the year seems to be completely separate from the spring spawning run. Recognition of the later spawning season has drastically modified estimates of the population status of Atlantic sturgeon in Virginia. With the combination of new telemetry data and historical documentation we describe a dual spawning strategy that likely occurs in various degrees along most, if not all, of the Atlantic sturgeon's range. Using new data combined with historical sources, a new spawning strategy emerges which managers and researchers should note when determining the status of Atlantic sturgeon populations and implementing conservation measures.	[Balazik, Matthew T.] Virginia Commonwealth Univ, Ctr Environm Studies, Richmond, VA 23284 USA; [Musick, John A.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	Virginia Commonwealth University; William & Mary; Virginia Institute of Marine Science	Balazik, MT (corresponding author), Virginia Commonwealth Univ, Ctr Environm Studies, 1000 West Cary St, Richmond, VA 23284 USA.	balazikmt@vcu.edu			Professional Association of Diving Instructors Foundation [7381]; NOAA Section 6 grant [NA13NMF4720037]; National Marine Fisheries Service	Professional Association of Diving Instructors Foundation; NOAA Section 6 grant; National Marine Fisheries Service	This work was supported by grant #7381, Professional Association of Diving Instructors Foundation (http://www.padifoundation.org/) to MTB, and NOAA Section 6 grant #NA13NMF4720037, National Marine Fisheries Service (http://www.nmfs.noaa.gov/sfa/state_federal/State-Federal-WEB/afca.htm) to GCG.	[Anonymous], 1878, F LESLIES ILLUSTRATE, V1878, P370, DOI [10.1074/jbc.M110.192013, DOI 10.1074/JBC.M110.192013]; ASSRT (Atlantic Sturgeon Status Review Team), 2007, STAT REV ATL STURG A; Balazik MT, 2015, N AM J FISH MANAGE, V35, P398, DOI 10.1080/02755947.2015.1011358; Balazik MT, 2013, T AM FISH SOC, V142, P1640, DOI 10.1080/00028487.2013.824924; Balazik MT, 2012, T AM FISH SOC, V141, P1465, DOI 10.1080/00028487.2012.703157; Balazik MT, 2012, T AM FISH SOC, V141, P1074, DOI 10.1080/00028487.2012.676590; Barbour P. L., 1986, COMPLETE WORKS CAPTA; Berg, 1962, FRESHWATER FISHES US; BERG LS, 1959, J FISH RES BOARD CAN, V16, P515, DOI 10.1139/f59-041; BIRSTEIN VJ, 1993, CONSERV BIOL, V7, P773, DOI 10.1046/j.1523-1739.1993.740773.x; Borodin N., 1925, T AM FISH SOC, V55, P184, DOI [10.1577/1548-8659(1925)55[184:BOOTAS]2.0.CO;2, DOI 10.1577/1548-8659(1925)55[184:BOOTAS]2.0.CO;2, DOI 10.1577/1548-8659(1925)55[]; Breece MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081321; Cobb J.N., 1900, REPORT COMMISSIONER, V25, P369; Coleman C. W., 1892, COSMOPOLITAN, P366; Collins MR, 2000, T AM FISH SOC, V129, P982, DOI 10.1577/1548-8659(2000)129&lt;0982:HUABCO&gt;2.3.CO;2; Dadswell MJ, 2006, FISHERIES, V31, P218, DOI 10.1577/1548-8446(2006)31[218:AROTSO]2.0.CO;2; DOVEL WL, 1983, NEW YORK FISH GAME J, V30, P140; Evermann B. W., 1903, STAT FISHERIES MI 28, P430; Fernandez-Pasquier V., 2000, Boletin Instituto Espanol de Oceanografia, V16, P109; Forsythe PS, 2012, CAN J FISH AQUAT SCI, V69, P60, DOI 10.1139/F2011-132; Goode GB, 1887, HIST METHODS FISHERI; Goode GB, 1887, GEOGRAPHICAL REV FIS; Hatin D, 2002, J APPL ICHTHYOL, V18, P586, DOI 10.1046/j.1439-0426.2002.00395.x; Hildebrand S. F., 1927, US BUREAU FISHERIES, V43; HOLCIK J, 1989, FRESHWATER FISHES EU, V1; Jerome Jr WC, 1965, MASSACHUSETTS DIVISI, V1; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; Leland III JG, 1968, SURVEY STURGEON FISH; Lossing Benson J., 1866, HUDSON WILDERNESS SE; McCord JW, 2007, AM FISH S S, V56, P397; Meehan W. E., 1909, T AM FISH SOC, V39, P85; Meehan W. E., 1893, FISH FISHING FISHERI; Murawski SA, 1997, NATL MARINE FISHERIE, V10, P1; NOAA (National Oceanic and Atmospheric Administration), 2012, US FED REG, V77, P5880; Randall MT, 2012, J APPL ICHTHYOL, V28, P489, DOI 10.1111/j.1439-0426.2012.01960.x; Rogers HM., 1936, THESIS U TORONTO; RYDER JA, 1888, B US FISH COMM, V8, P231; Scott W. B., 1973, FRESHWATER FISHES CA; Secor DH, 2002, AM FISH S S, V28, P89; Seeley HG., 1886, FRESH WATER FISHES E; Smith JA, 2015, T AM FISH SOC, V144, P48, DOI 10.1080/00028487.2014.965344; Smith T.I.J., 1984, North American Journal of Fisheries Management, V4, P164, DOI 10.1577/1548-8659(1984)4<164:TASFIS>2.0.CO;2; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Smith TIJ, 1997, ENVIRON BIOL FISH, V48, P335, DOI 10.1023/A:1007307507468; Sulak KJ, 1998, T AM FISH SOC, V127, P758, DOI 10.1577/1548-8659(1998)127<0758:ELHSOG>2.0.CO;2; Townsend CH, 1901, STAT FISHERIES MI 26, P311; USA Federal Register, 2012, US FED REG, V77, P5914; VanEenennaam JP, 1996, ESTUARIES, V19, P769, DOI 10.2307/1352296; Wharton J., 1957, BOUNTY CHESAPEAKE; Wipplehauser GS., 2013, REGIONAL CONSERVATIO; Yang G. R., 1986, ICHTHYOGRAPHY HUBEI; Zen Q.Z., 1990, FISHERIES RESOURCES; Zhuang P, 1997, ENVIRON BIOL FISH, V48, P257, DOI 10.1023/A:1007399729080	53	21	21	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128234	10.1371/journal.pone.0128234	http://dx.doi.org/10.1371/journal.pone.0128234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020631	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300090
J	Watzlawik, JO; Kahoud, RJ; O'Toole, RJ; White, KAM; Ogden, AR; Painter, MM; Wootla, B; Papke, LM; Denic, A; Weimer, JM; Carey, WA; Rodriguez, M				Watzlawik, Jens O.; Kahoud, Robert J.; O'Toole, Ryan J.; White, Katherine A. M.; Ogden, Alyssa R.; Painter, Meghan M.; Wootla, Bharath; Papke, Louisa M.; Denic, Aleksandar; Weimer, Jill M.; Carey, William A.; Rodriguez, Moses			Abbreviated Exposure to Hypoxia Is Sufficient to Induce CNS Dysmyelination, Modulate Spinal Motor Neuron Composition, and Impair Motor Development in Neonatal Mice	PLOS ONE			English	Article							WHITE-MATTER INJURY; OLIGODENDROCYTE LINEAGE PROGRESSION; CEREBRAL-BLOOD-FLOW; PERIVENTRICULAR LEUKOMALACIA; ANIMAL-MODELS; BRAIN; MATURATION; MOUSE; UNDERNUTRITION; REGENERATION	Neonatal white matter injury (nWMI) is an increasingly common cause of cerebral palsy that results predominantly from hypoxic injury to progenitor cells including those of the oligodendrocyte lineage. Existing mouse models of nWMI utilize prolonged periods of hypoxia during the neonatal period, require complex cross-fostering and exhibit poor growth and high mortality rates. Abnormal CNS myelin composition serves as the major explanation for persistent neuro-motor deficits. Here we developed a simplified model of nWMI with low mortality rates and improved growth without cross-fostering. Neonatal mice are exposed to low oxygen from postnatal day (P) 3 to P7, which roughly corresponds to the period of human brain development between gestational weeks 32 and 36. CNS hypomyelination is detectable for 2-3 weeks post injury and strongly correlates with levels of body and brain weight loss. Immediately following hypoxia treatment, cell death was evident in multiple brain regions, most notably in superficial and deep cortical layers as well as the subventricular zone progenitor compartment. PDGF alpha R, Nkx2.2, and Olig2 positive oligodendrocyte progenitor cell were significantly reduced until postnatal day 27. In addition to CNS dysmyelination we identified a novel pathological marker for adult hypoxic animals that strongly correlates with life-long neuro-motor deficits. Mice reared under hypoxia reveal an abnormal spinal neuron composition with increased small and medium diameter axons and decreased large diameter axons in thoracic lateral and anterior funiculi. Differences were particularly pronounced in white matter motor tracts left and right of the anterior median fissure. Our findings suggest that 4 days of exposure to hypoxia are sufficient to induce experimental nWMI in CD1 mice, thus providing a model to test new therapeutics. Pathological hallmarks of this model include early cell death, decreased OPCs and hypomyelination in early postnatal life, followed by dysmyelination, abnormal spinal neuron composition, and neuro-motor deficits in adulthood.	[Watzlawik, Jens O.; Kahoud, Robert J.; Painter, Meghan M.; Wootla, Bharath; Papke, Louisa M.; Denic, Aleksandar; Rodriguez, Moses] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Kahoud, Robert J.; Carey, William A.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA; [O'Toole, Ryan J.; White, Katherine A. M.; Ogden, Alyssa R.; Weimer, Jill M.] Childrens Hlth Res Ctr, Sanford Res, Sioux Falls, SD USA	Mayo Clinic; Mayo Clinic; Sanford Health	Rodriguez, M (corresponding author), Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA.	rodriguez.moses@mayo.edu	; WOOTLA, Bharath/E-5882-2015	Rodriguez, Moses/0000-0001-6328-6497; Watzlawik, Jens/0000-0003-0610-0267; Denic, Aleksandar/0000-0001-9157-5405; WOOTLA, Bharath/0000-0001-7522-1121	National Institutes of Health [R01 GM092993, R01 NS048357, 5R01NS082283-02, R21 NS073684]; National Institutes of Health COBRE grants at Sanford Research [P20 GM103620, P20 GM103548]; National Multiple Sclerosis Society [CA 1060A]; T. Denny Sanford Pediatric Collaborative Research Fund; High-Impact Pilot and Feasibility Award (HIPFA); Novel Methodology Award (NMDA) from the Mayo Clinic Center for Translational Science Activities (CTSA); Mayo Clinic CTSA grant from the National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; Applebaum Foundation; Hilton Foundation; Peterson Foundation; Moon and Marilyn Park Directorship Fund; McNeilus family	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health COBRE grants at Sanford Research; National Multiple Sclerosis Society(National Multiple Sclerosis Society); T. Denny Sanford Pediatric Collaborative Research Fund; High-Impact Pilot and Feasibility Award (HIPFA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novel Methodology Award (NMDA) from the Mayo Clinic Center for Translational Science Activities (CTSA); Mayo Clinic CTSA grant from the National Center for Advancing Translational Sciences (NCATS); Applebaum Foundation; Hilton Foundation; Peterson Foundation; Moon and Marilyn Park Directorship Fund; McNeilus family	This work was supported by grants from the National Institutes of Health (R01 GM092993 (MR), R01 NS048357 (MR), 5R01NS082283-02 (JMW) and R21 NS073684 (MR)), the National Institutes of Health COBRE grants at Sanford Research (P20 GM103620 and P20 GM103548) (JMW), the National Multiple Sclerosis Society (CA 1060A) (MR), the T. Denny Sanford Pediatric Collaborative Research Fund (JMW, WAC), a High-Impact Pilot and Feasibility Award (HIPFA) (MR) and Novel Methodology Award (NMDA) (MR) from the Mayo Clinic Center for Translational Science Activities (CTSA) and Mayo Clinic CTSA grant (UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS)) (MR). The authors also acknowledge with thanks support from the Applebaum (MR), Hilton (MR), and Peterson (MR) Foundations, the Moon and Marilyn Park Directorship Fund (JOW) and the McNeilus family (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 2006, ANN NEUROL, V60, P696, DOI 10.1002/ana.21008; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Chahboune H, 2009, CEREB CORTEX, V19, P2891, DOI 10.1093/cercor/bhp068; Chen Yiju, 2012, PLoS One, V7, pe34762, DOI 10.1371/journal.pone.0034762; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dean JM, 2011, DEV NEUROSCI-BASEL, V33, P251, DOI 10.1159/000327242; Denic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026001; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Douglas RM, 2007, AM J PHYSIOL-REG I, V292, pR1254, DOI 10.1152/ajpregu.00404.2006; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Fagel DM, 2009, J NEUROSCI, V29, P1202, DOI 10.1523/JNEUROSCI.4516-08.2009; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ganat Y, 2002, NEUROSCIENCE, V112, P977, DOI 10.1016/S0306-4522(02)00060-X; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; Howe CL, 2007, NEUROBIOL DIS, V25, P354, DOI 10.1016/j.nbd.2006.10.001; Jablonska B, 2012, J NEUROSCI, V32, P14775, DOI 10.1523/JNEUROSCI.2060-12.2012; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; Kahoud RJ, 2014, DEV DYNAM, V243, P440, DOI 10.1002/dvdy.24090; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Kovner Israel, 2010, Int J Body Compos Res, V8, P17; LAI M, 1980, J COMP NEUROL, V193, P973, DOI 10.1002/cne.901930410; LAI M, 1980, J COMP NEUROL, V193, P965, DOI 10.1002/cne.901930409; Lalonde R, 2003, PHYSIOL BEHAV, V80, P333, DOI 10.1016/j.physbeh.2003.08.006; Lan WCJ, 2011, PEDIATR RES, V70, P15, DOI 10.1203/PDR.0b013e31821b98a3; Li Q, 2009, AM J PATHOL, V175, P2133, DOI 10.2353/ajpath.2009.090354; Lodygensky GA, 2010, J ANAT, V217, P418, DOI 10.1111/j.1469-7580.2010.01280.x; Martini F., 2010, ANATOMY PHYSL; Maurissen JPJ, 2003, NEUROTOXICOL TERATOL, V25, P543, DOI 10.1016/S0892-0362(03)00073-4; Ment LR, 1998, DEV BRAIN RES, V111, P197, DOI 10.1016/S0165-3806(98)00139-4; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Radom-Aizik S, 2013, PEDIATR RES, V74, P111, DOI 10.1038/pr.2013.80; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; ROBAIN O, 1978, BRAIN RES, V149, P379, DOI 10.1016/0006-8993(78)90482-1; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Silbereis JC, 2010, DIS MODEL MECH, V3, P678, DOI 10.1242/dmm.002915; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; Verney C, 2012, J NEUROPATH EXP NEUR, V71, P251, DOI 10.1097/NEN.0b013e3182496429; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Voron S, 2011, VESTIBULAR SYSTEM; Watson C, 2012, ANAT REC, V295, P1692, DOI 10.1002/ar.22549; Watzlawik JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055149; Weimer JM, 2009, DEVELOPMENT, V136, P2965, DOI 10.1242/dev.036616; Weiss J, 2004, EXP NEUROL, V189, P141, DOI 10.1016/j.expneurol.2004.05.018; Welin AK, 2005, PEDIATR RES, V58, P100, DOI 10.1203/01.PDR.0000163388.04017.26; WIGGINS RC, 1978, J NEUROCHEM, V30, P1231, DOI 10.1111/j.1471-4159.1978.tb10450.x; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007	58	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128007	10.1371/journal.pone.0128007	http://dx.doi.org/10.1371/journal.pone.0128007			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020269	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300070
J	Yang, YF; Li, WQ; Zhang, HX; Yang, G; Wang, XJ; Ding, ML; Jiang, TZ; Lv, LX				Yang, Yongfeng; Li, Wenqiang; Zhang, Hongxing; Yang, Ge; Wang, Xiujuan; Ding, Minli; Jiang, Tianzi; Lv, Luxian			Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE GRIN2B; BIPOLAR DISORDER; GLUTAMATE; IDENTIFICATION; SUSCEPTIBILITY; PERFORMANCE; MECHANISMS; MUTATIONS; VARIANTS	Schizophrenia (SZ) is a common and complex psychiatric disorder that has a significant genetic component. The glutamatergic system is the major excitatory neurotransmitter system in the central nervous system, and is mediated by N-methyl-D-aspartate (NMDA) receptors. Disturbances in this system have been hypothesized to play a major role in SZ pathogenesis. Several studies have revealed that the NMDA receptor subunit 2B (GRIN2B) potentially associates with SZ and its psychiatric symptoms. In this study, we performed a case-control study to identify polymorphisms of the GRIN2B gene thatmay confer susceptibility to SZ in the Han Chinese population. Thirty-four single nucleotide polymorphisms (SNPs) were genotyped in 528 paranoid SZ patients and 528 control subjects. A significant association was observed in allele and genotype between SZ and controls at rs2098469 (chi(2) = 8.425 and 4.994; p = 0.025 and 0.014, respectively). Significant associations were found in the allele at rs12319804 (chi(2) = 4.436; p = 0.035), as well as in the genotype at rs12820037 and rs7298664 between SZ and controls (chi(2) = 11.162 and 38.204; p = 0.003 and 4.27x10(-8), respectively). After applying the Bonferroni correction, rs7298664 still had significant genotype associations with SZ (p = 1.71x10(-7)). In addition, rs2098469 genotype and allele frequencies, and 12820037 allele frequencies were nominally associated with SZ. Three haplotypes, CGA (rs10845849-rs12319804-rs10845851), CC (rs12582848-rs7952915), and AAGAC (rs2041986-rs11055665rs7314376- rs7297101-rs2098469), had significant differences between SZ and controls (chi(2) = 4.324, 4.582, and 4.492; p = 0.037, 0.032, and 0.034, respectively). In addition, three SNPs, rs2098469, rs12820037, and rs7298664, were significantly associated with cognition factors PANSS subscores in SZ (F = 16.799, 7.112, and 13.357; p = 0.000, 0.017, and 0.000, respectively). In conclusion, our study provides novel evidence for an association between GRIN2B polymorphisms and SZ susceptibility and symptoms in the Han Chinese population.	[Yang, Yongfeng; Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Yang, Yongfeng; Li, Wenqiang; Zhang, Hongxing; Yang, Ge; Wang, Xiujuan; Ding, Minli; Lv, Luxian] Xinxiang Med Univ, Affiliated Hosp 2, Henan Mental Hosp, Dept Psychiat, Xinxiang, Peoples R China; [Yang, Yongfeng; Li, Wenqiang; Zhang, Hongxing; Wang, Xiujuan; Ding, Minli; Lv, Luxian] Xinxiang Med Univ, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China	University of Electronic Science & Technology of China; Xinxiang Medical University; Xinxiang Medical University	Jiang, TZ (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China.	jiangtz@nlpr.ia.ac.cn; lvx928@126.com	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X	National Natural Science Foundation of China [U1404811, 81371472, 81201040, 81101000]; Program for New Century Excellent Talentsin University [NCET-10-0137]; Natural Science Foundation of Henan [112300413226, 122300413212]; Plan for Scientific Innovation Talent of Henan Province [124200510019]; Scientific Research Fund of Xinxiang Medical University [ZD2011-20, ZD200991, 2013QN102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talentsin University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Henan; Plan for Scientific Innovation Talent of Henan Province; Scientific Research Fund of Xinxiang Medical University	Funding for this study was provided by the National Natural Science Foundation of China (to Y-F Y, U1404811; to L-X L, 81371472; to W-Q L, 81201040; 81101000), the Program for New Century Excellent Talentsin University (to H-X Z, NCET-10-0137), the Natural Science Foundation of Henan (to L-X L, 112300413226; to W-Q L, 122300413212), the Plan for Scientific Innovation Talent of Henan Province (to L-X L, 124200510019), and the Scientific Research Fund of Xinxiang Medical University (to W-Q L, ZD2011-20; to L-X L, ZD200991; to Y-F Y, 2013QN102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Austin Jehannine, 2005, J Genet Couns, V14, P329, DOI 10.1007/s10897-005-1622-4; Bakker PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050970; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Breier A, 1999, BRIT J PSYCHIAT, V174, P16, DOI 10.1192/S0007125000293604; Cai J, 2013, PSYCHOPHARMACOLOGY, V230, P49, DOI 10.1007/s00213-013-3137-2; Cherlyn SYT, 2010, NEUROSCI BIOBEHAV R, V34, P958, DOI 10.1016/j.neubiorev.2010.01.002; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; Di Maria E, 2004, AM J MED GENET B, V128B, P27, DOI 10.1002/ajmg.b.30028; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Gaspar PA, 2009, J NEUROCHEM, V111, P891, DOI 10.1111/j.1471-4159.2009.06325.x; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hong CJ, 2001, PSYCHIAT GENET, V11, P219, DOI 10.1097/00041444-200112000-00007; Iwayama Y, 2006, NEUROSCI LETT, V394, P101, DOI 10.1016/j.neulet.2005.10.025; Jablensky A, 2011, GENES BRAIN BEHAV, V10, P410, DOI 10.1111/j.1601-183X.2011.00679.x; JAVITT D C, 1987, Hillside Journal of Clinical Psychiatry, V9, P12; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kim JH, 2012, PSYCHIAT RES, V197, P285, DOI 10.1016/j.psychres.2011.10.006; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Li DW, 2007, GENET MED, V9, P4, DOI 10.1097/01.gim.0000250507.96760.4b; Li WQ, 2013, PROG NEURO-PSYCHOPH, V44, P290, DOI 10.1016/j.pnpbp.2013.04.003; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Martucci L, 2006, SCHIZOPHR RES, V84, P214, DOI 10.1016/j.schres.2006.02.001; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; Miyatake R, 2002, MOL PSYCHIATR, V7, P1101, DOI 10.1038/sj.mp.4001152; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Myers RA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001318; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ocklenburg S, 2011, BEHAV BRAIN RES, V225, P284, DOI 10.1016/j.bbr.2011.07.042; Ohtsuki T, 2001, MOL PSYCHIATR, V6, P211, DOI 10.1038/sj.mp.4000808; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Schultz SK, 1999, LANCET, V353, P1425, DOI 10.1016/S0140-6736(98)07549-7; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Sodhi Monsheel, 2008, Expert Rev Neurother, V8, P1389, DOI 10.1586/14737175.8.9.1389; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; White T, 2006, BIOL PSYCHIAT, V60, P463, DOI 10.1016/j.biopsych.2006.01.002; Williams HJ, 2012, SCHIZOPHR RES, V141, P274, DOI 10.1016/j.schres.2012.08.024; Williams HJ, 2009, J HUM GENET, V54, P9, DOI 10.1038/jhg.2008.7; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979	51	15	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125925	10.1371/journal.pone.0125925	http://dx.doi.org/10.1371/journal.pone.0125925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020650	gold, Green Submitted, Green Published			2022-12-27	WOS:000355187300018
J	Capala, ME; Maat, H; Bonardi, F; van den Boom, V; Kuipers, J; Vellenga, E; Giepmans, BNG; Schuringa, JJ				Capala, Marta E.; Maat, Henny; Bonardi, Francesco; van den Boom, Vincent; Kuipers, Jeroen; Vellenga, Edo; Giepmans, Ben N. G.; Schuringa, Jan Jacob			Mitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; ACUTE MYELOID-LEUKEMIA; LONG-TERM MAINTENANCE; GTPASES; ACTIVATION; MIGRATION; NICHES; MICROENVIRONMENT; CHEMOTHERAPY; ENGRAFTMENT	Leukemic stem cells (LSCs) reside within bone marrow niches that maintain their relatively quiescent state and convey resistance to conventional treatment. Many of the microenvironmental signals converge on RAC GTPases. Although it has become clear that RAC proteins fulfill important roles in the hematopoietic compartment, little has been revealed about the downstream effectors and molecular mechanisms. We observed that in BCR-ABL-transduced human hematopoietic stem/progenitor cells (HSPCs) depletion of RAC2 but not RAC1 induced a marked and immediate decrease in proliferation, progenitor frequency, cobblestone formation and replating capacity, indicative for reduced self-renewal. Cell cycle analyses showed reduced cell cycle activity in RAC2-depleted BCR-ABL leukemic cobblestones coinciding with an increased apoptosis. Moreover, a decrease in mitochondrial membrane potential was observed upon RAC2 downregulation, paralleled by severe mitochondrial ultrastructural malformations as determined by automated electron microscopy. Proteome analysis revealed that RAC2 specifically interacted with a set of mitochondrial proteins including mitochondrial transport proteins SAM50 and Metaxin 1, and interactions were confirmed in independent co-immunoprecipitation studies. Downregulation of SAM50 also impaired the proliferation and replating capacity of BCR-ABL-expressing cells, again associated with a decreased mitochondrial membrane potential. Taken together, these data suggest an important role for RAC2 in maintaining mitochondrial integrity.	[Capala, Marta E.; Maat, Henny; Bonardi, Francesco; van den Boom, Vincent; Vellenga, Edo; Giepmans, Ben N. G.; Schuringa, Jan Jacob] Canc Res Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands; [Kuipers, Jeroen] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands	University of Groningen	Schuringa, JJ (corresponding author), Canc Res Ctr Groningen, Dept Expt Hematol, Groningen, Netherlands.	j.j.schuringa@umcg.nl	Giepmans, Ben N.G./R-4564-2016	Giepmans, Ben N.G./0000-0001-5105-5915	Netherlands Organization for Scientific Research [NWO-VIDI 91796312]; ZonMW [91111.006]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development)	This work was supported by a grant from The Netherlands Organization for Scientific Research (NWO-VIDI 91796312) to JJS and ZonMW 91111.006 to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cancelas JA, 2011, TRANSFUSION, V51, p153S, DOI 10.1111/j.1537-2995.2011.03378.x; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Capala ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111568; Carta A, 2005, BRIT J OPHTHALMOL, V89, P825, DOI 10.1136/bjo.2004.060590; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Filippi MD, 2004, NAT IMMUNOL, V5, P744, DOI 10.1038/ni1081; Flis K, 2012, LEUKEMIA LYMPHOMA, V53, P2474, DOI 10.3109/10428194.2012.696313; Fuhler GM, 2008, BLOOD, V111, P359, DOI 10.1182/blood-2006-11-060632; Gallipoli P, 2011, HEMATOL ONCOL CLIN N, V25, P951, DOI 10.1016/j.hoc.2011.09.001; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jansen M, 2005, STEM CELLS, V23, P335, DOI 10.1634/stemcells.2004-0216; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Mizukawa B, 2011, BLOOD, V118, P5235, DOI 10.1182/blood-2011-04-351817; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Nieborowska-Skorska M, 2012, BLOOD, V119, P4253, DOI 10.1182/blood-2011-10-385658; Orkin SH, 2008, CELL, V132, P712, DOI 10.1016/j.cell.2008.02.013; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Radich JP, 2013, J NATL COMPR CANC NE, V11, P663, DOI 10.6004/jnccn.2013.0196; Ravelli RBG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01804; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Rozenveld-Geugien M, 2007, EXP HEMATOL, V35, P782, DOI 10.1016/j.exphem.2007.02.006; Schepers H, 2007, BLOOD, V110, P2880, DOI 10.1182/blood-2006-08-039073; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Sengupta A, 2010, BLOOD, V116, P81, DOI 10.1182/blood-2009-10-247437; Sinclair A, 2013, BRIT J PHARMACOL, V169, P1693, DOI 10.1111/bph.12183; Skorski T, 1998, P NATL ACAD SCI USA, V95, P11858, DOI 10.1073/pnas.95.20.11858; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Taylor ML, 2000, HEMATOL ONCOL CLIN N, V14, P517, DOI 10.1016/S0889-8588(05)70294-X; Thomas EK, 2008, LEUKEMIA, V22, P898, DOI 10.1038/leu.2008.71; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; van den Boom V, 2013, BLOOD, V121, P2452, DOI 10.1182/blood-2012-08-451666; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Zamora M, 2004, J BIOL CHEM, V279, P38415, DOI 10.1074/jbc.M404928200; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	49	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128585	10.1371/journal.pone.0128585	http://dx.doi.org/10.1371/journal.pone.0128585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016997	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600121
J	Cavin, L; Boudad, L; Tong, HY; Lang, E; Tabouelle, J; Vullo, R				Cavin, Lionel; Boudad, Larbi; Tong, Haiyan; Laeng, Emilie; Tabouelle, Jerome; Vullo, Romain			Taxonomic Composition and Trophic Structure of the Continental Bony Fish Assemblage from the Early Late Cretaceous of Southeastern Morocco	PLOS ONE			English	Article							POLYPTERUS-SENEGALUS CLADISTIA; BAHARIYA FORMATION; DENTIGEROUS BONES; NORTH-AFRICA; FOOD-WEB; ACTINOPTERYGII; FOSSIL; OSTEOGLOSSOMORPHA; TELEOSTEI; DIPNOI	The mid-Cretaceous vertebrate assemblage from south-eastern Morocco is one of the most diversified continental vertebrate assemblages of this time worldwide. The bony fish component (coelacanths, lungfishes and ray-finned fishes) is represented by relatively complete specimens and, mostly, by fragmentary elements scattered along 250 kilometres of outcrops. Here we revisit the bony fish assemblage by studying both isolated remains collected during several fieldtrips and more complete material kept in public collections. The assemblage comprises several lungfish taxa, with the first mention of the occurrence of Arganodus tiguidiensis, and possibly two mawsoniid coelacanths. A large bichir, cf. Bawitius, is recorded and corresponds to cranial elements initially referred to 'Stromerichthys' from coeval deposits in Egypt. The ginglymodians were diversified with a large 'Lepidotes' plus two obaichthyids and a gar. We confirm here that this gar belongs to a genus distinctive from Recent gars, contrary to what was suggested recently. Teleosteans comprise a poorly known ichthyodectiform, a notopterid, a probable osteoglossomorph and a large tselfatiiform, whose cranial anatomy is detailed. The body size and trophic level for each taxon are estimated on the basis of comparison with extant closely related taxa. We plotted the average body size versus average trophic level for the Kem Kem assemblage, together with extant marine and freshwater assemblages. The Kem Kem assemblage is characterized by taxa of proportionally large body size, and by a higher average trophic level than the trophic level of the extant compared freshwater ecosystems, but lower than for the extant marine ecosystems. These results should be regarded with caution because they rest on a reconstructed assemblage known mostly by fragmentary remains. They reinforce, however, the ecological oddities already noticed for this mid-Cretaceous vertebrate ecosystem in North Africa.	[Cavin, Lionel; Laeng, Emilie] Museum Hist Nat, Dept Geol & Paleontol, CH-1211 Geneva 6, Switzerland; [Boudad, Larbi] Univ Moulay Ismail, Fac Sci, Dept Geol, Zitoune 50070, Meknes, Morocco; [Tong, Haiyan] Mahasarakham Univ, Palaeontol Res & Educ Ctr, Kantarawichai 44150, Mahasarakham, Thailand; [Tabouelle, Jerome] CREA 7 Cours Gambetta, Fabr Savoirs, F-76500 Elbeuf, France; [Vullo, Romain] Univ Rennes 1, CNRS, Lab Geosci Rennes, UMR 6118, F-35042 Rennes, France	University of Geneva; Moulay Ismail University of Meknes; Mahasarakham University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes	Cavin, L (corresponding author), Museum Hist Nat, Dept Geol & Paleontol, CP 6434, CH-1211 Geneva 6, Switzerland.	lionel.cavin@ville-ge.ch	Cavin, Lionel/AAZ-8120-2021	Cavin, Lionel/0000-0001-9666-5864	Swiss National Science Foundation [129923, 146868]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Grants of the Swiss National Science Foundation 129923 and 146868 (LC, EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis EP, 1922, J ANAT, V56, P189; Amiot R, 2010, PALAEOGEOGR PALAEOCL, V297, P439, DOI 10.1016/j.palaeo.2010.08.027; Amiot R, 2010, GEOLOGY, V38, P139, DOI 10.1130/G30402.1; Benyoucef M, 2015, CRETACEOUS RES, V55, P44, DOI 10.1016/j.cretres.2015.02.002; Berra TM., 2001, FRESHWATER FISH DIST; Brito Paulo M., 2011, Bulletin of the Kitakyushu Museum of Natural History and Human History Series A Natural History, P107; Broin de F., 1974, CR HEBD ACAD SCI, V279, P469; Candeiro CRA, 2011, J AFR EARTH SCI, V60, P79, DOI 10.1016/j.jafrearsci.2011.02.004; CASIER E., 1961, ANN MUS ROY AFRIQUE CENTR TERVUREN IN 8[DEGREE] SCI GEOL, V39, P1; Castro Darcilea Ferreira, 2004, Revista Brasileira de Paleontologia, V7, P245; Cavin L, 2010, J AFR EARTH SCI, V57, P391, DOI 10.1016/j.jafrearsci.2009.12.007; Cavin L, 1997, GEOLOGICAL SOC DANMA; Cavin L, 2001, B SOC GEOLOGIQUE FRA, V172, P141, DOI DOI 10.2113/172.5.661; Cavin L, 2001, ZOOLOGICAL J LINNEAN, V132, P1; Cavin L, 2007, ZOOL J LINN SOC-LOND, V149, P141, DOI 10.1111/j.1096-3642.2007.00238.x; Cavin L, 2013, J SYST PALAEONTOL, V11, P115, DOI 10.1080/14772019.2012.691559; Cavin Lionel, 2008, P199; Cavin L, 2009, GEOL SOC SPEC PUBL, V315, P125, DOI 10.1144/SP315.10; Cavin Lionel, 2004, P493; Churcher CS, 2001, PALAEONTOLOGY, V44, P305, DOI 10.1111/1475-4983.00181; Clemen G, 1998, ANN ANAT, V180, P211, DOI 10.1016/S0940-9602(98)80076-9; Dutheil DB, 1999, J VERTEBR PALEONTOL, V19, P243, DOI 10.1080/02724634.1999.10011138; Dutheil Didier B., 1999, P553; Forey P.L., 1998, HIST COELACANTH FISH; Forey P. L., 2011, PALAEONTOL ELECTRON, V14, P1; Forey PL, 2007, PALAEONTOL ELECTRON, V10; Forey PL, 1997, S AFR J SCI, V93, P564; Forey PL, 1998, ZOOL J LINN SOC-LOND, V123, P179, DOI 10.1111/j.1096-3642.1998.tb01299.x; Froese R., 2014, FISHBASE; Gayet M, 1996, CR ACAD SCI II A, V322, P701; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Grande L, 2010, COPEIA, P1; Grandstaff BS, 2012, J VERTEBR PALEONTOL, V32, P17, DOI 10.1080/02724634.2012.626823; Hilton EJ, 2003, ZOOL J LINN SOC-LOND, V137, P1, DOI 10.1046/j.1096-3642.2003.00032.x; Hugueny B, 1999, J FISH BIOL, V54, P1310, DOI 10.1111/j.1095-8649.1999.tb02057.x; Jonet S., 1971, Bolm Soc port Cienc nat, V(2)13, P33; Jonet S, 1981, COMUNICACOES SERVICO, V67, P191; Khalloufi B, PALEONTOLOGIE VERTEB; Kind Peter K., 2011, P61; Lang E, 2013, PALAEOGEOGR PALAEOCL, V381, P26, DOI 10.1016/j.palaeo.2013.04.011; Le Loeuff J., 2012, J STRATIGRAPHY, V36, P1; Lopez-Arbarello A, 2012, PLOS ONE, V7; Maisey J.G., 1986, American Museum Novitates, P1; MAISEY JG, 1994, ENVIRON BIOL FISH, V40, P1, DOI 10.1007/BF00002179; Martill DM, 2007, CRETACEOUS RES, V28, P895, DOI 10.1016/j.cretres.2007.01.002; MARTIN M, 1984, Palaeontologische Zeitschrift, V58, P265; Mawson J, 1907, Q J GEOL SOC LOND, V63, P128; McGowan AJ, 2009, GEOLOGY, V37, P843, DOI 10.1130/G30188A.1; Meunier FJ, 2013, CYBIUM, V37, P121; Mkhitaryan T. G., 2011, Trudy Zoologicheskogo Instituta, V315, P181; Nesov LA, 1981, PALEONTOLOGICHESKIY, V4, P98; Pauly D, 2005, B MAR SCI, V76, P197; Pittet F, 2010, COMPREHENSIVE REV GO, P332; Russell DA, 2003, CRETACEOUS RES, V24, P569, DOI 10.1016/S0195-6671(03)00072-7; Sauvage HE, 1897, DIRECTION TRAVAUX GE, P1; Schaal S., 1984, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V53, P1; Schwimmer DR, 2009, GEOL SOC AM SE M, V41, P6; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Smith JB, 2006, J PALEONTOL, V80, P1179, DOI 10.1666/0022-3360(2006)80[1179:MOPSOA]2.0.CO;2; Stromer E., 1925, Zeitschrift der Deutschen Geologischen Gesellschaft, V77, P348; Stromer E, 1936, ABHANDLUNGEN BAYERIS, P1; Tabaste N., 1963, Memoires de l'Institut Francais d'Afrique Noire, VNo. 68, P437; Taverne L, 2005, CYBIUM, V29, P65; Taverne L, 1999, AM MUSEUM NOVITATES, V3260, P12; Taverne Louis, 2004, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V348, P1; Taverne Louis, 2000, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V293, P1; Torices A, 2012, CRETACEOUS RES, V37, P231, DOI 10.1016/j.cretres.2012.04.004; Vullo R, 2008, ACTA GEOL POL, V58, P249; Vullo R, 2009, PALAEOGEOGR PALAEOCL, V276, P120, DOI 10.1016/j.palaeo.2009.03.004; Wacker K, 2001, ANN ANAT, V183, P37, DOI 10.1016/S0940-9602(01)80011-X; Weiler W, 1935, ABHANDLUNGEN BAYERIS, P1; Wenz S., 1981, Annales de Paleontologie Vertebres, V67, P1; Wenz S, 1980, MEMOIRE SOC GEOLOGIQ, V139, P187; Werner Christa, 1997, Cybium, V21, P67; Wilson MVH, 2008, GEOL SOC SPEC PUBL, V295, P185, DOI 10.1144/SP295.12; Woodward A. S., 1907, Geological Magazine London, V4; Yabumoto Yoshitaka, 2005, Bulletin of the National Science Museum Series C (Geology & Paleontology), V31, P39	77	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125786	10.1371/journal.pone.0125786	http://dx.doi.org/10.1371/journal.pone.0125786			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018561	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600032
J	Johnson, MW; Johnson, PS; Herrmann, ES; Sweeney, MM				Johnson, Matthew W.; Johnson, Patrick S.; Herrmann, Evan S.; Sweeney, Mary M.			Delay and Probability Discounting of Sexual and Monetary Outcomes in Individuals with Cocaine Use Disorders and Matched Controls	PLOS ONE			English	Article							IMPROVING HIV/AIDS KNOWLEDGE; TEST-RETEST RELIABILITY; SUBSTANCE USE DISORDERS; INJECTION-DRUG USERS; HIV RISK BEHAVIORS; CIGARETTE SMOKERS; HYPOTHETICAL REWARDS; POTENTIALLY REAL; CRACK COCAINE; PATHOLOGICAL GAMBLERS	Individuals with cocaine use disorders are disproportionately affected by HIV/AIDS, partly due to higher rates of unprotected sex. Recent research suggests delay discounting of condom use is a factor in sexual HIV risk. Delay discounting is a behavioral economic concept describing how delaying an event reduces that event's value or impact on behavior. Probability discounting is a related concept describing how the uncertainty of an event decreases its impact on behavior. Individuals with cocaine use disorders (n = 23) and matched non-co-caine-using controls (n = 24) were compared in decision-making tasks involving hypothetical outcomes: delay discounting of condom-protected sex (Sexual Delay Discounting Task), delay discounting of money, the effect of sexually transmitted infection (STI) risk on likelihood of condom use (Sexual Probability Discounting Task), and probability discounting of money. The Cocaine group discounted delayed condom-protected sex (i.e., were more likely to have unprotected sex vs. wait for a condom) significantly more than controls in two of four Sexual Delay Discounting Task partner conditions. The Cocaine group also discounted delayed money (i.e., preferred smaller immediate amounts over larger delayed amounts) significantly more than controls. In the Sexual Probability Discounting Task, both groups showed sensitivity to STI risk, however the groups did not differ. The Cocaine group did not consistently discount probabilistic money more or less than controls. Steeper discounting of delayed, but not probabilistic, sexual outcomes may contribute to greater rates of sexual HIV risk among individuals with cocaine use disorders. Probability discounting of sexual outcomes may contribute to risk of unprotected sex in both groups. Correlations showed sexual and monetary results were unrelated, for both delay and probability discounting. The results highlight the importance of studying specific behavioral processes (e.g., delay and probability discounting) with respect to specific outcomes (e.g., monetary and sexual) to understand decision making in problematic behavior.	[Johnson, Matthew W.; Johnson, Patrick S.; Herrmann, Evan S.; Sweeney, Mary M.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Behav Pharmacol Res Unit, Baltimore, MD 21205 USA	Johns Hopkins University	Johnson, MW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Behav Pharmacol Res Unit, Baltimore, MD 21205 USA.	mwj@jhu.edu	Johnson, Matthew/AAA-3299-2020	Sweeney, Mary Margaret/0000-0001-6931-4321	National Institute on Drug Abuse [R01DA032363, T32DA007209]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032363, T32DA007209, T32DA007294] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute on Drug Abuse (http://www.drugabuse.gov) grant R01DA032363 (MWJ). PSJ, ESH, and MMS were supported by an institutional training grant from the National Institute on Drug Abuse (T32DA007209). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMONS RB, 1962, PSYCHOL REP, V11, P111, DOI 10.1177/003329416201100106; Andrade LF, 2012, PSYCHOPHARMACOLOGY, V219, P491, DOI 10.1007/s00213-011-2508-9; Axon RN, 2009, J AM SOC HYPERTENS, V3, P35, DOI 10.1016/j.jash.2008.08.005; Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bickel WK, 2014, ANNU REV CLIN PSYCHO, V10, P641, DOI 10.1146/annurev-clinpsy-032813-153724; Bickel WK, 2009, J NEUROSCI, V29, P8839, DOI 10.1523/JNEUROSCI.5319-08.2009; Booth RE, 2000, DRUG ALCOHOL DEPEN, V58, P219, DOI 10.1016/S0376-8716(99)00094-0; BOOTH RE, 1993, AM J PUBLIC HEALTH, V83, P1144, DOI 10.2105/AJPH.83.8.1144; Bornovalova MA, 2005, EXP CLIN PSYCHOPHARM, V13, P311, DOI 10.1037/1064-1297.13.4.311; Bradford WD, 2010, MED DECIS MAKING, V30, P99, DOI 10.1177/0272989X09342276; Centers for Disease Control and Prevention, 2010, HIV AIDS US FACT SHE; CHAISSON RE, 1989, JAMA-J AM MED ASSOC, V261, P561, DOI 10.1001/jama.261.4.561; Chan SK, 2014, MMWR-MORBID MORTAL W, V63, P209; Coffey SF, 2003, EXP CLIN PSYCHOPHARM, V11, P18, DOI 10.1037/1064-1297.11.1.18; Dariotis JK, 2015, EXP CLIN PSYCHOPHARM, V23, P49, DOI 10.1037/a0038399; DARKE S, 1991, AIDS, V5, P181, DOI 10.1097/00002030-199102000-00008; Daugherty JR, 2010, PERS INDIV DIFFER, V48, P202, DOI 10.1016/j.paid.2009.10.007; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Du WJ, 2002, PSYCHOL REC, V52, P479, DOI 10.1007/BF03395199; Fields SA, 2013, APPETITE, V70, P60, DOI 10.1016/j.appet.2013.06.089; Green L, 1999, J EXP PSYCHOL LEARN, V25, P418, DOI 10.1037/0278-7393.25.2.418; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green RM, 2014, BEHAV PROCESS, V108, P50, DOI 10.1016/j.beproc.2014.09.008; Heil SH, 2006, ADDICT BEHAV, V31, P1290, DOI 10.1016/j.addbeh.2005.09.005; Heil SH, 2005, EXP CLIN PSYCHOPHARM, V13, P238, DOI 10.1037/1064-1297.13.3.238; Herrmann ES, 2014, DRUG ALCOHOL DEPEN, V144, P53, DOI 10.1016/j.drugalcdep.2014.07.026; Herrmann ES, 2013, DRUG ALCOHOL DEPEN, V127, P220, DOI 10.1016/j.drugalcdep.2012.07.006; Hinvest NS, 2010, Q J EXP PSYCHOL, V63, P1072, DOI 10.1080/17470210903276350; Holt DD, 2014, PSYCHON B REV, V21, P794, DOI 10.3758/s13423-013-0557-2; Holt DD, 2003, BEHAV PROCESS, V64, P355, DOI 10.1016/S0376-6357(03)00141-4; HUDGINS R, 1995, DRUG ALCOHOL DEPEN, V37, P7, DOI 10.1016/0376-8716(94)01060-X; HUDZIAK JJ, 1993, COMPR PSYCHIAT, V34, P375, DOI 10.1016/0010-440X(93)90061-8; Jarmolowicz DP, 2012, BEHAV PROCESS, V91, P308, DOI 10.1016/j.beproc.2012.09.001; Jikko Yuriko, 2007, Shinrigaku Kenkyu, V78, P269; Johnson MW, 2008, EXP CLIN PSYCHOPHARM, V16, P264, DOI 10.1037/1064-1297.16.3.264; Johnson MW, 2007, EXP CLIN PSYCHOPHARM, V15, P187, DOI 10.1037/1064-1297.15.2.187; Johnson MW, 2013, EXP CLIN PSYCHOPHARM, V21, P277, DOI 10.1037/a0033071; Johnson MW, 2012, EXP CLIN PSYCHOPHARM, V20, P191, DOI 10.1037/a0027088; Johnson MW, 2012, DRUG ALCOHOL DEPEN, V123, P15, DOI 10.1016/j.drugalcdep.2011.09.032; Johnson MW, 2010, EXP CLIN PSYCHOPHARM, V18, P99, DOI 10.1037/a0018333; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Johnson PS, 2015, J EXP ANAL BEHAV, V103, P87, DOI 10.1002/jeab.110; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kaplan BA, 2014, PSYCHOL REC, V64, P261, DOI 10.1007/s40732-014-0041-z; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Kral AH, 1998, AM J PUBLIC HEALTH, V88, P108, DOI 10.2105/AJPH.88.1.108; Lagorio CH, 2005, BEHAV PROCESS, V69, P173, DOI 10.1016/j.beproc.2005.02.003; Lawyer SR, 2013, BEHAV PROCESS, V96, P71, DOI 10.1016/j.beproc.2013.03.001; Lawyer SR, 2011, EXP CLIN PSYCHOPHARM, V19, P263, DOI 10.1037/a0024141; Lawyer SR, 2010, BEHAV PROCESS, V84, P687, DOI 10.1016/j.beproc.2010.04.002; Lejuez CW, 2005, DRUG ALCOHOL DEPEN, V77, P169, DOI 10.1016/j.drugalcdep.2004.08.013; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; Madden GJ, 2004, EXP CLIN PSYCHOPHARM, V12, P251, DOI 10.1037/1064-1297.12.4.251; Madden GJ, 2003, EXP CLIN PSYCHOPHARM, V11, P139, DOI 10.1037/1064-1297.11.2.139; MALOW RM, 1994, AIDS EDUC PREV, V6, P113; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Matusiewicz AK, 2013, BEHAV PROCESS, V100, P116, DOI 10.1016/j.beproc.2013.07.019; McCoy CB, 2004, ANN EPIDEMIOL, V14, P535, DOI 10.1016/j.annepidem.2003.10.001; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Morissette C, 2007, INT J DRUG POLICY, V18, P204, DOI 10.1016/j.drugpo.2006.08.004; Motulsky H, 2003, PRACTICAL GUIDE CURV; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Myerson J, 2003, J ECON PSYCHOL, V24, P619, DOI 10.1016/S0167-4870(03)00005-9; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Ohmura Y, 2005, PSYCHOPHARMACOLOGY, V182, P508, DOI 10.1007/s00213-005-0110-8; Petry NM, 2001, J ABNORM PSYCHOL, V110, P482, DOI 10.1037/0021-843X.110.3.482; Petry NM, 2001, SUBST USE MISUSE, V36, P1731, DOI 10.1081/JA-100107576; Prendergast ML, 2001, J CONSULT CLIN PSYCH, V69, P389, DOI 10.1037//0022-006X.69.3.389; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Rachlin H., 1989, JUDGMENT DECISION CH; Rasmussen EB, 2010, BEHAV PROCESS, V83, P23, DOI 10.1016/j.beproc.2009.09.001; Reynolds B, 2004, BEHAV PROCESS, V65, P35, DOI 10.1016/S0376-6357(03)00109-8; Reynolds B, 2003, BEHAV PROCESS, V64, P333, DOI 10.1016/S0376-6357(03)00168-2; Richards JB, 1999, J EXP ANAL BEHAV, V71, P121, DOI 10.1901/jeab.1999.71-121; Semaan S, 2002, J ACQ IMMUN DEF SYND, V30, pS73, DOI 10.1097/01.QAI.0000017613.32101.90; Shead NW, 2009, J EXP ANAL BEHAV, V92, P1, DOI 10.1901/jeab.2009.92-1; Strathdee SA, 2003, J URBAN HEALTH, V80, P7; Substance Abuse Mental Health Services Administration, 2014, NSDUH SER H, V(SMA) 14-4863; Takahashi T, 2009, NEUROENDOCRINOL LETT, V30, P749; Weller RE, 2008, APPETITE, V51, P563, DOI 10.1016/j.appet.2008.04.010; Wilkinson G, 1993, WRAT 3 WIDE RANGE AC; Winhusen TM, 2014, EVALUATION SUBSTANCE; Yi R, 2005, LEARN BEHAV, V33, P324, DOI 10.3758/BF03192861; Yi R, 2007, BEHAV PHARMACOL, V18, P633, DOI 10.1097/FBP.0b013e3282effbd3; Yi R, 2012, BEHAV PHARMACOL, V23, P358, DOI 10.1097/FBP.0b013e3283564e11; Yi R, 2012, NICOTINE TOB RES, V14, P547, DOI 10.1093/ntr/ntr252; Yoon JH, 2007, EXP CLIN PSYCHOPHARM, V15, P176, DOI 10.1037/1064-1297.15.2.186	88	58	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128641	10.1371/journal.pone.0128641	http://dx.doi.org/10.1371/journal.pone.0128641			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017273	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600123
J	Guo, ZX; Xing, ZQ; Cheng, XY; Fang, ZQ; Jiang, C; Su, J; Zhou, ZL; Xu, ZH; Holmberg, A; Nilsson, S; Liu, ZX				Guo, Zhaoxin; Xing, Zhaoquan; Cheng, Xiangyu; Fang, Zhiqing; Jiang, Chao; Su, Jing; Zhou, Zunlin; Xu, Zhonghua; Holmberg, Anders; Nilsson, Sten; Liu, Zhaoxu			Somatostatin Derivate (smsDX) Attenuates the TAM-Stimulated Proliferation, Migration and Invasion of Prostate Cancer via NF-kappa B Regulation	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; TRANSCRIPTION FACTOR; INFLAMMATION; INFILTRATION; EXPRESSION; CARCINOMA; ANGIOGENESIS; ASSOCIATION; PROGRESSION; METASTASIS	Tumor development and progression are influenced by macrophages of the surrounding microenvironment. To investigate the influences of an inflammatory tumor microenvironment on the growth and metastasis of prostate cancer, the present study used a co-culture model of prostate cancer (PCa) cells with tumor-associated macrophage (TAM)-conditioned medium (MCM). MCM promoted PCa cell (LNCaP, DU145 and PC-3) growth, and a xenograft model in nude mice consistently demonstrated that MCM could promote tumor growth. MCM also stimulated migration and invasion in vitro. Somatostatin derivate (smsDX) significantly attenuated the TAM-stimulated proliferation, migration and invasion of prostate cancer. Immunohistochemistry revealed that NF-kappa B was over-expressed in PCa and BPH with chronic inflammatory tissue specimens and was positively correlated with macrophage infiltration. Further investigation into the underlying mechanism revealed that NF-kappa B played an important role in macrophage infiltration. SmsDX inhibited the paracrine loop between TAM and PCa cells and may represent a potential therapeutic agent for PCa.	[Guo, Zhaoxin; Xing, Zhaoquan; Cheng, Xiangyu; Fang, Zhiqing; Jiang, Chao; Zhou, Zunlin; Xu, Zhonghua; Liu, Zhaoxu] Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China; [Guo, Zhaoxin; Fang, Zhiqing] Shandong Univ, Qilu Hosp, Dept Cardiol, Key Lab Cardiovasc Remodeling & Funct Res,Chinese, Jinan 250100, Shandong, Peoples R China; [Guo, Zhaoxin; Fang, Zhiqing] Shandong Univ, Qilu Hosp, Dept Cardiol, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Su, Jing; Liu, Zhaoxu] Shandong Univ, Sch Nursing, Jinan 250100, Shandong, Peoples R China; [Holmberg, Anders; Nilsson, Sten; Liu, Zhaoxu] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden	Shandong University; Shandong University; Shandong University; Shandong University; Karolinska Institutet	Liu, ZX (corresponding author), Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Shandong, Peoples R China.	zhaoxvl@sdu.edu.cn			National Natural Science Foundation of China [30772294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30772294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armani C, 2007, J LEUKOCYTE BIOL, V81, P845, DOI 10.1189/jlb.0606417; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Behe M, 2001, MED ONCOL, V18, P59; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; CHAO TC, 1995, REGUL PEPTIDES, V58, P1, DOI 10.1016/0167-0115(95)00051-C; Chen JJW, 2003, CLIN CANCER RES, V9, P729; Chen LY, 2012, BRAIN RES, V1475, P80, DOI 10.1016/j.brainres.2012.07.052; Comito G, 2014, ONCOGENE, V33, P2423, DOI 10.1038/onc.2013.191; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Eguchi K, 2013, DIABETES OBES METAB, V15, P152, DOI 10.1111/dom.12168; Fang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062823; Gollapudi K, 2013, AM J CANCER RES, V3, P523; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huang S, 2000, CLIN CANCER RES, V6, P2573; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang BN, 2001, REGUL PEPTIDES, V101, P43, DOI 10.1016/S0167-0115(01)00264-6; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Ludwig L, 2001, CANCER RES, V61, P4526; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Mayo MW, 2002, J BIOL CHEM, V277, P11116, DOI 10.1074/jbc.M108670200; Mikhaevich EI, 2013, B EXP BIOL MED+, V154, P669, DOI 10.1007/s10517-013-2026-3; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nonomura N, 2010, CANCER SCI, V101, P1570, DOI 10.1111/j.1349-7006.2010.01563.x; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pinter E, 2006, PHARMACOL THERAPEUT, V112, P440, DOI 10.1016/j.pharmthera.2006.04.010; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Shimura S, 2000, CANCER RES, V60, P5857; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; ten Bokum AMC, 2000, EUR CYTOKINE NETW, V11, P161; Tian H, 2009, INFLAMMATION, V32, P191, DOI 10.1007/s10753-009-9120-8; Wang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113754; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153; Wong CP, 2009, CANCER LETT, V276, P38, DOI 10.1016/j.canlet.2008.10.025; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055790; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	54	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0124292	10.1371/journal.pone.0124292	http://dx.doi.org/10.1371/journal.pone.0124292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010447	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900007
J	Hollander, K; Argubi-Wollesen, A; Reer, R; Zech, A				Hollander, Karsten; Argubi-Wollesen, Andreas; Reer, Ruediger; Zech, Astrid			Comparison of Minimalist Footwear Strategies for Simulating Barefoot Running: A Randomized Crossover Study	PLOS ONE			English	Article							STRIKE PATTERNS; SHOD CONDITIONS; STANCE PHASE; RUNNERS; BIOMECHANICS; WALKING	Possible benefits of barefoot running have been widely discussed in recent years. Uncertainty exists about which footwear strategy adequately simulates barefoot running kinematics. The objective of this study was to investigate the effects of athletic footwear with different minimalist strategies on running kinematics. Thirty-five distance runners (22 males, 13 females, 27.9 +/- 6.2 years, 179.2 +/- 8.4 cm, 73.4 +/- 12.1 kg, 24.9 +/- 10.9 km.week(-1)) performed a treadmill protocol at three running velocities (2.22, 2.78 and 3.33 m.s(-1)) using four footwear conditions: barefoot, uncushioned minimalist shoes, cushioned minimalist shoes, and standard running shoes. 3D kinematic analysis was performed to determine ankle and knee angles at initial foot-ground contact, rate of rear-foot strikes, stride frequency and step length. Ankle angle at foot strike, step length and stride frequency were significantly influenced by footwear conditions (p<0.001) at all running velocities. Posthoc pairwise comparisons showed significant differences (p<0.001) between running barefoot and all shod situations as well as between the uncushioned minimalistic shoe and both cushioned shoe conditions. The rate of rear-foot strikes was lowest during barefoot running (58.6% at 3.33 m.s(-1)), followed by running with uncushioned minimalist shoes (62.9%), cushioned minimalist (88.6%) and standard shoes (94.3%). Aside from showing the influence of shod conditions on running kinematics, this study helps to elucidate differences between footwear marked as minimalist shoes and their ability to mimic barefoot running adequately. These findings have implications on the use of footwear applied in future research debating the topic of barefoot or minimalist shoe running.	[Hollander, Karsten; Reer, Ruediger] Univ Hamburg, Inst Human Movement Sci, Dept Sports & Exercise Med, Hamburg, Germany; [Argubi-Wollesen, Andreas] Univ Hamburg, Inst Human Movement Sci, Hamburg, Germany; [Zech, Astrid] Univ Jena, Inst Sports Sci, Dept Exercise Physiol, Jena, Germany	University of Hamburg; University of Hamburg; Friedrich Schiller University of Jena	Zech, A (corresponding author), Univ Jena, Inst Sports Sci, Dept Exercise Physiol, Jena, Germany.	astrid.zech@uni-jena.de	Hollander, Karsten/H-9475-2015; Zech, Astrid/AAS-1760-2020	Hollander, Karsten/0000-0002-5682-9665; Argubi-Wollesen, Andreas/0000-0003-3006-4649; Zech, Astrid/0000-0001-7147-4113	Leguano GmbH, Germany	Leguano GmbH, Germany	The study was financially supported by the Leguano GmbH, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman AR, 2012, CURR SPORT MED REP, V11, P244, DOI 10.1249/JSR.0b013e31826c9bb9; Bishop M, 2006, J ATHL TRAINING, V41, P387; Bonacci J, 2013, BRIT J SPORT MED, V47, P387, DOI 10.1136/bjsports-2012-091837; Breine B, 2014, MED SCI SPORT EXER, V46, P1595, DOI 10.1249/MSS.0000000000000267; Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; DeLeo AT, 2004, CLIN BIOMECH, V19, P983, DOI 10.1016/j.clinbiomech.2004.07.005; Eils E, 2004, GAIT POSTURE, V20, P54, DOI 10.1016/S0966-6362(03)00095-X; Enders H, 2014, J SCI MED SPORT, V17, P218, DOI 10.1016/j.jsams.2013.03.015; Eslami M, 2007, CLIN BIOMECH, V22, P74, DOI 10.1016/j.clinbiomech.2006.08.002; Fellin RE, 2010, J SCI MED SPORT, V13, P646, DOI 10.1016/j.jsams.2010.03.006; Hall JPL, 2013, SPORTS MED, V43, P1335, DOI 10.1007/s40279-013-0084-3; Hamill J, 2011, FOOTWEAR SCI, V3, P33, DOI 10.1080/19424280.2010.542187; Heiderscheit BC, 2011, MED SCI SPORT EXER, V43, P296, DOI 10.1249/MSS.0b013e3181ebedf4; Hobara H, 2012, INT J SPORTS MED, V33, P310, DOI 10.1055/s-0031-1291232; Hollander K, 2014, GAIT POSTURE, V40, P381, DOI 10.1016/j.gaitpost.2014.05.006; Hsu AR, 2012, FOOT ANKLE INT, V33, P787, DOI 10.3113/FAI.2012.0787; Kurup H V, 2012, Foot Ankle Surg, V18, P79, DOI 10.1016/j.fas.2011.03.012; Lieberman DE, 2012, EXERC SPORT SCI REV, V40, P63, DOI 10.1097/JES.0b013e31824ab210; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Mullen S, 2013, J PEDIATR ORTHOPED, V33, P453, DOI 10.1097/BPO.0b013e31829241dc; Murphy K, 2013, SPORTS MED, V43, P1131, DOI 10.1007/s40279-013-0093-2; Nigg B, 2013, FOOTWEAR SCI, V5, P1, DOI 10.1080/19424280.2013.766649; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; RAO UB, 1992, J BONE JOINT SURG BR, V74, P525, DOI 10.1302/0301-620X.74B4.1624509; Ridge ST, 2013, MED SCI SPORT EXER, V45, P1363, DOI 10.1249/MSS.0b013e3182874769; Rothschild CE, 2012, J STRENGTH COND RES, V26, P2021, DOI 10.1519/JSC.0b013e31823a3c54; Ryan M, 2014, BRIT J SPORT MED, V48, P1257, DOI 10.1136/bjsports-2012-092061; Shih Y, 2013, GAIT POSTURE, V38, P490, DOI 10.1016/j.gaitpost.2013.01.030; Squadrone R, 2009, J SPORT MED PHYS FIT, V49, P6; Tam N, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-092404; Verbeke G, 2000, LINEAR MIXED MODELS; Wegener C, 2011, J FOOT ANKLE RES, V4, DOI 10.1186/1757-1146-4-3; Willy RW, 2014, MED SCI SPORT EXER, V46, P318, DOI 10.1249/MSS.0b013e3182a595d2; Wolf S, 2008, GAIT POSTURE, V27, P51, DOI 10.1016/j.gaitpost.2007.01.005; Zech A, 2015, EUR J SPORT SCI, V15, P279, DOI 10.1080/17461391.2014.936322	38	39	40	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125880	10.1371/journal.pone.0125880	http://dx.doi.org/10.1371/journal.pone.0125880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011042	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900015
J	Li, KKW; Qi, Y; Xia, T; Yao, Y; Zhou, LF; Lau, KM; Ng, HK				Li, Kay Ka-Wai; Qi, Yan; Xia, Tian; Yao, Yu; Zhou, Liangfu; Lau, Kin-Mang; Ng, Ho-Keung			CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1	PLOS ONE			English	Article							RESPONSE MEDIATOR PROTEIN-1; ADJUVANT CHEMOTHERAPY; INVASION; EXPRESSION; METASTASIS; CHILDREN; THERAPY; PATHWAY; FAMILY; TUMORS	Many facets of the tumor biology of medulloblastoma (MB) have not been fully elucidated. Collapsin response mediator protein 1 (CRMP1) is a member of cytoplasmic family of proteins that regulate the development of central nervous system. Recent studies demonstrated that CRMP1 could function as an invasion suppressor. We reported previously that high mobility group AT-hook 1 (HMGA1) contributed to development of MB and regulated its growth and migration/invasion. Transcriptional profiling and quantitative RT-PCR revealed increased expression of CRMP1 in HMGA1-depleted cells, suggesting that CRMP1 may be a downstream target of HMGA1 in MB. In this study, we showed HMGA1 can bind CRMP1 promoter by chromatin immunoprecipitation (ChIP) assay. Luciferase assay demonstrated a marked enhancement of CRMP1 transcription activity in HMGA1-depleted cells. Furthermore, quantitative RT-PCR revealed a negative correlation between HMGA1 and CRMP1 in 32 MB samples. To investigate the biological roles of CRMP1 in MB pathogenesis, we established MB clones stably expressing CRMP1. Functional analysis revealed that expression of CRMP1 significantly inhibited proliferation, migration, invasion and formation of filopodia and intense stress fiber of MB cells. Our data suggest that HMGA1 regulates CRMP1 expression and CRMP1 is implicated in MB pathogenesis.	[Li, Kay Ka-Wai; Qi, Yan; Xia, Tian; Lau, Kin-Mang; Ng, Ho-Keung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Li, Kay Ka-Wai; Ng, Ho-Keung] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Yao, Yu; Zhou, Liangfu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong, Shenzhen; Fudan University	Lau, KM (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	kmlau@cuhk.edu.hk; hkng@cuhk.edu.hk	Ng, Ho Keung/I-3952-2015	Lau, Kin-Mang/0000-0001-5888-1937	Hong Kong Research Grants Council [CUHK 469211]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This study was supported by Hong Kong Research Grants Council (ref. no. CUHK 469211).	Buel GR, 2010, J CELL BIOCHEM, V111, P20, DOI 10.1002/jcb.22659; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Charrier E, 2006, GENES CELLS, V11, P1337, DOI 10.1111/j.1365-2443.2006.01024.x; Chen JJW, 2001, CANCER RES, V61, P5223; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; Gao M, 2008, BIOCHEM BIOPH RES CO, V376, P283, DOI 10.1016/j.bbrc.2008.08.144; Giangaspero F, 2007, WHO CLASSIFICATION T, P132; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; HE XM, 1991, LAB INVEST, V64, P833; Jayasena CS, 2011, GENE EXPR PATTERNS, V11, P395, DOI 10.1016/j.gep.2011.05.002; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Keles GE, 1995, ONCOL RES, V7, P493; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lau KM, 2012, ACTA NEUROPATHOL, V123, P553, DOI 10.1007/s00401-011-0934-8; Li CX, 2004, J NEUROSCI, V24, P6161, DOI 10.1523/JNEUROSCI.1476-04.2004; Luo J, 2012, NEUROCHEM RES, V37, P1381, DOI 10.1007/s11064-012-0712-6; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Mukherjee J, 2009, CANCER RES, V69, P8545, DOI 10.1158/0008-5472.CAN-09-1778; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; O'Connor Kathleen, 2013, Small GTPases, V4, P141, DOI 10.4161/sgtp.25131; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Packer RJ, 2013, NEURO-ONCOLOGY, V15, P97, DOI 10.1093/neuonc/nos267; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0; Raverot G, 2010, J CLIN ENDOCR METAB, V95, P1708, DOI 10.1210/jc.2009-1191; Ribi K, 2005, NEUROPEDIATRICS, V36, P357, DOI 10.1055/s-2005-872880; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shah SN, 2012, HISTOL HISTOPATHOL, V27, P567, DOI 10.14670/HH-27.567; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Tan F, 2014, ONCOL LETT, V7, P1333, DOI 10.3892/ol.2014.1909; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; Wierinckx A, 2007, ENDOCR-RELAT CANCER, V14, P887, DOI 10.1677/ERC-07-0062; Yamashita N, 2012, MOL NEUROBIOL, V45, P234, DOI 10.1007/s12035-012-8242-4; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006	42	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127910	10.1371/journal.pone.0127910	http://dx.doi.org/10.1371/journal.pone.0127910			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009886	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900162
J	Petersen, MB; Giessing, A; Nielsen, J				Petersen, Michael Bang; Giessing, Ann; Nielsen, Jesper			Physiological Responses and Partisan Bias: Beyond Self-Reported Measures of Party Identification	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; POLITICAL BELIEFS; PUBLIC-OPINION; COGNITION; POLARIZATION; ATTITUDES; IDENTITY; POLICY; CUES	People are biased partisans: they tend to agree with policies from political parties they identify with, independent of policy content. Here, we investigate how physiological reactions to political parties shape bias. Using changes in galvanic skin conductance responses to the visual presentation of party logos, we obtained an implicit and physiological measure of the affective arousal associated with political parties. Subsequently, we exposed subjects to classical party cue experiments where the party sponsors of specific policies were experimentally varied. We found that partisan bias only obtains among those exhibiting a strong physiological reaction to the party source; being a self-reported party identifier is not sufficient on its own. This suggests that partisan bias is rooted in implicit, affective reactions.	[Petersen, Michael Bang; Giessing, Ann; Nielsen, Jesper] Aarhus Univ, Dept Polit Sci, Aarhus, Denmark	Aarhus University	Petersen, MB (corresponding author), Aarhus Univ, Dept Polit Sci, Aarhus, Denmark.	michael@ps.au.dk		Petersen, Michael Bang/0000-0002-6782-5635				Achen CH, 1982, QUANTITATIVE APPL SO; Bullock JG, 2011, AM POLIT SCI REV, V105, P496, DOI 10.1017/S0003055411000165; Burdein I, 2006, POLIT PSYCHOL, V27, P359, DOI 10.1111/j.1467-9221.2006.00504.x; Burden BC, 2005, POLIT PSYCHOL, V26, P869, DOI 10.1111/j.1467-9221.2005.00448.x; Campbell Angus., 1960, AM VOTER; Cohen GL, 2003, J PERS SOC PSYCHOL, V85, P808, DOI 10.1037/0022-3514.85.5.808; Downs A., 1957, EC THEORY DEMOCRACY; Druckman JN, 2013, AM POLIT SCI REV, V107, P57, DOI 10.1017/S0003055412000500; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Figner B., 2011, HDB PROCESS TRACING, P163, DOI DOI 10.4324/9780203875292-18/USING-SKIN-CONDUCTANCE-JUDGMENT-DECISION-MAKING-RESEARCH-MICHAEL-SCHULTE-MECKLENBECK-ANTON-KUEHBERGER-JOSEPH-JOHNSON-JOSEPH-JOHNSON; FIORINA MORRIS P., 1981, RETROSPECTIVE VOTING, P89; Franzese RJ., 2009, MODELING INTERPRETIN; Green D. P., 2002, PARTISAN HEARTS MIND; Greene S, 2002, POLIT BEHAV, V24, P171, DOI 10.1023/A:1021859907145; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greitemeyer T, 2009, EUR J SOC PSYCHOL, V39, P22, DOI 10.1002/ejsp.497; Huddy L, 2015, AM POLIT SCI REV, V109, P1, DOI 10.1017/S0003055414000604; Iyengar S, 2012, PUBLIC OPIN QUART, V76, P405, DOI 10.1093/poq/nfs038; Jennings, 1974, POLITICAL CHARACTER; Kam CD, 2005, POLIT BEHAV, V27, P163, DOI 10.1007/s11109-005-1764-y; Lau RR, 2006, CAMB STUD PUB OPIN, P1, DOI 10.2277/ 052161306X; Matz DC, 2005, J PERS SOC PSYCHOL, V88, P22, DOI 10.1037/0022-3514.88.1.22; McDermott R., 2007, THE AFFECT EFFECT, P375; MONDAK JJ, 1993, AM J POLIT SCI, V37, P186, DOI 10.2307/2111529; Neely F, 2007, POLIT PSYCHOL, V28, P667, DOI 10.1111/j.1467-9221.2007.00599.x; Niemi, 1981, GENERATIONS POLITICS; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Petersen MB, 2013, POLIT BEHAV, V35, P831, DOI 10.1007/s11109-012-9213-1; Pietraszewski D, 2015, COGNITION, V140, P24, DOI 10.1016/j.cognition.2015.03.007; RAHN WM, 1993, AM J POLIT SCI, V37, P472, DOI 10.2307/2111381; Rosema M, 2006, ELECT STUD, V25, P467, DOI 10.1016/j.electstud.2005.06.017; Smith KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025552; Sniderman P. M., 2014, PARADOXES LIBERAL DE; WALLIN BG, 1981, PSYCHOPHYSIOLOGY, V18, P470, DOI 10.1111/j.1469-8986.1981.tb02483.x	34	8	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126922	10.1371/journal.pone.0126922	http://dx.doi.org/10.1371/journal.pone.0126922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010527	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900048
J	Pithukpakorn, M; Roothumnong, E; Angkasekwinai, N; Suktitipat, B; Assawamakin, A; Luangwedchakarn, V; Umrod, P; Thongnoppakhun, W; Foongladda, S; Suputtamongkol, Y				Pithukpakorn, Manop; Roothumnong, Ekkapong; Angkasekwinai, Nasikarn; Suktitipat, Bhoom; Assawamakin, Anunchai; Luangwedchakarn, Voravich; Umrod, Pinklow; Thongnoppakhun, Wanna; Foongladda, Suporn; Suputtamongkol, Yupin			HLA-DRB1 and HLA-DQB1 Are Associated with Adult-Onset Immunodeficiency with Acquired Anti-Interferon-Gamma Autoantibodies	PLOS ONE			English	Article							THAI POPULATION; HLA; DISEASE; HAPLOTYPES; INFECTION; ALLELES; TAIWAN	Recently a newly identified clinical syndrome of disseminated non-tuberculous mycobacterial diseases (with or without other opportunistic infections in adult patients who were previously healthy, has been recognized in association with an acquired autoantibody to interferon-gamma. This syndrome is emerging as an important cause of morbidity and mortality, especially among people of Asian descent. Trigger for the production of this autoantibody remains unknown, but genetic factors are strongly suspected to be involved. We compared HLA genotyping between 32 patients with this clinical syndrome, and 38 controls. We found that this clinical syndrome was associated with very limited allele polymorphism, with HLA-DRB1 and DQB1 alleles, especially HLA-DRB1*15:01, DRB1*16:02, DQB1*05:01 and DQB1*05:02. Odds ratio of DRB1*15:01, DRB1*16:02, DQB1*05:01 and DQB1*05:02 were 7.03 (95% CI, 2.18-22.69, P<0.0001, 9.06 (95% CI, 2.79-29.46, P<0.0001), 6.68 (95% CI, 2.29-19.52, P = 0.0004), and 6.64 (95% CI, 2.30-19.20, P = 0.0004), respectively. Further investigation is warranted to provide better understanding on pathogenesis of this association.	[Pithukpakorn, Manop; Roothumnong, Ekkapong] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Med,Div Med Genet, Bangkok 10700, Thailand; [Roothumnong, Ekkapong; Assawamakin, Anunchai; Thongnoppakhun, Wanna] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Res & Dev,Div Mol Genet, Bangkok 10700, Thailand; [Angkasekwinai, Nasikarn; Suputtamongkol, Yupin] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Med,Div Infect Dis & Trop Med, Bangkok 10700, Thailand; [Suktitipat, Bhoom] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Biochem, Bangkok 10700, Thailand; [Assawamakin, Anunchai] Mahidol Univ, Fac Pharm, Dept Pharmacol, Bangkok 10700, Thailand; [Luangwedchakarn, Voravich; Umrod, Pinklow] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Immunol, Bangkok 10700, Thailand; [Foongladda, Suporn] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Microbiol, Bangkok 10700, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Suputtamongkol, Y (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Dept Med,Div Infect Dis & Trop Med, Bangkok 10700, Thailand.	yupin.sup@mahidol.ac.th	Angkasekwinai, Nasikarn/AAS-3199-2020; Suktitipat, Bhoom/H-4239-2019; Pithukpakorn, Manop/K-9825-2013	Suktitipat, Bhoom/0000-0001-8034-7757; Pithukpakorn, Manop/0000-0003-3611-5718	Siriraj Research Development Grant [R015634003]; National Science and Technology Development Agency Grant [P-13-00374]; Siriraj Core Research Facility (SiCRF) Grant; Siriraj Chalermphrakiat Grant	Siriraj Research Development Grant; National Science and Technology Development Agency Grant; Siriraj Core Research Facility (SiCRF) Grant; Siriraj Chalermphrakiat Grant	This work was supported by Siriraj Research Development Grant (Grant No. R015634003) and National Science and Technology Development Agency Grant (Grant No. P-13-00374) to YS; Siriraj Core Research Facility (SiCRF) Grant to MP; and Siriraj Chalermphrakiat Grant to MP, NA, BS, WT, SF and YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Brode SK, 2014, INT J TUBERC LUNG D, V18, P1370, DOI 10.5588/ijtld.14.0120; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Chetchotisakd P, 2007, CLIN INFECT DIS, V45, P421, DOI 10.1086/520030; Chi CY, 2013, BLOOD, V121, P1357, DOI 10.1182/blood-2012-08-452482; Ding L, 2012, J CLIN IMMUNOL, V32, P238, DOI 10.1007/s10875-011-9621-8; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Lionetti E, 2014, NEW ENGL J MED, V371, P1295, DOI 10.1056/NEJMoa1400697; Pratesi F, 2013, AUTOIMMUN REV, V12, P1182, DOI 10.1016/j.autrev.2013.08.002; Romphruk AV, 2010, TISSUE ANTIGENS, V75, P701, DOI 10.1111/j.1399-0039.2010.01448.x; Romphruk AV, 1999, EUR J IMMUNOGENET, V26, P129, DOI 10.1046/j.1365-2370.1999.00133.x; Stankov K, 2013, PEDIATRICS, V132, P1112, DOI 10.1542/peds.2013-1652; Tassaneeyakul W, 2009, PHARMACOGENET GENOM, V19, P704, DOI 10.1097/FPC.0b013e328330a3b8; Thomas GP, 2010, IMMUNOL REV, V233, P162, DOI 10.1111/j.0105-2896.2009.00852.x; Tsai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00321; Wallach D, 2006, J AM ACAD DERMATOL, V55, P1066, DOI 10.1016/j.jaad.2006.07.016	17	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128481	10.1371/journal.pone.0128481	http://dx.doi.org/10.1371/journal.pone.0128481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011559	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900240
J	Pitisuttithum, P; Rerks-Ngarm, S; Stablein, D; Dawson, P; Nitayaphan, S; Kaewkungwal, J; Michael, NL; Kim, JH; Robb, ML; O'Connell, RJ; Yoon, IK; Fernandez, S; Excler, JL				Pitisuttithum, Punnee; Rerks-Ngarm, Supachai; Stablein, Donald; Dawson, Peter; Nitayaphan, Sorachai; Kaewkungwal, Jaranit; Michael, Nelson L.; Kim, Jerome H.; Robb, Merlin L.; O'Connell, Robert J.; Yoon, In-Kyu; Fernandez, Stefan; Excler, Jean-Louis			Accuracy of Clinical Diagnosis of Dengue Episodes in the RV144 HIV Vaccine Efficacy Trial in Thailand	PLOS ONE			English	Article							DISEASE BURDEN; TRANSMISSION; INFECTION; AIDSVAX; ADULTS; ALVAC	RV144 was a community-based HIV vaccine efficacy trial conducted in HIV-uninfected adults in Thailand, where dengue virus continues to cause a large number of infections every year. We attempted to document the accuracy of clinically diagnosed dengue episodes reported as serious adverse events (SAEs) and adverse events (AEs) and examine whether dengue serology would support the clinical diagnosis. Subjects without a clinical dengue diagnosis but with an infection or idiopathic fever were selected as a control population. Dengue serology was performed by hemagglutination inhibition on plasma samples. A total of 124 clinical dengue episodes were reported (103 SAEs and 21 AEs). Overall 82.6% of the clinically diagnosed dengue episodes were supported by a positive dengue serology: 71.4% of the AEs and 85.0% of the SAEs. Of the 100 subjects with both clinical dengue and positive serology, all presented with fever, 83% with leucopenia, 54% with thrombocytopenia, and 27% with hemorrhagic symptoms. All episodes resolved spontaneously without sequellae. Only two of 15 subjects with a negative serology presented with fever. The sensitivity and specificity of clinical dengue diagnosis were 90.9% and 74.4%, respectively, when compared to the control population, and with a positive predictive value of 82.6% and negative predictive value of 84.7% when compared to dengue serology. Clinical diagnosis of dengue is an accurate method of dengue diagnosis in adults in Thailand. Large-scale clinical trials offer the opportunity to systematically study infectious diseases such as dengue and other infections that may occur during the trial.	[Pitisuttithum, Punnee] Mahidol Univ, Vaccine Trial Ctr, Fac Trop Med, Bangkok 10700, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Stablein, Donald; Dawson, Peter] EMMES Corp, Rockville, MD USA; [Nitayaphan, Sorachai] AFRIMS, Royal Thai Army Component, Bangkok, Thailand; [Kaewkungwal, Jaranit] Mahidol Univ, Fac Trop Med, Ctr Excellence Biomed & Publ Hlth Informat, Bangkok 10700, Thailand; [Michael, Nelson L.; Kim, Jerome H.; Robb, Merlin L.; O'Connell, Robert J.; Excler, Jean-Louis] US Mil HIV Res Program MHRP, Bethesda, MD 20817 USA; [Robb, Merlin L.; Excler, Jean-Louis] Henry M Jackson Fdn Advancement Mil Med, Bethesda, MD USA; [O'Connell, Robert J.] US Component AFRIMS, Dept Retrovirol, Bangkok, Thailand; [Yoon, In-Kyu; Fernandez, Stefan] AFRIMS, Dept Virol, Bangkok, Thailand	Mahidol University; Ministry of Public Health - Thailand; Emmes Corporation; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Mahidol University; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Excler, JL (corresponding author), US Mil HIV Res Program MHRP, Bethesda, MD 20817 USA.	jexcler@hivresearch.org		Kaewkungwal, Jaranit/0000-0001-7916-8460	U.S. Army Medical Research and Materiel Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; EMMES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI002642] Funding Source: NIH RePORTER	U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); EMMES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The preparation of this manuscript was supported in part by an Interagency Agreement Y1-AI-2642-12 between U.S. Army Medical Research and Materiel Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases. In addition this work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). Co-authors Donald Stablein (DS) and Peter Dawson (PD) are employed by The EMMES Corporation. EMMES provided support in the form of salary for authors DS and PD as well as other EMMES employees involved in the RV144 study design, analysis, and preparation of this manuscript. The specific roles of the authors DS and PD are articulated in the "author contributions" section. The EMMES Corporation otherwise did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung KLL, 2013, SE ASIAN J TROP MED, V44, P602; Campbell KM, 2013, AM J TROP MED HYG, V89, P1066, DOI 10.4269/ajtmh.13-0321; Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676; Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; MAKINO Y, 1994, MICROBIOL IMMUNOL, V38, P951, DOI 10.1111/j.1348-0421.1994.tb02152.x; Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0; Ministry of Public Health T, 2008, ANN EP SURV REP; Namvongsa Vannyda, 2013, Southeast Asian J Trop Med Public Health, V44, P772; Pitisuttithum P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027837; Pongpan S, 2014, RISK MANAG HEALTHC P, V7, P45, DOI 10.2147/RMHP.S57257; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996; World Health Organization (WHO) and Special Programme for Research and Training in Tropical Diseases (TDR), 2009, GEN S DENG GUID DIAG; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	21	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127998	10.1371/journal.pone.0127998	http://dx.doi.org/10.1371/journal.pone.0127998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011728	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900179
J	Sepanlou, SG; Malekzadeh, R; Poustchi, H; Sharafkhah, M; Ghodsi, S; Malekzadeh, F; Etemadi, A; Pourshams, A; Pharoah, PD; Abnet, CC; Brennan, P; Boffetta, P; Dawsey, SM; Kamangar, F				Sepanlou, Sadaf G.; Malekzadeh, Reza; Poustchi, Hossein; Sharafkhah, Maryam; Ghodsi, Saeed; Malekzadeh, Fatemeh; Etemadi, Arash; Pourshams, Akram; Pharoah, Paul D.; Abnet, Christian C.; Brennan, Paul; Boffetta, Paolo; Dawsey, Sanford M.; Kamangar, Farin			The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GLOBAL BURDEN; GOLESTAN COHORT; PREDICTION; POPULATION; PROFILE; VALIDATION; HEALTH; PREVENTION; MORTALITY	Background Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood markers of lipids. However, risk scoring systems that solely use office-based data, not including laboratory markers, may be advantageous. In the current analysis, we validated the office-based Framingham risk scoring system in Iran. Methods The study used data from the Golestan Cohort in North-East of Iran. The following risk factors were used in the development of the risk scoring method: sex, age, body mass index, systolic blood pressure, hypertension treatment, current smoking, and diabetes. Cardiovascular risk functions for prediction of 10-year risk of fatal CVDs were developed. Results A total of 46,674 participants free of CVD at baseline were included. Predictive value of estimated risks was examined. The resulting Area Under the ROC Curve (AUC) was 0.774 (95% CI: 0.762-0.787) in all participants, 0.772 (95% CI: 0.753-0.791) in women, and 0.763 (95% CI: 0.747-0.779) in men. AUC was higher in urban areas (0.790, 95% CI: 0.766-0.815). The predicted and observed risks of fatal CVD were similar in women. However, in men, predicted probabilities were higher than observed. Conclusion The AUC in the current study is comparable to results of previous studies while lipid profile was replaced by body mass index to develop an office-based scoring system. This scoring algorithm is capable of discriminating individuals at high risk versus low risk of fatal CVD.	[Sepanlou, Sadaf G.; Malekzadeh, Reza; Poustchi, Hossein; Sharafkhah, Maryam; Ghodsi, Saeed; Malekzadeh, Fatemeh; Etemadi, Arash; Pourshams, Akram; Kamangar, Farin] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Tehran, Iran; [Etemadi, Arash; Abnet, Christian C.; Dawsey, Sanford M.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Pharoah, Paul D.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Boffetta, Paolo] Icahn Sch Med Mt Sinai, Inst Translat Epidemiol, New York, NY 10029 USA; [Kamangar, Farin] Morgan State Univ, Sch Community Hlth & Policy, Dept Publ Hlth Anal, Baltimore, MD 21239 USA	Tehran University of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; World Health Organization; International Agency for Research on Cancer (IARC); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Morgan State University	Malekzadeh, R (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Tehran, Iran.	malek@ams.ac.ir	Malekzadeh, Reza/U-1382-2017; Etemadi, Arash/Y-7082-2018; Etemadi, Arash/C-1386-2016; Abnet, Christian C/C-4111-2015; Boffetta, Paolo/AAI-7767-2021; Sepanlou, Sadaf G/H-9343-2016; Pharoah, Paul/V-6658-2019	Malekzadeh, Reza/0000-0002-9820-6335; Etemadi, Arash/0000-0002-3458-1072; Etemadi, Arash/0000-0002-3458-1072; Abnet, Christian C/0000-0002-3008-7843; Boffetta, Paolo/0000-0002-3811-2791; Sepanlou, Sadaf G/0000-0002-3669-5129; Pharoah, Paul/0000-0001-8494-732X; Pourshams, Akram/0000-0002-7950-3983	Division of Cancer Epidemiology and Genetics of the National Cancer Institute, NIH; Digestive Disease Research Institute of Tehran University of Medical Sciences [82-603]; Cancer Research UK (CRUK); International Agency for Research on Cancer	Division of Cancer Epidemiology and Genetics of the National Cancer Institute, NIH; Digestive Disease Research Institute of Tehran University of Medical Sciences; Cancer Research UK (CRUK)(Cancer Research UK); International Agency for Research on Cancer	This study was supported in part by the intramural research program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute, NIH, by the Digestive Disease Research Institute of Tehran University of Medical Sciences (grant No 82-603), by Cancer Research UK (CRUK), and by the International Agency for Research on Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bozorgmanesh M, 2011, INT J CLIN PRACT, V65, P264, DOI 10.1111/j.1742-1241.2010.02529.x; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Etemadi A, 2014, EUR J EPIDEMIOL, V29, P95, DOI 10.1007/s10654-014-9883-6; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Forouzanfar MH, 2014, ARCH IRAN MED, V17, P304, DOI 0141705/AIM.004; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Islami F, 2013, HEART, V99, P272, DOI 10.1136/heartjnl-2012-302861; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; Johannesson M, 2001, EUR HEART J, V22, P919, DOI 10.1053/euhj.2000.2484; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; Khalili D, 2012, AM J EPIDEMIOL, V176, P177, DOI 10.1093/aje/kws204; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; Menotti A, 2005, NUTR METAB CARDIOVAS, V15, P426, DOI 10.1016/j.numecd.2005.07.007; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Naghavi M, 2014, ARCH IRAN MED, V17, P321, DOI 0141705/AIM.005; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Rastegarpanah M, 2008, ARCH IRAN MED, V11, P306, DOI 08113/AIM.0012; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Sepanlou SG, 2012, ARCH IRAN MED, V15, P531, DOI 012159/AIM.004; Shahraz S, 2014, ARCH IRAN MED, V17, P336, DOI 0141705/AIM.006; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; Zhang XF, 2005, J CLIN EPIDEMIOL, V58, P951, DOI 10.1016/j.jclinepi.2005.01.013	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126779	10.1371/journal.pone.0126779	http://dx.doi.org/10.1371/journal.pone.0126779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011607	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900041
J	Wagner, A; Schabussova, I; Ruttkowski, B; Peschke, R; Kundi, JKM; Kundi, M; Joachim, A; Wiedermann, U				Wagner, Angelika; Schabussova, Irma; Ruttkowski, Berbel; Peschke, Roman; Kur, Jozef; Kundi, Michael; Joachim, Anja; Wiedermann, Ursula			Prime-Boost Vaccination with Toxoplasma Lysate Antigen, but Not with a Mixture of Recombinant Protein Antigens, Leads to Reduction of Brain Cyst Formation in BALB/c Mice	PLOS ONE			English	Article							ALLERGIC IMMUNE-RESPONSES; MAJOR SURFACE PROTEIN; GONDII INFECTION; PUBLIC-HEALTH; HOST-CELLS; IMMUNIZATION; PARASITE; STRATEGIES; RESISTANCE; INTESTINE	Introduction Infection with the ubiquitous parasite Toxoplasma gondii is a threat for immunocompromised patients and pregnant women and effective immune-prophylaxis is still lacking. Methods Here we tested a mixture of recombinant T. gondii antigens expressed in different developmental stages, i.e., SAG1, MAG1 and GRA7 (SMG), and a lysate derived from T. gondii tachyzoites (TLA) for prophylactic vaccination against cyst formation. Both vaccine formulations were applied systemically followed by an oral TLA-booster in BALB/c mice. Results Systemic priming with SMG and oral TLA-booster did not show significant induction of protective immune responses. In contrast, systemic priming and oral booster with TLA induced higher levels of Toxoplasma-specific IgG, IgG1 and IgG2a in sera as well as high levels of Toxoplasma-specific IgG1 in small intestines. Furthermore, high levels of Toxoplasma-specific Th1-, Th17-and Th2-associated cytokines were only detected in restimulated splenocytes of TLA-vaccinated mice. Importantly, in mice orally infected with T. gondii oocysts, only TLA-vaccination and booster reduced brain cysts. Furthermore, sera from these mice reduced tachyzoites invasion of Vero cells in vitro, indicating that antibodies may play a critical role for protection against Toxoplasma infection. Additionally, supernatants from splenocyte cultures of TLA-vaccinated mice containing high levels of IFN-gamma lead to substantial production of nitric oxide (NO) after incubation with macrophages in vitro. Since NO is involved in the control of parasite growth, the high levels of IFN-gamma induced by vaccination with TLA may contribute to the protection against T. gondii. Conclusion In conclusion, our data indicate that prime-boost approach with TLA, but not with the mixture of recombinant antigens SMG, induces effective humoral and cellular Toxoplasma-specific responses and leads to significant reduction of cerebral cysts, thereby presenting a viable strategy for further vaccine development against T. gondii infection.	[Wagner, Angelika; Schabussova, Irma; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Ruttkowski, Berbel; Peschke, Roman; Joachim, Anja] Univ Vet Med, Inst Parasitol, Dept Pathobiol, Vienna, Austria; [Kur, Jozef] Gdansk Univ Technol, Fac Chem, Dept Microbiol, Gdansk, Poland; [Kundi, Michael] Med Univ Vienna, Inst Environm Hlth, Vienna, Austria; [Wiedermann, Ursula] Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Medical University of Vienna; University of Veterinary Medicine Vienna; Fahrenheit Universities; Gdansk University of Technology; Medical University of Vienna; University of Gothenburg	Wiedermann, U (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	ursula.wiedermann@meduniwien.ac.at		Wagner, Angelika/0000-0002-5447-9534; Schabussova, Irma/0000-0002-2109-2640; Wiedermann, Ursula/0000-0002-1302-3223; Joachim, Anja/0000-0003-3082-6885	Austrian Science Fund [SFB F46]	Austrian Science Fund(Austrian Science Fund (FWF))	The work was supported by Austrian Science Fund, SFB F46, https://www.fwf.ac.at/.	Allen A, 2013, SCIENCE, V341, P454, DOI 10.1126/science.341.6145.454; Bhopale GM, 2003, MICROBES INFECT, V5, P457, DOI 10.1016/S1286-4579(03)00048-0; Cenci-Goga BT, 2011, FOODBORNE PATHOG DIS, V8, P751, DOI 10.1089/fpd.2010.0795; Che FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000745; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Debierre-Grockiego F, 2010, TRENDS PARASITOL, V26, P404, DOI 10.1016/j.pt.2010.04.006; Djurkovic-Djakovic O, 2012, EXP PARASITOL, V131, P372, DOI 10.1016/j.exppara.2012.05.006; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673; Dziadek B, 2011, VACCINE, V29, P821, DOI 10.1016/j.vaccine.2010.11.002; Fiorino F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00128; Gatkowska J, 2006, EXP PARASITOL, V114, P220, DOI 10.1016/j.exppara.2006.03.011; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Holec L, 2007, CLIN VACCINE IMMUNOL, V14, P220, DOI 10.1128/CVI.00419-06; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Innes EA, 2006, PARASITOLOGY, V133, pS145, DOI 10.1017/S0031182006001855; Innes EA, 2009, PARASITOLOGY, V136, P1887, DOI 10.1017/S0031182009991636; Jones JL, 2012, CLIN INFECT DIS, V55, P845, DOI 10.1093/cid/cis508; Jongert E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000200019; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kur J, 2009, EXPERT REV VACCINES, V8, P791, DOI [10.1586/erv.09.27, 10.1586/ERV.09.27]; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; MACK DG, 1992, J CLIN INVEST, V90, P2585, DOI 10.1172/JCI116153; Min J, 2012, VACCINE, V30, P5631, DOI 10.1016/j.vaccine.2012.06.081; MINEO JR, 1993, J IMMUNOL, V150, P3951; MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054; Parmley S, 2002, J INFECT DIS, V185, pS90, DOI 10.1086/338464; Passos ST, 2010, J IMMUNOL, V184, P1776, DOI 10.4049/jimmunol.0901843; Petersen E, 1998, VACCINE, V16, P1283, DOI 10.1016/S0264-410X(98)00039-5; Pifer R, 2011, TRENDS PARASITOL, V27, P388, DOI 10.1016/j.pt.2011.03.009; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Sayles PC, 2000, INFECT IMMUN, V68, P1026, DOI 10.1128/IAI.68.3.1026-1033.2000; Sturge CR, 2014, INFECT IMMUN, V82, P3090, DOI 10.1128/IAI.01722-14; Stutz A, 2012, IMMUNOBIOLOGY, V217, P28, DOI 10.1016/j.imbio.2011.08.008; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Suzuki Y, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002018; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zhang NZ, 2013, EXPERT REV VACCINES, V12, P1287, DOI 10.1586/14760584.2013.844652; Zhang Y, 1999, INFECT IMMUN, V67, P4383, DOI 10.1128/IAI.67.9.4383-4392.1999	43	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126334	10.1371/journal.pone.0126334	http://dx.doi.org/10.1371/journal.pone.0126334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010355	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900026
J	Elvsashagen, T; Norbom, LB; Pedersen, PO; Quraishi, SH; Bjornerud, A; Malt, UF; Groote, IR; Westlye, LT				Elvsashagen, Torbjorn; Norbom, Linn B.; Pedersen, Per O.; Quraishi, Sophia H.; Bjornerud, Atle; Malt, Ulrik F.; Groote, Inge R.; Westlye, Lars T.			Widespread Changes in White Matter Microstructure after a Day of Waking and Sleep Deprivation	PLOS ONE			English	Article							DIFFUSION TENSOR; ANTIDEPRESSANT RESPONSE; PREFRONTAL CORTEX; WAKEFULNESS; METAANALYSIS; DISRUPTION; PLASTICITY; INTEGRITY; DISORDER; MEMORY	Background Elucidating the neurobiological effects of sleep and waking remains an important goal of the neurosciences. Recently, animal studies indicated that sleep is important for cell membrane and myelin maintenance in the brain and that these structures are particularly susceptible to insufficient sleep. Here, we tested the hypothesis that a day of waking and sleep deprivation would be associated with changes in diffusion tensor imaging (DTI) indices of white matter microstructure sensitive to axonal membrane and myelin alterations. Methods Twenty-one healthy adult males underwent DTI in the morning [7:30AM; time point (TP)1], after 14 hours of waking (TP2), and then after another 9 hours of waking (TP3). Whole brain voxel-wise analysis was performed with tract based spatial statistics. Results A day of waking was associated with widespread increases in white matter fractional anisotropy, which were mainly driven by radial diffusivity reductions, and sleep deprivation was associated with widespread fractional anisotropy decreases, which were mainly explained by reductions in axial diffusivity. In addition, larger decreases in axial diffusivity after sleep deprivation were associated with greater sleepiness. All DTI changes remained significant after adjusting for hydration measures. Conclusions This is the first DTI study of sleep deprivation in humans. Although previous studies have observed localized changes in DTI indices of cerebral microstructure over the course of a few hours, further studies are needed to confirm widespread DTI changes within hours of waking and to clarify whether such changes in white matter microstructure serve as neurobiological substrates of sleepiness.	[Elvsashagen, Torbjorn; Pedersen, Per O.; Malt, Ulrik F.] Inst Oslo Univ Hosp, Dept Psychosomat Med, Oslo, Norway; [Elvsashagen, Torbjorn] Inst Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Bjornerud, Atle; Groote, Inge R.] Inst Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Elvsashagen, Torbjorn; Westlye, Lars T.] Inst Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Norwegian Ctr Mental Disorders Res NORMENT, Oslo, Norway; [Malt, Ulrik F.] Inst Oslo Univ Hosp, Dept Res & Educ, Oslo, Norway; [Elvsashagen, Torbjorn; Malt, Ulrik F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Norbom, Linn B.; Groote, Inge R.; Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Bjornerud, Atle] Univ Oslo, Dept Phys AB, Oslo, Norway; [Quraishi, Sophia H.] Columbia Univ, Barnard Coll, New York, NY USA	University of Oslo; University of Oslo; University of Oslo; Columbia University	Elvsashagen, T (corresponding author), Inst Oslo Univ Hosp, Dept Psychosomat Med, Oslo, Norway.	telvsaha@ous-hf.no		Norbom, Linn/0000-0001-7489-2724; Malt, Ulrik/0000-0002-9881-2511; Westlye, Lars T./0000-0001-8644-956X	Research Council of Norway [167153/V50, 204966/F20]; South-Eastern Norway Regional Health Authority; Oslo University Hospital-Rikshospitalet; TOP study group; Mrs. Aslaug Throne-Holst	Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority; Oslo University Hospital-Rikshospitalet; TOP study group; Mrs. Aslaug Throne-Holst	This study was funded by the Research Council of Norway (#167153/V50, 204966/F20; LTW), the TOP study group (LTW), the South-Eastern Norway Regional Health Authority (TE, UFM), Oslo University Hospital-Rikshospitalet (TE, AB, UFM, LTW), and a research grant from Mrs. Aslaug Throne-Holst (TE). The funders had no role in study	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bellesi M, 2013, J NEUROSCI, V33, P14288, DOI 10.1523/JNEUROSCI.5102-12.2013; Benedetti F, 2011, NEUROPSYCHOBIOLOGY, V64, P141, DOI 10.1159/000328947; Benner T, 2011, MAGN RESON MED, V66, P154, DOI 10.1002/mrm.22837; Bollettini I, 2015, J AFFECT DISORDERS, V174, P233, DOI 10.1016/j.jad.2014.11.010; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Cajochen C, 2001, NEUROREPORT, V12, P2277, DOI 10.1097/00001756-200107200-00046; Choi KS, 2014, NEUROPSYCHOPHARMACOL, V39, P1332, DOI 10.1038/npp.2013.345; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2005, J NEUROCHEM, V94, P1411, DOI 10.1111/j.1471-4159.2005.03291.x; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Cole J, 2012, BRIT J PSYCHIAT, V201, P33, DOI 10.1192/bjp.bp.111.100594; Cui J, 2015, NEUROIMAGE, V106, P123, DOI 10.1016/j.neuroimage.2014.11.035; De Gennaro L, 2007, NEUROIMAGE, V36, P1277, DOI 10.1016/j.neuroimage.2007.04.013; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Hinard V, 2012, J NEUROSCI, V32, P12506, DOI 10.1523/JNEUROSCI.2306-12.2012; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hofstetter S, 2013, J NEUROSCI, V33, P12844, DOI 10.1523/JNEUROSCI.4520-12.2013; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084822; Kempton MJ, 2009, HUM BRAIN MAPP, V30, P291, DOI 10.1002/hbm.20500; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Mackiewicz M, 2009, TRENDS MOL MED, V15, P79, DOI 10.1016/j.molmed.2008.12.002; McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Muzur A, 2002, TRENDS COGN SCI, V6, P475, DOI 10.1016/S1364-6613(02)01992-7; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nortje G, 2013, J AFFECT DISORDERS, V150, P192, DOI 10.1016/j.jad.2013.05.034; OSWALD I, 1969, NATURE, V223, P893, DOI 10.1038/223893a0; Rocklage M, 2009, SLEEP, V32, P1100, DOI 10.1093/sleep/32.8.1100; Rosenberg J, 2014, NEUROIMAGE, V84, P428, DOI 10.1016/j.neuroimage.2013.07.086; Samann PG, 2010, MAGN RESON MATER PHY, V23, P375, DOI 10.1007/s10334-010-0213-z; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Shannon BJ, 2013, J NEUROPHYSIOL, V109, P1444, DOI 10.1152/jn.00651.2012; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Tinguely G, 2006, NEUROIMAGE, V32, P283, DOI 10.1016/j.neuroimage.2006.03.017; Tost H, 2010, NAT NEUROSCI, V13, P920, DOI 10.1038/nn.2572; Vederine FE, 2011, PROG NEURO-PSYCHOPH, V35, P1820, DOI 10.1016/j.pnpbp.2011.05.009; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; WU JC, 1990, AM J PSYCHIAT, V147, P14; Wu JC, 2006, NEUROPSYCHOPHARMACOL, V31, P2783, DOI 10.1038/sj.npp.1301166; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525	67	45	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127351	10.1371/journal.pone.0127351	http://dx.doi.org/10.1371/journal.pone.0127351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020651	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300036
J	Chang, JF; Viovy, N; Vuichard, N; Ciais, P; Campioli, M; Klumpp, K; Martin, R; Leip, A; Soussana, JF				Chang, Jinfeng; Viovy, Nicolas; Vuichard, Nicolas; Ciais, Philippe; Campioli, Matteo; Klumpp, Katja; Martin, Raphael; Leip, Adrian; Soussana, Jean-Francois			Modeled Changes in Potential Grassland Productivity and in Grass-Fed Ruminant Livestock Density in Europe over 1961-2010	PLOS ONE			English	Article							EDDY-COVARIANCE MEASUREMENTS; PASTURE SIMULATION-MODEL; CO2 ENRICHMENT; CLIMATE-CHANGE; NITROGEN BUDGETS; ORGANIC-MATTER; PLANT BIOMASS; ELEVATED CO2; DATA SET; CARBON	About 25% of European livestock intake is based on permanent and sown grasslands. To fulfill rising demand for animal products, an intensification of livestock production may lead to an increased consumption of crop and compound feeds. In order to preserve an economically and environmentally sustainable agriculture, a more forage based livestock alimentation may be an advantage. However, besides management, grassland productivity is highly vulnerable to climate (i.e., temperature, precipitation, CO2 concentration), and spatial information about European grassland productivity in response to climate change is scarce. The process-based vegetation model ORCHIDEE-GM, containing an explicit representation of grassland management (i.e., herbage mowing and grazing), is used here to estimate changes in potential productivity and potential grass-fed ruminant livestock density across European grasslands over the period 1961-2010. Here "potential grass-fed ruminant livestock density" denotes the maximum density of livestock that can be supported by grassland productivity in each 25 km x 25 km grid cell. In reality, livestock density could be higher than potential (e.g., if additional feed is supplied to animals) or lower (e.g., in response to economic factors, pedo-climatic and biotic conditions ignored by the model, or policy decisions that can for instance reduce livestock numbers). When compared to agricultural statistics (Eurostat and FAOstat), ORCHIDEE-GM gave a good reproduction of the regional gradients of annual grassland productivity and ruminant livestock density. The model however tends to systematically overestimate the absolute values of productivity in most regions, suggesting that most grid cells remain below their potential grassland productivity due to possible nutrient and biotic limitations on plant growth. When ORCHIDEE-GM was run for the period 1961-2010 with variable climate and rising CO2, an increase of potential annual production (over 3%) per decade was found: 97% of this increase was attributed to the rise in CO2, -3% to climate trends and 15% to trends in nitrogen fertilization and deposition. When compared with statistical data, ORCHIDEE-GM captures well the observed phase of climate-driven interannual variability in grassland production well, whereas the magnitude of the interannual variability in modeled productivity is larger than the statistical data. Regional grass-fed livestock numbers can be reproduced by ORCHIDEE-GM based on its simple assumptions and parameterization about productivity being the only limiting factor to define the sustainable number of animals per unit area. Causes for regional model-data misfits are discussed, including uncertainties in farming practices (e.g., nitrogen fertilizer application, and mowing and grazing intensity) and in ruminant diet composition, as well as uncertainties in the statistical data and in model parameter values.	[Chang, Jinfeng; Viovy, Nicolas; Vuichard, Nicolas; Ciais, Philippe] CEA, CNRS, UVSQ, Lab Sci Climat & Environm,UMR8212, F-91198 Gif Sur Yvette, France; [Campioli, Matteo] Univ Antwerp, Dept Biol, Res Grp Plant & Vegetat Ecol, Antwerp, Belgium; [Klumpp, Katja; Martin, Raphael; Soussana, Jean-Francois] INRA, Grassland Ecosyst Res Unit, UREP, Clermont Ferrand, France; [Leip, Adrian] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, VA, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; University of Antwerp; INRAE; European Commission Joint Research Centre; EC JRC ISPRA Site	Chang, JF (corresponding author), CEA, CNRS, UVSQ, Lab Sci Climat & Environm,UMR8212, F-91198 Gif Sur Yvette, France.	jinfeng.chang@lsce.ipsl.fr	Ciais, Philippe/A-6840-2011; Viovy, Nicolas/S-2631-2018; Chang, Jinfeng/H-7884-2019; Soussana, Jean-Francois/M-2814-2017; CHANG, Jinfeng/A-4603-2019; Soussana, Jean-Francois/E-2543-2012; Vuichard, Nicolas/A-6629-2011; Soussana, Jean-Francois/P-2094-2016; Campioli, Matteo/N-9380-2015	Ciais, Philippe/0000-0001-8560-4943; Viovy, Nicolas/0000-0002-9197-6417; Chang, Jinfeng/0000-0003-4463-7778; CHANG, Jinfeng/0000-0003-4463-7778; Soussana, Jean-Francois/0000-0002-1932-6583; Leip, Adrian/0000-0001-7616-5029; Campioli, Matteo/0000-0002-3427-2368; Vuichard, Nicolas/0000-0002-3397-7948; Martin, Raphael/0000-0001-8778-7915	AnimalChange project [266018]; French l'Institut national de la recherche agronomique (INRA); French Commissariat a l'energie atomique (CEA)	AnimalChange project; French l'Institut national de la recherche agronomique (INRA); French Commissariat a l'energie atomique (CEA)(French Atomic Energy Commission)	This work was supported by the AnimalChange project (grant no. 266018). The authors' acknowledge the PhD funding for JC by the French l'Institut national de la recherche agronomique (INRA) and the French Commissariat a l'energie atomique (CEA).	Aeschlimann U, 2005, PLANT CELL ENVIRON, V28, P823, DOI 10.1111/j.1365-3040.2005.01331.x; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Alberti G, 2010, AGR ECOSYST ENVIRON, V136, P139, DOI 10.1016/j.agee.2009.12.012; Alexandratos N., 2012, 1203 ESA FAO UN AGR, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; [Anonymous], 2000, EARTH INTERACT, DOI DOI 10.1175/1087-3562(2000)004%3C0003:PASAOT%3E2.0.CO;2; Aranjuelo I, 2005, ANN APPL BIOL, V146, P51, DOI 10.1111/j.1744-7348.2005.04074.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Beer C, 2014, J CLIMATE, V27, P4815, DOI 10.1175/JCLI-D-13-00543.1; Bouwman AF., 2006, INTEGRATED MODELLING, P1; BRIGGS JM, 1995, AM J BOT, V82, P1024, DOI 10.2307/2446232; Buttner G., 2004, EARSEL EPROCEEDINGS, V3; Campolongo F, 2000, SENSITIVITY ANAL, P65; Casasus I, 2007, AGR ECOSYST ENVIRON, V121, P365, DOI 10.1016/j.agee.2006.11.012; Casella E, 1997, J EXP BOT, V48, P1309, DOI 10.1093/jxb/48.6.1309; Chang JF, 2013, GEOSCI MODEL DEV, V6, P2165, DOI 10.5194/gmd-6-2165-2013; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Eurostat, 2011, HDB ANN CROP STAT; Eurostat, 2007, 2006EU27 NUTS EUR; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Fiala Karel, 2010, Ekologia (Bratislava), V29, P182, DOI 10.4149/ekol_2010_02_182; Fischer G, 2002, GLOBAL AGROECOLOGICA; Garnier E, 1999, NEW PHYTOL, V143, P119, DOI 10.1046/j.1469-8137.1999.00426.x; Graux AI, 2011, AGR ECOSYST ENVIRON, V144, P69, DOI 10.1016/j.agee.2011.07.001; Guenet B, 2013, GEOSCI MODEL DEV, V6, P2153, DOI 10.5194/gmd-6-2153-2013; Hadjigeorgiou I, 2005, LIVEST PROD SCI, V96, P51, DOI 10.1016/j.livprodsci.2005.05.016; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Hasha G, 2002, LIVESTOCK FEEDING FE; Henkin Z, 2005, AGR ECOSYST ENVIRON, V109, P255, DOI 10.1016/j.agee.2005.03.004; Henry HAL, 2005, OECOLOGIA, V142, P465, DOI 10.1007/s00442-004-1713-1; HUME CJ, 1986, QUANTITATIVE STUDY E; Hussain MZ, 2011, AGR ECOSYST ENVIRON, V141, P67, DOI 10.1016/j.agee.2011.02.013; IPCC, 2006, AGR OTH LAND US; IUCN/UNEP/WWF, 1991, CAR EARTH STRAT SUST; Izaurralde RC, 2011, AGRON J, V103, P371, DOI 10.2134/agronj2010.0304; JENKINSON DS, 1992, SOIL BIOL BIOCHEM, V24, P295, DOI 10.1016/0038-0717(92)90189-5; Jones MB, 2004, NEW PHYTOL, V164, P423, DOI 10.1111/j.1469-8137.2004.01201.x; Joyce CB, 2013, ECOL ENG IN PRESS; Jung M, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002915; Kaplova M, 2011, PLANT ECOL, V212, P809, DOI 10.1007/s11258-010-9865-z; Kattge J, 2009, GLOBAL CHANGE BIOL, V15, P976, DOI 10.1111/j.1365-2486.2008.01744.x; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Knorr W, 2005, GLOBAL CHANGE BIOL, V11, P1333, DOI 10.1111/j.1365-2486.2005.00977.x; Knorr W, 2001, GLOBAL BIOGEOCHEM CY, V15, P207, DOI 10.1029/1998GB001059; Kramer K, 2002, GLOBAL CHANGE BIOL, V8, P213, DOI 10.1046/j.1365-2486.2002.00471.x; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Leadley PW, 1999, OECOLOGIA, V118, P39, DOI 10.1007/s004420050701; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; LEE J, 1983, P 9 GEN M EUR GRASSL, P11; LEHOUEROU HN, 1988, J ARID ENVIRON, V15, P1, DOI 10.1016/S0140-1963(18)31001-2; Leip A, 2008, BIOGEOSCIENCES, V5, P73, DOI 10.5194/bg-5-73-2008; Leip A, 2011, EUROPEAN NITROGEN AS, P345, DOI DOI 10.1017/CBO9780511976988.019; Leip A, 2014, J AGR SCI, V152, pS22; Leip A, 2011, ENVIRON POLLUT, V159, P3243, DOI 10.1016/j.envpol.2011.01.040; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Marriott CA, 2004, AGRONOMIE, V24, P447, DOI 10.1051/agro:2004041; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Moorcroft PR, 2006, TRENDS ECOL EVOL, V21, P400, DOI 10.1016/j.tree.2006.04.009; Moral R, 2005, BIORESOURCE TECHNOL, V96, P153, DOI 10.1016/j.biortech.2004.05.003; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nippert JB, 2006, PLANT ECOL, V184, P65, DOI 10.1007/s11258-005-9052-9; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Papanastasis VP, 2008, ANIM FEED SCI TECH, V140, P1, DOI 10.1016/j.anifeedsci.2007.03.012; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; PAUSTIAN K, 1990, J APPL ECOL, V27, P60, DOI 10.2307/2403568; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peeters A, 2012, GRASSLAND SCI EUR, V17, P17; Peeters Alain, 2009, Grassland Science, V55, P113, DOI 10.1111/j.1744-697X.2009.00154.x; Riedo M, 1998, ECOL MODEL, V105, P141, DOI 10.1016/S0304-3800(97)00110-5; Rotter R, 1999, CLIMATIC CHANGE, V43, P651, DOI 10.1023/A:1005541132734; Scurlock JMO, 1999, ECOL APPL, V9, P913, DOI 10.1890/1051-0761(1999)009[0913:TNTACD]2.0.CO;2; SILVERTOWN J, 1994, ECOLOGY, V75, P2430, DOI 10.2307/1940896; Smit HJ, 2008, AGR SYST, V98, P208, DOI 10.1016/j.agsy.2008.07.004; Soussana JF, 2007, GRASS FORAGE SCI, V62, P127, DOI 10.1111/j.1365-2494.2007.00577.x; Soussana JF, 2010, J EXP BOT, V61, P2217, DOI 10.1093/jxb/erq100; Tenkorang F, 2009, NUTR CYCL AGROECOSYS, V83, P233, DOI 10.1007/s10705-008-9214-y; Topp CFE, 2004, GRASS FORAGE SCI, V59, P274, DOI 10.1111/j.1365-2494.2004.00427.x; Tubiello FN, 2007, P NATL ACAD SCI USA, V104, P19686, DOI 10.1073/pnas.0701728104; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Van den Pol-van Dasselaar A, 2012, GRASSLAND SCI EUR, V17, P279; van Ittersum MK, 2008, AGR SYST, V96, P150, DOI 10.1016/j.agsy.2007.07.009; Vuichard N, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002611; Vuichard N, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002612; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Weedon GP, 2011, J HYDROMETEOROL, V12, P823, DOI 10.1175/2011JHM1369.1; Weedon GP, 2010, 22 WATCH; Wint G. R. W., 2007, GRIDDED LIVESTOCK WO; Wirsenius, 2000, HUMAN USE LAND ORGAN; Wriedt G, 2009, AGR WATER MANAGE, V96, P771, DOI 10.1016/j.agwat.2008.10.012; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Yassoglou NJ, 2000, RALA REP, P27; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395; ZAEHLE S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI DOI 10.1029/2009GB003521; Zhao Y, 2012, BIOGEOSCIENCES, V9, P2537, DOI 10.5194/bg-9-2537-2012	96	29	29	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127554	10.1371/journal.pone.0127554	http://dx.doi.org/10.1371/journal.pone.0127554			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018186	Green Published, gold			2022-12-27	WOS:000355185600089
J	Ghazanfari, S; Driessen-Mol, A; Strijkers, GJ; Baaijens, FPT; Bouten, CVC				Ghazanfari, Samaneh; Driessen-Mol, Anita; Strijkers, Gustav J.; Baaijens, Frank P. T.; Bouten, Carlijn V. C.			The Evolution of Collagen Fiber Orientation in Engineered Cardiovascular Tissues Visualized by Diffusion Tensor Imaging	PLOS ONE			English	Article							QUANTITATIVE ASSESSMENT; ARTICULAR-CARTILAGE; CELL TRACTION; ALIGNMENT; EXPRESSION; GENERATION; ANISOTROPY; TRACKING; SYSTEM; MATRIX	The collagen architecture is the major determinant of the function and mechanical behavior of cardiovascular tissues. In order to engineer a functional and load-bearing cardiovascular tissue with a structure thatmimics the native tissue to meet in vivo mechanical demands, a complete understanding of the collagen orientation mechanism is required. Several methods have been used to visualize collagen architecture in tissue-engineered (TE) constructs, but they either have a limited imaging depth or have a complicated set up. In this study, Diffusion Tensor Imaging (DTI) is explored as a fast and reliable method to visualize collagen arrangement, and Confocal Laser Scanning Microscopy (CLSM) was used as a validation technique. Uniaxially constrained TE strips were cultured for 2 days, 10 days, 3 and 6 weeks to investigate the evolution of the collagen orientation with time. Moreover, a comparison of the collagen orientation in high and low aspect ratio (length/width) TE constructs was made with both methods. Both methods showed similar fiber orientation in TE constructs. Collagen fibers in the high aspect ratio samples were mostly aligned in the constrained direction, while the collagen fibers in low aspect ratio strips were mainly oriented in the oblique direction. The orientation changed to the oblique direction by extending culture time and could also be visualized. DTI captured the collagen orientation differences between low and high aspect ratio samples and with time. Therefore, it can be used as a fast, non-destructive and reliable tool to study the evolution of the collagen orientation in TE constructs.	[Ghazanfari, Samaneh; Driessen-Mol, Anita; Baaijens, Frank P. T.; Bouten, Carlijn V. C.] Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomechan & Engn, NL-5600 MB Eindhoven, Netherlands; [Strijkers, Gustav J.] Univ Amsterdam, Acad Med Ctr, Biomed NMR Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands	Eindhoven University of Technology; University of Amsterdam; Academic Medical Center Amsterdam	Ghazanfari, S (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Soft Tissue Biomechan & Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	samane.ghazanfari@gmail.com	Bouten, Carlijn/AAT-5187-2020	Bouten, Carlijn/0000-0003-1035-5094; Strijkers, Gustav/0000-0001-6700-5058; Ghazanfari, Samaneh/0000-0001-8177-7521; Baaijens, Frank/0000-0002-0975-5376	TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	The authors gratefully acknowledge the support of the TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPDEN RM, 1987, J ANAT, V155, P141; Auer M, 2005, IEEE T IMAGE PROCESS, V14, P475, DOI 10.1109/TIP.2005.843756; Baaijens F, 2010, J BIOMECH, V43, P166, DOI 10.1016/j.jbiomech.2009.09.022; Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Canham PB, 1997, CARDIOVASC RES, V34, P557, DOI 10.1016/S0008-6363(97)00056-4; Capuani S, 2005, SOLID STATE NUCL MAG, V28, P266, DOI 10.1016/j.ssnmr.2005.11.001; Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6; Dahl SLM, 2007, ANN BIOMED ENG, V35, P1749, DOI 10.1007/s10439-007-9340-8; Daniels F, 2006, P INT C BIOM ENG BIO, V2006, P344; Driessen NJB, 2008, BIOMECH MODEL MECHAN, V7, P93, DOI 10.1007/s10237-007-0078-x; Elbischger PJ, 2005, ST HEAL T, V113, P97; Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020; Friedrichs J, 2007, J MOL BIOL, V372, P594, DOI 10.1016/j.jmb.2007.06.078; Ghazanfari S, 2012, BIOCHEM BIOPH RES CO, V426, P54, DOI 10.1016/j.bbrc.2012.08.031; Hay D, 1991, CELL BIOL EXTRACELLU; Heemskerk AM, 2009, MAGN RESON MED, V61, P467, DOI 10.1002/mrm.21819; Hoerstrup SP, 2000, CIRCULATION, V102, P44; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Karlon WJ, 1998, ANAT RECORD, V252, P612, DOI 10.1002/(SICI)1097-0185(199812)252:4<612::AID-AR12>3.0.CO;2-1; KLEBE RJ, 1990, MATRIX, V9, P451, DOI 10.1016/S0934-8832(11)80014-4; Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013; LANIR Y, 1983, J BIOMECH, V16, P1, DOI 10.1016/0021-9290(83)90041-6; LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K; Meder R, 2006, OSTEOARTHR CARTILAGE, V14, P875, DOI 10.1016/j.joca.2006.03.002; Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nimni M., 1988, MOL STRUCTURE FUNCTI; Peeters THJM, 2009, COMPUT GRAPH FORUM, V28, P2140, DOI 10.1111/j.1467-8659.2009.01421.x; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Raya JG, 2011, INVEST RADIOL, V46, P401, DOI 10.1097/RLI.0b013e3182145aa8; Rubbens MP, 2009, ANN BIOMED ENG, V37, P1263, DOI 10.1007/s10439-009-9698-x; Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508; Schnell AM, 2001, THORAC CARDIOV SURG, V49, P221, DOI 10.1055/s-2001-16113; Soares ALF, 2012, COMPUT METHOD BIOMEC, P1, DOI [10.1080/10255842.2012.650321, DOI 10.1080/10255842.2012.650321]; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Thomopoulos S, 2005, J BIOMECH ENG-T ASME, V127, P742, DOI 10.1115/1.1992525; Tower TT, 2001, BIOPHYS J, V81, P2964, DOI 10.1016/S0006-3495(01)75936-X; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; van Vlimmeren MAA, 2011, TISSUE ENG PART C-ME, V17, P983, DOI [10.1089/ten.tec.2011.0070, 10.1089/ten.TEC.2011.0070]; Venkatasubramanian RT, 2010, ANN BIOMED ENG, V38, P694, DOI 10.1007/s10439-010-9921-9; Vilanova A, 2006, VISUALIZATION AND PROCESSING OF TENSOR FIELDS, P121, DOI 10.1007/3-540-31272-2_7; Yang ZC, 2006, J THEOR BIOL, V242, P607, DOI 10.1016/j.jtbi.2006.05.005	44	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127847	10.1371/journal.pone.0127847	http://dx.doi.org/10.1371/journal.pone.0127847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016649	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600098
J	Jayaraman, S; Fausey, CM; Smith, LB				Jayaraman, Swapnaa; Fausey, Caitlin M.; Smith, Linda B.			The Faces in Infant-Perspective Scenes Change over the First Year of Life	PLOS ONE			English	Article							VISUAL-ACUITY; RECOGNITION; EXPERIENCE; SPECIALIZATION; MECHANISMS; ATTENTION; TRACKING; CHILDREN; STIMULI; AREA	Mature face perception has its origins in the face experiences of infants. However, little is known about the basic statistics of faces in early visual environments. We used head cameras to capture and analyze over 72,000 infant-perspective scenes from 22 infants aged 111 months as they engaged in daily activities. The frequency of faces in these scenes declined markedly with age: for the youngest infants, faces were present 15 minutes in every waking hour but only 5 minutes for the oldest infants. In general, the available faces were well characterized by three properties: (1) they belonged to relatively few individuals; (2) they were close and visually large; and (3) they presented views showing both eyes. These three properties most strongly characterized the face corpora of our youngest infants and constitute environmental constraints on the early development of the visual system.	[Jayaraman, Swapnaa; Smith, Linda B.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Fausey, Caitlin M.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	Indiana University System; Indiana University Bloomington; University of Oregon	Jayaraman, S (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	swapnaa@indiana.edu			Indiana University through the Faculty Research Support Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007475] Funding Source: NIH RePORTER	Indiana University through the Faculty Research Support Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Indiana University through the Faculty Research Support Program (http://ovpr.indiana.edu/funding/internal-funding-programs/frsp-seed-funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslin RN, 2009, OPTOMETRY VISION SCI, V86, P561, DOI 10.1097/OPX.0b013e3181a76e96; Balas B, 2015, NEUROPSYCHOLOGIA; Bornstein M. H., 1995, CULT PSYCHOL, V1, P123, DOI [10.1177/1354067x9511009, DOI 10.1177/1354067X9511009]; Byrge L, 2014, TRENDS COGNITIVE SCI; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; Cashon CH, 2004, J COGN DEV, V5, P59, DOI 10.1207/s15327647jcd0501_4; Cicchino JB, 2011, COGNITION, V118, P171, DOI 10.1016/j.cognition.2010.11.005; Cohen LB, 2001, INFANT CHILD DEV, V10, P83, DOI 10.1002/icd.250; Collins WA, 2000, AM PSYCHOL, V55, P218, DOI 10.1037/0003-066X.55.2.218; CUMMINGS MF, 1988, BEHAV BRAIN RES, V29, P7, DOI 10.1016/0166-4328(88)90047-2; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; de Heering A, 2012, COGNITIVE DEV, V27, P17, DOI 10.1016/j.cogdev.2011.07.001; de Schonen S, 1978, Perception, V7, P499; DOBSON V, 1978, VISION RES, V18, P1233, DOI 10.1016/0042-6989(78)90109-8; Franchak JM, 2011, CHILD DEV, V82, P1738, DOI 10.1111/j.1467-8624.2011.01670.x; GOREN CC, 1975, PEDIATRICS, V56, P544; GOTTLIEB G, 1991, DEV PSYCHOL, V27, P4, DOI 10.1037/0012-1649.27.1.4; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heron-Delaney M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019858; Hofferth SL, 1996, FUTURE CHILD, V6, P41, DOI 10.2307/1602418; James KH, 2013, J COGNITION DEV; Johnson M., 2011, OXFORD HDB FACE PERC, P3, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0001; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Kadosh KC, 2007, TRENDS COGN SCI, V11, P367, DOI 10.1016/j.tics.2007.06.007; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kreader J. L., 2005, INFANT TODDLER CHILD; Maurer D, 2001, CLIN NEUROSCI RES, V1, P239, DOI 10.1016/S1566-2772(01)00010-X; Maurer D, 2001, DEV COGN NEUROSCI, P237; Maurer D, 2007, DEVELOPMENTAL SCI, V10, P40, DOI 10.1111/j.1467-7687.2007.00562.x; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; McKone E, 2012, COGN NEUROPSYCHOL, V29, P174, DOI 10.1080/02643294.2012.660138; Mondloch CJ, 2007, VIS COGN, V15, P564, DOI 10.1080/13506280600859383; Morrissey T. W.., 2007, CHILD CARE EARLY ED; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Moulson MC, 2009, CHILD DEV, V80, P1039, DOI 10.1111/j.1467-8624.2009.01315.x; Nelson CA, 2003, ANN NY ACAD SCI, V1008, P48, DOI 10.1196/annals.1301.005; Nelson CA, 2003, DEV FACE RECOGNITION; Oruc I, 2010, J VISION, V10, DOI 10.1167/10.12.20; Pascalis O, 2009, PERSPECT PSYCHOL SCI, V4, P200, DOI 10.1111/j.1745-6924.2009.01119.x; Pereira AF, 2014, PSYCHON B REV, V21, P178, DOI 10.3758/s13423-013-0466-4; Schmitow C, 2013, INT J BEHAV DEV, V37, P468, DOI 10.1177/0165025413495749; Scott LS, 2010, NEUROPSYCHOLOGIA, V48, P1857, DOI 10.1016/j.neuropsychologia.2010.02.008; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Slater A, 2010, CHILD DEV PERSPECT, V4, P205, DOI 10.1111/j.1750-8606.2010.00147.x; Smith L, 2014, J COGNITION DEV; Smith LB, 2014, DEVELOPMENTAL SCI, V17, P826, DOI 10.1111/desc.12200; Sugden NA, 2014, DEV PSYCHOBIOL, V56, P249, DOI 10.1002/dev.21183; Tabuchi A, 2003, NEUROOPHTHALMOLOGY, V20, P342; Tanaka J. W., 1997, PSYCHOL LEARN MOTIV, V36, P83, DOI DOI 10.1016/S0079-7421(08)60282-0; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Wagner D, 1996, HUMAN FACTORS DESIGN; WOODING AR, 1990, J PAEDIATR CHILD H, V26, P85, DOI 10.1111/j.1440-1754.1990.tb02392.x; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Yu C, 2012, COGNITION, V125, P244, DOI 10.1016/j.cognition.2012.06.016; Zhao L, 2008, PSYCHON B REV, V15, P1093, DOI 10.3758/PBR.15.6.1093	57	110	111	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0123780	10.1371/journal.pone.0123780	http://dx.doi.org/10.1371/journal.pone.0123780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26016988	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000355185600001
J	Mayor, NP; Robinson, J; McWhinnie, AJM; Ranade, S; Eng, K; Midwinter, W; Bultitude, WP; Chin, CS; Bowman, B; Marks, P; Braund, H; Madrigal, JA; Latham, K; Marsh, SGE				Mayor, Neema P.; Robinson, James; McWhinnie, Alasdair J. M.; Ranade, Swati; Eng, Kevin; Midwinter, William; Bultitude, Will P.; Chin, Chen-Shan; Bowman, Brett; Marks, Patrick; Braund, Henny; Madrigal, J. Alejandro; Latham, Katy; Marsh, Steven G. E.			HLA Typing for the Next Generation	PLOS ONE			English	Article							HIGH-RESOLUTION; HIGH-THROUGHPUT; HAPLOTYPES; SYSTEM; DONORS; LOCI	Allele-level resolution data at primary HLA typing is the ideal for most histocompatibility testing laboratories. Many high-throughput molecular HLA typing approaches are unable to determine the phase of observed DNA sequence polymorphisms, leading to ambiguous results. The use of higher resolution methods is often restricted due to cost and time limitations. Here we report on the feasibility of using Pacific Biosciences' Single Molecule Real-Time (SMRT) DNA sequencing technology for high-resolution and high-throughput HLA typing. Seven DNA samples were typed for HLA-A, -B and -C. The results showed that SMRT DNA sequencing technology was able to generate sequences that spanned entire HLA Class I genes that allowed for accurate allele calling. Eight novel genomic HLA class I sequences were identified, four were novel alleles, three were confirmed as genomic sequence extensions and one corrected an existing genomic reference sequence. This method has the potential to revolutionize the field of HLA typing. The clinical impact of achieving this level of resolution HLA typing data is likely to considerable, particularly in applications such as organ and blood stem cell transplantation where matching donors and recipients for their HLA is of utmost importance.	[Mayor, Neema P.; Robinson, James; McWhinnie, Alasdair J. M.; Midwinter, William; Bultitude, Will P.; Braund, Henny; Madrigal, J. Alejandro; Latham, Katy; Marsh, Steven G. E.] Royal Free Hosp, Anthony Nolan Res Inst, London NW3 2QG, England; [Mayor, Neema P.; Robinson, James; Madrigal, J. Alejandro; Marsh, Steven G. E.] UCL, Inst Canc, London, England; [Ranade, Swati; Eng, Kevin; Chin, Chen-Shan; Bowman, Brett; Marks, Patrick] Pacific Biosci, Menlo Pk, CA USA	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London	Marsh, SGE (corresponding author), Royal Free Hosp, Anthony Nolan Res Inst, Pond St, London NW3 2QG, England.	steven.marsh@ucl.ac.uk	Bultitude, Will/HHM-5134-2022; Mayor, Neema P/AAO-1674-2021; Robinson, James/A-2056-2011; Bultitude, Will/DTH-9544-2022	Mayor, Neema P/0000-0002-9226-143X; Robinson, James/0000-0002-2187-5944; Bultitude, Will/0000-0003-2728-4237; Marks, Patrick/0000-0002-3231-7163; Madrigal, Alejandro/0000-0001-8359-9917; Midwinter, William/0000-0001-5645-224X	Pacific Biosciences	Pacific Biosciences	Pacific Biosciences provided support in the form of salaries for authors SR, KE, C-SC, BB and PM. The authors affiliated with Pacific Biosciences were involved in the study design, data collection and analysis, and have reviewed, commented on and approved the content of the manuscript. The authors have reviewed the authors' roles in the online form and confirm they are correct.	Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Danzer M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-221; De Santis D, 2013, INT J IMMUNOGENET, V40, P72, DOI 10.1111/iji.12024; DEGLIESPOSTI MA, 1992, HUM IMMUNOL, V34, P242, DOI 10.1016/0198-8859(92)90023-G; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Furst D, 2013, BLOOD, V122, P3220, DOI 10.1182/blood-2013-02-482547; Holcomb CL, 2011, TISSUE ANTIGENS, V77, P206, DOI 10.1111/j.1399-0039.2010.01606.x; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hosomichi K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-355; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Lind C, 2013, HUM IMMUNOL, V74, P325, DOI 10.1016/j.humimm.2012.12.007; Lind C, 2010, HUM IMMUNOL, V71, P1033, DOI 10.1016/j.humimm.2010.06.016; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Robinson J, 2001, NUCLEIC ACIDS RES, V29, P210, DOI 10.1093/nar/29.1.210; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Rozemuller EH, 1996, TISSUE ANTIGENS, V47, P72, DOI 10.1111/j.1399-0039.1996.tb02516.x; Shaw BE, 2010, LEUKEMIA, V24, P58, DOI 10.1038/leu.2009.239; Shiina T, 2012, TISSUE ANTIGENS, V80, P305, DOI 10.1111/j.1399-0039.2012.01941.x; Spellman SR, 2012, BLOOD, V120, P259, DOI 10.1182/blood-2012-03-379032; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Tilanus MGJ, 2006, IMM HUM MHC P 3 INT, P304; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; Tu B, 2013, TISSUE ANTIGENS, V81, P150, DOI 10.1111/tan.12072; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109	28	94	96	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127153	10.1371/journal.pone.0127153	http://dx.doi.org/10.1371/journal.pone.0127153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018555	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600072
J	Roldan, VA; Bossio, L; Galvan, DE				Alonso Roldan, Virginia; Bossio, Luisina; Galvan, David E.			Sources of Variation in a Two-Step Monitoring Protocol for Species Clustered in Conspicuous Points: Dolichotis patagonum as a Case Study	PLOS ONE			English	Article							VIDEO-SURVEILLANCE; WILDLIFE; SYSTEM	In species showing distributions attached to particular features of the landscape or conspicuous signs, counts are commonly made by making focal observations where animals concentrate. However, to obtain density estimates for a given area, independent searching for signs and occupancy rates of suitable sites is needed. In both cases, it is important to estimate detection probability and other possible sources of variation to avoid confounding effects on measurements of abundance variation. Our objective was to assess possible bias and sources of variation in a two-step protocol in which random designs were applied to search for signs while continuously recording video cameras were used to perform abundance counts where animals are concentrated, using mara (Dolichotis patagonum) as a case study. The protocol was successfully applied to maras within the Peninsula Valdes protected area, given that the protocol was logistically suitable, allowed warrens to be found, the associated adults to be counted, and the detection probability to be estimated. Variability was documented in both components of the two-step protocol. These sources of variation should be taken into account when applying this protocol. Warren detectability was approximately 80% with little variation. Factors related to false positive detection were more important than imperfect detection. The detectability for individuals was approximately 90% using the entire day of observations. The shortest sampling period with a similar detection capacity than a day was approximately 10 hours, and during this period, the visiting dynamic did not show trends. For individual mara, the detection capacity of the camera was not significantly different from the observer during fieldwork. The presence of the camera did not affect the visiting behavior of adults to the warren. Application of this protocol will allow monitoring of the near-threatened mara providing a minimum local population size and a baseline for measuring long-term trends.	[Alonso Roldan, Virginia; Galvan, David E.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Bossio, Luisina] Univ Nacl Patagonia San Juan Bosco, Puerto Madryn, Chubut, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco	Roldan, VA (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina.	virginia.a.roldan@gmail.com		Galvan, David/0000-0001-8132-6069; Alonso Roldan, Virginia/0000-0003-0702-3566	People Trust for Endangered Species; Idea Wild; ALUAR; Chubut Province Government	People Trust for Endangered Species; Idea Wild; ALUAR; Chubut Province Government	Funding for this work was provided by People Trust for Endangered Species (www.ptes.org), Idea Wild (www.ideawild.org), ALUAR (www.aluar.com.ar) and Chubut Province Government (www.chubut.gov.ar) to VAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso Roldan V, 2012, THESIS U NACL SUR; [Anonymous], 2010, R LANG ENV STAT COMP; Baldi R, 2007, J ARID ENVIRON, V68, P9, DOI 10.1016/j.jaridenv.2006.03.025; Bennetts RE, 1999, AUK, V116, P316, DOI 10.2307/4089366; Bertiller MB, 1981, CONTRIBUCION CTR NAC, V41; Bloomquist CK, 2009, J WILDLIFE MANAGE, V73, P605, DOI 10.2193/2008-200; BRANCH LC, 1993, J MAMMAL, V74, P890, DOI 10.2307/1382427; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Burton AC, 2012, BIODIVERS CONSERV, V21, P3079, DOI 10.1007/s10531-012-0355-6; Clutton-Brock TH, 1999, AFR J ECOL, V37, P69, DOI 10.1046/j.1365-2028.1999.00160.x; Condit R, 2007, MAR MAMMAL SCI, V23, P834, DOI 10.1111/j.1748-7692.2007.00141.x; Dendrinos Panagiotis, 2007, Aquatic Mammals, V33, P179, DOI 10.1578/AM.33.2.2007.179; Dixon Victoria, 2009, Ecological Management & Restoration, V10, P156; Fyfe R.W., 1976, Occasional Pap Can Wildl Serv, VNo. 23, P1; Harvey ES, 2010, MAR TECHNOL SOC J, V44, P75, DOI 10.4031/MTSJ.44.1.3; Irigoyen AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061072; KUFNER MB, 1995, STUD NEOTROP FAUNA E, V30, P37, DOI 10.1080/01650529509360939; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P138, DOI 10.1111/j.1557-9263.2008.00155.x; Lambertucci SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067304; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; Ojeda R, 2008, IUCN 2009 IUCN RED L; Pelletier D, 2011, FISH RES, V107, P84, DOI 10.1016/j.fishres.2010.10.011; PINHEIRO J., 2009, NLME LINEAR NONLINEA; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Rappole JH, 1985, NOCTURNAL MAMMALS TE; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Schipper J., 2007, SMALL CARNIVORE CONS, V36, P38; Schwarz CJ, 1999, STAT SCI, V14, P427; Stewart PD, 1997, MAMMAL REV, V27, P185, DOI 10.1111/j.1365-2907.1997.tb00448.x; Sutherland WJ., 1996, ECOLOGICAL CENSUS TE, V2, DOI DOI 10.1017/CBO9780511790508; TABER AB, 1992, J ZOOL, V227, P417, DOI 10.1111/j.1469-7998.1992.tb04404.x; Taber AB, 1987, BEHAV ECOLOGY MARA D; Taber AB, 1992, J ZOOLOGY LONDON, P227; Venerus LA, 2008, FISHERIES MANAG ECOL, V15, P217, DOI 10.1111/j.1365-2400.2008.00603.x; Walker R. Susan, 2000, Mastozoologia Neotropical, V7, P89; Woltmann S, 2005, ORNITOL NEOTROP, V16, P337; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	40	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128133	10.1371/journal.pone.0128133	http://dx.doi.org/10.1371/journal.pone.0128133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011026	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900195
J	Ang, LW; Tay, J; Phoon, MC; Hsu, JP; Cutter, J; James, L; Goh, KT; Chow, VTK				Ang, Li Wei; Tay, Joanne; Phoon, Meng Chee; Hsu, Jung Pu; Cutter, Jeffery; James, Lyn; Goh, Kee Tai; Chow, Vincent Tak-Kwong			Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010	PLOS ONE			English	Article							MOUTH-DISEASE OUTBREAK; NEUTRALIZING ANTIBODY-RESPONSES; WESTERN-AUSTRALIA; HAND; FOOT; STRAINS; TAIWAN; CHINA; MALAYSIA; EPIDEMIC	Coxsackieviruses A6 (CV-A6) and A16 (CV-A16) and Enterovirus 71 (EV-A71) have caused periodic epidemics of hand, foot and mouth disease (HFMD) among children in Singapore. We conducted a cross-sectional study to estimate the seroprevalence of these enteroviruses among Singapore children and adolescents. The study was conducted between August 2008 and July 2010. It involved 700 Singapore residents aged 1-17 years whose residual sera were obtained following the completion of routine biochemical investigations in two public acute-care hospitals. The levels of neutralizing antibodies (NtAb) against CV-A6, CV-A16 and EV-A71 were analyzed by the microneutralization test. The age-specific geometric mean titer (GMT) of antibodies against each of the three enteroviruses and the 95% confidence intervals (CI) were calculated. The seroprevalence of CV-A6 and CV-A16 was high at 62.7%(95% CI: 59.1-66.2%) and 60.6% (95% CI: 56.9-64.1%), respectively. However, the seroprevalence of EV-A71 was significantly lower at 29.3% (95% CI: 26.0-32.8%). About 89.7% of the children and adolescents had been infected by at least one of the three enteroviruses by 13-17 years of age. About half (52.3%) were seropositive for two or all three enteroviruses, while only 16.1% had no NtAb against any of the three enteroviruses. High NtAb levels were observed in the younger age groups. CV-A6 and CV-A16 infections are very common among Singapore children and adolescents, while EV-A71 infections are less common. Infection is continually acquired from early childhood to adolescent age.	[Ang, Li Wei; James, Lyn] Minist Hlth, Epidemiol & Dis Control Div, Singapore 169854, Singapore; [Tay, Joanne; Cutter, Jeffery; Goh, Kee Tai] Minist Hlth, Communicable Dis Div, Singapore 169854, Singapore; [Phoon, Meng Chee; Hsu, Jung Pu; Chow, Vincent Tak-Kwong] Natl Univ Singapore, Dept Microbiol, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117545, Singapore; [Goh, Kee Tai] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore	Ministry of Health-Singapore; Ministry of Health-Singapore; National University of Singapore; National University of Singapore	Ang, LW (corresponding author), Minist Hlth, Epidemiol & Dis Control Div, Coll Med Bldg,16 Coll Rd, Singapore 169854, Singapore.	ang_li_wei@moh.gov.sg		Chow, Vincent/0000-0003-2634-6213; Ang, Li Wei/0000-0002-0036-255X	National University of Singapore	National University of Singapore(National University of Singapore)	VTC is supported by a research grant from the National University of Singapore.	AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; Ang LW, 2013, EPIDEMIOL INFECT, V141, P1721, DOI 10.1017/S0950268812002130; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Centers for Disease Control and Prevention the United States, 2013, US 10 MAY 2013 NONP; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chau BNT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021116, 10.1371/journal.pone.0025969]; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Chou AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831282; Chua K B, 2007, Malays J Pathol, V29, P69; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Flett K, 2012, EMERG INFECT DIS, V18, P1702, DOI 10.3201/eid1810.120813; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Han JF, 2014, J INFECTION, V69, P303, DOI 10.1016/j.jinf.2014.03.015; Herrero LJ, 2003, ARCH VIROL, V148, P1369, DOI 10.1007/s00705-003-0100-2; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang ML, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002067; Huang WC, 2012, J MICROBIOL IMMUNOL, V45, P96, DOI 10.1016/j.jmii.2011.09.025; Huiqin Z., 2012, FRONT MED, P206; Infectious Disease Surveillance Centre (IDSC) National Institute of Infectious Diseases (NID) Japan, 2004, INFECT AGENTS SURVEI, V25, P224; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; KOGON A, 1969, AM J EPIDEMIOL, V89, P51, DOI 10.1093/oxfordjournals.aje.a120915; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Li JX, 2014, EXPERT REV VACCINES, V13, P609, DOI 10.1586/14760584.2014.897617; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Li YY, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-246; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Lin YL, 2011, J IMMUNOASS IMMUNOCH, V32, P233, DOI 10.1080/15321819.2011.559297; Lo SH, 2011, J MICROBIOL IMMUNOL, V44, P252, DOI 10.1016/j.jmii.2011.01.031; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Ministry of Health Singapore, 2013, COMM DIS SURV SING 2; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Ooi EE, 2002, ENTEROVIRUS INFECT S, P66; Perera D, 2007, ARCH VIROL, V152, P1201, DOI 10.1007/s00705-006-0934-5; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Ryu WS, 2010, EMERG INFECT DIS, V16, P1764, DOI 10.3201/eid1611.100104; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Sabanathan S, 2014, J EPIDEMIOL COMMUN H, V68, P500, DOI 10.1136/jech-2014-203836; Singh S, 2002, MICROBIOL IMMUNOL, V46, P801, DOI 10.1111/j.1348-0421.2002.tb02767.x; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Khanh TH, 2012, EMERG INFECT DIS, V18, P2002, DOI 10.3201/eid1812.120929; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yin-Murphy Marguerite, 1993, Annals Academy of Medicine Singapore, V22, P281; Zeng M, 2011, EPIDEMIOL INFECT, V31, P1; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100545; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	65	46	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127999	10.1371/journal.pone.0127999	http://dx.doi.org/10.1371/journal.pone.0127999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011735	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900180
J	Benedetto, D; Rao, CM; Cefalu, C; Aguglia, DO; Cattadori, G; D'Ascola, DG; Benedetto, FA; Agostoni, P; Sciomer, S				Benedetto, Daniela; Rao, Carmelo Massimo; Cefalu, Claudia; Aguglia, Demetrio Oreste; Cattadori, Gaia; D'Ascola, Domenico Giuseppe; Benedetto, Frank Antonio; Agostoni, Piergiuseppe; Sciomer, Susanna			Effects of Blood Transfusion on Exercise Capacity in Thalassemia Major Patients	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; MAGNETIC-RESONANCE; ANEMIC PATIENTS; CARDIAC IRON; PERFORMANCE; TOLERANCE	Anemia has an important role in exercise performance. However, the direct link between rapid changes of hemoglobin and exercise performance is still unknown. To find out more on this topic, we studied 18 beta-thalassemia major patients free of relevant cardiac dysfunction (age 33.5 +/- 7.2 years, males = 10). Patients performed a maximal cardiopulmolmonary exercise test (cycloergometer, personalized ramp protocol, breath-by-breath measurements of expired gases) before and the day after blood transfusion (500 cc of red cell concentrates). After blood transfusion, hemoglobin increased from 10.5 +/- 0.8 g/dL to 12.1 +/- 1.2 (p < 0.001), peak VO2 from 1408 to 1546mL/min (p< 0.05), and VO2 at anaerobic threshold from 965 to 1024mL/min (p < 0.05). No major changes were observed as regards heart and respiratory rates either at peak exercise or at anaerobic threshold. Similarly, no relevant changes were observed in ventilation efficiency, as evaluated by the ventilation vs. carbon dioxide production relationship, or in O-2 delivery to the periphery as analyzed by the VO2 vs. workload relationship. The relationship between hemoglobin and VO2 changes showed, for each g/dL of hemoglobin increase, a VO2 increase = 82.5 mL/min and 35 mL/min, at peak exercise and at anaerobic threshold, respectively. In beta-thalassemia major patients, an acute albeit partial anemia correction by blood transfusion determinates a relevant increase of exercise performance, observed both at peak exercise and at anaerobic threshold.	[Benedetto, Daniela; Cefalu, Claudia; Cattadori, Gaia; Agostoni, Piergiuseppe] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Rao, Carmelo Massimo; Aguglia, Demetrio Oreste; Benedetto, Frank Antonio] Azienda Bianchi Melacrino Morelli, Dept Cardiol, Reggio Di Calabria, Italy; [D'Ascola, Domenico Giuseppe] Azienda Bianchi Melacrino Morelli, Dept Hematol, Reggio Di Calabria, Italy; [Agostoni, Piergiuseppe] Univ Milan, Dipartimento Sci Clin & Comunita, Sez Cardiovasc, Milan, Italy; [Sciomer, Susanna] Univ Roma La Sapienza, Dipartimento Sci Cardiovasc & Respiratorie, I-00185 Rome, Italy	IRCCS Centro Cardiologico Monzino; University of Milan; Sapienza University Rome	Agostoni, P (corresponding author), IRCCS, Ctr Cardiol Monzino, Milan, Italy.	piergiuseppe.agostoni@unimi.it	Corrà, Ugo/AAF-8322-2020; Agostoni, Piergiuseppe/ABG-9556-2020	Corrà, Ugo/0000-0002-9229-3298; Agostoni, Piergiuseppe/0000-0002-8345-6382; Cattadori, Gaia/0000-0002-0954-9871; Sciomer, Susanna/0000-0001-9487-833X; benedetto, daniela/0000-0001-7069-5635				Agostoni P, 1999, AM J CARDIOL, V83, P278, DOI 10.1016/S0002-9149(98)00839-X; Agostoni P, 2010, AM J HEMATOL, V85, P414, DOI 10.1002/ajh.21698; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; BISHOP JM, 1955, CLIN SCI, V14, P329; Gargiulo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087395; Guazzi M, 2001, AM J CARDIOL, V88, P452, DOI 10.1016/S0002-9149(01)01703-9; HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49; KOIKE A, 1990, J APPL PHYSIOL, V68, P2521, DOI 10.1152/jappl.1990.68.6.2521; Mancini DM, 2003, CIRCULATION, V107, P294, DOI 10.1161/01.CIR.0000044914.42696.6A; Marsella M, 2011, HAEMATOL-HEMATOL J, V96, P515, DOI 10.3324/haematol.2010.025510; Nanas S, 2009, SCAND J MED SCI SPOR, V19, P96, DOI 10.1111/j.1600-0838.2008.00778.x; Okonko DO, 2008, J AM COLL CARDIOL, V51, P103, DOI 10.1016/j.jacc.2007.09.036; Palazzuoli A, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.005; Pennell DJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-45; Pepe A, 2009, HEART, V95, P1688, DOI 10.1136/hrt.2008.156497; Pepe A, 2013, BRIT J HAEMATOL, V163, P520, DOI 10.1111/bjh.12557; Perego GB, 1996, J APPL PHYSIOL, V80, P623, DOI 10.1152/jappl.1996.80.2.623; Ponikowski P, 2007, J AM COLL CARDIOL, V49, P753, DOI 10.1016/j.jacc.2006.11.024; Positano V, 2009, NMR BIOMED, V22, P707, DOI 10.1002/nbm.1382; Robertson HT, 2004, J APPL PHYSIOL, V97, P697, DOI 10.1152/japplphysiol.00108.2004; Sohn EY, 2013, AM J HEMATOL, V88, P193, DOI 10.1002/ajh.23370; Stringer WW, 2012, PRINCIPLES EXERCISE, V5th, P154; Tanner MA, 2006, HAEMATOLOGICA, V91, P1388; Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029; Tocco F, 2006, CLIN PHYSIOL FUNCT I, V26, P319, DOI 10.1111/j.1475-097X.2006.00692.x; Vasileiadis I, 2009, ACTA PHYSIOL, V196, P357, DOI 10.1111/j.1748-1716.2008.01937.x	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127553	10.1371/journal.pone.0127553	http://dx.doi.org/10.1371/journal.pone.0127553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010540	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900108
J	Caseys, C; Stritt, C; Glauser, G; Blanchard, T; Lexer, C				Caseys, Celine; Stritt, Christoph; Glauser, Gaetan; Blanchard, Thierry; Lexer, Christian			Effects of Hybridization and Evolutionary Constraints on Secondary Metabolites: The Genetic Architecture of Phenylpropanoids in European Populus Species	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; PLANT DEFENSE; HYBRID ZONES; FLAVONOID BIOSYNTHESIS; HERBIVORE RESISTANCE; COMMUNITY; SELECTION; PATTERNS; GENOMICS; METABOLOMICS	The mechanisms responsible for the origin, maintenance and evolution of plant secondary metabolite diversity remain largely unknown. Decades of phenotypic studies suggest hybridization as a key player in generating chemical diversity in plants. Knowledge of the genetic architecture and selective constraints of phytochemical traits is key to understanding the effects of hybridization on plant chemical diversity and ecological interactions. Using the European Populus species P. alba (White poplar) and P. tremula (European aspen) and their hybrids as a model, we examined levels of inter- and intraspecific variation, heritabilities, phenotypic correlations, and the genetic architecture of 38 compounds of the phenylpropanoid pathway measured by liquid chromatography and mass spectrometry (UHPLC-MS). We detected 41 quantitative trait loci (QTL) for chlorogenic acids, salicinoids and flavonoids by genetic mapping in natural hybrid crosses. We show that these three branches of the phenylpropanoid pathway exhibit different geographic patterns of variation, heritabilities, and genetic architectures, and that they are affected differently by hybridization and evolutionary constraints. Flavonoid abundances present high species specificity, clear geographic structure, and strong genetic determination, contrary to salicinoids and chlorogenic acids. Salicinoids, which represent important defence compounds in Salicaceae, exhibited pronounced genetic correlations on the QTL map. Our results suggest that interspecific phytochemical differentiation is concentrated in downstream sections of the phenylpropanoid pathway. In particular, our data point to glycosyltransferase enzymes as likely targets of rapid evolution and interspecific differentiation in the 'model forest tree' Populus.	[Caseys, Celine; Stritt, Christoph; Blanchard, Thierry; Lexer, Christian] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland; [Caseys, Celine] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [Caseys, Celine] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Glauser, Gaetan] Univ Neuchatel, Fac Sci, Neuchatel Platform Analyt Chem, CH-2000 Neuchatel, Switzerland; [Lexer, Christian] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria	University of Fribourg; University of British Columbia; University of British Columbia; University of Neuchatel; University of Vienna	Caseys, C (corresponding author), Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland.	celine.caseys@gmail.com	Caseys, Celine/E-9837-2015; Glauser, Gaetan/K-7574-2017	Caseys, Celine/0000-0003-4187-9018; Glauser, Gaetan/0000-0002-0983-8614; Lexer, Christian/0000-0002-7221-7482	Swiss National Science Foundation (SNF) [31003A_127059, P2FRP3_151662]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Swiss National Science Foundation (SNF) grant 31003A_127059 to CL and postdoctoral fellowship P2FRP3_151662 to CC. http://www.snf.ch The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Aksamit-Stachurska A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-25; Anderson JT, 2011, FUNCT ECOL, V25, P312, DOI 10.1111/j.1365-2435.2010.01785.x; Arnold M. L, 2007, EVOLUTION GENETIC EX; Babst BA, 2014, J EXP BOT, V65, P4191, DOI 10.1093/jxb/eru192; Babst BA, 2010, J CHEM ECOL, V36, P286, DOI 10.1007/s10886-010-9757-7; Bangert RK, 2006, MOL ECOL, V15, P1379, DOI 10.1111/j.1365-294X.2005.02749.x; Barbehenn R, 2010, OECOLOGIA, V164, P993, DOI 10.1007/s00442-010-1733-y; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bernhardsson C, 2013, ECOL LETT, V16, P791, DOI 10.1111/ele.12114; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Brachi B, 2015, P NATL ACAD SCI USA, V112, P4032, DOI 10.1073/pnas.1421416112; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Caseys C, 2012, PLANT ECOL DIVERS, V5, P457, DOI 10.1080/17550874.2012.748850; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Chen F, 2009, CRIT REV PLANT SCI, V28, P375, DOI 10.1080/07352680903241279; Cheng DD, 2011, PHYTOCHEM REV, V10, P107, DOI 10.1007/s11101-010-9194-9; Chu SS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-76; Clotault J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038724; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; DeWoody J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079925; Dickmann DI, 2009, PSYCHOL MED, P1; Eckenwalder J.E., 1996, BIOL POPULUS ITS IMP, P542; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Fussi B, 2010, TREE GENET GENOMES, V6, P439, DOI 10.1007/s11295-009-0262-5; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gompert Z, 2009, MOL ECOL, V18, P1207, DOI 10.1111/j.1365-294X.2009.04098.x; Jaakola L, 2010, PLANT CELL ENVIRON, V33, P1239, DOI 10.1111/j.1365-3040.2010.02154.x; Johnson MTJ, 2011, NEW PHYTOL, V191, P589, DOI 10.1111/j.1469-8137.2011.03816.x; Karrenberg S, 2007, AM NAT, V169, P725, DOI 10.1086/516758; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Keefover-Ring K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107189; Lexer C, 2004, FOREST ECOL MANAG, V197, P49, DOI 10.1016/j.foreco.2004.05.004; Lexer C, 2010, GENETICS, V186, P699, DOI 10.1534/genetics.110.118828; Lexer C, 2009, TAXON, V58, P349, DOI 10.1002/tax.582003; Lindtke D, 2013, HEREDITY, V111, P474, DOI 10.1038/hdy.2013.69; Lindtke D, 2014, MOL ECOL, V23, P4316, DOI 10.1111/mec.12759; Lindtke D, 2012, MOL ECOL, V21, P5042, DOI 10.1111/j.1365-294X.2012.05744.x; Lynch M., 1998, GENETICS ANAL QUANTI; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Orians CM, 2010, OECOLOGIA, V163, P283, DOI 10.1007/s00442-009-1521-8; Philippe RN, 2007, CAN J BOT, V85, P1111, DOI 10.1139/B07-109; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2013, EVOLUTION, V67, P34, DOI 10.1111/j.1558-5646.2012.01771.x; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rieseberg LH, 2002, P NATL ACAD SCI USA, V99, P12242, DOI 10.1073/pnas.192360899; Rieseberg LH, 2002, AM NAT, V159, pS36, DOI 10.1086/338371; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Schweitzer JA, 2008, ECOSYSTEMS, V11, P1005, DOI 10.1007/s10021-008-9173-9; Sellis D, 2015, EVOLUTION, V69, P75, DOI 10.1111/evo.12548; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Stolting KN, 2015, NEW PHYTOL, V207, P723, DOI 10.1111/nph.13392; Stolting KN, 2013, MOL ECOL, V22, P842, DOI 10.1111/mec.12011; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; Tsai C.J., 2006, INT J APPL SCI ENG, V4, P221; van Loo M, 2008, NEW PHYTOL, V177, P506, DOI 10.1111/j.1469-8137.2007.02266.x; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Whitham TG, 1999, ECOLOGY, V80, P416; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Widmer A, 2009, HEREDITY, V102, P31, DOI 10.1038/hdy.2008.69; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yu O, 2008, PLANT J, V54, P750, DOI 10.1111/j.1365-313X.2008.03436.x; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	76	22	23	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128200	10.1371/journal.pone.0128200	http://dx.doi.org/10.1371/journal.pone.0128200			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010156	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900204
J	Chang, J; Xue, M; Yang, SL; Yao, B; Zhang, BX; Chen, XP; Pozzi, A; Zhang, MZ				Chang, Jian; Xue, Min; Yang, Shilin; Yao, Bing; Zhang, Bixiang; Chen, Xiaoping; Pozzi, Ambra; Zhang, Ming-Zhi			Inhibition of 11 beta-Hydroxysteroid Dehydrogenase Type II Suppresses Lung Carcinogenesis by Blocking Tumor COX-2 Expression as Well as the ERK and mTOR Signaling Pathways	PLOS ONE			English	Article							PROSTAGLANDIN-E SYNTHASE; STRESS-RESPONSE; CANCER CELLS; CYCLOOXYGENASE-2; GLUCOCORTICOIDS; GROWTH; ACTIVATION; APOPTOSIS; CHEMOPREVENTION; OVEREXPRESSION	Lung cancer is by far the leading cause of cancer death. Early diagnosis and prevention remain the best approach to reduce the overall morbidity and mortality. Experimental and clinical evidence have shown that cyclooxygenase-2 (COX-2) derived prostaglandin E-2 (PGE2) contributes to lung tumorigenesis. COX-2 inhibitors suppress the development and progression of lung cancer. However, increased cardiovascular risks of COX-2 inhibitors limit their use in chemoprevention of lung cancers. Glucocorticoids are endogenous and potent COX-2 inhibitors, and their local actions are down-regulated by 11 beta-hydroxysteroid dehydrogenase type II (11 beta HSD2)-mediated metabolism. We found that 11 beta HSD2 expression was increased in human lung cancers and experimental lung tumors. Inhibition of 11 beta HSD2 activity enhanced glucocorticoid-mediated COX-2 inhibition in human lung carcinoma cells. Furthermore, 11 beta HSD2 inhibition suppressed lung tumor growth and invasion in association with increased tissue active glucocorticoid levels, decreased COX-2 expression, inhibition of ERK and mTOR signaling pathways, increased tumor endoplasmic reticulum stress as well as increased lifespan. Therefore, 11 beta HSD2 inhibition represents a novel approach for lung cancer chemoprevention and therapy by increasing tumor glucocorticoid activity, which in turn selectively blocks local COX-2 activity and/or inhibits the ERK and mTOR signaling pathways.	[Chang, Jian; Xue, Min; Yang, Shilin; Yao, Bing; Pozzi, Ambra; Zhang, Ming-Zhi] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Zhang, Ming-Zhi] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Chang, Jian; Zhang, Bixiang; Chen, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Hepat Surg Ctr, Wuhan 430074, Peoples R China; [Zhang, Ming-Zhi] Xuzhou Med Coll, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Inst Canc, Xuzhou, Peoples R China	Vanderbilt University; Vanderbilt University; Huazhong University of Science & Technology; Xuzhou Medical University	Zhang, MZ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	ming-zhi.zhang@vanderbilt.edu			National Institutes of Health [CA-122620, DK-95785, DK-51265, CA-162433]; NATIONAL CANCER INSTITUTE [R01CA122620, R01CA162433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095785, R01DK095761, R01DK051265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health CA-122620, DK-95785, DK-51265 to MZ; CA-162433 to AP.	Bi N, 2010, CLIN CANCER RES, V16, P2383, DOI 10.1158/1078-0432.CCR-09-2793; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Britson JS, 2009, BIOCHEM BIOPH RES CO, V390, P849, DOI 10.1016/j.bbrc.2009.10.061; Brognard J, 2002, CELL DEATH DIFFER, V9, P893, DOI 10.1038/sj.cdd.4401054; Chang J, 2015, ONCOTARGET, V6, P2879, DOI 10.18632/oncotarget.2994; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Clark AR, 2003, CURR OPIN PHARMACOL, V3, P404, DOI 10.1016/S1471-4892(03)00073-0; Croxtall JD, 2003, BIOCHEM J, V371, P927, DOI 10.1042/BJ20021856; DENIS MG, 1992, J STEROID BIOCHEM, V41, P739, DOI 10.1016/0960-0760(92)90415-F; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Greenberg AK, 2002, AM J RESP CELL MOL, V27, P320, DOI 10.1165/rcmb.4710; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; Harris RC, 2011, COMPR PHYSIOL, V1, P1729, DOI 10.1002/cphy.c100077; Harris RC, 2004, ACTA PHYSIOL SCAND, V181, P543, DOI 10.1111/j.1365-201X.2004.01329.x; Hida T, 1998, CANCER RES, V58, P3761; Ho MY, 2013, CANCER RES, V73, P439, DOI 10.1158/0008-5472.CAN-12-2220; Houghton AM, 2013, NAT REV CANCER, V13, P233, DOI 10.1038/nrc3477; Hundertmark S, 1997, J ENDOCRINOL, V155, P171, DOI 10.1677/joe.0.1550171; Jakobsen CH, 2008, J LIPID RES, V49, P2089, DOI 10.1194/jlr.M700389-JLR200; Jiang L, 2013, MOL CANC RES; Jin HR, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.122; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kamei D, 2010, BIOCHEM J, V425, P361, DOI 10.1042/BJ20090045; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Kim BM, 2011, CANCER LETT, V300, P134, DOI 10.1016/j.canlet.2010.09.014; Kim BM, 2009, INT J ONCOL, V34, P1467, DOI 10.3892/ijo_00000276; Komaki R, 2004, SEMIN ONCOL, V31, P47, DOI 10.1053/j.seminoncol.2003.12.014; Koyama K, 2001, J STEROID BIOCHEM, V76, P153, DOI 10.1016/S0960-0760(00)00157-6; Krysan K, 2004, CANCER RES, V64, P6359, DOI 10.1158/0008-5472.CAN-04-1681; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Lipka C, 2004, HORM METAB RES, V36, P437, DOI 10.1055/s-2004-825724; Mao JT, 2011, CANCER PREV RES, V4, P984, DOI 10.1158/1940-6207.CAPR-11-0078; Morita M, 2007, INT J ONCOL, V30, P187; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Qiu R, 2012, J CANCER RES CLIN, V138, P119, DOI 10.1007/s00432-011-1080-3; Rabbitt EH, 2003, J STEROID BIOCHEM, V85, P415, DOI 10.1016/S0960-0760(03)00224-3; Rioux N, 1998, CANCER RES, V58, P5354; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; Schiffelers RM, 2005, NEOPLASIA, V7, P118, DOI 10.1593/neo.04340; Schmieder A, 2012, EUR J IMMUNOL, V42, P2971, DOI 10.1002/eji.201142331; Setia S, 2012, MOL CELL BIOCHEM, V366, P89, DOI 10.1007/s11010-012-1286-y; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Stewart PM, 2009, J CLIN INVEST, V119, P760, DOI 10.1172/JCI38936; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Um HJ, 2010, INT J ONCOL, V36, P1007, DOI 10.3892/ijo_00000581; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang XQ, 2009, MOL BIOL CELL, V20, P791, DOI 10.1091/mbc.E08-07-0732; White MC, 2013, J NEUROSCI RES, V91, P393, DOI 10.1002/jnr.23169; Yang L, 2003, J CLIN INVEST, V111, P727, DOI 10.1172/JCI200316492; Yao B, 2005, AM J PHYSIOL-REG I, V288, pR1767, DOI 10.1152/ajpregu.00786.2004; Zhang MZ, 2006, P NATL ACAD SCI USA, V103, P16045, DOI 10.1073/pnas.0602176103; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398; Zhang MZ, 1999, P NATL ACAD SCI USA, V96, P15280, DOI 10.1073/pnas.96.26.15280	55	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127030	10.1371/journal.pone.0127030	http://dx.doi.org/10.1371/journal.pone.0127030			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011146	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900056
J	Fujikawa, K; Fukumori, R; Nakamura, S; Kutsukake, T; Takarada, T; Yoneda, Y				Fujikawa, Koichi; Fukumori, Ryo; Nakamura, Saki; Kutsukake, Takaya; Takarada, Takeshi; Yoneda, Yukio			Potential Interactions of Calcium-Sensitive Reagents with Zinc Ion in Different Cultured Cells	PLOS ONE			English	Article							METHYL-D-ASPARTATE; NITRIC-OXIDE; MOLECULAR-MECHANISMS; RECEPTOR; NMDA; HOMEOSTASIS; EXPRESSION; DEATH; NEUROTOXICITY; MODULATION	Background Several chemicals have been widely used to evaluate the involvement of free Ca2+ in mechanisms underlying a variety of biological responses for decades. Here, we report high reactivity to zinc of well-known Ca2+-sensitive reagents in diverse cultured cells. Methodology/Principal Findings In rat astrocytic C6 glioma cells loaded with the fluorescent Ca2+ dye Fluo-3, the addition of ZnCl2 gradually increased the fluorescence intensity in a manner sensitive to the Ca2+ chelator EGTA irrespective of added CaCl2. The addition of the Ca2+ ionophore A23187 drastically increased Fluo-3 fluorescence in the absence of ZnCl2, while the addition of the Zn2+ ionophore pyrithione rapidly and additionally increased the fluorescence in the presence of ZnCl2, but not in its absence. In cells loaded with the zinc dye FluoZin-3 along with Fluo-3, a similarly gradual increase was seen in the fluorescence of Fluo-3, but not of FluoZin-3, in the presence of both CaCl2 and ZnCl2. Further addition of pyrithione drastically increased the fluorescence intensity of both dyes, while the addition of the Zn2+ chelator N, N, N', N'-tetrakis(2-pyridylmethyl) ethane-1,2-diamine (TPEN) rapidly and drastically decreased FluoZin-3 fluorescence. In cells loaded with FluoZin-3 alone, the addition of ZnCl2 induced a gradual increase in the fluorescence in a fashion independent of added CaCl2 but sensitive to EGTA. Significant inhibition was found in the vitality to reduce 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide in a manner sensitive to TPEN, EDTA and BAPTA in C6 glioma cells exposed to ZnCl2, with pyrithione accelerating the inhibition. Similar inhibition occurred in an EGTA-sensitive fashion after brief exposure to ZnCl2 in pluripotent P19 cells, neuronal Neuro2A cells and microglial BV2 cells, which all expressed mRNA for particular zinc transporters. Conclusions/Significance Taken together, comprehensive analysis is absolutely required for the demonstration of a variety of physiological and pathological responses mediated by Ca2+ in diverse cells enriched of Zn2+.	[Fujikawa, Koichi; Fukumori, Ryo; Nakamura, Saki; Kutsukake, Takaya; Takarada, Takeshi; Yoneda, Yukio] Kanazawa Univ, Div Pharmaceut Sci, Mol Pharmacol Lab, Grad Sch Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Div Pharmaceut Sci, Mol Pharmacol Lab, Grad Sch Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 24650196]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research to TT (No. 22500330) and YY (No. 24650196) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boom A, 2004, BBA-MOL CELL RES, V1742, P161, DOI 10.1016/j.bbamcr.2004.09.011; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Chowanadisai W, 2008, BRAIN RES, V1199, P10, DOI 10.1016/j.brainres.2008.01.015; CHRISTINE CW, 1990, J NEUROSCI, V10, P108; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Fukumori R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069718; Fukumori R, 2010, J PHARMACOL SCI, V112, P273, DOI 10.1254/jphs.09294FP; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Jagt TAV, 2009, NEUROSCIENCE, V159, P104, DOI 10.1016/j.neuroscience.2008.11.052; Jing Q, 2006, J NEUROSCI, V26, P6089, DOI 10.1523/JNEUROSCI.0475-06.2006; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kambe Y, 2011, NEUROCHEM INT, V59, P10, DOI 10.1016/j.neuint.2011.03.018; Kaneko M, 2015, J NEUROSCI RES, V93, P370, DOI 10.1002/jnr.23491; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Martin JL, 2006, CELL CALCIUM, V40, P393, DOI 10.1016/j.ceca.2006.04.008; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Nakamura Y, 2012, NEUROCHEM INT, V60, P448, DOI 10.1016/j.neuint.2011.08.018; Nakazato R, 2011, J PHARMACOL SCI, V116, P350, DOI 10.1254/jphs.11069FP; Ogura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048270; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; PUSKIN JS, 1975, BIOCHEMISTRY-US, V14, P187, DOI 10.1021/bi00672a031; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; Smerin YL, 2000, J PHARMACOL EXP THER, V292, P1104; St Croix CM, 2002, AM J PHYSIOL-LUNG C, V282, pL185, DOI 10.1152/ajplung.00267.2001; Takarada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063947; Takarada T, 2009, NEUROSCI LETT, V451, P99, DOI 10.1016/j.neulet.2008.12.037; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Taniura H, 2007, BIOCHEM BIOPH RES CO, V362, P1096, DOI 10.1016/j.bbrc.2007.08.126; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; VALLEE BL, 1995, NEUROCHEM INT, V27, P23, DOI 10.1016/0197-0186(94)00165-Q; Wei W, 2008, CANCER LETT, V260, P79, DOI 10.1016/j.canlet.2007.10.025; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WOLLHEIM CB, 1975, J BIOL CHEM, V250, P1354	49	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127421	10.1371/journal.pone.0127421	http://dx.doi.org/10.1371/journal.pone.0127421			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010609	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900089
J	Gianasi, BL; Verkaik, K; Hamel, JF; Mercier, A				Gianasi, Bruno L.; Verkaik, Katie; Hamel, Jean-Francois; Mercier, Annie			Novel Use of PIT Tags in Sea Cucumbers: Promising Results with the Commercial Species Cucumaria frondosa	PLOS ONE			English	Article							HOLOTHURIA-SCABRA; GROWTH; ECHINODERMATA; INVERTEBRATES; MOVEMENT; BEHAVIOR; BIOLOGY; URCHINS	The lack of a reliable and innocuous mark-recapture method has limited studies that would provide essential information for the management of commercial sea cucumbers. Tagging sea cucumbers is notoriously difficult because of their plastic nature and autolysis capacities. The markers that have so far been tested, mainly on or through the body wall, were either lost rapidly or had major drawbacks (e.g. suitable only for batch identification, requiring complex analysis, causing infections, necrosis, behavioural changes and mortality). The present study explored the efficacy of passive integrated transponder (PIT) tags for individually marking sea cucumbers by assessing retention rates and long-term side effects of tags inserted in previously unstudied tissues/organs. Individuals of the species Cucumaria frondosa were tagged in the body wall, aquapharyngeal bulb and at the base of the oral tentacles. They were monitored closely for evidence of stress, infection, change in feeding and spawning behaviour and tag retention rate. Implanting the tag in an oral tentacle to reach the hydrovascular system of the aquapharyngeal bulb achieved the best retention rates in full-size individuals: from a maximum of 92% after 30 days to 68% at the end of the experimental period (300 days). Efficacy was lower in smaller individuals (84% after 30 d and 42% after 300 d). Following a slight increase in cloacal movements for 15 h post tagging, no side effect was noted in sea cucumbers tagged in the aquapharyngeal bulb via the tentacles. Feeding and spawning behaviours were not affected and no signs of infections or abnormal cell development in the vicinity of the tags were observed. This study indicates that marking sea cucumbers with 8.2 mm long PIT tags implanted via the oral tentacle is an effective technique, yielding relatively high retention rates over long periods without any detectable physiological or behavioural effects.	[Gianasi, Bruno L.; Verkaik, Katie; Mercier, Annie] Mem Univ Newfoundland, Dept Ocean Sci OSC, St John, NF, Canada; [Hamel, Jean-Francois] Soc Explorat & Valuing Environm, St Philips, NF, Canada	Memorial University Newfoundland	Gianasi, BL (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci OSC, St John, NF, Canada.	brunolg@mun.ca	Mercier, Annie/B-4254-2012; Gianasi, Bruno/A-5163-2018	Gianasi, Bruno/0000-0002-4215-6199; Mercier, Annie/0000-0003-0807-2378	Research & Development Corporation of Newfoundland Labrador (RDC); Department of Fisheries and Aquaculture of Newfoundland Labrador (DFA); Canadian Centre for Fisheries Innovation (CCFI)	Research & Development Corporation of Newfoundland Labrador (RDC); Department of Fisheries and Aquaculture of Newfoundland Labrador (DFA); Canadian Centre for Fisheries Innovation (CCFI)	This study was funded by Research & Development Corporation of Newfoundland & Labrador (RDC), Department of Fisheries and Aquaculture of Newfoundland & Labrador (DFA) and Canadian Centre for Fisheries Innovation (CCFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SC, 2011, FISH FISH, V12, P317, DOI 10.1111/j.1467-2979.2010.00397.x; Cieciel K, 2009, N AM J FISH MANAGE, V29, P288, DOI 10.1577/M07-194.1; Conand C., 1991, P169; Conand C., 2004, PRESENT STATUS WORLD; Conand C., 1993, US NMFS MAR FISH REV, V55, P1; DOYLE WL, 1964, Q J MICROSC SCI, V105, P7; Hagen NT, 1996, AQUACULTURE, V139, P271, DOI 10.1016/0044-8486(95)01156-0; Hamel J-F, 1996, SPC BECHE DE MER INF, V8, P22; Hamel J-F, 2008, POPULATION STATUS FI; Hamel J-F, 1996, SPC BECHE DE MER INF, V8, P34; Hamel JF, 1999, J MAR BIOL ASSOC UK, V79, P121, DOI 10.1017/S0025315498000137; Hamel JF, 1998, CAN J ZOOL, V76, P1194, DOI 10.1139/cjz-76-6-1194; Hamel JF, 1996, CAN J FISH AQUAT SCI, V53, P253, DOI 10.1139/cjfas-53-2-253; Kirshenbaum S, 2006, FISH B-NOAA, V104, P299; KROPP RK, 1982, PAC SCI, V36, P445; Lauzon-Guay JS, 2008, AQUAT BIOL, V2, P105, DOI 10.3354/ab00040; LEGAULT C, 1993, J EXP MAR BIOL ECOL, V170, P55, DOI 10.1016/0022-0981(93)90129-C; Lokani P, 1992, SPC BECHE DE MER INF, V4, P9; MacTavish T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050031; Mercier A, 2013, WOODHEAD PUBL FOOD S, P431, DOI 10.1533/9780857097460.2.431; Mercier A, 2000, HYDROBIOLOGIA, V440, P81, DOI 10.1023/A:1004121818691; Mercier A, 2009, ADV MAR BIOL, V55, P1, DOI 10.1016/S0065-2881(09)55001-8; Morgan AD, 2000, J WORLD AQUACULT SOC, V31, P186, DOI 10.1111/j.1749-7345.2000.tb00352.x; Nelson EJ, 2012, REV FISH SCI, V20, P212, DOI 10.1080/10641262.2012.719043; PRIMAVERA JH, 1992, AUST J MAR FRESH RES, V43, P737; Purcell S.W., 2012, ASIA PACIFIC TROPICA, P92; Purcell SW, 2006, J EXP MAR BIOL ECOL, V334, P283, DOI 10.1016/j.jembe.2006.02.007; Purcell SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095075; Purcell SW, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3296; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Purcell Steven W., 2008, Beche-de-mer Information Bulletin, V28, P53; Purcell SW, 2009, AQUACULTURE, V296, P263, DOI 10.1016/j.aquaculture.2009.08.027; Ramofafia C, 1997, AQUACULTURE, V152, P119, DOI 10.1016/S0044-8486(96)01525-6; Reichenbach N, 1999, B MAR SCI, V64, P103; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; Shiell GR, 2006, MAR FRESHW BEHAV PHY, V39, P153, DOI 10.1080/10236240600688789; Slater MJ, 2010, AQUAC RES, V41, pe695, DOI 10.1111/j.1365-2109.2010.02607.x; So JJ, 2010, FISHERIES MANAG ECOL, V17, P473, DOI 10.1111/j.1365-2400.2010.00747.x; So JJ, 2011, MAR BIOL, V158, P859, DOI 10.1007/s00227-010-1613-3; Uthicke S, 2004, CONSERV BIOL, V18, P1395, DOI 10.1111/j.1523-1739.2004.00309.x; Uthicke S, 2004, CAN J FISH AQUAT SCI, V61, P519, DOI 10.1139/F04-013; Uthicke S, 2002, MAR ECOL PROG SER, V241, P221, DOI 10.3354/meps241221; Wilson CD, 2011, ANIM BEHAV, V81, P341, DOI 10.1016/j.anbehav.2010.10.003	43	22	25	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127884	10.1371/journal.pone.0127884	http://dx.doi.org/10.1371/journal.pone.0127884			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011165	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900157
J	Grunert, LW; Clarke, JW; Ahuja, C; Eswaran, H; Nijhout, HF				Grunert, Laura W.; Clarke, Jameson W.; Ahuja, Chaarushi; Eswaran, Harish; Nijhout, H. Frederik			A Quantitative Analysis of Growth and Size Regulation in Manduca sexta: The Physiological Basis of Variation in Size and Age at Metamorphosis	PLOS ONE			English	Article							BODY-SIZE; TOBACCO HORNWORM; CUTICULAR MORPHOGENESIS; JUVENILE-HORMONE; PUPAL COMMITMENT; SELECTION; TEMPERATURE; MECHANISMS; FECUNDITY; INSECTS	Body size and development time are important life history traits because they are often highly correlated with fitness. Although the developmental mechanisms that control growth have been well studied, the mechanisms that control how a species-characteristic body size is achieved remain poorly understood. In insects adult body size is determined by the number of larval molts, the size increment at each molt, and the mechanism that determines during which instar larval growth will stop. Adult insects do not grow, so the size at which a larva stops growing determines adult body size. Here we develop a quantitative understanding of the kinetics of growth throughout larval life of Manduca sexta, under different conditions of nutrition and temperature, and for genetic strains with different adult body sizes. We show that the generally accepted view that the size increment at each molt is constant (Dyar's Rule) is systematically violated: there is actually a progressive increase in the size increment from instar to instar that is independent of temperature. In addition, the mass-specific growth rate declines throughout the growth phase in a temperature-dependent manner. We show that growth within an instar follows a truncated Gompertz trajectory. The critical weight, which determines when in an instar a molt will occur, and the threshold size, which determines which instar is the last, are different in genetic strains with different adult body sizes. Under nutrient and temperature stress Manduca has a variable number of larval instars and we show that this is due to the fact that more molts at smaller increments are taken before threshold size is reached. We test whether the new insight into the kinetics of growth and size determination are sufficient to explain body size and development time through a mathematical model that incorporates our quantitative findings.	[Grunert, Laura W.; Clarke, Jameson W.; Ahuja, Chaarushi; Eswaran, Harish; Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Nijhout, HF (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	hfn@duke.edu		Eswaran, Harish/0000-0001-9604-1138	National Science Foundation [IOS-0744952 EF-103859, IOS-1121065]; Division Of Integrative Organismal Systems [1121065] Funding Source: National Science Foundation; Emerging Frontiers [1038593] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation grants: IOS-0744952 EF-103859 and IOS-1121065. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; BAPTIST R, 1976, THEOR APPL GENET, V47, P209, DOI 10.1007/BF00284390; BENNETCLARK HC, 1963, J INSECT PHYSIOL, V9, P43, DOI 10.1016/0022-1910(63)90083-0; Bodenheimer FS, 1933, Q REV BIOL, V8, P92, DOI 10.1086/394427; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Callier V, 2013, BIOL REV, V88, P944, DOI 10.1111/brv.12033; Callier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045455; Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108; Davidowitz G, 2004, INTEGR COMP BIOL, V44, P443, DOI 10.1093/icb/44.6.443; Davidowitz G, 2004, EVOL ECOL RES, V6, P49; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Davidowitz G, 2012, EVOLUTION, V66, P2916, DOI 10.1111/j.1558-5646.2012.01644.x; Davidowitz Goggy, 2008, Journal of Orthoptera Research, V17, P265, DOI 10.1665/1082-6467-17.2.265; Diamond SE, 2010, ECOL ENTOMOL, V35, P166, DOI 10.1111/j.1365-2311.2009.01166.x; Dyar H. G., 1890, Psyche, Vv, P420; Esperk T, 2007, J ECON ENTOMOL, V100, P627, DOI 10.1603/0022-0493(2007)100[627:IVINOL]2.0.CO;2; Flatt T, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P1; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hutchinson JMC, 1997, PHILOS T R SOC B, V352, P113, DOI 10.1098/rstb.1997.0007; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Kingsolver JG, 2008, SIZE TEMPERATURE FIT; Kingsolver JG, 2007, P ROY SOC B-BIOL SCI, V274, P977, DOI 10.1098/rspb.2006.0036; Koyama T, 2008, DEV BIOL, V324, P258, DOI 10.1016/j.ydbio.2008.09.017; Kremen C, 1998, J INSECT PHYSIOL, V44, P287, DOI 10.1016/S0022-1910(97)00121-2; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Nijhout H F, 2006, J Biol, V5, P16, DOI 10.1186/jbiol43; Nijhout H.F., 1994, INSECT HORMONES; Nijhout HF, 2015, ANNU REV ENTOMOL, V60, P141, DOI 10.1146/annurev-ento-010814-020841; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; Oldham S, 2002, DEVELOPMENT, V129, P4103; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Roff Derek A., 1992; Sears KE, 2012, PHYSIOL BIOCHEM ZOOL, V85, P159, DOI 10.1086/664619; Shingleton AW, 2005, CURR BIOL, V15, pR825, DOI 10.1016/j.cub.2005.10.006; Stearns S.C., 1992, pi; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Tammaru T, 2007, FUNCT ECOL, V21, P1099, DOI 10.1111/j.1365-2435.2007.01319.x; Tobler A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010723; TRUMAN JW, 1974, J EXP BIOL, V60, P371; Turner TL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001336; WOLFGANG WJ, 1986, DEV BIOL, V113, P305, DOI 10.1016/0012-1606(86)90166-1; WOLFGANG WJ, 1981, TISSUE CELL, V13, P757, DOI 10.1016/S0040-8166(81)80012-2	45	31	31	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127988	10.1371/journal.pone.0127988	http://dx.doi.org/10.1371/journal.pone.0127988			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011714	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900178
J	Hoang, V; Bi, JJ; Mohankumar, SM; Vyas, AK				Hoang, Vanessa; Bi, Jiangjiang; Mohankumar, Sheba M.; Vyas, Arpita K.			Liraglutide Improves Hypertension and Metabolic Perturbation in a Rat Model of Polycystic Ovarian Syndrome	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; GLUCAGON-LIKE PEPTIDE-1; HORMONE-SECRETION; ANDROGEN EXCESS; BLOOD-PRESSURE; WOMEN; RISK; GLUCOSE; OBESITY; HYPERGLYCEMIA	Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, with a prevalence of 5-8%. Type 2 diabetes and cardiovascular disease (CVD) are its long-term complications. Targeted therapies addressing both these complications together are lacking. Glucagon like peptide-1 (GLP-1) agonists that are used to treat type 2 diabetes mellitus have beneficial effects on the cardiovascular system. Hence we hypothesized that a GLP-1 agonist would improve both cardiovascular and metabolic outcomes in PCOS. To test this hypothesis, we used an established rat model of PCOS. Prepubertal female Sprague Dawley rats were sham-implanted or implanted s.c. with dihydrotestosterone (DHT) pellets (90 day release; 83 mu g/day). At 12 wks of age, sham implanted rats received saline injections and the DHT treated animals were administered either saline or liraglutide (0.2mg/kg s.c twice daily) for 4 weeks. Subgroups of rats were implanted with telemeters between 12-13 weeks of age to monitor blood pressure. DHT implanted rats had irregular estrus cycles and were significantly heavier than the control females at 12 weeks (mean +/- SEM 251.9 +/- 3.4 vs 216.8 +/- 3.4 respectively; p<0.05) and 4 weeks of treatment with liraglutide in DHT treated rats significantly decreased body weight (mean +/- SEM 294.75 +/- 3.2 in DHT+ saline vs 276.25 +/- 2.7 in DHT+ liraglutide group respectively; p<0.01). Liraglutide treatment in the DHT implanted rats significantly improved glucose excursion during oral glucose tolerance test (area under the curve: DHT+ saline 28674 +/- 310 vs 24990 +/- 420 in DHT+ liraglutide p<0.01). DHT rats were hypertensive and liraglutide treatment significantly improved mean arterial pressure. These results suggest that GLP-1 treatment could improve DHT-induced metabolic and blood pressure deficits associated with PCOS.	[Hoang, Vanessa; Bi, Jiangjiang; Vyas, Arpita K.] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Mohankumar, Sheba M.] Univ Georgia, Dept Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA; [Bi, Jiangjiang] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Anesthesiol, Wuhan 430074, Hubei, Peoples R China	Michigan State University; University System of Georgia; University of Georgia; Huazhong University of Science & Technology	Vyas, AK (corresponding author), Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA.	Arpita.Vyas@hc.msu.edu	MohanKumar, Sheba/AAH-8075-2020	MohanKumar, Sheba/0000-0002-3365-7864	National Institutes of Health from the Office of Research on Women's Health [K12HD065879]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD065879] Funding Source: NIH RePORTER	National Institutes of Health from the Office of Research on Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Institutes of Health grant K12HD065879 (BIRCWH) from the Office of Research on Women's Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Aydin K, 2014, CLIN ENDOCRINOL, V81, P588, DOI 10.1111/cen.12468; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Beckman JA, 2002, CIRC RES, V90, P107, DOI 10.1161/hh0102.102359; Bentley-Lewis R, 2011, ENDOCRIN METAB CLIN, V40, P433, DOI 10.1016/j.ecl.2011.01.009; Birdsall MA, 1997, ANN INTERN MED, V126, P32, DOI 10.7326/0003-4819-126-1-199701010-00005; Bloomgarden AT, 2004, DIABETES CARE, V27, P2554, DOI 10.2337/diacare.27.10.2554; Carmina E, 2009, CLIMACTERIC, V12, P22, DOI 10.1080/13697130903003842; Carreau AM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0564-3; CONWAY GS, 1992, CLIN ENDOCRINOL, V37, P119, DOI 10.1111/j.1365-2265.1992.tb02295.x; Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666; Cummings BP, 2010, DIABETES, V59, P2653, DOI 10.2337/db09-1564; Daan NM, FERTILITY STERILITY; DAHLGREN E, 1992, ACTA OBSTET GYN SCAN, V71, P599, DOI 10.3109/00016349209006227; De Leo V, 2009, DRUG TODAY, V45, P763, DOI 1396674/dot.2009.45.10.1429463; DiVasta-AD, 2013, CONT OB GYN; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Flint A, 2001, INT J OBESITY, V25, P781, DOI 10.1038/sj.ijo.0801627; Holte J, 1996, HUM REPROD, V11, P23; Jensterle M, ENDOCRINE RES, V20, P1; Keller J, 2011, ENDOCRINOLOGY, V152, P4927, DOI 10.1210/en.2011-1424; King AJ, 2007, HYPERTENSION, V50, P547, DOI 10.1161/HYPERTENSIONAHA.107.090696; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Lass N, 2011, J CLIN ENDOCR METAB, V96, P3533, DOI 10.1210/jc.2011-1609; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Lovshin JA, 2014, CAN J DIABETES, V38, P364, DOI 10.1016/j.jcjd.2014.05.001; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Meyer C, 2005, J CLIN ENDOCR METAB, V90, P4630, DOI 10.1210/jc.2004-1487; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Ndefo UA, P T, V38, P336; Okerson T, 2012, CARDIOVASC THER, V30, pe146, DOI 10.1111/j.1755-5922.2010.00256.x; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; Rasmussen CB, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00140; Salley KES, 2007, J CLIN ENDOCR METAB, V92, P4546, DOI 10.1210/jc.2007-1549; Sara L, 2012, ACTA PHYSIOL HUNG, V99, P279, DOI 10.1556/APhysiol.99.2012.3.5; Sara L, GYNECOL ENDOCRINOL; Sara L, 2012, FERTIL STERIL, V97, P462, DOI 10.1016/j.fertnstert.2011.11.015; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Sever MJ, 2014, EUR J ENDOCRINOL, V170, P451, DOI 10.1530/EJE-13-0797; Sirivelu MP, 2009, HUM REPROD, V24, P718, DOI 10.1093/humrep/den434; Svendsen PF, 2009, METABOLISM, V58, P586, DOI 10.1016/j.metabol.2008.11.009; TESFAMARIAM B, 1992, AM J PHYSIOL, V263, pH321, DOI 10.1152/ajpheart.1992.263.2.H321; Verdich C, 2001, J CLIN ENDOCR METAB, V86, P4382, DOI 10.1210/jc.86.9.4382; Vilsboll T, 2009, DRUG TODAY, V45, P101, DOI 10.1358/dot.2009.45.2.1336104; Vrbikova J, 2008, EUR J ENDOCRINOL, V159, P121, DOI 10.1530/EJE-08-0097; Vrbikova J, 2009, OBESITY FACTS, V2, P26, DOI 10.1159/000194971; Vyas AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017178; Wang B, DIABETES OBESITY MET, V15, P737; Wild S, 2000, CLIN ENDOCRINOL, V52, P595, DOI 10.1046/j.1365-2265.2000.01000.x; Yanes LL, 2011, GENDER MED, V8, P103, DOI 10.1016/j.genm.2010.11.013	51	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126119	10.1371/journal.pone.0126119	http://dx.doi.org/10.1371/journal.pone.0126119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010091	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900023
J	Lemieux, B; Blanchette, M; Monette, A; Mouland, AJ; Wellinger, RJ; Chabot, B				Lemieux, Bruno; Blanchette, Marco; Monette, Anne; Mouland, Andrew J.; Wellinger, Raymund J.; Chabot, Benoit			A Function for the hnRNP A1/A2 Proteins in Transcription Elongation	PLOS ONE			English	Article							RNA-POLYMERASE-II; 7SK SNRNP; P-TEFB; A1; RIBONUCLEOPROTEIN; EXPRESSION; REVEALS; COMPONENT; CHROMATIN; MULTIPLE	The hnRNP A1 and A2 proteins regulate processes such as alternative pre-mRNA splicing and mRNA stability. Here, we report that a reduction in the levels of hnRNP A1 and A2 by RNA interference or their cytoplasmic retention by osmotic stress drastically increases the transcription of a reporter gene. Based on previous work, we propose that this effect may be linked to a decrease in the activity of the transcription elongation factor P-TEFb. Consistent with this hypothesis, the transcription of the reporter gene was stimulated when the catalytic component of P-TEFb, CDK9, was inhibited with DRB. While low levels of A1/A2 stimulated the association of RNA polymerase II with the reporter gene, they also increased the association of CDK9 with the repressor 7SK RNA, and compromised the recovery of promoter-distal transcription on the Kitlg gene after the release of pausing. Transcriptome analysis revealed that more than 50% of the genes whose expression was affected by the siRNA-mediated depletion of A1/A2 were also affected by DRB. RNA polymerase II-chromatin immunoprecipitation assays on DRB-treated and A1/A2-depleted cells identified a common set of repressed genes displaying increased occupancy of polymerases at promoter-proximal locations, consistent with pausing. Overall, our results suggest that lowering the levels of hnRNP A1/A2 elicits defective transcription elongation on a fraction of P-TEFb-dependent genes, hence favoring the transcription of P-TEFb-independent genes.	[Lemieux, Bruno; Wellinger, Raymund J.; Chabot, Benoit] Univ Sherbrooke, Fac Med & Hlth Sci, RNA Grp, Sherbrooke, PQ J1K 2R1, Canada; [Lemieux, Bruno; Wellinger, Raymund J.; Chabot, Benoit] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Microbiol & Infect Dis, Sherbrooke, PQ J1K 2R1, Canada; [Blanchette, Marco] Stowers Inst Med Res, Kansas City, MO USA; [Monette, Anne; Mouland, Andrew J.] McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada	University of Sherbrooke; University of Sherbrooke; Stowers Institute for Medical Research; Lady Davis Institute; McGill University	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, RNA Grp, Sherbrooke, PQ J1K 2R1, Canada.	benoit.chabot@usherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759; Chabot, Benoit/0000-0003-0994-0042	Canadian Institute of Health Research [MOP93917, MOP97874, MOP56794]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the Canadian Institute of Health Research (MOP93917 to BC, MOP97874 to RJW and MOP56794 to AJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Fiset S, 2001, NUCLEIC ACIDS RES, V29, P2268, DOI 10.1093/nar/29.11.2268; Flynn RL, 2011, NATURE, V471, P532, DOI 10.1038/nature09772; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Ip JY, 2011, GENOME RES, V21, P390, DOI 10.1101/gr.111070.110; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Ji X, 2013, CELL, V153, P855, DOI 10.1016/j.cell.2013.04.028; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Markert A, 2008, EMBO REP, V9, P569, DOI 10.1038/embor.2008.72; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Moldon A, 2008, NATURE, V455, P997, DOI 10.1038/nature07325; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rozen S, 2000, Methods Mol Biol, V132, P365; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Svotelis A, 2009, METHODS MOL BIOL, V543, P243, DOI 10.1007/978-1-60327-015-1_16; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Xia H, 2005, J BIOL CHEM, V280, P13171, DOI 10.1074/jbc.M414120200; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806; Zhao TT, 2009, CELL DEATH DIFFER, V16, P244, DOI 10.1038/cdd.2008.146; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	52	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126654	10.1371/journal.pone.0126654	http://dx.doi.org/10.1371/journal.pone.0126654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011126	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900037
J	Lu, LL; Zhou, J; Shi, J; Peng, XJ; Qi, XX; Wang, Y; Li, FY; Zhou, FY; Liu, L; Liu, ZQ				Lu, Linlin; Zhou, Juan; Shi, Jian; Peng, Xiao-juan; Qi, Xiao-xiao; Wang, Ying; Li, Fang-yuan; Zhou, Fu-Yuan; Liu, Liang; Liu, Zhong-Qiu			Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients	PLOS ONE			English	Article							HUMAN-LIVER; 7-ETHYL-10-HYDROXYCAMPTOTHECIN SN-38; IRINOTECAN CPT-11; GLUCURONIDATION; POLYMORPHISMS; CANCER; ENZYMES; UGT1A1; MICROSOMES; ISOFORMS	UDP-glucuronosyltransferases (UGTs), the most important enzymes in body detoxification and homeostasis maintaining, govern the glucuronidation reaction of various endogenous and environmental carcinogens. The metabolic function of UGTs can be severely influenced by hepatocellular carcinoma (HCC), the fifth prevalent and third malignant cancer worldwide. Particularly in China, HBV-positive HCC account for approximately 80% of HCC patients. But rare papers addressed the alteration on the metabolism of UGTs specific substrates, translational and transcriptional activity of UGTs in HBV-positive HCC patients. In present study, we choose the main UGT isoforms, UGT1As, UGT1A1, UGT1A9, UGT1A4 and UGT2B7, to determine the alterations of metabolic activity, protein and gene expression of UGTs in HBV-positive HCC. The corresponding specific substrates such as genistein, SN-38, tamoxifen, propofol and zidovudine were utilized respectively in UGTs metabolic activity determination. Furthermore, the plausible mechanism responsible for UGTs alterations was addressed by analyzing the protein and gene expressions in tumor and the adjacent normal tissues in HBV-positive HCC. The results revealed that in the tumor human liver microsomes (HLMs), either V-max (maximum reaction rate, R-max for UGT1A1) or the clearance rates (V-max/K-m, Clint) of UGT1A, UGT1A1, UGT1A4, UGT1A9 and UGT2B7 were significant lower than those of in the adjacent normal HLMs. Subsequently, the relative protein and gene expressions of these isoforms were notably decreased in most of tumor tissues comparing with the adjacent normal tissues. More interestingly, in tumor tissues, the metabolic activity reduction ratio of each UGT isoform was closely related to its protein reduction ratio, indicating that decreasing protein level would contribute to the reduced metabolic function of UGTs in HBV-positive HCC. In summary, our study firstly determined the alteration of UGT function in HBV-positive HCC patients, which would provide an important insight for toxicity or efficacy determination of chemotherapeutic drugs, and even bring a new strategy for clinical regimen in the health cares for the relative patients.	[Lu, Linlin; Shi, Jian; Qi, Xiao-xiao; Wang, Ying; Li, Fang-yuan; Liu, Zhong-Qiu] Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China; [Zhou, Juan; Shi, Jian; Peng, Xiao-juan; Wang, Ying; Liu, Zhong-Qiu] Southern Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Guangzhou 510515, Guangdong, Peoples R China; [Zhou, Fu-Yuan] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou 510515, Guangdong, Peoples R China; [Liu, Liang] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China	Guangzhou University of Chinese Medicine; Southern Medical University - China; Southern Medical University - China; Macau University of Science & Technology	Liu, ZQ (corresponding author), Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China.	liuzq@gzucm.edu.cn	Liu, Zhongqiu/AHC-9661-2022; Liu, Zhongqiu/ABB-8204-2021; lu, Linlin/K-6600-2016	Liu, Zhongqiu/0000-0001-6986-9677; lu, Linlin/0000-0002-9943-2422	Project of National Natural Science Foundation of China [81120108025, 81473410]; Central Platform Project from Department of Education of Guangdong Province [GDJX20141L]	Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Platform Project from Department of Education of Guangdong Province	This work was mainly supported by Project of National Natural Science Foundation of China (81120108025 and 81473410) and the Central Platform Project from Department of Education of Guangdong Province (GDJX20141L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 1998, ANN ONCOL, V9, P845, DOI 10.1023/A:1008438109725; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Barve A, 2013, NATURE, V500, P203, DOI 10.1038/nature12301; Bellemare J, 2011, J PATHOL, V223, P425, DOI 10.1002/path.2805; Chung CJ, 2013, TOXICOL LETT, V216, P16, DOI 10.1016/j.toxlet.2012.11.002; DEBINSKI HS, 1995, GASTROENTEROLOGY, V108, P1464, DOI 10.1016/0016-5085(95)90695-9; Ehmer U, 2004, HEPATOLOGY, V39, P970, DOI 10.1002/hep.20131; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; ELMOUELHI M, 1987, CANCER RES, V47, P460; Fang JL, 2002, CANCER RES, V62, P1978; Fujiwara R, 2007, DRUG METAB DISPOS, V35, P747, DOI 10.1124/dmd.106.014191; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; Gagnon JF, 2006, CLIN CANCER RES, V12, P1850, DOI 10.1158/1078-0432.CCR-05-2130; Galijatovic A, 2000, PHARMACEUT RES, V17, P21, DOI 10.1023/A:1007506222436; Guillemette C, 2014, CLIN PHARMACOL THER, V96, P324, DOI 10.1038/clpt.2014.126; Hardwick RN, 2013, DRUG METAB DISPOS, V41, P554, DOI 10.1124/dmd.112.048439; Hu DG, 2014, MOL PHARMACOL, V85, P887, DOI 10.1124/mol.114.091603; Innocenti F, 2001, DRUG METAB DISPOS, V29, P686; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Jinno H, 2003, DRUG METAB DISPOS, V31, P108, DOI 10.1124/dmd.31.1.108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Rossi L, 2010, WORLD J GASTRO ONCOL, V2, P348, DOI 10.4251/wjgo.v2.i9.348; Stingl JC, 2014, PHARMACOL THERAPEUT, V141, P92, DOI 10.1016/j.pharmthera.2013.09.002; Strassburg CP, 1997, CANCER RES, V57, P2979; Strassburg CP, 2002, GUT, V50, P851, DOI 10.1136/gut.50.6.851; Tang L, 2009, MOL PHARM, V6, P1644, DOI [10.1021/mp9000298, DOI 10.1021/MP9000298]; Tang L, 2009, MOL PHARMACEUT, V6, P1466, DOI 10.1021/mp8002557; Wang T, 2013, NUCLEIC ACIDS RES, V41, P4743, DOI 10.1093/nar/gkt178; Xu Feng, 2005, Sheng Li Ke Xue Jin Zhan, V36, P295; Ye L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096664; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhu LL, 2012, CHEM RES TOXICOL, V25, P2663, DOI 10.1021/tx300310k	35	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127524	10.1371/journal.pone.0127524	http://dx.doi.org/10.1371/journal.pone.0127524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010150	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900104
J	Schlosser, K; McIntyre, LA; White, RJ; Stewart, DJ				Schlosser, Kenny; McIntyre, Lauralyn A.; White, R. James; Stewart, Duncan J.			Customized Internal Reference Controls for Improved Assessment of Circulating MicroRNAs in Disease	PLOS ONE			English	Article							POTENTIAL BIOMARKERS; SERUM MICRORNAS; CELLS; MECHANISM; MIR-210; KIDNEY	Background Altered levels of circulating extracellular miRNA in plasma and serum have shown promise as non-invasive biomarkers of disease. However, unlike the assessment of cellular miRNA levels for which there are accepted housekeeping genes, analogous reference controls for normalization of circulating miRNA are lacking. Here, we provide an approach to identify and validate circulating miRNA reference controls on a de novo basis, and demonstrate the advantages of these customized internal controls in different disease settings. Importantly, these internal controls overcome key limitations of external spike-in controls. Methods Using a global RT-qPCR screen of 1066 miRNAs in plasma from pulmonary hypertension patients (PAH) and healthy subjects as a case example, we identified a large pool of initial candidate miRNAs that were systematically ranked according to their plasma level stability using a predefined algorithm. The performance of the top candidates was validated against multiple comparators, and in a second independent cohort of PAH and control subjects. The broader utility of this approach was demonstrated in a completely different disease setting with 372 miRNAs screened in plasma from septic shock patients and healthy controls. Results Normalization of data with specific internal reference controls significantly reduced the overall variation in circulating miRNA levels between subjects (relative to raw data), provided a more balanced distribution of up-and down-regulated miRNAs, replicated the results obtained by the benchmark geometric averaging of all detected miRNAs, and outperformed the commonly used external spike-in strategy. Conclusions We demonstrate the feasibility of identifying circulating reference controls that can reduce extraneous technical variations, and improve the assessment of disease-related changes in plasma miRNA levels. This study provides a novel conceptual framework that addresses a critical and previously unmet need if circulating miRNAs are to advance as reliable diagnostic tools in medicine.	[Schlosser, Kenny; Stewart, Duncan J.] Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [McIntyre, Lauralyn A.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [White, R. James] Univ Rochester, Aab Cardiovasc Res Inst, Rochester, NY USA; [White, R. James] Univ Rochester, Div Pulm & Crit Care Med, Rochester, NY USA; [Stewart, Duncan J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Rochester; University of Rochester; University of Ottawa	Stewart, DJ (corresponding author), Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	djstewart@ohri.ca	McIntyre, Lauralyn/AAR-7710-2021	McIntyre, Lauralyn/0000-0001-7421-1407	Canadian Institutes of Health Research [MOP57726]; CREST Ontario Research Excellence Fund [GL2-01-042]; American Heart Association [SDG-073540N]; Heart & Stroke Foundation of Canada; Entelligence Young Investigator's grant from Actelion Pharmaceuticals US, Inc.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CREST Ontario Research Excellence Fund; American Heart Association(American Heart Association); Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Entelligence Young Investigator's grant from Actelion Pharmaceuticals US, Inc.	This work was supported by the Canadian Institutes of Health Research (MOP57726 to DJS), CREST Ontario Research Excellence Fund (GL2-01-042 to DJS), American Heart Association (SDG-073540N to RJW), Heart & Stroke Foundation of Canada (KS), and the Entelligence Young Investigator's grant from Actelion Pharmaceuticals US, Inc. (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bauters C, 2013, INT J CARDIOL, V168, P1837, DOI 10.1016/j.ijcard.2012.12.074; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Liu SS, 2014, BIOMED REP, V2, P424, DOI 10.3892/br.2014.246; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Lu XY, 2013, CELL RES, V23, P1356, DOI 10.1038/cr.2013.145; Makino K, 2012, CLIN EXP DERMATOL, V37, P34, DOI 10.1111/j.1365-2230.2011.04158.x; McIntyre LA, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.007; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Schlosser K, 2013, AM J RESP CRIT CARE, V188, P1472, DOI 10.1164/rccm.201308-1403LE; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Wylie Dennis, 2011, BMC Res Notes, V4, P555, DOI 10.1186/1756-0500-4-555; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	34	32	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127443	10.1371/journal.pone.0127443	http://dx.doi.org/10.1371/journal.pone.0127443			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010841	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900091
J	Wang, YB; Jiang, Q; Yang, ZM; Sun, W; Wang, DL				Wang, Yunbo; Jiang, Qi; Yang, Zhiming; Sun, Wei; Wang, Deli			Effects of Water and Nitrogen Addition on Ecosystem Carbon Exchange in a Meadow Steppe	PLOS ONE			English	Article							RAINFALL VARIABILITY; SEASONAL WATER; TERRESTRIAL ECOSYSTEMS; EXTREME PRECIPITATION; CO2 FLUX; RESPONSES; GRASSLAND; SOIL; C-3; AVAILABILITY	A changing precipitation regime and increasing nitrogen deposition are likely to have profound impacts on arid and semiarid ecosystem C cycling, which is often constrained by the timing and availability of water and nitrogen. However, little is known about the effects of altered precipitation and nitrogen addition on grassland ecosystem C exchange. We conducted a 3-year field experiment to assess the responses of vegetation composition, ecosystem productivity, and ecosystem C exchange to manipulative water and nitrogen addition in a meadow steppe. Nitrogen addition significantly stimulated aboveground biomass and net ecosystem CO2 exchange (NEE), which suggests that nitrogen availability is a primary limiting factor for ecosystem C cycling in the meadow steppe. Water addition had no significant impacts on either ecosystem C exchange or plant biomass, but ecosystem C fluxes showed a strong correlation with early growing season precipitation, rather than whole growing season precipitation, across the 3 experimental years. After we incorporated water addition into the calculation of precipitation regimes, we found that monthly average ecosystem C fluxes correlated more strongly with precipitation frequency than with precipitation amount. These results highlight the importance of precipitation distribution in regulating ecosystem C cycling. Overall, ecosystem C fluxes in the studied ecosystem are highly sensitive to nitrogen deposition, but less sensitive to increased precipitation.	[Wang, Yunbo; Jiang, Qi; Yang, Zhiming; Sun, Wei; Wang, Deli] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Yang, Zhiming] Heilongjiang Bayi Agr Univ, Vet & Anim Sci Coll, Daqing, Heilongjiang, Peoples R China	Northeast Normal University - China; Heilongjiang Bayi Agricultural University	Sun, W (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	sunwei@nenu.edu.cn; wangd@nenu.edu.cn			National Key Basic Research Program of China [2015CB150800]; National Natural Science Foundation of China [31270445, 31230012, 31201839]; Program for New Century Excellent Talents in University [NCET-12-0814]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Key Basic Research Program of China (2015CB150800), National Natural Science Foundation of China (31270445, 31230012, 31201839), and Program for New Century Excellent Talents in University (NCET-12-0814). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba L, 2012, PLANT SOIL, V352, P143, DOI 10.1007/s11104-011-0985-6; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Baldocchi DD, 2004, AGR FOREST METEOROL, V123, P13, DOI 10.1016/j.agrformet.2003.11.006; Bates JD, 2006, J ARID ENVIRON, V64, P670, DOI 10.1016/j.jaridenv.2005.06.026; Bronikowski A, 1996, BEHAV ECOL SOCIOBIOL, V39, P27, DOI 10.1007/s002650050263; Brueck H, 2010, PLANT SOIL, V328, P495, DOI 10.1007/s11104-009-0128-5; Chen SP, 2009, GLOBAL CHANGE BIOL, V15, P2450, DOI 10.1111/j.1365-2486.2009.01879.x; Cherwin K, 2012, OECOLOGIA, V169, P845, DOI 10.1007/s00442-011-2235-2; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gerten D, 2008, GLOBAL CHANGE BIOL, V14, P2365, DOI 10.1111/j.1365-2486.2008.01651.x; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; [韩梅 HAN Mei], 2006, [生态学报, Acta Ecologica Sinica], V26, P1825; Harper CW, 2005, GLOBAL CHANGE BIOL, V11, P322, DOI 10.1111/j.1365-2486.2005.00899.x; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; IPCC, 2007, CLIMATE CHANGE 2007, DOI DOI 10.1260/095830507781076194; Jiang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045205; KEMP PR, 1980, ECOLOGY, V61, P846, DOI 10.2307/1936755; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Koerner SE, 2014, ECOLOGY, V95, P98, DOI 10.1890/13-0526.1; Koerner SE, 2014, J VEG SCI, V25, P36, DOI 10.1111/jvs.12065; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Ma LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035165; Maragni LA, 2000, AM J BOT, V87, P230, DOI 10.2307/2656910; Menge DNL, 2007, GLOBAL CHANGE BIOL, V13, P2582, DOI 10.1111/j.1365-2486.2007.01456.x; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; NIHLGARD B, 1985, AMBIO, V14, P2; Niu SL, 2008, J EXP BOT, V59, P1431, DOI 10.1093/jxb/ern051; Niu SL, 2010, GLOBAL CHANGE BIOL, V16, P144, DOI 10.1111/j.1365-2486.2009.01894.x; Niu SL, 2009, ECOSYSTEMS, V12, P915, DOI 10.1007/s10021-009-9265-1; Niu SL, 2005, J EXP BOT, V56, P2867, DOI 10.1093/jxb/eri281; Qu GuoHui, 2003, Acta Prataculturae Sinica, V12, P18; Raghuwanshi R, 2004, WORLD J MICROB BIOT, V20, P1, DOI 10.1023/B:WIBI.0000013274.14957.44; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Risch AC, 2007, BIOGEOCHEMISTRY, V86, P91, DOI 10.1007/s10533-007-9148-5; Saarnio S, 2003, ECOSYSTEMS, V6, P46, DOI 10.1007/s10021-002-0208-3; Shaver GR, 1998, ECOL MONOGR, V68, P75, DOI 10.1890/0012-9615(1998)068[0075:BACFIW]2.0.CO;2; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Tieszen L. L., 1970, Proceedings of the South Dakota Academy of Science, V49, P78; Wang ZY, 2015, PLANT SOIL, V389, P59, DOI 10.1007/s11104-014-2337-9; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Wilcox KR, 2015, GLOBAL CHANGE BIOL, V21, P335, DOI 10.1111/gcb.12673; Winslow JC, 2003, ECOL MODEL, V163, P153, DOI 10.1016/S0304-3800(02)00415-5; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Yan LM, 2011, PLANT SOIL, V349, P227, DOI 10.1007/s11104-011-0864-1; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Zeppel MJB, 2014, BIOGEOSCIENCES, V11, P3083, DOI 10.5194/bg-11-3083-2014; Zhang BC, 2013, CLIMATIC CHANGE, V118, P197, DOI 10.1007/s10584-012-0622-2; Zhang YH, 2014, GLOBAL CHANGE BIOL, V20, P3520, DOI 10.1111/gcb.12611; Zhu T, 2004, YANG CAO BIOLOGICAL, P120	57	24	27	14	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127695	10.1371/journal.pone.0127695	http://dx.doi.org/10.1371/journal.pone.0127695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010888	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900133
J	Baronchelli, A; Loreto, V; Puglisi, A				Baronchelli, Andrea; Loreto, Vittorio; Puglisi, Andrea			Individual Biases, Cultural Evolution, and the Statistical Nature of Language Universals: The Case of Colour Naming Systems	PLOS ONE			English	Article							EMERGENCE; MODELS; CATEGORIES	Language universals have long been attributed to an innate Universal Grammar. An alternative explanation states that linguistic universals emerged independently in every language in response to shared cognitive or perceptual biases. A computational model has recently shown how this could be the case, focusing on the paradigmatic example of the universal properties of colour naming patterns, and producing results in quantitative agreement with the experimental data. Here we investigate the role of an individual perceptual bias in the framework of the model. We study how, and to what extent, the structure of the bias influences the corresponding linguistic universal patterns. We show that the cultural history of a group of speakers introduces population-specific constraints that act against the pressure for uniformity arising from the individual bias, and we clarify the interplay between these two forces.	[Baronchelli, Andrea] City Univ London, Dept Math, London EC1V 0HB, England; [Loreto, Vittorio; Puglisi, Andrea] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Loreto, Vittorio] ISI, I-10126 Turin, Italy; [Loreto, Vittorio] SONY CSL, F-75005 Paris, France; [Puglisi, Andrea] CNR, ISC, I-00185 Rome, Italy	City University London; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Baronchelli, A (corresponding author), City Univ London, Dept Math, London EC1V 0HB, England.	a.baronchelli.work@gmail.com	Puglisi, Andrea/C-5566-2008; Baronchelli, Andrea/F-9550-2016	Puglisi, Andrea/0000-0002-7229-9457; Baronchelli, Andrea/0000-0002-0255-0829	EveryAware European project [265432]; DRUST project - European Science Foundation; KREYON project - Templeton Foundation [51663]	EveryAware European project; DRUST project - European Science Foundation; KREYON project - Templeton Foundation	The authors are grateful to Animesh Mukherjee and Francesca Tria for helpful discussions. V.L. acknowledges support from the EveryAware European project nr. 265432 under FP7-ICT-2009-C and DRUST project funded by the European Science Foundation under EuroUnderstanding Collaborative Research Projects and the KREYON project funded by the Templeton Foundation under contract N. 51663. SONY-CSL provided support in the form of salaries for author VL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Baronchelli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048029; Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; BEDFORD RE, 1958, J OPT SOC AM, V48, P129, DOI 10.1364/JOSA.48.000129; Belpaeme T, 2005, ADAPT BEHAV, V13, P293, DOI 10.1177/105971230501300404; Berlin B., 1969, BASIC COLOR TERMS; Bickerton D., 2009, BIOL FDN ORIGIN SYNT, P3; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; Cavagna A, 2009, PHYS REP, V476, P51, DOI 10.1016/j.physrep.2009.03.003; Chater N, 2009, P NATL ACAD SCI USA, V106, P1015, DOI 10.1073/pnas.0807191106; Chomsky N, 1995, RULES REPRESENTATION; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Comrie B., 1989, LANGUAGE UNIVERSALS, V2nd; Cook R.S., 2005, HDB CATEGORIZATION C, P223; Croft W., 2002, TYPOLOGY UNIVERSALS, DOI DOI 10.1017/CBO9780511840579; De Beule J, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P83, DOI 10.1142/9789814295222_0011; Dowman M, 2007, COGNITIVE SCI, V31, P99, DOI 10.1080/03640210709336986; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Einstein A, 1910, ANN PHYS-BERLIN, V33, P1275; Endrikhovski S, 2002, J VISION, V2, P16, DOI [10.1167/2.10.16, DOI 10.1167/2.10.16]; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Gardner Howard, 1985, MINDS NEW SCI HIST C; Griffiths TL, 2007, COGNITIVE SCI, V31, P441, DOI 10.1080/15326900701326576; Hansen J.-P., 1988, PHYS TODAY, V41, P89; Jaeger H, 2009, BIOL FDN ORIGIN SYNT, V3; Jameson K., 1997, COLOR CATEGORIES THO, P295, DOI DOI 10.1017/CBO9780511519819.014; Jameson KA, 2009, J OPT SOC AM A, V26, P1424, DOI 10.1364/JOSAA.26.001424; Jameson KA, 2009, J OPT SOC AM A, V26, P1414, DOI 10.1364/JOSAA.26.001414; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; Kay P, 1999, BEHAV BRAIN SCI, V22, P957, DOI 10.1017/S0140525X99372216; Kay P., 1991, J LINGUIST ANTHROPOL, V1, P12, DOI [10.1525/jlin.1991.1.1.12, DOI 10.1525/JLIN.1991.1.1.12]; Kirby S, 2001, IEEE T EVOLUT COMPUT, V5, P102, DOI 10.1109/4235.918430; Kirby S, 2007, P NATL ACAD SCI USA, V104, P5241, DOI 10.1073/pnas.0608222104; Komarova NI, 2008, J THEOR BIOL, V253, P680, DOI 10.1016/j.jtbi.2008.03.030; Komarova NL, 2007, J MATH PSYCHOL, V51, P359, DOI 10.1016/j.jmp.2007.06.001; Lakoff George, 1987, WOMEN FIRE, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; Loreto V, 2012, P NATL ACAD SCI USA, V109, P6819, DOI 10.1073/pnas.1113347109; Mukherjee A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016677; Murphy G., 2004, BIG BOOK CONCEPTS; Narens L, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911500226; Pinker S, 1995, LANGUAGE INSTINCT; Plumacher M, 2007, CONV EVI LANG COMMUN, V8, P61; Puglisi A, 2008, P NATL ACAD SCI USA, V105, P7936, DOI 10.1073/pnas.0802485105; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Richerson P.J, 1988, CULTURE EVOLUTIONARY; Smith A., 2010, P 8 INT C EVOLANG8; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Steels Luc, 1995, Artificial Life, V2, P319; Taylor John R., 2003, LINGUISTIC CATEGORIZ; Wilson E.O., 1975, P1; WITKOWSKI SR, 1977, AM ANTHROPOL, V79, P50, DOI 10.1525/aa.1977.79.1.02a00050; Xiao YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024994; Xu J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3073	56	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125019	10.1371/journal.pone.0125019	http://dx.doi.org/10.1371/journal.pone.0125019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018391	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600010
J	Heslehurst, N; Dinsdale, S; Sedgewick, G; Simpson, H; Sen, S; Summerbell, CD; Rankin, J				Heslehurst, Nicola; Dinsdale, Sarah; Sedgewick, Gillian; Simpson, Helen; Sen, Seema; Summerbell, Carolyn Dawn; Rankin, Judith			An Evaluation of the Implementation of Maternal Obesity Pathways of Care: A Mixed Methods Study with Data Integration	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT-GAIN; HEALTH-CARE; PREGNANCY; TRENDS; WOMEN; RISK; OVERWEIGHT; BMI; TRIANGULATION	Objectives Maternal obesity has multiple associated risks and requires substantial intervention. This research evaluated the implementation of maternal obesity care pathways from multiple stakeholder perspectives. Study Design A simultaneous mixed methods model with data integration was used. Three component studies were given equal priority. 1: Semi-structured qualitative interviews explored obese pregnant women's experiences of being on the pathways. 2: A quantitative and qualitative postal survey explored healthcare professionals' experiences of delivering the pathways. 3: A case note audit quantitatively assessed pathway compliance. Data were integrated using following a thread and convergence coding matrix methods to search for agreement and disagreement between studies. Results Study 1: Four themes were identified: women's overall (positive and negative) views of the pathways; knowledge and understanding of the pathways; views on clinical and weight management advice and support; and views on the information leaflet. Key results included positive views of receiving additional clinical care, negative experiences of risk communication, and weight management support was considered a priority. Study 2: Healthcare professionals felt the pathways were worthwhile, facilitated good practice, and increased confidence. Training was consistently identified as being required. Healthcare professionals predominantly focussed on women's response to sensitive obesity communication. Study 3: There was good compliance with antenatal clinical interventions. However, there was poor compliance with public health and postnatal interventions. There were some strong areas of agreement between component studies which can inform future development of the pathways. However, disagreement between studies included a lack of shared priorities between healthcare professionals and women, different perspectives on communication issues, and different perspectives on women's prioritisation of weight management. Conclusion The differences between healthcare professionals' and women's priorities and perspectives are important factors to consider when developing care pathways. Shared perspectives could help facilitate more effective implementation of the pathway interventions that have poor compliance.	[Heslehurst, Nicola; Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Dinsdale, Sarah] Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England; [Sedgewick, Gillian; Simpson, Helen; Sen, Seema] South Tees Hosp NHS Fdn Trust, Women & Children Ctr, Middlesbrough, Cleveland, England; [Summerbell, Carolyn Dawn] Univ Durham, Sch Med Pharm & Hlth, Stockton On Tees, Teesside, England	Newcastle University - UK; University of Teesside; Durham University	Heslehurst, N (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	nicola.heslehurst@ncl.ac.uk	Summerbell, Carolyn D/O-3759-2015; Summerbell, Carolyn D/O-3001-2015; Summerbell, Carolyn/AAC-3159-2019	Summerbell, Carolyn D/0000-0003-1910-9383; Summerbell, Carolyn D/0000-0003-1910-9383; Summerbell, Carolyn/0000-0003-1910-9383; Heslehurst, Nicola/0000-0001-8656-2319	South Tees NHS Foundation Trust Small Grant Awards; South Tees NHS Trust; Teesside University; Medical Research Council [MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-034] Funding Source: researchfish	South Tees NHS Foundation Trust Small Grant Awards; South Tees NHS Trust; Teesside University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	NH, GS and HS were awarded funding for this research by the South Tees NHS Foundation Trust Small Grant Awards (co-funded by South Tees NHS Trust and Teesside University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi N, 2013, OBES REV, V14, P68, DOI 10.1111/j.1467-789X.2012.01059.x; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bastian LA, 2010, WOMEN HEALTH ISS, V20, P133, DOI 10.1016/j.whi.2009.11.005; Bazeley P, 2009, J MIX METHOD RES, V3, P203, DOI 10.1177/1558689809334443; Brannen J, 2005, INT J SOC RES METHOD, V8, P173, DOI [DOI 10.1080/13645570500154642, 10.1080/13645570500154642]; Bristowe K, 2012, QUAL HEALTH RES, V22, P1383, DOI 10.1177/1049732312451874; Bryman A., 1995, MIXING METHODS QUALI, P58; Bryman A, 2007, J MIX METHOD RES, V1, P8, DOI 10.1177/2345678906290531; Brynhildsen J, 2006, PUBLIC HEALTH, V120, P393, DOI 10.1016/j.puhe.2005.10.015; Centre for Maternal and Child Enquiries (CMACE), 2010, MAT OB UK FIND NAT P; Clinical Negligence Scheme for Trusts, 2011, MAT CLIN RISK MAN ST; CMACE-RCOG, 2010, MAN WOM OB PREGN; Cresswell JW, 1998, QUALITATIVE INQUIRY; Creswell JW, 2004, ANN FAM MED, V2, P7, DOI 10.1370/afm.104; Denison FC, 2009, BJOG-INT J OBSTET GY, V116, P1467, DOI 10.1111/j.1471-0528.2009.02222.x; Devine F, 1999, SOCIOLOGICAL RES MET; Dillman D. A., 2014, INTERNET PHONE MAIL; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Edwards P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Farmer T, 2006, QUAL HEALTH RES, V16, P377, DOI 10.1177/1049732305285708; Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015; General Medical Council, 2009, CONF; Gore SA, 2003, ANN BEHAV MED, V26, P149, DOI 10.1207/S15324796ABM2602_07; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; Heslehurst N, 2014, OBES REV, V15, P462, DOI [10.1111/obr.12160, 10.1016/j.preghy.2014.03.017]; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Heslehurst N, 2013, HLTH EXPECTATIONS, DOI 10.111/hex.12070; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Institute of Obstetricians and Gynaecologists Health Service Executive, 2011, OB PREGN CLIN PRACT; Knight Bridget A, 2010, Nurs Times, V106, P20; Knight M, 2010, OBSTET GYNECOL, V115, P989, DOI 10.1097/AOG.0b013e3181da8f09; LaCoursiere DY, 2005, AM J OBSTET GYNECOL, V192, P832, DOI 10.1016/j.ajog.2004.11.034; Maternity & Newborn Clinical Network, 2011, STAT CLIN GUID CAR O; Moran-Ellis J, 2006, QUAL RES, V6, P45, DOI [10.1177/1468794106058870, DOI 10.1177/1468794106058870]; Morgan KL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003983; National Institute for Health and Clinical Excellence, 2008, DIAB PREGN MAN DIAB; National Institute for Health and Clinical Excellence, 2010, WEIGHT MAN PREGN; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Queensland Maternity and Neonatal Clinical Guidelines Program, 2010, CLIN GUID OB, DOI [10.1038/ijo.2010.71, DOI 10.1038/IJO.2010.71]; Ray JG, 2007, EPIDEMIOLOGY, V18, P280, DOI 10.1097/01.ede.0000254686.01126.7e; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Siega-Riz AM, 2004, NUTR REV, V62, pS105, DOI 10.1111/j.1753-4887.2004.tb00079.x; Smith D, 2011, BJOG-INT J OBSTET GY, V118, P779, DOI 10.1111/j.1471-0528.2011.02924.x; Society of Obstetricians and Gynaecologists of Canada (SOGC), 2010, J OBSTET GYNAECOL CA, V239, P165; Srivastava A, 2009, FRAMEWORK ANAL QUALI, DOI DOI 10.1002/JIA2.25572; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; Turcksin R, 2014, MATERN CHILD NUTR, V10, P166, DOI 10.1111/j.1740-8709.2012.00439.x; Watson M, 2013, AUST NZ J OBSTET GYN, V53, P243, DOI 10.1111/ajo.12031; Yeh J, 2005, AM J OBSTET GYNECOL, V193, P1994, DOI 10.1016/j.ajog.2005.05.001	55	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127122	10.1371/journal.pone.0127122	http://dx.doi.org/10.1371/journal.pone.0127122			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018338	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000355185600070
J	Jetten, J; Branscombe, NR; Haslam, SA; Haslam, C; Cruwys, T; Jones, JM; Cui, LJ; Dingle, G; Liu, J; Murphy, S; Thai, A; Walter, Z; Zhang, AR				Jetten, Jolanda; Branscombe, Nyla R.; Haslam, S. Alexander; Haslam, Catherine; Cruwys, Tegan; Jones, Janelle M.; Cui, Lijuan; Dingle, Genevieve; Liu, James; Murphy, Sean; Thai, Anh; Walter, Zoe; Zhang, Airong			Having a Lot of a Good Thing: Multiple Important Group Memberships as a Source of Self-Esteem	PLOS ONE			English	Article							SOCIAL IDENTITY; GROUP IDENTIFICATION; PERCEIVED DISCRIMINATION; PHYSICAL HEALTH; LIFE; SUPPORT; CONSEQUENCES; INTEGRATION; PREDICTORS; DEPRESSION	Membership in important social groups can promote a positive identity. We propose and test an identity resource model in which personal self-esteem is boosted by membership in additional important social groups. Belonging to multiple important group memberships predicts personal self-esteem in children (Study 1a), older adults (Study 1b), and former residents of a homeless shelter (Study 1c). Study 2 shows that the effects of multiple important group memberships on personal self-esteem are not reducible to number of interpersonal ties. Studies 3a and 3b provide longitudinal evidence that multiple important group memberships predict personal self-esteem over time. Studies 4 and 5 show that collective self-esteem mediates this effect, suggesting that membership in multiple important groups boosts personal self-esteem because people take pride in, and derive meaning from, important group memberships. Discussion focuses on when and why important group memberships act as a social resource that fuels personal self-esteem.	[Jetten, Jolanda; Haslam, S. Alexander; Haslam, Catherine; Cruwys, Tegan; Dingle, Genevieve; Murphy, Sean; Thai, Anh; Walter, Zoe] Univ Queensland, Brisbane, Qld, Australia; [Branscombe, Nyla R.] Univ Kansas, Lawrence, KS 66045 USA; [Jones, Janelle M.] Univ London, London, England; [Cui, Lijuan] E China Normal Univ, Shanghai 200062, Peoples R China; [Liu, James] Victoria Univ Wellington, Wellington, New Zealand; [Zhang, Airong] CSIRO, Brisbane, Qld, Australia	University of Queensland; University of Kansas; University of London; East China Normal University; Victoria University Wellington; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Jetten, J (corresponding author), Univ Queensland, Brisbane, Qld, Australia.	j.jetten@psy.uq.edu.au	Zhang, Airong/I-8581-2015; Haslam, Catherine/Y-5763-2018; Haslam, Alex/AAA-2512-2019; Walter, Zoe C/I-5870-2016; Cruwys, Tegan/G-2956-2014; Murphy, Sean/AAC-7531-2019	Haslam, Catherine/0000-0003-0124-9601; Haslam, Alex/0000-0001-9523-7921; Walter, Zoe C/0000-0001-8310-4021; Cruwys, Tegan/0000-0001-5296-3480; Murphy, Sean/0000-0002-6783-9906; Murphy, Sean/0000-0002-2048-0131; Jones, Janelle/0000-0002-0910-2404; Branscombe, Nyla/0000-0001-9364-9041; Dingle, Genevieve/0000-0002-4915-169X; Liu, James/0000-0001-9520-5727	Australian Research Council Future Fellowship [FT110100238]; Australian Research Council Linkage Grant [LP110200437]; Canadian Institute for Advanced Research Social Interactions, Identity and Well-Being Program	Australian Research Council Future Fellowship(Australian Research Council); Australian Research Council Linkage Grant(Australian Research Council); Canadian Institute for Advanced Research Social Interactions, Identity and Well-Being Program	This study was supported by 1. Australian Research Council Future Fellowship (FT110100238) awarded to Jolanda Jetten (see http://www.arc.gov.au) 2. Australian Research Council Linkage Grant (LP110200437) to Jolanda Jetten and Genevieve Dingle (see http://www.arc.gov.au) 3. support from the Canadian Institute for Advanced Research Social Interactions, Identity and Well-Being Program to Nyla Branscombe, S. Alexander Haslam, and Catherine Haslam (see http://www.cifar.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailis DS, 2008, SOC SCI MED, V66, P1817, DOI 10.1016/j.socscimed.2007.12.028; Baray G, 2009, BRIT J SOC PSYCHOL, V48, P625, DOI 10.1348/014466608X389582; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; BATCHAVA Y, 1994, PERS SOC PSYCHOL B, V20, P494, DOI 10.1177/0146167294205006; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Bettencourt BA, 1997, PERS SOC PSYCHOL B, V23, P955, DOI 10.1177/0146167297239005; Boden-Albala B, 2005, NEUROLOGY, V64, P1888, DOI 10.1212/01.WNL.0000163510.79351.AF; Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037/0022-3514.77.1.135; BRANSCOMBE NR, 1994, EUR J SOC PSYCHOL, V24, P641, DOI 10.1002/ejsp.2420240603; Brook AT, 2008, PERS SOC PSYCHOL B, V34, P1588, DOI 10.1177/0146167208324629; Carrington P. J., 2011, SAGE HDB SOCIAL NETW, DOI 10.4135/9781446294413; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen S, 2003, PSYCHOL SCI, V14, P389, DOI 10.1111/1467-9280.01452; Cohen S., 1985, SOCIAL SUPPORT HLTH, P3; Cole SW, 1997, J PERS SOC PSYCHOL, V72, P320, DOI 10.1037/0022-3514.72.2.320; Cooley C. H., 1902, HUMAN NATURE SOCIAL; Correll J, 2005, PERS SOC PSYCHOL REV, V9, P341, DOI 10.1207/s15327957pspr0904_4; Crabtree JW, 2010, J SOC ISSUES, V66, P553, DOI 10.1111/j.1540-4560.2010.01662.x; CROCKER J, 1990, J PERS SOC PSYCHOL, V58, P60, DOI 10.1037/0022-3514.58.1.60; CROCKER J, 1994, PERS SOC PSYCHOL B, V20, P503, DOI 10.1177/0146167294205007; Cruwys T, 2014, PERS SOC PSYCHOL REV, V18, P215, DOI 10.1177/1088868314523839; Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013; De Cremer D, 2006, GROUP DYN-THEOR RES, V10, P233, DOI 10.1037/1089-2699.10.3.233; DiMaggio P, 2012, FACING SOCIAL CLASS: HOW SOCIETAL RANK INFLUENCES INTERACTION, P15; DOOSJE B, 1995, J EXP SOC PSYCHOL, V31, P410, DOI 10.1006/jesp.1995.1018; Durkheim E., 1951, SUICIDE STUDY SOCIOL; Emler N, 2003, SELF ESTEEM YOUTH DE, P1; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Haslam C, 2014, SOC SCI MED, V120, P57, DOI 10.1016/j.socscimed.2014.08.037; Haslam C, 2010, PSYCHOL AGING, V25, P157, DOI 10.1037/a0018256; Haslam S.A., 2002, STEREOTYPES EXPLANAT, P157; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; Helliwell JF, 2003, ECON MODEL, V20, P331, DOI 10.1016/S0264-9993(02)00057-3; Hogg, 1990, SOCIAL IDENTITY THEO, P28; Hogg M. A., 2011, HDB THEORIES SOCIAL, V2, P62, DOI DOI 10.4135/9781446249222.N29; HOGG MA, 1987, BRIT J SOC PSYCHOL, V26, P325, DOI 10.1111/j.2044-8309.1987.tb00795.x; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Iyer A, 2009, BRIT J SOC PSYCHOL, V48, P707, DOI 10.1348/014466608X397628; Jackman M.R., 1983, CLASS AWARENESS US; Jetten J, 1997, EUR J SOC PSYCHOL, V27, P635, DOI 10.1002/(SICI)1099-0992(199711/12)27:6<635::AID-EJSP835>3.0.CO;2-#; Jetten J, 2001, PERS SOC PSYCHOL B, V27, P1204, DOI 10.1177/0146167201279012; Jetten J, 2001, EUR J SOC PSYCHOL, V31, P621, DOI 10.1002/ejsp.72; Jetten J., 2012, SOCIAL CURE IDENTITY; Jetten J, 2008, EUR J SOC PSYCHOL, V38, P866, DOI 10.1002/ejsp.471; Jetten J, 2014, SOC ISS POLICY REV, V8, P103, DOI 10.1111/sipr.12003; Jetten J, 2013, SOC PSYCHOL PERS SCI, V4, P6, DOI 10.1177/1948550612439721; Jetten J, 2010, J CLIN EXP NEUROPSYC, V32, P408, DOI 10.1080/13803390903140603; Jones JM, 2011, SOC PSYCHOL PERS SCI, V2, P239, DOI 10.1177/1948550610386806; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Leary MR, 1999, CURR DIR PSYCHOL SCI, V8, P32, DOI 10.1111/1467-8721.00008; Leary MR, 2003, PSYCHOL INQ, V14, P52; LEE VE, 1989, SOCIOL EDUC, V62, P172, DOI 10.2307/2112866; Lewin K., 1948, RESOLVING SOCIAL CON; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; LUHTANEN R, 1992, PERS SOC PSYCHOL B, V18, P302, DOI 10.1177/0146167292183006; Luhtanen R., 1991, SOCIAL COMP CONT THE, P211; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; Nario-Redmond MR, 2013, SELF IDENTITY, V12, P468, DOI 10.1080/15298868.2012.681118; PHINNEY JS, 1990, PSYCHOL BULL, V108, P499, DOI 10.1037/0033-2909.108.3.499; Postmes T., 2006, INDIVIDUALITY GROUP, DOI 10.4135/9781446211946.n13; Putnam R., 2000, BOWLING ALONE COLLAP; Rafaeli-Mor E, 2002, PERS SOC PSYCHOL REV, V6, P31, DOI 10.1207/S15327957PSPR0601_2; Reynolds KJ, 2010, EUR J PERSONALITY, V24, P501, DOI 10.1002/per.784; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Roccas S, 2003, EUR J SOC PSYCHOL, V33, P351, DOI 10.1002/ejsp.151; Rosenberg M., 2001, EXENDING SELF ESTEEM, P400, DOI [10.1017/CBO9780511527739.018, DOI 10.1017/CBO9780511527739.018]; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Rowley SJ, 1998, J PERS SOC PSYCHOL, V74, P715, DOI 10.1037/0022-3514.74.3.715; Rubin M, 1998, Pers Soc Psychol Rev, V2, P40, DOI 10.1207/s15327957pspr0201_3; Sani F, 2012, BRIT J SOC PSYCHOL, V51, P781, DOI 10.1111/j.2044-8309.2012.02101.x; Schmitt MT, 2014, PSYCHOL BULL, V140, P921, DOI 10.1037/a0035754; Schmitt MT, 2002, PERS SOC PSYCHOL B, V28, P197, DOI 10.1177/0146167202282006; Spears R, 2002, SELF AND MOTIVATION: EMERGING PSYCHOLOGICAL PERSPECTIVES, P147, DOI 10.1037/10448-006; Tafarodi RW, 2001, PERS INDIV DIFFER, V31, P653, DOI 10.1016/S0191-8869(00)00169-0; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; THOITS PA, 1991, SOC PSYCHOL QUART, V54, P101, DOI 10.2307/2786929; Thoits PA, 2003, ADVANCES IN IDENTITY THEORY AND RESEARCH, P179, DOI 10.1007/978-1-4419-9188-1_13; Turner JC, 2006, INDIVIDUALITY GROUP, P1; Turner John C., 1982, SOCIAL IDENTITY INTE, P15, DOI DOI 10.1016/J.VACCINE.2011.08.002; Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Vygotsky L.S., 1981, CONCEPT ACTIVITY SOV, P144; WANN DL, 1993, INT J SPORT PSYCHOL, V24, P1	92	154	156	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124609	10.1371/journal.pone.0124609	http://dx.doi.org/10.1371/journal.pone.0124609			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017554	Green Published, gold			2022-12-27	WOS:000355185600005
J	Lingelem, ABD; Hjelseth, IA; Simm, R; Torgersen, ML; Sandvig, K				Lingelem, Anne Berit Dyve; Hjelseth, Ieva Ailte; Simm, Roger; Torgersen, Maria Lyngaas; Sandvig, Kirsten			Geldanamycin Enhances Retrograde Transport of Shiga Toxin in HEp-2 Cells	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; ACTIN-FILAMENT DYNAMICS; TO-GOLGI TRANSPORT; HEAT-SHOCK; ENDOPLASMIC-RETICULUM; KINASE CASCADE; EARLY-ENDOSOME; COMPLEX; P38; PHOSPHORYLATION	The heat shock protein 90 (Hsp90) inhibitor geldanamycin (GA) has been shown to alter endosomal sorting, diverting cargo destined for the recycling pathway into the lysosomal pathway. Here we investigated whether GA also affects the sorting of cargo into the retrograde pathway from endosomes to the Golgi apparatus. As a model cargo we used the bacterial toxin Shiga toxin, which exploits the retrograde pathway as an entry route to the cytosol. Indeed, GA treatment of HEp-2 cells strongly increased the Shiga toxin transport to the Golgi apparatus. The enhanced Golgi transport was not due to increased endocytic uptake of the toxin or perturbed recycling, suggesting that GA selectively enhances endosomal sorting into the retrograde pathway. Moreover, GA activated p38 and both inhibitors of p38 or its substrate MK2 partially counteracted the GA-induced increase in Shiga toxin transport. Thus, our data suggest that GA-induced p38 and MK2 activation participate in the increased Shiga toxin transport to the Golgi apparatus.	[Lingelem, Anne Berit Dyve; Hjelseth, Ieva Ailte; Simm, Roger; Torgersen, Maria Lyngaas; Sandvig, Kirsten] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Lingelem, Anne Berit Dyve; Hjelseth, Ieva Ailte; Simm, Roger; Torgersen, Maria Lyngaas; Sandvig, Kirsten] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Hjelseth, Ieva Ailte; Sandvig, Kirsten] Univ Oslo, Dept Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Sandvig, K (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway.	ksandvig@radium.uio.no	Torgersen, Maria Lyngaas/O-6240-2019; Torgersen, Maria Lyngaas L/F-3492-2017; Simm, Roger/AAN-8965-2020	Torgersen, Maria Lyngaas/0000-0003-2616-7194; Torgersen, Maria Lyngaas L/0000-0003-2616-7194; Simm, Roger/0000-0001-5187-2456	Norwegian Cancer Society; Research Council of Norway through Centres of Excellence funding scheme [179571]; South-Eastern Norway Regional Health Authority; University of Oslo	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway through Centres of Excellence funding scheme; South-Eastern Norway Regional Health Authority; University of Oslo	This work was supported by grants from the Norwegian Cancer Society, the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571, the South-Eastern Norway Regional Health Authority and the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bergan J, 2012, TOXICON, V60, P1085, DOI 10.1016/j.toxicon.2012.07.016; Breusegem SY, 2014, METHOD ENZYMOL, V534, P155, DOI 10.1016/B978-0-12-397926-1.00009-3; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Correa Sonia A L, 2012, J Signal Transduct, V2012, P649079, DOI 10.1155/2012/649079; Cortese K, 2013, MOL BIOL CELL, V24, P129, DOI 10.1091/mbc.E12-04-0282; Doshi BM, 2010, ANN NY ACAD SCI, V1197, P76, DOI 10.1111/j.1749-6632.2010.05191.x; Dyve AB, 2009, BIOCHEM BIOPH RES CO, V390, P109, DOI 10.1016/j.bbrc.2009.09.076; EIKLID K, 1980, J RECEPTOR RES, V1, P199, DOI 10.3109/10799898009044098; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Fukuyo Y, 2010, CANCER LETT, V290, P24, DOI 10.1016/j.canlet.2009.07.010; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; Guay J, 1997, J CELL SCI, V110, P357; Hong DS, 2013, CANCER TREAT REV, V39, P375, DOI 10.1016/j.ctrv.2012.10.001; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Kvalvaag AS, 2013, TRAFFIC, V14, P839, DOI 10.1111/tra.12077; Laufman O, 2011, J CELL BIOL, V194, P459, DOI 10.1083/jcb.201102045; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Ota A, 2010, CIRC RES, V106, P1404, DOI 10.1161/CIRCRESAHA.109.213769; Patki JM, 2013, PATHOL ONCOL RES, V19, P631, DOI 10.1007/s12253-013-9675-4; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rosenhagen MC, 2001, BIOL CHEM, V382, P499, DOI 10.1515/BC.2001.063; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sandvig K, 2014, PROG LIPID RES, V54, P1, DOI 10.1016/j.plipres.2014.01.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Skanland SS, 2009, CELL MICROBIOL, V11, P796, DOI 10.1111/j.1462-5822.2009.01292.x; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Tcatchoff L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040429; Tekle C, 2008, NANO LETT, V8, P1858, DOI 10.1021/nl0803848; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Utskarpen A, 2006, TRAFFIC, V7, P663, DOI 10.1111/j.1600-0854.2006.00418.x; Utskarpen A, 2007, BIOCHEM BIOPH RES CO, V358, P566, DOI 10.1016/j.bbrc.2007.04.159; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; Zheng CL, 2006, J BIOL CHEM, V281, P37215, DOI 10.1074/jbc.M603622200; Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003	54	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0129214	10.1371/journal.pone.0129214	http://dx.doi.org/10.1371/journal.pone.0129214			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017782	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600127
J	Milde, C; Rance, M; Kirsch, P; Trojan, J; Fuchs, X; Foell, J; Bekrater-Bodmann, R; Flor, H; Diers, M				Milde, Christopher; Rance, Mariela; Kirsch, Pinar; Trojan, Joerg; Fuchs, Xaver; Foell, Jens; Bekrater-Bodmann, Robin; Flor, Herta; Diers, Martin			Do Mirror Glasses Have the Same Effect on Brain Activity as a Mirror Box? Evidence from a Functional Magnetic Resonance Imaging Study with Healthy Subjects	PLOS ONE			English	Article							HAND MOVEMENTS; VISUAL FEEDBACK; MOTOR RECOVERY; THERAPY; ILLUSION; STROKE; PAIN; CONNECTIVITY; OPTIMIZATION; EXCITABILITY	Since its original proposal, mirror therapy has been established as a successful neurorehabilitative intervention in several neurological disorders to recover motor function or to relieve pain. Mirror therapy seems to operate by reactivating the contralesional representation of the non-mirrored limb in primary motor-and somatosensory cortex. However, mirror boxes have some limitations which prompted the use of additional mirror visual feedback devices. The present study evaluated the utility of mirror glasses compared to a mirror box. We also tested the hypothesis that increased interhemispheric communication between the motor hand areas is the mechanism by which mirror visual feedback recruits the representation of the non-mirrored limb. Therefore, mirror illusion capacity and brain activations were measured in a within-subject design during both mirror visual feedback conditions in counterbalanced order with 20 healthy subjects inside a magnetic resonance imaging scanner. Furthermore, we analyzed task-dependent functional connectivity between motor hand representations using psychophysiological interaction analysis during both mirror tasks. Neither the subjective quality of mirror illusions nor the patterns of functional brain activation differed between the mirror tasks. The sensorimotor representation of the non-mirrored hand was recruited in both mirror tasks. However, a significant increase in interhemispheric connectivity between the hand areas was only observed in the mirror glasses condition, suggesting different mechanisms for the recruitment of the representation of the non-mirrored hand in the two mirror tasks. We conclude that the mirror glasses might be a promising alternative to the mirror box, as they induce similar patterns of brain activation. Moreover, the mirror glasses can be easy applied in therapy and research. We want to emphasize that the neuronal mechanisms for the recruitment of the affected limb representation might differ depending on conceptual differences between MVF devices. However, our findings need to be validated within specific patient groups.	[Milde, Christopher; Rance, Mariela; Kirsch, Pinar; Trojan, Joerg; Fuchs, Xaver; Foell, Jens; Bekrater-Bodmann, Robin; Flor, Herta; Diers, Martin] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany; [Trojan, Joerg] Univ Koblenz Landau, Biol Psychol, Landau, Germany; [Foell, Jens] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Koblenz & Landau; State University System of Florida; Florida State University	Diers, M (corresponding author), Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany.	martin.diers@zi-mannheim.de	Diers, Martin/M-9155-2013; Trojan, Jörg/C-1616-2009; Fuchs, Xaver/HCI-1160-2022	Diers, Martin/0000-0002-3257-7299; Trojan, Jörg/0000-0003-4110-2647; Flor, Herta/0000-0003-4809-5398	PHANTOMMIND project - European Community [230249]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within funding programme Open Access Publishing	PHANTOMMIND project - European Community; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within funding programme Open Access Publishing	This research was supported by "Phantom phenomena: A window to the mind and the brain" (PHANTOMMIND project), which receives research funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement No. 230249 to Herta Flor. This manuscript reflects only the authors' views and the Community is not liable for any use that may be made of the information contained therein (URL: http://erc.europa.eu/projects-and-results/erc-funded-projects/phantommind? retain-filters=1). The authors also acknowledge financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler EL, 2008, SCAND J PLAST RECONS, V42, P110, DOI 10.1080/02844310701510355; Andersson J.L.R, 2007, TR07JA2 FMRIB; Chan BL, 2007, NEW ENGL J MED, V357, P2206, DOI 10.1056/NEJMc071927; Deconinck FJA, 2014, NEUROREHABILITATION, P1; Diers M, 2015, BRAIN RES, V1594, P173, DOI 10.1016/j.brainres.2014.11.001; Diers M, 2010, PAIN, V149, P296, DOI 10.1016/j.pain.2010.02.020; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Ezendam D, 2009, DISABIL REHABIL, V31, P2135, DOI 10.3109/09638280902887768; Foell J, 2014, EUR J PAIN, V18, P729, DOI 10.1002/j.1532-2149.2013.00433.x; Fotopoulou A, 2011, NEUROPSYCHOLOGIA, V49, P3946, DOI 10.1016/j.neuropsychologia.2011.10.011; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fukumura K, 2007, INT J NEUROSCI, V117, P1039, DOI 10.1080/00207450600936841; Garry MI, 2005, EXP BRAIN RES, V163, P118, DOI 10.1007/s00221-005-2226-9; Giraux P, 2003, NEUROIMAGE, V20, pS107, DOI 10.1016/j.neuroimage.2003.09.024; Hadoush H, 2013, NEUROREHABILITATION, V32, P617, DOI 10.3233/NRE-130884; Hamzei F, 2012, NEUROREHAB NEURAL RE, V26, P484, DOI 10.1177/1545968311427917; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Lappchen CH, 2012, J NEUROPHYSIOL, V108, P2857, DOI 10.1152/jn.00321.2012; Liepert J, 2001, CLIN NEUROPHYSIOL, V112, P114, DOI 10.1016/S1388-2457(00)00503-4; Lotze M, 2001, BRAIN, V124, P2268, DOI 10.1093/brain/124.11.2268; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Maeda F, 2014, J NEUROPHYSIOL, V87, P1329; Matthys K, 2009, ARCH PHYS MED REHAB, V90, P675, DOI 10.1016/j.apmr.2008.09.571; McCabe CS, 2008, CURR PAIN HEADACHE R, V12, P103, DOI 10.1007/s11916-008-0020-7; McCabe CS, 2003, RHEUMATOLOGY, V42, P97, DOI 10.1093/rheumatology/keg041; Michielsen ME, 2011, NEUROREHAB NEURAL RE, V25, P223, DOI 10.1177/1545968310385127; Moseley GL, 2008, PAIN, V138, P7, DOI 10.1016/j.pain.2008.06.026; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nojima I, 2013, EXP BRAIN RES, V227, P79, DOI 10.1007/s00221-013-3486-4; Nojima I, 2012, J NEUROSCI, V32, P1293, DOI 10.1523/JNEUROSCI.5364-11.2012; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; RAMACHANDRAN VS, 1992, NEUROREPORT, V3, P583, DOI 10.1097/00001756-199207000-00009; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Sathian K, 2000, NEUROREHAB NEURAL RE, V14, P73, DOI 10.1177/154596830001400109; SHEEHAN PW, 1967, J CLIN PSYCHOL, V23, P386, DOI 10.1002/1097-4679(196707)23:3<386::AID-JCLP2270230328>3.0.CO;2-S; Shinoura N, 2008, NEUROREHABILITATION, V23, P245; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stephan KE, 2010, WIRES COGN SCI, V1, P446, DOI 10.1002/wcs.58; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Sutbeyaz S, 2007, ARCH PHYS MED REHAB, V88, P555, DOI 10.1016/j.apmr.2007.02.034; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Walsh G, 2010, OPTOMETRY VISION SCI, V87, P971, DOI 10.1097/OPX.0b013e3181fcabc3; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Yavuzer G, 2008, ARCH PHYS MED REHAB, V89, P393, DOI 10.1016/j.apmr.2007.08.162	49	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127694	10.1371/journal.pone.0127694	http://dx.doi.org/10.1371/journal.pone.0127694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018572	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600092
J	Renosh, PR; Schmitt, FG; Loisel, H				Renosh, P. R.; Schmitt, Francois G.; Loisel, Hubert			Scaling Analysis of Ocean Surface Turbulent Heterogeneities from Satellite Remote Sensing: Use of 2D Structure Functions	PLOS ONE			English	Article							MULTIFRACTAL ANALYSIS; TEMPERATURE; PHYTOPLANKTON; EXAMPLE	Satellite remote sensing observations allow the ocean surface to be sampled synoptically over large spatio-temporal scales. The images provided from visible and thermal infrared satellite observations are widely used in physical, biological, and ecological oceanography. The present work proposes a method to understand the multi-scaling properties of satellite products such as the Chlorophyll-a (Chl-a), and the Sea Surface Temperature (SST), rarely studied. The specific objectives of this study are to show how the small scale heterogeneities of satellite images can be characterised using tools borrowed from the fields of turbulence. For that purpose, we show how the structure function, which is classically used in the frame of scaling time series analysis, can be used also in 2D. The main advantage of this method is that it can be applied to process images which have missing data. Based on both simulated and real images, we demonstrate that coarse-graining (CG) of a gradient modulus transform of the original image does not provide correct scaling exponents. We show, using a fractional Brownian simulation in 2D, that the structure function (SF) can be used with randomly sampled couple of points, and verify that 1 million of couple of points provides enough statistics.	[Renosh, P. R.; Schmitt, Francois G.; Loisel, Hubert] Univ Lille, ULCO, LOG CNRS, Lab Oceanol & Geosci,UMR 8187, Wimereux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale	Schmitt, FG (corresponding author), Univ Lille, ULCO, LOG CNRS, Lab Oceanol & Geosci,UMR 8187, Wimereux, France.	francois.schmitt@log.cnrs.fr	Renosh, P. R./H-6665-2019; Schmitt, François G./A-1999-2009	Renosh, P. R./0000-0001-5075-6744; Schmitt, François G./0000-0001-6733-0598	Centre National de la Recherche Scientifique; Centre National d'Etudes Spatiales	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	PRR received funding for his PhD thesis from Centre National de la Recherche Scientifique (http://www.cnrs.fr) and Centre National d'Etudes Spatiales (http://www.cnes;fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barriere O, 2007, THESIS U NANTES; CORRSIN S, 1951, J APPL PHYS, V22, P469, DOI 10.1063/1.1699986; de Montera L, 2011, OCEAN SCI, V7, P219, DOI 10.5194/os-7-219-2011; FRISCH U, 1978, J FLUID MECH, V87, P719, DOI 10.1017/S0022112078001846; Frisch U., 1995, TURBULENCE LEGACY AN; Kamont A, 1996, J PROBABILITY MATH S, V16, P85; Kolmogoroff AN, 1941, CR ACAD SCI URSS, V32, P16; Kolmogorov A.N., 1940, DOKL AKAD NAUK SSSR, V26, P115; KOLMOGOROV AN, 1962, J FLUID MECH, V13, P82, DOI 10.1017/S0022112062000518; Lovejoy S, 2001, INT J REMOTE SENS, V22, P1191, DOI 10.1080/01431160151144314; Lovejoy S, 2001, J PLANKTON RES, V23, P117, DOI 10.1093/plankt/23.2.117; Lovejoy S., 2013, The Weather and Climate: Emergent Laws and Multifractal Cascades; MANDELBROT BB, 1974, J FLUID MECH, V62, P331, DOI 10.1017/S0022112074000711; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Nicolis O, 2011, COMPUT STAT DATA AN, V55, P738, DOI 10.1016/j.csda.2010.06.020; Nieves V, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030823; Novikov E. A., 1964, IZVEST AKAD NAUK USS, V3, P408; Oboukhov A. M., 1949, IZV AKAD NAUK SSS GG, V13, P58; OBOUKHOV AM, 1962, J FLUID MECH, V13, P77, DOI 10.1017/S0022112062000506; Obukhov A., 1941, DOKL AKAD NAUK SSSR, V32, P22; SCHERTZER D, 1989, E MAJ INT S, V45, P49; Schertzer D, 1997, FRACTALS, V5, P427, DOI 10.1142/S0218348X97000371; SCHERTZER D, 1992, PHYSICA A, V185, P187, DOI 10.1016/0378-4371(92)90455-Y; Schmitt F, 1996, EUROPHYS LETT, V34, P195, DOI 10.1209/epl/i1996-00438-4; Seuront L, 1996, GEOPHYS RES LETT, V23, P3591, DOI 10.1029/96GL03473; Seuront L, 1996, NONLINEAR PROC GEOPH, V3, P236, DOI 10.5194/npg-3-236-1996; Seuront L, 1999, J PLANKTON RES, V21, P877, DOI 10.1093/plankt/21.5.877; Turiel A, 2005, IEEE GEOSCI REMOTE S, V2, P447, DOI 10.1109/LGRS.2005.852712; Turiel A, 2009, OCEAN SCI, V5, P447, DOI 10.5194/os-5-447-2009; Verrier S, 2014, J GEOPHYS RES-OCEANS, V119, P6444, DOI 10.1002/2014JC009811; Yahia H, 2008, INT J REMOTE SENS, V29, P4189, DOI 10.1080/01431160701840174	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126975	10.1371/journal.pone.0126975	http://dx.doi.org/10.1371/journal.pone.0126975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017551	Green Published, gold			2022-12-27	WOS:000355185600065
J	Sidhu, DM; Pexman, PM				Sidhu, David M.; Pexman, Penny M.			What's in a Name? Sound Symbolism and Gender in First Names	PLOS ONE			English	Article							TAKETE-MALUMA PHENOMENON; PHONETIC SYMBOLISM; CROSSMODAL CORRESPONDENCES; SHAPE CORRESPONDENCES; BRAND-NAME; ATTRACTIVENESS; CONSONANTS; MASCULINE; PHONOLOGY; LANGUAGES	Although the arbitrariness of language has been considered one of its defining features, studies have demonstrated that certain phonemes tend to be associated with certain kinds of meaning. A well-known example is the Bouba/Kiki effect, in which nonwords like bouba are associated with round shapes while nonwords like kiki are associated with sharp shapes. These sound symbolic associations have thus far been limited to nonwords. Here we tested whether or not the Bouba/Kiki effect extends to existing lexical stimuli; in particular, real first names. We found that the roundness/sharpness of the phonemes in first names impacted whether the names were associated with round or sharp shapes in the form of character silhouettes (Experiments 1a and 1b). We also observed an association between femaleness and round shapes, and maleness and sharp shapes. We next investigated whether this association would extend to the features of language and found the proportion of round-sounding phonemes was related to name gender (Analysis of Category Norms). Finally, we investigated whether sound symbolic associations for first names would be observed for other abstract properties; in particular, personality traits (Experiment 2). We found that adjectives previously judged to be either descriptive of a figuratively 'round' or a 'sharp' personality were associated with names containing either round-or sharp-sounding phonemes, respectively. These results demonstrate that sound symbolic associations extend to existing lexical stimuli, providing a new example of non-arbitrary mappings between form and meaning.	[Sidhu, David M.; Pexman, Penny M.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada	University of Calgary	Sidhu, DM (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	dsidhu@ucalgary.ca		Pexman, Penny/0000-0001-7130-0973	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 217309-2013]; Alberta Innovates [201500125] Funding Source: researchfish	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates	This work was supported by the Natural Sciences and Engineering Research Council (NSERC; http://www.nserc-crsng.gc.ca) of Canada under Discovery Grant # RGPIN 217309-2013 to PMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlner F, 2010, SIGN SYST STUD, P298; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Bremner AJ, 2013, COGNITION, V126, P165, DOI 10.1016/j.cognition.2012.09.007; Cassidy KW, 1999, J EXP PSYCHOL GEN, V128, P362, DOI 10.1037/0096-3445.128.3.362; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; CUTLER A, 1990, J LINGUIST, V26, P471, DOI 10.1017/S0022226700014754; DAVIS R, 1961, BRIT J PSYCHOL, V52, P259, DOI 10.1111/j.2044-8295.1961.tb00788.x; Dixson AF, 2003, ARCH SEX BEHAV, V32, P29, DOI 10.1023/A:1021889228469; Flumini A, 2014, J MEM LANG, V76, P47, DOI 10.1016/j.jml.2014.06.004; Gallace A, 2011, COGN NEUROSCI-UK, V2, P34, DOI 10.1080/17588928.2010.516820; Hanson-Vaux G, 2013, CHEM SENSES, V38, P161, DOI 10.1093/chemse/bjs087; Hockett C.F., 1963, UNIVERSALS LANGUAGE, P1; Hough C, 2000, J LINGUIST, V36, P1, DOI 10.1017/S0022226799007975; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kantner J, 2014, CAN J EXP PSYCHOL, V68, P163, DOI 10.1037/cep0000023; KEATING CF, 1985, SOC PSYCHOL QUART, V48, P61, DOI 10.2307/3033782; Klink RR, 2003, MARKET LETT, V14, P143, DOI 10.1023/A:1027476132607; Kohler W., 1929, GESTALT PSYCHOL; Kovic V, 2010, COGNITION, V114, P19, DOI 10.1016/j.cognition.2009.08.016; Lee K, 2004, MULTIVAR BEHAV RES, V39, P329, DOI 10.1207/s15327906mbr3902_8; Lee K, 2008, J PERS, V76, P1001, DOI 10.1111/j.1467-6494.2008.00512.x; Lowrey TM, 2007, J CONSUM RES, V34, P406, DOI 10.1086/518530; LYMAN B, 1979, PERCEPT MOTOR SKILL, V49, P839, DOI 10.2466/pms.1979.49.3.839; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Nielsen A, 2011, CAN J EXP PSYCHOL, V65, P115, DOI 10.1037/a0022268; Nielsen AKS, 2013, CAN J EXP PSYCHOL, V67, P153, DOI 10.1037/a0030553; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6; Perniss P, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00227; Pitcher BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064825; R Core Team, 2010, R LANG ENV STAT COMP; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; RICE P C, 1981, Journal of Anthropological Research, V37, P402; Sapir E, 1929, J EXP PSYCHOL, V12, P225, DOI 10.1037/h0070931; Saussure F. de., 1983, COURSE GEN LINGUISTI; Shakespeare, 1984, ROMEO JULIET; SLATER AS, 1985, SEX ROLES, V13, P429, DOI 10.1007/BF00287953; TAYLOR IK, 1962, CAN J PSYCHOLOGY, V16, P344, DOI 10.1037/h0083261; Topolinski S, 2014, J PERS SOC PSYCHOL, V106, P885, DOI 10.1037/a0036477; Tremblay A., 2015, PACKAGE LMER CONVENI; Van Overschelde JP, 2004, J MEM LANG, V50, P289, DOI 10.1016/j.jml.2003.10.003; Westbury C, 2005, BRAIN LANG, V93, P10, DOI 10.1016/j.bandl.2004.07.006; Yorkston E, 2004, J CONSUM RES, V31, P43, DOI 10.1086/383422	43	31	31	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126809	10.1371/journal.pone.0126809	http://dx.doi.org/10.1371/journal.pone.0126809			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CJ0RO	26016856	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600060
J	Trousselard, M; Leger, D; van Beers, P; Coste, O; Vicard, A; Pontis, J; Crosnier, SN; Chennaoui, M				Trousselard, Marion; Leger, Damien; van Beers, Pascal; Coste, Olivier; Vicard, Arnaud; Pontis, Julien; Crosnier, Sylvain-Nicolas; Chennaoui, Mounir			Sleeping under the Ocean: Despite Total Isolation, Nuclear Submariners Maintain Their Sleep and Wake Patterns throughout Their Under Sea Mission	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; SHIFT WORK; LIGHT; DISORDERS; ALERTNESS; BLIND; TIME; POLYSOMNOGRAPHY; TEMPERATURE; PARAMETERS	Background To assess the effects of isolation, inadequate exposure to light and specific shift work on the subjective and objective measurements of sleep and alertness of submariners. Purpose A strictly controlled randomized crossover study with the polysomnography recorded twice during the mission. Methods Setting: Shift and night work with prolonged (70 days) social isolation from the real world (with no phone or Internet contact with families or friends during a routine mission aboard the "Temeraire" French Strategic Submarine with Ballistic Nuclear missiles (SSBN). Participants: 19 submariners working on a 24-hour shift for three days in a row schedule. Interventions: The participants attended two polysomnographic (PSG) recordings of night sleep on Day 21 (D21) and Day 51 (D51) of the 70-day patrol; urine cortisol levels were also taken after sleep, and subjective assessments of sleep, sleepiness, mood and anxiety on D21 and D51. The light and temperature on board were also recorded. Results PSG analyses showed that sleep did not significantly vary in length (total sleep time) or in quality between D21 and D51. The mariners reported the same subjective sleep, sleepiness, anxiety or mood (except for a slightly worse score for confusion on D51). Blood cortisol levels did not vary significantly. Conclusions These results show that humans living in an isolated environment for more than two months with this specific shift schedule do not suffer from any significant effects on sleep, sleepiness and confusion between D21 and D51, when they follow an organized regular shift pattern with controlled light and temperature.	IRBA, Unite Stress, Bretigny Sur Orge, France; Univ Paris 05, Sorbonne Paris Cite, AP HP, Hotel Dieu,Ctr Sommeil & Vigilance, Paris, France; [Leger, Damien; van Beers, Pascal; Chennaoui, Mounir] Univ Paris 05, Sorbonne Paris Cite, Equipe Accueil Vigilance FAtigue SOMmeil VIFASOM, EA 7330, Paris, France; [van Beers, Pascal; Chennaoui, Mounir] IRBA, Unite Fatigue & Vigilance, Bretigny Sur Orge, France; [Coste, Olivier] HIA Desgenettes, Unite Sommeil, Lyon, France; [Vicard, Arnaud; Pontis, Julien; Crosnier, Sylvain-Nicolas] Escadrille Marins Lanceurs Engins SNLE, Serv Med ESNLE, Brest, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Leger, D (corresponding author), IRBA, Unite Stress, Bretigny Sur Orge, France.	damien.leger@htd.aphp.fr		chennaoui, mounir/0000-0002-4409-813X; marion, trousselard/0000-0003-0592-4547	IRBA (Institut de Recherche Biomedicale des Armees); DGA (Direction Generale de l'Armement)	IRBA (Institut de Recherche Biomedicale des Armees); DGA (Direction Generale de l'Armement)	This study was supported by the IRBA (Institut de Recherche Biomedicale des Armees) and the DGA (Direction Generale de l'Armement).	[Anonymous], 2013, INT CLASS SLEEP DIS; Basner M, 2013, P NATL ACAD SCI USA, V110, P2635, DOI 10.1073/pnas.1212646110; Bremner C, 2009, TIMES; Buguet A, 1981, INT REV ARMY NAVY AI, V54, P101; Chang AM, 2013, SLEEP, V36, P1239, DOI 10.5665/sleep.2894; Dijk DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000145; Duplessis CA, 2007, UNDERSEA HYPERBAR M, V34, P21; Eldevik MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070882; Gaggioni G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00126; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; Hadlow NC, 2014, CHRONOBIOL INT, V31, P243, DOI 10.3109/07420528.2013.844162; Hubbard J, 2013, SLEEP MED REV, V17, P445, DOI 10.1016/j.smrv.2012.12.004; Iber C, 2004, SLEEP, V27, P536, DOI 10.1093/sleep/27.3.536; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Juda M, 2013, J BIOL RHYTHM, V28, P141, DOI 10.1177/0748730412475042; Kelly TL, 1999, J BIOL RHYTHM, V14, P190, DOI 10.1177/074873099129000597; Kleitman N, 1949, SLEEP WAKEFULNESS CY, P329; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Leger D, 2002, CLIN NEUROPHYSIOL, V113, P1607, DOI 10.1016/S1388-2457(02)00221-3; Leger D, 2011, J PSYCHOSOM RES, V70, P29, DOI 10.1016/j.jpsychores.2010.09.006; Lockley SW, 2008, J SLEEP RES, V17, P207, DOI 10.1111/j.1365-2869.2008.00656.x; Moore HA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086176, 10.1371/journal.pone.0114565]; Morgenthaler TI, 2007, SLEEP, V30, P1445, DOI 10.1093/sleep/30.11.1445; Mulrine HM, 2012, CHRONOBIOL INT, V29, P1249, DOI 10.3109/07420528.2012.719957; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Roenneberg T., 2013, HDB EXP PHARM, V217, P311, DOI DOI 10.1007/978-3-642-25950-0_13; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Squarcini CFR, 2013, EUR J APPL PHYSIOL, V113, P157, DOI 10.1007/s00421-012-2415-8; Scheuermaier K, 2010, J BIOL RHYTHM, V25, P113, DOI 10.1177/0748730410361916; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; Swanson D, 2014, J EXP BIOL, V217, P866, DOI 10.1242/jeb.096677; Trousselard M, 2009, AVIAT SPACE ENVIR MD, V80, P850, DOI 10.3357/ASEM.2503.2009; United Nations Organisation, 2013, UN PEAC; Waage S, 2009, SLEEP, V32, P558, DOI 10.1093/sleep/32.4.558; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; World Nuclear Association, 2014, NUCL POW SHIPS; Zhong G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072661	41	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126721	10.1371/journal.pone.0126721	http://dx.doi.org/10.1371/journal.pone.0126721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016656	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600058
J	Faron, M; Fletcher, JR; Rasmussen, JA; Apicella, MA; Jones, BD				Faron, Matthew; Fletcher, Joshua R.; Rasmussen, Jed A.; Apicella, Michael A.; Jones, Bradley D.			Interactions of Francisella tularensis with Alveolar Type II Epithelial Cells and the Murine Respiratory Epithelium	PLOS ONE			English	Article							LIVE VACCINE STRAIN; SCHU S4; TULAREMIA VACCINE; HOST-DEFENSE; IN-VITRO; MICE; INFECTION; INNATE; GROWTH; MODEL	Francisella tularensis is classified as a Tier 1 select agent by the CDC due to its low infectious dose and the possibility that the organism can be used as a bioweapon. The low dose of infection suggests that Francisella is unusually efficient at evading host defenses. Although similar to 50 cfu are necessary to cause human respiratory infection, the early interactions of virulent Francisella with the lung environment are not well understood. To provide additional insights into these interactions during early Francisella infection of mice, we performed TEM analysis on mouse lungs infected with F. tularensis strains Schu S4, LVS and the O-antigen mutant Schu S4 waaY:: TrgTn. For all three strains, the majority of the bacteria that we could detect were observed within alveolar type II epithelial cells at 16 hours post infection. Although there were no detectable differences in the amount of bacteria within an infected cell between the three strains, there was a significant increase in the amount of cellular debris observed in the air spaces of the lungs in the Schu S4 waaY:: TrgTn mutant compared to either the Schu S4 or LVS strain. We also studied the interactions of Francisella strains with human AT-II cells in vitro by characterizing the ability of these three strains to invade and replicate within these cells. Gentamicin assay and confocal microscopy both confirmed that F. tularensis Schu S4 replicated robustly within these cells while F. tularensis LVS displayed significantly lower levels of growth over 24 hours, although the strain was able to enter these cells at about the same level as Schu S4 (1 organism per cell), as determined by confocal imaging. The Schu S4 waaY:: TrgTn mutant that we have previously described as attenuated for growth in macrophages and mouse virulence displayed interesting properties as well. This mutant induced significant airway inflammation (cell debris) and had an attenuated growth phenotype in the human AT-II cells. These data extend our understanding of early Francisella infection by demonstrating that Francisella enter significant numbers of AT-II cells within the lung and that the capsule and LPS of wild type Schu S4 helps prevent murine lung damage during infection. Furthermore, our data identified that human AT-II cells allow growth of Schu S4, but these same cells supported poor growth of the attenuated LVS strain in vitro. Collectively, these data further our understanding of the role of AT-II cells in Francisella infections.	[Faron, Matthew; Fletcher, Joshua R.; Jones, Bradley D.] Univ Iowa, Grad Program Genet, Iowa City, IA 52242 USA; [Rasmussen, Jed A.; Apicella, Michael A.; Jones, Bradley D.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Jones, BD (corresponding author), Univ Iowa, Grad Program Genet, Iowa City, IA 52242 USA.	bradley-jones@uiowa.edu		Jones, Brad/0000-0002-2698-8251	 [2PO1 AI044642];  [2U54 AI057160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, P01AI044642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by 2PO1 AI044642 MAA, BDJ; 2U54 AI057160 BDJ.	Bermudez LE, 1996, INFECT IMMUN, V64, P1400, DOI 10.1128/IAI.64.4.1400-1406.1996; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bradburne CE, 2013, J BIOL CHEM, V288, P10780, DOI 10.1074/jbc.M112.362178; CASTRANOVA V, 1988, TOXICOL APPL PHARM, V93, P472, DOI 10.1016/0041-008X(88)90051-8; Celli J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010314; CRAPO JD, 1983, AM REV RESPIR DIS, V128, pS42; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; David J, 2014, MICROBES INFECT, V16, P735, DOI 10.1016/j.micinf.2014.04.001; Eisele NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/249802; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; EVANS MJ, 1972, AEROSPACE MED, V43, P620; Faron M, 2013, INFECT IMMUN, V81, P2800, DOI 10.1128/IAI.00073-13; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; FERRIOLA PC, 1990, PATHOBIOLOGY, V58, P28, DOI 10.1159/000163562; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Francis E, 1926, J AMER MED ASSOC, V86, P1329, DOI 10.1001/jama.1926.02670440003002; FrankeUllmann G, 1996, J IMMUNOL, V157, P3097; Fujita R, 2003, CELL DEATH DIFFER, V10, P1336, DOI 10.1038/sj.cdd.4401300; Fujita R, 2003, CELL DEATH DIFFER, V10, P782, DOI 10.1038/sj.cdd.4401239; Gentry M, 2007, INFECT IMMUN, V75, P3969, DOI 10.1128/IAI.00157-07; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Guillot L, 2013, INT J BIOCHEM CELL B, V45, P2568, DOI 10.1016/j.biocel.2013.08.009; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Hsiao CHC, 2011, MICROBES INFECT, V13, P1033, DOI 10.1016/j.micinf.2011.05.014; JONES GS, 1982, J APPL PHYSIOL, V53, P258, DOI 10.1152/jappl.1982.53.1.258; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; LAURENZI GA, 1963, SCIENCE, V142, P1572, DOI 10.1126/science.142.3599.1572; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Long ME, 2013, INFECT IMMUN, V81, P850, DOI 10.1128/IAI.00822-12; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; McCormick TS, 2010, PERIODONTOL 2000, V54, P195, DOI 10.1111/j.1600-0757.2010.00373.x; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Oppenheim RW, 2001, J NEUROSCI, V21, P4752, DOI 10.1523/JNEUROSCI.21-13-04752.2001; Osmanagic E, 2010, J APPL PHYSIOL, V109, P1592, DOI 10.1152/japplphysiol.00736.2010; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Rasmussen JA, 2014, INFECT IMMUN, V82, P1523, DOI 10.1128/IAI.01640-13; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Schwingshackl A, 2013, AM J TRANSL RES, V5, P530; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sharma J, 2011, MICROB PATHOGENESIS, V51, P39, DOI 10.1016/j.micpath.2011.03.007; Steele S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003562; STUART BM, 1945, AM J MED SCI, V210, P223, DOI 10.1097/00000441-194508000-00013; Thomas-Charles CA, 2013, INFECT IMMUN, V81, P2828, DOI 10.1128/IAI.00170-13; Townsley MI, 2012, COMPR PHYSIOL, V2, P675, DOI 10.1002/cphy.c100081; Vir P, 2014, APMIS, V122, P268, DOI 10.1111/apm.12141; Wu Q, 2011, AM J PHYSIOL-LUNG C, V300, pL579, DOI 10.1152/ajplung.00336.2010; Zarrella TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022335; Zhou HX, 2010, J VIROL, V84, P3542, DOI 10.1128/JVI.02570-09	54	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127458	10.1371/journal.pone.0127458	http://dx.doi.org/10.1371/journal.pone.0127458			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010977	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900094
J	Kill, C; Galbas, M; Neuhaus, C; Hahn, O; Wallot, P; Kesper, K; Wulf, H; Dersch, W				Kill, Clemens; Galbas, Monika; Neuhaus, Christian; Hahn, Oliver; Wallot, Pascal; Kesper, Karl; Wulf, Hinnerk; Dersch, Wolfgang			Chest Compression Synchronized Ventilation versus Intermitted Positive Pressure Ventilation during Cardiopulmonary Resuscitation in a Pig Model	PLOS ONE			English	Article							IMPEDANCE THRESHOLD VALVE; PORCINE MODEL; MECHANICAL VENTILATION; GAS-EXCHANGE; LIFE-SUPPORT; HYPERVENTILATION; SURVIVAL; CPR	Background Guidelines recommend mechanical ventilation with Intermitted Positive Pressure Ventilation (IPPV) during resuscitation. The influence of the novel ventilator mode Chest Compression Synchronized Ventilation (CCSV) on gas exchange and arterial blood pressure compared with IPPV was investigated in a pig model. Methods In 12 pigs (general anaesthesia/intubation) ventricular fibrillation was induced and continuous chest compressions were started after 3min. Pigs were mechanically ventilated in a cross-over setting with 5 ventilation periods of 4min each: Ventilation modes were during the first and last period IPPV (100% O-2, tidalvolumes = 7ml/kgKG, respiratoryrate = 10/min), during the 2nd, 3rd and 4th period CCSV (100% O-2), a pressure-controlled and with each chest compression synchronized breathing pattern with three different presets in randomized order. Presets: CCSVA: P-insp = 60mbar, inspiratorytime = 205ms; CCSVB: P-insp = 60mbar, inspiratorytime = 265ms; CCSVC: P-insp = 45mbar, inspiratorytime = 265ms. Blood gas samples were drawn for each period, mean arterial (MAP) and centralvenous (CVP) blood pressures were continuously recorded. Results asmedian (25%/75% percentiles). Results Ventilation with each CCSV mode resulted in higher PaO2 than IPPV: PaO2: IPPVfirst: 19.6 (13.9/36.2) kPa, IPPVlast: 22.7(5.4/36.9) kPa (p = 0.77 vs IPPVfirst), CCSVA: 48.9(29.0/58.2) kPa (p = 0.028 vs IPPVfirst, p = 0.0001 vs IPPVlast), CCSVB: 54.0 (43.8/64.1) (p = 0.001 vs IPPVfirst, p = 0.0001 vs IPPVlast), CCSVC: 46.0 (20.2/58.4) (p = 0.006 vs IPPVfirst, p = 0.0001 vs IPPVlast). Both the MAP and the difference MAP-CVP did not decrease during twelve minutes CPR with all three presets of CCSV and were higher than the pressures of the last IPPV period. Conclusions All patterns of CCSV lead to a higher PaO2 and avoid an arterial blood pressure drop during resuscitation compared to IPPV in this pig model of cardiac arrest.	[Kill, Clemens; Galbas, Monika; Hahn, Oliver; Wallot, Pascal; Wulf, Hinnerk; Dersch, Wolfgang] Univ Marburg, Dept Anesthesiol & Crit Care, D-35032 Marburg, Germany; [Kill, Clemens; Dersch, Wolfgang] Univ Marburg, Dept Emergency Med, D-35032 Marburg, Germany; [Kesper, Karl] Univ Marburg, Dept Internal Med, Sect Resp Dis, D-35032 Marburg, Germany; [Neuhaus, Christian] Weinmann Emergency Med Technol GmbH Co KG, Hamburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg	Kill, C (corresponding author), Univ Marburg, Dept Anesthesiol & Crit Care, D-35032 Marburg, Germany.	killc@staff.uni-marburg.de			German governmental grant (Bundesministerium fur Wirtschaft und Informationstechnologie) [KF2502403FR0, KF2660001FR0]; Weinmann Emergency Medical Technology GmbH+Co.KG	German governmental grant (Bundesministerium fur Wirtschaft und Informationstechnologie); Weinmann Emergency Medical Technology GmbH+Co.KG	This work as supported by the German governmental grant (Bundesministerium fur Wirtschaft und Informationstechnologie, No KF2502403FR0, KF2660001FR0) as institutional funding to Philipps-University, Marburg URL: www.zim-bmwi.de. Weinmann Emergency Medical Technology GmbH+Co.KG, provided support in the form of a salary for author CN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; Botran M, 2011, INTENS CARE MED, V37, P1873, DOI 10.1007/s00134-011-2338-6; Brochard L, 1996, AM J RESP CRIT CARE, V154, P1323, DOI 10.1164/ajrccm.154.5.8912743; Chalkias A, 2013, EUR HEART J ACUTE CA; CRILEY JM, 1976, JAMA-J AM MED ASSOC, V236, P1246, DOI 10.1001/jama.236.11.1246; DEAKIN CD, 2010, RESUSCITATION, V81, P1305, DOI DOI 10.1016/J.RESUSCITATI0N.2010.08.017; Dorph E, 2004, RESUSCITATION, V61, P23, DOI 10.1016/j.resuscitation.2003.12.017; Ewy GA, 2005, CIRCULATION, V111, P2134, DOI 10.1161/01.CIR.0000162503.57657.FA; Gazmuri RJ, 2012, RESUSCITATION, V83, P259, DOI 10.1016/j.resuscitation.2011.07.034; HALPERIN HR, 1993, NEW ENGL J MED, V329, P762, DOI 10.1056/NEJM199309093291104; Hupfl M, 2010, LANCET, V376, P1552, DOI 10.1016/S0140-6736(10)61454-7; IDRIS AH, 1994, RESUSCITATION, V28, P143, DOI 10.1016/0300-9572(94)90087-6; Kill C, 2014, CRIT CARE MED, V42, pE89, DOI 10.1097/CCM.0b013e3182a63fa0; Kill C, 2012, CURR OPIN CRIT CARE, V18, P251, DOI 10.1097/MCC.0b013e3283523f69; Kill C, 2009, RESUSCITATION, V80, P1060, DOI 10.1016/j.resuscitation.2009.05.015; Kleinsasser A, 2002, CIRCULATION, V106, P373, DOI 10.1161/01.CIR.0000021428.94652.04; Langhelle A, 2002, RESUSCITATION, V52, P39, DOI 10.1016/S0300-9572(01)00442-7; Lurie KG, 2002, CIRCULATION, V105, P124, DOI 10.1161/hc0102.101391; Lurie KG, 2001, ANESTH ANALG, V93, P649, DOI 10.1097/00000539-200109000-00024; Iglesias JM, 2010, INTENS CARE MED, V36, P712, DOI 10.1007/s00134-010-1777-9; NOC M, 1994, AM J RESP CRIT CARE, V150, P861, DOI 10.1164/ajrccm.150.3.8087362; Richard JCM, 2011, AM J RESP CRIT CARE, V184, P32, DOI 10.1164/rccm.201103-0424UP; Timerman S, 2004, RESUSCITATION, V61, P273, DOI 10.1016/j.resuscitation.2004.01.025; Yannopoulos D, 2005, CIRCULATION, V112, P803, DOI 10.1161/CIRCULATIONAHA.105.541508; Yannopoulos D, 2007, ANESTH ANALG, V104, P157, DOI 10.1213/01.ane.0000249047.80184.5a; Yannopoulos D, 2010, CRIT CARE MED, V38, P254, DOI 10.1097/CCM.0b013e3181b42f6c	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127759	10.1371/journal.pone.0127759	http://dx.doi.org/10.1371/journal.pone.0127759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011525	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900140
J	Lindemark, F; Haaland, OA; Kvale, R; Flaatten, H; Johansson, KA				Lindemark, Frode; Haaland, Oystein A.; Kvale, Reidar; Flaatten, Hans; Johansson, Kjell A.			Age, Risk, and Life Expectancy in Norwegian Intensive Care: A Registry-Based Population Modelling Study	PLOS ONE			English	Article							SAPS-II; HOSPITAL DISCHARGE; ELDERLY-PATIENTS; MORTALITY; ICU; TRIAGE; DETERMINANTS; PRINCIPLES; SURVIVAL; IMPACT	Background Knowledge about the expected life years gained from intensive care unit (ICU) admission could inform priority-setting decisions across groups of ICU patients and across medical specialties. The aim of this study was to estimate expected remaining lifetime for patients admitted to ICUs during 2008-2010 and to estimate the gain in life years from ICU admission. Methods This is a descriptive, population modelling study of 30,712 adult mixed ICU admissions from the Norwegian Intensive Care Registry. The expected remaining lifetime for each patient was estimated using a decision-analytical model. Transition probabilities were based on registered Simplified Acute Physiology Score (SAPS) II, and standard and adjusted Norwegian life-tables. Results The hospital mortality was 19.4%(n = 5,958 deaths). 24% of the patients were estimated to die within the first year after ICU admission in our model. Under an intermediate (base case), optimistic (O), and pessimistic (P) scenario with respect to long-term mortality, the average expected remaining lifetime was 19.4, 19.9, and 12.7 years. The majority of patients had a life expectancy of more than five years (84.8% in the base case, 89.4% in scenario O, and 55.6% in scenario P), and few had a life expectancy of less than one year (0.7%, 0.1%, and 12.7%). The incremental gain from ICU admission compared to counterfactual general ward care was estimated to be 0.04 (scenario P, age 85+) to 1.14 (scenario O, age < 45) extra life years per patient. Conclusions Our research demonstrated a novel way of using routinely collected registry data to estimate and evaluate the expected lifetime outcomes for ICU patients upon admission. The majority had high life expectancies. The youngest age groups seemed to benefit the most from ICU admission. The study raises the question whether availability and rationing of ICU services are too strict in Norway.	[Lindemark, Frode; Johansson, Kjell A.] Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway; [Lindemark, Frode; Haaland, Oystein A.; Johansson, Kjell A.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Kvale, Reidar; Flaatten, Hans] Helse Bergen HF, Norwegian Intens Care Registry, Bergen, Norway; [Kvale, Reidar; Flaatten, Hans] Haukeland Hosp, Dept Anesthesia & Intens Care, N-5021 Bergen, Norway; [Flaatten, Hans] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Lindemark, F (corresponding author), Haukeland Hosp, Dept Res & Dev, N-5021 Bergen, Norway.	frode.lindemark@igs.uib.no	Flaatten, Hans/AAG-7030-2020; Johansson, Kjell Arne/ABE-3628-2020	Flaatten, Hans/0000-0001-9186-3482; Johansson, Kjell Arne/0000-0001-8912-8710	Western Norway Regional Health Authority [240046]	Western Norway Regional Health Authority	The article is part of the Western Norway Regional Health Authority (http://www.helse-vest.no/en/Sider/default.aspx) interdisciplinary research program "Priority setting across clinical specialties" (project code 240046). KAJ and FL were employed by this program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no specific project funding for OAH, RK and HF.	Aegerter P, 2005, INTENS CARE MED, V31, P416, DOI 10.1007/s00134-005-2557-9; Andersen FH, 2012, ACTA ANAESTH SCAND, V56, P1298, DOI 10.1111/j.1399-6576.2012.02782.x; Angus DC, 1997, CRIT CARE CLIN, V13, P389, DOI 10.1016/S0749-0704(05)70317-1; Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; Barnato AE, 2004, CRIT CARE CLIN, V20, P345, DOI 10.1016/j.ccc.2004.03.002; Biston P, 2014, INTENS CARE MED, V40, P50, DOI 10.1007/s00134-013-3121-7; Boumendil A, 2007, INTENS CARE MED, V33, P1252, DOI 10.1007/s00134-007-0621-3; Brinkman S, 2013, CRIT CARE MED, V41, P1229, DOI 10.1097/CCM.0b013e31827ca4e1; Brinkman S, 2013, CRIT CARE MED, V41, P1237, DOI 10.1097/CCM.0b013e31827ca4f9; Brock DW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P259; Christiansen CF, 2011, ACTA ANAESTH SCAND, V55, P962, DOI 10.1111/j.1399-6576.2011.02480.x; Daniels Norman, 2008, JUST HLTH M HLTH NEE; de Rooij SEJA, 2008, J AM GERIATR SOC, V56, P816, DOI 10.1111/j.1532-5415.2008.01671.x; Edbrooke DL, 2011, CRIT CARE, V15, DOI 10.1186/cc10029; ENGELHARDT HT, 1986, JAMA-J AM MED ASSOC, V255, P1159, DOI 10.1001/jama.255.9.1159; Evans TW, 2011, CHEST, V140, P1618, DOI 10.1378/chest.11-0957; Flaatten H, 2001, INTENS CARE MED, V27, P1005, DOI 10.1007/s001340100960; Foss AH, 1998, DEFINITIONS CALCULAT; Haaland OA, 2014, ACTA ANAESTH SCAND, V58, P701, DOI 10.1111/aas.12327; Haaland OA, 2014, ACTA ANAESTHESIOL SC; Hung MC, 2011, CRIT CARE, V15, DOI 10.1186/cc10128; Hunink MGM., 2001, DECISION MAKING HLTH, P305; Laake JH, 2010, ACTA ANAESTH SCAND, V54, P479, DOI 10.1111/j.1399-6576.2009.02170.x; Lanken PN, 1997, AM J RESP CRIT CARE, V156, P1282; Le Gall JR, 2005, CRIT CARE, V9, pR645, DOI 10.1186/cc3821; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; National Institute for Health and Clinical Excellence, 2009, APPR LIF EXT END LIF; National Institute for Health and Clinical Excellence, 2012, IP PREV TREAT ADV UN; Norheim OF, 2002, HEALTH CARE ANAL, V10, P309, DOI 10.1023/A:1022955909060; Norheim OF, 2008, BMJ-BRIT MED J, V337, P903; Norwegian Intensive Care Registry, 2010, ANN REP 2009; Norwegian Intensive Care Registry, 2011, ANN REP 2010; Norwegian Intensive Care Registry, 2009, ANN REP 2008; Ottersen T., 2013, THESIS U BERGEN; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; R Core Team, 2021, R LANGUAGE ENV STAT; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Scheunemann LP, 2011, CHEST, V140, P1625, DOI 10.1378/chest.11-0622; Sinuff T, 2004, CRIT CARE MED, V32, P1588, DOI 10.1097/01.CCM.0000130175.38521.9F; Sprung CL, 2013, INTENS CARE MED, V39, P1916, DOI 10.1007/s00134-013-3033-6; Sprung CL, 2012, CRIT CARE MED, V40, P132, DOI 10.1097/CCM.0b013e318232d6b0; Sprung CL, 2004, SURVIVING INTENSIVE, P235; Statistics Norway, 2012, TABL 07902 LIF TABL; Strand K, 2010, INTENS CARE MED, V36, P850, DOI 10.1007/s00134-010-1772-1; Strand K, 2009, ACTA ANAESTH SCAND, V53, P595, DOI 10.1111/j.1399-6576.2009.01948.x; Truog RD, 2006, CRIT CARE MED, V34, P958, DOI 10.1097/01.CCM.0000206116.10417.D9; Ward NS, 2007, CRIT CARE MED, V35, pS102, DOI 10.1097/01.CCM.0000252922.55244.FB; Williams TA, 2008, CRIT CARE MED, V36, P1523, DOI 10.1097/CCM.0b013e318170a405; Nguyen YL, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-29	49	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125907	10.1371/journal.pone.0125907	http://dx.doi.org/10.1371/journal.pone.0125907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011281	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900017
J	Sequeira, A; Rollins, B; Magnan, C; van Oven, M; Baldi, P; Myers, RM; Barchas, JD; Schatzberg, AF; Watson, SJ; Akil, H; Bunney, WE; Vawter, MP				Sequeira, Adolfo; Rollins, Brandi; Magnan, Christophe; van Oven, Mannis; Baldi, Pierre; Myers, Richard M.; Barchas, Jack D.; Schatzberg, Alan F.; Watson, Stanley J.; Akil, Huda; Bunney, William E.; Vawter, Marquis P.			Mitochondrial Mutations in Subjects with Psychiatric Disorders	PLOS ONE			English	Article							GENERATION SEQUENCING TECHNOLOGY; HETEROPLASMY; SCHIZOPHRENIA; MTDNA; GENOME; REGION; ORGANIZATION; HAPLOGROUPS; INVOLVEMENT; TRANSITION	A considerable body of evidence supports the role of mitochondrial dysfunction in psychiatric disorders and mitochondrial DNA (mtDNA) mutations are known to alter brain energy metabolism, neurotransmission, and cause neurodegenerative disorders. Genetic studies focusing on common nuclear genome variants associated with these disorders have produced genome wide significant results but those studies have not directly studied mtDNA variants. The purpose of this study is to investigate, using next generation sequencing, the involvement of mtDNA variation in bipolar disorder, schizophrenia, major depressive disorder, and methamphetamine use. MtDNA extracted from multiple brain regions and blood were sequenced (121 mtDNA samples with an average of 8,800x coverage) and compared to an electronic database containing 26,850 mtDNA genomes. We confirmed novel and rare variants, and confirmed next generation sequencing error hotspots by traditional sequencing and genotyping methods. We observed a significant increase of non-synonymous mutations found in individuals with schizophrenia. Novel and rare non-synonymous mutations were found in psychiatric cases in mtDNA genes: ND6, ATP6, CYTB, and ND2. We also observed mtDNA heteroplasmy in brain at a locus previously associated with schizophrenia (T16519C). Large differences in heteroplasmy levels across brain regions within subjects suggest that somatic mutations accumulate differentially in brain regions. Finally, multiplasmy, a heteroplasmic measure of repeat length, was observed in brain from selective cases at a higher frequency than controls. These results offer support for increased rates of mtDNA substitutions in schizophrenia shown in our prior results. The variable levels of heteroplasmic/multiplasmic somatic mutations that occur in brain may be indicators of genetic instability in mtDNA.	[Sequeira, Adolfo; Rollins, Brandi; Vawter, Marquis P.] Univ Calif Irvine, Dept Psychiat & Human Behav, Funct Genom Lab, Irvine, CA 92717 USA; [Magnan, Christophe; Baldi, Pierre] Univ Calif Irvine, IGB, Sch Informat & Comp Sci ICS, Irvine, CA USA; [van Oven, Mannis] Univ Med Ctr Rotterdam, Erasmus MC, Dept Forens Mol Biol, Rotterdam, Netherlands; [Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Barchas, Jack D.] Weill Cornell Med Coll, Dept Psychiat, New York, NY USA; [Schatzberg, Alan F.] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Watson, Stanley J.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Bunney, William E.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Erasmus University Rotterdam; Erasmus MC; HudsonAlpha Institute for Biotechnology; Cornell University; Stanford University; University of Michigan System; University of Michigan; University of California System; University of California Irvine	Vawter, MP (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Funct Genom Lab, Irvine, CA 92717 USA.	mvawter@uci.edu	Sequeira, Adolfo/K-7278-2015; magnan, christophe/AAJ-7622-2021	Sequeira, Adolfo/0000-0003-3040-1190; magnan, christophe/0000-0002-7044-2571; van Oven, Mannis/0000-0003-0026-7998	Pritzker Family Philanthropic Fund; NIMH [R01MH085801, MH099440, R01MH097082]; Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097082, R21MH099440, R01MH085801] Funding Source: NIH RePORTER	Pritzker Family Philanthropic Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pritzker Neuropsychiatric Disorders Research Fund L.L.C.; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The collection of brain tissue was supported by funding from the Pritzker Family Philanthropic Fund, and NIMH Grants R01MH085801, MH099440 (MPV) and R01MH097082 (AS). The authors (except CM, MvO, PB), are members of the Pritzker Neuropsychiatric Disorders Research Consortium, which is supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C. A shared intellectual property agreement exists between this philanthropic fund and the University of Michigan, Stanford University, the Weill Medical College of Cornell University, HudsonAlpha Institute of Biotechnology, and the University of California at Irvine, to encourage the development of appropriate findings for research and clinical applications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anglin RE, 2012, J NEUROPSYCH CLIN N, V24, P394, DOI 10.1176/appi.neuropsych.11110345; Anglin RE, 2012, J CLIN PSYCHIAT, V73, P506, DOI 10.4088/JCP.11r07237; Anglin RES, 2012, AM J MED GENET B, V159B, P749, DOI 10.1002/ajmg.b.32086; Bandelt HJ, 2012, FORENSIC SCI INT-GEN, V6, P143, DOI 10.1016/j.fsigen.2011.04.004; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019; Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029; Bertolin C, 2011, J HUM GENET, V56, P869, DOI 10.1038/jhg.2011.111; Caverzasi E, 2012, FUNCT NEUROL, V27, P13; Coto E, 2011, NEUROGENETICS, V12, P345, DOI 10.1007/s10048-011-0295-4; Dzitoyeva S, 2012, NEUROBIOL AGING, V33, P2881, DOI 10.1016/j.neurobiolaging.2012.02.006; Forster L, 2010, INT J LEGAL MED, V124, P133, DOI 10.1007/s00414-009-0385-0; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; Gruber S, 2003, INVEST RADIOL, V38, P403, DOI 10.1097/01.rli.0000073446.43445.20; Guo Y, 2012, MUTAT RES-GEN TOX EN, V744, P154, DOI 10.1016/j.mrgentox.2012.02.006; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Howell N, 2000, AM J HUM GENET, V66, P1589, DOI 10.1086/302910; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Huang Taosheng, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1908s71; Hudson G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004369; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Inczedy-Farkas G, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-9; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Kato M, 2011, NEUROSCI RES, V69, P331, DOI 10.1016/j.neures.2010.12.013; Kazuno A, 2009, AM J MED GENET B, V150B, P243, DOI 10.1002/ajmg.b.30804; Kim SY, 2010, BRAIN RES, V1348, P105, DOI 10.1016/j.brainres.2010.05.097; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Lutz-Bonengel S, 2004, INT J LEGAL MED, V118, P274, DOI 10.1007/s00414-004-0457-0; Manev Hari, 2012, Biomol Concepts, V3, P107; McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058; Mosquera-Miguel A, 2012, AM J MED GENET B, V159B, P414, DOI 10.1002/ajmg.b.32044; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Ongur D, 2009, PSYCHIAT RES-NEUROIM, V172, P44, DOI 10.1016/j.pscychresns.2008.06.002; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rezin GT, 2009, NEUROCHEM RES, V34, P1021, DOI 10.1007/s11064-008-9865-8; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Sequeira Adolfo, 2012, Frontiers in Genetics, V3, P103, DOI 10.3389/fgene.2012.00103; Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; Sosa MX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002737; Tang MY, 2004, CLIN CANCER RES, V10, P1041, DOI 10.1158/1078-0432.CCR-0701-3; Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Verge B, 2011, EUR PSYCHIAT, V26, P45, DOI 10.1016/j.eurpsy.2010.08.008; Verge B, 2012, J CLIN PSYCHIAT, V73, P684, DOI 10.4088/JCP.10m06718; Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462; Wang GX, 2013, PSYCHIAT RES, V209, P279, DOI 10.1016/j.psychres.2013.01.001; Wang PN, 2009, J ALZHEIMERS DIS, V18, P345, DOI 10.3233/JAD-2009-1156; Williams SL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003990; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yamamoto BK, 2008, J NEUROIMMUNE PHARM, V3, P203, DOI 10.1007/s11481-008-9121-7; Zaragoza MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012295	64	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127280	10.1371/journal.pone.0127280	http://dx.doi.org/10.1371/journal.pone.0127280			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011537	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900077
J	Zhang, P; Du, EQ; Ma, J; Wang, WB; Zhang, L; Tikoo, SK; Yang, ZQ				Zhang, Peng; Du, Enqi; Ma, Jing; Wang, Wenbin; Zhang, Lu; Tikoo, Suresh K.; Yang, Zengqi			A Novel and Simple Method for Rapid Generation of Recombinant Porcine Adenoviral Vectors for Transgene Expression	PLOS ONE			English	Article							CLASSICAL SWINE-FEVER; GENE-TRANSFER; NONHUMAN ADENOVIRUSES; IMMUNE-RESPONSES; INNATE IMMUNITY; PROTECTS PIGS; VACCINATION; CONSTRUCTION; EFFICIENT; TOXICITY	Many human (different serotypes) and nonhuman adenovirus vectors are being used for gene delivery. However, the current system for isolating recombinant adenoviral vectors is either time-consuming or expensive, especially for the generation of recombinant nonhuman adenoviral vectors. We herein report a new and simple cloning approach for the rapid generation of a porcine adenovirus (PAdV-3) vector which shows promise for gene transfer to human cells and evasion of human adenovirus type 5 (HAdV-5) immunity. Based on the final cloning plasmid, pFPAV3-CcdB-Cm, and our modified SLiCE strategy (SLiCE cloning and lethal CcdB screening), the process for generating recombinant PAdV-3 plasmids required only one step in 3 days, with a cloning efficiency as high as 620 +/- 49.56 clones/ng and zero background (100% accuracy). The recombinant PAdV-3 plasmids could be successfully rescued in porcine retinal pigment epithelium cells (VR1BL), which constitutively express the HAdV-5 E1 and PAdV-3 E1B 55k genes, and the foreign genes were highly expressed at 24 h after transduction into swine testicle (ST) cells. In conclusion, this strategy for generating recombinant PAdV-3 vectors based on our modified SLiCE cloning system was rapid and cost-efficient, which could be used as universal cloning method for modification the other regions of PAdV-3 genome as well as other adenoviral genomes.	[Zhang, Peng; Du, Enqi; Ma, Jing; Wang, Wenbin; Zhang, Lu; Yang, Zengqi] North West A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Tikoo, Suresh K.] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada; [Tikoo, Suresh K.] Univ Saskatchewan, Sch Publ Hlth, Vaccinol & Immunotherapeut Program, Saskatoon, SK, Canada; [Tikoo, Suresh K.] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada	Northwest A&F University - China; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Tikoo, SK (corresponding author), Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada.	suresh.tik@usask.ca; yzq8162@163.com			Research Starting Foundation; Northwest A F University [Z111021006]; National Natural Science Foundation of China [31101803/C1803]; Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences [SKLVBF201405]	Research Starting Foundation; Northwest A F University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences	This work was supported by the Research Starting Foundation, Northwest A & F University (Grant No. Z111021006), National Natural Science Foundation of China (Grant No. 31101803/C1803), and Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Grant No. SKLVBF201405).	Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; Bernard P, 1996, BIOTECHNIQUES, V21, P320; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Campos SK, 2004, HUM GENE THER, V15, P1125, DOI 10.1089/1043034042431182; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Croyle M A, 1998, Pharm Dev Technol, V3, P373, DOI 10.3109/10837459809009865; Dobbelstein M, 2004, CURR TOP MICROBIOL, V273, P291; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Goncalves MAFV, 2006, REV MED VIROL, V16, P167, DOI 10.1002/rmv.494; Hammond JM, 2000, VACCINE, V18, P1040, DOI 10.1016/S0264-410X(99)00347-3; Hammond JM, 2003, VIRUS RES, V97, P151, DOI 10.1016/j.virusres.2003.08.003; Hammond JM, 2001, VET MICROBIOL, V80, P101, DOI 10.1016/S0378-1135(00)00388-6; Hammond JM, 2001, ARCH VIROL, V146, P1787, DOI 10.1007/s007050170064; Hammond JM, 2001, VACCINE, V19, P3752, DOI 10.1016/S0264-410X(01)00084-6; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hofmann C, 1999, J VIROL, V73, P6930, DOI 10.1128/JVI.73.8.6930-6936.1999; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Li XX, 2004, VIRUS RES, V104, P181, DOI 10.1016/j.virusres.2004.04.011; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Moffatt S, 2000, VIROLOGY, V272, P159, DOI 10.1006/viro.2000.0350; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Ng P, 1999, HUM GENE THER, V10, P2667, DOI 10.1089/10430349950016708; Ng P, 2001, MOL THER, V3, P809, DOI 10.1006/mthe.2001.0323; Patel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015301; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Reddy PS, 1999, J VIROL, V73, P9137, DOI 10.1128/JVI.73.11.9137-9144.1999; Reddy PS, 1999, J GEN VIROL, V80, P563, DOI 10.1099/0022-1317-80-3-563; Reddy PS, 2003, VIROLOGY, V311, P384, DOI 10.1016/S0042-6822(03)00161-2; Reddy PS, 1999, J GEN VIROL, V80, P2909, DOI 10.1099/0022-1317-80-11-2909; Schnell MA, 2001, MOL THER, V3, P708, DOI 10.1006/mthe.2001.0330; Sharma A, 2010, GENE THER, V17, P634, DOI 10.1038/gt.2010.1; Sharma A, 2010, VIRUS RES, V153, P134, DOI 10.1016/j.virusres.2010.07.021; Sharma A, 2009, VIROLOGY, V386, P44, DOI 10.1016/j.virol.2009.01.008; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stone D, 2005, J VIROL, V79, P5090, DOI 10.1128/JVI.79.8.5090-5104.2005; Varnavski AN, 2005, GENE THER, V12, P427, DOI 10.1038/sj.gt.3302347; Varnavski AN, 2002, J VIROL, V76, P5711, DOI 10.1128/JVI.76.11.5711-5719.2002; Vlachaki MT, 2002, MOL THER, V6, P342, DOI 10.1006/mthe.2002.0669; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Volpers C, 2004, J GENE MED, V6, pS164, DOI 10.1002/jgm.496; Zakhartchouk A, 2003, VIROLOGY, V313, P377, DOI 10.1016/S0042-6822(03)00286-1; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	47	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127958	10.1371/journal.pone.0127958	http://dx.doi.org/10.1371/journal.pone.0127958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011074	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900172
J	Jain, S; Rajasingham, R; Noubary, F; Coonahan, E; Schoeplein, R; Baden, R; Curry, M; Afdhal, N; Kumar, S; Pollock, NR				Jain, Sidhartha; Rajasingham, Radha; Noubary, Farzad; Coonahan, Erin; Schoeplein, Ryan; Baden, Rachel; Curry, Michael; Afdhal, Nezam; Kumar, Shailendra; Pollock, Nira R.			Performance of an Optimized Paper-Based Test for Rapid Visual Measurement of Alanine Aminotransferase (ALT) in Fingerstick and Venipuncture Samples	PLOS ONE			English	Article							MICROFLUIDIC DEVICES; VENOUS-BLOOD; POINT; CAPILLARY; DIAGNOSTICS; SERUM; PLATFORM; GLUCOSE; ASSAYS	Background A paper-based, multiplexed, microfluidic assay has been developed to visually measure alanine aminotransferase (ALT) in a fingerstick sample, generating rapid, semi-quantitative results. Prior studies indicated a need for improved accuracy; the device was subsequently optimized using an FDA-approved automated platform (Abaxis Piccolo Xpress) as a comparator. Here, we evaluated the performance of the optimized paper test for measurement of ALT in fingerstick blood and serum, as compared to Abaxis and Roche/Hitachi platforms. To evaluate feasibility of remote results interpretation, we also compared reading cell phone camera images of completed tests to reading the device in real time. Methods 96 ambulatory patients with varied baseline ALT concentration underwent fingerstick testing using the paper device; cell phone images of completed devices were taken and texted to a blinded off-site reader. Venipuncture serum was obtained from 93/96 participants for routine clinical testing (Roche/Hitachi); subsequently, 88/93 serum samples were captured and applied to paper and Abaxis platforms. Paper test and reference standard results were compared by Bland-Altman analysis. Findings For serum, there was excellent agreement between paper test and Abaxis results, with negligible bias (+4.5 U/L). Abaxis results were systematically 8.6% lower than Roche/Hitachi results. ALT values in fingerstick samples tested on paper were systematically lower than values in paired serum tested on paper (bias -23.6 U/L) or Abaxis (bias -18.4 U/L); a correction factor was developed for the paper device to match fingerstick blood to serum. Visual reads of cell phone images closely matched reads made in real time (bias +5.5 U/L). Conclusions The paper ALT test is highly accurate for serum testing, matching the reference method against which it was optimized better than the reference methods matched each other. A systematic difference exists between ALT values in fingerstick and paired serum samples, and can be addressed by application of a correction factor to fingerstick values. Remote reading of this device is feasible.	[Jain, Sidhartha; Coonahan, Erin; Schoeplein, Ryan; Kumar, Shailendra] Diagnost For All, Cambridge, MA USA; [Rajasingham, Radha; Baden, Rachel; Pollock, Nira R.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Noubary, Farzad] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Noubary, Farzad] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Curry, Michael; Afdhal, Nezam] Beth Israel Deaconess Med Ctr, Div Hepatol, Boston, MA 02215 USA; [Pollock, Nira R.] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Tufts Medical Center; Tufts University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital	Pollock, NR (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.	nira.pollock@childrens.harvard.edu		Coonahan, Erin/0000-0002-6619-7761; Afdhal, Nezam/0000-0002-7342-6593	CIMIT (Center for Integration of Medicine and Innovative Technology) Young Investigator Award	CIMIT (Center for Integration of Medicine and Innovative Technology) Young Investigator Award	This work was supported by a CIMIT (Center for Integration of Medicine and Innovative Technology) Young Investigator Award (to Nira Pollock). Diagnostics For All provided all kits for the study and participated in study execution, analysis, and write-up.	[Anonymous], 2014, ALT ALAT GPT PACK IN; [Anonymous], 2010, CHOLESTECH LDX ALT A; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Boyd R, 2005, EMERG MED J, V22, P177, DOI 10.1136/emj.2003.011619; Byrnes S, 2013, BIOANALYSIS, V5, P2821, DOI 10.4155/bio.13.243; Cholestech LDX Technical Brief, 2001, CHOLESTECH LDX TECHN; Dou MW, 2014, ANAL CHEM, V86, P7978, DOI 10.1021/ac5021694; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; FALCH DK, 1981, SCAND J CLIN LAB INV, V41, P59, DOI 10.3109/00365518109092015; Green JL, 2010, CONTEMP CLIN TRIALS, V31, P279, DOI 10.1016/j.cct.2010.04.001; HAYMOND RE, 1975, CLIN CHEM, V21, P896; Hu J, 2014, BIOSENS BIOELECTRON, V54, P585, DOI 10.1016/j.bios.2013.10.075; JAMES DR, 1987, CLIN CHEM, V33, P826; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P2385, DOI 10.1001/jama.2013.283828; KUPKE IR, 1981, CLIN CHIM ACTA, V112, P177, DOI 10.1016/0009-8981(81)90376-4; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105; Mu X, 2014, ANAL CHEM, V86, P5338, DOI 10.1021/ac500247f; Noiphung J, 2014, BIOSENS BIOELECTRON; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Pollock NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075616; Pollock NR, 2013, CLIN GASTROENTEROL H, V11, P478, DOI 10.1016/j.cgh.2013.02.022; Pollock NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003981; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Schito M, 2012, J INFECT DIS, V205, pS169, DOI 10.1093/infdis/jis044; Sechi D, 2013, ANAL CHEM, V85, P10733, DOI 10.1021/ac4014868; WILLIAMS KM, 1987, TRANSFUSION, V27, P431, DOI 10.1046/j.1537-2995.1987.27587320539.x; Wu YF, 2014, BIOSENS BIOELECTRON, V52, P180, DOI 10.1016/j.bios.2013.08.039	30	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128118	10.1371/journal.pone.0128118	http://dx.doi.org/10.1371/journal.pone.0128118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020244	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300082
J	Mulinari, S; Juarez, SP; Wagner, P; Merlo, J				Mulinari, Shai; Juarez, Sol Pia; Wagner, Philippe; Merlo, Juan			Does Maternal Country of Birth Matter for Understanding Offspring's Birthweight? A Multilevel Analysis of Individual Heterogeneity in Sweden	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; BRIEF CONCEPTUAL TUTORIAL; FOREIGN-BORN STATUS; SOCIAL EPIDEMIOLOGY; ETHNIC INEQUALITIES; CAUSAL INFERENCE; BLOOD-PRESSURE; MARITAL-STATUS; HEALTH; RISK	Background Many public health and epidemiological studies have found differences between populations (e.g. maternal countries of birth) in average values of a health indicator (e.g. mean offspring birthweight). However, the approach based solely on population-level averages compromises our understanding of variability in individuals' health around the averages. If this variability is high, the exclusive study of averages may give misleading information. This idea is relevant when investigating country of birth differences in health. Methods and Results To exemplify this concept, we use information from the Swedish Medical Birth Register (2002-2010) and apply multilevel regression analysis of birthweight, with babies (n = 811,329) at the first, mothers (n = 571,876) at the second, and maternal countries of birth (n = 109) at the third level. We disentangle offspring, maternal and maternal country of birth components of the total offspring heterogeneity in birthweight for babies born within the normal timespan (37-42 weeks). We found that of such birthweight variation about 50% was at the baby level, 47% at the maternal level and only 3% at the maternal countries of birth level. Conclusion In spite of seemingly large differences in average birthweight among maternal countries of birth (range 3290-3677g), knowledge of the maternal country of birth does not provide accurate information for ascertaining individual offspring birthweight because of the high inter-offspring heterogeneity around country averages. Our study exemplifies the need for a better understanding of individual health diversity for which group averages may provide insufficient and even misleading information. The analytical approach we outline is therefore relevant to investigations of country of birth (and ethnic) differences in health in general.	[Mulinari, Shai] Lund Univ, Fac Social Sci, Dept Sociol, Lund, Sweden; [Mulinari, Shai; Juarez, Sol Pia; Wagner, Philippe; Merlo, Juan] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden; [Juarez, Sol Pia] Stockholm Univ, Ctr Hlth Equity Studies, S-10691 Stockholm, Sweden; [Juarez, Sol Pia] Karolinska Inst, Stockholm, Sweden	Lund University; Lund University; Stockholm University; Karolinska Institutet	Mulinari, S (corresponding author), Lund Univ, Fac Social Sci, Dept Sociol, Lund, Sweden.	shai.mulinari@soc.lu.se	Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708; Mulinari, Shai/0000-0001-8773-9796	Swedish Research Council (VR) [2013-2484, 2013-1695]	Swedish Research Council (VR)(Swedish Research Council)	Swedish Research Council, www.vr.se (VR) [2013-2484 to JM] and [2013-1695 to SM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2005, PEDIATRICS, V115, pE20, DOI 10.1542/peds.2004-1306; Acevedo-Garcia D, 2007, SOC SCI MED, V65, P2503, DOI 10.1016/j.socscimed.2007.06.033; Alexander G R, 1999, Matern Child Health J, V3, P225, DOI 10.1023/A:1022381506823; ANANTH CV, 1995, EPIDEMIOLOGY, V6, P391, DOI 10.1097/00001648-199507000-00011; Beckman A, 2004, J EPIDEMIOL COMMUN H, V58, P145, DOI 10.1136/jech.58.2.145; Bergvall N, 2008, INT J EPIDEMIOL, V37, P185, DOI 10.1093/ije/dym167; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Browne WJ, 2009, J R STAT SOC A STAT, V172, P579, DOI 10.1111/j.1467-985X.2009.00586.x; Browne WJ, 2009, MCMC ESTIMATION IN M; Buekens P, 1998, AM J PUBLIC HEALTH, V88, P808, DOI 10.2105/AJPH.88.5.808; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Crispi F, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.011; CUNNINGHAM FG, 2005, WILLIAMS OBSTETRICS; D'Onofrio BM, 2010, CHILD DEV, V81, P80, DOI 10.1111/j.1467-8624.2009.01382.x; Eikenes L, 2012, PEDIATR RES, V72, P649, DOI 10.1038/pr.2012.129; Essink-Bot ML, 2013, EUR J PUBLIC HEALTH, V23, P922, DOI 10.1093/eurpub/cks170; Fang J, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.1.e5; Flores MES, 2012, WOMEN HEALTH ISS, V22, pE501, DOI 10.1016/j.whi.2012.07.005; Forssell L, 2013, CLIN GASTROENTEROL H, V11, P790, DOI 10.1016/j.cgh.2013.01.024; Forssell L, 2012, CLIN GASTROENTEROL H, V10, P1369, DOI 10.1016/j.cgh.2012.09.014; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Fuentes-Afflick E, 1998, ARCH PEDIAT ADOL MED, V152, P1105; Glymour C, 2014, EPIDEMIOLOGY, V25, P488, DOI 10.1097/EDE.0000000000000122; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Gould JB, 2003, PEDIATRICS, V111, pE676, DOI 10.1542/peds.111.6.e676; Guendelman S, 1999, Matern Child Health J, V3, P177, DOI 10.1023/A:1022328020935; Harding S, 2006, INT J EPIDEMIOL, V35, P270, DOI 10.1093/ije/dyi225; Hsieh WS, 2011, J WOMENS HEALTH, V20, P1083, DOI 10.1089/jwh.2011.2809; KALLEN B, 1995, EUR J EPIDEMIOL, V11, P601, DOI 10.1007/BF01719316; Kaufman JS, 2003, SOC SCI MED, V57, P2397, DOI 10.1016/S0277-9536(03)00135-7; Kaufman JS, 1999, AM J EPIDEMIOL, V150, P113; Kaufman JS, 2002, INT J EPIDEMIOL, V31, P431, DOI 10.1093/ije/31.2.431; Kelly Y, 2009, J PUBLIC HEALTH-UK, V31, P131, DOI 10.1093/pubmed/fdn057; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Lawlor DA, 2009, LIFE COURSE APPROACH; Lewontin RC, 2006, INT J EPIDEMIOL, V35, P520, DOI 10.1093/ije/dyl062; Li XJ, 2012, SCAND J PUBLIC HEALT, V40, P634, DOI 10.1177/1403494812458845; Lohaugen GCC, 2013, J PEDIATR-US, V163, P447, DOI 10.1016/j.jpeds.2013.01.060; MALAMITSIPUCHNER A, 1994, PAEDIATR PERINAT EP, V8, P384, DOI 10.1111/j.1365-3016.1994.tb00477.x; Maldonado G, 2002, INT J EPIDEMIOL, V31, P422, DOI 10.1093/ije/31.2.422; Speciale AM, 2011, J IMMIGR MINOR HEALT, V13, P518, DOI 10.1007/s10903-010-9365-1; McCowan L, 2009, BEST PRACT RES CL OB, V23, P779, DOI 10.1016/j.bpobgyn.2009.06.003; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2004, AM J EPIDEMIOL, V159, P1168, DOI 10.1093/aje/kwh160; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2001, J EPIDEMIOL COMMUN H, V55, P791, DOI 10.1136/jech.55.11.791; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Merlo J, 2013, EUR J EPIDEMIOL, V28, P135; Merlo J, 2013, EUR J EPIDEMIOL S, V28, P148; Merlo J, 2010, INT J EPIDEMIOL, V39, P936; Merlo J, 2014, AM J EPIDEMIOL, V180, P208, DOI 10.1093/aje/kwu108; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Moore GS, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.044; Nazroo JY, 2003, AM J PUBLIC HEALTH, V93, P277, DOI 10.2105/AJPH.93.2.277; Nielsen PR, 2012, SCHIZOPHR BULL, V12, P1337; Oakes JM, 2009, INT J EPIDEMIOL, V38, P361, DOI 10.1093/ije/dyn356; Oakes JM, 2004, SOC SCI MED, V58, P1929, DOI 10.1016/j.socscimed.2003.08.004; Odibo AO, 2006, AM J PERINAT, V23, P325, DOI 10.1055/s-2006-947164; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Peoples JG, 2012, HUMANITY AN INTRODUC; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Phung H, 2003, EUR J EPIDEMIOL, V18, P235, DOI 10.1023/A:1023384213536; Pozza RD, 2006, CLIN CARDIOL, V29, P215, DOI 10.1002/clc.4960290509; Rasbash J, 2009, MLWIN VERSION 21; RASMUSSEN F, 1995, PAEDIATR PERINAT EP, V9, P441, DOI 10.1111/j.1365-3016.1995.tb00167.x; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Rose G, 1992, THE STRATEGY OF PREV; Roux AVD, 2012, ANNU REV PUBL HEALTH, V33, P41, DOI 10.1146/annurev-publhealth-031811-124534; Rundle D, 1996, AUST NZ J OBSTET GYN, V36, P430, DOI 10.1111/j.1479-828X.1996.tb02186.x; Sen A, 1994, THE HUMAN DEVELOPMEN; Shah PS, 2011, MATERN CHILD HLTH J, V15, P1097, DOI 10.1007/s10995-010-0654-z; Spallek J, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-6; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Streimish IG, 2012, EARLY HUM DEV, V88, P765, DOI 10.1016/j.earlhumdev.2012.04.004; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, J PUBLIC HEALTH-UK, V31, P324, DOI 10.1093/pubmed/fdp070; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Teitler JO, 2007, PEDIATRICS, V120, pE1182, DOI 10.1542/peds.2006-3526; Urquia Fernandez MA, 2009, EUR J PUBLIC HEALTH, V21, P104; Urquia ML, 2012, SOC SCI MED, V74, P1610, DOI 10.1016/j.socscimed.2012.02.013; Urquia ML, 2009, AM J PUBLIC HEALTH, V99, P285, DOI 10.2105/AJPH.2007.127498; Urquia ML, 2010, J EPIDEMIOL COMMUN H, V64, P243, DOI 10.1136/jech.2008.083535; van de Lagemaat M, 2012, BONE, V51, P441, DOI 10.1016/j.bone.2012.06.017; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P473, DOI 10.1097/EDE.0000000000000105; WHO, 1995, B WHO S, V73, P98; WILCOX AJ, 1992, AM J PUBLIC HEALTH, V82, P378, DOI 10.2105/AJPH.82.3.378; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Wingren CJ, 2012, SCAND J GASTROENTERO, V47, P632, DOI 10.3109/00365521.2012.661760; World Health Organization, 1997, MONITORING REPRODUCT	94	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0129362	10.1371/journal.pone.0129362	http://dx.doi.org/10.1371/journal.pone.0129362			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0SC	26020535	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300125
J	Palardy, G; Chitnis, AB				Palardy, Gregory; Chitnis, Ajay B.			Identification of the Mind Bomb1 Interaction Domain in Zebrafish DeltaD	PLOS ONE			English	Article							RECEPTOR INTERNALIZATION; JUXTAMEMBRANE DOMAIN; PRIMARY NEUROGENESIS; UBIQUITIN LIGASE; NOTCH; ENDOCYTOSIS; ACTIVATION; DROSOPHILA; INHIBITION; HOMOLOG	Ubiquitylation promotes endocytosis of the Notch ligands like Delta and Serrate and is essential for them to effectively activate Notch in a neighboring cell. The RING E3 ligase Mind bomb1 (Mib1) ubiquitylates DeltaD to facilitate Notch signaling in zebrafish. We have identified a domain in the intracellular part of the zebrafish Notch ligand DeltaD that is essential for effective interactions with Mib1. We show that elimination of the Mind bomb1 Interaction Domain (MID) or mutation of specific conserved motifs in this domain prevents effective Mib1-mediated ubiquitylation and internalization of DeltaD. Lateral inhibition mediated by Notch signaling regulates early neurogenesis in zebrafish. In this context, Notch activation suppresses neurogenesis, while loss of Notch-mediated lateral inhibition results in a neurogenic phenotype, where too many cells are allowed to become neurons. While Mib1-mediated endocytosis of DeltaD is essential for effective activation of Notch in a neighboring cell (in trans) it is not required for DeltaD to inhibit function of Notch receptors in the same cell (in cis). As a result, forms of DeltaD that have the MID can activate Notch in trans and suppress early neurogenesis when mRNA encoding it is ectopically expressed in zebrafish embryos. On the other hand, when the MID is eliminated/mutated in DeltaD, its ability to activate Notch in trans fails but ability to inhibit in cis is retained. As a result, ectopic expression of DeltaD lacking an effective MID results in a failure of Notch-mediated lateral inhibition and a neurogenic phenotype.	[Palardy, Gregory; Chitnis, Ajay B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Chitnis, AB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	chitnisa@mail.nih.gov			Eunice Kennedy Shriver National Insitute of Child Health and Human Development [1ZIAHD001012]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001012] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Insitute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by the intramural program of the Eunice Kennedy Shriver National Insitute of Child Health and Human Development 1ZIAHD001012.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CARPENTIER JL, 1994, DIABETOLOGIA, V37, pS117, DOI 10.1007/BF00400835; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Daskalaki A, 2011, J CELL BIOL, V195, P1017, DOI 10.1083/jcb.201105166; Fleming RJ, 2013, DEVELOPMENT, V140, P2039, DOI 10.1242/dev.087916; Haddon C, 1998, DEVELOPMENT, V125, P359; Irandoust MI, 2007, EMBO J, V26, P1782, DOI 10.1038/sj.emboj.7601640; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Matsuda M, 2009, DEVELOPMENT, V136, P197, DOI 10.1242/dev.027938; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; MORI S, 1994, J BIOL CHEM, V269, P4917; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; MYLES GM, 1994, MOL CELL BIOL, V14, P4843, DOI 10.1128/MCB.14.7.4843; Palmer WH, 2014, ELIFE, V3, DOI 10.7554/eLife.04415; Penengo L, 2003, ONCOGENE, V22, P3669, DOI 10.1038/sj.onc.1206585; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; PRAGER D, 1994, J BIOL CHEM, V269, P11934; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wright GJ, 2011, DEVELOPMENT, V138, P2947, DOI 10.1242/dev.066654	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127864	10.1371/journal.pone.0127864	http://dx.doi.org/10.1371/journal.pone.0127864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020642	gold, Green Submitted, Green Published			2022-12-27	WOS:000355187300060
J	Baker, LA; Lee, KCL; Jimenez, CP; Alibhai, H; Chang, YM; Leckie, PJ; Mookerjee, RP; Davies, NA; Andreola, F; Jalan, R				Baker, Luisa A.; Lee, Karla C. L.; Jimenez, Carolina Palacios; Alibhai, Hatim; Chang, Yu-Mei; Leckie, Pamela J.; Mookerjee, Rajeshwar P.; Davies, Nathan A.; Andreola, Fausto; Jalan, Rajiv			Circulating microRNAs Reveal Time Course of Organ Injury in a Porcine Model of Acetaminophen-Induced Acute Liver Failure	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; INDUCED HEPATOTOXICITY; BIOMARKERS; CANCER; EXPRESSION; PROGNOSIS; THERAPY; MARKERS; GENES; MICE	Acute liver failure is a rare but catastrophic condition which can progress rapidly to multi-organ failure. Studies investigating the onset of individual organ injury such as the liver, kidneys and brain during the evolution of acute liver failure, are lacking. MicroRNAs are short, non-coding strands of RNA that are released into the circulation following tissue injury. In this study, we have characterised the release of both global microRNA and specific microRNA species into the plasma using a porcine model of acetaminophen-induced acute liver failure. Pigs were induced to acute liver failure with oral acetaminophen over 19h +/- 2h and death occurred 13h +/- 3h thereafter. Global microRNA concentrations increased 4h prior to acute liver failure in plasma (P<0.0001) but not in isolated exosomes, and were associated with increasing plasma levels of the damage-associated molecular pattern molecule, genomic DNA (P<0.0001). MiR122 increased around the time of onset of acute liver failure (P<0.0001) and was associated with increasing international normalised ratio (P<0.0001). MiR192 increased 8h after acute liver failure (P<0.0001) and was associated with increasing creatinine (P<0.0001). The increase in miR124-1 occurred concurrent with the pre-terminal increase in intracranial pressure (P<0.0001) and was associated with decreasing cerebral perfusion pressure (P<0.002).	[Baker, Luisa A.; Lee, Karla C. L.; Jimenez, Carolina Palacios; Alibhai, Hatim; Chang, Yu-Mei] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Leckie, Pamela J.; Mookerjee, Rajeshwar P.; Davies, Nathan A.; Andreola, Fausto; Jalan, Rajiv] UCL, Sch Med, Royal Free Hosp, Liver Failure Grp,Inst Liver & Digest Hlth, London W1N 8AA, England	University of London; University of London Royal Veterinary College; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Jalan, R (corresponding author), UCL, Sch Med, Royal Free Hosp, Liver Failure Grp,Inst Liver & Digest Hlth, Mortimer St, London W1N 8AA, England.	r.jalan@ucl.ac.uk	Jimenez, Carolina/GYD-8755-2022; Andreola, Fausto/L-2972-2018	Andreola, Fausto/0000-0003-4926-0121; Mookerjee, Rajeshwar/0000-0002-6275-9384; , Luisa/0000-0002-4526-5868	Medical Research Council, United Kingdom [G0902211]; MRC [G0902211] Funding Source: UKRI; Medical Research Council [G0902211] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided to NAD by a Development Pathway Funding Scheme Grant from the Medical Research Council, United Kingdom (G0902211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Antoine DJ, 2013, HEPATOLOGY, V58, P777, DOI 10.1002/hep.26294; Bajt ML, 2006, TOXICOL SCI, V94, P217, DOI 10.1093/toxsci/kfl077; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cholongitas E, 2012, LIVER TRANSPLANT, V18, P405, DOI 10.1002/lt.23370; Ekser B, 2012, XENOTRANSPLANTATION, V19, P52, DOI 10.1111/j.1399-3089.2011.00686.x; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Gilje P, 2014, CRIT CARE, V18, DOI 10.1186/cc13753; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoffmann WE, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P351, DOI 10.1016/B978-0-12-370491-7.00012-X; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; John K, 2014, HEPATOLOGY, V60, P1346, DOI 10.1002/hep.27250; Karali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022166; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lee KCL, 2013, LIVER INT, V33, P544, DOI 10.1111/liv.12042; Lee WM, 2012, NAT REV GASTRO HEPAT, V9, P192, DOI 10.1038/nrgastro.2012.34; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Martino F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038269; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mladinov D, 2013, NUCLEIC ACIDS RES, V41, P1273, DOI 10.1093/nar/gks1228; Moore JK, 2013, EXPERT REV GASTROENT, V7, P701, DOI 10.1586/17474124.2013.837264; O'Riordan A, 2011, NEPHROL DIAL TRANSPL, V26, P3501, DOI 10.1093/ndt/gfr050; OGRADY JG, 1993, LANCET, V342, P273; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stravitz RT, 2009, CRIT CARE MED, V37, pS258, DOI 10.1097/CCM.0b013e3181aa5fb8; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Timoneda O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055402; Timoneda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044413; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang Y, 2013, J APPL TOXICOL, V33, P1330, DOI 10.1002/jat.2864; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Williams CD, 2011, TOXICOL APPL PHARM, V252, P289, DOI 10.1016/j.taap.2011.03.001; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6	50	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128076	10.1371/journal.pone.0128076	http://dx.doi.org/10.1371/journal.pone.0128076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018205	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000355185600109
J	Golland, Y; Arzouan, Y; Levit-Binnun, N				Golland, Yulia; Arzouan, Yossi; Levit-Binnun, Nava			The Mere Co-Presence: Synchronization of Autonomic Signals and Emotional Responses across Co-Present Individuals Not Engaged in Direct Interaction	PLOS ONE			English	Article							FACIAL EXPRESSIONS; SOCIAL-INTERACTION; BRAIN ACTIVITY; CONVERGENCE; INFORMATION; DYNAMICS; IMPLICIT; BEHAVIOR; FLOW	Existing evidence suggests that in social contexts individuals become coupled in their emotions and behaviors. Furthermore, recent biological studies demonstrate that the physiological signals of interacting individuals become coupled as well, exhibiting temporally synchronized response patterns. However, it is yet unknown whether people can shape each other's responses without the direct, face-to-face interaction. Here we investigated whether the convergence of physiological and emotional states can occur among "merely co-present" individuals, without direct interactional exchanges. To this end, we measured continuous autonomic signals and collected emotional responses of participants who watched emotional movies together, seated side-by-side. We found that the autonomic signals of co-present participants were idiosyncratically synchronized and that the degree of this synchronization was correlated with the convergence of their emotional responses. These findings suggest that moment-to-moment emotional transmissions, resulting in shared emotional experiences, can occur in the absence of direct communication and are mediated by autonomic synchronization.	[Golland, Yulia; Arzouan, Yossi; Levit-Binnun, Nava] Interdisciplinary Ctr IDC, Baruch Ivcher Sch Psychol, Sagol Ctr Brain & Mind, Herzliyya, Israel	Reichman University	Golland, Y (corresponding author), Interdisciplinary Ctr IDC, Baruch Ivcher Sch Psychol, Sagol Ctr Brain & Mind, Herzliyya, Israel.	yulia.golland@gmail.com			Israel Science Foundation [1370/12]	Israel Science Foundation(Israel Science Foundation)	This research was supported by Israel Science Foundation, grant 1370/12, awarded to Yulia Golland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2011, NEUROIMAGE, V54, P439, DOI 10.1016/j.neuroimage.2010.07.004; Anderson C, 2003, J PERS SOC PSYCHOL, V84, P1054, DOI 10.1037/0022-3514.84.5.1054; Atmaca S, 2008, SOC NEUROSCI-UK, V3, P410, DOI 10.1080/17470910801900908; Babiloni F, 2014, NEUROSCI BIOBEHAV R, V44, P76, DOI 10.1016/j.neubiorev.2012.07.006; Bayle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021584; BERNTSON GG, 1990, PSYCHOPHYSIOLOGY, V27, P586, DOI 10.1111/j.1469-8986.1990.tb01982.x; Bruder M, 2012, COGNITION EMOTION, V26, P480, DOI 10.1080/02699931.2011.645280; Butler EA, 2011, PERS SOC PSYCHOL REV, V15, P367, DOI 10.1177/1088868311411164; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; CONDON WS, 1974, CHILD DEV, V45, P456; de Groot JHB, 2012, PSYCHOL SCI, V23, P1417, DOI 10.1177/0956797612445317; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1111/1469-8986.3750693; Dumas G, 2011, IRBM, V32, P48, DOI 10.1016/j.irbm.2011.01.002; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Gallotti M, 2013, TRENDS COGN SCI, V17, P160, DOI 10.1016/j.tics.2013.02.002; Golland Y, 2014, PSYCHOPHYSIOLOGY, V51, P1101, DOI 10.1111/psyp.12261; Gregory SW, 1996, J PERS SOC PSYCHOL, V70, P1231, DOI 10.1037/0022-3514.70.6.1231; Guastello Stephen J, 2006, Nonlinear Dynamics Psychol Life Sci, V10, P365; GUERIN B, 1986, J EXP SOC PSYCHOL, V22, P38, DOI 10.1016/0022-1031(86)90040-5; Hari R, 2013, TRENDS COGN SCI, V17, P105, DOI 10.1016/j.tics.2013.01.003; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hatfield E., 1994, REV PERSONALITY SOCI; Helm JL, 2012, EMOTION, V12, P748, DOI 10.1037/a0025036; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hess U, 2010, BIOL PSYCHOL, V84, P514, DOI 10.1016/j.biopsycho.2009.11.001; Kenny D.A., 1998, HDB SOCIAL PSYCHOL, V4th ed., P233; Konvalinka I, 2014, NEUROIMAGE, V94, P79, DOI 10.1016/j.neuroimage.2014.03.003; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; LEVENSON RW, 1983, J PERS SOC PSYCHOL, V45, P587, DOI 10.1037/0022-3514.45.3.587; LEVENSON RW, 1992, J PERS SOC PSYCHOL, V63, P234, DOI 10.1037/0022-3514.63.2.234; Levenson RW, 2003, ANN NY ACAD SCI, V1000, P348, DOI 10.1196/annals.1280.016; Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175; Muller V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024893; Nummenmaa L, 2012, P NATL ACAD SCI USA, V109, P9599, DOI 10.1073/pnas.1206095109; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Saxbe D, 2010, J PERS SOC PSYCHOL, V98, P92, DOI 10.1037/a0016959; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Soto JA, 2009, EMOTION, V9, P874, DOI 10.1037/a0017399; Spiegelhalder K, 2014, BEHAV BRAIN RES, V258, P75, DOI 10.1016/j.bbr.2013.10.015; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Wagner H, 1999, SOCIAL CONTEXT NONVE, P262; Yun K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00959	51	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125804	10.1371/journal.pone.0125804	http://dx.doi.org/10.1371/journal.pone.0125804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26018597	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600034
J	Wang, XJ; Yang, JF; Yang, J; Mencl, WE; Shu, H; Zevin, JD				Wang, Xiaojuan; Yang, Jianfeng; Yang, Jie; Mencl, W. Einar; Shu, Hua; Zevin, Jason David			Language Differences in the Brain Network for Reading in Naturalistic Story Reading and Lexical Decision	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; DIVISION-OF-LABOR; CHINESE CHARACTERS; NEURAL SYSTEMS; FMRI; ACTIVATION; CORTEX; MODEL; TASK; ORGANIZATION	Differences in how writing systems represent language raise important questions about whether there could be a universal functional architecture for reading across languages. In order to study potential language differences in the neural networks that support reading skill, we collected fMRI data from readers of alphabetic (English) and morpho-syllabic (Chinese) writing systems during two reading tasks. In one, participants read short stories under conditions that approximate natural reading, and in the other, participants decided whether individual stimuli were real words or not. Prior work comparing these two writing systems has overwhelmingly used meta-linguistic tasks, generally supporting the conclusion that the reading system is organized differently for skilled readers of Chinese and English. We observed that language differences in the reading network were greatly dependent on task. In lexical decision, a pattern consistent with prior research was observed in which the Middle Frontal Gyrus (MFG) and right Fusiform Gyrus (rFFG) were more active for Chinese than for English, whereas the posterior temporal sulcus was more active for English than for Chinese. We found a very different pattern of language effects in a naturalistic reading paradigm, during which significant differences were only observed in visual regions not typically considered specific to the reading network, and the middle temporal gyrus, which is thought to be important for direct mapping of orthography to semantics. Indeed, in areas that are often discussed as supporting distinct cognitive or linguistic functions between the two languages, we observed interaction. Specifically, language differences were most pronounced in MFG and rFFG during the lexical decision task, whereas no language differences were observed in these areas during silent reading of text for comprehension.	[Wang, Xiaojuan; Yang, Jianfeng] Shaanxi Normal Univ, Sch Psychol, Key Lab Behav & Cognit Neurosci Shaanxi Prov, Xian, Peoples R China; [Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Shu, Hua] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Yang, Jianfeng; Zevin, Jason David] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Yang, Jie] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Mencl, W. Einar; Zevin, Jason David] Yale Univ, Haskins Labs, New Haven, CT USA; [Zevin, Jason David] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Zevin, Jason David] Univ So Calif, Dept Linguist, Los Angeles, CA 90089 USA	Shaanxi Normal University; Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; University of California System; University of California Irvine; Yale University; Haskins Laboratories; University of Southern California; University of Southern California	Yang, J (corresponding author), Shaanxi Normal Univ, Sch Psychol, Key Lab Behav & Cognit Neurosci Shaanxi Prov, Xian, Peoples R China.	yangjf@snnu.edu.cn; zevin@usc.edu	Zevin, Jason/AAG-3266-2021; Yang, Jianfeng/P-6459-2015	Zevin, Jason/0000-0001-8929-5914; Yang, Jianfeng/0000-0002-8213-1201	National Key Basic Research Program of China [2014CB846103]; Natural Science Foundation of China [31271082, 31171077, 31400966]; Humanities and Social Sciences Foundation of the Ministry of Education [14YJC190019]; National Institutes of Health [P01 HD001994, R01 HD067364]; Chinese Academy of Sciences [2012Y1SA0004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD001994, R01HD067364] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and Social Sciences Foundation of the Ministry of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the National Key Basic Research Program of China (grant number 2014CB846103 to HS) Natural Science Foundation of China (grant numbers 31271082 to HS, 31171077 to JFY, 31400966 to XJW) Humanities and Social Sciences Foundation of the Ministry of Education (grant number 14YJC190019 to XJW) the National Institutes of Health (grant numbers P01 HD001994 and R01 HD067364 to JZ and WEM) and Chinese Academy of Sciences Fellowships for Young International Scientists (grant number 2012Y1SA0004 to JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo HF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00548; Argall BD, 2006, HUM BRAIN MAPP, V27, P14, DOI 10.1002/hbm.20158; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; BALOTA DA, 1984, J EXP PSYCHOL HUMAN, V10, P340, DOI 10.1037/0096-1523.10.3.340; Balota DA, 2006, FROM INKMARKS TO IDEAS: CURRENT ISSUES IN LEXICAL PROCESSING, P229; BERNDT RS, 1987, BEHAV RES METH INSTR, V19, P1, DOI 10.3758/BF03207663; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Blumenfeld HK, 2006, BRAIN LANG, V99, P226, DOI 10.1016/j.bandl.2005.07.004; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Brennan J, 2012, BRAIN LANG, V120, P163, DOI 10.1016/j.bandl.2010.04.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chee MWL, 2000, NEUROIMAGE, V12, P392, DOI 10.1006/nimg.2000.0631; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeFrancis John., 1989, VISIBLE SPEECH DIVER; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; Dehaene S, 2010, SCIENCE, V330, P1359, DOI 10.1126/science.1194140; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friederici AD, 2010, HUM BRAIN MAPP, V31, P448, DOI 10.1002/hbm.20878; Friedman L, 2006, NEUROIMAGE, V33, P471, DOI 10.1016/j.neuroimage.2006.07.012; Frost R, 2012, BEHAV BRAIN SCI, V35, P263, DOI 10.1017/S0140525X11001841; Frost SJ, 2005, NEUROREPORT, V16, P621, DOI 10.1097/00001756-200504250-00021; Frost SJ, 2009, ANN DYSLEXIA, V59, P78, DOI 10.1007/s11881-009-0024-y; Hansell M, 2003, SINOTIBETAN LANGUAGE, P156; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Hsiao JH, 2010, COGN AFFECT BEHAV NE, V10, P552, DOI 10.3758/CABN.10.4.552; Kuperberg GR, 2006, NEUROIMAGE, V33, P343, DOI 10.1016/j.neuroimage.2006.06.001; Liu Y, 2007, HUM BRAIN MAPP, V28, P1223, DOI 10.1002/hbm.20356; Nakamura K, 2007, P NATL ACAD SCI USA, V104, P19643, DOI 10.1073/pnas.0704487104; Nakamura K, 2012, P NATL ACAD SCI USA, V109, P20762, DOI 10.1073/pnas.1217749109; Obleser J, 2010, CEREB CORTEX, V20, P633, DOI 10.1093/cercor/bhp128; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Perfetti CA, 2005, PSYCHOL REV, V112, P43, DOI 10.1037/0033-295X.112.1.43; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Rogers TT, 2006, COGN AFFECT BEHAV NE, V6, P201, DOI 10.3758/CABN.6.3.201; Saad Z, 2004, INT S BIOM IM WASH D; Seidenberg M. S., 2011, DYSLEXIA LANGUAGES O, P151; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Siok WT, 2003, HUM BRAIN MAPP, V18, P201, DOI 10.1002/hbm.10094; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; St George M, 1999, BRAIN, V122, P1317, DOI 10.1093/brain/122.7.1317; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Talairach J., 1988, COPLANAR STEREOTAXIC; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tan LH, 2003, HUM BRAIN MAPP, V18, P158, DOI 10.1002/hbm.10089; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Vogel AC, 2012, CEREB CORTEX, V22, P2715, DOI 10.1093/cercor/bhr295; Wang XJ, 2011, NEUROIMAGE, V55, P1346, DOI 10.1016/j.neuroimage.2010.12.062; Wu CY, 2012, NEUROIMAGE, V63, P381, DOI 10.1016/j.neuroimage.2012.06.047; Yang J, 2014, NEUROSCIENCE, V272, P102, DOI 10.1016/j.neuroscience.2014.04.044; Yang J, 2012, 3 ANN C SOC NEUR LAN; Yang JF, 2013, BILING-LANG COGN, V16, P354, DOI 10.1017/S1366728912000296; Yang JF, 2012, NEUROIMAGE, V60, P979, DOI 10.1016/j.neuroimage.2012.01.036; Yang JF, 2011, BRAIN LANG, V119, P68, DOI 10.1016/j.bandl.2011.03.004; Yang JF, 2009, J MEM LANG, V61, P238, DOI 10.1016/j.jml.2009.05.001; Yoon HW, 2006, NEUROSCI LETT, V392, P90, DOI 10.1016/j.neulet.2005.09.027; Yoon HW, 2005, NEUROSCI LETT, V373, P206, DOI 10.1016/j.neulet.2004.10.021	66	43	45	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124388	10.1371/journal.pone.0124388	http://dx.doi.org/10.1371/journal.pone.0124388			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017384	Green Published, gold			2022-12-27	WOS:000355185600004
J	Hanifa, Y; Telisinghe, L; Fielding, KL; Malden, JL; Churchyard, GJ; Grant, AD; Charalambous, S				Hanifa, Yasmeen; Telisinghe, Lilanganee; Fielding, Katherine L.; Malden, Justin L.; Churchyard, Gavin J.; Grant, Alison D.; Charalambous, Salome			The Diagnostic Accuracy of Urine Lipoarabinomannan Test for Tuberculosis Screening in a South African Correctional Facility	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ASSAY	Background We evaluated the diagnostic accuracy of the urine lipoarabinomannan (LAM) antigen detection assay (Clearview TB-ELISA) to screen for tuberculosis in a South African correctional facility. Methods Between September 2009 and October 2010, male offenders were screened for tuberculosis (symptoms, chest radiograph, two spot sputum specimens for microscopy and culture), and urine tested for LAM. Sensitivity, specificity and predictive values of LAM were calculated using definite and probable tuberculosis combined as our gold standard. Findings 33/871 (3.8%) participants (26% HIV-positive) had tuberculosis. Amongst HIV-positive vs. HIV-negative offenders the sensitivity and specificity of LAM was 7.1% vs. 0% and 98.5% vs. 99.8% respectively. Conclusion Urine LAM ELISA has inadequate sensitivity for TB screening in this population.	[Hanifa, Yasmeen; Telisinghe, Lilanganee; Malden, Justin L.; Churchyard, Gavin J.; Charalambous, Salome] Aurum Inst, Johannesburg, South Africa; [Telisinghe, Lilanganee; Malden, Justin L.; Churchyard, Gavin J.] Univ KwaZulu Natal, CAPRISA, Durban, South Africa; [Fielding, Katherine L.; Churchyard, Gavin J.; Grant, Alison D.] London Sch Hyg & Trop Med, London WC1, England; [Charalambous, Salome] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand	Hanifa, Y (corresponding author), Aurum Inst, Johannesburg, South Africa.	yasmeen.hanifa@lshtm.ac.uk		Churchyard, Gavin/0000-0002-4269-3699; Charalambous, Salome/0000-0001-7143-1009; HANIFA, YASMEEN/0000-0002-1677-0697	Department of Health and Human Services/Centers for Disease Control and Prevention (CDC) [PS024055]; National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [PS024055]; Global AIDS Program (GAP) [PS024055]; Medical Research Council [MR/K012126/1] Funding Source: researchfish; National Institute for Health Research [ACF-2012-25-011] Funding Source: researchfish	Department of Health and Human Services/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP); Global AIDS Program (GAP); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Participants in this study were enrolled in treatment programmes supported by the U.S. President's Emergency Plan for AIDS Relief and by Cooperative Agreement Number PS024055 from the Department of Health and Human Services/Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Global AIDS Program (GAP). The content of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Department of Health-Republic of South Africa, 2013, GUIDELINES FOR THE M; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Telisinghe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087262; United Nations Office on Drugs and Crime, 2006, HIV AIDS PREVENTION	9	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127956	10.1371/journal.pone.0127956	http://dx.doi.org/10.1371/journal.pone.0127956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010840	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000355183900171
J	Matsunaga, A; Harita, Y; Shibagaki, Y; Shimizu, N; Shibuya, K; Ono, H; Kato, H; Sekine, T; Sakamoto, N; Igarashi, T; Hattori, S				Matsunaga, Atsuko; Harita, Yutaka; Shibagaki, Yoshio; Shimizu, Nobutaka; Shibuya, Kazuhiko; Ono, Hiroshi; Kato, Hitoshi; Sekine, Takashi; Sakamoto, Naoko; Igarashi, Takashi; Hattori, Seisuke			Identification of 4-Trimethylaminobutyraldehyde Dehydrogenase (TMABA-DH) as a Candidate Serum Autoantibody Target for Kawasaki Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENDOTHELIAL-CELLS; ANTIENDOTHELIAL CELL; CORONARY-ARTERY; ACUTE PHASE; T-CELLS; ANTIBODIES; NEUTROPHILS; SUSCEPTIBILITY; AUTOIMMUNITY	Kawasaki disease (KD), an acute vasculitis that preferentially affects coronary arteries, is still the leading cause of acquired heart disease in children. Although the involvement of immune system malfunction in the onset of KD is suggested, its etiology still remains to be clarified. We investigated autoantibodies in KD patients, which are frequently found in sera from patients with autoimmune diseases, vasculitides and arteritides. We performed two-dimensional western blotting and LC-MS/MS to analyze the antigens of autoantibodies, detected two protein spots with 4 out of 24 sera from KD patients but not with 6 control sera, and identified the antigens as 4-trimethylaminobutyraldehyde dehydrogenase (TMABA-DH). A slot blot analysis with TMABA-DH as an antigen also revealed higher reactivities of patients' sera than control sera (positive rates: 18/43 vs 3/41). Using an enzyme-linked immunosorbent assay (ELISA), we found that the reactivity of anti-TMABA-DH antibodies in sera from KD patients was significantly higher than that in sera from age-matched controls. The optimal cut-off value of 0.043 had a sensitivity of 83.7% and a specificity of 80.0% in detecting KD patients (positive rates: 37/43 for KD patients, 9/41 for controls). Immunohistochemistry performed on thin sections of rat heart revealed that TMABA-DH colocalized with myosin light chains in cardiac myocytes. Patient sera with high reactivity gave similar immunostaining pattern. These results suggest that the detection of anti-TMABA-DH autoantibody could be a potential strategy for a diagnosis of KD.	[Matsunaga, Atsuko; Harita, Yutaka; Hattori, Seisuke] Univ Tokyo, Inst Med Sci, Div Cellular Prote, Minato Ku, Tokyo, Japan; [Matsunaga, Atsuko; Shibagaki, Yoshio; Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Minato Ku, Tokyo 108, Japan; [Harita, Yutaka; Shimizu, Nobutaka; Sekine, Takashi; Igarashi, Takashi] Univ Tokyo, Dept Pediat, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Shibuya, Kazuhiko] Tokyo Metropolitan Childrens Med Ctr, Fuchu, Tokyo, Japan; [Ono, Hiroshi; Kato, Hitoshi; Sakamoto, Naoko; Igarashi, Takashi] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan; [Sekine, Takashi] Toho Univ, Sch Med, Dept Pediat, Ohashi Hosp,Meguro Ku, Tokyo, Japan	University of Tokyo; Kitasato University; University of Tokyo; Tokyo Metropolitan Children's Medical Center; National Center for Child Health & Development - Japan; Toho University	Hattori, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Prote, Minato Ku, Tokyo, Japan.	hattoris@pharm.kitasato-u.ac.jp		Matsunaga, Atsuko/0000-0002-4019-1249	Ministry of Health, Labour and Welfare, Japan	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This research was funded by the Ministry of Health, Labour and Welfare, Japan to SH (2009 to 2011, Health and Labour Sciences Research Grants to The Study Group for Treatment Guideline on Refractory Kawasaki Disease, SH is a member of The Study Group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE J, 1992, P NATL ACAD SCI USA, V89, P4066, DOI 10.1073/pnas.89.9.4066; Abe J, 2008, J ALLERGY CLIN IMMUN, V122, P1008, DOI 10.1016/j.jaci.2008.09.011; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; CHARLES LA, 1991, J LEUKOCYTE BIOL, V50, P539, DOI 10.1002/jlb.50.6.539; Cunningham MW, 1999, J IMMUNOL, V163, P1060; DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776; DeLaurenzi V, 1996, NAT GENET, V12, P52; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; Falk RJ, 1997, J AM SOC NEPHROL, V8, P314; Fujieda M, 1997, CLIN EXP IMMUNOL, V107, P120, DOI 10.1046/j.1365-2249.1997.d01-894.x; Fujieda M, 2012, MICROBIOL IMMUNOL, V56, P56, DOI 10.1111/j.1348-0421.2011.00393.x; Geraghty MT, 1998, HUM MOL GENET, V7, P1411, DOI 10.1093/hmg/7.9.1411; Gibson KM, 1998, NEUROPEDIATRICS, V29, P14, DOI 10.1055/s-2007-973527; HULSE JD, 1980, J BIOL CHEM, V255, P1146; Inada T, 2008, PHARMACOGENET GENOM, V18, P317, DOI 10.1097/FPC.0b013e3282f70492; JENNETTE JC, 1990, BLOOD, V75, P2263; Karasawa R, 2010, CLIN EXP IMMUNOL, V161, P459, DOI 10.1111/j.1365-2249.2010.04218.x; Katsumata Y, 2013, MOD RHEUMATOL, V23, P71, DOI 10.1007/s10165-012-0624-y; Katsumata Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005330; KAWASAKI T, 1967, JAP J ALLERG, V16, P178, DOI DOI 10.4070/KCJ.2018.0214; Kentsis A, 2013, EMBO MOL MED, V5, P210, DOI 10.1002/emmm.201201494; Lee KH, 2003, ARTHRITIS RHEUM, V48, P2025, DOI 10.1002/art.11074; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; LEUNG DYM, 1986, J CLIN INVEST, V77, P1428, DOI 10.1172/JCI112454; Leung DYM, 2002, J PEDIATR-US, V140, P742, DOI 10.1067/mpd.2002.123664; LEUNG DYM, 1986, J EXP MED, V164, P1958, DOI 10.1084/jem.164.6.1958; Lin SW, 1996, GENOMICS, V34, P376, DOI 10.1006/geno.1996.0300; LINDQVIST KJ, 1971, CLIN EXP IMMUNOL, V9, P753; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MATSUURA H, 1987, BRIT HEART J, V58, P385; Nussinovitch U, 2009, ARCH IMMUNOL THER EX, V57, P95, DOI 10.1007/s00005-009-0013-1; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Radford DJ, 2000, ARTHRITIS RHEUM, V43, P1337, DOI 10.1002/1529-0131(200006)43:6<1337::AID-ANR16>3.0.CO;2-M; Regent A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3388; Rizzo WB, 1999, AM J HUM GENET, V65, P1547, DOI 10.1086/302681; Rowley AH, 2000, J INFECT DIS, V182, P1183, DOI 10.1086/315832; Rowley AH, 1997, J IMMUNOL, V159, P5946; Rowley AH, 2001, J IMMUNOL, V166, P1334, DOI 10.4049/jimmunol.166.2.1334; SIMA D, 1994, ARTHRITIS RHEUM, V37, P441, DOI 10.1002/art.1780370323; Talha SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084050; TAN EM, 1972, ARTHRITIS RHEUM, V15, P23, DOI 10.1002/art.1780150104; Uchida T, 2013, J PROTEOMICS, V91, P259, DOI 10.1016/j.jprot.2013.07.021; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Yeter D, 2012, AUTOIMMUN REV, V11, P903, DOI 10.1016/j.autrev.2012.03.006; Yoneyama K, 2014, ANTICANCER RES, V34, P5021; Yoshioka T, 1999, IMMUNOLOGY, V96, P465, DOI 10.1046/j.1365-2567.1999.00695.x	48	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128189	10.1371/journal.pone.0128189	http://dx.doi.org/10.1371/journal.pone.0128189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010099	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900203
J	Soss, SE; Rose, KL; Hill, S; Jouan, S; Chazin, WJ				Soss, Sarah E.; Rose, Kristie L.; Hill, Salisha; Jouan, Sophie; Chazin, Walter J.			Biochemical and Proteomic Analysis of Ubiquitination of Hsc70 and Hsp70 by the E3 Ligase CHIP	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; IDENTIFICATION; COMPLEX; DEGRADATION; PROTEASOME; CHAPERONES; SUBSTRATE; ENZYMES; E2S	The E3 ubiquitin ligase CHIP is involved in protein triage, serving as a co-chaperone for refolding as well as catalyzing ubiquitination of substrates. CHIP functions with both the stress induced Hsp70 and constitutive Hsc70 chaperones, and also plays a role in maintaining their balance in the cell. When the chaperones carry no client proteins, CHIP catalyzes their polyubiquitination and subsequent proteasomal degradation. Although Hsp70 and Hsc70 are highly homologous in sequence and similar in structure, CHIP mediated ubiquitination promotes degradation of Hsp70 with a higher efficiency than for Hsc70. Here we report a detailed and systematic investigation to characterize if there are significant differences in the CHIP in vitro ubiquitination of human Hsp70 and Hsc70. Proteomic analysis by mass spectrometry revealed that only 12 of 39 detectable lysine residues were ubiquitinated by UbcH5a in Hsp70 and only 16 of 45 in Hsc70. The only conserved lysine identified as ubiquitinated in one but not the other heat shock protein was K159 in Hsc70. Ubiquitination assays with K-R ubiquitin mutants showed that multiple Ub chain types are formed and that the distribution is different for Hsp70 versus Hsc70. CHIP ubiquitination with the E2 enzyme Ube2W is predominantly directed to the N-terminal amine of the substrate; however, some internal lysine modifications were also detected. Together, our results provide a detailed view of the differences in CHIP ubiquitination of these two very similar proteins, and show a clear example where substantial differences in ubiquitination can be generated by a single E3 ligase in response to not only different E2 enzymes but subtle differences in the substrate.	[Soss, Sarah E.; Rose, Kristie L.; Hill, Salisha; Jouan, Sophie; Chazin, Walter J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Soss, Sarah E.; Jouan, Sophie; Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA; [Rose, Kristie L.; Hill, Salisha] Vanderbilt Univ, Mass Spectrometry Res Ctr, Nashville, TN 37235 USA; [Chazin, Walter J.] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Chazin, WJ (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	walter.chazin@vanderbilt.edu			U.S. National Institutes of Health [R01 GM075156, P30 CA068485, P30 ES000267]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075156] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research reported in this publication was supported by grants from the U.S. National Institutes of Health: R01 GM075156 (WJC), P30 CA068485 (Vanderbilt Ingram Cancer Center), and P30 ES000267 (Vanderbilt Center for Molecular Toxicology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Christensen DE, 2009, FEBS J, V276, P5381, DOI 10.1111/j.1742-4658.2009.07249.x; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Graf C, 2010, BIOCHEMISTRY-US, V49, P2121, DOI 10.1021/bi901829f; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Meyer B, 2011, AMINO ACIDS, V41, P291, DOI 10.1007/s00726-010-0680-6; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200	27	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128240	10.1371/journal.pone.0128240	http://dx.doi.org/10.1371/journal.pone.0128240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010904	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900213
J	Turan, A; You, J; Egan, C; Fu, A; Khanna, A; Eshraghi, Y; Ghosh, R; Bose, S; Qavi, S; Arora, L; Sessler, DI; Doufas, AG				Turan, Alparslan; You, Jing; Egan, Cameron; Fu, Alex; Khanna, Ashish; Eshraghi, Yashar; Ghosh, Raktim; Bose, Somnath; Qavi, Shahbaz; Arora, Lovkesh; Sessler, Daniel I.; Doufas, Anthony G.			Chronic Intermittent Hypoxia Is Independently Associated with Reduced Postoperative Opioid Consumption in Bariatric Patients Suffering from Sleep-Disordered Breathing	PLOS ONE			English	Article							RECURRENT HYPOXEMIA; PAIN SENSITIVITY; APNEA; DEPRIVATION; PREVALENCE; ACTIVATION; HYPOPNEA; CHILDREN; BINDING	Background Evidence suggests that recurrent nocturnal hypoxemia may affect pain response and/or the sensitivity to opioid analgesia. We tested the hypothesis that nocturnal hypoxemia, quantified by sleep time spent at an arterial saturation (SaO(2)) < 90% and minimum nocturnal SaO(2) on polysomnography, are associated with decreased pain and reduced opioid consumption during the initial 72 postoperative hours in patients having laparoscopic bariatric surgery. Methods With Institutional Review Board approval, we examined the records of all patients who underwent laparoscopic bariatric surgery between 2004 and 2010 and had an available nocturnal polysomnography study. We assessed the relationships between the time-weighted average of pain score and total opioid consumption during the initial 72 postoperative hours, and: (a) the percentage of total sleep time spent at SaO(2) < 90%, (b) the minimum nocturnal SaO(2), and (c) the number of apnea/hypopnea episodes per hour of sleep. We used multivariable regression models to adjust for both clinical and sleep-related confounders. Results Two hundred eighteen patients were included in the analysis. Percentage of total sleep time spent at SaO(2) <90% was inversely associated with total postoperative opioid consumption; a 5-%-absolute increase in the former would relatively decrease median opioid consumption by 16% (98.75% CI: 2% to 28%, P = 0.006). However, the percentage of total sleep time spent at SaO(2) < 90% was not associated with pain. The minimum nocturnal SaO2 was associated neither with total postoperative opioid consumption nor with pain. In addition, neither pain nor total opioid consumption was significantly associated with the number of apnea/hypopnea episodes per hour of sleep. Conclusions Preoperative nocturnal intermittent hypoxia may enhance sensitivity to opioids.	[Turan, Alparslan; You, Jing; Egan, Cameron; Fu, Alex; Eshraghi, Yashar; Ghosh, Raktim; Sessler, Daniel I.] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA; [You, Jing] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Khanna, Ashish; Bose, Somnath; Qavi, Shahbaz; Arora, Lovkesh] Cleveland Clin, Inst Anesthesiol, Cleveland, OH USA; [Doufas, Anthony G.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Doufas, Anthony G.] Outcomes Res Consortium, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Stanford University	Doufas, AG (corresponding author), Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA.	agdoufas@stanford.edu	Egan, Cameron/AAG-1783-2021; Bose, Somnath/AAI-9003-2020; Sessler, Daniel/D-3504-2011; Eshraghi, Yashar/X-3885-2019; Ghosh, Raktim K/E-9828-2015; Doufas, Anthony G/L-9297-2019	Bose, Somnath/0000-0001-7310-9881; Sessler, Daniel/0000-0001-9932-3077; Ghosh, Raktim K/0000-0001-8401-4298; Egan, Cameron/0000-0002-8927-7588; Arora, Lovkesh/0000-0002-4142-2870				BONNET MH, 1992, SLEEP, V15, P526; Brown KA, 2004, ANESTHESIOLOGY, V100, P806, DOI 10.1097/00000542-200404000-00009; Brown KA, 2006, ANESTHESIOLOGY, V105, P665, DOI 10.1097/00000542-200610000-00009; Brown KA, 2009, ANESTHESIOLOGY, V110, P922, DOI 10.1097/ALN.0b013e31819c480a; Chervin RD, 2005, AM J RESP CRIT CARE, V171, P652, DOI 10.1164/rccm.200408-1056OC; Doufas AG, 2013, ANESTHESIOLOGY, V119, P1149, DOI 10.1097/ALN.0b013e3182a951fc; Doufas AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054807; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Farag E, 2014, ANESTHESIOLOGY, V121, P239, DOI 10.1097/ALN.0000000000000262; Finan PH, 2013, J PAIN, V14, P1539, DOI 10.1016/j.jpain.2013.08.007; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Gammaitoni AR, 2003, CLIN J PAIN, V19, P286, DOI 10.1097/00002508-200309000-00002; GUILLEMINAULT C, 1988, CHEST, V94, P32, DOI 10.1378/chest.94.1.32; Haack M, 2012, EUR J PAIN, V16, P522, DOI 10.1016/j.ejpain.2011.07.007; Haack M, 2009, PAIN, V145, P136, DOI 10.1016/j.pain.2009.05.029; Iber C, 2005, INT CLASSIFICATION S; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Khalid I, 2011, SLEEP, V34, P1687, DOI 10.5665/sleep.1436; Knotkova H, 2009, J PAIN SYMPTOM MANAG, V38, P426, DOI 10.1016/j.jpainsymman.2009.06.001; Laferriere A, 2003, BRAIN RES BULL, V59, P307, DOI 10.1016/S0361-9230(02)00915-2; Lerman Jerrold, 2006, Anesthesiology, V105, P645, DOI 10.1097/00000542-200610000-00004; Liao P, 2013, 2013 ASA ANN M; Mascha EJ, 2013, ANESTH ANALG, V117, P980, DOI 10.1213/ANE.0b013e3182a44cb9; Moss IR, 2006, ANESTHESIOLOGY, V105, P715, DOI 10.1097/00000542-200610000-00017; Moss IR, 2002, RESP PHYSIOL NEUROBI, V131, P15, DOI 10.1016/S1569-9048(02)00034-4; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Punjabi NM, 2008, AM J RESP CRIT CARE, V177, P1150, DOI 10.1164/rccm.200712-1884OC; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Redline S, 1997, SLEEP, V20, P1209, DOI 10.1093/sleep/20.12.1209; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Roehrs T, 2006, SLEEP, V29, P145, DOI 10.1093/sleep/29.2.145; Sadhasivam S, 2012, PEDIATRICS, V129, P832, DOI 10.1542/peds.2011-2607; Smith MT, 2007, SLEEP, V30, P494, DOI 10.1093/sleep/30.4.494; Smith MT, 2009, SLEEP, V32, P779, DOI 10.1093/sleep/32.6.779; Turan A, 2013, CLIN J PAIN, V29, P1050, DOI 10.1097/AJP.0b013e318287a258; Weingarten TN, 2011, OBES SURG, V21, P1407, DOI 10.1007/s11695-010-0217-9	38	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127809	10.1371/journal.pone.0127809	http://dx.doi.org/10.1371/journal.pone.0127809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010491	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900148
J	Yan, H; Liu, RQ; Liu, ZN; Wang, X; Luo, WB; Sheng, LX				Yan, Hong; Liu, Ruiquan; Liu, Zinan; Wang, Xue; Luo, Wenbo; Sheng, Lianxi			Growth and Physiological Responses to Water Depths in Carex schmidtii Meinsh.	PLOS ONE			English	Article							SUBMERGED WETLAND PLANTS; INDUCED SHOOT ELONGATION; RESOURCE-ALLOCATION; UNDERWATER PHOTOSYNTHESIS; FLOODING TOLERANCE; MEIONECTES-BROWNII; BIOMASS ALLOCATION; NATURAL VARIATION; SEDIMENT TYPE; STRESS	A greenhouse experiment was performed to investigate growth and physiological responses to water depth in completely submerged condition of a wetland plant Carex schmidtii Meinsh., one of the dominant species in the Longwan Crater Lake wetlands (China). Growth and physiological responses of C. schmidtii were investigated by growing under control (non-submerged) and three submerged conditions (5 cm, 15 cm and 25 cm water level). Total biomass was highest in control, intermediate in 5 cm treatment and lowest in the other two submerged treatments. Water depth prominently affected the first-order lateral root to main root mass ratio. Alcohol dehydrogenase (ADH) activity decreased but malondialdehyde (MDA) content increased as water depth increased. The starch contents showed no differences among the various treatments at the end of the experiment. However, soluble sugar contents were highest in control, intermediate in 5 cm and 15 cm treatments and lowest in 25 cm treatment. Our data suggest that submergence depth affected some aspects of growth and physiology of C. schmidtii, which can reduce anoxia damage not only through maintaining the non-elongation strategy in shoot part but also by adjusting biomass allocation to different root orders rather than adjusting root-shoot biomass allocation.	[Yan, Hong; Liu, Ruiquan; Liu, Zinan; Wang, Xue; Luo, Wenbo; Sheng, Lianxi] NE Normal Univ, Sch Environm, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Yan, Hong] Jilin Prov Acad Forestry Sci, Changchun, Peoples R China; [Luo, Wenbo] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Northeast Normal University - China; University of Montana System; University of Montana	Luo, WB (corresponding author), NE Normal Univ, Sch Environm, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China.	luowb330@nenu.edu.cn; shenglx@nenu.edu.cn			National Natural Science Foundation of China [31000184]; Environmental Public Welfare Sector Special Research Project [2011467032]; Natural Science Foundation Project [20130101111 JC]; China National special funds of science and technology for control and remediation of water pollution [2012ZX07201-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environmental Public Welfare Sector Special Research Project; Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); China National special funds of science and technology for control and remediation of water pollution	This study was supported by the National Natural Science Foundation of China (31000184), Environmental Public Welfare Sector Special Research Project (2011467032), Natural Science Foundation Project (20130101111 JC) and China National special funds of science and technology for control and remediation of water pollution (2012ZX07201-001).	Albrecht BG, 1997, NEW PHYTOL, V136, P137; Alcoverro T, 1999, MAR ECOL PROG SER, V187, P121, DOI 10.3354/meps187121; Armstrong W, 2000, PLANT ROOTS HIDDEN H, P729; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bailey-Serres J, 2010, CURR OPIN PLANT BIOL, V13, P489, DOI 10.1016/j.pbi.2010.08.002; Barrat-Segretain MH, 2007, AQUAT BOT, V87, P255, DOI 10.1016/j.aquabot.2007.06.009; Blom CWPM, 1996, TRENDS ECOL EVOL, V11, P290, DOI 10.1016/0169-5347(96)10034-3; Budelsky RA, 2000, J APPL ECOL, V37, P971, DOI 10.1046/j.1365-2664.2000.00540.x; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; Chen X, 2011, NEW PHYTOL, V190, P409, DOI 10.1111/j.1469-8137.2010.03639.x; Chen X, 2010, PLANT PHYSIOL, V154, P969, DOI 10.1104/pp.110.162792; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Colmer TD, 2008, NEW PHYTOL, V177, P918, DOI 10.1111/j.1469-8137.2007.02318.x; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; Das KK, 2005, PLANT SCI, V168, P131, DOI 10.1016/j.plantsci.2004.07.023; Edwards AL, 2003, CAN J BOT, V81, P964, DOI 10.1139/B03-091; Fraser LH, 2005, WETLANDS, V25, P520, DOI 10.1672/0277-5212(2005)025[0520:ACAOSS]2.0.CO;2; Fukao T, 2009, ANN BOT-LONDON, V103, P143, DOI 10.1093/aob/mcn172; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Li YZ, 2007, AQUAT BOT, V86, P295, DOI 10.1016/j.aquabot.2006.11.001; Luo WB, 2008, WETLANDS, V28, P866, DOI 10.1672/07-225.1; Luo WB, 2009, HYDROBIOLOGIA, V624, P151, DOI 10.1007/s10750-008-9689-1; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Munne-Bosch S, 2002, PLANTA, V214, P608, DOI 10.1007/s004250100646; Nabben RHM, 1999, NEW PHYTOL, V144, P313, DOI 10.1046/j.1469-8137.1999.00519.x; Pierik R, 2009, ANN BOT-LONDON, V103, P353, DOI 10.1093/aob/mcn143; Rich SM, 2013, PLANT CELL ENVIRON, V36, P213, DOI 10.1111/j.1365-3040.2012.02568.x; Rich SM, 2012, ANN BOT-LONDON, V110, P405, DOI 10.1093/aob/mcs051; Ridge I., 1987, Plant life in aquatic and amphibious habitats., P53; Sauter M, 2000, NATURWISSENSCHAFTEN, V87, P289, DOI 10.1007/s001140050725; Setter TL, 1996, J EXP BOT, V47, P1551, DOI 10.1093/jxb/47.10.1551; Sofo A, 2004, PHYSIOL PLANTARUM, V121, P58, DOI 10.1111/j.0031-9317.2004.00294.x; Visser EJW, 2000, NEW PHYTOL, V148, P93, DOI 10.1046/j.1469-8137.2000.00742.x; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Voesenek LACJ, 2004, ECOLOGY, V85, P16, DOI 10.1890/02-740; Wang QL, 2014, FLORA, V209, P279, DOI 10.1016/j.flora.2014.03.006; WEBB T, 1983, J EXP BOT, V34, P579, DOI 10.1093/jxb/34.5.579; WIGNARAJAH K, 1976, NEW PHYTOL, V77, P585, DOI 10.1111/j.1469-8137.1976.tb04650.x; Xie YH, 2005, FRESHWATER BIOL, V50, P391, DOI 10.1111/j.1365-2427.2004.01327.x; Xie Y, 2007, ANN BOT-LONDON, V100, P1517, DOI 10.1093/aob/mcm236; Yoshida S, 1971, INT RICE RES I; Zedler JB, 2010, FRONT ECOL ENVIRON, V8, P540, DOI 10.1890/090109	44	13	19	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128176	10.1371/journal.pone.0128176	http://dx.doi.org/10.1371/journal.pone.0128176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009895	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900202
J	Goodman, CA; Pol, D; Zacharewicz, E; Lee-Young, RS; Snow, RJ; Russell, AP; McConell, GK				Goodman, Craig A.; Pol, Derk; Zacharewicz, Evelyn; Lee-Young, Robert S.; Snow, Rod J.; Russell, Aaron P.; McConell, Glenn K.			Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1 alpha Protein and Mitochondrial Content	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PYRUVATE-DEHYDROGENASE COMPLEX; SKELETAL-MUSCLE; UP-REGULATION; LIPOPROTEIN-LIPASE; INSULIN-RESISTANCE; UBIQUITIN LIGASES; KINASE; MYOPATHY; ACTIVATION	One serious side effect of statin drugs is skeletal muscle myopathy. Although the mechanism(s) responsible for statin myopathy remains to be fully determined, an increase in muscle atrophy gene expression and changes in mitochondrial content and/or function have been proposed to play a role. In this study, we examined the relationship between statin-induced expression of muscle atrophy genes, regulators of mitochondrial biogenesis, and markers of mitochondrial content in slow-(ST) and fast-twitch (FT) rat skeletal muscles. Male Sprague Dawley rats were treated with simvastatin (60 or 80 mg.kg(-1).day(-1)) or vehicle control via oral gavage for 14 days. In the absence of overt muscle damage, simvastatin treatment induced an increase in atrogin-1, MuRF1 and myostatin mRNA expression; however, these were not associated with changes in peroxisome proliferator gamma co-activator 1 alpha (PGC-1 alpha) protein or markers of mitochondrial content. Simvastatin did, however, increase neuronal nitric oxide synthase (nNOS), endothelial NOS (eNOS) and AMPK alpha-subunit protein expression, and tended to increase total NOS activity, in FT but not ST muscles. Furthermore, simvastatin induced a decrease in beta-hydroxyacyl CoA dehydrogenase (beta-HAD) activity only in FT muscles. These findings suggest that the statin-induced activation of muscle atrophy genes occurs independent of changes in PGC-1 alpha protein and mitochondrial content. Moreover, muscle-specific increases in NOS expression and possibly NO production, and decreases in fatty acid oxidation, could contribute to the previously reported development of overt statin-induced muscle damage in FT muscles.	[Goodman, Craig A.; Pol, Derk; McConell, Glenn K.] Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia; [Goodman, Craig A.; McConell, Glenn K.] Victoria Univ, Inst Sport Exercise & Active Living, Melbourne, Vic 8001, Australia; [Goodman, Craig A.; McConell, Glenn K.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia; [Zacharewicz, Evelyn; Snow, Rod J.; Russell, Aaron P.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr, Burwood, Vic, Australia; [Lee-Young, Robert S.] Baker IDI Heart & Diabet Inst, Div Metab & Obes, Cellular & Mol Metab Lab, Melbourne, Australia	University of Melbourne; Victoria University; Victoria University; Deakin University; Baker Heart and Diabetes Institute	Goodman, CA (corresponding author), Univ Melbourne, Dept Physiol, Parkville, Vic 3052, Australia.	craig.goodman@vu.edu.au	Goodman, Craig/H-8085-2019; Snow, Rod J/G-1673-2010; Zacharewicz, Evelyn/T-5989-2019	Goodman, Craig/0000-0002-5874-7743; Snow, Rod J/0000-0002-4796-6916; Lee, Robert/0000-0002-8166-142X; Russell, Aaron/0000-0002-7323-9501; McConell, Glenn/0000-0002-8572-9065	Pfizer Inc., (Kent, UK)	Pfizer Inc., (Kent, UK)(Pfizer)	This research was supported by a grant from Pfizer Inc., (Kent, UK). The funder had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar MH, 2015, DIABETES-METAB RES, V31, P453, DOI 10.1002/dmrr.2601; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Buettner C, 2008, PHARMACOGENOMICS, V9, P1133, DOI 10.2217/14622416.9.8.1133; Cannata DJ, 2010, PEDIATR RES, V68, P393, DOI 10.1203/PDR.0b013e3181f1c048; Cao PR, 2009, FASEB J, V23, P2844, DOI 10.1096/fj.08-128843; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Constantin-Teodosiu D, 2013, DIABETES METAB J, V37, P301, DOI 10.4093/dmj.2013.37.5.301; Das AK, 2012, BIOCHEM BIOPH RES CO, V427, P36, DOI 10.1016/j.bbrc.2012.08.138; DePinieux G, 1996, BRIT J CLIN PHARMACO, V42, P333, DOI 10.1046/j.1365-2125.1996.04178.x; Dorajoo R, 2008, LIFE SCI, V82, P823, DOI 10.1016/j.lfs.2008.01.021; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Fujii T, 2008, AM J PHYSIOL-HEART C, V294, pH2785, DOI 10.1152/ajpheart.00149.2008; Gambelli S., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P85; Gao L, 2008, J PHARMACOL EXP THER, V326, P278, DOI 10.1124/jpet.107.136028; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; Gouni-Berthold I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072858; Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741; Harper CR, 2007, CURR OPIN LIPIDOL, V18, P401, DOI 10.1097/MOL.0b013e32825a6773; Hermida N, 2013, CARDIOVASC RES, V99, P44, DOI 10.1093/cvr/cvt070; Ito D, 2010, J HYPERTENS, V28, P2278, DOI 10.1097/HJH.0b013e32833e0924; Jukema JW, 2008, HEART, V94, P1656, DOI 10.1136/hrt.2008.151506; Kaji H, 2008, HORM METAB RES, V40, P746, DOI 10.1055/s-0028-1082051; Kaufmann P, 2006, CELL MOL LIFE SCI, V63, P2415, DOI 10.1007/s00018-006-6235-z; Kosmidou I, 2007, ARTERIOSCL THROM VAS, V27, P2642, DOI 10.1161/ATVBAHA.107.154492; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 2003, EUR J CLIN PHARMACOL, V58, P719, DOI 10.1007/s00228-002-0556-0; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee DH, 2014, JAMA INTERNAL MEDICI; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Leger B, 2006, FASEB J, V20, P583, DOI 10.1096/fj.05-5249fje; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Mallinson JE, 2012, J PHYSIOL-LONDON, V590, P6389, DOI 10.1113/jphysiol.2012.238022; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Meador BM, 2010, MUSCLE NERVE, V42, P469, DOI 10.1002/mus.21817; Mullen PJ, 2011, BBA-MOL CELL RES, V1813, P2079, DOI 10.1016/j.bbamcr.2011.07.019; Nadanaciva S, 2007, TOXICOL APPL PHARM, V223, P277, DOI 10.1016/j.taap.2007.06.003; Nakata S, 2007, ARTERIOSCL THROM VAS, V27, P92, DOI 10.1161/01.ATV.0000251615.61858.33; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Ohira M, 2012, METABOLISM, V61, P1452, DOI 10.1016/j.metabol.2012.03.010; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Parker BA, 2012, EXERC SPORT SCI REV, V40, P188, DOI 10.1097/JES.0b013e31826c169e; Pencina MJ, 2014, NEW ENGLAND JOURNAL, DOI [10.1056/NEJMoa1315665:null, DOI 10.1056/NEJMOA1315665:NULL]; Phillips PS, 2004, ATHEROSCLEROSIS, V177, P183, DOI 10.1016/j.atherosclerosis.2004.06.014; Phillips PS, 2002, ANN INTERN MED, V137, P581, DOI 10.7326/0003-4819-137-7-200210010-00009; Phillips PS, 2002, ATHEROSCLER THROMB V, V22, P878; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Rodriguez-Vita J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003959; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; SATO A, 1991, BIOCHEM PHARMACOL, V41, P1163, DOI 10.1016/0006-2952(91)90654-N; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schaefer WH, 2004, TOXICOL APPL PHARM, V194, P10, DOI 10.1016/j.taap.2003.08.013; Schick BA, 2007, CLIN PHARMACOL THER, V81, P650, DOI 10.1038/sj.clpt.6100124; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108; SMITH PF, 1991, J PHARMACOL EXP THER, V257, P1225; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Stringer HAJ, 2013, J NEUROL SCI, V325, P142, DOI 10.1016/j.jns.2012.12.023; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Suzuki N, 2010, J NEUROL SCI, V294, P95, DOI 10.1016/j.jns.2010.03.022; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Vaughan RA, 2013, EUR J PHARMACOL, V711, P1, DOI 10.1016/j.ejphar.2013.04.009; Venero CV, 2009, ENDOCRIN METAB CLIN, V38, P121, DOI 10.1016/j.ecl.2008.11.002; Wadley GD, 2007, J APPL PHYSIOL, V102, P314, DOI 10.1152/japplphysiol.00549.2006; Westwood FR, 2005, TOXICOL PATHOL, V33, P246, DOI 10.1080/01926230590908213; Westwood FR, 2008, TOXICOL PATHOL; Williams D, 2002, CLIN PHARMACOKINET, V41, P343, DOI 10.2165/00003088-200241050-00003; Yokoyama M, 2007, J LIPID RES, V48, P646, DOI 10.1194/jlr.M600301-JLR200	74	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128398	10.1371/journal.pone.0128398	http://dx.doi.org/10.1371/journal.pone.0128398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020641	Green Published, Green Accepted, gold			2022-12-27	WOS:000355187300108
J	Nascimento, CS; Barbosa, LT; Brito, C; Fernandes, RPM; Mann, RS; Pinto, APG; Oliveira, HC; Dodson, MV; Guimaraes, SEF; Duarte, MS				Nascimento, Carlos S.; Barbosa, Leandro T.; Brito, Claudson; Fernandes, Roberta P. M.; Mann, Renata S.; Pinto, Ana Paula G.; Oliveira, Haniel C.; Dodson, Mike V.; Guimaraes, Simone E. F.; Duarte, Marcio S.			Identification of Suitable Reference Genes for Real Time Quantitative Polymerase Chain Reaction Assays on Pectoralis major Muscle in Chicken (Gallus gallus)	PLOS ONE			English	Article							RT-PCR; EXPRESSION; NORMALIZATION; QUANTIFICATION; MODEL	Thirteen reference genes were investigated to determine their stability to be used as a housekeeping in gene expression studies in skeletal muscle of chickens. Five different algorithms were used for ranking of reference genes and results suggested that individual rankings of the genes differed among them. The stability of the expression of reference genes were validated using samples obtained from the Pectoralis major muscle in chicken. Samples were obtained from chickens in different development periods post hatch and under different nutritional diets. For gene expression calculation the Delta Delta Ct approach was applied to compare relative expression of pairs of genes within each of 52 samples when normalized to mitochondrially encoded cytochrome c oxidase II (MT-CO2) target gene. Our findings showed that hydroxymethylbilane synthase (HMBS) and hypoxanthine phosphoribosyl transferase 1 (HPRT1) are the most stable reference genes while transferrin receptor (TFRC) and beta-2-microglobulin (B2M) ranked as the least stable genes in the Pectoralis major muscle of chickens. Moreover, our results revealed that HMBS and HPRT1 gene expression did not change due to dietary variations and thus it is recommended for accurate normalization of RT-qPCR data in chicken Pectoralis major muscle.	[Nascimento, Carlos S.; Barbosa, Leandro T.; Brito, Claudson; Pinto, Ana Paula G.] Univ Fed Sergipe, Dept Anim Sci, Sao Cristovao, Sergipe, Brazil; [Fernandes, Roberta P. M.] Univ Fed Sergipe, Dept Physiol, Sao Cristovao, Sergipe, Brazil; [Mann, Renata S.] Univ Fed Sergipe, Dept Crop Sci, Sao Cristovao, Sergipe, Brazil; [Oliveira, Haniel C.] Univ Estadual Santa Cruz, Dept Anim Sci, Ilheus, BA, Brazil; [Dodson, Mike V.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Guimaraes, Simone E. F.; Duarte, Marcio S.] Univ Fed Vicosa, Dept Anim Sci, Anim Biotechnol Lab LABTEC, Vicosa, MG, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Estadual de Santa Cruz; Washington State University; Universidade Federal de Vicosa	Duarte, MS (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Anim Biotechnol Lab LABTEC, Vicosa, MG, Brazil.	marcio.duarte@ufv.br	Silva-Mann, Renata/ABB-7192-2020; Fernandes, Roberta/J-4301-2014; Duarte, Marcio/G-3815-2015; Silva-Mann, Renata/J-7954-2012; Brito, Claudson/AAE-3380-2019; Barbosa, Leandro/V-3649-2019; facioni guimaraes, simone eliza/HHZ-5341-2022	Silva-Mann, Renata/0000-0001-5993-3161; Fernandes, Roberta/0000-0003-1467-3946; Duarte, Marcio/0000-0002-5795-6420; Silva-Mann, Renata/0000-0001-5993-3161; Brito, Claudson/0000-0002-3339-8647; Barbosa, Leandro/0000-0002-1580-8913; facioni guimaraes, simone eliza/0000-0003-3704-8131	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe (FAPITEC) in Brazil	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe (FAPITEC) in Brazil	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Apoio a Pesquisa e a Inovacao Tecnologica do Estado de Sergipe (FAPITEC) in Brazil for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basu U, 2009, NUTR BIOCH GENOMICS, P30; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Ling DJ, 2012, PLOS ONE, P7; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Giner M, 2013, PLOS ONE, P8; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Najafpanah MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083041; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rostagno H.S., 2011, COMPOSICAO ALIMENTOS, V2, P186; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013; Yang Falong, 2013, BMC Res Notes, V6, P402, DOI 10.1186/1756-0500-6-402; Zang R, 2011, ASIAN J ANIM VET ADV, V6, P789, DOI 10.3923/ajava.2011.789.804	23	35	37	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127935	10.1371/journal.pone.0127935	http://dx.doi.org/10.1371/journal.pone.0127935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020643	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300066
J	Lin, FY; Tsao, NW; Shih, CM; Lin, YW; Yeh, JS; Chen, JW; Nakagami, H; Morishita, R; Sawamura, T; Huang, CY				Lin, Feng-Yen; Tsao, Nai-Wen; Shih, Chun-Ming; Lin, Yi-Wen; Yeh, Jong-Shiua; Chen, Jaw-Wen; Nakagami, Hironori; Morishita, Ryuichi; Sawamura, Tatsuya; Huang, Chun-Yao			The Biphasic Effects of Oxidized-Low Density Lipoprotein on the Vasculogenic Function of Endothelial Progenitor Cells	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CARDIOVASCULAR RISK-FACTORS; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; HEART-DISEASE; GENERAL-POPULATION; IN-VIVO; OX-LDL; PATHWAY; MORTALITY	Late-outgrowth endothelial progenitor cells (EPCs) are stress-resistant and responsible for reparative functions in the cardiovascular system. Oxidized-LDL (oxLDL) plays a critical role in cardiovascular disease pathogenesis. However, it is largely unknown what the impacts of oxLDL are on late-outgrowth EPCs. This study aimed to investigate the concentration- related effects of oxLDL on EPC functions and related angiogenesis, in vitro and in vivo. In this study, early and late-outgrowth EPCs were generated from circulating human mononuclear cells. oxLDL may regulate EPC vasculogenic function via the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1). Lower concentrations (5 mu g/mL) of oxLDL can potentiate EPC tube formation in vitro and in vivo by activating eNOS mechanisms, which are mediated by p38 MAPK-and SAPK/JNK-related pathways. Higher concentrations of oxLDL (10-50 mu g/mL) impaired EPC function via the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase pathways and consequent inhibition of eNOS activity, which could be reversed by anti-oxidants (diphenylene iodonium and apocynin) and gp91(phox) siRNA. In conclusion, oxLDL has concentration-dependent biphasic effects on human late-outgrowth EPC tube formation in vitro and in vivo.	[Lin, Feng-Yen; Shih, Chun-Ming; Huang, Chun-Yao] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Lin, Feng-Yen; Shih, Chun-Ming; Lin, Yi-Wen; Huang, Chun-Yao] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Tsao, Nai-Wen] Taipei Med Univ Hosp, Div Cardiovasc Surg, Taipei, Taiwan; [Yeh, Jong-Shiua] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Cardiovasc Med, Taipei, Taiwan; [Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Educ & Res, Taipei, Taiwan; [Nakagami, Hironori] Osaka Univ, Div Vasc Med & Epigenet, Osaka, Japan; [Morishita, Ryuichi] Osaka Univ, Dept Clin Gene Therapy, Osaka, Japan; [Sawamura, Tatsuya] Natl Cardiovasc Ctr Hosp & Res Inst, Dept Biosci, Osaka, Japan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Veterans General Hospital; Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan	Huang, CY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.	cyhuang@tmu.edu.tw	Nakagami, Hironori/GLU-0570-2022; Sawamura, Tatsuya/E-7103-2010	Nakagami, Hironori/0000-0003-4494-3601; 	Taipei Medical University [101TMU-TMUH-01-4, 103TMU-TMUH-10]; National Science Council in Taiwan [NSC 99-2314-B-038-007-MY3, NSC 102-2314-B-038-031]	Taipei Medical University; National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Taipei Medical University (101TMU-TMUH-01-4 and 103TMU-TMUH-10), the National Science Council (NSC 99-2314-B-038-007-MY3 and NSC 102-2314-B-038-031) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2004, CIRC RES, V94, P385, DOI 10.1161/01.RES.0000111804.34509.94; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Brinkley TE, 2009, HYPERTENSION, V53, P846, DOI 10.1161/HYPERTENSIONAHA.108.127043; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Calmarza P, 2014, ANGIOLOGY, V65, P357, DOI 10.1177/0003319713488639; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Chen JZ, 2004, J MOL CELL CARDIOL, V36, P233, DOI 10.1016/j.yjmcc.2003.10.005; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Di Santo S, 2008, BIOCHEM BIOPH RES CO, V373, P528, DOI 10.1016/j.bbrc.2008.06.066; Drogan D, 2010, ARTERIOSCL THROM VAS, V30, P2053, DOI 10.1161/ATVBAHA.110.209346; Duan J, 2000, CIRCULATION, V102, P370; Everaert BR, 2010, INT J CARDIOL, V144, P350, DOI 10.1016/j.ijcard.2010.04.018; Fang LH, 2014, TRANSL RES, V163, P99, DOI 10.1016/j.trsl.2013.09.004; Feng J, 2010, ARTERIOSCL THROM VAS, V30, P1703, DOI 10.1161/ATVBAHA.110.209726; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Hamed S, 2010, THROMB RES, V126, P166, DOI 10.1016/j.thromres.2010.03.002; Holvoet P, 1998, CIRCULATION, V98, P1487, DOI 10.1161/01.CIR.98.15.1487; Holvoet P, 2000, ARTERIOSCL THROM VAS, V20, P698, DOI 10.1161/01.ATV.20.3.698; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Holvoet P, 2007, ATHEROSCLEROSIS, V194, P245, DOI 10.1016/j.atherosclerosis.2006.08.002; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Imanishi T, 2004, CLIN EXP PHARMACOL P, V31, P407, DOI 10.1111/j.1440-1681.2004.04022.x; Ingram DA, 2007, STEM CELLS, V25, P297, DOI 10.1634/stemcells.2006-0340; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jang JJ, 2000, CIRCULATION, V102, P1414, DOI 10.1161/01.CIR.102.12.1414; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Koenig W, 2011, CLIN CHEM, V57, P1196, DOI 10.1373/clinchem.2011.165134; Linna M, 2013, AGE AGEING, V42, P110, DOI 10.1093/ageing/afs074; Ma FX, 2006, J LIPID RES, V47, P1227, DOI 10.1194/jlr.M500507-JLR200; MARTIN MJ, 1986, LANCET, V2, P933; Mehta JL, 1998, BIOCHEM BIOPH RES CO, V248, P511, DOI 10.1006/bbrc.1998.9004; Meisinger C, 2005, CIRCULATION, V112, P651, DOI 10.1161/CIRCULATIONAHA.104.529297; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Tie GD, 2010, J VASC RES, V47, P519, DOI 10.1159/000313879; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; van der Zwan LP, 2009, J LIPID RES, V50, P342, DOI 10.1194/jlr.P800030-JLR200; van Weel V, 2006, ARTERIOSCL THROM VAS, V26, P1383, DOI 10.1161/01.ATV.0000219234.78165.85; Wang XX, 2004, DRUG CHEM TOXICOL, V27, P243, DOI 10.1081/DCT-120037505; Wu YG, 2009, J CARDIOVASC PHARM, V53, P151, DOI 10.1097/FJC.0b013e318197c637; Zhou B, 2007, J LIPID RES, V48, P518, DOI 10.1194/jlr.M600251-JLR200	51	21	23	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0123971	10.1371/journal.pone.0123971	http://dx.doi.org/10.1371/journal.pone.0123971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017136	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600002
J	Maldonado, M; Aguilar, R; Blanco, J; Garcia, S; Serrano, A; Punzon, A				Maldonado, Manuel; Aguilar, Ricardo; Blanco, Jorge; Garcia, Silvia; Serrano, Alberto; Punzon, Antonio			Aggregated Clumps of Lithistid Sponges: A Singular, Reef-Like Bathyal Habitat with Relevant Paleontological Connections	PLOS ONE			English	Article							HEXACTINELLID SPONGE; SEA; OCEAN; WATER; BIODIVERSITY; ASSEMBLAGES; ECOLOGY	The advent of deep-sea exploration using video cameras has uncovered extensive sponge aggregations in virtually all oceans. Yet, a distinct type is herein reported from the Mediterranean: a monospecific reef-like formation built by the lithistid demosponge Leiodermatium pfeifferae. Erect, plate-like individuals (up to 80 cm) form bulky clumps, making up to 1.8 m high mounds (1.14 m on average) on the bottom, at a 760 m-deep seamount named SSS. The siliceous skeletal frameworks of the lithistids persist after sponge death, serving as a complex 3D substratum where new lithistids recruit, along with a varied fauna of other sessile and vagile organisms. The intricate aggregation of lithistid mounds functions as a "reef" formation, architecturally different from the archetypal "demosponge gardens" with disaggregating siliceous skeletons. Leiodermatium pfeifferae also occurred at two additional, close seamounts (EBJ and EBS), but, unlike at SSS, the isolated individuals never formed accretive clumps. The general oceanographic variables (temperature, salinity, dissolved nutrients, chlorophyll, and oxygen) revealed only minimal between-seamount differences, which cannot explain why sponge abundance at SSS is about two orders of magnitude higher than at EBJ or EBS. Large areas of the dense SSS aggregation were damaged, with detached and broken sponges and a few tangled fishing lines. Satellite vessel monitoring revealed low fishing activity around these seamounts. In contrast, international plans for gas and oil extraction at those locations raise serious concerns over the need for protecting urgently this unique, vulnerable habitat to avoid further alteration. Modern lithistids are a relict fauna from Jurassic and Cretaceous reefs and the roots of the very genus Leiodermatium can be traced back to those fossil formations. Therefore, understanding the causes behind the discovered lithistid aggregation is critical not only to its preservation, but also to elucidate how the extraordinary Mesozoic lithistid formations developed and functioned.	[Maldonado, Manuel] CSIC, CEAB, Blanes, Girona, Spain; [Aguilar, Ricardo; Blanco, Jorge; Garcia, Silvia] Oceana, Madrid, Spain; [Serrano, Alberto; Punzon, Antonio] Ctr Oceanog Santander, Inst Espanol Oceanog, Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Spanish Institute of Oceanography	Maldonado, M (corresponding author), CSIC, CEAB, Blanes, Girona, Spain.	maldonado@ceab.csic.es	Maldonado, Manuel/J-9331-2012; Punzón, Antonio/AAC-6717-2020	Maldonado, Manuel/0000-0002-7447-4212; Aguilar, Ricardo/0000-0001-6615-8626	Adessium Foundation; Georg Waechter Memorial Fund; Pictet Foundation; Spanish Government [CTM2012-37787]	Adessium Foundation; Georg Waechter Memorial Fund; Pictet Foundation; Spanish Government(Spanish GovernmentEuropean Commission)	This study was made possible through the generous funding support by Adessium Foundation, Georg Waechter Memorial Fund, and Pictet Foundation to OCEANA. The study also benefited from a CTM2012-37787 grant of the Spanish Government to MM.	Acosta J, 2004, MAR GEOL, V207, P247, DOI 10.1016/j.margeo.2004.04.003; Adachi NS, 2011, PALAIOS, V26, P106, DOI 10.2110/palo.2010.p10-097r; Antcliffe JB, 2014, BIOL REV, V89, P972, DOI 10.1111/brv.12090; Beaulieu SE, 2001, MAR BIOL, V138, P803, DOI 10.1007/s002270000500; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bo M, 2012, HYDROBIOLOGIA, V687, P163, DOI 10.1007/s10750-011-0964-1; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Carter HJ, 1873, ANN MAGAZINE NATURAL, V12, P349, DOI [DOI 10.1080/00222937308680782, 10.1080/00222937308680782]; Carter HJ, 1876, ANN MAGAZINE NATURAL, V18, P225; Charbonnier S, 2007, PALAEOGEOGR PALAEOCL, V250, P216, DOI 10.1016/j.palaeo.2007.03.013; Chu JWF, 2011, MAR ECOL PROG SER, V441, P1, DOI 10.3354/meps09381; Clark M. R., 2007, SEAMOUNTS ECOLOGY FI, P413, DOI 10.1002/9780470691953.; Conway K. W., 2007, 2007A2 GEOL SURV CAN, VA2, P1, DOI DOI 10.1002/9780470344620.FMATTER; CONWAY KW, 1991, CONT SHELF RES, V11, P771, DOI 10.1016/0278-4343(91)90079-L; Conway KW, 2005, GEO-MAR LETT, V25, P205, DOI 10.1007/s00367-004-0204-z; Cook SE, 2008, MAR ENVIRON RES, V66, pS80, DOI 10.1016/j.marenvres.2008.09.002; de Goeij JM, 2013, SCIENCE, V342, P108, DOI 10.1126/science.1241981; Elliott GRD, 2007, J EXP BIOL, V210, P3736, DOI 10.1242/jeb.003392; FAO, 2013, WORKSH DEV GLOB DAT, P1018; FINKS ROBERT M., 1960, BULL AMER MUS NAT HIST, V120, P1; Frohlich H, 1997, MAR BIOL, V128, P115, DOI 10.1007/s002270050075; GHIOLD J, 1991, NEW SCI, V129, P58; Glasby GP, 2003, MAR PETROL GEOL, V20, P163, DOI 10.1016/S0264-8172(03)00021-7; GYGI RA, 1986, ECLOGAE GEOL HELV, V79, P455; Hansell DA, 2003, LIMNOL OCEANOGR, V48, P150, DOI 10.4319/lo.2003.48.1.0150; Hintzen NT, 2012, FISH RES, V115, P31, DOI 10.1016/j.fishres.2011.11.007; Hogg M.M., 2010, DEEP SEA SPONGE GROU; Johns RA, 1994, ORDOVICIAN LITHISTID; Kahn AS, 2015, LIMNOL OCEANOGR, V60, P78, DOI 10.1002/lno.10002; Kauffman EG, 2000, LETHAIA, V33, P214, DOI 10.1080/00241160025100071; Kelly M, 2007, MARINE FAUNA NZ PORI; Kelly Michelle, 2000, Zoosystema, V22, P265; Kenchington E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109365; Klitgaard AB, 2004, PROG OCEANOGR, V61, P57, DOI 10.1016/j.pocean.2004.06.002; Knudby A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082306; Krautter M, 2001, FACIES, V44, P265, DOI 10.1007/BF02668178; Lazarus DB, 2009, P NATL ACAD SCI USA, V106, P9333, DOI 10.1073/pnas.0812979106; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Levi C., 1991, P72; LEVI C, 1983, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V5, P101; LEVI C, 1989, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V143, P25; Levi C, 1993, MEM MUS NATL HIST NA, V158, P1; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Longo C, 2005, J MAR BIOL ASSOC UK, V85, P1341, DOI 10.1017/S0025315405012518; Lowenstam HA, 1989, BIOMINERALIZATION; Luna GM, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004168; Magnino G., 1999, Biologia Marina Mediterranea, V6, P391; Maldonado M, 1999, NATURE, V401, P785, DOI 10.1038/44560; Maldonado M, 1996, DEEP-SEA RES PT I, V43, P897, DOI 10.1016/0967-0637(96)00042-8; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; Maldonado M, 2005, LIMNOL OCEANOGR, V50, P799, DOI 10.4319/lo.2005.50.3.0799; Maldonado M, 1999, MAR ECOL PROG SER, V185, P239, DOI 10.3354/meps185239; Maldonado M, 2008, TREBALLS SOC CATALAN, V59, P29; Maldonado M, 2012, ADV MAR BIOL, V62, P113, DOI 10.1016/B978-0-12-394283-8.00003-5; Maldonado M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00030; MALIVA R G, 1989, Palaios, V4, P519, DOI 10.2307/3514743; Manconi R, 2008, ZOOKEYS, P71, DOI 10.3897/zookeys.4.39; Milkov AV, 2004, EARTH-SCI REV, V66, P183, DOI 10.1016/j.earscirev.2003.11.002; Moret L., 1928, Travaux du Laboratoire de Geologie Lyon, V13, P123; Moret L, 1924, MEMOIRES SOC GEOLOGI, V1, P1; Moret L, 1925, MEM SOC GEOL FR, V5, P1; MORET L., 1926, MEMOIRES SOC GEOLOGI, V5, P1; Pile AJ, 2006, DEEP-SEA RES PT I, V53, P1148, DOI 10.1016/j.dsr.2006.03.008; Pisera A, 2011, SCI MAR, V75, P17, DOI 10.3989/scsimar.2011.75n1017; Pomponi Shirley A., 2001, Bulletin of the Biological Society of Washington, V10, P344; Reid REH., 1967, ASPECTS TETHYAN BIOG, V7, P171; REISWIG HM, 1973, J EXP MAR BIOL ECOL, V14, P231; RICE AL, 1990, PROG OCEANOGR, V24, P179, DOI 10.1016/0079-6611(90)90029-2; Rutzler K, 2012, ADV MAR BIOL, V61, P211, DOI 10.1016/B978-0-12-387787-1.00002-7; Samadi Sarah, 2007, Fish and Aquatic Resources Series, V12, P119; Schlacher-Hoenlinger MA, 2005, ZOOSYSTEMA, V27, P649; Schmidt O., 1870, GRUNDZUGE SPONGIEN F; SIEVER R, 1991, P287; Stone RP, 2014, NMESAFSC264 NOAA; UNEP, 2006, EC BIOD DEEP WAT HIG; Vamvakas CN, 1971, HELLENIC OCEANOLOGY, V20, P129; Watson R., 2007, SEAMOUNTS ECOLOGY FI, P400; Werner W., 1994, Courier Forschungsinstitut Senckenberg, V172, P381; Whitney F, 2005, CONT SHELF RES, V25, P211, DOI 10.1016/j.csr.2004.09.003; Wiedenmayer F, 1980, LIVING FOSSIL SPONGE, P55; Wiedenmeyer Felix, 1994, Schweizerische Palaeontologische Abhandlungen, V116, P1	81	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125378	10.1371/journal.pone.0125378	http://dx.doi.org/10.1371/journal.pone.0125378			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016786	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600019
J	Tareque, MI; Koshio, A; Tiedt, AD; Hasegawa, T				Tareque, Md. Ismail; Koshio, Atsushi; Tiedt, Andrew D.; Hasegawa, Toshihiko			Are the Rates of Hypertension and Diabetes Higher in People from Lower Socioeconomic Status in Bangladesh? Results from a Nationally Representative Survey	PLOS ONE			English	Article							BODY-MASS INDEX; NONCOMMUNICABLE DISEASES; RISK-FACTORS; HEALTH; INEQUALITIES; ADULTS; INCOME	Objective A well-established belief regarding inequalities in health around the world is that hypertension and diabetes are higher in groups of lower socioeconomic status. We examined whether rates of hypertension, diabetes, and the coexistence of hypertension and diabetes are higher in people from a lower socioeconomic status than in those from a higher socioeconomic status in Bangladesh. Methods We investigated a nationally representative dataset from the 2011 Bangladesh Demographic and Health Survey with objective measures for hypertension and diabetes. A wealth index was constructed from data on household assets using principal components analysis. Chi-square tests and logistic regressions were performed to test the associations between wealth level, hypertension and diabetes. Findings People from the highest wealth quintile were significantly more likely to have hypertension (Adjusted odds ratios [AOR] = 1.65, 95% confidence interval [CI] = 1.22-2.25), diabetes (AOR = 1.81, 95% CI = 1.21-2.71), and the coexistence of hypertension and diabetes (AOR = 2.17, 95% CI = 1.05-4.49) than people from the lowest wealth quintile. The odds of having hypertension, diabetes, and their coexistence were higher for older people, women, people who engaged in less physical labor, and people who were overweight and obese. Conclusion Wealthier people, particularly people from the fourth and highest wealth quintiles, should be careful to avoid unhealthy lifestyles to prevent hypertension and diabetes. Health policy makers and planners are urged to target wealthier strata in terms of hypertension and diabetes initiatives while paying special attention to older people, women, people who engage in less physical labor, and individuals who are overweight.	[Tareque, Md. Ismail] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Koshio, Atsushi] Grad Sch Project Design, Tokyo, Japan; [Tiedt, Andrew D.] US Dept Justice, Washington, DC 20530 USA; [Hasegawa, Toshihiko] Nippon Med Sch, Dept Hlth Policy & Management, Tokyo 113, Japan	University of Rajshahi; Nippon Medical School	Tareque, MI (corresponding author), Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh.	tareque_pshd@yahoo.com		Tareque, Md Ismail/0000-0002-6507-1171; Tiedt, Andrew/0000-0002-3774-3452	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [24790522]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Opinions or points of view expressed are those of the authors and do not necessarily reflect the official position or policies of the United States Department of Justice. Andrew D. Tiedt received no financial support for the research, authorship, and/or publication of this article. Md. Ismail Tareque received financial support from the Grant-in-Aid for Young Scientists 24790522 while working as a research analyst and preparing the manuscript in Nippon Medical School. The Grant-in-Aid for Young Scientists 24790522, funded by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, was awarded to Atsushi Koshio. MEXT had no further role in the interpretation of data or preparation of this article.	American Heart Association [AHA], 2012, HIGH BLOOD PRESSURE; Anderson G H, 1999, Saudi J Kidney Dis Transpl, V10, P286; August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862; Bays HE, 2007, INT J CLIN PRACT, V61, P737, DOI 10.1111/j.1742-1241.2007.01336.x; Busingye D, 2014, INT J EPIDEMIOL, V43, P1563, DOI 10.1093/ije/dyu112; Centers for Disease Control and Prevention [CDC], 2009, THE POWER OF PREVENT; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P149; D'Orazio P, 2005, CLIN CHEM, V51, P1573, DOI 10.1373/clinchem.2005.051979; de Gaudemaris R, 2002, HYPERTENSION, V39, P1119, DOI 10.1161/01.HYP.0000018912.05345.55; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Fleischer NL, 2011, AM J PUBLIC HEALTH, V101, P294, DOI 10.2105/AJPH.2009.190165; Ganz ML, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-50; Grant JF, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-6; Hughes ME, 2009, J HEALTH SOC BEHAV, V50, P344, DOI 10.1177/002214650905000307; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; James SA, 2006, AM J PUBLIC HEALTH, V96, P812, DOI 10.2105/AJPH.2005.076158; Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591; Lago RM, 2007, NAT CLIN PRACT ENDOC, V3, P667, DOI 10.1038/ncpendmet0638; Lehmann HP, 2001, CLINICAL DIAGNOSIS A; LILLARD LA, 1995, AM J SOCIOL, V100, P1131, DOI 10.1086/230634; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Minkler M, 2006, NEW ENGL J MED, V355, P695, DOI 10.1056/NEJMsa044316; National Institute of Population Research and Training [NIPORT] Mitra and Associates ICF International, 2013, INTERNATIONAL BANGLA; Razzaque A, 2011, ASIA-PAC J PUBLIC HE, V23, P183, DOI 10.1177/1010539510392743; Rutstein SO, 2004, DHS COMPARATIVE REPO; Saquib N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1032; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Sturm R, 2002, BMJ-BRIT MED J, V324, P20, DOI 10.1136/bmj.324.7328.20; Tareque MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103681; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; WHO, 2006, DEFINITION AND DIAGN; World Health Organization, 2009, GLOBAL HEALTH RISKS; Zimmer Z, 2008, SOC SCI MED, V66, P57, DOI 10.1016/j.socscimed.2007.08.032	36	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127954	10.1371/journal.pone.0127954	http://dx.doi.org/10.1371/journal.pone.0127954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017066	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600102
J	Alharbi, NK; Chinnakannan, SK; Gilbert, SC; Draper, SJ				Alharbi, Naif Khalaf; Chinnakannan, Senthil K.; Gilbert, Sarah C.; Draper, Simon J.			Investigation of IRES Insertion into the Genome of Recombinant MVA as a Translation Enhancer in the Context of Transcript Decapping	PLOS ONE			English	Article							VIRUS D10 PROTEIN; GENE-EXPRESSION; PROMOTER; VACCINES; SEQUENCE; DETERMINANTS; EFFICIENCY; STABILITY; SELECTION; IMPROVES	Recombinant modified vaccinia virus Ankara (MVA) has been used to deliver vaccine candidate antigens against infectious diseases and cancer. MVA is a potent viral vector for inducing high magnitudes of antigen-specific CD8(+) T cells; however the cellular immune responses to a recombinant antigen in MVA could be further enhanced by increasing transgene expression. Previous reports showed the importance of utilizing an early poxviral promoter for increasing transgene expression and therefore enhancing cellular immune responses. However, the vaccinia D10 decapping enzyme is reported to target and decap vaccinia virus early transcripts - a mechanism that could limit the usefulness of early promoters in MVA viral vectors if this enzyme shows the same activity in this closely related virus. Therefore, we attempted to increase transgene expression in recombinant MVA by inserting the encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) upstream of a transgene sequence that is controlled by the B8R early promoter, and assessed D10 enzyme decapping activity in MVA. The aim of the IRES element was to initiate translation of the transgene transcript (after the removal of the cap structure by the D10 decapping protein) in a cap-independent manner. Here, we report that overexpression of the D10 decapping protein, in trans, in MVA reduced growth and transgene expression; however, the IRES element was not able to compensate for the negative effect of the D10 decapping protein. Recombinant MVA with EMCV IRES induced levels of both gene expression and transcription that were similar to the control recombinant MVA, encoding the same transgene but without the IRES element. Both viruses were tested in BALB/c mice and induced similar magnitudes of epitope-specific CD8(+) T cells. This work indicates that the MVA version of the D10 decapping enzyme, overexpressed using a plasmid, is functional, but its negative effect on transgene expression by recombinant MVA cannot be overcome by the use of the EMCV IRES inserted upstream of the transgene initiation codon.	[Alharbi, Naif Khalaf; Chinnakannan, Senthil K.; Gilbert, Sarah C.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England; [Alharbi, Naif Khalaf] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia	University of Oxford; Jenner Institute; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC)	Alharbi, NK (corresponding author), Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England.	naif.alharbi@ndm.ox.ac.uk	Draper, Simon J/F-1758-2011; Chinnakannan, Senthil/AAP-9369-2020; Gilbert, Sarah C./H-2857-2019	Draper, Simon J/0000-0002-9415-1357; Chinnakannan, Senthil/0000-0002-4404-0229; Gilbert, Sarah C./0000-0002-6823-9750; Alharbi, Naif/0000-0002-6049-3383	UK MRC [G1000527]; UK Department for International Development (DFID) under the MRC/DFID [G1000527]; Medical Research Council [G1000527] Funding Source: researchfish; MRC [G1000527] Funding Source: UKRI	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SCG and SJD are Jenner Investigators (http://www.jenner.ac.uk). SJD is a Lister Institute Research Prize Fellow (http://www.lister-institute.org.uk) and a UK Medical Research Council (MRC; http://www.mrc.ac.uk) Career Development Fellow [grant number G1000527; this Fellowship is jointly funded by the UK MRC and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; BORMAN AM, 1995, NUCLEIC ACIDS RES, V23, P3656, DOI 10.1093/nar/23.18.3656; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Cottingham Matthew G, 2012, Methods Mol Biol, V890, P37, DOI 10.1007/978-1-61779-876-4_3; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Di Pilato M, 2013, J GEN VIROL, V94, P2771, DOI 10.1099/vir.0.057299-0; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Filbin ME, 2009, CURR OPIN STRUC BIOL, V19, P267, DOI 10.1016/j.sbi.2009.03.005; Garcia-Arriaza J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066894; Gilbert SC, 2013, VACCINE, V31, P4241, DOI 10.1016/j.vaccine.2013.03.020; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Kastenmuller W, 2006, VIROLOGY, V350, P276, DOI 10.1016/j.virol.2006.02.039; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Orubu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040167; Oseroff C, 2008, J IMMUNOL, V180, P7193, DOI 10.4049/jimmunol.180.11.7193; Parrish S, 2006, J VIROL, V80, P553, DOI 10.1128/JVI.80.2.553-561.2006; Parrish S, 2007, P NATL ACAD SCI USA, V104, P2139, DOI 10.1073/pnas.0611685104; Popov S, 2009, DNA CELL BIOL, V28, P103, DOI 10.1089/dna.2008.0792; Rehm KE, 2011, VACCINE, V29, P3276, DOI 10.1016/j.vaccine.2011.02.023; ROMERO P, 1990, IMMUNOL LETT, V25, P27, DOI 10.1016/0165-2478(90)90086-6; Shors T, 1999, J VIROL, V73, P791, DOI 10.1128/JVI.73.1.791-796.1999; Souliere MF, 2010, NUCLEIC ACIDS RES, V38, P7599, DOI 10.1093/nar/gkq628; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Wang ZD, 2010, VACCINE, V28, P1547, DOI 10.1016/j.vaccine.2009.11.056; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	29	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127978	10.1371/journal.pone.0127978	http://dx.doi.org/10.1371/journal.pone.0127978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011541	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900176
J	Cai, CF; Cheng, FY; Wu, J; Zhong, Y; Liu, GX				Cai, Changfu; Cheng, Fang-Yun; Wu, Jing; Zhong, Yuan; Liu, Gaixiu			The First High-Density Genetic Map Construction in Tree Peony (Paeonia Sect. Moutan) using Genotyping by Specific-Locus Amplified Fragment Sequencing	PLOS ONE			English	Article							SATURATED LINKAGE MAP; SEGREGATION DISTORTION; SNP DISCOVERY; QTL ANALYSIS; MARKERS; CULTIVARS; IDENTIFICATION	Genetic linkage maps, permitting the elucidation of genome structure, are one of most powerful genomic tools to accelerate marker-assisted breeding. However, due to a lack of sufficient user-friendly molecular markers, no genetic linkage map has been developed for tree peonies (Paeonia Sect. Moutan), a group of important horticultural plants worldwide. Specific-locus amplified fragment sequencing (SLAF-seq) is a recent molecular marker development technology that enable the large-scale discovery and genotyping of sequence-based marker in genome-wide. In this study, we performed SLAF sequencing of an F1 population, derived from the cross P. ostti 'FenDanBai' x P. x suffruticosa 'HongQiao', to identify sufficient high-quality markers for the construction of high-density genetic linkage map in tree peonies. After SLAF sequencing, a total of 78 Gb sequencing data and 285,403,225 pairend reads were generated. We detected 309,198 high-quality SLAFs from these data, of which 85,124 (27.5%) were polymorphic. Subsequently, 3518 of the polymorphic markers, which were successfully encoded in to Mendelian segregation types, and were in conformity with the criteria of high-quality markers, were defined as effective markers and used for genetic linkage mapping. Finally, we constructed an integrated genetic map, which comprised 1189 markers on the five linkage groups, and spanned 920.699 centiMorgans (cM) with an average inter-marker distance of 0.774 cM. There were 1115 'SNP-only' markers, 18 'InDelonly' markers, and 56 'SNP&InDel' markers on the map. Among these markers, 450 (37.85%) showed significant segregation distortion (P < 0.05). In conclusion, this investigation reported the first large-scale marker development and high-density linkage map construction for tree peony. The results of this study will serve as a solid foundation not only for marker-assisted breeding, but also for genome sequence assembly for tree peony.	[Cai, Changfu; Cheng, Fang-Yun; Wu, Jing; Zhong, Yuan] Beijing Forestry Univ, Landscape Architecture Coll, Natl Flower Engn Res Ctr, Beijing, Peoples R China; [Liu, Gaixiu] Natl Peony Garden, Luoyang, Henan, Peoples R China	Beijing Forestry University	Cheng, FY (corresponding author), Beijing Forestry Univ, Landscape Architecture Coll, Natl Flower Engn Res Ctr, Beijing, Peoples R China.	chengfy8@263.net			Natural Science Foundation of China [31471898]; National High Technology Research and Development Program of China (863 Program) [2011AA100207]; National Science and Technology Support Program of China [2012BAD01B07]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Support Program of China	This work was supported by the Natural Science Foundation of China (No. 31471898; http://www.nsfc.gov.cn; FYC), the National High Technology Research and Development Program of China (863 Program, 2011AA100207; http://www.863.gov.cn; FYC), and the National Science and Technology Support Program of China (2012BAD01B07; http://www.most.gov.cn; FYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Celton JM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-155; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Cheng F. Y., 2007, INT J PLANT BREEDING, V1, P89, DOI [10.3923/ijpbg.2007.89.94, DOI 10.3923/IJPBG.2007.89.94, DOI 10.3923/ijpbg.2007.89.94]; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; FAURE S, 1993, THEOR APPL GENET, V87, P517, DOI 10.1007/BF00215098; Gai SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055297; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Gonen S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-166; Guo DL, 2009, J HORTIC SCI BIOTECH, V84, P131, DOI 10.1080/14620316.2009.11512493; Han XY, 2008, BIOCHEM GENET, V46, P162, DOI 10.1007/s10528-007-9140-8; He D, 2014, PLANT BREEDING, V133, P138, DOI 10.1111/pbr.12100; Hong DY, 2005, ACTA PHYTOTAXON SIN, V43, P169, DOI 10.1360/aps040065; Iehisa JCM, 2014, DNA RES, V21, P555, DOI 10.1093/dnares/dsu020; Kakioka R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-32; Kang BY, 2011, GENOME, V54, P128, DOI 10.1139/G10-099; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li J.J., 2011, TREE PEONY OF CHINA; Li SS, 2015, FOOD CHEM, V173, P133, DOI 10.1016/j.foodchem.2014.10.017; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Ma H, 2004, GENETICS, V166, P419, DOI 10.1534/genetics.166.1.419; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Ooijen JV, 2006, JOINMAP 4 SOFTWARE C, P1; Oyant LHS, 2008, TREE GENET GENOMES, V4, P11, DOI 10.1007/s11295-007-0084-2; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Perfectti F, 1996, THEOR APPL GENET, V93, P440, DOI 10.1007/BF00223188; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Rogers A., 1995, PEONIES; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052097; Sun L., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1111/MPP.12078; Sun LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059562; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Suo ZL, 2005, HORTSCIENCE, V40, P329, DOI 10.21273/HORTSCI.40.2.329; Talukder ZI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098628; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Wang LY., 1998, CHINESE TREE PEONY; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wang WX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-523; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Wister J.C., 1962, THE PEONIES; Wu J, 2014, MOL BREEDING, V34, P1853, DOI 10.1007/s11032-014-0144-x; Xia C, 2014, EUPHYTICA, DOI [10.1007/s10681-014-1202-05, DOI 10.1007/S10681-014-1202-05]; Xu SZ, 2008, GENETICS, V180, P2201, DOI 10.1534/genetics.108.090688; Yagi M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-734; Yu C, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00796; Yu HP, 2013, SCI HORTIC-AMSTERDAM, V164, P58, DOI 10.1016/j.scienta.2013.06.043; Yuan JH, 2014, MOL ECOL, V23, P82, DOI 10.1111/mec.12567; Yuan JH, 2011, CONSERV GENET, V12, P1539, DOI 10.1007/s10592-011-0251-8; Yuan JH, 2010, INT J PLANT SCI, V171, P409, DOI 10.1086/651228; Zhang C, 2014, PLANT CELL REP, V33, P111, DOI 10.1007/s00299-013-1516-0; Zhang D.Q., 2007, FOREST STUD CHINA, V9, P1, DOI [10.1007/s11632-007-0001-7, DOI 10.1007/S11632-007-0001-7]; Zhang F, 2011, MOL BREEDING, V27, P11, DOI 10.1007/s11032-010-9409-1; Zhang F, 2010, SCI HORTIC-AMSTERDAM, V125, P422, DOI 10.1016/j.scienta.2010.03.028; Zhang JJ, 2012, PLANT CELL REP, V31, P299, DOI 10.1007/s00299-011-1164-1; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; [周海梅 ZHOU Haimei], 2009, [中国油脂, China Oils and Fats], V34, P72; Zhou H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079996	67	40	47	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128584	10.1371/journal.pone.0128584	http://dx.doi.org/10.1371/journal.pone.0128584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010095	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900243
J	Njue, M; Molyneux, S; Kombe, F; Mwalukore, S; Kamuya, D; Marsh, V				Njue, Maureen; Molyneux, Sassy; Kombe, Francis; Mwalukore, Salim; Kamuya, Dorcas; Marsh, Vicki			Benefits in Cash or in Kind? A Community Consultation on Types of Benefits in Health Research on the Kenyan Coast	PLOS ONE			English	Article							RESEARCH PARTICIPATION; CLINICAL-TRIALS; PAYMENT; ETHICS; KILIFI; PERCEPTIONS; EXPERIENCES; SETTINGS; CONSENT; MEMBERS	Background Providing benefits and payments to participants in health research, either in cash or in kind, is a common but ethically controversial practice. While much literature has concentrated on appropriate levels of benefits or payments, this paper focuses on less well explored ethical issues around the nature of study benefits, drawing on views of community members living close to an international health research centre in Kenya. Methods The consultation, including 90 residents purposively chosen to reflect diversity, used a two-stage deliberative process. Five half-day workshops were each followed by between two and four small group discussions, within a two week period (total 16 groups). During workshops and small groups, facilitators used participatory methods to share information, and promote reflection and debate on ethical issues around types of benefits, including cash, goods, medical and community benefits. Data from workshop and field notes, and voice recordings of small group discussions, were managed using Nvivo 10 and analysed using a Framework Analysis approach. Findings and Conclusions The methods generated in-depth discussion with high levels of engagement. Particularly for the most-poor, under-compensation of time in research carries risks of serious harm. Cash payments may best support compensation of costs experienced; while highly valued, goods and medical benefits may be more appropriate as an 'appreciatio' or incentive for participation. Community benefits were seen as important in supporting but not replacing individual-level benefits, and in building trust in researcher-community relations. Cash payments were seen to have higher risks of undue inducement, commercialising relationships and generating family conflicts than other benefits, particularly where payments are high. Researchers should consider and account for burdens families may experience when children are involved in research. Careful context-specific research planning and skilled and consistent communication about study benefits and payments are important, including in mitigating potential negative effects.	[Njue, Maureen; Molyneux, Sassy; Kombe, Francis; Mwalukore, Salim; Kamuya, Dorcas; Marsh, Vicki] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Molyneux, Sassy; Kamuya, Dorcas; Marsh, Vicki] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 7FZ, England; [Molyneux, Sassy; Kamuya, Dorcas; Marsh, Vicki] Univ Oxford, Nuffield Dept Populat Hlth, Ethox Ctr, Oxford OX3 7LF, England	Kenya Medical Research Institute; University of Oxford; University of Oxford	Marsh, V (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, POB 230-80108, Kilifi, Kenya.	vmarsh@kemri-wellcome.org	Molyneux, Catherine/HGB-8464-2022	Molyneux, Catherine/0000-0001-9522-416X; Kombe, Francis/0000-0003-0390-2336	Wellcome Trust [096527, WT085418, 092654/Z/10/A]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding provided by the following: Infrastructural support to all authors - Kenya Medical Research Institute- http://www.kemri.org/; MN SMolyneux DK VM - Wellcome Trust Strategic Award to the Global Health Bioethics Network (096527) - http://www.ethox.ox.ac.uk/research-1/global-health-ethics/the-global-health-bioethics-network; SMolyneux - The Wellcome Trust Fellowship (WT085418) - http://www.wellcome.ac.uk/; VM - The Wellcome Trust - (092654/Z/10/A) - http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, SCIENCE, V298, P2133, DOI [10.1126/science.1076899298/5601/2133[pii], DOI 10.1126/SCIENCE.1076899]; Ballantyne A, 2008, DEV WORLD BIOETH, V8, P178, DOI 10.1111/j.1471-8847.2006.00175.x; Benatar SR, 2010, J MED ETHICS, V36, P194, DOI 10.1136/jme.2009.032672; Chuma J, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-15; De Vries R, 2010, SOC SCI MED, V70, P1896, DOI 10.1016/j.socscimed.2010.02.031; Dickert N, 1999, NEW ENGL J MED, V341, P198, DOI 10.1056/NEJM199907153410312; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Grady Christine, 2001, American Journal of Bioethics, V1, P40, DOI 10.1162/152651601300169031; Green J, 2009, QUALITATIVE METHODS; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; Kamuya DM, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-90; Kamuya DM, 2013, DEV WORLD BIOETH, V13, P10, DOI 10.1111/dewb.12014; Lairumbi Geoffrey M, 2012, Philos Ethics Humanit Med, V7, P7, DOI 10.1186/1747-5341-7-7; Marsh V, 2008, SOC SCI MED, V67, P721, DOI 10.1016/j.socscimed.2008.02.007; Molyneux C, 2007, HEALTH POLICY PLANN, V22, P381, DOI 10.1093/heapol/czm031; Molyneux CS, 2005, SOC SCI MED, V61, P1463, DOI 10.1016/j.socscimed.2004.11.073; Molyneux S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054894; Molyneux S, 2012, BMC MED ETHICS, V13, DOI 10.1186/1472-6939-13-13; Ndebele P, 2008, MALAWI MED J, V20, P42; Njue M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113112; Parker M, 2007, COLORECTAL DIS, V9, P2, DOI 10.1111/j.1463-1318.2007.01368.x; Permuth-Wey J, 2009, ANN EPIDEMIOL, V19, P280, DOI 10.1016/j.annepidem.2009.01.004; Schulz-Baldes A, 2007, EMBO REP, V8, P8, DOI 10.1038/sj.embor.7400886; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Slomka J, 2007, J GEN INTERN MED, V22, P1403, DOI 10.1007/s11606-007-0319-9; Snethen JA, 2006, RES NURS HEALTH, V29, P223, DOI 10.1002/nur.20130; Wendler D, 2002, J PEDIATR-US, V141, P166, DOI 10.1067/mpd.2002.124381	27	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127842	10.1371/journal.pone.0127842	http://dx.doi.org/10.1371/journal.pone.0127842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010783	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900151
J	Thompson, HJ; Sedlacek, SM; Playdon, MC; Wolfe, P; McGinley, JN; Paul, D; Lakoski, SG				Thompson, Henry J.; Sedlacek, Scot M.; Playdon, Mary C.; Wolfe, Pamela; McGinley, John N.; Paul, Devchand; Lakoski, Susan G.			Weight Loss Interventions for Breast Cancer Survivors: Impact of Dietary Pattern	PLOS ONE			English	Article							LIFE-STYLE MODIFICATION; GLYCEMIC INDEX; PROSPECTIVE COHORT; AMERICAN SOCIETY; LOW-FAT; RISK; LOAD; CARBOHYDRATE; OBESITY; OVERWEIGHT	Body weight management is not emphasized in clinical practice guidelines for breast cancer survivors, reflecting the lack of evidence that weight loss improves prognosis. Even if this situation changes, the optimal design for weight loss interventions is unclear. We conducted a 6-month non-randomized, controlled weight loss intervention in 249 post-menopausal breast cancer survivors. This paper reports effects on two secondary endpoints, change in body weight and composition. Participants were predominantly non-Hispanic whites (89%) with a mean age of 54.9 +/- 9.2 years, a mean BMI of 29.0 +/- 2.6 kg/m:(2) and an average of 43 +/- 5% body fat. Two dietary interventions, low fat or low carbohydrate, were investigated and consisted of a 42 day cycle of menus and recipes. Weight loss counseling and anthropometric assessment were provided at monthly clinic visits. One hundred ninety-two women completed the trial (77% retention). In comparison to the nonintervention control, both intervention arms achieved significant decreases in body weight (12.5%), body fat (27.5%), waist circumference (9.5%), and hip circumference (7.8%) (all p < 0.001) with minimal effects on lean mass (1.3% decrease). Median time to 5 and 10% weight loss was 2 (95% confidence interval = 1 to 3) and 4 (95% confidence interval = 3 to 5) months, respectively, and 23% of participants experienced >= 15% weight loss. Loss of body weight and fat mass was rapid and substantial irrespective of dietary approach when a structured program was provided with monthly anthropometric assessment and weight loss counseling.	[Thompson, Henry J.; Sedlacek, Scot M.; Playdon, Mary C.; McGinley, John N.] Colorado State Univ, Canc Prevent Lab, Ft Collins, CO 80523 USA; [Sedlacek, Scot M.; Paul, Devchand] Rocky Mt Canc Ctr, Denver, CO USA; [Wolfe, Pamela] Univ Colorado Denver, Colorado Biostat Consortium, Denver, CO USA; [Lakoski, Susan G.] Univ Vermont, Dept Internal Med, Burlington, VT USA	Colorado State University; Rocky Mountain Cancer Centers; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Vermont	Thompson, HJ (corresponding author), Colorado State Univ, Canc Prevent Lab, Ft Collins, CO 80523 USA.	henry.thompson@colostate.edu	Playdon, Mary/I-4050-2016	Playdon, Mary/0000-0001-6082-0447	PHS from the National Cancer Institute [CA126704]	PHS from the National Cancer Institute	This work was supported in part by a gift from the Glendorn Foundation and by PHS Grant CA126704 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez JA, 2014, NAT REV ENDOCRINOL, V10, P749, DOI 10.1038/nrendo.2014.175; American Cancer Society, CANC FACTS FIG; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Borradaile KE, 2012, OBESITY, V20, P1218, DOI 10.1038/oby.2011.216; Byers T, 2011, DIABETES OBES METAB, V13, P1063, DOI 10.1111/j.1463-1326.2011.01464.x; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Demark-Wahnefried W, 2012, CANCER EPIDEM BIOMAR, V21, P1244, DOI 10.1158/1055-9965.EPI-12-0485; Dong JY, 2011, BREAST CANCER RES TR, V126, P287, DOI 10.1007/s10549-011-1343-3; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Fabian CJ, 2013, BREAST CANCER RES TR, V142, P119, DOI 10.1007/s10549-013-2730-8; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Harvie M., 2013, BR J NUTR, P1; IARC, 2002, IARC HDB CANC PREV, V6; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Larsson SC, 2009, INT J CANCER, V125, P153, DOI 10.1002/ijc.24310; Ligibel JA, 2014, J CLIN ONCOL, V32, P3568, DOI 10.1200/JCO.2014.58.4680; Llanos AAM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-175; National Institutes of Health National Heart Lung and Blood Institute North American Associaton for the Study of Obesity, PRACT GUID ID EV TRE; Patlak M, ROLE OBESITY CANC SU; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Playdon M, 2013, CURR BREAST CANC REP, P1; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Reeves MM, 2014, OBES REV, V15, P749, DOI 10.1111/obr.12190; Robertson HT, 2013, OBESITY, V21, P398, DOI 10.1002/oby.20019; Romieu I, 2012, AM J CLIN NUTR, V96, P345, DOI 10.3945/ajcn.111.026724; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sedlacek SM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-287; Shikany JM, 2011, NUTR CANCER, V63, P899, DOI 10.1080/01635581.2011.587227; Sieri S, 2013, NUTR METAB CARDIOVAS, V23, P628, DOI 10.1016/j.numecd.2012.01.001; Thompson HR, 2012, LOND ORIENT AFR LANG, V18, P1; Wadden TA, 2007, GASTROENTEROLOGY, V132, P2226, DOI 10.1053/j.gastro.2007.03.051; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Yancy WS, 2013, CONTEMP CLIN TRIALS, V35, P106, DOI 10.1016/j.cct.2013.03.002; Yun SH, 2010, ASIA PAC J CLIN NUTR, V19, P383	36	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127366	10.1371/journal.pone.0127366	http://dx.doi.org/10.1371/journal.pone.0127366			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010254	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900085
J	Haring, R; Schurmann, C; Homuth, G; Steil, L; Volker, U; Volzke, H; Keevil, BG; Nauck, M; Wallaschofski, H				Haring, Robin; Schurmann, Claudia; Homuth, Georg; Steil, Leif; Voelker, Uwe; Voelzke, Henry; Keevil, Brian G.; Nauck, Matthias; Wallaschofski, Henri			Associations between Serum Sex Hormone Concentrations and Whole Blood Gene Expression Profiles in the General Population	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ESTROGEN-RECEPTOR-BETA; TESTOSTERONE; ESTRADIOL; ERYTHROPOIESIS; METAANALYSIS; DISEASE; HEALTH; MEN	Background Despite observational evidence from epidemiological and clinical studies associating sex hormones with various cardiometabolic risk factors or diseases, pathophysiological explanations are sparse to date. To reveal putative functional insights, we analyzed associations between sex hormone levels and whole blood gene expression profiles. Methods We used data of 991 individuals from the population-based Study of Health in Pomerania (SHIP-TREND) with whole blood gene expression levels determined by array-based transcriptional profiling and serum concentrations of total testosterone (TT), sex hormone-binding globulin (SHBG), free testosterone (free T), dehydroepiandrosterone sulfate (DHEAS), androstenedione (AD), estradiol (E2), and estrone (E1) measured by liquid chromatography- tandem mass spectrometry (LC-MS/MS) and immunoassay. Associations between sex hormone concentrations and gene expression profiles were analyzed using sex-specific regression models adjusted for age, body mass index, and technical covariables. Results In men, positive correlations were detected between AD and DDIT4mRNA levels, as well as between SHBG and the mRNA levels of RPIA, RIOK3, GYPB, BPGM, and RAB2B. No additional significant associations were observed. Conclusions Besides the associations between AD and DDIT4 expression and SHBG and the transcript levels of RPIA, RIOK3, GYPB, BPGM, and RAB2B, the present study did not indicate any association between sex hormone concentrations and whole blood gene expression profiles in men and women from the general population.	[Haring, Robin; Nauck, Matthias; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Haring, Robin; Voelker, Uwe; Voelzke, Henry; Nauck, Matthias; Wallaschofski, Henri] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Schurmann, Claudia; Homuth, Georg; Steil, Leif; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Keevil, Brian G.] Univ S Manchester Hosp, Dept Clin Chem, Manchester M20 8LR, Lancs, England	Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; Greifswald Medical School; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Haring, R (corresponding author), European Univ Appl Sci, Fac Appl Publ Hlth, Rostock, Germany.	robin.haring@uni-greifswald.de	keevil, brian/AAP-6147-2020; Schurmann, Claudia/L-1204-2016; Steil, Leif/F-1246-2010; Wilkening, Robin/J-5535-2018	Schurmann, Claudia/0000-0003-4158-9192; Steil, Leif/0000-0002-0733-8421; Wilkening, Robin/0000-0002-8332-5016; Volker, Uwe/0000-0002-5689-3448	Federal Ministry of Education and Research; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania [(03IS2061A]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research) [03ZIK012]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work is part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (03IS2061A). Data collection was supported by the Community Medicine Research network (CMR) of the University of Greifswald, Germany, and is funded by the Federal Ministry of Education and Research, the Ministry of Cultural Affairs, as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The CMR encompasses several research projects that share data from the population-based Study of Health in Pomerania (SHIP; http://www.community-medicine.de). This study was also supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research, grant no. 03ZIK012). RH is the guarantor of this work, had full access to all the data, and takes full responsibility for the integrity of data and the accuracy of data analysis. Furthermore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; BLOBEL GA, 1995, MOL CELL BIOL, V15, P3147; Bord S, 2001, J CLIN ENDOCR METAB, V86, P2309, DOI 10.1210/jc.86.5.2309; Brand JS, 2011, INT J EPIDEMIOL, V40, P189, DOI 10.1093/ije/dyq158; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; EVENS RP, 1974, J CLIN PHARMACOL, V14, P94, DOI 10.1002/j.1552-4604.1974.tb02298.x; Haring R, 2012, J CLIN ENDOCR METAB, V97, P408, DOI 10.1210/jc.2011-2134; Herring MJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000271; Khetawat G, 2000, BLOOD, V95, P2289, DOI 10.1182/blood.V95.7.2289.007k03_2289_2296; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu M, 2013, MOL ENDOCRINOL, V27, P657, DOI 10.1210/me.2012-1397; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Owen LJ, 2014, ANN CLIN BIOCHEM, V51, P360, DOI 10.1177/0004563213501478; Rochira V, 2009, J STEROID BIOCHEM, V113, P189, DOI 10.1016/j.jsbmb.2008.12.007; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Waaseth M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-29; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Zhai GJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002025	23	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127466	10.1371/journal.pone.0127466	http://dx.doi.org/10.1371/journal.pone.0127466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001193	Green Submitted, Green Published, gold			2022-12-27	WOS:000354931700062
J	Chang, SJ; Li, S; Andreasen, A; Sha, XZ; Zhai, XY				Chang, Shi-Jie; Li, Shuo; Andreasen, Arne; Sha, Xian-Zheng; Zhai, Xiao-Yue			A Reference-Free Method for Brightness Compensation and Contrast Enhancement of Micrographs of Serial Sections	PLOS ONE			English	Article							3-DIMENSIONAL RECONSTRUCTION; CONFOCAL MICROSCOPY; LIGHT ATTENUATION; IMAGES; SCALE; MODEL; VISUALIZATION; NEPHRONS; MOUSE	Three-dimensional (3D) reconstruction of an organ or tissue from a stack of histologic serial sections provides valuable morphological information. The procedure includes section preparation of the organ or tissue, micrographs acquisition, image registration, 3D reconstruction, and visualization. However, the brightness and contrast through the image stack may not be consistent due to imperfections in the staining procedure, which may cause difficulties in micro-structure identification using virtual sections, region segmentation, automatic target tracing, etc. In the present study, a reference-free method, Sequential Histogram Fitting Algorithm (SHFA), is therefore developed for adjusting the severe and irregular variance of brightness and contrast within the image stack. To apply the SHFA, the gray value histograms of individual images are first calculated over the entire image stack and a set of landmark gray values are chosen. Then the histograms are transformed so that there are no abrupt changes in progressing through the stack. Finally, the pixel gray values of the original images are transformed into the desired ones based on the relationship between the original and the transformed histograms. The SHFA is tested on an image stacks from mouse kidney sections stained with toluidine blue, and captured by a slide scanner. As results, the images through the entire stack reveal homogenous brightness and consistent contrast. In addition, subtle color differences in the tissue are well preserved so that the morphological details can be recognized, even in virtual sections. In conclusion, compared with the existing histogram-based methods, the present study provides a practical method suitable for compensating brightness, and improving contrast of images derived from a large number of serial sections of biological organ.	[Chang, Shi-Jie; Sha, Xian-Zheng] China Med Univ, Dept Biomed Engn, Shenyang 110001, Liaoning, Peoples R China; [Li, Shuo] China Med Univ, Dept Biochem, Shenyang 110001, Liaoning, Peoples R China; [Andreasen, Arne] Aarhus Univ, Dept Biomed Anat, Aarhus, Denmark; [Zhai, Xiao-Yue] China Med Univ, Dept Histol & Embryol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University; Aarhus University; China Medical University	Zhai, XY (corresponding author), China Med Univ, Dept Histol & Embryol, Shenyang 110001, Liaoning, Peoples R China.	zhaixy@mail.cmu.edu.cn			National Science Foundation of China [31371219]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Science Foundation of China (Grant No. 31371219).	Ballesteros R, 2012, J DIGIT IMAGING, V25, P527, DOI 10.1007/s10278-011-9440-8; Capek M, 2006, MICROSC RES TECHNIQ, V69, P624, DOI 10.1002/jemt.20330; Chernov N., 2011, COMPUTER VISION, P285; Colin C, 2009, STAT COMPUT, V19, P271, DOI [10.1007/s11222-008-9091-x, DOI 10.1007/S11222-008-9091-X]; Dusch E, 2007, J MICROSC-OXFORD, V228, P132, DOI 10.1111/j.1365-2818.2007.01844.x; Eramian M, 2005, P 2 CAN C COMP ROB V, DOI [10.1109/CRV.2005.47, DOI 10.1109/CRV.2005.47]; KIKINIS R, 1992, JMRI-J MAGN RESON IM, V2, P619, DOI 10.1002/jmri.1880020603; Liang FM, 2001, STAT SINICA, V11, P1005; Molvaer RK, 2013, ACTA OPHTHALMOL, V91, P457, DOI 10.1111/j.1755-3768.2012.02446.x; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Song XF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032771, 10.1371/journal.pone.0049545]; Stanciu SG, 2010, MICROSC RES TECHNIQ, V73, P165, DOI 10.1002/jemt.20767; Sun K, 2009, MICROSURG, V29, P573, DOI 10.1002/micr.20646; Sun YL, 2004, MICROSC RES TECHNIQ, V64, P156, DOI 10.1002/jemt.20064; Udupa JK, 1997, IEEE T MED IMAGING, V16, P598, DOI 10.1109/42.640750; Wu HX, 2005, J MICROSC-OXFORD, V220, P9, DOI 10.1111/j.1365-2818.2005.01508.x; Zhai XY, 2007, J AM SOC NEPHROL, V18, P2937, DOI 10.1681/ASN.2007010056; Zhai XY, 2006, J AM SOC NEPHROL, V17, P77, DOI 10.1681/ASN.2005080796; Zhang YL, 2015, MICRON, V68, P122, DOI 10.1016/j.micron.2014.10.002	20	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127855	10.1371/journal.pone.0127855	http://dx.doi.org/10.1371/journal.pone.0127855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020531	Green Submitted, gold, Green Published			2022-12-27	WOS:000355187300059
J	Yin, XH; Huang, GL; Lin, DR; Wan, CC; Wang, YD; Song, JK; Xu, P				Yin, Xin-Hai; Huang, Guang-Lei; Lin, Du-Ren; Wan, Cheng-Cheng; Wang, Ya-Dong; Song, Ju-Kun; Xu, Ping			Exposure to Fluoride in Drinking Water and Hip Fracture Risk: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							BONE-MINERAL DENSITY; OSTEOPOROSIS; COHORT; BIAS	Background Many observational studies have shown that exposure to fluoride in drinking water is associated with hip fracture risk. However, the findings are varied or even contradictory. In this work, we performed a meta-analysis to assess the relationship between fluoride exposure and hip fracture risk. Methods PubMed and EMBASE databases were searched to identify relevant observational studies from the time of inception until March 2014 without restrictions. Data from the included studies were extracted and analyzed by two authors. Summary relative risks (RRs) with corresponding 95% confidence intervals (CIs) were pooled using random-or fixed-effects models as appropriate. Sensitivity analyses and meta-regression were conducted to explore possible explanations for heterogeneity. Finally, publication bias was assessed. Results Fourteen observational studies involving thirteen cohort studies and one case-control study were included in the meta-analysis. Exposure to fluoride in drinking water does not significantly increase the incidence of hip fracture (RRs, 1.05; 95% CIs, 0.96-1.15). Sensitivity analyses based on adjustment for covariates, effect measure, country, sex, sample size, quality of Newcastle-Ottawa Scale scores, and follow-up period validated the strength of the results. Meta-regression showed that country, gender, quality of Newcastle-Ottawa Scale scores, adjustment for covariates and sample size were not sources of heterogeneity. Little evidence of publication bias was observed. Conclusion The present meta-analysis suggests that chronic fluoride exposure from drinking water does not significantly increase the risk of hip fracture. Given the potential confounding factors and exposure misclassification, further large-scale, high-quality studies are needed to evaluate the association between exposure to fluoride in drinking water and hip fracture risk.	[Yin, Xin-Hai; Huang, Guang-Lei; Lin, Du-Ren; Wan, Cheng-Cheng; Wang, Ya-Dong; Song, Ju-Kun; Xu, Ping] Gui Zhou Prov Peoples Hosp, Dept Oral & Maxillary Surg, Guiyang, Gui Zhou, Peoples R China		Song, JK (corresponding author), Gui Zhou Prov Peoples Hosp, Dept Oral & Maxillary Surg, Guiyang, Gui Zhou, Peoples R China.	songjukun@163.com						ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; CAULEY JA, 1995, J BONE MINER RES, V10, P1076; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; DANIELSON C, 1992, JAMA-J AM MED ASSOC, V268, P746; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EKSTRAND J, 1978, CLIN PHARMACOL THER, V23, P329; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hillier S, 2000, LANCET, V355, P265, DOI 10.1016/S0140-6736(99)07161-5; Jacobsen S J, 1992, Ann Epidemiol, V2, P617, DOI 10.1016/1047-2797(92)90006-C; JACOBSEN SJ, 1993, AM J PUBLIC HEALTH, V83, P743, DOI 10.2105/AJPH.83.5.743; Karagas MR, 1996, ANN EPIDEMIOL, V6, P209, DOI 10.1016/1047-2797(96)00006-3; Kurttio P, 1999, AM J EPIDEMIOL, V150, P817, DOI 10.1093/oxfordjournals.aje.a010086; Lehmann R, 1998, BONE, V22, P273, DOI 10.1016/S8756-3282(97)00273-1; Li YM, 2001, J BONE MINER RES, V16, P932, DOI 10.1359/jbmr.2001.16.5.932; Nasman P, 2013, J DENT RES, V92, P1029, DOI 10.1177/0022034513506443; Park Eun Young, 2008, J Prev Med Public Health, V41, P147; Phipps KR, 2000, BRIT MED J, V321, P860, DOI 10.1136/bmj.321.7265.860; RAO HV, 1995, REGUL TOXICOL PHARM, V22, P30, DOI 10.1006/rtph.1995.1065; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Schemitsch E, 2009, J ORTHOP TRAUMA, V23, P385, DOI 10.1097/BOT.0b013e3181acc51f; Scrivo R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0445-5; SIMONEN O, 1985, LANCET, V2, P432; SOWERS MR, 1991, AM J EPIDEMIOL, V133, P649, DOI 10.1093/oxfordjournals.aje.a115940; Whitford GM, 1996, MONOGR ORAL SCI, V16, P1	25	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126488	10.1371/journal.pone.0126488	http://dx.doi.org/10.1371/journal.pone.0126488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020536	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300023
J	Zhang, Y; Tang, WX; Zhang, X; Zhang, YG; Zhang, L				Zhang, Yan; Tang, Wenxi; Zhang, Xiang; Zhang, Yaoguang; Zhang, Liang			National Health Insurance Development in China from 2004 to 2011: Coverage versus Benefits	PLOS ONE			English	Article								Background The simultaneous improvement of the security capability of China Health Insurance System and its development in the last decade remains uncertain. This study measures the status and trends of reimbursement levels of the China Health Insurance System, as well as to offer policy advice to subsequent insurance reforms. Methods The National Reimbursement Ratio was created to determine the reimbursement level of the national health insurance system based on total health expenditure and the covered population. Chinese total health expenditure data from 2004 to 2011 were extracted from China's Health Statistics according to the standards of the International Classification for Health Accounts by Healthcare Financing. Results In 2011, the medical expenditure per capita in China was USD 130.95 and the National Reimbursement Ratio was 26.39%. The National Reimbursement Ratio showed an intense transition from 2004 to 2011, with a sharp decrease from 98.51% in 2004 to 22.44% in 2009, and then a small increase to 26.39% in 2011. Conclusion The National Reimbursement Ratio was effective in revealing the reimbursement level of the national health insurance system and in predicting its trends. The challenge to China's healthcare reform is to switch from increasing insurance coverage to guaranteeing a steady increase in government input and building a powerful supervision mechanism.	[Zhang, Yan; Tang, Wenxi; Zhang, Xiang; Zhang, Liang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan 430030, Hubei, Peoples R China; [Zhang, Yaoguang] Natl Hlth & Family Planning Commiss, Ctr Hlth Stat Informat, Beijing 100044, Peoples R China	Huazhong University of Science & Technology	Zhang, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Med & Hlth Management, Wuhan 430030, Hubei, Peoples R China.	zhangliang@mails.tjmu.edu.cn			National Natural Science Fund [71273099]; China Medical Board [11-069]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); China Medical Board	This work was supported by the National Natural Science Fund (71273099), (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) and the China Medical Board (11-069), (http://chinamedicalboard.org.cn/%E9%A1%B9%E7%9B%AE%E4%BB%8B%E7%BB%8D/%E6%89%80%E6%9C%89%E6%8B%A8%E6%AC%BE?field_fiscal_year_value%5Bvalue%5D%5Byear%5D=&field_program_nid=All&field_related_partner_nid=600&title=). The funders have a great role in study design, data collection and decision to publish of the manuscript.	[Anonymous], 2014, CHIN NAT HLTH ACC RE; Barber S. L., 2010, WORLD HLTH REP, P37; Evans DB, 2010, B WORLD HEALTH ORGAN, V88, P402, DOI 10.2471/BLT.10.078741; Fu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108571; Hu SL, 2008, B WORLD HEALTH ORGAN, V86, P819, DOI 10.2471/BLT.08.060046; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Ma Y, 2010, EUR J NEUROL, V17, P1270, DOI 10.1111/j.1468-1331.2010.03007.x; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Musgrove P, 2002, B WORLD HEALTH ORGAN, V80, P134; National Health and Family Planning Commission, 2014, CHIN STAT YB HLTH FA; Nishi A, 2012, B WORLD HEALTH ORGAN, V90, P426, DOI 10.2471/BLT.11.095380; OECD Health Policy Unit, 2000, SYST HLTH ACC INT DA; Organization for Economic Cooperation and Development, 2010, ORG EC COOP DEV OECD; Tang SL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-S1-S8; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116897; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2009, HLTH FIN STRAT AS PA; World Health Organization World Bank USAID, 2003, GUID PROD NAT HLTH A; Yan Z, 2013, BMC HEALTH SERV RES, V14, P649; Zhao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111555	21	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0124995	10.1371/journal.pone.0124995	http://dx.doi.org/10.1371/journal.pone.0124995			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020248	gold, Green Published, Green Submitted			2022-12-27	WOS:000355187300010
J	Blundell, GM; Pendleton, GW				Blundell, Gail M.; Pendleton, Grey W.			Factors Affecting Haul-Out Behavior of Harbor Seals (Phoca vitulina) in Tidewater Glacier Inlets in Alaska: Can Tourism Vessels and Seals Coexist?	PLOS ONE			English	Article							BAY NATIONAL-PARK; DIVING BEHAVIOR; ABUNDANCE; GULF; DISTURBANCE; RICHARDSI; RESPONSES; PATTERNS; NUMBERS; BUDGET	Large numbers of harbor seals (Phoca vitulina) use habitat in tidewater glaciers in Alaska for pupping, breeding, and molting. Glacial fjords are also popular tourist destinations; however, visitation by numerous vessels can result in disturbance of seals during critical life-history phases. We explored factors affecting haul-out behavior of harbor seals at a glacial site frequented by tourism vessels. In 2008-10, we deployed VHF transmitters on 107 seals in Endicott Arm, Alaska. We remotely monitored presence and haul-out behavior of tagged seals and documented vessel presence with time-lapse cameras. We evaluated the influence of environmental and physical factors on the probability of being hauled out, duration of haul-out bouts, and as factors associated with the start and end of a haulout. Location, season, hour, and interactions of location by year, season, hour, and sex significantly influenced haul-out probability, as did ice, weather, and vessels. Seals were more likely to be hauled out with greater ice availability during the middle of the day, and less likely to be hauled out if vessels were present. Cruise ships had the strongest negative effect; however, most vessel types negatively affected haul-out probability. Haul-out duration was longest in association with starting on incoming tides, clear skies, no precipitation, occurring in the middle of the day, and ending in the late afternoon or evening. End of haulouts was associated with increasing cloud cover, low ice availability, and vessel presence; large-sized tourism vessels or all-vessel-types combined were significant predictors of ending a haul-out bout. Probability of being hauled out was highest in June, during pupping season. Potential disturbances of harbor seals could be reduced, enabling longer resting times for seals and fewer interruptions for nursing pups, if vessels focused the majority of visits to glacial habitat to before or after the hours of 08:00-17:00 or, less optimally, 09:00-16:00.	[Blundell, Gail M.; Pendleton, Grey W.] Alaska Dept Fish & Game, Div Wildlife Conservat, Juneau, AK 99811 USA	Alaska Department of Fish & Game	Blundell, GM (corresponding author), Alaska Dept Fish & Game, Div Wildlife Conservat, Juneau, AK 99811 USA.	gail.blundell@alaska.gov			National Oceanographic and Atmospheric Agency/National Marine Fisheries Service/Alaska Region	National Oceanographic and Atmospheric Agency/National Marine Fisheries Service/Alaska Region	Grant Numbers NA04NMF4390143 and NA08NMF4390544 awarded to Alaska Department of Fish and Game by the National Oceanographic and Atmospheric Agency/National Marine Fisheries Service/Alaska Region. The funders reviewed research proposals that described the intention to collect these data, the intended purpose for the data and, the ultimate purpose of the manuscript. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	ALLEN SG, 1984, FISH B-NOAA, V82, P493; Andersen SM, 2012, AQUAT CONSERV, V22, P113, DOI 10.1002/aqc.1244; [Anonymous], 2006, SAS MIXED MODELS; Arendt AA, 2002, SCIENCE, V297, P382, DOI 10.1126/science.1072497; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Blundell GM, 2008, MAR MAMMAL SCI, V24, P577, DOI 10.1111/j.1748-7692.2008.00194.x; Blundell GM, 2011, MAR ECOL PROG SER, V429, P277, DOI 10.3354/meps09073; Boveng PL, 2003, MAR MAMMAL SCI, V19, P111, DOI 10.1111/j.1748-7692.2003.tb01096.x; Brasseur S, 1996, MAR MAMMAL SCI, V12, P619; CALAMBOKIDIS J, 1987, CAN J ZOOL, V65, P1391, DOI 10.1139/z87-219; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; Frost KJ, 2001, MAR MAMMAL SCI, V17, P813, DOI 10.1111/j.1748-7692.2001.tb01300.x; Harding KC, 2005, FUNCT ECOL, V19, P129, DOI 10.1111/j.0269-8463.2005.00945.x; Hastings KK, 2004, CAN J ZOOL, V82, P1755, DOI 10.1139/Z04-145; Henry Edwige, 2001, Aquatic Mammals, V27, P140; Herreman JK, 2009, CAN J ZOOL, V87, P498, DOI 10.1139/Z09-033; Hoover-Miller A, 2013, J WILDLIFE MANAGE, V77, P689, DOI 10.1002/jwmg.510; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jansen JK, 2015, MAR MAMMAL SCI, V31, P66, DOI 10.1111/mms.12140; Jansen JK, 2010, J WILDLIFE MANAGE, V74, P1186, DOI 10.2193/2008-192; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Jensen FH, 2009, MAR ECOL PROG SER, V395, P161, DOI 10.3354/meps08204; Johnson A, 2007, CAN J ZOOL, V85, P290, DOI 10.1139/Z06-213; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; London JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038180; Mathews EA, 2006, MAR MAMMAL SCI, V22, P167, DOI 10.1111/j.1748-7692.2006.00011.x; Mathews EA, 1996, MAR MAMMAL SCI, V12, P483, DOI 10.1111/j.1748-7692.1996.tb00603.x; McNabb RW, 2014, J GEOPHYS RES-EARTH, V119, P153, DOI 10.1002/2013JF002915; MUELBERT MMC, 1993, CAN J ZOOL, V71, P1405, DOI 10.1139/z93-194; Osinga N, 2012, MAMM BIOL, V77, P281, DOI 10.1016/j.mambio.2012.02.005; Paterson W, 2012, J THERM BIOL, V37, P454, DOI 10.1016/j.jtherbio.2012.03.004; Pfeffer WT, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000590; Ramasco V, 2014, ANIM BEHAV, V94, P117, DOI 10.1016/j.anbehav.2014.05.015; Simpkins MA, 2003, MAR MAMMAL SCI, V19, P791, DOI 10.1111/j.1748-7692.2003.tb01130.x; Small RJ, 2003, MAR MAMMAL SCI, V19, P344, DOI 10.1111/j.1748-7692.2003.tb01113.x; Stamation KA, 2010, MAR MAMMAL SCI, V26, P98, DOI 10.1111/j.1748-7692.2009.00320.x; Stensland E, 2007, MAR ECOL PROG SER, V332, P225, DOI 10.3354/meps332225; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Suryan RM, 1999, FISH B-NOAA, V97, P332; Thompson PM, 2008, MAR MAMMAL SCI, V24, P138, DOI 10.1111/j.1748-7692.2007.00179.x; Ver Hoef JM, 2001, BAYESIAN HIERARCHICA; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Williams R, 2007, J ZOOL, V272, P390, DOI 10.1111/j.1469-7998.2006.00280.x; WILLIAMS TM, 1991, J COMP PHYSIOL B, V160, P637, DOI 10.1007/BF00571261; Womble JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055386; Womble JN, 2010, MAR MAMMAL SCI, V26, P686, DOI 10.1111/j.1748-7692.2009.00360.x; Young C., 2014, Tourism in Marine Environments, V10, P5, DOI 10.3727/154427314X14056884441626	47	8	8	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125486	10.1371/journal.pone.0125486	http://dx.doi.org/10.1371/journal.pone.0125486			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017404	Green Submitted, gold, Green Published			2022-12-27	WOS:000355185600024
J	Boone, DR; Micci, MA; Taglialatela, IG; Hellmich, JL; Weisz, HA; Bi, M; Prough, DS; DeWitt, DS; Hellmich, HL				Boone, Deborah R.; Micci, Maria-Adelaide; Taglialatela, Isabella G.; Hellmich, Judy L.; Weisz, Harris A.; Bi, Min; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.			Pathway-Focused PCR Array Profiling of Enriched Populations of Laser Capture Microdissected Hippocampal Cells after Traumatic Brain Injury	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; FLUORO-JADE; ACTIVATION; NEUROPROTECTION; PROTEIN; DEATH; REPRODUCIBILITY; MODULATION; MECHANISMS	Cognitive deficits in survivors of traumatic brain injury (TBI) are associated with irreversible neurodegeneration in brain regions such as the hippocampus. Comparative gene expression analysis of dying and surviving neurons could provide insight into potential therapeutic targets. We used two pathway-specific PCR arrays (RT2 Profiler Apoptosis and Neurotrophins & Receptors PCR arrays) to identify and validate TBI-induced gene expression in dying (Fluoro-Jade-positive) or surviving (Fluoro-Jade-negative) pyramidal neurons obtained by laser capture microdissection (LCM). In the Apoptosis PCR array, dying neurons showed significant increases in expression of genes associated with cell death, inflammation, and endoplasmic reticulum (ER) stress compared with adjacent, surviving neurons. Pro-survival genes with pleiotropic functions were also significantly increased in dying neurons compared to surviving neurons, suggesting that even irreversibly injured neurons are able to mount a protective response. In the Neurotrophins & Receptors PCR array, which consists of genes that are normally expected to be expressed in both groups of hippocampal neurons, only a few genes were expressed at significantly different levels between dying and surviving neurons. Immunohistochemical analysis of selected, differentially expressed proteins supported the gene expression data. This is the first demonstration of pathway-focused PCR array profiling of identified populations of dying and surviving neurons in the brain after TBI. Combining precise laser microdissection of identifiable cells with pathway-focused PCR array analysis is a practical, low-cost alternative to microarrays that provided insight into neuroprotective signals that could be therapeutically targeted to ameliorate TBI-induced neurodegeneration.	[Boone, Deborah R.; Micci, Maria-Adelaide; Taglialatela, Isabella G.; Hellmich, Judy L.; Weisz, Harris A.; Bi, Min; Prough, Donald S.; DeWitt, Douglas S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	department of Anesthesiology (UTMB); Moody Foundation;  [RO1 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052532] Funding Source: NIH RePORTER	department of Anesthesiology (UTMB); Moody Foundation; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by RO1 NS052532 (HLH), and in part by the department of Anesthesiology (UTMB) and a Moody Foundation grant to DSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen Kristina E, 2011, BMC Res Notes, V4, P69, DOI 10.1186/1756-0500-4-69; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328; Asztalos S, 2010, CANCER PREV RES, V3, P301, DOI 10.1158/1940-6207.CAPR-09-0069; Boone DR, 2013, JOVE-J VIS EXP, DOI 10.3791/50308; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Brain Trauma Foundation AAoNSCoNSJSoNaCC, 2003, GUID MAN SEV TRAUM B; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen W, 2007, TOHOKU J EXP MED, V212, P319, DOI 10.1620/tjem.212.319; Choi HJ, 2011, BRIT J PHARMACOL, V162, P175, DOI 10.1111/j.1476-5381.2010.01041.x; Ciotti P, 2009, DIAGN MOL PATHOL, V18, P112, DOI 10.1097/PDM.0b013e3181831320; Clark RE, 2013, P NATL ACAD SCI USA, V110, P10365, DOI 10.1073/pnas.1301225110; d'Hellencourt CL, 2005, J NEUROCHEM, V93, P206, DOI 10.1111/j.1471-4159.2004.03017.x; Dai C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015008; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Elliott-Hunt CR, 2007, J NEUROCHEM, V100, P780, DOI 10.1111/j.1471-4159.2006.04239.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Haines B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031739; Hansel NN, 2008, ALLERGY, V63, P366, DOI 10.1111/j.1398-9995.2007.01540.x; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hernandez-Baltazar D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070951; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hou H, 2008, BIOCHEM BIOPH RES CO, V369, P641, DOI 10.1016/j.bbrc.2008.02.094; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Ikeda T, 2000, ACTA NEUROPATHOL, V100, P161, DOI 10.1007/s004019900162; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kuga D, 2008, NEURO-ONCOLOGY, V10, P995, DOI 10.1215/15228517-2008-064; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mori M, 2004, CELL DEATH DIFFER, V11, P1223, DOI 10.1038/sj.cdd.4401483; Murakami H, 2000, KIDNEY INT, V58, P1346, DOI 10.1046/j.1523-1755.2000.00295.x; Nogueira-Silva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030517; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Pan CQ, 2012, FEBS LETT, V586, P2674, DOI 10.1016/j.febslet.2012.04.023; Petito CK, 2001, J NEUROPATH EXP NEUR, V60, P377, DOI 10.1093/jnen/60.4.377; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Ruan YL, 1997, J NEUROSCI RES, V50, P383, DOI 10.1002/(SICI)1097-4547(19971101)50:3<383::AID-JNR4>3.0.CO;2-E; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Salminen A, 1998, MOL BRAIN RES, V61, P203, DOI 10.1016/S0169-328X(98)00210-1; Satoh T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.169; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Slevin M, 2010, J VASC RES, V47, P323, DOI 10.1159/000265566; So T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00139; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; SUGIMOTO A, 1995, EMBO J, V14, P4434, DOI 10.1002/j.1460-2075.1995.tb00122.x; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Mena JET, 2014, ANAL BIOCHEM, V447, P126, DOI 10.1016/j.ab.2013.11.015; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang GB, 2013, NEUROSCI LETT, V543, P72, DOI 10.1016/j.neulet.2013.02.067; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077; Wu H, 2013, J MOL NEUROSCI, V49, P512, DOI 10.1007/s12031-012-9910-6; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zaheer S, 2013, NEUROCHEM RES, V38, P218, DOI 10.1007/s11064-012-0913-z; Zhang JH, 2004, DEV BRAIN RES, V152, P255, DOI 10.1016/j.devbrainres.2004.07.008	74	25	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127287	10.1371/journal.pone.0127287	http://dx.doi.org/10.1371/journal.pone.0127287			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016641	Green Submitted, gold, Green Published			2022-12-27	WOS:000355185600078
J	Korotkevych, NV; Labyntsev, AJ; Kolybo, DV; Komisarenko, SV				Korotkevych, Nataliia V.; Labyntsev, Andrii Ju.; Kolybo, Denis V.; Komisarenko, Serhiy V.			The Soluble Heparin-Binding EGF-Like Growth Factor Stimulates EGF Receptor Trafficking to the Nucleus	PLOS ONE			English	Article							ERBB RECEPTORS; LOCALIZATION; CELLS; PROTEIN; ACTIVATION; EXPRESSION; PATHWAY; KINASE; CANCER	Most ligands of epidermal growth factor receptor (EGFR) have the ability to induce EGFR translocation into the nucleus, where EGFR acts as an important transcriptional regulator. Soluble form of heparin-binding EGF-like growth factor (sHB-EGF) is one of the ligands for EGFR in many cell types; however, there is no evidence for the ability of sHB-EGF to induce EGFR nuclear importation. Here, we demonstrated that treatment of A431 cells with sHB-EGF resulted in nuclear localization of EGFR and such translocation occurs via retrograde pathway. It was shown by confocal microscopy and co-immunoprecipitation assay that the translocation complex consisted of both ligand and receptor. The chromatin immunoprecipitation assay showed the association of sHB-EGF-EGFR complex with promoter region of cyclin D1 in the cell nucleus and this association was prevented by application of EGFR kinase inhibitor AG-1478. The obtained data suggest that sHB-EGF acts similarly to other EGFR ligands and is capable to induce EGFR nuclear translocation as a part of ligand-receptor complex in a tyrosine phosphorylation-dependent manner.	[Korotkevych, Nataliia V.; Labyntsev, Andrii Ju.; Kolybo, Denis V.; Komisarenko, Serhiy V.] Natl Acad Sci Ukraine, Palladin Inst Biochem, Dept Mol Immunol, Kiev, Ukraine	National Academy of Sciences Ukraine; Palladin Institute of Biochemistry of NASU	Korotkevych, NV (corresponding author), Natl Acad Sci Ukraine, Palladin Inst Biochem, Dept Mol Immunol, Kiev, Ukraine.	gnr.nata@gmail.com	Labyntsev, Andrii/AAQ-5021-2020; Komisarenko, Sergiy/AAT-3457-2020	Labyntsev, Andrii/0000-0002-1793-4630; Komisarenko, Serhiy/0000-0002-3244-3194				Adam RM, 2003, CANCER RES, V63, P484; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand TM, 2013, RADIOTHER ONCOL, V108, P370, DOI 10.1016/j.radonc.2013.06.010; Bueter W, 2006, CYTOKINE, V36, P267, DOI 10.1016/j.cyto.2007.02.002; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kim JS, 2007, CLIN CANCER RES, V13, P6509, DOI 10.1158/1078-0432.CCR-07-1428; Korotkevich NV, 2014, BIOTECHNOL ACTA, V7, P46; Korotkevich NV, 2010, BIOTECHNOL ACTA, V3, P44; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; MARTI U, 1991, HEPATOLOGY, V13, P15, DOI 10.1016/0270-9139(91)90210-M; NAKANE PK, 1974, J HISTOCHEM CYTOCHEM, V22, P1084, DOI 10.1177/22.12.1084; Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393; Oliinyk ES, 2009, BIOTECHNOL ACTA, V2, P59; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Raabe TD, 2004, GLIA, V45, P197, DOI 10.1002/glia.10311; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Thompson M, 2007, BRAIN RES, V1139, P95, DOI 10.1016/j.brainres.2006.11.047; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Zscheppang K, 2006, PEDIATR PULM, V41, P1205, DOI 10.1002/ppul.20518	31	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127887	10.1371/journal.pone.0127887	http://dx.doi.org/10.1371/journal.pone.0127887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016774	gold, Green Submitted, Green Published			2022-12-27	WOS:000355185600099
J	Lambrus, BG; Cochet-Escartin, O; Gao, JR; Newmark, PA; Collins, EMS; Collins, JJ				Lambrus, Bramwell G.; Cochet-Escartin, Olivier; Gao, Jiarong; Newmark, Phillip A.; Collins, Eva-Maria S.; Collins, James J., Jr.			Tryptophan hydroxylase Is Required for Eye Melanogenesis in the Planarian Schmidtea mediterranea	PLOS ONE			English	Article							PIGMENTATION; REGENERATION; SYSTEM; BIOSYNTHESIS; MAINTENANCE; EVOLUTION; RECEPTOR; NEURONS; MODEL; COLOR	Melanins are ubiquitous and biologically important pigments, yet the molecular mechanisms that regulate their synthesis and biochemical composition are not fully understood. Here we present a study that supports a role for serotonin in melanin synthesis in the planarian Schmidtea mediterranea. We characterize the tryptophan hydroxylase (tph) gene, which encodes the rate-limiting enzyme in serotonin synthesis, and demonstrate by RNA interference that tph is essential for melanin production in the pigment cups of the planarian photoreceptors. We exploit this phenotype to investigate the biological function of pigment cups using a quantitative light-avoidance behavioral assay. Planarians lacking eye pigment remain phototactic, indicating that eye pigmentation is not essential for light avoidance in S. mediterranea, though it improves the efficiency of the photophobic response. Finally, we show that the eye pigmentation defect observed in tph knockdown animals can be rescued by injection of either the product of TPH, 5-hydroxytryptophan (5-HTP), or serotonin. Together, these results highlight a role for serotonin in melanogenesis, perhaps as a regulatory signal or as a pigment substrate. To our knowledge, this is the first example of this relationship to be reported outside of mammalian systems.	[Lambrus, Bramwell G.; Gao, Jiarong; Newmark, Phillip A.; Collins, James J., Jr.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA; [Lambrus, Bramwell G.; Gao, Jiarong; Newmark, Phillip A.; Collins, James J., Jr.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA; [Collins, James J., Jr.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Cochet-Escartin, Olivier; Collins, Eva-Maria S.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA; [Cochet-Escartin, Olivier; Collins, Eva-Maria S.] Univ Calif San Diego, Dept Phys, San Diego, CA USA	Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego; University of California System; University of California San Diego	Collins, EMS (corresponding author), Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA.	emscollins@physics.ucsd.edu; jamesj.collins@utsouthwestern.edu		Newmark, Phillip/0000-0003-0793-022X; Cochet-Escartin, Olivier/0000-0001-7924-702X	Burroughs Welcome Fund	Burroughs Welcome Fund(Burroughs Wellcome Fund)	This work was supported by the Burroughs Welcome Fund (E.M.S.C., B.G.L, O.C.E). P.A.N is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Brubacher JL, 2014, NAT PROTOC, V9, P661, DOI 10.1038/nprot.2014.041; CARPENTER KS, 1974, CELL TISSUE RES, V148, P143; Cebria F, 2005, DEVELOPMENT, V132, P3691, DOI 10.1242/dev.01941; Collins JJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000509; Cook LM, 2013, HEREDITY, V110, P207, DOI 10.1038/hdy.2012.92; Currie KW, 2013, DEVELOPMENT, V140, P3577, DOI 10.1242/dev.098590; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Hase S, 2006, PIGM CELL RES, V19, P248, DOI 10.1111/j.1600-0749.2006.00306.x; Inoue T, 2004, ZOOL SCI, V21, P275, DOI 10.2108/zsj.21.275; Ito S, 2000, PIGM CELL RES, V13, P103, DOI 10.1034/j.1600-0749.13.s8.19.x; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Lapan SW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002226; Lee HJ, 2011, BRIT J DERMATOL, V165, P1344, DOI 10.1111/j.1365-2133.2011.10490.x; Liao S, 2012, EXP DERMATOL, V21, P635, DOI 10.1111/j.1600-0625.2012.01531.x; Miyamura Y, 2007, PIGM CELL RES, V20, P2, DOI 10.1111/j.1600-0749.2006.00358.x; Ness DK, 1996, FUND APPL TOXICOL, V30, P153, DOI 10.1006/faat.1996.0052; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nilsson DE, 2009, PHILOS T R SOC B, V364, P2833, DOI 10.1098/rstb.2009.0083; Nishimura K, 2007, NEUROSCI RES, V59, P101, DOI 10.1016/j.neures.2007.05.014; Parker GH, 1900, AM J PHYSIOL, V4, P1; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Schiaffino MV, 2010, INT J BIOCHEM CELL B, V42, P1094, DOI 10.1016/j.biocel.2010.03.023; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sturm RA, 2009, PIGM CELL MELANOMA R, V22, P544, DOI 10.1111/j.1755-148X.2009.00606.x; Talbot J, 2011, J EXP BIOL, V214, P1063, DOI 10.1242/jeb.052290; Taliaferro WH, 1918, J EXPT ZOOLOGY, P1; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tobin DJ, 2011, PIGM CELL MELANOMA R, V24, P75, DOI 10.1111/j.1755-148X.2010.00803.x; VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407; Vogliardi S, 2002, J MASS SPECTROM, V37, P1292, DOI 10.1002/jms.383; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102	37	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127074	10.1371/journal.pone.0127074	http://dx.doi.org/10.1371/journal.pone.0127074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017970	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600068
J	Lang, A; Koch, R; Rohn, K; Gasse, H				Lang, Anja; Koch, Ruediger; Rohn, Karl; Gasse, Hagen			The Histological Components of the Phoniatrical Body-Cover Model in Minipigs of Different Ages	PLOS ONE			English	Article							HUMAN VOCAL FOLDS; LAMINA PROPRIA; EXTRACELLULAR-MATRIX; COW LARYNGES; EXCISED PIG; COLLAGEN; ELASTICITY; PHONATION; FIBERS; TISSUE	Pigs are models in human phoniatry. However, features of maturation and ageing have not been considered with regard to the so-called body-cover model in this species. Therefore, the glottis of "young" (2-3 months; n = 6) and "old" (4-7 years; n = 6) minipigs was investigated. Their cranial (CraF) and caudal (CauF) vocal folds were histomorphometrically and stratigraphically analysed with emphasis on their amounts of collagen structures and elastic fibres. A dense subepithelial layer (SEL) was a distinct feature of CraF and CauF of both age groups; it was spread upon the underlying loose, flexible "cover" like a fibro-elastic membrane. The "cover" was characterised by the so-called superficial layer (SL), which was distinctly loose in the "young" minipigs, but had a much denser texture in the "old" minipigs. Here, the SL was dominated by elastic fibres in the CraF, but was of mixed qualities (collagenous and elastic) in the CauF. The structural requirements for the SL's function as a loose "cover" were thus met only in the "young" animals. A clearly demarcated intermediate layer (IL)-characterised by high amounts of elastic fibres (as in humans)-was only found in the CraF of the "young" animals. In the "old" animals, it had lost its demarcation. In the depth of the CraF of the "old" animals, many thick collagen fibre bundles were detected in a location equivalent to that of the vocal muscle in the CauF. The development of their large diameters was interpreted as part of the maturation process, thereby supporting the hypothesis of their functional importance as a component of the "body." In the CauF, the amounts of collagen structures increased throughout the entire lamina propria, resulting in a loss of demarcated stratigraphical subdivisions in the "old" minipigs. This situation resembled that described in the vocal fold of geriatric humans.	[Lang, Anja; Koch, Ruediger; Gasse, Hagen] Univ Vet Med Hannover, Inst Anat, Hannover, NH, Germany; [Rohn, Karl] Univ Vet Med Hannover, Dept Biometry Epidemiol & Informat Proc, Hannover, NH, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Lang, A (corresponding author), Univ Vet Med Hannover, Inst Anat, Hannover, NH, Germany.	anja.lang@tiho-hannover.de						Alipour F, 2009, J VOICE, V23, P40, DOI 10.1016/j.jvoice.2007.03.007; Alipoura F, 2008, J ACOUST SOC AM, V123, P4572, DOI 10.1121/1.2908289; Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; BIEVER D M, 1989, Journal of Voice, V3, P120, DOI 10.1016/S0892-1997(89)80138-9; BLAKESLEE DB, 1995, J INVEST SURG, V8, P409, DOI 10.3109/08941939509031607; Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x; Ganderup NC, 2012, INT J TOXICOL, V31, P507, DOI 10.1177/1091581812462039; Garrett CG, 2000, LARYNGOSCOPE, V110, P814, DOI 10.1097/00005537-200005000-00011; Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115; Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311; Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213; Hahn MS, 2005, ANN OTO RHINOL LARYN, V114, P451, DOI 10.1177/000348940511400607; Hammond TH, 1998, OTOLARYNG HEAD NECK, V119, P314, DOI 10.1016/S0194-5998(98)70071-3; Hammond TH, 2000, ANN OTO RHINOL LARYN, V109, P913, DOI 10.1177/000348940010901004; HIRANO M, 1989, ACTA OTO-LARYNGOL, V107, P428, DOI 10.3109/00016488909127535; HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771; Hirano M., 1981, CLIN EXAMINATION VOI; Hirano M., 1983, VOCAL FOLD PHYSL, P22; Hirano M., 1977, DYNAMIC ASPECTS SPEE, P13; Hirano M., 1985, SPEECH SCI, P1; Infusino SA, 2013, INT J PEDIATR OTORHI, V77, P1651, DOI 10.1016/j.ijporl.2013.07.018; Ishii K, 1996, ACTA OTO-LARYNGOL, V116, P778, DOI 10.3109/00016489609137924; Jiang JJ, 2001, ANN OTO RHINOL LARYN, V110, P1120, DOI 10.1177/000348940111001207; Kurita S., 1983, VOCAL FOLD PHYSL CON, P3; Lang A, 2015, ANAT HISTOL EMBRYOL, V44, P186, DOI 10.1111/ahe.12125; Lang A, 2014, THESIS U VET MED HAN; Michael Swindle M., 2008, SOURCEBOOK MODELS BI, P233, DOI DOI 10.1007/978-1-59745-285-4_26; Roberts T, 2011, CLIN ANAT, V24, P544, DOI 10.1002/ca.21114; Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15, DOI 10.1177/000348940211100103; Sato K, 2001, ANN OTO RHINOL LARYN, V110, P417, DOI 10.1177/000348940111000505; Sherratt MJ, 2009, AGE, V31, P305, DOI 10.1007/s11357-009-9103-6; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Swindle MM, 2006, LAB ANIMAL MED MANAG; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P469, DOI 10.1177/000348940611500612; Titze IR, 1994, PRINCIPLES VOICE PRO; Woodson G, 2012, J VOICE, V26, P706, DOI 10.1016/j.jvoice.2012.03.003; Yumoto E, 1998, ARCH OTOLARYNGOL, V124, P897, DOI 10.1001/archotol.124.8.897	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128085	10.1371/journal.pone.0128085	http://dx.doi.org/10.1371/journal.pone.0128085			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018404	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600110
J	Varman, DR; Rajan, KE				Varman, Durairaj Ragu; Rajan, Koilmani Emmanuvel			Environmental Enrichment Reduces Anxiety by Differentially Activating Serotonergic and Neuropeptide Y (NPY)-Ergic System in Indian Field Mouse (Mus booduga): An Animal Model of Post-Traumatic Stress Disorder	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; ELEVATED PLUS-MAZE; NEUROTROPHIC FACTOR; BASOLATERAL AMYGDALA; HIPPOCAMPAL BDNF; 5-HT1A RECEPTORS; BRAIN; MICE; RATS; DEPRESSION	Exposure to a predator elicits an innate fear response and mimics several behavioral disorders related to post-traumatic stress disorder (PTSD). The protective role of an enriched condition (EC) against psychogenic stressors in various animal models has been well documented. However, this condition has not been tested in field mice in the context of PTSD. In this study, we show that field mice (Mus booduga) housed under EC exhibit predominantly proactive and less reactive behavior compared with mice housed under standard conditions (SC) during exposure to their natural predator (field rat Rattus rattus). Furthermore, we observed that EC mice displayed less anxiety-like behavior in an elevated plus maze (EPM) and light/dark-box after exposure to the predator (7 hrs/7 days). In EC mice, predator exposure elevated the level of serotonin (5-Hydroxytrypamine, [5-HT]) in the amygdala as part of the coping response. Subsequently, the serotonin transporter (SERT) and 5-HT1A receptor were up-regulated significantly, but the same did not occur in the 5-HT2C receptor, which is associated with the activation of calmodulin-dependent protein kinase-II (CaMKII) and a transcription factor cAMP response element binding protein (CREB). Our results show that predator exposure induced the activation of CaMKII/CREB, which is accompanied with increased levels of histone acetylation (H3, H4) and decreased histone deacetylases (HDAC1, 2). Subsequently, in the amygdala, the transcription of brain-derived neurotrophic factor (BDNF), neuropeptide Y (NPY) and its Y1 receptor were up-regulated, whereas the Y2 receptor was down-regulated. Therefore, EC facilitated a coping response against a fear associated cue in a PTSD animal model and reduced anxiety by differentially activating serotonergic and NPY-ergic systems.	[Varman, Durairaj Ragu; Rajan, Koilmani Emmanuvel] Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Tiruchirappalli, Tamil Nadu, India	Bharathidasan University	Rajan, KE (corresponding author), Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Palkalaiperur Campus, Tiruchirappalli, Tamil Nadu, India.	emmanuvel1972@yahoo.com	Durairaj, Ragu Varman/AAU-7637-2021; Rajan, Koilman Emmanuvel/GSM-7214-2022	Durairaj, Ragu Varman/0000-0002-9409-9456; 	Council of Scientific and Industrial Research (CSIR) [37(1426)/10/EMR-II/2010]; DRV [09/475(0183) 2012,-EMR-I]; UGC-SAP-DRS-II	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); DRV; UGC-SAP-DRS-II	This research was partially supported by Council of Scientific and Industrial Research (CSIR) through a major project to KER [37(1426)/10/EMR-II/2010] and DRV through Senior Research Fellowship [09/475(0183) 2012,-EMR-I]; KER thanks UGC-SAP-DRS-II.	Adamec R, 1998, NEUROSCI BIOBEHAV R, V23, P301, DOI 10.1016/S0149-7634(98)00032-3; Adamec R, 2004, PHYSIOL BEHAV, V83, P401, DOI 10.1016/j.physbeh.2004.08.029; Adamec RE, 2005, NEUROSCI BIOBEHAV R, V29, P1225, DOI 10.1016/j.neubiorev.2005.05.007; Akimova E, 2009, BIOL PSYCHIAT, V66, P627, DOI 10.1016/j.biopsych.2009.03.012; Asan E, 2013, HISTOCHEM CELL BIOL, V139, P785, DOI 10.1007/s00418-013-1081-1; Bacchi F, 2006, PEPTIDES, V27, P3202, DOI 10.1016/j.peptides.2006.07.020; BLANCHARD RJ, 1995, AGGRESSIVE BEHAV, V21, P123, DOI 10.1002/1098-2337(1995)21:2<123::AID-AB2480210205>3.0.CO;2-E; BLANCHARD RJ, 1989, J COMP PSYCHOL, V103, P70, DOI 10.1037/0735-7036.103.1.70; Boer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000431; Branchi I, 2011, NEUROSCI LETT, V495, P168, DOI 10.1016/j.neulet.2011.03.038; Breuillaud L, 2012, BIOL PSYCHIAT, V72, P528, DOI 10.1016/j.biopsych.2012.04.011; Campos AC, 2013, NEUROSCI LETT, V533, P34, DOI 10.1016/j.neulet.2012.11.016; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Charoenphandhu N, 2013, MOL CELL BIOCHEM, V375, P49, DOI 10.1007/s11010-012-1527-0; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Daftary SS, 2012, NEUROSCIENCE, V224, P125, DOI 10.1016/j.neuroscience.2012.08.025; Daws LC, 2009, PHARMACOL THERAPEUT, V121, P89, DOI 10.1016/j.pharmthera.2008.10.004; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Fendt M, 2009, PSYCHOPHARMACOLOGY, V206, P291, DOI 10.1007/s00213-009-1610-8; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fox C, 2006, BEHAV BRAIN RES, V175, P1, DOI 10.1016/j.bbr.2006.08.016; Frielingsdorf H, 2010, ANN NY ACAD SCI, V1208, P150, DOI 10.1111/j.1749-6632.2010.05722.x; Fu AL, 2008, J PSYCHIATR RES, V43, P55, DOI 10.1016/j.jpsychires.2008.01.018; Ganesh A, 2010, BRAIN RES, V1352, P108, DOI 10.1016/j.brainres.2010.06.058; Giesbrecht CJ, 2010, J NEUROSCI, V30, P16970, DOI 10.1523/JNEUROSCI.2306-10.2010; Goyal SN, 2009, BRAIN RES, V1266, P45, DOI 10.1016/j.brainres.2009.02.033; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Hendriksen H, 2012, NEUROPHARMACOLOGY, V63, P733, DOI 10.1016/j.neuropharm.2012.05.028; Holmes A, 2002, J MOL NEUROSCI, V18, P151, DOI 10.1385/JMN:18:1-2:151; Holmes A, 2000, PHYSIOL BEHAV, V71, P509, DOI 10.1016/S0031-9384(00)00373-5; Holmes A, 2008, NEUROSCI BIOBEHAV R, V32, P1293, DOI 10.1016/j.neubiorev.2008.03.006; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Jasinska AJ, 2012, TRENDS NEUROSCI, V35, P395, DOI 10.1016/j.tins.2012.01.001; Jorgensen H, 2002, J NEUROENDOCRINOL, V14, P788, DOI 10.1046/j.1365-2826.2002.00839.x; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; KALIN NH, 1994, BRAIN RES, V656, P182, DOI 10.1016/0006-8993(94)91382-X; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Karlsson RM, 2008, PSYCHOPHARMACOLOGY, V195, P547, DOI 10.1007/s00213-007-0945-2; Koh S, 2007, EPILEPSY BEHAV, V10, P26, DOI 10.1016/j.yebeh.2006.11.008; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; Kusserow H, 2004, MOL BRAIN RES, V129, P104, DOI 10.1016/j.molbrainres.2004.06.028; Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064; Li XB, 2006, EUR J PHARMACOL, V532, P74, DOI 10.1016/j.ejphar.2005.12.008; Masini CV, 2005, BEHAV NEUROSCI, V119, P280, DOI 10.1037/0735-7044.119.1.280; Matsumoto Y, 2013, PSYCHOPHARMACOLOGY, V229, P51, DOI 10.1007/s00213-013-3078-9; MCDONALD AJ, 1989, BRAIN RES, V500, P37, DOI 10.1016/0006-8993(89)90297-7; Mifsud KR, 2011, BRAIN BEHAV IMMUN, V25, P1305, DOI 10.1016/j.bbi.2011.06.005; Miyagawa K, 2012, BEHAV BRAIN RES, V235, P318, DOI 10.1016/j.bbr.2012.08.010; Mongeau R, 2010, J NEUROCHEM, V115, P438, DOI 10.1111/j.1471-4159.2010.06932.x; Mora F, 2007, BRAIN RES REV, V55, P78, DOI 10.1016/j.brainresrev.2007.03.011; Morrison KE, 2012, PHARMACOL BIOCHEM BE, V100, P592, DOI 10.1016/j.pbb.2011.09.005; Naert G, 2011, MOL CELL NEUROSCI, V46, P55, DOI 10.1016/j.mcn.2010.08.006; Nakajima M, 1998, PEPTIDES, V19, P359, DOI 10.1016/S0196-9781(97)00298-2; Nunes-de-Souza Ricardo Luiz, 2010, Psychol. Neurosci., V3, P59, DOI 10.3922/j.psns.2010.1.007; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Oztan O, 2011, NEUROSCI LETT, V501, P107, DOI 10.1016/j.neulet.2011.06.058; Pandey SC, 2003, ALCOHOL CLIN EXP RES, V27, P396, DOI 10.1097/01.ALC.0000056616.81971.49; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Sah R, 2013, MOL PSYCHIATR, V18, P646, DOI 10.1038/mp.2012.101; Sah R, 2009, BIOL PSYCHIAT, V66, P705, DOI 10.1016/j.biopsych.2009.04.037; Sajdyk TJ, 2002, PHARMACOL BIOCHEM BE, V71, P419, DOI 10.1016/S0091-3057(01)00679-7; Sakharkar AJ, 2012, ALCOHOL CLIN EXP RES, V36, P61, DOI 10.1111/j.1530-0277.2011.01581.x; Amaral VCS, 2010, HORM BEHAV, V57, P128, DOI 10.1016/j.yhbeh.2009.09.018; Sharma VK, 1999, J PINEAL RES, V26, P153, DOI 10.1111/j.1600-079X.1999.tb00577.x; Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002; St Jacques PL, 2011, NEUROIMAGE, V57, P608, DOI 10.1016/j.neuroimage.2011.04.039; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Takahashi LK, 2007, BEHAV NEUROSCI, V121, P100, DOI 10.1037/0735-7044.121.1.100; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; Tyagi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057945; Vicente MA, 2012, INT J NEUROPSYCHOPH, V15, P389, DOI 10.1017/S1461145711000873; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Yang M, 2004, PHYSIOL BEHAV, V81, P465, DOI 10.1016/j.physbeh.2004.02.010; Yehuda R, 2006, BIOL PSYCHIAT, V59, P660, DOI 10.1016/j.biopsych.2005.08.027; Zhang LL, 2011, NEUROSCIENCE, V196, P203, DOI 10.1016/j.neuroscience.2011.08.069	82	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127945	10.1371/journal.pone.0127945	http://dx.doi.org/10.1371/journal.pone.0127945			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016844	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600100
J	Betge, J; Kerr, G; Miersch, T; Leible, S; Erdmann, G; Galata, CL; Zhan, TZ; Gaiser, T; Post, S; Ebert, MP; Horisberger, K; Boutros, M				Betge, Johannes; Kerr, Grainne; Miersch, Thilo; Leible, Svenja; Erdmann, Gerrit; Galata, Christian L.; Zhan, Tianzuo; Gaiser, Timo; Post, Stefan; Ebert, Matthias P.; Horisberger, Karoline; Boutros, Michael			Amplicon Sequencing of Colorectal Cancer: Variant Calling in Frozen and Formalin-Fixed Samples	PLOS ONE			English	Article							FFPE TUMOR-TISSUES; GENOME; SPECIMENS; TUMORIGENESIS; MUTATIONS; BIOPSIES; VIEWER	Next generation sequencing (NGS) is an emerging technology becoming relevant for genotyping of clinical samples. Here, we assessed the stability of amplicon sequencing from formalin-fixed paraffin-embedded (FFPE) and paired frozen samples from colorectal cancer metastases with different analysis pipelines. 212 amplicon regions in 48 cancer related genes were sequenced with Illumina MiSeq using DNA isolated from resection specimens from 17 patients with colorectal cancer liver metastases. From ten of these patients, paired fresh frozen and routinely processed FFPE tissue was available for comparative study. Sample quality of FFPE tissues was determined by the amount of amplifiable DNA using qPCR, sequencing libraries were evaluated using Bioanalyzer. Three bioinformatic pipelines were compared for analysis of amplicon sequencing data. Selected hot spot mutations were reviewed using Sanger sequencing. In the sequenced samples from 16 patients, 29 non-synonymous coding mutations were identified in eleven genes. Most frequent were mutations in TP53 (10), APC (7), PIK3CA (3) and KRAS (2). A high concordance of FFPE and paired frozen tissue samples was observed in ten matched samples, revealing 21 identical mutation calls and only two mutations differing. Comparison of these results with two other commonly used variant calling tools, however, showed high discrepancies. Hence, amplicon sequencing can potentially be used to identify hot spot mutations in colorectal cancer metastases in frozen and FFPE tissue. However, remarkable differences exist among results of different variant calling tools, which are not only related to DNA sample quality. Our study highlights the need for standardization and benchmarking of variant calling pipelines, which will be required for translational and clinical applications.	[Betge, Johannes; Kerr, Grainne; Miersch, Thilo; Leible, Svenja; Erdmann, Gerrit; Zhan, Tianzuo; Boutros, Michael] Heidelberg Univ, Div Signaling & Funct Gen, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Betge, Johannes; Kerr, Grainne; Miersch, Thilo; Leible, Svenja; Erdmann, Gerrit; Zhan, Tianzuo; Boutros, Michael] Heidelberg Univ, Dept Cell & Mol Biol, Med Fac Mannheim, Heidelberg, Germany; [Betge, Johannes; Zhan, Tianzuo; Ebert, Matthias P.] Heidelberg Univ, Med Fac Mannheim, Univ Hosp Mannheim, Dept Med 2, Heidelberg, Germany; [Galata, Christian L.; Post, Stefan; Horisberger, Karoline] Heidelberg Univ, Med Fac Mannheim, Univ Hosp Mannheim, Dept Surg, Heidelberg, Germany; [Gaiser, Timo] Heidelberg Univ, Med Fac Mannheim, Univ Hosp Mannheim, Inst Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Betge, J (corresponding author), Heidelberg Univ, Div Signaling & Funct Gen, German Canc Res Ctr DKFZ, Heidelberg, Germany.	j.betge@dkfz.de; m.boutros@dkfz.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Betge, Johannes/0000-0001-9549-1866; Horisberger, Karoline/0000-0001-6143-6607; Zhan, Tianzuo/0000-0002-9346-3180; Erdmann, Gerrit/0000-0002-4183-3995	Hartmut-Hoffmann-Berling International Graduate School (HBIGS)	Hartmut-Hoffmann-Berling International Graduate School (HBIGS)	JB has been supported by a fellowship from the Hartmut-Hoffmann-Berling International Graduate School (HBIGS).	Ahls MG, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-11; BAKER SJ, 1990, CANCER RES, V50, P7717; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Becker K, 2013, J CLIN PATHOL, V66, P803, DOI 10.1136/jclinpath-2013-201549; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Do HD, 2012, ONCOTARGET, V3, P546; Endris V, 2013, J MOL DIAGN, V15, P765, DOI 10.1016/j.jmoldx.2013.06.002; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Han SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064271; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; Kim SY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-189; Lower M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002714; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pabinger S, 2014, BRIEF BIOINFORM, V15, P256, DOI 10.1093/bib/bbs086; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Roberts ND, 2013, BIOINFORMATICS, V29, P2223, DOI 10.1093/bioinformatics/btt375; Sah S, 2013, GENOME MED, V5, DOI 10.1186/gm481; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Simbolo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062692; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	30	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127146	10.1371/journal.pone.0127146	http://dx.doi.org/10.1371/journal.pone.0127146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010451	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900067
J	Chang, YJ; Hua, Y; Jiang, XQ; Tao, SH				Chang, Yujun; Hua, Yuan; Jiang, Xiaoqian; Tao, Shiheng			Influences of Dominance and Evolution of Sex in Finite Diploid Populations	PLOS ONE			English	Article							MUTATION-SELECTION BALANCE; DELETERIOUS MUTATIONS; RECOMBINATION; ACCUMULATION; SEGREGATION; FITNESS; MAINTENANCE; ADVANTAGE; LINKAGE; LIMITS	Most eukaryotes reproduce sexually. Although the benefits of sex in diploids mainly stem from recombination and segregation, the relative effects of recombination and segregation are relatively less known. In this study, we adopt an infinite loci model to illustrate how dominance coefficient of mutations affects the above-mentioned genetic events. However, we assume mutational effects to be independent and also ignore the effects of epistasis within loci. Our simulations show that with different levels of dominance, segregation and recombination may play different roles. In particular, recombination more commonly has a major impact on the evolution of sex when deleterious mutations are partially recessive. In contrast, when deleterious mutations are dominant, segregation becomes more important than recombination, a finding that is consistent with previous studies stating that segregation, rather than recombination, is more likely to drive the evolution of sex. Moreover, beneficial mutations alone remarkably increases the effects of recombination. We also note that populations favor sexual reproduction when deleterious mutations become more dominant or beneficial mutations become more recessive. Overall, these results illustrate that the existence of dominance is an important mechanism that affects the evolution of sex.	[Chang, Yujun; Hua, Yuan; Jiang, Xiaoqian; Tao, Shiheng] Northwest A&F Univ, Coll Life Sci, Bioinformat Ctr, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Jiang, Xiaoqian] Indiana Univ, Dept Biol, Bloomington, IN USA	Northwest A&F University - China; Indiana University System; Indiana University Bloomington	Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Bioinformat Ctr, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	shihengt@nwsuaf.edu.cn		Chang, Yujun/0000-0002-8987-4980				Agrawal AF, 2001, GENETICS, V158, P913; Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Agrawal AF, 2006, AM NAT, V168, P617, DOI 10.1086/508029; Agrawal AF, 2006, PLOS BIOL, V4, P1364, DOI 10.1371/journal.pbio.0040265; Agrawal AF, 2009, AM NAT, V174, pS54, DOI 10.1086/599082; Agrawal AF, 2009, EVOLUTION, V63, P2131, DOI 10.1111/j.1558-5646.2009.00695.x; Barton NH, 2005, GENETICS, V169, P2353, DOI 10.1534/genetics.104.032821; BELL G, 1988, J EVOLUTION BIOL, V1, P67, DOI 10.1046/j.1420-9101.1988.1010067.x; Bruggeman J, 2003, GENETICS, V164, P479; Charlesworth B, 1997, GENET RES, V70, P63, DOI 10.1017/S0016672397002899; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351; Chasnov JR, 2000, GENETICS, V156, P1419; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Comeron JM, 2008, HEREDITY, V100, P19, DOI 10.1038/sj.hdy.6801059; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fernandez B, 2004, GENETICS, V168, P1053, DOI 10.1534/genetics.104.027706; Garcia-Dorado A, 1999, GENET RES, V74, P341, DOI 10.1017/S0016672399004206; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Haag CR, 2007, GENETICS, V176, P1663, DOI 10.1534/genetics.107.073080; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Hadany L, 2008, ANN NY ACAD SCI, V1133, P26, DOI 10.1196/annals.1438.011; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P607, DOI 10.1017/S0305004100011750; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Hartfield M, 2010, GENETICS, V184, P1153, DOI 10.1534/genetics.109.112920; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Jiang X, 2013, HEREDITY, V111, P505, DOI 10.1038/hdy.2013.72; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; Lloyd RG, 1992, CURR OPIN GENET DEV, V2, P683, DOI 10.1016/S0959-437X(05)80127-3; Loewe L, 2006, BIOL LETTERS, V2, P426, DOI 10.1098/rsbl.2006.0481; Mandegar MA, 2007, P ROY SOC B-BIOL SCI, V274, P1301, DOI 10.1098/rspb.2007.0056; Martin G, 2006, GENETICS, V172, P593, DOI 10.1534/genetics.104.039982; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Otto SP, 1997, GENETICS, V147, P879; Otto SP, 2003, GENETICS, V164, P1099; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; PAMILO P, 1987, GENET RES, V49, P135, DOI 10.1017/S0016672300026938; Roze D, 2006, GENETICS, V173, P1793, DOI 10.1534/genetics.106.058586; Roze D, 2010, GENETICS, V184, P1095, DOI 10.1534/genetics.109.108258; Roze D, 2009, AM NAT, V174, pS79, DOI 10.1086/599083; Salathe M, 2008, EVOLUTION, V62, P295, DOI 10.1111/j.1558-5646.2007.00265.x; Sella G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000495; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Szafraniec K, 2003, GENET RES, V82, P19, DOI 10.1017/S001667230300630X; UYENOYAMA MK, 1989, GENETICS, V123, P873; Wang JL, 2003, GENETICS, V163, P429; Weissman DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002740; Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521; YUAN LW, 1990, GENETICS, V124, P263	55	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128459	10.1371/journal.pone.0128459	http://dx.doi.org/10.1371/journal.pone.0128459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011082	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900236
J	Kim, G; Gaitas, A				Kim, Gwangseong; Gaitas, Angelo			Extracorporeal Photo-Immunotherapy for Circulating Tumor Cells	PLOS ONE			English	Article							INTRAOPERATIVE BLOOD SALVAGE; BREAST-CANCER PATIENTS; DEPLETION; CAPTURE; FILTER; TRAIL	It is well established that metastasis through the circulatory system is primarily caused by circulating tumor cells (CTCs). In this preliminary effort, we report an approach to eliminate circulating tumor cells from the blood stream by flowing the blood though an extracorporeal tube and applying photodynamic therapy (PDT). Chlorin e6 (Ce6), a photosensitizer, was conjugated to CD44 antibody in order to target PC-3, a prostate cancer cell line. PC-3 cells were successfully stained by the Ce6-CD44 antibody conjugate. PDT was performed on whole blood spiked with stained PC-3 cells. As the blood circulated through a thin transparent medical tube, it was exposed to light of 660 nm wavelength generated by an LED array. An exposure of two minutes was sufficient to achieve selective cancer cell necrosis. In comparison, to PDT of cells growing inside a tissue culture, the PDT on thin tube exhibited significantly enhanced efficiency in cell killing, by minimizing light attenuation by blood. It suggests a new extracorporeal methodology of PDT for treating CTCs as well as other hematological pathogens.	[Kim, Gwangseong; Gaitas, Angelo] Kytaro Inc, Miami, FL 33199 USA; [Kim, Gwangseong; Gaitas, Angelo] Florida Int Univ, Miami, FL 33199 USA	State University System of Florida; Florida International University	Gaitas, A (corresponding author), Kytaro Inc, Miami, FL 33199 USA.	agaitas@fiu.edu		Gaitas, Angelo/0000-0003-4428-3949	National Institutes of Health [GM084520]; Kytaro, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM084520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kytaro, Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by National Institutes of Health (grant # GM084520). Kytaro, Inc. provided support in the form of salaries for authors AG and GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams D, CANC DET DIAGN TECHN, V301, P983; Adams D, 2011, P 102 AACE M; Angelo Gaitas GK, 2014, PLOSONE; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Doiron DR, 1983, LIGHT DOSIMETRY TISS, P63; Draffin JE, 2004, CANCER RES, V64, P5702, DOI 10.1158/0008-5472.CAN-04-0389; Edelman MJ, 1996, UROLOGY, V47, P179, DOI 10.1016/S0090-4295(99)80411-7; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; Fruhauf NR, 2001, PERFUSION-UK, V16, P51, DOI 10.1177/026765910101600i107; Gertler R, 2003, RECENT RES CANCER, V162, P149; Hu YJ, 2010, CYTOM PART A, V77A, P213, DOI 10.1002/cyto.a.20838; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; King MR, 2009, J BIONIC ENG, V6, P311, DOI 10.1016/S1672-6529(08)60129-8; Lopez-Riquelme N, 2013, APMIS, V121, P1139, DOI 10.1111/apm.12061; Lu J, 2010, INT J CANCER, V126, P669, DOI 10.1002/ijc.24814; Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Niedre M, 2002, PHOTOCHEM PHOTOBIOL, V75, P382, DOI 10.1562/0031-8655(2002)075<0382:DNILDO>2.0.CO;2; Perseghin P, 1997, VOX SANG, V72, P221, DOI 10.1046/j.1423-0410.1997.7240221.x; Rana K, 2009, BIOTECHNOL BIOENG, V102, P1692, DOI 10.1002/bit.22204; Sieben S, 2001, J MAGN MAGN MATER, V225, P175, DOI 10.1016/S0304-8853(00)01248-8; Stolik S, 2000, J PHOTOCH PHOTOBIO B, V57, P90, DOI 10.1016/S1011-1344(00)00082-8; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; TALIAFERRO WH, 1957, J CELL COMPAR PHYSL, V50, P1, DOI 10.1002/jcp.1030500403; Yoon HJ, 2013, NAT NANOTECHNOL, V8, P735, DOI 10.1038/nnano.2013.194	26	12	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127219	10.1371/journal.pone.0127219	http://dx.doi.org/10.1371/journal.pone.0127219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011055	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900073
J	Ling, ZM; Tang, Y; Li, YQ; Luo, HX; Liu, LL; Tu, QQ; Zhou, LH				Ling, Ze-Min; Tang, Ying; Li, Ying-Qin; Luo, Hao-Xuan; Liu, Lin-Lin; Tu, Qing-Qiang; Zhou, Li-Hua			Evaluation of Avulsion-Induced Neuropathology in Rat Spinal Cords with F-18-FDG Micro-PET/CT	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; VENTRAL ROOT AVULSION; NERVE GROWTH-FACTOR; NITRIC-OXIDE; AXONAL INJURY; GLUCOSE-TRANSPORTER; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; C-JUN; MOTONEURONS	Brachial plexus root avulsion (BPRA) leads to dramatic motoneuron death and glial reactions in the corresponding spinal segments at the late stage of injury. To protect spinal motoneurons, assessment of the affected spinal segments should be done at an earlier stage of the injury. In this study, we employed F-18-FDG small-animal PET/CT to assess the severity of BPRA-induced cervical spinal cord injuries. Adult Sprague-Dawley rats were randomly treated and divided into three groups: Av+NS (brachial plexus root avulsion (Av) treated with normal saline), Av+GM1 (treated with monosialoganglioside), and control. At time points of 3 day (d), 1 week (w), 2 w, 4 w and 8 w post-injury, F-18-FDG micro-PET/CT scans and neuropathology assessments of the injured spinal roots, as well as the spinal cord, were performed. The outcomes of the different treatments were compared. The results showed that BPRA induced local bleeding and typicalWallerian degeneration of the avulsed roots accompanied by F-18-FDG accumulations at the ipsilateral cervical intervertebral foramen. BPRA-induced astrocyte reactions and overexpression of neuronal nitric oxide synthase in the motoneurons correlated with higher F-18-FDG uptake in the ipsilateral cervical spinal cord during the first 2 w post-injury. The GM1 treatment reduced BPRA-induced astrocyte reactions and inhibited the de novo nNOS expressions in spinal motoneurons. The GM1 treatment also protected spinal motoneurons from avulsion within the first 4 w post-injury. The data from this study suggest that F-18-FDG PET/CT could be used to assess the severity of BPRA-induced primary and secondary injuries in the spinal cord. Furthermore, GM1 is an effective drug for reducing primary and secondary spinal cord injuries following BPRA.	[Ling, Ze-Min; Tang, Ying; Li, Ying-Qin; Luo, Hao-Xuan; Liu, Lin-Lin; Zhou, Li-Hua] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat, Guangzhou 510080, Guangdong, Peoples R China; [Tu, Qing-Qiang] Sun Yat Sen Univ, Labs Translat Med & Clin Res, Small Anim Mol Imaging Ctr, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhou, LH (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Anat, 74 Zhongshan Rd, Guangzhou 510080, Guangdong, Peoples R China.	zhoulih@mail.sysu.edu.cn			National Natural Science Foundation of China [31171290, 31471030]; Doctorial Research Foundation of the Ministry of Education, P.R. China [20110171110048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctorial Research Foundation of the Ministry of Education, P.R. China	This study was supported by grants from the National Natural Science Foundation of China (31171290, 31471030), the Doctorial Research Foundation of the Ministry of Education, P.R. China (20110171110048).	Avrova NF, 1998, NEUROCHEM RES, V23, P945, DOI 10.1023/A:1021076220411; Bach HG, 2009, J RECONSTR MICROSURG, V25, P97, DOI 10.1055/s-0028-1090615; Balsara RD, 2014, JOVE-J VIS EXP, DOI 10.3791/51495; Barbizan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063260; Bigbee AJ, 2007, EXP NEUROL, V204, P273, DOI 10.1016/j.expneurol.2006.11.003; Blight A R, 2001, Curr Opin Investig Drugs, V2, P801; Boutin H, 2015, EUR J NUCL MED MOL I, V42, P503, DOI 10.1007/s00259-014-2939-8; Buck D, 2012, J NUCL MED, V53, P1269, DOI 10.2967/jnumed.111.102608; Carlstedt T, 2008, RESTOR NEUROL NEUROS, V26, P225; Chai H, 1999, NEUROSCI LETT, V274, P147, DOI 10.1016/S0304-3940(99)00671-0; Cheng X, 2010, J BRACHIAL PLEX PERI, V5, DOI 10.1186/1749-7221-5-12; Cheng XR, 2014, AGEING RES REV, V13, P13, DOI 10.1016/j.arr.2013.10.002; Chong Ari, 2013, Chonnam Med J, V49, P38, DOI 10.4068/cmj.2013.49.1.38; CUELLO AC, 1989, P NATL ACAD SCI USA, V86, P2056, DOI 10.1073/pnas.86.6.2056; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; Ferrari G, 1996, PERSPECT DEV NEUROBI, V3, P93; Floeth FW, 2010, EUR RADIOL, V20, P2925, DOI 10.1007/s00330-010-1877-5; Fu R, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-84; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Grieco G, 1996, STROKE, V27, P858, DOI 10.1161/01.STR.27.5.858; Haberkorn U, 2001, EUR J NUCL MED, V28, P418, DOI 10.1007/s002590100489; Hsu CH, 2003, ANN NUCL MED, V17, P609, DOI 10.1007/BF03006677; Hu S, 2014, HANDCHIR MIKROCHIR P, V46, P80, DOI 10.1055/s-0034-1370958; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Kacem K, 1998, GLIA, V23, P1; Kinkel K, 1999, RADIOLOGY, V212, P711, DOI 10.1148/radiology.212.3.r99au29711; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lavisse S, 2015, EUR J NUCL MED MOL I, V42, P478, DOI 10.1007/s00259-014-2962-9; Lee SH, 2014, J NUCL MED, V55, P1737, DOI 10.2967/jnumed.114.140731; LI LX, 1995, P NATL ACAD SCI USA, V92, P9771, DOI 10.1073/pnas.92.21.9771; Lieberman BP, 2011, J NUCL MED, V52, P1947, DOI 10.2967/jnumed.111.093815; Marconi S, 2005, J NEUROIMMUNOL, V170, P115, DOI 10.1016/j.jneuroim.2005.03.025; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Martin LJ, 2005, J NEUROSCI, V25, P6449, DOI 10.1523/JNEUROSCI.0911-05.2005; Moran CM, 2011, ULTRASOUND MED BIOL, V37, P493, DOI 10.1016/j.ultrasmedbio.2010.11.010; MORGELLO S, 1995, GLIA, V14, P43, DOI 10.1002/glia.440140107; Nakahara M, 2015, ACTA RADIOL, V56, P829, DOI 10.1177/0284185114541983; NARAKAS AO, 1988, CLIN ORTHOP RELAT R, P43; NOVIKOV L, 1995, NEUROSCI LETT, V200, P45, DOI 10.1016/0304-3940(95)12078-I; Ohlsson M, 2006, EXP BRAIN RES, V170, P52, DOI 10.1007/s00221-005-0188-6; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Padma S, 2010, INDIAN J NUCL MED, V25, P173, DOI 10.4103/0972-3919.78257; Patel AB, 2014, P NATL ACAD SCI USA, V111, P5385, DOI 10.1073/pnas.1403576111; Rabin SJ, 2002, J BIOL CHEM, V277, P49466, DOI 10.1074/jbc.M203240200; RISLING M, 1989, BRAIN RES, V494, P13, DOI 10.1016/0006-8993(89)90138-8; Russell DS, 2014, JAMA NEUROL, V71, P1520, DOI 10.1001/jamaneurol.2014.1954; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; SJOGREN A, 1991, BRAIN RES, V559, P276, DOI 10.1016/0006-8993(91)90012-K; Strobel K, 2007, CLIN NUCL MED, V32, P646, DOI 10.1097/RLU.0b013e3180a1ac74; Tatsumi M, 2003, RADIOLOGY, V229, P831, DOI 10.1148/radiol.2293021168; Terzis JK, 2001, WORLD J SURG, V25, P1049, DOI 10.1007/s00268-001-0058-8; TYURIN VA, 1992, NEUROCHEM INT, V20, P401, DOI 10.1016/0197-0186(92)90055-V; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wang JC, 2013, J NUCL MED, V54, P785, DOI 10.2967/jnumed.112.111112; Wu WT, 1996, EXP NEUROL, V141, P190, DOI 10.1006/exnr.1996.0153; WU WT, 1993, EXP NEUROL, V120, P153, DOI 10.1006/exnr.1993.1050; Yu S, 1998, BRAIN RES, V797, P65, DOI 10.1016/S0006-8993(98)00372-2; Yuan QJ, 2003, DEV NEUROSCI-BASEL, V25, P72, DOI 10.1159/000071470; Yun MJ, 2002, SEMIN NUCL MED, V32, P70, DOI 10.1053/snuc.2002.29279; Zhou LH, 2006, EXP NEUROL, V197, P84, DOI 10.1016/j.expneurol.2005.08.019; Zhou LH, 2008, BRAIN CELL BIOL, V36, P213, DOI 10.1007/s11068-009-9040-4; Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278	64	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127685	10.1371/journal.pone.0127685	http://dx.doi.org/10.1371/journal.pone.0127685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010770	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900131
J	Lucena, MM; da Silva, FD; da Costa, AD; Guimaraes, GR; Ruas, ACN; Braga, FPB; Braga, MPB; Reis, JGC; da Costa, DCS; Palmeiro, MR; Rolla, VC; Valete-Rosalino, CM				Lucena, Marcia Mendonca; da Silva, Fernanda dos Santos; da Costa, Ananda Dutra; Guimaraes, Gabriela Rodrigues; Nunes Ruas, Ana Cristina; Bom Braga, Frederico Pereira; Bom Braga, Mateus Pereira; Correa Reis, Joao Gustavo; Silva da Costa, Daniel Cesar; Palmeiro, Mariana Reuter; Rolla, Valeria Cavalcanti; Valete-Rosalino, Claudia Maria			Evaluation of Voice Disorders in Patients with Active Laryngeal Tuberculosis	PLOS ONE			English	Article								Introduction Laryngeal tuberculosis (LTB) is the most frequent larynx granulomatous disease. In general there is lung involvement, but in an important proportion of cases you can find LTB without pulmonary disease. The lesions observed in LTB, such as ulceration and fibrosis, can interfere in the process of voice production. The involvement of the mucous lining of the vocal folds can change their flexibility and, consequently, change voice quality, and the main symptom is dysphonia present in almost 90% of cases. Objective To describe the anatomical characteristics and voice quality in LTB patients. Material and Method A descriptive cross-sectional study was conducted with 24 patients. Result The most frequently affected sites were vocal folds in 87.5% patients, vestibular folds in 66.7%, epiglottis in 41.7%, arytenoid in 50%, aryepiglottic folds in 33.3%, and interarytenoid region in 33.3% patients. We found 95.8% cases of dysphonia. The voice acoustic analysis showed 58.3% cases of Jitter alterations, 83.3% of Shimmer and 70.8% of GNE. Conclusion Voice disorders found in active laryngeal tuberculosis are similar to those reported after clinical healing of the disease, suggesting that sequelae and vocal adjustments may install during the active phase of the disease, negatively impacting the process of vocal quality reestablishment.	[Lucena, Marcia Mendonca; da Silva, Fernanda dos Santos; da Costa, Ananda Dutra; Bom Braga, Frederico Pereira; Bom Braga, Mateus Pereira; Correa Reis, Joao Gustavo; Silva da Costa, Daniel Cesar; Palmeiro, Mariana Reuter; Valete-Rosalino, Claudia Maria] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Res & Surveillance Leishmaniasis, Rio De Janeiro, RJ, Brazil; [Lucena, Marcia Mendonca; Nunes Ruas, Ana Cristina] Univ Fed Rio de Janeiro, Dept Speech Pathol, Rio De Janeiro, RJ, Brazil; [Guimaraes, Gabriela Rodrigues] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Rolla, Valeria Cavalcanti] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Res Mycobacteriosis, Rio De Janeiro, RJ, Brazil; [Valete-Rosalino, Claudia Maria] Univ Fed Rio de Janeiro, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Valete-Rosalino, CM (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Res & Surveillance Leishmaniasis, Rio De Janeiro, RJ, Brazil.	claudia.valete@ini.fiocruz.br	Rolla, Valeria Cavalcanti/AAI-6078-2021; Valete-Rosalino, Cláudia Maria/AAR-4293-2021	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; 	National Institute of Infectious Diseases (INI) [(PA2010-2013)-FIOCRUZ]; Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPq) [407758/2012-7]; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil [E-26/102.183/2013]; FAPERJ	National Institute of Infectious Diseases (INI); Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by National Institute of Infectious Diseases (INI) (PA2010-2013)-FIOCRUZ, Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPq) (407758/2012-7), and Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) (E-26/102.183/2013), Brazil. CMVR is the recipient of fellowships from FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behlau M, 2001, REVINTER RIO JANEIRO, V1, P86; Fagundes Raquel de Cássia Ferro, 2011, Rev. soc. bras. fonoaudiol., V16, P99, DOI 10.1590/S1516-80342011000100018; Gandhi S, 2012, INDIAN J OTOLARYNGOL, V64, P244, DOI 10.1007/s12070-011-0333-4; Haddad Leonardo, 2006, Rev. Bras. Otorrinolaringol., V72, P295, DOI 10.1590/S0034-72992006000300002; Hirano M, 1981, CLIN EXAMINATION VOI, V5, P100; Lim JY, 2006, EUR ARCH OTO-RHINO-L, V263, P838, DOI 10.1007/s00405-006-0063-5; Ling L, 2010, INT J INFECT DIS, V14, pE230, DOI 10.1016/j.ijid.2009.05.002; Martinez A, 2010, ACTA OTORRINOLARINGO, V62, P401; Ruas ACN, 2010, J LARYNGOL OTOL, V124, P1153, DOI 10.1017/S0022215110001106; Ozudogru E, 2005, Acta Otorhinolaryngol Ital, V25, P374; Porras Alonso E, 2002, Rev Laryngol Otol Rhinol (Bord), V123, P47; Sens Patricia Maria, 2008, Braz J Otorhinolaryngol, V74, P621; Tarantino AB, 2002, GUANABARA KOOGAN RIO, V5, P324	13	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126876	10.1371/journal.pone.0126876	http://dx.doi.org/10.1371/journal.pone.0126876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009888	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900042
J	Pistol, GC; Braicu, C; Motiu, M; Gras, MA; Marin, DE; Stancu, M; Calin, L; Israel-Roming, F; Berindan-Neagoe, I; Taranu, I				Pistol, Gina Cecilia; Braicu, Cornelia; Motiu, Monica; Gras, Mihail Alexandru; Marin, Daniela Eliza; Stancu, Mariana; Calin, Loredana; Israel-Roming, Florentina; Berindan-Neagoe, Ioana; Taranu, Ionelia			Zearalenone Mycotoxin Affects Immune Mediators, MAPK Signalling Molecules, Nuclear Receptors and Genome-Wide Gene Expression in Pig Spleen	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; FUMONISIN B-1; IN-VITRO; PORCINE; CELLS; FOOD; DEOXYNIVALENOL; TRANSCRIPTION; MACROPHAGES; ASSOCIATION	The toxicity of zearalenone (ZEA) was evaluated in swine spleen, a key organ for the innate and adaptative immune response. Weaned pigs were fed for 18 days with a control or a ZEA contaminated diet. The effect of ZEA was assessed on wide genome expression, pro-(TNF-alpha, IL-8, IL-6, IL-1 beta, IFN-gamma) and anti-inflammatory (IL-10, IL-4) cytokines, other molecules involved in inflammatory processes (MMPs/TIMPs), as well as signaling molecules, (p38/JNK1/JNK2-MAPKs) and nuclear receptors (PPAR gamma/NFkB/AP-1/STAT3/c-JUN). Microarray analysis showed that 46% of total number of differentially expressed genes was involved in cellular signaling pathway, 13% in cytokine network and 10% in the inflammatory response. ZEA increased expression and synthesis of pro-inflammatory (TNF-alpha, IL-8, IL-6, IL-1 beta) and had no effect on IFN-gamma, IL-4 and IL-10 cytokines in spleen. The inflammatory stimulation might be a consequence of JNK pathway activation rather than of p-38MAPK and NF-kB involvement whose gene and protein expression were suppressed by ZEA action. In summary, our findings indicated the role of ZEA as an immune disruptor at spleen level.	[Pistol, Gina Cecilia; Motiu, Monica; Gras, Mihail Alexandru; Marin, Daniela Eliza; Stancu, Mariana; Calin, Loredana; Taranu, Ionelia] Natl Inst Res & Dev Biol & Anim Nutr, Lab Anim Biol, Balotesti 077015, Ilfov, Romania; [Braicu, Cornelia; Berindan-Neagoe, Ioana] Oncol Inst Prof Dr I Chiricuta, Cluj Napoca 400015, Romania; [Braicu, Cornelia; Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Gen Biomed & Translat Med, Cluj Napoca 400565, Romania; [Israel-Roming, Florentina] Univ Agr & Vet Med, Dept Biotechnol, Bucharest 011464, Romania; [Berindan-Neagoe, Ioana] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy; University of Agronomic Science & Veterinary Medicine - Bucharest; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Pistol, GC (corresponding author), Natl Inst Res & Dev Biol & Anim Nutr, Lab Anim Biol, Balotesti 077015, Ilfov, Romania.	gina.pistol@ibna.ro	Pistol, Gina Cecilia/B-5801-2011; Berindan-Neagoe, Ioana/AAH-9854-2019; GRAS, MIHAIL ALEXANDRU C/B-7134-2012; Cecilia, Pistol Gina/ABB-4600-2020	Cecilia, Pistol Gina/0000-0003-1139-604X; Taranu, Ionelia/0000-0003-0727-5827; Motiu, Monica/0000-0003-3751-1608	National Research Project - Romanian Ministry of Research and Technology [PNII-PCCA 2011-102/2011-2016]	National Research Project - Romanian Ministry of Research and Technology	This work was supported by funds from the National Research Project PNII-PCCA 2011-102/2011-2016, granted by the Romanian Ministry of Research and Technology.	Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2197; Alexopoulos C, 2001, THERIOGENOLOGY, V55, P1745, DOI 10.1016/S0093-691X(01)00517-9; AZCONAOLIVERA JI, 1995, FOOD CHEM TOXICOL, V33, P433, DOI 10.1016/0278-6915(95)00012-Q; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calemine J, 2003, TOXICOLOGY, V194, P115, DOI 10.1016/S0300-483X(03)00286-5; Cano PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053647; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Chen JC, 2009, ANN NY ACAD SCI, V1160, P188, DOI 10.1111/j.1749-6632.2008.03815.x; Choi BK, 2012, TOX RESEARCH, V28, P279, DOI 10.5487/TR.2012.28.4.279; Choi K, 2009, J BIOL CHEM, V284, P17766, DOI 10.1074/jbc.M109.003111; Chowdhury Shankar R, 2007, BMC Genomics, V8, P215, DOI 10.1186/1471-2164-8-215; Devriendt B, 2009, VET RES, V40, DOI 10.1051/vetres/2009023; Ding Q, 2011, J LEUKOCYTE BIOL, V90, P77, DOI 10.1189/jlb.1210691; EFSA (European Food Safety Authority), 2004, EFSA J, V39, P1, DOI DOI 10.2903/J.EFSA.2004.39; Engelhardt G, 2006, MOL NUTR FOOD RES, V50, P401, DOI 10.1002/mnfr.200500191; Fink-Gremmels J, 2007, ANIM FEED SCI TECH, V137, P326, DOI 10.1016/j.anifeedsci.2007.06.008; Fishbourne E, 2013, VET MICROBIOL, V162, P937, DOI 10.1016/j.vetmic.2012.11.027; Gesslein B, 2010, MOL VIS, V16, P392; Ghisletti S, 2005, MOL CELL BIOL, V25, P2957, DOI 10.1128/MCB.25.8.2957-2968.2005; Grenier B, 2012, BIOCHEM PHARMACOL, V83, P1465, DOI 10.1016/j.bcp.2012.02.007; Hueza IM, 2014, TOXINS, V6, P1080, DOI 10.3390/toxins6031080; Jackowska M, 2013, ACTA VET HUNG, V61, P99, DOI 10.1556/AVet.2012.061; KUIPERGOODMAN T, 1987, REGUL TOXICOL PHARM, V7, P253, DOI 10.1016/0273-2300(87)90037-7; Lang TJ, 2004, CLIN IMMUNOL, V113, P224, DOI 10.1016/j.clim.2004.05.011; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Lemmer ER, 1999, CARCINOGENESIS, V20, P817, DOI 10.1093/carcin/20.5.817; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luongo D, 2008, TOXICON, V52, P156, DOI 10.1016/j.toxicon.2008.04.162; MacDonald SJ, 2005, J AOAC INT, V88, P1733; Marin DE, 2011, TOXICOL IN VITRO, V25, P1981, DOI 10.1016/j.tiv.2011.06.022; Marin DE, 2010, TOXICON, V56, P956, DOI 10.1016/j.toxicon.2010.06.020; Meadus WJ, 2002, J MOL ENDOCRINOL, V28, P79, DOI 10.1677/jme.0.0280079; Meissonnier GM, 2008, TOXICOL APPL PHARM, V231, P142, DOI 10.1016/j.taap.2008.04.004; Meurens F, 2009, VET RES, V40, DOI 10.1051/vetres:2008043; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Parveen M, 2009, FEBS LETT, V583, P2377, DOI 10.1016/j.febslet.2009.06.035; Perisic L, 2013, ARTERIOSCL THROM VAS, V33, P2432, DOI 10.1161/ATVBAHA.113.301743; Pistol G, 2007, J CELL MOL MED, V11, P339, DOI 10.1111/j.1582-4934.2007.00022.x; Pistol GC, 2014, BRIT J NUTR, V111, P452, DOI 10.1017/S0007114513002675; Ravindran J, 2011, TOXICOLOGY, V280, P44, DOI 10.1016/j.tox.2010.11.006; Richard JL, 2007, INT J FOOD MICROBIOL, V119, P3, DOI 10.1016/j.ijfoodmicro.2007.07.019; Richette P, 2007, ANN RHEUM DIS, V66, P345, DOI 10.1136/ard.2006.059550; Royaee AR, 2004, VET IMMUNOL IMMUNOP, V102, P199, DOI 10.1016/j.vetimm.2004.09.018; Ruh MF, 1998, ENDOCRINE, V9, P207, DOI 10.1385/ENDO:9:2:207; Sanchez-Lemus E, 2009, AM J PHYSIOL-REG I, V296, pR1376, DOI 10.1152/ajpregu.90962.2008; Seeboth J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-35; Singh NK, 2007, J ANIM SCI, V85, P1126, DOI 10.2527/jas.2006-524; Stec J, 2009, B VET I PULAWY, V53, P129; Stoeker L, 2011, CLIN VACCINE IMMUNOL, V18, P1834, DOI 10.1128/CVI.05277-11; Tabuc C, 2009, J FOOD PROTECT, V72, P662, DOI 10.4315/0362-028X-72.3.662; Taranu I, 2011, BRIT J NUTR, V106, P398, DOI 10.1017/S0007114511000341; Tiemann U, 2008, TOXICOL LETT, V179, P113, DOI 10.1016/j.toxlet.2008.04.016; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; von der Hardt K, 2004, CRIT CARE MED, V32, P1200, DOI 10.1097/01.CCM.0000124876.31138.F6; Wang YC, 2012, POULTRY SCI, V91, P1956, DOI 10.3382/ps.2011-02128; Wluka Anna, 2006, Ann Transplant, V11, P22; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yang J, 2012, MOL VIS, V18, P1484; Zeni P, 2007, AM J PHYSIOL-CELL PH, V293, pC855, DOI 10.1152/ajpcell.00470.2006; Zhang LL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-135; Zhou HR, 2003, TOXICOL SCI, V72, P130, DOI 10.1093/toxsci/kfg006	65	74	80	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127503	10.1371/journal.pone.0127503	http://dx.doi.org/10.1371/journal.pone.0127503			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011631	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900100
J	Xu, MM; Yu, WW; Tong, SL; Jia, L; Liang, FC; Pan, XC				Xu, Meimei; Yu, Weiwei; Tong, Shilu; Jia, Lei; Liang, Fengchao; Pan, Xiaochuan			Non-Linear Association between Exposure to Ambient Temperature and Children's Hand-Foot-and-Mouth Disease in Beijing, China	PLOS ONE			English	Article							HEAT-RELATED MORTALITY; CASE-CROSSOVER DESIGN; ENTEROVIRUS 71; VULNERABILITY	Background Hand, foot and mouth disease (HFMD) was listed as a notifiable communicable disease in 2008 and is an emerging public health problem in China, especially for children. However, few data are available on the risk assessment of the potential reasons for HFMD in Beijing. This study examined the association of temperature with the incidence of children's HFMD in Beijing at the daily scale for the first time. Methods A newly developed case-crossover design with a distributed lag nonlinear model (DLNM) was used to assess the delayed and cumulative associations of daily temperature with gender- and age-specific HFMD in Beijing, China, during 2010-2012. Relative humidity, day of the week, public holiday, season and long-term trends were controlled in the model. Results Among the total of 113,475 cases, the ratio between males and females was 1.52:1. HFMD was more prevalent in May-July. The temperature-HFMD relationships were non-linear in most age groups except for children aged 6-15 years, with a peak at 25.0 similar to 27.5 degrees C. The high-temperature risks were greater, appeared earlier and lasted longer than the low-temperature risks. The relative risks for female children and those aged 6-15 years were higher than those among other groups. Conclusion Rising temperatures increased the incidence of children's HFMD, with the largest association at 25.0 similar to 27.5 degrees C. Females and children aged 6-15 years were more vulnerable to changes in temperature with regard to the transmission of HFMD than males and other age groups, respectively. Further studies are warranted to confirm these findings in other populations.	[Xu, Meimei; Liang, Fengchao; Pan, Xiaochuan] Peking Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Beijing 100191, Peoples R China; [Yu, Weiwei] Univ Queensland, Sch Populat Hlth, Epidemiol & Biostat Discipline, Brisbane, Qld 4006, Australia; [Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4059, Australia; [Jia, Lei] Inst Infect Dis & Endem Dis Control, Beijing Ctr Dis Prevent & Control, Beijing 100013, Peoples R China	Peking University; University of Queensland; Queensland University of Technology (QUT)	Yu, WW (corresponding author), Univ Queensland, Sch Populat Hlth, Epidemiol & Biostat Discipline, Brisbane, Qld 4006, Australia.	w.yu@uq.edu.au; xcpan@bjmu.edu.cn	Ibrahim, Essam Hassan/G-1960-2018; Liang, Fenghua/HHM-3798-2022; Liang, Feng/GZK-4305-2022; Yu, Vivian/B-5837-2015	Ibrahim, Essam Hassan/0000-0003-0130-2257; Yu, Vivian/0000-0003-2452-8304	National Natural Science Foundation of China [81273033]; National Health and Medical Research Council (NHMRC) Research Fellowship [553043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council (NHMRC) Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Authors would like to acknowledge National Natural Science Foundation of China (#81273033) and National Health and Medical Research Council (NHMRC) Research Fellowship (#553043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [Anonymous], 2011, GUID CLIN MAN PUBL H; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Beijing Statistics Bureau, 2013, STAT COMM BEIJ 2012; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; Bendig J W, 1996, Commun Dis Rep CDR Rev, V6, pR81; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; CHANG HH, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0033067; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen CJ, 2013, INT CONF BIOMETR; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; DruytsVoets E, 1997, EPIDEMIOL INFECT, V119, P71, DOI 10.1017/S0950268897007656; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Ha J, 2011, SCI TOTAL ENVIRON, V409, P3274, DOI 10.1016/j.scitotenv.2011.05.034; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Ji Z, 2012, MICROBES ENVIRON, V27, P288, DOI 10.1264/jsme2.ME11352; Li T, 2013, EPIDEMIOL INFECT, P1; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Ma E, 2010, JPN J INFECT DIS, V63, P422; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Roberts S, 2007, ENVIRON RES, V104, P193, DOI 10.1016/j.envres.2007.01.009; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Suminski RR, 2008, INT J BIOMETEOROL, V52, P189, DOI 10.1007/s00484-007-0110-y; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	30	44	51	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126171	10.1371/journal.pone.0126171	http://dx.doi.org/10.1371/journal.pone.0126171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010147	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900024
J	Harris, JK; Fang, R; Wagner, BD; Choe, HN; Kelly, CJ; Schroeder, S; Moore, W; Stevens, MJ; Yeckes, A; Amsden, K; Kagalwalla, AF; Zalewski, A; Hirano, I; Gonsalves, N; Henry, LN; Masterson, JC; Robertson, CE; Leung, DY; Pace, NR; Ackerman, SJ; Furuta, GT; Fillon, SA				Harris, J. Kirk; Fang, Rui; Wagner, Brandie D.; Choe, Ha Na; Kelly, Caleb J.; Schroeder, Shauna; Moore, Wendy; Stevens, Mark J.; Yeckes, Alyson; Amsden, Katie; Kagalwalla, Amir F.; Zalewski, Angelika; Hirano, Ikuo; Gonsalves, Nirmala; Henry, Lauren N.; Masterson, Joanne C.; Robertson, Charles E.; Leung, Donald Y.; Pace, Norman R.; Ackerman, Steven J.; Furuta, Glenn T.; Fillon, Sophie A.			Esophageal Microbiome in Eosinophilic Esophagitis	PLOS ONE			English	Article							GUT MICROBIOME; CONSENSUS RECOMMENDATIONS; CHILDREN; ADULTS; DIET	Objective The microbiome has been implicated in the pathogenesis of a number of allergic and inflammatory diseases. The mucosa affected by eosinophilic esophagitis (EoE) is composed of a stratified squamous epithelia and contains intraepithelial eosinophils. To date, no studies have identified the esophageal microbiome in patients with EoE or the impact of treatment on these organisms. The aim of this study was to identify the esophageal microbiome in EoE and determine whether treatments change this profile. We hypothesized that clinically relevant alterations in bacterial populations are present in different forms of esophagitis. Design In this prospective study, secretions from the esophageal mucosa were collected from children and adults with EoE, Gastroesophageal Reflux Disease (GERD) and normal mucosa using the Esophageal String Test (EST). Bacterial load was determined using quantitative PCR. Bacterial communities, determined by 16S rRNA gene amplification and 454 pyrosequencing, were compared between health and disease. Results Samples from a total of 70 children and adult subjects were examined. Bacterial load was increased in both EoE and GERD relative to normal subjects. In subjects with EoE, load was increased regardless of treatment status or degree of mucosal eosinophilia compared with normal. Haemophilus was significantly increased in untreated EoE subjects as compared with normal subjects. Streptococcus was decreased in GERD subjects on proton pump inhibition as compared with normal subjects. Conclusions Diseases associated with mucosal eosinophilia are characterized by a different microbiome from that found in the normal mucosa. Microbiota may contribute to esophageal inflammation in EoE and GERD.	[Harris, J. Kirk; Wagner, Brandie D.; Stevens, Mark J.] Univ Colorado, Sch Med, Div Pulmonol, Aurora, CO USA; [Fang, Rui; Wagner, Brandie D.] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Choe, Ha Na; Kelly, Caleb J.; Schroeder, Shauna; Moore, Wendy; Yeckes, Alyson; Henry, Lauren N.; Masterson, Joanne C.; Furuta, Glenn T.; Fillon, Sophie A.] Univ Colorado, Childrens Hosp Colorado, Sch Med,Sect Pediat Gastroenterol, Digest Hlth Inst,Mucosal Inflammat Program,Gastro, Aurora, CO 80045 USA; [Amsden, Katie; Kagalwalla, Amir F.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Chicago, IL USA; [Amsden, Katie; Kagalwalla, Amir F.] Northwestern Univ, Chicago, IL 60611 USA; [Amsden, Katie; Kagalwalla, Amir F.] John H Stroger Hosp Cook Cty, Dept Pediat, Chicago, IL USA; [Zalewski, Angelika; Hirano, Ikuo; Gonsalves, Nirmala] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60611 USA; [Robertson, Charles E.; Pace, Norman R.] Univ Colorado, Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Leung, Donald Y.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Ackerman, Steven J.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; John H Stroger Junior Hospital Cook County; Northwestern University; Feinberg School of Medicine; University of Colorado System; University of Colorado Boulder; National Jewish Health; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fillon, SA (corresponding author), Univ Colorado, Childrens Hosp Colorado, Sch Med,Sect Pediat Gastroenterol, Digest Hlth Inst,Mucosal Inflammat Program,Gastro, Aurora, CO 80045 USA.	sophie.fillon@ucdenver.edu		Gonsalves, Nirmala/0000-0003-0722-6099; Kelly, Caleb/0000-0003-4861-1479; Harris, Jonathan/0000-0002-2378-4202; Wagner, brandie/0000-0002-2745-0103; ROBERTSON, CHARLES/0000-0002-4136-4121	National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI Grant [UL1 TR001082-RR025780, KL2 TR001080]; Ann & Robert H. Lurie Children's Hospital of Chicago CRU Grant [1UL1RR025741]; American Partnership For Eosinophilic Disorders (APFED) Junior Faculty HOPE Research Grant; NIH [DK100303]; Campaign Urging Research for Eosinophilic Diseases (CURED); Buckeye Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, KL2TR001080] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK100303] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI Grant; Ann & Robert H. Lurie Children's Hospital of Chicago CRU Grant; American Partnership For Eosinophilic Disorders (APFED) Junior Faculty HOPE Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Campaign Urging Research for Eosinophilic Diseases (CURED); Buckeye Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors recognize the support of REDCap for subjects' database supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI Grant Number UL1 TR001082-RR025780, and Ann & Robert H. Lurie Children's Hospital of Chicago CRU Grant Number 1UL1RR025741. This work was supported by the American Partnership For Eosinophilic Disorders (APFED) Junior Faculty HOPE Research Grant (SF), National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, Colorado CTSI Grant Number KL2 TR001080 (SF), NIH DK100303 (GTF), the Campaign Urging Research for Eosinophilic Diseases (CURED) (SJA/GTF), and the Buckeye Foundation (AFK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 2003, STAT ANAL COMPOSITIO; Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; Amir I, 2014, ENVIRON MICROBIOL, V16, P2905, DOI 10.1111/1462-2920.12285; Attwood SE, 2014, GASTROENTEROL CLIN N, V43, P185, DOI 10.1016/j.gtc.2014.02.010; Clementi CF, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00001; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Driss V, 2009, BLOOD, V113, P3235, DOI 10.1182/blood-2008-07-166595; Fillon SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042938; Filzmoser P, 2009, SCI TOTAL ENVIRON, V407, P6100, DOI 10.1016/j.scitotenv.2009.08.008; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Furuta GT, 2013, GUT, V62, P1395, DOI 10.1136/gutjnl-2012-303171; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Harris JK, 2010, APPL ENVIRON MICROB, V76, P3863, DOI 10.1128/AEM.02585-09; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; LEHRER RI, 1989, J IMMUNOL, V142, P4428; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Rutebemberwa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111150; Sherrill JD, 2014, MUCOSAL IMMUNOL, V7, P718, DOI 10.1038/mi.2013.90; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vesper BJ, 2009, CURR DRUG METAB, V10, P84, DOI 10.2174/138920009787048392; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yang LY, 2012, CLIN CANCER RES, V18, P2138, DOI 10.1158/1078-0432.CCR-11-0934; Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zemanick ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015101; Zoetendal EG, 2014, CURR OPIN GASTROEN, V30, P189, DOI 10.1097/MOG.0000000000000048	34	96	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128346	10.1371/journal.pone.0128346	http://dx.doi.org/10.1371/journal.pone.0128346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020633	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000355187300102
J	Shin, SK; Kim, J; Ha, SM; Oh, HS; Chun, J; Sohn, J; Yi, H				Shin, Su-Kyoung; Kim, Jinman; Ha, Sung-min; Oh, Hyun-Seok; Chun, Jongsik; Sohn, Jongryeul; Yi, Hana			Metagenomic Insights into the Bioaerosols in the Indoor and Outdoor Environments of Childcare Facilities	PLOS ONE			English	Article							CULTURE-INDEPENDENT ANALYSIS; SP NOV.; MICROBIAL COMMUNITIES; BACTERIAL COMMUNITY; AIRBORNE BACTERIAL; TEMPORAL VARIABILITY; EDIRNE CITY; FUNGI; DIVERSITY; AIR	Airborne microorganisms have significant effects on human health, and children are more vulnerable to pathogens and allergens than adults. However, little is known about the microbial communities in the air of childcare facilities. Here, we analyzed the bacterial and fungal communities in 50 air samples collected from five daycare centers and five elementary schools located in Seoul, Korea using culture-independent high-throughput pyrosequencing. The microbial communities contained a wide variety of taxa not previously identified in child daycare centers and schools. Moreover, the dominant species differed from those reported in previous studies using culture-dependent methods. The well-known fungi detected in previous culture-based studies (Alternaria, Aspergillus, Penicillium, and Cladosporium) represented less than 12% of the total sequence reads. The composition of the fungal and bacterial communities in the indoor air differed greatly with regard to the source of the microorganisms. The bacterial community in the indoor air appeared to contain diverse bacteria associated with both humans and the outside environment. In contrast, the fungal community was largely derived from the surrounding outdoor environment and not from human activity. The profile of the microorganisms in bioaerosols identified in this study provides the fundamental knowledge needed to develop public health policies regarding the monitoring and management of indoor air quality.	[Kim, Jinman; Sohn, Jongryeul; Yi, Hana] Korea Univ, Grad Sch, Dept Publ Hlth Sci, PLUS Program Embodiment Hlth Soc Interact BK21, Seoul, South Korea; [Ha, Sung-min; Oh, Hyun-Seok; Chun, Jongsik] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Ha, Sung-min; Oh, Hyun-Seok; Chun, Jongsik] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Yi, Hana] Korea Univ, Sch Biosyst & Biomed Sci, Seoul, South Korea	Korea University; Seoul National University (SNU); Seoul National University (SNU); Korea University	Yi, H (corresponding author), Korea Univ, Grad Sch, Dept Publ Hlth Sci, PLUS Program Embodiment Hlth Soc Interact BK21, Seoul, South Korea.	hanayi@korea.ac.kr	Chun, Jongsik/R-8458-2017	Chun, Jongsik/0000-0003-3385-5171; Ha, Sung-min/0000-0003-3945-8329	Korea Ministry of Environment [ARQ201303173002, 2013001650001]; Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2013R1A1A3010041]	Korea Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning(National Research Foundation of Korea)	This work was supported by the Korea Ministry of Environment as "The Environmental Health Action Program (ARQ201303173002)" and " Converging Technology Project (2013001650001)", and by Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2013R1A1A3010041).	Adams RI, 2013, MICROB ECOL, V66, P735, DOI 10.1007/s00248-013-0266-4; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Adams RI, 2013, PLOS ONE, V8, P78866, DOI DOI 10.1371/journal.pone.0078866; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; Andersson AM, 1999, J APPL MICROBIOL, V86, P622, DOI 10.1046/j.1365-2672.1999.00706.x; Aydogdu H, 2005, INDOOR BUILT ENVIRON, V14, P411, DOI 10.1177/1420326X05057539; Aydogdu H, 2010, ENVIRON MONIT ASSESS, V164, P53, DOI 10.1007/s10661-009-0874-0; Bartlett KH, 2004, J OCCUP ENVIRON HYG, V1, P639, DOI 10.1080/15459620490497744; Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4; Bertolini V, 2013, APPL MICROBIOL BIOT, V97, P6561, DOI 10.1007/s00253-012-4450-0; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9263, DOI 10.5194/acp-9-9263-2009; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Chen NT, 2012, J ENVIRON MONITOR, V14, P2692, DOI 10.1039/c2em30113j; Cho BC, 2011, FEMS MICROBIOL ECOL, V76, P327, DOI 10.1111/j.1574-6941.2011.01053.x; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crameri R, 2014, ALLERGY, V69, P176, DOI 10.1111/all.12325; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Despres VR, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.15598; Dziewit L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-124; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elbert W, 2007, ATMOS CHEM PHYS, V7, P4569, DOI 10.5194/acp-7-4569-2007; Faergemann J, 2002, CLIN MICROBIOL REV, V15, P545, DOI 10.1128/CMR.15.4.545-563.2002; Fahlgren C, 2010, APPL ENVIRON MICROB, V76, P3015, DOI 10.1128/AEM.02092-09; Fang ZG, 2007, MICROB ECOL, V54, P487, DOI 10.1007/s00248-007-9216-3; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Frohlich-Nowoisky J, 2012, BIOGEOSCIENCES, V9, P1125, DOI 10.5194/bg-9-1125-2012; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Gaitanis G, 2012, CLIN MICROBIOL REV, V25, P106, DOI 10.1128/CMR.00021-11; Gandolfi I, 2013, APPL MICROBIOL BIOT, V97, P4727, DOI 10.1007/s00253-013-4901-2; Gauzere C, 2014, INDOOR AIR, V24, P29, DOI 10.1111/ina.12053; Gupta AK, 2004, J AM ACAD DERMATOL, V51, P785, DOI 10.1016/j.jaad.2003.12.034; Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Hur M, 2011, APPL ENVIRON MICROB, V77, P7611, DOI 10.1128/AEM.06102-11; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jeon YS, 2013, CURR MICROBIOL, V67, P557, DOI 10.1007/s00284-013-0401-y; Jo WK, 2005, CHEMOSPHERE, V61, P1570, DOI 10.1016/j.chemosphere.2005.04.103; Kampfer P, 2012, INT J SYST EVOL MICR, V62, P2750, DOI 10.1099/ijs.0.039057-0; Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093; Khan ST, 2008, INT J SYST EVOL MICR, V58, P383, DOI 10.1099/ijs.0.65103-0; Kim JL, 2007, INDOOR AIR, V17, P153, DOI 10.1111/j.1600-0668.2006.00466.x; Kim KY, 2007, BUILD ENVIRON, V42, P2188, DOI 10.1016/j.buildenv.2006.04.013; Kim KY, 2011, IND HEALTH, V49, P242, DOI 10.2486/indhealth.MS1199; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lee JH, 2012, J MICROBIOL, V50, P181, DOI 10.1007/s12275-012-1214-6; Lee L, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-27; Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14; Lis DO, 2013, AM J INFECT CONTROL, V41, P438, DOI 10.1016/j.ajic.2012.05.023; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Neri M, 2006, MUTAT RES-REV MUTAT, V612, P1, DOI 10.1016/j.mrrev.2005.04.001; NOBLE WC, 1984, J MED MICROBIOL, V17, P1, DOI 10.1099/00222615-17-1-1; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Robertson CE, 2013, APPL ENVIRON MICROB, V79, P3485, DOI 10.1128/AEM.00331-13; Roda C, 2011, ENVIRON RES, V111, P1010, DOI 10.1016/j.envres.2011.06.009; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suk WA, 2003, MUTAT RES-REV MUTAT, V544, P235, DOI 10.1016/j.mrrev.2003.06.007; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; URAKAMI T, 1990, INT J SYST BACTERIOL, V40, P287, DOI 10.1099/00207713-40-3-287; Veyisoglu A, 2013, INT J SYST EVOL MICR, V63, P2823, DOI 10.1099/ijs.0.049551-0; Wellner S, 2013, INT J SYST EVOL MICR, V63, P2690, DOI 10.1099/ijs.0.047787-0; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Yamamoto N, 2012, ISME J, V6, P1801, DOI 10.1038/ismej.2012.30; Yi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0583-3; Yooseph S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081862; Zukiewicz-Sobczak WA, 2013, POSTEP DERM ALERGOL, V30, P42, DOI 10.5114/pdia.2013.33377	86	64	65	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126960	10.1371/journal.pone.0126960	http://dx.doi.org/10.1371/journal.pone.0126960			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020512	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300029
J	Cooper-Knock, J; Bury, JJ; Heath, PR; Wyles, M; Higginbottom, A; Gelsthorpe, C; Highley, JR; Hautbergue, G; Rattray, M; Kirby, J; Shaw, PJ				Cooper-Knock, Johnathan; Bury, Joanna J.; Heath, Paul R.; Wyles, Matthew; Higginbottom, Adrian; Gelsthorpe, Catherine; Highley, J. Robin; Hautbergue, Guillaume; Rattray, Magnus; Kirby, Janine; Shaw, Pamela J.			C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT; RNA FOCI; ALS; EXPANSION; PROTEINS; MUTATIONS; ONSET; SENSE	Objective An intronic GGGGCC-repeat expansion of C9ORF72 is the most common genetic variant of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. The mechanism of neurodegeneration is unknown, but a direct effect on RNA processing mediated by RNA foci transcribed from the repeat sequence has been proposed. Methods Gene expression profiling utilised total RNA extracted from motor neurons and lymphoblastoid cell lines derived from human ALS patients, including those with an expansion of C9ORF72, and controls. In lymphoblastoid cell lines, expansion length and the frequency of sense and antisense RNA foci was also examined. Results Gene level analysis revealed a number of differentially expressed networks and both cell types exhibited dysregulation of a network functionally enriched for genes encoding 'RNA splicing' proteins. There was a significant overlap of these genes with an independently generated list of GGGGCC-repeat protein binding partners. At the exon level, in lymphoblastoid cells derived from C9ORF72-ALS patients splicing consistency was lower than in lines derived from non-C9ORF72 ALS patients or controls; furthermore splicing consistency was lower in samples derived from patients with faster disease progression. Frequency of sense RNA foci showed a trend towards being higher in lymphoblastoid cells derived from patients with shorter survival, but there was no detectable correlation between disease severity and DNA expansion length. Significance Up-regulation of genes encoding predicted binding partners of the C9ORF72 expansion is consistent with an attempted compensation for sequestration of these proteins. A number of studies have analysed changes in the transcriptome caused by C9ORF72 expansion, but to date findings have been inconsistent. As a potential explanation we suggest that dynamic sequestration of RNA processing proteins by RNA foci might lead to a loss of splicing consistency; indeed in our samples measurement of splicing consistency correlates with disease severity.	[Cooper-Knock, Johnathan; Bury, Joanna J.; Heath, Paul R.; Wyles, Matthew; Higginbottom, Adrian; Gelsthorpe, Catherine; Highley, J. Robin; Hautbergue, Guillaume; Kirby, Janine; Shaw, Pamela J.] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield S10 2HQ, S Yorkshire, England; [Rattray, Magnus] Univ Manchester, Life Sci, Manchester M13 9PT, Lancs, England	University of Sheffield; University of Manchester	Shaw, PJ (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, 385A Glossop Rd, Sheffield S10 2HQ, S Yorkshire, England.	pamela.shaw@sheffield.ac.uk	Rattray, Magnus/B-4393-2009; Rattray, Magnus/AAE-3297-2021; Kirby, Janine/B-3980-2009	Rattray, Magnus/0000-0001-8196-5565; Rattray, Magnus/0000-0001-8196-5565; Kirby, Janine/0000-0002-7468-5917; Cooper-Knock, Johnathan/0000-0002-0873-8689; Shaw, Pamela/0000-0002-8925-2567; Highley, Robin/0000-0002-4969-6526; Bury, Joanna J/0000-0002-8735-2791	EU [259867]; SOPHIA project; EU Joint Programme - Neurodegenerative Disease Research; Medical Research Council; Motor Neurone Disease Association [MR/K003771/1]; Medical Research Council [G0 800380]; Motor Neurone Disease Association; Wellcome Trust; Medical Research Council [G0800380, MR/K003771/1, MR/K000039/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish; MRC [MR/K003771/1, G0800380, MR/K000039/1] Funding Source: UKRI	EU(European Commission); SOPHIA project; EU Joint Programme - Neurodegenerative Disease Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge grants from the 'EU Framework 7' (Euromotor No259867) and the SOPHIA project (funded by 'EU Joint Programme - Neurodegenerative Disease Research' and 'Medical Research Council') to PJS and JK. PJS is an NIHR Senior Investigator. JCK and JRH are supported by 'Motor Neurone Disease Association' / 'Medical Research Council' Lady Edith Wolfson Fellowship awards ([MR/K003771/1] and [G0 800380] respectively). Samples used in this research were in part obtained from the UK MND DNA Bank for MND Research, funded by the 'Motor Neurone Disease Association' and the 'Wellcome Trust'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Bengtsson H., 2008, 745 U CAL DEP STAT; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; Buchman VL, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-12; Cooper-Knock J, 2014, BRAIN, V137, P2040, DOI 10.1093/brain/awu120; Cooper-Knock J, 2014, ACTA NEUROPATHOL, V127, P333, DOI 10.1007/s00401-014-1251-9; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; INCE PG, 1995, DEMENTIA, V6, P162, DOI 10.1159/000106940; Ismail A, 2013, J NEUROL NEUROSUR PS, V84, P79, DOI 10.1136/jnnp-2012-303326; Jawaid A, 2010, EUR J NEUROL, V17, P733, DOI 10.1111/j.1468-1331.2009.02923.x; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Mackenzie IR, 2013, ACTA NEUROPATHOL, V126, P859, DOI 10.1007/s00401-013-1181-y; Matus Soledad, 2013, Int J Cell Biol, V2013, P674751, DOI 10.1155/2013/674751; Mizielinska S, 2013, ACTA NEUROPATHOL, V126, P845, DOI 10.1007/s00401-013-1200-z; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Parakh S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408681; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Pickrell JK, 2014, PLOS GENET, V6; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Raman R, 2015, NEUROPATH APPL NEURO, V41, P201, DOI 10.1111/nan.12147; Rattray M, 2006, BRIEF BIOINFORM, V7, P37, DOI 10.1093/bib/bbk003; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrl C, 2014, J LIPID RES, V55, P94, DOI 10.1194/jlr.M043299; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sathasivam S, 2005, LANCET NEUROL, V4, P500, DOI 10.1016/S1474-4422(05)70142-3; Sveen A, 2011, GENOME MED, V3, DOI 10.1186/gm248; Vijayalakshmi K, 2011, NEUROBIOL DIS, V41, P695, DOI 10.1016/j.nbd.2010.12.005; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007	41	71	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127376	10.1371/journal.pone.0127376	http://dx.doi.org/10.1371/journal.pone.0127376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016851	Green Published, gold, Green Accepted			2022-12-27	WOS:000355185600080
J	Duc, KD; Lee, CY; Parutto, P; Cohen, D; Segal, M; Rouach, N; Holcman, D				Duc, K. Dao; Lee, C. Y.; Parutto, Pierre; Cohen, Dror; Segal, Menahem; Rouach, Nathalie; Holcman, David			Bursting Reverberation as a Multiscale Neuronal Network Process Driven by Synaptic Depression-Facilitation	PLOS ONE			English	Article							NEURAL-NETWORKS; HIPPOCAMPAL; OSCILLATIONS; MECHANISMS	Neuronal networks can generate complex patterns of activity that depend on membrane properties of individual neurons as well as on functional synapses. To decipher the impact of synaptic properties and connectivity on neuronal network behavior, we investigate the responses of neuronal ensembles from small (5-30 cells in a restricted sphere) and large (acute hippocampal slice) networks to single electrical stimulation: in both cases, a single stimulus generated a synchronous long-lasting bursting activity. While an initial spike triggered a reverberating network activity that lasted 2-5 seconds for small networks, we found here that it lasted only up to 300 milliseconds in slices. To explain this phenomena present at different scales, we generalize the depression-facilitation model and extracted the network time constants. The model predicts that the reverberation time has a bell shaped relation with the synaptic density, revealing that the bursting time cannot exceed a maximum value. Furthermore, before reaching its maximum, the reverberation time increases sub-linearly with the synaptic density of the network. We conclude that synaptic dynamics and connectivity shape the mean burst duration, a property present at various scales of the networks. Thus bursting reverberation is a property of sufficiently connected neural networks, and can be generated by collective depression and facilitation of underlying functional synapses.	[Duc, K. Dao; Parutto, Pierre; Holcman, David] Ecole Normale Super, IBENS, F-75005 Paris, France; [Lee, C. Y.; Rouach, Nathalie] Coll France, CNRS, Ctr Interdisciplinary Res Biol,U 1050,UMR 7241, Neuroglial Interact Cerebral Physiopathol,INSERM, Paris, France; [Cohen, Dror; Segal, Menahem] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Weizmann Institute of Science	Holcman, D (corresponding author), Ecole Normale Super, IBENS, 46 Rue Ulm, F-75005 Paris, France.	david.holcman@ens.fr	Rouach, Nathalie/L-4767-2017; SEGAL, MENAHEM/K-1577-2012	Rouach, Nathalie/0000-0002-5574-888X; holcman, david/0000-0001-9854-5014; Dao Duc, Khanh/0000-0002-9685-5171; Parutto, Pierre/0000-0002-9866-407X				Andersson M, 2010, J NEUROSCI, V30, P5776, DOI 10.1523/JNEUROSCI.3957-09.2010; Andersson MS, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-87; Atluri PP, 1996, J NEUROSCI, V16, P5661; Bacci A, 1999, EUR J NEUROSCI, V11, P389, DOI 10.1046/j.1460-9568.1999.00440.x; Bart E, 2005, J COMPUT NEUROSCI, V19, P357, DOI 10.1007/s10827-005-3099-4; Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X; Bressloff PC, 2011, J MATH NEUROSCI, V1, DOI 10.1186/2190-8567-1-2; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Cohen D, 2011, J NEUROPHYSIOL, V106, P2314, DOI 10.1152/jn.00969.2010; Cohen D, 2009, J NEUROPHYSIOL, V101, P2077, DOI 10.1152/jn.91085.2008; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Melamed O, 2008, J COMPUT NEUROSCI, V25, P308, DOI 10.1007/s10827-008-0080-z; Mills JD, 1999, J NEUROPHYSIOL, V81, P2253, DOI 10.1152/jn.1999.81.5.2253; Muller M, 2010, J NEUROSCI, V30, P2007, DOI 10.1523/JNEUROSCI.4378-09.2010; Pannasch U, 2012, JOVE-J VIS EXP, DOI 10.3791/4418; Picardo MA, 2011, NEURON, V71, P695, DOI 10.1016/j.neuron.2011.06.018; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; Tabak J, 2001, J NEUROSCI, V21, P8966, DOI 10.1523/JNEUROSCI.21-22-08966.2001; Traub R.D., 1991, NEURONAL NETWORKS HI; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wyart C, 2005, J NEUROPHYSIOL, V93, P3370, DOI 10.1152/jn.00530.2004; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003	30	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0124694	10.1371/journal.pone.0124694	http://dx.doi.org/10.1371/journal.pone.0124694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017681	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600006
J	Fan, L; Xiao, HP; Mai, GL; Su, B; Ernst, J; Hu, ZY				Fan, Lin; Xiao, Heping; Mai, Guangliang; Su, Bo; Ernst, Joel; Hu, Zhongyi			Impaired M. tuberculosis Antigen-Specific IFN-gamma Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary Tuberculosis	PLOS ONE			English	Article							CD4 T-CELLS; INTERFERON-GAMMA; IMMUNE-RESPONSE; MYCOBACTERIUM-BOVIS; BCG VACCINATION; MICE; INFECTION; APOPTOSIS; ABSENCE; DEATH	Background Th1 cells play an essential role in immune protection against tuberculosis. Th17 cells might be involved with immune pathology in active human tuberculosis (TB). The balance between Th1 and Th17 cells in patients with cavitary tuberculosis needs to be clarified which might help understanding the immunological basis of pathologic pathogenesis in TB. Method Initially treated pulmonary TB (PTB) patients with or without cavities were recruited before chemotherapy. We isolated peripheral blood mononuclear cells, stimulated with phytohemagglutinin (PHA), PPD, or ESAT-6 antigens, and assayed supernatant IFN-gamma and IL-17 by ELISA after 24 or 72 hours incubation, respectively. Cells were also stained with antibodies to CD3, CD4, CD8, IFN-gamma or IL-17 and the proportion of stained cells was measured by flow cytometry. Results We found wide variation of IFN-gamma response in active PTB patients, but less subject-to-subject variation of IL-17 was observed as we previously reported. There were no significant differences in IFN-gamma and IL-17 between cavitary and non-cavitary PTB; however, we found decreased IFN-gamma secretion in severe cavitary PTB compared to mild lesion non-cavitary PTB (p < 0.05). We also found a decrease in the proportion of CD3+CD4+ T cells in the blood of severe cavitary PTB patients (p < 0.05). Conclusions IL-17 seemed to have no association with the formation of cavities in active PTB from the study of PBMC. Impaired IFN-gamma without IL-17 enhancement occurs in peripheral blood during severe cavitary PTB. Our results demonstrate that M. tuberculosis antigen-specific Th1 response is decreased when PTB lesions develop to severe cavities.	[Fan, Lin; Xiao, Heping; Mai, Guangliang; Hu, Zhongyi] Tongji Univ, Sch Med, Clin & Res Ctr TB, Shanghai Key Lab TB,Shanghai Pulm Hosp, Shanghai 200433, Peoples R China; [Su, Bo] Tongji Univ, Sch Med, Cent Lab, Shanghai Pulm Hosp, Shanghai 200433, Peoples R China; [Ernst, Joel] NYU, Sch Med, Div Infect Dis, New York, NY 10016 USA	Tongji University; Tongji University; New York University	Ernst, J (corresponding author), NYU, Sch Med, Div Infect Dis, New York, NY 10016 USA.	joel.ernst@med.nyu.edu; fanlinsj@aliyun.com		Ernst, Joel/0000-0001-9951-6207	National Key Basic Research Program (973) sub-project in China [2012CB518706]	National Key Basic Research Program (973) sub-project in China	This study was supported by the National Key Basic Research Program (973) sub-project in China (2012CB518706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barry S, 2009, TUBERCULOSIS, V89, P48, DOI 10.1016/j.tube.2008.07.002; Caruso AM, 1999, J IMMUNOL, V162, P5407; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Di Carlo P, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-108; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Eurosurveillance editorial team, 2013, EURO SURVEILL, V18, P20615; Fan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042716; Geldmacher C, 2012, CURR OPIN HIV AIDS, V7, P268, DOI 10.1097/COH.0b013e3283524e32; Geldmacher C, 2010, J EXP MED, V207, P2869, DOI 10.1084/jem.20100090; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kubler A, 2015, J PATHOL, V235, P431, DOI 10.1002/path.4432; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lyadova IV, 2001, CLIN EXP IMMUNOL, V126, P274, DOI 10.1046/j.1365-2249.2001.01667.x; Mazzarella G, 2003, CLIN EXP IMMUNOL, V132, P283, DOI 10.1046/j.1365-2249.2003.02121.x; MUKADI Y, 1993, LANCET, V342, P143, DOI 10.1016/0140-6736(93)91346-N; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nunnari G, 2013, CLIN INVEST MED, V36, pE64; Peng MY, 2008, CELL MOL IMMUNOL, V5, P203, DOI 10.1038/cmi.2008.25; Rodriguez-Guell E, 2008, CLIN VACCINE IMMUNOL, V15, P1485, DOI 10.1128/CVI.00131-08; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Singh A, 2013, J INFECT DIS, V208, P603, DOI 10.1093/infdis/jit206; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09; Wu HP, 2007, RESP MED, V101, P48, DOI 10.1016/j.rmed.2006.04.016; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	34	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127087	10.1371/journal.pone.0127087	http://dx.doi.org/10.1371/journal.pone.0127087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018190	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600069
J	Stanton, BA; Coutermarsh, B; Barnaby, R; Hogan, D				Stanton, Bruce A.; Coutermarsh, Bonita; Barnaby, Roxanna; Hogan, Deborah			Pseudomonas aeruginosa Reduces VX-809 Stimulated F508del-CFTR Chloride Secretion by Airway Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CFTR POTENTIATOR; IN-VITRO; TRAFFICKING; DELTA-F508-CFTR; DEGRADATION; COMBINATION; LUMACAFTOR; PROTEASOME	Background P. aeruginosa is an opportunistic pathogen that chronically infects the lungs of 85% of adult patients with Cystic Fibrosis (CF). Previously, we demonstrated that P. aeruginosa reduced wt-CFTR Cl secretion by airway epithelial cells. Recently, a new investigational drug VX-809 has been shown to increase F508del-CFTR Cl secretion in human bronchial epithelial (HBE) cells, and, in combination with VX-770, to increase FEV1 (forced expiratory volume in 1 second) by an average of 3-5% in CF patients homozygous for the F508del-CFTR mutation. We propose that P. aeruginosa infection of CF lungs reduces VX-809 + VX-770-stimulated F508del-CFTR Cl secretion, and thereby reduces the clinical efficacy of VX-809 + VX-770. Methods and Results F508del-CFBE cells and primary cultures of CF-HBE cells (F508del/F508del) were exposed to VX-809 alone or a combination of VX-809 + VX-770 for 48 hours and the effect of P. aeruginosa on F508del-CFTR Cl secretion was measured in Ussing chambers. The effect of VX-809 on F508del-CFTR abundance was measured by cell surface biotinylation and western blot analysis. PAO1, PA14, PAK and 6 clinical isolates of P. aeruginosa (3 mucoid and 3 non-mucoid) significantly reduced drug stimulated F508del-CFTR Cl secretion, and plasma membrane F508del-CFTR. Conclusion The observation that P. aeruginosa reduces VX-809 and VX-809 + VX-770 stimulated F508del CFTR Cl secretion may explain, in part, why VX-809 + VX-770 has modest efficacy in clinical trials.	[Stanton, Bruce A.; Coutermarsh, Bonita; Barnaby, Roxanna; Hogan, Deborah] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA	Dartmouth College	Stanton, BA (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA.	BAS@dartmouth.edu			National Institutes of Health [R01-HL074175, R01-DK/HL45881, P30GM106394]; Cystic Fibrosis Foundation [STANTO07R0]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-HL074175, R01-DK/HL45881 and P30GM106394 (BAS) (http://www.nih.gov/) and Cystic Fibrosis Foundation grant STANTO07R0 (BAS) (http://www.cff.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl CD, 2014, J BIOL CHEM, V289, P7460, DOI 10.1074/jbc.M113.518092; Ballok AE, 2013, J BACTERIOL, V195, P4013, DOI 10.1128/JB.00339-13; Bomberger JM, 2012, J BIOL CHEM, V287, P17130, DOI 10.1074/jbc.M111.338855; Bomberger JM, 2011, METHODS MOL BIOL, V741, P271, DOI 10.1007/978-1-61779-117-8_18; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Collawn JF, 2014, AM J PHYSIOL-LUNG C, V307, pL917, DOI 10.1152/ajplung.00326.2014; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Guimbellot JS, 2014, PEDIATR PULM, V49, P217; Haws CM, 1996, AM J PHYSIOL-CELL PH, V270, pC1544, DOI 10.1152/ajpcell.1996.270.5.C1544; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Moreau-Marquis S, 2013, PEDIATR PULM, V48, P255; Moreau-Marquis S, 2015, J ANTIMICROB CHEMOTH, V70, P160, DOI 10.1093/jac/dku357; Ramsey B, 2014, PEDIATR PULM, V49, P305; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Stanke F, 2014, EUR J HUM GENET, V22, P660, DOI 10.1038/ejhg.2013.209; Stanke F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-62; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Talebian L, 2009, CELL PHYSIOL BIOCHEM, V23, P199, DOI 10.1159/000204108; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Veit G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008889; Wang YT, 2014, INT J BIOCHEM CELL B, V52, P47, DOI 10.1016/j.biocel.2014.04.001; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6	31	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127742	10.1371/journal.pone.0127742	http://dx.doi.org/10.1371/journal.pone.0127742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018799	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600095
J	Zarate-Barrera, TG; Maldonado, JH				Zarate-Barrera, Tatiana G.; Maldonado, Jorge H.			Valuing Blue Carbon: Carbon Sequestration Benefits Provided by the Marine Protected Areas in Colombia	PLOS ONE			English	Article								Marine protected areas are aimed to protect and conserve key ecosystems for the provision of a number of ecosystem services that are the basis for numerous economic activities. Among the several services that these areas provide, the capacity of sequestering (capturing and storing) organic carbon is a regulating service, provided mainly by mangroves and seagrasses, that gains importance as alternatives for mitigating global warming become a priority in the international agenda. The objective of this study is to value the services associated with the capture and storage of oceanic carbon, known as Blue Carbon, provided by a new network of marine protected areas in Colombia. We approach the monetary value associated to these services through the simulation of a hypothetical market for oceanic carbon. To do that, we construct a benefit function that considers the capacity of mangroves and seagrasses for capturing and storing blue carbon, and simulate scenarios for the variation of key variables such as the market carbon price, the discount rate, the natural rate of loss of the ecosystems, and the expectations about the post-Kyoto negotiations. The results indicate that the expected benefits associated to carbon capture and storage provided by these ecosystems are substantial but highly dependent on the expectations in terms of the negotiations surrounding the extension of the Kyoto Protocol and the dynamics of the carbon credit's demand and supply. We also find that the natural loss rate of these ecosystems does not seem to have a significant effect on the annual value of the benefits. This approach constitutes one of the first attempts to value blue carbon as one of the services provided by conservation.	[Zarate-Barrera, Tatiana G.; Maldonado, Jorge H.] Univ Los Andes, CEDE, Dept Econ, Bogota, Colombia	Universidad de los Andes (Colombia)	Maldonado, JH (corresponding author), Univ Los Andes, CEDE, Dept Econ, Bogota, Colombia.	jmaldona@uniandes.edu.co		Maldonado, Jorge/0000-0001-5501-6374	Americas Business Council through Universidad de los Andes	Americas Business Council through Universidad de los Andes	The authors thank the Americas Business Council, who funded the project through a contract with Universidad de los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Alonso D, 2008, ANALISIS VACIOS PROP; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2007, WORLDS MANGR 1980 20; Barrera CA, 2013, DOCUMENTO CEDE, V56, P1; Bowen A., 2016, CASE CARBON PRICING; Boyle K, 1985, TOTAL VALUE WILDLIFE; Carbon Finance, 2013, MAPP CARB PRIC IN 20; Carbon Finance, 2012, CARB FIN SUST DEV; Casas-Monroy O, 2000, INFORME ESTADO AMBIE, P45; CDB UNEP, 2004, CONV BIOL DIV CONC I; CI GCRMN NOAA, 2008, SOC COND WORLDS TROP; Conservation International, 2008, EC VAL COR REEFS MAN; Cuervo R., 2014, DOCUMENTO CEDE, V2014, P1; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Emerton L, 2005, WORKSH BUILD DIV POR; EONG OJ, 1993, CHEMOSPHERE, V27, P1097, DOI 10.1016/0045-6535(93)90070-L; FAMA EF, 1965, J BUS, V38, P34, DOI 10.1086/294743; Greiner JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072469; Harrison M., 2010, VALUING FUTURE SOCIA; HighLevel Panel on the CDM Policy Dialogue, 2012, CLIMATE CHANGE CARBO; IAvH IDEAM IIAP INVEMAR & SINCHI, 2011, INF EST MED AMB REC; ICE, 2010, CHIC CLIM EXCH CLOS; INVEMAR UAESPNN TNC, 2008, PLAN ACC CREAC SUBS; IPCC, 2007, CONTRIBUTION WORKING; IUCN TNC World Bank, 2004, MUCH IS EC WORTH ASS; Jenkins WA, 2010, ECOL ECON, V69, P1051, DOI 10.1016/j.ecolecon.2009.11.022; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; 김민규, 2008, [JOURNAL OF KOREA WATER RESOURCES ASSOCITION, 한국수자원학회 논문집], V41, P1; Lavery PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073748; Lopez H, 2008, SOCIAL DISCOUNT RATE; Maldonado JH, 2013, DOCUMENTO CEDE, V52, P1; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Ministerio de Medio Ambiente y Desarrollo Sostenible, 2011, INF MDL COL; Montanez-Gil AM, 2014, DOCUMENTO CEDE, V11, P1; Moreno-Sanchez RP, 2013, DOCUMENTO CEDE, V55, P1; Murray B., 2011, GREEN PAYMENTS BLUE; Nellemann C., 2009, BLUE CARBON RAPID RE; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Price R, 2007, SOCIAL COAST CARBON; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sedjo R, 2012, ANNU REV RESOUR ECON, V4, P126, DOI 10.1146/annurev-resource-083110-115941; Seeberg-Elverfeldt C, 2010, CARBON FINANCE POSSI; Sifleet S., 2011, 1106 NI R; Suzuki A, 2004, GLOBAL ENV CHANGE OC, P229; U.S. Environmental Protection Agency, 2013, FACT SHEET SOC COST; UNEP, 2011, OTH 70 UNEP MAR COAS; UNEP-WCMC, 2006, FRONT LIN SHOR PROT, P33; United Nations, 2021, CLIM CHANG REC THREA; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Zarate TG, 2014, DOCUMENTO CEDE, V6, P1	51	29	29	8	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126627	10.1371/journal.pone.0126627	http://dx.doi.org/10.1371/journal.pone.0126627			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018814	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600056
J	Gera, N; Yang, AR; Holtzman, TS; Lee, SX; Wong, ET; Swanson, KD				Gera, Nidhi; Yang, Aaron; Holtzman, Talia S.; Lee, Sze Xian; Wong, Eric T.; Swanson, Kenneth D.			Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; ALTERNATING ELECTRIC-FIELDS; MYOSIN-II; MAMMALIAN SEPTINS; CONTRACTILE RING; SPATIAL CONTROL; HELA-CELLS; CYTOKINESIS; ANILLIN	The anti-tumor effects of chemotherapy and radiation are thought to be mediated by triggering G(1)/S or G(2)/M cell cycle checkpoints, while spindle poisons, such as paclitaxel, block metaphase exit by initiating the spindle assembly checkpoint. In contrast, we have found that 150 kilohertz (kHz) alternating electric fields, also known as Tumor Treating Fields (TTFields), perturbed cells at the transition from metaphase to anaphase. Cells exposed to the TTFields during mitosis showed normal progression to this point, but exhibited uncontrolled membrane blebbing that coincided with metaphase exit. The ability of such alternating electric fields to affect cellular physiology is likely to be dependent on their interactions with proteins possessing high dipole moments. The mitotic Septin complex consisting of Septin 2, 6 and 7, possesses a high calculated dipole moment of 2711 Debyes (D) and plays a central role in positioning the cytokinetic cleavage furrow, and governing its contraction during ingression. We showed that during anaphase, TTFields inhibited Septin localization to the anaphase spindle midline and cytokinetic furrow, as well as its association with microtubules during cell attachment and spreading on fibronectin. After aberrant metaphase exit as a consequence of TTFields exposure, cells exhibited aberrant nuclear architecture and signs of cellular stress including an overall decrease in cellular proliferation, followed by apoptosis that was strongly influenced by the p53 mutational status. Thus, TTFields are able to diminish cell proliferation by specifically perturbing key proteins involved in cell division, leading to mitotic catastrophe and subsequent cell death.	[Gera, Nidhi] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yang, Aaron; Holtzman, Talia S.; Lee, Sze Xian; Wong, Eric T.; Swanson, Kenneth D.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurooncol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Swanson, KD (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neurooncol, Boston, MA 02215 USA.	kswanson@bidmc.harvard.edu		Yang, Aaron/0000-0003-3319-4916	National Institutes of Health [R56AI085131]; NovoCure Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NovoCure Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health R56AI085131 to K. D. S., and an unrestricted grant from NovoCure Inc. to K. D. S. and E. T. W. (http://www.novocure.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Antoons G, 2002, J PHYSIOL-LONDON, V543, P889, DOI 10.1113/jphysiol.2002.025619; Bertin A, 2012, MOL BIOL CELL, V23, P423, DOI 10.1091/mbc.E11-10-0850; Bowen JR, 2011, J CELL BIOL, V194, P187, DOI 10.1083/jcb.201102076; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DeMay BS, 2011, BIOPHYS J, V101, P985, DOI 10.1016/j.bpj.2011.07.008; DeMay BS, 2011, J CELL BIOL, V193, P1065, DOI 10.1083/jcb.201012143; Durand DM, 2001, P IEEE, V89, P1065, DOI 10.1109/5.939821; Elhajouji A, 1998, MUTAGENESIS, V13, P193; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; Field CM, 2005, DEVELOPMENT, V132, P2849, DOI 10.1242/dev.01843; Frenette P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034888; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Ghossoub R, 2013, J CELL SCI, V126, P2583, DOI 10.1242/jcs.111377; Giansanti MG, 1999, J CELL SCI, V112, P2323; Gilden JK, 2012, J CELL BIOL, V196, P103, DOI 10.1083/jcb.201105127; Goldbach P, 2010, MOL BIOL CELL, V21, P1482, DOI 10.1091/mbc.E09-08-0714; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kirson Eilon D, 2009, BMC Med Phys, V9, P1, DOI 10.1186/1756-6649-9-1; Kirson ED, 2009, CLIN EXP METASTAS, V26, P633, DOI 10.1007/s10585-009-9262-y; Kops GJPL, 2012, CHROMOSOMA, V121, P509, DOI 10.1007/s00412-012-0378-5; Liu JH, 2012, CURR BIOL, V22, P64, DOI 10.1016/j.cub.2011.11.040; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; Margolis RL, 2003, J CELL BIOCHEM, V88, P673, DOI 10.1002/jcb.10411; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Orth JD, 2011, CANCER RES, V71, P4608, DOI 10.1158/0008-5472.CAN-11-0412; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pethig R, 1996, CRIT REV BIOTECHNOL, V16, P331, DOI 10.3109/07388559609147425; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Posterino GS, 2000, J PHYSIOL-LONDON, V527, P131, DOI 10.1111/j.1469-7793.2000.t01-2-00131.x; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Wong ET, 2014, CANCER MED-US, V3, P592, DOI 10.1002/cam4.210	59	112	116	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125269	10.1371/journal.pone.0125269	http://dx.doi.org/10.1371/journal.pone.0125269			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010837	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900011
J	Manley, E				Manley, Ed			Estimating Urban Traffic Patterns through Probabilistic Interconnectivity of Road Network Junctions	PLOS ONE			English	Article							ROUTE CHOICE; ANGULARITY; PATH	The emergence of large, fine-grained mobility datasets offers significant opportunities for the development and application of new methodologies for transportation analysis. In this paper, the link between routing behaviour and traffic patterns in urban areas is examined, introducing a method to derive estimates of traffic patterns from a large collection of fine-grained routing data. Using this dataset, the interconnectivity between road network junctions is extracted in the form of a Markov chain. This representation encodes the probability of the successive usage of adjacent road junctions, encoding routes as flows between decision points rather than flows along road segments. This network of functional interactions is then integrated within a modified Markov chain Monte Carlo (MCMC) framework, adapted for the estimation of urban traffic patterns. As part of this approach, the data-derived links between major junctions influence the movement of directed random walks executed across the network to model origin-destination journeys. The simulation process yields estimates of traffic distribution across the road network. The paper presents an implementation of the modified MCMC approach for London, United Kingdom, building an MCMC model based on a dataset of nearly 700000 minicab routes. Validation of the approach clarifies how each element of the MCMC framework contributes to junction prediction performance, and finds promising results in relation to the estimation of junction choice and minicab traffic distribution. The paper concludes by summarising the potential for the development and extension of this approach to the wider urban modelling domain.	UCL, CASA, London, England	University of London; University College London	Manley, E (corresponding author), UCL, CASA, Gower St, London, England.	ed.manley@ucl.ac.uk		Manley, Ed/0000-0002-8904-0513	UK Engineering and Physical Sciences Research Council [EP/G023212/1]; Transport for London (TfL)	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Transport for London (TfL)	This work is part of the STANDARD Project -Spatio-Temporal Analysis of Network Data and Road Developments, supported by the UK Engineering and Physical Sciences Research Council (EP/G023212/1) and Transport for London (TfL).	[Anonymous], PHYS REV LETT; Bierlaire M, 2010, SWISS TRANSP RES C A; Broach J, 2012, TRANSPORT RES A-POL, V46, P1730, DOI 10.1016/j.tra.2012.07.005; CASCETTA E, 1989, TRANSPORT RES B-METH, V23, P1, DOI 10.1016/0191-2615(89)90019-2; Dalton RC, 2003, ENVIRON BEHAV, V35, P107, DOI 10.1177/0013916502238867; Harvey F., 2008, TRANSP RES BOARD 87; Hazelton ML, 2004, TRANSPORT SCI, V38, P331, DOI 10.1287/trsc.1030.0052; Hirst MA, 1976, GEOGR ANN B, P79; Horton FE, 1969, HIGHWAY RES RECORD; Lynch K, 1960, IMAGE CITY, V1; Manley EJ, 2015, J TRANSP GEOGR, V43, P123, DOI 10.1016/j.jtrangeo.2015.01.006; MONTELLO DR, 1991, ENVIRON BEHAV, V23, P47, DOI 10.1177/0013916591231003; Park ES, 2008, J INTELL TRANSPORT S, V12, P139, DOI 10.1080/15472450802262364; Qin X, 2005, J TRANSP ENG-ASCE, V131, P345, DOI 10.1061/(ASCE)0733-947X(2005)131:5(345); Spissu E, 2011, TRANSPORT RES REC, P96, DOI 10.3141/2230-11; Wolf J, 2004, TRANSPORT RES REC, P46, DOI 10.3141/1870-06	16	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127095	10.1371/journal.pone.0127095	http://dx.doi.org/10.1371/journal.pone.0127095			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009884	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900062
J	McGowan, I; Anton, PA; Elliott, J; Cranston, RD; Duffill, K; Althouse, AD; Hawkins, KL; De Rosa, SC				McGowan, Ian; Anton, Peter A.; Elliott, Julie; Cranston, Ross D.; Duffill, Kathryn; Althouse, Andrew D.; Hawkins, Kevin L.; De Rosa, Stephen C.			Exploring the Feasibility of Multi-Site Flow Cytometric Processing of Gut Associated Lymphoid Tissue with Centralized Data Analysis for Multi-Site Clinical Trials	PLOS ONE			English	Article							INFECTION; CELLS	The purpose of this study was to determine whether the development of a standardized approach to the collection of intestinal tissue from healthy volunteers, isolation of gut associated lymphoid tissue mucosal mononuclear cells (MMC), and characterization of mucosal T cell phenotypes by flow cytometry was sufficient to minimize differences in the normative ranges of flow parameters generated at two trial sites. Forty healthy male study participants were enrolled in Pittsburgh and Los Angeles. MMC were isolated from rectal biopsies using the same biopsy acquisition and enzymatic digestion protocols. As an additional comparator, peripheral blood mononuclear cells (PBMC) were collected from the study participants. For quality control, cryopreserved PBMC from a single donor were supplied to both sites from a central repository (qPBMC). Using a jointly optimized standard operating procedure, cells were isolated from tissue and blood and stained with monoclonal antibodies targeted to T cell phenotypic markers. Site-specific flow data were analyzed by an independent center which analyzed all data from both sites. Ranges for frequencies for overall CD4+ and CD8+ T cells, derived from the qPBMC samples, were equivalent at both UCLA and MWRI. However, there were significant differences across sites for the majority of T cell activation and memory subsets in qPBMC as well as PBMC and MMC. Standardized protocols to collect, stain, and analyze MMC and PBMC, including centralized analysis, can reduce but not exclude variability in reporting flow data within multi-site studies. Based on these data, centralized processing, flow cytometry, and analysis of samples may provide more robust data across multi-site studies. Centralized processing requires either shipping of fresh samples or cryopreservation and the decision to perform centralized versus site processing needs to take into account the drawbacks and restrictions associated with each method.	[McGowan, Ian; Cranston, Ross D.; Althouse, Andrew D.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Anton, Peter A.; Elliott, Julie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Anton, Peter A.; Elliott, Julie] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA; [Duffill, Kathryn; Althouse, Andrew D.] Magee Womens Res Inst, Pittsburgh, PA USA; [Hawkins, Kevin L.; De Rosa, Stephen C.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [De Rosa, Stephen C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	McGowan, I (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	imcgowan@pitt.edu	Althouse, Andrew/AAF-5053-2019; Althouse, Andrew/AAF-4836-2019; M, Ian/AAP-1032-2021; M, i/HCI-9242-2022	Althouse, Andrew/0000-0002-8654-5014; M, Ian/0000-0002-6470-8476; Cranston, Ross/0000-0002-2687-6217	HIV Vaccine Trials Network (HVTN) [UM1AI068618]; Center for HIV/AIDS Vaccine Immunology [U19AI067854]; Mucosal Immunology Group [UM1AI068618]; CFARs at UCLA (Mucosal Immunology Core Laboratory and Flow Cytometry Core) [AI028697-20]; University of Washington/Fred Hutchinson Cancer Research Center [AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, UM1AI068614, U01AI068618, U19AI067854, UM1AI068618, P30AI028697, U01AI068614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	HIV Vaccine Trials Network (HVTN); Center for HIV/AIDS Vaccine Immunology; Mucosal Immunology Group; CFARs at UCLA (Mucosal Immunology Core Laboratory and Flow Cytometry Core); University of Washington/Fred Hutchinson Cancer Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the HIV Vaccine Trials Network (HVTN) (UM1AI068618), the Center for HIV/AIDS Vaccine Immunology (U19AI067854), and by funds received through the Mucosal Immunology Group (http://public.hivmucosalgroup.org), a group funded by a supplement to the HVTN Laboratory Program (UM1AI068618). This work was also supported by the CFARs at UCLA (Mucosal Immunology Core Laboratory and Flow Cytometry Core: AI028697-20) and University of Washington/Fred Hutchinson Cancer Research Center (AI027757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge J, 2014, J IMMUNOL METHODS; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Bissessor M, 2013, SEX TRANSM DIS, V40, P768, DOI 10.1097/OLQ.0000000000000022; Esparza J, 2013, VACCINE, V31, P3502, DOI 10.1016/j.vaccine.2013.05.018; Ibarrondo FJ, 2013, MUCOSAL IMMUNOL, V6, P591, DOI 10.1038/mi.2012.101; KAGAN J, 1993, ANN NY ACAD SCI, V677, P50, DOI 10.1111/j.1749-6632.1993.tb38763.x; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Poles MA, 2001, J VIROL, V75, P8390, DOI 10.1128/JVI.75.18.8390-8399.2001; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Shattock RJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007385; Shete A, 2013, J IMMUNOASS IMMUNOCH, V34, P333, DOI 10.1080/15321819.2012.741087; Yang OO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088621; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	13	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126454	10.1371/journal.pone.0126454	http://dx.doi.org/10.1371/journal.pone.0126454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010577	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000355183900029
J	Probst, AJ; Weinmaier, T; DeSantis, TZ; Domingo, JWS; Ashbolt, N				Probst, Alexander J.; Weinmaier, Thomas; DeSantis, Todd Z.; Domingo, Jorge W. Santo; Ashbolt, Nicholas			New Perspectives on Microbial Community Distortion after Whole-Genome Amplification	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; ESCHERICHIA-COLI O157-H7; DIVERSITY; METAGENOMICS; ENVIRONMENTS; SEDIMENT; OUTBREAK; BACTERIA; SEQUENCE; AQUIFER	Whole-genome amplification (WGA) has become an important tool to explore the genomic information of microorganisms in an environmental sample with limited biomass, however potential selective biases during the amplification processes are poorly understood. Here, we describe the effects of WGA on 31 different microbial communities from five biotopes that also included low-biomass samples from drinking water and groundwater. Our findings provide evidence that microbiome segregation by biotope was possible despite WGA treatment. Nevertheless, samples from different biotopes revealed different levels of distortion, with genomic GC content significantly correlated with WGA perturbation. Certain phylogenetic clades revealed a homogenous trend across various sample types, for instance Alpha- and Betaproteobacteria showed a decrease in their abundance after WGA treatment. On the other hand, Enterobacteriaceae, an important biomarker group for fecal contamination in groundwater and drinking water, were strongly affected by WGA treatment without a predictable pattern. These novel results describe the impact of WGA on low-biomass samples and may highlight issues to be aware of when designing future metagenomic studies that necessitate preceding WGA treatment.	[Probst, Alexander J.; Weinmaier, Thomas; DeSantis, Todd Z.] Second Genome Inc, Dept Bioinformat, San Francisco, CA USA; [Domingo, Jorge W. Santo; Ashbolt, Nicholas] US EPA, Cincinnati, OH 45268 USA	United States Environmental Protection Agency	Domingo, JWS (corresponding author), US EPA, Cincinnati, OH 45268 USA.	Santodomingo.Jorge@epa.gov; Ashbolt@ualberta.ca	Probst, Alexander J/K-2813-2016; Ashbolt, Nicholas/H-4004-2014; Weinmaier, Thomas/K-5780-2013	Ashbolt, Nicholas/0000-0002-3853-0096; Weinmaier, Thomas/0000-0002-9552-3220; Probst, Alexander/0000-0002-9392-6544	US EPA Carbon Sequestration Program; Alberta Innovates [201300490] Funding Source: researchfish	US EPA Carbon Sequestration Program; Alberta Innovates	US EPA Carbon Sequestration Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia CB, 2006, APPL ENVIRON MICROB, V72, P3291, DOI 10.1128/AEM.72.5.3291-3301.2006; Akama T, 2013, PATHOGENS, V2, P591, DOI 10.3390/pathogens2040591; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beaulieu JJ, 2014, BIOGEOCHEMISTRY, V121, P107, DOI 10.1007/s10533-014-9971-4; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Cooper M, 2011, APPL ENVIRON MICROB, V77, P5438, DOI 10.1128/AEM.00192-11; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Direito SOL, 2014, ENVIRON MICROBIOL, V16, P643, DOI 10.1111/1462-2920.12365; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; GELDREICH EE, 1992, WATER RES, V26, P1127, DOI 10.1016/0043-1354(92)90150-3; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; La Duc MT, 2009, APPL ENVIRON MICROB, V75, P6559, DOI 10.1128/AEM.01073-09; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miezeiewski M, 2015, ISME J, V9, P321, DOI 10.1038/ismej.2014.127; Olsen SJ, 2002, EMERG INFECT DIS, V8, P370, DOI 10.3201/eid0804.000218; Probst A, 2010, APPL ENVIRON MICROB, V76, P2837, DOI 10.1128/AEM.02167-09; Probst AJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6497; Probst AJ, 2014, MICROARRAYS: CURRENT TECHNOLOGY, INNOVATIONS AND APPLICATIONS, P99; Probst AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099801; Probst AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065388; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Revetta RP, 2013, FEMS MICROBIOL ECOL, V86, P404, DOI 10.1111/1574-6941.12170; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Sharon I, 2013, SCIENCE, V342, P1057, DOI 10.1126/science.1247023; Tyson GW, 2005, TRENDS MICROBIOL, V13, P411, DOI 10.1016/j.tim.2005.07.003; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114; Venkateswaran K, 2001, SYST APPL MICROBIOL, V24, P311, DOI 10.1078/0723-2020-00018; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	46	17	17	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0124158	10.1371/journal.pone.0124158	http://dx.doi.org/10.1371/journal.pone.0124158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010362	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900006
J	Rango, M; Bonifati, C; Bresolin, N				Rango, Mario; Bonifati, Cristiana; Bresolin, Nereo			Post-Activation Brain Warming: A 1-H MRS Thermometry Study	PLOS ONE			English	Article							OXIDATIVE-METABOLISM; CEREBRAL OXYGEN; TEMPERATURE; BLOOD; MODEL	Purpose Temperature plays a fundamental role for the proper functioning of the brain. However, there are only fragmentary data on brain temperature (T-br) and its regulation under different physiological conditions. Methods We studied T-br in the visual cortex of 20 normal subjects serially with a wide temporal window under different states including rest, activation and recovery by a visual stimulation-Magnetic Resonance Spectroscopy Thermometry combined approach. We also studied T-br in a control region, the centrum semiovale, under the same conditions. Results Visual cortex mean baseline T-br was higher than mean body temperature (37.38 vs 36.60, P< 0.001). During activation T-br remained unchanged at first and then showed a small decrease (-0.20 C degrees) around the baseline value. After the end of activation T-br increased consistently (+ 0.60 C degrees) and then returned to baseline values after some minutes. Centrum semiovale T-br remained unchanged through rest, visual stimulation and recovery. Conclusion These findings have several implications, among them that neuronal firing itself is not a major source of heat release in the brain and that there is an aftermath of brain activation that lasts minutes before returning to baseline conditions.	[Rango, Mario; Bonifati, Cristiana; Bresolin, Nereo] Univ Milan, Dept Neurol Sci, IRCCS Ca Granda Osped Maggiore Policlin Fdn, Milan, Italy; [Rango, Mario; Bonifati, Cristiana; Bresolin, Nereo] Univ Milan, Magnet Resonance Spect Ctr, IRCCS Ca Granda Osped Maggiore Policlin Fdn, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Rango, M (corresponding author), Univ Milan, Dept Neurol Sci, IRCCS Ca Granda Osped Maggiore Policlin Fdn, Milan, Italy.	mariocristia@yahoo.it	rango, mario/AIA-9372-2022	Bresolin, Nereo/0000-0001-6694-3595				CADY EB, 1995, MAGN RESON MED, V33, P862, DOI 10.1002/mrm.1910330620; Chadzynski GL, 2011, J MAGN RESON, V212, P55, DOI 10.1016/j.jmr.2011.06.009; Corbett R, 1997, J CEREBR BLOOD F MET, V17, P363, DOI 10.1097/00004647-199704000-00001; CORBETT RJT, 1995, J NEUROCHEM, V64, P1224; Edden RAE, 2007, MAGN RESON MED, V57, P977, DOI 10.1002/mrm.21234; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; GEORGE JS, 1993, ADV EXP MED BIOL, V333, P125; Gorbach AM, 2003, ANN NEUROL, V54, P297, DOI 10.1002/ana.10646; Katz-Brull R, 2006, MAGN RESON MED, V56, P348, DOI 10.1002/mrm.20972; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kiyatkin EA, 2002, EUR J NEUROSCI, V16, P164, DOI 10.1046/j.1460-9568.2002.02066.x; Kiyatkin EA, 2010, FRONT BIOSCI-LANDMRK, V15, P73, DOI 10.2741/3608; Lu HZ, 2004, J CEREBR BLOOD F MET, V24, P764, DOI 10.1097/01.WCB.0000124322.60992.5C; Madsen PL, 1998, J CEREBR BLOOD F MET, V18, P742, DOI 10.1097/00004647-199807000-00005; Marrett S., 1992, Society for Neuroscience Abstracts, V18, P1394; Martin JH, 1996, NEUROANATOMY, V17, P345; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Pouwels PJW, 1997, NMR BIOMED, V10, P73, DOI 10.1002/(SICI)1099-1492(199704)10:2<73::AID-NBM448>3.0.CO;2-4; Rango M, 1997, MAGNET RESON MED, V38, P878, DOI 10.1002/mrm.1910380605; Rango M, 2012, NEUROREPORT, V23, P483, DOI 10.1097/WNR.0b013e3283534a60; Siegel GJ, 1981, BASIC NEUROCHEMISTRY, V13, P231; Siesjo B, 1978, BRAIN ENERGY METABOL, V4, P79; SIGGAARDANDERSEN O, 1984, CLIN CHEM, V30, P1646; Sukstanskii AL, 2006, P NATL ACAD SCI USA, V103, P12144, DOI 10.1073/pnas.0604376103; Tang B, 2013, BRAIN IMAGING BEHAV, V7, P177, DOI 10.1007/s11682-012-9212-1; Trubel HKF, 2006, J CEREBR BLOOD F MET, V26, P68, DOI 10.1038/sj.jcbfm.9600164; Volgushev M, 2000, J PHYSIOL-LONDON, V528, P669; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Yablonskiy DA, 2000, P NATL ACAD SCI USA, V97, P7603, DOI 10.1073/pnas.97.13.7603; Zhu M, 2008, MAGN RESON MED, V60, P536, DOI 10.1002/mrm.21699; Zhu XH, 2001, MAGN RESON MED, V46, P841, DOI 10.1002/mrm.1267	31	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127314	10.1371/journal.pone.0127314	http://dx.doi.org/10.1371/journal.pone.0127314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011731	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900081
J	Ruzo, A; Ismailoglu, I; Popowski, M; Haremaki, T; Croft, GF; Deglincerti, A; Brivanlou, AH				Ruzo, Albert; Ismailoglu, Ismail; Popowski, Melissa; Haremaki, Tomomi; Croft, Gist F.; Deglincerti, Alessia; Brivanlou, Ali H.			Discovery of Novel Isoforms of Huntingtin Reveals a New Hominid-Specific Exon	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DISEASE GENE; CASPASE CLEAVAGE; NUCLEAR; PROTEIN; LETHALITY; BIOGPS; DOMAIN	Huntington's disease (HD) is a devastating neurological disorder that is caused by an expansion of the poly-Q tract in exon 1 of the Huntingtin gene (HTT). HTT is an evolutionarily conserved and ubiquitously expressed protein that has been linked to a variety of functions including transcriptional regulation, mitochondrial function, and vesicle transport. This large protein has numerous caspase and calpain cleavage sites and can be decorated with several post-translational modifications such as phosphorylations, acetylations, sumoylations, and palmitoylations. However, the exact function of HTT and the role played by its modifications in the cell are still not well understood. Scrutiny of HTT function has been focused on a single, full length mRNA. In this study, we report the discovery of 5 novel HTT mRNA splice isoforms that are expressed in normal and HTT-expanded human embryonic stem cell (hESC) lines as well as in cortical neurons differentiated from hESCs. Interestingly, none of the novel isoforms generates a truncated protein. Instead, 4 of the 5 new isoforms specifically eliminate domains and modifications to generate smaller HTT proteins. The fifth novel isoform incorporates a previously unreported additional exon, dubbed 41b, which is hominid-specific and introduces a potential phosphorylation site in the protein. The discovery of this hominid-specific isoform may shed light on human-specific pathogenic mechanisms of HTT, which could not be investigated with current mouse models of the disease.	[Ruzo, Albert; Ismailoglu, Ismail; Popowski, Melissa; Haremaki, Tomomi; Croft, Gist F.; Deglincerti, Alessia; Brivanlou, Ali H.] Rockefeller Univ, Mol Embryol Lab, New York, NY 10021 USA	Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Mol Embryol Lab, 1230 York Ave, New York, NY 10021 USA.	brvnlou@rockefeller.edu		Croft, Gist/0000-0002-9721-0148; Ismailoglu, Ismail/0000-0003-4865-273X	Cure Huntington's Disease Initiative (CHDI) Foundation [A-8185]	Cure Huntington's Disease Initiative (CHDI) Foundation	This work is supported by a grant from the Cure Huntington's Disease Initiative (CHDI) Foundation #A-8185 (http://chdifoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal RS, 2008, AUTOPHAGY, V4, P91, DOI 10.4161/auto.5201; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Desmond CR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412379; Dragatsis I, 1998, DEVELOPMENT, V125, P1529; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hughes AC, 2014, J MOL BIOL, V426, P1428, DOI 10.1016/j.jmb.2013.12.028; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Menalled LB, 2002, TRENDS PHARMACOL SCI, V23, P32, DOI 10.1016/S0165-6147(00)01884-8; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Woda JM, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-17; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	29	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127687	10.1371/journal.pone.0127687	http://dx.doi.org/10.1371/journal.pone.0127687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010866	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900132
J	Steinhoff-Wagner, J; Schonhusen, U; Zitnan, R; Hudakova, M; Pfannkuche, H; Hammon, HM				Steinhoff-Wagner, Julia; Schoenhusen, Ulrike; Zitnan, Rudolf; Hudakova, Monika; Pfannkuche, Helga; Hammon, Harald M.			Ontogenic Changes of Villus Growth, Lactase Activity, and Intestinal Glucose Transporters in Preterm and Term Born Calves with or without Prolonged Colostrum Feeding	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; NEONATAL CALVES; GASTROINTESTINAL-TRACT; ENZYME-ACTIVITIES; DAIRY-COWS; METABOLISM; MATURATION; ABSORPTION; MORPHOLOGY; MUCOSA	Oral glucose supply is important for neonatal calves to stabilize postnatal plasma glucose concentration. The objective of this study was to investigate ontogenic development of small intestinal growth, lactase activity, and glucose transporter in calves (n = 7 per group) that were born either preterm (PT; delivered by section 9 d before term) or at term (T; spontaneous vaginal delivery) or spontaneously born and fed colostrum for 4 days (TC). Tissue samples from duodenum and proximal, mid, and distal jejunum were taken to measure villus size and crypt depth, protein concentration of mucosa and brush border membrane vesicles (BBMV), total DNA and RNA concentration of mucosa, mRNA expression and activity of lactase, and mRNA expression of sodium-dependent glucose co-transporter-1 (SGLT1) and facilitative glucose transporter 2 (GLUT2) in mucosal tissue. Additionally, protein expression of SGLT1 in BBMV and GLUT2 in crude mucosal membranes and immunochemical localization of GLUT2 in the enterocytes were determined. Villus height in distal jejunum was lower in TC than in T. Crypt depth in all segments was largest and the villus height/crypt depth ratio in jejunum was smallest in TC calves. Concentration of RNA was highest in duodenal mucosa of TC calves, but neither lactase mRNA and activity nor SGLT1 and GLUT2 mRNA and protein expression differed among groups. Localization of GLUT2 in the apical membrane was greater, whereas in the basolateral membrane was lower in TC than in T and PT calves. Our study indicates maturation processes after birth for mucosal growth and trafficking of GLUT2 from the basolateral to the apical membrane. Minor differences of mucosal growth, lactase activity, and intestinal glucose transporters were seen between PT and T calves, pointing at the importance of postnatal maturation and feeding for mucosal growth and GLUT2 trafficking.	[Steinhoff-Wagner, Julia; Schoenhusen, Ulrike; Hammon, Harald M.] Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, D-18196 Dummerstorf, Germany; [Zitnan, Rudolf] Natl Ctr Agr & Food Nitra, Inst Nutr, Kosice 04181, Slovakia; [Hudakova, Monika] Sch Econ & Management Publ Adm, Bratislava 85104, Slovakia; [Pfannkuche, Helga] Univ Leipzig, Inst Vet Physiol, D-04103 Leipzig, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Leipzig University	Hammon, HM (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, D-18196 Dummerstorf, Germany.	hammon@fbn-dummerstorf.de	Hammon, Harald/AAD-9990-2020; Hudáková, Monika/ABG-2596-2020; Steinhoff-Wagner, Julia/H-9730-2019	Hudáková, Monika/0000-0003-0454-9626; Steinhoff-Wagner, Julia/0000-0003-0180-9859	German Research Foundation [HA 4372/5-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (HA 4372/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird AR, 1996, J ANIM SCI, V74, P2523; Bittrich S, 2004, J DAIRY SCI, V87, P1786, DOI 10.3168/jds.S0022-0302(04)73334-2; Bittrich S, 2002, J ANIM PHYSIOL AN N, V86, P185, DOI 10.1046/j.1439-0396.2002.00372.x; Blattler U, 2001, J NUTR, V131, P1256; Blum JW, 2006, J ANIM PHYSIOL AN N, V90, P1, DOI 10.1111/j.1439-0396.2005.00614.x; Blum JW, 2000, LIVEST PROD SCI, V66, P151, DOI 10.1016/S0301-6226(00)00222-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRITT DG, 1974, J DAIRY SCI, V57, P416, DOI 10.3168/jds.S0022-0302(74)84906-4; Buhler C, 1998, J ANIM SCI, V76, P758; Cherbuy C, 1997, AM J PHYSIOL-GASTR L, V272, pG1530, DOI 10.1152/ajpgi.1997.272.6.G1530; Cohen M, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140091; CREAMER B, 1961, GUT, V2, P110, DOI 10.1136/gut.2.2.110; FUJITA M, 1971, BIOCHIM BIOPHYS ACTA, V233, P404, DOI 10.1016/0005-2736(71)90337-3; GALJAARD H, 1972, EXP CELL RES, V73, P197, DOI 10.1016/0014-4827(72)90120-6; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P37; Hadorn U, 1997, J NUTR, V127, P2011, DOI 10.1093/jn/127.10.2011; Hammon HM, 2013, J ANIM SCI, V91, P685, DOI 10.2527/jas.2012-5758; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Lohrenz AK, 2011, J DAIRY SCI, V94, P4546, DOI 10.3168/jds.2011-4333; Mir PS, 1997, CAN J ANIM SCI, V77, P441, DOI 10.4141/A96-097; Ontsouka EC, 2004, J DAIRY SCI, V87, P4230, DOI 10.3168/jds.S0022-0302(04)73568-7; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfannkuche H, 2014, J ANIM PHYSIOL AN N, V98, P140, DOI 10.1111/jpn.12057; Roder PV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089977; Sangild P. T., 2001, P3, DOI 10.1079/9780851995175.0003; SANGILD PT, 1995, PEDIATR RES, V37, P207, DOI 10.1203/00006450-199502000-00014; Sangild PT, 2002, J NUTR, V132, P3785, DOI 10.1093/jn/132.9.2673; Sauter SN, 2004, BIOL NEONATE, V85, P94, DOI 10.1159/000074965; Schmidt M, 2004, THERIOGENOLOGY, V61, P1729, DOI 10.1016/j.theriogenology.2003.10.002; Schroder B, 1996, J COMP PHYSIOL B, V166, P230, DOI 10.1007/BF00263987; Shirazi-Beechey S. P., 1995, Ruminant physiology: digestion, metabolism, growth and reproduction. Proceedings 8th International Symposium on Ruminant Physiology., P117; Steinhoff-Wagner J, 2011, J DAIRY SCI, V94, P5111, DOI 10.3168/jds.2011-4355; Steinhoff-Wagner J, 2014, J DAIRY SCI, V97, P6358, DOI 10.3168/jds.2014-8391; Steinhoff-Wagner J, 2011, J NUTR, V141, P48, DOI 10.3945/jn.110.128652; TIVEY DR, 1994, EXP PHYSIOL, V79, P189, DOI 10.1113/expphysiol.1994.sp003752; TRAHAIR JF, 1987, Q J EXP PHYSIOL CMS, V72, P71, DOI 10.1113/expphysiol.1987.sp003056; Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409; Zitnan R, 2008, VET MED-CZECH, V53, P525, DOI 10.17221/1968-VETMED	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128154	10.1371/journal.pone.0128154	http://dx.doi.org/10.1371/journal.pone.0128154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011395	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900198
J	Zheng, W; Zhang, XY; Lu, Q				Zheng, Wei; Zhang, Xiaoya; Lu, Qi			A BHR Composite Network-Based Visualization Method for Deformation Risk Level of Underground Space	PLOS ONE			English	Article							TUNNEL CONSTRUCTION; 3D; TECHNOLOGY; STATION; SYSTEM	This study proposes a visualization processing method for the deformation risk level of underground space. The proposed method is based on a BP-Hopfield-RGB (BHR) composite network. Complex environmental factors are integrated in the BP neural network. Dynamic monitoring data are then automatically classified in the Hopfield network. The deformation risk level is combined with the RGB color space model and is displayed visually in real time, after which experiments are conducted with the use of an ultrasonic omnidirectional sensor device for structural deformation monitoring. The proposed method is also compared with some typical methods using a benchmark dataset. Results show that the BHR composite network visualizes the deformation monitoring process in real time and can dynamically indicate dangerous zones.	[Zheng, Wei; Zhang, Xiaoya; Lu, Qi] Chongqing Univ, Coll Optoelect Engn, Educ Minist China, Key Lab Optoelect Technol & Syst, Chongqing 630044, Peoples R China	Chongqing University	Zheng, W (corresponding author), Chongqing Univ, Coll Optoelect Engn, Educ Minist China, Key Lab Optoelect Technol & Syst, Chongqing 630044, Peoples R China.	zw3475@163.com			National Natural Science Foundation of China [61174006]; Fundamental Research Funds for the Central Universities [106112015CDJXY120014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The project is supported by the National Natural Science Foundation of China (Grant No. 61174006) and the Fundamental Research Funds for the Central Universities (Project No. 106112015CDJXY120014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmet M, 2014, NEUROCOMPUTING, V145, P230, DOI 10.1016/j.neucom.2014.05.038; Albertini MK, 2013, ADV DATA ANAL CLASSI, V7, P435, DOI 10.1007/s11634-013-0145-3; BENJAMIN CO, 1995, COMPUT IND ENG, V28, P43, DOI 10.1016/0360-8352(94)00021-E; Chen LH, 2014, APPL MECH MATER, V501-504, P839, DOI 10.4028/www.scientific.net/AMM.501-504.839; Chia CC, 2012, STRUCT CONTROL HLTH, V19, P605, DOI 10.1002/stc.1504; Giangarra PP, 2011, IBM J RES DEV, V55, DOI 10.1147/JRD.2010.2086250; Glisic B, 2014, COMPUT-AIDED CIV INF, V29, P382, DOI 10.1111/mice.12060; Heddam S, 2014, ENVIRON MONIT ASSESS, V186, P7837, DOI 10.1007/s10661-014-3971-7; Kai C, 2013, PROC SPIE, V8769, DOI 10.1117/12.2020749; Kamat VR, 2011, J CONSTR ENG M, V137, P853, DOI 10.1061/(ASCE)CO.1943-7862.0000262; Kim S, 2013, IEEE T VIS COMPUT GR, V19, P1438, DOI 10.1109/TVCG.2013.66; Koo B, 2010, IEICE T COMMUN, VE93B, P2963, DOI 10.1587/transcom.E93.B.2963; Lavine A, 2003, ENG GEOL, V70, P71, DOI 10.1016/S0013-7952(03)00083-8; Li XJ, 2009, J COMPUT CIVIL ENG, V23, P348, DOI 10.1061/(ASCE)0887-3801(2009)23:6(348); Liang GL, 2012, DISASTER ADV, V5, P312; Linderman LE, 2013, STRUCT CONTROL HLTH, V20, P1007, DOI 10.1002/stc.1514; Marzouk MM, 2014, SMART STRUCT SYST, V13, P407, DOI 10.12989/sss.2014.13.3.407; Scaioni M, 2014, EARTH SCI INFORM, V7, P83, DOI 10.1007/s12145-014-0152-8; Sikora M, 2010, ARCH MIN SCI, V55, P91; Silvestrini M, 2009, J LOSS PREVENT PROC, V22, P449, DOI 10.1016/j.jlp.2009.02.018; Simbeye DS, 2014, COMPUT ELECTRON AGR, V102, P31, DOI 10.1016/j.compag.2014.01.004; Smith DV, 2002, P SOC PHOTO-OPT INS, V4758, P251, DOI 10.1117/12.462230; Sousa H, 2013, SMART STRUCT SYST, V11, P365, DOI 10.12989/sss.2013.11.4.365; Sun P, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/542501; Szedlak A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105842; Tang SL, 2011, ADV MATER RES-SWITZ, V225-226, P26, DOI 10.4028/www.scientific.net/AMR.225-226.26; Wu SL, 2013, ADV MATER RES-SWITZ, V779-780, P463, DOI 10.4028/www.scientific.net/AMR.779-780.463; Ye XW, 2012, INT J DISTRIB SENS N, DOI 10.1155/2012/685054; Yeung JS, 2013, TUNN UNDERGR SP TECH, V38, P534, DOI 10.1016/j.tust.2013.09.002; Zheng W, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/3/037001; Zhou Y, 2013, AUTOMAT CONSTR, V34, P25, DOI 10.1016/j.autcon.2012.10.011	31	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127088	10.1371/journal.pone.0127088	http://dx.doi.org/10.1371/journal.pone.0127088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011618	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900060
J	Kim, HJ; Lee, HJ; An, SY; Sim, S; Park, B; Kim, SW; Lee, JS; Hong, SK; Choi, HG				Kim, Hyung-Jong; Lee, Hyo-Jeong; An, Soo-Youn; Sim, Songyong; Park, Bumjung; Kim, Si Whan; Lee, Joong Seob; Hong, Sung Kwang; Choi, Hyo Geun			Analysis of the Prevalence and Associated Risk Factors of Tinnitus in Adults	PLOS ONE			English	Article							OCCUPATIONAL NOISE EXPOSURE; OLDER-ADULTS; HEARING-LOSS; POPULATION; HEALTH; SALICYLATE; SYMPTOMS	Background Tinnitus is a common condition in adults; however, the pathophysiology of tinnitus remains unclear, and no large population-based study has assessed the associated risk factors. The aim of this study was to analyze the prevalence and associated risk factors of tinnitus. Methods We conducted a cross-sectional study using data from the Korea National Health and Nutrition Examination Survey, with 19,290 participants ranging in age from 20 to 98 years old, between 2009 and 2012. We investigated the prevalence of tinnitus using a questionnaire and analyzed various possible factors associated with tinnitus using simple and multiple logistic regression analysis with complex sampling. Results The prevalence of tinnitus was 20.7%, and the rates of tinnitus associated with no discomfort, moderate annoyance, and severe annoyance were 69.2%, 27.9%, and 3.0%, respectively. The prevalence of tinnitus and the rates of annoying tinnitus increased with age. The adjusted odds ratio (AOR) of tinnitus was higher for females, those with a smoking history, those reporting less sleep (<= 6 h), those with more stress, those in smaller households, those with a history of hyperlipidemia osteoarthritis, rheumatoid arthritis, asthma, depression, thyroid disease, an abnormal tympanic membrane, unilateral hearing loss, bilateral hearing loss, noise exposure from earphones, noise exposure at the workplace, noise exposure outside the workplace, and brief noise exposure. Additionally, unemployed individuals and soldiers had higher AORs for tinnitus. The AOR of annoying tinnitus increased with age, stress, history of hyperlipidemia, unilateral hearing loss, and bilateral hearing loss. Conclusions Tinnitus is very common in the general population and is associated with gender, smoking, stress, sleep, hearing loss, hyperlipidemia, osteoarthritis, rheumatoid arthritis, asthma, depression, and thyroid disease history.	[Kim, Hyung-Jong; Lee, Hyo-Jeong; Park, Bumjung; Kim, Si Whan; Lee, Joong Seob; Hong, Sung Kwang; Choi, Hyo Geun] Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [An, Soo-Youn] Dongnam Inst Radiol & Med Sci DIRAMS, Thyroid Head & Neck Canc Ctr, Dept Otorhinolaryngol Head & Neck Surg, Busan, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea	Hallym University; Korea Institute of Radiological & Medical Sciences; Hallym University	Choi, HG (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Lee, Hyo-Jeong/AAK-7973-2020; Choi, Hyo Geun/K-4461-2019	Lee, Hyo-Jeong/0000-0003-2258-0803; Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation of Korea [NRF-2013R1A1A3006802]; Hallym University Sacred Heart Hospital [HURF-2015-0193]	National Research Foundation of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported by a Research Grant from the National Research Foundation of Korea (NRF-2013R1A1A3006802) and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2015-0193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, GLOB BURD DIS, DOI DOI 10.1097/mao.0000000000001630; Appleton SL, 2008, OBES RES CLIN PRACT, V2, P91, DOI 10.1016/j.orcp.2008.04.005; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baigi A, 2011, EAR HEARING, V32, P787, DOI 10.1097/AUD.0b013e31822229bd; BHATIA PL, 1977, LARYNGOSCOPE, V87, P2082; Canis M, 2011, AM J OTOLARYNG, V32, P19, DOI 10.1016/j.amjoto.2009.09.004; Cho YS, 2010, CLIN EXP OTORHINOLAR, V3, P183, DOI 10.3342/ceo.2010.3.4.183; CHUNG DY, 1984, AUDIOLOGY, V23, P441; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Coles R R, 1984, J Laryngol Otol Suppl, V9, P7; Davis A., 2000, TINNITUS HDB; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; Elliott B, 2000, Nurse Pract, V25, P92; Elliott B, 2000, NURSE PRACT, V25, P99; Engdahl B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000512; Fujii K, 2011, J EPIDEMIOL, V21, P299, DOI 10.2188/jea.JE20100124; FURST DE, 1987, ARTHRITIS RHEUM, V30, P146, DOI 10.1002/art.1780300204; Gopinath B, 2010, EAR HEARING, V31, P407, DOI 10.1097/AUD.0b013e3181cdb2a2; Gopinath B, 2010, ANN EPIDEMIOL, V20, P129, DOI 10.1016/j.annepidem.2009.09.002; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; HALLA JT, 1991, ANN RHEUM DIS, V50, P682, DOI 10.1136/ard.50.10.682; Hallam RS., 2006, TINNITUS TREATMENT, P65; Hiller W, 2006, ARCH OTOLARYNGOL, V132, P1323, DOI 10.1001/archotol.132.12.1323; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Hoffman H., 2004, TINNITUS THEORY MANA, P16; Jastreboff PJ, 1996, AM J OTOL, V17, P236; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Mahboubi H, 2013, LARYNGOSCOPE, V123, P2001, DOI 10.1002/lary.24015; McCormack A, 2014, J PSYCHOSOM RES, V76, P56, DOI 10.1016/j.jpsychores.2013.08.018; MCKENNA L, 1991, CLIN OTOLARYNGOL, V16, P452, DOI 10.1111/j.1365-2273.1991.tb01038.x; Meyler D, 2007, SOC SCI MED, V64, P2297, DOI 10.1016/j.socscimed.2007.02.007; Michikawa T, 2010, J EPIDEMIOL, V20, P271, DOI 10.2188/jea.JE20090121; Negrila-Mezei A, 2011, J Med Life, V4, P412; Nguyen TVN, 1998, OTOLARYNG HEAD NECK, V119, P14, DOI 10.1016/S0194-5998(98)70167-6; Nondahl David M, 2002, J Am Acad Audiol, V13, P323; Nondahl DM, 2012, EAR HEARING, V33, P640, DOI 10.1097/AUD.0b013e31825069e8; Nondahl DM, 2011, INT J AUDIOL, V50, P313, DOI 10.3109/14992027.2010.551220; Nondahl DM, 2010, INT J AUDIOL, V49, P580, DOI 10.3109/14992021003753508; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Perry BP, 2000, TINNITUS HDB, P221; Pouryaghoub G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-137; Quaranta A, 1996, SCAND AUDIOL, V25, P9; Reynolds P, 2004, CLIN OTOLARYNGOL, V29, P628, DOI 10.1111/j.1365-2273.2004.00879.x; Rubak T, 2008, INT J AUDIOL, V47, P109, DOI 10.1080/14992020701581430; Seydel C, 2013, EAR HEARING, V34, P661, DOI 10.1097/AUD.0b013e31828149f2; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Sindhusake D, 2003, INT J AUDIOL, V42, P289, DOI 10.3109/14992020309078348; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; STOUFFER JL, 1990, J SPEECH HEAR DISORD, V55, P439, DOI 10.1044/jshd.5503.439; TYLER RS, 1983, J SPEECH HEAR DISORD, V48, P150, DOI 10.1044/jshd.4802.150; Unterrainer J, 2001, Int Tinnitus J, V7, P109; Wallhausser-Franke E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034583; Wang Jian-Ping, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P736; Xu X, 2011, J AM ACAD AUDIOL, V22, P578, DOI 10.3766/jaaa.22.9.3	54	142	152	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127578	10.1371/journal.pone.0127578	http://dx.doi.org/10.1371/journal.pone.0127578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020239	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300046
J	Marteinson, SC; Giroux, JF; Helie, JF; Gentes, ML; Verreault, J				Marteinson, Sarah C.; Giroux, Jean-Francois; Helie, Jean-Francois; Gentes, Marie-Line; Verreault, Jonathan			Field Metabolic Rate Is Dependent on Time-Activity Budget in Ring-Billed Gulls (Larus delawarensis) Breeding in an Anthropogenic Environment	PLOS ONE			English	Article							DAILY ENERGY-EXPENDITURE; KITTIWAKES RISSA-TRIDACTYLA; DOUBLY LABELED WATER; REPRODUCTIVE ENERGETICS; FORAGING BEHAVIOR; HEART-RATE; PREY; ALBATROSSES; INCUBATION; SEABIRDS	Environmental and behavioral factors have long been assumed to affect variation in avian field metabolic rate (FMR). However, due to the difficulties in measuring continuous behavior of birds over prolonged periods of time, complete time-activity budgets have rarely been examined in relation to FMR. Our objective was to determine the effect of activity (measured by detailed time-activity budgets) and a series of extrinsic and intrinsic factors on FMR of the omnivorous ring-billed gull (Larus delawarensis). The experiment was conducted during the incubation period when both members of the pair alternate between attending the nest-site and leaving the colony to forage in aquatic and anthropogenic environments (city, agricultural). FMR was determined using the doubly labeled water method. Time-activity budgets were extrapolated from spatio-temporal data (2-5 days) obtained from bird-borne GPS data loggers. Gulls had low FMRs compared to those predicted by allometric equations based on recorded FMRs from several seabird species. Gulls proportioned their time mainly to nest-site attendance (71% of total tracking time), which reduced FMR/g bodymass, and was the best variable explaining energy expenditure. The next best variable was the duration of foraging trips, which increased FMR/g; FMR/g was also elevated by the proportion of time spent foraging or flying (17% and 8% of tracking time respectively). Most environmental variables-measured did not impact FMR/g, however, the percent of time birds were subjected to temperatures below their lower critical temperature increased FMR. Time-activity budgets varied between the sexes, and with temperature and capture date suggesting that these variables indirectly affected FMR/g. The gulls foraged preferentially in anthropogenic-related habitats, which may have contributed to their low FMR/g due to the high availability of protein-and lipid-rich foods. This study demonstrates that activities were the best predictors of FMR/g in ring-billed gulls, thus providing strong support for this long-standing theory in bioenergetics.	[Marteinson, Sarah C.; Gentes, Marie-Line; Verreault, Jonathan] Univ Quebec, Ctr Rech Toxicol Environm TOXEN, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Giroux, Jean-Francois] Univ Quebec, Dept Sci Biol, GRECA, Montreal, PQ H3C 3P8, Canada; [Helie, Jean-Francois] Univ Quebec, Ctr Rech Geochim & Geodynam GEOTOP, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal	Verreault, J (corresponding author), Univ Quebec, Ctr Rech Toxicol Environm TOXEN, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada.	verreault.jonathan@uqam.ca	Marteinson, Sarah/AAE-6614-2020; Giroux, Jean-François/L-7945-2019	Giroux, Jean-François/0000-0002-6732-489X; Helie, Jean-Francois/0000-0002-0994-5620	Natural Sciences and Engineering Research Council of Canada [385787]; Canada Research Chair in Comparative Avian Toxicology [225707]; Fonds quebecois de la recherche sur la nature et les technologies [168434]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Comparative Avian Toxicology; Fonds quebecois de la recherche sur la nature et les technologies(FQRNT)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca, to JV (#385787) and J-FG, the Canada Research Chair in Comparative Avian Toxicology, http://www.chairschaires.gc.ca/(#225707) to JV and Fonds quebecois de la recherche sur la nature et les technologies, http://www.frqnt.gouv.qc.ca/, (#168434) to SCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Auman HJ, 2008, WATERBIRDS, V31, P122, DOI 10.1675/1524-4695(2008)31[122:SMDAFC]2.0.CO;2; BAERTSCHI P, 1976, EARTH PLANET SC LETT, V31, P341, DOI 10.1016/0012-821X(76)90115-1; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; Bech C, 2002, COMP BIOCHEM PHYS A, V133, P765, DOI 10.1016/S1095-6433(02)00153-8; Belant JL, 1997, LANDSCAPE URBAN PLAN, V38, P245, DOI 10.1016/S0169-2046(97)00037-6; BIRTFRIESEN VL, 1989, ECOLOGY, V70, P357, DOI 10.2307/1937540; BRYANT DM, 1991, IBIS, V133, P236, DOI 10.1111/j.1474-919X.1991.tb04565.x; BURGER J, 1988, COLON WATERBIRD, V11, P9, DOI 10.2307/1521165; Burnham KP, 2002, MODEL SELECTION MULT, DOI [10.1111/1365-2656.12141, DOI 10.1111/1365-2656.12141]; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Caron-Beaudoin E, 2013, CAN J ZOOL, V91, P689, DOI 10.1139/cjz-2013-0008; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; DAVIS RW, 1989, J ANIM ECOL, V58, P59, DOI 10.2307/4986; De Wit JC., 1980, GEOSTANDARD NEWSLETT, V4, P33, DOI [DOI 10.1111/J.1751-908X.1980.TB00270.X, 10.1111/j.1751-908X.1980.tb00270.x]; ELLIS HI, 1980, FED PROC, V39, P1165; Ellis Hugh I., 2002, P359; Fort J, 2011, COMP BIOCHEM PHYS A, V158, P358, DOI 10.1016/j.cbpa.2010.05.004; Furness RW, 1996, ECOLOGY, V77, P1181, DOI 10.2307/2265587; Fyhn M, 2001, PHYSIOL BIOCHEM ZOOL, V74, P343, DOI 10.1086/320419; GABRIELSEN GW, 1991, AUK, V108, P71; GABRIELSEN GW, 1987, CONDOR, V89, P126, DOI 10.2307/1368766; Horita J., 2004, HDB STABLE ISOTOPE A; Jodice PGR, 2003, PHYSIOL BIOCHEM ZOOL, V76, P375, DOI 10.1086/375431; Marzluff John M., 2001, P1; MONTEVECCHI WA, 1992, ECOLOGY, V73, P823, DOI 10.2307/1940160; Mullers RHE, 2009, MAR ECOL PROG SER, V393, P161, DOI 10.3354/meps08250; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Pallet I.L., 2012, BIRDS N AM ONLINE; Patenaude-Monette M, 2014, PLOS ONE, V9, P1, DOI [10.1371/ journal. pone. 0102162, DOI 10.1371/J0URNAL.P0NE.0102162, 10.1371/journal.pone.0102162]; Peronnet F, 2012, EUR J APPL PHYSIOL, V112, P2213, DOI 10.1007/s00421-011-2194-7; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Racine F, 2012, ANIM BEHAV, V84, P175, DOI 10.1016/j.anbehav.2012.04.028; RICKLEFS RE, 1984, AUK, V101, P707, DOI 10.2307/4086898; Ryder JP, 2012, BIRDS N AM; Shaffer SA, 2004, J AVIAN BIOL, V35, P551, DOI 10.1111/j.0908-8857.2004.03264.x; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Speakman J. R., 1999, DLW ANAL PROGRAM; Speakman JR, 1997, DOUBLY LABELED WATER; STAHEL CD, 1984, J COMP PHYSIOL, V154, P487, DOI 10.1007/BF02515153; Thomson DL, 1998, ARDEA, V86, P169; TINBERGEN JM, 1994, FUNCT ECOL, V8, P563, DOI 10.2307/2389916; Tinbergen JM, 2002, ENERGETICS INCUBATIO; WEATHERS WW, 1980, AUK, V97, P861; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2002, J EXP BIOL, V205, P475; Welcker J, 2009, FUNCT ECOL, V23, P1081, DOI 10.1111/j.1365-2435.2009.01585.x; Whittow G. Causey, 2002, P409; Williams TD, 2001, CURR ORNITHOL, V16, P355	49	11	11	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0126964	10.1371/journal.pone.0126964	http://dx.doi.org/10.1371/journal.pone.0126964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020626	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300030
J	Yang, WQ; Jin, SH; He, S; Fan, Q; Zhu, YJ				Yang, Wenqi; Jin, Shenghua; He, Surina; Fan, Qian; Zhu, Yijie			The Impact of Power on Humanity: Self-Dehumanization in Powerlessness	PLOS ONE			English	Article							HUMANNESS; ATTRIBUTION; BEHAVIOR; INHIBITION; AUSTRALIA; PREJUDICE; EMOTIONS; INGROUPS; PEOPLE; SHAME	Power gives people the ability to control themselves and their environment, and this control is considered a fundamental human need. We investigated whether experiencing powerlessness induces the experience of self-dehumanization using three methods: priming, role-playing, and cueing. People in a position of low power viewed themselves (Experiments 1-3) as less human relative to people in a position of high power; furthermore, people with low power believed that they were viewed as less human by others as well (Experiments 2-3). In all of the experiments, human nature traits were most negatively affected by powerlessness in self-perception judgments, and uniquely human traits were most negatively affected by powerlessness in meta-perception judgments. Furthermore, the powerless believed they were viewed as less human not only by the powerful people but also the outside observers of the power dynamic. Self-dehumanization also appears to be a consequence of powerlessness rather than an incidental result of a change in mood or a negative self-view. Our findings are an important extension of previous work on the adverse effects of powerlessness and dehumanization.	[Yang, Wenqi; Jin, Shenghua; He, Surina; Fan, Qian; Zhu, Yijie] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China	Beijing Normal University	Yang, WQ (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	wenqiyang_psych@126.com			Major Project of National Social Science Foundation [12ZD228]; National Fund for Fostering Talents of Basic Science [J1103601, J1210048]; Fundamental Research Funds for the Central Universities	Major Project of National Social Science Foundation; National Fund for Fostering Talents of Basic Science; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The present research is funded by "Major Project of National Social Science Foundation (12&ZD228)", "National Fund for Fostering Talents of Basic Science (J1103601 & J1210048)" and "the Fundamental Research Funds for the Central Universities". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2002, J PERS SOC PSYCHOL, V83, P1362, DOI 10.1037//0022-3514.83.6.1362; Bain P, 2012, J CROSS CULT PSYCHOL, V43, P53, DOI 10.1177/0022022111419029; Bain P, 2009, GROUP PROCESS INTERG, V12, P789, DOI 10.1177/1368430209340415; Bandura A, 1999, Pers Soc Psychol Rev, V3, P193, DOI 10.1207/s15327957pspr0303_3; Bastian B, 2013, PERS SOC PSYCHOL B, V39, P156, DOI 10.1177/0146167212471205; Bastian B, 2012, J EXP SOC PSYCHOL, V48, P486, DOI 10.1016/j.jesp.2011.10.009; Bastian B, 2011, BASIC APPL SOC PSYCH, V33, P295, DOI 10.1080/01973533.2011.614132; Bastian B, 2010, J EXP SOC PSYCHOL, V46, P107, DOI 10.1016/j.jesp.2009.06.022; Baumeister R. F., 1999, SELF SOCIAL PSYCHOL; Carney DR, 2010, PSYCHOL SCI, V21, P1363, DOI 10.1177/0956797610383437; Chen S, 2001, J PERS SOC PSYCHOL, V80, P173, DOI 10.1037//0022-3514.80.2.173; Fast NJ, 2009, PSYCHOL SCI, V20, P502, DOI 10.1111/j.1467-9280.2009.02311.x; Fiske A.P., 1991, STRUCTURES SOCIAL LI; FISKE ST, 1993, AM PSYCHOL, V48, P621, DOI 10.1037/0003-066X.48.6.621; Fiske ST, 2010, HDB SOCIAL PSYCHOL, P1; French J. R. P., 1959, STUDIES SOCIAL POWER, P150; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Guinote A., 2010, SOCIAL PSYCHOL POWER, P141; Guinote A, 2007, EUR REV SOC PSYCHOL, V18, P256, DOI 10.1080/10463280701692813; Guinote A, 2007, J EXP SOC PSYCHOL, V43, P685, DOI 10.1016/j.jesp.2006.06.008; Guinote A, 2007, J EXP SOC PSYCHOL, V43, P433, DOI 10.1016/j.jesp.2006.03.003; Gwinn JD, 2013, J EXP SOC PSYCHOL, V49, P464, DOI 10.1016/j.jesp.2013.01.005; Haslam N, 2005, J PERS SOC PSYCHOL, V89, P937, DOI 10.1037/0022-3514.89.6.937; Haslam N, 2008, EUR REV SOC PSYCHOL, V19, P55, DOI 10.1080/10463280801981645; Haslam N, 2007, PERS SOC PSYCHOL B, V33, P57, DOI 10.1177/0146167206293191; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Inesi ME, 2012, J EXP SOC PSYCHOL, V48, P795, DOI 10.1016/j.jesp.2012.01.008; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Kemeny ME, 2004, PSYCHOL INQ, V15, P153; Kenny D. A, 1994, INTERPERSONAL PERCEP; KENNY DA, 1993, PSYCHOL BULL, V114, P145, DOI 10.1037/0033-2909.114.1.145; Kentle RL, 1991, BIG 5 INVENTORY; Koval P, 2012, PERS SOC PSYCHOL B, V38, P283, DOI 10.1177/0146167211423777; Kozak MN, 2006, J PERS SOC PSYCHOL, V90, P543, DOI 10.1037/0022-3514.90.4.543; Kraus MW, 2011, J EXP SOC PSYCHOL, V47, P974, DOI 10.1016/j.jesp.2011.03.017; Lammers J, 2008, PSYCHOL SCI, V19, P558, DOI 10.1111/j.1467-9280.2008.02123.x; Lammers J, 2011, GROUP PROCESS INTERG, V14, P113, DOI 10.1177/1368430210370042; Leyens JP, 2000, PERS SOC PSYCHOL REV, V4, P186, DOI 10.1207/S15327957PSPR0402_06; Leyens JP, 2001, EUR J SOC PSYCHOL, V31, P395, DOI 10.1002/ejsp.50; Lindner EG, 2004, PSYCHOHISTORIE POLIT, P143; Loughnan S, 2007, PSYCHOL SCI, V18, P116, DOI 10.1111/j.1467-9280.2007.01858.x; Overbeck JR, 2006, ORGAN BEHAV HUM DEC, V99, P227, DOI 10.1016/j.obhdp.2005.10.003; Park J, 2012, J CROSS CULT PSYCHOL, V43, P774, DOI 10.1177/0022022111414417; Richeson JA, 2003, PSYCHOL SCI, V14, P287, DOI 10.1111/1467-9280.03437; Rucker DD, 2012, J CONSUM PSYCHOL, V22, P352, DOI 10.1016/j.jcps.2011.06.001; Rus D, 2012, LEADERSHIP QUART, V23, P13, DOI 10.1016/j.leaqua.2011.11.002; SCHEIER MF, 1983, J EXP SOC PSYCHOL, V19, P205, DOI 10.1016/0022-1031(83)90038-0; Schuh SC, 2014, J BUS ETHICS, V120, P363, DOI 10.1007/s10551-013-1663-9; Sidanius J., 2001, SOCIAL DOMINANCE INT; Skinner E. A., 1995, PERCEIVED CONTROL MO; Sligte DJ, 2011, J EXP SOC PSYCHOL, V47, P891, DOI 10.1016/j.jesp.2011.03.009; Smith PK, 2008, PSYCHOL SCI, V19, P441, DOI 10.1111/j.1467-9280.2008.02107.x; Smith PK, 2008, SOC COGNITION, V26, P1, DOI 10.1521/soco.2008.26.1.1; Smith PK, 2010, SOC PERSONAL PSYCHOL, V4, P918, DOI 10.1111/j.1751-9004.2010.00300.x; Tangney JP, 1996, J PERS SOC PSYCHOL, V70, P1256, DOI 10.1037/0022-3514.70.6.1256; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Willis GB, 2010, SPAN J PSYCHOL, V13, P777, DOI 10.1017/S1138741600002432; Willis GB, 2010, J EXP SOC PSYCHOL, V46, P416, DOI 10.1016/j.jesp.2009.10.009	59	28	30	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0125721	10.1371/journal.pone.0125721	http://dx.doi.org/10.1371/journal.pone.0125721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0SC	26020267	Green Published, gold, Green Submitted			2022-12-27	WOS:000355187300016
J	Kaur, H; Allan, EL; Mamadu, I; Hall, Z; Ibe, O; El Sherbiny, M; van Wyk, A; Yeung, S; Swamidoss, I; Green, MD; Dwivedi, P; Culzoni, MJ; Clarke, S; Schellenberg, D; Fernandez, FM; Onwujekwe, O				Kaur, Harparkash; Allan, Elizabeth Louise; Mamadu, Ibrahim; Hall, Zoe; Ibe, Ogochukwu; El Sherbiny, Mohamed; van Wyk, Albert; Yeung, Shunmay; Swamidoss, Isabel; Green, Michael D.; Dwivedi, Prabha; Julia Culzoni, Maria; Clarke, Sian; Schellenberg, David; Fernandez, Facundo M.; Onwujekwe, Obinna			Quality of Artemisinin-Based Combination Formulations for Malaria Treatment: Prevalence and Risk Factors for Poor Quality Medicines in Public Facilities and Private Sector Drug Outlets in Enugu, Nigeria	PLOS ONE			English	Article							ANTIMALARIAL-DRUGS	Background Artemisinin-based combination therapies are recommended by the World Health Organisation (WHO) as first-line treatment for Plasmodium falciparum malaria, yet medication must be of good quality for efficacious treatment. A recent meta-analysis reported 35% (796/2, 296) of antimalarial drug samples from 21 Sub-Saharan African countries, purchased from outlets predominantly using convenience sampling, failed chemical content analysis. We used three sampling strategies to purchase artemisinin-containing antimalarials (ACAs) in Enugu metropolis, Nigeria, and compared the resulting quality estimates. Methods ACAs were purchased using three sampling approaches - convenience, mystery clients and overt, within a defined area and sampling frame in Enugu metropolis. The active pharmaceutical ingredients were assessed using high-performance liquid chromatography and confirmed by mass spectrometry at three independent laboratories. Results were expressed as percentage of APIs stated on the packaging and used to categorise each sample as acceptable quality, substandard, degraded, or falsified. Results Content analysis of 3024 samples purchased from 421 outlets using convenience (n=200), mystery (n=1,919) and overt (n=905) approaches, showed overall 90.8% ACAs to be of acceptable quality, 6.8% substandard, 1.3% degraded and 1.2% falsified. Convenience sampling yielded a significantly higher prevalence of poor quality ACAs, but was not evident by the mystery and overt sampling strategies both of which yielded results that were comparable between each other. Artesunate (n=135; 4 falsified) and dihydroartemisinin (n=14) monotherapy tablets, not recommended by WHO, were also identified. Conclusion Randomised sampling identified fewer falsified ACAs than previously reported by convenience approaches. Our findings emphasise the need for specific consideration to be given to sampling frame and sampling approach if representative information on drug quality is to be obtained.	[Kaur, Harparkash; Allan, Elizabeth Louise; Hall, Zoe; van Wyk, Albert; Yeung, Shunmay] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Mamadu, Ibrahim; El Sherbiny, Mohamed; Yeung, Shunmay] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Ibe, Ogochukwu; Onwujekwe, Obinna] Univ Nigeria, Dept Pharmacol & Therapeut, Enugu, Nigeria; [Swamidoss, Isabel; Green, Michael D.] US Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA; [Dwivedi, Prabha] Ctr Dis Control & Prevent, Atlanta, GA USA; [Julia Culzoni, Maria] Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, Santa Fe, Argentina; [Julia Culzoni, Maria] Consejo Nacl Invest Cient & Tecn, Santa Fe, Argentina; [Clarke, Sian; Schellenberg, David] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Fernandez, Facundo M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Nigeria; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National University of the Littoral; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of London; London School of Hygiene & Tropical Medicine; University System of Georgia; Georgia Institute of Technology	Kaur, H (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, Keppel St, London WC1, England.	harparkash.kaur@lshtm.ac.uk	Fernandez, Facundo Martin/B-7015-2008; Onwujekwe, Obinna/O-6232-2014; Clarke, Sian/AAF-5805-2019	Fernandez, Facundo Martin/0000-0002-0302-2534; Onwujekwe, Obinna/0000-0002-1214-4285; Yeung, Shunmay/0000-0002-0997-0850; Schellenberg, David/0000-0001-8222-0186; Hall, Zoe/0000-0002-1434-8329; Dwivedi, Prabha/0000-0002-6435-2166	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The authors are grateful to the Artemisinin Combination Therapy consortium via an award from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous P, 2005, NATURE, V434, P132, DOI 10.1038/434132a; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Blessy M, 2014, J Pharm Anal, V4, P159, DOI 10.1016/j.jpha.2013.09.003; Chaccour CJ, 2012, LANCET, V380; Culzoni MJ, 2014, MEDCHEMCOMM, V5, P9, DOI 10.1039/c3md00235g; Faucon B, 2013, WALL STREET J; Federal Ministry of Health National Malaria Control Programme Abuja Nigeria, 2009, AB NIG STRAT PLAN 20; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Malaria Operational Plan Nigeria, 2013, MAL OP PLAN NIG; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Monge ME, 2013, CHEM REV, V113, P2269, DOI 10.1021/cr300309q; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Newton P, 2001, LANCET, V357, P1948, DOI 10.1016/S0140-6736(00)05085-6; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2014, LANCET GLOB HEALTH, V2, pE509, DOI 10.1016/S2214-109X(14)70279-7; Newton PN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001139; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Phanouvong S., 2005, 7 INT C AIDS AS PAC; Roberts M, 2012, 3 MALARIA DRUGS FAKE; Rozendaal J, 2001, LANCET, V357, P890, DOI 10.1016/S0140-6736(05)71830-4; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; United States Pharmacopeia, 2001, GUID SAMPL ANT DRUG	25	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125577	10.1371/journal.pone.0125577	http://dx.doi.org/10.1371/journal.pone.0125577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26018221	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000355185600029
J	Machado, MV; Michelotti, GA; Xie, GH; de Almeida, TP; Boursier, J; Bohnic, B; Guy, CD; Diehl, AM				Machado, Mariana Verdelho; Michelotti, Gregory Alexander; Xie, Guanhua; de Almeida, Thiago Pereira; Boursier, Jerome; Bohnic, Brittany; Guy, Cynthia D.; Diehl, Anna Mae			Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; CHOLINE-DEFICIENT DIET; INSULIN-RESISTANCE; VITAMIN-E; FIBROSIS; MICE; SEVERITY; HEDGEHOG; INJURY	Background and aims Non-alcoholic steatohepatitis (NASH), the potentially progressive form of nonalcoholic fatty liver disease (NAFLD), is the pandemic liver disease of our time. Although there are several animal models of NASH, consensus regarding the optimal model is lacking. We aimed to compare features of NASH in the two most widely-used mouse models: methionine-choline deficient (MCD) diet and Western diet. Methods Mice were fed standard chow, MCD diet for 8 weeks, or Western diet (45% energy from fat, predominantly saturated fat, with 0.2% cholesterol, plus drinking water supplemented with fructose and glucose) for 16 weeks. Liver pathology and metabolic profile were compared. Results The metabolic profile associated with human NASH was better mimicked by Western diet. Although hepatic steatosis (i.e., triglyceride accumulation) was also more severe, liver nonesterified fatty acid content was lower than in the MCD diet group. NASH was also less severe and less reproducible in the Western diet model, as evidenced by less liver cell death/apoptosis, inflammation, ductular reaction, and fibrosis. Various mechanisms implicated in human NASH pathogenesis/progression were also less robust in the Western diet model, including oxidative stress, ER stress, autophagy deregulation, and hedgehog pathway activation. Conclusion Feeding mice a Western diet models metabolic perturbations that are common in humans with mild NASH, whereas administration of a MCD diet better models the pathobiological mechanisms that cause human NAFLD to progress to advanced NASH.	[Machado, Mariana Verdelho; Michelotti, Gregory Alexander; Xie, Guanhua; de Almeida, Thiago Pereira; Boursier, Jerome; Diehl, Anna Mae] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Machado, Mariana Verdelho] Hosp Santa Maria, CHLN, Dept Gastroenterol, Lisbon, Portugal; [Bohnic, Brittany] Duke Univ, Med Ctr, Div Endocrinol, Durham, NC 27710 USA; [Guy, Cynthia D.] Duke Univ, Med Ctr, Div Pathol, Durham, NC 27710 USA	Duke University; Universidade de Lisboa; Hospital Santa Maria; Duke University; Duke University	Diehl, AM (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA.	diehl004@mc.duke.edu		de Almeida Pereira, Thiago/0000-0002-8755-0683; , Gregory/0000-0002-3936-4675	NIH [DK0077794, DK053792]; Duke Endowment: The Florence McAlister Professorship; Fundacao para a Ciencia e Tecnologia, FCT, Portugal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK053792, R01DK053792, R01DK077794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke Endowment: The Florence McAlister Professorship; Fundacao para a Ciencia e Tecnologia, FCT, Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research is supported by NIH DK0077794 and DK053792 (Diehl AM), and Duke Endowment: The Florence McAlister Professorship (Diehl AM). MVM received a PhD grant from Fundacao para a Ciencia e Tecnologia, FCT, Portugal. The funders had no role in study design, dara collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri N, 2014, DIGEST DIS SCI, V59, P1617, DOI 10.1007/s10620-014-3031-8; Asai A, 2014, AM J PHYSIOL-GASTR L, V306, pG496, DOI 10.1152/ajpgi.00291.2013; Athyros VG, 2010, LANCET, V376, P1916, DOI 10.1016/S0140-6736(10)61272-X; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Choi SS, 2006, HEPATOLOGY, V44, P1267, DOI 10.1002/hep.21375; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fleig SV, 2007, LAB INVEST, V87, P1227, DOI 10.1038/labinvest.3700689; Gonzalez-Rodriguez A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.162; Guy CD, 2012, HEPATOLOGY, V55, P1711, DOI 10.1002/hep.25559; Hardwick RN, 2010, DRUG METAB DISPOS, V38, P2293, DOI 10.1124/dmd.110.035006; Henkel A, 2013, SEMIN LIVER DIS, V33, P321, DOI 10.1055/s-0033-1358522; Hirsova P, 2015, HEPATOLOGY, V61, P15, DOI 10.1002/hep.27279; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P109, DOI 10.1097/MPG.0b013e31820e82a1; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Jha P, 2014, BBA-MOL BASIS DIS, V1842, P959, DOI 10.1016/j.bbadis.2014.02.012; Kashima J, 2014, HEPATOL RES, V44, P779, DOI 10.1111/hepr.12183; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Krawczyk M, 2013, SEMIN LIVER DIS, V33, P369, DOI 10.1055/s-0033-1358525; Lake AD, 2014, TOXICOL SCI, V137, P26, DOI 10.1093/toxsci/kft230; Larter CZ, 2008, J HEPATOL, V49, P407, DOI 10.1016/j.jhep.2008.03.026; Leclercq IA, 2007, LAB INVEST, V87, P56, DOI 10.1038/labinvest.3700489; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Machado MV, 2014, WORLD J GASTROENTERO, V20, P12956, DOI 10.3748/wjg.v20.i36.12956; Machado MV, 2014, GUT; Mells JE, 2012, AM J PHYSIOL-GASTR L, V302, pG225, DOI 10.1152/ajpgi.00274.2011; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Murphy SK, 2013, GASTROENTEROLOGY, V145, P1076, DOI 10.1053/j.gastro.2013.07.047; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oz HS, 2008, DIGEST DIS SCI, V53, P767, DOI 10.1007/s10620-007-9900-7; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5834; Purnell JQ, 2013, JAMA-J AM MED ASSOC, V309, P85, DOI 10.1001/jama.2012.190505; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Samra R.A., 2010, FAT DETECTION TASTE; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schattenberg JRM, 2005, J BIOL CHEM, V280, P9887, DOI 10.1074/jbc.M410310200; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Sreekumar R, 2003, HEPATOLOGY, V38, P244, DOI 10.1053/jhep.2003.50290; Syn WK, 2009, GASTROENTEROLOGY, V137, P1478, DOI 10.1053/j.gastro.2009.06.051; Ucar F, 2013, REDOX REP, V18, P127, DOI 10.1179/1351000213Y.0000000050; Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986; Wortham M, 2008, DIGEST DIS SCI, V53, P2761, DOI 10.1007/s10620-007-0193-7; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893	46	216	225	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127991	10.1371/journal.pone.0127991	http://dx.doi.org/10.1371/journal.pone.0127991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017539	Green Published, gold			2022-12-27	WOS:000355185600105
J	McKerr, C; Adak, GK; Nichols, G; Gorton, R; Chalmers, RM; Kafatos, G; Cosford, P; Charlett, A; Reacher, M; Pollock, KG; Alexander, CL; Morton, S				McKerr, Caoimhe; Adak, Goutam K.; Nichols, Gordon; Gorton, Russell; Chalmers, Rachel M.; Kafatos, George; Cosford, Paul; Charlett, Andre; Reacher, Mark; Pollock, Kevin G.; Alexander, Claire L.; Morton, Stephen			An Outbreak of Cryptosporidium parvum across England & Scotland Associated with Consumption of Fresh Pre-Cut Salad Leaves, May 2012	PLOS ONE			English	Article							FOOD	Background We report a widespread foodborne outbreak of Cryptosporidium parvum in England and Scotland in May 2012. Cases were more common in female adults, and had no history of foreign travel. Over 300 excess cases were identified during the period of the outbreak. Speciation and microbiological typing revealed the outbreak strain to be C. parvum gp60 subtype IIaA15G2R1. Methods Hypothesis generation questionnaires were administered and an unmatched case control study was undertaken to test the hypotheses raised. Cases and controls were interviewed by telephone. Controls were selected using sequential digit dialling. Information was gathered on demographics, foods consumed and retailers where foods were purchased. Results Seventy-four laboratory confirmed cases and 74 controls were included in analyses. Infection was found to be strongly associated with the consumption of pre-cut mixed salad leaves sold by a single retailer. This is the largest documented outbreak of cryptosporidiosis attributed to a food vehicle.	[McKerr, Caoimhe; Gorton, Russell; Reacher, Mark] Publ Hlth England, Field Epidemiol Serv, London, England; [Adak, Goutam K.; Nichols, Gordon] Publ Hlth England, Dept Gastrointestinal Emerging & Zoonot Infect, London, England; [Chalmers, Rachel M.] Publ Hlth Wales, Cryptosporidium Reference Unit, Swansea, W Glam, Wales; [Kafatos, George; Charlett, Andre] Publ Hlth England, Stat Modelling & Econ Dept, London, England; [Cosford, Paul] Publ Hlth England, London, England; [Pollock, Kevin G.; Alexander, Claire L.] Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Morton, Stephen] Publ Hlth England Ctr, Yorkshire Humber, England; [McKerr, Caoimhe] Publ Hlth England, Field Epidemiol Training Programme, London, England; [Nichols, Gordon] Univ E Anglia, Norwich Med Sch, Norwich, England; [Nichols, Gordon] Univ Thessaly, Fac Med, Larisa, Greece; [Nichols, Gordon] Univ Exeter, European Ctr Environm & Human Hlth, Exeter, Devon, England	Public Health England; Public Health England; Public Health England; Public Health England; Public Health England; University of East Anglia; University of Thessaly; University of Exeter	Morton, S (corresponding author), Publ Hlth England Ctr, Yorkshire Humber, England.	stephen.morton@phe.gov.uk	Reacher, Mark/Y-6979-2018; Nichols, Gordon L./J-1114-2014	Reacher, Mark/0000-0001-6871-7903; Nichols, Gordon L./0000-0003-0773-9556; Kafatos, George/0000-0001-7871-9216; Morton, William Stephen/0000-0001-7122-0201				Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Amoros I, 2012, J FOOD PROTECT, V73, P1138; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; CASEMORE DP, 1990, EPIDEMIOL INFECT, V104, P1, DOI 10.1017/S0950268800054480; Cleary P, 2010, EURO SURVEILL, V15, P19732; Doherty L, 1997, Commun Dis Rep CDR Rev, V7, pR73; Ethelberg S, 2009, EPIDEMIOL INFECT, V137, P348, DOI 10.1017/S0950268808001817; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; Insulander M, 2008, Euro Surveill, V13; Irvine WN, 2009, EPIDEMIOL INFECT, V137, P1449, DOI 10.1017/S0950268809002416; Lake Iain R., 2005, Journal of Water and Health, V3, P469; Macarisin D, 2010, APPL ENVIRON MICROB, V76, P555, DOI 10.1128/AEM.02118-09; Mota A, 2009, J FOOD PROTECT, V72, P2184, DOI 10.4315/0362-028X-72.10.2184; Nichols GL., 2014, CRYPTOSPORIDIUM PARA, P81; Nygard K, 2008, FOODBORNE PATHOG DIS, V5, P165, DOI 10.1089/fpd.2007.0053; Ponka A, 2009, EUROSURVEILLANCE, V14, P8; Quiroz ES, 2000, J INFECT DIS, V181, P695, DOI 10.1086/315279; Robertson L J, 2003, TRENDS PARASITOL, V1, P39; Slayton RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055300; Smith A, 2006, EPIDEMIOL INFECT, V134, P1141, DOI 10.1017/S0950268806006406; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Wall PG, 1996, CDR REV, V6, P93; Yoshida H, 2007, JPN J INFECT DIS, V60, P405	23	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125955	10.1371/journal.pone.0125955	http://dx.doi.org/10.1371/journal.pone.0125955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017538	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600045
J	Ayturk, DG; Castrucci, AM; Carr, DE; Keller, SR; Provencio, I				Aytuerk, Didem Goez; Castrucci, Ana Maria; Carr, David E.; Keller, Susanna R.; Provencio, Ignacio			Lack of Melanopsin Is Associated with Extreme Weight Loss in Mice upon Dietary Challenge	PLOS ONE			English	Article							GANGLION-CELLS; RD MOUSE; LIGHT; MELATONIN; GLYCOGEN; LIVER; GENE; FAT	Metabolic disorders have been established as major risk factors for ocular complications and poor vision. However, little is known about the inverse possibility that ocular disease may cause metabolic dysfunction. To test this hypothesis, we assessed the metabolic consequences of a robust dietary challenge in several mouse models suffering from retinal mutations. To this end, mice null for melanopsin (Opn4(-/-)), the photopigment of intrinsically photosensitive retinal ganglion cells (ipRGCs), were subjected to five weeks of a ketogenic diet. These mice lost significantly more weight than wild-type controls or mice lacking rod and cone photoreceptors (Pde6b(rd1/rd1)). Although ipRGCs are critical for proper circadian entrainment, and circadian misalignment has been implicated in metabolic pathology, we observed no differences in entrainment between Opn4(-/-) and control mice. Additionally, we observed no differences in any tested metabolic parameter between these mouse strains. Further studies are required to establish the mechanism giving rise to this dramatic phenotype observed in melanopsin-null mice. We conclude that the causality between ocular disease and metabolic disorders merits further investigation due to the popularity of diets that rely on the induction of a ketogenic state. Our study is a first step toward understanding retinal pathology as a potential cause of metabolic dysfunction.	[Aytuerk, Didem Goez; Castrucci, Ana Maria; Provencio, Ignacio] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Carr, David E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Keller, Susanna R.] Univ Virginia, Sch Med, Dept Med, Div Endocrinol, Charlottesville, VA 22908 USA; [Castrucci, Ana Maria] Univ Sao Paulo, Dept Fisiol, Sao Paulo, Brazil	University of Virginia; University of Virginia; University of Virginia; Universidade de Sao Paulo	Provencio, I (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.	ip7m@virginia.edu		Provencio, Ignacio/0000-0003-1175-920X; Castrucci, Ana Maria/0000-0002-2065-8198; Keller, Susanna/0000-0002-3089-7766	National Institutes of Health [R01 NS052112]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a National Institutes of Health (R01 NS052112) and a gift of the Owens Family Foundation to IP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcouwer SF, 2014, ANN NY ACAD SCI, V1311, P174, DOI 10.1111/nyas.12412; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; BOWES C, 1989, P NATL ACAD SCI USA, V86, P9722, DOI 10.1073/pnas.86.24.9722; Cajochen C, 2005, J CLIN ENDOCR METAB, V90, P1311, DOI 10.1210/jc.2004-0957; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Izumida Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3316; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kirkby LA, 2013, P NATL ACAD SCI USA, V110, P12090, DOI 10.1073/pnas.1222150110; KLEIN DC, 1971, P NATL ACAD SCI USA, V68, P3107, DOI 10.1073/pnas.68.12.3107; Kreitzman SN, 1992, THE AMERICAN JOURNAL, V56, p292S; Lingappa JR, 2013, J NEUROSCI, V33, P4867, DOI 10.1523/JNEUROSCI.3829-12.2013; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MacKay EM, 1932, J BIOL CHEM, V96, P373; Maury E, 2014, DIABETES METAB, V40, P338, DOI 10.1016/j.diabet.2013.12.005; Neuhuber W, 2011, AUTON NEUROSCI-BASIC, V165, P67, DOI 10.1016/j.autneu.2010.10.004; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Rao S, 2013, NATURE, V494, P243, DOI 10.1038/nature11823; Renna JM, 2011, NAT NEUROSCI, V14, P827, DOI 10.1038/nn.2845; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127031	10.1371/journal.pone.0127031	http://dx.doi.org/10.1371/journal.pone.0127031			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011287	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900057
J	Bassetti, M; Merelli, M; Ansaldi, F; de Florentiis, D; Sartor, A; Scarparo, C; Callegari, A; Righi, E				Bassetti, Matteo; Merelli, Maria; Ansaldi, Filippo; de Florentiis, Daniela; Sartor, Assunta; Scarparo, Claudio; Callegari, Astrid; Righi, Elda			Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; ANTIFUNGAL SUSCEPTIBILITY; NOSOCOMIAL CANDIDEMIA; SPECIES DISTRIBUTION; SEPTIC SHOCK; EPIDEMIOLOGY; MORTALITY; FLUCONAZOLE; INFECTION; TRENDS	Background Candida is an important cause of bloodstream infections (BSI) in nosocomial settings causing significant mortality and morbidity. This study was performed to evaluate contemporary epidemiology, species distribution, antifungal susceptibility and outcome of candida BSI in an Italian hospital. Methods All consecutive patients who developed candidemia at Santa Maria della Misericordia University Hospital (Italy) between January 2009 and June 2014 were enrolled in the study. Results A total of 204 episodes of candidemia were identified during the study period with an incidence of 0.79 episodes/1000 admissions. C. albicans was isolated in 60.3% of cases, followed by C. parapsilosis (16.7%), C. glabrata (11.8%) and C. tropicalis (6.4%). Of all Candida BSI, 124 (60.8 %) occurred in patients admitted to IMW, 31/204 (15.2 %) in ICUs, 33/204 (16.2%) in surgical units and 16/204 (7.8%) in Hematology/Oncology wards. Overall, 47% of patients died within 30 days from the onset of candidemia. C. parapsilosis and C. glabrata candidemia were associated with the lowest mortality rate (36%), while patients with C. tropicalis BSI had the highest mortality rate (58.3%). Lower mortality rates were detected in patients receiving therapy within 48 hours from the time of execution of the blood cultures (57,1% vs 38,9%, P < 0.05). At multivariate analysis, steroids treatment (OR=0.27, p=0.005) and CVC removal (OR=3.77, p=0.014) were independently associated with lower and higher survival probability, respectively. Candidemia in patients with peripherally inserted central catheters (PICC) showed to be associated with higher mortality in comparison with central venous catheters (CVC, Short catheters and Portacath) and no CVC use. For each point increase of APACHE III score, survival probability decreased of 2%. Caspofungin (OR=3.45, p=0.015) and Amphothericin B lipid formulation (OR=15.26, p=0.033) were independently associated with higher survival probability compared with no treatment.	[Bassetti, Matteo; Merelli, Maria; Callegari, Astrid; Righi, Elda] Santa Maria Misericordia Univ Hosp, Div Infect Dis, Udine, Italy; [Ansaldi, Filippo] Univ Genoa, Dept Hlth Sci, IRCCS San Martino IST, Genoa, Italy; [de Florentiis, Daniela] USMAF, Minist Hlth, Genoa, Italy; [Scarparo, Claudio] Santa Maria Misericordia Univ Hosp, Microbiol Unit, Udine, Italy	Hospital Santa Maria della Misericordia; University of Genoa; IRCCS AOU San Martino IST; Hospital Santa Maria della Misericordia	Bassetti, M (corresponding author), Azienda Osped Univ Santa Maria Misericordia, Clin Malattie Infett, Udine, Italy.	mattba@tin.it	Righi, Elda/Y-3558-2019; Merelli, Maria/AAC-7748-2022; Bassetti, Matteo/L-3081-2019; Sartor, Assunta/ADI-1177-2022	Righi, Elda/0000-0001-8718-1200; Merelli, Maria/0000-0003-3907-5264; 	Pfizer Inc.; MSD; Gilead Sciences; Teva Inc.; Astellas Pharma Inc.	Pfizer Inc.(Pfizer); MSD; Gilead Sciences(Gilead Sciences); Teva Inc.; Astellas Pharma Inc.(Astellas Pharmaceuticals)	MB serves on scientific advisory boards for Pfizer Inc, MSD, and Astellas Pharma Inc.; has received funding for travel or speaker honoraria from Pfizer Inc., MSD, Gilead Sciences, Teva Inc., and Astellas Pharma Inc. The other authors have declared that no competing interests exist.	Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Bassetti M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-21; Bassetti M, 2013, CLIN MICROBIOL INFEC, V19, pE281, DOI 10.1111/1469-0691.12155; Bassetti M, 2007, DIAGN MICROBIOL INFE, V58, P3; Bassetti M, 2014, INTENS CARE MED, V40, P839, DOI 10.1007/s00134-014-3310-z; Bassetti M, 2013, J CLIN MICROBIOL, V51, P4167, DOI 10.1128/JCM.01998-13; Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Blyth CC, 2009, PEDIATRICS, V123, P1360, DOI 10.1542/peds.2008-2055; Bouza E, 2008, INT J ANTIMICROB AG, V32, pS87, DOI 10.1016/S0924-8579(08)70006-2; Chitnis AS, 2012, PEDIATRICS, V130, pE46, DOI 10.1542/peds.2011-3620; Clinical and Laboratory Standards Institute, 2011, M27S4 CLSI; Colombo AL, 2014, INTENS CARE MED, V40, P1489, DOI 10.1007/s00134-014-3400-y; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Dominic RM, 2007, K U MED J KUMJ, V5, P19; European Committee on Antimicrobial Susceptibility test, 2011, ANT CAND INF EUCAST; European Committee on Antimicrobial Susceptibility test, 2013, ANT CAND INF EUCAST; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Garnacho-Montero J, 2013, J ANTIMICROB CHEMOTH, V68, P206, DOI 10.1093/jac/dks347; Girao E, 2008, MED MYCOL, V46, P581, DOI 10.1080/13693780802004996; Han DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107371; Kett DH, 2011, CRIT CARE MED, V39, P665, DOI 10.1097/CCM.0b013e318206c1ca; Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305; Lortholary O, 2014, INTENS CARE MED, V40, P1303, DOI 10.1007/s00134-014-3408-3; Luzzati R, 2014, AGING CLIN EXP RES; Ma CF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-337; Magill SS, 2014, NEW ENGL J MED, V370, P2542, DOI 10.1056/NEJMc1405194; Marchetti O, 2004, CLIN INFECT DIS, V38, P311, DOI 10.1086/380637; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Montagna MT, 2014, EUR REV MED PHARMACO, V18, P661; Montravers P, 2013, INTENS CARE MED, V39, P2226, DOI 10.1007/s00134-013-3134-2; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Pagano L, 2006, HAEMATOLOGICA, V91, P1068; Pfaller MA, 1996, CLIN INFECT DIS, V22, pS89, DOI 10.1093/clinids/22.Supplement_2.S89; Pfaller MA, 2008, J CLIN MICROBIOL, V4; Slavin MA, 2010, J ANTIMICROB CHEMOTH, V65, P1042, DOI 10.1093/jac/dkq053; Stratman RC, 2010, NUTR CLIN PRACT, V25, P282, DOI 10.1177/0884533610368704; Tortorano AM, 2013, INFECTION, V41, P655, DOI 10.1007/s15010-013-0455-6; Tortorano AM, 2006, INT J ANTIMICROB AG, V27, P359, DOI 10.1016/j.ijantimicag.2006.01.002; Vincent JL, 1998, INTENS CARE MED, V24, P206, DOI 10.1007/s001340050552; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wu ZB, 2014, INT J INFECT DIS, V22, P4, DOI 10.1016/j.ijid.2013.11.011	41	77	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127534	10.1371/journal.pone.0127534	http://dx.doi.org/10.1371/journal.pone.0127534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010361	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900106
J	Liu, J; Qu, B; Zhu, YX; Hu, BX				Liu, Jie; Qu, Bo; Zhu, Yaxin; Hu, Bingxue			The Influence of Social Support on Quality of Life of Men Who Have Sex with Men in China: A Preliminary Study	PLOS ONE			English	Article							STRUCTURAL EQUATION MODEL; GAY MEN; HIV; HEALTH; DEPRESSION; WOMEN; STIGMA; EXPERIENCES; CHALLENGES; SYPHILIS	The quality of life (QOL) of men who have sex with men (MSM) has received increasing attention in recent years. Our study surveyed the QOL and explored the influence of social support on QOL in Chinese MSM. A cross-sectional survey was conducted from September 2013 to March 2014 of 438 MSM in Huludao and Zhengzhou City, China. The results of univariate analysis showed that higher QOL scores were associated with receiving psychosocial counseling, higher health education, younger age and marital status of being single or unmarried p < 0.05). The structural equation model fitted well, with chi(2) = 2083.47 (p < 0.05), RMSEA = 0.07, and GFI = 0.88. Among the latent factors, social support, with a factor load of 0.47, had greater impact on QOL than demographic characteristics. Within social support, the item loads for psychosocial counseling and health education were 0.17 and 0.29, respectively. Basic demographic characteristics also influenced social support, with a factor load of -0.65. For demographic characteristics, the greatest item loads were for marital status and age (0.77 and 0.71, respectively). These findings suggest that strengthening social support, especially for older and married individuals, would improve QOL in MSM in China.	[Liu, Jie; Qu, Bo; Zhu, Yaxin; Hu, Bingxue] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Qu, B (corresponding author), China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang 110001, Liaoning, Peoples R China.	qubo6666@163.com			National Natural Science Foundation of China [81273186, 71473269]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Number 81273186 and 71473269). BQ received the funding.	Asante KO, 2013, AFR HEALTH SCI, V13, P270, DOI 10.4314/ahs.v13i2.11; Baker SR, 2007, QUAL LIFE RES, V16, P297, DOI 10.1007/s11136-006-9108-x; Bastardo YM, 2000, AIDS CARE, V12, P673, DOI 10.1080/095401200750003842; Bouhnik AD, 2006, JAIDS-J ACQ IMM DEF, V42, P597, DOI 10.1097/01.qai.0000221674.76327.d7; Bucciardini R, 2014, HIV CLIN TRIALS, V15, P176, DOI 10.1310/hct1504-176; Cao Z, 2014, SEX TRANSM DIS, V41, P98, DOI 10.1097/OLQ.0000000000000074; Chirawu P, 2010, AIDS CARE, V22, P81, DOI 10.1080/09540120903012577; Chow EPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089959; Chow EPF, 2013, SEX HEALTH, V10, P533, DOI 10.1071/SH13097; Darbes LA, 2012, AIDS BEHAV, V16, P159, DOI 10.1007/s10461-010-9868-8; Deuba K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058099; Eriksson LE, 2007, INT J STD AIDS, V18, P207, DOI 10.1258/095646207780132442; Feng MC, 2009, AIDS CARE, V21, P482, DOI 10.1080/09540120802290373; Fueki K, 2011, J ORAL REHABIL, V38, P86, DOI 10.1111/j.1365-2842.2010.02134.x; Gallicchio L, 2007, QUAL LIFE RES, V16, P777, DOI 10.1007/s11136-006-9162-4; Gielen AC, 2001, SOC SCI MED, V52, P315, DOI 10.1016/S0277-9536(00)00135-0; Gore-Felton C, 2006, J HEALTH PSYCHOL, V11, P711, DOI 10.1177/1359105306066626; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Hoover KW, 2010, SEX TRANSM DIS, V37, P771, DOI 10.1097/OLQ.0b013e3181e50058; Huang ZJ, 2012, AIDS BEHAV, V16, P858, DOI 10.1007/s10461-011-0119-4; Lari MA, 2013, IRAN J PSYCHIATRY BE, V7, P61; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li YZ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-531; Mavandadi S, 2009, JAIDS-J ACQ IMM DEF, V51, P91, DOI 10.1097/QAI.0b013e318199069b; Mazaheri M, 2012, IRAN J PSYCHIATRY, V5, P134; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Mohamed BA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/971203; Munoz M, 2011, PSYCHIAT RES, V186, P402, DOI 10.1016/j.psychres.2010.06.019; Ou FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038861; Rao D, 2012, INT J STD AIDS, V23, P481, DOI 10.1258/ijsa.2009.009428; Razavi P, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/849406; Safren SA, 2011, AIDS BEHAV, V15, pS30, DOI 10.1007/s10461-011-9898-x; Sandfort TGM, 2003, ARCH SEX BEHAV, V32, P15, DOI 10.1023/A:1021885127560; Semple SJ, 2012, DRUG ALCOHOL DEPEN, V125, P154, DOI 10.1016/j.drugalcdep.2012.04.007; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; So WKW, 2013, EUR J ONCOL NURS, V17, P442, DOI 10.1016/j.ejon.2012.11.001; Srisurapanont M, 2001, AIDS PATIENT CARE ST, V15, P211, DOI 10.1089/10872910151133765; Stephenson R, 2014, AIDS CARE, V26, P191, DOI 10.1080/09540121.2013.808731; Sun W, 2014, INT J INFECT DIS, V28, P147, DOI 10.1016/j.ijid.2014.07.010; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239; Vyavaharkar M, 2011, AIDS EDUC PREV, V23, P78, DOI 10.1521/aeap.2011.23.1.78; Wang FTY, 2009, CULT HEALTH SEX, V11, P285, DOI 10.1080/13691050802572711; Wang Hsiu-Hung, 2003, Kaohsiung Journal of Medical Sciences, V19, P345, DOI 10.1016/S1607-551X(09)70436-X; Wong CF, 2014, PREV SCI, V15, P44, DOI 10.1007/s11121-012-0348-4; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098366; Wu Z, 2010, J ACQ IMMUN DEF SYND, V53, P1, DOI DOI 10.1097/QAI.0B013E3181C7D379; Yadav S, 2010, QUAL LIFE RES, V19, P157, DOI 10.1007/s11136-009-9574-z; Yamamura S, 2005, J PHARM PHARM SCI, V8, P544; Yang C, 2013, J COMMUNITY PSYCHOL, V41, P435, DOI 10.1002/jcop.21548; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058440, 10.1371/journal.pone.0066496]; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693	52	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127644	10.1371/journal.pone.0127644	http://dx.doi.org/10.1371/journal.pone.0127644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010133	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900124
J	Ross, E; Ata, R; Thavarajah, T; Medvedev, S; Bowden, P; Marshall, JG; Antonescu, CN				Ross, Eden; Ata, Rehman; Thavarajah, Thanusi; Medvedev, Sergei; Bowden, Peter; Marshall, John G.; Antonescu, Costin N.			AMP-Activated Protein Kinase Regulates the Cell Surface Proteome and Integrin Membrane Traffic	PLOS ONE			English	Article							CANCER-CELLS; LIQUID-CHROMATOGRAPHY; INDUCED GROWTH; GLUCOSE-UPTAKE; ENERGY SENSOR; ENDOCYTOSIS; MIGRATION; RECEPTOR; A-769662; METABOLISM	The cell surface proteome controls numerous cellular functions including cell migration and adhesion, intercellular communication and nutrient uptake. Cell surface proteins are controlled by acute changes in protein abundance at the plasma membrane through regulation of endocytosis and recycling (endomembrane traffic). Many cellular signals regulate endomembrane traffic, including metabolic signaling; however, the extent to which the cell surface proteome is controlled by acute regulation of endomembrane traffic under various conditions remains incompletely understood. AMP-activated protein kinase (AMPK) is a key metabolic sensor that is activated upon reduced cellular energy availability. AMPK activation alters the endomembrane traffic of a few specific proteins, as part of an adaptive response to increase energy intake and reduce energy expenditure. How increased AMPK activity during energy stress may globally regulate the cell surface proteome is not well understood. To study how AMPK may regulate the cell surface proteome, we used cell-impermeable biotinylation to selectively purify cell surface proteins under various conditions. Using ESI-MS/MS, we found that acute (90 min) treatment with the AMPK activator A-769662 elicits broad control of the cell surface abundance of diverse proteins. In particular, A-769662 treatment depleted from the cell surface proteins with functions in cell migration and adhesion. To complement our mass spectrometry results, we used other methods to show that A-769662 treatment results in impaired cell migration. Further, A-769662 treatment reduced the cell surface abundance of beta 1-integrin, a key cell migration protein, and AMPK gene silencing prevented this effect. While the control of the cell surface abundance of various proteins by A-769662 treatment was broad, it was also selective, as this treatment did not change the cell surface abundance of the transferrin receptor. Hence, the cell surface proteome is subject to acute regulation by treatment with A-769662, at least some of which is mediated by the metabolic sensor AMPK.	[Ross, Eden; Ata, Rehman; Thavarajah, Thanusi; Medvedev, Sergei; Bowden, Peter; Marshall, John G.; Antonescu, Costin N.] Ryerson Univ, Dept Biol & Chem, Toronto, ON M5B 2K3, Canada	Toronto Metropolitan University	Antonescu, CN (corresponding author), Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 2K3, Canada.	cantonescu@ryerson.ca	Marshall, John G/E-8974-2012	Marshall, John G/0000-0002-7124-1448; Antonescu, Costin/0000-0001-9192-6340	Ryerson University	Ryerson University	This work was supported by funding provided by Ryerson University to C.N.A. in the form of start-up funds and a Dean's Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Antonescu CN, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016964; Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Aoh QL, 2013, MOL BIOL CELL, V24, P832, DOI 10.1091/mbc.E12-10-0750; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Bergeron JJ, 2007, NAT BIOTECHNOL, V25, P61, DOI 10.1038/nbt0107-61; Binz PA, 2008, NAT BIOTECHNOL, V26, P862, DOI 10.1038/nbt0808-862; Bisi S, 2013, CURR OPIN CELL BIOL, V25, P565, DOI 10.1016/j.ceb.2013.04.001; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bowden P, 2012, J PROTEOME RES, V11, P2032, DOI 10.1021/pr2000013; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chen ZP, 2006, AM J RESP CELL MOL, V35, P127, DOI 10.1165/rcmb.2006-0044OC; Danzer C, 2012, J PROTEOME RES, V11, P1598, DOI 10.1021/pr2007895; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Ferla R, 2012, ONCOL LETT, V4, P1077, DOI 10.3892/ol.2012.843; Florentinus AK, 2012, J PROTEOMICS, V75, P1303, DOI 10.1016/j.jprot.2011.11.002; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Garcia-Garcia C, 2010, BIOCHEM PHARMACOL, V79, P853, DOI 10.1016/j.bcp.2009.10.022; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jankowski A, 2008, ANAL BIOCHEM, V380, P235, DOI 10.1016/j.ab.2008.05.047; Jinadasa T, 2014, J BIOL CHEM, V289, P20879, DOI 10.1074/jbc.M114.555284; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kaiser R, 2012, J CELL MOL MED, V16, P2387, DOI 10.1111/j.1582-4934.2012.01553.x; Kanellis J, 2006, IMMUNOL CELL BIOL, V84, P6, DOI 10.1111/j.1440-1711.2005.01388.x; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Klip A, 2009, ACTA PHYSIOL, V196, P27, DOI 10.1111/j.1748-1716.2009.01974.x; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Lee SK, 2013, ANAL BIOANAL CHEM, V405, P5501, DOI 10.1007/s00216-013-6969-z; Liang KW, 2008, EUR J PHARMACOL, V590, P343, DOI 10.1016/j.ejphar.2008.06.034; Liu XM, 2011, AM J PHYSIOL-HEART C, V300, pH84, DOI 10.1152/ajpheart.00749.2010; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; Moreno D, 2008, FEBS LETT, V582, P2650, DOI 10.1016/j.febslet.2008.06.044; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Niehage C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020399; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; PosthumaDeBoer J, 2013, BRIT J CANCER, V109, P2142, DOI 10.1038/bjc.2013.578; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Schiess R, 2009, MOL CELL PROTEOMICS, V8, P624, DOI 10.1074/mcp.M800172-MCP200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sing A, 2014, CELL, V158, P1293, DOI 10.1016/j.cell.2014.07.036; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhu PH, 2011, ANAL BIOCHEM, V409, P189, DOI 10.1016/j.ab.2010.10.027; Zhu YL, 2014, INT J MOL SCI, V15, P11190, DOI 10.3390/ijms150611190	81	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128013	10.1371/journal.pone.0128013	http://dx.doi.org/10.1371/journal.pone.0128013			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010094	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900183
J	Tyndale, RF; Zhu, AZX; George, TP; Cinciripini, P; Hawk, LW; Schnoll, RA; Swan, GE; Benowitz, NL; Heitjan, DF; Lerman, C				Tyndale, Rachel F.; Zhu, Andy Z. X.; George, Tony P.; Cinciripini, Paul; Hawk, Larry W., Jr.; Schnoll, Robert A.; Swan, Gary E.; Benowitz, Neal L.; Heitjan, Daniel F.; Lerman, Caryn		PGRN-PNAT Res Grp	Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; LUNG-CANCER; MOLECULAR-GENETICS; CHRNA5-CHRNA3-CHRNB4; CYP2A6; VARENICLINE; COTININE; AFRICAN; CLUSTER	CHRNA5-A3-B4 variants, rs16969968, rs588765 and rs578776, are consistently associated with tobacco consumption among smokers, but the association with smoking cessation is less consistent. Among the studies that reported significant associations with cessation, the effects were observed in smokers treated with placebo treatment in some studies and conversely in those receiving active pharmacological therapy (bupropion and nicotine replacement therapies) in others. Thus, it remains unclear whether CHRNA5-A3-B4 is a useful marker for optimizing smoking cessation. Using data from 654 Caucasian smokers treated with placebo, nicotine patch or varenicline, we investigated whether CHRNA5-A3-B4 variants were associated with smoking cessation outcomes, and whether there were significant genotype-by-treatment or haplotype-by-treatment interactions. We observed no significant associations between CHRNA5-A3-B4 variants and smoking cessation, despite replicating previous associations with baseline tobacco consumption. At end of treatment the effect size on smoking cessation in the placebo, patch and varenicline groups for rs16969968 [GG vs. GA+AA] was OR = 0.66 (P = 0.23), OR = 1.01 (P = 0.99), and OR = 1.30 (P = 0.36) respectively, of rs588765 [CC vs. CT+TT] was OR = 0.96 (P = 0.90), OR = 0.84 (P = 0.58), and OR = 0.74 (P = 0.29) respectively, and for rs578776 [GG vs. GA+ AA] on smoking cessation was OR = 1.02 (P = 0.95), OR = 0.75 (P = 0.35), and OR = 1.20 (P = 0.51) respectively. Furthermore, we observed no associations with cessation using the CHRNA5-A3-B4 haplotype (constructed using rs16969968 and rs588765), nor did we observe any significant genotype-by-treatment interactions, with or without adjusting for the rate of nicotine metabolism (all P>0.05). We also observed no significant genetic associations with 6 month or 12 month smoking abstinence. In conclusion, we found no association between CHRNA5-A3-B4 variants and smoking cessation rates in this clinical trial; however, as expected, significant associations with baseline tobacco consumption were replicated. Our data suggest that CHRNA5-A3-B4 gene variants do not exhibit a robust association with smoking cessation and are unlikely to be useful for clinically optimizing smoking cessation pharmacotherapy for Caucasian smokers.	[Tyndale, Rachel F.; George, Tony P.] Campbell Family Mental Hlth Res Inst, CAMH, Toronto, ON, Canada; [Tyndale, Rachel F.; Zhu, Andy Z. X.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Tyndale, Rachel F.; George, Tony P.] Univ Toronto, Dept Psychiat, Div Brain & Therapeut, Toronto, ON, Canada; [Cinciripini, Paul] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA; [Hawk, Larry W., Jr.] SUNY Buffalo, Dept Psychol, Buffalo, NY 14260 USA; [Hawk, Larry W., Jr.] SUNY Buffalo, Ctr Children & Families, Buffalo, NY 14260 USA; [Schnoll, Robert A.; Lerman, Caryn] Univ Penn, Ctr Interdisciplinary Res Nicotine Addict, Dept Psychiat, Philadelphia, PA 19104 USA; [Swan, Gary E.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Benowitz, Neal L.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Heitjan, Daniel F.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Texas System; UTMD Anderson Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Pennsylvania; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania	Tyndale, RF (corresponding author), Campbell Family Mental Hlth Res Inst, CAMH, Toronto, ON, Canada.	r.tyndale@utoronto.ca	Lerman, Caryn/AHC-5180-2022	Hawk, Larry/0000-0001-6593-9746; Tyndale, Rachel/0000-0003-1297-2053; Bergen, Andrew/0000-0002-1237-7644	National Institute on Drug Abuse; National Cancer Institute; National Human Genome Research Institute; National Institute on General Medical Sciences [U01 DA20830]; Abramson Cancer Center at the University of Pennsylvania [P30 CA16520]; Commonwealth of Pennsylvania Department of Health; Canadian Institutes of Health Research [CIHR TMH109787]; endowed Chair in Addiction for the Department of Psychiatry; CAMH foundation; Canada Foundation for Innovation [20289, 16014]; Ontario Ministry of Research and Innovation; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH109787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA020830] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Abramson Cancer Center at the University of Pennsylvania; Commonwealth of Pennsylvania Department of Health; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); endowed Chair in Addiction for the Department of Psychiatry; CAMH foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse, the National Cancer Institute, the National Human Genome Research Institute, and the National Institute on General Medical Sciences (U01 DA20830; CL and RFT), funding from the Abramson Cancer Center at the University of Pennsylvania (P30 CA16520; CL), a grant from the Commonwealth of Pennsylvania Department of Health (CL), a grant from the Canadian Institutes of Health Research (CIHR TMH109787), an endowed Chair in Addiction for the Department of Psychiatry (RFT), CAMH foundation (RFT), the Canada Foundation for Innovation (#20289 and #16014), and the Ontario Ministry of Research and Innovation (RFT). No funder had a role in study design, collection and analysis of data, writing of the manuscript, or in the decision to submit this manuscript for review.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Bergen AW, 2013, PHARMACOGENET GENOM, V23, P94, DOI 10.1097/FPC.0b013e32835cdabd; Breitling LP, 2010, PHARMACOGENOMICS, V11, P527, DOI [10.2217/pgs.10.1, 10.2217/PGS.10.1]; Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Chen LS, 2014, ADDICTION, V109, P128, DOI 10.1111/add.12353; Chen LS, 2012, AM J PSYCHIAT, V169, P735, DOI 10.1176/appi.ajp.2012.11101545; Conti DV, 2008, HUM MOL GENET, V17, P2834, DOI 10.1093/hmg/ddn181; Freathy RM, 2009, HUM MOL GENET, V18, P2922, DOI 10.1093/hmg/ddp216; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Helen GS, 2012, CANCER EPIDEM BIOMAR, V21, P1105, DOI 10.1158/1055-9965.EPI-12-0236; Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; Lea RA, 2006, J ANAL TOXICOL, V30, P386, DOI 10.1093/jat/30.6.386; Lerman C, 2015, LANCET RESP MED, V3, P131, DOI 10.1016/S2213-2600(14)70294-2; Lessov CN, 2004, PSYCHOL MED, V34, P865, DOI 10.1017/S0033291703001582; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Munafo MR, 2012, JNCI-J NATL CANCER I, V104, P740, DOI 10.1093/jnci/djs191; Munafo MR, 2011, NICOTINE TOB RES, V13, P982, DOI 10.1093/ntr/ntr106; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sarginson JE, 2011, AM J MED GENET B, V156B, P275, DOI 10.1002/ajmg.b.31155; Siedlinski M, 2011, THORAX, V66, P894, DOI 10.1136/thoraxjnl-2011-200154; Spitz MR, 2012, J NATL CANCER I, V104, P720, DOI 10.1093/jnci/djs211; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub4; Swan GE, 2012, PHARMACOGENOMICS J, V12, P349, DOI 10.1038/tpj.2011.19; Tanner J, 2015, CANC EPIDEM IN PRESS; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Uhl GR, 2010, MOL MED, V16, P513, DOI 10.2119/molmed.2010.00052; Wassenaar CA, 2011, J NATL CANCER I, V103, P1342, DOI 10.1093/jnci/djr237; World Health Organization, 2019, WHO REPORT GLOBAL TO; Xian H, 2003, NICOTINE TOB RES, V5, P245, DOI 10.1080/1462220031000073667; Zhu AZX, 2014, CLIN PHARMACOL THER, V96, P256, DOI 10.1038/clpt.2014.88; Zhu AZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070938; Zhu AZX, 2013, ADDICTION, V108, P1818, DOI 10.1111/add.12250; Zhu AZX, 2013, CANCER EPIDEM BIOMAR, V22, P708, DOI 10.1158/1055-9965.EPI-12-1234-T	48	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128109	10.1371/journal.pone.0128109	http://dx.doi.org/10.1371/journal.pone.0128109			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010901	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900193
J	Zhang, XY; Guo, Q; Zhang, YX; Lou, LD; Ding, DQ				Zhang, Xiangyi; Guo, Qi; Zhang, Youxue; Lou, Liandi; Ding, Daoqun			Different Timing Features in Brain Processing of Core and Moral Disgust Pictures: An Event-Related Potentials Study	PLOS ONE			English	Article							EMOTIONALLY NEGATIVE STIMULI; TIME-COURSE; ERP; ATTENTION; WORDS; P300; BIAS; REAPPRAISAL; INFORMATION; AVOIDANCE	Disgust, an emotion motivating withdrawal from offensive stimuli, protects us from the risk of biological pathogens and sociomoral violations. Homogeneity of its two types, namely, core and moral disgust has been under intensive debate. To examine the dynamic relationship between them, we recorded event-related potentials (ERPs) for core disgust, moral disgust and neutral pictures while participants performed a modified oddball task. ERP analysis revealed that N1 and P2 amplitudes were largest for the core disgust pictures, indicating automatic processing of the core disgust-evoking pictures. N2 amplitudes were higher for pictures evoking moral disgust relative to core disgust and neutral pictures, reflecting a violation of social norms. The core disgust pictures elicited larger P3 and late positive potential (LPP) amplitudes in comparison with the moral disgust pictures which, in turn, elicited larger P3 and LPP amplitudes when compared to the neutral pictures. Taken together, these findings indicated that core and moral disgust pictures elicited different neural activities at various stages of information processing, which provided supporting evidence for the heterogeneity of disgust.	[Zhang, Xiangyi; Ding, Daoqun] Hunan Normal Univ, Dept Psychol, Key Lab Cognit & Human Behav Hunan Prov, Changsha, Hunan, Peoples R China; [Guo, Qi] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China; [Zhang, Youxue] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Lou, Liandi] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China	Hunan Normal University; Liaoning Normal University; University of Electronic Science & Technology of China; East China Normal University	Ding, DQ (corresponding author), Hunan Normal Univ, Dept Psychol, Key Lab Cognit & Human Behav Hunan Prov, Changsha, Hunan, Peoples R China.	psychding@hunnu.edu.cn		zhang, xiangyi/0000-0002-1115-9573	National Social Science Foundation of China [11BSH046]; Hunan Provincial Natural Science Foundation of China [14JJ 4027]; Program for Excellent Talents in Hunan Normal University [2012 YX04]	National Social Science Foundation of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Program for Excellent Talents in Hunan Normal University	This research was supported by the National Social Science Foundation of China (No. 11BSH046), the Hunan Provincial Natural Science Foundation of China (No. 14JJ 4027), the Program for Excellent Talents in Hunan Normal University (No. 2012 YX04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Borg JS, 2008, J COGNITIVE NEUROSCI, V20, P1529, DOI 10.1162/jocn.2008.20109; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Briggs KE, 2009, INT J PSYCHOPHYSIOL, V72, P299, DOI 10.1016/j.ijpsycho.2009.01.009; Campanella S, 2002, BIOL PSYCHOL, V59, P171, DOI 10.1016/S0301-0511(02)00005-4; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, 2003, PSYCHOPHYSIOLOGY, V40, P381, DOI 10.1111/1469-8986.00041; Carretie L, 2011, BIOL PSYCHOL, V86, P247, DOI 10.1016/j.biopsycho.2010.12.005; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Carretie L, 1997, ELECTROEN CLIN NEURO, V103, P298, DOI 10.1016/S0013-4694(96)96565-7; Carretie L, 2007, NEUROPSYCHOLOGIA, V45, P1187, DOI 10.1016/j.neuropsychologia.2006.10.013; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Chapman HA, 2013, PSYCHOL BULL, V139, P300, DOI 10.1037/a0030964; Chen J, 2008, NEUROSCI LETT, V445, P135, DOI 10.1016/j.neulet.2008.08.061; Clark JA, 2010, BIOL PHILOS, V25, P75, DOI 10.1007/s10539-009-9170-1; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Feng CL, 2014, SOC NEUROSCI-UK, V9, P364, DOI 10.1080/17470919.2014.896827; Feng CL, 2012, BRAIN RES, V1489, P48, DOI 10.1016/j.brainres.2012.10.019; Feng CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029668; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hinojosa JA, 2009, COGN AFFECT BEHAV NE, V9, P173, DOI 10.3758/CABN.9.2.173; Huang YX, 2007, NEUROSCI LETT, V412, P134, DOI 10.1016/j.neulet.2006.10.061; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Keil A, 2006, PROG BRAIN RES, V156, P217, DOI 10.1016/S0079-6123(06)56011-X; Kissler J, 2006, PROG BRAIN RES, V156, P147, DOI 10.1016/S0079-6123(06)56008-X; KOK A, 1988, BIOL PSYCHOL, V27, P51, DOI 10.1016/0301-0511(88)90005-1; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Lahat A, 2013, CHILD DEV, V84, P955, DOI 10.1111/cdev.12001; Lang P. J., 2005, INT AFFECTIVE PICTUR; Lee SWS, 2011, COMPONENTS EMOTIONAL; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; LUCK SJ, 2000, NEW COGNITIVE NEUROS, P687; Luo PC, 2014, NEUROSCI LETT, V578, P85, DOI 10.1016/j.neulet.2014.06.032; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Luo Y, 2013, BIOL PSYCHOL, V94, P242, DOI 10.1016/j.biopsycho.2013.06.005; Marzillier S, 2004, COGNITION EMOTION, V18, P313, DOI 10.1080/02699930341000130; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Ottaviani C, 2013, INT J PSYCHOPHYSIOL, V89, P57, DOI 10.1016/j.ijpsycho.2013.05.003; Parkinson C, 2011, J COGNITIVE NEUROSCI, V23, P3162, DOI 10.1162/jocn_a_00017; Polezzi D, 2008, BEHAV BRAIN RES, V190, P218, DOI 10.1016/j.bbr.2008.03.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Roseman IJ, 2004, EMOTION, V4, P145, DOI 10.1037/1528-3542.4.2.145; Royzman EB, 2008, MOTIV EMOTION, V32, P100, DOI 10.1007/s11031-008-9089-x; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Rozin P., 2000, HDB EMOTIONS, P637; Rozin P., 2008, DISGUST BODY SOUL EM, P9; Rozin P, 2013, TRENDS COGN SCI, V17, P367, DOI 10.1016/j.tics.2013.06.001; Rozin P, 2009, SCIENCE, V323, P1179, DOI 10.1126/science.1170492; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; Simpson J, 2006, MOTIV EMOTION, V30, P31, DOI 10.1007/s11031-006-9005-1; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; Weinberg A, 2011, PSYCHOPHYSIOLOGY, V48, P842, DOI 10.1111/j.1469-8986.2010.01149.x; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Wu Y, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00131; Yang JM, 2013, BRAIN RES, V1533, P91, DOI 10.1016/j.brainres.2013.08.020; Yang Q, 2014, INT J PSYCHOPHYSIOL, V94, P84, DOI 10.1016/j.ijpsycho.2014.07.008; Yang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065094; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Yoder KJ, 2014, NEUROPSYCHOLOGIA, V60, P39, DOI 10.1016/j.neuropsychologia.2014.05.022; Yuan JJ, 2008, PSYCHOPHYSIOLOGY, V45, P986, DOI 10.1111/j.1469-8986.2008.00693.x; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan JJ, 2015, SCI CHINA LIFE SCI, V58, P480, DOI 10.1007/s11427-014-4739-6; Yuan JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089844; Yuan JJ, 2012, COGN AFFECT BEHAV NE, V12, P175, DOI 10.3758/s13415-011-0064-8; Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188	80	8	13	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128531	10.1371/journal.pone.0128531	http://dx.doi.org/10.1371/journal.pone.0128531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011635	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900241
J	Zou, WH; Cui, DW; Wang, X; Guo, HH; Yao, X; Jin, M; Huang, QL; Gao, M; Wen, XH				Zou, Weihua; Cui, Dawei; Wang, Xiang; Guo, Huihui; Yao, Xing; Jin, Miao; Huang, Qiuling; Gao, Min; Wen, Xiaohong			Clinical Characteristics and Molecular Epidemiology of Noroviruses in Outpatient Children with Acute Gastroenteritis in Huzhou of China	PLOS ONE			English	Article							VIRAL GASTROENTERITIS; INFECTION; ROTAVIRUS; DIARRHEA; ADULTS; PREVALENCE; OUTBREAKS; ETIOLOGY; VIRUSES; AGENTS	Background Noroviruses (NoVs) are considered major causative pathogens associated with the morbidity and mortality of young children with acute gastroenteritis. However, few studies have examined NoVs causing acute diarrhea among outpatient children worldwide. This study was conducted to investigate the clinical features and molecular epidemiology of NoVs in outpatient children with acute gastroenteritis in Huzhou, China, between April 2013 and April 2014. Methods Stool specimens from 1346 outpatient children enrolled (under 5 years of age) with acute gastroenteritis were examined for NoVs by multiplex RT-PCR, and sequences of the partial capsids of NoVs were analyzed phylogenetically, while the relevant clinical data were analyzed statistically. Results Of 1346 specimens, 383 (28.5%, 383/1346) were positive for NoVs. The proportion of GII genotypes (26.9%) was significantly higher than that of GI genotypes (1.6%). The GII. 4 genotype was the most prevalent of GII genotypes and was clustered into GII. 4/Sydney (37.8%) and GII. 4/2006b (62.2%), whereas GI strains were clustered into GI. 1. Additionally, the younger children (12 to <24 months of age) were more susceptible to NoVs than children in other age groups, and the highest percentage of NoV infections occurred in April 2013. The diarrheal frequency (times/d) and WBC counts of the infected outpatient group with NoVs were significantly higher than were those of the uninfected outpatient group. Conclusion NoVs were confirmed to be the major viral agents responsible for acute gastroenteritis in outpatient children in Huzhou, China, and GII. 4/Sydney and GII. 4/2006b variants were identified as the predominant strains in this study.	[Zou, Weihua; Yao, Xing; Huang, Qiuling; Gao, Min] Huzhou Cent Hosp, Dept Clin Lab, Huzhou 313000, Peoples R China; [Cui, Dawei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Ctr Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xiang; Guo, Huihui; Wen, Xiaohong] First Peoples Hosp Huzhou, Huzhou Teachers Coll, Ctr Clin Lab, Huzhou 313000, Peoples R China; [Jin, Miao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China	Huzhou University; Zhejiang University; Huzhou University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wen, XH (corresponding author), First Peoples Hosp Huzhou, Huzhou Teachers Coll, Ctr Clin Lab, Huzhou 313000, Peoples R China.	xiaohongwen2015@163.com	Cui, Dawei/ABG-4534-2021; guo, huihui/GYQ-8331-2022	Wang, Xiang/0000-0002-0913-0501	National Key Programs for Infectious Diseases of China [2012ZX10004-210]; Public Welfare Research Programs of Technology Application of Huzhou [2012GS05, 2012YSB27, 2013GY16]	National Key Programs for Infectious Diseases of China; Public Welfare Research Programs of Technology Application of Huzhou	This study was supported by the National Key Programs for Infectious Diseases of China (2012ZX10004-210, http://program.most.gov.cn/), and the Public Welfare Research Programs of Technology Application of Huzhou (Grant No. 2012GS05, 2012YSB27, and 2013GY16; http://www.huzhou.com.cn).	Anderson EJ, 2010, EXPERT REV ANTI-INFE, V8, P205, DOI [10.1586/eri.10.1, 10.1586/ERI.10.1]; Bereciartu A, 2002, J CLIN VIROL, V25, P197, DOI 10.1016/S1386-6532(02)00010-0; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Chen Y, 2013, PEDIATR INFECT DIS J, V32, pE285, DOI 10.1097/INF.0b013e31828c3de4; Dennehy PH, 2011, PEDIATR INFECT DIS J, V30, P63, DOI 10.1097/INF.0b013e3182059102; Dey SK, 2010, PEDIATR INFECT DIS J, V29, pE32, DOI 10.1097/INF.0b013e3181d742bf; El Qazoui M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-300; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Froggatt PC, 2004, J MED VIROL, V72, P307, DOI 10.1002/jmv.10569; Hall AJ, 2014, MMWR-MORBID MORTAL W, V63, P491; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Kapikian AZ, 2009, OVERVIEW VIRAL GASTR, P7; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Kittigul L, 2009, J MED VIROL, V81, P345, DOI 10.1002/jmv.21380; Levett PN, 1996, J CLIN MICROBIOL, V34, P1497, DOI 10.1128/JCM.34.6.1497-1501.1996; Mai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071483; Mladenova Z, 2008, J MED VIROL, V80, P2161, DOI 10.1002/jmv.21307; Nakanishi K, 2009, J CLIN VIROL, V46, P94, DOI 10.1016/j.jcv.2009.06.014; O'Ryan M, 2014, EXPERT REV ANTI-INFE, V12, P621, DOI 10.1586/14787210.2014.901168; Oldak E, 2009, ADV MED SCI-POLAND, V54, P183, DOI 10.2478/v10039-009-0046-z; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Rimoldi SG, 2011, ARCH VIROL, V156, P1583, DOI 10.1007/s00705-011-1037-5; Rohayem J, 2009, CLIN MICROBIOL INFEC, V15, P524, DOI 10.1111/j.1469-0691.2009.02846.x; Sai LT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-302; So Cheol Whoan, 2013, Korean J Pediatr, V56, P383, DOI 10.3345/kjp.2013.56.9.383; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian G, 2014, J MED VIROL, V86, P1235, DOI 10.1002/jmv.23802; Victoria M, 2007, PEDIATR INFECT DIS J, V26, P602, DOI 10.1097/INF.0b013e3180618bea; Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768; Wilhelmi de Cal Isabel, 2008, Enferm Infecc Microbiol Clin, V26 Suppl 13, P61, DOI 10.1157/13128782; World Health Organization, 2009, DIARRH WHY CHILDR AR; Wu W, 2014, ARCH VIROL, P1; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09; Yoon JS, 2008, J CLIN MICROBIOL, V46, P1474, DOI 10.1128/JCM.02282-07	37	4	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127596	10.1371/journal.pone.0127596	http://dx.doi.org/10.1371/journal.pone.0127596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011043	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900115
J	Cassani, JR; Croshaw, DA; Bozzo, J; Brooks, B; Everham, EM; Ceilley, DW; Hanson, D				Cassani, John R.; Croshaw, Dean A.; Bozzo, Joseph; Brooks, Brenda; Everham, Edwin M., III; Ceilley, David W.; Hanson, Deborah			Herpetofaunal Community Change in Multiple Habitats after Fifteen Years in a Southwest Florida Preserve, USA	PLOS ONE			English	Article							DECLINING AMPHIBIAN POPULATIONS; CONSERVATION BIOLOGY; GULF-COAST; REPTILES; EXTINCTIONS; PREDATION; INVASIONS; RICHNESS; PITFALLS; CLIMATE	Herpetofaunal declines have been documented globally, and southern Florida, USA, is an especially vulnerable region because of high impacts from hydrological perturbations and nonindigenous species. To assess the extent of recent change in herpetofauna community composition, we established a baseline inventory during 1995-97 at a managed preserve in a habitat rich area of southwest Florida, and repeated our sampling methods fifteen years later (2010-11). Nine drift fence arrays were placed in four habitat types: mesic flatwood, mesic hammock, depression marsh, and wet prairie. Trapping occurred daily for one week during 7-8 sampling runs in each period (57 and 49 total sampling days, respectively). Species richness was maintained in mesic hammock habitats but varied in the others. Catch rates of several native species (Anaxyrus terrestris, Lithobates grylio, Anolis carolinensis, Nerodia fasciata) declined significantly. Other native species (Lithobates sphenocephalus, Siren lacertian, and Notophthalmus viridescens piaropicola) that were abundant in 1995-97 declined by greater than 50%. Catch rate of only two species (the nonindigenous Anolis sagrei and the native Diadophis punctatus) increased significantly. Hierarchical cluster analysis indicated similarity within habitat types but significant dissimilarity between sampling periods, confirming shifts in community composition. Analysis of individual species' contributions to overall similarity across habitats shows a shift from dominance of native species in the 1990s to increased importance of nonindigenous species in 2010-11. Although natural population fluctuations may have influenced differences between the two sampling periods, our results suggest considerable recent change in the structure and composition of this southwest Florida herpetofaunal community. The causes are unknown, but hydrological shifts and ecological impacts of nonindigenous species may have contributed.	[Cassani, John R.; Everham, Edwin M., III; Ceilley, David W.] Florida Gulf Coast Univ, Dept Marine & Ecol Sci, Ft Myers, FL USA; [Croshaw, Dean A.] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA; [Bozzo, Joseph] South Florida Water Management Dist, Estero, FL USA; [Brooks, Brenda; Hanson, Deborah] Corkscrew Reg Ecosyst Watershed Land & Water Trus, Estero, FL USA	State University System of Florida; Florida Gulf Coast University; State University System of Florida; Florida Gulf Coast University; South Florida Water Management District	Croshaw, DA (corresponding author), Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA.	dcroshaw@fgcu.edu						Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; [Anonymous], 2005, FLORIDAS WETLANDS UP; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Bartareau T, 2013, COLLINSORUM, V2, P16; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; BLOOM SA, 1981, MAR ECOL PROG SER, V5, P125, DOI 10.3354/meps005125; Bohm M, 2013, BIOL CONSERV, V157, P372, DOI 10.1016/j.biocon.2012.07.015; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brodman R, 2002, AM MIDL NAT, V147, P135, DOI 10.1674/0003-0031(2002)147[0135:HCORAA]2.0.CO;2; Burbrink FT, 1998, BIOL CONSERV, V86, P107, DOI 10.1016/S0006-3207(98)00054-8; Butterfield B. P., 1997, STRANGERS PARADISE I; Campbell T. S., 2007, ROLE EARLY DETECTION; Campbell TS, 2000, THESIS U TENNESEE KN; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Collins J.P., 2009, EXTINCTION OUR TIMES; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Croshaw Dean A., 2013, Herpetology Notes, V6, P533; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; Delis PR, 1996, BIODIVERS CONSERV, V5, P1579, DOI 10.1007/BF00052117; Dodd CK, 2007, AM MIDL NAT, V158, P29, DOI 10.1674/0003-0031(2007)158[29:CIANFG]2.0.CO;2; Dodd C. Kenneth Jr, 2003, P94; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; ENGE KM, 1986, FOREST ECOL MANAG, V14, P177, DOI 10.1016/0378-1127(86)90116-7; Enge KM, 1997, HABITAT OCCURRENCE F; Erwin KL, 2008, ECOLOGICAL MEMORANDU; Everham Edwin M. III, 2013, Florida Scientist, V76, P138; Florida Department of Environmental Protection, 2007, FLOR DROUGHT ACT PLA; Florida Natural Areas Inventory, 2010, GUID NAT COMM FLOR; Forys EA, 2002, ECOSYSTEMS, V5, P339, DOI 10.1007/s10021-001-0078-0; Forys EA, 1999, BIOL CONSERV, V87, P341, DOI 10.1016/S0006-3207(98)00073-1; Gardner TA, 2007, BIOL CONSERV, V138, P166, DOI 10.1016/j.biocon.2007.04.017; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Gorley C.K., 2006, GETTING STARTED PRIM; Hayek LC, 1994, MEASURING MONITORING, P209; KIESECKER JM, 1995, P NATL ACAD SCI USA, V92, P11049, DOI 10.1073/pnas.92.24.11049; Krysko KL, 2005, AMPHIBIANS AND REPTILES: STATUS AND CONSERVATION IN FLORIDA, P132; Krysko KL, 2011, ZOOTAXA, P1; LeBuff C, 2013, AMPHIBIANS REPTILES; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; MEANS DB, 1987, J BIOGEOGR, V14, P551, DOI 10.2307/2844880; Meshaka W.E., 2011, HERPETOL CONSERV BIO, V6, P1; Meshaka WE, 2001, CUBAN TREEFROG FLORI; Moreno-Rueda G, 2009, ECOL RES, V24, P335, DOI 10.1007/s11284-008-0509-x; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; Rowe LR, 1995, OECOLOGIA, V102, P397; Sexton Owen J., 1998, P340; Smith KG, 2006, BIOL CONSERV, V127, P327, DOI 10.1016/j.biocon.2005.04.026; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Surdick J. A., 2013, Florida Scientist, V76, P436; TOFT CA, 1985, COPEIA, P1; Tuberville Tracey D., 2000, Journal of the Elisha Mitchell Scientific Society, V116, P19; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Wilson LD, 1983, SPECIAL PUBLICATION, V9; Wyatt JL, 2004, SOUTHEAST NAT, V3, P695, DOI 10.1656/1528-7092(2004)003[0695:CIOPBC]2.0.CO;2	57	8	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125845	10.1371/journal.pone.0125845	http://dx.doi.org/10.1371/journal.pone.0125845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016475	Green Submitted, gold, Green Published			2022-12-27	WOS:000355185600037
J	Kristensen, B; Hegedus, L; Lundy, SK; Brimnes, MK; Smith, TJ; Nielsen, CH				Kristensen, Birte; Hegedus, Laszlo; Lundy, Steven K.; Brimnes, Marie K.; Smith, Terry J.; Nielsen, Claus H.			Characterization of Regulatory B Cells in Graves' Disease and Hashimoto's Thyroiditis	PLOS ONE			English	Article							T-CELLS; SELF-ANTIGEN; EXPRESSION; PROLIFERATION; ESTABLISHMENT; THYROGLOBULIN; SUPPRESSION; MECHANISMS; SUBSET; MOUSE	A hallmark of regulatory B cells is IL-10 production, hence their designation as IL-10(+) B cells. Little is known about the ability of self-antigens to induce IL-10(+) B cells in Graves' disease (GD), Hashimoto's thyroiditis (HT), or other autoimmune disease. Here we pulsed purified B cells from 12 HT patients, 12 GD patients, and 12 healthy donors with the thyroid self-antigen, thyroglobulin (TG) and added the B cells back to the remaining peripheral blood mononuclear cells (PBMCs). This procedure induced IL-10(+) B-cell differentiation in GD. A similar tendency was observed in healthy donors, but not in cells from patients with HT. In GD, B cells primed with TG induced IL-10-producing CD4(+) T cells. To assess the maximal frequency of inducible IL-10(+) B cells in the three donor groups PBMCs were stimulated with PMA/ionomycin. The resulting IL-10(+) B-cell frequency was similar in the three groups and correlated with free T-3 levels in GD patients. IL-10(+) B cells from both patient groups displayed CD25 or TIM-1 more frequently than did those from healthy donors. B-cell expression of two surface marker combinations previously associated with regulatory B-cell functions, CD24(hi)CD38(hi) and CD27(+) CD43(+), did not differ between patients and healthy donors. In conclusion, our findings indicate that autoimmune thyroiditis is not associated with reduced frequency of IL-10(+) B cells. These results do not rule out regulatory B-cell dysfunction, however. The observed phenotypic differences between IL-10(+) B cells from patients and healthy donors are discussed.	[Kristensen, Birte; Brimnes, Marie K.; Nielsen, Claus H.] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis & Rheumatol, Inst Inflammat Res, Copenhagen, Denmark; [Kristensen, Birte; Hegedus, Laszlo] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; [Lundy, Steven K.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Smith, Terry J.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Kellogg Eye Ctr, Ann Arbor, MI USA; [Smith, Terry J.] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Dept Internal Med, Ann Arbor, MI USA	Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nielsen, CH (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis & Rheumatol, Inst Inflammat Res, Copenhagen, Denmark.	claus.henrik.nielsen@regionh.dk	Smith, Terry/ABG-1360-2020	Smith, Terry/0000-0002-6279-9685; Nielsen, Claus Henrik/0000-0001-7543-9016; Lundy, Steven/0000-0002-3655-2216	Novo Nordisk Foundation Aase and Ejnar Danielsen Fond [94-101-12676]; Novo Nordisk Foundation; National Institutes of Health [AI105029, EY008976, EY011708, DK063121]; Dryer Foundation; Center for Vision from the National Eye Institute [EY007003]; Research to Prevent Blindness; Bell Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY008976, R01EY011708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI105029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063121] Funding Source: NIH RePORTER	Novo Nordisk Foundation Aase and Ejnar Danielsen Fond; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dryer Foundation; Center for Vision from the National Eye Institute; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Bell Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funding sources for this work included: Novo Nordisk Foundation (94-101-12676)- http://www.novonordiskfonden.dk/en Aase and Ejnar Danielsen Fond - BK; Unrestricted grant from Novo Nordisk Foundation- http://www.novonordiskfonden.dk/en - LH; National Institutes of Health AI105029, and an unrestricted grant from the Dryer Foundation - SKL; National Institutes of Health grants EY008976, EY011708, DK063121 - http://grants.nih.gov/grants/oer.htm and Center for Vision grant EY007003 from the National Eye Institute, http://www.nei.nih.gov/ and unrestricted grant from Research to Prevent Blindness - http://www.rpbusa.org/rpb/ and the Bell Charitable Foundation http://www.hoovers.com/company-information/cs/companyprofile Bell_Charitable_Foundation.c19b01ef78f32c30.html - TJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audo R, 2014, ARTHRITIS RHEUMATOL, V66, pS168, DOI 10.1002/art.38666; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Brent GA, 2011, NEW ENGL J MED, V358, P2594; Brix TH, 2012, CLIN ENDOCRINOL, V76, P457, DOI 10.1111/j.1365-2265.2011.04318.x; Cantaert T, 2012, ARTHRITIS RHEUM-US, V64, P1859, DOI 10.1002/art.34364; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; de Andres C, 2014, J NEUROIMMUNOL, V270, P37, DOI 10.1016/j.jneuroim.2014.02.003; de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Effraimidis G, 2014, EUR J ENDOCRINOL, V170, pR241, DOI 10.1530/EJE-14-0047; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Gary-Gouy H, 2002, BLOOD, V100, P4537, DOI 10.1182/blood-2002-05-1525; Griffin DO, 2012, MOL MED, V18, P1003, DOI 10.2119/molmed.2012.00203; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hahne M, 1996, EUR J IMMUNOL, V26, P721, DOI 10.1002/eji.1830260332; Humar M, 2008, J PHARMACOL EXP THER, V324, P1037, DOI 10.1124/jpet.107.132407; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jensen E, 2004, CLIN CHEM LAB MED, V42, P824, DOI 10.1515/CCLM.2004.136; Jensen EA, 2006, CLIN CHEM LAB MED, V44, P991, DOI 10.1515/CCLM.2006.166; Kessel A, 2012, AUTOIMMUN REV, V11, P670, DOI 10.1016/j.autrev.2011.11.018; Klinker MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070131; Klinker MW, 2012, MOL MED, V18, P123, DOI 10.2119/molmed.2011.00333; Kristensen B, 2015, CLIN EXP IMMUNOL, V180, P58, DOI 10.1111/cei.12557; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; Langkjaer A, 2012, CLIN IMMUNOL, V145, P1, DOI 10.1016/j.clim.2012.07.004; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089236; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; MCGREGOR AM, 1980, NEW ENGL J MED, V303, P302, DOI 10.1056/NEJM198008073030603; MINGARI MC, 1984, NATURE, V312, P641, DOI 10.1038/312641a0; Nielsen CH, 2007, CLIN EXP IMMUNOL, V147, P287, DOI 10.1111/j.1365-2249.2006.03283.x; Nielsen CH, 2007, EXPERT OPIN BIOL TH, V7, P1061, DOI 10.1517/14712598.7.7.1061; OGARRA A, 1992, ANN NY ACAD SCI, V651, P182; Reyes JL, 2015, J IMMUNOL, V194, P364, DOI 10.4049/jimmunol.1400738; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788; WEISS I, 1981, J CLIN ENDOCR METAB, V53, P1223, DOI 10.1210/jcem-53-6-1223; Zha BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049835; Zhong XM, 2007, EUR J IMMUNOL, V37, P2405, DOI 10.1002/eji.200737461	41	27	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127949	10.1371/journal.pone.0127949	http://dx.doi.org/10.1371/journal.pone.0127949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016954	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600101
J	Ma, MM; Anderson, BD; Wang, T; Chen, YA; Zhang, DM; Gray, GC; Lu, JH				Ma, Mengmeng; Anderson, Benjamin D.; Wang, Tao; Chen, Yingan; Zhang, Dingmei; Gray, Gregory C.; Lu, Jiahai			Serological Evidence and Risk Factors for Swine Influenza Infections among Chinese Swine Workers in Guangdong Province	PLOS ONE			English	Article							FARM RESIDENTS; SOUTHERN CHINA; AVIAN-LIKE; A VIRUSES; FEEDING OPERATIONS; PIGS; ANTIBODIES; TRANSMISSION; HUMANS; SEROPREVALENCE	During July to September 2014, we performed a controlled, cross-sectional, seroepidemiologic study among 203 swine workers and 115 control subjects in Guangdong Province. Sera were tested using a hemagglutination inhibition assay against locally-isolated swine H3N2 and H1N1 viruses and commercially-obtained human influenza viral antigens. We found swine workers had a greater prevalence and odds of seropositivity against the swine H3N2 virus (17.3% vs. 7.0%; adjusted OR, 3.4; 95% CI, 1.1 -10.7). Younger age, self-report of a respiratory illness during the last 12 months, and seropositivity against seasonal H3N2 virus were identified as significant risk factors for seropositivity against swine H3N2 virus. As swine workers in China may be exposed to novel influenza viruses, it seems prudent for China to conduct special surveillance for such viruses among them. It also seems wise to offer such workers seasonal influenza vaccines with a goal to reduce cross-species influenza virus transmission.	[Ma, Mengmeng; Zhang, Dingmei; Lu, Jiahai] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Anderson, Benjamin D.; Gray, Gregory C.] Duke Univ, Global Hlth Inst, Div Infect Dis, Durham, NC 27708 USA; [Wang, Tao] Zhongshan Ctr Dis Control & Prevent, Zhongshan, Guangdong, Peoples R China; [Wang, Tao; Lu, Jiahai] Sun Yat Sen Univ, Zhongshan Inst, Sch Publ Hlth, Zhongshan, Guangdong, Peoples R China; [Chen, Yingan] Guangzhou Baiyun Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Zhang, Dingmei; Lu, Jiahai] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Duke University; Sun Yat Sen University; Sun Yat Sen University	Gray, GC (corresponding author), Duke Univ, Global Hlth Inst, Div Infect Dis, Durham, NC 27708 USA.	gregory.gray@duke.edu; lujiahai@mail.sysu.edu.cn	Gray, Gregory C./ABF-1298-2020; Zhang, Dingmei/ABC-7476-2020	Gray, Gregory/0000-0002-4628-5908	Natural Science Foundation of China [81172735, 81373050]; US National Institutes of Health [R01AI108993-01A1]; National Major Science and Technology Special Projects for Infectious Diseases of China [2012ZX10004-902]; Guangzhou Medical Science and Technology Project [20141A010096]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108993] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Major Science and Technology Special Projects for Infectious Diseases of China; Guangzhou Medical Science and Technology Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Natural Science Foundation of China (grant nos. 81172735 (JL), 81373050 (JL)); the US National Institutes of Health (grant no. R01AI108993-01A1 (GCG)); the National Major Science and Technology Special Projects for Infectious Diseases of China (grant no. 2012ZX10004-902 (JL)); and the Guangzhou Medical Science and Technology Project (grant no. 20141A010096 (YC)). Specifically, JL and GCG took the roles of study design, decision to publish and preparation of the manuscript, and YC took the role of data collection.	Cao N, 2013, J CLIN VIROL, V58, P647, DOI 10.1016/j.jcv.2013.09.017; Chen JD, 2014, ARCH VIROL, V159, P2705, DOI 10.1007/s00705-014-2040-4; Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721; Coman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098248; Fournie G, 2012, TRENDS EMERGENCE SWI; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerloff NA, 2011, EMERG INFECT DIS, V17, P403, DOI [10.3201/eid1703100581, 10.3201/eid1703.100851]; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Gray GC, 2013, CLIN INFECT DIS, V57, P1713, DOI 10.1093/cid/cit650; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kitikoon P, 2011, VET MICROBIOL, V148, P413, DOI 10.1016/j.vetmic.2010.09.019; Krueger WS, 2013, CURR TOP MICROBIOL, V370, P201, DOI 10.1007/82_2012_268; Krumbholz A, 2010, J MED VIROL, V82, P1617, DOI 10.1002/jmv.21869; Lopez-Robles G, 2012, TRANSBOUND EMERG DIS, V59, P183, DOI 10.1111/j.1865-1682.2011.01250.x; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Messenger AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089055; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; National Bureau of Statistics of China, 2013, CENS DAT; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; Olsen CW, 2002, EMERG INFECT DIS, V8, P814, DOI 10.3201/eid0808.010474; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; Saenz RA, 2006, VECTOR-BORNE ZOONOT, V6, P338, DOI 10.1089/vbz.2006.6.338; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Su S, 2012, J VIROL, V86, P01315; Terebuh P, 2010, INFLUENZA OTHER RESP, V4, P387, DOI 10.1111/j.1750-2659.2010.00175.x; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; US Envriromental Protection Agency, 2014, REG DEF LARG CAFOS M; Wang DY, 2013, EMERG INFECT DIS, V19, P1709, DOI 10.3201/eid1910.130420; Yin XC, 2014, J MED VIROL, V86, P592, DOI 10.1002/jmv.23842; Zhou H, 2014, JPN J INFECT DIS, V67, P184, DOI 10.7883/yoken.67.184; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073724; Zhou P, 2014, J MED VIROL, V86, P597, DOI 10.1002/jmv.23869; Zhu XY, 2012, P NATL ACAD SCI USA, V109, P18903, DOI 10.1073/pnas.1212579109	36	92	95	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128479	10.1371/journal.pone.0128479	http://dx.doi.org/10.1371/journal.pone.0128479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016740	gold, Green Submitted, Green Published			2022-12-27	WOS:000355185600119
J	Chen, JJ; Cai, WY; Liu, XW; Luo, QC; Chen, G; Huang, WF; Li, N; Cai, JC				Chen, Jia-jia; Cai, Wang-yu; Liu, Xue-wen; Luo, Qi-cong; Chen, Gang; Huang, Wei-feng; Li, Na; Cai, Jian-chun			Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion	PLOS ONE			English	Article							EXPRESSION SUPPRESSES; FASCIN1 EXPRESSION; PROLIFERATION; METASTASIS; CARCINOMA; MIR-145; KNOCKDOWN; GROWTH	MicroRNAs (miRs) play important roles in modulating gene expression during the processes of tumorigenesis and tumor development. Previous studies have found that miR-145 is down-regulated in the stomach neoplasm and is related to tumor migration and invasion. However, both the molecular mechanism and function of miR-145 in gastric cancer remain unclear. The present study is the first demonstration of the significant down-regulation of miR-145 expression in infiltrative gastric cancer compared to expanding gastric cancer. Additionally, correlation analyses revealed strong inverse correlations between miR-145 and FSCN1 expression levels in infiltrative gastric cancer. Furthermore, we demonstrated that miR-145 directly targets FSCN1 and suppresses cell migration and invasion in gastric cancer. Knocking down the expression of FSCN1 led to the suppression of migration and invasion in gastric cancer cells, and re-expressing FSCN1 in miR-145-overexpressing cells reversed their migration and invasion defects. Thus, we concluded that miR-145 regulates cell migration and invasion in gastric cancer primarily by directly targeting FSCN1.	[Chen, Jia-jia; Cai, Wang-yu; Liu, Xue-wen; Luo, Qi-cong; Chen, Gang; Huang, Wei-feng; Li, Na; Cai, Jian-chun] Xiamen Univ, Zhongshan Hosp, Dept Gastrointestinal Surg, Xiamen, Fujian, Peoples R China; [Chen, Jia-jia; Cai, Wang-yu; Liu, Xue-wen; Luo, Qi-cong; Chen, Gang; Cai, Jian-chun] Xiamen Univ, Coll Med, Inst Gastrointestinal Oncol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Cai, WY (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastrointestinal Surg, Xiamen, Fujian, Peoples R China.	zaizai005@126.com; jianchunfh2@sina.com	LUO, QI/GQH-7209-2022		National Natural Science Foundation of China [81172283]; Natural Science Foundation of Fujian Province [2012D037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	1. National Natural Science Foundation of China (Grant No. 81172283) JCC (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Natural Science Foundation of Fujian Province (Grant No. 2012D037) JCC (http://xmgl.fjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2014, GUT, V63, P64, DOI 10.1136/gutjnl-2013-305033; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Dynoodt P, 2013, INT J ONCOL, V42, P1443, DOI 10.3892/ijo.2013.1823; Espejo Romero Hernán, 2003, Rev. gastroenterol. Perú, V23, P199; Feng Y, 2014, BRIT J CANCER, V110, P2300, DOI 10.1038/bjc.2014.122; Fu H, 2009, PATHOLOGY, V41, P655, DOI 10.3109/00313020903273100; Fuse M, 2011, INT J ONCOL, V38, P1093, DOI 10.3892/ijo.2011.919; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanker LC, 2013, ANTICANCER RES, V33, P371; Hashimoto Y, 2011, J PATHOL, V224, P289, DOI 10.1002/path.2894; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamikihara T, 2012, PATHOL INT, V62, P161, DOI 10.1111/j.1440-1827.2011.02774.x; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Lu RJ, 2014, J CANCER RES CLIN, V140, P387, DOI 10.1007/s00432-013-1577-z; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; MING SC, 1977, CANCER, V39, P2475, DOI 10.1002/1097-0142(197706)39:6<2475::AID-CNCR2820390626>3.0.CO;2-L; Park SH, 2014, INT J ONCOL, V44, P637, DOI 10.3892/ijo.2013.2232; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takikita M, 2011, ANTICANCER RES, V31, P945; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645	26	7	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126890	10.1371/journal.pone.0126890	http://dx.doi.org/10.1371/journal.pone.0126890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010149	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900044
J	Doropoulos, C; Ward, S; Roff, G; Gonzalez-Rivero, M; Mumby, PJ				Doropoulos, Christopher; Ward, Selina; Roff, George; Gonzalez-Rivero, Manuel; Mumby, Peter J.			Linking Demographic Processes of Juvenile Corals to Benthic Recovery Trajectories in Two Common Reef Habitats	PLOS ONE			English	Article							LIFE-HISTORY STRATEGIES; POPULATION-DYNAMICS; POSTSETTLEMENT SURVIVAL; POCILLOPORA-DAMICORNIS; SCLERACTINIAN CORALS; HERMATYPIC CORALS; CLIMATE-CHANGE; LONG-TERM; RECRUITMENT; MORTALITY	Tropical reefs are dynamic ecosystems that host diverse coral assemblages with different life-history strategies. Here, we quantified how juvenile (<50 mm) coral demographics influenced benthic coral structure in reef flat and reef slope habitats on the southern Great Barrier Reef, Australia. Permanent plots and settlement tiles were monitored every six months for three years in each habitat. These environments exhibited profound differences: the reef slope was characterised by 95% less macroalgal cover, and twice the amount of available settlement substrata and rates of coral settlement than the reef flat. Consequently, post-settlement coral survival in the reef slope was substantially higher than that of the reef flat, and resulted in a rapid increase in coral cover from 7 to 31% in 2.5 years. In contrast, coral cover on the reef flat remained low (similar to 10%), whereas macroalgal cover increased from 23 to 45%. A positive stock-recruitment relationship was found in brooding corals in both habitats; however, brooding corals were not directly responsible for the observed changes in coral cover. Rather, the rapid increase on the reef slope resulted from high abundances of broadcast spawning Acropora recruits. Incorporating our results into transition matrix models demonstrated that most corals escape mortality once they exceed 50 mm, but for smaller corals mortality in brooders was double those of spawners (i.e. acroporids and massive corals). For corals on the reef flat, sensitivity analysis demonstrated that growth and mortality of larger juveniles (21-50 mm) highly influenced population dynamics; whereas the recruitment, growth and mortality of smaller corals (<20 mm) had the highest influence on reef slope population dynamics. Our results provide insight into the population dynamics and recovery trajectories in disparate reef habitats, and highlight the importance of acroporid recruitment in driving rapid increases in coral cover following large-scale perturbation in reef slope environments.	[Doropoulos, Christopher; Ward, Selina; Roff, George; Mumby, Peter J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Doropoulos, Christopher; Roff, George; Mumby, Peter J.] Australian Res Council Ctr Excellence Coral Reef, St Lucia, Qld, Australia; [Gonzalez-Rivero, Manuel] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Doropoulos, C (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	c.doropoulos@gmail.com	Roff, George/ABB-4406-2021; Mumby, Peter/F-9914-2010; Roff, George/C-8766-2015; González-Rivero, Manuel/A-3482-2016; Doropoulos, Christopher/B-7249-2016	Roff, George/0000-0002-2823-0575; Mumby, Peter/0000-0002-6297-9053; Roff, George/0000-0002-2823-0575; González-Rivero, Manuel/0000-0003-0252-584X; Doropoulos, Christopher/0000-0001-8038-2771	Winifred Violet Scott Foundation; QLD Smart Future Scholarship; ARC Discovery Grant; ARC Laureate Fellowship	Winifred Violet Scott Foundation; QLD Smart Future Scholarship; ARC Discovery Grant(Australian Research Council); ARC Laureate Fellowship(Australian Research Council)	Financial assistance was provided to CD from the Winifred Violet Scott Foundation and a QLD Smart Future Scholarship; to SW from an ARC Discovery Grant; and to PJM from an ARC Laureate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Baria MVB, 2012, B MAR SCI, V88, P61, DOI 10.5343/bms.2011.1075; Bates D., 2013, LME4 LINEAR MIXED EF; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bramanti L, 2015, CORAL REEFS, P1; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Caswell, 2000, MATRIX POPULATION MO; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Crawley M.J., 2007, R BOOK; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Doropoulos C, 2014, CORAL REEFS, V33, P613, DOI 10.1007/s00338-014-1149-y; Doropoulos C, 2012, ECOLOGY, V93, P2131, DOI 10.1890/12-0495.1; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Edmunds P, 2014, MARINE FRESHWATER RE; Edwards AJ, 2001, MAR POLLUT BULL, V42, P7, DOI 10.1016/S0025-326X(00)00200-9; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gorley RN, 2006, PRIMER V6; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harriott V.J., 1983, Coral Reefs, V2, P9, DOI 10.1007/BF00304727; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2005, LIMNOL OCEANOGR, V50, P265, DOI 10.4319/lo.2005.50.1.0265; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 1996, ECOLOGY, V77, P2256, DOI 10.2307/2265718; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HUGHES TP, 1987, AM NAT, V129, P818, DOI 10.1086/284677; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kerry JT, 2012, CORAL REEFS, V31, P415, DOI 10.1007/s00338-011-0859-7; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; KOJIS BL, 1986, MAR BIOL, V91, P291, DOI 10.1007/BF00428623; Lenihan HS, 2011, ECOLOGY, V92, P1959, DOI 10.1890/11-0108.1; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; McCauley DJ, 2010, MAR BIOL, V157, P2739, DOI 10.1007/s00227-010-1533-2; Melbourne-Thomas J, 2011, ECOL APPL, V21, P1380, DOI 10.1890/09-1564.1; Ortiz JC, 2009, CORAL REEFS, V28, P999, DOI 10.1007/s00338-009-0546-0; Ortiz JC, 2014, NAT CLIM CHANGE, V4, P1090, DOI 10.1038/NCLIMATE2439; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Penin L, 2013, MAR ECOL PROG SER, V473, P149, DOI 10.3354/meps10101; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Pinheiro J., 2007, R PACKAGE VERSION, V3, P57; POTTS DC, 1984, LIMNOL OCEANOGR, V29, P504, DOI 10.4319/lo.1984.29.3.0504; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Riegl BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036921; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P145, DOI 10.3354/meps001145; Roff G, 2014, MAR BIOL, V161, P1385, DOI 10.1007/s00227-014-2426-6; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Roth MS, 2009, MAR ECOL PROG SER, V376, P133, DOI 10.3354/meps07787; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; SATO M, 1985, CORAL REEFS, V4, P27, DOI 10.1007/BF00302201; Steneck RS, 2014, MAR ECOL PROG SER, V506, P115, DOI 10.3354/meps10764; STIMSON JS, 1978, MAR BIOL, V48, P173, DOI 10.1007/BF00395017; Tanner JE, 2009, ECOLOGY, V90, P506, DOI 10.1890/08-0399.1; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; TANNER JE, 1994, ECOLOGY, V75, P2204, DOI 10.2307/1940877; Torda G, 2013, MOL ECOL, V22, P5821, DOI 10.1111/mec.12539; Trapon ML, 2013, CORAL REEFS, V32, P1051, DOI 10.1007/s00338-013-1059-4; Trapon ML, 2013, MAR ECOL PROG SER, V488, P157, DOI 10.3354/meps10389; Trapon ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057788; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; Vermeij MJA, 2005, MAR ECOL PROG SER, V295, P123, DOI 10.3354/meps295123; WALLACE CC, 1985, MAR ECOL PROG SER, V21, P289, DOI 10.3354/meps021289; Webster FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124162; Yearsley JM, 2004, ECOL MODEL, V177, P245, DOI 10.1016/j.ecolmodel.2003.12.053	84	79	79	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128535	10.1371/journal.pone.0128535	http://dx.doi.org/10.1371/journal.pone.0128535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009892	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900242
J	Flaherty, BR; Wang, YX; Trope, EC; Ho, TG; Muralidharan, V; Kennedy, EJ; Peterson, DS				Flaherty, Briana R.; Wang, Yuxiao; Trope, Edward C.; Ho, Tienhuei G.; Muralidharan, Vasant; Kennedy, Eileen J.; Peterson, David S.			The Stapled AKAP Disruptor Peptide STAD-2 Displays Antimalarial Activity through a PKA-Independent Mechanism	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; INHIBITORS; TARGETS; GENE; ERYTHROCYTES; COMBINATION; EFFICACY; SUBUNIT	Drug resistance poses a significant threat to ongoing malaria control efforts. Coupled with lack of a malaria vaccine, there is an urgent need for the development of new antimalarials with novel mechanisms of action and low susceptibility to parasite drug resistance. Protein Kinase A (PKA) has been implicated as a critical regulator of pathogenesis in malaria. Therefore, we sought to investigate the effects of disrupted PKA signaling as a possible strategy for inhibition of parasite replication. Host PKA activity is partly regulated by a class of proteins called A Kinase Anchoring Proteins (AKAPs), and interaction between HsPKA and AKAP can be inhibited by the stapled peptide Stapled AKAP Disruptor 2 (STAD-2). STAD-2 was tested for permeability to and activity against Plasmodium falciparum blood stage parasites in vitro. The compound was selectively permeable only to infected red blood cells (iRBC) and demonstrated rapid antiplasmodial activity, possibly via iRBC lysis (IC50 approximate to 1 mu M). STAD-2 localized within the parasite almost immediately post-treatment but showed no evidence of direct association with PKA, indicating that STAD-2 acts via a PKA-independent mechanism. Furosemide-insensitive parasite permeability pathways in the iRBC were largely responsible for uptake of STAD-2. Further, peptide import was highly specific to STAD-2 as evidenced by low permeability of control stapled peptides. Selective uptake and antiplasmodial activity of STAD-2 provides important groundwork for the development of stapled peptides as potential antimalarials. Such peptides may also offer an alternative strategy for studying protein-protein interactions critical to parasite development and pathogenesis.	[Flaherty, Briana R.; Trope, Edward C.; Peterson, David S.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Flaherty, Briana R.; Muralidharan, Vasant; Peterson, David S.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Wang, Yuxiao; Ho, Tienhuei G.; Kennedy, Eileen J.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Muralidharan, Vasant] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kennedy, EJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	ekennedy@uga.edu; dspete@uga.edu		Peterson, David/0000-0003-4394-6181; Kennedy, Eileen/0000-0001-5610-1677; Muralidharan, Vasant/0000-0001-6367-6284	NIH [1K22CA154600, 2T32AI060546-06]; NATIONAL CANCER INSTITUTE [R03CA188439, K22CA154600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH 1K22CA154600 for EJK, NIH 2T32AI060546-06 for DSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoon BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110041; [Anonymous], 2012, Drug Discov Today Technol, V9, pe1, DOI 10.1016/j.ddtec.2012.01.004; [Anonymous], 2013, EM RESP ART RES GREA; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Beitz E, 2004, P NATL ACAD SCI USA, V101, P1153, DOI 10.1073/pnas.0307295101; Bowman JD, 2014, ANTIMICROB AGENTS CH, V58, P811, DOI 10.1128/AAC.01500-13; Chapuis H, 2012, AMINO ACIDS, V43, P2047, DOI 10.1007/s00726-012-1283-1; Chinappi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014064; Copolovici DM, 2014, ACS NANO, V8, P1972, DOI 10.1021/nn4057269; Cui HK, 2013, BIOORGAN MED CHEM, V21, P3547, DOI 10.1016/j.bmc.2013.02.011; Delfino RT, 2002, BIOPHYS CHEM, V98, P287, DOI 10.1016/S0301-4622(02)00077-7; Desai SA, 2014, TRENDS PARASITOL, V30, P151, DOI 10.1016/j.pt.2014.01.003; Doerig C, 2004, BBA-PROTEINS PROTEOM, V1697, P155, DOI 10.1016/j.bbapap.2003.11.021; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Ferreira PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023875; Fisher N, 2012, J BIOL CHEM, V287, P9731, DOI 10.1074/jbc.M111.324319; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Gold MG, 2012, EMBO MOL MED, V4, P15, DOI 10.1002/emmm.201100184; Harikishore A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02501; Haste NM, 2012, MICROBES INFECT, V14, P838, DOI 10.1016/j.micinf.2012.05.004; Kamena F, 2011, CHEM BIODIVERS, V8, P1, DOI 10.1002/cbdv.201000318; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kolevzon N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086802; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; Li JL, 2000, MOL BIOCHEM PARASIT, V109, P157, DOI 10.1016/S0166-6851(00)00242-5; Liu YJ, 2007, P NATL ACAD SCI USA, V104, P12560, DOI 10.1073/pnas.0705313104; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Maciaszek JL, 2014, BIOPHYS J, V106, P1258, DOI 10.1016/j.bpj.2014.02.001; Merckx A, 2009, TRENDS PARASITOL, V25, P139, DOI 10.1016/j.pt.2008.12.005; Merckx A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040019; Mharakurwa S, 2011, P NATL ACAD SCI USA, V108, P18796, DOI 10.1073/pnas.1116162108; Nguitragool W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093759; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Nomura W, 2013, ACS CHEM BIOL, V8, P2235, DOI 10.1021/cb400495h; Okutsu R, 2008, KIDNEY INT, V74, P1429, DOI 10.1038/ki.2008.402; Pavlovic-Djuranovic S, 2003, FEBS LETT, V555, P500, DOI 10.1016/S0014-5793(03)01313-9; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Ramdani Ghania, 2014, Biomed J, V37, P284, DOI 10.4103/2319-4170.132910; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Schwobel B, 2003, MALAR J, V2; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Shretta R, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-399; Sparr C, 2013, ANTIMICROB AGENTS CH, V57, P4689, DOI 10.1128/AAC.00427-13; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2014, J MED CHEM, V57, P6275, DOI 10.1021/jm4011675; Wang YX, 2014, ACS CHEM BIOL, V9, P635, DOI 10.1021/cb400900r; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; WHO, 2014, WORLD MAL REP 2014, DOI [10.1007/s00108-013-3390-9, DOI 10.1007/S00108-013-3390-9]; WHO - World Health Organization, 2012, UPD ART RES APR 2012; Winzeler EA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0544-6; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wurtz N, 2011, PARASITOLOGY, V138, P1, DOI 10.1017/S003118201000096X; Yang BX, 2006, FEBS LETT, V580, P6679, DOI 10.1016/j.febslet.2006.11.025; Yeung BKS, 2010, J MED CHEM, V53, P5155, DOI 10.1021/jm100410f	60	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0129239	10.1371/journal.pone.0129239	http://dx.doi.org/10.1371/journal.pone.0129239			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010880	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900252
J	Kreitz, C; Schnuerch, R; Gibbons, H; Memmert, D				Kreitz, Carina; Schnuerch, Robert; Gibbons, Henning; Memmert, Daniel			Some See It, Some Don't: Exploring the Relation between Inattentional Blindness and Personality Factors	PLOS ONE			English	Article							LATENT INHIBITION; WORKING-MEMORY; DIVERGENT THINKING; GERMAN VERSION; EYE-MOVEMENTS; BIG 5; OPENNESS; CREATIVITY; EXPERIENCE; INTELLIGENCE	Human awareness is highly limited, which is vividly demonstrated by the phenomenon that unexpected objects go unnoticed when attention is focused elsewhere (inattentional blindness). Typically, some people fail to notice unexpected objects while others detect them instantaneously. Whether this pattern reflects stable individual differences is unclear to date. In particular, hardly anything is known about the influence of personality on the likelihood of inattentional blindness. To fill this empirical gap, we examined the role of multiple personality factors, namely the Big Five, BIS/BAS, absorption, achievement motivation, and schizotypy, in these failures of awareness. In a large-scale sample (N = 554), susceptibility to inattentional blindness was associated with a low level of openness to experience and marginally with a low level of achievement motivation. However, in a multiple regression analysis, only openness emerged as an independent, negative predictor. This suggests that the general tendency to be open to experience extends to the domain of perception. Our results complement earlier work on the possible link between inattentional blindness and personality by demonstrating, for the first time, that failures to consciously perceive unexpected objects reflect individual differences on a fundamental dimension of personality.	[Kreitz, Carina; Memmert, Daniel] German Sport Univ Cologne, Inst Cognit & Team, Racket Sport Res, Cologne, Germany; [Schnuerch, Robert; Gibbons, Henning] Univ Bonn, Dept Psychol, Bonn, Germany	German Sport University Cologne; University of Bonn	Kreitz, C (corresponding author), German Sport Univ Cologne, Inst Cognit & Team, Racket Sport Res, Cologne, Germany.	c.kreitz@dshs-koeln.de			German Research Council (Deutsche Forschungsgemeinschaft) [ME 2678/11.1]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The reported research was supported by a grant from the German Research Council (Deutsche Forschungsgemeinschaft, http://www.dfg.de/) to DM, ME 2678/11.1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN LM, 1995, PERS INDIV DIFFER, V19, P893, DOI 10.1016/S0191-8869(95)00078-X; Ansburg PI, 2003, PERS INDIV DIFFER, V34, P1141, DOI 10.1016/S0191-8869(02)00104-6; BARUCH I, 1988, PERS INDIV DIFFER, V9, P777, DOI 10.1016/0191-8869(88)90067-0; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Braunstein-Bercovitz H, 2002, SCHIZOPHR RES, V53, P109, DOI 10.1016/S0920-9964(01)00166-9; Bredemeier K, 2014, PSYCHOL CONSCIOUSNES, V1, P370, DOI [10.1037/cns0000032, DOI 10.1037/CNS0000032]; Bredemeier K, 2012, PSYCHON B REV, V19, P239, DOI 10.3758/s13423-011-0204-8; Brown-Iannuzzi JL, 2014, J EXP PSYCHOL GEN, V143, P33, DOI 10.1037/a0031407; Calvillo DP, 2014, PSYCHON B REV, V21, P670, DOI 10.3758/s13423-013-0543-8; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davies AMA, 2013, CONSCIOUS COGN, V22, P221, DOI 10.1016/j.concog.2012.11.015; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; Drew T, 2013, PSYCHOL SCI, V24, P1848, DOI 10.1177/0956797613479386; Eysenck H. J., 1983, ROEPER REV, V5, P10, DOI DOI 10.1080/02783198309552714; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fougnie D, 2007, PSYCHON B REV, V14, P142, DOI 10.3758/BF03194041; French, 2014, PSYCHOL CONSCIOUSNES, V1, P60, DOI [10.1037/css0000003, DOI 10.1037/CSS0000003]; Furnham A, 2008, PERS INDIV DIFFER, V45, P613, DOI 10.1016/j.paid.2008.06.023; Goldberg L. R., 1992, PSYCHOL ASSESSMENT, V4, P26, DOI [10.1037/1040-3590.4.1.26, DOI 10.1037/1040-3590.4.1.26]; Grant P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00001; Gray J.A., 1981, MODEL PERSONALITY, P246, DOI DOI 10.1007/978-3-642-67783-0_8; Gray J. A., 1972, BIOL BASES INDIVIDUA, P182, DOI [10.1016/0005-7967(70)90069-0, DOI 10.1016/B978-0-12-515350-8.50017-X]; HAINES RF, 1991, PERSP VIS R, P171; Hannon EM, 2010, PERCEPTION, V39, P309, DOI 10.1068/p6379; Harris JA, 2004, PERS INDIV DIFFER, V36, P913, DOI 10.1016/S0191-8869(03)00161-2; Hewig J, 2006, BIOL PSYCHOL, V71, P42, DOI 10.1016/j.biopsycho.2005.01.006; Higgins ET, 1998, ADV EXP SOC PSYCHOL, V30, P1, DOI 10.1016/S0065-2601(08)60381-0; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Huttermann S, 2012, PERCEPTION, V41, P963, DOI 10.1068/p7294; Hyman IE, 2010, APPL COGNITIVE PSYCH, V24, P597, DOI 10.1002/acp.1638; John O.P., 1999, HDB PERSONALITY THEO, V1999, P102, DOI DOI 10.1037/A0019265; Kasof J, 1997, CREATIVITY RES J, V10, P303, DOI 10.1207/s15326934crj1004_2; King LA, 1996, J RES PERS, V30, P189, DOI 10.1006/jrpe.1996.0013; Koivisto M, 2004, VISION RES, V44, P3211, DOI 10.1016/j.visres.2004.07.026; Koivisto M, 2008, PSYCHOL RES-PSYCH FO, V72, P39, DOI 10.1007/s00426-006-0072-4; Kreitz C, 2015, ATTEN PERCEPT PSYCHO, V77, P759, DOI 10.3758/s13414-014-0819-8; Lang FR, 2001, DIAGNOSTICA, V47, P111, DOI 10.1026//0012-1924.47.3.111; LUBOW RE, 1992, PERS INDIV DIFFER, V13, P563, DOI 10.1016/0191-8869(92)90197-W; Mack A, 2002, CONSCIOUS COGN, V11, P488, DOI 10.1016/S1053-8100(02)00028-4; Mack A., 1998, INATTENTIONAL BLINDN; Mason O, 2005, SCHIZOPHR RES, V78, P293, DOI 10.1016/j.schres.2005.06.020; McCrae RR, 1997, AM PSYCHOL, V52, P509, DOI 10.1037/0003-066X.52.5.509; MCCRAE RR, 1994, EUR J PERSONALITY, V8, P251, DOI 10.1002/per.2410080404; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P1258, DOI 10.1037/0022-3514.52.6.1258; Memmert D, 2014, COGNITIVE DEV, V32, P103, DOI 10.1016/j.cogdev.2014.09.002; Memmert D, 2010, J GEN PSYCHOL, V137, P129, DOI 10.1080/00221301003645061; Memmert D, 2009, CREATIVITY RES J, V21, P302, DOI 10.1080/10400410802633798; Most S. B., 2000, PSYCHE, V6, P14; Most SB, 2005, PSYCHOL REV, V112, P217, DOI 10.1037/0033-295X.112.1.217; Most SB, 2001, PSYCHOL SCI, V12, P9, DOI 10.1111/1467-9280.00303; Newby EA, 1998, PERCEPTION, V27, P1025, DOI 10.1068/p271025; Nusbaum EC, 2011, PERS INDIV DIFFER, V51, P571, DOI 10.1016/j.paid.2011.05.013; Richards A, 2012, CONSCIOUS COGN, V21, P170, DOI 10.1016/j.concog.2011.09.013; Richards A, 2010, PSYCHOL RES-PSYCH FO, V74, P513, DOI 10.1007/s00426-009-0273-8; RITZ T, 1995, DIAGNOSTICA, V41, P53; Savine AC, 2010, COGNITION EMOTION, V24, P338, DOI 10.1080/02699930903381564; Schuler H., 2001, LEISTUNGSMOTIVATIONS; Seegmiller JK, 2011, J EXP PSYCHOL LEARN, V37, P785, DOI 10.1037/a0022474; Silvia PJ, 2009, J RES PERS, V43, P1087, DOI 10.1016/j.jrp.2009.04.015; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Strobel A., 2001, DIFFER DIAGNOST PSYC, V22, P216, DOI [10.1024//0170-1789.22.3.216, DOI 10.1024//0170-1789.22.3.216]; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Zamir E, 2014, DIAGNOSIS, V1, P245, DOI 10.1515/dx-2014-0017	66	18	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128158	10.1371/journal.pone.0128158	http://dx.doi.org/10.1371/journal.pone.0128158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011567	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900200
J	Nomokonova, T; Losey, RJ; Goriunova, OI; Novikov, AG; Weber, AW				Nomokonova, Tatiana; Losey, Robert J.; Goriunova, Ol'ga I.; Novikov, Alexei G.; Weber, Andrzej W.			A 9,000 Year History of Seal Hunting on Lake Baikal, Siberia: The Zooarchaeology of Sagan-Zaba II	PLOS ONE			English	Article							MIDDLE HOLOCENE; CIS-BAIKAL; BRONZE-AGE; VEGETATION; CLIMATE; POLLEN; REGION; DYNAMICS; RECORDS; RECONSTRUCTION	Sagan-Zaba II, a habitation site on the shore of Siberia's Lake Baikal, contains a record of seal hunting that spans much of the Holocene, making it one of the longest histories of seal use in North Asia. Zooarchaeological analyses of the 16,000 Baikal seal remains from this well-dated site clearly show that sealing began here at least 9000 calendar years ago. The use of these animals at Sagan-Zaba appears to have peaked in the Middle Holocene, when foragers used the site as a spring hunting and processing location for yearling and juvenile seals taken on the lake ice. After 4800 years ago, seal use declined at the site, while the relative importance of ungulate hunting and fishing increased. Pastoralists began occupying Sagan-Zaba at some point during the Late Holocene, and these groups too utilized the lake's seals. Domesticated animals are increasingly common after about 2000 years ago, a pattern seen elsewhere in the region, but spring and some summer hunting of seals was still occurring. This use of seals by prehistoric herders mirrors patterns of seal use among the region's historic and modern groups. Overall, the data presented in the paper demonstrate that Lake Baikal witnessed thousands of years of human use of aquatic resources.	[Nomokonova, Tatiana] Univ British Columbia, Anthropol Program, Community Culture & Global Studies, Kelowna, BC, Canada; [Losey, Robert J.; Weber, Andrzej W.] Univ Alberta, Dept Anthropol, Edmonton, AB, Canada; [Goriunova, Ol'ga I.; Novikov, Alexei G.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Lab Archaeol & Paleoecol, Irkutsk 664003, Russia	University of British Columbia; University of Alberta; Russian Academy of Sciences	Losey, RJ (corresponding author), Univ Alberta, Dept Anthropol, Edmonton, AB, Canada.	robert.losey@ualberta.ca	Goriunova, Olga/L-1252-2017; Weber, Andrzej W/F-9780-2016	Gorunova, Ol'ga/0000-0002-5159-0894; Novikov, Aleksei/0000-0001-8965-8957	Social Sciences and Humanities Research Council of Canada (Major Collaborative Research Initiative) [412-2005-1004, 412-2011-1001]	Social Sciences and Humanities Research Council of Canada (Major Collaborative Research Initiative)	The project is funded by the Social Sciences and Humanities Research Council of Canada (Major Collaborative Research Initiative, grant numbers 412-2005-1004 and 412-2011-1001). AW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MP, 1990, STRATIGRAFIIA PALEOG, P88; Amano M, 2000, ADV ECOL RES, V31, P449, DOI 10.1016/S0065-2504(00)31024-8; Balikci A, 1970, THE NETSILIK ESKIMO; Bezrukova EV, 2013, QUATERN INT, V290, P35, DOI 10.1016/j.quaint.2012.10.043; Bezrukova EV, 2010, PALAEOGEOGR PALAEOCL, V296, P185, DOI 10.1016/j.palaeo.2010.07.020; Boas F, 1888, 6 SMITHS I; Bogoras W, 1904, CHUKCHEE MEMOIRS A 1, V11; Braje TJ, 2011, HUMAN IMPACTS ON SEALS, SEA LIONS, AND SEA OTTERS: INTEGRATING ARCHAEOLOGY AND ECOLOGY IN THE NORTHEAST PACIFIC, P1, DOI 10.1525/california/9780520267268.001.0001; Buck C.E., 1999, INTERNET ARCHAEOLOGY, V7, DOI [10.11141/IA.7.1, DOI 10.11141/IA.7.1]; Dashibalov BB, 1995, ARKHEOLOGICHESKIE PA; Demske D, 2005, GLOBAL PLANET CHANGE, V46, P255, DOI 10.1016/j.gloplacha.2004.09.020; Devlet Ekaterina, 2001, ARCHAEOLOGY SHAMANIS, P43; Diab MC, 1998, J ARCHAEOL SCI, V25, P1, DOI 10.1006/jasc.1997.0196; Dikov N.N., 1977, ARKHEOLOGICHESKIE PA; [Долганов Вадим Александрович Dolganov V.A.], 2011, [Вестник Новосибирского государственного университета. Серия: История, филология, Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriya: Istoriya, filologiya], V10, P84; [Долганов Вадим Александрович Dolganov V.A.], 2013, [Вестник Новосибирского государственного университета. Серия: История, филология, Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriya: Istoriya, filologiya], V12, P125; Edlund A.-C., 2004, LINGUAGEM CULTURA E, P215; Erlandson JM, 2001, J ARCHAEOL RES, V9, P287, DOI 10.1023/A:1013062712695; Georgi, 1777, OPISANIE VSEKH ROS 3; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goriunova O.I, 2002, DREVNIE MOGILNIKI PR; GORIUNOVA OI, 2000, OLKHONSKII RAION MAT; Goriunova OI, 2007, PROBLEMY ARKHEOLOGII, V13, P212; Goriunova OI, 2007, SEVERNAIA EVRAZIIA A, V1, P168; Goriunova OI, 2012, EVRAZIIA KAINOZOE ST, V1, P86; Goriunova OI, 2008, PROBLEMY ARKHEOLGII, V14, P32; Goriunova OI, 2009, IZVESTIIA LAB DREVNI, V7, P73; Grousset R, 2005, EMPIRE STEPPES HIST; Hodgetts L, 2005, Exploitation and Cultural Importance of Sea Mammals, P62; Juel E, 1945, ETHNOS, V10, P143; Katzenberg MA, 2012, J ARCHAEOL SCI, V39, P2612, DOI 10.1016/j.jas.2011.08.010; Katzenberg MA, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P175; Katzenberg MA, 2009, J ARCHAEOL SCI, V36, P663, DOI 10.1016/j.jas.2008.10.012; Katzenberg MA, 1999, J ARCHAEOL SCI, V26, P651, DOI 10.1006/jasc.1998.0382; Kharinskii AV, 2001, PREDBAIKALE KON TYS; Kharinsky A. V., 2005, IZVESTIIA LAB DREVNI, V3, P198; Kiryak (Dikova) MA, 2010, BAR INT SERIES, V2099; Klevezal G.A., 1988, REGISTRIRUIUSHCHIE S; Kreinovich EA, 1934, SOV ETNOGR, V5, P78; Kuzmin YV, 2006, BAR INT SERIES, V1540, P167; Lam YM, 2005, EVOL ANTHROPOL, V14, P99, DOI 10.1002/evan.20053; Levin N.P., 1897, IZVESTIIA VOSTOCHNO, V28, P44; Losey RJ, 2014, SERIIA GEOARKHEOLOGI, V7, P3; Losey RJ, 2008, J ARCHAEOL SCI, V35, P577, DOI 10.1016/j.jas.2007.05.005; Losey RJ, 2016, QUATERN INT, V419, P62, DOI 10.1016/j.quaint.2014.08.021; Losey RJ, 2012, J ISL COAST ARCHAEOL, V7, P126, DOI 10.1080/15564894.2011.611854; Lyman R. Lee, 2004, VERTEBRATE TAPHONOMY; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; Mackay AW, 2013, QUATERN INT, V290, P46, DOI 10.1016/j.quaint.2012.09.031; Mikhailov T. M., 1987, BURIATSKII SHAMANIZM; Monks G, 2005, P 9 ICAZ C DURH 2002; Nelson R.K, 1969, HUNTERS NO ICE; Nomokonova T, 2011, THESIS U ALBERTA; Nomokonova T., 2009, PREHISTORIC FISHING; Nomokonova T., 2013, P 27 ANN INT AB S, P25; Nomokonova T, 2009, SERIIA ISTORIIA FILO, V5, p[116, 8]; Nomokonova T, 2013, J ETHNOBIOL, V33, P259, DOI 10.2993/0278-0771-33.2.259; Nomokonova T, 2013, QUATERN INT, V290, P110, DOI 10.1016/j.quaint.2012.06.007; Nomokonova Tatiana, 2011, Asian Perspectives, V49, P157; Nomokonova TIU, 2013, DREVNIE KULTURY MONG, V4, P329; Nomokonova TIU, 2014, ARCHAEOL ETHNOG ANTH, V3, P21; Nuttall M., 1992, ARCTIC HOMELAND KINS; Ohtsuka K, 1994, B NATL MUSEUM ETHNOL, V19, P543; Okladnikov A.P., 1974, PETROGLIFY BAIKALA P; PASTUKHOV V D, 1969, Zoologicheskii Zhurnal, V48, P722; Pastukhov VD, 1993, NERPA BAIKALA BIOLOG; PELLY DF, 2001, PORTRAIT RELATIONSHI; Petrov E. A., 2009, BAIKALSKAIA NERPA; SCHEFFER VB, 1950, SCIENCE, V112, P309, DOI 10.1126/science.112.2907.309-a; Shichi K, 2009, QUATERN INT, V205, P98, DOI 10.1016/j.quaint.2009.02.005; Stora J, 2002, INT J OSTEOARCHAEOL, V12, P49, DOI 10.1002/oa.612.abs; Stora J., 2000, ARCHAEOZOOLOGIA, V11, P199; Tarasov P, 2007, PALAEOGEOGR PALAEOCL, V252, P440, DOI 10.1016/j.palaeo.2007.05.002; Tarasov PE, 2009, CLIM PAST, V5, P285, DOI 10.5194/cp-5-285-2009; Toporkov NN, 1926, SEVERNAIA AZIIA, V5-6, P63; Walker MJC, 2012, J QUATERNARY SCI, V27, P649, DOI 10.1002/jqs.2565; WEBER A, 1995, J WORLD PREHIST, V9, P99, DOI 10.1007/BF02221004; WEBER A, 1993, J ARCHAEOL SCI, V20, P629, DOI 10.1006/jasc.1993.1038; Weber A.W., 2008, NO HUNTER GATHERERS, V4; Weber AW, 2011, J ANTHROPOL ARCHAEOL, V30, P523, DOI 10.1016/j.jaa.2011.06.006; Weber AW, 2010, J ANTHROPOL ARCHAEOL, V29, P491, DOI 10.1016/j.jaa.2010.08.002; Weber AW, 2002, J ANTHROPOL ARCHAEOL, V21, P230, DOI 10.1006/jaar.2001.0395; Weber AW, 1998, J ARCHAEOL SCI, V25, P215, DOI 10.1006/jasc.1997.0235; Weber AW, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P1; Weber AW, QUATERN INT IN PRESS; Weber AW, 2012, NO HUNTER GATHERES R, V6; White D, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P1; Zhambalova S.G., 1984, ETNICHESKAIA ISTORII, P97	88	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128314	10.1371/journal.pone.0128314	http://dx.doi.org/10.1371/journal.pone.0128314			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26009890	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900222
J	Ouyang, YL; Li, FQ; Shao, Q; Heussen, FM; Keane, PA; Stubiger, N; Sadda, SR; Pleyer, U				Ouyang, Yanling; Li, Fuqiang; Shao, Qing; Heussen, Florian M.; Keane, Pearse A.; Stuebiger, Nicole; Sadda, Srinivas R.; Pleyer, Uwe			Subretinal Fluid in Eyes with Active Ocular Toxoplasmosis Observed Using Spectral Domain Optical Coherence Tomography	PLOS ONE			English	Article							NONMYDRIATIC FUNDUS PHOTOGRAPHY; RETINAL IRREGULARITIES; DISEASE; RETINOCHOROIDITIS; MANIFESTATIONS; DETACHMENT; PROGNOSIS; THERAPY; MACULA	Purpose To describe the clinical finding of subretinal fluid (SRF) in the posterior pole by spectral domain optical coherence tomography (SD-OCT) in eyes with active ocular toxoplasmosis (OT). Design Retrospective case series. Participants Thirty-eight eyes from 39 patients with active OT. Methods Eyes with active OT which underwent SD-OCT were reviewed. SRFs in the posterior pole were further analyzed. Main Outcome Measures Presence of SRF; its accompanying features, e.g. retinal necrosis, cystoid macular edema (CME), choroidal neovascularization (CNV); and longitudinal changes of SRF, including maximum height and total volume before and after treatment. Results SRF presented in 45.5%(or 15/33) of eyes with typical active OT and in 51.3%(or 20/39) of eyes with active OT. The mean maximum height and total volume of SRF were 161.0 (range: 23-478) mu m and 0.47 (range: 0.005-4.12) mm3, respectively. For 12 eyes with SRF related to active retinal necrosis, SRF was observed with complete absorption after conventional anti- toxoplasmosis treatment. The mean duration for observation of SRF clearance was 33.8 (range: 7-84) days. The mean rate of SRF clearance was 0.0128 (range: 0.0002-0.0665) mm3/day. Conclusions SRF (i.e., serous retinal detachment) is a common feature in patients with active OT when SD-OCT is performed. The majority of SRF was associated with retinal necrosis and reacted well to conventional therapy, regardless of total fluid volume. However, SRF accompanying with CME or CNV responded less favorably or remained refractory to conventional or combined intravitreal treatment, even when the SRF was small in size.	[Ouyang, Yanling; Shao, Qing; Heussen, Florian M.; Stuebiger, Nicole; Pleyer, Uwe] Charite, Dept Ophthalmol, D-13353 Berlin, Germany; [Li, Fuqiang] Jilin Univ, Affiliated Hosp 2, Ctr Eye, Changchun 130023, Peoples R China; [Keane, Pearse A.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Keane, Pearse A.] UCL, Inst Ophthalmol, London, England; [Sadda, Srinivas R.] Doheny Eye Inst, Los Angeles, CA 90033 USA; [Sadda, Srinivas R.] Dept Ophthalmol, Los Angeles, CA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jilin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Doheny Eye Institute	Ouyang, YL (corresponding author), Charite, Dept Ophthalmol, D-13353 Berlin, Germany.	yanlingyouyang@gmail.com	Keane, Pearse/AAE-5709-2019	Keane, Pearse/0000-0002-9239-745X; Heussen, Florian Moritz/0000-0003-0536-9870	Federal Ministry of Education and Research of Germany (BMBF) through the Toxonet 02 research collaboration; National Institute for Health Research [CL-2010-18-004, CS-2014-14-023] Funding Source: researchfish	Federal Ministry of Education and Research of Germany (BMBF) through the Toxonet 02 research collaboration; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the funding from the Federal Ministry of Education and Research of Germany (BMBF) through the Toxonet 02 research collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmaca LS, 2006, GRAEF ARCH CLIN EXP, V244, P1688, DOI 10.1007/s00417-006-0345-z; Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P129, DOI 10.1080/08820530500231961; Bosch-Driessen LEH, 2002, OPHTHALMOLOGY, V109, P869, DOI 10.1016/S0161-6420(02)00990-9; Bosch-Driessen LH, 2000, OPHTHALMOLOGY, V107, P36, DOI 10.1016/S0161-6420(99)00013-5; Delair E, 2011, OCUL IMMUNOL INFLAMM, V19, P91, DOI 10.3109/09273948.2011.564068; Diniz B, 2011, CLIN OPHTHALMOL, V5, P645, DOI 10.2147/OPTH.S20033; Dodds E, 1999, FOCAL POINTS CLIN MO, VXVII; Dodds EM, 2008, AM J OPHTHALMOL, V146, P856, DOI 10.1016/j.ajo.2008.09.006; Foster C.S., 2013, DIAGNOSIS TREATMENT; FRIEDMAN.CT, 1969, ARCH OPHTHALMOL-CHIC, V81, P481; Garweg JG, 2011, OCUL IMMUNOL INFLAMM, V19, P255, DOI 10.3109/09273948.2011.595872; Garza-Leon M, 2012, OCUL IMMUNOL INFLAMM, V20, P130, DOI 10.3109/09273948.2012.656878; HOLLAND GN, 1989, ARCH OPHTHALMOL-CHIC, V107, P1759, DOI 10.1001/archopht.1989.01070020841024; Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032; Keane PA, 2013, JAMA OPHTHALMOL, V131, P341, DOI 10.1001/jamaophthalmol.2013.1724; Keane PA, 2012, SURV OPHTHALMOL, V57, P389, DOI 10.1016/j.survophthal.2012.01.006; Kianersi Farzan, 2012, International Ophthalmology, V32, P539, DOI 10.1007/s10792-012-9599-0; Kovacevic-Pavicevic D, 2012, EYE, V26, P723, DOI 10.1038/eye.2012.20; KRAUSHAR MF, 1979, ANN OPHTHALMOL, V11, P1513; Lehpamer B, 2013, AM J OPHTHALMOL, V155, P143, DOI 10.1016/j.ajo.2012.06.028; Lieb DF, 2004, AM J OPHTHALMOL, V137, P940, DOI 10.1016/j.ajo.2003.10.027; Maenz M, 2014, PROG RETIN EYE RES, V39, P77, DOI 10.1016/j.preteyeres.2013.12.005; Matsubayashi H., 1961, Keio Journal of Medicine, V10, P209, DOI 10.2302/kjm.10.209; Orefice JL, 2007, BRIT J OPHTHALMOL, V91, P773, DOI 10.1136/bjo.2006.108068; Ouyang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086626; Ouyang YL, 2013, INVEST OPHTH VIS SCI, V54, P5694, DOI 10.1167/iovs.13-12043; Ouyang YL, 2013, INVEST OPHTH VIS SCI, V54, P1460, DOI 10.1167/iovs.12-10727; Ouyang YL, 2011, INVEST OPHTH VIS SCI, V52, P7019, DOI 10.1167/iovs.11-8046; Regatieri Caio V, 2012, Int Ophthalmol Clin, V52, P33, DOI 10.1097/IIO.0b013e318265d439; SCHLAEGEL TF, 1984, ARCH OPHTHALMOL-CHIC, V102, P697, DOI 10.1001/archopht.1984.01040030553014; Smith Justine R, 2002, Curr Opin Ophthalmol, V13, P387, DOI 10.1097/00055735-200212000-00008; WILLERSON D, 1977, BRIT J OPHTHALMOL, V61, P693, DOI 10.1136/bjo.61.11.693; Wirthlin R, 2006, ARCH OPHTHALMOL-CHIC, V124, P741, DOI 10.1001/archopht.124.5.741	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127683	10.1371/journal.pone.0127683	http://dx.doi.org/10.1371/journal.pone.0127683			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010656	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900130
J	Wang, Q; Wang, JM; Zhang, YY; Zhang, Y; Xu, SC; Lu, YM				Wang, Qing; Wang, Jingmao; Zhang, Yiying; Zhang, Yue; Xu, Shunchao; Lu, Yingmin			The Application of Fluorescence In Situ Hybridization in Different Ploidy Levels Cross-Breeding of Lily	PLOS ONE			English	Article							ASIATIC LILIES LILIUM; KARYOTYPE ANALYSIS; SEXUAL POLYPLOIDIZATION; BANDING-PATTERNS; F-1 HYBRID; 2N POLLEN; LONGIFLORUM; CHROMOSOMES; RDNA; 5S	21 crossing were conducted between Asiatic Lily with different ploidy levels, the results showed that the interploidy hybridization between diploid and tetraploid lilies was not as successful as intraploidy hybridization. Regardless of male sterility, triploid lilies could be used as female parents in the hybridization which the progenies were aneuploidy. 3xx4x crosses could be cultured more successfully than 3xx2x crosses. 45S rDNA was mapped on the chromosomes of seven Lilium species and their progenies using fluorescence in situ hybridization (FISH). FISH revealed six to sixteen 45S rDNA gene loci, and normally the sites were not in pairs. The asymmetry indexes of LA (Longiflorum hybrids x Asiatic hybrids) hybrids was higher than Asiatic hybrids, the evolution degree was LA hybrids > Asiatic hybrids. 45S rDNA distributed variably on chromosome 1-10 and 12 among Asiatic hybrids. Chromosome 1 had invariable sites of 45S rDNA in all Asiatic hybrids, which could be considered as the characteristic of Asiatic hybrids. LA hybrid 'Freya' had two sites of 45S rDNA on one homologous chromosome 5, and also it could be found in the progenies. The karyotype and fluorescence in situ hybridization with 45S rDNA as probe were applied to identify the different genotypes of 9 hybrids. Typical chromosomes with parental signal sites could be observed in all the genotypes of hybrids, it was confirmed that all the hybrids were true.	[Wang, Qing; Wang, Jingmao; Zhang, Yiying; Zhang, Yue; Xu, Shunchao; Lu, Yingmin] Beijing Forestry Univ, Coll Landscape Architecture, Beijing 100083, Peoples R China	Beijing Forestry University	Lu, YM (corresponding author), Beijing Forestry Univ, Coll Landscape Architecture, Beijing 100083, Peoples R China.	luyingmin@bjfu.edu.cn			'863' research program [2011AA10020804]; China National Natural Science Foundation [31071815, 31272204]; D. Programs Foundation of the Ministry of Education of China [20110014110006]	'863' research program(National High Technology Research and Development Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by the '863' research program (Grant No. 2011AA10020804), China National Natural Science Foundation (Grant No. 31071815 and No. 31272204), and the D. Programs Foundation of the Ministry of Education of China (Grant No. 20110014110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu M, 2007, EUPHYTICA, V155, P143, DOI 10.1007/s10681-006-9317-y; Barba-Gonzalez R, 2005, EUPHYTICA, V143, P67, DOI 10.1007/s10681-005-2657-1; Barba-Gonzalez R, 2004, THEOR APPL GENET, V109, P1125, DOI 10.1007/s00122-004-1739-0; Barba-Gonzalez R, 2006, EUPHYTICA, V151, P243, DOI 10.1007/s10681-006-9148-x; BRANDHAM PE, 1982, GENETICA, V59, P29, DOI 10.1007/BF00130812; Carputo D, 2005, ANN APPL BIOL, V146, P71, DOI 10.1111/j.1744-7348.2005.04070.x; Chung MY, 2006, HORTSCIENCE, V41, P1040; Eeckhautt T, 2006, ACTA HORTIC, P113, DOI 10.17660/ActaHortic.2006.714.13; GILL B S, 1974, Cereal Research Communications, V2, P87; Hasterok R, 2001, THEOR APPL GENET, V103, P486, DOI 10.1007/s001220100653; HOLM PB, 1976, CARLSBERG RES COMMUN, V41, P217; Hwang YJ, 2011, HORTIC ENVIRON BIOTE, V52, P292, DOI 10.1007/s13580-011-0225-2; JOHNSTON SA, 1980, THEOR APPL GENET, V57, P5, DOI 10.1007/BF00276002; Karlov GI, 1999, GENOME, V42, P681, DOI 10.1139/gen-42-4-681; Kohler C, 2010, HEREDITY, V105, P57, DOI 10.1038/hdy.2009.176; KONGSUWAN K, 1977, CHROMOSOMA, V60, P169, DOI 10.1007/BF00288463; Koo DH, 2002, MOL CELLS, V13, P413; KUSPIRA J, 1986, CAN J GENET CYTOL, V28, P867, DOI 10.1139/g86-121; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lim KB, 2001, THEOR APPL GENET, V103, P219, DOI 10.1007/s001220100638; Lim KB, 2003, THEOR APPL GENET, V106, P568, DOI 10.1007/s00122-002-1070-6; Lim KB, 2000, CHROMOSOME RES, V8, P119, DOI 10.1023/A:1009290418889; Lim KB, 2001, GENOME, V44, P911, DOI 10.1139/gen-44-5-911; Lim KiByung, 2004, Korean Journal of Breeding, V36, P123; Lim KY, 2005, CYTOGENET GENOME RES, V109, P298, DOI 10.1159/000082413; Lyrene PM, 2003, EUPHYTICA, V133, P27, DOI 10.1023/A:1025608408727; MAHESHWARI P, 1948, BOT REV, V14, P1, DOI 10.1007/BF02861693; Marasek A, 2004, ACTA HORTIC, P77, DOI 10.17660/ActaHortic.2004.651.7; Mizuochi H, 2007, EUPHYTICA, V155, P235, DOI 10.1007/s10681-006-9325-y; Noda S., 1956, MEM FAC SCI KYUSHU E, V2, P95; Ramanna MS, 2003, EUPHYTICA, V133, P3, DOI 10.1023/A:1025600824483; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; Sato T, 2009, ACTA HORTIC, P243; Schmitzer E., 1991, Quarterly Bulletin of the North American Lily Society, V45, P6; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Sijak-Yakovev S, 2003, PLANT SYST EVOL, V236, P165, DOI [10.1007/s00606-002-0240-y, 10.1007/S00606-002-0240-y]; SMYTH DR, 1989, PLANT SYST EVOL, V163, P53, DOI 10.1007/BF00936153; Snowdon RJ, 2000, ANN BOT-LONDON, V86, P201, DOI 10.1006/anbo.2000.1156; Son JH, 1978, KOR J BOT, V21, P29; Stebbins G. L., 1971, CHROMOSOMAL EVOLUTIO; STEWART RN, 1947, AM J BOT, V34, P9, DOI 10.2307/2437190; Sultana S, 2010, J PLANT BIOL, V53, P433, DOI 10.1007/s12374-010-9133-8; Synge P. M., 1980, LILIES; Taketa S, 1999, THEOR APPL GENET, V98, P1, DOI 10.1007/s001220051033; Van Tuyl JM, 2003, ACTA HORTIC, P13, DOI 10.17660/ActaHortic.2003.612.1; Veilleux R., 1985, Plant Breeding Reviews, V3, P253; VOSA CG, 1976, HEREDITY, V37, P395, DOI 10.1038/hdy.1976.104; WATANABE K, 1992, EUPHYTICA, V60, P21; Wiejacha K, 2001, ACTA HORTIC, P281, DOI 10.17660/ActaHortic.2001.546.34; WOODCOCK H. B. D., 1950, Lilies of the world.; Xie SL, 2010, ACTA HORTIC, V855, P299; Zhou SJ, 2012, EUPHYTICA, V184, P401, DOI 10.1007/s10681-011-0609-5; Zhou SJ, 2011, HORTSCIENCE, V46, P558, DOI 10.21273/HORTSCI.46.4.558; Zhou SJ, 2008, J GENET GENOMICS, V35, P687, DOI 10.1016/S1673-8527(08)60091-0; Zhou SJ, 2007, INTERGENOMIC RECOMBI, P23	55	13	15	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126899	10.1371/journal.pone.0126899	http://dx.doi.org/10.1371/journal.pone.0126899			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010356	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900046
J	Yang, FY; Song, LM; Wang, HP; Wang, J; Xu, ZQ; Xing, NZ				Yang, Feiya; Song, Liming; Wang, Huiping; Wang, Jun; Xu, Zhiqing; Xing, Nianzeng			Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth	PLOS ONE			English	Article							ANDROGEN RECEPTOR; APOPTOSIS; ANGIOGENESIS; EXPRESSION; PROLIFERATION; MECHANISMS; REDUCTION; STRESS; ROLES; CD34	Quercetin and 2-Methoxyestradiol (2-ME) are promising anti-cancer substances. Our previous in vitro study showed that quercetin synergized with 2-Methoxyestradiol exhibiting increased antiproliferative and proapoptotic activity in both androgen-dependent LNCaP and androgen-independent PC-3 human prostate cancer cell lines. In the present study, we determined whether their combination could inhibit LNCaP and PC-3 xenograft tumor growth in vivo and explored the underlying mechanism. Human prostate cancer LNCaP and PC-3 cells were inoculated subcutaneously in male BALB/c nude mice. When xenograft tumors reached about 100 mm(3), mice were randomly allocated to vehicle control, quercetin or 2-Methoxyestradiol singly treated and combination treatment groups. After therapeutic intervention for 4 weeks, combination treatment of quercetin and 2-ME i) significantly inhibited prostate cancer xenograft tumor growth by 46.8% for LNCaP and 51.3% for PC-3 as compared to vehicle control group, more effective than quercetin (28.4% for LNCaP, 24.8% for PC3) or 2-ME (32.1% for LNCaP, 28.9% for PC3) alone; ii) was well tolerated by BALB/c mice and no obvious toxic reactions were observed; iii) led to higher Bax/Bcl-2 ratio, cleaved caspase-3 protein expression and apoptosis rate; and iv) resulted in lower phosphorylated AKT (pAKT) protein level, vascular endothelial growth factor protein and mRNA expression, microvascular density and proliferation rate than single drug treatment. These effects were more remarkable compared to vehicle group. Therefore, combination of quercetin and 2-ME can serve as a novel clinical treatment regimen owning the potential of enhancing antitumor effect on prostate cancer in vivo and lessening the dose and side effects of either quercetin or 2-ME alone. These in vivo results will lay a further solid basis for subsequent researches on this novel therapeutic regimen in human prostate cancer.	[Yang, Feiya; Song, Liming; Xing, Nianzeng] Capital Med Univ, Beijing Chaoyang Hosp, Dept Urol, Beijing, Peoples R China; [Wang, Huiping] Natl Res Inst Family Planning, Dept Reprod Immunol & Pharmacol, Beijing, Peoples R China; [Wang, Jun] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang 110001, Peoples R China; [Xu, Zhiqing] Capital Med Univ, Inst Neurosci, Beijing Key Lab Neural Regenerat & Repair, Beijing, Peoples R China	Capital Medical University; National Research Institute for Family Planning - China; China Medical University; Capital Medical University	Xing, NZ (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Urol, Beijing, Peoples R China.	xingnianzeng@126.com	wang, hui/GRS-4730-2022		Beijing Natural Science Foundation [7122075]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	The work was supported by Beijing Natural Science Foundation (no. 7122075).	Badziul D, 2014, MOL CELL BIOCHEM, V392, P213, DOI 10.1007/s11010-014-2032-4; Baran I, 2014, LEUKEMIA RES, V38, P836, DOI 10.1016/j.leukres.2014.04.010; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Bettencourt MC, 1998, J UROLOGY, V160, P459, DOI 10.1016/S0022-5347(01)62925-2; Borghetti GS, 2009, AAPS PHARMSCITECH, V10, P235, DOI 10.1208/s12249-009-9196-3; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Bu SZ, 2002, FEBS LETT, V531, P141, DOI 10.1016/S0014-5793(02)03478-6; Casarez EV, 2007, CANCER RES, V67, P8316, DOI 10.1158/0008-5472.CAN-07-1755; Chang YF, 2009, NUTR CANCER, V61, P735, DOI 10.1080/01635580902825571; Cialdella-Kam L, 2013, BRIT J NUTR, V109, P1923, DOI 10.1017/S0007114512003972; Ehteda A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-86; Erbersdobler A, 2010, WORLD J UROL, V28, P687, DOI 10.1007/s00345-009-0471-4; Ferruelo A, 2014, Actas Urol Esp, V38, P397, DOI 10.1016/j.acuro.2014.02.012; Fleshner Neil, 2005, Can J Urol, V12 Suppl 1, P14; Ghosh R, 2009, J STEROID BIOCHEM, V113, P25, DOI 10.1016/j.jsbmb.2008.11.002; Harrison MR, 2011, INVEST NEW DRUG, V29, P1465, DOI 10.1007/s10637-010-9455-x; Hotte SJ, 2010, CURR ONCOL, V17, pS72; Kim YH, 2007, J CELL BIOCHEM, V100, P998, DOI 10.1002/jcb.21098; Kumar R, 2011, J NUTR BIOCHEM, V22, P723, DOI 10.1016/j.jnutbio.2010.06.003; Lee DH, 2008, J CELL BIOCHEM, V105, P546, DOI 10.1002/jcb.21851; Lee DH, 2008, BIOCHEM PHARMACOL, V75, P2345, DOI 10.1016/j.bcp.2008.03.013; Liu KC, 2014, ENVIRON TOXICOL, V29, P428, DOI 10.1002/tox.21769; Ma ZS, 2004, J ENDOCRINOL, V181, P493, DOI 10.1677/joe.0.1810493; Ma ZS, 2004, INT J ONCOL, V24, P1297; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mehta RG, 2010, PHARM RES-DORDR, V27, P950, DOI 10.1007/s11095-010-0085-y; Miyata Y, 2015, PROSTATE, V75, P84, DOI 10.1002/pros.22894; Miyata Y, 2013, UROLOGY, V81, P136, DOI 10.1016/j.urology.2012.08.014; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Mueck AO, 2010, STEROIDS, V75, P625, DOI 10.1016/j.steroids.2010.02.016; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047516, 10.1371/journal.pone.0052279]; Qadan LR, 2001, BIOCHEM BIOPH RES CO, V285, P1259, DOI 10.1006/bbrc.2001.5320; Qu SF, 2014, MOL ONCOL, V8, P311, DOI 10.1016/j.molonc.2013.12.004; Reiner T, 2009, CANCER LETT, V276, P21, DOI 10.1016/j.canlet.2008.10.026; Senthilkumar K, 2010, MOL CELL BIOCHEM, V344, P173, DOI 10.1007/s11010-010-0540-4; Sharmila G, 2014, CLIN NUTR, V33, P718, DOI 10.1016/j.clnu.2013.08.011; Shimada K, 2004, MOL CARCINOGEN, V39, P1, DOI 10.1002/mc.10158; Shoskes DA, 1999, UROLOGY, V54, P960, DOI 10.1016/S0090-4295(99)00358-1; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song JH, 2014, J BUON, V19, P770; Tevaarwerk AJ, 2009, CLIN CANCER RES, V15, P1460, DOI 10.1158/1078-0432.CCR-08-1599; Van Veldhuizen PJ, 2008, INT J CANCER, V122, P567, DOI 10.1002/ijc.23117; Visagie M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071935; Wang GD, 2013, ONCOL REP, V30, P357, DOI 10.3892/or.2013.2469; Wang PW, 2014, J NUTR BIOCHEM, V25, P73, DOI 10.1016/j.jnutbio.2013.09.005; Wang PW, 2012, NUTR CANCER, V64, P580, DOI 10.1080/01635581.2012.661514; Xing NZ, 2001, CARCINOGENESIS, V22, P409, DOI 10.1093/carcin/22.3.409; Xu HL, 2013, BIOORG MED CHEM LETT, V23, P3631, DOI 10.1016/j.bmcl.2013.04.007; Yu PC, 2010, CIRC RES, V106, P1221, DOI 10.1161/CIRCRESAHA.109.207670	49	34	35	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128277	10.1371/journal.pone.0128277	http://dx.doi.org/10.1371/journal.pone.0128277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011145	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900216
J	Yang, Z; Li, JJ; Liu, QS; Yuan, TT; Zhang, YY; Chen, LQ; Lou, Q; Sun, ZH; Ying, HZ; Xu, JQ; Dimitrov, DS; Zhang, MY				Yang, Zheng; Li, Jingjing; Liu, Qingsheng; Yuan, Tingting; Zhang, Yanyu; Chen, Li-Qing; Lou, Qi; Sun, Zehua; Ying, Huazhong; Xu, Jianqing; Dimitrov, Dimiter S.; Zhang, Mei-Yun			Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 Antibodies	PLOS ONE			English	Article							B-CELL RECEPTORS; POTENT NEUTRALIZATION; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; VACCINE DESIGN; BROAD; GP120; ANTIGEN; VIRUS; EPITOPE	A fundamental challenge for developing an effective and safe HIV-1 vaccine is to identify vaccine immunogens that can initiate and maintain immune responses leading to elicitation of broadly neutralizing HIV-1 antibodies (bnAbs) through complex maturation pathways. We have previously found that HIV-1 envelope glycoproteins (Env) lack measurable binding to putative germline predecessors of known bnAbs and proposed to search for non-HIV immunogens that could initiate their somatic maturation. Using bnAb b12 as a model bnAb and yeast display technology, we isolated five (poly) peptides from plant leaves, insects, E. coli strains, and sea water microbes that bind to b12 putative germline and intermediate antibodies. Rabbit immunization with the (poly) peptides alone induced high titers of cross-reactive antibodies that neutralized HIV-1 isolates SF162 and JRFL. Priming rabbits with the (poly) peptides followed by boosts with trimeric gp140(SF162) and then resurfaced Env (RSC3) induced antibodies that competed with mature b12 and neutralized tier 1 and 2 viruses from clade B, C and E, while control rabbits without (poly) peptide priming induced antibodies that did not compete with mature b12 and neutralized fewer isolates. The degree of competition with mature b12 for binding to gp140SF162 correlated with the neutralizing activity of the rabbit IgG. Reversing the order of the two boosting immunogens significantly affected the binding profile and neutralization potency of the rabbit IgG. Our study is the first to provide evidence that appears to support the concept that non-HIV immunogens may initiate immune responses leading to elicitation of cross-clade neutralizing antibodies.	[Yang, Zheng; Li, Jingjing; Liu, Qingsheng; Yuan, Tingting; Zhang, Yanyu; Sun, Zehua; Zhang, Mei-Yun] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Dept Microbiol, Pok Fu Lam, Hong Kong, Peoples R China; [Chen, Li-Qing; Lou, Qi; Ying, Huazhong] Zhejiang Acad Med Sci, Ctr Lab Anim, Shanghai, Zhejiang, Peoples R China; [Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Inst Biomed Sci, Shanghai 201508, Peoples R China; [Dimitrov, Dimiter S.] NCI, Prot Interact Grp, Immunol Lab, Canc & Inflammat Program,Ctr Canc Res,NIH, Frederick, MD 21701 USA; [Zhang, Mei-Yun] Shenzhen Third Peoples Hosp, Liver Dis Inst, Shenzhen 518112, Peoples R China	University of Hong Kong; Zhejiang Academy of Medical Sciences; Fudan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhang, MY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Dept Microbiol, Pok Fu Lam, Hong Kong, Peoples R China.	zhangmy2014@hotmail.com		Yang, Zheng/0000-0003-0217-6694	General Research Fund (GRF) from Hong Kong Research Grants Consuls (RGC) [785112]; China 12th 5-year Mega project for HIV/AIDS [2012ZX10001006]; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER	General Research Fund (GRF) from Hong Kong Research Grants Consuls (RGC); China 12th 5-year Mega project for HIV/AIDS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a General Research Fund (GRF) (#785112) from Hong Kong Research Grants Consuls (RGC) (http://www.ugc.edu.hk/eng/rgc/index.htm) and the China 12th 5-year Mega project for HIV/AIDS (#2012ZX10001006) (http://www.most.gov.cn/tztg/index.htm) to M-Y Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astronomo RD, 2008, J VIROL, V82, P6359, DOI 10.1128/JVI.00293-08; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bhattacharyya S, 2013, J BIOL CHEM, V288, P9815, DOI 10.1074/jbc.M112.425959; Bhattacharyya S, 2010, J BIOL CHEM, V285, P27100, DOI 10.1074/jbc.M110.152272; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Clarke J. D., 2009, COLD SPRING HARBOR P, V2009, DOI DOI 10.1101/PDB.PR0T5177.; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dal Porto JM, 1998, J IMMUNOL, V161, P5373; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; McGaughey GB, 2004, CURR HIV RES, V2, P193, DOI 10.2174/1570162043484933; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Prabakaran Ponraj, 2012, Front Microbiol, V3, P277, DOI 10.3389/fmicb.2012.00277; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Srivastava V, 2013, J VIROL, V87, P5831, DOI 10.1128/JVI.00273-13; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wilson K., 1997, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB0204S56; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yuan T, 2011, MABS, V3; Yuan TT, 2011, VACCINE, V29, P6903, DOI 10.1016/j.vaccine.2011.07.046; Zhang MY, 2010, MABS-AUSTIN, V2, P266, DOI 10.4161/mabs.2.3.11416; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	43	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126428	10.1371/journal.pone.0126428	http://dx.doi.org/10.1371/journal.pone.0126428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010511	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900028
J	Zordoky, BN; Sung, MM; Ezekowitz, J; Mandal, R; Han, B; Bjorndahl, TC; Bouatra, S; Anderson, T; Oudit, GY; Wishart, DS; Dyck, JRB				Zordoky, Beshay N.; Sung, Miranda M.; Ezekowitz, Justin; Mandal, Rupasri; Han, Beomsoo; Bjorndahl, Trent C.; Bouatra, Souhaila; Anderson, Todd; Oudit, Gavin Y.; Wishart, David S.; Dyck, Jason R. B.		Alberta HEART	Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; DIASTOLIC DYSFUNCTION; EUROPEAN-SOCIETY; TASK-FORCE; NT-PROBNP; DIAGNOSIS; PREVALENCE; BIOMARKERS; COMMUNITY; CARNITINE	Background Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly recognized as an important clinical entity. Preclinical studies have shown differences in the pathophysiology between HFpEF and HF with reduced ejection fraction (HFrEF). Therefore, we hypothesized that a systematic metabolomic analysis would reveal a novel metabolomic fingerprint of HFpEF that will help understand its pathophysiology and assist in establishing new biomarkers for its diagnosis. Methods and Results Ambulatory patients with clinical diagnosis of HFpEF (n = 24), HFrEF (n = 20), and age-matched non-HF controls (n = 38) were selected for metabolomic analysis as part of the Alberta HEART (Heart Failure Etiology and Analysis Research Team) project. 181 serum metabolites were quantified by LC-MS/MS and H-1-NMR spectroscopy. Compared to non-HF control, HFpEF patients demonstrated higher serum concentrations of acylcarnitines, carnitine, creatinine, betaine, and amino acids; and lower levels of phosphatidylcholines, lysophosphatidylcholines, and sphingomyelins. Medium and long-chain acylcarnitines and ketone bodies were higher in HFpEF than HFrEF patients. Using logistic regression, two panels of metabolites were identified that can separate HFpEF patients from both non-HF controls and HFrEF patients with area under the receiver operating characteristic (ROC) curves of 0.942 and 0.981, respectively. Conclusions The metabolomics approach employed in this study identified a unique metabolomic fingerprint of HFpEF that is distinct from that of HFrEF. This metabolomic fingerprint has been utilized to identify two novel panels of metabolites that can separate HFpEF patients from both non-HF controls and HFrEF patients.	[Zordoky, Beshay N.; Sung, Miranda M.; Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Zordoky, Beshay N.; Sung, Miranda M.; Dyck, Jason R. B.] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Zordoky, Beshay N.; Sung, Miranda M.; Dyck, Jason R. B.] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Ezekowitz, Justin; Oudit, Gavin Y.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Mandal, Rupasri; Bjorndahl, Trent C.; Bouatra, Souhaila; Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Mandal, Rupasri; Han, Beomsoo; Bjorndahl, Trent C.; Bouatra, Souhaila; Wishart, David S.] Univ Alberta, Metabol Innovat Ctr TMIC, Edmonton, AB, Canada; [Han, Beomsoo; Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Anderson, Todd] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci, Calgary, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; Libin Cardiovascular Institute Of Alberta; University of Calgary	Dyck, JRB (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	jason.dyck@ualberta.ca	Wishart, David Scott/ABI-3181-2020; Zordoky, Beshay/AAB-4390-2020; Ezekowitz, Justin A/C-4579-2013	Ezekowitz, Justin A/0000-0002-2724-4086; Dyck, Jason/0000-0002-7045-2884; Zordoky, Beshay/0000-0002-9358-4185; Wishart, David S/0000-0002-3207-2434	Alberta Heart Failure Etiology and Analysis Research Team (Alberta HEART) - Alberta Innovates-Health Solutions Interdisciplinary Team Grant [AHFMR ITG 200801018]; Canadian Institutes of Health Research post-doctoral fellowship; AIHS clinician fellowship; Alberta Innovates [201201143, 201200819] Funding Source: researchfish	Alberta Heart Failure Etiology and Analysis Research Team (Alberta HEART) - Alberta Innovates-Health Solutions Interdisciplinary Team Grant; Canadian Institutes of Health Research post-doctoral fellowship(Canadian Institutes of Health Research (CIHR)); AIHS clinician fellowship; Alberta Innovates	This research was supported by the Alberta Heart Failure Etiology and Analysis Research Team (Alberta HEART), funded by Alberta Innovates-Health Solutions Interdisciplinary Team Grant #AHFMR ITG 200801018. BNZ is the recipient of Canadian Institutes of Health Research post-doctoral fellowship and AIHS clinician fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhayaratna WP, 2006, HEART, V92, P1259, DOI 10.1136/hrt.2005.080150; Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Anjan VY, 2012, AM J CARDIOL, V110, P870, DOI 10.1016/j.amjcard.2012.05.014; Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Bionda C, 2006, ANN CLIN LAB SCI, V36, P299; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Du Zhi-Yong, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P415; Dunlay Shannon M, 2014, Curr Heart Fail Rep, V11, P404, DOI 10.1007/s11897-014-0220-x; Dunn WB, 2007, METABOLOMICS, V3, P413, DOI 10.1007/s11306-007-0063-5; El-Aroussy W, 2000, MOL CELL BIOCHEM, V213, P37, DOI 10.1023/A:1007142919941; Ezekowitz JA, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-91; Ferro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041686; Fonseca Candida, 2004, Rev Port Cardiol, V23, P979; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Haris M, 2014, NAT MED, V20, P209, DOI 10.1038/nm.3436; Kalim S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000542; Kang SM, 2011, CLIN BIOCHEM, V44, P293, DOI 10.1016/j.clinbiochem.2010.11.010; Jorge AJL, 2013, REV PORT CARDIOL, V32, P647, DOI 10.1016/j.repc.2012.10.019; Lommi J, 1997, J INTERN MED, V242, P231, DOI 10.1046/j.1365-2796.1997.00187.x; Lommi J, 1996, J AM COLL CARDIOL, V28, P665, DOI 10.1016/0735-1097(96)00214-8; Lukacs Imre, 2005, Orv Hetil, V146, P1919; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Marcovina SM, 2013, TRANSL RES, V161, P73, DOI 10.1016/j.trsl.2012.10.006; Martin MA, 2000, BBA-MOL BASIS DIS, V1502, P330, DOI 10.1016/S0925-4439(00)00061-2; Martos R, 2009, EUR J HEART FAIL, V11, P191, DOI 10.1093/eurjhf/hfn036; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Melenovsky V, 2012, EUR J HEART FAIL, V14, P754, DOI 10.1093/eurjhf/hfs080; Mottram PM, 2003, AM J CARDIOL, V92, P1434, DOI 10.1016/j.amjcard.2003.08.053; Ojala M, 2010, J MACH LEARN RES, V11, P1833; Oktay A Afsin, 2013, Curr Heart Fail Rep, V10, P401; OKUMURA K, 1991, J MOL CELL CARDIOL, V23, P409, DOI 10.1016/0022-2828(91)90165-I; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pasini E, 2008, AM J CARDIOL, V101, p11E, DOI 10.1016/j.amjcard.2008.02.074; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Putko BN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099495; Rhee EP, 2012, CLIN CHEM, V58, P139, DOI 10.1373/clinchem.2011.169573; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; Strilakou AA, 2013, EUR J PHARMACOL, V709, P20, DOI 10.1016/j.ejphar.2013.03.025; Tenori L, 2013, INT J CARDIOL, V168, pE113, DOI 10.1016/j.ijcard.2013.08.042; Thomas MD, 2006, HEART, V92, P603, DOI 10.1136/hrt.2005.063768; Tschope C, 2005, EUR HEART J, V26, P2277, DOI 10.1093/eurheartj/ehi406; van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044; Wang J, 2013, MOL BIOSYST, V9, P2618, DOI 10.1039/c3mb70227h; Wang YC, 2013, J CARD FAIL, V19, P163, DOI 10.1016/j.cardfail.2013.01.010; Yamaguchi H, 2004, J AM COLL CARDIOL, V43, P55, DOI 10.1016/j.jacc.2003.07.037; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zakeri R, 2013, CIRCULATION, V128, P1085, DOI 10.1161/CIRCULATIONAHA.113.001475; Zamora E, 2013, CLIN CHEM; Zile MR, 2013, J CARDIOVASC TRANSL, V6, P501, DOI 10.1007/s12265-013-9472-1	52	106	110	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0124844	10.1371/journal.pone.0124844	http://dx.doi.org/10.1371/journal.pone.0124844			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010610	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900009
J	Fischer, D; Wahlfors, T; Mattila, H; Oja, H; Tammela, TLJ; Schleutker, J				Fischer, Daniel; Wahlfors, Tiina; Mattila, Henna; Oja, Hannu; Tammela, Teuvo L. J.; Schleutker, Johanna			MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NITRIC-OXIDE SYNTHASE; MICRORNA; EXPRESSION; GENE; IDENTIFICATION; VARIANTS; LINKAGE; COMMON; LET-7	Background Heritable factors are evidently involved in prostate cancer (PrCa) carcinogenesis, but currently, genetic markers are not routinely used in screening or diagnostics of the disease. More precise information is needed for making treatment decisions to distinguish aggressive cases from indolent disease, for which heritable factors could be a useful tool. The genetic makeup of PrCa has only recently begun to be unravelled through large-scale genome-wide association studies (GWAS). The thus far identified Single Nucleotide Polymorphisms (SNPs) explain, however, only a fraction of familial clustering. Moreover, the known risk SNPs are not associated with the clinical outcome of the disease, such as aggressive or metastasised disease, and therefore cannot be used to predict the prognosis. Annotating the SNPs with deep clinical data together with miRNA expression profiles can improve the understanding of the underlying mechanisms of different phenotypes of prostate cancer. Results In this study microRNA (miRNA) profiles were studied as potential biomarkers to predict the disease outcome. The study subjects were from Finnish high risk prostate cancer families. To identify potential biomarkers we combined a novel non-parametrical test with an importance measure provided from a Random Forest classifier. This combination delivered a set of nine miRNAs that was able to separate cases from controls. The detected miRNA expression profiles could predict the development of the disease years before the actual PrCa diagnosis or detect the existence of other cancers in the studied individuals. Furthermore, using an expression Quantitative Trait Loci (eQTL) analysis, regulatory SNPs for miRNA miR-483-3p that were also directly associated with PrCa were found. Conclusion Based on our findings, we suggest that blood-based miRNA expression profiling can be used in the diagnosis and maybe even prognosis of the disease. In the future, miRNA profiling could possibly be used in targeted screening, together with Prostate Specific Antigene (PSA) testing, to identify men with an elevated PrCa risk.	[Fischer, Daniel] Univ Tampere, Sch Hlth Sci, Tampere 33014, Finland; [Wahlfors, Tiina; Mattila, Henna] Univ Tampere, BioMediTech, Tampere 33014, Finland; [Wahlfors, Tiina; Mattila, Henna] Fimlab Labs, Tampere, Finland; [Oja, Hannu] Univ Turku, Dept Math & Stat, Turku 20014, Finland; [Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Sch Med, Tampere 33014, Finland; [Schleutker, Johanna] Univ Turku, Inst Biomed, Med Biochem & Genet, Turku, Finland	Tampere University; Tampere University; University of Turku; Tampere University; Tampere University Hospital; Tampere University; University of Turku	Schleutker, J (corresponding author), Univ Turku, Inst Biomed, Med Biochem & Genet, Turku, Finland.	johanna.schleutker@utu.fi	Fischer, Daniel/C-8791-2017; Wahlfors, Tiina/U-7635-2018	Fischer, Daniel/0000-0002-7513-683X; Schleutker, Johanna/0000-0002-1863-0305; Wahlfors, Tiina/0000-0002-3910-796X	Medical Research Fund of Tampere University Hospital [9L091, 9M094, 9N069]; Finnish Cancer Organizations; Sigrid Juselius Foundation; Academy of Finland [116437, 251074]; Finnish Doctoral Programme in Stochastics and Statistics	Medical Research Fund of Tampere University Hospital; Finnish Cancer Organizations; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Doctoral Programme in Stochastics and Statistics	This work was supported by Medical Research Fund of Tampere University Hospital (9L091, 9M094, and 9N069), the Finnish Cancer Organizations, the Sigrid Juselius Foundation, and the Academy of Finland (grants 116437 and 251074) for JS. This work was also supported by The Finnish Doctoral Programme in Stochastics and Statistics for DF.	Aaltomaa SH, 2000, BJU INT, V86, P234, DOI 10.1046/j.1464-410x.2000.00787.x; Afanasyeva EA, 2011, CELL DEATH DIFFER, V18, P974, DOI 10.1038/cdd.2010.164; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Barh D, 2010, CURR ONCOL, V17, P70; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borel C, 2011, GENOME RES, V21, P68, DOI 10.1101/gr.109371.110; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390; Dahiya R, 1997, INT J CANCER, V72, P762, DOI 10.1002/(SICI)1097-0215(19970904)72:5<762::AID-IJC10>3.0.CO;2-B; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Ekmekcioglu S, 2006, INT J CANCER, V119, P861, DOI 10.1002/ijc.21767; Fischer D, 2015, J STAT SOFT IN PRESS; Fischer D, 2014, SCAND J STAT, V41, P672, DOI 10.1111/sjos.12055; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gui JH, 2011, CLIN SCI, V120, P183, DOI 10.1042/CS20100297; Guo Z, 2012, P NATL ACAD SCI USA, V109, P5826, DOI 10.1073/pnas.1118118109; Hoffman AE, 2013, CANCER EPIDEM BIOMAR, V22, P1; Kim ST, 2010, PROSTATE, V70, P1729, DOI 10.1002/pros.21208; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Loibl S, 2005, EUR J CANCER, V41, P265, DOI 10.1016/j.ejca.2004.07.010; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Scelfo RAM, 2002, ONCOGENE, V21, P2564, DOI 10.1038/sj.onc.1205336; Schaid DJ, 2006, HUM GENET, V120, P471, DOI 10.1007/s00439-006-0219-9; Schleutker J, 2000, CLIN CANCER RES, V6, P4810; Siltanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072040; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Varghese JS, 2010, CURR OPIN GENET DEV, V20, P201, DOI 10.1016/j.gde.2010.03.012; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Verbeeren J, 2010, MOL CELL, V37, P821, DOI 10.1016/j.molcel.2010.02.014; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004	39	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127427	10.1371/journal.pone.0127427	http://dx.doi.org/10.1371/journal.pone.0127427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020509	Green Published, gold			2022-12-27	WOS:000355187300041
J	Huynh, MD; Page, JT; Richardson, BA; Udall, JA				Huynh, Mark D.; Page, Justin T.; Richardson, Bryce A.; Udall, Joshua A.			Insights into Transcriptomes of Big and Low Sagebrush	PLOS ONE			English	Article							SUBGENUS TRIDENTATAE; AGE DISTRIBUTIONS; EVOLUTION; ARTEMISIA; DUPLICATION; SELECTION	We report the sequencing and assembly of three transcriptomes from Big (Artemisia tridentatassp. wyomingensis and Artemisia tridentatassp. tridentata) and Low (A. arbuscula ssp. arbuscula) sagebrush. The sequence reads are available in the Sequence Read Archive of NCBI. We demonstrate the utilities of these transcriptomes for gene discovery and phylogenomic analysis. An assembly of 61,883 transcripts followed by transcript identification by the program TRAPID revealed 16 transcripts directly related to terpene synthases, proteins critical to the production of multiple secondary metabolites in sagebrush. A putative terpene synthase was identified in two of our sagebrush samples. Using paralogs with synonymous mutations we reconstructed an evolutionary time line of ancient genome duplications. By applying a constant mutation rate to the data we estimate that these three ancient duplications occurred about 18, 34 and 60 million years ago. These transcriptomes offer a foundation for future studies of sagebrush, including inferences in chemical defense and the identification of species and subspecies of sagebrush for restoration and preservation of the threatened sage-grouse.	[Huynh, Mark D.; Page, Justin T.; Udall, Joshua A.] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Richardson, Bryce A.] USDA, Forest Serv, Rocky Mt Res Stn, Provo, UT 84606 USA	Brigham Young University; United States Department of Agriculture (USDA); United States Forest Service	Udall, JA (corresponding author), Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA.	jaudall@byu.edu	Udall, Joshua A/A-7298-2009	Udall, Joshua A/0000-0003-0978-4764	USDA Forest Service National Fire Plan; Great Basin Native Plant Program	USDA Forest Service National Fire Plan; Great Basin Native Plant Program	This study was supported by USDA Forest Service National Fire Plan, (http://www.forestsandrangelands.gov/resources/overview/nfp_research.shtml), Great Basin Native Plant Program, (http://www.fs.fed.us/rm/boise/research/shrub/greatbasin.shtml).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bajgain P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-370; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; BEETLE A. A., 1960, STUDY SAGEBRUSH SECT, P83; Bel MV, 2012, GENOME BIO, V14, P1; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bohlmann J, 1997, J BIOL CHEM, V272, P21784, DOI 10.1074/jbc.272.35.21784; Byrd DW, 1999, BIOCHEM SYST ECOL, V27, P11, DOI 10.1016/S0305-1978(98)00064-7; Chaudhuri P, 2012, J AM STAT ASSOC, V94, P807; Copeland HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067261; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Frye GG, 2013, ECOLOGY, V94, P308, DOI 10.1890/12-1313.1; Funk VA, 2005, BIOL SKR, V55, P3403; Hsieh MH, 2005, PLANT PHYSIOL, V138, P641, DOI 10.1104/pp.104.058735; Irmisch S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-84; JONES RJ, 1986, AUST VET J, V63, P259, DOI 10.1111/j.1751-0813.1986.tb02990.x; Joshi N, 2013, SICKLE SLIDING WINDO; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Kim KJ, 2005, MOL BIOL EVOL, V22, P1783, DOI 10.1093/molbev/msi174; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mahalovich M. F., 2004, Native Plants Journal, V5, P141, DOI 10.2979/NPJ.2004.5.2.141; McArthur ED, 1999, AM J BOT, V86, P1754, DOI 10.2307/2656673; MCARTHUR ED, 1988, J HERED, V79, P268, DOI 10.1093/oxfordjournals.jhered.a110508; McArthur ED, 1999, USDA FOR SERV RMRS P, V11, P3; McLachlan G.J., 1999, J STAT SOFTW, V4, DOI DOI 10.18637/JSS.V004.I02; Ohno S., 1970, EVOLUTION GENE DUPLI; REMINGTON TE, 1985, J WILDLIFE MANAGE, V49, P1055, DOI 10.2307/3801395; Rensing SA, 2014, CURR OPIN PLANT BIOL, V17, P43, DOI 10.1016/j.pbi.2013.11.002; Rosentreter R., 2005, P SAG GROUS HAB REST, P3; Sanz M., 2011, Collectanea Botanica (Barcelona), V30, P7, DOI 10.3989/collectbot.2011.v30.001; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; STEVENS R, 1974, J RANGE MANAGE, V27, P325, DOI 10.2307/3896837; Thacker ET, 2012, J WILDLIFE MANAGE, V76, P588, DOI 10.1002/jwmg.273; Theis N, 2003, INT J PLANT SCI, V164, pS93, DOI 10.1086/374190; Turi CE, 2014, PHYTOCHEMISTRY, V98, P9, DOI 10.1016/j.phytochem.2013.11.016; Ulappa AC, 2014, J MAMMAL, V95, P834, DOI 10.1644/14-MAMM-A-025; Umlauf D, 2004, PHYTOCHEMISTRY, V65, P2463, DOI 10.1016/j.phytochem.2004.08.019; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; WHITE SM, 1982, J RANGE MANAGE, V35, P107, DOI 10.2307/3898533	40	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127593	10.1371/journal.pone.0127593	http://dx.doi.org/10.1371/journal.pone.0127593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020526	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300047
J	Yu, LY; Zhang, WJ; Liu, LM; Yang, J				Yu, Lingyu; Zhang, Wenjing; Liu, Lemian; Yang, Jun			Determining Microeukaryotic Plankton Community around Xiamen Island, Southeast China, Using Illumina MiSeq and PCR-DGGE Techniques	PLOS ONE			English	Article							MOLECULAR DIVERSITY; MICROBIAL DIVERSITY; GENETIC DIVERSITY; JIULONG RIVER; FRESH-WATER; PHYTOPLANKTON; PATTERNS; SEA; MICROZOOPLANKTON; PICOPLANKTON	Microeukaryotic plankton are important components of aquatic environments and play key roles in marine microbial food webs; however, little is known about their genetic diversity in subtropical offshore areas. Here we examined the community composition and genetic diversity of the microeukaryotic plankton in Xiamen offshore water by PCR-DGGE (polymerase chain reaction-denaturing gradient gel electrophoresis), clone-based sequencing and Illumina based sequencing. The Illumina MiSeq sequencing revealed a much (approximately two orders of magnitude) higher species richness of the microeukaryotic community than DGGE, but there were no significant difference in species richness and diversity among the northern, eastern, southern or western stations based on both methods. In this study, Copepoda, Ciliophora, Chlorophyta, Dinophyceae, Cryptophyta and Bacillariophyta (diatoms) were the dominant groups even though diatoms were not detected by DGGE. Our Illumina based results indicated that two northern communities (sites N2 and N3) were significantly different from others in having more protozoa and fewer diatoms. Redundancy analysis (RDA) showed that both temperature and salinity were the significant environmental factors influencing dominant species communities, whereas the full microeukaryotic community appeared to be affected by a complex of environmental factors. Our results suggested that extensive sampling combined with more deep sequencing are needed to obtain the complete diversity of the microeukaryotic community, and different diversity patterns for both abundant and rare taxa may be important in evaluating the marine ecosystem health.	[Yu, Lingyu; Zhang, Wenjing] Xiamen Univ, Coll Ocean & Earth Sci, Lab Marine Biodivers & Global Change MBiGC, Xiamen, Peoples R China; [Liu, Lemian; Yang, Jun] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Aquat EcoHlth Grp, Xiamen, Peoples R China	Xiamen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS	Zhang, WJ (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Lab Marine Biodivers & Global Change MBiGC, Xiamen, Peoples R China.	zhangwenjing@xmu.edu.cn	CAS, KLUEH/T-5743-2019; Yang, Jun/E-6680-2011; Zhang, Wenjing/H-5057-2012; CAS, KLUEH-Cooperation/E-1148-2017	Yang, Jun/0000-0002-7920-2777; Zhang, Wenjing/0000-0002-2600-5040; Liu, Lemian/0000-0002-8977-6969	National Natural Science Foundation of China [41276133]; National Natural Science Foundation Committee of China; Natural Science Foundation of Fujian Province [2014J01163]; Fujian Provincial Department of Science and Technology; Global Change and Air-sea Interaction Project [GASI-03-01-02-03]; National Bureau of Oceanography of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation Committee of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Fujian Provincial Department of Science and Technology; Global Change and Air-sea Interaction Project; National Bureau of Oceanography of China	This work was supported by the National Natural Science Foundation of China (41276133), National Natural Science Foundation Committee of China (http://www.nsfc.gov.cn/) (WJZ); the Natural Science Foundation of Fujian Province (2014J01163), Fujian Provincial Department of Science and Technology (http://www.fjkjt.gov.cn/) (WJZ); and the Global Change and Air-sea Interaction Project (GASI-03-01-02-03), National Bureau of Oceanography of China (http://www.soa.gov.cn/) (WJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2006, SYST APPL MICROBIOL, V29, P593, DOI 10.1016/j.syapm.2006.01.006; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Anjusha A, 2013, J MARINE SYST, V115, P40, DOI 10.1016/j.jmarsys.2013.02.003; Anonymous, 2011, Marine Sciences (Beijing), V35, P89; Bao Lei, 2007, Marine Environmental Science, V26, P504; Behnke A, 2006, APPL ENVIRON MICROB, V72, P3626, DOI 10.1128/AEM.72.5.3626-3636.2006; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bowman JP, 2003, APPL ENVIRON MICROB, V69, P2448, DOI 10.1128/AEM.69.5.2448-2462.2003; Brock T D, 1987, S SOC GEN MICROBIOL, V41, P1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; [陈纪新 Chen Jixin], 2003, [海洋环境科学, Marine Environmental Science], V22, P16; Chin T.G., 1965, OCEANOL LIMNOL SIN, V7, P373; Clarke K., 2001, PRIMER V5 USER MANUA; del Campo J, 2011, PROTIST, V162, P435, DOI 10.1016/j.protis.2010.10.003; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; DYAL PL, 1995, MOL ECOL, V4, P499, DOI 10.1111/j.1365-294X.1995.tb00244.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Estudillo CB, 2000, AQUACULTURE, V190, P155, DOI 10.1016/S0044-8486(00)00390-2; Faria DG, 2014, J OCEANOGR, V70, P11, DOI 10.1007/s10872-013-0208-2; FERRIERPAGES C, 1994, MAR ECOL PROG SER, V108, P283, DOI 10.3354/meps108283; Foucher ALJL, 2004, SOIL BIOL BIOCHEM, V36, P2027, DOI 10.1016/j.soilbio.2004.05.021; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Guan HS, 2005, Environmental Informatics, Proceedings, P185; Hambright KD, 2015, ISME J, V9, P256, DOI 10.1038/ismej.2014.103; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Hong H, 2007, J MICROBIOL METH, V69, P52, DOI 10.1016/j.mimet.2006.11.016; Huang BQ, 2000, J OCEANOGR TAIWAN ST, V19, P329; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; LaybournParry J, 1997, POLAR BIOL, V17, P54, DOI 10.1007/s003000050104; Legatzki A, 2011, GEOMICROBIOL J, V28, P99, DOI 10.1080/01490451003738465; Leps J, 2003, MULTIVARIATE ANAL EC; Lindstrom ES, 2000, MICROBIAL ECOL, V40, P104; Liu LM, 2011, HYDROBIOLOGIA, V678, P113, DOI 10.1007/s10750-011-0834-x; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Maskaoui K, 2002, ENVIRON POLLUT, V118, P109, DOI 10.1016/S0269-7491(01)00208-1; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Nubel U, 1999, APPL ENVIRON MICROB, V65, P422; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Sun J, 2010, CHIN J OCEANOL LIMN, V28, P315, DOI 10.1007/s00343-010-9285-x; Tan SZ, 2013, OPTIK, V124, P6611, DOI 10.1016/j.ijleo.2013.05.025; Wang YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101121; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090053; Zeng Xiang-bo, 2010, Xiamen Daxue Xuebao (Ziran Kexue Ban), V49, P109; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zinger L, 2012, MOL ECOL, V21, P1878, DOI 10.1111/j.1365-294X.2011.05362.x	54	37	40	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0127721	10.1371/journal.pone.0127721	http://dx.doi.org/10.1371/journal.pone.0127721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020532	Green Submitted, Green Published, gold			2022-12-27	WOS:000355187300053
J	Kang, MC; Andreani, M; Kenworthy, AK				Kang, Minchul; Andreani, Manuel; Kenworthy, Anne K.			Validation of Normalizations, Scaling, and Photofading Corrections for FRAP Data Analysis	PLOS ONE			English	Article							FLUORESCENCE PHOTOBLEACHING RECOVERY; ANOMALOUS DIFFUSION; MOBILITY; BINDING; DYNAMICS; PROTEIN; CHROMATIN; KINETICS	Fluorescence Recovery After Photobleaching (FRAP) has been a versatile tool to study transport and reaction kinetics in live cells. Since the fluorescence data generated by fluorescence microscopy are in a relative scale, a wide variety of scalings and normalizations are used in quantitative FRAP analysis. Scaling and normalization are often required to account for inherent properties of diffusing biomolecules of interest or photochemical properties of the fluorescent tag such as mobile fraction or photofading during image acquisition. In some cases, scaling and normalization are also used for computational simplicity. However, to our best knowledge, the validity of those various forms of scaling and normalization has not been studied in a rigorous manner. In this study, we investigate the validity of various scalings and normalizations that have appeared in the literature to calculate mobile fractions and correct for photofading and assess their consistency with FRAP equations. As a test case, we consider linear or affine scaling of normal or anomalous diffusion FRAP equations in combination with scaling for immobile fractions. We also consider exponential scaling of either FRAP equations or FRAP data to correct for photofading. Using a combination of theoretical and experimental approaches, we show that compatible scaling schemes should be applied in the correct sequential order; otherwise, erroneous results may be obtained. We propose a hierarchical workflow to carry out FRAP data analysis and discuss the broader implications of our findings for FRAP data analysis using a variety of kinetic models.	[Kang, Minchul; Andreani, Manuel] St Thomas Univ, Sch Sci Technol & Engn Management, Miami Gardens, FL 33054 USA; [Kenworthy, Anne K.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University	Kang, MC (corresponding author), St Thomas Univ, Sch Sci Technol & Engn Management, Miami Gardens, FL 33054 USA.	mkang@stu.edu		Kenworthy, Anne/0000-0001-6567-9059	NSF/DMS from the National Science Foundation [0970008]; St Thomas University undergraduate research program from St Thomas University	NSF/DMS from the National Science Foundation; St Thomas University undergraduate research program from St Thomas University	This work was funded in part by grant NSF/DMS 0970008 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5300&org=DMS) from the National Science Foundation (to AKK). This work was also funded in part by St Thomas University undergraduate research program (http://www.stu.edu/ResearchOpportunities/tabid/4860/Default.aspx) from St Thomas University (to MK and MA). The funding sources had no role in the study design, collection, analysis or interpretation of data, writing the report, or the decision to submit the paper for publication	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; Cao J, 2008, J CELL BIOL, V182, P301, DOI 10.1083/jcb.200712036; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; Choi S, 2012, J PROTEOME RES, V11, P4983, DOI 10.1021/pr3005524; Daddysman MK, 2013, J PHYS CHEM B, V117, P1241, DOI 10.1021/jp310348s; Day Charles A, 2012, Curr Protoc Cytom, VChapter 2, DOI 10.1002/0471142956.cy0219s62; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Elzie CA, 2009, METHODS MOL BIOL, V571, P349, DOI 10.1007/978-1-60761-198-1_24; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Goehring NW, 2010, BIOPHYS J, V99, P2443, DOI 10.1016/j.bpj.2010.08.033; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Hofling F, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046602; Kang M, 2012, TRAFFIC, V13, P1589, DOI 10.1111/tra.12008; Kang MC, 2011, BIOPHYS J, V100, P791, DOI 10.1016/j.bpj.2010.11.091; Kang MC, 2010, BIOPHYS J, V99, P2737, DOI 10.1016/j.bpj.2010.09.013; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; Lorente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085817; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2012, BIOPHYS J, V102, P1656, DOI 10.1016/j.bpj.2012.02.029; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Mullineaux CW, 1997, NATURE, V390, P421, DOI 10.1038/37157; Periasamy N, 1996, PHOTOCHEM PHOTOBIOL, V63, P265, DOI 10.1111/j.1751-1097.1996.tb03023.x; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Rapsomaniki MA, 2012, BIOINFORMATICS, V28, P1800, DOI 10.1093/bioinformatics/bts241; Saxton MJ, 2001, BIOPHYS J, V81, P2226, DOI 10.1016/S0006-3495(01)75870-5; Sbalzarini IF, 2005, BIOPHYS J, V89, P1482, DOI 10.1529/biophysj.104.057885; Siggia ED, 2000, BIOPHYS J, V79, P1761, DOI 10.1016/S0006-3495(00)76428-9; SONG LL, 1995, BIOPHYS J, V68, P2588, DOI 10.1016/S0006-3495(95)80442-X; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Sprague BL, 2006, BIOPHYS J, V91, P1169, DOI 10.1529/biophysj.105.073676; Weiss M, 2004, TRAFFIC, V5, P662, DOI 10.1111/j.1600-0854.2004.00215.x; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042854	34	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127966	10.1371/journal.pone.0127966	http://dx.doi.org/10.1371/journal.pone.0127966			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017223	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600103
J	Kaye, TG; Falk, AR; Pittman, M; Sereno, PC; Martin, LD; Burnham, DA; Gong, EP; Xu, X; Wang, YN				Kaye, Thomas G.; Falk, Amanda R.; Pittman, Michael; Sereno, Paul C.; Martin, Larry D.; Burnham, David A.; Gong, Enpu; Xu, Xing; Wang, Yinan			Laser-Stimulated Fluorescence in Paleontology	PLOS ONE			English	Article							MICRORAPTOR; FEATHERS	Fluorescence using ultraviolet (UV) light has seen increased use as a tool in paleontology over the last decade. Laser-stimulated fluorescence (LSF) is a next generation technique that is emerging as a way to fluoresce paleontological specimens that remain dark under typical UV. A laser's ability to concentrate very high flux rates both at the macroscopic and microscopic levels results in specimens fluorescing in ways a standard UV bulb cannot induce. Presented here are five paleontological case histories that illustrate the technique across a broad range of specimens and scales. Novel uses such as back-lighting opaque specimens to reveal detail and detection of specimens completely obscured by matrix are highlighted in these examples. The recent cost reductions in medium-power short wavelength lasers and use of standard photographic filters has now made this technique widely accessible to researchers. This technology has the potential to automate multiple aspects of paleontology, including preparation and sorting of microfossils. This represents a highly cost-effective way to address paleontology's preparatory bottleneck.	[Kaye, Thomas G.] Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Falk, Amanda R.] Southwestern Oklahoma State Univ, Dept Biol, Weatherford, OK USA; [Pittman, Michael] Univ Hong Kong, Dept Earth Sci, Vertebrate Palaeontol Lab, Pokfulam, Hong Kong, Peoples R China; [Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Martin, Larry D.; Burnham, David A.] Univ Kansas, Div Vertebrate Paleontol, Nat Hist Museum, Biodivers Inst, Lawrence, KS 66045 USA; [Gong, Enpu] Northeastern Univ, Dept Geol, Shenyang, Liaoning, Peoples R China; [Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China	University of Hong Kong; University of Chicago; University of Kansas; Northeastern University - China; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Kaye, TG (corresponding author), Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA.	tomkaye@u.washington.edu	Pittman, Michael/F-9779-2012	Pittman, Michael/0000-0002-6149-3078; Burnham, David/0000-0001-9561-1450; Kaye, Thomas/0000-0001-7996-618X	Dr. Stephen S. F. Hui Trust Fund [201403173007]; Faculty of Science and Department of Earth Sciences of the University of Hong Kong; National Natural Science Foundation of China [41120124002]; 973 (National Basic Research) program [2012CB821900]; University of Kansas Natural History Museum and Biodiversity Institute	Dr. Stephen S. F. Hui Trust Fund; Faculty of Science and Department of Earth Sciences of the University of Hong Kong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 (National Basic Research) program(National Basic Research Program of China); University of Kansas Natural History Museum and Biodiversity Institute	This work was supported by the Dr. Stephen S. F. Hui Trust Fund (201403173007), Faculty of Science and Department of Earth Sciences of the University of Hong Kong, the National Natural Science Foundation of China (41120124002), the 973 (National Basic Research) program (2012CB821900) and a Panorama grant supplied by the University of Kansas Natural History Museum and Biodiversity Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, EFF LOW DOS RAD CROP; Bergmann U, 2010, P NATL ACAD SCI USA, V107, P9060, DOI 10.1073/pnas.1001569107; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Birkmann H, 1996, J PALEONTOL, V70, P1084, DOI 10.1017/S0022336000038774; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; COOK SF, 1962, J PALEONTOL, V36, P483; Croft DA, 2004, PALAEONTOLOGY, V47, P795, DOI 10.1111/j.0031-0239.2004.00398.x; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Eichler Bernd, 2010, Geologica Saxonica, V56, P137; Electric G., 2014, UVA BLUB CATALOG; Endo H., 2008, ANATOMICAL IMAGING N; Frey E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031945; Gong En-Pu, 2012, Palaeoworld, V21, P81, DOI 10.1016/j.palwor.2012.05.003; Hibbs AR, 2004, CONFOCAL MICROSCOPY; Hone DWE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009223; Kaye TG, 2010, 70 ANN M SOC VERT PA; Kaye T, 2007, J VERTEBR PALEONTOL, V27, p98A; Mateus Octavio, 2008, Journal of Paleontological Techniques, V2, P1; Matsumoto B., 2003, CELL BIOL APPL CONFO; MIETHE A., 1928, PALAEONTOL ZEITSCHR, V9, P343; Rauhut OWM, 2005, P ROY SOC B-BIOL SCI, V272, P1179, DOI 10.1098/rspb.2005.3071; Rowe T, 2001, NATURE, V410, P539, DOI 10.1038/35069145; SCHOMACKER KT, 1992, LASER SURG MED, V12, P63, DOI 10.1002/lsm.1900120111; Schopf JW, 2005, GEOBIOLOGY, V3, P1, DOI 10.1111/j.1472-4669.2005.00044.x; Schopf JW, 2011, TOP GEOBIOL, V36, P241, DOI 10.1007/978-94-007-0680-4_10; Schopf JW, 2006, ASTROBIOLOGY, V6, P1, DOI 10.1089/ast.2006.6.1; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002995; Tischlinger H., 2005, ZITTELIANA B, V26, P26; Tischlinger H, 2010, ULTRAVIOLET LIGHT TO; Tischlinger Helmut, 2013, P549; Warren TS, 1999, GEM GUIDES BOOK; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342	33	43	44	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125923	10.1371/journal.pone.0125923	http://dx.doi.org/10.1371/journal.pone.0125923			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016843	Green Submitted, Green Published, gold			2022-12-27	WOS:000355185600040
J	Khalil, HA; Lei, NY; Nie, WX; Lewis, MS; Stelzner, MG; Martin, MG; Dunn, JCY; Yoo, J				Khalil, Hassan A.; Lei, Nan Ye; Nie, Wenxian; Lewis, Michael S.; Stelzner, Matthias G.; Martin, Martin G.; Dunn, James C. Y.; Yoo, James			Primary Myofibroblasts Maintain Short-Term Viability following Submucosal Injection in Syngeneic, Immune-Competent Mice Utilizing Murine Colonoscopy	PLOS ONE			English	Article							TNF-ALPHA; EXPRESSION; MODELS; COX-2	The myofibroblast is an important stromal cell of the gastrointestinal tract. Current in vitro and in vivo models either do not accurately recreate stromal-epithelial interactions or are not specific to myofibroblasts. We sought to create an animal model that would allow the study of myofibroblast-epithelial interactions. We isolated and cultured colonic myofibroblasts from FVB mice. Cells were alpha-SMA and vimentin positive but desmin negative on immunoblot analysis. We injected the myofibroblasts into the colonic submucosa of syngeneic adult mice (n = 8) via a miniendoscopic system. We then isolated green fluorescent protein (GFP) positive colonic myofibroblasts from C57BL/6-Tg(CAG-EGFP) 1Osb/Jmice and injected them into the colonic lamina propria of C57BL/6J mice at 1x10(5) (n = 14), 1x10(6) (n = 9), or 5x10(6) cells/mL (n = 4). A subset of mice were injected with serum-free media and ink without cells (n = 3). Mice underwent repeat endoscopy and euthanasia one or 7 days after injection. Colons were isolated and either fixed in 10% formalin or the inked sites were individually excised and lysed for DNA. We assessed the injection sites via histology and immunohistochemical stains for alpha-SMA and GFP. We used qPCR to quantify GFP DNA transcripts at the lamina propria injection sites. Submucosal injection ofmyofibroblasts resulted in the formation of a subepithelial wheal on endoscopy, which persisted to day 7. Myofibroblasts injected either into the submucosa or lamina propria maintained viability on post-injection day 7 as evidenced by positive alpha-SMA staining. qPCR of lamina propria injections showed a dose-dependent increase in GFP DNA transcripts on post-injection day 1, whereas the number of transcripts on day 7 was equivalent for the concentrations injected. We demonstrate short-term survival of primary cultured colonic myofibroblasts in syngeneic mice. This may prove to be a valuable model for studying the role ofmyofibroblasts in states of health and disease.	[Khalil, Hassan A.; Lei, Nan Ye; Nie, Wenxian; Stelzner, Matthias G.; Dunn, James C. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Lewis, Michael S.] VA Greater Los Angeles Hlth Syst, Dept Pathol & Lab Med, Los Angeles, CA USA; [Stelzner, Matthias G.] VA Greater Los Angeles Hlth Syst, Dept Surg, Los Angeles, CA USA; [Martin, Martin G.] Univ Calif Los Angeles, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA 90024 USA; [Yoo, James] Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; Tufts Medical Center	Yoo, J (corresponding author), Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA.	JYoo@tuftsmedicalcenter.org	Martín, María/HDL-9512-2022; Khalil, Hassan A/AAM-7914-2021	Khalil, Hassan A/0000-0002-3835-1290	National Institutes of Health K08 award [DK085136-03]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases [DK085535]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085535, P30DK041301, K08DK085136] Funding Source: NIH RePORTER	National Institutes of Health K08 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by a National Institutes of Health K08 award #DK085136-03 (JY), and was performed as a project of the Intestinal Stem Cell Consortium (https://iscc.coh.org), a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases #DK085535 (MGM, JCYD, MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canfield JG, 2006, J NEUROSCI METHODS; Ernst M, 2012, J GASTROEN HEPATOL, V27, P39, DOI 10.1111/j.1440-1746.2011.06883.x; Hayashi Y, 2008, J PHARMACOL EXP THER, V326, P523, DOI 10.1124/jpet.108.137083; Khalil H, 2013, JOVE-J VIS EXP, DOI 10.3791/50611; Koliaraki V, 2012, J CLIN INVEST, V122, P4231, DOI 10.1172/JCI63917; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Mehner C, 2013, CELL RES; Mifflin RC, 2011, AM J PHYSIOL-GASTR L, V300, pG684, DOI 10.1152/ajpgi.00474.2010; Mizoguchi A, 2012, PROG MOL BIOL TRANSL, V105, P263, DOI 10.1016/B978-0-12-394596-9.00009-3; Perez CER, 2011, AM J PHYSIOL-GASTR L, V300, pG637, DOI 10.1152/ajpgi.00381.2010; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Yoo J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-90; Yoo J, 2012, AM J PHYSIOL-GASTR L, V302, pG805, DOI 10.1152/ajpgi.00522.2011; Yoo J, 2011, BIOCHEM BIOPH RES CO, V413, P30, DOI 10.1016/j.bbrc.2011.08.029; Zigmond E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028858	15	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127258	10.1371/journal.pone.0127258	http://dx.doi.org/10.1371/journal.pone.0127258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016485	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600077
J	Yuste, C; Rubio-Navarro, A; Barraca, D; Aragoncillo, I; Vega, A; Abad, S; Santos, A; Macias, N; Mahillo, I; Gutierrez, E; Praga, M; Egido, J; Lopez-Gomez, JM; Moreno, JA				Yuste, Claudia; Rubio-Navarro, Alfonso; Barraca, Daniel; Aragoncillo, Ines; Vega, Almudena; Abad, Soraya; Santos, Alba; Macias, Nicolas; Mahillo, Ignacio; Gutierrez, Eduardo; Praga, Manuel; Egido, Jesus; Manuel Lopez-Gomez, Juan; Antonio Moreno, Juan			Haematuria Increases Progression of Advanced Proteinuric Kidney Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; STEROID PULSE THERAPY; ACUTE-RENAL-FAILURE; IGA NEPHROPATHY; NATURAL-HISTORY; RISK; PREDICT; EPIDEMIOLOGY; OUTCOMES; ADULTS	Background Haematuria has been traditionally considered as a benign hallmark of some glomerular diseases; however new studies show that haematuria may decrease renal function. Objective To determine the influence of haematuria on the rate of chronic kidney disease (CKD) progression in 71 proteinuric patients with advanced CKD (baseline eGFR <30 mL/min) during 12 months of follow-up. Results The mean rate of decline in eGFR was higher in patients with both haematuria and proteinuria (haemoproteinuria, HP, n=31) than in patients with proteinuria alone (P patients, n=40) (-3.8 +/- 8.9 vs 0.9 +/- 9.5 mL/min/1.73m(2)/year, p<0.05, respectively). The deleterious effect of haematuria on rate of decline in eGFR was observed in patients <65 years (-6.8 +/- 9.9 (HP) vs. 0.1 +/- 11.7 (P) mL/min/1.73m(2)/year, p<0.05), but not in patients >65 years (-1.2 +/- 6.8 (HP) vs. 1.5 +/- 7.7 (P) mL/min/1.73m(2)/year). Furthermore, the harmful effect of haematuria on eGFR slope was found patients with proteinuria >0.5 g/24 h (-5.8 +/- 6.4 (HP) vs. -1.37 +/- 7.9 (P) mL/min/1.73m2/year, p<0.05), whereas no significant differences were found in patients with proteinuria <0.5 g/24 h (-0.62 +/- 7.4 (HP) vs. 3.4 +/- 11.1 (P) mL/min/1.73m(2)/year). Multivariate analysis reported that presence of haematuria was significantly and independently associated with eGFR deterioration after adjusting for traditional risk factors, including age, serum phosphate, mean proteinuria and mean serum PTH (beta=-4.316, p=0.025). Conclusions The presence of haematuria is closely associated with a faster decrease in renal function in advanced proteinuric CKD patients, especially in younger CKD patients with high proteinuria levels; therefore this high risk subgroup of patients would benefit of intensive medical surveillance and treatment.	[Yuste, Claudia; Barraca, Daniel; Aragoncillo, Ines; Vega, Almudena; Abad, Soraya; Santos, Alba; Macias, Nicolas; Manuel Lopez-Gomez, Juan] Gregorio Maranon Hosp, Renal Unit, Madrid, Spain; [Rubio-Navarro, Alfonso; Egido, Jesus; Antonio Moreno, Juan] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Renal Vasc & Diabet Res Lab, Madrid, Spain; [Mahillo, Ignacio] IIS Fdn Jimenez Diaz, Dept Epidemiol, Madrid, Spain; [Gutierrez, Eduardo; Praga, Manuel] Doce Octubre Hosp, Dept Nephrol, Madrid, Spain; [Egido, Jesus] Ctr Invest Biomed Red Diabet & Enfermedad Metab A, Madrid, Spain; [Egido, Jesus] FRIAT IRSIN, Madrid, Spain	General University Gregorio Maranon Hospital; Autonomous University of Madrid; Fundacion Jimenez Diaz; Fundacion Jimenez Diaz; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Moreno, JA (corresponding author), Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Renal Vasc & Diabet Res Lab, Madrid, Spain.	jamoreno@fjd.es	PRAGA, MANUEL/W-4091-2017; Moreno, Juan Antonio/B-3487-2018; Macías, Nicolás/AAI-2628-2021; Rubio, Alfonso/ABH-5028-2020; Mahillo-Fernandez, Ignacio/T-2042-2018	Moreno, Juan Antonio/0000-0002-7468-2871; Macías, Nicolás/0000-0003-2133-0933; Rubio, Alfonso/0000-0001-5677-3123; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541; Yuste, Claudia/0000-0001-6327-9588	FIS (Programa Miguel Servet) [CP10/00479, PI13/00802, PI14/00883]; Spanish Society of Nephrology; Fundacion Lilly, FRIAT (Fundacion Renal Inigo Alvarez de Toledo); ISCIII fund [PI14/00386]	FIS (Programa Miguel Servet); Spanish Society of Nephrology; Fundacion Lilly, FRIAT (Fundacion Renal Inigo Alvarez de Toledo); ISCIII fund	This work was supported by grants from FIS (Programa Miguel Servet: CP10/00479, PI13/00802 and PI14/00883) and Spanish Society of Nephrology to Juan Antonio Moreno. Fundacion Lilly, FRIAT (Fundacion Renal Inigo Alvarez de Toledo) and ISCIII fund PI14/00386 to Jesus Egido.	Abdel-Rahman EM, 2014, NEPHRON CLIN PRACT, V127, P15, DOI 10.1159/000363708; BEUKHOF JR, 1986, KIDNEY INT, V29, P549, DOI 10.1038/ki.1986.33; Brodsky SV, 2011, KIDNEY INT, V80, P182, DOI 10.1038/ki.2011.44; Chen TK, 2014, SEMIN ARTHRITIS RHEU, V44, P198, DOI 10.1016/j.semarthrit.2014.03.008; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Deltas C, 2012, PEDIATR NEPHROL, V27, P1221, DOI 10.1007/s00467-011-1935-5; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El-Ghoul B, 2009, J AM GERIATR SOC, V57, P2217, DOI 10.1111/j.1532-5415.2009.02561.x; Espinosa M, 2009, NEPHROL DIAL TRANSPL, V24, P886, DOI 10.1093/ndt/gfn563; Fogazzi GB, 2008, AM J KIDNEY DIS, V51, P1052, DOI 10.1053/j.ajkd.2007.11.039; Frimat L, 1997, NEPHROL DIAL TRANSPL, V12, P2569; Gale DP, 2013, PEDIATR NEPHROL, V28, P1183, DOI 10.1007/s00467-012-2399-y; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P1242, DOI 10.1093/ndt/gfn610; Gutieerrez E, 2007, CLIN J AM SOC NEPHRO, V2, P51, DOI 10.2215/CJN.02670706; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; HEYMAN SN, 1995, NEPHROL DIAL TRANSPL, V10, P591; Hirano K, 2013, CLIN EXP NEPHROL, V17, P555, DOI 10.1007/s10157-012-0744-x; Kawamura T, 2014, NEPHROL DIAL TRANSPL, V29, P1546, DOI 10.1093/ndt/gfu020; Khan UA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071784; Kido R, 2010, AM J TRANSPLANT, V10, P1597, DOI 10.1111/j.1600-6143.2010.03077.x; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lin HY, 2009, CIRC-CARDIOVASC GENE, V2, P450, DOI 10.1161/CIRCGENETICS.109.862920; Lucove J, 2008, AM J KIDNEY DIS, V51, P21, DOI 10.1053/j.ajkd.2007.09.014; Nath KA, 2000, KIDNEY INT, V57, P2423, DOI 10.1046/j.1523-1755.2000.00101.x; OTERO A, 2005, KIDNEY INT S99, V68, P16; PALLER MS, 1994, P NATL ACAD SCI USA, V91, P7002, DOI 10.1073/pnas.91.15.7002; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Suzuki K, 2014, CLIN EXP NEPHROL, V18, P606, DOI 10.1007/s10157-013-0867-8; Szeto CC, 2001, AM J MED, V110, P434, DOI 10.1016/S0002-9343(01)00659-3; Tanaka K, 2014, CLIN EXP NEPHROL; Tracz MJ, 2007, J AM SOC NEPHROL, V18, P414, DOI 10.1681/ASN.2006080894; Vivante A, 2011, JAMA-J AM MED ASSOC, V306, P729, DOI 10.1001/jama.2011.1141; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yuste C, 2013, NEFROLOGIA, V33, P685, DOI 10.3265/Nefrologia.pre2013.May.11900	38	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0128575	10.1371/journal.pone.0128575	http://dx.doi.org/10.1371/journal.pone.0128575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26016848	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600120
J	Cardona-Arias, JA; Velez, ID; Lopez-Carvajal, L				Antonio Cardona-Arias, Jaiberth; Dario Velez, Ivan; Lopez-Carvajal, Liliana			Efficacy of Thermotherapy to Treat Cutaneous Leishmaniasis: A Meta-Analysis of Controlled Clinical Trials	PLOS ONE			English	Article							LOCAL HEAT THERAPY; MEGLUMINE ANTIMONIATE; TOPICAL PAROMOMYCIN; METHYLBENZETHONIUM CHLORIDE; SODIUM STIBOGLUCONATE; DOUBLE-BLIND; GLUCANTIME; TROPICA; RADIOFREQUENCY; PUBLICATION	Introduction The efficacy of thermotherapy for the treatment of cutaneous leishmaniasis presents diverse results with low statistical power. Objective To evaluate the efficacy of thermotherapy to treat cutaneous leishmaniasis. Methods A meta-analysis of controlled clinical trials in 12 databases based on the implementation of a research protocol with inclusion and exclusion criteria and an assessment of methodological quality. The reproducibility and completeness were guaranteed in the information search and extraction. Heterogeneity, sensitivity and publication bias were assessed by graphical methods (Galbraith, L'Abble,, funnel plot, Egger plot, and influence plot) and analytical methods (DerSimonian-Laird, Begg and Egger). Random-effects forest plots were constructed, and a cumulative meta-analysis was performed. Results Eight studies were included with 622 patients who underwent thermotherapy, with an efficacy of 73.2% (95% confidence interval (CI)=69.6-76.7%), and with 667 patients who underwent systemic treatment, with an efficacy of 70.6% (95% CI=67.1-74.1%). Heterogeneity between studies, good sensitivity for the combined measure, and no publication bias were observed. The relative risk for comparison of the efficacy of treatment was 1.02 (95% CI=0.91, 1.15), showing that the effectiveness of thermotherapy is equal to that of pentavalent antimonial drugs. Conclusion Due to its efficacy, greater safety and lower cost, thermotherapy should be the first treatment option for cutaneous leishmaniasis in areas where the prevalence of the mucocutaneous form is low and in patients with contraindications to systemic treatment, such as kidney, liver and heart diseases, as well as in pregnant women, infants, and patients with human immunodeficiency virus infection/acquired immune deficiency syndrome.	[Antonio Cardona-Arias, Jaiberth] Cooperat Univ Colombia, Sch Med, Medellin, Colombia; [Dario Velez, Ivan] Univ Antioquia, PECET, Medellin, Colombia; [Lopez-Carvajal, Liliana] Univ Antioquia, PECET, Epidemiol, Medellin, Colombia; [Antonio Cardona-Arias, Jaiberth] Univ Antioquia UofA, Sch Microbiol, Medellin, Colombia	Universidad Cooperativa de Colombia; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia	Velez, ID (corresponding author), Univ Antioquia, PECET, Medellin, Colombia.	idvelez@pecet-colombia.org	Cardona, Jaiberth/GZL-3892-2022	Cardona Arias, Jaiberth/0000-0002-7101-929X				Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Arevalo I, 2007, CLIN INFECT DIS, V44, P1549, DOI 10.1086/518172; Armijos RX, 2004, ACTA TROP, V91, P153, DOI 10.1016/j.actatropica.2004.03.009; Aronson NE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000628; Asilian A, 2006, CLIN EXP DERMATOL, V31, P634, DOI 10.1111/j.1365-2230.2006.02182.x; Bailey MS, 2007, CLIN DERMATOL, V25, P203, DOI 10.1016/j.clindermatol.2006.05.008; Berman JD, 1996, CLIN DERMATOL, V14, P519, DOI 10.1016/0738-081X(96)00048-X; Buffet P A, 2003, Bull Soc Pathol Exot, V96, P383; Bumb RA, 2013, BRIT J DERMATOL, V168, P1114, DOI 10.1111/bjd.12205; Correia D, 1996, Rev Soc Bras Med Trop, V29, P447, DOI 10.1590/S0037-86821996000500007; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dowlati Y, 1996, CLIN DERMATOL, V14, P513, DOI 10.1016/0738-081X(96)00047-8; Firooz Alireza, 2005, J Drugs Dermatol, V4, P73; Gonzalez U, 2009, COCHRANE DB SYST REV, V15, DOI DOI 10.1002/14651858.CD004834; GROGL M, 1992, AM J TROP MED HYG, V47, P117, DOI 10.4269/ajtmh.1992.47.117; Hadighi R, 2007, PARASITOL RES, V101, P1319, DOI 10.1007/s00436-007-0638-0; Hadighi R, 2006, PLOS MED, V3, P659, DOI 10.1371/journal.pmed.0030162; HEPBURN NC, 1994, T ROY SOC TROP MED H, V88, P700, DOI 10.1016/0035-9203(94)90237-2; Kedzierski L, 2009, CURR MED CHEM, V16, P599, DOI 10.2174/092986709787458489; KRAUSE G, 1994, T ROY SOC TROP MED H, V88, P92, DOI 10.1016/0035-9203(94)90517-7; LARBI EB, 1995, AM J TROP MED HYG, V52, P166, DOI 10.4269/ajtmh.1995.52.166; LEVINE N, 1992, ARCH DERMATOL, V128, P759, DOI 10.1001/archderm.128.6.759; Lobo IMF, 2006, T ROY SOC TROP MED H, V100, P642, DOI 10.1016/j.trstmh.2005.08.011; Lopez L, 2013, REV INST MED TROP SP, V55, P197, DOI 10.1590/S0036-46652013000300011; Lopez L, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-58; Moher D, 2009, PLOS MED, V6, DOI DOI 10.1371/J0URNAL.PMED.1000114; Moreira Rosilene da Conceição R., 2002, Cad. Saúde Pública, V18, P187, DOI 10.1590/S0102-311X2002000100019; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; National Institute of Health of Colombia Ministry of Social Protection of the Republic of Colombia Pan American Health Organization, 2013, PROT PUBL HLTH SURV; NAVIN TR, 1990, AM J TROP MED HYG, V42, P43, DOI 10.4269/ajtmh.1990.42.43; Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007; Organizacion Panamericana de la Salud, 2013, LEISHM AM REC TRAT W; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; Palumbo E, 2009, AM J THER, V16, P178, DOI 10.1097/MJT.0b013e3181822e90; Prasad N, 2011, LANCET, V377, P610, DOI 10.1016/S0140-6736(10)61495-X; Reithinger R, 2005, CLIN INFECT DIS, V40, P1148, DOI 10.1086/428736; Sadeghian G, 2007, CLIN EXP DERMATOL, V32, P371, DOI 10.1111/j.1365-2230.2007.02405.x; Safi N, 2012, MIL MED, V177, P345, DOI 10.7205/MILMED-D-11-00161; Sampaio R N, 1997, Rev Soc Bras Med Trop, V30, P457, DOI 10.1590/S0037-86821997000600003; Seaton RA, 1999, QJM-MON J ASSOC PHYS, V92, P659, DOI 10.1093/qjmed/92.11.659; Soto J, 1998, CLIN INFECT DIS, V26, P56, DOI 10.1086/516267; Soto Jaime, 2006, Biomed., V26, P194; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Tuon FF, 2008, INT J DERMATOL, V47, P109, DOI 10.1111/j.1365-4632.2008.03417.x; Uribarren T, 2013, LEISHMANIASIS; VelascoCastrejon O, 1997, AM J TROP MED HYG, V57, P309, DOI 10.4269/ajtmh.1997.57.309; Velez I D, 2001, Cad Saude Publica, V17, P171, DOI 10.1590/S0102-311X2001000100018; Velez I, 2010, AM J TROP MED HYG, V83, P351, DOI 10.4269/ajtmh.2010.10-0060; Weigel M M, 2001, Rev Panam Salud Publica, V10, P395, DOI 10.1590/S1020-49892001001200005; WHO, 2010, WHO TECH REP SER, V949, P1; Zerehsaz F, 1999, INT J DERMATOL, V38, P610, DOI 10.1046/j.1365-4362.1999.00727.x	52	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0122569	10.1371/journal.pone.0122569	http://dx.doi.org/10.1371/journal.pone.0122569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009885	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900002
J	Asbe, A; Matsushita, SC; Gordon, S; Kirkpatrick, HE; Madlung, A				Asbe, Amelia; Matsushita, Starr C.; Gordon, Spencer; Kirkpatrick, H. E.; Madlung, Andreas			Floral Reversion in Arabidopsis suecica Is Correlated with the Onset of Flowering and Meristem Transitioning	PLOS ONE			English	Article							MADS-BOX PROTEINS; INFLORESCENCE ARCHITECTURE; NATURAL VARIATION; THALIANA; PLANTS; GYNOECIUM; TIME; PHOTOPERIOD; MORPHOLOGY; IMPATIENS	Angiosperm flowers are usually determinate structures that may produce seeds. In some species, flowers can revert from committed flower development back to an earlier developmental phase in a process called floral reversion. The allopolyploid Arabidopsis suecica displays photoperiod-dependent floral reversion in a subset of its flowers, yet little is known about the environmental conditions enhancing this phenotype, or the morphological processes leading to reversion. We have used light and electron microscopy to further describe this phenomenon. Additionally, we have further studied the phenology of flowering and floral reversion in A. suecica. In this study we confirm and expand upon our previous findings that floral reversion in the allopolyploid A. suecica is photoperiod-dependent, and show that its frequency is correlated with the timing for the onset of flowering. Our results also suggest that floral reversion in A. suecica displays natural variation in its penetrance between geographic populations of A. suecica.	[Asbe, Amelia; Matsushita, Starr C.; Gordon, Spencer; Kirkpatrick, H. E.; Madlung, Andreas] Univ Puget Sound, Dept Biol, Tacoma, WA 98416 USA		Madlung, A (corresponding author), Univ Puget Sound, Dept Biol, Tacoma, WA 98416 USA.	amadlung@pugetsound.edu			National Science Foundation [IOS-1118539]; University of Puget Sound	National Science Foundation(National Science Foundation (NSF)); University of Puget Sound	This work was supported by National Science Foundation, grant #IOS-1118539 (to AM), www.nsf.gov; University of Puget Sound, Summer Research Fellowship (to AA, SG), www.pugetsound.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani MC, 2010, CURR TOP DEV BIOL, V91, P323, DOI 10.1016/S0070-2153(10)91011-9; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; BATTEY NH, 1990, BOT REV, V56, P162, DOI 10.1007/BF02858534; Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; DIGGLE PK, 1995, ANNU REV ECOL SYST, V26, P531, DOI 10.1146/annurev.es.26.110195.002531; DIOMAIUTO J, 1988, Phytomorphology, V38, P163; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Grbic V, 1996, DEVELOPMENT, V122, P2395; Gregis V, 2008, PLANT J, V56, P891, DOI 10.1111/j.1365-313X.2008.03648.x; Gregis V, 2009, PLANT J, V60, P626, DOI 10.1111/j.1365-313X.2009.03985.x; Hegarty M, 2013, CYTOGENET GENOME RES, V140, P204, DOI 10.1159/000353361; Jackson SD, 2009, NEW PHYTOL, V181, P517, DOI 10.1111/j.1469-8137.2008.02681.x; Jakobsson M, 2006, MOL BIOL EVOL, V23, P1217, DOI 10.1093/molbev/msk006; Johansson M, J EXP BOT; JSTOR, GLOB PLANTS LUN ANN; Jung JH, 2014, PLANT SCI, V215, P29, DOI 10.1016/j.plantsci.2013.10.010; KAMM A, 1995, PLANT MOL BIOL, V27, P853, DOI 10.1007/BF00037014; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; LLOYD DG, 1980, NEW PHYTOL, V86, P69, DOI 10.1111/j.1469-8137.1980.tb00780.x; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; Madlung A, 2012, PHYSIOL PLANTARUM, V144, P123, DOI 10.1111/j.1399-3054.2011.01526.x; McCullough E, 2010, NEW PHYTOL, V186, P239, DOI 10.1111/j.1469-8137.2009.03141.x; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Nooden LD, 2001, J EXP BOT, V52, P2151, DOI 10.1093/jexbot/52.364.2151; Ordidge M, 2005, PLANT J, V44, P985, DOI 10.1111/j.1365-313X.2005.02607.x; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Payne T, 2004, DEVELOPMENT, V131, P3737, DOI 10.1242/dev.01216; Poduska B, 2003, GENETICS, V163, P1457; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Prenner G, 2009, TRENDS PLANT SCI, V14, P302, DOI 10.1016/j.tplants.2009.03.004; Sall T, 2004, HEREDITAS, V141, P313, DOI 10.1111/j.1601-5223.2004.01833.x; Savolainen O, 2011, SCIENCE, V334, P49, DOI 10.1126/science.1213788; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Sun B, 2009, GENE DEV, V23, P1791, DOI 10.1101/gad.1800409; Teo ZWN, 2014, TRENDS PLANT SCI, V19, P158, DOI 10.1016/j.tplants.2013.11.001; Tooke F, 2000, PLANT CELL, V12, P1837, DOI 10.1105/tpc.12.10.1837; Tooke F, 2005, J EXP BOT, V56, P2587, DOI 10.1093/jxb/eri254; Trigueros M, 2009, PLANT CELL, V21, P1394, DOI 10.1105/tpc.109.065508; Wang JL, 2006, GENETICS, V173, P965, DOI 10.1534/genetics.106.056580; Wang Q, 2007, CURR BIOL, V17, P1513, DOI 10.1016/j.cub.2007.07.059; Xing SP, 2013, PLANT J, V75, P566, DOI 10.1111/tpj.12221; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	48	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127897	10.1371/journal.pone.0127897	http://dx.doi.org/10.1371/journal.pone.0127897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011630	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900161
J	Baselga, A; Bonthoux, S; Balent, G				Baselga, Andres; Bonthoux, Sebastien; Balent, Gerard			Temporal Beta Diversity of Bird Assemblages in Agricultural Landscapes: Land Cover Change vs. Stochastic Processes	PLOS ONE			English	Article							FARMLAND BIRDS; CLIMATE-CHANGE; TIME-LAG; RESPONSES; TURNOVER; COMMUNITIES; VEGETATION; DYNAMICS; BIODIVERSITY; ABANDONMENT	Temporal variation in the composition of species assemblages could be the result of deterministic processes driven by environmental change and/or stochastic processes of colonization and local extinction. Here, we analyzed the relative roles of deterministic and stochastic processes on bird assemblages in an agricultural landscape of southwestern France. We first assessed the impact of land cover change that occurred between 1982 and 2007 on (i) the species composition (presence/absence) of bird assemblages and (ii) the spatial pattern of taxonomic beta diversity. We also compared the observed temporal change of bird assemblages with a null model accounting for the effect of stochastic dynamics on temporal beta diversity. Temporal assemblage dissimilarity was partitioned into two separate components, accounting for the replacement of species (i.e. turnover) and for the nested species losses (or gains) from one time to the other (i.e. nestedness-resultant dissimilarity), respectively. Neither the turnover nor the nestedness-resultant components of temporal variation were accurately explained by any of the measured variables accounting for land cover change (r(2)<0.06 in all cases). Additionally, the amount of spatial assemblage heterogeneity in the region did not significantly change between 1982 and 2007, and site-specific observed temporal dissimilarities were larger than null expectations in only 1% of sites for temporal turnover and 13% of sites for nestedness-resultant dissimilarity. Taken together, our results suggest that land cover change in this agricultural landscape had little impact on temporal beta diversity of bird assemblages. Although other unmeasured deterministic process could be driving the observed patterns, it is also possible that the observed changes in presence/absence species composition of local bird assemblages might be the consequence of stochastic processes in which species populations appeared and disappeared from specific localities in a random-like way. Our results might be case-specific, but if stochastic dynamics are generally dominant, the ability of correlative and mechanistic models to predict land cover change effects on species composition would be compromised.	[Baselga, Andres] Univ Santiago de Compostela, Fac Biol, Dept Zool, Santiago De Compostela 15782, Spain; [Bonthoux, Sebastien; Balent, Gerard] INRA, UMR DYNAFOR 1201, F-31320 Castanet Tolosan, France; [Bonthoux, Sebastien] ENSNP, UMR CITERES 7324, F-41000 Blois, France	Universidade de Santiago de Compostela; INRAE	Baselga, A (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Zool, Rua Lope Gomez de Marzoa S-N, Santiago De Compostela 15782, Spain.	andres.baselga@usc.es	Baselga, Andres/A-6740-2008	Baselga, Andres/0000-0001-7914-7109	French National Institute for Agricultural Research (INRA)	French National Institute for Agricultural Research (INRA)	The authors thank the French National Institute for Agricultural Research (INRA) for supporting this long term research on bird communities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeler DG, 2012, FRESHWATER BIOL, V57, P1782, DOI 10.1111/j.1365-2427.2012.02838.x; BALENT G, 1992, LANDSCAPE ECOL, V6, P195; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Benedetti-Cecchi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002777; Berg A, 2002, BIRD STUDY, V49, P153, DOI 10.1080/00063650209461260; Betts MG, 2014, ECOGRAPHY, V37, P517, DOI 10.1111/ecog.00740; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Bonthoux S, 2013, OECOLOGIA, V172, P563, DOI 10.1007/s00442-012-2498-2; Bonthoux S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054179; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Crawley M.J., 2007, R BOOK; Cunningham R, 2014, ECOL APPL, V24, P1275, DOI 10.1890/13-0872.1; Deconchat M, 2001, FORESTRY, V74, P105, DOI 10.1093/forestry/74.2.105; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Gil-Tena A, 2009, GLOBAL CHANGE BIOL, V15, P474, DOI 10.1111/j.1365-2486.2008.01730.x; Guilherme JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073619; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; Bellocq MI, 2011, ECOSCIENCE, V18, P354, DOI 10.2980/18-4-3431; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Korhonen JJ, 2010, ECOLOGY, V91, P508, DOI 10.1890/09-0392.1; Lindstrom A, 2013, ECOGRAPHY, V36, P313, DOI 10.1111/j.1600-0587.2012.07799.x; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Core Team, 2021, R LANGUAGE ENV STAT; Sanderson FJ, 2013, AGR ECOSYST ENVIRON, V168, P16, DOI 10.1016/j.agee.2013.01.015; Sanderson FJ, 2009, AGR ECOSYST ENVIRON, V129, P37, DOI 10.1016/j.agee.2008.07.001; Schaefer HC, 2008, GLOBAL ECOL BIOGEOGR, V17, P38, DOI 10.1111/j.1466-8238.2007.00341.x; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; Sirami C, 2008, ECOGRAPHY, V31, P509, DOI 10.1111/j.0906-7590.2008.05403.x; Sirami C, 2007, DIVERS DISTRIB, V13, P42, DOI 10.1111/j.1472-4642.2006.00297.x; Soderstrom B, 2000, CONSERV BIOL, V14, P522, DOI 10.1046/j.1523-1739.2000.98564.x; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wretenberg J, 2010, BIOL CONSERV, V143, P375, DOI 10.1016/j.biocon.2009.11.001	47	41	42	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127913	10.1371/journal.pone.0127913	http://dx.doi.org/10.1371/journal.pone.0127913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010153	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900164
J	Bourjade, M; Thierry, B; Hausberger, M; Petit, O				Bourjade, Marie; Thierry, Bernard; Hausberger, Martine; Petit, Odile			Is Leadership a Reliable Concept in Animals? An Empirical Study in the Horse	PLOS ONE			English	Article							EQUUS-FERUS-PRZEWALSKII; COLLECTIVE DECISION-MAKING; SOCIAL RELATIONSHIPS; CONSENSUS DECISION; GROUP DEPARTURES; MOVEMENTS; BEHAVIOR; EVOLUTION; DOMINANCE; COORDINATION	Leadership is commonly invoked when accounting for the coordination of group movements in animals, yet it remains loosely defined. In parallel, there is increased evidence of the sharing of group decisions by animals on the move. How leadership integrates within this recent framework on collective decision-making is unclear. Here, we question the occurrence of leadership in horses, a species in which this concept is of prevalent use. The relevance of the three main definitions of leadership - departing first, walking in front travel position, and eliciting the joining of mates - was tested on the collective movements of two semi-free ranging groups of Przewalski horses (Equus ferus przewalskii). We did not find any leader capable of driving most group movements or recruiting mates more quickly than others. Several group members often displayed pre-departure behaviours at the same time, and the simultaneous departure of several individuals was common. We conclude that the decision-making process was shared by several group members a group movement (i.e., partially shared consensus) and that the leadership concept did not help to depict individual departure and leading behaviour across movements in both study groups. Rather, the different proxies of leadership produced conflicting information about individual contributions to group coordination. This study discusses the implications of these findings for the field of coordination and decision-making research.	[Bourjade, Marie] Univ Toulouse Jean Jaures, Unite Rech Interdisciplinaire Octogone, Lab Cognit Commun Dev, Toulouse, France; [Bourjade, Marie] Assoc Takh Cheval Przewalski, Stn Biol Tour Valat, Arles, France; [Thierry, Bernard; Petit, Odile] CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France; [Thierry, Bernard; Petit, Odile] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Hausberger, Martine] Univ Rennes 1, CNRS, Lab Ethol Anim & Humaine, Rennes, France	Universite de Toulouse; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Bourjade, M (corresponding author), Univ Toulouse Jean Jaures, Unite Rech Interdisciplinaire Octogone, Lab Cognit Commun Dev, Toulouse, France.	marie.bourjade@univ-tlse2.fr			GDR of Ethology [2822]; MAVA Foundation; Station Biologique de la Tour du Valat	GDR of Ethology; MAVA Foundation; Station Biologique de la Tour du Valat	Financial and logistic supports came from the GDR of Ethology (2822), the MAVA Foundation and the Station Biologique de la Tour du Valat.	Akos Z, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003446; BERGER J, 1977, BEHAV ECOL SOCIOBIOL, V2, P131, DOI 10.1007/BF00361898; Boinski S., 2000, MOVE WHY ANIMALS TRA; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Bourjade M, 2010, BEHAV PROCESS, V84, P648, DOI 10.1016/j.beproc.2010.02.027; Bourjade M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004888; Bourjade M, 2009, ETHOLOGY, V115, P321, DOI 10.1111/j.1439-0310.2009.01614.x; BYRNE RW, 1990, AM J PRIMATOL, V20, P313, DOI 10.1002/ajp.1350200409; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dumont B, 2005, APPL ANIM BEHAV SCI, V95, P55, DOI 10.1016/j.applanim.2005.04.005; Faria JJ, 2010, ANIM BEHAV, V79, P895, DOI 10.1016/j.anbehav.2009.12.039; Feh C, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P83; FEIST JD, 1976, Z TIERPSYCHOL, V41, P337; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Fureix C, 2012, APPL ANIM BEHAV SCI, V138, P216, DOI 10.1016/j.applanim.2012.02.009; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hinde RA., 1974, BIOL BASES HUMAN SOC; Holekamp KE, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P587; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; King AJ, 2011, INT J PRIMATOL, V32, P1245, DOI 10.1007/s10764-011-9526-7; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; King SRB, 2010, APPL ANIM BEHAV SCI, V125, P22, DOI 10.1016/j.applanim.2010.03.006; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Krueger K, 2014, BEHAV PROCESS, V103, P91, DOI 10.1016/j.beproc.2013.10.007; Kummer H., 1968, SOCIAL ORG HAMADRYAS; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Lamprecht J, 1996, SOC SCI INFORM, V35, P595, DOI 10.1177/053901896035004001; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Linklater WL, 2000, BIOL REV, V75, P1, DOI 10.1017/S0006323199005411; List C, 2004, TRENDS ECOL EVOL, V19, P168, DOI 10.1016/j.tree.2004.02.004; Meunier H, 2008, PRIMATES, V49, P26, DOI 10.1007/s10329-007-0055-0; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nakayama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043747; Nakayama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036606; Ozogany K, 2015, J STAT PHYS, V158, P628, DOI 10.1007/s10955-014-1131-7; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pillot MH, 2010, BEHAV PROCESS, V83, P235, DOI 10.1016/j.beproc.2009.11.006; Pyritz LW, 2011, INT J PRIMATOL, V32, P1268, DOI 10.1007/s10764-011-9524-9; Ramseyer A, 2009, ETHOLOGY, V115, P948, DOI 10.1111/j.1439-0310.2009.01686.x; Ramseyer A, 2009, ANIM BEHAV, V78, P71, DOI 10.1016/j.anbehav.2009.03.017; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; REINHARDT V, 1983, BEHAVIOUR, V83, P251, DOI 10.1163/156853983X00183; Sarova R, 2010, ANIM BEHAV, V79, P1037, DOI 10.1016/j.anbehav.2010.01.019; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Souris AC, 2007, APPL ANIM BEHAV SCI, V107, P307, DOI 10.1016/j.applanim.2006.09.023; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2011, INT J PRIMATOL, V32, P1413, DOI 10.1007/s10764-011-9520-0; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Sueur C, 2010, ANIM COGN, V13, P239, DOI 10.1007/s10071-009-0261-9; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M, 2007, DEVELOPMENTAL SCI, V10, P121, DOI 10.1111/j.1467-7687.2007.00573.x; Tyler S., 1972, ANIM BEHAV MONOGR, V5, P87, DOI [DOI 10.1016/0003-3472(72)90003-6, 10.1016/0003-3472(72)90003-6]; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Welsh DA, 1975, THESIS DALHOUSIE U; Wolf M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2777; Xia CJ, 2014, BIOL CONSERV, V177, P142, DOI 10.1016/j.biocon.2014.06.021	69	15	15	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126344	10.1371/journal.pone.0126344	http://dx.doi.org/10.1371/journal.pone.0126344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010442	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900027
J	Chen, Y; Wang, ZT; Wang, ZY; Chen, DY; Chai, YC; Pang, XH; Sun, LH; Wang, XW; Yang, T; Wu, H				Chen, Ying; Wang, Zhentao; Wang, Zhaoyan; Chen, Dongye; Chai, Yongchuan; Pang, Xiuhong; Sun, Lianhua; Wang, Xiaowen; Yang, Tao; Wu, Hao			Targeted Next-Generation Sequencing in Uyghur Families with Non-Syndromic Sensorineural Hearing Loss	PLOS ONE			English	Article							RECESSIVE DEAFNESS; MUTATIONS; GENE; SPECTRUM	The mutation spectrum of deafness genes may vary in different ethnical groups. In this study, we investigated the genetic etiology of nonsyndromic deafness in four consanguineous and two multiplex Uyghur families in which mutations in common deafness genes GJB2, SLC26A4 and MT-RNR1 were excluded. Targeted next-generation sequencing of 97 deafness genes was performed in the probands of each family. Novel pathogenic mutations were identified in four probands including the p.L416R/p.A438T compound heterozygous mutations in TMC1, the homozygous p.V1880E mutation in MYO7A, c.1238delT frameshifting deletion in PCDH15 and c.9690+1G>A splice site mutation in MYO15A. Co-segregation of the mutations and the deafness were confirmed within each family by Sanger sequencing. No pathogenic mutations were identified in one multiplex family and one consanguineous family. Our study provided a useful piece of information for the genetic etiology of deafness in Uyghurs.	[Chen, Ying; Wang, Zhentao; Wang, Zhaoyan; Chen, Dongye; Chai, Yongchuan; Pang, Xiuhong; Sun, Lianhua; Wang, Xiaowen; Yang, Tao; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Chen, Ying; Wang, Zhentao; Wang, Zhaoyan; Chen, Dongye; Chai, Yongchuan; Pang, Xiuhong; Sun, Lianhua; Wang, Xiaowen; Yang, Tao; Wu, Hao] Shanghai Jiao Tong Univ, Ear Inst, Shanghai 200030, Peoples R China; [Chen, Ying; Wang, Zhentao; Wang, Zhaoyan; Chen, Dongye; Chai, Yongchuan; Pang, Xiuhong; Sun, Lianhua; Wang, Xiaowen; Yang, Tao; Wu, Hao] Shanghai Key Lab Translat Med Ear & Nose Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, T (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China.	yangtfxl@sina.com; wuhao622@sina.cn	Pang, Xiuhong/ABE-2751-2021	Yang, Tao/0000-0001-6011-987X	Shanghai Municipal Science and Technology Commission [14DZ2260300]; National Basic Research Program of China [2011CB504501]; National Science Foundation of China [81170924, 81330023, 81222010, 81371101]; Shanghai Municipal Education Commission; Specialized Research Fund for the Doctoral Program of Higher Education [20130073110011];  [2012BAI09B02]	Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); 	This research was supported by grants from Shanghai Municipal Science and Technology Commission (14DZ2260300 to HW), National Basic Research Program of China (2011CB504501 to HW), National Science Foundation of China (81170924, 81330023 to HW and 81222010, 81371101 to TY), Minister of Science and Technology (2012BAI09B02 to HW), the Oriental Scholar project from Shanghai Municipal Education Commission (to TY) and Specialized Research Fund for the Doctoral Program of Higher Education (20130073110011 to TY).	Baek JI, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-60; Chen Y, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-154; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Ji YB, 2011, ACTA OTO-LARYNGOL, V131, P124, DOI 10.3109/00016489.2010.483479; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Lezirovitz K, 2008, EUR J HUM GENET, V16, P89, DOI 10.1038/sj.ejhg.5201917; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Mutai H, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-172; Nance WE, 2003, MENT RETARD DEV D R, V9, P109, DOI 10.1002/mrdd.10067; Tekin M, 2008, CLIN GENET, V73, P554, DOI 10.1111/j.1399-0004.2008.01004.x; Vozzi D, 2014, GENE, V542, P209, DOI 10.1016/j.gene.2014.03.033; Wang ZT, 2014, INT J PEDIATR OTORHI, V78, P1513, DOI 10.1016/j.ijporl.2014.06.023; Xu DR, 2011, J TRANSL MED, V9, DOI [10.1186/1479-5876-9-167, 10.1186/1479-5876-9-74]; Yang T, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-85; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030720	15	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127879	10.1371/journal.pone.0127879	http://dx.doi.org/10.1371/journal.pone.0127879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26011067	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900156
J	Guthrie, N; Bradlyn, A; Thompson, SK; Yen, S; Haritatos, J; Dillon, F; Cole, SW				Guthrie, Nicole; Bradlyn, Andrew; Thompson, Sharon K.; Yen, Sophia; Haritatos, Jana; Dillon, Fred; Cole, Steve W.			Development of an Accelerometer-Linked Online Intervention System to Promote Physical Activity in Adolescents	PLOS ONE			English	Article							FINANCIAL INCENTIVES; INTRINSIC MOTIVATION; SELF-DETERMINATION; ACTIVITY MONITORS; VIDEO GAMES; ENERGY-COST; HEART-RATE; CHILDREN; VALIDITY; MODERATE	Most adolescents do not achieve the recommended levels of moderate-to-vigorous physical activity (MVPA), placing them at increased risk for a diverse array of chronic diseases in adulthood. There is a great need for scalable and effective interventions that can increase MVPA in adolescents. Here we report the results of a measurement validation study and a preliminary proof-of-concept experiment testing the impact of Zamzee, an accelerometer-linked online intervention system that combines proximal performance feedback and incentive motivation features to promote MVPA. In a calibration study that parametrically varied levels of physical activity in 31 12-14 year-old children, the Zamzee activity meter was shown to provide a valid measure of MVPA (sensitivity in detecting MVPA = 85.9%, specificity = 97.5%, and r = .94 correspondence with the benchmark RT3 accelerometer system; all p < .0001). In a subsequent randomized controlled multi-site experiment involving 182 middle school-aged children assessed for MVPA over 6 wks, intent-to-treat analyses found that those who received access to the Zamzee intervention had average MVPA levels 54% greater than those of a passive control group (p < 0.0001) and 68% greater than those of an active control group that received access to a commercially available active videogame (p < .0001). Zamzee's effects on MVPA did not diminish significantly over the course of the 6-wk study period, and were statistically significant in both females and males, and in normal- vs. high-BMI subgroups. These results provide promising initial indications that combining the Zamzee activity meter with online proximal performance feedback and incentive motivation features can positively impact MVPA levels in adolescents.	[Guthrie, Nicole; Haritatos, Jana; Dillon, Fred; Cole, Steve W.] HopeLab Fdn, Redwood City, CA 94063 USA; [Bradlyn, Andrew] W Virginia Univ, Morgantown, WV 26506 USA; [Thompson, Sharon K.] Santech Inc, La Jolla, CA USA; [Yen, Sophia] Stanford Med Sch, Dept Pediat, Div Adolescent Med, Stanford, CA USA	West Virginia University; Stanford University	Cole, SW (corresponding author), HopeLab Fdn, Redwood City, CA 94063 USA.	scole@hopelab.org			HopeLab Foundation; Santech Inc.	HopeLab Foundation; Santech Inc.	The research reported here was supported by the nonprofit HopeLab Foundation. HopeLab develops behavioral interventions to improve health in young people. The design, conduct, analysis, and reporting of this study represents a scientific collaboration between HopeLab and Drs. Bradlyn, Yen, and Thompson. Nicole Guthrie, Jana Haritatos, Fred Dillon, and Steve Cole are employed by HopeLab Foundation, which funded this research, had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. None of the authors have any financial or other conflicting interest in the scientific results of this study. Santech Inc. provided support in the form of a salary for author SKT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; [Anonymous], 1996, ACTIVITY PHYSICAL AN; Baranowski T, 2008, AM J PREV MED, V34, P74, DOI 10.1016/j.amepre.2007.09.027; Barnett A, 2011, J PHYS ACT HEALTH, V8, P724, DOI 10.1123/jpah.8.5.724; Bassett DR, 2000, MED SCI SPORT EXER, V32, pS471, DOI 10.1097/00005768-200009001-00006; Blair SN, 2004, AM J CLIN NUTR, V79, P913; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Charness G, 2009, ECONOMETRICA, V77, P909, DOI 10.3982/ECTA7416; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Cole SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033909; Coleman KJ, 1997, MED SCI SPORT EXER, V29, P1535, DOI 10.1097/00005768-199711000-00022; Dietz W, GROWTH CHART TRAININ; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Eston RG, 1998, J APPL PHYSIOL, V84, P362, DOI 10.1152/jappl.1998.84.1.362; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; FREDERICK CM, 1995, INT J SPORT PSYCHOL, V26, P5; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hurling R, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e7; Katzmarzyk PT, 2008, APPL PHYSIOL NUTR ME, V33, P371, DOI 10.1139/H07-176; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Ludwig DS, 2009, JAMA-J AM MED ASSOC, V301, P533, DOI 10.1001/jama.2009.52; Madden M., 2013, TEENS TECHNOLOGY 201; Maloney AE, 2008, OBESITY, V16, P2074, DOI 10.1038/oby.2008.295; Matton L, 2006, MED SCI SPORT EXER, V38, P1114, DOI 10.1249/01.mss.0000222840.58767.40; McMurray RG, MED SCI SPORTS EXERC, V30, P1238; Merom D, 2007, AM J PREV MED, V32, P290, DOI 10.1016/j.amepre.2006.12.007; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Owens SG, 2011, J STRENGTH COND RES, V25, P3191, DOI 10.1519/JSC.0b013e3182132d55; Pan Y, 2008, J AM DIET ASSOC, V108, P276, DOI 10.1016/j.jada.2007.10.049; Perkins DF, 2004, YOUTH SOC, V35, P495, DOI 10.1177/0044118X03261619; Promberger M, 2013, HEALTH PSYCHOL, V32, P950, DOI 10.1037/a0032727; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Rothney MP, 2008, OBESITY, V16, P1946, DOI 10.1038/oby.2008.279; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Staiano AE, 2012, GAMES HEALTH J, V1, P377, DOI 10.1089/g4h.2012.0052; Tan B, 2002, INT J SPORTS MED, V23, P125, DOI 10.1055/s-2002-20132; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Trudeau F, 2004, MED SCI SPORT EXER, V36, P1937, DOI 10.1249/01.MSS.0000145525.29140.3B; Tudor-Locke C, 2009, SPORTS MED, V39, P981, DOI 10.2165/11319600-000000000-00000; Unnithan VB, 2006, INT J SPORTS MED, V27, P804, DOI 10.1055/s-2005-872964; Volpp KG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-272; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819; Volpp KG, 2008, JAMA-J AM MED ASSOC, V300, P2631, DOI 10.1001/jama.2008.804; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; Welk GJ, 2000, MED SCI SPORT EXER, V32, pS489, DOI 10.1097/00005768-200009001-00008	49	14	14	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128639	10.1371/journal.pone.0128639	http://dx.doi.org/10.1371/journal.pone.0128639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010359	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900246
J	Korhonen, MJ; Halonen, JI; Brookhart, MA; Kawachi, I; Pentti, J; Karlsson, H; Kivimaki, M; Vahtera, J				Korhonen, Maarit Jaana; Halonen, Jaana I.; Brookhart, M. Alan; Kawachi, Ichiro; Pentti, Jaana; Karlsson, Hasse; Kivimaeki, Mika; Vahtera, Jussi			Childhood Adversity as a Predictor of Non-Adherence to Statin Therapy in Adulthood	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTH-CARE UTILIZATION; CARDIOVASCULAR-DISEASE; MEDICATION ADHERENCE; PSYCHOSOCIAL FACTORS; LIVING-CONDITIONS; RISK; ASSOCIATION; EXPERIENCES; ONSET	Purpose To investigate whether adverse experiences in childhood predict non-adherence to statin therapy in adulthood. Methods A cohort of 1378 women and 538 men who initiated statin therapy during 2008-2010 after responding to a survey on childhood adversities, was followed for non-adherence during the first treatment year. Log-binomial regression was used to estimate predictors of non-adherence, defined as the proportion of days covered by dispensed statin tablets <80%. In fully adjusted models including age, education, marital status, current smoking, heavy alcohol use, physical inactivity, obesity, presence of depression and cardiovascular comorbidity, the number of women ranged from 1172 to 1299 and that of men from 473 to 516, because of missing data on specific adversities and covariates. Results Two in three respondents reported at least one of the following six adversities in the family: divorce/separation of the parents, long-term financial difficulties, severe conflicts, frequent fear, severe illness, or alcohol problem of a family member. 51% of women and 44% of men were non-adherent. In men, the number of childhood adversities predicted an increased risk of non-adherence (risk ratio [RR] per adversity 1.11, 95% confidence interval [CI] 1.01-1.21], P for linear trend 0.013). Compared with those reporting no adversities, men reporting 3-6 adversities had a 1.44-fold risk of non-adherence (95% CI 1.12-1.85). Experiencing severe conflicts in the family (RR 1.27, 95% CI 1.03-1.57]) and frequent fear of a family member (RR 1.27, 95% CI 1.00-1.62]) in particular, predicted an increased risk of non-adherence. In women, neither the number of adversities nor any specific type of adversity predicted non-adherence. Conclusions Exposure to childhood adversity may predict non-adherence to preventive cardiovascular medication in men. Usefulness of information on childhood adversities in identification of adults at high risk of non-adherence deserves further research.	[Korhonen, Maarit Jaana] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Korhonen, Maarit Jaana; Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Halonen, Jaana I.] Finnish Inst Occupat Hlth, Helsinki, Finland; [Halonen, Jaana I.] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Brookhart, M. Alan] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Pentti, Jaana] Finnish Inst Occupat Hlth, Turku, Finland; [Karlsson, Hasse] Univ Turku, Dept Clin Sci, Turku, Finland; [Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland	University of Turku; University of Turku; Finnish Institute of Occupational Health; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health; Finnish Institute of Occupational Health; University of Turku; University of London; University College London; University of Turku	Korhonen, MJ (corresponding author), Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland.	maarit.korhonen@utu.fi	Kivimaki, Mika/B-3607-2012	Kivimaki, Mika/0000-0002-4699-5627; Korhonen, Maarit/0000-0002-2953-4757; Vahtera, Jussi/0000-0002-6036-061X; Karlsson, Hasse/0000-0002-4992-1893; Halonen, Jaana/0000-0003-1142-0388	Academy of Finland ERA-AGE2 program [264944]; Finnish Work Environment Foundation; United Kingdom Medical Research Council [K013351]; Economic and Social Research Council, United Kingdom; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; British Heart Foundation [RG/13/2/30098] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish	Academy of Finland ERA-AGE2 program; Finnish Work Environment Foundation; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council, United Kingdom(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Academy of Finland (www.aka.fi) ERA-AGE2 program, grant number 264944), the Finnish Work Environment Foundation (www.tsr.fi) to MK, the United Kingdom Medical Research Council (www.mrc.ac.uk) to MK (grant number K013351) and the Economic and Social Research Council, United Kingdom, (www.esrc.ac.uk) to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Board of Official Statistics of Finland (OSF), 2011, OFF STAT FINL CLASS; Anda RF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-198; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Bonomi AE, 2008, J GEN INTERN MED, V23, P294, DOI 10.1007/s11606-008-0516-1; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Chartier MJ, 2007, AM J EPIDEMIOL, V165, P1031, DOI 10.1093/aje/kwk113; Chowdhury R, 2013, EUR HEART J, V34, P2940, DOI 10.1093/eurheartj/eht295; Ciechanowski P, 2006, GEN HOSP PSYCHIAT, V28, P9, DOI 10.1016/j.genhosppsych.2005.07.004; Ciechanowski P, 2004, PSYCHOSOM MED, V66, P720, DOI 10.1097/01.psy.0000138125.59122.23; Dormuth CR, 2009, CIRCULATION, V119, P2051, DOI 10.1161/CIRCULATIONAHA.108.824151; Fuller-Thomson E, 2013, PUBLIC HEALTH, V127, P449, DOI 10.1016/j.puhe.2013.01.006; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Gentil L, 2012, J AM GERIATR SOC, V60, P2297, DOI 10.1111/j.1532-5415.2012.04239.x; Gilman SE, 2010, ACAD PEDIATR, V10, P159, DOI 10.1016/j.acap.2010.03.008; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Kauhanen Laura, 2011, Adv Prev Med, V2011, P478741, DOI 10.4061/2011/478741; Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9; Kestila L, 2006, EUR J PUBLIC HEALTH, V16, P617, DOI 10.1093/eurpub/ckl054; Kivimaki M, 2006, ANN EPIDEMIOL, V16, P737, DOI 10.1016/j.annepidem.2006.01.004; Kivimaki M, 2013, CAN MED ASSOC J, V185, pE784, DOI 10.1503/cmaj.122010; Korkeila J, 2010, J AFFECT DISORDERS, V127, P130, DOI 10.1016/j.jad.2010.04.031; Korkeila J, 2010, HEART, V96, P298, DOI 10.1136/hrt.2009.188250; Kriegbaum M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004178; Lewey J, 2013, AM HEART J, V165, P665, DOI 10.1016/j.ahj.2013.02.011; Lovallo WR, 2013, INT J PSYCHOPHYSIOL, V90, P8, DOI 10.1016/j.ijpsycho.2012.10.006; Maunder Robert G, 2008, J Am Acad Psychoanal Dyn Psychiatry, V36, P11, DOI 10.1521/jaap.2008.36.1.11; Mullainathan Sendhil, 2013, SCARCITY; Nandi A, 2012, EPIDEMIOLOGY, V23, P223, DOI 10.1097/EDE.0b013e31824570bd; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Non AL, 2014, AM J EPIDEMIOL, V180, P263, DOI 10.1093/aje/kwu127; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Peura S., 2007, PHARM PRICING REIMBU; Rahkonen O, 1997, SOC SCI MED, V44, P327, DOI 10.1016/S0277-9536(96)00102-5; Rich-Edwards JW, 2012, CIRCULATION, V126, P920, DOI 10.1161/CIRCULATIONAHA.111.076877; Rikala M, 2013, BASIC CLIN PHARMACOL, V113, P173, DOI 10.1111/bcpt.12075; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Romppainen T, 2014, EUR J CLIN PHARMACOL, V70, P1275, DOI 10.1007/s00228-014-1737-3; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Sjosten N, 2013, J HYPERTENS, V31, P1477, DOI 10.1097/HJH.0b013e32836098d1; Stilley CS, 2010, HEALTH PSYCHOL, V29, P50, DOI 10.1037/a0016940; Sumanen M, 2005, J PSYCHOSOM RES, V59, P331, DOI 10.1016/j.jpsychores.2005.04.005; Tamayo T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-525; Thunander Sundbom Lena, 2012, Pharmacy Practice (Internet), V10, P207, DOI 10.4321/s1886-36552012000400005; Vahtera J, 2010, OCCUP ENVIRON MED, V67, P479, DOI 10.1136/oem.2008.045096; World Health Organization Collaborating Centre for Drug Statistics Methodology, 2014, US ATC DDD	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127638	10.1371/journal.pone.0127638	http://dx.doi.org/10.1371/journal.pone.0127638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011609	Green Published, Green Accepted, gold			2022-12-27	WOS:000355183900120
J	Modakh, JK; Liu, YC; Machuca, MA; Supuran, CT; Roujeinikova, A				Modakh, Joyanta K.; Liu, Yu C.; Machuca, Mayra A.; Supuran, Claudiu T.; Roujeinikova, Anna			Structural Basis for the Inhibition of Helicobacter pylori alpha-Carbonic Anhydrase by Sulfonamides	PLOS ONE			English	Article							CLONING; ULCER; EXPRESSION; FEATURES; COMPLEX; TARGETS	Periplasmic alpha-carbonic anhydrase of Helicobacter pylori (HpaCA), an oncogenic bacterium in the human stomach, is essential for its acclimation to low pH. It catalyses the conversion of carbon dioxide to bicarbonate using Zn(II) as the cofactor. In H. pylori, Neisseria spp., Brucella suis and Streptococcus pneumoniae this enzyme is the target for sulfonamide antibacterial agents. We present structural analysis correlated with inhibition data, on the complexes of HpaCA with two pharmacological inhibitors of human carbonic anhydrases, acetazolamide and methazolamide. This analysis reveals that two sulfonamide oxygen atoms of the inhibitors are positioned proximal to the putative location of the oxygens of the CO2 substrate in the Michaelis complex, whilst the zinc-coordinating sulfonamide nitrogen occupies the position of the catalytic water molecule. The structures are consistent with acetazolamide acting as site-directed, nanomolar inhibitors of the enzyme by mimicking its reaction transition state. Additionally, inhibitor binding provides insights into the channel for substrate entry and product exit. This analysis has implications for the structure-based design of inhibitors of bacterial carbonic anhydrases.	[Modakh, Joyanta K.; Liu, Yu C.; Machuca, Mayra A.; Roujeinikova, Anna] Monash Univ, Dept Microbiol, Fac Biomed & Psychol Sci, Clayton, Vic 3168, Australia; [Supuran, Claudiu T.] Univ Florence, Polo Sci, Lab Chim Bioinorgan, Florence, Italy; [Supuran, Claudiu T.] Univ Florence, Sez Sci Farmaceut, Neurofarba Dept, Florence, Italy; [Roujeinikova, Anna] Monash Univ, Dept Biochem & Mol Biol, Fac Biomed & Psychol Sci, Clayton, Vic, Australia	Monash University; University of Florence; University of Florence; Monash University	Roujeinikova, A (corresponding author), Monash Univ, Dept Microbiol, Fac Biomed & Psychol Sci, Clayton, Vic 3168, Australia.	anna.roujeinikova@monash.edu		Roujeinikova, Anna/0000-0001-8478-4751	Australian Research Council Fellowship [DP1094619]	Australian Research Council Fellowship(Australian Research Council)	This work was supported by the Australian Research Council Fellowship to AR (grant number DP1094619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burghout P, 2010, J BACTERIOL, V192, P4054, DOI 10.1128/JB.00151-10; Bury-Mone S, 2008, INFECT IMMUN, V76, P497, DOI 10.1128/IAI.00993-07; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chirica LC, 2002, BBA-PROTEINS PROTEOM, V1601, P192, DOI 10.1016/S1570-9639(02)00467-3; Chirica LC, 2001, BBA-PROTEIN STRUCT M, V1544, P55, DOI 10.1016/S0167-4838(00)00204-1; DAVENPORT HW, 1968, GASTROENTEROLOGY   S, V54, P702; Di Fiore A, 2013, ACTA CRYSTALLOGR D, V69, P1150, DOI 10.1107/S0907444913007208; Dunn BE, 1997, CLIN MICROBIOL REV, V10, P720, DOI 10.1128/CMR.10.4.720; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gisbert JP, 2010, J CLIN GASTROENTEROL, V44, P313, DOI 10.1097/MCG.0b013e3181c8a1a3; Graham DY, 2007, HELICOBACTER, V12, P275, DOI 10.1111/j.1523-5378.2007.00518.x; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Huang SH, 1998, J MOL BIOL, V283, P301, DOI 10.1006/jmbi.1998.2077; James P, 2014, ACTA CRYSTALLOGR D, V70, P2607, DOI 10.1107/S1399004714016526; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Malfertheiner P, 2011, LANCET, V377, P905, DOI 10.1016/S0140-6736(11)60020-2; Marcus EA, 2005, J BACTERIOL, V187, P729, DOI 10.1128/JB.187.2.729-738.2005; Maren T H, 1995, J Glaucoma, V4, P49; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Modak JK, 2013, ACTA CRYSTALLOGR F, V69, P1252, DOI 10.1107/S1744309113026146; Nishimori I, 2006, J MED CHEM, V49, P2117, DOI 10.1021/jm0512600; Nishimori I, 2008, CURR PHARM DESIGN, V14, P622, DOI 10.2174/138161208783877875; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Penston JG, 1997, BRIT J CLIN PHARMACO, V43, P223, DOI 10.1046/j.1365-2125.1997.00551.x; PUSCAS I, 1984, ANN NY ACAD SCI, V429, P587, DOI 10.1111/j.1749-6632.1984.tb12392.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sachs G, 2005, PHYSIOLOGY, V20, P429, DOI 10.1152/physiol.00032.2005; Sjoblom B, 2009, P NATL ACAD SCI USA, V106, P10609, DOI 10.1073/pnas.0904184106; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00034; SUPURAN CT, 1994, CARBONIC ANHYDRASE AND MODULATION OF PHYSIOLOGIC AND PATHOLOGIC PROCESSES IN THE ORGANISM, P30; Vakil N, 2006, AM J GASTROENTEROL, V101, P497, DOI 10.1111/j.1572-0241.2006.00454.x; VALEAN S, 1984, ANN NY ACAD SCI, V429, P597; VANEECHOUTTE M, 1988, J CLIN MICROBIOL, V26, P2544, DOI 10.1128/JCM.26.12.2544-2548.1988; WALSH JH, 1995, NEW ENGL J MED, V333, P984, DOI 10.1056/NEJM199510123331508; West D, 2012, BIOCHEMISTRY-US, V51, P9156, DOI 10.1021/bi301155z; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winum JY, 2010, CURR PHARM DESIGN, V16, P3310, DOI 10.2174/138161210793429850; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Zheng JY, 2008, BIOCHEMISTRY-US, V47, P12028, DOI 10.1021/bi801473w; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	52	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127149	10.1371/journal.pone.0127149	http://dx.doi.org/10.1371/journal.pone.0127149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010545	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900068
J	Singh, V; Sharma, G; Gardas, RL				Singh, Vickramjeet; Sharma, Gyanendra; Gardas, Ramesh L.			Thermodynamic and Ultrasonic Properties of Ascorbic Acid in Aqueous Protic Ionic Liquid Solutions	PLOS ONE			English	Article							VOLUMETRIC PROPERTIES; THIAMINE HYDROCHLORIDE; MOLECULAR-INTERACTIONS; TRANSPORT-PROPERTIES; BIPHASIC SYSTEMS; PLUS SUCROSE; AMINO-ACIDS; SUDAN-I; WATER; BEHAVIOR	In this work, we report the thermodynamic and ultrasonic properties of ascorbic acid (vitamin C) in water and in presence of newly synthesized ammonium based protic ionic liquid (diethylethanolammonium propionate) as a function of concentration and temperature. Apparent molar volume and apparent molar isentropic compression, which characterize the solvation state of ascorbic acid (AA) in presence of protic ionic liquid (PIL) has been determined from precise density and speed of sound measurements at temperatures (293.15 to 328.15) K with 5 K interval. The strength of molecular interactions prevailing in ternary solutions has been discussed on the basis of infinite dilution partial molar volume and partial molar isentropic compression, corresponding volume of transfer and interaction coefficients. Result has been discussed in terms of solute-solute and solute-solvent interactions occurring between ascorbic acid and PIL in ternary solutions (AA + water + PIL).	[Singh, Vickramjeet; Sharma, Gyanendra; Gardas, Ramesh L.] Indian Inst Technol, Dept Chem, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Gardas, RL (corresponding author), Indian Inst Technol, Dept Chem, Madras 600036, Tamil Nadu, India.	gardas@iitm.ac.in	Gardas, Ramesh L./B-2358-2008; singh, vickramjeet/R-3778-2019; Singh, Vickramjeet/AFS-3556-2022	Gardas, Ramesh L./0000-0002-6185-5825; Singh, Vickramjeet/0000-0002-6854-1503; Sharma, Gyanendra/0000-0002-5835-1255	Council of Scientific and Industrial Research (CSIR), India [01(2525)/11/EMR-II]; CSIR	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to Council of Scientific and Industrial Research (CSIR, http://www.csirhrdg.res.in/), India for the financial support through grant numbers 01(2525)/11/EMR-II. Dr. Vickramjeet Singh acknowledges the financial support from CSIR through his post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelblat A, 2007, J MOL LIQ, V131, P7, DOI 10.1016/j.molliq.2006.08.022; Attri P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086530; Attri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068970; Ayranci G, 2007, J CHEM THERMODYN, V39, P1620, DOI 10.1016/j.jct.2007.04.009; Banik I, 2012, J MOL LIQ, V169, P8, DOI 10.1016/j.molliq.2012.03.006; Banipal PK, 2015, FOOD CHEM, V168, P142, DOI 10.1016/j.foodchem.2014.06.104; Banipal PK, 2013, Z PHYS CHEM, V227, P1707, DOI 10.1524/zpch.2013.0394; Banipal TS, 2013, THERMOCHIM ACTA, V553, P31, DOI 10.1016/j.tca.2012.10.017; Birch GG, 2002, PURE APPL CHEM, V74, P1103, DOI 10.1351/pac200274071103; Chailapakul O, 2008, FOOD CHEM, V109, P876, DOI 10.1016/j.foodchem.2008.01.018; Clayden J., 2001, ORGANIC CHEM; Comunian TA, 2013, FOOD RES INT, V52, P373, DOI 10.1016/j.foodres.2013.03.028; DESNOYER.JE, 1969, J PHYS CHEM-US, V73, P3346, DOI 10.1021/j100844a032; Dhondge SS, 2013, J CHEM THERMODYN, V67, P217, DOI 10.1016/j.jct.2013.08.016; Elyasi M, 2013, FOOD CHEM, V141, P4311, DOI 10.1016/j.foodchem.2013.07.020; Freire MG, 2011, GREEN CHEM, V13, P1536, DOI 10.1039/c1gc15110j; Freire MG, 2010, GREEN CHEM, V12, P1715, DOI 10.1039/c0gc00179a; HAKIN AW, 1993, CAN J CHEM, V71, P925, DOI 10.1139/v93-123; Hayakawa EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085467; HEPLER LG, 1969, CAN J CHEMISTRY, V47, P4613, DOI 10.1139/v69-762; Jamal MA, 2014, FOOD CHEM, V146, P460, DOI 10.1016/j.foodchem.2013.09.076; Jiang XF, 2014, J CHEM THERMODYN, V71, P50, DOI 10.1016/j.jct.2013.11.002; Jiang XF, 2013, J CHEM ENG DATA, V58, P2970, DOI 10.1021/je400395u; Kant S, 2013, J CHEM ENG DATA, V58, P1294, DOI 10.1021/je301362j; Kant S, 2009, J MOL LIQ, V150, P39, DOI 10.1016/j.molliq.2009.09.010; KAULGUD MV, 1978, INDIAN J CHEM A, V16, P955; Kawada H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062717; Keshapolla D, 2014, J MOL LIQ, V199, P330, DOI 10.1016/j.molliq.2014.09.030; Lan W, 2011, CARBOHYD POLYM, V86, P672, DOI 10.1016/j.carbpol.2011.05.013; MCMILLAN WG, 1945, J CHEM PHYS, V13, P276, DOI 10.1063/1.1724036; Monti DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029794; Mourao T, 2014, ACS SUSTAIN CHEM ENG, V2, P2426, DOI 10.1021/sc500444w; Parke SA, 1999, CHEM SENSES, V24, P271, DOI 10.1093/chemse/24.3.271; Pereira JFB, 2010, GREEN CHEM, V12, P1661, DOI 10.1039/c003578e; Ping JF, 2012, FOOD CHEM, V135, P362, DOI 10.1016/j.foodchem.2012.05.013; Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947; Raja S., 2012, SCI TECHNOL HUM VAL, V1, P7; Rusen Feng, 2010, Journal of Environmental Protection, V1, P95, DOI 10.4236/jep.2010.12012; Sahin M, 2011, J CHEM THERMODYN, V43, P177, DOI 10.1016/j.jct.2010.08.017; SAVAGE JJ, 1976, J SOLUTION CHEM, V5, P733, DOI 10.1007/BF00643457; Sdiri S., 2012, FOOD RES INT, V50, P143; Seuvre AM, 2010, FOOD CHEM, V122, P455, DOI 10.1016/j.foodchem.2009.04.101; SHAMIM M, 1979, AUST J CHEM, V32, P2293, DOI 10.1071/CH9792293; Singh V, 2015, FOOD CHEM, V169, P478, DOI 10.1016/j.foodchem.2014.08.023; Singh V, 2014, J CHEM THERMODYN, V71, P37, DOI 10.1016/j.jct.2013.11.021; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Tian MM, 2014, FOOD CHEM, V145, P28, DOI 10.1016/j.foodchem.2013.08.029; Tsuda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091193; Valente A, 2011, FOOD RES INT, V44, P2237, DOI 10.1016/j.foodres.2011.02.012; Ventura SPM, 2011, J CHEM ENG DATA, V56, P4253, DOI 10.1021/je200714h; Wong SZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066691; Wu B, 2008, J CHEM ENG DATA, V53, P983, DOI 10.1021/je700729p; Wu B, 2009, J CHEM ENG DATA, V54, P1430, DOI 10.1021/je800622e; Yuan JP, 1998, J AGR FOOD CHEM, V46, P5078, DOI 10.1021/jf9805404; Zafarani-Moattar MT, 2011, BIOTECHNOL PROGR, V27, P986, DOI 10.1002/btpr.613; Zhang HJ, 2014, FOOD CHEM, V151, P429, DOI 10.1016/j.foodchem.2013.11.016; Zhu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047058	57	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126091	10.1371/journal.pone.0126091	http://dx.doi.org/10.1371/journal.pone.0126091			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009887	gold, Green Published, Green Submitted			2022-12-27	WOS:000355183900022
J	Zhang, J; Liu, T; Feng, RF; Liu, C; Chi, S				Zhang, Jing; Liu, Tao; Feng, Rongfang; Liu, Cui; Chi, Shan			Genetic Map Construction and Quantitative Trait Locus (QTL) Detection of Six Economic Traits Using an F-2 Population of the Hybrid from Saccharina longissima and Saccharina japonica	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; SEGREGATION DISTORTION; LINKAGE MAP; LAMINARIA-JAPONICA; PHAEOPHYTA GAMETOPHYTES; MICROSATELLITE MARKERS; GRAIN-YIELD; DNA; GENOME; MAIZE	Saccharina (Laminaria) is one of the most important economic seaweeds. Previously, four genetic linkage maps of Saccharina have been constructed and five QTLs have been identified. However, they were not enough for its breeding. In this work, Saccharina longissima (female) and Saccharina japonica (male), which showed obvious differences in morphology and genetics, were applied in hybridization to yield the F-2 mapping population with 102 individuals. Using these 102 F-2 hybrids, the genetic linkage map of Saccharina was constructed by MapMaker software based on 37 amplified fragment length polymorphisms (AFLPs), 22 sequence-related amplified polymorphisms (SRAPs) and 139 simple sequence repeats (SSRs) markers. Meanwhile, QTL analysis was performed for six economic traits. The linkage map constructed in this research consisted of 422 marker loci (137 AFLPs, 57 SRAPs and 228 SSRs), which formed 45 linkage groups (LGs) with an average marker space of 7.92 cM; they spanned a total length of 2233.1 cM, covering the whole estimated genome size. A total of 29 QTLs were identified for six economic traits, which explained 1.06 to 64.00% of phenotypic variation, including three QTLs for frond length (FL) and raw weight (RW), five QTLs for frond width (FW), two QTLs for frond fascia width (FFW) and frond thickness (FT), and fourteen QTLs for base shape (BS). The results of this research will improve the breeding efficiency and be beneficial for marker-assisted selection (MAS) schemes in Saccharina breeding.	[Zhang, Jing] Qilu Univ Technol, Jinan, Shandong, Peoples R China; [Zhang, Jing; Liu, Tao; Liu, Cui; Chi, Shan] Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China; [Feng, Rongfang] Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China	Qilu University of Technology; Ocean University of China; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Liu, T (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China.	our_science@sina.com	Zhang, Jing/ABD-1862-2021		National High Technology Joint Research Program of China [2012AA10A406]; National Natural Science Foundation of China [31402300]; Special Fund of Fundamental Scientific Research Business Expense for Higher School of Central Government [201262003]	National High Technology Joint Research Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund of Fundamental Scientific Research Business Expense for Higher School of Central Government	This work was supported by the National High Technology Joint Research Program of China (2012AA10A406), the National Natural Science Foundation of China (Grant No. 31402300) and Special Fund of Fundamental Scientific Research Business Expense for Higher School of Central Government (201262003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1939, SCI REP TOHOKU IMP U, V14, P327; An X.L., 2010, FISH SCI, V29, P115; Barchi L, 2010, GENOME, V53, P805, DOI [10.1139/g10-073, 10.1139/G10-073]; Basten CJ, 2005, QTL CARTOGRAPHER VER; Bidinger FR, 2007, CROP SCI, V47, P969, DOI 10.2135/cropsci2006.07.0465; Billot C, 1998, MOL ECOL, V7, P1778, DOI 10.1046/j.1365-294x.1998.00516.x; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Butcher PA, 2002, THEOR APPL GENET, V104, P1185, DOI 10.1007/s00122-001-0820-1; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Ding WD, 2010, AQUACULT INT, V18, P575, DOI 10.1007/s10499-009-9277-z; Doucleff M, 2004, THEOR APPL GENET, V109, P1178, DOI 10.1007/s00122-004-1728-3; Edwards KJ, 1996, BIOTECHNIQUES, V20, P758; Fang T.C., 1962, B BOT, V10, P197; Fang TC, 1983, J SHANDONG COLL OCEA, V13, P63; Fang TC, 1985, J SHANDONG COLL OCEA, V15, P64; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gong L, 2008, GENOME, V51, P878, DOI 10.1139/G08-072; Gosselin I, 2002, THEOR APPL GENET, V104, P987, DOI 10.1007/s00122-001-0823-y; Guillemaut P, 1992, PLANT MOL BIOL REP, V10, P60, DOI 10.1007/BF02669265; Hong YB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-17; Hong YanBin, 2008, Agricultural Sciences in China, V7, P915, DOI 10.1016/S1671-2927(08)60130-3; Kiani SP, 2009, PLANT BREEDING, V128, P363, DOI 10.1111/j.1439-0523.2009.01628.x; Korol A., 2007, AQUACULTURE GENOME T, P169; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Ky CL, 2000, THEOR APPL GENET, V101, P669, DOI 10.1007/s001220051529; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEWIS RJ, 1993, J PHYCOL, V29, P363, DOI 10.1111/j.0022-3646.1993.00363.x; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li YH, 2007, J INTEGR PLANT BIOL, V49, P392, DOI 10.1111/j.1744-7909.2007.00397.x; Liu FL, 2010, MAR BIOTECHNOL, V12, P386, DOI 10.1007/s10126-009-9229-7; Liu FL, 2010, J APPL PHYCOL, V22, P109, DOI 10.1007/s10811-009-9426-9; Liu FL, 2009, J PHYCOL, V45, P1228, DOI 10.1111/j.1529-8817.2009.00729.x; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; Luo L, 2005, HEREDITY, V94, P347, DOI 10.1038/sj.hdy.6800615; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; Mu P, 2003, CHINESE SCI BULL, V48, P2718, DOI 10.1360/03wc0180; Nikaido A, 1999, GENES GENET SYST, V74, P55, DOI 10.1266/ggs.74.55; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; PATERSON AH, 1991, GENETICS, V127, P181; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Rebetzke GJ, 2005, PLANT SOIL, V272, P87, DOI 10.1007/s11104-004-4040-8; Shi YY, 2007, MOL ECOL NOTES, V7, P620, DOI 10.1111/j.1471-8286.2006.01652.x; Sraphet S, 2011, THEOR APPL GENET, V122, P1161, DOI 10.1007/s00122-010-1520-5; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Tseng C. K., 1983, COMMON SEAWEEDS CHIN; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; Vengadessan V., 2013, ISRN GENET, V2013, P1, DOI [10.5402/2013/471632, DOI 10.5402/2013/471632]; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang CM, 2005, GENET RES, V86, P97, DOI 10.1017/S0016672305007779; Wang GL, 2011, ACTA OCEANOL SIN, V30, P112, DOI 10.1007/s13131-011-0125-4; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080569; Wang XL, 2005, J INTEGR PLANT BIOL, V47, P753, DOI 10.1111/j.1744-7909.2005.00059.x; Wang XL, 2004, AQUACULTURE, V238, P143, DOI 10.1016/j.aquaculture.2004.05.007; YABU H, 1973, Bulletin of the Faculty of Fisheries Hokkaido University, V23, P171; YABU H, 1991, Japanese Journal of Phycology, V39, P185; Yang GP, 2009, J PHYCOL, V45, P873, DOI 10.1111/j.1529-8817.2009.00720.x; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2015, J APPL PHYCOL, V27, P479, DOI 10.1007/s10811-014-0301-y; Zhang J, 2011, J APPL PHYCOL, V23, P165, DOI 10.1007/s10811-011-9650-y; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z; Zhang ZY., 1999, J DALIAN FISHERIES U, V14, P13; Zhou LR, 2004, HYDROBIOLOGIA, V512, P141, DOI 10.1023/B:HYDR.0000020319.36532.eb	70	8	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128588	10.1371/journal.pone.0128588	http://dx.doi.org/10.1371/journal.pone.0128588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010152	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900244
J	Iakovleva, I; Begum, A; Pokrzywa, M; Walfridsson, M; Sauer-Eriksson, AE; Olofsson, A				Iakovleva, Irina; Begum, Afshan; Pokrzywa, Malgorzata; Walfridsson, Malin; Sauer-Eriksson, A. Elisabeth; Olofsson, Anders			The Flavonoid Luteolin, but Not Luteolin-7-O-Glucoside, Prevents a Transthyretin Mediated Toxic Response	PLOS ONE			English	Article							FAMILIAL AMYLOID POLYNEUROPATHY; NATIVE-STATE; LIVER-TRANSPLANTATION; INHIBITORS; AMYLOIDOGENESIS; POTENT; DIFLUNISAL; TAFAMIDIS; CARDIOMYOPATHY; STABILIZATION	Transthyretin (TTR) is a homotetrameric plasma protein with amyloidogenic properties that has been linked to the development of familial amyloidotic polyneuropathy (FAP), familial amyloidotic cardiomyopathy, and senile systemic amyloidosis. The in vivo role of TTR is associated with transport of thyroxine hormone T4 and retinol-binding protein. Loss of the tetrameric integrity of TTR is a rate-limiting step in the process of TTR amyloid formation, and ligands with the ability to bind within the thyroxin binding site (TBS) can stabilize the tetramer, a feature that is currently used as a therapeutic approach for FAP. Several different flavonoids have recently been identified that impair amyloid formation. The flavonoid luteolin shows therapeutic potential with low incidence of unwanted side effects. In this work, we show that luteolin effectively attenuates the cytotoxic response to TTR in cultured neuronal cells and rescues the phenotype of a Drosophila melanogaster model of FAP. The plant-derived luteolin analogue cynaroside has a glucoside group in position 7 of the flavone A-ring and as opposed to luteolin is unable to stabilize TTR tetramers and thus prevents a cytotoxic effect. We generated high-resolution crystal-structures of both TTR wild type and the amyloidogenic mutant V30M in complex with luteolin. The results show that the A-ring of luteolin, in contrast to what was previously suggested, is buried within the TBS, consequently explaining the lack of activity from cynaroside. The flavonoids represent an interesting group of drug candidates for TTR amyloidosis. The present investigation shows the potential of luteolin as a stabilizer of TTR in vivo. We also show an alternative orientation of luteolin within the TBS which could represent a general mode of binding of flavonoids to TTR and is of importance concerning the future design of tetramer stabilizing drugs.	Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Begum, Afshan; Sauer-Eriksson, A. Elisabeth] Umea Univ, Dept Chem, S-90187 Umea, Sweden; [Pokrzywa, Malgorzata] Airopt Sp Zoo ZIWT, PL-61612 Poznan, Poland	Umea University; Umea University	Olofsson, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.olofsson@medchem.umu.se	Pokrzywa, Małgorzata/GQA-6257-2022	Sauer-Eriksson, Elisabeth/0000-0003-0124-0199; BEGUM, AFSHAN/0000-0001-5047-5168	Swedish Research Council; Parkinsonfonden; Insamlingsstiftelsen vid Umea Universitet; Alzheimerfonden; J.C. Kempes stiftelse; Hjarnfonden; Magnus-Bergvalls stiftelse; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting; Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinsonfonden; Insamlingsstiftelsen vid Umea Universitet; Alzheimerfonden; J.C. Kempes stiftelse; Hjarnfonden; Magnus-Bergvalls stiftelse; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting; Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	The authors thank the Swedish Research Council (www.vr.se), Parkinsonfonden (www.parkinsonfonden.se), Insamlingsstiftelsen vid Umea Universitet (www.medforsk.org.umu.se/), Alzheimerfonden (www.alzheimerfonden.se), J.C. Kempes stiftelse (www.kempe.com, Hjarnfonden (www.hjarnfonden.se), Magnus-Bergvalls stiftelse (www.magnbergvallsstiftelse.nu/), O.E. och Edlas stiftelse, Torsten Soderbergs stiftelse (www.torstensoderbergsstiftelse.se), Vasterbottens Lans lasting (ALF-medel), Patientforeningen FAMY/AMYL (www.famy.se), and the Medical Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Airoptic Sp provided support in the form of a salary for author MP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Bastianetto S, 2011, CURR ALZHEIMER RES, V8, P445, DOI 10.2174/156720511796391854; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Cardoso I, 2007, BIOCHEM J, V408, P131, DOI 10.1042/BJ20070689; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Colon W, 1996, CIBA F SYMP, V199, P228; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Dajas Federico, 2013, Central Nervous System Agents in Medicinal Chemistry, V13, P30; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; Gavrin LK, 2012, J MED CHEM, V55, P10823, DOI 10.1021/jm301182j; Green NS, 2003, J AM CHEM SOC, V125, P13404, DOI 10.1021/ja030294z; Grimster NP, 2013, J AM CHEM SOC, V135, P5656, DOI 10.1021/ja311729d; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Johnson SM, 2005, J MED CHEM, V48, P1576, DOI 10.1021/jm049274d; Johnson SM, 2009, J MED CHEM, V52, P1115, DOI 10.1021/jm801347s; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalkunte SS, 2013, AM J PATHOL, V183, P1425, DOI 10.1016/j.ajpath.2013.07.022; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lindhagen-Persson M, 2008, AMYLOID, V15, P240, DOI 10.1080/13506120802524916; Lu XY, 2011, PHARMAZIE, V66, P600, DOI 10.1691/ph.2011.1517; MCCUTCHEN SL, 1993, BIOCHEMISTRY-US, V32, P12119, DOI 10.1021/bi00096a024; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Morais-de-Sa E, 2004, J BIOL CHEM, V279, P53483, DOI 10.1074/jbc.M408053200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Okamoto S, 2011, AMYLOID, V18, P200, DOI 10.3109/13506129.2011.615872; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Pokrzywa M, 2007, EUR J NEUROSCI, V26, P913, DOI 10.1111/j.1460-9568.2007.05728.x; Pokrzywa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014343; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Reixach N, 2006, BIOCHEM BIOPH RES CO, V348, P889, DOI 10.1016/j.bbrc.2006.07.109; Sant'Anna RO, 2013, INT J MOL SCI, V14, P5284, DOI 10.3390/ijms14035284; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155; Sharma P, 2003, LIVER TRANSPLANT, V9, P1273, DOI 10.1016/j.lts.2003.09.016; Taliou A, 2013, CLIN THER, V35, P592, DOI 10.1016/j.clinthera.2013.04.006; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Trivella DBB, 2011, J STRUCT BIOL, V173, P323, DOI 10.1016/j.jsb.2010.10.003; TURNER RA, 1986, CLIN THER, V9, P37; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yokoyama T, 2014, J MED CHEM, V57, P1090, DOI 10.1021/jm401832j	52	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2015	10	5							e0128222	10.1371/journal.pone.0128222	http://dx.doi.org/10.1371/journal.pone.0128222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0SC	26020516	Green Published, Green Submitted, gold			2022-12-27	WOS:000355187300089
J	Fujiwara, K; Koyama, K; Suga, K; Ikemura, M; Saito, Y; Hino, A; Iwanari, H; Kusano-Arai, O; Mitsui, K; Kasahara, H; Fukayama, M; Kodama, T; Hamakubo, T; Momose, T				Fujiwara, Kentaro; Koyama, Keitaro; Suga, Kosuke; Ikemura, Masako; Saito, Yasutaka; Hino, Akihiro; Iwanari, Hiroko; Kusano-Arai, Osamu; Mitsui, Kenichi; Kasahara, Hiroyuki; Fukayama, Masashi; Kodama, Tatsuhiko; Hamakubo, Takao; Momose, Toshimitsu			Y-90-Labeled Anti-ROBO1 Monoclonal Antibody Exhibits Antitumor Activity against Small Cell Lung Cancer Xenografts	PLOS ONE			English	Article							PHASE I/II; RADIOIMMUNOTHERAPY; CARCINOMA; ANTIGEN; Y-90; RECEPTORS; MIGRATION; ROBO1	Introduction ROBO1 is a membrane protein that contributes to tumor metastasis and angiogenesis. We previously reported that Y-90-labeled anti-ROBO1 monoclonal antibody (Y-90-anti-ROBO1 IgG) showed an antitumor effect against ROBO1-positive tumors. In this study, we performed a biodistribution study and radioimmunotherapy (RIT) against ROBO1-positive small cell lung cancer (SCLC) models. Methods For the biodistribution study, In-111-labeled anti-ROBO1 monoclonal antibody (In-111-anti-ROBO1 IgG) was injected into ROBO1-positive SCLC xenograft mice via the tail vein. To evaluate antitumor effects, an RIT study was performed, and SCLC xenograft mice were treated with Y-90-anti-ROBO1 IgG. Tumor volume and body weight were periodically measured throughout the experiments. The tumors and organs of mice were then collected, and a pathological analysis was carried out. Results As a result of the biodistribution study, we observed tumor uptake of In-111-anti-ROBO1 IgG. The liver, kidney, spleen, and lung showed comparably high accumulation of In-111-labeled anti-ROBO1. In the RIT study, Y-90-anti-ROBO1 IgG significantly reduced tumor volume compared with baseline. Pathological analyses of tumors revealed coagulation necrosis and fatal degeneration of tumor cells, significant reduction in the number of Ki-67-positive cells, and an increase in the number of apoptotic cells. A transient reduction of hematopoietic cells was observed in the spleen, sternum, and femur. Conclusions These results suggest that RIT with Y-90-anti-ROBO1 IgG is a promising treatment for ROBO1-positive SCLC.	[Fujiwara, Kentaro; Koyama, Keitaro; Momose, Toshimitsu] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo, Japan; [Suga, Kosuke] SANKYO LABO SERV Co Ltd, Edogawa Ku, Tokyo, Japan; [Ikemura, Masako; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo, Japan; [Saito, Yasutaka; Hino, Akihiro; Kasahara, Hiroyuki] FUJIFILM RI Pharma Co Ltd, Sammu City, Chiba, Japan; [Iwanari, Hiroko; Kusano-Arai, Osamu; Mitsui, Kenichi; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Meguro Ku, Tokyo, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Syst Biol & Med, Meguro Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; Fujifilm Corporation; University of Tokyo; University of Tokyo	Momose, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo, Japan.	tmomo-tky@umin.ac.jp			Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP); SANKYO LABO SERVICE Co., Ltd.	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); SANKYO LABO SERVICE Co., Ltd.	This research was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). Co-authors Yasutaka Saito, Akihiro Hino and Hiroyuki Kasahara are employed by FUJIFILM RI Pharma Co., Ltd. FUJIFILM RI Pharma Co., Ltd. joined this study as a collaborating company in the Japan Society for the Promotion of Science through the "Funding Program for World-Leading Innovative R&D on Science and Technology." It was responsible for radiolabelling of antibodies. Co-author Kosuke Suga is employed by SANKYO LABO SERVICE Co., Ltd. SANKYO LABO SERVICE Co., Ltd. provided support in the form of salary for author KS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al-Ejeh F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004630; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brouwers AH, 2004, J NUCL MED, V45, P327; Dubben HH, 1998, RADIOTHER ONCOL, V47, P167, DOI 10.1016/S0167-8140(97)00215-6; Forrer F, 2013, J NUCL MED, V54, P1045, DOI 10.2967/jnumed.112.115170; Fujiwara K, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0029-3; GOLDENBERG DM, 1993, AM J MED, V94, P297, DOI 10.1016/0002-9343(93)90062-T; HUI TE, 1994, CANCER, V73, P951; Ito H, 2006, CLIN CANCER RES, V12, P3257, DOI 10.1158/1078-0432.CCR-05-2787; Jhanwar YS, 2005, J NUCL MED, V46, p141S; Kalemkerian GP, 2011, J NATL COMPR CANC NE, V9, P1086, DOI 10.6004/jnccn.2011.0092; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Mertsch S, 2008, J NEURO-ONCOL, V87, P1, DOI 10.1007/s11060-007-9484-2; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; Onthank DC, 2004, BIOCONJUGATE CHEM, V15, P235, DOI 10.1021/bc034108q; Oriuchi N, 1998, CANCER IMMUNOL IMMUN, V46, P311, DOI 10.1007/s002620050492; PARK CH, 1987, NUCL MED COMMUN, V8, P1075, DOI 10.1097/00006231-198712000-00018; Scott AM, 2005, J CLIN ONCOL, V23, P4567, DOI 10.1200/JCO.2005.01.903; Sharkey RM, 2005, J NUCL MED, V46, p115S; Stabin MG, 1996, J NUCL MED, V37, P538; Staudacher AH, 2014, EJNMMI RES, V4, DOI 10.1186/2191-219X-4-2; Takahashi K, 2010, RADIAT RES, V173, P184, DOI 10.1667/RR1839.1; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; USUDA S, 1986, J IMMUNOL METHODS, V87, P203, DOI 10.1016/0022-1759(86)90532-6; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Veeravagu A, 2008, CLIN CANCER RES, V14, P7330, DOI 10.1158/1078-0432.CCR-08-0797; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wiseman GA, 2000, EUR J NUCL MED, V27, P766, DOI 10.1007/s002590000276; Xian J, 2004, CANCER RES, V64, P6432, DOI 10.1158/0008-5472.CAN-04-2561; Xu Y, 2010, NEUROSCI BULL, V26, P474, DOI 10.1007/s12264-010-0730-9; Yoshida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059248; Zhan JB, 2013, EXPERT OPIN INV DRUG, V22, P235, DOI 10.1517/13543784.2013.750293	33	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125468	10.1371/journal.pone.0125468	http://dx.doi.org/10.1371/journal.pone.0125468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017283	Green Published, gold, Green Submitted			2022-12-27	WOS:000355185600023
J	Jancic, S; Nguyen, HDT; Frisvad, JC; Zalar, P; Schroers, HJ; Seifert, KA; Gunde-Cimerman, N				Jancic, Saso; Nguyen, Hai D. T.; Frisvad, Jens C.; Zalar, Polona; Schroers, Hans-Josef; Seifert, Keith A.; Gunde-Cimerman, Nina			Taxonomic Revision of the Wallemia sebi Species Complex	PLOS ONE			English	Article							FARMERS LUNG-DISEASE; METABOLITE PRODUCTION; GENUS WALLEMIA; WATER ACTIVITY; ENVIRONMENTS; DIVERSITY; PHYLOGENY; LIFE; TEMPERATURE; PREVALENCE	Wallemia sebi is a xerophilic food-and air-borne fungus. The name has been used for strains that prevail in cold, temperate and tropical climates. In this study, multi-locus phylogenetic analyses, using the internal transcribed spacer (ITS) regions, DNA replication licensing factor (MCM7), pre-rRNA processing protein (TSR1), RNA polymerase II largest subunit (RPB1), RNA polymerase II second largest subunit (RPB2) and a new marker 3'-phosphoadenosine-5'-phosphatase (HAL2), confirmed the previous hypothesis that W. sebi presents a complex of at least four species. Here, we confirm and apply the phylogenetic analyses based species hypotheses from a companion study to guide phenotypic assessment of W. sebi like strains from a wide range of substrates, climates and continents allowed the recognition of W. sebi sensu stricto and three new species described as W. mellicola, W. Canadensis, and W. tropicalis. The species differ in their conidial size, xerotolerance, halotolerance, chaotolerance, growth temperature regimes, extracellular enzyme activity profiles, and secondary metabolite patterns. A key to all currently accepted Wallemia species is provided that allow their identification on the basis of physiological, micromorphological and culture characters.	[Jancic, Saso; Zalar, Polona; Gunde-Cimerman, Nina] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia; [Nguyen, Hai D. T.; Seifert, Keith A.] Univ Ottawa, Dept Biol, Fac Sci, Ottawa, ON, Canada; [Frisvad, Jens C.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Schroers, Hans-Josef] Agr Inst Slovenia, Ljubljana, Slovenia; [Seifert, Keith A.] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Biodivers Mycol, Ottawa, ON, Canada; [Gunde-Cimerman, Nina] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	University of Ljubljana; University of Ottawa; Technical University of Denmark; Agricultural Institute Slovenia; Agriculture & Agri Food Canada	Gunde-Cimerman, N (corresponding author), Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia.	ninagunde-cimerman@bf.uni-lj.si	Frisvad, Jens C/K-2818-2017	Frisvad, Jens C/0000-0002-0573-4340; Gunde-Cimerman, Nina/0000-0002-9464-3263	Slovenian Research Agency through the Infrastructural Centre Mycosmo; Slovenian Ministry of Higher Education, Science and Technology; European Regional Development Fund through the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP) [OP13.1.1.2.02.0005]; Alfred P. Sloan Foundation Program on the Microbiology of the Built Environment; FP7 Project CropSustaIn [FP7-REGPOT-CT2012-316205];  [1000-11-310102]	Slovenian Research Agency through the Infrastructural Centre Mycosmo; Slovenian Ministry of Higher Education, Science and Technology; European Regional Development Fund through the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP); Alfred P. Sloan Foundation Program on the Microbiology of the Built Environment(Alfred P. Sloan Foundation); FP7 Project CropSustaIn; 	This work was funded by the Slovenian Research Agency (https://www.arrs.gov.si/en/dobrodoslica.asp) through the Infrastructural Centre Mycosmo (http://www.ex-genebank.com/) and the Young Researcher Grant to SJ, 1000-11-310102. This work was partly funded by Slovenian Ministry of Higher Education, Science and Technology (http://www.arhiv.mvzt.gov.si/en/) and European Regional Development Fund through the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP, http://cipkebip.org/, OP13.1.1.2.02.0005), and by grants to KAS and HDTN from the Alfred P. Sloan Foundation Program on the Microbiology of the Built Environment (http://www.sloan.org/major-program-areas/). Parts of this work were realized within the frame of FP7 Project CropSustaIn (FP7-REGPOT-CT2012-316205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, P NATL ACAD SCI USA, V107, P13748, DOI 10.1073/pnas.1000454107; [Anonymous], 2002, PAUP 4 0 PHYLOGENETI; [Anonymous], 1997, FUNGI FOOD SPOILAGE; Botic T, 2012, FEMS MICROBIOL LETT, V326, P40, DOI 10.1111/j.1574-6968.2011.02428.x; Brizzio S, 2007, CAN J MICROBIOL, V53, P519, DOI 10.1139/W07-010; Cantrell SA, 2013, MYCOLOGIA, V105, P827, DOI 10.3852/12-288; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Garcia V, 2012, FEMS MICROBIOL ECOL, V82, P523, DOI 10.1111/j.1574-6941.2012.01465.x; Desroches TC, 2014, INDOOR AIR, P1, DOI [10.1111/ina.12081, DOI 10.1111/INA.12081]; Frank M, 1999, TETRAHEDRON LETT, V40, P133, DOI 10.1016/S0040-4039(98)80039-7; FRISVAD JC, 1987, J CHROMATOGR, V404, P195, DOI 10.1016/S0021-9673(01)86850-3; Frisvad JC, 2008, MYCOL RES, V112, P231, DOI 10.1016/j.mycres.2007.08.018; Frisvad Jens C, 2012, Methods Mol Biol, V944, P47, DOI 10.1007/978-1-62703-122-6_3; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Gams W, 1998, CBS COURSE MYCOLOGY; Gock MA, 2003, INT J FOOD MICROBIOL, V81, P11, DOI 10.1016/S0168-1605(02)00166-6; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guarro J, 2008, J CLIN MICROBIOL, V46, P1129, DOI 10.1128/JCM.01920-07; Hallsworth JE, 2007, ENVIRON MICROBIOL, V9, P801, DOI 10.1111/j.1462-2920.2006.01212.x; HANHELA R, 1995, SCAND J WORK ENV HEA, V21, P223, DOI 10.5271/sjweh.31; Hibbett DS, 2006, MYCOLOGIA, V98, P917, DOI 10.3852/mycologia.98.6.917; Hu L, 2014, WORLD J MICROB BIOT, V30, P1085, DOI 10.1007/s11274-013-1528-5; Johan-Olsen O., 1887, SOP KLIPFISK SAKALDT; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kralj Kuncic M, 2013, FUNGAL BIOL-UK, V117, P466, DOI 10.1016/j.funbio.2013.04.003; Kuncic MK, 2010, APPL ENVIRON MICROB, V76, P329, DOI 10.1128/AEM.02318-09; Lappalainen MHJ, 2012, INT ARCH ALLERGY IMM, V159, P194, DOI 10.1159/000335596; Lappalainen S, 1998, ANN ALLERG ASTHMA IM, V81, P585, DOI 10.1016/S1081-1206(10)62710-X; Liu WC, 2010, FUNGAL DIVERS, V42, P1, DOI 10.1007/s13225-010-0022-8; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; McNEILL J., 2012, INT CODE NOMENCLATUR; Miller JD, 2010, CHEM-BIOL INTERACT, V183, P113, DOI 10.1016/j.cbi.2009.09.023; Moore RT, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P13; Moss MO, 1998, J APPL MICROBIOL, V84, p62S, DOI 10.1046/j.1365-2672.1998.0840s162S.x; Nguyen HDT, 2013, MYCOLOGIA, V105, P1231, DOI 10.3852/12-351; Nguyen HDT, PLOS ONE IN PRESS; Padamsee M, 2012, FUNGAL GENET BIOL, V49, P217, DOI 10.1016/j.fgb.2012.01.007; PATERSON R.R.M., 1994, IMI TECHNICAL HDB; Peng XP, 2011, ARCH PHARM RES, V34, P907, DOI 10.1007/s12272-011-0607-0; Quaedvlieg W, 2014, PERSOONIA, V33, P1, DOI 10.3767/003158514X681981; Reboux G, 2001, AM J RESP CRIT CARE, V163, P1534, DOI 10.1164/ajrccm.163.7.2006077; Rittenour William R, 2014, Environ Sci Process Impacts, V16, P33, DOI 10.1039/c3em00441d; Rohlf F.J., 2002, NTSYS PC NUMERICAL T; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roussel S, 2005, ANN AGR ENV MED, V12, P217; Sakamoto T, 1989, Arerugi, V38, P352; Sampaio JP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1873, DOI 10.1016/B978-0-444-52149-1.00155-5; Samson R. A., 2002, INTRO FOOD AIRBORNE; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Singh P, 2011, MICROB ECOL, V61, P507, DOI 10.1007/s00248-010-9765-8; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Sonjak S, 2005, FEMS MICROBIOL ECOL, V53, P51, DOI 10.1016/j.femsec.2004.10.014; Strauss MLA, 2001, J APPL MICROBIOL, V91, P182, DOI 10.1046/j.1365-2672.2001.01379.x; Suchodolski JS, 2008, VET MICROBIOL, V132, P379, DOI 10.1016/j.vetmic.2008.05.017; TAKAHASHI I, 1993, J ANTIBIOT, V46, P1312, DOI 10.7164/antibiotics.46.1312; Takahashi T, 1997, MYCOPATHOLOGIA, V139, P23, DOI 10.1023/A:1006831111595; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Vaupotic T, 2007, FUNGAL GENET BIOL, V44, P1109, DOI 10.1016/j.fgb.2007.02.005; Vestergren T, 1902, MICROMYCETES RARIORE, VXXII; Visagie CM, 2014, STUD MYCOL, P63, DOI 10.1016/j.simyco.2014.07.002; von Arx JA, 1970, GENERA FUNGI SPORULA; WHEELER KA, 1988, T BRIT MYCOL SOC, V90, P365, DOI 10.1016/S0007-1536(88)80144-X; Whewell William, 1840, PHILOS INDUCTIVE SCI; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Williams JP, 2009, ENVIRON MICROBIOL, V11, P3292, DOI 10.1111/j.1462-2920.2009.02079.x; Wilson E. O., 1998, CONSILIENCE UNITY KN; WOOD GM, 1990, FOOD ADDIT CONTAM, V7, P69, DOI 10.1080/02652039009373822; Yuan ZL, 2010, APPL ENVIRON MICROB, V76, P1642, DOI 10.1128/AEM.01911-09; Zajc J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-617; Zalar P, 2005, ANTON LEEUW INT J G, V87, P311, DOI 10.1007/s10482-004-6783-x; Zeng QY, 2004, APPL ENVIRON MICROB, V70, P7295, DOI 10.1128/AEM.70.12.7295-7302.2004	75	24	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0125933	10.1371/journal.pone.0125933	http://dx.doi.org/10.1371/journal.pone.0125933			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017053	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600042
J	de Carvalho, APM; Lima, JY; Azevedo, CT; Botta, S; de Queiroz, FF; Campos, AS; Barbosa, LD; da Silveira, LS				Martins de Carvalho, Anna Paula; Lima, Juliana Ywasaki; Azevedo, Carolina Torres; Botta, Silvina; de Queiroz, Fybio Ferreira; Campos, Adelia Seplveda; Barbosa, Lupercio de Araujo; da Silveira, Leonardo Serafim			Ossification Pattern of Estuarine Dolphin (Sotalia guianensis) Forelimbs, from the Coast of the State of Espirito Santo, Brazil	PLOS ONE			English	Article							AGE; GROWTH; MATURITY; CETACEA	The estuarine dolphin, Sotalia guianensis, is one of the most abundant cetacean species in Brazil. Determination of age and of aspects associated with the development of this species is significant new studies. Counts of growth layer groups in dentin are used to estimate age of these animals, though other ways to evaluate development are also adopted, like the measurement of total length (TL). This study presents a procedure to evaluate the development of the estuarine dolphin based on the ossification pattern of forelimbs. Thirty-seven estuarine dolphins found in the state of Espirito Santo, Brazil, were examined. Age was estimated, TL was measured and ossification of epiphyses was examined by radiography. We analyzed results using the Spearman correlation. Inspection of radiographs allowed evaluation of the significance of the correlation between age and development of the proximal (r = 0.9109) and distal (r = 0.9092) radial epiphyses, and of the distal ulnar epiphyses (r = 0.9055). Radiographic analysis of forelimbs proved to be an appropriate method to evaluate physical maturity, and may be a helpful tool to estimate age of these animals in ecological and population studies.	[Martins de Carvalho, Anna Paula; Lima, Juliana Ywasaki; Azevedo, Carolina Torres; de Queiroz, Fybio Ferreira; da Silveira, Leonardo Serafim] Univ Estadual Norte Fluminense, Lab Morphol & Anim Pathol, Rio De Janeiro, Brazil; [Botta, Silvina] Univ Fed Rio Grande do Sul, Coll Oceanog, EcoMega, Lab Ecol & Marine Megafauna Conservat Studies, Rio Grande, RS, Brazil; [Campos, Adelia Seplveda] Doctor Vet Med, Rio De Janeiro, Brazil; [Barbosa, Lupercio de Araujo] Inst Consciencia Ambiental, Vila Velha, ES, England	Universidade Estadual do Norte Fluminense; Universidade Federal do Rio Grande do Sul	de Carvalho, APM (corresponding author), Univ Estadual Norte Fluminense, Lab Morphol & Anim Pathol, Campos Goytacazes, Rio De Janeiro, Brazil.	annapmcarvalho@gmail.com	Lima, Juliana/U-2098-2019; botta, silvina/D-7528-2016	Ywasaki Lima, Juliana/0000-0002-5494-6809; Botta, Silvina/0000-0001-6219-6932	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), http://www.capes.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butti C, 2007, J ANAT, V211, P639, DOI 10.1111/j.1469-7580.2007.00805.x; Calzada N, 1997, CAN J ZOOL, V75, P632, DOI 10.1139/z97-078; Carvalho APM, 2012, ARQ BRAS MED VET ZOO, V64, P205, DOI 10.1590/S0102-09352012000100029; Di Giancamillo M, 1998, CAN J ZOOL, V76, P1286, DOI 10.1139/cjz-76-7-1286; Fettuccia DC, 2006, THESIS U FEDERAL AAM; Flores PAC, 2008, ENCY MARINE MAMMALS, P1188; Galatius A, 2006, ACTA ZOOL-STOCKHOLM, V87, P77, DOI 10.1111/j.1463-6395.2006.00223.x; Hohn A.A., 1990, P575; HOHN AA, 1989, MAR MAMMAL SCI, V5, P315, DOI 10.1111/j.1748-7692.1989.tb00346.x; HUI CA, 1979, FISH B-NOAA, V77, P295; IBAMA, 2001, NAM AQ BRAS PLAN AC; IUCN, LIST VERM ESP AM VER; Martins RJC, 1977, ORTOD, V10, P164; Mellor L, 2009, PAEDOMORPHIC OSSIFIC; Menezes ME, 1996, ESTUDOS BIOL CURITIB, V4, P23, DOI [10.1002/(SICI)1097-0193(1996)4:1<23::AID-HBM2>3.0.CO;2-R, DOI 10.1002/(SICI)1097-0193(1996)4:1<23::AID-HBM2>3.0.CO;2-R, DOI 10.1002/(SICI)1097-0193(1996)4:1&LT;23::AID-HBM2&GT;3.0.CO;2-R]; Moscatiello VAM, 2008, ORTODON ORTOP FACIAL, V13, P92; NORRIS KENNETH S., 1961, JOUR MAMMAL, V42, P471, DOI 10.2307/1377364; OGDEN JA, 1981, SKELETAL RADIOL, V7, P119, DOI 10.1007/BF00347376; Perrin W.F., 1980, REPORTS INT WHALING, V3, P1; Perrin WF., 1975, B SCRIPPS I OCEANOGR, V21; Ramos Renata Maria Arruda, 2000, Aquatic Mammals, V26, P65; Rosas FCW, 2003, FISH B-NOAA, V101, P377; Santos SCBN, 1999, ORTOD, V32, P33; Simoes-Lopes P.C., 1988, BIOTRONICS, V1, P57; Sp?nola JL., 2006, THESIS U FEDERAL PAR; Stockin KA, 2008, NEW ZEAL J MAR FRESH, V42, P307, DOI 10.1080/00288330809509958; Sydney NV, 2011, J BIOSCIENCES, V36, P117, DOI 10.1007/s12038-011-9005-5; Tavano O, 1982, PEDIAT CLIN, V6, P7	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127435	10.1371/journal.pone.0127435	http://dx.doi.org/10.1371/journal.pone.0127435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017269	Green Published, Green Submitted, gold			2022-12-27	WOS:000355185600083
J	Pomerantz, J; Hank, C; Sugimoto, CR				Pomerantz, Jeffrey; Hank, Carolyn; Sugimoto, Cassidy R.			The State of Social Media Policies in Higher Education	PLOS ONE			English	Article								This paper presents an analysis of the current state of development of social media policies at institution of higher education. Content analysis of social media policies for all institutions listed in the Carnegie Classification Data File revealed that less than one-quarter of institutions had an accessible social media policy. Analysis was done by institution and campus unit, finding that social media policies were most likely to appear at doctorate-granting institutions and health, athletics, and library units. Policies required that those affiliated with the institution post appropriate content, represent the unit appropriately, and moderate conversations with coworkers and external agencies. This analysis may inform the development and revision of social media policies across the field of higher education, taking into consideration the rapidly changing landscape of social media, issues of academic freedom, and notions of interoperability with policies at the unit and campus levels.	[Pomerantz, Jeffrey] Univ N Carolina, Sch Informat & Lib Sci, Chapel Hill, NC USA; [Hank, Carolyn] Univ Tennessee, Sch Informat Sci, Knoxville, TN USA; [Sugimoto, Cassidy R.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Tennessee System; University of Tennessee Knoxville; Indiana University System; Indiana University Bloomington	Sugimoto, CR (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	sugimoto@indiana.edu	Sugimoto, Cassidy R/AAV-2705-2021	Sugimoto, Cassidy R/0000-0001-8608-3203; Pomerantz, Jeffrey/0000-0003-1056-3627	Association for Library and Information Science Education (ALISE)	Association for Library and Information Science Education (ALISE)	Association for Library and Information Science Education (ALISE)(http://www.alise.org/) provided a Research Grant to the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso O., 2009, P SIGIR 2009 WORKSH; Amazon Web Services LLC, 2012, AM MECH TURK PART AG; Amazon Web Services LLC, 2011, REQ BEST PRACT GUID; American Association of University Professors, 2013, SOC MED POL VIOL AC; American Association of University Professors, 1940, 1940 STAT PRINC AC F; Anderson D, 2013, UNM TODAY       0603; Armstrong J, 2008, REV CURRENT DEV INT, P141; Barlow M, 2011, EXECUTIVES GUIDE ENT; Basken P., 2013, CHRONICLE HIGHER ED; Belson K, 2012, NY TIMES; Blanchard O., 2011, SOCIAL MEDIA ROI MAN; Boudreaux C, 2011, SOCIAL MEDIA MANAGEM, P274; Boudreaux C, 2009, ANAL SOCIAL MEDIA PO; boyd d, 2008, 1344756 ID SOC SCI R; Brito, 2011, SMART BUSINESS SOCIA; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Chretien KC, 2011, ACAD MED, V86, P1545, DOI 10.1097/ACM.0b013e3182356128; Garner J, 2010, CLIN TEACH, V7, P112, DOI 10.1111/j.1743-498X.2010.00356.x; Gillette F, 2011, BUSINESSWEEK MA 0622; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Holsti O. R., 1969, CONTENT ANAL SOCIAL; Horling B, 2009, OFFICIAL GOOGLE 1204; Ingeno L., 2013, INSIDE HIGHER ED; Kansas Board of Regents, 2013, POL CHAPT 2 F US SOC; Kingkade T., 2013, HUFFINGTON POST 0702; Lehavot K, 2009, ETHICS BEHAV, V19, P129, DOI 10.1080/10508420902772728; Llopis-Jepsen C, 2014, TOPEKA CAPITAL  0514; McCormick AC., 2005, CHANGE, V37, P51, DOI 10.3200/CHNG.37.5.51-57; McDonald SJ, 2012, 2012 NAT C LAW HIGH; Melendez B., 1985, HONOR CODE STUDY; Moore K, 2012, COMPUT HUM BEHAV, V28, P267, DOI 10.1016/j.chb.2011.09.009; National Labor Relations Board, 2012, 1259 OM NAT LAB REL; Neuendorf KA, 2001, CONTENT ANAL GUIDEBO; Pew Research Center's Internet & American Life Project, SOC NETW; Pilon M, 2012, NY TIMES; Ross J., 2010, HUMAN FACTORS COMPUT, DOI [10.1145/1753846.1753873, DOI 10.1145/1753846.1753873]; Schneider EF, 2011, AM J PHARM EDUC, V75, DOI 10.5688/ajpe75470; Shaw Aaron D., 2011, P ACM 2011 C COMPUTE, P275, DOI [DOI 10.1145/1958824.1958865, 10.1145/1958824.1958865]; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Stutzman Frederic, 2012, P ACM 2012 C COMPUTE, P769, DOI [10.1145/2145204.2145320, DOI 10.1145/2145204.2145320]; Tufekci Z, 2012, J COMMUN, V62, P363, DOI 10.1111/j.1460-2466.2012.01629.x; Wentworth K, 2013, UNM TODAY; Zhou K., 2011, SOCIAL MEDIA MANAGEM	43	25	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0127485	10.1371/journal.pone.0127485	http://dx.doi.org/10.1371/journal.pone.0127485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0RO	26017549	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600085
J	Sirikharin, R; Taengchaiyaphum, S; Sanguanrut, P; Chi, TD; Mavichak, R; Proespraiwong, P; Nuangsaeng, B; Thitamadee, S; Flegel, TW; Sritunyalucksana, K				Sirikharin, Ratchanok; Taengchaiyaphum, Suparat; Sanguanrut, Piyachat; Thanh Duong Chi; Mavichak, Rapeepat; Proespraiwong, Porranee; Nuangsaeng, Bunlung; Thitamadee, Siripong; Flegel, Timothy W.; Sritunyalucksana, Kallaya			Characterization and PCR Detection Of Binary, Pir-Like Toxins from Vibrio parahaemolyticus Isolates that Cause Acute Hepatopancreatic Necrosis Disease (AHPND) in Shrimp	PLOS ONE			English	Article								Unique isolates of Vibrio parahaemolyticus (VPAHPND) have previously been identified as the causative agent of acute hepatopancreatic necrosis disease (AHPND) in shrimp. AHPND is characterized by massive sloughing of tubule epithelial cells of the hepatopancreas (HP), proposed to be induced by soluble toxins released from VPAHPND that colonize the shrimp stomach. Since these toxins (produced in broth culture) have been reported to cause AHPND pathology in reverse gavage bioassays with shrimp, we used ammonium sulfate precipitation to prepare protein fractions from broth cultures of VPAHPND isolates for screening by reverse gavage assays. The dialyzed 60% ammonium sulfate fraction caused high mortality within 24-48 hours post-administration, and histological analysis of the moribund shrimp showed typical massive sloughing of hepatopancreatic tubule epithelial cells characteristic of AHPND. Analysis of the active fraction by SDS-PAGE revealed two major bands at marker levels of approximately 16 kDa (ToxA) and 50 kDa (ToxB). Mass spectrometry analysis followed by MASCOT analysis revealed that both proteins had similarity to hypothetical proteins of V. parahaemolyticus M0605 (contig034 GenBank accession no. JALL01000066.1) and similarity to known binary insecticidal toxins called 'Photorhabdus insect related' proteins A and B (Pir-A and Pir-B), respectively, produced by the symbiotic, nematode bacterium Photorhabdus luminescens. In in vivo tests, it was shown that recombinant ToxA and ToxB were both required in a dose dependent manner to cause AHPND pathology, indicating further similarity to Pir-A and -B. A single-step PCR method was designed for detection of the ToxA gene and was validated using 104 bacterial isolates consisting of 51 VPAHPND isolates, 34 non-AHPND VP isolates and 19 other isolates of bacteria commonly found in shrimp ponds (including other species of Vibrio and Photobacterium). The results showed 100% specificity and sensitivity for detection of VPAHPND isolates in the test set.	[Sirikharin, Ratchanok; Taengchaiyaphum, Suparat; Sanguanrut, Piyachat; Thanh Duong Chi; Sritunyalucksana, Kallaya] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Shrimp Virus Interact Lab ASVI, Bangkok 10400, Thailand; [Sirikharin, Ratchanok; Sanguanrut, Piyachat; Thanh Duong Chi; Thitamadee, Siripong; Flegel, Timothy W.; Sritunyalucksana, Kallaya] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok 10400, Thailand; [Sirikharin, Ratchanok; Thitamadee, Siripong] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Mavichak, Rapeepat; Proespraiwong, Porranee] Charoen Pokphand Co Ltd, Aquat Anim Hlth Res Ctr, Samutsakorn 74000, Thailand; [Nuangsaeng, Bunlung] Burapha Univ, BMC, Chanthaburi 22170, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Mahidol University; Burapha University	Sritunyalucksana, K (corresponding author), NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Shrimp Virus Interact Lab ASVI, Rama 6 Rd, Bangkok 10400, Thailand.	kallaya@biotec.or.th	Taengchaiyaphum, Suparat/AAU-6637-2021	Flegel, Timothy W./0000-0002-1913-213X	Royal Golden Jubilee Ph.D. Program; Thailand Research Fund; National Research Council of Thailand; Agricultural Research and Development Agency; Charoen Pokphand Co. Ltd.	Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Thailand Research Fund(Thailand Research Fund (TRF)); National Research Council of Thailand(National Research Council of Thailand (NRCT)); Agricultural Research and Development Agency; Charoen Pokphand Co. Ltd.	This work was supported by The Royal Golden Jubilee Ph.D. Program, the Thailand Research Fund, http://rgj.trf.or.th, to RS; National Research Council of Thailand, http://en.nrct.go.th/, to KS; and The Agricultural Research and Development Agency, http://www.arda.or.th/, to TWF. Charoen Pokphand Co. Ltd. provided support in the form of salaries for authors RM and PP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bell T.A., 1988, HDB NORMAL PENAEID S; Chen C, 2003, OCEANOL LIMNOL SIN, V34, P2; ENGLARD S, 1990, METHOD ENZYMOL, V182, P285; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Gomez-Gil B, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00055-14; Gomez-Jimenez S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00800-14; Joshi J, 2014, AQUACULTURE, V428, P297, DOI 10.1016/j.aquaculture.2014.03.030; Kondo H, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00221-14; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Nunan L, 2014, DIS AQUAT ORGAN, V111, P81, DOI 10.3354/dao02776; Rodou A, 2010, TOXINS, V2, P1250, DOI 10.3390/toxins2061250; Sambrook J., 2001, MOL CLONING LAB MANU; Soto-Rodriguez SA, 2015, APPL ENV MI IN PRESS, V81; Su Y.Y., 2014, INT C INF COMM TECHN; TANIGUCHI H, 1985, J BACTERIOL, V162, P510, DOI 10.1128/JB.162.2.510-515.1985; Waterfield N, 2005, FEMS MICROBIOL LETT, V245, P47, DOI 10.1016/j.femsle.2005.02.018; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Yang YT, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00816-14	18	141	156	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2015	10	5							e0126987	10.1371/journal.pone.0126987	http://dx.doi.org/10.1371/journal.pone.0126987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0RO	26017673	gold, Green Published, Green Submitted			2022-12-27	WOS:000355185600066
J	Bavry, AA; Elgendy, IY; Mahmoud, A; Jadhav, MP; Huo, TY				Bavry, Anthony A.; Elgendy, Islam Y.; Mahmoud, Ahmed; Jadhav, Manoj P.; Huo, Tianyao			Critical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials	PLOS ONE			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITORS; ELEVATION MYOCARDIAL-INFARCTION; UNFRACTIONATED-HEPARIN; CLOPIDOGREL PRETREATMENT; COMPARING BIVALIRUDIN; ACUTE CATHETERIZATION; PLATELET-AGGREGATION; CLINICAL-TRIALS; HIGH-RISK; SAFETY	Percutaneous coronary intervention with bivalirudin plus bail-out glycoprotein IIb/IIIa inhibitors has been shown to be as effective as unfractionated heparin plus routine glycoprotein IIb/IIIa inhibitors in preventing cardiac ischemic events, but with a lower bleeding risk. It is unknown whether bivalirudin would have the same beneficial effects if compared with heparin when the use of glycoprotein IIb/IIIa inhibitors was similar between treatment arms. We searched the MEDLINE, Web of Science, and Cochrane databases from inception until March 2015 for randomized trials that compared bivalirudin to heparin in patients undergoing percutaneous coronary intervention. We required that the intended use of glycoprotein IIb/IIIa inhibitors was similar between the study groups. Summary estimates were principally constructed by the Peto method. Fifteen trials met our inclusion criteria, which yielded 25,824 patients. Bivalirudin versus heparin was associated with an increased hazard of stent thrombosis (odds ratio [OR] 1.49, 95% confidence interval [CI] 1.15-1.92, P = .002, I-2 = 16.9%), with a similar hazard of myocardial infarction (OR 1.09, 95% CI 0.98-1.22, P = .11, I-2 = 35.8%), all-cause mortality (OR 0.88, 95% CI 0.72-1.08, P = .21, I-2 = 31.5%) and major adverse cardiac events (OR 1.04, 95% CI 0.94-1.14, P = .46, I-2 = 53.9%). Bivalirudin was associated with a reduced hazard of major bleeding (OR 0.80, 95% CI 0.70-0.92, P = .001, I-2 = 63.5%). The dose of heparin in the control arm modified this association; when the dose of unfractionated heparin in the control arm was >= 100 units/kg, bivalirudin was associated with a reduction in major bleeding (OR 0.55, 95% CI 0.45-0.68, P < .0001), but when the dose of unfractionated heparin was <= 75 units/kg, bivalirudin was not associated with reduction in bleeding (OR 1.09, 95% CI 0.91-1.31, P = .36). Among patients undergoing PCI, bivalirudin was associated with an increased hazard of stent thrombosis. Bivalirudin may be associated with a reduced hazard of major bleeding; however, this benefit was no longer apparent when compared with a dose of unfractionated heparin <= 75 units/kg.	[Bavry, Anthony A.] North Florida South Georgia Vet Hlth Syst, Gainesville, FL 32608 USA; [Bavry, Anthony A.; Elgendy, Islam Y.; Mahmoud, Ahmed; Jadhav, Manoj P.; Huo, Tianyao] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida	Bavry, AA (corresponding author), North Florida South Georgia Vet Hlth Syst, Gainesville, FL 32608 USA.	anthony.bavry@va.gov	Elgendy, Islam Y/C-3900-2017; Mahmoud, Ahmed Naguib/C-3239-2017	Elgendy, Islam Y/0000-0001-9853-7591; Mahmoud, Ahmed Naguib/0000-0003-2459-5195				Anand SX, 2007, AM J CARDIOL, V100, P417, DOI 10.1016/j.amjcard.2007.02.106; Antman EM, 2002, AM HEART J, V143, P229, DOI 10.1067/mhj.2002.120405; Bertrand OF, 2012, AM J CARDIOL, V110, P599, DOI 10.1016/j.amjcard.2012.03.051; BITTL JA, 1995, NEW ENGL J MED, V333, P764, DOI 10.1056/NEJM199509213331204; Bittl JA, 2001, AM HEART J, V142, P952, DOI 10.1067/mhj.2001.119374; Briguori C, 2015, JACC-CARDIOVASC INTE, V8, P414, DOI 10.1016/j.jcin.2014.10.015; Cassese S, 2015, EUROINTERVENTION, V11, P196, DOI 10.4244/EIJY14M08_01; Cavender MA, 2014, LANCET, V384, P599, DOI 10.1016/S0140-6736(14)61216-2; Deshpande Niteen V, 2012, Indian Heart J, V64, P444, DOI 10.1016/j.ihj.2012.07.022; Eslam RB, 2009, EUR HEART J, V30, P1831, DOI 10.1093/eurheartj/ehp186; Feldman A, 2014, INT J ANGIOL, V23, P227, DOI 10.1055/s-0034-1372244; Gibson CM, 2006, J AM COLL CARDIOL, V47, P2364, DOI 10.1016/j.jacc.2005.12.077; Han YL, 2015, JAMA-J AM MED ASSOC, V313, P1336, DOI 10.1001/jama.2015.2323; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944; Kastrati A, 2011, NEW ENGL J MED, V365, P1980, DOI 10.1056/NEJMoa1109596; Kleiman NS, 2002, AM HEART J, V143, P585, DOI 10.1067/mhj.2002.120297; Lev EI, 2006, THROMB HAEMOSTASIS, V95, P441, DOI 10.1160/TH05-10-0700; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Li GH, 2007, ARTERIOSCL THROM VAS, V27, P1850, DOI 10.1161/ATVBAHA.107.144576; Lincoff AM, 2004, AM J CARDIOL, V93, P1092, DOI 10.1016/j.amjcard.2004.01.033; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Lincoff AM, 2002, AM HEART J, V143, P847, DOI 10.1067/mhj.2002.122173; Mahaffey Kenneth W, 2003, J Invasive Cardiol, V15, P611; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moliterno DJ, 2011, CATHETER CARDIO INTE, V77, P1001, DOI 10.1002/ccd.22876; Nairooz R, 2014, AM J CARDIOL, V114, P250, DOI 10.1016/j.amjcard.2014.04.033; Parodi G, 2010, AM J CARDIOL, V105, P1053, DOI 10.1016/j.amjcard.2009.12.001; Patti G, 2012, AM J CARDIOL, V110, P478, DOI 10.1016/j.amjcard.2012.04.017; Saucedo JF, 2005, AM J CARDIOL, V95, P1453, DOI 10.1016/j.amjcard.2005.02.012; Schulz S, 2014, EUR HEART J, V35, P2285, DOI 10.1093/eurheartj/ehu182; Schulz S, 2010, EUR HEART J, V31, P2482, DOI 10.1093/eurheartj/ehq330; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Shuster JJ, 2012, RES SYNTH METHODS, V3, P30, DOI 10.1002/jrsm.1039; Sibbing D, 2008, EUR HEART J, V29, P1504, DOI 10.1093/eurheartj/ehn195; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2007, LANCET, V369, P907, DOI 10.1016/S0140-6736(07)60450-4; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Stone GW, 2011, LANCET, V377, P2193, DOI 10.1016/S0140-6736(11)60764-2; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tavano D, 2009, AM J CARDIOL, V104, P1222, DOI 10.1016/j.amjcard.2009.06.035; THEROUX P, 1995, CIRCULATION, V91, P2132, DOI 10.1161/01.CIR.91.8.2132; TOPOL EJ, 1993, CIRCULATION, V87, P1622, DOI 10.1161/01.CIR.87.5.1622; Valgimigli M, 2015, PRESENTED AT ACC 15; Waksman R, 2013, J INTERV CARDIOL, V26, P107, DOI 10.1111/joic.12005; White HD, 2008, J AM COLL CARDIOL, V52, P807, DOI 10.1016/j.jacc.2008.05.036; Winchester DE, 2011, J AM COLL CARDIOL, V57, P1190, DOI 10.1016/j.jacc.2010.10.030; Xiang DC, 2013, CHINESE MED J-PEKING, V126, P3064, DOI 10.3760/cma.j.issn.0366-6999.20122569; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zeymer U, 2014, EUR HEART J, V35, P2460, DOI 10.1093/eurheartj/ehu214	56	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127832	10.1371/journal.pone.0127832	http://dx.doi.org/10.1371/journal.pone.0127832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010682	Green Submitted, Green Published, gold			2022-12-27	WOS:000355183900150
J	Behling, J; Chan, AK; Zeh, C; Nekesa, C; Heinzerling, L				Behling, Juliane; Chan, Adrienne K.; Zeh, Clement; Nekesa, Carolyne; Heinzerling, Lucie			Evaluating HIV Prevention Programs: Herpes Simplex Virus Type 2 Antibodies as Biomarker for Sexual Risk Behavior in Young Adults in Resource-Poor Countries	PLOS ONE			English	Article							GENITAL ULCER DISEASE; LINKED IMMUNOSORBENT ASSAYS; WESTERN KENYA; INFECTION; PREVALENCE; PERFORMANCE; UGANDA; RAKAI; HSV-2; POPULATIONS	Background Measuring effectiveness of HIV prevention interventions is challenged by bias when using self-reported knowledge, attitude or behavior change. HIV incidence is an objective marker to measure effectiveness of HIV prevention interventions, however, because new infection rates are relatively low, prevention studies require large sample sizes. Herpes simplex virus type 2 (HSV-2) is similarly transmitted and more prevalent and could thus serve as a proxy marker for sexual risk behavior and therefore HIV infection. Methods HSV-2 antibodies were assessed in a sub-study of 70,000 students participating in an education intervention in Western Province, Kenya. Feasibility of testing for HSV-2 antibodies was assessed comparing two methods using Fisher's exact test. Three hundred and ninety four students (aged 18 to 22 years) were randomly chosen from the cohort and tested for HIV, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. Out of these, 139 students were tested for HSV-2 with ELISA and surveyed for sexual risk behavior and 89 students were additionally tested for HSV-2 with a point-of-contact (POC) test. Results Prevalence rates were 0.5%, 1.8%, 0.3% and 2.3% for HIV, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis, respectively. Prevalence of HSV-2 antibodies was 3.4 % as measured by POC test (n=89) and 14.4 % by ELISA (n=139). Specificity of the POC test compared with ELISA was 100%, and the sensitivity only 23.1%. Associations between self-reported sexual behavior and HSV-2 serostatus could not be shown. Conclusions Associations between self-reported sexual risk behavior and HSV-2 serostatus could not be shown, probably due to social bias in interviews since its transmission is clearly linked. HSV-2 antibody testing is feasible in resource-poor settings and shows higher prevalence rates than other sexually transmitted diseases thus representing a potential biomarker for evaluation of HIV prevention interventions.	[Behling, Juliane; Heinzerling, Lucie] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Dermatol STIs & Allergy, D-91054 Erlangen, Germany; [Chan, Adrienne K.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Zeh, Clement] Ctr Dis Control & Prevent, Kisumu, Kenya; [Nekesa, Carolyne] Innovat Poverty Act, Busia, Kenya	University of Erlangen Nuremberg; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Innovations for Poverty Action (IPA)	Heinzerling, L (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Dermatol STIs & Allergy, D-91054 Erlangen, Germany.	lucie.heinzerling@uk-erlangen.de		, lucie/0000-0003-4587-007X	William and Flora Hewlett Foundation [2007-9148]	William and Flora Hewlett Foundation	Funding was provided by The William and Flora Hewlett Foundation (Grant No. 2007-9148). (http://www.hewlett.org/about-us), Focus Diagnostics Inc. generously provided the ELISA as well as the POC kits free of charge for this study. (http://www.focusdx.com/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Ashley RL, 2000, SEX TRANSM DIS, V27, P266, DOI 10.1097/00007435-200005000-00005; Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Bastien S, 2012, INT J STD AIDS, V23, P761, DOI 10.1258/ijsa.2012.011433; Celum CL, 2005, J INFECT DIS, V191, pS107, DOI 10.1086/425272; COWAN FM, 1994, BRIT MED J, V309, P1325, DOI 10.1136/bmj.309.6965.1325; Cusini M, 2001, J ANTIMICROB CHEMOTH, V47, P9, DOI 10.1093/jac/47.suppl_1.9; DANGOR Y, 1990, SEX TRANSM DIS, V17, P184, DOI 10.1097/00007435-199010000-00007; Delany-Moretlwe S, 2010, SEX TRANSM INFECT, V86, P46, DOI 10.1136/sti.2009.036541; Duflo E., 2012, ED HIV EARLY FERTILI; Duflo E, 2006, ED HIV AIDS PREVENTI; Emonyi IW, 2000, E AFR MED J, V77, P428; Feldblum PJ, 2000, SEX TRANSM INFECT, V76, P454, DOI 10.1136/sti.76.6.454; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Gamiel JL, 2008, CLIN VACCINE IMMUNOL, V15, P888, DOI 10.1128/CVI.00453-07; Geretti AM, 2005, SEX TRANSM INFECT, V81, P316, DOI 10.1136/sti.2004.013110; Hogrefe W, 2002, J CLIN MICROBIOL, V40, P3635, DOI 10.1128/JCM.40.10.3635-3640.2002; Huygens P, 1996, SOC SCI MED, V42, P221, DOI 10.1016/0277-9536(95)00088-7; Laeyendecker O, 2004, J CLIN MICROBIOL, V42, P1794, DOI 10.1128/JCM.42.4.1794-1796.2004; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Luseno WK, 2014, J PRIM PREV; Morrow RA, 2003, J CLIN MICROBIOL, V41, P5212, DOI 10.1128/JCM.41.11.5212-5214.2003; Organization. WH, 2003, WHORHI0110; Paz-Bailey G, 2005, CLIN INFECT DIS, V41, P1304, DOI 10.1086/496979; Philip SS, 2008, CLIN INFECT DIS, V47, pE79, DOI 10.1086/592696; Remis RS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-550; Sangani P, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001220.PUB2, 10.1002/14651858.CD001220.pub2]; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Smith JS, 2009, SEX TRANSM INFECT, V85, P92, DOI 10.1136/sti.2008.031815; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stephenson J, 2004, LANCET, V363, P1177, DOI 10.1016/S0140-6736(04)15983-7; Tan Darrell H S, 2009, Can J Infect Dis Med Microbiol, V20, pe1; Tobian AAR, 2009, J INFECT DIS, V199, P945, DOI 10.1086/597074; Turner KR, 2002, SEX TRANSM DIS, V29, P422, DOI 10.1097/00007435-200207000-00011; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wools KK, 1998, E AFR MED J, V75, P679	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128370	10.1371/journal.pone.0128370	http://dx.doi.org/10.1371/journal.pone.0128370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010772	gold, Green Submitted, Green Published			2022-12-27	WOS:000355183900231
J	Debevc, M; Milosevic, D; Kozuh, I				Debevc, Matjaz; Milosevic, Danijela; Kozuh, Ines			A Comparison of Comprehension Processes in Sign Language Interpreter Videos with or without Captions	PLOS ONE			English	Article							HARD-OF-HEARING; DEAF; ADULTS	One important theme in captioning is whether the implementation of captions in individual sign language interpreter videos can positively affect viewers' comprehension when compared with sign language interpreter videos without captions. In our study, an experiment was conducted using four video clips with information about everyday events. Fifty-one deaf and hard of hearing sign language users alternately watched the sign language interpreter videos with, and without, captions. Afterwards, they answered ten questions. The results showed that the presence of captions positively affected their rates of comprehension, which increased by 24% among deaf viewers and 42% among hard of hearing viewers. The most obvious differences in comprehension between watching sign language interpreter videos with and without captions were found for the subjects of hiking and culture, where comprehension was higher when captions were used. The results led to suggestions for the consistent use of captions in sign language interpreter videos in various media.	[Debevc, Matjaz; Kozuh, Ines] Univ Maribor, Fac Elect Engn & Comp Sci, Inst Media Commun, SLO-2000 Maribor, Slovenia; [Milosevic, Danijela] Univ Kragujevac, Fac Tech Sci Cacak, Dept Informat Technol, Cacak, Serbia	University of Maribor; University of Kragujevac	Debevc, M (corresponding author), Univ Maribor, Fac Elect Engn & Comp Sci, Inst Media Commun, SLO-2000 Maribor, Slovenia.	matjaz.debevc@um.si	Kozuh, Ines/AAL-3680-2020; Debevc, Matjaž/AAY-3715-2021	Debevc, Matjaž/0000-0003-4638-7864; Kozuh, Ines/0000-0001-7875-5583	Swiss National Science Foundation [IZKOZ3_136107/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Swiss National Science Foundation, Project Number: IZKOZ3_136107/1. The "International Short Visits" of the Swiss National Science Foundation (SNSF) allow for researchers working in Switzerland to go abroad or for researchers from elsewhere to come to Switzerland. Dr. Matjaz Debevc visited ETH Zurich and performed the research at this institution.	Allen C, 2009, WORLD FEDERATION DEA; Andrew KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089994; Brickman B, 1995, J SCI PERSONS DISABI, V3, P40; Burnham D, 2008, J DEAF STUD DEAF EDU, V13, P391, DOI 10.1093/deafed/enn003; Cambra C, 2008, AM ANN DEAF, V153, P425; Cambra C, 2010, DEAF EDUC INT, V12, P34, DOI 10.1179/146431510X12626982043606; Cavender A, 2008, HUM-COMPUT INT-SPRIN, P25, DOI 10.1007/978-1-84800-050-6_3; Cohen J.E., 1988, STAT POWER ANAL BEHA; d'Ydewalle G, 2007, EUR PSYCHOL, V12, P196, DOI 10.1027/1016-9040.12.3.196; De Linde Zoe., 1999, SEMIOTICS SUBTITLING; Deaf News Network (DNN), 2014, FCC REQ CAPT VID CLI; Debevc M, 2011, MULTIMED TOOLS APPL, V54, P181, DOI 10.1007/s11042-010-0529-8; Debevc M, 2010, LECT NOTES COMPUT SC, V6389, P203; dYdewalle G, 1987, EYE MOVEMENTS PHYSL, DOI DOI 10.1016/B978-0-444-70113-8.50047-3; European Broadcasting Union (EBU), 2004, ACC SERV INCL REC RE; European Commission, 2010, EUR DIS STRAT 2010 2; European Federation of Hard of Hearing People, 2011, STAT SUBT ACC EU 201; European Union of the Deaf, 2012, SLOV; Fajardo I, 2003, HCI INT, P950; Gulliver S.R., 2003, INF SOC J, V2, P374, DOI [10.1007/s10209-003-0067-5, DOI 10.1007/S10209-003-0067-5]; Gulliver SR, 2003, P IEEE INT C MULT EX, V1, P753; Hanson VL, 2013, ACM T WEB, V7, DOI 10.1145/2435215.2435217; Hanson VL, 2008, HUM-COMPUT INT-SPRIN, P215, DOI 10.1007/978-1-84800-050-6_13; Holzinger A, 2005, COMMUN ACM, V48, P71, DOI 10.1145/1039539.1039541; Hong R., 2011, P ACM INT C MULT MM, V7, P35, DOI DOI 10.1145/2043612.2043613; Howell D, 2002, STAT METHODS PSYCHOL, V5th ed; Jacobs I, 2001, INTERACTIONS, V8, P35, DOI [10.1145/379537.379550, DOI 10.1145/379537.379550]; Jelinek Lewis M S, 2001, J Deaf Stud Deaf Educ, V6, P43; Kim Y, 2006, J SPECIAL ED THEORY, V7, P489; Kirkland CE, 1995, ANN M AM ED RES ASS; KOSKINEN PS, 1993, READ TEACH, V47, P36; Kozuh I, 2014, ENHANCING UNIVERSAL, P1; Margaret SJ, 2001, J DEAF STUDIES DEAL, V6, P43; Marschark M, 1996, READING COMPREHENSION DIFFICULTIES, P279; Marschark M., 2004, SIGN LANGUAGE STUDIE, V4, P345, DOI DOI 10.1353/SLS.2004.0018; NUGENT GC, 1983, J SPEC EDUC, V17, P227, DOI 10.1177/002246698301700214; Paivio, 1986, MENTAL REPRESENTATIO; Perego E, 2010, MEDIA PSYCHOL, V13, P243, DOI 10.1080/15213269.2010.502873; Sadler KL, 2009, THESIS U PITTSBURGH; Schirmer BR, 2001, DIMENSIONS DEAFNESS; Steinfeld A, 1998, VOLTA REV, V100, P29; Strassman BK, 2012, AM ANN DEAF, V157, P340; Szarkowska A, 2011, AM ANN DEAF, V156, P363, DOI 10.1353/aad.2011.0039; Wehrmeyer J, 2014, J EYE MOVEMENT RES, V7; Yoon JO, 2011, AM ANN DEAF, V156, P283, DOI 10.1353/aad.2011.0026	45	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127577	10.1371/journal.pone.0127577	http://dx.doi.org/10.1371/journal.pone.0127577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010899	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900113
J	Go, VF; Frangakis, C; Nguyen, LM; Latkin, C; Ha, TV; Mo, TT; Sripaipan, T; Davis, WW; Zelaya, C; Pham, TV; Celentano, DD; Quan, VM				Go, Vivian F.; Frangakis, Constantine; Nguyen Le Minh; Latkin, Carl; Ha, Tran Viet; Mo, Tran Thi; Sripaipan, Teerada; Davis, Wendy W.; Zelaya, Carla; Pham The Vu; Celentano, David D.; Quan, Vu Minh			Efficacy of a Multi-level Intervention to Reduce Injecting and Sexual Risk Behaviors among HIV-Infected People Who Inject Drugs in Vietnam: A Four-Arm Randomized Controlled Trial	PLOS ONE			English	Article							NORTHERN VIETNAM; USERS; FAMILY; TRANSMISSION; PREVENTION; PARTNERS; STIGMA	Introduction Injecting drug use is a primary driver of HIV epidemics in many countries. People who inject drugs (PWID) and are HIV infected are often doubly stigmatized and many encounter difficulties reducing risk behaviors. Prevention interventions for HIV-infected PWID that provide enhanced support at the individual, family, and community level to facilitate risk-reduction are needed. Methods 455 HIV-infected PWID and 355 of their HIV negative injecting network members living in 32 sub-districts in Thai Nguyen Province were enrolled. We conducted a two-stage randomization: First, sub-districts were randomized to either a community video screening and house-to-house visits or standard of care educational pamphlets. Second, within each subdistrict, participants were randomized to receive either enhanced individual level post-test counseling and group support sessions or standard of care HIV testing and counseling. This resulted in four arms: 1) standard of care; 2) community level intervention; 3) individual level intervention; and 4) community plus individual intervention. Follow-up was conducted at 6, 12, 18, and 24 months. Primary outcomes were self-reported HIV injecting and sexual risk behaviors. Secondary outcomes included HIV incidence among HIV negative network members. Results Fewer participants reported sharing injecting equipment and unprotected sex from baseline to 24 months in all arms (77% to 4% and 24% to 5% respectively). There were no significant differences at the 24-month visit among the 4 arms (Wald = 3.40 (3 df); p = 0.33; Wald = 6.73 (3 df); p = 0.08). There were a total of 4 HIV seroconversions over 24 months with no significant difference between intervention and control arms. Discussion Understanding the mechanisms through which all arms, particularly the control arm, demonstrated both low risk behaviors and low HIV incidence has important implications for policy and prevention programming.	[Go, Vivian F.; Ha, Tran Viet; Mo, Tran Thi; Sripaipan, Teerada] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA; [Frangakis, Constantine] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Nguyen Le Minh; Pham The Vu] Thai Nguyen Ctr Prevent Med, Thai Nguyen, Vietnam; [Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Davis, Wendy W.; Zelaya, Carla; Celentano, David D.; Quan, Vu Minh] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Go, VF (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA.	vgo@unc.edu		Vu, Quan/0000-0003-4462-0546	National Institute on Drug Abuse [1 R01 DA022962-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022962] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the National Institute on Drug Abuse (http://www.drugabuse.gov): 1 R01 DA022962-01 [VFG CF NLM CL TVH TTM TS WWD CZ PTV DDC VMQ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achy-Brou AC, 2010, BIOMETRICS, V66, P824, DOI 10.1111/j.1541-0420.2009.01334.x; [Anonymous], AIDS BEHAV; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Caceres CF, 2010, JAIDS-J ACQ IMM DEF, V54, P204, DOI 10.1097/QAI.0b013e3181d61def; Coates TJ, 2014, LANCET GLOB HEALTH, V2, pE267, DOI 10.1016/S2214-109X(14)70032-4; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; Crawford ND, 2010, JAIDS-J ACQ IMM DEF, V55, pS84, DOI 10.1097/QAI.0b013e3181fbca5a; Crepaz N, 2002, AIDS, V16, P135, DOI 10.1097/00002030-200201250-00002; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; DEREN S, 1998, AIDS BEHAV, V0002; DESJARLAIS DC, 1984, LANCET, V2, P1346; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Go VF, 2006, JAIDS-J ACQ IMM DEF, V42, P108, DOI 10.1097/01.qai.0000199354.88607.2f; Go VF, 2013, SOC SCI MED, V96, P154, DOI 10.1016/j.socscimed.2013.07.006; Hammett TM, 2005, JAIDS-J ACQ IMM DEF, V38, P228, DOI 10.1097/00126334-200502010-00016; Hien NT, 2004, AIDS EDUC PREV, V16, P137, DOI 10.1521/aeap.16.3.5.137.35527; Hong K. T., 2011, UNDERSTANDING CHALLE; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; Khoat DV, 2005, AIDS CARE, V17, pS181, DOI 10.1080/09540120500119940; Koblavi-Deme S, 2001, J CLIN MICROBIOL, V39, P1808, DOI 10.1128/JCM.39.5.1808-1812.2001; Latkin CA, 2009, SOC SCI MED, V68, P740, DOI 10.1016/j.socscimed.2008.11.019; Li L, 2013, INT J DRUG POLICY, V24, P545, DOI 10.1016/j.drugpo.2013.06.007; Marks G, 1999, AIDS, V13, P297, DOI [10.1097/00002030-199902250-00001, 10.1080/088395199117432]; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mazhnaya A, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18825; Ministry of Health of Vietnam, 2011, RES HIV STI INT BIOL; Nyblade L., 2008, COMMUNITIES CONFRONT; O'Connell AA, 2014, AIDS BEHAV; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Panda S, 2000, INT J STD AIDS, V11, P468, DOI 10.1258/0956462001916137; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rudolph AE, 2012, AIDS CARE, V24, P239, DOI 10.1080/09540121.2011.596517; Salter ML, 2010, AIDS EDUC PREV, V22, P558, DOI 10.1521/aeap.2010.22.6.558; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Socialist Republic of Viet Nam, 2014, VIETN AIDS RESP PROG; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Strathdee SA, 2012, CURR OPIN HIV AIDS, V7, P320, DOI 10.1097/COH.0b013e32835369ad; Thai Nguyen Provincial HIV/AIDS Control Center, 2014, BI ANN REP PROV HIV; TURNER JC, 1975, EUR J SOC PSYCHOL, V5, P5, DOI 10.1002/ejsp.2420050102; UN Country Team, 2005, 5 UN COUNTR TEAM; United Nations Office on Drugs and Crime (UNODC), 2013, WORLD DRUG REP 2013; van Empelen P, 2003, SOC SCI MED, V57, P1593, DOI 10.1016/S0277-9536(02)00557-9; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Wolitski RJ, 1997, AIDS EDUC PREV, V9, P52; Wu ZK, 2014, BIOMETRICS, V70, P1014, DOI 10.1111/biom.12214	49	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0125909	10.1371/journal.pone.0125909	http://dx.doi.org/10.1371/journal.pone.0125909			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26011427	Green Published, Green Submitted, gold			2022-12-27	WOS:000355183900018
J	Herzog, D; Poellinger, A; Doellinger, F; Schuermann, D; Temmesfeld-Wollbrueck, B; Froeling, V; Schreiter, NF; Neumann, K; Hippenstiel, S; Suttorp, N; Hubner, RH				Herzog, Dominik; Poellinger, Alexander; Doellinger, Felix; Schuermann, Dirk; Temmesfeld-Wollbrueck, Bettina; Froeling, Vera; Schreiter, Nils F.; Neumann, Konrad; Hippenstiel, Stefan; Suttorp, Norbert; Hubner, Ralf-Harto			Modifying Post-Operative Medical Care after EBV Implant May Reduce Pneumothorax Incidence	PLOS ONE			English	Article							LUNG-VOLUME REDUCTION; ADVANCED EMPHYSEMA; ENDOBRONCHIAL VALVES; CLINICAL-OUTCOMES; THERAPY; COPD	Objective Endoscopic lung volume reduction (ELVR) with valves has been shown to improve COPD patients with severe emphysema. However, a major complication is pneumothoraces, occurring typically soon after valve implantation, with severe consequences if not managed promptly. Based on the knowledge that strain activity is related to a higher risk of pneumothoraces, we asked whether modifying post-operative medical care with the inclusion of strict short-term limitation of strain activity is associated with a lower incidence of pneumothorax. Methods Seventy-two (72) emphysematous patients without collateral ventilation were treated with bronchial valves and included in the study. Thirty-two (32) patients received standard post-implantation medical management (Standard Medical Care (SMC)), and 40 patients received a modified medical care that included an additional bed rest for 48 hours and cough suppression, as needed (Modified Medical Care (MMC)). Results The baseline characteristics were similar for the two groups, except there were more males in the SMC cohort. Overall, ten pneumothoraces occurred up to four days after ELVR, eight pneumothoraces in the SMC, and only two in the MMC cohorts (p=0.02). Complicated pneumothoraces and pneumothoraces after upper lobe treatment were significantly lower in MMC (p=0.02). Major clinical outcomes showed no significant differences between the two cohorts. Conclusions In conclusion, modifying post-operative medical care to include bed rest for 48 hours after ELVR and cough suppression, if needed, might reduce the incidence of pneumothoraces. Prospective randomized studies with larger numbers of well-matched patients are needed to confirm the data.	[Herzog, Dominik; Schuermann, Dirk; Temmesfeld-Wollbrueck, Bettina; Hippenstiel, Stefan; Suttorp, Norbert; Hubner, Ralf-Harto] Charite, Dept Internal Med Infect Dis & Resp Med, D-13353 Berlin, Germany; [Poellinger, Alexander; Doellinger, Felix; Schreiter, Nils F.] Charite, Inst Radiol, D-13353 Berlin, Germany; [Froeling, Vera] Charite, Dept Nucl Med, D-13353 Berlin, Germany; [Neumann, Konrad] Charite, Inst Biometry & Clin Epidemiol, D-12203 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hubner, RH (corresponding author), Charite, Dept Internal Med Infect Dis & Resp Med, Augustenburger Pl 1, D-13353 Berlin, Germany.	ralf-harto.huebner@charite.de	Hubner, Ralf-Harto/G-4665-2016	Schurmann, Dirk/0000-0002-6879-9213; Hubner, Ralf-Harto/0000-0001-5969-2089; Suttorp, Norbert/0000-0002-3958-1151; Doellinger, Felix/0000-0003-3661-8569; Hippenstiel, Stefan/0000-0002-5146-1064	Pulmonx	Pulmonx	I have read the journal's policy and the authors of this manuscript have the following competing interests: Ralf-Harto Huebner has received lecture fees for educational activities from Pulmonx. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.	Bellemare F, 2003, AM J RESP CRIT CARE, V168, P305, DOI 10.1164/rccm.200208-876OC; BENSE L, 1992, CHEST, V101, P891, DOI 10.1378/chest.101.4.891; BENSE L, 1987, EUR J RESPIR DIS, V71, P181; Bosc C, 2014, EUR RESPIR J, V44; Casha AR, 2014, EUR J CARDIO-THORAC, V45, P1011, DOI 10.1093/ejcts/ezt659; CRAN IR, 1967, THORAX, V22, P462, DOI 10.1136/thx.22.5.462; Criner GJ, 2010, SEMIN RESP CRIT CARE, V31, P348, DOI 10.1055/s-0030-1254075; Dejene S, 2013, ANN THORAC MED, V8, P176, DOI 10.4103/1817-1737.114283; Dransfield MT, 2007, CHEST, V132, P464, DOI 10.1378/chest.07-0863; Giesirich W, 2014, EUR RESPIR J, V9, P44; Gompelmann D, 2010, RESPIRATION, V80, P419, DOI 10.1159/000319441; Gompelmann D, 2014, DTSCH ARZTEBL INT, V111, P827, DOI 10.3238/arztebl.2014.0827; Gompelmann D, 2014, RESPIRATION, V87, P485, DOI 10.1159/000360641; Herth FJF, 2013, EUR RESPIR J, V41, P302, DOI 10.1183/09031936.00015312; Herth FJF, 2012, EUR RESPIR J, V39, P1334, DOI 10.1183/09031936.00161611; Herzog D, 2014, PNEUMOLOGE, V11, P135, DOI 10.1007/s10405-013-0738-8; Higuchi T, 2006, THORAX, V61, P409, DOI 10.1136/thx.2005.051219; Hoshino A, 2014, PEDIATR INT, V56, P510, DOI 10.1111/ped.12325; Leppert PM, 2014, AM J RESP CRIT CARE, V189; Sahn SA, 2000, NEW ENGL J MED, V342, P868, DOI 10.1056/NEJM200003233421207; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shah PL, 2014, THORAX, V69, P280, DOI 10.1136/thoraxjnl-2013-203743; Tidwell SL, 2012, SOUTH MED J, V105, P56, DOI 10.1097/SMJ.0b013e31823c5c49; Toma TP, 2003, LANCET, V361, P931, DOI 10.1016/S0140-6736(03)12762-6; Valipour A, 2014, RESPIRATION, V87, P513, DOI 10.1159/000360642; Venuta F, 2005, ANN THORAC SURG, V79, P411, DOI 10.1016/j.athoracsur.2004.07.048; Wan IYP, 2006, CHEST, V129, P518, DOI 10.1378/chest.129.3.518	27	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128097	10.1371/journal.pone.0128097	http://dx.doi.org/10.1371/journal.pone.0128097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010886	Green Published, gold			2022-12-27	WOS:000355183900192
J	Kiss, K; Baghy, K; Spisak, S; Szanyi, S; Tulassay, Z; Zalatnai, A; Lohr, JM; Jesenofsky, R; Kovalszky, I; Firneisz, G				Kiss, Katalin; Baghy, Kornelia; Spisak, Sandor; Szanyi, Szilard; Tulassay, Zsolt; Zalatnai, Attila; Lohr, J. -Matthias; Jesenofsky, Ralf; Kovalszky, Ilona; Firneisz, Gabor			Chronic Hyperglycemia Induces Trans-Differentiation of Human Pancreatic Stellate Cells and Enhances the Malignant Molecular Communication with Human Pancreatic Cancer Cells	PLOS ONE			English	Article							GENE-TRANSCRIPTION; DIABETES-MELLITUS; SP1; ADENOCARCINOMA; IDENTIFICATION; PROLIFERATION; ACTIVATION; FIBROSIS; GROWTH; CXCR4	Background Diabetes mellitus is linked to pancreatic cancer. We hypothesized a role for pancreatic stellate cells (PSC) in the hyperglycemia induced deterioration of pancreatic cancer and therefore studied two human cell lines (RLT-PSC, T3M4) in hyperglycemic environment. Methodology/Principal Findings The effect of chronic hyperglycemia (CHG) on PSCs was studied using mRNA expression array with real-time PCR validation and bioinformatic pathway analysis, and confirmatory protein studies. The stress fiber formation (IC: alpha SMA) indicated that PSCs tend to transdifferentiate to a myofibroblast-like state after exposure to CHG. The phosphorylation of p38 and ERK1/2 was increased with a consecutive upregulation of CDC25, SP1, cFOS and p21, and with downregulation of PPAR. after PSCs were exposed to chronic hyperglycemia. CXCL12 levels increased significantly in PSC supernatant after CHG exposure independently from TGF-beta 1 treatment (3.09-fold with a 2.73-fold without TGF-beta 1, p<0.05). The upregualtion of the SP1 transcription factor in PSCs after CHG exposure may be implicated in the increased CXCL12 and IGFBP2 production. In cancer cells, hyperglycemia induced an increased expression of CXCR4, a CXCL12 receptor that was also induced by PSC's conditioned medium. The receptor-ligand interaction increased the phosphorylation of ERK1/2 and p38 resulting in activation of MAP kinase pathway, one of the most powerful stimuli for cell proliferation. Certainly, conditioned medium of PSC increased pancreatic cancer cell proliferation and this effect could be partially inhibited by a CXCR4 inhibitor. As the PSC conditioned medium (normal glucose concentration) increased the ERK1/2 and p38 phosphorylation, we concluded that PSCs produce other factor(s) that influence(s) pancreatic cancer behaviour. Conclusions Hyperglycemia induces increased CXCL12 production by the PSCs, and its receptor, CXCR4 on cancer cells. The ligand-receptor interaction activates MAP kinase signaling that causes increased cancer cell proliferation and migration.	[Kiss, Katalin; Baghy, Kornelia; Zalatnai, Attila; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Spisak, Sandor] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA; [Szanyi, Szilard] Heidelberg Univ, Dept Gen Surg, Heidelberg, Germany; [Szanyi, Szilard] Semmelweis Univ, Sch PhD Studies, H-1085 Budapest, Hungary; [Tulassay, Zsolt; Firneisz, Gabor] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Lohr, J. -Matthias] Karolinska Univ Hosp, Gastroctr, Karolinska Inst, Stockholm, Sweden; [Jesenofsky, Ralf] Heidelberg Univ, Dept Med 2, Mannheim, Germany	Semmelweis University; Harvard University; Boston Children's Hospital; Harvard Medical School; Ruprecht Karls University Heidelberg; Semmelweis University; Semmelweis University; Karolinska Institutet; Karolinska University Hospital; Ruprecht Karls University Heidelberg	Firneisz, G (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	firneisz.gabor@med.semmelweis-univ.hu	Löhr, Matthias/A-3692-2012; Firneisz, Gabor/AAC-9654-2021; Kovalszky, Ilona/ABH-2832-2020; Baghy, Kornélia/ABH-2549-2020	Löhr, Matthias/0000-0002-7647-198X; Firneisz, Gabor/0000-0002-9123-8131; Kovalszky, Ilona/0000-0002-0179-3378; Baghy, Kornélia/0000-0002-5323-2775	OTKA [100904]; School of Ph.D. Studies, Semmelweis University, Hungary	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); School of Ph.D. Studies, Semmelweis University, Hungary	This study has been supported in part by the OTKA 100904 grant. The balance of support came from: School of Ph.D. Studies, Semmelweis University, Hungary. The authors would not have had been able to conduct any of these experiments without the gifted materials as follows: JML, RJ transferred the immortalized human pancreatic stellate (RLT-PSC) cell line to the Semmelweis University under an MTA agreement. The T3M4 human pancreatic ductal adenocarcinoma cell line was a kind gift from the European Pancreas Center in Heidelberg. The reagents used in the mRNA expression array were kind gifts by GF, such as AMD3100 and the reagents that were used to assess CXCL12, IGFBP2, CXCR4, CXCR7 at protein and mRNA levels. The funders at OTKA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Assar O, 2014, RADIOTHER ONCOL, V111, P243, DOI 10.1016/j.radonc.2014.03.014; American Cancer Society, 2013, CANC FACTS FIG 2013; Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 2008, LANGENBECK ARCH SURG, V393, P891, DOI 10.1007/s00423-008-0279-5; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bachet JB, 2012, ANN ONCOL, V23, P2327, DOI 10.1093/annonc/mdr617; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Biankin AV, 2001, CANCER RES, V61, P8830; Carstensen B, 2014, DIABETOLOGIA, V57, pA245; Chen R, 2006, PROTEOMICS, V6, P3871, DOI 10.1002/pmic.200500702; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; Dovzhanskiy DI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-226; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Fujita H, 2010, PANCREAS; Gao ZJ, 2010, PANCREATOLOGY, V10, P186, DOI 10.1159/000236012; Garcia-Moruja C, 2005, J MOL BIOL, V348, P43, DOI 10.1016/j.jmb.2005.02.016; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; Hamada S, 2012, BIOCHEM BIOPH RES CO, V421, P349, DOI 10.1016/j.bbrc.2012.04.014; Haugwitz U, 2002, NUCLEIC ACIDS RES, V30, P1967, DOI 10.1093/nar/30.9.1967; Heinrich EL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-68; Hong OK, 2007, J CELL BIOCHEM, V101, P665, DOI 10.1002/jcb.21222; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jesnowski R, 2005, LAB INVEST, V85, P1276, DOI 10.1038/labinvest.3700329; Jiang NY, 2008, CANCER EPIDEM BIOMAR, V17, P1648, DOI 10.1158/1055-9965.EPI-07-2791; Klein AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072311; Ko SH, 2006, J CELL BIOCHEM, V98, P343, DOI 10.1002/jcb.20797; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Liao WC, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7371; Lohr JM, 2009, J PANCREAS, V10, P472; Lohr M, 2001, CANCER RES, V61, P550; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Megyesi J, 2014, AM J PHYSL RENAL PHY; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Nomiyama Y, 2007, PANCREAS, V34, P364, DOI 10.1097/MPA.0b013e31802f0531; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Shi C, 2009, ARCH PATHOL LAB MED, V133, P365, DOI 10.1043/1543-2165-133.3.365; Shibuya K, 2015, ONCOTARGET, V6, P651, DOI 10.18632/oncotarget.2892; Shmelkov E, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-15; Srichai MB, 2010, CELL-EXTRACELLULAR MATRIX INTERACTIONS IN CANCER, P19, DOI 10.1007/978-1-4419-0814-8_2; Sun K, 2006, ACTA PHARMACOL SIN, V27, P715, DOI 10.1111/j.1745-7254.2006.00299.x; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Xu ZG, 2003, KIDNEY INT, V63, P958, DOI 10.1046/j.1523-1755.2003.00836.x; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Zhou LL, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/834528	51	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128059	10.1371/journal.pone.0128059	http://dx.doi.org/10.1371/journal.pone.0128059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010611	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900189
J	Sheehan, KCF; Lazear, HM; Diamond, MS; Schreiber, RD				Sheehan, Kathleen C. F.; Lazear, Helen M.; Diamond, Michael S.; Schreiber, Robert D.			Selective Blockade of Interferon-alpha and -beta Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection	PLOS ONE			English	Article							IFN-GAMMA RECEPTOR; I INTERFERON; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; T-CELLS; ANTIVIRAL RESPONSE; DIRECT STIMULATION; POSITIVE FEEDBACK; VIRAL-INFECTION; B-CELLS	Although type I interferons (IFNs) were first described almost 60 years ago, the ability to monitor and modulate the functional activities of the individual IFN subtypes that comprise this family has been hindered by a lack of reagents. The major type I IFNs, IFN-beta and the multiple subtypes of IFN-alpha, are expressed widely and induce their effects on cells by interacting with a shared heterodimeric receptor (IFNAR). In the mouse, the physiologic actions of IFN-alpha and IFN-beta have been defined using polyclonal anti-type I IFN sera, by targeting IFNAR using monoclonal antibodies or knockout mice, or using Ifnb(-/-) mice. However, the corresponding analysis of IFN-alpha has been difficult because of its polygenic nature. Herein, we describe two monoclonal antibodies (mAbs) that differentially neutralize murine IFN-beta or multiple subtypes of murine IFN-alpha. Using these mAbs, we distinguish specific contributions of IFN-beta versus IFN-alpha in restricting viral pathogenesis and identify IFN-alpha as the key mediator of the antiviral response in mice infected with West Nile virus. This study thus suggests the utility of these new reagents in dissecting the antiviral and immunomodulatory roles of IFN-beta versus IFN-alpha in murine models of infection, immunity, and autoimmunity.	[Sheehan, Kathleen C. F.; Diamond, Michael S.; Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Lazear, Helen M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Sheehan, Kathleen C. F.; Diamond, Michael S.; Schreiber, Robert D.] Washington Univ, Sch Med, Ctr Human Immunol, St Louis, MO USA; [Sheehan, Kathleen C. F.; Diamond, Michael S.; Schreiber, Robert D.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	Schreiber@immunology.wustl.edu	Schreiber, Robert/Q-7550-2019; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Lazear, Helen/0000-0002-8649-4579; Schreiber, Robert/0000-0003-1590-2341	 [U54 AI057160];  [R01 CA043059];  [U19 AI083019];  [U19 AI106772];  [R01 AI104972]; NATIONAL CANCER INSTITUTE [R01CA043059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106772, U19AI083019, U54AI057160, R01AI104972] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U54 AI057160 (RDS) http://www.niaid.nih.gov/labsandresources/resources/rce/Pages/default.aspx, R01 CA043059 (RDS) http://www.cancer.gov, U19 AI083019 (MSD) http://www.niaid.nih.gov, U19 AI106772 (MSD) http://www.niaid.nih.gov and the R01 AI104972 (MSD) http://www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Axtell RC, 2013, CLIN REV ALLERG IMMU, V44, P114, DOI 10.1007/s12016-011-8296-5; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; BELARDELLI F, 1987, J GEN VIROL, V68, P2203, DOI 10.1099/0022-1317-68-8-2203; Biggioggero M, 2010, AUTOIMMUNITY, V43, P248, DOI 10.3109/08916930903510971; Boasso A, 2011, BLOOD, V118, P5152, DOI 10.1182/blood-2011-03-344218; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Buontempo PJ, 2006, J INTERF CYTOK RES, V26, P40, DOI 10.1089/jir.2006.26.40; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Carrero JA, 2013, INT IMMUNOL, V25, P663, DOI 10.1093/intimm/dxt050; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Daffis S, 2011, J VIROL, V85, P5664, DOI 10.1128/JVI.00232-11; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Donlin LT, 2014, J IMMUNOL, V193, P2373, DOI 10.4049/jimmunol.1400486; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Ebel GD, 2001, EMERG INFECT DIS, V7, P650; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; GRESSER I, 1976, J EXP MED, V144, P1316, DOI 10.1084/jem.144.5.1316; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Hertzog PJ, 2013, CYTOKINE GROWTH F R, V24, P217, DOI 10.1016/j.cytogfr.2013.04.002; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Isaacs J D, 1990, Semin Immunol, V2, P449; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Khabar KSA, 2007, BIOCHIMIE, V89, P761, DOI 10.1016/j.biochi.2007.02.008; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lewerenz M, 1998, J MOL BIOL, V282, P585, DOI 10.1006/jmbi.1998.2026; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; MUELLER C, 1994, ACTA ASTRONAUT, V33, P9, DOI 10.1016/0094-5765(94)90102-3; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NAGANO Y, 1958, CR SOC BIOL, V152, P1627; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Oritani K, 2000, NAT MED, V6, P659, DOI 10.1038/76233; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Rizza P, 2010, AUTOIMMUNITY, V43, P204, DOI 10.3109/08916930903510880; Runkel L, 1998, J BIOL CHEM, V273, P8003, DOI 10.1074/jbc.273.14.8003; SalazarMather TP, 1996, J IMMUNOL, V157, P3054; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; SCHREIBER RD, 1984, CONTEMP TOP IMMUNOBI, V13, P171; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; SHEEHAN KCF, 1988, J IMMUNOL, V140, P4231; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TANIGUCHI T, 1980, NATURE, V285, P547, DOI 10.1038/285547a0; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; TRINCHIERI G, 1977, NATURE, V270, P611, DOI 10.1038/270611a0; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; ZWARTHOFF EC, 1985, NUCLEIC ACIDS RES, V13, P791, DOI 10.1093/nar/13.3.791	86	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128636	10.1371/journal.pone.0128636	http://dx.doi.org/10.1371/journal.pone.0128636			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010249	Green Published, gold, Green Submitted			2022-12-27	WOS:000355183900245
J	Wachowicz, B; Beldzik, E; Domagalik, A; Fafrowicz, M; Gawlowska, M; Janik, J; Lewandowska, K; Oginska, H; Marek, T				Wachowicz, Barbara; Beldzik, Ewa; Domagalik, Aleksandra; Fafrowicz, Magdalena; Gawlowska, Magda; Janik, Justyna; Lewandowska, Koryna; Oginska, Halszka; Marek, Tadeusz			Different Types of Errors in Saccadic Task Are Sensitive to Either Time of Day or Chronic Sleep Restriction	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; ATTENTION SYSTEM; HUMAN BRAIN; DEPRIVATION; INHIBITION; COMPONENTS; VIGILANCE; COGNITION; NETWORKS; MODEL	Circadian rhythms and restricted sleep length affect cognitive functions and, consequently, the performance of day to day activities. To date, no more than a few studies have explored the consequences of these factors on oculomotor behaviour. We have implemented a spatial cuing paradigm in an eye tracking experiment conducted four times of the day after one week of rested wakefulness and after one week of chronic partial sleep restriction. Our aim was to verify whether these conditions affect the number of a variety of saccadic task errors. Interestingly, we found that failures in response selection, i.e. premature responses and direction errors, were prone to time of day variations, whereas failures in response execution, i.e. omissions and commissions, were considerably affected by sleep deprivation. The former can be linked to the cue facilitation mechanism, while the latter to wake state instability and the diminished ability of top-down inhibition. Together, these results may be interpreted in terms of distinctive sensitivity of orienting and alerting systems to fatigue. Saccadic eye movements proved to be a novel and effective measure with which to study the susceptibility of attentional systems to time factors, thus, this approach is recommended for future research.	[Wachowicz, Barbara; Beldzik, Ewa; Domagalik, Aleksandra; Fafrowicz, Magdalena; Lewandowska, Koryna; Oginska, Halszka; Marek, Tadeusz] Jagiellonian Univ, Inst Appl Psychol, Dept Cognit Neurosci & Neuroergon, Krakow, Poland; [Wachowicz, Barbara; Beldzik, Ewa; Domagalik, Aleksandra; Fafrowicz, Magdalena; Gawlowska, Magda; Janik, Justyna; Marek, Tadeusz] Jagiellonian Univ, Malopolska Ctr Biotechnol, Dept Neurobiol, Krakow, Poland; [Lewandowska, Koryna] Jagiellonian Univ, Inst Culture, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University	Domagalik, A (corresponding author), Jagiellonian Univ, Inst Appl Psychol, Dept Cognit Neurosci & Neuroergon, Krakow, Poland.	aleksandra.domagalik@uj.edu.pl	Beldzik, Ewa/V-5522-2019; Domagalik, Aleksandra/E-7980-2013	Beldzik, Ewa/0000-0002-5511-4131; Domagalik, Aleksandra/0000-0003-3183-6719; Sikora-Wachowicz, Barbara/0000-0002-7398-9767; Gawlowska, Magda/0000-0003-2079-9211; Lewandowska, Koryna/0000-0003-4826-6361	Polish National Science Centre [2011/01/B/HS6/00446]	Polish National Science Centre	This research was supported by the Polish National Science Centre (http://www.ncn.gov.pl/). Grant number: 2011/01/B/HS6/00446.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Bukhtiyarov I. V., 2013, Human Physiology, V39, P741, DOI 10.1134/S0362119713070062; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fafrowicz M, 2006, ERGONOMIA INT J ERGO, V29, P13; FISCHER B, 1995, BIOL CYBERN, V72, P185, DOI 10.1007/BF00201483; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Marek T, 2010, CHRONOBIOL INT, V27, P945, DOI 10.3109/07420528.2010.489400; Martella D, 2014, EXP PSYCHOL, V61, P99, DOI 10.1027/1618-3169/a000229; Monk T, 2005, CLIN SPORTS MED, DOI [10.1016/J.CSN.2004.12.002, DOI 10.1016/J.CSN.2004.12.002]; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nieuwenhuis S, 2013, J EXP PSYCHOL HUMAN, V39, P1797, DOI 10.1037/a0033980; Oginska H, 2014, J SLEEP RES, V23, P339, DOI 10.1111/jsr.12115; Oginska H, 2011, PERS INDIV DIFFER, V50, P1039, DOI 10.1016/j.paid.2011.01.020; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Postma A, 2000, COGNITION, V77, P97, DOI 10.1016/S0010-0277(00)00090-1; Roca J, 2012, ACTA PSYCHOL, V140, P164, DOI 10.1016/j.actpsy.2012.03.007; Sagaspe P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039410; Schmidt C, 2007, COGN NEUROPSYCHOL, V24, P755, DOI 10.1080/02643290701754158; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Valdez P, 2005, BIOL RHYTHM RES, V36, P57, DOI 10.1080/09291010400028633; Valdez P, 2010, CHRONOBIOL INT, V27, P393, DOI 10.3109/07420521003765861; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117	35	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126502	10.1371/journal.pone.0126502	http://dx.doi.org/10.1371/journal.pone.0126502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010673	Green Submitted, gold, Green Published			2022-12-27	WOS:000355183900030
